PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, SY; Yu, JS; Jones, JW; Pierzchalski, K; Kane, MA; Trainor, PA; Xavier-Neto, J; Moise, AR				Wang, Suya; Yu, Jianshi; Jones, Jace W.; Pierzchalski, Keely; Kane, Maureen A.; Trainor, Paul A.; Xavier-Neto, Jose; Moise, Alexander R.			Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells	FASEB JOURNAL			English	Article						cardiac development; RhoA; cytoskeletal remodeling; retinoic acid; vitamin A	ZEBRAFISH HEART REGENERATION; SMOOTH-MUSCLE DIFFERENTIATION; RHO-KINASE-ACTIVITY; IN-VITRO; MESENCHYMAL TRANSITION; CARDIAC DEVELOPMENT; MOUSE DEVELOPMENT; AVIAN HEART; RNA-SEQ; EXPRESSION	All-trans-retinoic acid (RA), a vitamin A metabolite, is an important signaling molecule required for the proper development of the heart. The epicardium is the main source of RA in the embryonic heart, yet the cardiogenic functions of epicardial-produced RA are not fully understood. Here, we investigated the roles of RA signaling in the embryonic epicardium using in vivo and in vitro models of excess or deficiency of RA. Our results suggested that RA signaling facilitates the cytoskeletal rearrangement required for the epicardial-to-mesenchymal transition of epicardial cells. In vivo treatment with an inhibitor of RA synthesis delayed the migration of epicardial-derived precursor cells (EPDCs) into the myocardium; the opposite was seen in the case of dehydrogenase/reductase superfamily (DHRS)3-deficient embryos, a mouse model of RA excess. Analysis of the behavior of epicardial cells exposed to RA receptor agonists or inhibitors of RA synthesis in vitro revealed that appropriate levels of RA are important in orchestrating the platelet-derived growth factor-induced loss of epithelial character, cytoskeletal remodeling, and migration, necessary for the infiltration of the myocardium by EPDCs. To understand the molecular mechanisms by which RA regulates epicardial cytoskeletal rearrangement, we used a whole transcriptome profiling approach, which in combination with pull-down and inhibition assays, demonstrated that the Ras homolog gene family, member A (RhoA) pathway is required for the morphologic changes induced by RA in epicardial cells. Collectively, these data demonstrate that RA regulates the cytoskeletal rearrangement of epicardial cells via a signaling cascade that involves the RhoA pathway.Wang, S., Yu, J., Jones, J. W., Pierzchalski, K., Kane, M. A., Trainor, P. A., Xavier-Neto, J., Moise, A. R. Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells.	[Wang, Suya; Moise, Alexander R.] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Yu, Jianshi; Jones, Jace W.; Pierzchalski, Keely; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Xavier-Neto, Jose] Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Sao Paulo, Brazil; [Moise, Alexander R.] Laurentian Univ, Northern Ontario Sch Med, Dept Chem & Biochem, Sudbury, ON, Canada	University of Kansas; University System of Maryland; University of Maryland Baltimore; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Laurentian University; Northern Ontario School of Medicine	Moise, AR (corresponding author), Northern Ontario Sch Med, Med Sci Div, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada.	amoise@nosm.ca	AR, Moise/P-2474-2019; Moise, Alexander R/C-9498-2009; Wang, Suya/AAW-5584-2020	AR, Moise/0000-0003-2307-6035; Moise, Alexander R/0000-0003-2307-6035; Jones, Jace/0000-0003-0460-0380; Trainor, Paul/0000-0003-2774-3624	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [R01HD077260]; Fulbright U.S. Scholar Award - Bureau of Educational and Cultural Affairs (U.S. Department of State); Commission for Educational Exchange between the United States of America and Brazil; Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES); University of Maryland School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; Northern Ontario School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD077260] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; Fulbright U.S. Scholar Award - Bureau of Educational and Cultural Affairs (U.S. Department of State); Commission for Educational Exchange between the United States of America and Brazil; Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Maryland School of Pharmacy Mass Spectrometry Center; Northern Ontario School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Henry Sucov (University of Southern California-Los Angeles, Los Angeles, CA, USA) for his kind gift of the MEC1 cell line and for helpful advice. The authors thank the University of Kansas Microscopy and Analytical Imaging Laboratory for help in image analysis and the James Martin Laboratory (Baylor College of Medicine, Houston, TX, USA) for helpful advice. The authors thank Nancy Muma (University of Kansas) for the kind gift of the antibody against RhoA. This work was supported, in part, by U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01HD077260 (to A.R.M., M.A.K., and P.A.T.), and by a Fulbright U.S. Scholar Award (to A.R.M.), funded by the Bureau of Educational and Cultural Affairs (U.S. Department of State); the Commission for Educational Exchange between the United States of America and Brazil; and the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES). Additional support to M.A.K. was provided by the University of Maryland School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014), and by start-up funds to A.R.M. from the Northern Ontario School of Medicine. A.R.M. is a member of the Biomolecular Sciences Program (Laurentian University). The authors declare no conflicts of interest.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnold SLM, 2015, BIOCHEM PHARMACOL, V95, P177, DOI 10.1016/j.bcp.2015.03.001; Artamonov MV, 2015, J BIOL CHEM, V290, P10353, DOI 10.1074/jbc.M114.613190; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Azambuja AP, 2010, CIRC RES, V107, P204, DOI 10.1161/CIRCRESAHA.109.214650; Bax NAM, 2010, DEV DYNAM, V239, P2307, DOI 10.1002/dvdy.22363; BEARD RL, 1995, J MED CHEM, V38, P2820, DOI 10.1021/jm00015a004; Bilbija D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044740; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Braitsch CM, 2012, DEV BIOL, V368, P345, DOI 10.1016/j.ydbio.2012.06.002; Chen F, 2014, J CLIN INVEST, V124, P801, DOI 10.1172/JCI70291; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; COUCHMAN JR, 1979, J CELL SCI, V39, P149; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Dolle Pascal, 2009, Nucl Recept Signal, V7, pe006, DOI 10.1621/nrs.07006; Fang M, 2016, J MOL CELL CARDIOL, V91, P23, DOI 10.1016/j.yjmcc.2015.12.019; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Fischer AH, 2008, CSH PROTOC, P655; Garcia-Mariscal Alberto, 2018, Small GTPases, V9, P433, DOI 10.1080/21541248.2016.1248272; Hanato T, 2011, BIRTH DEFECTS RES B, V92, P10, DOI 10.1002/bdrb.20279; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Jones JW, 2015, ANAL CHEM, V87, P3222, DOI 10.1021/ac504597q; Kam RKT, 2013, J BIOL CHEM, V288, P31477, DOI 10.1074/jbc.M113.514984; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kennedy-Lydon T, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2147; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; KILBURN KH, 1982, TERATOLOGY, V26, P155, DOI 10.1002/tera.1420260207; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Lu J, 2001, DEV BIOL, V240, P404, DOI 10.1006/dbio.2001.0403; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marin-Juez R, 2016, P NATL ACAD SCI USA, V113, P11237, DOI 10.1073/pnas.1605431113; Matt N, 2005, DEV DYNAM, V233, P167, DOI 10.1002/dvdy.20313; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Metzler MA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120812; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nishijima S, 2000, TERATOLOGY, V62, P115, DOI 10.1002/1096-9926(200008)62:2<115::AID-TERA8>3.3.CO;2-R; OSTER G, 1974, AM J OBSTET GYNECOL, V119, P583, DOI 10.1016/0002-9378(74)90117-3; Paik J, 2014, J BIOL CHEM, V289, P15104, DOI 10.1074/jbc.M113.540211; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rudat C, 2013, CARDIOVASC RES, V100, P411, DOI 10.1093/cvr/cvt210; Ruiz-Villalba A, 2012, CURR OPIN PEDIATR, V24, P569, DOI 10.1097/MOP.0b013e328357a532; Shannon SR, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.264; Singh A, 2016, CELL REP, V15, P1384, DOI 10.1016/j.celrep.2016.04.027; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Stefanovic S, 2017, MECH DEVELOP, V143, P9, DOI 10.1016/j.mod.2016.12.002; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Volz KS, 2015, ELIFE, V4, DOI 10.7554/eLife.10036; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Xavier-Neto J, 2000, DEV BIOL, V219, P129, DOI 10.1006/dbio.1999.9588; Xavier-Neto J, 2015, BBA-GENE REGUL MECH, V1849, P94, DOI 10.1016/j.bbagrm.2014.08.003; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	71	21	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3765	3781		10.1096/fj.201701038R	http://dx.doi.org/10.1096/fj.201701038R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29447006	Green Published			2022-12-26	WOS:000435104500024
J	Xu, JM; Yi, J; Zhang, HJ; Feng, F; Gu, SL; Weng, LH; Zhang, J; Chen, YZ; An, N; Liu, Z; An, QX; Yin, W; Hu, XB				Xu, Jinmei; Yi, Jing; Zhang, Huijie; Feng, Fan; Gu, Shunli; Weng, Lihong; Zhang, Jing; Chen, Yaozhen; An, Ning; Liu, Zheng; An, Qunxing; Yin, Wen; Hu, Xingbin			Platelets directly regulate DNA damage and division of Staphylococcus aureus	FASEB JOURNAL			English	Article						immunity; infection; inflammation; DNA damage	GROWTH-FACTOR-BETA; HOST-DEFENSE; IN-VITRO; LIPOPOLYSACCHARIDE; THROMBOCYTOPENIA; ACTIVATION; SECRETION; PATHOGENS; RECEPTOR; BLOOD	Platelets (PLTs) are classically used in the clinical setting to maintain hemostasis. Recent evidence supports important roles for PLTs in host inflammatory and immune responses, and PLT-rich plasma has been demonstrated to inhibit the growth of bacteria in vitro and in vivo; however, few studies have examined whether PLTs can inhibit bacterial growth directly, and related mechanisms have not been elucidated further. Accordingly, in this study, we evaluated the effects of PLTs on bacterial growth. We washed and purified PLTs from peripheral blood, then confirmed that PLTs significantly inhibited the growth of Staphylococcus aureus when cocultured in vitro. Moreover, PLTs damaged DNA and blocked cell division in S. aureus. During coculture, PLT-derived TGF-1 was dramatically down-regulated compared with that in PLT culture alone, and the addition of TGF-1 to the coculture system promoted the inhibition of PLTs on S. aureus. Analysis of a murine S. aureus infection model demonstrated that the depletion of PLTs exacerbated the severity of infection, whereas the transfusion of PLTs alleviated this infection. Our observations demonstrate that PLTs could directly inhibit the growth of S. aureus by damaging DNA and blockage cell division, and that PLT-derived TGF-1 may play an important role in this machinery.Xu, J., Yi, J., Zhang, H., Feng, F., Gu, S., Weng, L., Zhang, J., Chen, Y., An, N., Liu, Z., An, Q., Yin, W., Hu, X. Platelets directly regulate DNA damage and division of Staphylococcus aureus.	[Xu, Jinmei; Yi, Jing; Zhang, Huijie; Gu, Shunli; Zhang, Jing; Chen, Yaozhen; An, Ning; An, Qunxing; Yin, Wen; Hu, Xingbin] Fourth Mil Med Univ, Xijing Hosp, Dept Transfus Med, Changle Rd, Xian 710032, Shaanxi, Peoples R China; [Feng, Fan] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Surg, Xian, Shaanxi, Peoples R China; [Zhang, Huijie] Chongqing Med Univ, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing, Peoples R China; [Weng, Lihong] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Beckman Res Inst, Duarte, CA USA; [Liu, Zheng] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	Air Force Military Medical University; Air Force Military Medical University; Chongqing Medical University; City of Hope; Beckman Research Institute of City of Hope; Columbia University	Yin, W; Hu, XB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Transfus Med, Changle Rd, Xian 710032, Shaanxi, Peoples R China.	yinwen@fmmu.edu.cn; hxbyqh@fmmu.edu.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022; Hu, XB/U-8501-2019	Hu, Xingbin/0000-0002-3952-3373	Natural Science Foundation of Shaanxi Province [2016JQ8033]; Xijing Hospital Foundation [XJZT15M12]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Xijing Hospital Foundation	This work was supported by the Natural Science Foundation of Shaanxi Province (2016JQ8033) and the Xijing Hospital Foundation (XJZT15M12). The authors declare no conflicts of interest.	Aktan I, 2013, VET IMMUNOL IMMUNOP, V152, P209, DOI 10.1016/j.vetimm.2012.12.007; Ali RA, 2017, J IMMUNOL, V198, P344, DOI 10.4049/jimmunol.1601178; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brecher ME, 2013, TRANSFUSION, V53, P221, DOI 10.1111/j.1537-2995.2012.03708.x; Chabert A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06024-2; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Czapiga M, 2005, EXP HEMATOL, V33, P73, DOI 10.1016/j.exphem.2004.09.010; Dai G., 1999, Tubercle and Lung Disease, V79, P207, DOI 10.1054/tuld.1998.0198; Despotovic D, 2017, FEBS J, V284, P2194, DOI 10.1111/febs.14113; Francois B, 1997, AM J MED, V103, P114, DOI 10.1016/S0002-9343(97)00136-8; Grundler K, 2014, CRIT CARE, V18, DOI 10.1186/cc13724; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Harvey AR, 2015, TRANSFUSION, V55, P709, DOI 10.1111/trf.12918; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Lin XR, 2015, CLIN EXP HYPERTENS, V37, P82, DOI 10.3109/10641963.2014.913600; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; MARCUS AJ, 1982, BIOCHEM BIOPH RES CO, V109, P130, DOI 10.1016/0006-291X(82)91575-3; Mariani E, 2014, CYTOTHERAPY, V16, P1294, DOI 10.1016/j.jcyt.2014.06.003; Marriott AS, 2015, DNA REPAIR, V33, P90, DOI 10.1016/j.dnarep.2015.06.008; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Patrignani P, 2006, BLOOD, V107, P3572, DOI 10.1182/blood-2005-12-4811; Puebla-Osorio N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.115; Schleicher RI, 2015, BLOOD, V126, P1483, DOI 10.1182/blood-2013-12-544445; SLOAND EM, 1992, EUR J HAEMATOL, V48, P168; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Tsegaye TS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-48; Unsal E, 2016, EUR J OBSTET GYN R B, V197, P125, DOI 10.1016/j.ejogrb.2015.12.016; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhang S, 2015, CIRCULATION, V131, P1160, DOI 10.1161/CIRCULATIONAHA.114.013743	40	3	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3707	3716		10.1096/fj.201701190R	http://dx.doi.org/10.1096/fj.201701190R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29430991				2022-12-26	WOS:000435104500019
J	Gao, HY; Azam, T; Randeniya, S; Couturier, J; Rouhier, N; Johnson, MK				Gao, Huanyao; Azam, Tamanna; Randeniya, Sajini; Couturier, Jeremy; Rouhier, Nicolas; Johnson, Michael K.			Function and maturation of the Fe-S center in dihydroxyacid dehydratase from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; MAGNETIC CIRCULAR-DICHROISM; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; AZOTOBACTER-VINELANDII; SCAFFOLD PROTEIN; ACID DEHYDRATASE; 2FE-2S FERREDOXIN; 4FE-4S CLUSTER; NITRIC-OXIDE	Dihydroxyacid dehydratase (DHAD) is the third enzyme required for branched-chain amino acid biosynthesis in bacteria, fungi, and plants. DHAD enzymes contain two distinct types of active-site Fe-S clusters. The best characterized examples are Escherichia coli DHAD, which contains an oxygen-labile [Fe4S4] cluster, and spinach DHAD, which contains an oxygen-resistant [Fe2S2] cluster. Although the Fe-S cluster is crucial for DHAD function, little is known about the cluster-coordination environment or the mechanism of catalysis and cluster biogenesis. Here, using the combination of UV-visible absorption and circular dichroism and resonance Raman and electron paramagnetic resonance, we spectroscopically characterized the Fe-S center in DHAD from Arabidopsis thaliana (At). Our results indicated that AtDHAD can accommodate [Fe2S2] and [Fe4S4] clusters. However, only the [Fe2S2] cluster-bound form is catalytically active. We found that the [Fe2S2] cluster is coordinated by at least one non-cysteinyl ligand, which can be replaced by the thiol group(s) of dithiothreitol. In vitro cluster transfer and reconstitution reactions revealed that [Fe2S2] cluster-containing NFU2 protein is likely the physiological cluster donor for in vivo maturation of AtDHAD. Insummary, AtDHAD binds either one[Fe4S4] or one [Fe2S2] cluster, with only the latter being catalytically competent and capable of substrate and product binding, and NFU2 appears to be the physiological [Fe2S2] cluster donor for DHAD maturation. This work represents the first in vitro characterization of recombinant AtDHAD, providing new insights into the properties, biogenesis, and catalytic role of the active-site Fe-S center in a plant DHAD.	[Gao, Huanyao; Azam, Tamanna; Randeniya, Sajini; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Gao, Huanyao; Azam, Tamanna; Randeniya, Sajini; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA; [Couturier, Jeremy; Rouhier, Nicolas] Univ Lorraine, INRA, Fac Sci & Technol, Interact Arbres Microorganismes UMR1136, F-54500 Vandoeuvre Les Nancy, France; [Gao, Huanyao] Mayo Clin, 200 1st St SW, Rochester, MN 55902 USA; [Randeniya, Sajini] Novavax Inc, 9920 Belward Campus Dr, Rockville, MD 20850 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; INRAE; Universite de Lorraine; Mayo Clinic	Johnson, MK (corresponding author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.	mkj@uga.edu	Couturier, Jérémy/AAF-6588-2020	Couturier, Jérémy/0000-0003-3127-2669; Rouhier, Nicolas/0000-0002-2036-7884	National Institutes of Health [R37GM62524]; French National Research Agency, "Investissements d'Avenir" Program [ANR-11-LABX-0002-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Research Agency, "Investissements d'Avenir" Program(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37GM62524 (to M.K.J.) and by a grant from the French National Research Agency as part of the "Investissements d'Avenir" Program (ANR-11-LABX-0002-01, Laboratory of Excellence (ARBRE)). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; ARFIN SM, 1969, J BIOL CHEM, V244, P2250; Balk J, 2014, ANNU REV PLANT BIOL, V65, P125, DOI 10.1146/annurev-arplant-050213-035759; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BERTRAND P, 1985, BIOCHIM BIOPHYS ACTA, V831, P261, DOI 10.1016/0167-4838(85)90044-5; BERTRAND P, 1979, BIOCHIM BIOPHYS ACTA, V579, P107, DOI 10.1016/0005-2795(79)90091-6; Binder Stefan, 2010, Arabidopsis Book, V8, pe0137, DOI 10.1199/tab.0137; Blank L, 2002, MICROBIOL-SGM, V148, P133, DOI 10.1099/00221287-148-1-133; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; CHENG H, 1994, BIOCHEMISTRY-US, V33, P3155, DOI 10.1021/bi00177a003; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702; Duan XW, 2009, BIOCHEM J, V417, P783, DOI 10.1042/BJ20081423; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FLINT DH, 1993, J BIOL CHEM, V268, P25547; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1993, J BIOL CHEM, V268, P14732; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FLINT DH, 1988, J BIOL CHEM, V263, P3558; Flint DH, 1996, J BIOL CHEM, V271, P16068; Flint DH, 1996, J BIOL CHEM, V271, P16053, DOI 10.1074/jbc.271.27.16053; FLINT DH, 1993, BIOORG CHEM, V21, P367, DOI 10.1006/bioo.1993.1031; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3871, DOI 10.1021/bi5014485; FU WG, 1992, J BIOL CHEM, V267, P15502; FUJINAGA J, 1993, BIOCHEM BIOPH RES CO, V194, P104, DOI 10.1006/bbrc.1993.1791; Gao HY, 2013, BIOCHEMISTRY-US, V52, P6633, DOI 10.1021/bi4007622; HAN S, 1989, J AM CHEM SOC, V111, P3496, DOI 10.1021/ja00192a002; HAN S, 1989, J AM CHEM SOC, V111, P3505, DOI 10.1021/ja00192a003; HILL RK, 1973, J AM CHEM SOC, V95, P7857, DOI 10.1021/ja00804a048; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Jiang LX, 2016, J EXP BOT, V67, P379, DOI [10.1093/jxb/eru449, 10.1093/jxb/erv478]; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Kiritani K., 1970, METHOD ENZYMOL, V17, P755; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8056, DOI 10.1021/bi300664j; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; McCarthy EL, 2017, SCIENCE, V358, P373, DOI 10.1126/science.aan4574; MEYER J, 1994, BIOCHEMISTRY-US, V33, P13642, DOI 10.1021/bi00250a014; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Nath K, 2016, PLANT PHYSIOL, V172, P2459, DOI 10.1104/pp.16.01564; NIELSEN BE, 1969, ACTA CHEM SCAND, V23, P967, DOI 10.3891/acta.chem.scand.23-0967; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Orio M, 2008, INORG CHEM, V47, P5394, DOI 10.1021/ic701730h; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; PIRRUNG MC, 1991, J AM CHEM SOC, V113, P1020, DOI 10.1021/ja00003a042; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; RICHARDS AJM, 1990, SPECTROCHIM ACTA A, V46, P987, DOI 10.1016/0584-8539(90)80015-Q; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; Sellers VM, 1998, J BIOL CHEM, V273, P22311, DOI 10.1074/jbc.273.35.22311; Singh BK, 1999, BOOKS SOIL PLANT ENV, P227; SINGH BK, 1995, PLANT CELL, V7, P935; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Subramanian S, 2015, J AM CHEM SOC, V137, P4567, DOI 10.1021/jacs.5b01869; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Vranish JN, 2015, J AM CHEM SOC, V137, P390, DOI 10.1021/ja510998s; Wachnowsky C, 2016, J BIOL INORG CHEM, V21, P825, DOI 10.1007/s00775-016-1381-8; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	73	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4422	4433		10.1074/jbc.RA117.001592	http://dx.doi.org/10.1074/jbc.RA117.001592			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29425096	hybrid, Green Published			2022-12-26	WOS:000428204300014
J	Ballotta, D; Lui, F; Porro, CA; Nichelli, PF; Benuzzi, F				Ballotta, Daniela; Lui, Fausta; Porro, Carlo Adolfo; Nichelli, Paolo Frigio; Benuzzi, Francesca			Modulation of neural circuits underlying temporal production by facial expressions of pain	PLOS ONE			English	Article							TIME PERCEPTION; INTERNAL CLOCK; DURATION JUDGMENTS; EMOTION; EMPATHY; MECHANISMS; SYSTEMS; MEMORY; FMRI; EXPECTANCY	According to the Scalar Expectancy Theory, humans are equipped with a biological internal clock, possibly modulated by attention and arousal. Both emotions and pain are arousing and can absorb attentional resources, thus causing distortions of temporal perception. The aims of the present single-event fMRI study were to investigate: a) whether observation of facial expressions of pain interferes with time production; and b) the neural network subserving this kind of temporal distortions. Thirty healthy volunteers took part in the study. Subjects were asked to perform a temporal production task and a concurrent gender discrimination task, while viewing faces of unknown people with either pain-related or neutral expressions. Behavioural data showed temporal underestimation (i.e., longer produced intervals) during implicit pain expression processing; this was accompanied by increased activity of right middle temporal gyrus, a region known to be active during the perception of emotional and painful faces. Psycho-Physiological Interaction analyses showed that: 1) the activity of middle temporal gyrus was positively related to that of areas previously reported to play a role in timing: left primary motor cortex, middle cingulate cortex, supplementary motor area, right anterior insula, inferior frontal gyrus, bilateral cerebellum and basal ganglia; 2) the functional connectivity of supplementary motor area with several frontal regions, anterior cingulate cortex and right angular gyrus was correlated to the produced interval during painful expression processing. Our data support the hypothesis that observing emotional expressions distorts subjective time perception through the interaction of the neural network subserving processing of facial expressions with the brain network involved in timing. Within this frame, middle temporal gyrus appears to be the key region of the interplay between the two neural systems.	[Ballotta, Daniela; Lui, Fausta; Porro, Carlo Adolfo; Nichelli, Paolo Frigio; Benuzzi, Francesca] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Lui, Fausta; Porro, Carlo Adolfo; Nichelli, Paolo Frigio; Benuzzi, Francesca] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Ballotta, D (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	daniela.ballotta@unimore.it	Lui, Fausta/P-3816-2015; Nichelli, Paolo/F-7336-2015	Lui, Fausta/0000-0001-6577-059X; Nichelli, Paolo/0000-0001-9756-6796; Benuzzi, Francesca/0000-0002-3498-3303				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ALLAN LG, 1991, LEARN MOTIV, V22, P39, DOI 10.1016/0023-9690(91)90016-2; Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Benuzzi F, 2005, PERCEPT MOTOR SKILL, V101, P737; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Borgomaneri S, 2014, SOC COGN AFFECT NEUR, V9, P1451, DOI 10.1093/scan/nst139; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Budell L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107526; Budell L, 2010, NEUROIMAGE, V53, P355, DOI 10.1016/j.neuroimage.2010.05.037; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cheng R.-K., 2016, TIMING TIME PERCEPT, V4, P99, DOI [10.1163/22134468-00002064, DOI 10.1163/22134468-00002064]; Costa T, 2014, SOC COGN AFFECT NEUR, V9, P1690, DOI 10.1093/scan/nst164; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Davis M.H., 1980, JSAS CAT SEL DOC PSY, V10; Dirnberger G, 2012, NEUROIMAGE, V63, P591, DOI 10.1016/j.neuroimage.2012.06.041; Droit-Volet S, 2004, COGNITION EMOTION, V18, P849, DOI 10.1080/02699930341000194; Droit-Volet S., 2013, TIMING TIME PERCEPT, V1, P99, DOI DOI 10.1163/22134468-00002004; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2007, BEHAV PROCESS, V74, P244, DOI 10.1016/j.beproc.2006.09.012; Droit-Volet S, 2010, EMOTION, V10, P908, DOI 10.1037/a0020258; Droit-Volet S, 2009, PHILOS T R SOC B, V364, P1943, DOI 10.1098/rstb.2009.0013; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; ELBERT T, 1991, PSYCHOPHYSIOLOGY, V28, P648, DOI 10.1111/j.1469-8986.1991.tb01009.x; FALK JL, 1954, J EXP PSYCHOL, V47, P279, DOI 10.1037/h0061946; Favilla S, 2014, NEUROIMAGE, V90, P153, DOI 10.1016/j.neuroimage.2014.01.001; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gil S., 2011, ATTENTION REPRESENTA, P61; Gil S, 2007, EMOTION, V7, P219, DOI 10.1037/1528-3542.7.1.219; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; Gil S, 2011, ACTA PSYCHOL, V136, P354, DOI 10.1016/j.actpsy.2010.12.010; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Grommet EK, 2011, BEHAV PROCESS, V86, P88, DOI 10.1016/j.beproc.2010.10.003; HARE RD, 1963, J CLIN PSYCHOL, V19, P378, DOI 10.1002/1097-4679(196307)19:3<378::AID-JCLP2270190340>3.0.CO;2-F; Hellstrom C, 1997, Eur J Pain, V1, P133, DOI 10.1016/S1090-3801(97)90071-9; ISLER H, 1987, HEADACHE, V27, P261, DOI 10.1111/j.1526-4610.1987.hed2705261.x; Lake JI, 2013, NEUROPSYCHOLOGIA, V51, P284, DOI 10.1016/j.neuropsychologia.2012.09.014; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lui MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021829; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Nichelli P., 1996, TIME INTERNAL CLOCKS, P187; Noulhiane M, 2007, EMOTION, V7, P697, DOI 10.1037/1528-3542.7.4.697; Oaten MJ, 2015, PHYSIOL BEHAV, V138, P107, DOI 10.1016/j.physbeh.2014.10.023; Ogden RS, 2015, COGNITION EMOTION, V29, P910, DOI 10.1080/02699931.2014.954529; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Simon D, 2006, PAIN, V126, P309, DOI 10.1016/j.pain.2006.08.033; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sun YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep16988; Talairach J, 1988, CO PLANAR STEREOTAXI; Tipples J, 2015, BRAIN TOPOGR, V28, P104, DOI 10.1007/s10548-013-0350-6; Vicario CM, 2014, CEPHALALGIA, V34, P548, DOI 10.1177/0333102413517774; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wearden JH, 2006, Q J EXP PSYCHOL, V59, P1709, DOI 10.1080/17470210500314729; Wearden JH, 2010, Q J EXP PSYCHOL, V63, P531, DOI 10.1080/17470210903024768; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P289; Wearden JH, 2007, J EXP PSYCHOL HUMAN, V33, P716, DOI 10.1037/0096-1523.33.3.716; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Yamada Y, 2011, CONSCIOUS COGN, V20, P1835, DOI 10.1016/j.concog.2011.06.016; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319; Zakay D., 2005, PSYCHOL FR, V50, P65, DOI [10.1016/j.psfr.2004.10.004, DOI 10.1016/J.PSFR.2004.10.004]; Zhang JJ, 2012, HEADACHE, V52, P1483, DOI 10.1111/j.1526-4610.2012.02222.x	80	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193100	10.1371/journal.pone.0193100	http://dx.doi.org/10.1371/journal.pone.0193100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447256	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900111
J	Peng, R; Meng, XR; Zhao, GM; Li, YM; Zhu, JM				Peng, Rui; Meng, Xiangrui; Zhao, Guangming; Li, Yingming; Zhu, Jianming			Experimental research on the structural instability mechanism and the effect of multi-echelon support of deep roadways in a kilometre-deep well	PLOS ONE			English	Article								We study the structural instability mechanism and effect of a multi-echelon support in very-deep roadways. We conduct a scale model test for analysing the structural failure mechanism and the effect of multi-echelon support of roadways under high horizontal stress. Mechanical bearing structures are classified according to their secondary stress distribution and the strength degradation of the surrounding rock after roadway excavation. A new method is proposed by partitioning the mechanical bearing structure of the surrounding rock into weak, key and main coupling bearing stratums. In the surrounding rock, the main bearing stratum is the plastic reshaping and flowing area. The weak bearing stratum is the peeling layer or the caving part. And the key bearing stratum is the shearing and yielding area. The structural fracture mechanism of roadways is considered in analysing the bearing structure instability of the surrounding rock, and multi-echelon support that considers the structural characteristics of roadway bearings is proposed. Results of the experimental study indicate that horizontal pressure seriously influences the stability of the surrounding rock, as indicated by extension of the weak bearing area and the transfer of the main and key bearing zones. The falling roof, rib spalling, and floor heave indicate the decline of the bearing capacity of surrounding rock, thereby causing roadway structural instability. Multi-echelon support is proposed according to the mechanical bearing structure of the surrounding rock without support. The redesigned support can reduce the scope of the weak bearing area and limit the transfer of the main and key bearing areas. Consequently, kilometre-deep roadway disasters, such as wedge roof caving, floor heave, and rib spalling, can be avoided to a certain degree, and plastic flow in the surrounding rock is relieved. The adverse effect of horizontal stress on the vault, spandrel and arch foot decreases. The stability of the soft rock surrounding the roadways is maintained.	[Peng, Rui; Zhu, Jianming] North China Inst Sci & Technol, Sch Safety Engn, Beijing, Peoples R China; [Meng, Xiangrui; Zhao, Guangming; Li, Yingming] Anhui Univ Sci & Technol, Dept Energy & Secur, Huainan, Anhui, Peoples R China	North China Institute Science & Technology; Anhui University of Science & Technology	Meng, XR (corresponding author), Anhui Univ Sci & Technol, Dept Energy & Secur, Huainan, Anhui, Peoples R China.	1013236800@qq.com			Central University of China [3142017087]; Science and Technology Research and Development Project of Langfang in China [2017013151]; National Natural Science Foundation of China [51774012, 51674008, 51474006, 51574006]	Central University of China; Science and Technology Research and Development Project of Langfang in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the Basic Research and Research Business Expense Subsidy Project of The Central University of China (3142017087) to RP. This research is also supported by Science and Technology Research and Development Project of Langfang in China (2017013151) to RP. This research has been financed by the National Natural Science Foundation of China (Nos. 51774012 to XM, 51674008 to QZ, 51474006 to XM, 51574006 to YL).	Cai MF, 2013, ROCK MECH ENG, P283; [陈建功 Chen Jiangong], 2011, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V33, P1964; Chen L., 2016, SPRINGERPLUS, V5, P1; Cheng YM, 2012, J MECH, V28, P163, DOI 10.1017/jmech.2012.17; Dong FT, 1994, J CHINA COAL SOC, V19, P31; Fahimifar A, 2014, STRUCT INFRASTRUCT E, V10, P1432, DOI 10.1080/15732479.2013.824489; FANG Zu-lie, 1999, CURRENT SITUATION PR, P48; [高明仕 GAO Mingshi], 2011, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V40, P333; Gdoutos EE, 1990, FRACTURE MECH CRITER, P76; Huang YD, 2005, COAL SCI TECHNOL, V33, P31; Kang H., 2014, INT J COAL SCI TECHN, V1, P261, DOI 10.1007/s40789-014-0043-0; Kang HP, 1996, ROCK SOIL MECH, V17, P84; Kang HP, 1997, MECH ENG, V19, P34; [李树清 LI Shuqing], 2006, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V28, P377; [孟波 Meng Bo], 2014, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V43, P1003; Meng QB, 2016, INT J MIN SCI TECHNO, V26, P209, DOI 10.1016/j.ijmst.2015.12.006; RICE Jr, 1968, INT J FRACT MECH, V4, P41; [杨本生 Yang Bensheng], 2014, [煤炭学报, Journal of China Coal Society], V39, P1504; Yu MH, 2017, ROCK STRENGTH THEORY, P203; [余伟健 Yu Weijian], 2014, [煤炭学报, Journal of China Coal Society], V39, P614; [余伟健 Yu Weijian], 2010, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V29, P2134; Zareifard MR, 2015, INT J GEOMECH, V15, DOI 10.1061/(ASCE)GM.1943-5622.0000400	22	13	13	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192470	10.1371/journal.pone.0192470	http://dx.doi.org/10.1371/journal.pone.0192470			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447180	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900035
J	Camacho-Cervantes, M; Ojanguren, AF; Dominguez-Dominguez, O; Magurran, AE				Camacho-Cervantes, Morelia; Ojanguren, Alfredo F.; Dominguez-Dominguez, Omar; Magurran, Anne E.			Sociability between invasive guppies and native topminnows	PLOS ONE			English	Article							HETEROSPECIFIC ATTRACTION; 3-SPINED STICKLEBACKS; BEHAVIOR; FISH; INFORMATION; EVOLUTION; ECOLOGY; CHOICE	The role of interspecific social interactions during species invasions may be more decisive than previously thought. Research has revealed that invasive fish improve their foraging success by shoaling with native Mexican species, and potentially increase the chances of invasion success. However, do native individuals tend to associate with invaders as well? We tested the hypothesis that the twoline skiffia (Neotoca bilineata) and the Lerma live-bearer (Poeciliopsis infans), both native endemic Mexican topminnows, will associate with guppies, a notorious invasive species present in Mexico. Our investigation shows that guppies, twoline skiffias and Lerma livebearers have a mutual tendency to associate with each other. Although there is a marked tendency to shoal with heterospecifics in this system, shoaling partners do not necessarily benefit equally from the association. Further research on invasive-native social interactions is needed to promote our understanding of potential facilitation by natives.	[Camacho-Cervantes, Morelia; Ojanguren, Alfredo F.; Magurran, Anne E.] Univ St Andrews, Ctr Biol Div, St Andrews, Fife, Scotland; [Dominguez-Dominguez, Omar] Univ Michoacana, Fac Biol, Morelia, Michoacan, Mexico; [Camacho-Cervantes, Morelia] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City, DF, Mexico; [Ojanguren, Alfredo F.] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Spain	University of St Andrews; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Nacional Autonoma de Mexico; University of Oviedo	Camacho-Cervantes, M (corresponding author), Univ St Andrews, Ctr Biol Div, St Andrews, Fife, Scotland.; Camacho-Cervantes, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City, DF, Mexico.	mcc@cmarl.unam.mx	Camacho-Cervantes, Morelia/HGE-1088-2022	Camacho-Cervantes, Morelia/0000-0002-7123-7924; Magurran, Anne/0000-0002-0036-2795; Ojanguren, Alfredo/0000-0001-6273-1122	European Research Council [BioTIME 250189]; Concejo Estatal de Ciencia y Tecnologia del Estado de Michoacan; CECTI Michoacan	European Research Council(European Research Council (ERC)European Commission); Concejo Estatal de Ciencia y Tecnologia del Estado de Michoacan; CECTI Michoacan	This investigation was funded by the European Research Council though a grant (project BioTIME 250189) awarded to AEM and the Concejo Estatal de Ciencia y Tecnologia del Estado de Michoacan through a grant awarded to MCC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Adrian Ortega-Iturriaga, Diego Chechenquillo, Hugo Camacho, Christian Cortes, Maria Zirion, Hernando Rodriguez-Correa, Pits Ceba, Orca Mer and Francisco Mora Ardila. This investigation was funded by the European Research Council (project BioTIME 250189) and CECTI Michoacan.	Altieri AH, 2010, ECOLOGY, V91, P1269, DOI 10.1890/09-1301.1; [Anonymous], 2007, CE014 U NAC AUT MEX; Barber I, 1995, BEHAVIOUR, V132, P1223, DOI 10.1163/156853995X00540; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Camacho-Cervantes M, 2014, BEHAVIOUR, V151, P769, DOI 10.1163/1568539X-00003169; Camacho-Cervantes M, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140101; Camacho-Cervantes M, 2015, ANIM BEHAV, V106, P115, DOI 10.1016/j.anbehav.2015.05.012; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Deacon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024416; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Goodale E, 2010, TRENDS ECOL EVOL, V25, P354, DOI 10.1016/j.tree.2010.01.002; GOULD SJ, 1991, J SOC ISSUES, V47, P43, DOI 10.1111/j.1540-4560.1991.tb01822.x; Griffiths SW, 1997, ANIM BEHAV, V53, P945, DOI 10.1006/anbe.1996.0315; Hernandez-Brito D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100593; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Kimbro DL, 2013, ECOL LETT, V16, P821, DOI 10.1111/ele.12106; KRAKAUER DC, 1995, BEHAV ECOL SOCIOBIOL, V36, P421, DOI 10.1007/s002650050165; Krause J, 2000, P ROY SOC B-BIOL SCI, V267, P2011, DOI 10.1098/rspb.2000.1243; KRAUSE J, 1993, J FISH BIOL, V43, P775; Krause J, 2002, LIVING GROUPS; Leimar O, 2010, ROYAL SOC PHILOS T B, V365; MAGURRAN AE, 1995, ADV STUD BEHAV, V24, P155, DOI 10.1016/S0065-3454(08)60394-0; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Magurran AE, 2009, SCIENCE, V325, P1215, DOI 10.1126/science.1177215; Mathis A, 2003, BEHAV ECOL, V14, P334, DOI 10.1093/beheco/14.3.334; MCFARLAND WN, 1982, BEHAV ECOL SOCIOBIOL, V11, P71, DOI 10.1007/BF00300094; Metlen KL, 2015, BIOL INVASIONS, V17, P1227, DOI 10.1007/s10530-014-0790-2; Mirande L, 2015, J PEST SCI, V88, P155, DOI 10.1007/s10340-014-0597-z; Monkkonen M, 1999, EVOL ECOL, V13, P91; MONKKONEN M, 1990, OECOLOGIA, V85, P218, DOI 10.1007/BF00319404; MORSE DH, 1977, BIOSCIENCE, V27, P332, DOI 10.2307/1297632; Pinheiro J., NLME LINEAR NONLINEA; Pupin F, 2007, ANIM BEHAV, V74, P1683, DOI 10.1016/j.anbehav.2007.03.020; R Core Team, 2021, R LANGUAGE ENV STAT; Rasband WS, 2015, IMAGEJ U S; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Simberloff D, 1999, BIOL INVASIONS, V1; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Thompson KA, 2012, BIOL INVASIONS, V14, P1515, DOI 10.1007/s10530-012-0176-2; Valero A, 2008, BIOL LETTERS, V4, P149, DOI 10.1098/rsbl.2007.0604; Venables WN., 2002, MODERN APPL STAT S 4; Webb JK, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1014; WOLF NG, 1985, BEHAV ECOL SOCIOBIOL, V17, P47, DOI 10.1007/BF00299428	46	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192539	10.1371/journal.pone.0192539	http://dx.doi.org/10.1371/journal.pone.0192539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444149	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500070
J	Liang, DY; Huang, W; Chang, Q; Hou, YQ				Liang, Dong-Yu; Huang, Wei; Chang, Qing; Hou, Yan-Qiang			ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-kappa B dependent cFLIP(L) expression	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; DOWN-REGULATION; DECOY RECEPTOR; C-FLIP; CANCER; INHIBITION; MODULATION; MONOCYTES; LIGAND; DEATH	Evidence has shown that most hepatocellular carcinoma (HCC) cells are resistant to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. However, the molecular mechanisms underlying TRAIL-mediated apoptosis resistance are not well understood. In this study, we reported that downregulation of Decoy receptor 3 (DcR3) expression by lentiviral vectors carrying shRNA against DcR3 (LV-ShDcR3, shDcR3) in Huh7 both greatly enhanced TRAIL-mediated apoptosis and reduced cell proliferation capability. In addition, silencing DcR3 resulted in upregulation of the cell apoptotic regulators including Bid, caspase-3, and caspase-8. Caspase inhibitors inhibited shDcR3-mediated cell death, which indicated that downregulation of DcR3 expression in Huh7 cells increased TRAIL-induced caspase-dependent apoptotic cell death. Furthermore, although the knockdown of DcR3 altered the expression of some Bcl-2- and IAP-family proteins, this change was inhibited by pretreatment with a pancaspase inhibitor, which indicated the cytotoxic effect of shDcR3 was not due to the expression of these proteins. In contrast, shDcR3 significantly inhibited TRAIL-induced transcription factor nuclear kappa B (NF-kappa B) activation through the I kappa B kinase (IKK) pathway, as well as inhibited TRAIL-induced increases in FLICE-inhibitory protein long form (cFLIP(L)) expression at the transcriptional level. Silencing cFLIP(L) expression mimicked the cytotoxic effect of shDcR3 on TRAIL-mediated cell apoptosis. Moreover, overexpression of cFLIP(L) effectively prevented the increase in cell apoptosis in Huh7 cells co-treated with TRAIL and shDcR3. Taken together, our findings indicated that silencing DcR3 sensitizes TRAIL-mediated apoptosis in HCC cells by inhibiting NF-kappa B.	[Liang, Dong-Yu; Hou, Yan-Qiang] Shanghai Jiao Tong Univ, Songjiang Hosp, Affiliated Peoples Hosp 1, Dept Cent Lab, Shanghai, Peoples R China; [Liang, Dong-Yu; Chang, Qing] Affiliated Shanghai Univ Med & Hlth Sci, Jiading Dist Cent Hosp, Dept Cent Lab, Shanghai, Peoples R China; [Huang, Wei] Affiliated Shanghai Univ Med & Hlth Sci, Jiading Dist Cent Hosp, Dept Blood Bank, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Medicine & Health Sciences; Shanghai University of Medicine & Health Sciences	Hou, YQ (corresponding author), Shanghai Jiao Tong Univ, Songjiang Hosp, Affiliated Peoples Hosp 1, Dept Cent Lab, Shanghai, Peoples R China.; Chang, Q (corresponding author), Affiliated Shanghai Univ Med & Hlth Sci, Jiading Dist Cent Hosp, Dept Cent Lab, Shanghai, Peoples R China.	robie0510@hotmail.com; zxsys2017@163.com	liang, dy/GZA-4770-2022		National Nature Science Foundation of China [81401937]; Natural Science Foundation of Shanghai, China [16ZR1430200]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai)	This study was supported by the National Nature Science Foundation of China (No. 81401937) and partially supported by the Natural Science Foundation of Shanghai, China (No. 16ZR1430200).	Aiba Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/258164; Chen CF, 2013, ACCIDENT ANAL PREV, V53, P105, DOI 10.1016/j.aap.2013.01.004; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Connell LC, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0415-3; Deng Q, 2014, GENE THER, V21, P317, DOI 10.1038/gt.2013.88; EI-Emshaty Hoda M, 2014, Hepatogastroenterology, V61, P1393; Eissner G, 2000, J IMMUNOL, V164, P6193, DOI 10.4049/jimmunol.164.12.6193; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Garimella SV, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3645; Gupta SC, 2011, J BIOL CHEM, V286, P1134, DOI 10.1074/jbc.M110.191379; Hafeez S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145780; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hsu MJ, 2004, EXP CELL RES, V292, P241, DOI 10.1016/j.yexcr.2003.09.019; Jiao P, 2013, MOL CELL BIOCHEM, V382, P217, DOI 10.1007/s11010-013-1737-0; Kang YJ, 2011, EXP MOL MED, V43, P24, DOI 10.3858/emm.2011.43.1.003; Lee SJ, 2012, INT J ONCOL, V41, P1425, DOI 10.3892/ijo.2012.1575; Li L, 2016, ONCOL REP, V35, P3009, DOI 10.3892/or.2016.4666; Liang CJ, 2017, ONCOTARGETS THER, V10, P417, DOI 10.2147/OTT.S127202; Lin WW, 2011, BIOCHEM PHARMACOL, V81, P838, DOI 10.1016/j.bcp.2011.01.011; Marquardt JU, 2014, CANCER CELL, V25, P550, DOI 10.1016/j.ccr.2014.04.002; Momeny M, 2010, MED ONCOL, V27, P833, DOI 10.1007/s12032-009-9294-9; Nazim UM, 2017, ONCOTARGET, V8, P18095, DOI 10.18632/oncotarget.14994; Omar HA, 2014, BASIC CLIN PHARMACOL, V114, P464, DOI 10.1111/bcpt.12190; Opferman JT, 2016, FEBS J, V283, P2661, DOI 10.1111/febs.13472; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Park SS, 2017, INT J BIOCHEM CELL B, V83, P47, DOI 10.1016/j.biocel.2016.12.001; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Plenchette S, 2015, REDOX BIOL, V6, P507, DOI 10.1016/j.redox.2015.08.019; Refaat A, 2014, ONCOL LETT, V7, P1327, DOI 10.3892/ol.2014.1922; Seo OW, 2012, EXP MOL MED, V44, P653, DOI 10.3858/emm.2012.44.11.074; Shin EC, 2002, EXP MOL MED, V34, P114, DOI 10.1038/emm.2002.17; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vanden Berghe Wim, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P247; Walczak H, 2000, CANCER RES, V60, P3051; Wan YC, 2014, CURR MED CHEM, V21, P3877, DOI 10.2174/0929867321666140826115258; Wan ZJ, 2015, ONCOL REP, V33, P1560, DOI 10.3892/or.2015.3743; Wei W, 2013, PLOS ONE, V8; Xu LP, 2011, MOL CANCER THER, V10, P550, DOI 10.1158/1535-7163.MCT-10-0571; Yang CR, 2005, J IMMUNOL, V174, P1647, DOI 10.4049/jimmunol.174.3.1647; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang TX, 2015, CELL BIOCHEM BIOPHYS, V71, P291, DOI 10.1007/s12013-014-0197-9; Zhang LQ, 2015, CELL SIGNAL, V27, P306, DOI 10.1016/j.cellsig.2014.11.014	45	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191545	10.1371/journal.pone.0191545	http://dx.doi.org/10.1371/journal.pone.0191545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444104	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500022
J	Liang, ZB; Liu, FX; Gao, JL				Liang, Zhibing; Liu, Fuxian; Gao, Jiale			Improved GGIW-PHD filter for maneuvering non-ellipsoidal extended targets or group targets tracking based on sub-random matrices	PLOS ONE			English	Article							PROBABILITY HYPOTHESIS DENSITY; MULTI-BERNOULLI FILTER; OBJECT	For non-ellipsoidal extended targets and group targets tracking (NETT and NGTT), using an ellipsoid to approximate the target extension may not be accurate enough because of the lack of shape and orientation information. In consideration of this, we model a non-ellipsoidal extended target or target group as a combination of multiple ellipsoidal sub-objects, each represented by a random matrix. Based on these models, an improved gamma Gaussian inverse Wishart probability hypothesis density (GGIW-PHD) filter is proposed to estimate the measurement rates, kinematic states, and extension states of the sub-objects for each extended target or target group. For maneuvering NETT and NGTT, a multi-model (MM) approach based GGIW-PHD (MM-GGIW-PHD) filter is proposed. The common and the individual dynamics of the sub-objects belonging to the same extended target or target group are described by means of the combination between the overall maneuver model and the sub-object models. For the merging of updating components, an improved merging criterion and a new merging method are derived. A specific implementation of prediction partition with pseudo-likelihood method is presented. Two scenarios for non-maneuvering and maneuvering NETT and NGTT are simulated. The results demonstrate the effectiveness of the proposed algorithms.	[Liang, Zhibing; Liu, Fuxian; Gao, Jiale] Air Force Engn Univ, Air & Missile Def Coll, Xian, Shaanxi, Peoples R China	Air Force Engineering University	Liang, ZB (corresponding author), Air Force Engn Univ, Air & Missile Def Coll, Xian, Shaanxi, Peoples R China.	lzb_liangzhibing@163.com			National Natural Science Foundation of China [71701209, 71771216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China [grant numbers: 71701209, 71771216]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vo BT, 2013, IEEE T SIGNAL PROCES, V61, P3460, DOI 10.1109/TSP.2013.2259822; Bar-Shalom Y., 2004, ESTIMATION APPL TRAC; Baum M, 2014, IEEE T AERO ELEC SYS, V50, P149, DOI 10.1109/TAES.2013.120107; Baumgartl Martin, 2011, 2011 Conference on Lasers & Electro-Optics Europe & 12th European Quantum Electronics Conference (CLEO EUROPE/EQEC), DOI 10.1109/CLEOE.2011.5942896; Beard M, 2016, IEEE T SIGNAL PROCES, V64, P1638, DOI 10.1109/TSP.2015.2505683; Feldmann M, 2011, IEEE T SIGNAL PROCES, V59, P1409, DOI 10.1109/TSP.2010.2101064; Gilholm K, 2005, IEE P-RADAR SON NAV, V152, P364, DOI 10.1049/ip-rsn:20045114; Gilholm K, 2005, PROC SPIE, V5913, DOI 10.1117/12.618730; Granstrom K, 2015, IEEE T GEOSCI REMOTE, V53, P6617, DOI 10.1109/TGRS.2015.2444794; Granstrom K., 2012, 2012 15th International Conference on Information Fusion (FUSION 2012), P2170; Granstrom K., 2012, 2012 15th International Conference on Information Fusion (FUSION 2012), P2162; Granstrom K, 2014, IEEE T AERO ELEC SYS, V50, P1; Granstrom K., 2010, 2010 13 INT C INFORM, P1, DOI DOI 10.1109/ICIF.2010.5711885; Granstrom K, 2012, IEEE T SIGNAL PROCES, V60, P5657, DOI 10.1109/TSP.2012.2212888; Granstrom K, 2012, IEEE T AERO ELEC SYS, V48, P3268, DOI 10.1109/TAES.2012.6324703; He Y., 2013, RADAR DATA PROCESSIN, V3; Koch JW, 2008, IEEE T AERO ELEC SYS, V44, P1042, DOI 10.1109/TAES.2008.4655362; Lan J, 2016, IEEE T AERO ELEC SYS, V52, P2973, DOI 10.1109/TAES.2016.130346; Lan J, 2014, IEEE T SIGNAL PROCES, V62, P2450, DOI 10.1109/TSP.2014.2309561; Lian F, 2010, IET RADAR SONAR NAV, V4, P685, DOI 10.1049/iet-rsn.2009.0109; Lundquist C, 2013, IEEE J-STSP, V7, P472, DOI 10.1109/JSTSP.2013.2245632; Mahler R, 2007, IEEE T AERO ELEC SYS, V43, P1523, DOI 10.1109/TAES.2007.4441756; Mahler R, 2009, FUSION: 2009 12TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION, VOLS 1-4, P915; Mahler RPS, 2003, IEEE T AERO ELEC SYS, V39, P1152, DOI 10.1109/TAES.2003.1261119; Orguner U., 2011, 14 INT C INFORM FUSI, P65; Pasha SA, 2009, IEEE T AERO ELEC SYS, V45, P919, DOI 10.1109/TAES.2009.5259174; Salmond DJ, 2003, IEE P-RADAR SON NAV, V150, P389, DOI 10.1049/ip-rsn:20030933; Vo BT, 2009, IEEE T SIGNAL PROCES, V57, P409, DOI 10.1109/TSP.2008.2007924; Zhang GH, 2014, 2014 17TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION); Zong P, 2016, IEEE SENS J, V16, P1428, DOI 10.1109/JSEN.2015.2499268	30	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192473	10.1371/journal.pone.0192473	http://dx.doi.org/10.1371/journal.pone.0192473			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444144	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500068
J	Lim, WH; Choi, SH; Yoo, RE; Kang, KM; Yun, TJ; Kim, JH; Sohn, CH				Lim, Woo Hyeon; Choi, Seung Hong; Yoo, Roh-Eul; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho			Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients	PLOS ONE			English	Article							T1-WEIGHTED MR-IMAGES; HIGH SIGNAL INTENSITY; HYPERINTENSE DENTATE NUCLEUS; MULTIPLE-SCLEROSIS; GLOBUS-PALLIDUS; ADJUVANT TEMOZOLOMIDE; INVIVO DETERMINATION; IONIZING-RADIATION; CONTRAST AGENT; BARRIER	Objective This study evaluated the possibility of accelerated gadolinium accumulation in irradiated brain parenchyma where the blood-brain barrier was weakened. Methods From January 2010 to June 2015, 44 patients with supratentorial glioblastoma were retrospectively identified who underwent pre- and post-radiation brain MR imaging, including R1 mapping. The mean dose of administered gadobutrol (Gadovist, Bayer, Germany) was 5.1 vials. Regions of interest (ROIs) were drawn around tumors that were located within 50-100% iso-dose lines of maximum radiation dose. ROIs were also drawn at globus pallidus, thalamus, and cerebral white matter. Averages of R1 values (unit: s(-1)) before and after radiation and those of R1 ratio (post-radiation R1/pre-radiation R1) were compared by t-test or rank sum test as appropriate. Multiple linear regression analysis was performed to evaluate independent association factors for R1 value increase at irradiated parenchyma. Results The mean R1 values in peri-tumoral areas were significantly increased after radiotherapy (0.7901 +/- 0.0977 [mean +/- SD] vs. 0.8146 +/- 0.1064; P<.01). The mean R1 ratio of high radiation dose areas was significantly higher than that of low dose areas (1.0055 +/- 0.0654 vs. 0.9882 +/- 0.0642; P<.01). The mean R1 ratio was lower in those who underwent hypofractionated radiotherapy (mean dose, 45.0 Gy) than those who underwent routine radiotherapy (mean dose, 61.1 Gy) (0.9913 +/- 0.0740 vs. 1.0463 +/- 0.0633; P = .08). Multiple linear regression analysis revealed that only radiotherapy type was significantly associated with increased R1 (P = .02) around tumors. Conclusions Radiotherapy can induce R1 value increase in the brain parenchyma, which might suggest accelerated gadolinium accumulation due to damage to the blood-brain barrier.	[Lim, Woo Hyeon; Choi, Seung Hong; Yoo, Roh-Eul; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Inst Basic Sci, Ctr Nanoparticle Res, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Inst Basic Sci, Ctr Nanoparticle Res, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea.	verocay@snuh.org	Sohn, ChulHo/AAV-4565-2021		Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare Family Affairs [HI16C1111]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016M3C7A1914002]; Creative-Pioneering Researchers Program through Seoul National University (SNU);  [IBS-R006-D1]	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare Family Affairs; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Creative-Pioneering Researchers Program through Seoul National University (SNU); 	This study was supported by a grant from the Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare & Family Affairs (HI16C1111 to SC), by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), by the Creative-Pioneering Researchers Program through Seoul National University (SNU), and by Project Code (IBS-R006-D1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JC, 1999, J NEURO-ONCOL, V44, P283, DOI 10.1023/A:1006337912345; BLUML S, 1993, MAGN RESON MED, V30, P289, DOI 10.1002/mrm.1910300304; d'Avella D, 1998, ACT NEUR S, V71, P282; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Errante Y, 2014, INVEST RADIOL, V49, P685, DOI 10.1097/RLI.0000000000000072; Fauquette W, 2012, BRAIN RES, V1433, P114, DOI 10.1016/j.brainres.2011.11.022; Fujioka M, 2003, ANN NEUROL, V54, P732, DOI 10.1002/ana.10751; Fujioka M, 1999, STROKE, V30, P1038, DOI 10.1161/01.STR.30.5.1038; Ginat DT, 2012, RADIOGRAPHICS, V32, P499, DOI 10.1148/rg.322105761; HENKELMAN RM, 1991, RADIOLOGY, V179, P199, DOI 10.1148/radiology.179.1.1848714; Hui F K, 2009, AJNR Am J Neuroradiol, V30, pE1, DOI 10.3174/ajnr.A1205; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kanda T, 2015, RADIOLOGY, V276, P228, DOI 10.1148/radiol.2015142690; Kanda T, 2015, RADIOLOGY, V275, P803, DOI 10.1148/radiol.14140364; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kasahara S, 2011, RADIOLOGY, V258, P222, DOI 10.1148/radiol.10100508; Lai PH, 1999, AM J ROENTGENOL, V172, P1109, DOI 10.2214/ajr.172.4.10587157; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; LARSSON HBW, 1988, MAGN RESON MED, V7, P43, DOI 10.1002/mrm.1910070106; Li ZM, 2016, J MAGN RESON IMAGING, V43, P698, DOI 10.1002/jmri.25030; LOEVNER LA, 1995, AM J NEURORADIOL, V16, P1473; Malayeri AA, 2016, J AM COLL RADIOL, V13, P237, DOI 10.1016/j.jacr.2015.11.009; Maramattom BV, 2005, NEUROLOGY, V64, P1276, DOI 10.1212/01.WNL.0000156805.45547.6E; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Nordal RA, 2005, INT J RADIAT ONCOL, V62, P279, DOI 10.1016/j.ijrobp.2005.01.039; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Roccatagliata L, 2009, RADIOLOGY, V251, P503, DOI 10.1148/radiol.2511081269; RUBIN P, 1994, RADIOTHER ONCOL, V31, P51, DOI 10.1016/0167-8140(94)90413-8; Steen RG, 2001, INT J RADIAT ONCOL, V49, P79, DOI 10.1016/S0360-3016(00)01351-1; Steen RG, 2001, ANN NEUROL, V50, P787, DOI 10.1002/ana.10029; Stikov N, 2015, MAGN RESON MED, V73, P514, DOI 10.1002/mrm.25135; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Swaminathan S, 2016, MAGN RESON IMAGING, V34, P1373, DOI 10.1016/j.mri.2016.08.016; VALK PE, 1991, AM J NEURORADIOL, V12, P45; Weberling LD, 2015, INVEST RADIOL, V50, P743, DOI 10.1097/RLI.0000000000000206; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192838	10.1371/journal.pone.0192838	http://dx.doi.org/10.1371/journal.pone.0192838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444157	Green Published, gold			2022-12-26	WOS:000425183500094
J	Ohata, Y; Tsuchiya, M; Hirai, H; Yamaguchi, S; Akashi, T; Sakamoto, K; Yamaguchi, A; Ikeda, T; Kayamori, K				Ohata, Yae; Tsuchiya, Maiko; Hirai, Hideaki; Yamaguchi, Satoshi; Akashi, Takumi; Sakamoto, Kei; Yamaguchi, Akira; Ikeda, Tohru; Kayamori, Kou			Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; LIF; ANGIOGENESIS; EXPRESSION; LYMPHANGIOGENESIS; MYOFIBROBLASTS; TUMORIGENESIS; INTERLEUKIN-6; STATISTICS; INDUCTION	The interaction between cancer cells and the cancer stroma plays a crucial role in tumor progression and metastasis in diverse malignancies, including oral cancer. However, the mechanism underlying this interaction remains incompletely elucidated. Here, to investigate the interaction between oral cancer cells and fibroblasts, which are major cellular components of the tumor stroma, we conducted an in vitro study by using human oral squamous cell carcinoma (OSCC) cell lines and normal human dermal fibroblasts (NHDFs). The results of transwell assays revealed that the migration and invasion of 2 OSCC cell lines, HO1-N-1 and HSC3, were markedly stimulated upon coculturing with NHDFs. To investigate the factors that promote tumor invasion, we isolated NHDFs from cocultures prepared with HO1-N-1 cells and performed microarray analysis. Among the various genes that were upregulated, we identified the gene encoding leukemia inhibitory factor (LIF), and we focused on LIF in further analyses. We confirmed that all OSCC-derived conditioned media potently upregulated LIF expression in NHDFs, and the results of our transwell analysis demonstrated that NHDF-induced OSCC migration and invasion were inhibited by LIF-neutralizing antibodies. Furthermore, immunohistochemical analysis of patient samples revealed that in 44 out of 112 OSCC cases, LIF was expressed in the tumor stroma, particularly in cancer-associated fibroblasts (CAFs), and, notably, clinicopathological analyses confirmed that LIF expression in CAFs was significantly correlated with increased depth of tumor invasion. Collectively, our results suggest that OSCC stimulates fibroblasts to produce LIF, which, in turn, participates in cancer-cell invasion. Our finding offers a potential therapeutic strategy targeting the cancer stroma for the treatment of OSCC patients.	[Ohata, Yae; Tsuchiya, Maiko; Sakamoto, Kei; Ikeda, Tohru; Kayamori, Kou] Tokyo Med & Dent Univ, Dept Oral Pathol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Hirai, Hideaki] Tokyo Med & Dent Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med & Dent Sci, Tokyo, Japan; [Yamaguchi, Satoshi] Tokyo Med & Dent Univ, Dept Maxillofacial Surg, Grad Sch Med & Dent Sci, Tokyo, Japan; [Akashi, Takumi] Tokyo Med & Dent Univ, Dept Surg Pathol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Yamaguchi, Akira] Tokyo Dent Coll, Dept Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Dental College	Kayamori, K (corresponding author), Tokyo Med & Dent Univ, Dept Oral Pathol, Grad Sch Med & Dent Sci, Tokyo, Japan.	kayamori.mpa@tmd.ac.jp	Yamaguchi, Akira/AAX-9286-2020		Ministry of Education, Culture, Sports, Science, and Technology of Japan [16K20410, 25253098]; Iwadare Scholarship Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Iwadare Scholarship Foundation	This work was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (https://www.jsps.go.jp/english/e-grants/), Grant-in-Aid for Young Scientists (B), 16K20410 to KK; Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (https://www.jsps.go.jp/english/e-grants/), Grant-in-Aid for Scientific Research (A), 25253098 to AY. The Iwadare Scholarship Foundation supported YO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Miwako Hamagaki for technical assistance. The author Yae Ohata was the recipient of The Iwadare Scholarship Foundation.	Albrengues J, 2014, CELL REP, V7, P1664, DOI 10.1016/j.celrep.2014.04.036; Bello IO, 2011, ORAL ONCOL, V47, P33, DOI 10.1016/j.oraloncology.2010.10.013; Bolt R, 2017, CARCINOGENESIS; Daly AJ, 2008, ORAL ONCOL, V44, P646, DOI 10.1016/j.oraloncology.2007.08.012; Dhanda J, 2014, BRIT J CANCER, V111, P2114, DOI 10.1038/bjc.2014.500; Fujii N, 2012, J ORAL PATHOL MED, V41, P444, DOI 10.1111/j.1600-0714.2012.01127.x; Fullar A, 2012, EXP CELL RES, V318, P1517, DOI 10.1016/j.yexcr.2012.03.023; Graf U, 2011, GENES-BASEL, V2, P280, DOI 10.3390/genes2010280; Ha SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099955; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jobe NP, 2016, HISTOCHEM CELL BIOL, V146, P205, DOI 10.1007/s00418-016-1433-8; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kamohara H, 2007, INT J ONCOL, V30, P977; Kayamori K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154112; Kayamori K, 2010, AM J PATHOL, V176, P968, DOI 10.2353/ajpath.2010.090299; Kellermann MG, 2007, HISTOPATHOLOGY, V51, P849, DOI 10.1111/j.1365-2559.2007.02873.x; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Lin NN, 2017, J ORAL PATHOL MED, V46, P21, DOI 10.1111/jop.12452; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; Liu SC, 2013, J CLIN INVEST, V123, P5269, DOI 10.1172/JCI63428; Lopez-Graniel CM, 2001, J EXP CLIN CANC RES, V20, P463; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Ohshio Y, 2015, CANCER SCI, V106, P134, DOI 10.1111/cas.12584; Qiao Y, 2017, ONCOGENE; Routray S, 2014, ORAL DIS, V20, P246, DOI 10.1111/odi.12107; Sobral LM, 2011, ORAL ONCOL, V47, P840, DOI 10.1016/j.oraloncology.2011.06.011; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yue Xuetian, 2015, Cancer Cell Microenviron, V2; Yue XT, 2016, ONCOTARGET, V7, P3777, DOI 10.18632/oncotarget.6756; Zhao D, 2008, J ORAL PATHOL MED, V37, P616, DOI 10.1111/j.1600-0714.2008.00707.x	34	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191865	10.1371/journal.pone.0191865	http://dx.doi.org/10.1371/journal.pone.0191865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444110	gold, Green Submitted, Green Published			2022-12-26	WOS:000425183500038
J	Thode, SK; Rojek, E; Kozlowski, M; Ahmad, R; Haugen, P				Thode, Sunniva Katharina; Rojek, Ewelina; Kozlowski, Mikolaj; Ahmad, Rafi; Haugen, Peik			Distribution of siderophore gene systems on a Vibrionaceae phylogeny: Database searches, phylogenetic analyses and evolutionary perspectives	PLOS ONE			English	Article							SP NOV.; DESFERRIOXAMINE-B; IRON UTILIZATION; PLASMID PJM1; BIOSYNTHESIS; IDENTIFICATION; PATHOGEN; ANGUILLARUM; TRANSPORT; ANGUIBACTIN	Siderophores are small molecules synthesized and secreted by bacteria and fungi to scavenge iron. Extracellular ferri-siderohores are recognized by cognate receptors on the cell surface for transport over membranes. Several siderophore systems from Vibrionaceae representatives are known and well understood, e.g., the molecular structure of the siderophore, the biosynthesis gene cluster and pathway, and the gene expression pattern. Less is known about how these systems are distributed among the similar to 140 Vibrionaceae species, and which evolutionary processes contributed to the present-day distribution. In this work, we compiled existing knowledge on siderophore biosynthesis systems and siderophore receptors from Vibrionaceae and used phylogenetic analyses to investigate their organization, distribution, origin and evolution. Through literature searches, we identified nine different siderophore biosynthesis systems and thirteen siderophore receptors in Vibrionaceae. Homologs were identified by BLAST searches, and the results were mapped onto a Vibrionaceae phylogeny. We identified 81 biosynthetic systems distributed in 45 Vibrionaceae species and 16 unclassified Vibrionaceae strains, and 409 receptors in 89 Vibrionaceae species and 49 unclassified Vibrionaceae strains. The majority of taxa are associated with at least one type of siderophore biosynthesis system, some (e.g., aerobactin and vibrioferrin) of which are widely distributed in the family, whereas others (i.e., bisucaberin and vibriobactin) are found in one lineage. Cognate receptors are found more widespread. Phylogenetic analysis of three siderophore systems (piscibactin, vibrioferrin and aerobactin) show that their present-day distribution can be explained by an old insertion into Vibrionaceae, followed mainly by stable vertical evolution and extensive loss, and some cases of horizontal gene transfers. The present work provides an up to date overview of the distribution of siderophore-based iron acquisition systems in Vibrionaceae, and presents phylogenetic analysis of these systems. Our results suggest that the present-day distribution is a result of several evolutionary processes, such as old and new gene acquisitions, gene loss, and both vertical and horizontal gene transfers.	[Thode, Sunniva Katharina; Haugen, Peik] UiT Arctic Univ Norway, Dept Chem, Fac Sci & Technol, Tromso, Norway; [Thode, Sunniva Katharina; Haugen, Peik] UiT Arctic Univ Norway, Ctr Bioinformat SfB, Fac Sci & Technol, Tromso, Norway; [Rojek, Ewelina; Kozlowski, Mikolaj; Ahmad, Rafi] Inland Norway Univ Appl Sci, Dept Nat Sci & Technol, Fac Educ & Nat Sci, Hamar, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Inland Norway University of Applied Sciences	Haugen, P (corresponding author), UiT Arctic Univ Norway, Dept Chem, Fac Sci & Technol, Tromso, Norway.; Haugen, P (corresponding author), UiT Arctic Univ Norway, Ctr Bioinformat SfB, Fac Sci & Technol, Tromso, Norway.; Ahmad, R (corresponding author), Inland Norway Univ Appl Sci, Dept Nat Sci & Technol, Fac Educ & Nat Sci, Hamar, Norway.	rafi.ahmad@inn.no; peik.haugen@uit.no	Ahmad, Rafi/AAW-5433-2020	Ahmad, Rafi/0000-0002-0383-7848; Haugen, Peik/0000-0002-4711-5513				ACTIS LA, 1986, J BACTERIOL, V167, P57, DOI 10.1128/jb.167.1.57-65.1986; Alice AF, 2005, J BACTERIOL, V187, P2209, DOI 10.1128/JB.187.6.2209-2214.2005; ANDRUS CR, 1983, CURR MICROBIOL, V9, P209, DOI 10.1007/BF01567583; Aoki T, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00404-17, 10.1128/genomea.00404-17]; Aso H, 2002, FEMS MICROBIOL LETT, V212, P65, DOI 10.1016/S0378-1097(02)00741-3; Balado M, 2006, MICROBIOL-SGM, V152, P3517, DOI 10.1099/mic.0.29298-0; Balado M, 2015, ACS CHEM BIOL, V10, P2850, DOI 10.1021/acschembio.5b00624; Balado M, 2009, APPL ENVIRON MICROB, V75, P2775, DOI 10.1128/AEM.02897-08; Bottcher T, 2014, ANGEW CHEM INT EDIT, V53, P3510, DOI 10.1002/anie.201310729; Butterton JR, 2000, J BACTERIOL, V182, P1731, DOI 10.1128/JB.182.6.1731-1738.2000; Cano-Gomez A, 2010, FEMS MICROBIOL LETT, V302, P175, DOI 10.1111/j.1574-6968.2009.01850.x; Chimetto LA, 2011, INT J SYST EVOL MICR, V61, P3009, DOI 10.1099/ijs.0.026997-0; Colquhoun DJ, 2001, MICROB PATHOGENESIS, V31, P213, DOI 10.1006/mpat.2001.0464; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Di Lorenzo M, 2003, J BACTERIOL, V185, P5822, DOI 10.1128/JB.185.19.5822-5830.2003; ENGER O, 1991, CAN J MICROBIOL, V37, P618, DOI 10.1139/m91-105; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Funahashi T, 2003, MICROBIOL-SGM, V149, P1217, DOI 10.1099/mic.0.26066-0; Funahashi T, 2002, J BACTERIOL, V184, P936, DOI 10.1128/jb.184.4.936-946.2002; Funahashi T, 2009, BIOL PHARM BULL, V32, P359, DOI 10.1248/bpb.32.359; Giubergia S, 2016, INT J SYST EVOL MICR, V66, P347, DOI 10.1099/ijsem.0.000723; Gomez-Gil B, 2003, INT J SYST EVOL MICR, V53, P1569, DOI 10.1099/ijs.0.02670-0; Gomez-Gil B, 2016, ANTON LEEUW INT J G, V109, P817, DOI 10.1007/s10482-016-0681-x; Goudenege D, 2014, APPL MICROBIOL BIOT, V98, P10165, DOI 10.1007/s00253-014-6086-8; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hjerde E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-616; Holmstrom K, 2003, J BACTERIOL, V185, P831, DOI 10.1128/JB.185.3.831-842.2003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kadi N, 2008, CHEM COMMUN, P5119, DOI 10.1039/b813029a; Kirchberger PC, 2014, INT J SYST EVOL MICR, V64, P3208, DOI 10.1099/ijs.0.060145-0; Kumar NR, 2007, INT J SYST EVOL MICR, V57, P2241, DOI 10.1099/ijs.0.65017-0; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasa A, 2013, SYST APPL MICROBIOL, V36, P96, DOI 10.1016/j.syapm.2012.11.005; Lemos ML, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P117; Li YJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00342; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; Balcazar JL, 2012, J ANTIBIOT, V65, P301, DOI 10.1038/ja.2012.22; Martin JD, 2006, J BIOL INORG CHEM, V11, P633, DOI 10.1007/s00775-006-0112-y; Martinez JS, 2001, LIMNOL OCEANOGR, V46, P420, DOI 10.4319/lo.2001.46.2.0420; Mey AR, 2002, INFECT IMMUN, V70, P3419, DOI 10.1128/IAI.70.7.3419-3426.2002; Miethke M, 2013, METALLOMICS, V5, P15, DOI 10.1039/c2mt20193c; Moon YH, 2004, MICROBIOL IMMUNOL, V48, P389, DOI 10.1111/j.1348-0421.2004.tb03528.x; Mustapha S, 2013, INDIAN J SCI TECHNOL, V2, P302; Naka H, 2008, ENVIRON MICROBIOL, V10, P265, DOI 10.1111/j.1462-2920.2007.01450.x; Naka H, 2013, MICROBIOLOGYOPEN, V2, P182, DOI 10.1002/mbo3.65; Naka H, 2012, BIOMETALS, V25, P125, DOI 10.1007/s10534-011-9488-4; Nam YD, 2007, INT J SYST EVOL MICR, V57, P562, DOI 10.1099/ijs.0.64653-0; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nielsen A, 2012, MAR DRUGS, V10, P2584, DOI 10.3390/md10112584; Osorio CR, 2006, MICROBIOL-SGM, V152, P3327, DOI 10.1099/mic.0.29190-0; Osorio CR, 2015, APPL ENVIRON MICROB, V81, P5867, DOI 10.1128/AEM.01580-15; Payne SM, 2016, MICROBIOL MOL BIOL R, V80, P69, DOI 10.1128/MMBR.00046-15; Reitz ZL, 2017, METALLOMICS, V9, P824, DOI 10.1039/c7mt00111h; Rivas R, 2006, INT J SYST EVOL MICR, V56, P1067, DOI 10.1099/ijs.0.64099-0; Rogers MB, 2000, J BACTERIOL, V182, P2350, DOI 10.1128/JB.182.8.2350-2353.2000; Sandy M, 2010, J NAT PROD, V73, P1038, DOI 10.1021/np900750g; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; SIMPSON LM, 1983, INFECT IMMUN, V41, P644, DOI 10.1128/IAI.41.2.644-649.1983; Souto A, 2012, EUR J ORG CHEM, V2012, P5693, DOI 10.1002/ejoc.201200818; STOEBNER JA, 1992, J BACTERIOL, V174, P3270, DOI 10.1128/jb.174.10.3270-3274.1992; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan W, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00001; Tanabe T, 2005, MICROBIOL IMMUNOL, V49, P823, DOI 10.1111/j.1348-0421.2005.tb03671.x; Tanabe T, 2005, FEMS MICROBIOL LETT, V249, P309, DOI 10.1016/j.femsle.2005.06.025; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; Tanabe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105749; Tanabe T, 2012, MICROBIOL-SGM, V158, P2039, DOI 10.1099/mic.0.059568-0; Tanabe T, 2011, BIOL PHARM BULL, V34, P570, DOI 10.1248/bpb.34.570; Thode SK, 2017, PEERJ, V5, DOI 10.7717/peerj.3461; Thode SK, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0342-7; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Urbanczyk Y, 2015, SYST APPL MICROBIOL, V38, P300, DOI 10.1016/j.syapm.2015.04.001; Wang QY, 2008, ARCH MICROBIOL, V190, P595, DOI 10.1007/s00203-008-0407-1; Wang QY, 2007, ARCH MICROBIOL, V188, P433, DOI 10.1007/s00203-007-0261-6; Webster ACD, 2000, INFECT IMMUN, V68, P526, DOI 10.1128/IAI.68.2.526-534.2000; Winkelmann G, 2002, BIOMETALS, V15, P153, DOI 10.1023/A:1015206419613; Wyckoff EE, 2001, J BACTERIOL, V183, P1830, DOI 10.1128/JB.183.5.1830-1834.2001; Wyckoff EE, 2015, J BACTERIOL, V197, P2840, DOI 10.1128/JB.00417-15; YAMAMOTO S, 1993, J BIOCHEM-TOKYO, V113, P538, DOI 10.1093/oxfordjournals.jbchem.a124079; Yoshizawa S, 2012, INT J SYST EVOL MICR, V62, P1864, DOI 10.1099/ijs.0.025916-0; Yoshizawa S, 2010, J GEN APPL MICROBIOL, V56, P499, DOI 10.2323/jgam.56.499; Zane HK, 2014, J AM CHEM SOC, V136, P5615, DOI 10.1021/ja5019942	88	32	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191860	10.1371/journal.pone.0191860	http://dx.doi.org/10.1371/journal.pone.0191860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444108	gold, Green Submitted, Green Published			2022-12-26	WOS:000425183500037
J	Netto, CD; Godoy-Santos, AL; Pontin, PA; Natalino, RJM; Pereira, CAM; Lima, FDD; da Fonseca, LF; Staggers, JR; Cavinatto, LM; Schon, LC; de Camargo, OP; Fernandes, TD				Netto, Cesar de Cesar; Godoy-Santos, Alexandre Leme; Pontin, Pedro Augusto; Mendonca Natalino, Renato Jose; Martins Pereira, Cesar Augusto; de Oliveira Lima, Francisco Diego; da Fonseca, Lucas Furtado; Staggers, Jackson Rucker; Cavinatto, Leonardo Muntada; Schon, Lew Charles; de Camargo, Olavo Pires; Fernandes, Tulio Diniz			Novel animal model for Achilles tendinopathy: Controlled experimental study of serial injections of collagenase in rabbits	PLOS ONE			English	Article							LEVEL LASER THERAPY; GROWTH FACTOR-BB; INDUCED TENDINITIS; TENDON INJURIES; CONTINUUM MODEL; RAT MODEL; EXPRESSION; TENDINOSIS; PAIN	Our goal was to develop a novel technique for inducing Achilles tendinopathy in animal models which more accurately represents the progressive histological and biomechanical characteristic of chronic Achilles tendinopathy in humans. In this animal research study, forty-five rabbits were randomly assigned to three groups and given bilateral Achilles injections. Low dose (LD group) (n = 18) underwent a novel technique with three low-dose (0.1mg) injections of collagenase that were separated by two weeks, the high dose group (HD) (n = 18) underwent traditional single high-dose (0.3mg) injections, and the third group were controls (n = 9). Six rabbits were sacrificed from each experimental group (LD and HD) at 10, 12 and 16 weeks. Control animals were sacrificed after 16 weeks. Histological and biomechanical properties were then compared in all three groups. At 10 weeks, Bonar score and tendon cross sectional area was highest in HD group, with impaired biomechanical properties compared to LD group. At 12 weeks, Bonar score was higher in LD group, with similar biomechanical findings when compared to HD group. After 16 weeks, Bonar score was significantly increased for both LD group (11,8 +/- 2,28) and HD group (5,6 +/- 2,51), when compared to controls (2 +/- 0,76). LD group showed more pronounced histological and biomechanical findings, including cross sectional area of the tendon, Young's modulus, yield stress and ultimate tensile strength. In conclusion, Achilles tendinopathy in animal models that were induced by serial injections of low-dose collagenase showed more pronounced histological and biomechanical findings after 16 weeks than traditional techniques, mimicking better the progressive and chronic characteristic of the tendinopathy in humans.	[Netto, Cesar de Cesar; Godoy-Santos, Alexandre Leme; Pontin, Pedro Augusto; Mendonca Natalino, Renato Jose; Martins Pereira, Cesar Augusto; de Oliveira Lima, Francisco Diego; Cavinatto, Leonardo Muntada; de Camargo, Olavo Pires; Fernandes, Tulio Diniz] Univ Sao Paulo, Dept Orthopaed & Traumatol, Sch Med, Sao Paulo, SP, Brazil; [Netto, Cesar de Cesar; da Fonseca, Lucas Furtado; Schon, Lew Charles] Medstar Union Mem Hosp, Dept Orthopaed Foot & Ankle Surg, Baltimore, MD USA; [Netto, Cesar de Cesar] Hosp Special Surg, Dept Orthopaed Foot & Ankle Surg, 535 E 70th St, New York, NY 10021 USA; [Staggers, Jackson Rucker] Univ Alabama Birmingham, Dept Orthopaed, Birmingham, AL USA	Universidade de Sao Paulo; Union Memorial Hospital; University of Alabama System; University of Alabama Birmingham	Netto, CD (corresponding author), Univ Sao Paulo, Dept Orthopaed & Traumatol, Sch Med, Sao Paulo, SP, Brazil.; Netto, CD (corresponding author), Medstar Union Mem Hosp, Dept Orthopaed Foot & Ankle Surg, Baltimore, MD USA.; Netto, CD (corresponding author), Hosp Special Surg, Dept Orthopaed Foot & Ankle Surg, 535 E 70th St, New York, NY 10021 USA.	cesardecesarnetto@gmail.com	de Cesar Netto, Cesar/D-3046-2018; Natalino, Renato/N-9392-2016; CAMARGO, OLAVO PIRES/P-8336-2015	de Cesar Netto, Cesar/0000-0001-6037-0685; Natalino, Renato/0000-0002-4708-792X; CAMARGO, OLAVO PIRES/0000-0002-1128-7292; Diniz Fernandes, Tulio/0000-0002-9687-7143; Godoy-Santos, Alexandre/0000-0002-6672-1869	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP), a Brazilian Government Research Support Agency	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP), a Brazilian Government Research Support Agency	This study was funded by the Brazilian Government Agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), URL: http://www.fapesp.br.; The authors have no financial disclosures or conflicts of interest to report. This study was financed by the "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP), a Brazilian Government Research Support Agency.	Alfredson H, 2000, SPORTS MED, V29, P135, DOI 10.2165/00007256-200029020-00005; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Carpenter JE, 2004, BIOMATERIALS, V25, P1715, DOI 10.1016/S0142-9612(03)00507-6; Casalechi HL, 2013, LASER MED SCI, V28, P989, DOI 10.1007/s10103-012-1189-x; Chen JM, 2011, TISSUE ENG PT A, V17, P2037, DOI [10.1089/ten.TEA.2010.0492, 10.1089/ten.tea.2010.0492]; Chen YJ, 2004, J ORTHOP RES, V22, P854, DOI 10.1016/j.orthres.2003.10.013; Cook JL, 2016, BRIT J SPORT MED, V50, P1187, DOI 10.1136/bjsports-2015-095422; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; Dahlgren LA, 2002, J ORTHOP RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8; Dahlgren LA, 2006, J ORTHOP RES, V24, P183, DOI 10.1002/jor.20000; Davidson CJ, 1997, MED SCI SPORT EXER, V29, P313, DOI 10.1097/00005768-199703000-00005; Dirks RC, 2011, J MUSCULOSKEL NEURON, V11, P141; Fearon A, 2014, J SCI MED SPORT, V17, P346, DOI 10.1016/j.jsams.2013.07.008; Fu SC, 2009, J NEUROSCI METH, V179, P309, DOI 10.1016/j.jneumeth.2009.02.011; Godbout C, 2006, J APPL PHYSIOL, V101, P1720, DOI 10.1152/japplphysiol.00301.2006; Hast MW, 2014, BONE JOINT RES, V3, P193, DOI 10.1302/2046-3758.36.2000281; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Khan KM, 1996, RADIOLOGY, V200, P821, DOI 10.1148/radiology.200.3.8756939; KVIST M, 1991, ANN CHIR GYNAECOL FE, V80, P188; KVIST M, 1994, SPORTS MED, V18, P173, DOI 10.2165/00007256-199418030-00004; Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Lui PPY, 2010, AM J SPORT MED, V38, P757, DOI 10.1177/0363546509355402; Lui PPY, 2010, RHEUMATOLOGY, V49, P231, DOI 10.1093/rheumatology/kep384; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; LYSHOLM J, 1987, AM J SPORT MED, V15, P168, DOI 10.1177/036354658701500213; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Marcos RL, 2012, J ORTHOP RES, V30, P1945, DOI 10.1002/jor.22156; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; McCreesh K, 2013, INT J EXP PATHOL, V94, P242, DOI 10.1111/iep.12029; NISBET NW, 1960, J BONE JOINT SURG BR, V42, P360, DOI 10.1302/0301-620X.42B2.360; Orfei CP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161590; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Rui YF, 2013, STEM CELLS DEV, V22, P1076, DOI 10.1089/scd.2012.0555; Shah V, 2013, J ORTHOP RES, V31, P413, DOI 10.1002/jor.22222; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Sobhani S, 2013, SCAND J MED SCI SPOR, V23, P669, DOI 10.1111/j.1600-0838.2012.01509.x; Solchaga LA, 2014, J ORTHOP RES, V32, P145, DOI 10.1002/jor.22483; Soslowsky L J, 1996, J Shoulder Elbow Surg, V5, P383; Stone D, 1999, J ORTHOP RES, V17, P168, DOI 10.1002/jor.1100170204; Tsai YP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/402692; Urdzikova LM, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-42; Waldecker Ute, 2012, Foot Ankle Surg, V18, P119, DOI 10.1016/j.fas.2011.04.007; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342	44	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192769	10.1371/journal.pone.0192769	http://dx.doi.org/10.1371/journal.pone.0192769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438431	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400054
J	Beniaminov, AD; Dezhenkova, LG; Mamaeva, OK; Shchyolkina, AK; Tevyashova, AN; Kaluzhny, DN; Shtil, AA				Beniaminov, Artemy D.; Dezhenkova, Lyubov G.; Mamaeva, Olga K.; Shchyolkina, Anna K.; Tevyashova, Anna N.; Kaluzhny, Dmitry N.; Shtil, Alexander A.			Divalent cations are dispensable for binding to DNA of a novel positively charged olivomycin A derivative	PLOS ONE			English	Article							SPECIFICITY; LIGANDS; COMPLEX	The current model of binding of the antitumor antibiotic olivomycin A (1) to GC-rich DNA regions presumes that coordination of the magnesium divalent cation with drug dimers is necessary for binding of 1 into the minor groove of the DNA duplex. Previously we have synthesized the derivatives of 1 termed 'short acid' (2) and its N,N-dimethylaminoethylamide (3). The latter compound demonstrated an improved tolerance in vivo compared to 1 and good therapeutic potency in animal models. We herein report that compound 3 is able to form stable complexes with DNA in the absence of Mg2+, in striking contrast to 1 whose binding to the DNA absolutely requires Mg2+. The mode of binding of 3 to DNA is similar in the presence or absence of Mg2+ as determined by circular dichroism. The affinity to DNA of 3 in Mg2+-free solution was similar to that of 1 or 3 in the presence of Mg2+ at low ionic strength. Non-electrostatic contributions to total free energy of binding of 1 and 3 to DNA were comparable for Mg2+-free complexes. Our data strongly suggest that electrostatic interaction of the positively charged 3 can compensate for the absence of divalent ions in complexes with DNA. This new property of the olivomycin A derivative expands the mechanistic knowledge of the modes of interaction with DNA of small molecular weight drug candidates.	[Beniaminov, Artemy D.; Mamaeva, Olga K.; Shchyolkina, Anna K.; Kaluzhny, Dmitry N.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Dezhenkova, Lyubov G.; Tevyashova, Anna N.] Gause Inst New Antibiot, Moscow, Russia; [Tevyashova, Anna N.] Mendeleev Univ Chem Technol, 9 Miusskaya Sq, Moscow, Russia; [Shtil, Alexander A.] NN Blokhin Natl Med Res Ctr Oncol, Moscow, Russia; [Shtil, Alexander A.] ITMO Univ, St Petersburg, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Gause Institute of New Antibiotics; Mendeleev University of Chemical Technology of Russia; ITMO University	Kaluzhny, DN (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	uzhny@mail.ru; shtilaa@yahoo.com	Kaluzhny, Dmitry N/G-7256-2014; Tevyashova, Anna/A-8293-2014; Shchyolkina, Anna/AAB-8268-2021; Beniaminov, Artemy D/G-7435-2014	Beniaminov, Artemy D/0000-0002-9076-5386; Kaluzhny, Dmitry/0000-0001-7090-3334	Pharma program [14.N08.12.0058]; Russian Science Foundation [16-14-10396]	Pharma program; Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by Pharma-2020 program (state contract 14.N08.12.0058 with the Ministry of Education and Science of the Russian Federation) to AT. Part of this work was funded by the Russian Science Foundation (project 16-14-10396) to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brikenshtein V Kh, 1984, Mol Biol (Mosk), V18, P1606; Chaires JB, 1996, BIOCHEMISTRY-US, V35, P2047, DOI 10.1021/bi952812r; CHEN KX, 1989, FEBS LETT, V245, P145, DOI 10.1016/0014-5793(89)80209-1; FOX KR, 1985, NUCLEIC ACIDS RES, V13, P8695, DOI 10.1093/nar/13.24.8695; GAO XL, 1992, J MOL BIOL, V223, P259, DOI 10.1016/0022-2836(92)90730-8; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043792; Kaluzhny DN, 2009, CHEMMEDCHEM, V4, P1641, DOI 10.1002/cmdc.200900227; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; PITINA L R, 1982, Pharmaceutical Chemistry Journal (English Translation of Khimiko-Farmatsevticheskii Zhurnal), V16, P327, DOI 10.1007/BF00762046; Tevyashova AN, 2011, BIOORGAN MED CHEM, V19, P7387, DOI 10.1016/j.bmc.2011.10.055; Tevyashova AN, 2009, BIOORGAN MED CHEM, V17, P4961, DOI 10.1016/j.bmc.2009.05.076; Yang TP, 2010, CHEM-BIOL INTERACT, V183, P181, DOI 10.1016/j.cbi.2009.09.018	13	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191923	10.1371/journal.pone.0191923	http://dx.doi.org/10.1371/journal.pone.0191923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420558	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900029
J	Dutton, CL; Subalusky, AL; Anisfeld, SC; Njoroge, L; Rosi, EJ; Post, DM				Dutton, Christopher L.; Subalusky, Amanda L.; Anisfeld, Shimon C.; Njoroge, Laban; Rosi, Emma J.; Post, David M.			The influence of a semi-arid sub-catchment on suspended sediments in the Mara River, Kenya	PLOS ONE			English	Article							LAND-USE; EAST-AFRICA; ECOSYSTEM ENGINEERS; CLIMATE-CHANGE; WATER-QUALITY; LAKE VICTORIA; RUNOFF; WILDLIFE; YIELD; POPULATION	The Mara River Basin in East Africa is a trans-boundary basin of international significance experiencing excessive levels of sediment loads. Sediment levels in this river are extremely high (turbidities as high as 6,000 NTU) and appear to be increasing over time. Large wildlife populations, unregulated livestock grazing, and agricultural land conversion are all potential factors increasing sediment loads in the semi-arid portion of the basin. The basin is well-known for its annual wildebeest (Connochaetes taurinus) migration of approximately 1.3 million individuals, but it also has a growing population of hippopotami (Hippopotamus amphibius), which reside within the river and may contribute to the flux of suspended sediments. We used in situ pressure transducers and turbidity sensors to quantify the sediment flux at two sites for the Mara River and investigate the origin of riverine suspended sediment. We found that the combined Middle Mara-Talek catchment, a relatively flat but semi-arid region with large populations of wildlife and domestic cattle, is responsible for 2/3 of the sediment flux. The sediment yield from the combined Middle Mara-Talek catchment is approximately the same as the headwaters, despite receiving less rainfall. There was high monthly variability in suspended sediment fluxes. Although hippopotamus pools are not a major source of suspended sediments under baseflow, they do contribute to short-term variability in suspended sediments. This research identified sources of suspended sediments in the Mara River and important regions of the catchment to target for conservation, and suggests hippopotami may influence riverine sediment dynamics.	[Dutton, Christopher L.; Post, David M.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Subalusky, Amanda L.; Rosi, Emma J.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Anisfeld, Shimon C.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Njoroge, Laban] Natl Museums Kenya, Invertebrate Zool Sect, Nairobi, Kenya	Yale University; Cary Institute of Ecosystem Studies; Yale University	Dutton, CL (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	christopher.dutton@yale.edu	Dutton, Christopher/H-9664-2019; Post, David M/A-6987-2009; Rosi, Emma/F-1777-2011	Dutton, Christopher/0000-0002-1091-7571; Post, David M/0000-0003-1434-7729; Rosi, Emma/0000-0002-3476-6368	US National Science Foundation [NSF DEB 1354053, 1354062]; National Geographic Society Committee for Research and Exploration; Yale Tropical Resources Institute; Lindsay Fellowship for Research in Africa; Robert and Patricia Switzer Foundation; WWF-UK; Direct For Biological Sciences [1354053] Funding Source: National Science Foundation; Division Of Environmental Biology [1354062] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee for Research and Exploration(National Geographic Society); Yale Tropical Resources Institute; Lindsay Fellowship for Research in Africa; Robert and Patricia Switzer Foundation; WWF-UK; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by US National Science Foundation (https://www.nsf.gov/) grants to DMP and EJRM (NSF DEB 1354053 and 1354062); a grant from the National Geographic Society Committee for Research and Exploration (http://www.nationalgeographic.com/explorers/grants-programs/cre/) to DMP; grants from the Yale Tropical Resources Institute (https://environment.yale.edu/tri/) and the Lindsay Fellowship for Research in Africa to CLD; and a fellowship from the Robert and Patricia Switzer Foundation (http://www.switzernetwork.org/) to ALS. CLD and ALS also received funding from WWF-UK (http://www.wwf.org.uk/) to assist with maintenance of one of the water quality sondes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud AA, 2002, RAPID SOCIOECONOMIC; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2014, PROPAGATE PROPAGATIO; Baker DB, 2004, J AM WATER RESOUR AS, V40, P503, DOI 10.1111/j.1752-1688.2004.tb01046.x; Baldyga TJ, 2008, AFR J ECOL, V46, P46, DOI 10.1111/j.1365-2028.2007.00806.x; Bilotta GS, 2008, WATER RES, V42, P2849, DOI 10.1016/j.watres.2008.03.018; Butt B, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-9; Butt B, 2012, POLIT GEOGR, V31, P104, DOI 10.1016/j.polgeo.2011.11.002; Castillo SM, 2009, ASSESSMENT POTENTIAL; Defersha MB, 2012, CATENA, V89, P54, DOI 10.1016/j.catena.2011.07.010; Droppo IG, 2001, HYDROL PROCESS, V15, P1551, DOI 10.1002/hyp.228; DUNNE T, 1979, J HYDROL, V42, P281, DOI 10.1016/0022-1694(79)90052-0; Dunne T, 2011, J ARID ENVIRON, V75, P58, DOI 10.1016/j.jaridenv.2010.09.001; Dutton C, 2013, J SOIL SEDIMENT, V13, P1708, DOI 10.1007/s11368-013-0725-z; Edwards TK, 1999, TECHNIQUES WATER RES, P97; ESRI, 2014, ARCGIS 10 2 2 DESKT; Foster SSD, 1984, P HAR S JUL 1984; Fox J., 2019, R COMPANION APPL REG, V.; Gereta E, 1998, AFR J ECOL, V36, P1, DOI 10.1046/j.1365-2028.1998.102-89102.x; Gereta Emmanuel, 2002, Ecohydrology & Hydrobiology, V2, P135; Glover P.E., 1968, AFR J ECOL, V6, P125, DOI [10.1111/j.1365-2028.1968.tb00909.x, DOI 10.1111/J.1365-2028.1968.TB00909.X]; Goulden M, 2009, HYDROLOG SCI J, V54, P805, DOI 10.1623/hysj.54.5.805; GRIMSHAW DL, 1980, J HYDROL, V47, P151, DOI 10.1016/0022-1694(80)90053-0; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Hoffman C. M, 2007, GEOSPATIAL MAPPING A; Homewood K, 2001, P NATL ACAD SCI USA, V98, P12544, DOI 10.1073/pnas.221053998; Kanga EM, 2011, ORYX, V45, P20, DOI 10.1017/S0030605310000931; Kiragu GM, 2009, ASSESSMENT SUSPENDED; Krhoda GO, 2006, HYDROLOGY MARA RIVER; Lamprey RH, 2004, J BIOGEOGR, V31, P997, DOI 10.1111/j.1365-2699.2004.01062.x; Lewis J, 1996, WATER RESOUR RES, V32, P2299, DOI 10.1029/96WR00991; Lewison RL, 2016, IUCN RED LIST THREAT; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; LVBC & WWF-ESARPO, 2010, ASS RES FLOWS MAR RI; LVSC, 2008, CATCHM MAN IN PRESS; Mango LM, 2011, HYDROL EARTH SYST SC, V15, P2245, DOI 10.5194/hess-15-2245-2011; Marshall CN, 1992, EC ASSESSMENT TOURIS; Mati Bancy M., 2008, Lakes & Reservoirs Research and Management, V13, P169, DOI 10.1111/j.1440-1770.2008.00367.x; McCartney B., 2010, EVALUATION WATER QUA; McClain ME, 2014, HYDROLOG SCI J, V59, P801, DOI 10.1080/02626667.2013.853121; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Mnaya B, 2017, ORYX, V51, P581, DOI 10.1017/S0030605317001338; Moore JW, 2006, BIOSCIENCE, V56, P237, DOI 10.1641/0006-3568(2006)056[0237:AEEIS]2.0.CO;2; Mosepele K, 2009, BIOSCIENCE, V59, P53, DOI 10.1525/bio.2009.59.1.9; Mwangi HM, 2016, J HYDROL-REG STUD, V5, P244, DOI 10.1016/j.ejrh.2015.12.059; Naiman RJ, 1997, BIOSCIENCE, V47, P521, DOI 10.2307/1313120; NEWCOMBE C P, 1991, North American Journal of Fisheries Management, V11, P72, DOI 10.1577/1548-8675(1991)011<0072:EOSSOA>2.3.CO;2; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ottichilo W.K., 2000, WILDLIFE DYNAMICS AN; Rapp A., 1977, FAO CONSERVATION GUI, V1; Rasmussen PP, GUIDELINES PROCEDURE; Rosburg TT, 2016, J HYDROL, V538, P429, DOI 10.1016/j.jhydrol.2016.04.040; Serneels S, 2001, INT J REMOTE SENS, V22, P3397, DOI 10.1080/01431160152609236; Singler H, 2006, WATER QUALITY BASLIN; Slattery MC, 1997, EARTH SURF PROC LAND, V22, P705, DOI 10.1002/(SICI)1096-9837(199708)22:8&lt;705::AID-ESP739&gt;3.0.CO;2-6; Subalusky AL, 2014, FRESHWATER BIOL; SUTHERLAND RA, 1990, APPL GEOGR, V10, P91, DOI 10.1016/0143-6228(90)90046-R; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Taylor KG, 2009, J SOIL SEDIMENT, V9, P281, DOI 10.1007/s11368-009-0103-z; Terer JK, 2005, STUDY HYDROLOGIC CHA; USEPA, 2007, 841R07001 USEPA; Vanmaercke M, 2014, EARTH-SCI REV, V136, P350, DOI 10.1016/j.earscirev.2014.06.004; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Walling D. E, 1987, SEDIMENT TRANSPORT G; Walling DE, 2005, SCI TOTAL ENVIRON, V344, P159, DOI 10.1016/j.scitotenv.2005.02.011; Weber KT, 2011, PASTORALISM, V1, DOI 10.1186/2041-7136-1-19; Wohl E, 2006, GEOMORPHOLOGY, V79, P217, DOI 10.1016/j.geomorph.2006.06.020; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019; Ziegler AC, 2002, TURB OTH SED SURR WO, P3	69	28	28	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							0192828	10.1371/journal.pone.0192828	http://dx.doi.org/10.1371/journal.pone.0192828			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420624	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900119
J	Fan, Y; Tian, C; Liu, QL; Zhen, XY; Zhang, H; Zhou, LN; Li, TBA; Zhang, Y; Ding, SB; He, DL; Jin, X; Liu, J; Zhang, BB; Wu, NN; Manyande, A; Zhu, MS				Fan, Ying; Tian, Chong; Liu, Qilin; Zhen, Xianyue; Zhang, Hui; Zhou, Liangneng; Li, Taibiao; Zhang, Yun; Ding, Shibin; He, Dongliang; Jin, Xin; Liu, Jian; Zhang, Beibei; Wu, Nannan; Manyande, Anne; Zhu, Maoshu			Preconception paternal bisphenol A exposure induces sex-specific anxiety and depression behaviors in adult rats	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; PERINATAL EXPOSURE; SOCIOSEXUAL BEHAVIOR; POSTNATAL EXPOSURE; RECEPTOR-GAMMA; MICE; CHILDREN; FEMALE; HYPERACTIVITY; CHEMICALS	Bisphenol A (BPA), an environmental endocrine-disrupting compound, has drawn a great attention for its adverse effect on behavioral development. Maternal exposure to this compound has been reported to induce anxiety and depression in offspring, but the effect of its paternal exposure is rarely discussed. This study investigated whether preconception paternal BPA exposure can affect the emotions of male rats and their offspring. Eighteen adult male rats (F0) received either a vehicle or 50 mu g/kg/day BPA diet for 21 weeks and were then mated with non-exposed females to produce offspring (F1). The affective behaviors of F0 and F1 rats were evaluated in the open-field test, the elevated-plus maze and the forced swimming test, and their serum corticosterone were then examined. BPA exposure induced increased anxiety behaviors along with increased serum corticosterone in F0 rats. This paternal exposure also led to increased anxiety behaviors in F1 females and aggravated depression behaviors in both sexes of F1 rats. Furthermore, only F1 females exhibited increased serum corticosterone. Overall, these data indicate that preconception paternal exposure to a low dose of BPA may induce transgenerational sex-specific impairments in the affection of adult rats.	[Fan, Ying] Fifth Hosp Xiamen, Dept Psychiat, Xiamen, Peoples R China; [Tian, Chong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Nursing, Wuhan, Hubei, Peoples R China; [Liu, Qilin] Fifth Hosp Xiamen, Dept Gastroenterol, Xiamen, Peoples R China; [Zhen, Xianyue] Wuhan Mental Hlth Ctr, Dept 110, Wuhan, Hubei, Peoples R China; [Zhang, Hui] Fifth Hosp Xiamen, Dept Neurol, Xiamen, Peoples R China; [Zhou, Liangneng] Fifth Hosp Xiamen, Dept Resp, Xiamen, Peoples R China; [Li, Taibiao; Zhang, Yun] Fifth Hosp Xiamen, Dept Chinese Med, Xiamen, Peoples R China; [Ding, Shibin] Xinxiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xinxiang, Peoples R China; [He, Dongliang; Jin, Xin; Liu, Jian; Zhang, Beibei; Wu, Nannan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan, Hubei, Peoples R China; [Manyande, Anne] Univ W London, Sch Psychol Social Work & Human Sci, London, England; [Zhu, Maoshu] Fifth Hosp Xiamen, Cent Lab, Xiamen, Peoples R China	Huazhong University of Science & Technology; Xinxiang Medical University; Huazhong University of Science & Technology; University of West London	Zhu, MS (corresponding author), Fifth Hosp Xiamen, Cent Lab, Xiamen, Peoples R China.	1336620278@qq.com	Tian, Chong/AAE-7514-2022	Tian, Chong/0000-0002-3231-9409; Jin, Xin/0000-0001-6461-6005	Xiamen Science and Technology Program of China [3502Z20154071]; Provincial Natural Science Foundation of Fujian [2016D020, 2018D0022]; Fundamental Research Funds for the Central Universities [2015QN096]; National Natural Science Foundation of China [81373007]	Xiamen Science and Technology Program of China; Provincial Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Xiamen Science and Technology Program of China 3502Z20154071, Provincial Natural Science Foundation of Fujian grants 2016D020 and 2018D0022, Fundamental Research Funds for the Central Universities 2015QN096 and National Natural Science Foundation of China grants 81373007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2015, NAT REV NEUROSCI, V16, P332, DOI 10.1038/nrn3818; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Chen F, 2015, J BIOMED RES, V29, P250, DOI 10.7555/JBR.29.20140058; Chen F, 2014, BRAIN RES, V1571, P12, DOI 10.1016/j.brainres.2014.05.010; Chianese R., 2017, CURR MED CHEM; Dessi-Fulgheri F, 2002, ENVIRON HEALTH PERSP, V110, P403, DOI 10.1289/ehp.02110s3403; Dobrzynska MM, 2015, MUTAT RES-GEN TOX EN, V789, P36, DOI 10.1016/j.mrgentox.2015.06.015; Evans SF, 2014, NEUROTOXICOLOGY, V45, P91, DOI 10.1016/j.neuro.2014.10.003; Fan Y, 2013, HORM BEHAV, V64, P598, DOI 10.1016/j.yhbeh.2013.08.014; Farabollino F, 2002, ENVIRON HEALTH PERSP, V110, P409, DOI 10.1289/ehp.02110s3409; Fujimoto T, 2006, BRAIN RES, V1068, P49, DOI 10.1016/j.brainres.2005.11.028; Fujimoto T, 2013, J TOXICOL SCI, V38, P539, DOI 10.2131/jts.38.539; Harley KG, 2013, ENVIRON RES, V126, P43, DOI 10.1016/j.envres.2013.06.004; Harris AP, 2013, PSYCHONEUROENDOCRINO, V38, P648, DOI 10.1016/j.psyneuen.2012.08.007; He DL, 2015, CHEMOSPHERE, V139, P2, DOI 10.1016/j.chemosphere.2015.05.036; Hermans-Borgmeyer I, 2000, MECH DEVELOP, V97, P197, DOI 10.1016/S0925-4773(00)00422-6; Komada M, 2014, TOXICOLOGY, V323, P51, DOI 10.1016/j.tox.2014.06.009; Matsushima A, 2007, J BIOCHEM, V142, P517, DOI 10.1093/jb/mvm158; Mileva G, 2014, INT J ENV RES PUB HE, V11, P7537, DOI 10.3390/ijerph110707537; Perez-Lobato R, 2016, NEUROTOXICOLOGY, V53, P12, DOI 10.1016/j.neuro.2015.12.001; Poimenova A, 2010, NEUROSCIENCE, V167, P741, DOI 10.1016/j.neuroscience.2010.02.051; Porrini S, 2005, BRAIN RES BULL, V65, P261, DOI 10.1016/j.brainresbull.2004.11.014; Rivier C, 2014, FRONT NEUROENDOCRIN, V35, P221, DOI 10.1016/j.yfrne.2013.10.005; Roen EL, 2015, ENVIRON RES, V142, P739, DOI 10.1016/j.envres.2015.01.014; Smarr MM, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0060-5; Tian YH, 2010, SYNAPSE, V64, P432, DOI 10.1002/syn.20746; Tohme M, 2014, FASEB J, V28, P3124, DOI 10.1096/fj.13-240465; Vandenberg LN, 2012, CIENC SAUDE COLETIVA, V17, P407, DOI 10.1590/S1413-81232012000200015; von Goetz N, 2010, RISK ANAL, V30, P473, DOI 10.1111/j.1539-6924.2009.01345.x; Xu XH, 2013, HORM BEHAV, V63, P766, DOI 10.1016/j.yhbeh.2013.03.004; Xu XH, 2012, HORM BEHAV, V62, P480, DOI 10.1016/j.yhbeh.2012.08.005; Xu XH, 2010, TOXICOL APPL PHARM, V249, P188, DOI 10.1016/j.taap.2010.09.007; Ye XY, 2006, J CHROMATOGR B, V831, P110, DOI 10.1016/j.jchromb.2005.11.050; Zhou R, 2015, J PSYCHIATR RES, V64, P121, DOI 10.1016/j.jpsychires.2015.02.018; Zhou R, 2011, NEUROPHARMACOLOGY, V60, P789, DOI 10.1016/j.neuropharm.2011.01.031	35	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192434	10.1371/journal.pone.0192434	http://dx.doi.org/10.1371/journal.pone.0192434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420593	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000424517900074
J	Jaudan, A; Sharma, S; Abd Malek, SN; Dixit, A				Jaudan, Alka; Sharma, Sapna; Abd Malek, Sri Nurestri; Dixit, Aparna			Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action	PLOS ONE			English	Article							OXIDATIVE STRESS; CYTOCHROME-C; QUERCETIN; CYCLE; RESVERATROL; PHYTOCHEMICALS; PROLIFERATION; GENERATION; FLAVONOIDS; TOXICITY	Pinostrobin (P-N) is a naturally occurring dietary bioflavonoid, found in various medicinal herbs/plants. Though anti-cancer potential of many such similar constituents has been demonstrated, critical biochemical targets and exact mechanism for their apoptosis-inducing actions have not been fully elucidated. The present study was aimed to investigate if P-N induced apoptosis in cervical cancer cells (HeLa) of human origin. It is demonstrated that P-N at increasing dose effectivity reduced the cell viability as well as GSH and NO2- levels. Condensed nuclei with fragmented chromatin and changes in mitochondrial matrix morphology clearly indicated the role of mitochondria in P-N induced apoptosis. A marked reduction in mitochondrial membrane potential and increased ROS production after P-N treatment showed involvement of free radicals, which in turn further augment ROS levels. P-N treatment resulted in DNA damage, which could have been triggered by an increase in ROS levels. Decrease in apoptotic cells in the presence of caspase 3 inhibitor in P-N-treated cells suggested that PN induced apoptosis via caspase dependent pathways. Additionally, a significant increase in the expression of proteins of extrinsic (TRAIL R1/DR4, TRAIL R2/DR5, TNF RI/TNFRSF1A, FADD, Fas/TNFRSF6) and intrinsic pathway (Bad, Bax, HTRA2/Omi, SMAC/Diablo, cytochrome C, Pro-Caspase-3, Cleaved Caspase-3) was observed in the cells exposed to P-N. Taken together, these observations suggest that P-N efficiently induces apoptosis through ROS mediated extrinsic and intrinsic dependent signaling pathways, as well as ROS mediated mitochondrial damage in HeLa cells.	[Jaudan, Alka; Sharma, Sapna; Dixit, Aparna] Jawaharlal Nehru Univ, Sch Biotechnol, Gene Regulat Lab, New Delhi, India; [Abd Malek, Sri Nurestri] Univ Malaya, Fac Sci, Kuala Lumpur, Malaysia	Jawaharlal Nehru University, New Delhi; Universiti Malaya	Dixit, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, Gene Regulat Lab, New Delhi, India.	adixit7@gmail.com	Malek, Sri Nurestri/W-8556-2019; Malek, Sri Nurestri Abd/B-9834-2010	Malek, Sri Nurestri/0000-0001-6278-8559; Malek, Sri Nurestri Abd/0000-0001-6278-8559	Jawaharlal Nehru University, New Delhi, India; Department of Science and Technology, New Delhi, India [SR/PURSE/Phase2/11(C)]; Department of Biotechnology, Ministry of Science and Technology, India	Jawaharlal Nehru University, New Delhi, India; Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Department of Biotechnology, Ministry of Science and Technology, India	The Jawaharlal Nehru University, New Delhi, India is acknowledged for providing financial support. The Department of Science and Technology, New Delhi, India is acknowledged for PURSE grant [SR/PURSE/Phase2/11(C) 2015] to the Jawaharlal Nehru University, New Delhi, India. The Department of Biotechnology, Ministry of Science and Technology, India is acknowledged for providing research fellowship to AJ. Advanced Instrumentation Research Facility (AIRF), Jawaharlal Nehru University, New Delhi is acknowledged for providing the TEM, FACS, Confocal and Live Cell Imaging Facilities.	Abdelwahab SI, 2011, J ETHNOPHARMACOL, V137, P963, DOI 10.1016/j.jep.2011.07.010; Altinoz MA, 2007, CELL BIOL INT, V31, P473, DOI 10.1016/j.cellbi.2006.11.013; Ariffin SHZ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-6; Ashidi JS, 2010, J ETHNOPHARMACOL, V128, P501, DOI 10.1016/j.jep.2010.01.009; Beevi SS, 2007, CLIN CHIM ACTA, V375, P119, DOI 10.1016/j.cca.2006.06.028; Bhamarapravati S, 2003, P 3 WORLD C MED AR P, P521; Bi L, 2016, INTEGR CANCER THER, V15, P226, DOI 10.1177/1534735416637424; Bishayee K, 2013, CELL PROLIFERAT, V46, P153, DOI 10.1111/cpr.12017; Cao XD, 2012, NAT PROD RES, V26, P2089, DOI 10.1080/14786419.2011.628174; Chua A.J.S., 2012, CURRENT MICROSCOPY C, P763; Del Follo-Martinez A, 2013, NUTR CANCER, V65, P494, DOI 10.1080/01635581.2012.725194; El Hady FA., 2013, INT J PHARM SCI REV, V21, P338; EVANS VG, 1993, CELL BIOL INT, V17, P461, DOI 10.1006/cbir.1993.1087; Foppoli C., 2014, CANCER CYTOPATHOL, P51, DOI [10.1016/B978-0-12-405205-5.00006-4, DOI 10.1016/B978-0-12-405205-5.00006-4]; Gokbulut AA, 2013, HEMATOLOGY, V18, P144, DOI 10.1179/1607845412Y.0000000042; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haddad AQ, 2006, PROSTATE CANCER P D, V9, P68, DOI 10.1038/sj.pcan.4500845; Hsu YL, 2011, MOL NUTR FOOD RES, V55, P318, DOI 10.1002/mnfr.201000148; Hunter P, 2014, EMBO REP, V15, P485, DOI 10.1002/embr.201438780; Jadaun A, 2017, J PHOTOCH PHOTOBIO B, V167, P299, DOI 10.1016/j.jphotobiol.2017.01.010; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kim SJ, 2012, MOL MED REP, V6, P1443, DOI 10.3892/mmr.2012.1085; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Li JM, 2015, BANGL J PHARMACOL, V10, P820, DOI 10.3329/bjp.v10i4.23039; Li XX, 2015, MOL MED REP, V11, P3746, DOI 10.3892/mmr.2015.3224; Li Y, 2016, ADV MATER TECHNOL-US, V1, DOI 10.1002/admt.201600102; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Maciejczyk A, 2013, GINEKOL POL, V84, P590; Mahyar-Roemer M, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-27; Meydani M, 2017, FUNCT FOOD SCI TECHN, P125; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Nicholson RA, 2010, FITOTERAPIA, V81, P826, DOI 10.1016/j.fitote.2010.05.005; Padma VV, 2007, BASIC CLIN PHARMACOL, V100, P302, DOI 10.1111/j.1742-7843.2007.00046.x; Pal D, 2011, J ADV PHARM TECHNOL, V2, P207, DOI 10.4103/2231-4040.90874; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Raja SB, 2017, FOOD CHEM TOXICOL, V106, P92, DOI 10.1016/j.fct.2017.05.006; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Riley JS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.213; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Sayre CL, 2015, J PHARM PHARM SCI, V18, P368, DOI 10.18433/J3BK5T; Sayre CL, 2013, J PHARM PHARM SCI, V16, P272, DOI 10.18433/J3X01Q; Takeara R, 2003, PHYTOMEDICINE, V10, P490, DOI 10.1078/094471103322331430; Tatiraju DV., 2013, J PHARMACOGN PHYTOCH, V2, P55; Thakur VS, 2014, AAPS J, V16, P151, DOI 10.1208/s12248-013-9548-5; Wang H, 2012, ANTI-CANCER AGENT ME, V12, P1281, DOI 10.2174/187152012803833026; WHO, 2016, HUMAN PAPILLOMAVIRUS, DOI 10.12968/indn.2020.2.20; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Wu N, 2011, PHYTOMEDICINE, V18, P110, DOI 10.1016/j.phymed.2010.07.001; Xiao XY, 2011, CANCER LETT, V302, P69, DOI 10.1016/j.canlet.2010.12.016; Xu WL, 2017, MOLECULES, V22, DOI 10.3390/molecules22081299; Yong WK, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/921306; Zhang X, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/05/P05014	59	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191523	10.1371/journal.pone.0191523	http://dx.doi.org/10.1371/journal.pone.0191523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420562	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900016
J	Jiang, HQ; Hultkvist, H; Holm, J; Vanky, F; Yang, YQ; Svedjeholm, R				Jiang, Huiqi; Hultkvist, Henrik; Holm, Jonas; Vanky, Farkas; Yang, Yanqi; Svedjeholm, Rolf			Impact of underlying heart disease per se on the utility of preoperative NT-proBNP in adult cardiac surgery	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; CORONARY-ARTERY-DISEASE; PROGNOSTIC VALUE; INDEPENDENT PREDICTOR; VALVE-REPLACEMENT; OUTPUT SYNDROME; RENAL-FUNCTION; PLASMA-LEVELS; GUIDELINES; MORTALITY	Objective The primary aim was to investigate the role of underlying heart disease on preoperative NT-proBNP levels in patients admitted for adult cardiac surgery, after adjusting for the known confounders age, gender, obesity and renal function. The second aim was to investigate the predictive value of preoperative NT-proBNP with regard to severe postoperative heart failure (SPHF) and postoperative mortality. Methods A retrospective cohort study based on preoperative NT-proBNP measurements in an unselected cohort including all patients undergoing first time surgery for coronary artery disease (CAD; n = 2226), aortic stenosis (AS; n = 406) or mitral regurgitation (MR; n = 346) from April 2010 to August 2016 in the southeast region of Sweden (n = 2978). Concomitant procedures were not included, with the exception of Maze or tricuspid valve procedures. Results Preoperative NT-proBNP was 1.67 times (p<0.0001) and 1.41 times (p<0.0001) higher in patients with AS or MR respectively, than in patients with CAD after adjusting for confounders. NT-proBNP demonstrated significant discrimination with regard to SPHF in CAD (AUC = 0.79, 95% CI 0.73 +/- 0.85, p<0.0001), MR (AUC = 0.80, 95% CI 0.72 +/- 0.87, p<0.0001) and AS (AUC = 0.66, 95% CI 0.51 +/- 0.81, p = 0.047). In CAD patients NT-proBNP demonstrated significant discrimination with regard to postoperative 30-day or in-hospital mortality (AUC = 0.78; 95% CI 0.71 +/- 0.85, p<0.0001). The number of deaths was too few in the AS and MR group to permit analysis. Elevated NT-proBNP emerged as an independent risk factor for SPHF, and postoperative mortality in CAD. Conclusions Patients with AS or MR have higher preoperative NT-proBNP than CAD patients even after adjusting for confounders. The predictive value of NT-proBNP with regard to SPHF was confirmed in CAD and MR patients but was less convincing in AS patients.	[Jiang, Huiqi; Hultkvist, Henrik; Holm, Jonas; Vanky, Farkas; Yang, Yanqi; Svedjeholm, Rolf] Linkoping Univ, Div Cardiovasc Med, Fac Med & Hlth Sci, Dept Cardiothorac Surg & Cardiothorac Anesthesia, Linkoping, Sweden; [Jiang, Huiqi; Yang, Yanqi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiothorac Surg, Guangzhou, Guangdong, Peoples R China	Linkoping University; Sun Yat Sen University	Svedjeholm, R (corresponding author), Linkoping Univ, Div Cardiovasc Med, Fac Med & Hlth Sci, Dept Cardiothorac Surg & Cardiothorac Anesthesia, Linkoping, Sweden.	rolf.svedjeholm@regionostergotland.se			Region Ostergotland [LIO-443891]	Region Ostergotland	This work was supported by Region Ostergotland [LIO-443891], https://www. researchweb.org/is/lio/Projektansokniogar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendes E, 2004, ANESTH ANALG, V98, P11, DOI [10.1213/01.ANE.0000093249.35075.F1, 10.1213/01.ANE.0000093249-35075.F1]; Bergler-Klein J, 2014, CAN J CARDIOL, V30, P1027, DOI 10.1016/j.cjca.2014.07.014; Cantinotti M, 2015, CLIN CHEM LAB MED, V53, P1839, DOI 10.1515/cclm-2014-1084; Chenevier-Gobeaux C, 2005, CLIN CHIM ACTA, V361, P167, DOI 10.1016/j.cccn.2005.05.021; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Cuthbertson BH, 2013, BRIT J ANAESTH, V110, P214, DOI 10.1093/bja/aes379; Cuthbertson BH, 2005, CRIT CARE MED, V33, P437, DOI 10.1097/01.CCM.0000150822.10160.0A; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Fellahi JL, 2012, J CARDIOTHOR VASC AN, V26, P624, DOI 10.1053/j.jvca.2011.07.029; Fox AA, 2008, J THORAC CARDIOV SUR, V136, P452, DOI 10.1016/j.jtcvs.2007.12.036; Georges A, 2004, EUR J CARDIO-THORAC, V25, P941, DOI 10.1016/j.ejcts.2004.02.029; Holm J, 2014, BRIT J ANAESTH, V113, P75, DOI 10.1093/bja/aeu088; Holm J, 2013, SCAND CARDIOVASC J, V47, P28, DOI 10.3109/14017431.2012.731518; Jo YY, 2011, KOREAN J ANESTHESIOL, V61, P35, DOI 10.4097/kjae.2011.61.1.35; Jogia PM, 2007, ANAESTH INTENS CARE, V35, P363, DOI 10.1177/0310057X0703500307; Maganti M, 2010, J THORAC CARDIOV SUR, V140, P790, DOI 10.1016/j.jtcvs.2009.11.022; Maganti MD, 2005, CIRCULATION, V112, pI448, DOI 10.1161/CIRCULATIONAHA.104.526087; Magne J, 2012, HEART, V98, P584, DOI 10.1136/heartjnl-2011-301128; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Marechaux S, 2011, ECHOCARDIOGR-J CARD, V28, P695, DOI 10.1111/j.1540-8175.2011.01418.x; Ndrepepa G, 2005, AM J CARDIOL, V95, P553, DOI 10.1016/j.amjcard.2004.10.034; Nozohoor S, 2009, J CARDIOTHOR VASC AN, V23, P161, DOI 10.1053/j.jvca.2008.11.006; O'Connor GT, 1998, ANN THORAC SURG, V66, P1323, DOI 10.1016/S0003-4975(98)00762-0; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Palazzuoli A, 2012, EUR J PREV CARDIOL, V19, P366, DOI 10.1177/1741826711406608; Pascual-Figal DA, 2007, HEART, V93, P1077, DOI 10.1136/hrt.2006.101303; Pedrazzini GB, 2008, AM J CARDIOL, V102, P749, DOI 10.1016/j.amjcard.2008.04.055; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rao V, 1996, J THORAC CARDIOV SUR, V112, P38, DOI 10.1016/S0022-5223(96)70176-9; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Roberts E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h910; Schachner T, 2010, CLINICS, V65, P1239, DOI 10.1590/S1807-59322010001200004; Singh Satyajit, 2014, Asian Cardiovasc Thorac Ann, V22, P674, DOI 10.1177/0218492313504420; Singh S, 2014, J CARDIAC SURG, V29, P134, DOI 10.1111/jocs.12280; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455; Vanky FB, 2006, ANN THORAC SURG, V81, P1297, DOI 10.1016/j.athoracsur.2005.11.036; Vikholm P, 2014, J CARDIOTHOR VASC AN, V28, P520, DOI 10.1053/j.jvca.2014.01.002; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wei XB, 2017, EUR J PREV CARDIOL, V24, P676, DOI 10.1177/2047487316686436; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Wirth J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113710; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192503	10.1371/journal.pone.0192503	http://dx.doi.org/10.1371/journal.pone.0192503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420603	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900085
J	Mamulwar, M; Godbole, S; Bembalkar, S; Kamble, P; Dulhani, N; Yadav, R; Kadu, C; Kumar, P; Lalikar, S; Acharya, S; Gangakhedkar, R; Risbud, A; Venkatesh, S				Mamulwar, Megha; Godbole, Sheela; Bembalkar, Shilpa; Kamble, Pranil; Dulhani, Nisha; Yadav, Rajesh; Kadu, Chitra; Kumar, Pradeep; Lalikar, Shivraj; Acharya, Shrikala; Gangakhedkar, Raman; Risbud, Arun; Venkatesh, Srinivas			Differing HIV vulnerability among female sex workers in a high HIV burden Indian state	PLOS ONE			English	Article							PREVENTION; HIV/AIDS; INTERVENTION; MICROFINANCE	Introduction The HIV sentinel surveillance [HSS] conducted in 2010-11 among female sex workers [FSW] in the state of Maharashtra, India provided an opportunity to assess characteristics of different types of FSWs and their HIV risk. It is important for India's National AIDS Control Program, to understand the differences in vulnerability among these FSW, in order to define more specific and effective risk reduction intervention strategies. Therefore, we analyzed data from HSS with the objective of understanding the HIV vulnerability among different types of FSW in Maharashtra. Material and methods Cross sectional data collected as a part of HSS among FSWs in year 2010-11 from 21 sentinel sites in the state of Maharashtra were analyzed to understand the vulnerability and characteristics of different types of female sex workers based on their place of solicitation using multinomial logistic regression. Results While the HIV prevalence was 6.6% among all FSWs, it was 9.9% among brothel based [BB], 9% among street based [SB] and 3.1% and 3.7% among home based [HB], and bar based [Bar-B] sex workers respectively. SB FSWs were least likely to be located in HIV low burden districts [ANC] [ARRR: 0.61[95% CI: 0.49, 0.77]], but were 6 times more likely to be recently [<1 year] involved in sex work [ARRR: 6.15 [95% CI: 3.15, 12.0]]. The number of clients of SB FSWs in the preceding week were lower than 11% [ARRR: 0.89 [95% CI: 0.87, 0.90]] as compared to the BB FSWs denoting lesser client load. The duration since last paid sex was shorter [ARRR: 0.94[95% CI: 0.91, 0.96]] as compared to the BB FSWs. Conclusion Street based FSWs have emerged as one of the most vulnerable types of FSW with a high HIV prevalence similar to BB FSWs. Our study reveals that they have more frequent sex acts despite lower client loads, and are more likely to be located in districts highly affected by HIV (ANC prevalence >1%). We identify them as a group to be focused on for prevention interventions and it is likely that they would be easily amenable to novel interventions due to their higher literacy rate as compared to other typologies.	[Mamulwar, Megha; Godbole, Sheela; Bembalkar, Shilpa; Kamble, Pranil; Dulhani, Nisha; Yadav, Rajesh; Kadu, Chitra; Gangakhedkar, Raman; Risbud, Arun] Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India; [Kumar, Pradeep] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, SIMU, New Delhi, India; [Lalikar, Shivraj] Maharashtra State AIDS Control Soc, STI, Monitoring & Evaluat, Bombay, Maharashtra, India; [Acharya, Shrikala] Mumbai Dist AIDS Control Soc, Bombay, Maharashtra, India; [Venkatesh, Srinivas] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Kamble, Pranil] GOI, DGHS, Natl Ctr Dis Control, Delhi, India; [Dulhani, Nisha] Evalueserve, Gurgaon, Haryana, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); National Centre for Disease Control (NCDC)	Godbole, S (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India.	sgodbole@nariindia.org	Godbole, Sheela/ABG-4942-2020	Acharya, Shrikala/0000-0001-8968-4258; Godbole, Sheela/0000-0001-6537-9064; Kumar, Pradeep/0000-0002-7638-1263	National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare Government of India	National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare Government of India	The HSS 2010-11 round conducted for HRG was funded by National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare Government of India. The HIV Sentinel surveillance is a national activity conducted by NACO and the overall design of the surveillance is attributable to them. The data analysis plan and manuscript development was led by the first and corresponding and other authors from NARI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avert NACO USAID MSACS M, 2009, BEH SURV SURV MAH; Bannakkopa RM, 2008, AIDS, P22; Brahme R, 2006, J ACQ IMMUN DEF SYND, P41; Buzdugan R, 2009, TROP MED INT HEALTH, V14, P673, DOI 10.1111/j.1365-3156.2009.02278.x; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dandona Rakhi, 2006, BMC Int Health Hum Rights, V6, P5, DOI 10.1186/1472-698X-6-5; Dworkin SL, 2009, AIDS BEHAV, V13, P462, DOI 10.1007/s10461-009-9532-3; Godbole S, 2017, 9 IAS C HIV SCI IAS; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Gurung A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S10; Khot S., 2010, NEEDS ASSESSMENT BAR; Kumar GA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-65; Kumar R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-549; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, MIN HLTH FAM WELF G; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2015, INT BIOL BEH SURV IB; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2012, HIV SENT SURV 2010 1; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2010, HIV SENT SURV 2010 O; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2007, TARG INT NACP 3 OP G; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, HIV SENT SURV NAT RE; National AIDS Control Organisation & National Institute of Medical Statistics Ministry of Health and Family Welfare IG of I, 2015, TECHNICAL REPORT; Nirgude Abhay, 2011, Indian J Community Med, V36, P31, DOI 10.4103/0970-0218.80790; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Ranebennur V, 2014, HIV AIDS-RES PALLIAT, V6, P9, DOI 10.2147/HIV.S54062; Thappa D. M., 2007, Indian Journal of Sexually Transmitted Diseases, V28, P69; Trust IHA, 2010, HIV AIDS SIT RESP MA; Tsai Laura Cordisco, 2011, Open Womens Health J, V5, P26; UNAIDS, 2013, GLOBAL REPORT UNAIDS; Witte SS, 2015, AM J PUBLIC HEALTH, V105, pE95, DOI 10.2105/AJPH.2014.302291	30	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192130	10.1371/journal.pone.0192130	http://dx.doi.org/10.1371/journal.pone.0192130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420577	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900041
J	Ahmad, A; Sattar, MA; Azam, M; Khan, SA; Bhatt, O; Johns, EJ				Ahmad, Ashfaq; Sattar, Munavvar A.; Azam, Maleeha; Khan, Safia A.; Bhatt, Owais; Johns, Edward J.			Interaction between nitric oxide and renal alpha(1)-adrenoreceptors mediated vasoconstriction in rats with left ventricular hypertrophyin Wistar Kyoto rats	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; CYSTATHIONINE GAMMA-LYASE; IN-VIVO; HYDROGEN-SULFIDE; ANGIOTENSIN-II; L-ARGININE; ADRENERGIC VASOCONSTRICTION; CARDIAC-HYPERTROPHY; SMOOTH-MUSCLE; BLOOD-FLOW	Left ventricular hypertrophy (LVH) is associated with decreased responsiveness of renal alpha(1)-adrenoreceptors subtypes to adrenergic agonists. Nitric oxide donors are known to have antihypertrophic effects however their impact on responsiveness of renal alpha(1)-adrenoreceptors subtypes is unknown. This study investigated the impact of nitric oxide (NO) and its potential interaction with the responsiveness of renal alpha(1)-adrenoreceptors subtypes to adrenergic stimulation in rats with left ventricular hypertrophy (LVH). This study also explored the impact of NO donor on CSE expression in normal and LVH kidney. LVH was induced using isoprenaline and caffeine in drinking water for 2 weeks while NO donor (L-arginine, 1.25g/Lin drinking water) was given for 5 weeks. Intrarenal noradrenaline, phenylephrine and methoxamine responses were determined in the absence and presence of selective alpha(1)-adrenoceptor antagonists, 5- methylurapidil (5-MeU), chloroethylclonidine (CeC) and BMY 7378. Renal cortical endothelial nitric oxide synthase mRNA was upregulated 7 fold while that of cystathione Upsilon lyase was unaltered in the NO treated LVH rats (LVH-NO) group compared to LVH group. The responsiveness of renal alpha(1A), alpha(1B) and alpha(1D)-adrenoceptors in the low dose and high dose phases of 5-MeU, CEC and BMY7378 to adrenergic agonists was increased along with cGMP in the kidney of LVH-NO group. These findings suggest that exogenous NO precursor up-regulated the renal eNOS/NO/cGMP pathway in LVH rats and resulted in augmented alpha(1A), alpha(1B) and alpha(1D) adrenoreceptors responsiveness to the adrenergic agonists. There is a positive interaction between H2S and NO production in normal animals but this interaction appears absent in LVH animals.	[Ahmad, Ashfaq; Sattar, Munavvar A.; Khan, Safia A.] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Ahmad, Ashfaq; Bhatt, Owais] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Azam, Maleeha] COMSATS Inst Informat Technol, Dept Biosci, Translat Genom Lab, Islamabad, Pakistan; [Johns, Edward J.] Univ Coll Cork, Dept Physiol, Cork, Ireland	Universiti Sains Malaysia; Virginia Commonwealth University; COMSATS University Islamabad (CUI); University College Cork	Ahmad, A (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia.; Ahmad, A (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	aahmad2@vcu.edu	Ahmad, Ashfaq/GQV-4782-2022; Azam, Maleeha/AAD-9924-2022; Azam, Maleeha/L-1721-2017	Ahmad, Ashfaq/0000-0002-9185-4639; Azam, Maleeha/0000-0003-0170-3325	USM fellowship (Teaching) [1002/JHEA/ATSG4001]; USM-RU [1001/PFARMASI/815078]	USM fellowship (Teaching); USM-RU	The Institute of Postgraduate Studies (IPS) is acknowledged for the provision of a USM fellowship (Teaching) to Ashfaq Ahmad (APEX (1002/JHEA/ATSG4001)). The authors fully acknowledge USM-RU grant no. 1001/PFARMASI/815078 for this work to Munavvar A.Sattar.	Abdulla MH, 2012, BRIT J NUTR, V107, P218, DOI 10.1017/S0007114511002716; Abdulla MH, 2011, EUR J NUTR, V50, P251, DOI 10.1007/s00394-010-0133-8; Abdulla MH, 2011, EUR J NUTR, V50, P689, DOI 10.1007/s00394-011-0180-9; Ahmad A, 2016, JPP, P03; Ahmad A, 2016, TURK J BIOL, V40, P1129, DOI 10.3906/biy-1506-78; Ahmad A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154995; Ahmad A, 2014, CAN J PHYSIOL PHARM, V92, P1029, DOI 10.1139/cjpp-2014-0236; Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Arevalo-Leon LE, 2003, VASC PHARMACOL, V40, P91, DOI 10.1016/S1537-1891(02)00336-1; Armenia A, 2004, BRIT J PHARMACOL, V142, P719, DOI 10.1038/sj.bjp.0705842; Bell DG, 2001, MED SCI SPORT EXER, V33, P1399, DOI 10.1097/00005768-200108000-00024; BODEBOGER SM, 1994, CLIN SCI, V87, P303, DOI 10.1042/cs0870303; Booz GW, 2005, HYPERTENSION, V45, P341, DOI 10.1161/01.HYP.0000156878.17006.02; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busse R, 1996, J VASC RES, V33, P181, DOI 10.1159/000159147; Cannino G, 2009, MITOCHONDRION, V9, P471, DOI 10.1016/j.mito.2009.08.007; Chander V, 2006, ARCH MED RES, V37, P19, DOI 10.1016/j.arcmed.2005.05.018; COLLOMP K, 1991, INT J SPORTS MED, V12, P439, DOI 10.1055/s-2007-1024710; DiBona GF, 1997, PHYSIOL REV, V77, P75, DOI 10.1152/physrev.1997.77.1.75; ELHAWARY AM, 1992, J PHARMACOL EXP THER, V260, P709; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Flanagan ET, 2008, EXP PHYSIOL, V93, P1058, DOI 10.1113/expphysiol.2008.043216; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARCIASAINZ JA, 1993, CELL SIGNAL, V5, P539; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Goligorsky MS, 2002, KIDNEY INT, V61, P855, DOI 10.1046/j.1523-1755.2002.00233.x; Greenwood JP, 2001, J AM COLL CARDIOL, V38, P1711, DOI 10.1016/S0735-1097(01)01600-X; GROSS G, 1988, EUR J PHARMACOL, V151, P333, DOI 10.1016/0014-2999(88)90819-9; Grossi L, 2008, HYDROGEN SULFIDE NEU; Grossi L, 2009, BIOORG MED CHEM LETT, V19, P6092, DOI 10.1016/j.bmcl.2009.09.030; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hassan MI, 2012, BRIT J PHARMACOL, V166, P2231, DOI 10.1111/j.1476-5381.2012.01949.x; HOGIKYAN RV, 1994, AM J PHYSIOL, V266, pE717, DOI 10.1152/ajpendo.1994.266.5.E717; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Khan MAH, 2008, BRIT J PHARMACOL, V153, P1232, DOI 10.1038/bjp.2008.13; Khan MAH, 2008, ACTA PHARMACOL SIN, V29, P193, DOI 10.1111/j.1745-7254.2008.00727.x; KOBAYASHI R, 1993, HYPERTENSION, V21, P1051, DOI 10.1161/01.HYP.21.6.1051; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Liang MY, 2000, AM J PHYSIOL-REG I, V278, pR1117, DOI 10.1152/ajpregu.2000.278.5.R1117; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTSON DL, 1992, HYPERTENSION, V19, P766, DOI 10.1161/01.HYP.19.6.766; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; NUNES JP, 1993, N-S ARCH PHARMACOL, V348, P264; Ohashi Y, 1998, J CLIN INVEST, V102, P2061, DOI 10.1172/JCI4394; Ortiz PA, 2002, AM J PHYSIOL-RENAL, V282, pF777, DOI 10.1152/ajprenal.00334.2001; Palmer RM, 1987, NITRIC OXIDE RELEASE; PIASCIK MT, 1991, EUR J PHARMACOL, V199, P279, DOI 10.1016/0014-2999(91)90491-8; SAKUMA I, 1992, CIRC RES, V70, P607, DOI 10.1161/01.RES.70.3.607; Salomonsson M, 2001, AM J PHYSIOL-RENAL, V281, pF264, DOI 10.1152/ajprenal.2001.281.2.F264; Santha P, 2012, IDEGGYOGY SZEMLE, V65, P195; SATTAR MA, 1994, J CARDIOVASC PHARM, V23, P232, DOI 10.1097/00005344-199402000-00009; SATTAR MA, 1994, J CARDIOVASC PHARM, V24, P420, DOI 10.1097/00005344-199409000-00010; Shah AM, 2000, PHARMACOL THERAPEUT, V86, P49, DOI 10.1016/S0163-7258(99)00072-8; Shen JG, 2006, J NEUROCHEM, V96, P1078, DOI 10.1111/j.1471-4159.2005.03589.x; Shokoji T, 2003, HYPERTENSION, V41, P266, DOI 10.1161/01.HYP.0000049621.85474.CF; SUN CLJ, 1983, PHARMACOLOGY, V27, P319; Testai L, 2015, NITRIC OXIDE-BIOL CH, V47, P25, DOI 10.1016/j.niox.2015.03.003; Tripatara P, 2007, J AM SOC NEPHROL, V18, P570, DOI 10.1681/ASN.2006050450; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang YF, 2006, BIOCHEM BIOPH RES CO, V345, P851, DOI 10.1016/j.bbrc.2006.04.162; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Xu SL, 2013, AM J PHYSIOL-HEART C, V305, pH1484, DOI 10.1152/ajpheart.00382.2013; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yatsu T, 2003, EUR J PHARMACOL, V461, P191, DOI 10.1016/S0014-2999(03)01305-0; Ye SH, 1997, J CLIN INVEST, V99, P540, DOI 10.1172/JCI119191; Yong QC, 2011, ANTIOXID REDOX SIGN, V14, P2081, DOI 10.1089/ars.2010.3572; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zou AP, 1997, HYPERTENSION, V29, P194, DOI 10.1161/01.HYP.29.1.194	68	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0189386	10.1371/journal.pone.0189386	http://dx.doi.org/10.1371/journal.pone.0189386			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447158	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900003
J	Luczkiewicz, P; Daszkiewicz, K; Witkowski, W; Chroscielewski, J; Ferenc, T; Baczkowski, B				Luczkiewicz, Piotr; Daszkiewicz, Karol; Witkowski, Wojciech; Chroscielewski, Jacek; Ferenc, Tomasz; Baczkowski, Boguslaw			The influence of a change in the meniscus cross-sectional shape on the medio-lateral translation of the knee joint and meniscal extrusion	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; MAGNETIC-RESONANCE IMAGES; CONTACT PRESSURE; ARTICULAR-CARTILAGE; OSTEOARTHRITIS; SIZE; ATTACHMENTS; SENSITIVITY; ACCURACY; GEOMETRY	Objective The purpose of this study was to evaluate the influence of a change in the meniscus cross sectional shape on its position and on the biomechanics of a knee joint. Methods One main finite element model of a left knee joint was created on the basis of MRI images. The model consisted of bones, articular cartilages, menisci and ligaments. Eight variants of this model with an increased or decreased meniscus height were then prepared. Nonlinear static analyses with a fixed flexion/extension movement for a compressive load of 1000 N were performed. The additional analyses for those models with a constrained medio-lateral relative bone translation allowed for an evaluation of the influence of this translation on a meniscus external shift. Results It was observed that a decrease in the meniscus height caused a decrease in the contact area, together with a decrease in the contact force between the flattened meniscus and the cartilage. For the models with an increased meniscus height, a maximal value of force acting on the meniscus in a medio-lateral direction was obtained. The results have shown that the meniscus external shift was approximately proportional to the meniscus slope angle, but that relationship was modified by a medio-lateral relative bone translation. It was found that the translation of the femur relative to the tibia may be dependent on the geometry of the menisci. Conclusions The results have suggested that a change in the meniscus geometry in the cross sectional plane can considerably affect not only the meniscal external shift, but also the medio-lateral translation of the knee joint as well as the congruency of the knee joint.	[Luczkiewicz, Piotr; Baczkowski, Boguslaw] Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland; [Daszkiewicz, Karol; Witkowski, Wojciech; Chroscielewski, Jacek; Ferenc, Tomasz] Gdansk Univ Technol, Fac Civil & Environm Engn, Dept Mech Mat, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology	Luczkiewicz, P (corresponding author), Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland.	plucz@gumed.edu.pl	Ferenc, Tomasz/Q-5856-2016; Luczkiewicz, Piotr/AAC-2970-2020; Witkowski, Wojciech/E-3550-2017; Chróścielewski, Jacek/N-5959-2018	Ferenc, Tomasz/0000-0002-2551-7570; Luczkiewicz, Piotr/0000-0001-8988-1251; Witkowski, Wojciech/0000-0003-2832-7892; Chróścielewski, Jacek/0000-0002-7648-2785; Daszkiewicz, Karol/0000-0002-0522-7752	Faculty of Civil and Environmental Engineering, Gdahsk University of Technology; Medical University of Gdansk, Gdansk University of Technology	Faculty of Civil and Environmental Engineering, Gdahsk University of Technology; Medical University of Gdansk, Gdansk University of Technology	Abaqus calculations were carried out at the Academic Computer Center in Gdahsk. Karol Daszkiewicz and Tomasz Ferenc are supported with grants for the development of young scientists from the Faculty of Civil and Environmental Engineering, Gdahsk University of Technology. The study was financed by Medical University of Gdansk, Gdansk University of Technology and private donation from Dr Luczkiewicz.	Ali Aidy, 2010, American Journal of Engineering and Applied Sciences, V3, P232, DOI 10.3844/ajeassp.2010.232.239; [Anonymous], AB 6 14 2 US MAN; Arno S, 2012, KNEE, V19, P896, DOI 10.1016/j.knee.2012.04.005; Bao HRC, 2013, J ORTHOP SCI, V18, P256, DOI 10.1007/s00776-012-0334-5; Belvedere C, 2011, J BIOMECH, V44, P877, DOI 10.1016/j.jbiomech.2010.12.004; Blanc R, 2012, MED IMAGE ANAL, V16, P1156, DOI 10.1016/j.media.2012.04.004; Bloecker K, 2015, ARTHRIT CARE RES, V67, P1545, DOI 10.1002/acr.22615; Bloecker K, 2013, OSTEOARTHR CARTILAGE, V21, P419, DOI 10.1016/j.joca.2012.11.015; Bruns K, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-32; Burkhart TA, 2013, J BIOMECH, V46, P1477, DOI 10.1016/j.jbiomech.2013.03.022; Conconi M, 2014, J BIOMECH, V47, P3787, DOI 10.1016/j.jbiomech.2014.10.030; DeFrate LE, 2004, J BIOMECH, V37, P1499, DOI 10.1016/j.jbiomech.2004.01.012; DeFrate LE, 2006, AM J SPORT MED, V34, P1240, DOI 10.1177/0363546506287299; Donahue TLH, 2002, J BIOMECH ENG-T ASME, V124, P273, DOI 10.1115/1.1470171; Donahue TLH, 2004, J ORTHOP RES, V22, P807, DOI 10.1016/j.orthres.2003.12.010; Donahue TLH, 2003, J BIOMECH, V36, P19, DOI 10.1016/S0021-9290(02)00305-6; Erdemir A, 2016, J KNEE SURG, V29, P107, DOI 10.1055/s-0035-1564600; Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012; Gardiner JC, 2003, J ORTHOP RES, V21, P1098, DOI 10.1016/S0736-0266(03)00113-X; Hauch KN, 2010, J BIOMECH, V43, P463, DOI 10.1016/j.jbiomech.2009.09.043; Holzapfel G.A., 2001, NONLINEAR SOLID MECH; Huang A, 2002, J BIOMECH ENG-T ASME, V124, P481, DOI 10.1115/1.1503061; Hwang SH, 2012, OSTEOARTHR CARTILAGE, V20, P110, DOI 10.1016/j.joca.2011.11.005; Jung KA, 2010, RHEUMATOL INT, V30, P1325, DOI 10.1007/s00296-009-1153-7; Kaukinen P, 2016, OSTEOARTHR CARTILAGE, V24, P1565, DOI 10.1016/j.joca.2016.05.001; Kazemi M, 2013, COMPUT MATH METHOD M, V2013, P27, DOI DOI 10.1155/2013/718423; Khoshgoftar M, 2015, J BIOMECH, V48, P1427, DOI 10.1016/j.jbiomech.2015.02.034; KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lee DH, 2011, KNEE SURG SPORT TR A, V19, P222, DOI 10.1007/s00167-010-1274-2; Li G, 2001, J BIOMECH ENG-T ASME, V123, P341, DOI 10.1115/1.1385841; Luczkiewicz P, 2017, MED HYPOTHESES, V101, P48, DOI 10.1016/j.mehy.2017.02.003; Luczkiewicz P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167733; Luczkiewicz P, 2015, J BIOMECH, V48, P1356, DOI 10.1016/j.jbiomech.2015.03.002; McNulty AL, 2015, J BIOMECH, V48, P1469, DOI 10.1016/j.jbiomech.2015.02.008; Meakin JR, 2003, KNEE, V10, P33, DOI 10.1016/S0968-0160(02)00106-0; Patel R, 2016, EUR J RADIOL OPEN, V3, P100, DOI 10.1016/j.ejro.2016.05.002; Pena E, 2006, INT J NUMER METH ENG, V68, P836, DOI 10.1002/nme.1726; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124; Shirazi R, 2008, J BIOMECH, V41, P3340, DOI 10.1016/j.jbiomech.2008.09.033; Stehling C, 2012, EUR J RADIOL, V81, P1839, DOI 10.1016/j.ejrad.2011.05.027; Szarmach A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159156; Tummala S, 2012, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: DEFORMATION AND FLOW, P51, DOI 10.1007/978-1-4614-3172-5_7; Van Den Broeck J, 2013, BONE JOINT J B S34, V95- B, P186; Van den Broeck J, 2014, MED ENG PHYS, V36, P949, DOI 10.1016/j.medengphy.2014.03.016; WALKER PS, 1975, CLIN ORTHOP RELAT R, P184; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Weissheimer A, 2012, AM J ORTHOD DENTOFAC, V142, P801, DOI 10.1016/j.ajodo.2012.07.015; Wenger A, 2013, ARTHRITIS RHEUM-US, V65, P1804, DOI 10.1002/art.37947; Wenger A, 2012, EUR RADIOL, V22, P211, DOI 10.1007/s00330-011-2234-z; Yang NH, 2010, J APPL BIOMECH, V26, P432, DOI 10.1123/jab.26.4.432; Yao J, 2006, J BIOMECH ENG-T ASME, V128, P399, DOI 10.1115/1.2191077	53	10	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193020	10.1371/journal.pone.0193020	http://dx.doi.org/10.1371/journal.pone.0193020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447236	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900098
J	Mendis, HC; Thomas, VP; Schwientek, P; Salamzade, R; Chien, JT; Waidyarathne, P; Kloepper, J; De La Fuente, L				Mendis, Hajeewaka C.; Thomas, Varghese P.; Schwientek, Patrick; Salamzade, Rauf; Chien, Jung-Ting; Waidyarathne, Pramuditha; Kloepper, Joseph; De La Fuente, Leonardo			Strain-specific quantification of root colonization by plant growth promoting rhizobacteria Bacillus firmus I-1582 and Bacillus amyloliquefaciens QST713 in non-sterile soil and field conditions	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS STRAINS; NEMATODE MELOIDOGYNE-INCOGNITA; SOLANI DAMPING-OFF; SYSTEMIC RESISTANCE; TOMATO PLANTS; BIOCONTROL; RHIZOSPHERE; BACTERIA; MAIZE; PROTECTION	Bacillus amyloliquefaciens QST713 and B. firmus I-1582 are bacterial strains which are used as active ingredients of commercially-available soil application and seed treatment products Serenade (R) and VOTiVO (R), respectively. These bacteria colonize plant roots promoting plant growth and offering protection against pathogens/pests. The objective of this study was to develop a qPCR protocol to quantitate the dynamics of root colonization by these two strains under field conditions. Primers and TaqMan (R) probes were designed based on genome comparisons of the two strains with publicly-available and unpublished bacterial genomes of the same species. An optimized qPCR protocol was developed to quantify bacterial colonization of corn roots after seed treatment. Treated corn seeds were planted in non-sterile soil in the greenhouse and grown for 28 days. Specific detection of bacteria was quantified weekly, and showed stable colonization between similar to 104-10(5) CFU/g during the experimental period for both bacteria, and the protocol detected as low as 10(3) CFU/g bacteria on roots. In a separate experiment, streptomycin-resistant QST713 and rifampicin-resistant I-1582 strains were used to compare dilution-plating on TSA with the newly developed qPCR method. Results also indicated that the presence of natural microflora and another inoculated strain does not affect root colonization of either one of these strains. The same qPCR protocol was used to quantitate root colonization by QST713 and I-1582 in two corn and two soybean varieties grown in the field. Both bacteria were quantitated up to two weeks after seeds were planted in the field and there were no significant differences in root colonization in either bacteria strain among varieties. Results presented here confirm that the developed qPCR protocol can be successfully used to understand dynamics of root colonization by these bacteria in plants growing in growth chamber, greenhouse and the field.	[Mendis, Hajeewaka C.; Kloepper, Joseph; De La Fuente, Leonardo] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Thomas, Varghese P.; Schwientek, Patrick; Salamzade, Rauf; Chien, Jung-Ting] Bayer, Crop Sci Div, Biol, West Sacramento, CA USA; [Waidyarathne, Pramuditha] Lincoln Univ, Ctr Adv Computat Solut, Christchurch, New Zealand; [Salamzade, Rauf] Broad Inst MIT & Harvard, Cambridge, MA USA; [Waidyarathne, Pramuditha] Coconut Res Inst Sri Lanka, Lunuwila, Sri Lanka	Auburn University System; Auburn University; Bayer AG; Bayer CropScience; Lincoln University - New Zealand; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	De La Fuente, L (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	lzd0005@auburn.edu		Salamzade, Rauf/0000-0002-1923-5948; Mendis, Hajeewaka/0000-0002-2346-9077	Bayer CropScience LP; Bayer CropScience	Bayer CropScience LP(Bayer AG); Bayer CropScience(Bayer AG)	JK and LDLF received funding from Bayer CropScience LP for this project. Bayer CropScience provided support in the form of salaries and funds for supplies for authors VPT, PS, RS, JTC, HM, JK and LD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdelrahman M, 2016, PLANT SCI, V246, P128, DOI 10.1016/j.plantsci.2016.02.008; Arrebola E, 2010, J APPL MICROBIOL, V108, P386, DOI 10.1111/j.1365-2672.2009.04438.x; Asaka O, 1996, APPL ENVIRON MICROB, V62, P4081, DOI 10.1128/AEM.62.11.4081-4085.1996; ASO, CROP PROTECTION, V93, P1; Babu AN, 2015, PLANT SCI, V231, P62, DOI 10.1016/j.plantsci.2014.11.006; Castillo JD, 2013, PLANT DIS, V97, P967, DOI 10.1094/PDIS-10-12-0978-RE; Chen XH, 2009, J MOL MICROB BIOTECH, V16, P14, DOI 10.1159/000142891; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; Couillerot O, 2010, SOIL BIOL BIOCHEM, V42, P2298, DOI 10.1016/j.soilbio.2010.09.003; De La Fuente L, 2006, FEMS MICROBIOL ECOL, V56, P64, DOI 10.1111/j.1574-6941.2006.00074.x; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Gardener BBM, 2005, PHYTOPATHOLOGY, V95, P715, DOI 10.1094/PHYTO-95-0715; Glick B. R., 1999, BIOCH GENETIC MECH U, DOI DOI 10.1142/P130; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Huang XQ, 2012, MICROBIOL RES, V167, P135, DOI 10.1016/j.micres.2011.06.002; Hurek T, 2003, J BIOTECHNOL, V106, P169, DOI 10.1016/j.jbiotec.2003.07.010; Jogaiah S, MOL PLANT PATHOLOGY; Jogaiah Sudisha, 2010, Archives of Phytopathology and Plant Protection, V43, P368, DOI 10.1080/03235400701806377; Joshi R, 2006, PHYTOPATHOLOGY, V96, P145, DOI 10.1094/PHYTO-96-0145; Kamilova F, 2005, ENVIRON MICROBIOL, V7, P1809, DOI 10.1111/j.1462-2920.2005.00889.x; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; KLOEPPER JW, 1992, CAN J MICROBIOL, V38, P1219, DOI 10.1139/m92-202; Kumar A, 2011, BACTERIA IN AGROBIOLOGY: CROP ECOSYSTEMS, P37, DOI 10.1007/978-3-642-18357-7_2; Lahlali R, 2013, PHYTOPATHOLOGY, V103, P245, DOI 10.1094/PHYTO-06-12-0123-R; Leclere V, 2005, APPL ENVIRON MICROB, V71, P4577, DOI 10.1128/AEM.71.8.4577-4584.2005; LIDDELL CM, 1989, PHYTOPATHOLOGY, V79, P1327, DOI 10.1094/Phyto-79-1327; Mavrodi OV, 2007, APPL ENVIRON MICROB, V73, P5531, DOI 10.1128/AEM.00925-07; Mendoza AR, 2008, BIOCONTROL SCI TECHN, V18, P377, DOI 10.1080/09583150801952143; Mosimann C, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02150; Pereira TP, 2014, MOL BIOTECHNOL, V56, P660, DOI 10.1007/s12033-014-9742-4; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Podile A., 2007, PLANT ASS BACTERIA, P195, DOI [10.1094/Phyto-71-642, DOI 10.1094/PHYTO-71-642]; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Reiss A, 2017, CROP PROT, V93, P1, DOI 10.1016/j.cropro.2016.11.009; Saharan BS, 2011, LIFE SCI MED RES; Schmidt E. L., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P803; Simons M, 1996, MOL PLANT MICROBE IN, V9, P600, DOI 10.1094/MPMI-9-0600; Terefe M, 2009, J INVERTEBR PATHOL, V100, P94, DOI 10.1016/j.jip.2008.11.004; Von Felten A, 2010, J MICROBIOL METH, V81, P108, DOI 10.1016/j.mimet.2010.02.003; Yuan J, 2013, J AGR FOOD CHEM, V61, P3774, DOI 10.1021/jf400038z	41	54	55	7	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193119	10.1371/journal.pone.0193119	http://dx.doi.org/10.1371/journal.pone.0193119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447287	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900113
J	Rather, SA; Subramaniam, S; Danda, S; Pandey, AK				Rather, Shabir A.; Subramaniam, Shweta; Danda, Shagun; Pandey, Arun K.			Discovery of two new species of Crotalaria (Leguminosae, Crotalarieae) from Western Ghats, India	PLOS ONE			English	Article							DNA-SEQUENCES; MAXIMUM-LIKELIHOOD; MIXED MODELS; TRNL-F; FABACEAE; ALIGNMENT; ANGIOSPERMS; MORPHOLOGY; NUCLEAR	Two new species of Fabaceae-Papilionoideae are described and illustrated. Crotalaria suffruticosa from Karul Ghat region of Maharashtra is morphologically close to C. albida and C. epunctata. C. multibracteata from Panhala region of Maharashtra resembles C. vestita. C. suffruticosa differs from C. albida and C. epunctata in its habit, leaf, inflorescence, callosity, keel type, stigma, style morphology and number of seeds/pod. To test if the new species differ from their morphologically most similar species, we measured various traits and performed a Principal Component Analysis (PCA). This analysis shows that the new species differs from similar species in gross morphology for several diagnostic traits and showed correlations between the variables or distance among groups and estimated the contribution of each character. Phylogenetic analyses were also conducted based on nuclear (ITS) and plastid (matK) markers. The analyses revealed nucleotide differences between the new species and their close allies attributing to their distinctiveness. A map and key including all species of Crotalaria from Maharashtra state are provided. Conservation status of the two new species have also been assessed.	[Rather, Shabir A.; Subramaniam, Shweta; Danda, Shagun; Pandey, Arun K.] Univ Delhi, Dept Bot, Plant Systemat Lab, Delhi, India	University of Delhi	Pandey, AK (corresponding author), Univ Delhi, Dept Bot, Plant Systemat Lab, Delhi, India.	arunpandey79@gmail.com		Subramaniam, Shweta/0000-0003-0400-6875	University Grants Commission New Delhi, India [BSR-2013-2014-UGC, RGNF-2015-2017-SC-DEL-21275]	University Grants Commission New Delhi, India(University Grants Commission, India)	This work was supported by Fellowship to Research Scholars (Shabir Ahmad Rather and Shagun Danda) from University Grants Commission (BSR-2013-2014-UGC to SAR and RGNF-2015-2017-SC-DEL-21275 to SD) New Delhi, India.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2017, JSTOR GLOBAL PLANTS; [Anonymous], 2017, C CHINESE VIRTUAL HE; [Anonymous], 2002, ESRI DATA MAPS ARCGI; Ansari AA, 2008, CROTALARIA IN INDIA; Boatwright JS, 2009, S AFR J BOT, V75, P546, DOI 10.1016/j.sajb.2009.06.001; Boatwright JS, 2008, SYST BOT, V33, P752, DOI 10.1600/036364408786500271; Boatwright JS, 2011, TAXON, V60, P161, DOI 10.1002/tax.601014; Chase MW, 2000, ANN BOT-LONDON, V86, P935, DOI 10.1006/anbo.2000.1262; Danda S, 2016, SYST BOT, V41, P307, DOI 10.1600/036364416X691894; Endress PK, 2010, J SYST EVOL, V48, P225, DOI 10.1111/j.1759-6831.2010.00087.x; Flores AS, 2006, BOT J LINN SOC, V151, P271, DOI 10.1111/j.1095-8339.2006.00479.x; Gene Codes Corporation, SEQ 5 1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris JG, 2001, PLANT IDENTIFICATION; Heracle BioSoft, 2016, DNA SEQ ASS 4 36; Hewson H., 1990, PLANT INDUMENTUM H 9, V9; Hickey M, 2007, CAMBRIDGE ILLUSTRATE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodkinson TR, 2002, AM J BOT, V89, P279, DOI 10.3732/ajb.89.2.279; Hopper SD, 1999, BOT J LINN SOC, V131, P285, DOI 10.1111/j.1095-8339.1999.tb00770.x; IUCN, 2012, GUID APPL IUCN RED L; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kucharczyk H, 2012, APPL PCA TAXONOMY RE, DOI [10.5772/37602, DOI 10.5772/37602]; Kumar S, 2003, LEGUMES S ASIA CHECK, P140; le Roux MM, 2013, TAXON, V62, P957, DOI 10.12705/625.1; Lewis G.P., 2005, LEGUMES WORLD, P187; Maddison WP, 2009, MESQUITE 3 2 MODULAR; McAleece N., 1997, BIODIVERSITY PROFESS; Pandey A, 2010, GENET RESOUR CROP EV, V57, P461, DOI 10.1007/s10722-009-9517-0; POLHILL R. M., 1982, CROTALARIA AFRICA MA; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanjappa M., 1992, LEGUMES OF INDIA; Scuri S, 2006, ACTA HYDROCH HYDROB, V34, P498, DOI 10.1002/aheh.200600646; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUBRAMANIAM S, 2013, ACTA BIOL INDICA, V2, P253; Subramaniam S, 2015, PLANT SYST EVOL, V301, P2261, DOI 10.1007/s00606-015-1228-8; Subramaniam S, 2013, PLANT SYST EVOL, V299, P1089, DOI 10.1007/s00606-013-0781-2; Thiers B, 2020, INDEX HERBARIORUM GL; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Wyk B. E, 2005, LEGUMES WORLD, P21; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192226	10.1371/journal.pone.0192226	http://dx.doi.org/10.1371/journal.pone.0192226			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447200	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900025
J	Takahata, K; Horiuchi, S; Tadokoro, Y; Shuo, T; Sawano, E; Shinohara, K				Takahata, Kaori; Horiuchi, Shigeko; Tadokoro, Yuriko; Shuo, Takuya; Sawano, Erika; Shinohara, Kazuyuki			Effects of breast stimulation for spontaneous onset of labor on salivary oxytocin levels in low-risk pregnant women: A feasibility study	PLOS ONE			English	Article							NIPPLE STIMULATION; RATING-SCALES; RESPONSES; PLASMA; INDUCTION; PROLACTIN; UTERINE	Objectives This preliminary study aimed to 1) determine changes in the salivary oxytocin (OT) level during breast stimulation for promoting the spontaneous onset of labor in low-risk term pregnancies, and 2) clarify the feasibility of the breast stimulation intervention protocol in terms of practicality and acceptability. Methods We used a single arm trial design. Sixteen low-risk pregnant women between 38 and 40 weeks of gestation with cephalic presentation participated. They performed breast stimulation for 3 days with an attendant midwife in a single maternity hospital. Each breast was stimulated for 15 minutes for a total of 1 hour per day. Saliva was collected 10 minutes before the intervention and 15, 30, 60, 75, and 90 minutes after the intervention, yielding 18 samples per woman. Results Among a total of 282 saliva samples from the 16 participants, OT level was measured in 142 samples (missing rate: 49.6%). The median OT level showed the highest values on day 3 of the breast stimulation, with a marked increase 30 min after the intervention. In the mixed models after multiple imputation for missing data, the OT level on the first day of intervention was significantly lower than that on the third day of intervention. Fatigue from breast stimulation decreased on subsequent days, and most of the women (75%) felt no discomfort with the protocol. Uterine hyperstimulation was not observed. Conclusion Following a 3-day breast stimulation protocol for spontaneous onset of labor, the mean OT level showed the highest values on day 3. The breast stimulation intervention protocol showed good feasibility in terms of practicality and acceptability among the pregnant women. Additional large-scale studies are warranted to confirm the protocol's effectiveness.	[Takahata, Kaori; Tadokoro, Yuriko] St Lukes Int Univ, Tokyo, Japan; [Horiuchi, Shigeko] St Lukes Int Univ, Grad Sch Nursing Sci, Tokyo, Japan; [Horiuchi, Shigeko] St Lukes Matern Care Home, Tokyo, Japan; [Shuo, Takuya] Hokuriku Univ, Kanazawa, Ishikawa, Japan; [Sawano, Erika; Shinohara, Kazuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurobiol & Behav, Nagasaki, Japan	St. Luke's International Hospital; St. Luke's International Hospital; Hokuriku University; Nagasaki University	Takahata, K (corresponding author), St Lukes Int Univ, Tokyo, Japan.	kaoritakahata@slcn.ac.jp	horiuchi, shigeko/AAH-2458-2020; takahata, kaori/ABE-1278-2020	horiuchi, shigeko/0000-0001-7412-3941; takahata, kaori/0000-0002-8141-3354; Tadokoro, Yuriko/0000-0002-4074-4683	Japan Society for the Promotion of Science [B26293475, 17H01613]; Terumo Foundation for Life Sciences and Arts; Yamaji Fumiko Nursing Research Fund; Grants-in-Aid for Scientific Research [17H01613] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Terumo Foundation for Life Sciences and Arts; Yamaji Fumiko Nursing Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (B26293475), and Japan Society for the Promotion of Science (17H01613) (https://www.jsps.go.jp/english/e-grants/grants01.html) awarded to SH, Terumo Foundation for Life Sciences and Arts (https://www.terumozaidan.or.jp/english/), and the Yamaji Fumiko Nursing Research Fund (http://www.smtb.jp/tools/english/), and by a generous donation from The Japan Health Foundation (http://www.jnhf.or.jp/under_construction/) awarded to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewole I F, 1993, Afr J Med Med Sci, V22, P81; AMICO JA, 1986, CLIN ENDOCRINOL, V25, P97, DOI 10.1111/j.1365-2265.1986.tb01670.x; Boulvain M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000451.pub2; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; CHAYEN B, 1986, J REPROD MED, V31, P116; CHEN C, 1995, PSYCHOL SCI, V6, P170, DOI 10.1111/j.1467-9280.1995.tb00327.x; CHRISTENSSON K, 1989, ACTA OBSTET GYN SCAN, V68, P205, DOI 10.3109/00016348909020990; Curtis P, 1999, BIRTH-ISS PERINAT C, V26, P115, DOI 10.1046/j.1523-536x.1999.00115.x; Damania K K, 1992, J Postgrad Med, V38, P58; Demirel G, 2015, WORLDV EVID-BASED NU, V12, P273, DOI 10.1111/wvn.12116; ELLIOTT JP, 1984, AM J OBSTET GYNECOL, V149, P628, DOI 10.1016/0002-9378(84)90247-3; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Feldman R, 2011, DEVELOPMENTAL SCI, V14, P752, DOI 10.1111/j.1467-7687.2010.01021.x; Feldman R, 2010, PSYCHONEUROENDOCRINO, V35, P1133, DOI 10.1016/j.psyneuen.2010.01.013; FINLEY BE, 1986, OBSTET GYNECOL, V67, P836, DOI 10.1097/00006250-198606000-00018; Gregory SG, 2013, JAMA PEDIATR, V167, P959, DOI 10.1001/jamapediatrics.2013.2904; Grewen KM, 2010, PSYCHOPHYSIOLOGY, V47, P625, DOI 10.1111/j.1469-8986.2009.00968.x; Gulmezoglu AM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945.pub3; Haefeli M, 2006, EUR SPINE J, V15, pS17, DOI 10.1007/s00586-005-1044-x; Henderson J, 2013, ACTA OBSTET GYN SCAN, V92, P1159, DOI 10.1111/aogs.12211; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; Hoffman ER, 2012, EAT BEHAV, V13, P256, DOI 10.1016/j.eatbeh.2012.02.004; Kavanagh J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003392.pub2; LEAKE RD, 1984, AM J OBSTET GYNECOL, V148, P259, DOI 10.1016/S0002-9378(84)80064-2; Lee JW, 2002, RES NURS HEALTH, V25, P295, DOI 10.1002/nur.10041; Oberg AS, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0965; Prevost M, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00001; ROSS MG, 1986, AM J PERINAT, V3, P339, DOI 10.1055/s-2007-999893; SALMON YM, 1986, OBSTET GYNECOL, V67, P21; Singh N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/695037; Takahata K., 2015, J JAPAN ACAD MIDWIFE, V29, P251; Terkawi AS, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.079; Waldenstrom U, 2004, BIRTH-ISS PERINAT C, V31, P17, DOI 10.1111/j.0730-7659.2004.0270.x; White-Traut R, 2009, DEV PSYCHOBIOL, V51, P367, DOI 10.1002/dev.20376	35	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192757	10.1371/journal.pone.0192757	http://dx.doi.org/10.1371/journal.pone.0192757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447299	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900052
J	Arakaki, X; Shoga, M; Li, LY; Zouridakis, G; Tran, T; Fonteh, AN; Dawlaty, J; Goldweber, R; Pogoda, JM; Harrington, MG				Arakaki, Xianghong; Shoga, Michael; Li, Lianyang; Zouridakis, George; Thao Tran; Fonteh, Alfred N.; Dawlaty, Jessica; Goldweber, Robert; Pogoda, Janice M.; Harrington, Michael G.			Alpha desynchronization/synchronization during working memory testing is compromised in acute mild traumatic brain injury (mTBI)	PLOS ONE			English	Article							4TH INTERNATIONAL-CONFERENCE; NEURAL OSCILLATIONS; CONSENSUS STATEMENT; SPORT HELD; EEG; CONCUSSION; ATTENTION; PHASE; PERFORMANCE; THETA	Diagnosing and monitoring recovery of patients with mild traumatic brain injury (mTBI) is challenging because of the lack of objective, quantitative measures. Diagnosis is based on description of injuries often not witnessed, subtle neurocognitive symptoms, and neuropsychological testing. Since working memory (WM) is at the center of cognitive functions impaired in mTBI, this study was designed to define objective quantitative electroencephalographic (qEEG) measures of WM processing that may correlate with cognitive changes associated with acute mTBI. First-time mTBI patients and mild peripheral (limb) trauma controls without head injury were recruited from the emergency department. WM was assessed by a continuous performance task (N-back). EEG recordings were obtained during N-back testing on three occasions: within five days, two weeks, and one month after injury. Compared with controls, mTBI patients showed abnormal induced and evoked alpha activity including event-related desynchronization (ERD) and synchronization (ERS). For induced alpha power, TBI patients had excessive frontal ERD on their first and third visit. For evoked alpha, mTBI patients had lower parietal ERD/ERS at the second and third visits. These exploratory qEEG findings offer new and non-invasive candidate measures to characterize the evolution of injury over the first month, with potential to provide much-needed objective measures of brain dysfunction to diagnose and monitor the consequences of mTBI.	[Arakaki, Xianghong; Shoga, Michael; Thao Tran; Fonteh, Alfred N.; Dawlaty, Jessica; Harrington, Michael G.] Huntington Med Res Inst, Neurosci, Pasadena, CA 91101 USA; [Li, Lianyang; Zouridakis, George] Univ Houston, Biomed Imaging Lab, Houston, TX USA; [Goldweber, Robert] Huntington Hosp, Emergency Dept, Pasadena, CA USA; [Pogoda, Janice M.] Columbus Biometr LLC, Reno, NV USA	Huntington Medical Research Institutes; University of Houston System; University of Houston; University of Southern California; Huntington Memorial Hospital	Arakaki, X (corresponding author), Huntington Med Res Inst, Neurosci, Pasadena, CA 91101 USA.	xianghong@hmri.org	Zouridakis, George/R-8876-2019	Zouridakis, George/0000-0002-7770-9857; Harrington, Michael/0000-0002-7923-8032	Department of the army, USAMRAA, military medical research and development [DoD: W81XWH-13-1-0005]; HMRI; Columbus Biometrics	Department of the army, USAMRAA, military medical research and development; HMRI; Columbus Biometrics	This research was funded by a grant from the DoD: W81XWH-13-1-0005, Department of the army, USAMRAA, military medical research and development. HMRI provided additional financial support. Columbus Biometrics provided support in the form of salaries for author JMP but did not have any additional role in the study design, data collection or decision to publish of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Columbus Biometrics was a paid independent consultant, and Columbus Biometrics assisted in statistical analyses and manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a grant from the DoD: W81XWH-13-1-0005, Department of the army, USAMRAA, military medical research and development. HMRI provided additional financial support.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Axmacher N, 2010, EUR J NEUROSCI, V31, P177, DOI 10.1111/j.1460-9568.2009.07041.x; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Bastiaansen M, 2003, CORTEX, V39, P967, DOI 10.1016/S0010-9452(08)70873-6; Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Brincat SL, 2016, J NEUROSCI, V36, P9739, DOI 10.1523/JNEUROSCI.0274-16.2016; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cooper NR, 2006, NEUROREPORT, V17, P205, DOI 10.1097/01.wnr.0000198433.29389.54; Darowski ES, 2008, NEUROPSYCHOLOGY, V22, P638, DOI 10.1037/0894-4105.22.5.638; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Deiber MP, 2009, NEUROBIOL AGING, V30, P1444, DOI 10.1016/j.neurobiolaging.2007.11.021; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dipoppa M, 2013, P NATL ACAD SCI USA, V110, P12828, DOI 10.1073/pnas.1303270110; Dong SS, 2015, BRAIN RES, V1616, P146, DOI 10.1016/j.brainres.2015.05.003; Doppelmayr M, 2005, NEUROSCI LETT, V381, P309, DOI 10.1016/j.neulet.2005.02.037; Eckart C, 2016, NEUROIMAGE, V137, P61, DOI 10.1016/j.neuroimage.2016.05.049; Ergen M, 2014, INT J PSYCHOPHYSIOL, V94, P463, DOI 10.1016/j.ijpsycho.2014.08.177; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Foster JJ, 2016, J NEUROPHYSIOL, V115, P168, DOI 10.1152/jn.00860.2015; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Grabner RH, 2006, BRAIN RES BULL, V69, P422, DOI 10.1016/j.brainresbull.2006.02.009; Grabner RH, 2004, COGNITIVE BRAIN RES, V20, P212, DOI 10.1016/j.cogbrainres.2004.02.010; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitland I, 2013, BEHAV BRAIN RES, V249, P55, DOI 10.1016/j.bbr.2013.04.013; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hsueh JJ, 2016, HUM BRAIN MAPP, V37, P2662, DOI 10.1002/hbm.23201; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Ishibashi K, 2014, EUR J NEUROSCI, V40, P2701, DOI 10.1111/ejn.12633; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; Jonassen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030564; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Khader P, 2007, COGN AFFECT BEHAV NE, V7, P212, DOI 10.3758/CABN.7.3.212; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Lee RR, 2014, PROG NEUROL SURG, V28, P94, DOI 10.1159/000358768; Lei SG, 2011, HUM FACTORS, V53, P168, DOI 10.1177/0018720811400601; Lenartowicz A, 2016, NEUROIMAGE-CLIN, V11, P210, DOI 10.1016/j.nicl.2016.01.023; Lenartowicz A, 2014, J NEUROSCI, V34, P1171, DOI 10.1523/JNEUROSCI.1765-13.2014; Li LY, 2016, IEEE ENG MED BIO, P1862, DOI 10.1109/EMBC.2016.7591083; Li LY, 2015, IEEE ENG MED BIO, P6963, DOI 10.1109/EMBC.2015.7319994; Liguori C, 2016, EUR J NUCL MED MOL I, V43, P2040, DOI 10.1007/s00259-016-3417-2; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Manza P, 2014, J NEUROSCI, V34, P5998, DOI 10.1523/JNEUROSCI.4641-13.2014; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Masurkar AV, 2014, CURR GERIATR REP, V3, P91, DOI 10.1007/s13670-014-0080-y; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Medaglia JD, 2015, BRAIN IMAGING BEHAV, V9, P285, DOI 10.1007/s11682-014-9306-z; Muhl C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00114; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pesonen M, 2007, BRAIN RES, V1138, P171, DOI 10.1016/j.brainres.2006.12.076; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Plume A., 2014, SCI ENG ETHICS, V38, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sauseng P, 2012, CURR BIOL, V22, pR306, DOI 10.1016/j.cub.2012.03.029; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; van der Horn H. J., 2015, BRAIN IMAGING BEHAV; Vorobyov S, 2002, BIOL CYBERN, V86, P293, DOI 10.1007/s00422-001-0298-6; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zhang GH, 2015, J VISION, V15, DOI 10.1167/15.10.8	88	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0188101	10.1371/journal.pone.0188101	http://dx.doi.org/10.1371/journal.pone.0188101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444081	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500002
J	Nielsen, TRH; Fonvig, CE; Dahl, M; Mollerup, PM; Lausten-Thomsen, U; Pedersen, O; Hansen, T; Holm, JC				Nielsen, Tenna Ruest Haarmark; Fonvig, Cilius Esmann; Dahl, Maria; Mollerup, Pernille Maria; Lausten-Thomsen, Ulrik; Pedersen, Oluf; Hansen, Torben; Holm, Jens-Christian			Childhood obesity treatment; Effects on BMI SDS, body composition, and fasting plasma lipid concentrations	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; CHRONIC CARE TREATMENT; MASS INDEX; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; WEIGHT-LOSS; LMS METHOD; CHILDREN; FAT; ADOLESCENTS	Objective The body mass index (BMI) standard deviation score (SDS) may not adequately reflect changes in fat mass during childhood obesity treatment. This study aimed to investigate associations between BMI SDS, body composition, and fasting plasma lipid concentrations at baseline and during childhood obesity treatment. Methods 876 children and adolescents (498 girls) with overweight/obesity, median age 11.2 years (range 1.6-21.7), and median BMI SDS 2.8 (range 1.3-5.7) were enrolled in a multidisciplinary outpatient treatment program and followed for a median of 1.8 years (range 0.4-7.4). Height and weight, body composition measured by dual-energy X-ray absorptiometry, and fasting plasma lipid concentrations were assessed at baseline and at follow-up. Lipid concentrations (total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), non-HDL, and triglycerides (TG)) were available in 469 individuals (264 girls). Linear regressions were performed to investigate the associations between BMI SDS, body composition indices, and lipid concentrations. Results At baseline, BMI SDS was negatively associated with concentrations of HDL (p = 6.7*10(-4))and positively with TG (p = 9.7*10(-6)). Reductions in BMI SDS were associated with reductions in total body fat percentage (p<2*10(-16)) and percent truncal body fat (p<2* 10(-16)). Furthermore, reductions in BMI SDS were associated with improvements in concentrations of TC, LDL, HDL, non-HDL, LDL/HDL-ratio, and TG (all p < 0.0001). Changes in body fat percentage seemed to mediate the changes in plasma concentrations of TC, LDL, and non-HDL, but could not alone explain the changes in HDL, LDL/HDL-ratio or TG. Among 81 individuals with available lipid concentrations, who increased their BMI SDS, 61% improved their body composition, and 80% improved their lipid concentrations. Conclusion Reductions in the degree of obesity during multidisciplinary childhood obesity treatment are accompanied by improvements in body composition and fasting plasma lipid concentrations. Even in individuals increasing their BMI SDS, body composition and lipid concentrations may improve.	[Nielsen, Tenna Ruest Haarmark; Fonvig, Cilius Esmann; Dahl, Maria; Mollerup, Pernille Maria; Lausten-Thomsen, Ulrik; Holm, Jens-Christian] Copenhagen Univ Hosp Holbaek, Childrens Obes Clin, Dept Pediat, Holbaek, Denmark; [Nielsen, Tenna Ruest Haarmark; Fonvig, Cilius Esmann; Pedersen, Oluf; Hansen, Torben; Holm, Jens-Christian] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Fonvig, Cilius Esmann] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark; [Lausten-Thomsen, Ulrik; Holm, Jens-Christian] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Nielsen, TRH (corresponding author), Copenhagen Univ Hosp Holbaek, Childrens Obes Clin, Dept Pediat, Holbaek, Denmark.; Nielsen, TRH (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark.	ter@regionsjaelland.dk	Fonvig, Cilius/I-1234-2013; Pedersen, Oluf/Z-1731-2019; Holm, Jens-Christian/T-4594-2017; Pedersen, Oluf/AAG-8015-2020	Fonvig, Cilius/0000-0002-5031-0125; Pedersen, Oluf/0000-0002-3321-3972; Holm, Jens-Christian/0000-0003-4653-342X; Hansen, Torben/0000-0001-8748-3831; Lausten-Thomsen, Ulrik/0000-0003-1136-4347	Danish Innovation Foundation [0603-00484B, 0603-00457B]; Novo Nordisk Foundation [NNF150C0016544]; Region Zealand Health and Medical Research Foundation	Danish Innovation Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Region Zealand Health and Medical Research Foundation	The study was supported by the Danish Innovation Foundation (grants 0603-00484B and 0603-00457B), the Novo Nordisk Foundation (grant number NNF150C0016544), and the Region Zealand Health and Medical Research Foundation.; The study is part of the research activities in TARGET (The Impact of our Genomes on Individual Treatment Response in Obese Children, www.target.ku.dlk), and BIOCHILD (Genetics and Systems Biology of Childhood Obesity in India and Denmark, www.biochiki.ku.dk). The study is part of The Danish Childhood Obesity Biobank; ClinicalTrials.gov ID-no.: NCT00928473. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). The authors wish to thank Mrs. Oda Troest and Mrs. Birgitte Hollose for their technical expertise, Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Holbwk for their	Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; [Anonymous], 2021, LANG ENV STAT COMP; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Boeke CE, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-99; Bohn B, 2015, OBESITY FACTS, V8, P156, DOI 10.1159/000381227; Botton J, 2007, METABOLISM, V56, P614, DOI 10.1016/j.metabol.2006.12.006; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Lorenzo A, 2006, NUTR METAB CARDIOVAS, V16, P513, DOI 10.1016/j.numecd.2005.10.010; Eissa MA, 2016, J PEDIATR-US, V170, P199, DOI 10.1016/j.jpeds.2015.11.018; Fan B, 2014, J CLIN DENSITOM, V17, P344, DOI 10.1016/j.jocd.2013.08.019; Farpour-Lambert NJ, 2015, OBESITY FACTS, V8, P342, DOI 10.1159/000441483; Fernandez ML, 2008, J AM COLL NUTR, V27, P1, DOI 10.1080/07315724.2008.10719668; Freedman DS, 2009, ARCH PEDIAT ADOL MED, V163, P805, DOI 10.1001/archpediatrics.2009.104; Freedman DS, 2004, INT J OBESITY, V28, P10, DOI 10.1038/sj.ijo.0802544; Frisard MI, 2005, OBES RES, V13, P845, DOI 10.1038/oby.2005.97; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Holm JC, 2011, INT J PEDIATR OBES, V6, P188, DOI 10.3109/17477166.2011.575157; James WPT, 2008, INT J OBESITY, V32, pS120, DOI 10.1038/ijo.2008.247; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Johnson R, 1997, CLIN CHEM, V43, P2183; Karlsson AK, 2013, OBESITY, V21, P1018, DOI 10.1002/oby.20205; Kelishadi R, 2015, J RES MED SCI, V20, P294; Kennedy AP, 2009, OBESITY, V17, P2094, DOI 10.1038/oby.2009.101; Lamb MM, 2011, AM J CLIN NUTR, V94, P877, DOI 10.3945/ajcn.111.015776; Lausten-Thomsen U, 2014, EUR J PEDIATR, V173, P623, DOI 10.1007/s00431-013-2226-x; Mollerup PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173033; Morrison SA, 2016, J CLIN DENSITOM, V19, P290, DOI 10.1016/j.jocd.2015.06.003; Nielsen TRH, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0868-y; Nielsen TRH, 2012, CHILD OBES, V8, P533, DOI 10.1089/chi.2011.0098; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Podenphant J, 1996, SCAND J CLIN LAB INV, V56, P615, DOI 10.3109/00365519609090596; Pratt RE, 2014, J CLIN LIPIDOL, V8, P181, DOI 10.1016/j.jacl.2014.01.003; Rosenbaum M, 2014, J ENDOCRINOL, V223, pT83, DOI 10.1530/JOE-14-0358; Ryder JR, 2013, PEDIATR OBES, V8, pE59, DOI 10.1111/j.2047-6310.2013.00162.x; Shaw NJ, 2007, ARCH DIS CHILD, V92, P872, DOI 10.1136/adc.2007.117911; Taylor RW, 2002, AM J CLIN NUTR, V76, P1416, DOI 10.1093/ajcn/76.6.1416; Taylor SA, 2011, INT J PEDIATR OBES, V6, pE307, DOI 10.3109/17477166.2011.575149; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Warner JT, 1997, ANN HUM BIOL, V24, P209, DOI 10.1080/03014469700004942; Whitehead TP, 1996, ANN CLIN BIOCHEM, V33, P99, DOI 10.1177/000456329603300201; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282	45	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0190576	10.1371/journal.pone.0190576	http://dx.doi.org/10.1371/journal.pone.0190576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444114	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500008
J	Wilson, EA; Briggs, CJ; Dudley, TL				Wilson, Emily A.; Briggs, Cheryl J.; Dudley, Tom L.			Invasive African clawed frogs in California: A reservoir for or predator against the chytrid fungus?	PLOS ONE			English	Article							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; XENOPUS-LAEVIS; AMPHIBIAN DECLINES; POPULATIONS; DYNAMICS; CHYTRIDIOMYCOSIS; DAPHNIA; LARVAE; HOSTS	Amphibian species are experiencing population declines due to infection by the fungal pathogen, Batrachochytrium dendrobatidis (Bd). The African clawed frog (Xenopus laevis), an asymptomatic carrier of Bd, has been implicated in the spread of this pathogen through global trade and established invasive populations on several continents. However, research has not explored the relationships of both life stages of this amphibian with Bd. While the post-metamorphic individuals may act as a reservoir, spreading the infection to susceptible species, the filter-feeding larvae may consume the motile Bd zoospores from the water column, potentially reducing pathogen abundance and thus the likelihood of infection. We explore these contrasting processes by assessing Bd prevalence and infection intensities in field populations of post-metamorphic individuals, and performing laboratory experiments to determine if larval X. laevis preyed upon Bd zoospores. The water flea, Daphnia magna, was included in the Bd consumption trials to compare consumption rates and to explore whether intraguild predation between the larval X. laevis and Daphnia may occur, potentially interfering with control of Bd zoospores by Daphnia. Field surveys of three X. laevis populations in southern California, in which 70 post-metamorphic individuals were tested for Bd, found 10% infection prevalence. All infected individuals had very low infection loads (all Bd loads were below 5 zoospore equivalents). Laboratory experiments found that larval X. laevis consume Bd zoospores and therefore may reduce Bd abundance and transmission between amphibians. However, metamorphic and juvenile X. laevis exhibited intraguild predation by consuming Daphnia, which also prey upon Bd zoospores. The results suggest that X laevis is not a large reservoir for Bd and its larval stage may offer some reduction of Bd transmission through direct predation.	[Wilson, Emily A.; Dudley, Tom L.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wilson, EA (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	eawilson@ucsb.edu			National Institute of Health (NIH) Ecology and Evolution of Infectious Diseases Grant [R01GM109499]; National Science Foundation (NSF) Long Term Research in Environmental Biology grant [DEB-1557190]	National Institute of Health (NIH) Ecology and Evolution of Infectious Diseases Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Long Term Research in Environmental Biology grant(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of Health (NIH) Ecology and Evolution of Infectious Diseases Grant R01GM109499 to CJB, and National Science Foundation (NSF) Long Term Research in Environmental Biology grant DEB-1557190 received by CJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135389; Amaral P, 2012, HERPETOL J, V22, P187; Barata C, 1998, FUNCT ECOL, V12, P442, DOI 10.1046/j.1365-2435.1998.00201.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; DEMOTT WR, 1995, HYDROBIOLOGIA, V307, P127, DOI 10.1007/BF00032004; DiRenzo GV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093356; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Gosner K. L., 1960, Herpetologica, V16, P183; Growth Green J., 1956, J ZOOL, V126, P173; Hamilton PT, 2012, FRESHWATER BIOL, V57, P676, DOI 10.1111/j.1365-2427.2011.02731.x; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Hite JL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0832; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Lillo F, 2011, BIOL INVASIONS, V13, P1533, DOI 10.1007/s10530-010-9911-8; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mandl JN, 2015, CELL, V160, P20, DOI 10.1016/j.cell.2014.12.003; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Ouellet M, 2012, AMPHIBIA-REPTILIA, V33, P415, DOI 10.1163/15685381-00002845; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; SCHOONBEE HJ, 1992, WATER SA, V18, P227; SEALE DB, 1982, HYDROBIOLOGIA, V87, P161, DOI 10.1007/BF00015196; Searle CL, 2013, ECOL EVOL, V3, P4129, DOI 10.1002/ece3.777; SNELL TW, 1984, AQUACULTURE, V37, P359, DOI 10.1016/0044-8486(84)90300-4; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tinsley RC, 2015, BIOL CONSERV, V184, P380, DOI 10.1016/j.biocon.2015.01.034; Venesky MD, 2014, J ANIM ECOL, V83, P557, DOI 10.1111/1365-2656.12159; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Vredenburg VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063791; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wassersug R., 1996, BIOL XENOPUS; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Weldon C., 2005, THESIS; Wilson EA, 2017, BIOL INVASIONS, V20, P1; Yang H, 2009, DIS AQUAT ORGAN, V86, P9, DOI 10.3354/dao02098	41	1	1	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191537	10.1371/journal.pone.0191537	http://dx.doi.org/10.1371/journal.pone.0191537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444096	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500021
J	Drag, M; Hansen, MB; Kadarmideen, HN				Drag, Markus; Hansen, Mathias B.; Kadarmideen, Haja N.			Systems genomics study reveals expression quantitative trait loci, regulator genes and pathways associated with boar taint in pigs	PLOS ONE			English	Article							INTACT MALE; LINKAGE DISEQUILIBRIUM; ANDROSTENONE LEVELS; SKATOLE METABOLISM; WIDE ASSOCIATION; RNA-SEQ; LANDRACE; PARAMETERS; YORKSHIRE; GENETICS	Boar taint is an offensive odour and/or taste from a proportion of non-castrated male pigs caused by skatole and androstenone accumulation during sexual maturity. Castration is widely used to avoid boar taint but is currently under debate because of animal welfare concerns. This study aimed to identify expression quantitative trait loci (eQTLs) with potential effects on boar taint compounds to improve breeding possibilities for reduced boar taint. Danish Landrace male boars with low, medium and high genetic merit for skatole and human nose score (HNS) were slaughtered at similar to 100 kg. Gene expression profiles were obtained by RNA-Seq, and genotype data were obtained by an Illumina 60K Porcine SNP chip. Following quality control and filtering, 10,545 and 12,731 genes from liver and testis were included in the eQTL analysis, together with 20,827 SNP variants. A total of 205 and 109 single-tissue eQTLs associated with 102 and 58 unique genes were identified in liver and testis, respectively. By employing a multivariate Bayesian hierarchical model, 26 eQTLs were identified as significant multi-tissue eQTLs. The highest densities of eQTLs were found on pig chromosomes SSC12, SSC1, SSC13, SSC9 and SSC14. Functional characterisation of eQTLs revealed functions within regulation of androgen and the intracellular steroid hormone receptor signalling pathway and of xenobiotic metabolism by cytochrome P450 system and cellular response to oestradiol. A QTL enrichment test revealed 89 QTL traits curated by the Animal Genome PigQTL database to be significantly overlapped by the genomic coordinates of cis-acting eQTLs. Finally, a subset of 35 cis-acting eQTLs overlapped with known boar taint QTL traits. These eQTLs could be useful in the development of a DNA test for boar taint but careful monitoring of other overlapping QTL traits should be performed to avoid any negative consequences of selection.	[Drag, Markus; Hansen, Mathias B.; Kadarmideen, Haja N.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Anat Biochem & Physiol, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Kadarmideen, Haja N.] Tech Univ Denmark, Sect Syst Genom, Dept Bio & Hlth Informat, Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Kadarmideen, HN (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Anat Biochem & Physiol, Dept Vet & Anim Sci, Frederiksberg C, Denmark.; Kadarmideen, HN (corresponding author), Tech Univ Denmark, Sect Syst Genom, Dept Bio & Hlth Informat, Lyngby, Denmark.	hajak@dtu.dk	Drag, Markus Hodal/AAE-4233-2021	Drag, Markus Hodal/0000-0002-7412-6402; Kadarmideen, Haja/0000-0001-6294-382X	Green Development and Demonstration Programme (GUDP) [VETENH/ANHJ NR. 14029]; Veterinary Department of the Ministry of Food, Agriculture and Fisheries, Denmark; University of Copenhagen, Faculty of Health and Medical Sciences, Denmark	Green Development and Demonstration Programme (GUDP); Veterinary Department of the Ministry of Food, Agriculture and Fisheries, Denmark; University of Copenhagen, Faculty of Health and Medical Sciences, Denmark	This "AGES" project was funded by the Green Development and Demonstration Programme (GUDP, grant number VETENH/ANHJ NR. 14029) and Veterinary Department of the Ministry of Food, Agriculture and Fisheries, Denmark and University of Copenhagen, Faculty of Health and Medical Sciences, Denmark.; We thank the Danish Pig Research Centre (VSP-SEGES) for animals and breeding data used in this study and the staff of Danish Crown Herning for assistance during sample collection at the slaughter house. Furthermore, we acknowledge the Green Development and Demonstration Programme (GUDP, grant number VETENH/ANHJ NR. 14029) and Veterinary Department of the Ministry of Food, Agriculture and Fisheries, Denmark and University of Copenhagen, Faculty of Health and Medical Sciences, Denmark for funding.	Alteen MG, 2016, BIOCHEMISTRY-US, V55, P2735, DOI 10.1021/acs.biochem.5b01285; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andresen O., 2006, ACTA VET SCAND, V48, P1, DOI [10.1186/1751-0147-48-S1-S5, DOI 10.1186/1751-0147-48-S1-S5]; Andrews S, FASTQC QUALITY CONTR; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Babol J, 2004, MEAT SCI, V67, P351, DOI 10.1016/j.meatsci.2003.11.008; Babol J, 1999, J ANIM SCI, V77, P84; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BONNEAU M, 1982, LIVEST PROD SCI, V9, P687, DOI 10.1016/0301-6226(82)90017-3; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen G, 2007, J ANIM SCI, V85, P2457, DOI 10.2527/jas.2007-0087; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; CLAUS R, 1980, ACTA ENDOCRINOL-COP, V94, P404, DOI 10.1530/acta.0.0940404; Clavero S, 2010, MOL MED, V16, P381, DOI 10.2119/molmed.2010.00038; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Diaz GJ, 2000, J AGR FOOD CHEM, V48, P833, DOI 10.1021/jf990805u; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drag M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11928-0; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Edson KZ, 2013, BIOCHEMISTRY-US, V52, P8276, DOI 10.1021/bi401208m; Ernst CW, 2013, TRENDS GENET, V29, P215, DOI 10.1016/j.tig.2013.02.002; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Gonzalez-Prendes R, 2017, SCI REP-UK, V7, DOI 10.1038/srep39830; Grindflek E, 2011, J ANIM SCI, V89, P680, DOI 10.2527/jas.2010-3290; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; Grosse-Brinkhaus C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0194-z; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072298; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Habtemichael N, 2002, GENE, V283, P271, DOI 10.1016/S0378-1119(01)00881-2; Hansen MB, BINOM TEST QTL BINOM; Hart T, 2015, 2015015412 BIORXIVOR; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hess Rex A, 2003, Reprod Biol Endocrinol, V1, P52, DOI 10.1186/1477-7827-1-52; Hiratsuka M, 2006, MUTAT RES-FUND MOL M, V599, P98, DOI 10.1016/j.mrfmmm.2006.02.008; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Ingham AB, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-10; Kadarmideen HN, 2006, MAMM GENOME, V17, P548, DOI 10.1007/s00335-005-0169-x; Kadarmideen HN, 2014, LIVEST SCI, V166, P232, DOI 10.1016/j.livsci.2014.04.028; Kogelman LJA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0229-0; Kogelman LJA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00214; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lanthier F, 2007, LIVEST SCI, V106, P145, DOI 10.1016/j.livsci.2006.07.009; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee GJ, 2005, ANIM GENET, V36, P14, DOI 10.1111/j.1365-2052.2004.01214.x; Lervik S, 2015, ANIMAL, V9, P1832, DOI 10.1017/S1751731115000907; Leung MCK, 2010, ANIM BIOTECHNOL, V21, P77, DOI 10.1080/10495390903500607; Li G., 2013, ARXIV13112948; LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138; Lukic B, 2015, ANIM GENET, V46, P607, DOI 10.1111/age.12369; Madan M, 2016, AM J CANCER RES, V6, P1231; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mathur PK, 2012, MEAT SCI, V91, P414, DOI 10.1016/j.meatsci.2012.02.025; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Meuwissen THE, 2001, GENETICS, V157, P1819; Miles C., 2008, NAT ED, V1, P208; Miyagawa S, 2009, MOL ENDOCRINOL, V23, P871, DOI 10.1210/me.2008-0478; Moe M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-405; Moe M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-29; Moe M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-32; Nicolazzi EL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1497-1; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintanilla R, 2003, J ANIM SCI, V81, P385; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rasmussen MK, 2014, COMPUT STRUCT BIOTEC, V11, P106, DOI 10.1016/j.csbj.2014.09.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robic A, 2008, GENET SEL EVOL, V40, P129, DOI 10.1051/gse:2007040; Rowe SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-424; Sahadevan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091077; Sellier P, 2000, LIVEST PROD SCI, V63, P265, DOI 10.1016/S0301-6226(99)00127-X; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Squires E, 2010, P 10 LOND SWIN C FOC; Squires EJ, 1997, J ANIM SCI, V75, P2506; Strathe AB, 2013, J ANIM SCI, V91, P4659, DOI 10.2527/jas.2013-6454; Strathe AB, 2013, J ANIM SCI, V91, P2587, DOI 10.2527/jas.2012-6107; Tajet H., 2006, ACTA VET SCAND, V48, P1; Team RC, 2014, R LANG ENV STAT COMP; Tuna M, 2012, BREAST CANCER RES TR, V132, P189, DOI 10.1007/s10549-011-1579-y; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; Varona L, 2005, J ANIM SCI, V83, P301; Walker WH, 2010, PHILOS T R SOC B, V365, P1557, DOI 10.1098/rstb.2009.0258; Wang L, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-115; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Wesoly Raffael, 2012, Animals (Basel), V2, P221, DOI 10.3390/ani2020221; Westra HJ, 2014, BBA-MOL BASIS DIS, V1842, P1896, DOI 10.1016/j.bbadis.2014.04.024; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Zadinova K, 2016, ANIM SCI PAP REP, V34, P107; Zamaratskaia G, 2005, REPROD DOMEST ANIM, V40, P500, DOI 10.1111/j.1439-0531.2005.00613.x; Zamaratskaia G, 2004, LIVEST PROD SCI, V87, P91, DOI 10.1016/j.livprodsci.2003.09.022; Zamaratskaia G, 2009, ANIMAL, V3, P1508, DOI 10.1017/S1751731108003674	103	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192673	10.1371/journal.pone.0192673	http://dx.doi.org/10.1371/journal.pone.0192673			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438444	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400040
J	Su, T; Si, MR; Zhao, YF; Liu, Y; Yao, SM; Che, CC; Chen, C				Su, Tao; Si, Meiru; Zhao, Yunfeng; Liu, Yan; Yao, Shumin; Che, Chengchuan; Chen, Can			A thioredoxin-dependent peroxiredoxin Q from Corynebacterium glutamicum plays an important role in defense against oxidative stress	PLOS ONE			English	Article							BACTERIOFERRITIN COMIGRATORY PROTEIN; ESCHERICHIA-COLI; PEROXIDASE-ACTIVITY; THIOL; GLUTATHIONE; MYCOREDOXIN; EXPRESSION; MYCOTHIOL; REDUCTION; ACID	Peroxiredoxin Q (PrxQ) that belonged to the cysteine-based peroxidases has long been identified in numerous bacteria, but the information on the physiological and biochemical functions of PrxQ remain largely lacking in Corynebacterium glutamicum. To better systematically understand PrxQ, we reported that PrxQ from model and important industrial organism C. glutamicum, encoded by the gene ncgl2403 annotated as a putative PrxQ, played important roles in adverse stress resistance. The lack of C. glutamicum prxQ gene resulted in enhanced cell sensitivity, increased ROS accumulation, and elevated protein carbonylation levels under adverse stress conditions. Accordingly, PrxQ-mediated resistance to adverse stresses mainly relied on the degradation of ROS. The physiological roles of PrxQ in resistance to adverse stresses were corroborated by its induced expression under adverse stresses, regulated directly by the stress-responsive ECF-sigma factor SigH. Through catalytical kinetic activity, heterodimer formation, and bacterial two-hybrid analysis, we proved that C. glutamicum PrxQ catalytically eliminated peroxides by exclusively receiving electrons from thioredoxin (Trx)/thioredoxin reductase (TrxR) system and had a broad range of oxidizing substrates, but a better efficiency for peroxynitrite and cumene hydroperoxide (CHP). Site-directed mutagenesis confirmed that the conserved Cys49 and Cys54 are the peroxide oxidation site and the resolving Cys residue, respectively. It was also discovered that C. glutamicum PrxQ mainly existed in monomer whether under its native state or functional state. Based on these results, a catalytic model of PrxQ is being proposed. Moreover, our result that C. glutamicum PrxQ can prevent the damaging effects of adverse stresses by acting as thioredoxin-dependent monomeric peroxidase could be further applied to improve the survival ability and robustness of the important bacterium during fermentation process.	[Su, Tao; Si, Meiru; Zhao, Yunfeng; Yao, Shumin; Che, Chengchuan] Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China; [Liu, Yan] Qufu Normal Univ, Sch Geog & Tourism, Rizhao, Shandong, Peoples R China; [Chen, Can] Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou, Henan, Peoples R China	Qufu Normal University; Qufu Normal University; Zhoukou Normal University	Chen, C (corresponding author), Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou, Henan, Peoples R China.	chenc02@126.com		Chen, Can/0000-0001-7726-7166	National Natural Science Foundation of China [31500087, 31271475]; Natural Science Foundation of Shandong Province, China [ZR2015CM012, BS2011SW012]; Science and Technology Plan Project of Shandong Higher Education Institutions [J16LE03]; laboratory innovation project of Qufu Normal University [SK201503]; Key Scientific and Technological Project of Henan Province, China [152300410229]; international cooperation grant from Henan Province Science and Technology Agency [172102410060]; Foundation of Henan Educational Committee [17B180008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Science and Technology Plan Project of Shandong Higher Education Institutions; laboratory innovation project of Qufu Normal University; Key Scientific and Technological Project of Henan Province, China; international cooperation grant from Henan Province Science and Technology Agency; Foundation of Henan Educational Committee	This work was supported by National Natural Science Foundation of China (Nos. 31500087 and 31271475) MS YZ, the Natural Science Foundation of Shandong Province, China (Nos. ZR2015CM012 and BS2011SW012) MS YL, Science and Technology Plan Project of Shandong Higher Education Institutions (J16LE03) TS, the laboratory innovation project of Qufu Normal University (SK201503) MS, the Key Scientific and Technological Project of Henan Province, China (No. 152300410229) CC, the international cooperation grant from Henan Province Science and Technology Agency (No. 172102410060) CC, and Foundation of Henan Educational Committee (No. 17B180008) CC.; This work was supported by the National Natural Science Foundation of China (Nos. 31500087 and 31271475), the Natural Science Foundation of Shandong Province, China (Nos. ZR2015CM012 and B52011SW012), Science and Technology Plan Project of Shandong Higher Education Institutions (J16LE03), and the laboratory innovation project of Qufu Normal University (SK201503), the Key Scientific and Technological Project of Henan Province, China (No. 152300410229), the international cooperation grant from Henan Province Science and Technology Agency (No. 172102410060), and Foundation of Henan Educational Committee (No. 17B180008).	Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Busche T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-445; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Cheng G, 2005, ARCH BIOCHEM BIOPHYS, V435, P42, DOI 10.1016/j.abb.2004.12.016; Clarke DJ, 2010, BIOCHEMISTRY-US, V49, P1319, DOI 10.1021/bi901703m; Demicheli V, 2016, BIOCHEMISTRY-US, V55, P3403, DOI 10.1021/acs.biochem.6b00045; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Ehira S, 2009, J BACTERIOL, V191, P2964, DOI 10.1128/JB.00112-09; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FLORIS R, 1993, EUR J BIOCHEM, V215, P767, DOI 10.1111/j.1432-1033.1993.tb18091.x; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; HAYASHI Y, 1979, J BIOL CHEM, V254, P9101; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Horta BB, 2010, J BIOL CHEM, V285, P16051, DOI 10.1074/jbc.M109.094839; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Kim IS, 2009, MOL CELLS, V28, P479, DOI 10.1007/s10059-009-0168-y; Kim SJ, 2003, J BIOL CHEM, V278, P10790, DOI 10.1074/jbc.M209553200; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kong W, 2000, BIOCHEM J, V351, P107, DOI 10.1042/0264-6021:3510107; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; Latifi A, 2007, FREE RADICAL BIO MED, V42, P424, DOI 10.1016/j.freeradbiomed.2006.11.011; Limauro D, 2010, BIOCHIMIE, V92, P1435, DOI 10.1016/j.biochi.2010.07.006; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Miller JH, 1992, SHORT COURSE BACTERI, V1; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Pedrajas JR, 2016, ANTIOXID REDOX SIGN, V24, P115, DOI 10.1089/ars.2015.6366; Reyes AM, 2016, FREE RADICAL BIO MED, V101, P249, DOI 10.1016/j.freeradbiomed.2016.10.005; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Si MR, 2017, P NATL ACAD SCI USA, V114, pE2233, DOI 10.1073/pnas.1614902114; Si MR, 2017, ANTIOXID REDOX SIGN, V26, P1, DOI 10.1089/ars.2016.6650; Si MR, 2015, BIOCHEM J, V469, P45, DOI 10.1042/BJ20141080; Si MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131634; Si MR, 2015, APPL ENVIRON MICROB, V81, P2781, DOI 10.1128/AEM.04221-14; Si MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115075; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067; Vinckx T, 2011, BIOMETALS, V24, P523, DOI 10.1007/s10534-010-9403-4; Wakita M, 2007, J BIOL CHEM, V282, P27792, DOI 10.1074/jbc.M702855200; Wang G, 2005, INFECT IMMUN, V73, P378, DOI 10.1128/IAI.73.1.378-384.2005; Wang TT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005020; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005	60	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192674	10.1371/journal.pone.0192674	http://dx.doi.org/10.1371/journal.pone.0192674			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438446	gold, Green Submitted, Green Published			2022-12-26	WOS:000425083400041
J	Saxe, GN; Calderone, D; Morales, LJ				Saxe, Glenn N.; Calderone, Daniel; Morales, Leah J.			Brain entropy and human intelligence: A resting-state fMRI study	PLOS ONE			English	Article							DEMOGRAPHIC-VARIABLES; FREE-ENERGY; PERFORMANCE; COMPLEXITY; PRINCIPLE; LANGUAGE; ANATOMY; NETWORK; SYSTEM	Human intelligence comprises comprehension of and reasoning about an infinitely variable external environment. A brain capable of large variability in neural configurations, or states, will more easily understand and predict variable external events. Entropy measures the variety of configurations possible within a system, and recently the concept of brain entropy has been defined as the number of neural states a given brain can access. This study investigates the relationship between human intelligence and brain entropy, to determine whether neural variability as reflected in neuroimaging signals carries information about intellectual ability. We hypothesize that intelligence will be positively associated with entropy in a sample of 892 healthy adults, using resting-state fMRI. Intelligence is measured with the Shipley Vocabulary and WASI Matrix Reasoning tests. Brain entropy was positively associated with intelligence. This relation was most strongly observed in the prefrontal cortex, inferior temporal lobes, and cerebellum. This relationship between high brain entropy and high intelligence indicates an essential role for entropy in brain functioning. It demonstrates that access to variable neural states predicts complex behavioral performance, and specifically shows that entropy derived from neuroimaging signals at rest carries information about intellectual capacity. Future work in this area may elucidate the links between brain entropy in both resting and active states and various forms of intelligence. This insight has the potential to provide predictive information about adaptive behavior and to delineate the subdivisions and nature of intelligence based on entropic patterns.	[Saxe, Glenn N.; Calderone, Daniel; Morales, Leah J.] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY 10003 USA	New York University	Saxe, GN (corresponding author), NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY 10003 USA.	Glenn.Saxe@nyumc.org		Morales, Leah/0000-0001-6561-4773; Saxe, Glenn/0000-0002-4756-1169	Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research	Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research	Data were provided by the Brain Genomics Superstruct Project (GSP) of Harvard University and the Massachusetts General Hospital, (Principal Investigators: Randy Buckner, Joshua Roffman, and Jordan Smoller), with support from the Center for Brain Science Neuroinformatics Research Group, the Athinoula A. Martinos Center for Biomedical Imaging, and the Center for Human Genetic Research. 20 individual investigators at Harvard and MGH generously contributed data to the overall project. We also thank Ze Wang who provided technical assistance in applying the Brain Entropy Mapping Toolbox.	[Anonymous], 2007, STAT PARAMETRIC MAPP, P1; Behrmann M, 2015, ANN NY ACAD SCI, V1359, P30, DOI 10.1111/nyas.12833; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Boltzmann L., 1964, LECT GAS THEORY, Vix; BRILLOUIN L, 1953, J APPL PHYS, V24, P1152, DOI 10.1063/1.1721463; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G., 2006, RHYTHMS BRAIN, Vxiv; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Delcros JG, 1996, HYBRIDOMA, V15, P177, DOI 10.1089/hyb.1996.15.177; Edelman GM, 1987, NEURAL DARWINISM THE, Vxxii; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Friston K, 2016, TRENDS COGN SCI, V20, P500, DOI 10.1016/j.tics.2016.05.001; Friston KJ, 2007, SYNTHESE, V159, P417, DOI 10.1007/s11229-007-9237-y; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2013, FRONT HUM NEUROSCI, V7; Geake JG, 2005, NEUROIMAGE, V26, P555, DOI 10.1016/j.neuroimage.2005.01.035; Gottfredson LS, 1997, INTELLIGENCE, V24, P13, DOI 10.1016/S0160-2896(97)90011-8; Gray Jeremy R, 2004, Discov Med, V4, P157; Holmes AJ, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.31; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lim S, 2015, NAT NEUROSCI, V18, P1804, DOI 10.1038/nn.4158; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; McNorgan C, 2015, NEUROPSYCHOLOGIA, V67, P148, DOI 10.1016/j.neuropsychologia.2014.12.014; Miskovic V, 2016, CORTEX, V83, P51, DOI 10.1016/j.cortex.2016.07.006; Noonan KA, 2013, J COGNITIVE NEUROSCI, V25, P1824, DOI 10.1162/jocn_a_00442; Pellionisz A., 1979, NEUROSCIENCES RES PR, Vvii; Pernet CR, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00606; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rondi-Reig L, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00205; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Schoenberg MR, 2003, ARCH CLIN NEUROPSYCH, V18, P804; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Schultz DH, 2016, J NEUROSCI, V36, P8551, DOI 10.1523/JNEUROSCI.0358-16.2016; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shokri-Kojori E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00411; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; SZILARD L, 1964, BEHAV SCI, V9, P301, DOI 10.1002/bs.3830090402; Tang YY, 2012, TRENDS COGN SCI, V16, P330, DOI 10.1016/j.tics.2012.05.001; TRUJILLO-ORTIZ A., 2007, HZMVNTEST HENZE ZIRK; Verboven S, 2005, CHEMOMETR INTELL LAB, V75, P127, DOI 10.1016/j.chemolab.2004.06.003; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Yang AC, 2013, PROG NEURO-PSYCHOPH, V47, P52, DOI 10.1016/j.pnpbp.2013.07.022; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Zachary RS, 1986, SHIPLEY INSTITUTE OF; Zagha E, 2014, CURR OPIN NEUROBIOL, V29, P178, DOI 10.1016/j.conb.2014.09.010	50	50	52	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191582	10.1371/journal.pone.0191582	http://dx.doi.org/10.1371/journal.pone.0191582			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432427	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300008
J	Lam, CT; Mueller, J; Asma, B; Asiedu, M; Krieger, MS; Chitalia, R; Dahl, D; Taylor, P; Schmitt, JW; Ramanujam, N				Lam, Christopher T.; Mueller, Jenna; Asma, Betsy; Asiedu, Mercy; Krieger, Marlee S.; Chitalia, Rhea; Dahl, Denali; Taylor, Peyton; Schmitt, John W.; Ramanujam, Nimmi			An integrated strategy for improving contrast, durability, and portability of a Pocket Colposcope for cervical cancer screening and diagnosis	PLOS ONE			English	Article							SWEDE SCORE; TRIAL	Introduction We have previously developed a portable Pocket Colposcope for cervical cancer screening in resource-limited settings. In this manuscript we report two different strategies (cross-polarization and an integrated reflector) to improve image contrast levels achieved with the Pocket Colposcope and evaluate the merits of each strategy compared to a standard-of-care digital colposcope. The desired outcomes included reduced specular reflection (glare), increased illumination beam pattern uniformity, and reduced electrical power budget. In addition, anti-fogging and waterproofing features were incorporated to prevent the Pocket Colposcope from fogging in the vaginal canal and to enable rapid disinfection by submersion in chemical agents. Methods Cross-polarization (Generation 3 Pocket Colposcope) and a new reflector design (Generation 4 Pocket Colposcope) were used to reduce glare and improve contrast. The reflector design (including the angle and height of the reflector sidewalls) was optimized through ray-tracing simulations. Both systems were characterized with a series of bench tests to assess specular reflection, beam pattern uniformity, and image contrast. A pilot clinical study was conducted to compare the Generation 3 and 4 Pocket Colposcopes to a standard-of-care colposcope (Leisegang Optik 2). Specifically, paired images of cervices were collected from the standard-of-care colposcope and either the Generation 3 (n = 24 patients) or the Generation 4 (n = 32 patients) Pocket Colposcopes. The paired images were blinded by device, randomized, and sent to an expert physician who provided a diagnosis for each image. Corresponding pathology was obtained for all image pairs. The primary outcome measures were the level of agreement (%) and kappa (kappa) statistic between the standard-of-care colposcope and each Pocket Colposcope (Generation 3 and Generation 4). Results Both generations of Pocket Colposcope had significantly higher image contrast when compared to the standard-of-care colposcope. The addition of anti-fog and waterproofing features to the Generation 3 and 4 Pocket Colposcope did not impact image quality based on qualitative and quantitative metrics. The level of agreement between the Generation 3 Pocket Colposcope and the standard-of-care colposcope was 75.0% (kappa = 0.4000, p = 0.0028, n = 24). This closely matched the level of agreement between the Generation 4 Pocket Colposcope and the standard-of-care colposcope which was also 75.0% (kappa = 0.4941, p = 0.0024, n = 32). Conclusion Our results indicate that the Generation 3 and 4 Pocket Colposcopes perform comparably to the standard-of-care colposcope, with the added benefit of being low-cost and waterproof, which is ideal for use in resource-limited settings. Additionally, the reflector significantly reduces the electrical requirements of the Generation 4 Pocket Colposcope enhancing portability without altering performance compared to the Generation 3 system.	[Lam, Christopher T.; Mueller, Jenna; Asiedu, Mercy; Krieger, Marlee S.; Chitalia, Rhea; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Lam, Christopher T.; Asma, Betsy; Asiedu, Mercy; Dahl, Denali; Schmitt, John W.; Ramanujam, Nimmi] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Mueller, Jenna; Krieger, Marlee S.; Ramanujam, Nimmi] Duke Univ, Ctr Global Womens Hlth Technol, Durham, NC USA; [Taylor, Peyton; Schmitt, John W.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Lam, CT (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Lam, CT (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	ctl11@duke.edu	Ramanujam, Nimmi/AAA-7575-2021	Ramanujam, Nimmi/0000-0001-7319-8415; Lam, Christopher/0000-0002-8491-8702	National Institute of Health [R01 CM 93380, R01 CA195500]; NATIONAL CANCER INSTITUTE [R01CA195500, R01CA193380] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health R01 CM 93380 (https://projectrepoeter.nih.gov/project_info_description, cfin?aid=91095898&icde=32376282) to CTL and National Institute of Health R01 CA195500 (https://projectreporter.nih.gov/project_info_details.cfm? aid=90900478&icde=32376282) to NR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2012, ANN TROP MED PUBLIC, V5, P3, DOI 10.4103/1755-6783.92871; [Anonymous], 2010, TIR12A; Blumenthal PD, 2005, INT J GYNECOLOGY OBS, V89; Bolton FJ, 2016, DEV BENCH TESTING MU; Catarino R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134309; Chernomordik V, 2012, POLARIZATION IMAGING; Das A, 2011, ELIMINATION SPECULAR, P237; El Meslouhi O, 2011, OPEN COMPUT SCI, V1, P341, DOI 10.2478/s13537-011-0020-2; Food Administration D, 2016, REPR MED DEV HLTH CA; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; IEC I, 2012, 606011 IECI; Kass A, 2015, OPTICAL DESIGN LOW C; Koren N., 2006, IMATEST PROGRAM COMP; Lam CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135869; Laude-Boulesteix B, 2004, POLARIZED IMAGES CER, P243; Mink JW, 2016, INITIAL CLIN TESTING; Nessa A, 2014, INT J GYNECOL CANCER, V24, P339, DOI 10.1097/IGC.0000000000000042; Ngonzi J, 2013, J LOW GENIT TRACT DI, V17, P372, DOI 10.1097/LGT.0b013e31827ba7c5; Park SY, 2010, IEEE INT C SEMANT CO, P160, DOI 10.1109/ICSC.2010.85; Peddie D, 2016, PACIFIC J REPROD HLT, V1; Rashmi B., 2016, J POSTGRADUATE MED E, V50, P69, DOI [10.5005/jp-journals-10028-1196, DOI 10.5005/JP-JOURNALS-10028-1196]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sikkens M, 2003, STRUCTURED DESIGN ME, P46; Sinclair CF, 2016, LARYNGEAL EXAM INDIC, P17; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; WHO, 2013, WHO GUID SCREEN TREA; Xue Z, 2007, COMP PERFORMANCE ANA; Zimmerman-Moreno G, 2006, AUTOMATIC DETECTION	28	17	17	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192530	10.1371/journal.pone.0192530	http://dx.doi.org/10.1371/journal.pone.0192530			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425225	Green Published, gold, Green Submitted			2022-12-26	WOS:000424700800027
J	Arikan, OA; Mulbry, W; Rice, C; Lansing, S				Arikan, Osman A.; Mulbry, Walter; Rice, Clifford; Lansing, Stephanie			The fate and effect of monensin during anaerobic digestion of dairy manure under mesophilic conditions	PLOS ONE			English	Article							METHANE PRODUCTION; SWINE MANURE; IONOPHORE ANTIBIOTICS; BIOGAS PRODUCTION; CATTLE MANURE; WATER; TEMPERATURE; WASTE; FARMS; METHANOGENESIS	There is growing concern about residual antibiotics and feed additives in the manure of treated animals because of the effects of these residues in the environment. Monensin is the most widely used ionophore coccidiostat in the U.S. The objective of this study was to determine the fate and effect of monensin during the anaerobic digestion of dairy manure. Duplicate plug flow field-scale digesters were operated using non-amended dairy manure and dairy manure amended with monensin to 1 and 10 mg/L for 56 days at 30 degrees C at an organic loading rate of 1.4 kg VS/m(3)-d and 17-day hydraulic retention time. Results showed that monensin was reduced approximately 70% during anaerobic digestion. Methane production from digesters using manure amended with 1 mg/L monensin was comparable to that from digesters operated without added monensin. However, digesters using manure amended with 10 mg/L monensin yielded 75% less methane than digesters using manure without added monensin. These results suggest that anaerobic digestion is an effective treatment for reducing, but not eliminating, monensin in dairy manure. Monensin did not reduce methane production at concentrations expected in dairy manure at recommended dosage rates.	[Arikan, Osman A.; Mulbry, Walter; Rice, Clifford] USDA ARS, Beltsville Agr Res Ctr, Sustainable Agr Syst Lab, Beltsville, MD 20705 USA; [Arikan, Osman A.; Lansing, Stephanie] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA; [Arikan, Osman A.] Istanbul Tech Univ, Dept Environm Engn, Istanbul, Turkey	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Istanbul Technical University	Arikan, OA (corresponding author), USDA ARS, Beltsville Agr Res Ctr, Sustainable Agr Syst Lab, Beltsville, MD 20705 USA.; Arikan, OA (corresponding author), Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA.; Arikan, OA (corresponding author), Istanbul Tech Univ, Dept Environm Engn, Istanbul, Turkey.	arikan@itu.edu.tr	ARIKAN, OSMAN A/F-1193-2015	ARIKAN, OSMAN A/0000-0002-0716-1865				AgSTAR, 2017, DAT LIV DIG; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; [Anonymous], [No title captured]; [Anonymous], 2014, R LANG ENV STAT COMP; Arikan OA, 2006, PROCESS BIOCHEM, V41, P1637, DOI 10.1016/j.procbio.2006.03.010; Arikan OA, 2015, WASTE MANAGE, V43, P108, DOI 10.1016/j.wasman.2015.06.005; Bak SA, 2013, INT J ENVIRON AN CH, V93, P1500, DOI 10.1080/03067319.2013.763250; Callaway T R, 2003, Curr Issues Intest Microbiol, V4, P43; Campos JL, 2001, APPL BIOCHEM BIOTECH, V95, P1, DOI 10.1385/ABAB:95:1:01; Capleton AC, 2006, TOXICOL LETT, V163, P213, DOI 10.1016/j.toxlet.2005.10.023; Cha JM, 2005, J CHROMATOGR A, V1065, P187, DOI 10.1016/j.chroma.2004.12.091; DONOHO A, 1978, J AGR FOOD CHEM, V26, P1090, DOI 10.1021/jf60219a005; DONOHO AL, 1984, J ANIM SCI, V58, P1528, DOI 10.2527/jas1984.5861528x; Dungan RS, 2017, J ENVIRON QUAL, V46, P1455, DOI 10.2134/jeq2017.06.0229; El-Mashad HM, 2010, BIORESOURCE TECHNOL, V101, P4021, DOI 10.1016/j.biortech.2010.01.027; Hansen M, 2009, TRAC-TREND ANAL CHEM, V28, P534, DOI 10.1016/j.trac.2009.02.015; HAWKES FR, 1984, AGR WASTES, V10, P241, DOI 10.1016/0141-4607(84)90001-5; HILPERT R, 1984, AGR WASTES, V10, P103, DOI 10.1016/0141-4607(84)90010-6; HILPERT R, 1981, ZBL BAKT MIK HYG I C, V2, P11, DOI 10.1016/S0721-9571(81)80014-2; Ince B, 2013, BIOPROC BIOSYST ENG; KENNEDY KJ, 1987, J FERMENT BIOENG, V65, P31, DOI 10.1016/0385-6380(87)90062-8; Kim SC, 2006, WATER RES, V40, P2549, DOI 10.1016/j.watres.2006.04.036; Lansing SA, 2015, T ASABE, V58, P441; Lansing S, 2010, BIOMASS BIOENERG, V34, P1711, DOI 10.1016/j.biombioe.2010.07.005; LO KV, 1985, BIOMASS, V6, P301, DOI 10.1016/0144-4565(85)90055-1; Masse Daniel I, 2014, Animals (Basel), V4, P146, DOI 10.3390/ani4020146; McClary DG, 2008, 095735 NADA; Mellon M., 2001, HOGGING IT ESTIMATES; Mitchell SM, 2013, BIORESOURCE TECHNOL, V149, P244, DOI 10.1016/j.biortech.2013.09.048; Odongo NE, 2007, J DAIRY SCI, V90, P1781, DOI 10.3168/jds.2006-708; SAFLEY LM, 1994, BIORESOURCE TECHNOL, V47, P165, DOI 10.1016/0960-8524(94)90116-3; Sassman SA, 2007, ENVIRON TOXICOL CHEM, V26, P1614, DOI 10.1897/07-073R.1; Varel VH, 2012, J APPL MICROBIOL, V112, P705, DOI 10.1111/j.1365-2672.2012.05250.x; VAREL VH, 1982, APPL ENVIRON MICROB, V44, P1415, DOI 10.1128/AEM.44.6.1415-1420.1982; Watanabe N, 2008, J ENVIRON QUAL, V37, pS78, DOI 10.2134/jeq2007.0371; WEDEGAERTNER TC, 1983, J ANIM SCI, V57, P168, DOI 10.2527/jas1983.571168x; WHETSTONE HD, 1981, J ANIM SCI, V53, P803, DOI 10.2527/jas1981.533803x; WILDENAUER FX, 1984, APPL MICROBIOL BIOT, V19, P125, DOI 10.1007/BF00302453; Zizek S, 2011, CHEMOSPHERE, V83, P517, DOI 10.1016/j.chemosphere.2010.12.058	39	12	12	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192080	10.1371/journal.pone.0192080	http://dx.doi.org/10.1371/journal.pone.0192080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420605	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900038
J	Lee, JS; Oh, BL; Lee, HY; Song, YW; Lee, EY				Lee, Jeong Seok; Oh, Baek-Lok; Lee, Hee Young; Song, Yeong Wook; Lee, Eun Young			Comorbidity, disability, and healthcare expenditure of ankylosing spondylitis in Korea: A population-based study	PLOS ONE			English	Article							COST-OF-ILLNESS; RHEUMATOID-ARTHRITIS; EXTRAARTICULAR MANIFESTATIONS; PSORIATIC-ARTHRITIS; ULCERATIVE-COLITIS; WORK DISABILITY; MORTALITY; BURDEN	Background Ankylosing spondylitis (AS) is an inflammatory rheumatic disease typically diagnosed in young age and follows a chronic progressive course. Its impact on the patient is life-long and the burden that AS exerts on society is increasing cumulatively every year. We aimed to quantify the burden of AS and to identify the factors associated with comorbidity, disability, and healthcare expenditure in Korean AS patients. Methods We conducted a nationwide, population-based study using health insurance data (2003-2013). The analysis included individuals with incident AS (1,111 patients) and controls (5,555 patients) matched by age, sex, income, and geographic region. The incidence rates of extra-articular manifestations (EAMs), comorbidities, mortality, and disability (type and severity) were compared between AS patients and controls. Annual health expenditure per patient was also analyzed. Associations were expressed as odds ratios (ORs) with 95% confidence intervals (95% CIs). Results During the follow-up, 28% of AS patients experienced at least one EAM. AS diagnosis was significantly associated with Charlson comorbidity index >= 3 (OR 2.18, 95% CI 1.91-2.48). Disability rate was higher in AS patients than in controls regardless of cause and severity (OR 2.94, 95% CI 2.48-3.48), but crude incidence rate ratios for mortality were not significantly higher. On multivariate analysis, male sex (OR 3.18, 95% CI 2.13-4.75), presence of an EAM (OR 1.63, 95% CI 1.15-2.32), and older age at diagnosis (OR 1.27, 95% CI 1.20-1.35) were evidently associated with increased disability in AS. Presence of an EAM was also associated with increased AS-unrelated expenditures in biologic-naive patients (median, 1112 vs. 877 USD per person, P<0.05). Conclusions In patients with AS, demographic factors and systemic manifestations including EAMs and other comorbidities were associated with increased disability and healthcare expenditures.	[Lee, Jeong Seok; Song, Yeong Wook; Lee, Eun Young] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Oh, Baek-Lok] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Lee, Hee Young] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, EY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	elee@snu.ac.kr	lee, hy/GRS-0797-2022	Lee, Jeong Seok/0000-0001-8261-7044; Lee, Eun Young/0000-0001-6975-8627	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277 to EYL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonen A, 2001, ANN RHEUM DIS, V60, P353, DOI 10.1136/ard.60.4.353; Boonen A, 2006, J RHEUMATOL, V33, P4; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooksey R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126105; El Maghraoui A, 1999, J RHEUMATOL, V26, P2205; Exarchou S, 2016, ANN RHEUM DIS, V75, P1466, DOI 10.1136/annrheumdis-2015-207688; Franke LC, 2009, CLIN EXP RHEUMATOL, V27, pS118; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gao Xin, 2012, J Med Econ, V15, P1054, DOI 10.3111/13696998.2012.692341; Greenberg JD, 2016, J RHEUMATOL, V43, P88, DOI 10.3899/jrheum.150540; Hallert E, 2012, RHEUMATOLOGY, V51, P338, DOI 10.1093/rheumatology/ker332; Haroon NN, 2015, ANN INTERN MED, V163, P409, DOI 10.7326/M14-2470; Huscher D, 2006, ANN RHEUM DIS, V65, P1175, DOI 10.1136/ard.2005.046367; JAYSON MIV, 1968, ANN RHEUM DIS, V27, P219, DOI 10.1136/ard.27.3.219; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kim HY, 2016, NAT REV RHEUMATOL, V12, P183, DOI 10.1038/nrrheum.2015.165; Krishnan E, 2012, ANN RHEUM DIS, V71, P213, DOI 10.1136/annrheumdis-2011-200354; Lee J., 2016, INT J EPIDEMIOL; Lee TJ, 2014, J KOREAN MED SCI, V29, P190, DOI 10.3346/jkms.2014.29.2.190; Maas F, 2016, ARTHRITIS CARE RES; MCEWEN C, 1971, ARTHRITIS RHEUM, V14, P291, DOI 10.1002/art.1780140302; Reveille JD, 2012, AM J MED SCI, V343, P371, DOI 10.1097/MAJ.0b013e3182514093; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stolwijk C, 2015, ANN RHEUM DIS, V74, P1373, DOI 10.1136/annrheumdis-2014-205253; Szabo SM, 2011, ARTHRITIS RHEUM-US, V63, P3294, DOI 10.1002/art.30581; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Zink A, 2000, J RHEUMATOL, V27, P613	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192524	10.1371/journal.pone.0192524	http://dx.doi.org/10.1371/journal.pone.0192524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420599	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900087
J	Meisel, JD; Sarmiento, OL; Olaya, C; Lemoine, PD; Valdivia, JA; Zarama, R				Meisel, Jose D.; Sarmiento, Olga L.; Olaya, Camilo; Lemoine, Pablo D.; Valdivia, Juan A.; Zarama, Roberto			Towards a novel model for studying the nutritional stage dynamics of the Colombian population by age and socioeconomic status	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; OBESITY; SYSTEM; HEALTH; CHILDREN; SCIENCE; TRENDS; DIET	Low-and middle-income countries (LMICs) are experiencing a nutritional transition in which the burden of obesity tends to shift towards the lower-socioeconomic status (SES) group. We propose a system dynamics (SD) model for assessing the nutritional stage dynamics of the Colombian urban population by age and SES projected to 2030. This SD model captures the ageing population according to body mass index (BMI) categories and SES. In this model, the transference rates (TRs) between BMI categories by age and SES are estimated using a heuristic based on data obtained from national surveys. The simulation results show that the Colombian population, particularly those aged 20 to 39 years with a lower SES, is moving towards the overweight and obese categories. The TRs for overweight and obese categories in the lower SES group (the mean TR from not overweight to overweight = 0.0215 (per year) and mean TR from overweight to obese = 0.0098 (per year)) are increasing more rapidly than the those in the middle (the mean TR from not overweight to overweight = 0.0162 (per year) and mean TR from overweight to obese = 0.0065 (per year)) and higher SES groups (the mean TR from not overweight to overweight = 0.0166 and mean TR from overweight to obese = 0.0054 (per year)). Additionally, from 2005 to 2010, individuals aged 20 to 39 years had the highest TRs towards the overweight and obese categories (from 0.026 to 0.036 per year and from 0.0064 to 0.012 per year, respectively). The TRs also indicated that children aged 0 to 14 years are moving from the obese to overweight and from the overweight to not overweight categories. These TRs show that the Colombian population is experiencing an SES-related nutritional transition that is affecting the lower SES population. The proposed model could be implemented to assess the nutritional transitions experienced in other LMICs.	[Meisel, Jose D.; Olaya, Camilo; Lemoine, Pablo D.; Zarama, Roberto] Univ Los Andes, Fac Engn, Dept Ind Engn, Bogota, Colombia; [Meisel, Jose D.] Univ Ibague, Fac Ingn, Ibague, Colombia; [Meisel, Jose D.; Sarmiento, Olga L.; Olaya, Camilo; Lemoine, Pablo D.; Valdivia, Juan A.; Zarama, Roberto] CeiBA Complex Syst Res Ctr, Bogota, Colombia; [Sarmiento, Olga L.] Univ Los Andes, Sch Med, Dept Publ Hlth, Bogota, Colombia; [Lemoine, Pablo D.] Ctr Nacl Consultoria, Bogota, Colombia; [Valdivia, Juan A.] Univ Chile, Fac Ciencias, Dept Fis, Santiago, Chile; [Valdivia, Juan A.] CEDENNA, Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile	Universidad de los Andes (Colombia); CEIBA; Universidad de los Andes (Colombia); Universidad de Chile	Meisel, JD (corresponding author), Univ Los Andes, Fac Engn, Dept Ind Engn, Bogota, Colombia.; Meisel, JD (corresponding author), Univ Ibague, Fac Ingn, Ibague, Colombia.; Meisel, JD (corresponding author), CeiBA Complex Syst Res Ctr, Bogota, Colombia.	jd.meisel28@uniandes.edu.co	Sarmiento, Olga L/AAS-4165-2020; Zarama, Roberto/E-3101-2010; Valdivia, Juan Alejandro/A-3631-2008; Olaya, Camilo/Y-2350-2019; Meisel, Jose/AAV-8857-2021; Meisel, Jose David/K-8040-2019; Meisel, Jose David/K-7895-2019	Sarmiento, Olga L/0000-0002-9190-3568; Zarama, Roberto/0000-0002-5018-9783; Valdivia, Juan Alejandro/0000-0003-3381-9904; Meisel, Jose/0000-0002-1032-0900; Olaya, Camilo/0000-0002-2126-7498	Fundacion Centro de Estudios Interdisciplinarios Basicos y Aplicados - Fundacion CEIBA; Universidad de Ibague; Colciencias; Fundacion CeiBA; "Programa nacional de formacion doctoral Francisco Jose de Caldas" from Colciencias [511-2010, 567-2012]; Fondecyt [1150718]; Centro para el Desarrollo de la Nanociencias y la Nanotecnologia (CEDENNA); Colciencias [750-2013]; Research office at the Universidad de los Andes; Universidad de Ibague [16-414-INT]	Fundacion Centro de Estudios Interdisciplinarios Basicos y Aplicados - Fundacion CEIBA; Universidad de Ibague; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fundacion CeiBA; "Programa nacional de formacion doctoral Francisco Jose de Caldas" from Colciencias; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centro para el Desarrollo de la Nanociencias y la Nanotecnologia (CEDENNA); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Research office at the Universidad de los Andes; Universidad de Ibague	This work was funded by the Fundacion Centro de Estudios Interdisciplinarios Basicos y Aplicados - Fundacion CEIBA, Universidad de Ibague, and Colciencias. Fundacion CeiBA funded the doctoral students, Universidad de Ibague funded the publication of the article, and the "Programa nacional de formacion doctoral Francisco Jose de Caldas" from Colciencias", (Convocatorias 511-2010 and 567-2012) funded the work of JDM and PDL. JAV thanks Fondecyt grant 1150718 and the support of Centro para el Desarrollo de la Nanociencias y la Nanotecnologia (CEDENNA). OLS, JDM, and PDL received funding from Colciencias grant 750-2013. OLS received funding from the Research office at the Universidad de los Andes. JDM thanks the Universidad de Ibague (project 16-414-INT) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid TK, 2003, MED SCI SPORT EXER, V35, P400, DOI 10.1249/01.MSS.0000053659.32126.2D; Abdel-Hamid TK, 2009, THINKING CIRCLES OBE; Abidin NZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114135; [Anonymous], ENC NAC DEM SAL 2010; [Anonymous], 2005, DEM HLTH SURV PROGR; [Anonymous], 2010, DEM HLTH SURV PROGR; [Anonymous], 2013, GLOB BURD DIS GEN EV; Auchincloss AH, 2011, AM J PREV MED, V40, P303, DOI 10.1016/j.amepre.2010.10.033; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Dangerfield BC, 2010, P INT SYST DYN C KOR; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Departamento Administrativo Nacional de Estadistica, EST VIT; Departamento Administrativo Nacional de Estadistica, SER DE POBL; Departamento Administrativo Nacional de Estadisticas (Dane), 2011, PROYECC POBL; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Fallah-Fini S, 2014, AM J PUBLIC HEALTH, V104, P1230, DOI 10.2105/AJPH.2014.301882; Fotso JC, 2005, SOC INDIC RES, V72, P189, DOI 10.1007/s11205-004-5579-8; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Gonzalez SA, 2014, J PHYS ACT HEALTH, V11, pS33, DOI 10.1123/jpah.2014-0170; Hammond RA, 2009, PREV CHRONIC DIS, V6; Homer J., 2006, OBESITY POPULATION D; HUANG TT, 2009, PREV CHRONIC DIS, V6; Instituto Nacional de Salud Pblica, 2020, CURS AV IN NOM 051 E; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Karanfil O., 2009, SYSTEM DYNAMICS MODE; Karanfil O, 2011, MULTISCALE PARADIGM; Lemoine PD, 2016, PREV MED, V88, P39, DOI 10.1016/j.ypmed.2016.03.015; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Meisel JD, 2016, KYBERNETES, V45, P554, DOI 10.1108/K-01-2015-0010; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Profamilia, 2005, ENC NAC DEM SALUD 20; Rahmandad Hazhir, 2012, Social Computing, Behavioral-Cultural Modeling and Prediction. Proceedings of the 5th International Conference, SBP 2012, P306, DOI 10.1007/978-3-642-29047-3_37; Rutstein S. O., 2004, DHS COMP REPORTS; Sabounchi NS, 2014, AM J PUBLIC HEALTH, V104, P1240, DOI 10.2105/AJPH.2014.301898; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Stunkard A. J., 2000, Obesity and poverty: a new public health challenge., P23; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Vandenbroeck P, 2007, FORESIGHT TACKLING O; WHO, 2006, WHO CHILD GROWTH STA; World Data Bank, WORLD DEV IND; World Health Organization, 2013, PROJ MORT CAUS DEATH	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191929	10.1371/journal.pone.0191929	http://dx.doi.org/10.1371/journal.pone.0191929			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420563	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900030
J	Sinnathamby, G; Henderson, G; Umair, S; Janssen, P; Bland, R; Simpson, H				Sinnathamby, Gajenathirin; Henderson, Gemma; Umair, Saleh; Janssen, Peter; Bland, Ross; Simpson, Heather			The bacterial community associated with the sheep gastrointestinal nematode parasite Haemonchus contortus	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MELOIDOGYNE-INCOGNITA; MARINE NEMATODES; LECTIN-BINDING; SURFACE-COAT; DIVERSITY; XENORHABDUS; POPULATION; WOLBACHIA; SYMBIONTS	Culture-independent methods were used to study the microbiota of adult worms, third-stage larvae and eggs, both in faeces and laid in vitro, of Haemonchus contortus, a nematode parasite of the abomasa of ruminants which is a major cause of production losses and ill-health. Bacteria were identified in eggs, the female reproductive tract and the gut of adult and third-stage larvae (L3). PCR amplification of 16S rRNA sequences, denaturing gradient gel electrophoresis (DGGE) and clone libraries were used to compare the composition of the microbial communities of the different life-cycle stages of the parasites, as well as parasites and their natural environments. The microbiomes of adult worms and L3 were different from those in the abomasum or faeces respectively. The H. contortus microbiota was mainly comprised of members of the phyla Proteobacteria, Firmicutes and Bacteroidetes. Bacteria were localised in the gut, inside eggs and within the uterus of adult female worms using the universal FISH Eub338 probe, which targets most bacteria, and were also seen in these tissues by light and transmission electron microscopy. Streptococcus/Lactococcus sp. were identified within the distal uterus with the probe Strc493. Sequences from the genera Weissella and Leuconostoc were found in all life-cycle stages, except eggs collected from faeces, in which most sequences belonged to Clostridium sp. Bacteria affiliated with Weissella/Leuconostoc were identified in both PCR-DGGE short sequences and clone libraries of nearly full length 16S rRNA bacterial sequences in all life-cycle stages and subsequently visualised in eggs by fluorescent in situ hybridisation (FISH) with group-specific probes. This strongly suggests they are vertically transmitted endosymbionts. As this study was carried out on a parasite strain which has been maintained in the laboratory, other field isolates will need to be examined to establish whether these bacteria are more widely dispersed and have potential as targets to control H. contortus infections.	[Sinnathamby, Gajenathirin; Simpson, Heather] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Henderson, Gemma; Umair, Saleh; Janssen, Peter; Bland, Ross] AgResearch Ltd, Palmerston North, New Zealand	Massey University; AgResearch - New Zealand	Simpson, H (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	H.V.Simpson@massey.ac.nz		Henderson, Gemma/0000-0002-8258-2811	Meat and Wool New Zealand [96MU 25/1.1]; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	Meat and Wool New Zealand; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	This work was supported by Meat and Wool New Zealand (96MU 25/1.1 Development of alternative methods of parasite control) H.V. Simpson; Massey University Research Fund, H.V. Simpson; C. Alma Baker Trust, H.V. Simpson; E. & C. Thoms Bequest, H.V. Simpson.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; Albers A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atibalentja N, 2008, SYMBIOSIS, V46, P87; BADLEY JE, 1987, PARASITE IMMUNOL, V9, P133, DOI 10.1111/j.1365-3024.1987.tb00494.x; Baquiran JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067425; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bjorkroth KJ, 2002, INT J SYST EVOL MICR, V52, P141, DOI 10.1099/00207713-52-1-141; BOEMARE NE, 1988, J GEN MICROBIOL, V134, P751; Brunsdon RV, 1988, NZ J ZOOL, V15, P328; Bulgheresi S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw007; Burnell AM, 2000, NEMATOLOGY, V2, P31, DOI 10.1163/156854100508872; Cao Y, 2015, J BASIC MICROB, V55, P950, DOI 10.1002/jobm.201400816; Casiraghi M, 2002, INT J PARASITOL, V32, P1457, DOI 10.1016/S0020-7519(02)00158-3; Coomans A, 2000, NEMATOLOGY, V2, P443, DOI 10.1163/156854100509303; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; De Barbieri I, 2015, LIVEST SCI, V178, P119, DOI 10.1016/j.livsci.2015.05.023; De Mendoza MEL, 2000, PARASITOLOGY, V120, P203, DOI 10.1017/S0031182099005326; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Finegold S.M., 1983, HUMAN INTESTINAL MIC, P3, DOI DOI 10.1016/B978-0-12-341280-5.50007-0; Fusco V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00155; Ghafouri S, 2007, NEMATOLOGY, V9, P87, DOI 10.1163/156854107779969718; Gibson KE, 2005, ENVIRON MICROBIOL, V7, P203, DOI 10.1111/j.1462-2920.2004.00683.x; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gottlieb Y, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-133; Greiman SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098453; Greiman SE, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-303; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Hillrichs K, 2012, PARASITOL RES, V110, P449, DOI 10.1007/s00436-011-2511-4; Hoang KL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01444; Hoerauf A., 2007, Wolbachia: a bug's life in another bug, P31, DOI 10.1159/000104231; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Kamboj K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01204; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kersters K, 2001, PROTEOBACTERIA ENCY, P1; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kurz CL, 2000, TRENDS MICROBIOL, V8, P142, DOI 10.1016/S0966-842X(99)01691-1; Lacharme-Lora L, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S17; Ladygina N, 2009, FEMS MICROBIOL ECOL, V69, P53, DOI 10.1111/j.1574-6941.2009.00687.x; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17128; Lefoulon E, 2016, PEERJ, V4, DOI 10.7717/peerj.1840; Leng J, 2011, CHINA MOL BIOL REP, V39, P1181; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Marchetti M, 2014, MOL PLANT MICROBE IN, V27, P956, DOI 10.1094/MPMI-03-14-0083-R; Marchetti M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000280; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Muyzer G, 1996, MOL MICROBIAL ECOLOG, P1; Niu QH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20178; Nussbaumer AD, 2004, AQUAT MICROB ECOL, V34, P239, DOI 10.3354/ame034239; OTT JA, 1991, MAR ECOL-P S Z N I, V12, P261, DOI 10.1111/j.1439-0485.1991.tb00258.x; PAGE AP, 1992, PARASITOLOGY, V105, P285, DOI 10.1017/S0031182000074217; POLITZ SM, 1992, PARASITOL TODAY, V8, P6, DOI 10.1016/0169-4758(92)90302-I; POLZ MF, 1992, MICROBIAL ECOL, V24, P313, DOI 10.1007/BF00167789; Portal-Celhay C, 2012, INFECT IMMUN, V80, P1288, DOI 10.1128/IAI.05522-11; PRICHARD RK, 1980, AUST VET J, V56, P239, DOI 10.1111/j.1751-0813.1980.tb15983.x; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rothmann W, 2016, THESIS; Sacket D, ASSESSING EC COST EN, P1; SILVERMAN PH, 1959, PARASITOLOGY, V49, P23, DOI 10.1017/S0031182000026688; Simcock DC, 1999, INT J PARASITOL, V29, P1053, DOI 10.1016/S0020-7519(99)00065-X; Simpson HV, 1999, NEW ZEAL VET J, V47, P20, DOI 10.1080/00480169.1999.36102; SMITH HV, 1981, MOL BIOCHEM PARASIT, V4, P183, DOI 10.1016/0166-6851(81)90017-7; SPIEGEL Y, 1995, J NEMATOL, V27, P127; Stoll Norman R., 1943, JOUR PARASITOL, V29, P407, DOI 10.2307/3272850; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; Urquhart GM, VET PARASITOLOGY, V2; Vandekerckhove TTM, 2000, INT J SYST EVOL MICR, V50, P2197, DOI 10.1099/00207713-50-6-2197; Vlassoff A, 2001, NEW ZEAL VET J, V49, P213, DOI 10.1080/00480169.2001.36235; Wang JX, 1996, FUND APPL NEMATOL, V19, P363; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	88	18	19	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192164	10.1371/journal.pone.0192164	http://dx.doi.org/10.1371/journal.pone.0192164			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420571	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900044
J	Hersh, DS; Anastasiadis, P; Mohammadabadi, A; Nguyen, BA; Guo, SJ; Winkles, JA; Kim, AJ; Gullapalli, R; Keller, A; Frenkel, V; Woodworth, GF				Hersh, David S.; Anastasiadis, Pavlos; Mohammadabadi, Ali; Nguyen, Ben A.; Guo, Sijia; Winkles, Jeffrey A.; Kim, Anthony J.; Gullapalli, Rao; Keller, Asaf; Frenkel, Victor; Woodworth, Graeme F.			MR-guided transcranial focused ultrasound safely enhances interstitial dispersion of large polymeric nanoparticles in the living brain	PLOS ONE			English	Article							EXTRACELLULAR-SPACE; IN-VIVO; NONTHERMAL ABLATION; BARRIER DISRUPTION; CONTRAST AGENT; DRUG-DELIVERY; TUMOR-MODEL; BLOOD; DIFFUSION; THROMBOLYSIS	Generating spatially controlled, non-destructive changes in the interstitial spaces of the brain has a host of potential clinical applications, including enhancing the delivery of therapeutics, modulating biological features within the tissue microenvironment, altering fluid and pressure dynamics, and increasing the clearance of toxins, such as plaques found in Alzheimer's disease. Recently we demonstrated that ultrasound can non-destructively enlarge the interstitial spaces of the brain ex vivo. The goal of the current study was to determine whether these effects could be reproduced in the living brain using non-invasive, transcranial MRI-guided focused ultrasound (MRgFUS). The left striatum of healthy rats was treated using MRgFUS. Computer simulations facilitated treatment planning, and targeting was validated using MRI acoustic radiation force impulse imaging. Following MRgFUS treatments, Evans blue dye or nanoparticle probes were infused to assess changes in the interstitial space. In MRgFUS-treated animals, enhanced dispersion was observed compared to controls for 70 nm (12.8 +/- 0.9 mm(3) vs. 10.6 +/- 1.0 mm(3), p = 0.01), 200 nm (10.9 +/- 1.4 mm(3) vs. 7.4 +/- 0.7 mm(3), p = 0.01) and 700 nm (7.5 +/- 0.4 mm(3) vs. 5.4 +/- 1.2 mm(3), p = 0.02) nanoparticles, indicating enlargement of the interstitial spaces. No evidence of significant histological or electrophysiological injury was identified. These findings suggest that transcranial ultrasound can safely and effectively modulate the brain interstitium and increase the dispersion of large therapeutic entities such as particulate drug carriers or modified viruses. This has the potential to expand the therapeutic uses of MRgFUS.	[Hersh, David S.; Kim, Anthony J.; Woodworth, Graeme F.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Anastasiadis, Pavlos; Mohammadabadi, Ali; Nguyen, Ben A.; Guo, Sijia; Gullapalli, Rao; Frenkel, Victor] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.; Kim, Anthony J.; Frenkel, Victor; Woodworth, Graeme F.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Kim, Anthony J.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Keller, Asaf] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Woodworth, GF (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Frenkel, V (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA.; Frenkel, V; Woodworth, GF (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.	VFrenkel@som.umaryland.edu; GWoodworth@som.umaryland.edu	Mohammadabadi, Ali/U-7127-2019; Anastasiadis, Pavlos/B-3685-2011	Anastasiadis, Pavlos/0000-0002-0230-7925; Mohammadabadi, Ali/0000-0002-9124-3942; Hersh, David/0000-0003-1177-2201	Focused Ultrasound Foundation; National Institutes of Health [K08NS09043]; National Science Foundation [NSF EAGER 1557922]; NATIONAL CANCER INSTITUTE [T32CA154274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS090430] Funding Source: NIH RePORTER	Focused Ultrasound Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Focused Ultrasound Foundation, the National Institutes of Health (K08NS09043 (G.F.W.)) and the National Science Foundation (NSF EAGER 1557922 (V.F., A.J.K., and G.F.W)). There was no additional external funding received for this study.	Abi-Jaoudeh N, 2012, J VASC INTERV RADIOL, V23, P953, DOI 10.1016/j.jvir.2012.04.001; Arvanitis CD, 2015, IEEE T MED IMAGING, V34, P1270, DOI 10.1109/TMI.2014.2383835; Arvanitis CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045783; Aryal M, 2015, J CONTROL RELEASE, V204, P60, DOI 10.1016/j.jconrel.2015.02.033; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Doinikov AA, 2014, IEEE T ULTRASON FERR, V61, P1470, DOI 10.1109/TUFFC.2014.3061; Elias WJ, 2016, NEW ENGL J MED, V375, P730, DOI 10.1056/NEJMoa1600159; Fishman PS, 2017, NEUROTHERAPEUTICS, V14, P393, DOI 10.1007/s13311-017-0515-1; Foley CP, 2012, ANN BIOMED ENG, V40, P292, DOI 10.1007/s10439-011-0440-0; Frenkel V, 2006, ACAD RADIOL, V13, P469, DOI 10.1016/j.acra.2005.08.024; Frenkel V, 2006, RADIOLOGY, V239, P86, DOI 10.1148/radiol.2391042181; Frenkel V, 2001, ULTRASONICS, V39, P153, DOI 10.1016/S0041-624X(00)00064-0; Hancock HA, 2009, ULTRASOUND MED BIOL, V35, P1722, DOI 10.1016/j.ultrasmedbio.2009.04.020; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Hersh DS, 2016, BRAIN RES, V1646, P543, DOI 10.1016/j.brainres.2016.06.040; Hertzberg Y, 2010, MED PHYS, V37, P2934, DOI 10.1118/1.3395553; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jones G, 2010, IEEE T BIO-MED ENG, V57, P33, DOI 10.1109/TBME.2009.2028316; Kaye EA, 2011, MAGN RESON MED, V65, P738, DOI 10.1002/mrm.22662; Kobus T, 2016, ULTRASOUND MED BIOL, V42, P481, DOI 10.1016/j.ultrasmedbio.2015.10.009; Kovacs ZI, 2017, P NATL ACAD SCI USA, V114, pE75, DOI 10.1073/pnas.1614777114; Krasovitski B, 2011, P NATL ACAD SCI USA, V108, P3258, DOI 10.1073/pnas.1015771108; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kuroda K., 2017, J MAGN RESON IMAGING; Kyrtsos CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139574; Lewis GK, 2012, J NEUROSURG, V117, P1128, DOI 10.3171/2012.7.JNS11144; Liu Y, 2010, AAPS PHARMSCITECH, V11, P1005, DOI 10.1208/s12249-010-9458-0; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139667; Lizzi FL, 2003, ULTRASOUND MED BIOL, V29, P1593, DOI 10.1016/S0301-5629(03)01052-4; Mano Y., 2015, J NEUROSURG, P1; Mano Y, 2016, J NEUROSURG, V124, P1490, DOI 10.3171/2015.3.JNS142152; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; McDannold N, 2013, J NEUROSURG, V119, P1208, DOI 10.3171/2013.8.JNS122387; McDannold N, 2016, J NEUROSURG, V125, P1539, DOI 10.3171/2015.10.JNS151525; NANCE EA, 2012, SCI TRANSL MED, V4; Nance E, 2014, J CONTROL RELEASE, V189, P123, DOI 10.1016/j.jconrel.2014.06.031; O'Neill BE, 2009, ULTRASOUND MED BIOL, V35, P416, DOI 10.1016/j.ultrasmedbio.2008.09.021; O'Reilly MA, 2011, ULTRASOUND MED BIOL, V37, P1930, DOI 10.1016/j.ultrasmedbio.2011.08.001; Olbricht W, 2013, J ACOUST SOC AM, V134, P1569, DOI 10.1121/1.4812879; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palmeri ML, 2004, IEEE T ULTRASON FERR, V51, P551, DOI 10.1109/TUFFC.2004.1320828; Poff JA, 2008, RADIOLOGY, V248, P485, DOI 10.1148/radiol.2482071674; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Schneider CS, 2015, BIOMATERIALS, V42, P42, DOI 10.1016/j.biomaterials.2014.11.054; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stone MJ, 2007, THROMB RES, V121, P193, DOI 10.1016/j.thromres.2007.03.023; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Ter Haar G, 2007, INT J HYPERTHER, V23, P89, DOI 10.1080/02656730601186138; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Vargova L, 2008, PHYSIOL RES, V57, pS89, DOI 10.33549/physiolres.931603; Wang ST, 2017, J CEREBR BLOOD F MET, V37, P706, DOI 10.1177/0271678X16637881; Wang S, 2012, J CONTROL RELEASE, V162, P218, DOI 10.1016/j.jconrel.2012.06.025; Wolak DJ, 2013, MOL PHARMACEUT, V10, P1492, DOI 10.1021/mp300495e; Ziadloo A, 2013, J ACOUST SOC AM, V133, P1827, DOI 10.1121/1.4789390; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	61	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192240	10.1371/journal.pone.0192240	http://dx.doi.org/10.1371/journal.pone.0192240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415084	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300062
J	Wu, HL; Zhao, YC; Huang, QL; Cai, MX; Pan, Q; Fu, MS; An, XH; Xia, ZJ; Liu, M; Jin, Y; He, L; Shang, J				Wu, Huali; Zhao, Yucheng; Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Xia, Zhenjiang; Liu, Meng; Jin, Yu; He, Ling; Shang, Jing			NK 1R/5-HT1AR interaction is related to the regulation of melanogenesis	FASEB JOURNAL			English	Article						protein-protein interaction; signaling cascades; NK1R; 5-HT1AR; heterdimerization	RESONANCE ENERGY-TRANSFER; CELL-SURFACE EXPRESSION; SUBSTANCE-P; SEROTONIN RECEPTORS; MELANIN SYNTHESIS; TRYPTOPHAN-HYDROXYLASE; NEUROKININ-1 RECEPTOR; TRANSCRIPTION FACTOR; DISULFIDE BONDS; UP-REGULATION	Substance P (SP) is a candidate mediator along the brain-skin axis and can mimic the effects of stress to regulate melanogenesis. Previously, we and others have found that the regulation of SP for pigmentary function was mediated by neurokinin 1 receptor (NK1R). Emerging evidence has accumulated that psychologic stress can induce dysfunction in the cutaneous serotonin 5-hydroxytryptamine (5-HT)-5-HT1A/1B receptor system, thereby resulting in skin hypopigmentation. Moreover, NK1R and 5-HTR (except 5-HT3) belong to GPCR. The present study aimed at assessing the possible existence of NK1R-5-HTR interactions and related melanogenic functions. Western blot and PCR detection revealed that SP reduced expression of 5-HT1A receptor via the NK1 receptor. Biochemical analyses showed that NK1R and 5-HT1AR could colocalize and interact in a cell and in the skin. When the N terminus of the NK1R protein was removed NK1R surface targeting was prevented, the interaction between NK1R-5-HT1AR decreased, and the depigmentation caused by SP and WAY100635 could be rescued. Importantly, pharmaceutical coadministration of NK1R agonist (SP) and 5-HT1A antagonist (WAY100635) enhanced the NK1-5-HT1A receptor coimmunoprecipitation along with the depigmentary response. SP and WAY100635 cooperation elicited activation of a signaling cascade (the extracellular, regulated protein kinase p-JNK signaling pathway) and inhibition of p70S6K1 phosphorylation and greatly reduced melanin production in vitro and in vivo in mice and zebrafish. Moreover, the SP-induced depigmentation response did not be occur in 5-htr1aa(+/-)zebrafish embryos. Taken together, the results of our systemic study increases our knowledge of the roles of NK1R and 5-HT1AR in melanogenesis and provides possible, novel therapeutic strategies for treatment of skin hypo/hyperpigmentation.	[Wu, Huali; Zhao, Yucheng; Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Wu, Huali; He, Ling] China Pharmaceut Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab Tradit Chinese Med TCM Evaluat &, Nanjing, Jiangsu, Peoples R China; [Huang, Qiaoling; Cai, Minxuan; Pan, Qi; Fu, Mengsi; An, Xiaohong; Shang, Jing] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Nanjing, Jiangsu, Peoples R China; [Xia, Zhenjiang; Shang, Jing] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining, Qinghai, Peoples R China; [Liu, Meng] Xinjiang Med Univ, Affiliated Tumor Hosp, Urumqi, Peoples R China; [Jin, Yu] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; Chinese Academy of Sciences; Xinjiang Medical University; University of California System; University of California Santa Barbara	Shang, J (corresponding author), China Pharmaceut Univ, 639 Longmian Rd, Nanjing 210009, Jiangsu, Peoples R China.	shangjing21cn@cpu.edu.cn			Science and Technology Plan Projects in Qinghai Province [2015-ZJ-733]; Science and Technology Plan Projects in Xinjiang [2014AB043]; National Natural Science Foundation of China [81603216]; CMA-L'OREAL China Skin/Hair Grant [S2017140917]; One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province [Y229461211]; Prospective Joint Research Project of Jiangsu Province [BY2016078-02]	Science and Technology Plan Projects in Qinghai Province; Science and Technology Plan Projects in Xinjiang; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CMA-L'OREAL China Skin/Hair Grant; One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province; Prospective Joint Research Project of Jiangsu Province	This study was supported by Science and Technology Plan Projects in Qinghai Province (2015-ZJ-733); Science and Technology Plan Projects in Xinjiang (2014AB043); The National Natural Science Foundation of China (81603216); 2017 CMA-L'OREAL China Skin/Hair Grant S2017140917; One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province (Y229461211); and Prospective Joint Research Project of Jiangsu Province (BY2016078-02). The authors declare no conflicts of interest.	AGNATI LF, 1983, ACTA PHYSIOL SCAND, V118, P293, DOI 10.1111/j.1748-1716.1983.tb07273.x; Aktan S, 1998, DERMATOLOGY, V197, P230, DOI 10.1159/000018002; Al Niami F, 2008, BRIT J HOSP MED, V69, P510, DOI 10.12968/hmed.2008.69.9.31046; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Arck PC, 2001, FASEB J, V15, P2536, DOI 10.1096/fj.00-0699fje; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; AZMITIA EC, 1969, SCIENCE, V166, P1274, DOI 10.1126/science.166.3910.1274; Bellot M, 2015, NAT CHEM BIOL, V11, P271, DOI [10.1038/NCHEMBIO.1766, 10.1038/nchembio.1766]; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chernova I, 2009, J LEUKOCYTE BIOL, V85, P154, DOI 10.1189/jlb.0408260; Choi TY, 2007, PIGM CELL RES, V20, P120, DOI 10.1111/j.1600-0749.2007.00365.x; Cooksey CJ, 1997, J BIOL CHEM, V272, P26226, DOI 10.1074/jbc.272.42.26226; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; Fadda F, 2000, NEWS PHYSIOL SCI, V15, P260; Falabella R, 2003, J EUR ACAD DERMATOL, V17, P355, DOI 10.1046/j.1468-3083.2003.00792_6.x; Fanelli F, 2013, PROG MOL BIOL TRANSL, V117, P105, DOI 10.1016/B978-0-12-386931-9.00005-2; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; FONG TM, 1992, J BIOL CHEM, V267, P25664; Franco R, 2008, BRAIN RES REV, V58, P475, DOI 10.1016/j.brainresrev.2008.06.002; Froger N, 2001, J NEUROSCI, V21, P8188, DOI 10.1523/JNEUROSCI.21-20-08188.2001; Fujita W, 2014, BIOCHEM PHARMACOL, V92, P448, DOI 10.1016/j.bcp.2014.09.015; Fukushima Y, 1997, FEBS LETT, V409, P283, DOI 10.1016/S0014-5793(97)00531-0; Fuxe K, 2014, NEUROPSYCHOPHARMACOL, V39, P131, DOI 10.1038/npp.2013.242; Gayen A, 2011, BBA-BIOMEMBRANES, V1808, P127, DOI 10.1016/j.bbamem.2010.09.023; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Holst B, 1996, EMBO J, V15, P3538, DOI 10.1002/j.1460-2075.1996.tb00723.x; Horrell EMW, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00095; Hu WP, 2004, NEUROSCI LETT, V365, P147, DOI 10.1016/j.neulet.2004.04.072; Jang JY, 2011, J ETHNOPHARMACOL, V137, P1207, DOI 10.1016/j.jep.2011.07.047; Jones K, 2002, PIGM CELL RES, V15, P335, DOI 10.1034/j.1600-0749.2002.02014.x; Katsanos GS, 2008, J BIOL REG HOMEOS AG, V22, P93; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kimyai-Asadi A, 2001, J CUTAN MED SURG, V5, P140, DOI 10.1007/s102270000016; Le Gouill C, 1999, J BIOL CHEM, V274, P12548, DOI 10.1074/jbc.274.18.12548; Lee MH, 2006, PHYTOCHEMISTRY, V67, P1262, DOI 10.1016/j.phytochem.2006.05.008; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; LEVITIN HP, 1980, GEN COMP ENDOCR, V40, P8, DOI 10.1016/0016-6480(80)90090-8; Liao S, 2012, EXP DERMATOL, V21, P635, DOI 10.1111/j.1600-0625.2012.01531.x; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lundeberg L, 2002, ARCH DERMATOL RES, V294, P393, DOI 10.1007/s00403-002-0350-y; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Martinez-Esparza M, 2001, INT J BIOCHEM CELL B, V33, P971, DOI 10.1016/S1357-2725(01)00068-1; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Minami M, 2001, EUR J PHARMACOL, V428, P215, DOI 10.1016/S0014-2999(01)01297-3; Mizusawa K, 2011, GEN COMP ENDOCR, V171, P75, DOI 10.1016/j.ygcen.2010.12.008; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Negroiu G, 2000, J BIOL CHEM, V275, P32200, DOI 10.1074/jbc.M005186200; Nordlind K, 2008, EXP DERMATOL, V17, P301, DOI 10.1111/j.1600-0625.2007.00670.x; Olivarius FD, 1999, J PHOTOCH PHOTOBIO B, V48, P42, DOI 10.1016/S1011-1344(99)00007-X; Park PJ, 2015, J INVEST DERMATOL, V135, P551, DOI 10.1038/jid.2014.423; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; Ping FF, 2012, INT J BIOCHEM CELL B, V44, P2342, DOI 10.1016/j.biocel.2012.09.025; Ptak K, 2009, J NEUROSCI, V29, P3720, DOI 10.1523/JNEUROSCI.5271-08.2009; Racke K, 1996, BEHAV BRAIN RES, V73, P83; Renner U, 2012, J CELL SCI, V125, P2486, DOI 10.1242/jcs.101337; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Rodriguez-Vallecillo E, 2014, PSYCHIAT CLIN N AM, V37, P625, DOI 10.1016/j.psc.2014.08.009; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, DERMATOLOGY, V211, P199, DOI 10.1159/000087012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Soriano A, 2009, J MED CHEM, V52, P5590, DOI 10.1021/jm900298c; Tansky MF, 2007, P NATL ACAD SCI USA, V104, P10691, DOI 10.1073/pnas.0703394104; Thomsen M, 2012, J INTERN MED, V271, P305, DOI 10.1111/j.1365-2796.2011.02447.x; Tobin DJ, 2006, CHEM SOC REV, V35, P52, DOI 10.1039/b505793k; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wang Q, 2014, CELL SIGNAL, V26, P1846, DOI 10.1016/j.cellsig.2014.04.017; Ward DT, 1998, J BIOL CHEM, V273, P14476, DOI 10.1074/jbc.273.23.14476; WESSELY SC, 1989, BRIT J PSYCHIAT, V155, P686; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Zhou J, 2016, EUR J PHARMACOL, V775, P106, DOI 10.1016/j.ejphar.2016.02.026; Zhou J, 2015, CYTOKINE, V74, P137, DOI 10.1016/j.cyto.2015.01.034; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z; Zmijewski MA, 2011, DERM-ENDOCRINOL, V3, P3, DOI 10.4161/derm.3.1.14617	86	4	6	3	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3193	3214		10.1096/fj.201700564RR	http://dx.doi.org/10.1096/fj.201700564RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29430989				2022-12-26	WOS:000432546000025
J	Chen, EF; Wang, MH; He, F; Sun, RY; Cheng, W; Zee, BCY; Lau, SYF; Wang, XX; Chong, KC				Chen, Enfu; Wang, Maggie H.; He, Fan; Sun, Riyang; Cheng, Wei; Zee, Benny C. Y.; Lau, Steven Y. F.; Wang, Xiaoxiao; Chong, Ka Chun			An increasing trend of rural infections of human influenza A (H7N9) from 2013 to 2017: A retrospective analysis of patient exposure histories in Zhejiang province, China	PLOS ONE			English	Article							AVIAN INFLUENZA; A(H7N9) VIRUS; POULTRY MARKETS; RISK-FACTORS; EPIDEMIOLOGY; WAVES; TRANSMISSION; EVOLUTION; CHICKENS; VACCINES	Background Although investigations have shown that closing live poultry markets (LPMs) is highly effective in controlling human influenza A (H7N9) infections, many of the urban LPMs were shut down, but rural LPMs remained open. This study aimed to compare the proportional changes between urban and rural infections in the Zhejiang province from 2013 to 2017 by analyzing the exposure histories of human cases. Methods All laboratory-confirmed cases of H7N9 from 2013 (the first wave) to 2017 (the fifth wave) in the Zhejiang province of China were analyzed. Urban and rural infections were defined based on the locations of poultry exposure (direct and indirect) in urban areas (central towns) and rural areas (towns and villages on the outskirts of cities). A Chi-square trend test was used to compare the proportional trend between urban and rural infections over time and logistic regression was used to obtain the odds ratio by years. Results From 2013 to 2017, a statistically significant trend in rural infections was observed (p < 0.01). The incremental odds ratio by years of rural infections was 1.59 with 95% confidence intervals of 1.34 to 1.86. Each year, significant increases in the proportion of live poultry transactions in LPMS and poultry processing plants were detected in conjunction with an increased proportion of urban and rural infections. Conclusion The empirical evidence indicated a need for heightened infection control measures in rural areas, such as serving rural farms and backyards as active surveillance points for the H7N9 virus. Other potential interventions such as the vaccination of poultry and extending the closure of LPMs to the provincial level require further careful investigations.	[Chen, Enfu; He, Fan; Cheng, Wei; Wang, Xiaoxiao] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wang, Maggie H.; Sun, Riyang; Zee, Benny C. Y.; Lau, Steven Y. F.; Chong, Ka Chun] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Maggie H.; Zee, Benny C. Y.; Chong, Ka Chun] Chinese Univ Hong Kong, Shenzhen Res Inst, Clin Trials & Biostat Lab, Shenzhen, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Wang, XX (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Chong, KC (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.; Chong, KC (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Clin Trials & Biostat Lab, Shenzhen, Peoples R China.	xxwang@cdc.zj.cn; marc@cuhk.edu.hk	Chong, Marc Ka-chun/S-7258-2019; Zee, Benny Chung Ying/G-5606-2017; Wang, Maggie Haitian/F-5954-2017	Chong, Marc Ka-chun/0000-0001-5610-1298; Zee, Benny Chung Ying/0000-0002-7238-845X; Wang, Maggie Haitian/0000-0003-1223-4595	Basic research project from Shenzhen Municipal Science and Technology Program [JCYJ20150630165236958]; National Natural Science Foundation of China [81473035]; Zhejiang Province Major Science and Technology Program [2014C03039]; Medical Research Programme [2016RCA008]	Basic research project from Shenzhen Municipal Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Major Science and Technology Program; Medical Research Programme	The work is supported by Basic research project from Shenzhen Municipal Science and Technology Program (Grant number: JCYJ20150630165236958), National Natural Science Foundation of China (Grant number: 81473035), Zhejiang Province Major Science and Technology Program (2014C03039), and Medical Research Programme (2016RCA008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the physicians and staff at Hangzhou, Huzhou, Jiaxing, Wenzhou, Shaoxing municipal center for disease control and prevention for their support and assistance with this investigation. We also thank Dr. Shuo Su and two reviewers for their valuable and constructive comments. The work is supported by Basic research project from Shenzhen Municipal Science and Technology Program (Grant number: JCYJ20150630165236958), National Natural Science Foundation of China (Grant number: 81473035), Zhejiang Province Major Science and Technology Program (2014C03039), and Medical Research Programme (2016RCA008).	Chan EYY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2245-9; Chen E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.43.20616; Chong KC, 2016, EPIDEMIOL INFECT, V144, P1584, DOI 10.1017/S0950268815002812; Chong KC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-309; Fielding R, 2007, HEALTH EDUC, V107, P437, DOI 10.1108/09654280710778574; Gong ZY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-244; Gu H, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3394; Guan Y, 2013, VIRUS RES, V178, P35, DOI 10.1016/j.virusres.2013.05.012; He F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2278-0; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Liu B, 2014, CLIN INFECT DIS, V59, P787, DOI 10.1093/cid/ciu423; Liu QF, 2015, J VIROL, V89, P7401, DOI 10.1128/JVI.00031-15; Ma QX, 2014, EMERG INFECT DIS, V20, P2152, DOI 10.3201/eid2012.140733; Ma XW, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0554-8; Murhekar M, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.008, 10.5365/WPSAR.2013.4.2.008]; National Bureau of Statistics of the People's Republic of China, STAT PROC DEF URB RU; National Health and Family Planning Commission of the People's Republic of China, 2013, CHIN GUID DIAGN TREA; Peng ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095430; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Reuters, REUTERS; Samaan G, 2011, PREV VET MED, V100, P71, DOI 10.1016/j.prevetmed.2011.03.003; Smith GJ, 2006, P NATL ACAD SCI USA, P103; Su S, 2017, TRENDS MICROBIOL, V25, P713, DOI 10.1016/j.tim.2017.06.008; Su S, 2015, J VIROL, V89, P8671, DOI 10.1128/JVI.01034-15; Sun Y, 2015, J CLIN VIROL, V70, P16, DOI 10.1016/j.jcv.2015.06.092; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Vong S, 2014, CLIN INFECT DIS, V59, P795, DOI 10.1093/cid/ciu424; Wang D., 2016, J VIROL; Wang XY, 2015, EPIDEMIOL INFECT, V143, P1839, DOI 10.1017/S095026881400257X; Wang X, 2013, TRANSPORT RES REC, P10, DOI 10.3141/2382-02; World Health Organization, 2013, GLOB AL RESP GAR HUM; World Health Organization, 2017, HUM INF AV INFL A H7; Xiang NJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2049-2; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Zhou L, 2017, EMERG INFECT DIS, V23, P1355, DOI 10.3201/eid2308.170640; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	37	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193052	10.1371/journal.pone.0193052	http://dx.doi.org/10.1371/journal.pone.0193052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447278	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900103
J	Gai, XC; Zhang, Q; Lu, HB; Yang, ZQ; Zhu, LS; Li, X; Wang, XP				Gai, Xiaochun; Zhang, Qun; Lu, Haibing; Yang, Zhanqing; Zhu, Lisai; Li, Xin; Wang, Xinping			A neonatal murine model for evaluation of enterovirus E HY12 virus infection and pathogenicity	PLOS ONE			English	Article							BOVINE	Backgrounds HY12 viruses are enteroviruses recently isolated from cattle characterized by severe respiratory and digestive disease with high morbidity and mortality in China. While the viruses exhibit unique biological and molecular characters distinct from known enterovirus E, the pathogenicity and viral pathogenesis remains largely unknown. Methods Neonatal mice of Balb/C, ICR, and Kunming strain are infected with HY12 to determine the susceptible mouse strain. The minimal infection dose, the virus infection routes, the pathogenicity and tissue tropism for HY12 were determined by infecting susceptible mice with HY12 viruses, and confirmed by different approaches including virus isolation and recovery, virus detection, histopathology, and immunohistochemistry. Results A murine model for HY12 infection was successfully established and employed to investigate the pathogenicity of HY12 viruses. ICR mouse strain is the most susceptible strain for HY12 infection with a minimal infective dose as 2x10(6) TCID50/mouse. HY12 viruses have the capability of infecting ICR suckling mice via all infection routes including intranasal administration, oral administration, intraperitoneal injection, subcutaneous injection, and intramuscular injection, which are confirmed by the isolation and recovery of viruses from HY12-infected mice; detection of viruses by RT-PCR; observations of pathological lesions and inflammatory cell infiltrations in the intestine, lung, liver, and brain; uncovering of HY12 virus antigens in majority of tissues, especially in intestine, lung, and infected brain of mice by immunohistochemistry assay. Conclusions A neonatal murine model for HY12 infection is successfully established for determining the susceptible mouse strain, the minimal infective dose, the infection route, the viral pathogenicity and the tropism of HY12, thus providing an invaluable model system for elucidating the pathogenesis of HY12 viruses and the elicited immunity.	[Gai, Xiaochun; Zhang, Qun; Lu, Haibing; Yang, Zhanqing; Zhu, Lisai; Li, Xin; Wang, Xinping] Jilin Univ, Coll Vet Med, Changchun, Jilin, Peoples R China; [Wang, Xinping] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun, Jilin, Peoples R China.; Wang, XP (corresponding author), Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun, Jilin, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; Wang, Xinping/0000-0003-1623-9262	National Science Foundation of China [31572531]; National Key Research and Development Program of China [2017YFD0500104, 2016YFD0500904]; National Natural Science Foundation of China [31572531]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (31572531) (http://www.nsfc.gov.cn/); National Key Research and Development Program of China (2017YFD0500104, 2016YFD0500904) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (grant NO: 31572531), and the National Key Research and Development Program of China "grants No: 2017YFD0500104; 2016YFD0500904".	Anbalagan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097517; Blas-Machado U, 2007, VET PATHOL, V44, P110, DOI 10.1354/vp.44-1-110; Blas-Machado U, 2011, VET PATHOL, V48, P1075, DOI 10.1177/0300985810395728; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; Donin DG, 2014, TROP ANIM HEALTH PRO, V46, P523, DOI 10.1007/s11250-013-0523-z; Fujii K, 2013, P NATL ACAD SCI USA, V110, P14753, DOI 10.1073/pnas.1217563110; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; King AMQ, 2012, 9 REPORT INT COMMITT, P855; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li YL, 2012, ARCH VIROL, V157, P2369, DOI 10.1007/s00705-012-1424-6; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; MOLL T, 1963, AM J VET RES, V24, P545; Omatsu T, 2014, VIRUS GENES, V48, P550, DOI 10.1007/s11262-014-1057-9; Phyu WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147463; Psalla D, 2006, J COMP PATHOL, V135, P142, DOI 10.1016/j.jcpa.2006.04.003; Straub O C, 1965, Dtsch Tierarztl Wochenschr, V72, P54; Wang MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174600; Wang XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045871; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Yang S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-291; Zhang HL, 2014, VIRUS RES, V191, P101, DOI 10.1016/j.virusres.2014.07.032	22	5	6	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193155	10.1371/journal.pone.0193155	http://dx.doi.org/10.1371/journal.pone.0193155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447290	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900114
J	Keleher, MR; Zaidi, R; Shah, S; Oakley, ME; Pavlatos, C; El Idrissi, S; Xing, XY; Li, DF; Wang, T; Cheverud, JM				Keleher, Madeline Rose; Zaidi, Rabab; Shah, Shyam; Oakley, M. Elsa; Pavlatos, Cassondra; El Idrissi, Samir; Xing, Xiaoyun; Li, Daofeng; Wang, Ting; Cheverud, James M.			Maternal high-fat diet associated with altered gene expression, DNA methylation, and obesity risk in mouse offspring	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; LIVER-DISEASE; INSULIN-RESISTANCE; DIFFERENTIAL EXPRESSION; OXIDATIVE STRESS; LIPID-METABOLISM; PREGNANCY; MITOCHONDRIAL; DYSFUNCTION; HYPERTENSION	We investigated maternal obesity in inbred SM/J mice by assigning females to a high-fat diet or a low-fat diet at weaning, mating them to low-fat-fed males, cross-fostering the offspring to low-fat-fed SM/J nurses at birth, and weaning the offspring onto a high-fat or low-fat diet. A maternal high-fat diet exacerbated obesity in the high-fat-fed daughters, causing them to weigh more, have more fat, and have higher serum levels of leptin as adults, accompanied by dozens of gene expression changes and thousands of DNA methylation changes in their livers and hearts. Maternal diet particularly affected genes involved in RNA processing, immune response, and mitochondria. Between one-quarter and one-third of differentially expressed genes contained a differentially methylated region associated with maternal diet. An offspring high-fat diet reduced overall variation in DNA methylation, increased body weight and organ weights, increased long bone lengths and weights, decreased insulin sensitivity, and changed the expression of 3,908 genes in the liver. Although the offspring were more affected by their own diet, their maternal diet had epigenetic effects lasting through adulthood, and in the daughters these effects were accompanied by phenotypic changes relevant to obesity and diabetes.	[Keleher, Madeline Rose] Washington Univ, Dept Evolut Ecol & Populat Biol, St Louis, MO 63130 USA; [Zaidi, Rabab; Shah, Shyam; Oakley, M. Elsa; Pavlatos, Cassondra; El Idrissi, Samir; Cheverud, James M.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Xing, Xiaoyun; Li, Daofeng; Wang, Ting] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Loyola University Chicago; Washington University (WUSTL)	Keleher, MR (corresponding author), Washington Univ, Dept Evolut Ecol & Populat Biol, St Louis, MO 63130 USA.	mkeleher@wustl.edu	Zaidi, Syeda/AAP-1178-2020; Li, Daofeng/L-8143-2019; Li, Daofeng/E-5386-2011	Li, Daofeng/0000-0001-7492-3703; Li, Daofeng/0000-0001-7492-3703; Zaidi, Syeda/0000-0002-8023-0863	American Heart Association [16PRE26420105]; Thermo Fisher Scientific (Antibody Scholarship Award); Core Laboratory for Clinical Studies and the Diabetes Models Phenotyping Core (Washington University DRC) [P30 DK020579]; Genome Technology Access Center at Washington University School of Medicine (NCI Cancer Center Support Grant) [P30 CA91842]; Genome Technology Access Center at Washington University School of Medicine (ICTS/CTSA from the National Center for Research Resources) [UL1TR000448]; American Heart Association; Thermo Fisher Scientific; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Thermo Fisher Scientific (Antibody Scholarship Award); Core Laboratory for Clinical Studies and the Diabetes Models Phenotyping Core (Washington University DRC); Genome Technology Access Center at Washington University School of Medicine (NCI Cancer Center Support Grant); Genome Technology Access Center at Washington University School of Medicine (ICTS/CTSA from the National Center for Research Resources); American Heart Association(American Heart Association); Thermo Fisher Scientific; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the American Heart Association (#16PRE26420105 to MK), Thermo Fisher Scientific (Antibody Scholarship Award to MK), the Core Laboratory for Clinical Studies and the Diabetes Models Phenotyping Core (Washington University DRC, Grant #P30 DK020579), and the Genome Technology Access Center at Washington University School of Medicine (NCI Cancer Center Support Grant #P30 CA91842 and ICTS/CTSA Grant# UL1TR000448 from the National Center for Research Resources). This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. We received funding from the American Heart Association and Thermo Fisher Scientific. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the American Heart Association (#16PRE26420105), Thermo Fisher Scientific (Antibody Scholarship Award), the Core Laboratory for Clinical Studies and the Diabetes Models Phenotyping Core (Washington University DRC, Grant #P30 DK020579), and the Genome Technology Access Center at Washington University School of Medicine (NCI Cancer Center Support Grant #P30 CA91842 and ICTS/CTSA Grant# UL1TR000448 from the National Center for Research Resources). This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.	Aboouf MA, 2015, DIABETES RES CLIN PR, V109, P40, DOI 10.1016/j.diabres.2015.05.016; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bar J, 2012, ARCH GYNECOL OBSTET, V286, P1343, DOI 10.1007/s00404-012-2450-z; Bellisario V, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00285; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Cheverud JM, 2011, OBESITY, V19, P160, DOI 10.1038/oby.2010.141; Cheverud JM, 1999, PHYSIOL GENOMICS, V1, P33, DOI 10.1152/physiolgenomics.1999.1.1.33; Cheverud JM, 2004, DIABETES, V53, P2700, DOI 10.2337/diabetes.53.10.2700; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Costa SMR, 2016, INT J OBESITY, V40, P1627, DOI 10.1038/ijo.2016.142; Deng Fei-Yan, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M111.011700; Do GM, 2011, MOL NUTR FOOD RES, V55, pS173, DOI 10.1002/mnfr.201100064; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Ehrich TH, 2003, OBES RES, V11, P1400, DOI 10.1038/oby.2003.189; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Eriksson JG, 2014, ANN MED, V46, P434, DOI 10.3109/07853890.2014.919728; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fernandez-Twinn DS, 2012, ENDOCRINOLOGY, V153, P5961, DOI 10.1210/en.2012-1508; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Gaillard R, 2015, EUR J EPIDEMIOL, V30, P1141, DOI 10.1007/s10654-015-0085-7; Gaillard R, 2014, HYPERTENSION, V63, P683, DOI 10.1161/HYPERTENSIONAHA.113.02671; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; Grindler NM, 2013, MOL HUM REPROD, V19, P486, DOI 10.1093/molehr/gat026; Guenard F, 2013, P NATL ACAD SCI USA, V110, P11439, DOI 10.1073/pnas.1216959110; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Inuzuka H, 2013, HYPERTENS PREGNANCY, V32, P410, DOI 10.3109/10641955.2013.813535; Joshi SR, 2016, PULM CIRC, V6, P360, DOI 10.1086/688060; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kenney-Hunt JP, 2008, GENETICS, V178, P2275, DOI 10.1534/genetics.107.084434; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kim DG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0467-5; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Latouche C, 2014, J NUTR, V144, P237, DOI 10.3945/jn.113.186775; Leary C, 2015, HUM REPROD, V30, P122, DOI 10.1093/humrep/deu276; Levy E, 2010, ENDOCRINOLOGY, V151, P958, DOI 10.1210/en.2009-0866; Li DF, 2015, METHODS, V72, P29, DOI 10.1016/j.ymeth.2014.10.032; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; Liang MM, 2016, PLACENTA, V40, P52, DOI 10.1016/j.placenta.2016.02.015; Liao YC, 2011, AM J CLIN NUTR, V94, P921, DOI 10.3945/ajcn.110.008813; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; MacArthur JW, 1944, AM NAT, V78, P142, DOI 10.1086/281181; Madan JC, 2009, CYTOKINE, V47, P61, DOI 10.1016/j.cyto.2009.05.004; Miller C, 2014, FASEB S, V28, P11; Mina TH, 2017, PSYCHOL MED, V47, P353, DOI 10.1017/S0033291716002452; Mischke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078623; Mouralidarane A, 2015, INT J OBESITY, V39, P1339, DOI 10.1038/ijo.2015.85; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Muka T, 2016, NUTR METAB CARDIOVAS, V26, P553, DOI 10.1016/j.numecd.2016.04.002; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Oestreich AK, 2017, TRENDS GENET, V33, P399, DOI 10.1016/j.tig.2017.03.008; Partridge CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-99; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Pocernich CB, 2012, BBA-MOL BASIS DIS, V1822, P625, DOI 10.1016/j.bbadis.2011.10.003; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017; Pugh SJ, 2015, J NUTR, V145, P2562, DOI 10.3945/jn.115.215525; Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; Saharan S, 2014, J ALZHEIMERS DIS, V40, P519, DOI 10.3233/JAD-132483; Satoh K, 2011, J BIOL CHEM, V286, P20591, DOI 10.1074/jbc.M110.204685; Sferruzzi-Perri AN, 2013, FASEB J, V27, P3928, DOI 10.1096/fj.13-234823; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Soubry A, 2015, INT J OBESITY, V39, P650, DOI 10.1038/ijo.2013.193; Stenvinkel P, 2006, CLIN J AM SOC NEPHRO, V1, P281, DOI 10.2215/CJN.01281005; Stevens M, 2013, GENOME RES, V23, P1541, DOI 10.1101/gr.152231.112; Stirrat LI, 2014, RES REP NEONATOL, V4, P43, DOI 10.2147/RRN.S46783; Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603; Wang D, 2015, J MICROENCAPSUL, V32, P443, DOI 10.3109/02652048.2015.1046515; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Wankhade UD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175675; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Wildsmith KR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt187; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044; Yokomori H, 2012, HEPATOL RES, V42, P508, DOI 10.1111/j.1872-034X.2011.00945.x; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zain SM, 2013, J GASTROEN HEPATOL, V28, P873, DOI 10.1111/jgh.12104; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zhu MJ, 2016, J PHYSL, V586, p2651 ; Zordoky BNM, 2008, CURR DRUG METAB, V9, P122	104	66	68	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192606	10.1371/journal.pone.0192606	http://dx.doi.org/10.1371/journal.pone.0192606			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447215	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900042
J	Maniwa, K; Yamashita, H; Tsukano, H; Hishida, R; Endo, N; Shibata, M; Shibuki, K				Maniwa, Keiichi; Yamashita, Haruyoshi; Tsukano, Hiroaki; Hishida, Ryuichi; Endo, Naoto; Shibata, Minoru; Shibuki, Katsuei			Tomographic optical imaging of cortical responses after crossing nerve transfer in mice	PLOS ONE			English	Article							CALLOSAL PROJECTION NEURONS; MOUSE SOMATOSENSORY CORTEX; VISUAL-CORTEX; FLAVOPROTEIN AUTOFLUORESCENCE; HAND REPRESENTATION; CORPUS-CALLOSUM; INJURED ARM; PLASTICITY; REORGANIZATION; MONKEYS	To understand the neural mechanisms underlying the therapeutic effects of crossing nerve transfer for brachial plexus injuries in human patients, we investigated the cortical responses after crossing nerve transfer in mice using conventional and tomographic optical imaging. The distal cut ends of the left median and ulnar nerves were connected to the central cut ends of the right median and ulnar nerves with a sciatic nerve graft at 8 weeks of age. Eight weeks after the operation, the responses in the primary somatosensory cortex (S1) elicited by vibratory stimulation applied to the left forepaw were visualized based on activity-dependent flavoprotein fluorescence changes. In untreated mice, the cortical responses to left forepaw stimulation were mainly observed in the right S1. In mice with nerve crossing transfer, cortical responses to left forepaw stimulation were observed in the left S1 together with clear cortical responses in the right S1. We expected that the right S1 responses in the untreated mice were produced by thalamic inputs to layer IV, whereas those in the operated mice were mediated by callosal inputs from the left S1 to layer II/III of the right S1. To confirm this hypothesis, we performed tomographic imaging of flavoprotein fluorescence responses by macroconfocal microscopy. Flavoprotein fluorescence responses in layer IV were dominant compared to those in layer II/III in untreated mice. In contrast, responses in layer II/III were dominant compared to those in layer IV in operated mice. The peak latency of the cortical responses in the operated mice was longer than that in the untreated mice. These results confirmed our expectation that drastic reorganization in the cortical circuits was induced after crossing nerve transfer in mice.	[Maniwa, Keiichi; Tsukano, Hiroaki; Hishida, Ryuichi; Shibuki, Katsuei] Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata, Japan; [Maniwa, Keiichi; Yamashita, Haruyoshi; Endo, Naoto] Niigata Univ, Dept Orthoped Surg, Fac Med, Niigata, Japan; [Shibata, Minoru] Niigata Univ, Dept Plast Surg, Fac Med, Niigata, Japan	Niigata University; Niigata University; Niigata University	Shibuki, K (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata, Japan.	shibuki@bri.niigata-u.ac.jp	Tsukano, Hiroaki/G-5053-2013	Tsukano, Hiroaki/0000-0001-8511-7256	Japanese Government [JP22240044, JP22115011, JP16H01892]; Grants-in-Aid for Scientific Research [17K07051] Funding Source: KAKEN	Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) from Japanese Government (JP22240044, JP22115011 and JP16H01892) to K.S.	Addas BMJ, 2009, NEUROSURG CLIN N AM, V20, P27, DOI 10.1016/j.nec.2008.07.018; Cardoso MD, 2016, ACTA NEUROCHIR, V158, P1793, DOI 10.1007/s00701-016-2855-8; CZEIGER D, 1993, J COMP NEUROL, V330, P502, DOI 10.1002/cne.903300406; Fabri M, 2006, EUR J NEUROSCI, V23, P3139, DOI 10.1111/j.1460-9568.2006.04823.x; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Graziano A, 2008, J COMP NEUROL, V507, P1258, DOI 10.1002/cne.21592; GU YD, 1994, J HAND SURG-BRIT EUR, V19B, P69, DOI 10.1016/0266-7681(94)90053-1; GU YD, 1992, J HAND SURG-BRIT EUR, V17B, P518, DOI 10.1016/S0266-7681(05)80235-9; Hishida R, 2014, NEUROSCI RES, V87, P49, DOI 10.1016/j.neures.2014.07.004; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Iwamura Y, 2002, BEHAV BRAIN RES, V135, P185, DOI 10.1016/S0166-4328(02)00164-X; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; Kakinoki R, 2017, J HAND SURG-ASIAN-PA, V22, P138, DOI 10.1142/S0218810417500162; Kamatani D, 2007, NEUROIMAGE, V35, P47, DOI 10.1016/j.neuroimage.2006.08.049; Kitaura H, 2007, NEUROSCI RES, V59, P160, DOI 10.1016/j.neures.2007.06.1469; Kitaura H, 2010, BRAIN RES, V1319, P54, DOI 10.1016/j.brainres.2010.01.020; Komagata S, 2011, J NEUROSCI, V31, P4896, DOI 10.1523/JNEUROSCI.6753-10.2011; Lou L, 2006, NEUROSCIENCE, V138, P1225, DOI 10.1016/j.neuroscience.2005.11.062; Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Murakami H, 2004, EUR J NEUROSCI, V19, P1352, DOI 10.1111/j.1460-9568.2004.03237.x; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Ramos RL, 2008, NEUROSCIENCE, V153, P654, DOI 10.1016/j.neuroscience.2008.02.069; Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075; Rochefort NL, 2008, TRENDS MOL MED, V14, P389, DOI 10.1016/j.molmed.2008.07.005; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shih AY, 2015, MICROCIRCULATION, V22, P204, DOI 10.1111/micc.12195; SHIMOJO S, 1981, PERCEPTION, V10, P391, DOI 10.1068/p100391; Socolovsky M, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.12.FOCUS16431; Sugita Y, 1996, NATURE, V380, P523, DOI 10.1038/380523a0; Takase Y, 2013, DEV GROWTH DIFFER, V55, P792, DOI 10.1111/dgd.12106; Tanaka Y, 2007, VISION RES, V47, P1350, DOI 10.1016/j.visres.2006.10.028; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Vanzetta I, 2006, J PHYSIOL-PARIS, V100, P201, DOI 10.1016/j.jphysparis.2007.01.002; VITERBO F, 1994, BRIT J PLAST SURG, V47, P75, DOI 10.1016/0007-1226(94)90162-7; Wang M, 2010, NEUROSURGERY, V67, P136, DOI 10.1227/01.NEU.0000370603.45342.6B; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WHITE EL, 1991, J COMP NEUROL, V303, P233, DOI 10.1002/cne.903030206; Yamashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035676; Yellen G, 2015, CURR OPIN CHEM BIOL, V27, P24, DOI 10.1016/j.cbpa.2015.05.024; Yoshitake K, 2013, CELL REP, V5, P1365, DOI 10.1016/j.celrep.2013.11.006; Zhang L, 2017, NEUROSURGERY, V80, P627, DOI 10.1093/neuros/nyw160; Zuo CT, 2010, J NEUROSURG, V113, P133, DOI 10.3171/2010.1.JNS09448	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0193017	10.1371/journal.pone.0193017	http://dx.doi.org/10.1371/journal.pone.0193017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444175	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500108
J	Sapoznik, E; Niu, GG; Zhou, Y; Prim, PM; Criswell, TL; Soker, S				Sapoznik, Etai; Niu, Guoguang; Zhou, Yu; Prim, Peter M.; Criswell, Tracy L.; Soker, Shay			A real-time monitoring platform of myogenesis regulators using double fluorescent labeling	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MUSCLE STEM-CELLS; SKELETAL-MUSCLE; TNF-ALPHA; MUSCULAR-DYSTROPHY; DIFFERENTIATION; C2C12; PROTEIN; REGENERATION; FIBRONECTIN	Real-time, quantitative measurement of muscle progenitor cell (myoblast) differentiation is an important tool for skeletal muscle research and identification of drugs that support skeletal muscle regeneration. While most quantitative tools rely on sacrificial approach, we developed a double fluorescent tagging approach, which allows for dynamic monitoring of myoblast differentiation through assessment of fusion index and nuclei count. Fluorescent tagging of both the cell cytoplasm and nucleus enables monitoring of cell fusion and the formation of new myotube fibers, similar to immunostaining results. This labeling approach allowed monitoring the effects of Myf5 overexpression, TNF alpha, and Wnt agonist on myoblast differentiation. It also enabled testing the effects of surface coating on the fusion levels of scaffold-seeded myoblasts. The double fluorescent labeling of myoblasts is a promising technique to visualize even minor changes in myogenesis of myoblasts in order to support applications such as tissue engineering and drug screening.	[Sapoznik, Etai; Niu, Guoguang; Zhou, Yu; Prim, Peter M.; Criswell, Tracy L.; Soker, Shay] Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA	Wake Forest University	Soker, S (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.	ssoker@wakehealth.edu	Prim, Peter Michael/AAX-8437-2021		National Heart, Lung, and Blood Institute [R01HL098912]; National Institute of Biomedical Imaging and Bioengineering [R21EB017819]; Department of Defense USAMRAA (AFIRM) [W81XWH-08-2-0032]; National Cancer Institute [P30CA012197, P30CA016086]; National Cancer Institute (Wake Forest Comprehensive Cancer Center)	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Department of Defense USAMRAA (AFIRM)(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (Wake Forest Comprehensive Cancer Center)	The authors like to acknowledge financial support from the following: National Heart, Lung, and Blood Institute (R01HL098912 to SS), National Institute of Biomedical Imaging and Bioengineering (R21EB017819 to SS), Department of Defense USAMRAA (AFIRM W81XWH-08-2-0032 to SS) and the National Cancer Institute (P30CA012197 to SS and the Wake Forest Comprehensive Cancer Center and P30CA016086 to the UNC Lineberger Comprehensive Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors like to acknowledge financial support from the following: National Heart, Lung, and Blood Institute (R01HL098912 to SS), National Institute of Biomedical Imaging and Bioengineering (R21EB017819 to SS), Department of Defense USAMRAA (AFIRM W81XWH-08-2-0032 to SS) and the National Cancer Institute (P30CA012197 to the Wake Forest Comprehensive Cancer Center and P30CA016086 to the UNC Lineberger Comprehensive Cancer Center).	Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418; Bettadapur A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28855; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Biressi S, 2013, DEV BIOL, V379, P195, DOI 10.1016/j.ydbio.2013.04.021; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Bonifacio A, 2016, ARCHIVES OF TOXICOLO, P1; Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Cornelison DDW, 2017, METHODS MOL BIOL, V1556, P3, DOI 10.1007/978-1-4939-6771-1_1; DeBrosse C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88207; Demonbreun AR, 2017, CURR OPIN PHARMACOL, V34, P7, DOI 10.1016/j.coph.2017.03.008; Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222; Edmunds KJ, 2016, EUROPEAN JOURNAL OF, V26; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Grabowska I, 2011, CELL BIOL INT, V35, P125, DOI 10.1042/CBI20090335; Gribova V, 2016, BIOCHEM BIOPH RES CO, V474, P515, DOI 10.1016/j.bbrc.2016.04.130; Gutpell K, 2013, JOVE-J VIS EXP, DOI 10.3791/50119; Harikumar A, 2017, STEM CELL REPORTS; Ho AT, 2016, ENGRAFTMENT DYNAMICS, P181; Hofmann MC, 2012, TISSUE ENG PART C-ME, V18, P677, DOI [10.1089/ten.tec.2011.0490, 10.1089/ten.TEC.2011.0490]; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Ikeda K, 2017, SCI REPORTS, V7; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Klyen BR, 2014, BIOMED OPT EXPRESS, V5, P1217, DOI 10.1364/BOE.5.001217; Kodaka M, 2015, EXP CELL RES, V336, P171, DOI 10.1016/j.yexcr.2015.06.015; Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028; Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032; Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126; Madden L, 2015, ELIFE, V4, DOI 10.7554/eLife.04885; McColl R, 2016, BIOTECHNIQUES, V61, P323, DOI 10.2144/000114485; Meijering E, 2016, NAT BIOTECHNOL, V34, P1250, DOI 10.1038/nbt.3722; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Mohammadi M, 2017, CURRENT PHARMACEUTIC, V1398; Muses S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024826; Nucciotti V, 2010, P NATL ACAD SCI USA, V107, P7763, DOI 10.1073/pnas.0914782107; Ozturk MS, 2016, ANN BIOMED ENG, V44, P667, DOI 10.1007/s10439-015-1511-4; Park I, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122068; Passipieri JA, 2017, TISSUE ENG; Patel HJ, 2016, LIFE SCI; Plaisance I, 2008, AM J PHYSIOL-ENDOC M, V294, pE241, DOI 10.1152/ajpendo.00129.2007; Plotnikov SV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2967536; Rakhilin S, 2011, J BIOMOL SCREEN, V16, P565, DOI 10.1177/1087057111401392; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Sincennes MC, 2016, STEM CELL TRANSL MED, V5, P282, DOI 10.5966/sctm.2015-0266; Smith AST, 2016, DRUG DISCOV TODAY, V21, P1387, DOI 10.1016/j.drudis.2016.04.013; Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069; Suh GC, 2017, FABRICATION MICROMOL, P147; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Syverud BC, 2017, TISSUE ENG; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Vandenburgh H, 2010, TISSUE ENG PART B-RE, V16, P55, DOI [10.1089/ten.teb.2009.0445, 10.1089/ten.TEB.2009.0445]; Vandenburgh H, 2009, FASEB J, V23, P3325, DOI 10.1096/fj.09-134411; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Webster MT, 2016, CELL STEM CELL, V18, P243, DOI 10.1016/j.stem.2015.11.005; Yan JY, 2016, J MOL CELL CARDIOL, V97, P278, DOI 10.1016/j.yjmcc.2016.06.003; Yang XJ, 2014, BIOMED OPT EXPRESS, V5, P136, DOI 10.1364/BOE.5.000136; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zhao Q, 2015, BIOCHEM BIOPH RES CO, V458, P790, DOI 10.1016/j.bbrc.2015.02.026; zturk-Kaloglu D, 2016, TISSUE ENG	71	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192654	10.1371/journal.pone.0192654	http://dx.doi.org/10.1371/journal.pone.0192654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444187	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500081
J	Werner, P; Al-Hamadi, A; Limbrecht-Ecklundt, K; Walter, S; Traue, HC				Werner, Philipp; Al-Hamadi, Ayoub; Limbrecht-Ecklundt, Kerstin; Walter, Steffen; Traue, Harald C.			Head movements and postures as pain behavior	PLOS ONE			English	Article							FACIAL EXPRESSION; ACTIVITY PATTERNS; CLUSTER-ANALYSIS; ASSESSMENT TOOLS; VALIDATION; DIFFERENTIATION; STIMULUS; ABILITY; FACES; CUES	Pain assessment can benefit from observation of pain behaviors, such as guarding or facial expression, and observational pain scales are widely used in clinical practice with nonverbal patients. However, little is known about head movements and postures in the context of pain. In this regard, we analyze videos of three publically available datasets. The BioVid dataset was recorded with healthy participants subjected to painful heat stimuli. In the BP4D dataset, healthy participants performed a cold-pressor test and several other tasks (meant to elicit emotion). The UNBC dataset videos show shoulder pain patients during range-of-motion tests to their affected and unaffected limbs. In all videos, participants were sitting in an upright position. We studied head movements and postures that occurred during the painful and control trials by measuring head orientation from video over time, followed by analyzing posture and movement summary statistics and occurrence frequencies of typical postures and movements. We found significant differences between pain and control trials with analyses of variance and binomial tests. In BioVid and BP4D, pain was accompanied by head movements and postures that tend to be oriented downwards or towards the pain site. We also found differences in movement range and speed in all three datasets. The results suggest that head movements and postures should be considered for pain assessment and research. As additional pain indicators, they possibly might improve pain management whenever behavior is assessed, especially in nonverbal individuals such as infants or patients with dementia. However, in advance more research is needed to identify specific head movements and postures in pain patients.	[Werner, Philipp; Al-Hamadi, Ayoub] Otto von Guericke Univ, Inst Informat Technol & Commun, Neuroinformat Technol Grp, Magdeburg, Germany; [Limbrecht-Ecklundt, Kerstin] Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Hamburg, Germany; [Walter, Steffen; Traue, Harald C.] Univ Clin Psychosomat Med & Psychotherapy, Med Psychol, Ulm, Germany	Otto von Guericke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Werner, P (corresponding author), Otto von Guericke Univ, Inst Informat Technol & Commun, Neuroinformat Technol Grp, Magdeburg, Germany.	philipp.werner@ovgu.de	Werner, Philipp/W-3629-2019	Werner, Philipp/0000-0003-4762-2926	German Research Foundation [AL 638/3-1, AL 638/3-2, TR 233/12-1, TR 233/12-2]	German Research Foundation(German Research Foundation (DFG))	This research was funded by the German Research Foundation (www.dfg.de), grant numbers AL 638/3-1, AL 638/3-2, TR 233/12-1 and TR 233/12-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghowinem S, 2013, INT CONF AFFECT, P283, DOI 10.1109/ACII.2013.53; Ambadar Z, 2009, J NONVERBAL BEHAV, V33, P17, DOI 10.1007/s10919-008-0059-5; AMBUEL B, 1992, J PEDIATR PSYCHOL, V17, P95, DOI 10.1093/jpepsy/17.1.95; Aung MSH, 2016, IEEE T AFFECT COMPUT, V7, P435, DOI 10.1109/TAFFC.2015.2462830; Bischoff C, 1983, PERSPECTIVES RES HEA; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Craig K. D., 1992, APS J, V1, P153; Dowman R, 2014, COGN AFFECT BEHAV NE, V14, P805, DOI 10.3758/s13415-013-0233-z; Feldt K S, 2000, Pain Manag Nurs, V1, P13, DOI 10.1053/jpmn.2000.5831; Fuchs-Lacelle S, 2004, PAIN MANAG NURS, V5, P37, DOI 10.1016/j.pmn.2003.10.001; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Gelinas C, 2013, SEMIN RESP CRIT CARE, V34, P153, DOI 10.1055/s-0033-1342970; Geuter S, 2014, PAIN, V155, P994, DOI 10.1016/j.pain.2014.02.005; Girard J.M., 2014, CURRENT OPINION PSYC, V4, P75, DOI DOI 10.1016/J.C0PSYC.2014.12.010; Girard JM, 2014, IMAGE VISION COMPUT, V32, P641, DOI 10.1016/j.imavis.2013.12.007; Hadjistavropoulos T, 2002, BEHAV RES THER, V40, P551, DOI 10.1016/S0005-7967(01)00072-9; Hair J. F., 2000, READING UNDERSTANDIN, P147; Hammal Z, 2015, IEEE T AFFECT COMPUT, V6, P361, DOI 10.1109/TAFFC.2015.2422702; Hammal Z, 2014, IEEE T AFFECT COMPUT, V5, P155, DOI 10.1109/TAFFC.2014.2326408; Herr K, 2006, PAIN MANAG NURS, V7, P44, DOI 10.1016/j.pmn.2006.02.003; K_achele M., 2015, EANN, P275; KEEFE FJ, 1982, BEHAV THER, V13, P363, DOI 10.1016/S0005-7894(82)80001-4; KELTNER D, 1995, J PERS SOC PSYCHOL, V68, P441, DOI 10.1037/0022-3514.68.3.441; Kunz M, 2004, J PAIN, V5, P368, DOI 10.1016/j.jpain.2004.06.002; Kunz M, 2014, EUR J PAIN, V18, P813, DOI 10.1002/j.1532-2149.2013.00421.x; Lane RD, 2000, COGNITIVE NEUROSCIEN, P71; Lichtner V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-138; Lucey P., 2011, INT C AUT FAC GEST R; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Merkel S I, 1997, Pediatr Nurs, V23, P293; Mignault A, 2003, J NONVERBAL BEHAV, V27, P111, DOI 10.1023/A:1023914509763; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; Morales M, 2000, INFANT BEHAV DEV, V23, P231, DOI 10.1016/S0163-6383(01)00038-8; Murphy-Chutorian E, 2009, IEEE T PATTERN ANAL, V31, P607, DOI 10.1109/TPAMI.2008.106; Niese R, 2013, IEEE SYS MAN CYBERN, P487, DOI 10.1109/SMC.2013.89; Pantic M, 2002, BEHAV BRAIN SCI, V25, P469; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Prkachin KM, 2008, PAIN, V139, P267, DOI 10.1016/j.pain.2008.04.010; Pudas-Tahka SM, 2009, J ADV NURS, V65, P946, DOI 10.1111/j.1365-2648.2008.04947.x; Rovniak LS, 2010, HEALTH PSYCHOL, V29, P496, DOI 10.1037/a0020428; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sikka K, 2015, PEDIATRICS, V136, pE124, DOI 10.1542/peds.2015-0029; STEINIER J, 1972, ANAL CHEM, V44, P1906, DOI 10.1021/ac60319a045; Teufel R, 1989, CLIN PERSPECTIVES HE; Traue H C, 1992, Int J Psychosom, V39, P18; TRAUE HC, 1985, J PSYCHOSOM RES, V29, P375, DOI 10.1016/0022-3999(85)90023-6; von Baeyer CL, 2007, PAIN, V127, P140, DOI 10.1016/j.pain.2006.08.014; von Baeyer CL, 2005, J PAIN, V6, P218, DOI 10.1016/j.jpain.2005.01.349; WALLBOTT HG, 1986, J PERS SOC PSYCHOL, V51, P690, DOI 10.1037/0022-3514.51.4.690; Walsh J, 2014, PAIN, V155, P2282, DOI 10.1016/j.pain.2014.08.019; Walter Steffen, 2013, 2013 IEEE International Conference on Cybernetics (CYBCO), P128, DOI 10.1109/CYBConf.2013.6617456; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; WATSON DH, 1993, CEPHALALGIA, V13, P272, DOI 10.1046/j.1468-2982.1993.1304272.x; WAXER P, 1974, J ABNORM PSYCHOL, V83, P319, DOI 10.1037/h0036706; Werner P., 2016, IEEE T AFFECT COMPUT, P1; Werner P, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.119; Werner P, 2014, INT C PATT RECOG, P4582, DOI 10.1109/ICPR.2014.784; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Xiong XH, 2013, PROC CVPR IEEE, P532, DOI 10.1109/CVPR.2013.75; Yip CHT, 2008, MANUAL THER, V13, P148, DOI 10.1016/j.math.2006.11.002; Zhang X, 2014, IMAGE VISION COMPUT, V32, P692, DOI 10.1016/j.imavis.2014.06.002; Zwakhalen Sandra M G, 2006, BMC Geriatr, V6, P3, DOI 10.1186/1471-2318-6-3	64	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192767	10.1371/journal.pone.0192767	http://dx.doi.org/10.1371/journal.pone.0192767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444153	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500088
J	Clipman, SJ; Henderson-Frost, J; Fu, KY; Bern, C; Flores, J; Gilman, RH				Clipman, Steven J.; Henderson-Frost, Josephine; Fu, Katherine Y.; Bern, Caryn; Flores, Jorge; Gilman, Robert H.			Genetic association study of NLRP1, CARD, and CASP1 inflammasome genes with chronic Chagas cardiomyopathy among Trypanosoma cruzi seropositive patients in Bolivia	PLOS ONE			English	Article							GAMMA-INDUCING FACTOR; DISEASE; PATHOGENESIS	About 20-30% of people infected with Chagas disease present with chronic Chagas cardiomyopathy (CCC), the most serious and frequent manifestation of the disease, while others remain asymptomatic and often do not experience Chagas-specific mortality. It is not currently well understood what causes these differential disease outcomes, but a genetic predisposition within the host could play an important role. This study examined variants in the NLRP1, CARD, and CASP1 inflammasome genes among 62 T. cruzi seropositive patients from Bolivia (38 cases with CCC and 24 asymptomatic controls) to uncover associations with CCC. All subjects underwent a complete medical examination including electrocardiogram (EKG) and echocardiogram. After genotype calling and quality control filtering with exclusion of 3 cases and 3 controls, association analysis was performed across 76 directly genotyped SNPs in NLRP1, CARD, and CASP1 genes, adjusting for age, sex, and population stratification. One SNP (rs11651270; Bonferroni-corrected p = 0.036) corresponding to a missense mutation in NLPR1 was found to be significant after adjustment for multiple testing, and a suggestive association was seen in CARD11 (rs6953573; Bonferroni-corrected p = 0.060). Although limited by sample size, the study results suggest variations in the inflammasome, particularly in NLRP1 and CARD11, may be associated with CCC.	[Clipman, Steven J.; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Henderson-Frost, Josephine] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Fu, Katherine Y.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Bern, Caryn] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Flores, Jorge] Hosp San Juan Dios, Santa Cruz, Bolivia; [Flores, Jorge] Catholic Univ Bolivia, Santa Cruz, Bolivia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Gilman, RH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	rgilman1@jhmi.edu	Clipman, Steven J./ABA-4050-2020	Clipman, Steven J./0000-0002-2366-8420; Bern, Caryn/0000-0001-8195-7303	US National Institutes of Health, National Institute on Allergy and Infectious Disease [5R01AI107028-04]	US National Institutes of Health, National Institute on Allergy and Infectious Disease	Funding was provided by the US National Institutes of Health, National Institute on Allergy and Infectious Disease Grant number: 5R01AI107028-04 to RHG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2016, DEATHS CAUS AG SEX C; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bleda S, 2016, ANN VASC SURG, V36, P260, DOI 10.1016/j.avsg.2016.05.090; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clark EH, 2015, AM J TROP MED HYG, V92, P39, DOI 10.4269/ajtmh.14-0246; Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x; Cunha-Neto E, 2001, AUTOIMMUNITY, V34, P187, DOI 10.3109/08916930109007383; Cunha-Neto E, 2011, ADV PARASIT, V76, P129, DOI 10.1016/B978-0-12-385895-5.00006-2; da Silva WC, 2017, DATA BRIEF, V10, P33, DOI 10.1016/j.dib.2016.11.053; Deng XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079629; Fernandez AB, 2015, GLOB HEART, V10, P159, DOI 10.1016/j.gheart.2015.07.004; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Geldhoff M, 2013, IMMUNOGENETICS, V65, P9, DOI 10.1007/s00251-012-0653-x; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Kaplinski M, 2015, CLIN INFECT DIS, V61, P918, DOI 10.1093/cid/civ446; Latz E, 2013, NATURE REV IMMUNOLOG, V13; Maguire JH, 2015, NEW ENGL J MED, V373, P1369, DOI 10.1056/NEJMe1510170; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Organizacion Panamericana de la Salud, 2006, OPSHDMCD42506; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pontillo A, 2016, J MED VIROL, V88, P1646, DOI 10.1002/jmv.24514; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rappaport N, 2013, DATABASE J BIOL DATA, V2013; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Sherbuk JE, 2015, GLOB HEART, V10, P173, DOI 10.1016/j.gheart.2015.07.003; Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5; Yazdi AS, 2010, J INNATE IMMUN, V2, P228, DOI 10.1159/000283688	34	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192378	10.1371/journal.pone.0192378	http://dx.doi.org/10.1371/journal.pone.0192378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438387	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400021
J	de Oliveira, TB; Peixoto, LD; Teodoro, PE; de Alvarenga, AA; Bhering, LL; Campo, CBH				de Oliveira, Tassia Boeno; Peixoto, Leonardo de Azevedo; Teodoro, Paulo Eduardo; de Alvarenga, Amauri Alves; Bhering, Leonardo Lopes; Hoffmann Campo, Clara Beatriz			The number of measurements needed to obtain high reliability for traits related to enzymatic activities and photosynthetic compounds in soybean plants infected with Phakopsora pachyrhizi	PLOS ONE			English	Article							METHYL JASMONATE; DISEASE DEVELOPMENT; POSSIBLE MECHANISMS; RESISTANCE; RUST; FRUIT; ACID; ARABIDOPSIS; RESPONSES; GENETICS	Asian rust affects the physiology of soybean plants and causes losses in yield. Repeatability coefficients may help breeders to know how many measurements are needed to obtain a suitable reliability for a target trait. Therefore, the objectives of this study were to determine the repeatability coefficients of 14 traits in soybean plants inoculated with Phakopsora pachyrhizi and to establish the minimum number of measurements needed to predict the breeding value with high accuracy. Experiments were performed in a 3x2 factorial arrangement with three treatments and two inoculations in a random block design. Repeatability coefficients, coefficients of determination and number of measurements needed to obtain a certain reliability were estimated using ANOVA, principal component analysis based on the covariance matrix and the correlation matrix, structural analysis and mixed model. It was observed that the principal component analysis based on the covariance matrix out-performed other methods for almost all traits. Significant differences were observed for all traits except internal CO2 concentration for the treatment effects. For the measurement effects, all traits were significantly different. In addition, significant differences were found for all Treatment x Measurement interaction traits except coumestrol, chitinase and chlorophyll content. Six measurements were suitable to obtain a coefficient of determination higher than 0.7 for all traits based on principal component analysis. The information obtained from this research will help breeders and physiologists determine exactly how many measurements are needed to evaluate each trait in soybean plants infected by P. pachyrhizi with a desirable reliability.	[de Oliveira, Tassia Boeno; Peixoto, Leonardo de Azevedo; Teodoro, Paulo Eduardo; Bhering, Leonardo Lopes] Univ Fed Vicosa, Vicosa, MG, Brazil; [de Alvarenga, Amauri Alves] Univ Fed Lavras, Setor Fisiol Vegetal, Lavras, MG, Brazil; [Hoffmann Campo, Clara Beatriz] Natl Soybean Res Ctr, Empresa Brasileira Pesquisa Agropecuaria EMBRAPA, Rodovia Carlos Joao Str, Londrina, PR, Brazil	Universidade Federal de Vicosa; Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Bhering, LL (corresponding author), Univ Fed Vicosa, Vicosa, MG, Brazil.	leonardo.bhering@ufv.br	TEODORO, PAULO/D-5903-2014; Bhering, Leonardo/AAK-9548-2020	TEODORO, PAULO/0000-0002-8236-542X; Bhering, Leonardo/0000-0002-6072-0996	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior); Cnpq (National Counsel of Technological and Scientific Development); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Cnpq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	This work was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior), Cnpq (National Counsel of Technological and Scientific Development), FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais), Funarbe (Fundacao Arthur Bernardes) to TB, and Federal University of Vicosa for financial support. We also thank the Biometric Lab (Federal University of Vicosa, Brazil) where all analyses were performed by remote access. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatepaulo ARR, 2008, ANIM GENET, V39, P328, DOI 10.1111/j.1365-2052.2008.01713.x; Abdelrahman M, 2018, PLANT CELL ENV; ABEYWARDENA V, 1972, J GENET, V61, P27, DOI 10.1007/BF02984099; [Anonymous], 2015, OUTLOOKS PEST MANAGE, DOI DOI 10.1564/V26_JUN_06; da Cruz MFA, 2013, BRAGANTIA, V72, P162, DOI 10.1590/S0006-87052013005000025; Belhadj A, 2006, J AGR FOOD CHEM, V54, P9119, DOI 10.1021/jf0618022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao SF, 2008, POSTHARVEST BIOL TEC, V49, P301, DOI 10.1016/j.postharvbio.2007.12.007; Carvalho LP, 2016, GENETICS MOL RES GMR, V15; Chen JP, 2014, CROP PROT, V56, P31, DOI 10.1016/j.cropro.2013.10.007; Choi JJ, 2008, FUNCT INTEGR GENOMIC, V8, P341, DOI 10.1007/s10142-008-0080-0; Chung G, 2008, CRIT REV PLANT SCI, V27, P295, DOI 10.1080/07352680802333904; CONAB-COMPANHIA NACIONAL DE ABASTECIMENTO, 2017, COMP NAC AB SAFR 201; Cruz CD, 2012, MODELOS BIOMETRICOS; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; da Silva AC, 2014, ACTA SCI-AGRON, V36, P159, DOI 10.4025/actasciagron.v36i2.17441; Negreiros JRD, 2014, PESQUI AGROPECU BRAS, V49, P40, DOI 10.1590/S0100-204X2014000100006; Danner MA, 2010, CIENC RURAL, V40, P2086, DOI 10.1590/S0103-84782010005000163; Godoy Claudia V., 2006, Fitopatologia Brasileira, V31, P63, DOI 10.1590/S0100-41582006000100011; HARMAN GE, 1993, PHYTOPATHOLOGY, V83, P313, DOI 10.1094/Phyto-83-313; Hartman GL, 2005, PLANT DIS, V89, P664, DOI 10.1094/PD-89-0664; Ishiga Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26959; Kendrick MD, 2011, PHYTOPATHOLOGY, V101, P535, DOI 10.1094/PHYTO-09-10-0257; Kumudini S, 2010, CROP SCI, V50, P2533, DOI 10.2135/cropsci2010.01.0003; Laviola BG, 2013, IND CROP PROD, V51, P70, DOI 10.1016/j.indcrop.2013.08.016; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Lygin AV, 2009, PHYTOPATHOLOGY, V99, P1412, DOI 10.1094/PHYTO-99-12-1412; Matsuo E, 2009, BIOSCIENCE J, V25; Milfont MD, 2013, ENVIRON CHEM LETT, V11, P335, DOI 10.1007/s10311-013-0412-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohammadi M, 2002, MYCOPATHOLOGIA, V154, P119, DOI 10.1023/A:1016039517933; Pereira MR, 2014, ORGANELLES PROTEOMIC, V1, P16; RESENDE M.D.V. de, 2002, GENETICA BIOMETRICA; Ribeiro L. P., 2015, Revista Brasileira de Milho e Sorgo, V14, P392; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Srivastava P, 2011, CROP PROT, V30, P726, DOI 10.1016/j.cropro.2011.02.023; Team RC, 2014, R LANG ENV STAT COMP; Teodoro PE, 2016, PESQUI AGROPECU BRAS, V51, P112, DOI 10.1590/S0100-204X2016000200003; Thomma BPHJ, 2000, PLANT PHYSIOL BIOCH, V38, P421, DOI 10.1016/S0981-9428(00)00756-7; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Torres F. E., 2015, Journal of Agronomy, V14, P180; Torres FE, 2015, BRAGANTIA, V74, P161, DOI 10.1590/1678-4499.0393; Tremblay A, 2010, PLANT SCI, V179, P183, DOI 10.1016/j.plantsci.2010.04.011; USDA, 2017, WORLD AGR SUPPL DEM; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; de Resende MDV, 2016, CROP BREED APPL BIOT, V16, P330, DOI 10.1590/1984-70332016v16n4a49; Yao HJ, 2005, POSTHARVEST BIOL TEC, V35, P253, DOI 10.1016/j.postharvbio.2004.09.001; Yao HJ, 2005, J APPL MICROBIOL, V98, P941, DOI 10.1111/j.1365-2672.2004.02531.x; Yorinori JT, 2005, PLANT DIS, V89, P675, DOI 10.1094/PD-89-0675	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192189	10.1371/journal.pone.0192189	http://dx.doi.org/10.1371/journal.pone.0192189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438380	Green Published, gold			2022-12-26	WOS:000425083400014
J	Ho, HH; Li, YH; Lee, JC; Wang, CW; Yu, YL; Hueng, DY; Ma, HI; Hsu, HH; Juan, CJ				Ho, Hsing-Hao; Li, Ya-Hui; Lee, Jih-Chin; Wang, Chih-Wei; Yu, Yi-Lin; Hueng, Dueng-Yuan; Ma, Hsin-I; Hsu, Hsian-He; Juan, Chun-Jung			Vestibular schwannomas: Accuracy of tumor volume estimated by ice cream cone formula using thin-sliced MR images	PLOS ONE			English	Article							GAMMA-KNIFE RADIOSURGERY; FACIAL-NERVE FUNCTION; ACOUSTIC NEUROMAS; STEREOTAXIC RADIOSURGERY; NEUROFIBROMATOSIS TYPE-2; CONSERVATIVE MANAGEMENT; ABC/2 FORMULA; GROWTH; SIZE; PREDICTORS	Purpose We estimated the volume of vestibular schwannomas by an ice cream cone formula using thin-sliced magnetic resonance images (MRI) and compared the estimation accuracy among different estimating formulas and between different models. Methods The study was approved by a local institutional review board. A total of 100 patients with vestibular schwannomas examined by MRI between January 2011 and November 2015 were enrolled retrospectively. Informed consent was waived. Volumes of vestibular schwannomas were estimated by cuboidal, ellipsoidal, and spherical formulas based on a one-component model, and cuboidal, ellipsoidal, Linskey's, and ice cream cone formulas based on a two-component model. The estimated volumes were compared to the volumes measured by planimetry. Intraobserver reproducibility and interobserver agreement was tested. Estimation error, including absolute percentage error (APE) and percentage error (PE), was calculated. Statistical analysis included intraclass correlation coefficient (ICC), linear regression analysis, one-way analysis of variance, and paired t-tests with P < 0.05 considered statistically significant. Results Overall tumor size was 4.80 +/- 6.8 mL (mean +/- standard deviation). All ICCs were no less than 0.992, suggestive of high intraobserver reproducibility and high interobserver agreement. Cuboidal formulas significantly overestimated the tumor volume by a factor of 1.9 to 2.4 (P <= 0.001). The one-component ellipsoidal and spherical formulas overestimated the tumor volume with an APE of 20.3% and 29.2%, respectively. The two-component ice cream cone method, and ellipsoidal and Linskey's formulas significantly reduced the APE to 11.0%, 10.1%, and 12.5%, respectively (all P < 0.001). Conclusion The ice cream cone method and other two-component formulas including the ellipsoidal and Linskey's formulas allow for estimation of vestibular schwannoma volume more accurately than all one-component formulas.	[Ho, Hsing-Hao; Li, Ya-Hui; Wang, Chih-Wei; Hsu, Hsian-He; Juan, Chun-Jung] Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Ho, Hsing-Hao; Li, Ya-Hui; Wang, Chih-Wei; Hsu, Hsian-He; Juan, Chun-Jung] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Lee, Jih-Chin] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Lee, Jih-Chin] Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Yu, Yi-Lin; Hueng, Dueng-Yuan; Ma, Hsin-I] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Yu, Yi-Lin; Hueng, Dueng-Yuan; Ma, Hsin-I] Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Juan, CJ (corresponding author), Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan.; Juan, CJ (corresponding author), Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.; Ma, HI (corresponding author), Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan.; Ma, HI (corresponding author), Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan.	uf004693@mail2000.com.tw; peterjuancj@yahoo.com.tw	Hueng, Dueng-Yuan/AAM-7807-2021; Juan, Chun-Jung/AAE-8438-2020	Hueng, Dueng-Yuan/0000-0001-7868-3161; Juan, Chun-Jung/0000-0001-5219-0406	Ministry of Science and Technology of Taiwan [MOST-105-2314-B-016-024-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	C.J.J. was partially supported by the Ministry of Science and Technology of Taiwan (https://www.most.gov.tw) (MOST-105-2314-B-016-024-MY2) for attending the 55th Annual Meeting of the American Society of Neuroradiology for presentation of part of this study and for the PLOS publication fee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Sanosi A, 2006, SKULL BASE-INTERD AP, V16, P95, DOI 10.1055/s-2006-934112; [Anonymous], 2006, STEREOTACTIC RADIOSU; Baser ME, 2002, J NEUROSURG, V96, P217, DOI 10.3171/jns.2002.96.2.0217; Bathla G, 2017, OTOL NEUROTOL, V38, P889, DOI 10.1097/MAO.0000000000001423; Bathla G, 2016, OTOL NEUROTOL, V37, P1168, DOI 10.1097/MAO.0000000000001150; Bloch O, 2011, J NEURO-ONCOL, V102, P281, DOI 10.1007/s11060-010-0315-5; Chen Joseph C T, 2006, Perm J, V10, P9; Cross JJ, 2006, CLIN OTOLARYNGOL, V31, P123, DOI 10.1111/j.1749-4486.2006.01161.x; Falcioni M, 2011, J NEUROSURG, V115, P820, DOI 10.3171/2011.5.JNS101597; Fang Y., 2014, COMPLEXITY, V2014, P1, DOI DOI 10.1016/J.CELREP.2014.03.032; Fiirgaard B, 1997, NEURORADIOLOGY, V39, P599, DOI 10.1007/s002340050475; FLICKINGER JC, 1993, RADIOTHER ONCOL, V27, P91, DOI 10.1016/0167-8140(93)90127-T; Goldberg HI., 1991, MAGNETIC RESONANCE I, P327; Harris GJ, 2008, NEUROSURGERY, V62, P1314, DOI 10.1227/01.neu.0000333303.79931.83; Ho HH, 2017, J RADIOL SCI, V42, P1; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Kaltoft M, 2012, NEUROSURGERY, V70, P278, DOI 10.1227/NEU.0b013e31822f7d5f; Kondziolka D, 1998, Neurosurg Focus, V5, pe2, DOI 10.3171/foc.1998.5.3.5; Kondziolka D, 1998, NEW ENGL J MED, V339, P1426, DOI 10.1056/NEJM199811123392003; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Li D, 2015, CLIN NEUROL NEUROSUR, V138, P72, DOI 10.1016/j.clineuro.2015.08.003; LINSKEY ME, 1991, AM J NEURORADIOL, V12, P1165; LINSKEY ME, 1993, INT J RADIAT ONCOL, V25, P227, DOI 10.1016/0360-3016(93)90343-T; McLean ACL, 2016, CLIN NEUROL NEUROSUR, V145, P68, DOI 10.1016/j.clineuro.2016.04.010; Nakamura H, 2000, AM J NEURORADIOL, V21, P1540; Pellet W, 2003, ADV TECH STAND NEUR, V28, P227; Plotkin SR, 2009, J NEURO-ONCOL, V93, P61, DOI 10.1007/s11060-009-9867-7; Roche PH, 2007, ACTA NEUROCHIR, V149, P267, DOI 10.1007/s00701-006-1093-x; Tan M, 2010, LARYNGOSCOPE, V120, P144, DOI 10.1002/lary.20672; Tang S, 2014, OTOL NEUROTOL, V35, P1271, DOI 10.1097/MAO.0000000000000459; van de Langenberg R, 2009, NEURORADIOLOGY, V51, P517, DOI 10.1007/s00234-009-0529-4; Varughese JK, 2010, CLIN OTOLARYNGOL, V35, P97, DOI 10.1111/j.1749-4486.2010.02099.x; Vokurka EA, 2002, AM J NEURORADIOL, V23, P459; Walz PC, 2012, OTOLARYNG HEAD NECK, V147, P737, DOI 10.1177/0194599812447766; Wang CW, 2009, ACTA RADIOL, V50, P306, DOI 10.1080/02841850802647039; Yamada I, 2000, J MAGN RESON IMAGING, V12, P826, DOI 10.1002/1522-2586(200012)12:6<826::AID-JMRI5>3.0.CO;2-D; Yu YL, 2013, CLIN NEUROL NEUROSUR, V115, P1371, DOI 10.1016/j.clineuro.2012.12.029	37	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192411	10.1371/journal.pone.0192411	http://dx.doi.org/10.1371/journal.pone.0192411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438424	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400022
J	Vagasi, CI; Patras, L; Pap, PL; Vincze, O; Muresan, C; Nemeth, J; Lendvai, AZ				Vagasi, Csongor I.; Patras, Laura; Pap, Peter L.; Vincze, Orsolya; Muresan, Cosmin; Nemeth, Jozsef; Lendvai, Adam Z.			Experimental increase in baseline corticosterone level reduces oxidative damage and enhances innate immune response	PLOS ONE			English	Article							GALLUS-GALLUS-DOMESTICUS; LIVING HOUSE SPARROWS; ANNUAL-CYCLE; COCCIDIAN INFECTION; MODERATE ELEVATION; HUMORAL IMMUNITY; STRESS HORMONES; LIFE-HISTORY; SHORT-TERM; WILD	Glucocorticoid (GC) hormones are significant regulators of homeostasis. The physiological effects of GCs critically depend on the time of exposure (short vs. long) as well as on their circulating levels (baseline vs. stress-induced). Previous experiments, in which chronic and high elevation of GC levels was induced, indicate that GCs impair both the activity of the immune system and the oxidative balance. Nonetheless, our knowledge on how mildly elevated GC levels, a situation much more common in nature, might influence homeostasis is limited. Therefore, we studied whether an increase in GC level within the baseline range suppresses or enhances condition (body mass, hematocrit and coccidian infestation) and physiological state (humoral innate immune system activity and oxidative balance). We implanted captive house sparrows Passer domesticus with either 60 days release corticosterone (CORT) or control pellets. CORT-treated birds had elevated baseline CORT levels one week after the implantation, but following this CORT returned to its pre-treatment level and the experimental groups had similar CORT levels one and two months following the implantation. The mass of tail feathers grown during the initial phase of treatment was smaller in treated than in control birds. CORT implantation had a transient negative effect on body mass and hematocrit, but both of these traits resumed the pre-treatment values by one month post-treatment. CORT treatment lowered oxidative damage to lipids (malondialdehyde) and enhanced constitutive innate immunity at one week and one month post-implantation. Our findings suggest that a relatively short-term (i.e. few days) elevation of baseline CORT might have a positive and stimulatory effect on animal physiology.	[Vagasi, Csongor I.; Pap, Peter L.; Vincze, Orsolya] Babes Bolyai Univ, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, Cluj Napoca, Romania; [Vagasi, Csongor I.; Pap, Peter L.; Vincze, Orsolya; Lendvai, Adam Z.] Univ Debrecen, Dept Evolutionary Zool, Behav Ecol Res Grp, Debrecen, Hungary; [Patras, Laura] Babes Bolyai Univ, Dept Mol Biol & Biotechnol, Cluj Napoca, Romania; [Muresan, Cosmin] Univ Agr Sci & Vet Med, Emergency Hosp, Cluj Napoca, Romania; [Nemeth, Jozsef] Univ Debrecen, Dept Pharmacol & Pharmacotherapy, Debrecen, Hungary	Babes Bolyai University from Cluj; University of Debrecen; Babes Bolyai University from Cluj; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of Debrecen	Vagasi, CI (corresponding author), Babes Bolyai Univ, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, Cluj Napoca, Romania.; Vagasi, CI; Lendvai, AZ (corresponding author), Univ Debrecen, Dept Evolutionary Zool, Behav Ecol Res Grp, Debrecen, Hungary.	csvagasi@gmail.com; az.lendvai@gmail.com	Lendvai, Adam Z/B-8546-2008; Vincze, Orsolya/AEQ-1159-2022; Patras, Laura/C-4477-2017; Vágási, Csongor I./AAU-4548-2020	Lendvai, Adam Z/0000-0002-8953-920X; Vincze, Orsolya/0000-0001-5789-2124; Patras, Laura/0000-0002-6981-3881; Vágási, Csongor I./0000-0002-8736-2391; muresan, cosmin/0000-0002-5064-6841	Hungarian Research Foundation (OTKA grant) [PD 76862]; Romanian Ministry of Education and Research [PN II. RU TE 291/2010, PN-III-P4-1D-PCE-2016-0404]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (HAS); Hungarian National Research, Development and Innovation Office [PD 121166]; Janos Bolyai Research Scholarship of the HAS; Hungarian Eotvos Scholarship [MAE02016_15/76740]; Hungary's Human Resources Development Operational Programme [EFOP-3.6.2-16-2017-00009, EFOP-3.6.1-16-2016-00022]; OTKA grant [K 113108]	Hungarian Research Foundation (OTKA grant)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (HAS); Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Janos Bolyai Research Scholarship of the HAS; Hungarian Eotvos Scholarship; Hungary's Human Resources Development Operational Programme; OTKA grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by the Hungarian Research Foundation (OTKA grant #PD 76862 to AZL) and the Romanian Ministry of Education and Research (#PN II. RU TE 291/2010 to PLP). During the preparation of the manuscript, CIV was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (HAS) and by a postdoctoral grant of the Hungarian National Research, Development and Innovation Office (#PD 121166), PLP by a research grant from the Romanian Ministry of Education and Research (#PN-III-P4-1D-PCE-2016-0404) and a Janos Bolyai Research Scholarship of the HAS, OV by the Hungarian Eotvos Scholarship (MAE02016_15/76740), Jozsef Nemeth by Hungary's Human Resources Development Operational Programme (EFOP-3.6.2-16-2017-00009), and AZL by an OTKA grant (#K 113108) and Hungary's Human Resources Development Operational Programme (#EFOP-3.6.1-16-2016-00022).	Almasi B, 2012, J EVOLUTION BIOL, V25, P1189, DOI 10.1111/j.1420-9101.2012.02508.x; Almasi B, 2013, HORM BEHAV, V64, P161, DOI 10.1016/j.yhbeh.2013.03.001; Altan O, 2003, BRIT POULTRY SCI, V44, P545, DOI 10.1080/00071660310001618334; Apanius V, 1998, ADV STUD BEHAV, V27, P133; Beck ML, 2016, GEN COMP ENDOCR, V233, P109, DOI 10.1016/j.ygcen.2016.05.021; Birnie-Gauvin K, 2017, J EXP BIOL, V220, P1693, DOI 10.1242/jeb.155465; Bokony V, 2014, BEHAV ECOL, V25, P124, DOI 10.1093/beheco/art094; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Bourgeon S, 2006, J EXP BIOL, V209, P4957, DOI 10.1242/jeb.02610; Bowers EK, 2014, ECOLOGY, V95, P3027; Braude S, 1999, BEHAV ECOL, V10, P345, DOI 10.1093/beheco/10.3.345; Breuner CW, 2013, FUNCT ECOL, V27, P24, DOI 10.1111/1365-2435.12016; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Butler MW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P78, DOI 10.1086/648483; Caro P, 2007, BIOGERONTOLOGY, V8, P1, DOI 10.1007/s10522-006-9026-x; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Cohen AA, 2012, TRENDS ECOL EVOL, V27, P428, DOI 10.1016/j.tree.2012.04.008; Costantini D, 2012, J EXP BIOL, V215, P374, DOI 10.1242/jeb.062034; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; Crossin GT, 2016, FUNCT ECOL, V30, P116, DOI 10.1111/1365-2435.12482; Currie S, 2010, P ROY SOC B-BIOL SCI, V277, P905, DOI 10.1098/rspb.2009.1562; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DesRochers DW, 2009, COMP BIOCHEM PHYS A, V152, P46, DOI 10.1016/j.cbpa.2008.08.034; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Fair J, 2007, IBIS, V149, P535, DOI 10.1111/j.1474-919X.2007.00680.x; Fox J., 2019, R COMPANION APPL REG, V.; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Grace JK, 2017, GEN COMP ENDOCR, V253, P1, DOI 10.1016/j.ygcen.2017.08.011; Greiner Ellis C., 2008, P108; Halliwell B., 2007, FREE RADICALS BIOL M; Hau M, 2016, ADV STUD BEHAV, V48, P41, DOI 10.1016/bs.asb.2016.01.002; Hennin HL, 2016, ECOL EVOL, V6, P1702, DOI 10.1002/ece3.1999; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Horak P, 2010, J EXP BIOL, V213, P2225, DOI 10.1242/jeb.042085; Jenni-Eiermann S, 2015, METHODS ECOL EVOL, V6, P237, DOI 10.1111/2041-210X.12314; Jovani R, 2017, BIOL REV, V92, P1113, DOI 10.1111/brv.12273; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lendvai AZ, 2011, J EXP BIOL, V214, P821, DOI 10.1242/jeb.047712; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P745, DOI 10.1016/j.cbpc.2004.09.014; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Martin LB, 2005, GEN COMP ENDOCR, V140, P126, DOI 10.1016/j.ygcen.2004.10.010; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Merrill L, 2012, OECOLOGIA, V170, P25, DOI 10.1007/s00442-012-2281-4; Muller C, 2009, GEN COMP ENDOCR, V160, P59, DOI 10.1016/j.ygcen.2008.10.018; Pap PL, 2015, PHYSIOL BIOCHEM ZOOL, V88, P395, DOI 10.1086/681243; Pap PL, 2014, PHYSIOL BIOCHEM ZOOL, V87, P729, DOI 10.1086/676934; Pap PL, 2011, AUK, V128, P330, DOI 10.1525/auk.2011.10142; Pap PL, 2010, NATURWISSENSCHAFTEN, V97, P891, DOI 10.1007/s00114-010-0706-7; Pap PL, 2009, J EXP BIOL, V212, P3228, DOI 10.1242/jeb.031948; Perez-Rodriguez L, 2015, PHYSIOL BIOCHEM ZOOL, V88, P345, DOI 10.1086/680688; Pinheiro J, R PACKAGE VERSION; Pravosudov VV, 2003, P ROY SOC B-BIOL SCI, V270, P2599, DOI 10.1098/rspb.2003.2551; Pravosudov VV, 2005, J NEUROBIOL, V62, P82, DOI 10.1002/neu.20069; Quispe R, 2015, GEN COMP ENDOCR, V212, P100, DOI 10.1016/j.ygcen.2015.01.007; R Core Team, 2013, R LANG ENV STAT COMP; Roberts ML, 2007, HORM BEHAV, V51, P126, DOI 10.1016/j.yhbeh.2006.09.004; Romero LM, 2006, GEN COMP ENDOCR, V149, P58, DOI 10.1016/j.ygcen.2006.05.004; Romero LM, 2015, STRESS, V18, P491, DOI 10.3109/10253890.2015.1073255; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; Romero LM, 2005, COMP BIOCHEM PHYS A, V142, P65, DOI 10.1016/j.cbpa.2005.07.014; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sild E, 2014, GEN COMP ENDOCR, V204, P203, DOI 10.1016/j.ygcen.2014.05.026; Speakman JR, 2015, ECOL EVOL, V5, pS745, DOI 10.1002/ece3.1790; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Spiers JG, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00456; Stier KS, 2009, J EXP BIOL, V212, P2084, DOI 10.1242/jeb.024406; Tartu S, 2016, FUNCT ECOL, V30, P596, DOI 10.1111/1365-2435.12534; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; You JM, 2009, CAN J PHYSIOL PHARM, V87, P440, DOI [10.1139/y09-027, 10.1139/Y09-027]; Yu BP, 2001, ANN NY ACAD SCI, V928, P39	81	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192701	10.1371/journal.pone.0192701	http://dx.doi.org/10.1371/journal.pone.0192701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432437	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000424814300039
J	Gonzalez-Cantero, J; Martin-Rodriguez, JL; Gonzalez-Cantero, A; Arrebola, JP; Gonzalez-Calvin, JL				Gonzalez-Cantero, Jorge; Luis Martin-Rodriguez, Jose; Gonzalez-Cantero, Alvaro; Pedro Arrebola, Juan; Luis Gonzalez-Calvin, Jorge			Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; MAGNETIC-RESONANCE-SPECTROSCOPY; TYPE-2 DIABETES-MELLITUS; VISCERAL ADIPOSE-TISSUE; HEPATIC STEATOSIS; CARDIOVASCULAR-DISEASE; NATURAL-HISTORY; UNITED-STATES; PREVALENCE; POPULATION	Aims Insulin resistance is the pathophysiological precursor of type 2 diabetes mellitus (DM-2), and its relationship with non-alcoholic fatty liver disease (NAFLD) has been widely studied in patients with obesity or metabolic syndrome using not only ultrasound but also liver biopsies or proton magnetic resonance spectroscopy (H-1-MRS) to assess liver fat content. In contrast, there are no studies on insulin resistance and NAFLD in lean or overweight Caucasian individuals using H-1-MRS or liver biopsies for the quantification of hepatic triglyceride content. Our objectives were to study the presence of insulin resistance in lean and overweight Caucasian adults and investigate its possible relationship with liver triglyceride content, waist circumference (as proxy of visceral adiposity), BMI, and cardiometabolic risk factors. Methods A cross-sectional study was conducted in 113 non-obese, non-diabetic individuals classified as overweight (BMI 25-29.9 kg/m(2)) or lean (BMI 19.5-24.9 kg/m(2)). Hepatic triglyceride content was quantified by 3T H-1-MRS. NAFLD was defined as hepatic triglyceride content >5.56%. Insulin resistance (HOMA-IR), serum adiponectin, and tumor necrosis factor (TNF) were determined. Results HOMA-IR was significantly correlated with hepatic triglyceride content (r:0.76; p<0.0001). The lean-with-NAFLD group had significantly higher HOMA-IR (p<0.001) and lower serum adiponectin (p<0.05) than the overweight-without-NAFLD group. Insulin resistance was independently associated with NAFLD but not with waist circumference or BMI. Regression analysis showed hepatic triglyceride content to be the most important determinant of insulin resistance (p<0.01). Conclusions Our findings suggest that NAFLD, once established, seems to be involved in insulin resistance and cardio-metabolic risk factors above and beyond waist circumference and BMI in non-obese, non-diabetic Caucasian individuals.	[Gonzalez-Cantero, Jorge] HGU Gregorio Maranon, Dept Radiol, Madrid, Spain; [Gonzalez-Cantero, Jorge; Luis Gonzalez-Calvin, Jorge] Univ Granada, Granada, Spain; [Luis Martin-Rodriguez, Jose; Gonzalez-Cantero, Alvaro] Univ Hosp San Cecilio, Dept Radiol, Granada, Spain; [Gonzalez-Cantero, Alvaro; Pedro Arrebola, Juan] Complejo Hosp Toledo, Dept Dermatol, Toledo, Castilla La Man, Spain; [Pedro Arrebola, Juan; Luis Gonzalez-Calvin, Jorge] Complejo Hosp Univ Granada, Inst Invest Biosanitaria Ibs CIBERESP, Granada, Spain; [Luis Gonzalez-Calvin, Jorge] Univ Hosp San Cecilio, Dept Gastroenterol, Granada, Spain	General University Gregorio Maranon Hospital; University of Granada; Hospital Universitario San Cecilio; Complejo Hospitalario de Toledo; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Granada; Hospital Universitario San Cecilio	Gonzalez-Cantero, J (corresponding author), HGU Gregorio Maranon, Dept Radiol, Madrid, Spain.; Gonzalez-Cantero, J (corresponding author), Univ Granada, Granada, Spain.	jorgegonzalezcantero@gmail.com	González-Cantero, Álvaro/J-6480-2019; MARTIN-RODRIGUEZ, JOSE LUIS/AAB-6389-2022; Arrebola, Juan P/A-5205-2017	González-Cantero, Álvaro/0000-0001-8060-4784; Gonzalez Cantero, Jorge Luis/0000-0001-9526-3919; Arrebola, Juan P./0000-0002-8643-2423				Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cuthbertson DJ, 2017, INT J OBESITY, V41, P853, DOI 10.1038/ijo.2017.4; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Feldman A, 2017, AM J GASTROENTEROL, V112, P102, DOI 10.1038/ajg.2016.318; Gastaldelli A, 2017, CLIN SCI, V131, P2701, DOI 10.1042/CS20170987; Gonzalez-Calvin JL, 2004, J CLIN ENDOCR METAB, V89, P4325, DOI 10.1210/jc.2004-0077; Gonzalez-Calvin JL, 2009, J CLIN ENDOCR METAB, V94, P4844, DOI 10.1210/jc.2009-0835; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kim NH, 2014, LIVER INT, V34, P604, DOI 10.1111/liv.12454; Knudsen SH, 2012, J APPL PHYSIOL, V113, P7, DOI 10.1152/japplphysiol.00189.2011; Kullberg J, 2007, CLIN PHYSIOL FUNCT I, V27, P148, DOI 10.1111/j.1475-097X.2007.00728.x; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; Martin-Rodriguez JL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006770; Martin-Rodriguez JL, 2014, EUR J GASTROEN HEPAT, V26, P88, DOI 10.1097/MEG.0b013e3283650650; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maximos M, 2015, HEPATOLOGY, V61, P153, DOI 10.1002/hep.27395; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Noureddin M, 2013, HEPATOLOGY, V58, P1930, DOI 10.1002/hep.26455; Oka R, 2012, J ATHEROSCLER THROMB, V19, P814, DOI 10.5551/jat.12294; Omelchenko E, 2014, J AM SOC HYPERTENS, V8, P376, DOI 10.1016/j.jash.2014.03.002; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Takeno K, 2016, J CLIN ENDOCR METAB, V101, P3676, DOI 10.1210/jc.2016-1650; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wei JL, 2015, AM J GASTROENTEROL, V110, P1306, DOI 10.1038/ajg.2015.235; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49	37	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192663	10.1371/journal.pone.0192663	http://dx.doi.org/10.1371/journal.pone.0192663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425212	Green Submitted, Green Published, gold			2022-12-26	WOS:000424700800035
J	Szczegielniak, J; Latawiec, KJ; Luniewski, JE; Stanislawski, R; Bogacz, K; Krajczy, M; Rydel, M				Szczegielniak, Jan; Latawiec, Krzysztof J.; Luniewski, Jacek E.; Stanislawski, Rafal; Bogacz, Katarzyna; Krajczy, Marcin; Rydel, Marek			A study on nonlinear estimation of submaximal effort tolerance based on the generalized MET concept and the 6MWT in pulmonary rehabilitation	PLOS ONE			English	Article							6-MINUTE WALK TEST; PEAK OXYGEN-UPTAKE; EXERCISE TESTS; LUNG-FUNCTION; LIMITATIONS; DISEASE; PEOPLE	Background The six-minute walk test (6MWT) is considered to be a simple and inexpensive tool for the assessment of functional tolerance of submaximal effort. The aim of this work was 1) to background the nonlinear nature of the energy expenditure process due to physical activity, 2) to compare the results/scores of the submaximal treadmill exercise test and those of 6MWT in pulmonary patients and 3) to develop nonlinear mathematical models relating the two. Methods The study group included patients with the COPD. All patients were subjected to a submaximal exercise test and a 6MWT. To develop an optimal mathematical solution and compare the results of the exercise test and the 6MWT, the least squares and genetic algorithms were employed to estimate parameters of polynomial expansion and piecewise linear models. Results Mathematical analysis enabled to construct nonlinear models for estimating the MET result of submaximal exercise test based on average walk velocity (or distance) in the 6MWT. Conclusions Submaximal effort tolerance in COPD patients can be effectively estimated from new, rehabilitation-oriented, nonlinear models based on the generalized MET concept and the 6MWT.	[Szczegielniak, Jan; Luniewski, Jacek E.; Bogacz, Katarzyna; Krajczy, Marcin] Opole Univ Technol, Dept Phys Educ & Physiotherapy, Opole, Poland; [Latawiec, Krzysztof J.; Stanislawski, Rafal; Rydel, Marek] Opole Univ Technol, Dept Elect Control & Comp Engn, Opole, Poland	Opole University of Technology; Opole University of Technology	Latawiec, KJ (corresponding author), Opole Univ Technol, Dept Elect Control & Comp Engn, Opole, Poland.	k.latawiec@po.opole.pl	Stanislawski, Rafal/L-1606-2019; Bogacz, Katarzyna/Y-1732-2018; Rydel, Marek/O-3336-2017; Jacek, Luniewski/AAB-8003-2020; Szczegielniak, Jan/AAQ-1532-2021; Krajczy, Marcin/Y-1416-2018	Stanislawski, Rafal/0000-0002-6014-3682; Bogacz, Katarzyna/0000-0002-6543-4120; Rydel, Marek/0000-0002-7753-0558; Jacek, Luniewski/0000-0002-5086-4144; Latawiec, Krzysztof/0000-0002-1646-4921; Krajczy, Marcin/0000-0002-2098-2481				Adonis A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157132; Ainsworth B. E., 2011, MED SCI SPORTS EXERC, V43; Altini M, 2017, IEEE EMBS INT C BIOM; Altini M, 2016, ARTIF INTELL MED, V68, P37, DOI 10.1016/j.artmed.2016.02.002; Andersen LK, 2016, NEUROLOGY, V86, P442, DOI 10.1212/WNL.0000000000002332; [Anonymous], 2015, LACTATE TESTING LACT; Arbillaga-Etxarri A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146705; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Astrand PO, 1977, TXB WORK PHYSL, P354; Beatty AL, 2012, ARCH INTERN MED, V172, P1096, DOI 10.1001/archinternmed.2012.2198; Bell M, 2015, COPD-J COPD FDN, V2, P321, DOI 10.15326/jcopdf.2.4.2014.0157; Bellet RN, 2012, PHYSIOTHERAPY, V98, P277, DOI 10.1016/j.physio.2011.11.003; Buckley JP, 2016, SPORTS MED, V46, P1953, DOI 10.1007/s40279-016-0521-1; Chiaranda G, 2012, J CARDIOPULM REHABIL, V32, P262, DOI 10.1097/HCR.0b013e3182663507; Connors G, 1993, GUIDELINES PULMONARY; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; da Silva RM, 2014, PEDIATR TRANSPLANT, V18, P586, DOI 10.1111/petr.12318; Fregonezi G, 2012, J CARDIOPULM REHABIL, V32, P219, DOI 10.1097/HCR.0b013e318259b6a5; Ghofraniha L., 2015, J CARDIO THORACIC ME, V3, P284, DOI [DOI 10.22038/JCTM.2015.4374, https://doi.org/10.22038/JCTM.2015.4374]; Gomberg-Maitland M, 2007, J HEART LUNG TRANSPL, V26, P732, DOI 10.1016/j.healun.2007.04.013; Goodwin Matthew L, 2007, J Diabetes Sci Technol, V1, P558; Heresi GA, 2011, AM J RESP CRIT CARE, V183, P1122, DOI 10.1164/rccm.201012-2079ED; Hills Andrew P, 2014, Front Nutr, V1, P5, DOI 10.3389/fnut.2014.00005; Holland AE, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-136; Ingle L, 2005, EUR HEART J, V26, P1742, DOI 10.1093/eurheartj/ehi259; Kern L, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-167; Khodadadi A., 2008, COBRA PREPRINT SERIE, P44; Kozey S, 2010, J PHYS ACT HEALTH, V7, P508, DOI 10.1123/jpah.7.4.508; Liu WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162444; Mackenzie B., 2015, VO2 MAX; Mador MJ, 2016, J CARDIOPULM REHABIL, V36, P132, DOI 10.1097/HCR.0000000000000154; Mandic S, 2013, DISABIL REHABIL, V35, P1853, DOI 10.3109/09638288.2012.759629; Marjanski T, 2015, ANN ONCOL         S1, V26, pi22; Mathioudakis AG, 2015, J THORACIC DIS S1, V7; Meira L, 2015, EUROPEAN RESP J S59, V46; Moran P, 2012, J STRENGTH COND RES, V26, P563, DOI 10.1519/JSC.0b013e318225f395; Nilsagard Y, 2016, PHYSIOTHER RES INT, V21, P102, DOI 10.1002/pri.1625; Pollentier Brittany, 2010, Cardiopulm Phys Ther J, V21, P13; Rydel M, 2018, AUTOMATICA, V88, P107, DOI 10.1016/j.automatica.2017.11.016; Serra AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117359; Solway S, 2001, CHEST, V119, P256, DOI 10.1378/chest.119.1.256; Someya F, 2013, CLIN MED INSIGHTS-CI, V7, P1, DOI 10.4137/CCRPM.S10764; Stanislawski R, 2017, J FRANKLIN I, V354, P3008, DOI 10.1016/j.jfranklin.2017.02.003; Stanislawski R, 2017, FRACT CALC APPL ANAL, V20, P243, DOI 10.1515/fca-2017-0013; Stanislawski R, 2016, DISCRETE DYN NAT SOC, V2016, DOI 10.1155/2016/9590687; Stanislawski R, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/512104; Stellmann JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123822; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Toriello A, 2012, EUR J OPER RES, V219, P86, DOI 10.1016/j.ejor.2011.12.030; Venkatesh N, 2011, SRI RAMACHANDRA J ME, V4, P30; Wilms B, 2014, INT J OBESITY, V38, P1383, DOI 10.1038/ijo.2014.22; Zainuldin R, 2015, J CARDIOPULM REHABIL, V35, P65, DOI 10.1097/HCR.0000000000000074; Zhang YL, 2015, J ECONOMETRICS, V187, P95, DOI 10.1016/j.jeconom.2015.02.006; Zoladz JA, 2007, J PHYSIOL PHARMACOL, V58, P265; Zugck C, 2000, EUR HEART J, V21, P540, DOI 10.1053/euhj.1999.1861	55	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0191875	10.1371/journal.pone.0191875	http://dx.doi.org/10.1371/journal.pone.0191875			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425213	Green Published, Green Submitted, gold			2022-12-26	WOS:000424700800009
J	Packer, RMA; McGreevy, PD; Salvin, HE; Valenzuela, MJ; Chaplin, CM; Volk, HA				Packer, Rowena M. A.; McGreevy, Paul D.; Salvin, Hannah E.; Valenzuela, Michael J.; Chaplin, Chloe M.; Volk, Holger A.			Cognitive dysfunction in naturally occurring canine idiopathic epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; BEHAVIORAL-CHANGES; RISK-FACTORS; TASK-FORCE; FOLLOW-UP; PET DOGS; ALZHEIMERS; MORTALITY; DEMENTIA; DISEASE	Globally, epilepsy is a common serious brain disorder. In addition to seizure activity, epilepsy is associated with cognitive impairments including static cognitive impairments present at onset, progressive seizure-induced impairments and co-morbid dementia. Epilepsy occurs naturally in domestic dogs but its impact on canine cognition has yet to be studied, despite canine cognitive dysfunction (CCD) recognised as a spontaneous model of dementia. Here we use data from a psychometrically validated tool, the canine cognitive dysfunction rating (CCDR) scale, to compare cognitive dysfunction in dogs diagnosed with idiopathic epilepsy (IE) with controls while accounting for age. An online cross-sectional study resulted in a sample of 4051 dogs, of which n = 286 had been diagnosed with IE. Four factors were significantly associated with a diagnosis of CCD (above the diagnostic cut-off of CCDR >= 50): (i) epilepsy diagnosis: dogs with epilepsy were at higher risk; (ii) age: older dogs were at higher risk; (iii) weight: lighter dogs (kg) were at higher risk; (iv) training history: dogs with more exposure to training activities were at lower risk. Impairments in memory were most common in dogs with IE, but progression of impairments was not observed compared to controls. A significant interaction between epilepsy and age was identified, with IE dogs exhibiting a higher risk of CCD at a young age, while control dogs followed the expected pattern of low-risk throughout middle age, with risk increasing exponentially in geriatric years. Within the IE sub-population, dogs with a history of cluster seizures and high seizure frequency had higher CCDR scores. The age of onset, nature and progression of cognitive impairment in the current IE dogs appear divergent from those classically seen in CCD. Longitudinal monitoring of cognitive function from seizure onset is required to further characterise these impairments.	[Packer, Rowena M. A.; Chaplin, Chloe M.; Volk, Holger A.] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [McGreevy, Paul D.; Salvin, Hannah E.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Valenzuela, Michael J.] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Sydney, NSW, Australia	University of London; University of London Royal Veterinary College; University of Sydney; University of Sydney	Packer, RMA (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England.	rpacker@rvc.ac.uk	Volk, Holger Andreas/B-9965-2011	Volk, Holger Andreas/0000-0002-7312-638X; Packer, Rowena/0000-0002-9988-9828; McGreevy, Paul/0000-0001-7220-8378	Biotechnology and Biological Sciences Research Council [BB/P010881/1, BB/P001874/1]; BBSRC [BB/P010881/1, BB/P001874/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RMAP is funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) grant number BB/P010881/1. HV is funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) grant number BB/P001874/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Armasu M, 2014, VET J, V202, P292, DOI 10.1016/j.tvjl.2014.08.008; Azkona G, 2009, J SMALL ANIM PRACT, V50, P87, DOI 10.1111/j.1748-5827.2008.00718.x; Berendt M, 2007, J VET INTERN MED, V21, P754, DOI 10.1892/0891-6640(2007)21[754:PDRFAL]2.0.CO;2; Berendt M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0461-2; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; BOURGEOIS BFD, 1983, ANN NEUROL, V14, P438, DOI 10.1002/ana.410140407; BRETELER MMB, 1991, INT J EPIDEMIOL, V20, pS36, DOI 10.1093/ije/20.Supplement_2.S36; Breteler MMB, 1995, AM J EPIDEMIOL, V142, P1300, DOI 10.1093/oxfordjournals.aje.a117597; Bromley RL, 2011, EPILEPSY BEHAV, V22, P9, DOI 10.1016/j.yebeh.2011.04.009; Chapagain D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00100; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Dodrill CB, 2002, PROG BRAIN RES, V135, P399; Dodrill CB, 2004, EPILEPSY BEHAV, V5, pS21, DOI 10.1016/j.yebeh.2003.11.004; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Fast R, 2013, J VET INTERN MED, V27, P822, DOI 10.1111/jvim.12109; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Galis F, 2007, J EXP ZOOL PART B, V308B, P119, DOI 10.1002/jez.b.21116; Griffith HR, 2006, EPILEPSY BEHAV, V8, P161, DOI 10.1016/j.yebeh.2005.09.004; Head E, 2013, BBA-MOL BASIS DIS, V1832, P1384, DOI 10.1016/j.bbadis.2013.03.016; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Heske L, 2014, VET J, V202, P471, DOI 10.1016/j.tvjl.2014.09.023; Hulsmeyer V, 2010, J VET INTERN MED, V24, P171, DOI 10.1111/j.1939-1676.2009.0438.x; Ibrahim GM, 2014, HUM BRAIN MAPP, V35, P5686, DOI 10.1002/hbm.22580; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Jokeit H, 1999, J NEUROL NEUROSUR PS, V67, P44, DOI 10.1136/jnnp.67.1.44; Jokinen TS, 2015, J VET INTERN MED, V29, P1081, DOI 10.1111/jvim.12611; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Kleen JK, 2012, COGNITIVE BEHAV COMO; Lagae L, 2006, SEIZURE-EUR J EPILEP, V15, P235, DOI 10.1016/j.seizure.2006.02.013; Landsberg G, 2003, EFFECTS AGING BEHAV; Landsberg GM., 2017, CANINE FELINE DEMENT, P1; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; Marshall-Pescini S, 2008, BEHAV PROCESS, V78, P449, DOI 10.1016/j.beproc.2008.02.022; Marshall-Pescini S, 2016, ANIM COGN, V19, P571, DOI 10.1007/s10071-016-0960-y; Marshall-Pescini S, 2009, BEHAV PROCESS, V81, P416, DOI 10.1016/j.beproc.2009.03.015; Menlove L, 2015, SEIZURE-EUR J EPILEP, V25, P126, DOI 10.1016/j.seizure.2014.10.002; Neilson JC, 2001, J AM VET MED ASSOC, V218, P1787, DOI 10.2460/javma.2001.218.1787; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; Osella MC, 2007, APPL ANIM BEHAV SCI, V105, P297, DOI 10.1016/j.applanim.2006.11.007; Packer RMA, 2016, EPILEPSY BEHAV, V55, P62, DOI 10.1016/j.yebeh.2015.11.014; Patronek GJ, 1997, J GERONTOL A-BIOL, V52, pB171, DOI 10.1093/gerona/52A.3.B171; Proschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Reid SWJ, 2000, VET REC, V147, P630, DOI 10.1136/vr.147.22.630; Salvin HE, 2011, VET J, V188, P331, DOI 10.1016/j.tvjl.2010.05.014; Salvin HE, 2010, VET J, V184, P277, DOI 10.1016/j.tvjl.2009.11.007; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Shihab N, 2011, EPILEPSY BEHAV, V21, P160, DOI 10.1016/j.yebeh.2011.03.018; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Taylor J, 2010, EPILEPSIA, V51, P48, DOI 10.1111/j.1528-1167.2009.02195.x; Tellez-Zenteno JF, 2005, EPILEPSIA, V46, P1955, DOI 10.1111/j.1528-1167.2005.00344.x; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Vermeulen J, 1995, EPILEPSY RES, V22, P65, DOI 10.1016/0920-1211(95)00047-X; Vingerhoets G, 2006, SEIZURE-EUR J EPILEP, V15, P221, DOI 10.1016/j.seizure.2006.02.012; Weissl J, 2012, J VET INTERN MED, V26, P116, DOI 10.1111/j.1939-1676.2011.00853.x; Wessmann A, 2016, VET REC, V179, DOI 10.1136/vr.103355; Wilson SJ, 2015, EPILEPSIA, V56, P674, DOI 10.1111/epi.12962; Witt JA, 2014, ACTA NEUROL SCAND, V130, P172, DOI 10.1111/ane.12260; Witt JA, 2012, J NEUROL, V259, P1727, DOI 10.1007/s00415-012-6526-2	64	39	40	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192182	10.1371/journal.pone.0192182	http://dx.doi.org/10.1371/journal.pone.0192182			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420639	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900048
J	Li, L; Liu, TZ; Li, YH; Wu, CM; Luo, KT; Yin, YJ; Chen, YP; Nowsheen, S; Wu, JH; Lou, ZK; Yuan, J				Li, Lei; Liu, Tongzheng; Li, Yunhui; Wu, Chenming; Luo, Kuntian; Yin, Yujiao; Chen, Yuping; Nowsheen, Somaira; Wu, Jinhuan; Lou, Zhenkun; Yuan, Jian			The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization	ONCOGENE			English	Article							HIPPO PATHWAY; GROWTH-CONTROL; CANCER-CELLS; DNA-DAMAGE; DIFFERENTIATION; INHIBITION; PHOSPHORYLATION; TUMORIGENESIS; INACTIVATION; APOPTOSIS	The Yes-associated protein 1 (YAP1), a major downstream effector of the Hippo pathway, functions as a transcriptional regulator and has an important role in cellular control of organ size and tumor growth. Elevated oncogenic activity of YAP1 has been clarified in different types of human cancers, which contributes to cancer cell survival and chemoresistance. However, the molecular mechanism of YAP1 overexpression in cancer is still not clear. Here we demonstrate that the deubiquitination enzyme USP9X deubiquitinates and stabilizes YAP1, thereby promoting cancer cell survival. Increased USP9X expression correlates with increased YAP1 protein in human breast cancer cell lines and patient samples. Moreover, depletion of USP9X increases YAP1 polyubiquitination, which in turn elevates YAP1 turnover and cell sensitivity to chemotherapy. Overall, our study establishes the USP9X-YAP1 axis as an important regulatory mechanism of breast cancer and provides a rationale for potential therapeutic interventions in the treatment of breast cancer.	[Li, Lei; Li, Yunhui; Wu, Chenming; Luo, Kuntian; Yin, Yujiao; Chen, Yuping; Yuan, Jian] Tongji Univ, East Hosp, Res Ctr Translat Med, Sch Med, Shanghai 200120, Peoples R China; [Li, Lei; Li, Yunhui; Wu, Chenming; Luo, Kuntian; Yin, Yujiao; Chen, Yuping; Yuan, Jian] Tongji Univ, East Hosp, Key Lab Arrhythmias, Minist Educ China,Sch Med, Shanghai 200120, Peoples R China; [Liu, Tongzheng] Jinan Univ, Inst Tumor Pharmacol, Guangzhou 510632, Guangdong, Peoples R China; [Luo, Kuntian; Lou, Zhenkun; Yuan, Jian] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Nowsheen, Somaira] Mayo Clin, Grad Sch Biomed Sci, Sch Med, Med Scientist Training Program, Rochester, MN 55905 USA; [Wu, Jinhuan] Tianjin Med Univ, Sch Biomed Engn & Technol, Tianjin, Peoples R China	Tongji University; Ministry of Education, China; Tongji University; Jinan University; Mayo Clinic; Mayo Clinic; Tianjin Medical University	Yuan, J (corresponding author), Tongji Univ, East Hosp, Res Ctr Translat Med, Sch Med, Shanghai 200120, Peoples R China.; Yuan, J (corresponding author), Tongji Univ, East Hosp, Key Lab Arrhythmias, Minist Educ China,Sch Med, Shanghai 200120, Peoples R China.; Liu, TZ (corresponding author), Jinan Univ, Inst Tumor Pharmacol, Guangzhou 510632, Guangdong, Peoples R China.; Lou, ZK; Yuan, J (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	Liutongzheng@jnu.edu.cn; Lou.zhenkun@mayo.edu; yuanjian229@hotmail.com	Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022	Yuan, Jian/0000-0002-2801-8849; Lou, Zhenkun/0000-0003-1938-3091	NSFC [81773758, 81572770, 31371367]; National Institutes of Health [CA203971, CA203561, CA189666, CA130996]; Ovarian Cancer SPORE in Mayo Clinic [P50CA136393]; Pilot Project Award Program of Mayo Clinic Fraternal Order of Eagles Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA148940, P50CA136393, R01CA130996, R01CA189666, R01CA203971, R01CA129344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer SPORE in Mayo Clinic; Pilot Project Award Program of Mayo Clinic Fraternal Order of Eagles Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs William G. Kaelin, Qing Zhang, Kunliang Guan, and Junjie Chen for kindly providing constructs. This study was supported by NSFC (81773758, 81572770, and 31371367), National Institutes of Health grant (CA203971, CA203561, CA189666, and CA130996), Ovarian Cancer SPORE in Mayo Clinic (P50CA136393), and the Pilot Project Award Program of Mayo Clinic Fraternal Order of Eagles Cancer Research Fund.	Basu-Roy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7411; Bora-Singhal N, 2015, STEM CELLS, V33, P1705, DOI 10.1002/stem.1993; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Nguyen HT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.1; Nguyen HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169587; Jung KH, 2016, STEM CELLS, V34, P1284, DOI 10.1002/stem.2283; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Kim MJ, 2016, EMBO REP, V17, P64, DOI 10.15252/embr.201540809; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu TZ, 2016, CANCER RES, V76, P572, DOI 10.1158/0008-5472.CAN-15-0671; Luo KT, 2017, EMBO J, V36, P1434, DOI 10.15252/embj.201695669; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nguyen LT, 2015, CANCER CELL, V27, P797, DOI 10.1016/j.ccell.2015.05.005; Pefani DE, 2016, MOL CELL, V63, P156, DOI 10.1016/j.molcel.2016.05.012; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Peterson LF, 2015, BLOOD, V125, P3588, DOI 10.1182/blood-2014-10-605584; Piersma B, 2015, AM J PATHOL, V185, P3326, DOI 10.1016/j.ajpath.2015.08.011; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Savio MG, 2016, CURR BIOL, V26, P173, DOI 10.1016/j.cub.2015.11.050; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Strano S, 2007, MOL CELL, V27, P863, DOI 10.1016/j.molcel.2007.09.004; Svalina MN, 2014, CANCER CELL, V26, P154, DOI 10.1016/j.ccr.2014.07.011; Tremblay AM, 2014, CANCER CELL, V26, P273, DOI 10.1016/j.ccr.2014.05.029; Tu KS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-110; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; von Eyss B, 2015, CANCER CELL, V28, P743, DOI 10.1016/j.ccell.2015.10.013; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wolfsperger F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.405; Yu FX, 2015, ANNU REV PHYSIOL, V77, P201, DOI 10.1146/annurev-physiol-021014-071733; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	42	42	42	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2422	2431		10.1038/s41388-018-0134-2	http://dx.doi.org/10.1038/s41388-018-0134-2			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29449692	Green Accepted			2022-12-26	WOS:000431386000006
J	Lopes, AP; Hillen, MR; Chouri, E; Blokland, SLM; Bekker, CPJ; Kruize, AA; Rossato, M; van Roon, JAG; Radstake, TRDJ				Lopes, Ana P.; Hillen, Maarten R.; Chouri, Eleni; Blokland, Sofie L. M.; Bekker, Cornelis P. J.; Kruize, Aike A.; Rossato, Marzia; van Roon, Joel A. G.; Radstake, Timothy R. D. J.			Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjogren's syndrome	PLOS ONE			English	Article							NORMALIZATION STRATEGIES; MICRORNA BIOGENESIS; PATHOGENESIS; BIOMARKERS; MONOCYTES; TARGET	Background Considering the important role of miRNAs in the regulation of post-transcriptional expression of target genes, we investigated circulating small non-coding RNAs (snc) RNA levels in patients with primary Sjogren's syndrome (pSS). In addition we assessed if serum sncRNA levels can be used to differentiate patients with specific disease features. Methods Serum RNA was isolated from 37 pSS patients as well as 21 patients with incomplete Sjogren's Syndrome (iSS) and 17 healthy controls (HC) allocated to two independent cohorts: discovery and validation. OpenArray profiling of 758 sncRNAs was performed in the discovery cohort. Selected sncRNAs were measured in the validation cohort using single-assay RT-qPCR. In addition, unsupervised hierarchical clustering was performed within the pSS group. Results Ten sncRNAs were differentially expressed between the groups in the array. In the validation cohort, we confirmed the increased expression of U6-snRNA and miR-661 in the iSS group as compared to HC. We were unable to validate differential expression of any miRNAs in the pSS group. However, within this group several miRNAs correlated with laboratory parameters. Unsupervised clustering distinguished three clusters of pSS patients. Patients in one cluster showed significantly higher serum IgG, prevalence of anti-SSB autoantibodies, IFN-score, and decreased leukocyte counts compared to the two other clusters. Conclusion We were unable to identify any serum sncRNAs with differential expression in pSS patients. However, we show that circulating miRNA levels are associated with disease parameters in pSS patients and can be used to distinguish pSS patients with more severe B cell hyperactivity. As several of these miRNAs are implicated in the regulation of B cells, they may play a role in the perpetuation of the disease.	[Lopes, Ana P.; Hillen, Maarten R.; Chouri, Eleni; Blokland, Sofie L. M.; Bekker, Cornelis P. J.; Kruize, Aike A.; van Roon, Joel A. G.; Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Lopes, Ana P.; Hillen, Maarten R.; Chouri, Eleni; Blokland, Sofie L. M.; Bekker, Cornelis P. J.; Rossato, Marzia; van Roon, Joel A. G.; Radstake, Timothy R. D. J.] Univ Utrecht, Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Rossato, Marzia] Univ Verona, Funct Genom Ctr, Verona, Italy	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Verona	van Roon, JAG (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.; van Roon, JAG (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands.	j.vanRoon@umcutrecht.nl	Rossato, Marzia/AAB-7827-2019; Hillen, Maarten/T-8079-2019	Rossato, Marzia/0000-0002-6101-1550; Hillen, Maarten/0000-0002-9505-3468; Lopes, Ana P/0000-0003-4954-5151	Portuguese National Funding Agency for Science, Research and Technology: Fundacao para a Ciencia e a Tecnologia [SFRH/BD/116082/2016]; Dutch Arthritis Association [RF-14-2-301]; ERC starting grant [ERC-2011-StG]	Portuguese National Funding Agency for Science, Research and Technology: Fundacao para a Ciencia e a Tecnologia; Dutch Arthritis Association; ERC starting grant	APL was supported by a PhD grant from the Portuguese National Funding Agency for Science, Research and Technology: Fundacao para a Ciencia e a Tecnologia (SFRH/BD/116082/2016). MRH was supported by the Dutch Arthritis Association (RF-14-2-301). TR was funded by an ERC starting grant (ERC-2011-StG, Circumvent).	Alevizos I, 2011, ARTHRITIS RHEUM-US, V63, P535, DOI 10.1002/art.30131; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benz F, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.81; Bockmeyer CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31992; BRITO-ZERON P, 2016, ANN RHEUM DIS; Brkic Z, 2013, ANN RHEUM DIS, V72, P728, DOI 10.1136/annrheumdis-2012-201381; Chen JQ, 2016, AUTOIMMUN REV, V15, P1171, DOI 10.1016/j.autrev.2016.09.003; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cuppen BVJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1085-z; Dong Lingli, 2013, Current Immunology Reviews, V9, P13; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gourzi VC, 2015, CLIN EXP IMMUNOL, V182, P14, DOI 10.1111/cei.12664; Holdgate N., 2016, F1000RES, V5; Hu RZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4131; Iqbal J, 2012, BLOOD, V119, P4939, DOI 10.1182/blood-2011-07-370122; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Konsta OD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00071; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Marabita F, 2016, BRIEF BIOINFORM, V17, P204, DOI 10.1093/bib/bbv056; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nocturne G, 2013, NAT REV RHEUMATOL, V9, P544, DOI 10.1038/nrrheum.2013.110; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qu ZG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/527895; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Williams AEG, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0987-0	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193157	10.1371/journal.pone.0193157	http://dx.doi.org/10.1371/journal.pone.0193157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447268	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900115
J	Schmidt, R; Gravuer, K; Bossange, AV; Mitchell, J; Scow, K				Schmidt, Radomir; Gravuer, Kelly; Bossange, Anne V.; Mitchell, Jeffrey; Scow, Kate			Long-term use of cover crops and no-till shift soil microbial community life strategies in agricultural soil	PLOS ONE			English	Article							OPERON COPY NUMBER; SAN-JOAQUIN VALLEY; ORGANIC-MATTER; SUSTAINABLE INTENSIFICATION; CARBON SEQUESTRATION; BACTERIAL DIVERSITY; RESIDUE MANAGEMENT; CROPPING SYSTEM; TIME; AGGREGATE	Reducing tillage and growing cover crops, widely recommended practices for boosting soil health, have major impacts on soil communities. Surprisingly little is known about their impacts on soil microbial functional diversity, and especially so in irrigated Mediterranean ecosystems. In long-term experimental plots at the West Side Research and Extension Center in California's Central Valley, we characterized soil microbial communities in the presence or absence of physical disturbance due to tillage, in the presence or absence of cover crops, and at three depths: 0-5, 5-15 and 15-30 cm. This characterization included qPCR for bacterial and archaeal abundances, DNA sequencing of the 16S rRNA gene, and phylogenetic estimation of two ecologically important microbial traits (rRNA gene copy number and genome size). Total (bacterial + archaeal) diversity was higher in no-till than standard till; diversity increased with depth in no-till but decreased with depth in standard till. Total bacterial numbers were higher in cover cropped plots at all depths, while no-till treatments showed higher numbers in 0-5 cm but lower numbers at lower depths compared to standard tillage. Trait estimates suggested that different farming practices and depths favored distinctly different microbial life strategies. Tillage in the absence of cover crops shifted microbial communities towards fast growing competitors, while no-till shifted them toward slow growing stress tolerators. Across all treatment combinations, increasing depth resulted in a shift towards stress tolerators. Cover crops shifted the communities towards ruderals-organisms with wider metabolic capacities and moderate rates of growth. Overall, our results are consistent with decreasing nutrient availability with soil depth and under no-till treatments, bursts of nutrient availability and niche homogenization under standard till-age, and increases in C supply and variety provided by cover crops. Understanding how agricultural practices shift microbial abundance, diversity and life strategies, such as presented here, can assist with designing farming systems that can support high yields, while enhancing C sequestration and increasing resilience to climate change.	[Schmidt, Radomir; Bossange, Anne V.; Scow, Kate] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Gravuer, Kelly; Mitchell, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Schmidt, R (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	radschmidt@ucdavis.edu	Gravuer, Kelly/AAJ-4802-2020; Scow, Kate/ABE-6730-2020	Scow, Kate/0000-0002-2649-1122; Gravuer, Kelly/0000-0002-2567-658X	United States Department of Agriculture Natural Resources Conservation Service [69-3A75-12-249]; United States Department of Agriculture National Institute of Food and Agriculture [CA-2122-H]	United States Department of Agriculture Natural Resources Conservation Service; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was supported by the United States Department of Agriculture Natural Resources Conservation Service (https://www.nrcs.usda.gov/wps/portal/nrcs/site/national/home/) grant #69-3A75-12-249 (J.M). This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture (https://nifa.usda.gov/), Hatch Project CA-2122-H (K.S). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the National Institute of Food and Agriculture (NIFA) or the United States Department of Agriculture (USDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ME, 2015, APPL SOIL ECOL, V86, P106; Abreu ME, 2013, APPL SOIL ECOL, V72, P49; Barberan A, 2014, ECOL LETT, V17, P794, DOI 10.1111/ele.12282; Barrett M, 2016, ENVIRON SCI POLLUT R, V23, P7899, DOI 10.1007/s11356-015-6030-1; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; BUHLER DD, 1995, CROP SCI, V35, P1247, DOI 10.2135/cropsci1995.0011183X003500050001x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carbonetto B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099949; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Chavez-Romero Y, 2016, SOIL TILL RES, V159, P1, DOI 10.1016/j.still.2016.01.007; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; Degrune F, 2016, AGR ECOSYST ENVIRON, V224, P12, DOI 10.1016/j.agee.2016.03.017; Dhainaut Medina DS, 2015, LONG TERM REDUCED TI; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fierer N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00614; Franzluebbers AJ, 2010, CARBON MANAG, V1, P237, DOI 10.4155/CMT.10.25; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Giller KE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00870; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; Gravuer K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01271; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Guieysse B, 2012, CURR OPIN BIOTECH, V23, P467, DOI 10.1016/j.copbio.2011.12.022; Ho A, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix006; Ho A, 2013, ENV MICROBIOL REP, V5, P335, DOI 10.1111/j.1758-2229.2012.00370.x; Kaurin A, 2015, BIOL FERT SOILS, V51, P923, DOI 10.1007/s00374-015-1037-9; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kirkby CA, 2014, SOIL BIOL BIOCHEM, V68, P402, DOI 10.1016/j.soilbio.2013.09.032; Kirkegaard JA, 2014, CROP PASTURE SCI, V65, P583, DOI 10.1071/CP14019; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kong AYY, 2011, SOIL BIOL BIOCHEM, V43, P20, DOI 10.1016/j.soilbio.2010.09.005; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Laliberte E., 2014, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lee HA, 2015, PUBLIC HEALTH NUTR, V6, P1, DOI DOI 10.1038/NC0MMS8904); Liu HW, 2016, SOIL TILL RES, V158, P91, DOI 10.1016/j.still.2015.12.007; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Madejon E, 2009, SOIL TILL RES, V105, P55, DOI 10.1016/j.still.2009.05.007; Martiny JBH, 2015, SCIENCE, V350, DOI 10.1126/science.aac9323; Mathesius KM, 2015, PHYS PROPERTIES SOIL; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Maul JE, 2014, APPL SOIL ECOL, V77, P42, DOI 10.1016/j.apsoil.2014.01.002; Mitchell JP, 2017, SOIL TILL RES, V165, P325, DOI 10.1016/j.still.2016.09.001; Mitchell JP, 2015, AGRON J, V107, P588, DOI 10.2134/agronj14.0415; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Muyzer G, 1996, MOL MICROBIAL ECOLOG, P2645; Navarro-Noya YE, 2013, SOIL BIOL BIOCHEM, V65, P86, DOI 10.1016/j.soilbio.2013.05.009; Nemergut DR, 2016, ISME J, V10, P1147, DOI 10.1038/ismej.2015.191; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; Poeplau C, 2015, AGR ECOSYST ENVIRON, V200, P33, DOI 10.1016/j.agee.2014.10.024; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez-Villanueva DA, 2015, APPL SOIL ECOL, V90, P49, DOI 10.1016/j.apsoil.2015.01.010; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Sengupta A, 2015, MICROB ECOL, V70, P853, DOI 10.1007/s00248-015-0609-4; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Simon HM, 2000, ENVIRON MICROBIOL, V2, P495, DOI 10.1046/j.1462-2920.2000.00131.x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; Smith RG, 2011, AGRON J, V103, P51, DOI 10.2134/agronj2010.0290; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P6670, DOI 10.1128/AEM.70.11.6670-6677.2004; Teasdale J., 2003, PRINCIPLES PRACTICES; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; [USDA_ NRCS Institute SQ], 1999, USDA NRCS SOIL QUAL; [USDA_ NRCS United States Department of Agriculture Natural Resources Conservation Service (USDA NRCS) NRCS U], 2004, 42 USDA NRCS NAT SOI; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Veenstra J. J., 2006, California Agriculture, V60, P146, DOI 10.3733/ca.v060n03p146; Verzeaux J, 2016, GEODERMA, V281, P49, DOI 10.1016/j.geoderma.2016.06.035; Wang ZT, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0366-x; Wessen E, 2010, SOIL BIOL BIOCHEM, V42, P1759, DOI 10.1016/j.soilbio.2010.06.013; Williams A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160974; Williams A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00065	78	91	95	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192953	10.1371/journal.pone.0192953	http://dx.doi.org/10.1371/journal.pone.0192953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447262	gold, Green Published			2022-12-26	WOS:000425283900082
J	Wang, XQ; Omar, O; Vazirisani, F; Thomsen, P; Ekstrom, K				Wang, Xiaoqin; Omar, Omar; Vazirisani, Forugh; Thomsen, Peter; Ekstrom, Karin			Mesenchymal stem cell-derived exosomes have altered microRNA profiles and induce osteogenic differentiation depending on the stage of differentiation	PLOS ONE			English	Article							HUMAN BONE-MARROW; EXTRACELLULAR VESICLES; MEDIATED TRANSFER; STROMAL CELLS; NEURAL CELLS; EXPRESSION; MIR-31; ANGIOGENESIS; REGENERATION; OSTEOPOROSIS	Human mesenchymal stem cell (hMSC)-derived exosomes have shown regenerative effects, but their role in osteogenesis and the underlying mechanism are yet to be determined. In this study, we examined the time-course secretion of exosomes by hMSCs during the entire process of osteogenic differentiation. Exosomes derived from hMSCs in various stages of osteogenic differentiation committed homotypic cells to differentiate towards osteogenic lineage, but only exosomes from late stages of osteogenic differentiation induced extracellular matrix mineralisation. Exosomes from expansion and early and late stages of osteogenic differentiation were internalised by a subpopulation of hMSCs. MicroRNA profiling revealed a set of differentially expressed exosomal microRNAs from the late stage of osteogenic differentiation, which were osteogenesis related. Target prediction demonstrated that these microRNAs enriched pathways involved in regulation of osteogenic differentiation and general mechanisms how exosomes exert their functions, such as "Wnt signalling pathway" and "endocytosis". Taken together, the results show that MSCs secrete exosomes with different biological properties depending on differentiation stage of their parent cells. The exosomal cargo transferred from MSCs in the late stage of differentiation induces osteogenic differentiation and mineralisation. Moreover, it is suggested that the regulatory effect on osteogenesis by exosomes is at least partly exerted by exosomal microRNA.	[Wang, Xiaoqin; Omar, Omar; Vazirisani, Forugh; Thomsen, Peter; Ekstrom, Karin] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden; [Wang, Xiaoqin; Omar, Omar; Vazirisani, Forugh; Thomsen, Peter; Ekstrom, Karin] BIOMATCELL, VINN Excellence Ctr Biomat & Cell Therapy, Gothenburg, Sweden	University of Gothenburg	Ekstrom, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden.; Ekstrom, K (corresponding author), BIOMATCELL, VINN Excellence Ctr Biomat & Cell Therapy, Gothenburg, Sweden.	karin.ekstrom@biomaterials.gu.se	Omar, Omar/C-9264-2019; Ekström, Karin/M-7501-2013	Omar, Omar/0000-0002-2610-1294; Ekström, Karin/0000-0001-7808-4572; Wang, Xiaoqin/0000-0001-9779-5089; Thomsen, Peter/0000-0003-3910-6665	BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Swedish Research Council [K2015-52X-09495-28-4]; LUA/ALF Research Grant "Optimization of osseointegration for treatment of transfemoral amputees" [ALFGBG-448851]; IngaBritt and Arne Lundberg Foundation [2014-0049]; Stiftelsen Hjalmar Svenssons Forskningsfond [HJSV2014073, HJSV2013030, HJSV201341, HJSV2014059]; Magnus Bergvalls stiftelse [20140115]; Vilhelm and Martina Lundgren Vetenskapsfond [107/2014]; Area of Advance Materials of Chalmers and GU Biomaterials within the Strategic Research Area initiative; Stiftelsen Hjalmar Svenssons Forskningsfond (Adlerbertska forskningsstiftelsen) [E 2015/78]	BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Swedish Research Council(Swedish Research CouncilEuropean Commission); LUA/ALF Research Grant "Optimization of osseointegration for treatment of transfemoral amputees"; IngaBritt and Arne Lundberg Foundation; Stiftelsen Hjalmar Svenssons Forskningsfond; Magnus Bergvalls stiftelse; Vilhelm and Martina Lundgren Vetenskapsfond; Area of Advance Materials of Chalmers and GU Biomaterials within the Strategic Research Area initiative; Stiftelsen Hjalmar Svenssons Forskningsfond (Adlerbertska forskningsstiftelsen)	The study was supported by the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy (www.biomatcell.org.gu.ge), the Vastra Gotaland Region (www.vgregion.se), the Swedish Research Council (www.vr.se), K2015-52X-09495-28-4, (PT), the LUA/ALF Research Grant "Optimization of osseointegration for treatment of transfemoral amputees" (http://www.researchweb.org/is/alfgbg), ALFGBG-448851 (PT), the IngaBritt and Arne Lundberg Foundation (http://www.lundbergsstiftelsen.se), 2014-0049 (PT), Stiftelsen Hjalmar Svenssons Forskningsfond (https://stiftelsemedel.se, HJSV2014073 (XW), HJSV2013030 (XW), HJSV201341 (KE), HJSV2014059 (KE) Adlerbertska forskningsstiftelsen (www.adlerbertska.se) E 2015/78 (KE)), Magnus Bergvalls stiftelse (www.magnusbergvallsstiftelse.nu) 20140115 (KE), the Vilhelm and Martina Lundgren Vetenskapsfond (http://www.wmlundgren.se) 107/2014 (PT) and the Area of Advance Materials of Chalmers and GU Biomaterials within the Strategic Research Area initiative launched by the Swedish Government (www.chalmers.se/en/areas-of-advance/materials) (PT). The grant providers were not involved in the study design, data acquisition, interpretation, writing and submission of the article. The authors confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurekli C, 2015, STEM CELL REV REP, V11, P150, DOI 10.1007/s12015-014-9545-9; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Baglio SR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0116-z; Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Bakhshandeh B, 2012, BIOTECHNOL LETT, V34, P1579, DOI 10.1007/s10529-012-0934-3; Berrondo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147236; Chang W, 2015, MOL CELLS, V38, P643, DOI 10.14348/molcells.2015.0050; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Davis C, 2017, TISSUE ENG PT A, V23, P1231, DOI [10.1089/ten.tea.2016.0525, 10.1089/ten.TEA.2016.0525]; Deng Y, 2014, INVEST OPHTH VIS SCI, V55, P6016, DOI 10.1167/iovs.14-14977; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Fang SJ, 2015, INT J MOL SCI, V16, P8227, DOI 10.3390/ijms16048227; Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hoseinzadeh S, 2016, IN VITRO CELL DEV-AN, V52, P479, DOI 10.1007/s11626-015-9992-x; Huang C, 2016, FEBS LETT, V590, P795, DOI 10.1002/1873-3468.12112; Hyun J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14135; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katsuda T, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0214-y; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Konala VBR, 2016, CYTOTHERAPY, V18, P13, DOI 10.1016/j.jcyt.2015.10.008; Lai Ruenn Chai, 2012, Int J Proteomics, V2012, P971907, DOI 10.1155/2012/971907; Lamichhane TN, 2015, TISSUE ENG PART B-RE, V21, P45, DOI [10.1089/ten.TEB.2014.0300, 10.1089/ten.teb.2014.0300]; Lee HK, 2014, STEM CELLS DEV, V23, P2851, DOI 10.1089/scd.2014.0146; Li F, 2012, BIOCHEM BIOPH RES CO, V426, P475, DOI 10.1016/j.bbrc.2012.08.095; Lunavat TR, 2016, BIOMATERIALS, V102, P231, DOI 10.1016/j.biomaterials.2016.06.024; Martins M, 2016, STEM CELL REP, V6, P284, DOI 10.1016/j.stemcr.2016.01.001; Meng YB, 2015, J ORTHOP RES, V33, P957, DOI 10.1002/jor.22884; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muller L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20254; Omar OM, 2011, BIOMATERIALS, V32, P8190, DOI 10.1016/j.biomaterials.2011.07.055; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Shapiro IM, 2015, BONE, V79, P29, DOI 10.1016/j.bone.2015.05.013; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Sun YX, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/412327; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Takeuchi T, 2015, P NATL ACAD SCI USA, V112, pE2497, DOI 10.1073/pnas.1412651112; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Teng XM, 2015, CELL PHYSIOL BIOCHEM, V37, P2415, DOI 10.1159/000438594; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trohatou O, 2014, STEM CELL TRANSL MED, V3, P54, DOI 10.5966/sctm.2013-0081; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vallabhaneni KC, 2015, ONCOTARGET, V6, P4953, DOI 10.18632/oncotarget.3211; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Wang KX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120593; Wang XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13721; Wang ZS, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S94689; Weilner S, 2016, AGING CELL, V15, P744, DOI 10.1111/acel.12484; Weilner S, 2015, BONE, V79, P43, DOI 10.1016/j.bone.2015.05.027; Wu GS, 2016, CARBOHYD POLYM, V138, P49, DOI 10.1016/j.carbpol.2015.11.044; Wu KM, 2013, ACS APPL MATER INTER, V5, P2733, DOI 10.1021/am400374c; Xie Q, 2014, BIOCHEM BIOPH RES CO, V446, P98, DOI 10.1016/j.bbrc.2014.02.058; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114627; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Yu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073304; Zhang B, 2015, STEM CELLS, V33, P2158, DOI 10.1002/stem.1771; Zhang B, 2015, STEM CELL TRANSL MED, V4, P513, DOI 10.5966/sctm.2014-0267; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; Zhang FX, 2013, MOL MED REP, V8, P1084, DOI 10.3892/mmr.2013.1615; Zhang JY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0417-0; Zhao WG, 2015, MOL CELL BIOCHEM, V405, P125, DOI 10.1007/s11010-015-2404-4	69	101	113	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193059	10.1371/journal.pone.0193059	http://dx.doi.org/10.1371/journal.pone.0193059			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447276	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900105
J	Zhong, QY; Gelaye, B; Smoller, JW; Avillach, P; Cai, TX; Williams, MA				Zhong, Qiu-Yue; Gelaye, Bizu; Smoller, Jordan W.; Avillach, Paul; Cai, Tianxi; Williams, Michelle A.			Adverse obstetric outcomes during delivery hospitalizations complicated by suicidal behavior among US pregnant women	PLOS ONE			English	Article							PERINATAL OUTCOMES; RISK-FACTORS; DEPRESSION; IDEATION; POPULATION; EXPOSURE; INFANTS; GROWTH	Objective The effects of suicidal behavior on obstetric outcomes remain dangerously unquantified. We sought to report on the risk of adverse obstetric outcomes for US women with suicidal behavior at the time of delivery. Methods We performed a cross-sectional analysis of delivery hospitalizations from 2007-2012 National (Nationwide) Inpatient Sample. From the same hospitalization record, International Classification of Diseases codes were used to identify suicidal behavior and adverse obstetric outcomes. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were obtained using logistic regression. Results Of the 23,507,597 delivery hospitalizations, 2,180 were complicated by suicidal behavior. Women with suicidal behavior were at a heightened risk for outcomes including antepartum hemorrhage (aOR = 2.34; 95% CI: 1.47-3.74), placental abruption (aOR = 2.07; 95% CI: 1.17-3.66), postpartum hemorrhage (aOR = 2.33; 95% CI: 1.61-3.37), premature delivery (aOR = 3.08; 95% CI: 2.43-3.90), stillbirth (aOR = 10.73; 95% CI: 7.41-15.56), poor fetal growth (aOR = 1.70; 95% CI: 1.10-2.62), and fetal anomalies (aOR = 3.72; 95% CI: 2.57-5.40). No significant association was observed for maternal suicidal behavior with cesarean delivery, induction of labor, premature rupture of membranes, excessive fetal growth, and fetal distress. The mean length of stay was longer for women with suicidal behavior. Conclusion During delivery hospitalization, women with suicidal behavior are at increased risk for many adverse obstetric outcomes, highlighting the importance of screening for and providing appropriate clinical care for women with suicidal behavior during pregnancy.	[Zhong, Qiu-Yue; Gelaye, Bizu; Avillach, Paul; Williams, Michelle A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Smoller, Jordan W.] Harvard Med Sch, Boston, MA USA; [Avillach, Paul; Cai, Tianxi] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [Avillach, Paul] Boston Childrens Hosp, Childrens Hosp, Informat Program, Boston, MA USA; [Cai, Tianxi] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Zhong, QY (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	qyzhong@mail.harvard.edu			National Institutes of Health (the National Institute on Minority Health and Health Disparities) [T37-M D001449]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS) [8UL1TR 000170-08]	National Institutes of Health (the National Institute on Minority Health and Health Disparities); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by awards from the National Institutes of Health (the National Institute on Minority Health and Health Disparities, https://www.nimhd.nih.gov/): T37-M D001449; and the National Center for Research Resources (NCRR), the National Center for Advancing Translational Sciences (NCATS, littps://ncats.nih.gov/): 8UL1TR 000170-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Anderson HD, 2015, J AM BOARD FAM MED, V28, P65, DOI 10.3122/jabfm.2015.01.140181; Bryant A, 2012, ANESTH ANALG, V115, P1127, DOI 10.1213/ANE.0b013e3182691e62; Chaudron LH, 2013, AM J PSYCHIAT, V170, P12, DOI 10.1176/appi.ajp.2012.12040440; Czeizel AE, 1997, OBSTET GYNECOL, V90, P195, DOI 10.1016/S0029-7844(97)00216-0; Czeizel AE, 1999, INT J GYNECOL OBSTET, V65, P39, DOI 10.1016/S0020-7292(99)00007-7; DAY NL, 1989, PEDIATRICS, V84, P536; Flint C, 2002, ACTA OBSTET GYN SCAN, V81, P516, DOI 10.1034/j.1600-0412.2002.810607.x; Fontanella CA, 2015, JAMA PEDIATR, V169, P466, DOI 10.1001/jamapediatrics.2014.3561; Gandhi SG, 2006, OBSTET GYNECOL, V107, P984, DOI 10.1097/01.AOG.0000216000.50202.f6; Garite TJ, 2004, AM J OBSTET GYNECOL, V191, P700, DOI 10.1016/j.ajog.2004.03.040; Gelaye B, 2016, ARCH WOMEN MENT HLTH, V19, P741, DOI 10.1007/s00737-016-0646-0; Gidai J, 2010, PHARMACOEPIDEM DR S, V19, P175, DOI 10.1002/pds.1885; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Healthcare Cost And Utilization, 2015, INTR UCHP NAT INP SA; Hornbrook MC, 2007, HEALTH SERV RES, V42, P908, DOI 10.1111/j.1475-6773.2006.00635.x; Houchens RL., 2014, HCUP NIS RELATED REP; Huybrechts KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092778; Iribarren C, 2000, SOC PSYCH PSYCH EPID, V35, P288, DOI 10.1007/s001270050241; Kennare R, 2005, AUST NZ J OBSTET GYN, V45, P220, DOI 10.1111/j.1479-828X.2005.00379.x; Kuklina EV, 2008, MATERN CHILD HLTH J, V12, P469, DOI 10.1007/s10995-007-0256-6; Kulkarni J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094788; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock M. K, 2012, SUICIDE GLOBAL PERSP; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Oates M, 2003, BRIT J PSYCHIAT, V183, P279, DOI 10.1192/bjp.183.4.279; Page A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-68; Phillips MR, 2014, LANCET PSYCHIAT, V1, P168, DOI 10.1016/S2215-0366(14)70303-7; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Sadowski A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003062; Timmermann G, 2008, TOXICOL IND HEALTH, V24, P109, DOI 10.1177/0748233708089004; van Heeringen K, 2012, NEUROBIOLOGICAL BASI, P113, DOI DOI 10.1201/B12215-7; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; Walkup JT, 2012, PHARMACOEPIDEM DR S, V21, P174, DOI 10.1002/pds.2335; World Health Organization & Practice Management Information Corporation, 1998, ICD 9 CM INT CLASS D; Zhong QY, 2016, ARCH WOMEN MENT HLTH, V19, P463, DOI 10.1007/s00737-015-0597-x	37	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192943	10.1371/journal.pone.0192943	http://dx.doi.org/10.1371/journal.pone.0192943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447245	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900080
J	Ni, YZ; Alwell, K; Moomaw, CJ; Woo, D; Adeoye, O; Flaherty, ML; Ferioli, S; Mackey, J; La Rosa, FD; Martini, S; Khatri, P; Kleindorfer, D; Kissela, BM				Ni, Yizhao; Alwell, Kathleen; Moomaw, Charles J.; Woo, Daniel; Adeoye, Opeolu; Flaherty, Matthew L.; Ferioli, Simona; Mackey, Jason; La Rosa, Felipe De Los Rios; Martini, Sharyl; Khatri, Pooja; Kleindorfer, Dawn; Kissela, Brett M.			Towards phenotyping stroke: Leveraging data from a large-scale epidemiological study to detect stroke diagnosis	PLOS ONE			English	Article							ISCHEMIC-STROKE; FEATURE-SELECTION; MISSING DATA; RISK-FACTOR; PREDICTION; POPULATION; PROGNOSIS; ICD-9-CM; RECORDS; RATES	Objective 1) To develop a machine learning approach for detecting stroke cases and subtypes from hospitalization data, 2) to assess algorithm performance and predictors on real-world data collected by a large-scale epidemiology study in the US; and 3) to identify directions for future development of high-precision stroke phenotypic signatures. Materials and methods We utilized 8,131 hospitalization events (ICD-9 codes 430 +/- 438) collected from the Greater Cincinnati/Northern Kentucky Stroke Study in 2005 and 2010. Detailed information from patients' medical records was abstracted for each event by trained research nurses. By analyzing the broad list of demographic and clinical variables, the machine learning algorithms predicted whether an event was a stroke case and, if so, the stroke subtype. The performance was validated on gold-standard labels adjudicated by stroke physicians, and results were compared with stroke classifications based on ICD-9 discharge codes, as well as labels determined by study nurses. Results The best performing machine learning algorithm achieved a performance of 88.57%/93.81%/92.80%/93.30%/89.84%/98.01% (accuracy/precision/recall/F-measure/area under ROC curve/area under precision-recall curve) on stroke case detection. For detecting stroke subtypes, the algorithm yielded an overall accuracy of 87.39% and greater than 85% precision on individual subtypes. The machine learning algorithms significantly outperformed the ICD-9 method on all measures (P value<0.001). Their performance was comparable to that of study nurses, with better tradeoff between precision and recall. The feature selection uncovered a subset of predictive variables that could facilitate future development of effective stroke phenotyping algorithms. Discussion and conclusions By analyzing a broad array of patient data, the machine learning technologies held promise for improving detection of stroke diagnosis, thus unlocking high statistical power for subsequent genetic and genomic studies.	[Ni, Yizhao] Cincinnati Childrens Hosp Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; [Ni, Yizhao] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45220 USA; [Alwell, Kathleen; Moomaw, Charles J.; Woo, Daniel; Flaherty, Matthew L.; Ferioli, Simona; Khatri, Pooja; Kleindorfer, Dawn; Kissela, Brett M.] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Adeoye, Opeolu] Univ Cincinnati, Dept Emergency Med & Neurosurg, Cincinnati, OH USA; [Mackey, Jason] Indiana Univ, Dept Neurol, Indianapolis, IN 46204 USA; [La Rosa, Felipe De Los Rios] Baptist Hlth Neurosci Ctr, Miami, FL USA; [Martini, Sharyl] Michael E DeBakey VA Med Ctr, Houston, TX USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University-Purdue University Indianapolis; Baylor College of Medicine	Ni, YZ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA.; Ni, YZ (corresponding author), Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45220 USA.	yizhao.ni@cchmc.org		Kissela, Brett/0000-0002-9773-4013; Ni, Yizhao/0000-0001-8599-454X	National Library of Medicine [1R01LM012230]; National Human Genome Research Institute [1U01HG008666]; National Institute of Neurological Disorders and Stroke [R01NS30678]; Cincinnati Children's Hospital Medical Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030678] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cincinnati Children's Hospital Medical Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant number 1R01LM012230 from National Library of Medicine, https://www.nlm.nih.gov, to YN; grant number 1U01HG008666, from National Human Genome Research Institute, https://www.genorne.gov, to YN; grant number: R01NS30678, from National Institute of Neurological Disorders and Stroke, https://www.ninds.nih.gov, to KA, CM, DW, OA, MF, SF, JM, FDLRLR, SM, PK, DK, BK; and no grant number, from Cincinnati Children's Hospital Medical Center, https://www.cincinnatichildrens.org, to YN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Arsava EM, 2015, STROKE, V46, P634, DOI 10.1161/STROKEAHA.114.006396; Asadi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088225; Aslanyan S, 2004, STROKE, V35, pE153, DOI 10.1161/01.STR.0000126598.88662.16; Bentley P, 2014, NEUROIMAGE-CLIN, V4, P635, DOI 10.1016/j.nicl.2014.02.003; Bishop Christopher M., 2006, PATTERN RECOGNITION; Black M, 2015, OMICS, V19, P451, DOI 10.1089/omi.2015.0083; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brown RD, 1996, STROKE, V27, P373; Chang TE, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003056; Cheng CA, 2014, STUD HEALTH TECHNOL, V202, P115, DOI 10.3233/978-1-61499-423-7-115; Colak C, 2015, COMPUT METH PROG BIO, V119, P181, DOI 10.1016/j.cmpb.2015.03.002; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Ding YF, 2010, J MACH LEARN RES, V11, P131; Feigin VL, 2004, STROKE, V35, P2045; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Haibo H, 2008, ADASYN ADAPTIVE SYNT, P1322; Hardy M. A., 1993, REGRESSION DUMMY VAR; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hayden DT, 2015, STROKE, V46, P3488, DOI 10.1161/STROKEAHA.115.011139; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Ho King Chung, 2014, AMIA Annu Symp Proc, V2014, P1787; Isaac S., 1995, HDB RES EVALUATION E; Jackson CA, 2010, STROKE, V41, P624, DOI 10.1161/STROKEAHA.109.558809; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Jiang G, 2016, PUBLIC HEALTH, V131, P11, DOI 10.1016/j.puhe.2015.10.008; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kleindorfer D, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0421-2; Knottnerus ILH, 2011, STROKE, V42, P1196, DOI 10.1161/STROKEAHA.110.602383; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Konig IR, 2008, INT J DATA MIN BIOIN, V2, P289, DOI 10.1504/IJDMB.2008.022149; KRAAIJEVELD CL, 1984, STROKE, V15, P723, DOI 10.1161/01.STR.15.4.723; Liao KP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1885; Linder R, 2006, METHOD INFORM MED, V45, P536; Lindgren A, 2014, J STROKE, V16, P114, DOI 10.5853/jos.2014.16.3.114; MathWorks, 2017, MATLAB LANG TECHN CO; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; McDonald J.H, 2014, HDB BIOL STAT, V3rd; Mitchell AB, 2015, STROKE, V46, P1690, DOI 10.1161/STROKEAHA.115.008940; Mo H, 2015, J AM MED INFORM ASSN, V22, P1220, DOI 10.1093/jamia/ocv112; Moons KGM, 2002, J EPIDEMIOL COMMUN H, V56, pI30, DOI 10.1136/jech.56.suppl_1.i30; Mowery DL, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0065-1; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; National heart lung and blood institute, 2016, IS STROK DIAGN; Ni YZ, 2017, STROKE, V48; Ni YZ, 2016, J AM MED INFORM ASSN, V23, P671, DOI 10.1093/jamia/ocv216; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Olson KL, 2014, AM J MANAGED CARE, V20; Ozkul-Wermester O, 2014, EUR NEUROL, V72, P45, DOI 10.1159/000358297; Peng SY, 2010, EUR J NEUROL, V17, P945, DOI 10.1111/j.1468-1331.2010.02955.x; Purrucker JC, 2015, J NEUROL NEUROSUR PS, V86, P1021, DOI 10.1136/jnnp-2014-309260; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Rice J.A., 2006, MATH STAT DATA ANAL; Sanders LM, 2012, NEUROLOGY, V79, P971, DOI 10.1212/WNL.0b013e31825f9d02; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Shaikh Q, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-149; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Sima C, 2006, BIOINFORMATICS, V22, P2430, DOI 10.1093/bioinformatics/btl407; Simel D., 2011, GOLDMANS CECIL MED; Smith SD, 2011, RADIOL CLIN N AM, V49, P27, DOI 10.1016/j.rcl.2010.07.011; Tang FH, 2011, COMPUT BIOL MED, V41, P529, DOI 10.1016/j.compbiomed.2011.05.001; TEASDALE G, 1974, LANCET, V2, P81; Tirschwell DL, 2002, STROKE, V33, P2801, DOI 10.1161/01.STR.0000044166.28481.BC; Tonk M, 2007, J NEUROL SCI, V257, P273, DOI 10.1016/j.jns.2007.01.037; Trivedi MM, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0461-7; Twala BETH, 2008, PATTERN RECOGN LETT, V29, P950, DOI 10.1016/j.patrec.2008.01.010; Tyan YS, 2014, INT J BIOMED IMAGING, V2014, DOI 10.1155/2014/947539; Wolfe CDA, 1999, STROKE, V30, P350, DOI 10.1161/01.STR.30.2.350; Woodfield R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140533; Yew KS, 2009, AM FAM PHYSICIAN, V80, P33; Zhai H, 2014, 2 ASE INT C BIG DAT; Zhai HJ, 2014, RESUSCITATION, V85, P1065, DOI 10.1016/j.resuscitation.2014.04.009	79	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192586	10.1371/journal.pone.0192586	http://dx.doi.org/10.1371/journal.pone.0192586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444182	Green Submitted, gold, Green Published			2022-12-26	WOS:000425183500075
J	Rutkowsky, JM; Lee, LL; Puchowicz, M; Golub, MS; Befroy, DE; Wilson, DW; Anderson, S; Cline, G; Bini, J; Borkowski, K; Knotts, TA; Rutledge, JC				Rutkowsky, Jennifer M.; Lee, Linda L.; Puchowicz, Michelle; Golub, Mari S.; Befroy, Douglas E.; Wilson, Dennis W.; Anderson, Steven; Cline, Gary; Bini, Jason; Borkowski, Kamil; Knotts, Trina A.; Rutledge, John C.		Mouse Metab Phenotyping Ctr I	Reduced cognitive function, increased blood-brain-barrier transport and inflammatory responses, and altered brain metabolites in LDLr -/-and C57BL/6 mice fed a western diet	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; CEREBRAL MITOCHONDRIAL DYSFUNCTION; POLYUNSATURATED FATTY-ACIDS; HIGH-ENERGY DIET; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; INSULIN-RESISTANCE; DEMENTIA DIFFERENTIATION; GLUCOSE-METABOLISM; SPATIAL MEMORY	Recent work suggests that diet affects brain metabolism thereby impacting cognitive function. Our objective was to determine if a western diet altered brain metabolism, increased blood-brain barrier (BBB) transport and inflammation, and induced cognitive impairment in C57BL/6 (WT) mice and low-density lipoprotein receptor null (LDLr -/-) mice, a model of hyperlipidemia and cognitive decline. We show that a western diet and LDLr -/- moderately influence cognitive processes as assessed by Y-maze and radial arm water maze. Also, western diet significantly increased BBB transport, as well as microvessel factor VIII in LDLr -/- and microglia IBA1 staining in WT, both indicators of activation and neuroinflammation. Interestingly, LDLr -/- mice had a significant increase in F-18-fluorodeoxyglucose uptake irrespective of diet and brain 1 H-magnetic resonance spectroscopy showed increased lactate and lipid moieties. Metabolic assessments of whole mouse brain by GC/MS and LC/MS/MS showed that a western diet altered brain TCA cycle and beta-oxidation intermediates, levels of amino acids, and complex lipid levels and elevated proinflammatory lipid mediators. Our study reveals that the western diet has multiple impacts on brain metabolism, physiology, and altered cognitive function that likely manifest via multiple cellular pathways.	[Rutkowsky, Jennifer M.; Knotts, Trina A.; Rutledge, John C.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Lee, Linda L.] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Puchowicz, Michelle] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Golub, Mari S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Befroy, Douglas E.] Yale Univ, Sch Med, Dept Diagnost Radiol, Magnet Resonance Res Ctr, New Haven, CT 06510 USA; [Wilson, Dennis W.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Anderson, Steven] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Cline, Gary] Yale Univ, Dept Endocrinol, New Haven, CT USA; [Bini, Jason] Yale Univ, Dept Diagnost Radiol, Yale PET Ctr, New Haven, CT 06510 USA; [Borkowski, Kamil] Univ Calif Davis, Genome Ctr, West Coast Metabol Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; Case Western Reserve University; University of California System; University of California Davis; Yale University; University of California System; University of California Davis; University of California System; University of California Davis; Yale University; Yale University; University of California System; University of California Davis	Rutkowsky, JM (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	jrutkowsky@ucdavis.edu		Rutkowsky, Jennifer/0000-0002-0046-7693; Bini, Jason/0000-0003-4047-6575	National Institute of Aging [AG045541, AG039094]; Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund; National Science Foundation [OSTI 97-24412]; Drs. K. C. Kent Lloyd (National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U24-DK092993, U24-DK092993-05S1, NIDDK U24-DK059635, NIDDK U24-DK076174]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK092993, U2CDK092993] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund; National Science Foundation(National Science Foundation (NSF)); Drs. K. C. Kent Lloyd (National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Aging AG039094 and AG045541 and the Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund (JCR), and the National Science Foundation OSTI 97-24412 (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jeffrey Walton from the UC Davis Nuclear Magnetic Resonance Facility for his assistance and expertise with Magnetic Resonance Imaging as well as Lynette Bower and Todd Tolentino who supervised the phenotyping at UC Davis Mouse Biology Program. We would also like to acknowledge the UC Davis MMPC Complications and Pathology Core and the Energy Balance, Exercise & Behavior Core, Yale MMPC Integrated Physiology Core-Mouse Imaging, and Case Western MMPC Analytical Core. Members of the Mouse Metabolic Phenotyping Center Imaging. Finally, we would like to acknowledge Drs. K. C. Kent Lloyd (National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) U24-DK092993 and U24-DK092993-05S1), Gerald I. Shulman (NIDDK U24-DK059635), and Henri Brunengraber (NIDDK U24-DK076174) for their support of this work. Working Group include: Jennifer M. Rutkowsky, Michelle Puchowicz, Douglas E. Befroy, Gary Cline, and John C. Rutledge. Jennifer M. Rutkowsky (jrutkowsky@ucclavis.eclu) serves as lead author for this group.	Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Agrawal K, 2017, J LIPID RES, V58, P188, DOI 10.1194/jlr.M071738; Algarzae N, 2012, NEUROSCIENCE, V225, P22, DOI 10.1016/j.neuroscience.2012.08.057; Assaad HI, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0795-z; Aung HH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-80; Aung HH, 2013, ARTERIOSCL THROM VAS, V33, P2088, DOI 10.1161/ATVBAHA.113.301375; BALAMANYAM NV, 1980, ARCH NEUROL-CHICAGO, V37, P352, DOI 10.1001/archneur.1980.00500550054006; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016; Best T, 2015, NUTR NEUROSCI, V18, P76, DOI 10.1179/1476830513Y.0000000101; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Brinton RD, 2008, ADV DRUG DELIVER REV, V60, P1504, DOI 10.1016/j.addr.2008.06.003; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; BUCHANAN MR, 1991, WIEN KLIN WOCHENSCHR, V103, P416; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Buga GM, 2006, J LIPID RES, V47, P2148, DOI 10.1194/jlr.M600214-JLR200; Cajka T, 2014, TRAC-TREND ANAL CHEM, V61, P192, DOI 10.1016/j.trac.2014.04.017; Calderon-Garciduenas L, 2015, J ALZHEIMERS DIS, V45, P757, DOI 10.3233/JAD-142685; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Cermenati G, 2017, J STEROID BIOCHEM, V168, P60, DOI 10.1016/j.jsbmb.2017.02.002; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen PY, 2015, J NUTR BIOCHEM, V26, P521, DOI 10.1016/j.jnutbio.2014.12.007; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chico L, 2013, FREE RADICAL RES, V47, P569, DOI 10.3109/10715762.2013.804622; Coenen KR, 2007, AM J PHYSIOL-ENDOC M, V293, pE492, DOI 10.1152/ajpendo.00171.2007; Davidson TL, 2012, PHYSIOL BEHAV, V107, P26, DOI 10.1016/j.physbeh.2012.05.015; de la Monte SM, 2010, J ALZHEIMERS DIS, V21, P967, DOI 10.3233/JAD-2010-091726; de Oliveira J, 2011, NEUROSCIENCE, V197, P99, DOI 10.1016/j.neuroscience.2011.09.009; de Oliveira J, 2013, NEUROCHEM RES, V38, P2028, DOI 10.1007/s11064-013-1110-4; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Durazzo TC, 2016, BIOL PSYCHIAT, V79, P481, DOI 10.1016/j.biopsych.2015.03.029; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Fayed N, 2014, ACAD RADIOL, V21, P1211, DOI 10.1016/j.acra.2014.04.009; Fiehn O., 2016, CURRENT PROTOCOLS MO, V114; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; Freeman LR, 2014, NUTR NEUROSCI, V17, P241, DOI 10.1179/1476830513Y.0000000092; Gallacher J, 2010, ARTERIOSCL THROM VAS, V30, P599, DOI 10.1161/ATVBAHA.109.197368; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Moreira ELG, 2012, J ALZHEIMERS DIS, V32, P495, DOI 10.3233/JAD-2012-120541; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Golub MS, 2008, NEUROBIOL AGING, V29, P1512, DOI 10.1016/j.neurobiolaging.2007.03.015; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Harris SR, 2013, CHEM RES TOXICOL, V26, P213, DOI 10.1021/tx3003643; Hashimoto M, 2011, J PHARMACOL SCI, V116, P150, DOI 10.1254/jphs.10R33FM; Heemskerk MM, 2015, NUTRIENTS, V7, P7676, DOI 10.3390/nu7095362; Hollestellel MJ, 2004, THROMB HAEMOSTASIS, V91, P267, DOI 10.1160/TH03-05-0310; Hu Hua, 2014, Shanghai Arch Psychiatry, V26, P129, DOI 10.3969/j.issn.1002-0829.2014.03.004; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jorgensen W, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13207; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kan HW, 2015, MOL MED REP, V12, P4546, DOI 10.3892/mmr.2015.3894; Kanoski SE, 2010, J ALZHEIMERS DIS, V21, P207, DOI 10.3233/JAD-2010-091414; Kaufman MJ, 2015, DRUG ALCOHOL DEPEN, V152, P47, DOI 10.1016/j.drugalcdep.2015.04.023; Kendig MD, 2013, PHYSIOL BEHAV, V120, P164, DOI 10.1016/j.physbeh.2013.08.012; Kerrouche N, 2006, J CEREBR BLOOD F MET, V26, P1213, DOI 10.1038/sj.jcbfm.9600296; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kitagawa K, 2010, J ALZHEIMERS DIS, V20, P855, DOI 10.3233/JAD-2010-091324; Kitaguchi H, 2007, NEUROSCI LETT, V417, P128, DOI 10.1016/j.neulet.2007.02.021; Kombu RS, 2011, METHODS MOL BIOL, V708, P147, DOI 10.1007/978-1-61737-985-7_8; La Frano MR, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1170-6; Lee LL, 2017, AM J PHYSIOL-CELL PH, V312, pC500, DOI 10.1152/ajpcell.00120.2016; Li QL, 2012, FREE RADICAL BIO MED, V52, P1043, DOI 10.1016/j.freeradbiomed.2011.12.022; Liguori C, 2015, J NEUROL NEUROSUR PS, V86, P655, DOI 10.1136/jnnp-2014-308577; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Maesako M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072796; Makaryus R, 2011, J CEREBR BLOOD F MET, V31, P1432, DOI 10.1038/jcbfm.2011.1; Martinez-Clemente M, 2010, HEPATOLOGY, V51, P817, DOI 10.1002/hep.23463; Martinez-Gardeazabal J., 2017, BIOCH BIOPHYS ACTA; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McCoin CS, 2016, J INHERIT METAB DIS, V39, P399, DOI 10.1007/s10545-016-9915-3; MOCH D, 1990, BIOMED BIOCHIM ACTA, V49, P201; Molino Y, 2017, FASEB J, V31, P1807, DOI 10.1096/fj.201600827R; Monteiro J, 2014, FOOD FUNCT, V5, P426, DOI 10.1039/c3fo60551e; Morris MC, 2014, NEUROBIOL AGING, V35, pS59, DOI 10.1016/j.neurobiolaging.2014.03.038; MURTAGHMARK CM, 1995, J GERONTOL A-BIOL, V50, pB148, DOI 10.1093/gerona/50A.3.B148; Ng KF, 2015, MAGNETIC RESONANCE I; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Pallebage-Gamarallage M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-117; Palomera-Avalos V, 2017, REJUVENATION RES; Pascual B, 2010, STROKE, V41, P2889, DOI 10.1161/STROKEAHA.110.591552; Pascual M, 2003, J NEUROCHEM, V87, P1535, DOI 10.1046/j.1471-4159.2003.02130.x; PEELING J, 1993, AM J PHYSIOL, V265, pG572, DOI 10.1152/ajpgi.1993.265.3.G572; Pospisil P, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0518-1; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rackayova V, 2015, METAB BRAIN DIS; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Rizi EP, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0219-0; Sakamoto H, 2017, BIOCHEM BIOPH RES CO, V482, P202, DOI 10.1016/j.bbrc.2016.11.041; Serrano-Pozo A, 2013, AM J PATHOL, V182, P2332, DOI 10.1016/j.ajpath.2013.02.031; Shulman RG, 1999, P NATL ACAD SCI USA, V96, P3245, DOI 10.1073/pnas.96.6.3245; Shulman RG, 2003, CR BIOL, V326, P253, DOI 10.1016/S1631-0691(03)00071-4; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Stott DJ, 2001, BLOOD COAGUL FIBRIN, V12, P651, DOI 10.1097/00001721-200112000-00006; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Trevino S, 2015, SYNAPSE, V69, P421, DOI 10.1002/syn.21832; Valls-Pedret C, 2015, JAMA INTERN MED, V175, P1094, DOI 10.1001/jamainternmed.2015.1668; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; WEBER E, 1990, THROMB RES, V57, P383, DOI 10.1016/0049-3848(90)90254-A; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wirths O, 2010, NEUROBIOL AGING, V31, P747, DOI 10.1016/j.neurobiolaging.2008.06.011; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yahiatene I, 2014, PHYS CHEM CHEM PHYS, V16, P21595, DOI 10.1039/c4cp03260h; Yang L, 2006, METABOLOMICS, V2, P85, DOI 10.1007/s11306-006-0019-1; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665; Zhang YF, 2015, J NEUROCHEM, V132, P301, DOI 10.1111/jnc.12965; Zheng H, 2017, BBA-MOL BASIS DIS, V1863, P266, DOI 10.1016/j.bbadis.2016.11.003; Zwingmann C, 2003, HEPATOLOGY, V37, P420, DOI 10.1053/jhep.2003.50052	115	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191909	10.1371/journal.pone.0191909	http://dx.doi.org/10.1371/journal.pone.0191909			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444171	Green Submitted, gold, Green Published			2022-12-26	WOS:000425183500043
J	Woods, AL; Rice, AJ; Garvican-Lewis, LA; Wallett, AM; Lundy, B; Rogers, MA; Welvaert, M; Halson, S; McKune, A; Thompson, KG				Woods, Amy L.; Rice, Anthony J.; Garvican-Lewis, Laura A.; Wallett, Alice M.; Lundy, Bronwen; Rogers, Margot A.; Welvaert, Marijke; Halson, Shona; McKune, Andrew; Thompson, Kevin G.			The effects of intensified training on resting metabolic rate (RMR), body composition and performance in trained cyclists	PLOS ONE			English	Article							FAT-FREE MASS; HEART-RATE-VARIABILITY; FEMALE ATHLETE TRIAD; PARASYMPATHETIC HYPERACTIVITY; CARBOHYDRATE SUPPLEMENTATION; ENERGY AVAILABILITY; CONSENSUS STATEMENT; THYROID-HORMONE; MUSCLE DAMAGE; SPORT-SCIENCE	Background Recent research has demonstrated decreases in resting metabolic rate (RMR), body composition and performance following a period of intensified training in elite athletes, however the underlying mechanisms of change remain unclear. Therefore, the aim of the present study was to investigate how an intensified training period, designed to elicit overreaching, affects RMR, body composition, and performance in trained endurance athletes, and to elucidate underlying mechanisms. Method Thirteen (n = 13) trained male cyclists completed a six-week training program consisting of a "Baseline" week (100% of regular training load), a "Build" week (similar to 120% of Baseline load), two "Loading" weeks (similar to 140, 150% of Baseline load, respectively) and two "Recovery" weeks (similar to 80% of Baseline load). Training comprised of a combination of laboratory based interval sessions and on-road cycling. RMR, body composition, energy intake, appetite, heart rate variability (HRV), cycling performance, biochemical markers and mood responses were assessed at multiple time points throughout the six-week period. Data were analysed using a linear mixed modeling approach. Results The intensified training period elicited significant decreases in RMR (F(5,123.36) = 12.0947, p = <0.001), body mass (F(2,19.242) = 4.3362, p = 0.03), fat mass (F(2,20.35) = 56.2494, p = <0.001) and HRV (F(2,22.608) = 6.5212, p = 0.005); all of which improved following a period of recovery. A state of overreaching was induced, as identified by a reduction in anaerobic performance (F(5,121.87) = 8.2622, p = <0.001), aerobic performance (F(5,118.26) = 2.766, p = 0.02) and increase in total mood disturbance (F(5, 110.61) = 8.1159, p = <0.001). Conclusion Intensified training periods elicit greater energy demands in trained cyclists, which, if not sufficiently compensated with increased dietary intake, appears to provoke a cascade of metabolic, hormonal and neural responses in an attempt to restore homeostasis and conserve energy. The proactive monitoring of energy intake, power output, mood state, body mass and HRV during intensified training periods may alleviate fatigue and attenuate the observed decrease in RMR, providing more optimal conditions for a positive training adaptation.	[Woods, Amy L.; Garvican-Lewis, Laura A.; Wallett, Alice M.; Welvaert, Marijke; McKune, Andrew; Thompson, Kevin G.] Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia; [Woods, Amy L.; Rice, Anthony J.; Garvican-Lewis, Laura A.; Wallett, Alice M.; Halson, Shona] Australian Inst Sport, Dept Physiol, Bruce, ACT, Australia; [Garvican-Lewis, Laura A.] Australian Catholic Univ, Mary Mackillop Inst Hlth Res, Melbourne, Vic, Australia; [Lundy, Bronwen] Australian Inst Sport, Dept Nutr, Bruce, ACT, Australia; [McKune, Andrew] Univ KwaZulu Natal, Sch Hlth Sci, Discipline Biokinet Exercise & Leisure Sci, Durban, South Africa	University of Canberra; Australian Institute of Sport; Australian Catholic University; Australian Institute of Sport; University of Kwazulu Natal	Woods, AL (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia.; Woods, AL (corresponding author), Australian Inst Sport, Dept Physiol, Bruce, ACT, Australia.	u3095542@uni.canberra.edu.au	Welvaert, Marijke/GOE-6151-2022; Rogers, Margot/GYJ-0209-2022; McKune, Andrew/AAM-3086-2020; Welvaert, Marijke/K-8486-2013	McKune, Andrew/0000-0002-5479-1544; Halson, Shona/0000-0002-1047-3878; Welvaert, Marijke/0000-0002-0802-8134	University of Canberra Research Institute for Sport and Exercise; Australian Institute of Sport; School of Health Sciences, University of KwaZulu-Natal, Durban	University of Canberra Research Institute for Sport and Exercise; Australian Institute of Sport; School of Health Sciences, University of KwaZulu-Natal, Durban	The study was funded by contributions from the University of Canberra Research Institute for Sport and Exercise, the Australian Institute of Sport and the School of Health Sciences, University of KwaZulu-Natal, Durban. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2004, J APPL PHYSIOL, V96, P1331, DOI 10.1152/japplphysiol.00973.2003; [Anonymous], 2013, J EXERCISE PHYSL ONL, DOI DOI 10.1371/JOURNAL.PONE.0199794; [Anonymous], J SPORTS SCI; [Anonymous], 2006, COMP EFFECTS POSTEXE; [Anonymous], OVERTRAINING SPORT; [Anonymous], WHAT IS TSS; [Anonymous], THESIS; [Anonymous], KUBIO USER GUIDE; [Anonymous], 12 ANN C ECSS JYV FI; [Anonymous], 1997, RUNNING INJURIES; [Anonymous], APPL PHYSL NUTR META; [Anonymous], EXERCISE HUMAN REPRO; [Anonymous], SCAND J MED SCI SPOR; [Anonymous], AM J PHYSL ENDOCRINO; [Anonymous], 2014, PHYSL TESTS ELITE AT; [Anonymous], INT J SPORTS PHYSL P; Aubry A, 2014, MED SCI SPORT EXER, V46, P1769, DOI 10.1249/MSS.0000000000000301; BARRON JL, 1985, J CLIN ENDOCR METAB, V60, P803, DOI 10.1210/jcem-60-4-803; Bellenger CR, 2016, INT J SPORT PHYSIOL, V11, P685, DOI 10.1123/ijspp.2015-0495; Berger BG, 1999, SPORT PSYCHOL, V13, P444, DOI 10.1123/tsp.13.4.444; Bianco AC, 2005, BIOSCIENCE REP, V25, P191, DOI 10.1007/s10540-005-2885-6; Blundell JE, 2015, PHYSIOL BEHAV, V152, P473, DOI 10.1016/j.physbeh.2015.05.031; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Burt DG, 2014, EUR J SPORT SCI, V14, P337, DOI 10.1080/17461391.2013.783628; Clark B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115308; Comotto S, 2015, J SPORT MED PHYS FIT, V55, P361; Costa RJS, 2005, INT J SPORTS MED, V26, P880, DOI 10.1055/s-2005-837467; da Silva VP, 2015, ANN NONINVAS ELECTRO, V20, P108, DOI 10.1111/anec.12237; de Koning J J, 1999, J Sci Med Sport, V2, P266, DOI 10.1016/S1440-2440(99)80178-9; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; De Souza MJ, 2008, BONE, V43, P140, DOI 10.1016/j.bone.2008.03.013; Decroix L, 2016, INT J SPORT PHYSIOL, V11, P933, DOI 10.1123/ijspp.2015-0570; Desgorces FD, 2004, EUR J APPL PHYSIOL, V91, P677, DOI 10.1007/s00421-003-1030-0; Dolezal BA, 2000, MED SCI SPORT EXER, V32, P1202, DOI 10.1097/00005768-200007000-00003; Donahoo WT, 2004, CURR OPIN CLIN NUTR, V7, P599, DOI 10.1097/00075197-200411000-00003; Fronczek R, 2008, J CLIN SLEEP MED, V4, P248; Garvican LA, 2011, EUR J APPL PHYSIOL, V111, P1089, DOI 10.1007/s00421-010-1732-z; Goto K, 2013, CLIN PHYSIOL FUNCT I, V33, P131, DOI [10.1111/cpf.12005, 10.1111]; Halson Shona L, 2014, Sports Med, V44 Suppl 2, pS139, DOI 10.1007/s40279-014-0253-z; Halson SL, 2004, SPORTS MED, V34, P967, DOI 10.2165/00007256-200434140-00003; Halson SL, 2004, J APPL PHYSIOL, V97, P1245, DOI 10.1152/japplphysiol.01368.2003; Halson SL, 2003, MED SCI SPORT EXER, V35, P854, DOI 10.1249/01.MSS.0000064964.80040.E9; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Hausswirth C, 2014, MED SCI SPORT EXER, V46, P1036, DOI 10.1249/MSS.0000000000000177; Henning PC, 2014, J CLIN ENDOCR METAB, V99, P956, DOI 10.1210/jc.2013-3046; Hopkins M, 2016, INT J OBESITY, V40, P312, DOI 10.1038/ijo.2015.155; Ihle R, 2004, J BONE MINER RES, V19, P1231, DOI 10.1359/JBMR.040410; JEUKENDRUP AE, 1992, INT J SPORTS MED, V13, P534, DOI 10.1055/s-2007-1021312; JOHANSEN K, 1978, ACTA MED SCAND, V204, P357; Jurimae J, 2004, J SCI MED SPORT, V7, P335, DOI 10.1016/S1440-2440(04)80028-8; Jurimae J, 2003, EUR J APPL PHYSIOL, V90, P533, DOI 10.1007/s00421-003-0879-2; Karl JP, 2016, METABOLISM, V65, P416, DOI 10.1016/j.metabol.2015.11.001; Keesey RE, 2008, APPETITE, V51, P442, DOI 10.1016/j.appet.2008.06.009; Kellmann M., 2001, RECOVERY STRESS QUES; Kentta G, 2006, EUR J SPORT SCI, V6, P245, DOI 10.1080/17461390601012652; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Knab AM, 2011, MED SCI SPORT EXER, V43, P1643, DOI 10.1249/MSS.0b013e3182118891; Koehler K, 2016, J SPORT SCI, V34, P1921, DOI 10.1080/02640414.2016.1142109; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Kyriakidis M, 2016, EUR J OBSTET GYN R B, V198, P131, DOI 10.1016/j.ejogrb.2016.01.018; LaForgia J, 2004, EUR J CLIN NUTR, V58, P1132, DOI 10.1038/sj.ejcn.1601941; Larsen I, 2014, SCAND J MED SCI SPOR, V24, pE174, DOI 10.1111/sms.12132; Le Meur Y, 2013, MED SCI SPORT EXER, V45, P2061, DOI 10.1249/MSS.0b013e3182980125; Lithander FE, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-41; Maestu J, 2005, SPORTS MED, V35, P597; Main L, 2009, EUR J SPORT SCI, V9, P195, DOI 10.1080/17461390902818260; Main LC, 2016, RES SPORTS MED, V24, P269, DOI 10.1080/15438627.2016.1202828; McMurray RG, 2005, SPORTS MED, V35, P393, DOI 10.2165/00007256-200535050-00003; Meeusen R, 2004, EUR J APPL PHYSIOL, V91, P140, DOI 10.1007/s00421-003-0940-1; Meeusen R, 2006, EUR J SPORT SCI, V6, P1, DOI 10.1080/17461390600617717; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Melin A, 2015, SCAND J MED SCI SPOR, V25, P610, DOI 10.1111/sms.12261; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Ortiga-Carvalho TM, 2016, COMPR PHYSIOL, V6, P1387, DOI 10.1002/cphy.c150027; Otter RTA, 2016, INT J SPORTS MED, V37, P12, DOI 10.1055/s-0035-1555779; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Petibois C, 2002, SPORTS MED, V32, P867, DOI 10.2165/00007256-200232130-00005; Piacentini MF, 2016, INT J SPORT PHYSIOL, V11, P824, DOI 10.1123/ijspp.2015-0279; Pichot V, 2002, MED SCI SPORT EXER, V34, P1660, DOI 10.1097/00005768-200210000-00019; POEHLMAN ET, 1988, AM J CLIN NUTR, V47, P793, DOI 10.1093/ajcn/47.5.793; Popovic V, 2005, HORM METAB RES, V37, P533, DOI 10.1055/s-2005-870418; Ramson R, 2008, EUR J APPL PHYSIOL, V104, P839, DOI 10.1007/s00421-008-0839-y; Rietjens GJWM, 2005, INT J SPORTS MED, V26, P16, DOI 10.1055/s-2004-817914; Roffey DM, 2006, JPEN-PARENTER ENTER, V30, P426, DOI 10.1177/0148607106030005426; Saunders PU, 2004, J APPL PHYSIOL, V96, P931, DOI 10.1152/japplphysiol.00725.2003; Saw AE, 2016, BRIT J SPORT MED, V50, P281, DOI 10.1136/bjsports-2015-094758; Scharhag-Rosenberger F, 2014, MED SCI SPORT EXER, V46, P1736, DOI 10.1249/MSS.0000000000000286; Shei RJ, 2016, INT J SPORTS MED, V37, P341, DOI 10.1055/s-0035-1565139; Slivka DR, 2010, J STRENGTH COND RES, V24, P2604, DOI 10.1519/JSC.0b013e3181e8a4eb; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Svendsen IS, 2016, EUR J APPL PHYSIOL, V116, P867, DOI 10.1007/s00421-016-3340-z; ten Haaf T, 2017, INT J SPORT PHYSIOL, V12, P87, DOI 10.1123/ijspp.2016-0404; Tenforde AS, 2016, SPORTS MED, V46, P171, DOI 10.1007/s40279-015-0411-y; Trexler ET, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-7; Urhausen A, 2002, SPORTS MED, V32, P95, DOI 10.2165/00007256-200232020-00002; URHAUSEN A, 1995, SPORTS MED, V20, P251, DOI 10.2165/00007256-199520040-00004; WESTERTERP KR, 1994, EUR J APPL PHYSIOL O, V69, P203, DOI 10.1007/BF01094789; Woods AL, 2017, INT J SPORT NUTR EXE, V27, P83, DOI 10.1123/ijsnem.2016-0116; Woods AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173807; Woods AL, 2016, INT J SPORT NUTR EXE, V26, P454, DOI 10.1123/ijsnem.2015-0315	100	37	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191644	10.1371/journal.pone.0191644	http://dx.doi.org/10.1371/journal.pone.0191644			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444097	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500026
J	Ahluwalia, A; Misto, A; Vozzi, F; Magliaro, C; Mattei, G; Marescotti, MC; Avogaro, A; Iori, E				Ahluwalia, Arti; Misto, Alessandra; Vozzi, Federico; Magliaro, Chiara; Mattei, Giorgio; Marescotti, Maria Cristina; Avogaro, Angelo; Iori, Elisabetta			Systemic and vascular inflammation in an in-vitro model of central obesity	PLOS ONE			English	Article							FREE FATTY-ACIDS; ADIPOSE-TISSUE; METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; LACTATE PRODUCTION; LIPID-METABOLISM; GLUCOSE; CELL; DIFFERENTIATION	Metabolic disorders due to over-nutrition are a major global health problem, often associated with obesity and related morbidities. Obesity is peculiar to humans, as it is associated with lifestyle and diet, and so difficult to reproduce in animal models. Here we describe a model of human central adiposity based on a 3-tissue system consisting of a series of interconnected fluidic modules. Given the causal link between obesity and systemic inflammation, we focused primarily on pro-inflammatory markers, examining the similarities and differences between the 3-tissue model and evidence from human studies in the literature. When challenged with high levels of adiposity, the in-vitro system manifests cardiovascular stress through expression of E-selectin and von Willebrand factor as well as systemic inflammation (expressing IL-6 and MCP-1) as observed in humans. Interestingly, most of the responses are dependent on the synergic interaction between adiposity and the presence of multiple tissue types. The set-up has the potential to reduce animal experiments in obesity research and may help unravel specific cellular mechanisms which underlie tissue response to nutritional overload.	[Ahluwalia, Arti; Magliaro, Chiara; Mattei, Giorgio] Univ Pisa, Res Ctr E Piaggio, Pisa, Italy; [Misto, Alessandra; Vozzi, Federico] Italian Natl Council Res, Inst Clin Physiol, Pisa, Italy; [Marescotti, Maria Cristina; Avogaro, Angelo; Iori, Elisabetta] Univ Padua, Dept Med, Padua, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Ahluwalia, A (corresponding author), Univ Pisa, Res Ctr E Piaggio, Pisa, Italy.	arti.ahluwalia@unipi.it	Vozzi, Federico/C-9706-2014; Vozzi, Federico/O-3276-2019; Avogaro, Angelo/S-3808-2016	Vozzi, Federico/0000-0001-5457-2328; Vozzi, Federico/0000-0001-5457-2328; Ahluwalia, Arti/0000-0001-5370-6750; Mattei, Giorgio/0000-0003-0441-9653; AVOGARO, ANGELO/0000-0002-1177-0516	European Union Seventh Framework Programme [304961]	European Union Seventh Framework Programme(European Commission)	The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 304961 (ReLiver). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska A, 2014, ENDOCRINE, V45, P422, DOI 10.1007/s12020-013-0025-9; Ahluwalia A, SCI REP; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; BOUMA ME, 1989, IN VITRO CELL DEV B, V25, P267; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Choi Jai Min, 2016, F1000Res, V5, P270, DOI 10.12688/f1000research.8153.1; Chudek Jerzy, 2006, Pharmacol Rep, V58 Suppl, P81; Cinti S, 2002, J ENDOCRINOL INVEST, V25, P823, DOI 10.1007/BF03344046; de Kreutzenberg SV, 2000, J CLIN ENDOCR METAB, V85, P793, DOI 10.1210/jc.85.2.793; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Demir MV, 2015, NIGER J CLIN PRACT, V18, P757, DOI 10.4103/1119-3077.158145; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Egert S, 2014, BRIT J NUTR, V112, P1315, DOI 10.1017/S0007114514002001; Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]; Field BCT, 2009, BRIT J CLIN PHARMACO, V68, P830, DOI 10.1111/j.1365-2125.2009.03522.x; Frayn K. N., 2010, METABOLIC REGULATION; Madrono AG, 2011, NUTR HOSP, V26, P594, DOI [10.1590/S0212-16112011000300024, 10.3305/nh.2011.26.3.5171]; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iori E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034704; Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040; Kapiotis S, 2006, ARTERIOSCL THROM VAS, V26, P2541, DOI 10.1161/01.ATV.0000245795.08139.70; KASHIWAGI A, 1983, J CLIN INVEST, V72, P1246, DOI 10.1172/JCI111080; Lai M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.30; Lee WJ, 2009, INT J OBESITY, V33, P465, DOI 10.1038/ijo.2009.24; LLOYD B, 1978, CLIN CHEM, V24, P1724; Lo KA, 2013, CELL REP, V5, P259, DOI 10.1016/j.celrep.2013.08.039; Lobato NS, 2012, BRAZ J MED BIOL RES, V45, P392, DOI 10.1590/S0100-879X2012007500058; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; MARIN P, 1987, METABOLISM, V36, P1154, DOI 10.1016/0026-0495(87)90242-3; Mathew M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-9; Mattei G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173206; Mattei G, 2014, PROCESSES, V2, P548, DOI 10.3390/pr2030548; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Murray ET, 2015, INT J OBESITY, V39, P1010, DOI 10.1038/ijo.2015.19; Rios-Hoyol A, 2014, INT J VITAM NUTR RES, V84, P113, DOI 10.1024/0300-9831/a000198; Samec S, 1998, DIABETES, V47, P1693, DOI 10.2337/diabetes.47.11.1693; Sindhu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133494; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; THACKER SV, 1987, AM J PHYSIOL, V253, pE336, DOI 10.1152/ajpendo.1987.253.4.E336; Turner PA, 2014, BIOTECHNOL BIOENG, V111, P174, DOI 10.1002/bit.25099; Ucciferri Nadia, 2014, Front Bioeng Biotechnol, V2, P74, DOI 10.3389/fbioe.2014.00074; Varga O, 2010, OBES REV, V11, P792, DOI 10.1111/j.1467-789X.2009.00667.x; Vinci B, 2012, BIOTECHNOL J, V7, P117, DOI 10.1002/biot.201100177; Vinci B, 2010, BIOTECHNOL J, V5, P618, DOI 10.1002/biot.201000009; Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P316, DOI 10.1021/bp0341996; Vozzi F, 2009, TISSUE ENG PT A, V15, P1291, DOI 10.1089/ten.tea.2008.0066; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Xiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14584; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Zagotta I, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00079; Zhao L, 2016, MOL NUTR FOOD RES, V60, P909, DOI 10.1002/mnfr.201500635	55	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192824	10.1371/journal.pone.0192824	http://dx.doi.org/10.1371/journal.pone.0192824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438401	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400058
J	Warren, JA; Ratnasekera, TDP; Campbell, DA; Anderson, GS				Warren, Jodie A.; Ratnasekera, T. D. Pulindu; Campbell, David A.; Anderson, Gail S.			Hyperspectral measurements of immature Lucilia sericata (Meigen) (Diptera: Calliphoridae) raised on different food substrates	PLOS ONE			English	Article							ROBINEAU-DESVOIDY DIPTERA; FORENSIC ENTOMOLOGY; GENE-EXPRESSION; POSTMORTEM INTERVAL; CUTICULAR HYDROCARBONS; POTENTIAL USE; TISSUE-TYPE; FLY; TEMPERATURE; VICINA	Immature Lucilia sericata (Meigen) raised on beef liver, beef heart, pork liver and pork heart at a mean temperature of 20.6 degrees C took a minimum of 20 days to complete development. Minimum development time differences within stages were observed between the meat types (pork/beef), but not the organ types (liver/heart). Daily hyperspectral measurements were conducted and a functional regression was completed to examine the main effects of meat and organ type on daily spectral measurements. The model examined post feeding larval spectral measurements of insects raised on beef liver alone, the effect of those raised on pork compared with those raised on beef, the effect of those raised on heart compared with those raised on liver and the interactional effect of those raised on pork heart compared with those raised on beef liver. The analyses indicated that the spectral measurements of post feeding L. sericata raised on pork and beef organs (liver and heart) are affected by the meat and organ type.	[Warren, Jodie A.; Anderson, Gail S.] Simon Fraser Univ, Sch Criminol, Burnaby, BC, Canada; [Ratnasekera, T. D. Pulindu; Campbell, David A.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University	Warren, JA (corresponding author), Simon Fraser Univ, Sch Criminol, Burnaby, BC, Canada.	jwarren@sfu.ca		Warren, Jodie-Ann/0000-0002-2308-6121; Campbell, David/0000-0001-8722-4450	ASD Inc.; ASD Inc, a Panalytical company	ASD Inc.; ASD Inc, a Panalytical company	This work was supported by ASD Inc. (a Panalytical company) through the Alexander Goetz instrument award program. J. Warren was a recipient of the award and was supplied with a Lab Spec 4 spectrometer for the current research. https://www.asdi.com/support/student-support-programs/goetz-instrument-support-program/goetz-instrument-program-recipients-2013. No funders played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the many volunteers that assisted with the spectral measuring and maintaining the Lucilia sericata colonies. We would also like to thank ASD Inc, a Panalytical company for awarding J. Warren the Alexander Goetz prize so that this research could be conducted.	Anderson GS, 2016, LAWYERS GUIDE FORENS, P499; Baque M, 2015, INT J LEGAL MED, V129, P891, DOI 10.1007/s00414-015-1180-8; Benbow ME, 2013, J MED ENTOMOL, V50, P440, DOI 10.1603/ME12194; Bernhardt V, 2016, INT J LEGAL MED; Beuter L, 2013, NEOTROP ENTOMOL, V42, P426, DOI 10.1007/s13744-013-0134-4; Boatright SA, 2010, J MED ENTOMOL, V47, P917, DOI 10.1603/ME09206; Boehme P, 2014, INT J LEGAL MED, V128, P565, DOI 10.1007/s00414-013-0922-8; Boehme P, 2013, INT J LEGAL MED, V127, P243, DOI 10.1007/s00414-012-0699-1; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; Butcher JB, 2013, FORENSIC SCI INT, V232, P25, DOI 10.1016/j.forsciint.2013.06.018; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; Clark K, 2006, FORENSIC SCI INT, V156, P145, DOI 10.1016/j.forsciint.2004.12.025; Council of Canadian Academies, 2009, SUBST EQ FOOD SAF AS, P1; El-Moaty ZA, 2013, J ASIA-PAC ENTOMOL, V16, P297, DOI 10.1016/j.aspen.2013.03.008; Fan YL, 2003, NATURWISSENSCHAFTEN, V90, P121, DOI 10.1007/s00114-003-0402-y; Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799; Flores M, 2014, FORENSIC SCI INT, V245, P24, DOI 10.1016/j.forsciint.2014.09.023; Gallagher MB, 2010, J FORENSIC SCI, V55, P438, DOI 10.1111/j.1556-4029.2009.01285.x; Grassberger M, 2002, FORENSIC SCI INT, V128, P177, DOI 10.1016/S0379-0738(02)00199-8; Harnden LM, 2016, FORENSIC SCI INT, V266, P109, DOI 10.1016/j.forsciint.2016.05.007; Jennings JH, 2014, J INSECT PHYSIOL, V61, P16, DOI 10.1016/j.jinsphys.2013.12.004; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Ma Q, 2012, ISME J, V6, P1356, DOI 10.1038/ismej.2011.210; Makki R, 2014, ANNU REV ENTOMOL, V59, P405, DOI 10.1146/annurev-ento-011613-162056; Martins GF, 2012, ISJ-INVERT SURVIV J, V9, P139; Moore HE, 2014, FORENSIC SCI INT, V240, P48, DOI 10.1016/j.forsciint.2014.04.002; Moore HE, 2013, J FORENSIC SCI, V58, P404, DOI 10.1111/1556-4029.12016; Moore HE, 2013, ANAL CUTICULAR HYDRO; Nansen C, 2015, PLOS ONE, V10, P1; Niederegger S, 2013, PARASITOL RES, V112, P2847, DOI 10.1007/s00436-013-3456-6; Otte T, 2015, J CHEM ECOL, V41, P32, DOI 10.1007/s10886-014-0535-9; Pechal JL, 2014, FORENSIC SCI INT, V245, P65, DOI 10.1016/j.forsciint.2014.10.019; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Pechal JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079035; Rajpurohit S, 2017, J EVOLUTION BIOL, V30, P66, DOI 10.1111/jeb.12988; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Richards CS, 2013, INT J LEGAL MED, V127, P259, DOI 10.1007/s00414-012-0697-3; Richards CS, 2012, FORENSIC SCI INT, V220, P251, DOI 10.1016/j.forsciint.2012.03.012; Rivers D. B., 2014, SCI FORENSIC ENTOMOL; Tarone AM, 2011, J MED ENTOMOL, V48, P1062, DOI 10.1603/ME11004; Tarone AM, 2008, J FORENSIC SCI, V53, P942, DOI 10.1111/j.1556-4029.2008.00744.x; Tarone AM, 2007, J FORENSIC SCI, V52, P1350, DOI 10.1111/j.1556-4029.2007.00587.x; Tarone AM, 2011, J FORENSIC SCI, V56, pS112, DOI 10.1111/j.1556-4029.2010.01632.x; Thyssen PJ, 2014, PARASITOL RES, V113, P3373, DOI 10.1007/s00436-014-4002-x; Tomberlin JK, 2011, ANNU REV ENTOMOL, V56, P401, DOI 10.1146/annurev-ento-051710-103143; Tomberlin JK, 2012, ANIM BEHAV, V84, P1449, DOI 10.1016/j.anbehav.2012.09.013; Tomberlin JK, 2011, TRENDS ECOL EVOL, V26, P53, DOI 10.1016/j.tree.2010.12.001; Voss SC, 2016, INT J LEGAL MED; Warren JA, 2009, CAN SOC FORENSIC SCI, V42, P161, DOI 10.1080/00085030.2009.10757604; Warren JA, 2017, INSECTS, V8, DOI 10.3390/insects8020034; Warren JA, 2017, FORENSIC SCI INT, V278, P205, DOI 10.1016/j.forsciint.2017.06.027; Wells JD, 2010, ESTIMATING POSTMORTE; Wilson JM, 2014, J MED ENTOMOL, V51, P1067, DOI 10.1603/ME14012; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019	54	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192786	10.1371/journal.pone.0192786	http://dx.doi.org/10.1371/journal.pone.0192786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438393	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400055
J	Bridges, DC; Tovar, KR; Wu, B; Hansma, PK; Kosik, KS				Bridges, Daniel C.; Tovar, Kenneth R.; Wu, Bian; Hansma, Paul K.; Kosik, Kenneth S.			MEA Viewer: A high-performance interactive application for visualizing electrophysiological data	PLOS ONE			English	Article								Action potentials can be recorded extracellularly from hundreds of neurons simultaneously with multi-electrode arrays. These can typically have as many as 120 or more electrodes. The brief duration of action potentials requires a high sampling frequency to reliably capture each waveform. The resulting raw data files are therefore large and difficult to visualize with traditional plotting tools. Common approaches to deal with the difficulties of data display, such as extracting spike times and performing spike train analysis, are useful in many contexts but they also significantly reduce data dimensionality. The use of tools which minimize data processing enable the development of heuristic perspective of experimental results. Here we introduce MEA Viewer, a high-performance open source application for the direct visualization of multi-channel electrophysiological data. MEA Viewer includes several high-performance visualizations, including an easily navigable overview of recorded extracellular action potentials from all data channels overlaid with spike timestamp data and an interactive raster plot. MEA Viewer can also display the two dimensional extent of action potential propagation in single neurons by signal averaging extracellular action potentials (eAPs) from single neurons detected on multiple electrodes. This view extracts and displays eAP timing information and eAP waveforms that are otherwise below the spike detection threshold. This entirely new method of using MEAs opens up novel research applications for medium density arrays. MEA Viewer is licensed under the General Public License version 3, GPLv3, and is available at http://github.com/dbridges/mea-tools.	[Bridges, Daniel C.; Tovar, Kenneth R.; Wu, Bian; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Bridges, Daniel C.; Hansma, Paul K.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bridges, DC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.; Bridges, DC (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	bridges2@gmail.com			U.S. Army Research Laboratory; Defense Advanced Research Projects Agency [W911NF-15-2-0056]; California NanoSystems Institute (CNSI)	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); California NanoSystems Institute (CNSI)	This research was sponsored by the U.S. Army Research Laboratory and Defense Advanced Research Projects Agency under Cooperative Agreement Number W911NF-15-2-0056 to KSK. The views, opinions, and/or findings contained in this material are those of the authors and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. Additional support was also provided by the California NanoSystems Institute (CNSI).	Bakkum DJ, 2013, NATURE COMMUNICATION; Campagnola L., 2015, P PYTH SCI C, V2015, DOI [10.25080/majora-7b98e3ed-00e, DOI 10.25080/MAJORA-7B98E3ED-00E]; Egert U, 2002, J NEUROSCIENCE METHO; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Garcia S, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00010; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Khaliq ZM, 2005, J NEUROSCI, V25, P454, DOI 10.1523/JNEUROSCI.3045-04.2005; Latimer KW, 2014, ADV NEUR IN, V27; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Ray S, 2016, NEUROINFORMATICS, V14, P147, DOI 10.1007/s12021-015-9282-5; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; Roudi Y, 2015, CURR OPIN NEUROBIOL, V32, P38, DOI 10.1016/j.conb.2014.10.011; Sobolev A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00015; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Teeters JL, 2015, NEURON, V88, P629, DOI 10.1016/j.neuron.2015.10.025; Tovar KR, 2017, RECORDING ACTION POT	16	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192477	10.1371/journal.pone.0192477	http://dx.doi.org/10.1371/journal.pone.0192477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425223	Green Published, gold, Green Submitted			2022-12-26	WOS:000424700800023
J	Chang, CK; Lin, XR; Lin, YL; Fang, WH; Lin, SW; Chang, SY; Kao, JT				Chang, Chun-Kai; Lin, Xiu-Ru; Lin, Yen-Lin; Fang, Woei-Horng; Lin, Shu-Wha; Chang, Sui-Yuan; Kao, Jau-Tsuen			Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; NONFASTING TRIGLYCERIDES; REMNANT CHOLESTEROL; RISK-FACTORS; AV GENE; HYPERTRIGLYCERIDEMIA; EVENTS; DEFICIENCY; OUTCOMES; ALPHA	Hyperlipidemia is a risk factor of arteriosclerosis, stroke, and other coronary heart disease, which has been shown to correlate with single nucleotide polymorphisms of genes essential for lipid metabolism, such as lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5). In this study, the effect of magnolol, the main active component extracted from Magnolia officinalis, on LPL activity was investigated. A dose-dependent up-regulation of LPL activity, possibly through increasing LPL mRNA transcription, was observed in mouse 3T3-L1 pre-adipocytes cultured in the presence of magnolol for 6 days. Subsequently, a transgenic knock-in mice carrying APOA5 c.553G>T variant was established and then fed with corn oil with or without magnolol for four days. The baseline plasma triglyceride levels in transgenic knock-in mice were higher than those in wild-type mice, with the highest increase occurred in homozygous transgenic mice (106 mg/dL vs 51 mg/dL, p<0.01). After the induction of hyperglyceridemia along with the administration of magnolol, the plasma triglyceride level in heterozygous transgenic mice was significantly reduced by half. In summary, magnolol could effectively lower the plasma triglyceride levels in APOA5 c.553G>T variant carrier mice and facilitate the triglyceride metabolism in postprandial hypertriglyceridemia.	[Chang, Chun-Kai; Lin, Xiu-Ru; Lin, Yen-Lin; Fang, Woei-Horng; Lin, Shu-Wha; Chang, Sui-Yuan; Kao, Jau-Tsuen] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan; [Chang, Chun-Kai; Fang, Woei-Horng; Lin, Shu-Wha; Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lin, Xiu-Ru] Natl Yang Ming Univ Hosp, Dept Lab Med, Yilan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chang, SY; Kao, JT (corresponding author), Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan.; Chang, SY (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	sychang@ntu.edu.tw; jtkao@ntu.edu.tw		LIN, SHU-WHA/0000-0001-6748-5581; Chang, Chun-Kai/0000-0003-3933-3374; CHANG, SUI-YUAN/0000-0002-6009-6724; FANG, WOEI-HORNG/0000-0003-4728-5931; KAO, JAU-TSUEN/0000-0003-1918-0366	National Science Council of Taiwan [NSC 98-2320-B-002-019-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the National Science Council of Taiwan (NSC 98-2320-B-002-019-MY3 to J.T.K.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; Brunzell JD, 1995, METABOLIC MOL BASES; CARLSON LA, 1986, ACTA MED SCAND, V219, P435; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chen JS, 2005, J CELL BIOCHEM, V94, P1028, DOI 10.1002/jcb.20361; Choi SS, 2009, LIFE SCI, V84, P908, DOI 10.1016/j.lfs.2009.04.001; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Feng JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023655; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; GENE IS, 2011, ATHEROSCLEROSIS; GENE IS, 1984, ATHEROSCLEROSIS; GENE IS, 2003, ATHEROSCLEROSIS; GENE IS, 2006, ATHEROSCLEROSIS; GENE IS, 2012, ATHEROSCLEROSIS; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Gottsater A, 2002, J INTERN MED, V251, P61, DOI 10.1046/j.1365-2796.2002.00926.x; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Huang YJ, 2012, CLIN CHIM ACTA, V413, P246, DOI 10.1016/j.cca.2011.09.045; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; King AJ, 2010, EUR J PHARMACOL, V637, P155, DOI 10.1016/j.ejphar.2010.03.056; KORN ED, 1955, J BIOL CHEM, V215, P1; Labreuche J, 2009, ATHEROSCLEROSIS, V203, P331, DOI 10.1016/j.atherosclerosis.2008.08.040; Lindman AS, 2010, EUR J EPIDEMIOL, V25, P789, DOI 10.1007/s10654-010-9501-1; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lopez-Miranda J, 2007, BRIT J NUTR, V98, P458, DOI 10.1017/S000711450774268X; LOPEZMIRANDA J, 2012, BR J NUTR, V220, P22; LOYC, 1994, BIOCHEM PHARMACOL; Muroyama A, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/985157; Nabika T, 2002, ATHEROSCLEROSIS, V165, P201, DOI 10.1016/S0021-9150(02)00252-6; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Perez-Martinez P, 2010, ATHEROSCLEROSIS SUPP, V11, P39, DOI 10.1016/j.atherosclerosissup.2010.03.002; Ribalta J, 2002, CLIN CHEM, V48, P1597; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Scott R, 2009, DIABETES CARE, V32, P493, DOI 10.2337/dc08-1543; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; TALMUD PJ, 2002, HUM MOL GENET, pA5; TANG Y, SUN, P553; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Varbo A, 2011, ANN NEUROL, V69, P628, DOI 10.1002/ana.22384; Watts GF, 2013, NAT REV CARDIOL, V10, P648, DOI 10.1038/nrcardio.2013.140; YU KCW, 2001, FRONT BIOSCI, V6, pD33; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	54	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192740	10.1371/journal.pone.0192740	http://dx.doi.org/10.1371/journal.pone.0192740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425239	Green Submitted, gold, Green Published			2022-12-26	WOS:000424700800040
J	Shen, LM; Tenzer, S; Hess, M; Distler, U; Tubbe, I; Montermann, E; Schimmer, S; Dittmer, U; Grabbe, S; Bros, M				Shen, Limei; Tenzer, Stefan; Hess, Moritz; Distler, Ute; Tubbe, Ingrid; Montermann, Evelyn; Schimmer, Simone; Dittmer, Ulf; Grabbe, Stephan; Bros, Matthias			Friend virus limits adaptive cellular immune responses by imprinting a maturation-resistant and T helper type 2-biased immunophenotype in dendritic cells	PLOS ONE			English	Article							RETROVIRUS INFECTION; LEUKEMIA-VIRUS; FUNCTIONAL IMPAIRMENT; HUMAN MACROPHAGES; GAMMA-INTERFERON; IN-VIVO; MICE; INTERLEUKIN-10; REPLICATION; CYTOKINES	The murine Friend virus (FV) retrovirus model has been widely used to study anti-viral immune responses, and virus-induced cancer. Here we analyzed FV immune evasion mechanisms on the level of dendritic cells (DC) essential for the induction of primary adaptive immune responses. Comparative quantitative proteome analysis of FV-infected DC (FV-DC) of different genotypes (BALB/c, C57BL/6) and non-infected DC revealed numerous genotype-independently regulated proteins rergulating metabolic activity, cytoskeletal rearrangements, and antigen processing/presentation. These alterations may promote virion production in FV-DC. Stimulation of FV-DC with LPS resulted in strongly enhanced IL-10 production which was partially responsible for their attenuated T cell (CD4(+), CD8(+)) stimulatory capacity. Stimulated FV-DC induced less IFN-gamma production in T cells required for cellular anti-viral responses, but more T helper cell type 2 (Th2)-associated cytokines (IL-4, IL-5, IL13). We conclude that FV reprograms DC to promote viral spreading and immune deviation by imprinting a largely maturation-resistant, Th2-biased immunophenotype.	[Shen, Limei; Tubbe, Ingrid; Montermann, Evelyn; Grabbe, Stephan; Bros, Matthias] Univ Med Ctr, Dept Dermatol, Mainz, Germany; [Tenzer, Stefan; Distler, Ute] Univ Med Ctr, Inst Immunol, Mainz, Germany; [Hess, Moritz] Univ Med Ctr, Inst Med Biometry Epidemiol & Informat, Mainz, Germany; [Schimmer, Simone; Dittmer, Ulf] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Duisburg Essen	Grabbe, S (corresponding author), Univ Med Ctr, Dept Dermatol, Mainz, Germany.	stephan.grabbe@unimedizin-mainz.de	Grabe, Stephan/AAJ-4578-2021; Tenzer, Stefan/AAE-2180-2020	Grabe, Stephan/0000-0002-6863-8719; Tenzer, Stefan/0000-0003-3034-0017; Distler, Ute/0000-0002-8031-6384				Akhmetzyanova I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005224; Alexa A., 2010, R PACKAGE VERSION, V2; Altinoz MA, 2016, METAB BRAIN DIS, V31, P983, DOI 10.1007/s11011-016-9845-7; [Anonymous], 2013, RETROVIROLOGY, V10, P109; Balkow S, 2007, BLOOD, V110, P3949, DOI 10.1182/blood-2007-05-092189; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Bedoui S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00533; BENDAVID Y, 1990, P NATL ACAD SCI USA, V87, P1332, DOI 10.1073/pnas.87.4.1332; Bosch B, 2013, J BIOL CHEM, V288, P13236, DOI 10.1074/jbc.M112.442640; Brown C, 2011, J MOL BIOL, V410, P761, DOI 10.1016/j.jmb.2011.03.076; Cibulka J, 2012, VIRUSES-BASEL, V4, P325, DOI 10.3390/v4030325; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Dittmer U, 2002, J VIROL, V76, P450, DOI 10.1128/JVI.76.1.450-454.2002; Dittmer U, 2001, J VIROL, V75, P654, DOI 10.1128/JVI.75.2.654-660.2001; DONCKIER V, 1994, TRANSPLANTATION, V57, P1436, DOI 10.1097/00007890-199405270-00005; Duell BL, 2012, FEMS IMMUNOL MED MIC, V64, P295, DOI 10.1111/j.1574-695X.2012.00931.x; Fahel JS, 2015, INFECT IMMUN, V83, P1210, DOI 10.1128/IAI.02592-14; Gibbert K, 2013, BRIT J PHARMACOL, V168, P1048, DOI 10.1111/bph.12010; Gonzalez-Leal IJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003194; Goodwin CM, 2015, TRENDS MICROBIOL; Gupta S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00068; Ha SD, 2012, ANTIVIR RES, V93, P175, DOI 10.1016/j.antiviral.2011.11.009; Hasenkrug KJ, 2007, FRONT BIOSCI-LANDMRK, V12, P1544, DOI 10.2741/2167; Hasenkrug KJ, 1997, P NATL ACAD SCI USA, V94, P7811, DOI 10.1073/pnas.94.15.7811; Hasenkrug KJ, 1998, J VIROL, V72, P6559, DOI 10.1128/JVI.72.8.6559-6564.1998; Ho HH, 2010, J INTERF CYTOK RES, V30, P893, DOI 10.1089/jir.2010.0046; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Igarashi M, 2010, CIRC RES, V107, P1387, DOI 10.1161/CIRCRESAHA.110.226613; Joedicke Jara J., 2014, Virologica Sinica, V29, P48, DOI 10.1007/s12250-014-3396-z; Juban G, 2009, MOL CELL BIOL, V29, P2852, DOI 10.1128/MCB.01435-08; Kubinak JL, 2013, GENES IMMUN, V14, P365, DOI 10.1038/gene.2013.27; Laidlaw TM, 2012, CLIN EXP ALLERGY, V42, P1313, DOI 10.1111/j.1365-2222.2012.03982.x; Larsson L, 2010, GENES IMMUN, V11, P181, DOI 10.1038/gene.2009.103; Le Bel M, 2014, J INNATE IMMUN, V6, P159, DOI 10.1159/000353694; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nair SR, 2010, J GEN VIROL, V91, P440, DOI 10.1099/vir.0.015834-0; Naslavsky N, 2007, BIOCHEM BIOPH RES CO, V357, P792, DOI 10.1016/j.bbrc.2007.04.022; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; R-Core-Team, 2015, LANG ENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rothoeft T, 2006, EUR J IMMUNOL, V36, P3105, DOI 10.1002/eji.200636145; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Shen LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080904; Smooker PM, 2010, TRENDS PARASITOL, V26, P506, DOI 10.1016/j.pt.2010.06.001; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TAGA K, 1993, BLOOD, V81, P2964; Takeda E, 2008, J VIROL, V82, P10998, DOI 10.1128/JVI.01311-08; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tsuji-Kawahara S, 2013, J VIROL, V87, P13760, DOI 10.1128/JVI.02506-13; Tsuji-Kawahara S, 2010, J VIROL, V84, P6082, DOI 10.1128/JVI.02516-09; VANDERGAAG HC, 1990, VIROLOGY, V177, P837, DOI 10.1016/0042-6822(90)90561-5; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695; Zelinskyy G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-109; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	62	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192541	10.1371/journal.pone.0192541	http://dx.doi.org/10.1371/journal.pone.0192541			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425215	gold, Green Submitted, Green Published			2022-12-26	WOS:000424700800028
J	Kromann-Hansen, T; Lange, EL; Lund, IK; Hoyer-Hansen, G; Andreasen, PA; Komives, EA				Kromann-Hansen, Tobias; Lange, Eva Louise; Lund, Ida K.; Hoyer-Hansen, Gunilla; Andreasen, Peter A.; Komives, Elizabeth A.			Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation	PLOS ONE			English	Article							FACTOR VIIA; SERINE-PROTEASE; CRYSTAL-STRUCTURE; THROMBIN; TRYPSIN; SITE; ATHEROSCLEROSIS; ALLOSTERY; ANTIBODY; SPECIFICITY	The catalytic activity of trypsin-like serine proteases is in many cases regulated by conformational changes initiated by binding of physiological modulators to exosites located distantly from the active site. A trypsin-like serine protease of particular interest is urokinase-type plasminogen activator (uPA), which is involved in extracellular tissue remodeling processes. Herein, we used hydrogen/deuterium exchange mass spectrometry (HDXMS) to study regulation of activity in the catalytic domain of the murine version of uPA (muPA) by two muPA specific monoclonal antibodies. Using a truncated muPA variant (muPA(16-243)), containing the catalytic domain only, we show that the two monoclonal antibodies, despite binding to an overlapping epitope in the 37s and 70s loops of muPA(16-243), stabilize distinct muPA(16-243) conformations. Whereas the inhibitory antibody, mU1 was found to increase the conformational flexibility of muPA(16-243), the stimulatory antibody, mU3, decreased muPA(16-243) conformational flexibility. Furthermore, the HDXMS data unveil the existence of a pathway connecting the 70s loop to the active site region. Using alanine scanning mutagenesis, we further identify the 70s loop as an important exosite for the activation of the physiological uPA substrate plasminogen. Thus, the data presented here reveal important information about dynamics in uPA by demonstrating how various ligands can modulate uPA activity by mediating long-range conformational changes. Moreover, the results provide a possible mechanism of plasminogen activation.	[Kromann-Hansen, Tobias; Komives, Elizabeth A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Kromann-Hansen, Tobias; Lange, Eva Louise; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Lund, Ida K.; Hoyer-Hansen, Gunilla] Rigshosp, Finsen Lab, Copenhagen, Denmark; [Lund, Ida K.; Hoyer-Hansen, Gunilla] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Kromann-Hansen, Tobias] Lillebaelt Hosp, Dept Immunol & Biochem, Beriderbakken 4, Vejle, Denmark	University of California System; University of California San Diego; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen	Kromann-Hansen, T (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Kromann-Hansen, T (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.; Kromann-Hansen, T (corresponding author), Lillebaelt Hosp, Dept Immunol & Biochem, Beriderbakken 4, Vejle, Denmark.	tkromanntofting@ucsd.edu			Danish National Research Foundation [26-331-6]; Lundbeck Foundation [R83 A7826]; National Institute of Health [R01HL127041-02]; Carlsberg Foundation [CF15-0814]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127041] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carlsberg Foundation(Carlsberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Danish National Research Foundation (Grant 26-331-6 to P.A.A.), the Lundbeck Foundation (Grant R83 A7826 to P.A.A.), the National Institute of Health (Grant R01HL127041-02 to E.A.K.) and the Carlsberg Foundation (CF15-0814 to T.K.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjelke JR, 2008, J BIOL CHEM, V283, P25863, DOI 10.1074/jbc.M800841200; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; Cozen AE, 2004, CIRCULATION, V109, P2129, DOI 10.1161/01.CIR.0000127369.24127.03; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Debela M, 2016, BIOL CHEM, V397, P1251, DOI 10.1515/hsz-2016-0205; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Fleetwood AJ, 2014, J IMMUNOL, V192, P3540, DOI 10.4049/jimmunol.1302864; Fuglestad B, 2012, BIOPHYS J, V103, P79, DOI 10.1016/j.bpj.2012.05.047; Fuhrman B, 2012, ATHEROSCLEROSIS, V222, P8, DOI 10.1016/j.atherosclerosis.2011.10.044; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; HAMILTON JA, 1992, ANN NY ACAD SCI, V667, P87; Hamilton JA, 2008, ARTHRITIS RHEUM-US, V58, P645, DOI 10.1002/art.23269; Handley LD, 2015, BIOCHEMISTRY-US, V54, P6650, DOI 10.1021/acs.biochem.5b00825; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hu JH, 2015, CARDIOVASC RES, V105, P372, DOI 10.1093/cvr/cvv007; Jiang LG, 2013, BIOCHEM J, V449, P161, DOI 10.1042/BJ20121132; Ke SH, 1997, J BIOL CHEM, V272, P1811, DOI 10.1074/jbc.272.3.1811; Kromann-Hansen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03457-7; Kromann-Hansen T, 2013, BIOCHEMISTRY-US, V52, P7114, DOI 10.1021/bi400491k; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Liu Z, 2012, BIOCHEMISTRY-US, V51, P7804, DOI 10.1021/bi3005957; Lund IK, 2008, J BIOL CHEM, V283, P32506, DOI 10.1074/jbc.M801924200; Madsen JJ, 2015, J THROMB HAEMOST, V13, P262, DOI 10.1111/jth.12791; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Song HJ, 2014, J BIOL CHEM, V289, P35388, DOI 10.1074/jbc.M114.614297; Sorensen HP, 2015, J MOL BIOL, V427, P3110, DOI 10.1016/j.jmb.2015.08.005; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192661	10.1371/journal.pone.0192661	http://dx.doi.org/10.1371/journal.pone.0192661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420634	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900105
J	Lad, EM; Mukherjee, D; Stinnett, SS; Cousins, SW; Potter, GG; Burke, JR; Farsiu, S; Whitson, HE				Lad, Eleonora M.; Mukherjee, Dibyendu; Stinnett, Sandra S.; Cousins, Scott W.; Potter, Guy G.; Burke, James R.; Farsiu, Sina; Whitson, Heather E.			Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; SMALL VESSEL DISEASE; VISUAL-FIELD LOSS; AUTOMATIC SEGMENTATION; MULTIPLE-SCLEROSIS; SD-OCT; THICKNESS; DYSFUNCTION; DEMENTIA	Inner retina in Alzheimer's Disease (AD) may experience neuroinflammation resulting in atrophy. The objective of our study was to determine whether retinal GCIPL (ganglion cell-inner plexiform layer) or nerve fiber layer (NFL) thickness may serve as noninvasive bio-markers to diagnose AD. This cross-sectional case-control study enrolled 15 mild cognitive impairment (MCI) patients, 15 mild-moderate AD patients, and 18 cognitively normal adults. NFL and GCIPL thicknesses on optical coherence tomography (OCT) were measured using Duke Optical Coherence Tomography Retinal Analysis Program (DOCTRAP) and Spectralis software. We demonstrated that regional thicknesses of NFL or GCIPL on macular or nerve OCTs did not differ between groups. However, a multi-variate regression analysis identified macular areas with a significant thickening or thinning in NFL and GCIPL in MCI and AD patients. Our primary findings controvert previous reports of thinner NFL in moderate-to-severe AD. The areas of thickening of GCIPL and NFL in the macula adjacent to areas of thinning, as revealed by a more complex statistical model, suggest that NFL and GCIPL may undergo dynamic changes during AD progression.	[Lad, Eleonora M.; Stinnett, Sandra S.; Cousins, Scott W.; Farsiu, Sina; Whitson, Heather E.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Mukherjee, Dibyendu; Farsiu, Sina] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA; [Potter, Guy G.; Burke, James R.] Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Whitson, Heather E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Lad, EM (corresponding author), Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA.	nora.lad@duke.edu	Whitson, Heather/K-8941-2019; Burke, James R/E-4245-2016; Mukherjee, Dibyendu/AAH-5457-2020	Burke, James R/0000-0002-3408-7787; Mukherjee, Dibyendu/0000-0002-4055-9891; Stinnett, Sandra/0000-0001-7192-0195; Whitson, Heather/0000-0002-8417-4846	Alzheimer's Association New Investigator Research Grant [NIRG-13-282202]; Duke Institute for Brain Sciences Incubator Award; Duke/Duke-NUS pilot award; NATIONAL EYE INSTITUTE [P30EY005722] Funding Source: NIH RePORTER	Alzheimer's Association New Investigator Research Grant; Duke Institute for Brain Sciences Incubator Award; Duke/Duke-NUS pilot award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by an Alzheimers Association New Investigator Research Grant (NIRG-13-282202, HEW), https://www.alz.org/; Duke Institute for Brain Sciences Incubator Award (EML), https://dibs.duke.edu/; and Duke/Duke-NUS pilot award (HEW), https://medicine.duke.edu/medicinenews/funding-opp-duke-nus-research-collaborations-pilot-projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Alzheimer's Association New Investigator Research Grant (NIRG-13-282202), Duke Institute for Brain Sciences Incubator Award, Duke/Duke-NUS pilot award.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 1991, Ophthalmology, V98, P786; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Bates KA, 2002, NEUROSCIENCE, V113, P785, DOI 10.1016/S0306-4522(02)00230-0; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Bowd C, 2011, EYE, V25, P224, DOI 10.1038/eye.2010.203; Chen MF, 2015, INVEST OPHTH VIS SCI, V56, P674, DOI 10.1167/iovs.14-15936; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Chiu SJ, 2012, BIOMED OPT EXPRESS, V3, P1127, DOI 10.1364/BOE.3.001127; Chiu SJ, 2012, INVEST OPHTH VIS SCI, V53, P53, DOI 10.1167/iovs.11-7640; COGAN DG, 1985, AM J OPHTHALMOL, V100, P68, DOI 10.1016/S0002-9394(14)74985-2; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; Cordeiro MF, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.3; CRONINGOLOMB A, 1991, ANN NEUROL, V29, P41, DOI 10.1002/ana.410290110; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Esiri MM, 2014, ALZ DIS ASSOC DIS, V28, P30, DOI 10.1097/WAD.0b013e31829b72f1; Ferrari L, 2017, J ALZHEIMERS DIS, V56, P1101, DOI 10.3233/JAD-160886; Frost S, 2010, J ALZHEIMERS DIS, V22, P1, DOI 10.3233/JAD-2010-100819; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; GILMORE GC, 1994, J GERONTOL, V49, pP52, DOI 10.1093/geronj/49.2.P52; Grossman I, 2010, EPMA J, V1, P293, DOI 10.1007/s13167-010-0024-3; Hagerman KE., 2007, VIS IMPAIR RES, V9, P19, DOI 10.1080/13882350701198868; He XF, 2012, INT J OPHTHALMOL-CHI, V5, P401, DOI 10.3980/j.issn.2222-3959.2012.03.30; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Jain N, 2010, INVEST OPHTH VIS SCI, V51, P4875, DOI 10.1167/iovs.09-4962; Javaid FZ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00055; Kaarniranta K, 2011, J ALZHEIMERS DIS, V24, P615, DOI 10.3233/JAD-2011-101908; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Kilimann I, 2014, J ALZHEIMERS DIS, V40, P687, DOI 10.3233/JAD-132345; Kim M, 2011, INVEST OPHTH VIS SCI, V52, P6882, DOI 10.1167/iovs.11-7276; Knoll Brianna, 2016, Alzheimers Dement (Amst), V4, P85; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Li ST, 2012, IEEE T BIO-MED ENG, V59, P417, DOI 10.1109/TBME.2011.2173935; Lin IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108938; Liu AKL, 2015, ACTA NEUROPATHOL, V129, P527, DOI 10.1007/s00401-015-1392-5; Liu DC, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0268-6; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Maldonado RS, 2011, OPHTHALMOLOGY, V118, P2315, DOI 10.1016/j.ophtha.2011.05.028; MANDYBUR TI, 1989, ACTA NEUROPATHOL, V78, P329, DOI 10.1007/BF00687764; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIELKE R, 1995, INT J NEUROSCI, V82, P1, DOI 10.3109/00207459508994285; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pache M, 2003, AGE AGEING, V32, P422, DOI 10.1093/ageing/32.4.422; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parnell Miles, 2012, Int J Alzheimers Dis, V2012, P786494, DOI 10.1155/2012/786494; Petzold A, 2017, LANCET NEUROL, V16, P797, DOI 10.1016/S1474-4422(17)30278-8; Plassman BL, 2011, ANN NEUROL, V70, P418, DOI 10.1002/ana.22362; Ritchie CW., 2011, INVEST OPHTH VIS SCI, V52, P6683; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Shen Y, 2014, CURR ALZHEIMER RES, V11, P259, DOI 10.2174/1567205011666140131114418; Shults J, 2015, WIRES COMPUT STAT, V7, P194, DOI 10.1002/wics.1349; Simonett JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29187; Stelmack Joan, 2005, Optometry, V76, P318, DOI 10.1016/S1529-1839(05)70315-8; Thal LJ, 2006, ALZ DIS ASSOC DIS, V20, P6, DOI 10.1097/01.wad.0000191420.61260.a8; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; TRICK GL, 1995, NEUROLOGY, V45, P68, DOI 10.1212/WNL.45.1.68; TSAI CS, 1991, ARCH OPHTHALMOL-CHIC, V109, P199, DOI 10.1001/archopht.1991.01080020045040; UHLMANN RF, 1991, J GEN INTERN MED, V6, P126, DOI 10.1007/BF02598307; Whittaker KW, 2002, EYE, V16, P206, DOI 10.1038/sj/EYE/6700037; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	63	61	61	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192646	10.1371/journal.pone.0192646	http://dx.doi.org/10.1371/journal.pone.0192646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420642	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900102
J	Wang, Y; Liu, ZZ; Han, Y; Xu, JP; Huang, W; Li, ZS				Wang, Ying; Liu, Zhenzhen; Han, Yi; Xu, Jiping; Huang, Wen; Li, Zhaoshen			Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; WEIGHT-LOSS; ENERGY-EXPENDITURE; BODY-COMPOSITION; FOOD-INTAKE; CANCER; FAT; THERMOGENESIS; MUSCLE; DIET	Medium Chain Triglycerides (MCT) is a dietary supplement and usually used along with medications for treating food absorption disorders including diarrhea, steatorrhea and liver disease. It has been shown that MCT plays a role in lowering weight, and decreasing metabolic syndrome, abdominal obesity and inflammation. However, it is still unknown whether MCT enhances exercise endurance. Here, we demonstrated that MCT containing diet improves high temperature induced exercise performance impairment. We found that MCT up-regulates the expression and protein levels of genes involved in mitochondrial biogenesis and metabolism. Further investigation demonstrated that the increased mitochondrial biogenesis and metabolism is mediated through the activation of Akt and AMPK signaling pathways and inhibition of TGF-beta signaling pathway. Collectively, our findings indicate a beneficial effect of dietary MCT in exercise performance through the increase of mitochondrial biogenesis and metabolism.	[Wang, Ying; Liu, Zhenzhen; Han, Yi; Xu, Jiping; Huang, Wen; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Huang, W (corresponding author), Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China.	huangsh666@163.com						Abe S, 2016, J NUTR, V146, P1017, DOI 10.3945/jn.115.228965; BABA N, 1982, AM J CLIN NUTR, V35, P678, DOI 10.1093/ajcn/35.4.678; BRAY GA, 1980, INT J OBESITY, V4, P27; Casalena G, 2012, SEMIN NEPHROL, V32, P295, DOI 10.1016/j.semnephrol.2012.04.009; Clegg ME, 2013, EUR J NUTR, V52, P1579, DOI 10.1007/s00394-012-0463-9; Clegg ME, 2010, INT J FOOD SCI NUTR, V61, P653, DOI 10.3109/09637481003702114; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DERYNCK R, 1987, CANCER RES, V47, P707; DICKSON RB, 1987, P NATL ACAD SCI USA, V84, P837, DOI 10.1073/pnas.84.3.837; Goedecke JH, 1999, INT J SPORT NUTR, V9, P35, DOI 10.1123/ijsn.9.1.35; Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Mumme K, 2015, J ACAD NUTR DIET, V115, P249, DOI 10.1016/j.jand.2014.10.022; NEBELING LC, 1995, J AM DIET ASSOC, V95, P693, DOI 10.1016/S0002-8223(95)00189-1; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001; Costa ACR, 2012, NUTR HOSP, V27, P103, DOI [10.1590/S0212-16112012000100011, 10.3305/nh.2012.27.1.5369]; ROTHWELL NJ, 1987, METABOLISM, V36, P128, DOI 10.1016/0026-0495(87)90005-9; Saifudeen I, 2017, J CARD FAIL, V23, P240, DOI 10.1016/j.cardfail.2016.08.001; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sohn EJ, 2012, CELL MOL BIOL NOIS S, V58; St-Onge MP, 2014, EUR J CLIN NUTR, V68, P1134, DOI 10.1038/ejcn.2014.145; St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467; St-Onge MP, 2002, J NUTR, V132, P329; Van Wymelbeke V, 1998, AM J CLIN NUTR, V68, P226, DOI 10.1093/ajcn/68.2.226; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Zhao JX, 2015, LIFE SCI, V141, P74, DOI 10.1016/j.lfs.2015.09.001	35	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191182	10.1371/journal.pone.0191182	http://dx.doi.org/10.1371/journal.pone.0191182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420554	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900012
J	Wendel, U; Persson, N; Risinger, C; Bengtsson, E; Nodin, B; Danielsson, L; Welinder, C; Fredrikson, GN; Jansson, B; Blixt, O				Wendel, Ulrika; Persson, Nina; Risinger, Christian; Bengtsson, Eva; Nodin, Bjorn; Danielsson, Lena; Welinder, Charlotte; Fredrikson, Gunilla Nordin; Jansson, Bo; Blixt, Ola			A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ACCUMULATION; PROTEINS; N-EPSILON-(CARBOXYMETHYL)LYSINE; GLYCOXIDATION; PROGRESSION; RECEPTOR; PLASMA	Advanced glycation end products are formed by non-enzymatic reactions between proteins and carbohydrates, causing irreversible lysine and arginine alterations that severely affect protein structure and function. The resulting modifications induce inflammation by binding to scavenger receptors. An increase in advanced glycation end products is observed in a number of diseases e.g. atherosclerosis and cancer. Since advanced glycation end products also are present in healthy individuals, their detection and quantification are of great importance for usage as potential biomarkers. Current methods for advanced glycation end product detection are though limited and solely measure total glycation. This study describes a new epitope-mapped single chain variable fragment, D1-B2, against carboxymethyllysine, produced from a phage library that was constructed from mouse immunizations. The phage library was selected against advanced glycation end product targets using a phage display platform. Characterization of its binding pattern was performed using large synthetic glycated peptide and protein libraries displayed on microarray slides. D1-B2 showed a preference for an aspartic acid, three positions N-terminally from a carboxymethyllysine residue and also bound to a broad collection of glycated proteins. Positive immunohistochemical staining of mouse atherosclerotic plaques and of a tissue microarray of human pancreatic tumors confirmed the usability of the new scFv for advanced glycation end product detection in tissues. This study demonstrates a promising methodology for high-throughput generation of epitope-mapped monoclonal antibodies against AGE.	[Wendel, Ulrika; Persson, Nina; Risinger, Christian; Blixt, Ola] Univ Copenhagen, Fac Sci, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark; [Bengtsson, Eva; Fredrikson, Gunilla Nordin] Malmo Lund Univ, Scania Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden; [Nodin, Bjorn; Welinder, Charlotte; Jansson, Bo] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Danielsson, Lena] Lund Univ, Dept Lab Med, Clin Chem & Pharmacol, Lund, Sweden; [Welinder, Charlotte] Lund Univ, Biomed Ctr D13, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Lund, Sweden	University of Copenhagen; Lund University; Lund University; Lund University; Lund University	Blixt, O (corresponding author), Univ Copenhagen, Fac Sci, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark.	olablixt@chem.ku.dk	Bengtsson, Eva/AAA-1968-2019; Bengtsson, Eva/AGH-2754-2022; Welinder, Charlotte/G-1144-2014	Bengtsson, Eva/0000-0001-7075-1772; Welinder, Charlotte/0000-0001-9626-0576; Blixt, Ola/0000-0003-4143-6276	Danish Research Council [4005-00285]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Research Council (https://dff.dk/en/application), grant nr. 4005-00285, received by OB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf JM, 2017, BIOCHEMISTRY-MOSCOW+, V82, P579, DOI 10.1134/S0006297917050066; Awasthi S, 2016, SPECTROCHIM ACTA A, V163, P60, DOI 10.1016/j.saa.2016.03.023; Bandholtz L, 2005, ARTERIOSCL THROM VAS, V25, P2151; Bennmann D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112115; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2013, METHODS MOL BIOL, V1047, P201, DOI 10.1007/978-1-62703-544-6_14; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; BROWNLEE M, 1984, ANN INTERN MED, V101, P527, DOI 10.7326/0003-4819-101-4-527; CERAMI A, 1985, J AM GERIATR SOC, V33, P626, DOI 10.1111/j.1532-5415.1985.tb06319.x; Chiavarina B, 2014, ONCOTARGET, V5, P5472, DOI 10.18632/oncotarget.2121; de Groot L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3538; DUNN JA, 1989, BIOCHEMISTRY-US, V28, P9464, DOI 10.1021/bi00450a033; Engelbertsen D, 2015, J IMMUNOL, V195, P3020, DOI 10.4049/jimmunol.1402869; Foster D, 2014, CANCER EPIDEM BIOMAR, V23, P2186, DOI 10.1158/1055-9965.EPI-14-0564; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; Imanaga Y, 2000, ATHEROSCLEROSIS, V150, P343, DOI 10.1016/S0021-9150(99)00396-2; Kolbus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033932; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; KUME S, 1995, AM J PATHOL, V147, P654; Lindner Peter, 2001, P637; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X; Mohd J, 2015, INT UNION BIOCH MOL, V67, P897; Nagai R, 2007, BBA-MOL BASIS DIS, V1772, P1192, DOI 10.1016/j.bbadis.2007.09.001; Nagai R, 2016, GLYCOCONJUGATE J, V33, P545, DOI 10.1007/s10719-016-9708-9; Paradela-Dobarro B, 2016, J MOL ENDOCRINOL, V56, P23, DOI 10.1530/JME-15-0031; Persson N, 2017, GLYCOBIOLOGY, P1; Persson N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168761; Rockefeller T., 1977, J BIOL CHEM, V252, P2992; Sakata N, 2001, CARDIOVASC RES, V49, P466, DOI 10.1016/S0008-6363(00)00262-5; Schaefer JV, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P21, DOI 10.1007/978-3-642-01144-3_3; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Shahsavarian MA, 2014, J IMMUNOL METHODS, V407, P26, DOI 10.1016/j.jim.2014.03.015; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sorensen KK, 2017, ACS INFECT DIS, P1; Takino JI, 2010, J ONCOL, V2010, DOI 10.1155/2010/739852; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Van Heijst JWJ, 2005, ANN NY ACAD SCI, V1043, P725, DOI 10.1196/annals.1333.084; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; YAN SD, 1994, J BIOL CHEM, V269, P9889; Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j	46	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191872	10.1371/journal.pone.0191872	http://dx.doi.org/10.1371/journal.pone.0191872			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420566	gold, Green Published			2022-12-26	WOS:000424517900028
J	Zhu, ZQ; Hao, DJ; Wang, B; Gao, WJ; Yang, RZ; Guo, H; Wang, YY; Kong, LB				Zhu, Ziqi; Hao, Dingjun; Wang, Biao; Gao, Wenjie; Yang, Ruize; Guo, Hua; Wang, Yongyi; Kong, Lingbo			Selection of surgical treatment approaches for cervicothoracic spinal tuberculosis: A 10-year case review	PLOS ONE			English	Review							MODIFIED ANTERIOR APPROACH; UPPER THORACIC SPINE; CERVICAL-SPINE; JUNCTION; DECOMPRESSION; VERTEBRAE	Background Cervicothoracic spinal tuberculosis is a rare disease. Due to its difficult and challenging surgical exposure, its surgical treatment approach remains inconclusive. Long-term follow-up studies to address this puzzling issue are rarely seen in the literature. The purpose of this study was to explore the selection of surgical treatment approaches for cervicothoracic spinal tuberculosis through a 10-year case review. Methods From January 2003 to January 2013, 45 patients suffering from cervicothoracic spinal tuberculosis were treated surgically. According to the relation between the tuberculosis lesion segments and the suprasternal notch on sagittal MRI, 19 patients were treated with a single-stage anterior debridement, fusion and instrumentation approach, and the other 26 patients were treated with a single-stage anterior debridement and fusion, posterior fusion and instrumentation approach. The clinical efficacy was evaluated using statistical analysis based on the Cobb angle of kyphosis, the Neck Disability Index (NDI) and the Japanese Orthopedic Association (JOA) scoring system. The neurofunctional recovery was assessed by the American Spinal Injury Association (ASIA) system. Results All patients were followed up for 6.6 years on average (range 3-13 years). No instrumentation loosening, migration or breakage was observed during the follow-up. The kyphosis angle and NDI and JOA scores were significantly changed from preoperative values of 34.7 +/- 6.8 degrees, 39.6 +/- 4.6 and 10.7 +/- 2.8 to postoperative values of 10.2 +/- 2.4 degrees, 11.4 +/- 3.6 and 17.6 +/- 2.4, respectively (p<0.05). Aside from one recurrent patient, bone fusion was achieved in the other 44 patients within 6 to 9 months (mean 7.2 months). No severe postoperative complications occurred, and patients' neurologic function was improved in various degrees. Conclusions In the surgical treatment of cervicothoracic spinal tuberculosis, single-stage cervical anterior approach with or without partial manubriotomy is capable of complete debridement for tuberculosis lesions. The manner of fixation should be selected based on the anatomical relation of the suprasternal notch and the diseased segments as revealed on sagittal MRI images.	[Zhu, Ziqi] Xian Med Univ, Xian, Shaanxi, Peoples R China; [Zhu, Ziqi; Hao, Dingjun; Wang, Biao; Gao, Wenjie; Yang, Ruize; Guo, Hua; Wang, Yongyi; Kong, Lingbo] Xi An Jiao Tong Univ, Coll Med, Honghui Hosp, Dept Spine Surg, Xian, Shaanxi, Peoples R China	Xi'an Medical University; Xi'an Jiaotong University	Wang, B; Kong, LB (corresponding author), Xi An Jiao Tong Univ, Coll Med, Honghui Hosp, Dept Spine Surg, Xian, Shaanxi, Peoples R China.	wangbiaowb1987@126.com; lingbokong@163.com		Hao, Dingjun/0000-0002-0946-6080; Wang, Biao/0000-0001-6631-9127				AN HS, 1991, SPINE, V16, pS548, DOI 10.1097/00007632-199110001-00019; BIRCH R, 1990, J BONE JOINT SURG BR, V72, P904, DOI 10.1302/0301-620X.72B5.2211781; Cohen ZR, 2004, J SPINAL DISORD TECH, V17, P543, DOI 10.1097/01.bsd.0000117541.10843.c9; DARLING GE, 1995, SPINE, V20, P1519, DOI 10.1097/00007632-199507000-00015; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; HSU LCS, 1984, J BONE JOINT SURG BR, V66, P1; Hu H, 2007, SPINE, V32, P601, DOI 10.1097/01.brs.0000256383.29014.42; Jain AK, 2010, J BONE JOINT SURG BR, V92B, P905, DOI 10.1302/0301-620X.92B7.24668; Kaya RA, 2006, SURG NEUROL, V65, P454, DOI 10.1016/j.surneu.2005.08.017; KURZ LT, 1991, SPINE, V16, pS542, DOI 10.1097/00007632-199110001-00018; MICHELI LJ, 1983, J BONE JOINT SURG AM, V65, P992, DOI 10.2106/00004623-198365070-00015; Mihir B, 2006, SPINE, V31, pE244, DOI 10.1097/01.brs.0000214883.11874.80; Pointillart V, 2007, SPINE, V32, P2875, DOI 10.1097/BRS.0b013e31815b7632; Prabhakar MM, 2006, J SPINAL CORD MED, V29, P163, DOI 10.1080/10790268.2006.11753871; Resnick Daniel K, 2002, Neurosurg Focus, V12, pE7; Sar C, 1999, J SPINAL DISORD, V12, P102; Sharan AD, 2000, SPINE PHILA PA 1976, V25; SUNDARESAN N, 1984, J NEUROSURG, V61, P686, DOI 10.3171/jns.1984.61.4.0686; Tamura M, 2005, J NEUROSURG-SPINE, V2, P226, DOI 10.3171/spi.2005.2.2.0226; Zhang HQ, 2015, INT ORTHOP, V39, P1605, DOI 10.1007/s00264-015-2778-7	20	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192581	10.1371/journal.pone.0192581	http://dx.doi.org/10.1371/journal.pone.0192581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420648	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900098
J	Zhang, HL; Song, Y; Yang, HM; Liu, ZY; Gao, LF; Liang, XH; Ma, CH				Zhang, Hualin; Song, Yang; Yang, Huimin; Liu, Zhiyan; Gao, Lifen; Liang, Xiaohong; Ma, Chunhong			Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-kappa B/IL-6/STAT3 axis	ONCOGENE			English	Article							TRAIL-INDUCED APOPTOSIS; CD8(+) T-CELLS; UP-REGULATION; POOR-PROGNOSIS; EXPRESSION; IMMUNOGLOBULIN; HEPATOCYTES; CHECKPOINTS; DYSFUNCTION; RESISTANCE	T-cell immunoglobulin and mucin-domain containing-3 (Tim-3), mediating immune exhaustion in tumor microenvironment, has become a promising target for tumor therapy. However, the exact mechanisms for tumor cell-intrinsic Tim-3 in tumor development and its potential contribution in Tim-3-targeted therapy strategy have not been elucidated yet. In this study, we showed that human liver cancer tissues contained high ratio of Tim-3-expressing hepatocytes, and cytokines rich in tumor microenvironment and HBV involved in Tim-3 upregulation in malignant hepatocytes. We demonstrated that hepatocyte-specific Tim-3 overexpression enhances tumor cell growth, whereas Tim-3 inhibition on malignant hepatocytes by anti-Tim-3 antibodies or RNAi suppresses tumor growth both in vitro and in Tim-3 knockout mice. Mechanistically, the hepatocyte-Tim-3 receptor activates NF-kappa B phosphorylation, which in turn stimulates IL-6 secretion and STAT3 phosphorylation. Our results identify tumor cell-intrinsic functions of Tim-3 in tumorigenesis and suggest that blocking Tim-3 in tumor cells might contribute to the clinical efficacy of anti-Tim-3 antibody treatment in the future tumor therapy.	[Zhang, Hualin; Song, Yang; Gao, Lifen; Liang, Xiaohong; Ma, Chunhong] Shandong Univ, Key Lab Infect & Immun Shandong Prov, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Zhang, Hualin; Song, Yang; Gao, Lifen; Liang, Xiaohong; Ma, Chunhong] Shandong Univ, Sch Basic Med, Dept Immunol, Jinan 250012, Shandong, Peoples R China; [Yang, Huimin] Shandong Univ, Qilu Hosp, Dept Nephrol, Jinan 250012, Shandong, Peoples R China; [Liu, Zhiyan] Shandong Univ, Dept Pathol & Pathophysiol, Jinan 250012, Shandong, Peoples R China; [Ma, Chunhong] Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Liang, XH; Ma, CH (corresponding author), Shandong Univ, Key Lab Infect & Immun Shandong Prov, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.; Liang, XH; Ma, CH (corresponding author), Shandong Univ, Sch Basic Med, Dept Immunol, Jinan 250012, Shandong, Peoples R China.; Ma, CH (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China.	liangxiaohong@sdu.edu.cn; machunhong@sdu.edu.cn	Liu, Zhiyan/C-5298-2016; , 刘志艳/AAN-9477-2020; ma, chunhong/C-6043-2008	Liu, Zhiyan/0000-0001-9668-7756; ma, chunhong/0000-0002-8121-4718; Liang, xiaohong/0000-0002-7626-3478	National Key Research and Development Program [2016YFE0127000]; National Natural Science Fund for Outstanding Youth Fund [81425012]; National Science Foundation of China [81425012, 81672425, 81372211, 91529305]; Key Research & Development Plan of Shandong Province [2016ZDJS07A17, 2017GSF18185]	National Key Research and Development Program; National Natural Science Fund for Outstanding Youth Fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research & Development Plan of Shandong Province	This work was supported by grants from the National Key Research and Development Program (No. 2016YFE0127000), the National Natural Science Fund for Outstanding Youth Fund (81425012), the National Science Foundation of China (No. 81672425, 81425012, 81372211, 91529305), Key Research & Development Plan of Shandong Province (2016ZDJS07A17, 2017GSF18185).	Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]; Dolina JS, 2014, HEPATOLOGY, V59, P1351, DOI 10.1002/hep.26938; Du J, 2009, CELL DEATH DIFFER, V16, P219, DOI 10.1038/cdd.2008.144; Du W., 2017, INT J MOL SCI, V18, P645, DOI [10.3390/ijms18030645, DOI 10.3390/IJMS18030645]; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Kikushige Y, 2015, CELL STEM CELL, V17, P341, DOI 10.1016/j.stem.2015.07.011; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; Luan F, 2009, GUT, V58, P1528, DOI 10.1136/gut.2008.174029; Marraco SAF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00310; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Piao YR, 2013, ASIAN PAC J CANCER P, V14, P3897, DOI 10.7314/APJCP.2013.14.6.3897; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Restifo NP, 2016, NAT REV CANCER, V16, P121, DOI 10.1038/nrc.2016.2; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Tomkowicz B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140694; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Yan WJ, 2015, GUT, V64, P1593, DOI 10.1136/gutjnl-2014-307671; Yi WJ, 2017, IMMUNOLOGY, V150, P301, DOI 10.1111/imm.12686; Yuan J, 2013, NEOPLASMA; Zhou EC, 2015, INT J CLIN EXP PATHO, V8, P8018; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072; Zhuang XW, 2012, AM J CLIN PATHOL, V137, P978, DOI 10.1309/AJCP9Q6OVLVSHTMY	37	39	52	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2456	2468		10.1038/s41388-018-0140-4	http://dx.doi.org/10.1038/s41388-018-0140-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29449693				2022-12-26	WOS:000431386000009
J	Blum, W; Henzi, T; Schwaller, B; Pecze, L				Blum, Walter; Henzi, Thomas; Schwaller, Beat; Pecze, Laszlo			Biological noise and positional effects influence cell stemness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer stem cells; cancer biology; differentiation; cell differentiation; growth factor	MESOTHELIAL CELLS; REPORTER SYSTEM; CANCER; IDENTIFICATION; PROLIFERATION; POPULATIONS; CALRETININ; PROMOTE; GROWTH; VITRO	Biological (or cellular) noise is the random quantitative variability of proteins and other molecules in individual, genetically identical cells. As the result of biological noise in the levels of some transcription factors that determine a cell's differentiation status, differentiated cells may dedifferentiate to a stem cell state given a sufficiently long time period. Here, to provide direct evidence supporting this hypothesis, we used a live-cell monitoring system based on enhanced green fluorescent protein (eGFP) expression to continuously assess the stemness of individual human and murine malignant mesothelioma cells over a period of up to 3 months. Re-expression of the transcription factors, the top hierarchical stemness markers Sox2 (SRY-box 2) and Oct4 (octamer-binding transcription factor), monitored as cell eGFP expression was observed in a subpopulation of differentiated eGFP(-) malignant mesothelioma cells. However, we found that this transition was extremely rare. Of note, when it did occur, neighboring cells that were not direct descendants of a newly emerged eGFP(+) stem cell were more likely than non-neighboring cells to also become an eGFP(+) stem cell. This observation suggested a positional effect and led to a clustered mosaic reappearance of eGFP(+) stem cells. Moreover, stem cells reappeared even in cell cultures derived from one single differentiated eGFP(-) cell. On the basis of our experimental in vitro and in vivo findings, we developed a tumor growth model to predict the clustered localization of cancer stem cells within a tumor mass.	[Blum, Walter; Henzi, Thomas; Schwaller, Beat; Pecze, Laszlo] Univ Fribourg, Unit Anat, Med Sect, CH-1700 Fribourg, Switzerland	University of Fribourg	Schwaller, B; Pecze, L (corresponding author), Univ Fribourg, Dept Med, Route Albert Gockel 1, CH-1700 Fribourg, Switzerland.	beat.schwaller@unifr.ch; laszlo.pecze@unifr.ch		Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation [130680, 168449]; Forschungspool der Universitat Fribourg	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungspool der Universitat Fribourg	This work was supported by Swiss National Science Foundation Grants 130680 (to B.S.) and 168449 (to W.B.) and a grant from the Forschungspool der Universitat Fribourg (to B.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akrap N, 2016, STEM CELL REP, V6, P121, DOI 10.1016/j.stemcr.2015.12.006; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Bartfeld S, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.261; Blum W, 2017, STEM CELL REP, V8, P1005, DOI 10.1016/j.stemcr.2017.02.005; Blum W, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0311-6; Blum W, 2015, IN VITRO CELL DEV-AN, V51, P714, DOI 10.1007/s11626-015-9885-z; Blum W, 2013, INT J CANCER, V133, P2077, DOI 10.1002/ijc.28218; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; Dauleh S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158997; David Ebdon., 1985, STAT GEOGRAPHY; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Enderling H, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00076; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/NMETH.2411, 10.1038/nmeth.2411]; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hale JS, 2012, CELL ADHES MIGR, V6, P346, DOI 10.4161/cam.21294; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Kim HW, 2009, J KOREAN ACAD NURS, V39, P33, DOI 10.4040/jkan.2009.39.1.33; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Palle K, 2015, CANCERS, V7, P2330, DOI 10.3390/cancers7040894; Pasetto R, 2005, Med Lav, V96, P330; Pecze L, 2015, BBA-MOL CELL RES, V1853, P632, DOI 10.1016/j.bbamcr.2014.12.025; Poleszczuk J, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3923527; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; Smith Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep12617; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Tang BW, 2015, STEM CELL REP, V4, P155, DOI 10.1016/j.stemcr.2014.11.002; Thiagarajan PS, 2015, STEM CELLS, V33, P2114, DOI 10.1002/stem.2021; Toom A. L., 1978, LOCALLY INTERACTING; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; van Neerven SM, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1098791; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Yan K, 2014, GENE DEV, V28, P1085, DOI 10.1101/gad.235515.113; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	46	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5247	5258		10.1074/jbc.RA117.001643	http://dx.doi.org/10.1074/jbc.RA117.001643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440274	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000429409300029
J	Kontur, WS; Bingman, CA; Olmsted, CN; Wassarman, DR; Ulbrich, A; Gall, DL; Smith, RW; Yusko, LM; Fox, BG; Noguera, DR; Coon, JJ; Donohue, TJ				Kontur, Wayne S.; Bingman, Craig A.; Olmsted, Charles N.; Wassarman, Douglas R.; Ulbrich, Arne; Gall, Daniel L.; Smith, Robert W.; Yusko, Larissa M.; Fox, Brian G.; Noguera, Daniel R.; Coon, Joshua J.; Donohue, Timothy J.			Novosphingobium aromaticivorans uses a Nu-class glutathione S-transferase as a glutathione lyase in breaking the beta-aryl ether bond of lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; enzyme mechanism; enzyme structure; lignin degradation; Escherichia coli (E; coli); beta-aryl ether; deglutathionylation; glutathione S-transferases; Novosphingobium aromaticivorans; Nu-class	ESCHERICHIA-COLI; STRAIN; CLEAVAGE; BACTERIUM; IDENTIFICATION; MECHANISM; GUAIACYL; FEATURES; ENZYMES; SYSTEM	As a major component of plant cell walls, lignin is a potential renewable source of valuable chemicals. Several sphingomonad bacteria have been identified that can break the -aryl ether bond connecting most phenylpropanoid units of the lignin heteropolymer. Here, we tested three sphingomonads predicted to be capable of breaking the -aryl ether bond of the dimeric aromatic compound guaiacylglycerol--guaiacyl ether (GGE) and found that Novosphingobium aromaticivorans metabolizes GGE at one of the fastest rates thus far reported. After the ether bond of racemic GGE is broken by replacement with a thioether bond involving glutathione, the glutathione moiety must be removed from the resulting two stereoisomers of the phenylpropanoid conjugate -glutathionyl--hydroxypropiovanillone (GS-HPV). We found that the Nu-class glutathione S-transferase NaGST(Nu) is the only enzyme needed to remove glutathione from both (R)- and (S)-GS-HPV in N. aromaticivorans. We solved the crystal structure of NaGST(Nu) and used molecular modeling to propose a mechanism for the glutathione lyase (deglutathionylation) reaction in which an enzyme-stabilized glutathione thiolate attacks the thioether bond of GS-HPV, and the reaction proceeds through an enzyme-stabilized enolate intermediate. Three residues implicated in the proposed mechanism (Thr(51), Tyr(166), and Tyr(224)) were found to be critical for the lyase reaction. We also found that Nu-class GSTs from Sphingobium sp. SYK-6 (which can also break the -aryl ether bond) and Escherichia coli (which cannot break the -aryl ether bond) can also cleave (R)- and (S)-GS-HPV, suggesting that glutathione lyase activity may be common throughout this widespread but largely uncharacterized class of glutathione S-transferases.	[Kontur, Wayne S.; Olmsted, Charles N.; Wassarman, Douglas R.; Gall, Daniel L.; Fox, Brian G.; Noguera, Daniel R.; Coon, Joshua J.; Donohue, Timothy J.] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53706 USA; [Kontur, Wayne S.; Bingman, Craig A.; Olmsted, Charles N.; Wassarman, Douglas R.; Gall, Daniel L.; Smith, Robert W.; Fox, Brian G.; Noguera, Daniel R.; Coon, Joshua J.; Donohue, Timothy J.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Ulbrich, Arne; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; [Bingman, Craig A.; Smith, Robert W.; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ulbrich, Arne; Yusko, Larissa M.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Gall, Daniel L.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Donohue, Timothy J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Donohue, TJ (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	tdonohue@bact.wisc.edu	Ulbrich, Arne/ABG-8048-2021; Donohue, Timothy/C-3273-2015	Donohue, Timothy/0000-0001-8738-2467; Wassarman, Douglas/0000-0002-6922-9378; Noguera, Daniel/0000-0003-0372-3063	Federal funds from NCI, National Institutes of Health (NIH) [ACB-12002]; NIGMS, NIH [AGM-12006, P41-GM103311]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NIH-Office of Research Infrastructure Programs High-End Instrumentation Grant [1S10OD012289-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012289] Funding Source: NIH RePORTER	Federal funds from NCI, National Institutes of Health (NIH); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NIH-Office of Research Infrastructure Programs High-End Instrumentation Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Matthew Scarborough for assistance with phylogenetic analysis using RAxML. We thank Craig Ogata for beamline assistance. GM/CA@APS has been funded in whole or in part with Federal funds from NCI, National Institutes of Health (NIH), Grant ACB-12002 and NIGMS, NIH, Grant AGM-12006. This research used resources of the Advanced Photon Source, a DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. The Eiger 16M detector was funded by NIH-Office of Research Infrastructure Programs High-End Instrumentation Grant 1S10OD012289-01A1. Molecular modeling was performed with the UCSF Chimera package, which is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, NIH, Grant P41-GM103311).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Casanas A, 2016, ACTA CRYSTALLOGR D, V72, P1036, DOI 10.1107/S2059798316012304; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; DOHERTY AJ, 1995, NUCLEIC ACIDS RES, V23, P2074, DOI 10.1093/nar/23.11.2074; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREDRICKSON JK, 1991, APPL ENVIRON MICROB, V57, P796, DOI 10.1128/AEM.57.3.796-803.1991; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Gall DL, 2017, CURR OPIN BIOTECH, V45, P120, DOI 10.1016/j.copbio.2017.02.015; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Gall DL, 2014, J BIOL CHEM, V289, P8656, DOI 10.1074/jbc.M113.536250; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; MASAI E, 1989, FEBS LETT, V249, P348, DOI 10.1016/0014-5793(89)80656-8; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Notomista E, 2011, MICROB ECOL, V61, P582, DOI 10.1007/s00248-010-9786-3; Ohta Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15105; Pal R, 2006, INT J SYST EVOL MICR, V56, P667, DOI 10.1099/ijs.0.64161-0; Palamuru S, 2015, APPL ENVIRON MICROB, V81, P8164, DOI 10.1128/AEM.01573-15; Pereira JH, 2016, J BIOL CHEM, V291, P10228, DOI 10.1074/jbc.M115.700427; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robertson GJ, 2017, BIOPHYS CHEM, V224, P40, DOI 10.1016/j.bpc.2017.02.004; Roret T, 2015, FUNGAL GENET BIOL, V83, P103, DOI 10.1016/j.fgb.2015.09.002; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SISTROM WR, 1962, J GEN MICROBIOL, V28, P607, DOI 10.1099/00221287-28-4-607; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Stolz A, 2000, INT J SYST EVOL MICR, V50, P35, DOI 10.1099/00207713-50-1-35; Stourman NV, 2011, BIOCHEMISTRY-US, V50, P1274, DOI 10.1021/bi101861a; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanamura K, 2011, BIOSCI BIOTECH BIOCH, V75, P2404, DOI 10.1271/bbb.110525; Tavano CL, 2005, J BACTERIOL, V187, P5249, DOI 10.1128/JB.187.15.5249-5258.2005; Thuillier A, 2013, FEBS LETT, V587, P2125, DOI 10.1016/j.febslet.2013.05.031; United States Department of Energy, 2015, DOESC0170 OFF SCI; VICUNA R, 1987, APPL ENVIRON MICROB, V53, P2605; Wadington MC, 2010, BIOCHEMISTRY-US, V49, P10765, DOI 10.1021/bi101851x; Wadington MC, 2009, BIOCHEMISTRY-US, V48, P6559, DOI 10.1021/bi9008825; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X	46	32	35	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4955	4968		10.1074/jbc.RA117.001268	http://dx.doi.org/10.1074/jbc.RA117.001268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449375	hybrid, Green Published			2022-12-26	WOS:000429409300001
J	Ramon, P; Velazquez, E; Escudero, A; de la Cruz, M				Ramon, Pablo; Velazquez, Eduardo; Escudero, Adrian; de la Cruz, Marcelino			Environmental heterogeneity blurs the signature of dispersal syndromes on spatial patterns of woody species in a moist tropical forest	PLOS ONE			English	Article							GAP-PHASE REGENERATION; SEED DISPERSAL; RECRUITMENT LIMITATION; HABITAT ASSOCIATIONS; LOCAL NEIGHBORHOOD; DISTRIBUTIONS; CONSEQUENCES; DIVERSITY; ECOLOGY; TREES	We assessed the relative importance of dispersal limitation, environmental heterogeneity and their joint effects as determinants of the spatial patterns of 229 species in the moist tropical forest of Barro Colorado Island (Panama). We differentiated five types of species according to their dispersal syndrome; autochorous, anemochorous, and zoochorous species with small, medium-size and large fruits. We characterized the spatial patterns of each species and we checked whether they were best fitted by Inhomogeneous Poisson (IPP), Homogeneous Poisson cluster (HPCP) and Inhomogeneous Poisson cluster processes (IPCP) by means of the Akaike Information Criterion. We also assessed the influence of species' dispersal mode in the average cluster size. We found that 63% of the species were best fitted by IPCP regardless of their dispersal syndrome, although anemochorous species were best described by HPCP. Our results indicate that spatial patterns of tree species in this forest cannot be explained only by dispersal limitation, but by the joint effects of dispersal limitation and environmental heterogeneity. The absence of relationships between dispersal mode and degree of clustering suggests that several processes modify the original spatial pattern generated by seed dispersal. These findings emphasize the importance of fitting point process models with a different biological meaning when studying the main determinants of spatial structure in plant communities.	[Ramon, Pablo] Univ Tecn Particular Loja, Dept Ciencias Biol, San Cayetano Alto, Loja, Ecuador; [Velazquez, Eduardo] Univ Magallanes, Ctr Univ Coyhaique, Coyhaique, Chile; [Escudero, Adrian; de la Cruz, Marcelino] Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, ESCET, Madrid, Spain	Universidad Tecnica Particular de Loja; Universidad de Magallanes; Universidad Rey Juan Carlos	Ramon, P (corresponding author), Univ Tecn Particular Loja, Dept Ciencias Biol, San Cayetano Alto, Loja, Ecuador.	paramon@utpl.edu.ec	de la Cruz, Marcelino/M-6124-2015; Escudero, Adrian/H-5046-2015	de la Cruz, Marcelino/0000-0002-9080-4525; Escudero, Adrian/0000-0002-1427-5465; Ramon, Pablo/0000-0003-4123-4172	National Science Foundation [DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197]; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Celera Foundation; Islas-Espacio [CGL2009-13190-C03-02]; Spanish Ministerio de Ciencia [CGL2015-66809-P]; REMEDINAL3 project - Comunidad de Madrid; Universidad Tecnica Particular de Loja [PROY_CCNN_0001]; UPM-SANTANDER scholarship	National Science Foundation(National Science Foundation (NSF)); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Celera Foundation; Islas-Espacio; Spanish Ministerio de Ciencia(Spanish Government); REMEDINAL3 project - Comunidad de Madrid(Comunidad de Madrid); Universidad Tecnica Particular de Loja; UPM-SANTANDER scholarship	The BCI forest dynamics research project was made possible by National Science Foundation grants to Stephen P. Hubbell: DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, support from the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation, the Celera Foundation, and numerous private individuals. This study was partially supported by the Islas-Espacio CGL2009-13190-C03-02 and Roots project CGL2015-66809-P funded by the Spanish Ministerio de Ciencia, the REMEDINAL3 project financed by Comunidad de Madrid, PROY_CCNN_0001 financed by Universidad Tecnica Particular de Loja and a UPM-SANTANDER scholarship 2012.	AUGSPURGER CK, 1986, AM J BOT, V73, P353, DOI 10.2307/2444078; Baddeley A, 2015, SPATIAL POINT PATTER; Beaudrot L, 2013, ECOGRAPHY, V36, P984, DOI 10.1111/j.1600-0587.2013.00122.x; BROKAW NVL, 1987, J ECOL, V75, P9, DOI 10.2307/2260533; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; Chase JM, 2014, J VEG SCI, V25, P319, DOI 10.1111/jvs.12159; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Condit R, 2000, SCI REPORTS, V88, P1414; Condit R, BARRO COLORADO FORES; CONNELL J H, 1971, P298; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; de Bello F, 2013, J ECOL, V101, P1237, DOI 10.1111/1365-2745.12139; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Hardesty BD, 2003, PLANT ECOL, V164, P49, DOI 10.1023/A:1021251831806; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; Heydel F, 2017, OIKOS, V126, P738, DOI 10.1111/oik.03442; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1989, OECOLOGIA, V79, P417, DOI 10.1007/BF00384323; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Hubbell Stephen P., 2001, V32, pi; Illian J, 2008, STAT ANAL MODELLING; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jara-Guerrero A, 2015, OIKOS, V124, P1360, DOI 10.1111/oik.02098; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Law R, 2003, ECOLOGY, V84, P252, DOI 10.1890/0012-9658(2003)084[0252:PGISAT]2.0.CO;2; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; LEVEY DJ, 1988, ECOLOGY, V69, P1076, DOI 10.2307/1941263; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Metz MR, 2008, J TROP ECOL, V24, P9, DOI 10.1017/S0266467407004695; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Muller-Landau Helene C., 2005, P267, DOI 10.1017/CBO9780511541971.012; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Pinto SM, 2010, AM NAT, V175, P675, DOI 10.1086/652467; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; R Core Team, 2021, R LANGUAGE ENV STAT; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Schiffers K, 2008, ECOGRAPHY, V31, P545, DOI 10.1111/j.0906-7590.2008.05374.x; Schreeg LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013685; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shen GC, 2013, ECOLOGY, V94, P2436, DOI 10.1890/12-1983.1; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Velazquez E, 2016, ECOGRAPHY, V39, P1042, DOI 10.1111/ecog.01579; Velazquez E, 2016, OIKOS, V125, P872, DOI 10.1111/oik.02520; Velazquez E, 2015, J VEG SCI, V26, P1068, DOI 10.1111/jvs.12313; Waagepetersen R, 2009, J R STAT SOC B, V71, P685, DOI 10.1111/j.1467-9868.2008.00702.x; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; WEBSTER R, 1989, J SOIL SCI, V40, P493, DOI 10.1111/j.1365-2389.1989.tb01291.x; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Wiegand T, 2009, AM NAT, V174, pE106, DOI 10.1086/605368; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	78	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192341	10.1371/journal.pone.0192341	http://dx.doi.org/10.1371/journal.pone.0192341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451871	Green Published, Green Submitted, gold			2022-12-26	WOS:000425369800010
J	Goriewa-Duba, K; Duba, A; Kwiatek, M; Wisniewska, H; Wachowska, U; Wiwart, M				Goriewa-Duba, Klaudia; Duba, Adrian; Kwiatek, Michal; Wisniewska, Halina; Wachowska, Urszula; Wiwart, Marian			Chromosomal distribution of pTa-535, pTa-86, pTa-713, 35S rDNA repetitive sequences in interspecific hexaploid hybrids of common wheat (Triticum aestivum L.) and spelt (Triticum spelta L.)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; WILD EMMER WHEAT; GENETIC DIVERSITY; DNA-SEQUENCES; GRAIN-YIELD; A-GENOME; AEGILOPS; IDENTIFICATION; TRANSLOCATION; QUALITY	Fluorescent in situ hybridization (FISH) relies on fluorescent-labeled probes to detect specific DNA sequences in the genome, and it is widely used in cytogenetic analyses. The aim of this study was to determine the karyotype of T. aestivum and T. spelta hybrids and their parental components (three common wheat cultivars and five spelt breeding lines), to identify chromosomal aberrations in the evaluated wheat lines, and to analyze the distribution of polymorphisms of repetitive sequences in the examined hybrids. The FISH procedure was carried out with four DNA clones, pTa-86, pTa-535, pTa-713 and 35S rDNA used as probes. The observed polymorphisms between the investigated lines of common wheat, spelt and their hybrids was relatively low. However, differences were observed in the distribution of repetitive sequences on chromosomes 4A, 6A, 1B and 6B in selected hybrid genomes. The polymorphisms observed in common wheat and spelt hybrids carry valuable information for wheat breeders. The results of our study are also a valuable source of knowledge about genome organization and diversification in common wheat, spelt and their hybrids. The relevant information is essential for common wheat breeders, and it can contribute to breeding programs aimed at biodiversity preservation.	[Goriewa-Duba, Klaudia; Wiwart, Marian] Univ Warmia & Mazury, Dept Plant Breeding & Seed Prod, Olsztyn, Warmian Masuria, Poland; [Duba, Adrian; Wachowska, Urszula] Univ Warmia & Mazury, Dept Entomol Phytopathol & Mol Diagnost, Olsztyn, Warmian Masuria, Poland; [Kwiatek, Michal] Polish Acad Sci, Inst Plant Genet, Poznan, Wielkopolskie V, Poland; [Kwiatek, Michal; Wisniewska, Halina] Poznan Univ Life Sci, Dept Genet & Plant Breeding, Poznan, Wielkopolskie V, Poland	University of Warmia & Mazury; University of Warmia & Mazury; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Poznan University of Life Sciences	Goriewa-Duba, K (corresponding author), Univ Warmia & Mazury, Dept Plant Breeding & Seed Prod, Olsztyn, Warmian Masuria, Poland.	klaudia.goriewa@uwm.edu.pl	Wiwart, Marian/AAC-6367-2021; Kwiatek, Michał T./ABG-5673-2020; Wiwart, Marian/ABC-4518-2020	Kwiatek, Michał T./0000-0001-9442-3124; Wiwart, Marian/0000-0003-2693-7021; Wachowska, Urszula/0000-0002-9043-6128; WISNIEWSKA, HALINA/0000-0002-5488-0715; Goriewa-Duba, Klaudia/0000-0002-6628-3117				Abd El-Twab M.H., 2006, CHROMOSOME BOT, V1, P1, DOI [10.3199/iscb.1.1, DOI 10.3199/ISCB.1.1]; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Armentia A., 2012, American Journal of Plant Sciences, V3, P1779; Arzani A, 2017, COMPR REV FOOD SCI F, V16, P477, DOI 10.1111/1541-4337.12262; Badaeva ED, 2015, CYTOGENET GENOME RES, V146, P71, DOI 10.1159/000433458; BREIMAN A, 1995, ISR J PLANT SCI, V43, P85, DOI 10.1080/07929978.1995.10676595; Campbell KG, 1997, PL BRED RE, V15, P187; Cox T. S., 1998, Journal of Crop Production, V1, P1, DOI 10.1300/J144v01n01_01; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Dedkova OS, 2004, RUSS J GENET+, V40, P1111, DOI 10.1023/B:RUGE.0000044755.18085.7e; Devos KM, 1992, THEOR APPL GENET, V83, P931, DOI 10.1007/BF00232953; Ehdaie B, 2012, EUPHYTICA, V186, P219, DOI 10.1007/s10681-011-0585-9; El-Twab Magdy Hussein Abd, 2003, Chromosome Science, V7, P71; Escarnot E, 2012, BIOTECHNOL AGRON SOC, V16, P243; Feldman M., 2001, WORLD WHEAT BOOK HIS; FENN D, 1994, CEREAL CHEM, V71, P189; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GILL BS, 1987, CROP SCI, V27, P445, DOI 10.2135/cropsci1987.0011183X002700030004x; HARRISON GE, 1995, THEOR APPL GENET, V90, P157, DOI 10.1007/BF00222197; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hoffmann B, 2008, CEREAL RES COMMUN, V36, P269, DOI 10.1556/CRC.36.2008.2.7; Howell T, 2014, THEOR APPL GENET, V127, P2695, DOI 10.1007/s00122-014-2408-6; IQBAL MJ, 1995, THEOR APPL GENET, V91, P1048, DOI 10.1007/BF00223918; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KIHARA H, 1944, AGR HORTIC, V19, P889, DOI DOI 10.1016/J.JGG.2011.07.002; Kim W, 2004, CROP SCI, V44, P1254, DOI 10.2135/cropsci2004.1254; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Kowalczyk K, 2007, ZESZYTY PROBLEMOWE P, V517, P439; Kwiatek Michal, 2016, Journal of Plant Protection Research, V56, P319, DOI 10.1515/jppr-2016-0050; Kwiatek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158883; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; Mankeviciene A, 2014, FOOD ADDIT CONTAM A, V31, P132, DOI 10.1080/19440049.2013.861614; Pahr S, 2012, CLIN EXP ALLERGY, V42, P597, DOI 10.1111/j.1365-2222.2012.03961.x; Peleg Z, 2008, THEOR APPL GENET, V117, P103, DOI 10.1007/s00122-008-0756-9; Peng J, 2000, GENOME RES, V10, P1509, DOI 10.1101/gr.150300; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Pospisil R, 2011, ACTA FYTOTECHNICA ZO; Purnhauser L, 2011, EUPHYTICA, V179, P287, DOI 10.1007/s10681-010-0312-y; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Ren TH, 2009, EUPHYTICA, V169, P207, DOI 10.1007/s10681-009-9924-5; Rozen S., 2000, METHODS MOL BIOL, V132; Ruibal-Mendieta NL, 2005, J AGR FOOD CHEM, V53, P2751, DOI 10.1021/jf048506e; Salina EA, 2006, GENOME, V49, P1023, DOI 10.1139/G06-050; Salina EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-414; SCHMID JE, 1994, EUPHYTICA, V75, P105, DOI 10.1007/BF00024537; Siedler Hedda, 1994, Genetic Resources and Crop Evolution, V41, P27, DOI 10.1007/BF00051420; Smale M, 2002, CROP SCI, V42, P1766, DOI 10.2135/cropsci2002.1766; Stallknecht GF, PROGR NEW CROPS; Waga J, 2002, B IHAR, V221, P3; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; WINZELER H, 1994, EUPHYTICA, V74, P211, DOI 10.1007/BF00040403; Wiwart M., 2004, Bodenkultur, V55, P103	52	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192862	10.1371/journal.pone.0192862	http://dx.doi.org/10.1371/journal.pone.0192862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447228	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900062
J	Khan, AR; Kroenke, CD; Wiborg, O; Chuhutin, A; Nyengaard, JR; Hansen, B; Jespersen, SN				Khan, Ahmad Raza; Kroenke, Christopher D.; Wiborg, Ove; Chuhutin, Andrey; Nyengaard, Jens R.; Hansen, Brian; Jespersen, Sune Norhoj			Differential microstructural alterations in rat cerebral cortex in a model of chronic mild stress depression	PLOS ONE			English	Article							STRUCTURE TENSOR ANALYSIS; FIELD DIFFUSION MRI; WATER DIFFUSION; CORTICAL THICKNESS; PREFRONTAL CORTEX; MICROSCOPY DATA; MOOD DISORDERS; BRAIN; HIPPOCAMPAL; KURTOSIS	Chronic mild stress leads to depression in many cases and is linked to several debilitating diseases including mental disorders. Recently, neuronal tracing techniques, stereology, and immunohistochemistry have revealed persistent and significant microstructural alterations in the hippocampus, hypothalamus, prefrontal cortex, and amygdala, which form an interconnected system known as the stress circuit. Most studies have focused only on this circuit, however, some studies indicate that manipulation of sensory and motor systems may impact genesis and therapy of mood disorders and therefore these areas should not be neglected in the study of brain microstructure alterations in response to stress and depression. For this reason, we explore the microstructural alterations in different cortical regions in a chronic mild stress model of depression. The study employs ex-vivo diffusion MRI (d-MRI) to assess cortical microstructure in stressed (anhedonic and resilient) and control animals. MRI is followed by immunohistochemistry to substantiate the d-MRI findings. We find significantly lower extracellular diffusivity in auditory cortex (AC) of stress groups and a significantly higher fractional anisotropy in the resilient group. Neurite density was not found to be significantly higher in any cortical ROIs in the stress group compared to control, although axonal density is higher in the stress groups. We also report significant thinning of motor cortex (MC) in both stress groups. This is in agreement with recent clinical and preclinical studies on depression and similar disorders where significant microstructural and metabolic alterations were found in AC and MC. Our findings provide further evidence that the AC and MC are sensitive towards stress exposure and may extend our understanding of the microstructural effects of stress beyond the stress circuit of the brain. Progress in this field may provide new avenues of research to help in diagnosis and treatment intervention for depression and related disorders.	[Khan, Ahmad Raza; Wiborg, Ove; Chuhutin, Andrey; Hansen, Brian; Jespersen, Sune Norhoj] Aarhus Univ Hosp, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Kroenke, Christopher D.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Nyengaard, Jens R.] Aarhus Univ, Sect Stereol & Microscopy, Ctr Stochast Geometry & Adv Bioimaging, Core Ctr Mol Morphol, Aarhus, Denmark; [Jespersen, Sune Norhoj] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark	Aarhus University; Oregon Health & Science University; Aarhus University; Aarhus University	Jespersen, SN (corresponding author), Aarhus Univ Hosp, Ctr Functionally Integrat Neurosci, Aarhus, Denmark.; Jespersen, SN (corresponding author), Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark.	sune@cfin.au.dk	Jespersen, Sune Nørhøj/B-1914-2008; Khan, Ahmad Raza/L-1461-2019; Chuhutin, Andrey/V-6098-2018	Jespersen, Sune Nørhøj/0000-0003-3146-4329; Khan, Ahmad Raza/0000-0002-7396-3073; Chuhutin, Andrey/0000-0001-9262-5101	Lundbeck Foundation [R83-A7548]; Simon Fougner Hartmanns Familiefond; NIH [1R01EB012874-01]; Lippert's Foundation; Korning's Foundation; Augustinus Foundation; Danish Research Counsil's Infrastructure program; Velux Foundations; Department of Clinical Medicine, AU; Villum Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012874] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Simon Fougner Hartmanns Familiefond; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lippert's Foundation; Korning's Foundation; Augustinus Foundation; Danish Research Counsil's Infrastructure program; Velux Foundations(Velux Fonden); Department of Clinical Medicine, AU; Villum Foundation(Villum Fonden); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Lundbeck Foundation grant R83-A7548 supported SNJ and ARK. Simon Fougner Hartmanns Familiefond supported SNJ. AC, ARK, and BH acknowledge support from NIH 1R01EB012874-01. The authors wish to thank Lippert's Foundation, Korning's Foundation, and the Augustinus Foundation for financial support. The 9.4T lab was made possible by funding from the Danish Research Counsil's Infrastructure program, the Velux Foundations, and the Department of Clinical Medicine, AU. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Lundbeck Foundation grant R83-A7548 and Simon Fougner Hartmanns Familiefond. AC, ARK, and BH acknowledge support from NIH 1R01EB012874-01. The authors wish to thank Lippert's Foundation, Korning's Foundation and the Augustinus Foundation for financial support. The 9. 4T lab was made possible by funding from the Danish Research Counsil's Infrastructure program, the Velux Foundations, and the Department of Clinical Medicine, AU. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anacker C, 2016, BIOL PSYCHIAT, V79, P840, DOI 10.1016/j.biopsych.2015.08.009; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1997, ANN NY ACAD SCI, V820, P123, DOI 10.1111/j.1749-6632.1997.tb46192.x; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belzung C, 2014, PHARMACOL BIOCHEM BE, V122, P144, DOI 10.1016/j.pbb.2014.04.002; Borgonovo J, 2017, PARKINSONISM RELAT D, V35, P17, DOI 10.1016/j.parkreldis.2016.11.009; Bose M, 2010, SYNAPSE, V64, P97, DOI 10.1002/syn.20710; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Canbeyli R, 2010, BEHAV BRAIN RES, V207, P249, DOI 10.1016/j.bbr.2009.11.002; Cardinale F, 2014, NEUROINFORMATICS, V12, P535, DOI 10.1007/s12021-014-9229-2; Christ M, 2008, J NEURAL TRANSM, V115, P1199, DOI 10.1007/s00702-008-0036-5; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; Cumming G., 2013, PSYCHOL SCI; Dagnino-Subiabre A, 2005, NEUROSCIENCE, V135, P1067, DOI 10.1016/j.neuroscience.2005.07.032; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Palacios RDY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095077; Palacios RDY, 2011, BIOL PSYCHIAT, V70, P449, DOI 10.1016/j.biopsych.2011.05.014; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Egeland M, 2015, NAT REV NEUROSCI, V16, P189, DOI 10.1038/nrn3855; Ferrari AJ, 2013, PLOS MED; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Hansen B, 2016, SCI REPORTS, P6; Hansen B, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00040; Hansen B, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3741; Hansen B, 2016, NEUROIMAGE, V142, P371, DOI 10.1016/j.neuroimage.2016.08.022; Hansen B, 2016, MAGN RESON MED, V76, P1455, DOI 10.1002/mrm.26055; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Henckens MJAG, 2015, NEUROIMAGE, V105, P312, DOI 10.1016/j.neuroimage.2014.10.037; Hu H, 2010, NEUROSCIENCE, V169, P171, DOI 10.1016/j.neuroscience.2010.04.057; Huang H, 2008, J NEUROSCI, V28, P1427, DOI 10.1523/JNEUROSCI.3194-07.2008; Hui ES, 2008, ENG MED BIOL SOC 200; Janakiraman U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146671; Jarnum H, 2011, ACTA PSYCHIAT SCAND, V124, P435, DOI 10.1111/j.1600-0447.2011.01766.x; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jayatissa MN, 2010, STRESS, V13, P95, DOI 10.3109/10253890902951786; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2017, NEUROIMAGE; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jespersen SN, 2012, IEEE T MED IMAGING, V31, P16, DOI 10.1109/TMI.2011.2162099; Keifer Jr O, 2015, NAT COMMUN, P6; Khan AR, 2018, NEUROIMAGE, V167, P342, DOI 10.1016/j.neuroimage.2017.11.053; Khan AR, 2016, NEUROIMAGE, V142, P411, DOI 10.1016/j.neuroimage.2016.07.001; Khan AR, 2016, DATA BRIEF, V8, P934, DOI 10.1016/j.dib.2016.06.061; Khan AR, 2015, NEUROIMAGE, V111, P192, DOI 10.1016/j.neuroimage.2015.01.061; Kjolby BF, 2016, NMR BIOMED, V29, P1709, DOI 10.1002/nbm.3623; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Leigland LA, 2013, NEUROIMAGE, V83, P1081, DOI 10.1016/j.neuroimage.2013.07.068; Manji HK, 2000, MOL PSYCHIATR, V5, P578, DOI 10.1038/sj.mp.4000811; McEwen BS, 2015, NEUROBIOL STRESS, V1, P1, DOI 10.1016/j.ynstr.2014.09.001; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Novikov D.S., 2016, ARXIV161202059; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Paxinos G, 2007, RAT BRAIN STEREOTAXI, P32; Pijlman FTA, 2003, EUR NEUROPSYCHOPHARM, V13, P369, DOI 10.1016/S0924-977X(03)00040-3; Pijlman FTA, 2002, BEHAV BRAIN RES, V136, P365, DOI 10.1016/S0166-4328(02)00128-6; Radley JJ, 2005, EXP NEUROL, V196, P199, DOI 10.1016/j.expneurol.2005.07.008; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rajkowska G, 2016, BIPOLAR DISORD, V18, P41, DOI 10.1111/bdi.12364; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smiley JF, 2016, J CHEM NEUROANAT, V76, P108, DOI 10.1016/j.jchemneu.2015.10.008; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Tietze A, 2015, AM J NEURORADIOL, V36, P1472, DOI 10.3174/ajnr.A4311; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Varga Z, 2017, BEHAV BRAIN RES, V316, P104, DOI 10.1016/j.bbr.2016.08.030; Vyas A, 2002, J NEUROSCI, V22, P6810; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Wiborg O, 2013, CELL TISSUE RES, V354, P155, DOI 10.1007/s00441-013-1664-0; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wilson MA, 2015, NEUROBIOL STRESS, V1, P195, DOI 10.1016/j.ynstr.2015.06.001; World Health Organization, 2008, The global burden of disease: 2004 update; Yu B, 2015, SCI REPORTS, P5; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhao YJ, 2014, PSYCHOL MED, V44, P2927, DOI 10.1017/S0033291714000518	87	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192329	10.1371/journal.pone.0192329	http://dx.doi.org/10.1371/journal.pone.0192329			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432490	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300021
J	Lu, RB; Chang, YH; Wang, TY; Lee, SY; Chen, PS; Yang, YK				Lu, Ru-Band; Chang, Yun-Hsuan; Wang, Tzu-Yun; Lee, Sheng-Yu; Chen, Po See; Yang, Yen Kuang			The aldehyde dehydrogenase 2 polymorphisms on neuropsychological performance in bipolar II disorder with or without comorbid anxiety disorder	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; ALCOHOL-METABOLISM; PANIC DISORDER; RATING-SCALE; PREVALENCE; DEPRESSION; AMYGDALA; ADOLESCENTS	Anxiety disorders (ADs), the most common comorbid illnesses with bipolar disorder (BP) has been reported to associate with dopamine system. Dopamine, metabolized to 3,4-dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase 2 (ALDH2), and the distribution of the ALDH2*1/*1, and ALDH2*1/*2+ ALDH*2/*2 alleles in the Han Chinese general population is relatively equal. The association between dopamine metabolic enzymes and cognitive performance in patients with bipolar II disorder (BP-II) comorbid with AD is unclear. This study proposed to explore the role of ALDH2 polymorphisms on neuropsychological performance between BP-II comorbid with or without AD. One hundred ninety-seven BP-II patients with and without a comorbid AD were recruited and compared with 130 healthy controls (HCs). A polymerase chain reaction and a restriction fragment length polymorphism analysis were used to determine genotypes for ALDH2, and study participants underwent neuropsychological tests. An interaction between AD comorbidity and the ALDH2 polymorphisms was found in different domain of cognitive dysfunction in the BP-II patients. The ALDH2 polymorphisms might have different effects on the neuropsychological performance of BP-II patients with and without comorbid AD.	[Lu, Ru-Band; Chang, Yun-Hsuan; Wang, Tzu-Yun; Lee, Sheng-Yu; Chen, Po See; Yang, Yen Kuang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan, Taiwan; [Chang, Yun-Hsuan] Asia Univ, Dept Psychol, Coll Med & Hlth Sci, Taichung, Taiwan; [Chang, Yun-Hsuan] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Tzu-Yun; Chen, Po See; Yang, Yen Kuang] Natl Cheng Kung Univ Hosp, Dou Liou Branch, Dept Psychiat, Tainan, Yunlin, Taiwan; [Lee, Sheng-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lee, Sheng-Yu] Natl Yang Ming Univ, Coll Med, Dept Psychiat, Taipei, Taiwan; [Lee, Sheng-Yu] Kaohsiung Med Univ Kaohsiung, Fac Med, Dept Psychiat, Kaohsiung, Taiwan; [Chen, Po See; Yang, Yen Kuang] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; National Cheng Kung University	Chang, YH (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan, Taiwan.; Chang, YH (corresponding author), Asia Univ, Dept Psychol, Coll Med & Hlth Sci, Taichung, Taiwan.; Chang, YH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	yhchang@asia.edu.tw	Chen, Po See/AAA-6492-2021	Chang, Yun-Hsuan/0000-0001-8662-2457	Ministry of Science and Technology [MOST 105-2410-H-468-001]; National Science Council [NSC98-2314-B-006-022-MY3, NSC102-2622-B-006-002-CC2]; National Cheng Kung University Project for Promoting Academic Excellence and Developing World Class Research Centers	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University Project for Promoting Academic Excellence and Developing World Class Research Centers	This work was supported in part by grant MOST 105-2410-H-468-001 (to YHC) from Ministry of Science and Technology; NSC98-2314-B-006-022-MY3 and NSC102-2622-B-006-002-CC2 (to RBL) from National Science Council, and the National Cheng Kung University Project for Promoting Academic Excellence and Developing World Class Research Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grant MOST 105-2410-H-468-001 (to YHC) from Ministry of Science and Technology; NSC98-2314-B-006-022-MY3 and NSC102-2622-B-006-002-CC2 (to RBL) from National Science Council, and the National Cheng Kung University Project for Promoting Academic Excellence and Developing World Class Research Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL DP, 1992, PHARMACOGENETICS, V2, P48, DOI 10.1097/00008571-199204000-00002; Airaksinen E, 2005, J PSYCHIAT RES, V39, P207, DOI 10.1016/j.jpsychires.2004.06.001; Akiskal HS, 2000, J AFFECT DISORDERS, V59, pS5, DOI 10.1016/S0165-0327(00)00203-2; Albert U, 2008, J AFFECT DISORDERS, V105, P297, DOI 10.1016/j.jad.2007.05.020; Angst J, 1998, J AFFECT DISORDERS, V50, P143, DOI 10.1016/S0165-0327(98)00142-6; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Bauer MS, 2005, J AFFECT DISORDERS, V85, P301, DOI 10.1016/j.jad.2004.11.009; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Boldrini M, 2005, ACTA PSYCHIAT SCAND, V111, P150, DOI 10.1111/j.1600-0447.2004.00247.x; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Chang K, 2005, J AM ACAD CHILD PSY, V44, P565, DOI 10.1097/01.chi.0000159948.75136.0d; Chang YH, 2012, PROG NEURO-PSYCHOPH, V36, P194, DOI 10.1016/j.pnpbp.2011.09.013; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Chen YW, 1995, PSYCHIAT RES, V59, P57, DOI 10.1016/0165-1781(95)02752-1; Conners C.K., 2000, CONTINUOUS PERFORM 2; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; DANDRE F, 1995, MOL CELL PROBE, V9, P189, DOI 10.1006/mcpr.1995.0030; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Dilsaver SC, 2003, J AFFECT DISORDERS, V77, P173, DOI 10.1016/S0165-0327(02)00114-3; Dittmann S, 2008, BIPOLAR DISORD, V10, P877, DOI 10.1111/j.1399-5618.2008.00640.x; Drijgers RL, 2012, J NEUROL SCI, V320, P121, DOI 10.1016/j.jns.2012.07.015; Dunner DL, 2004, J CLIN PSYCHIAT, V65, P5; Elsworth JD, 1997, EXP NEUROL, V144, P4, DOI 10.1006/exnr.1996.6379; ENDICOTT J, 1985, J AFFECT DISORDERS, V8, P17, DOI 10.1016/0165-0327(85)90068-0; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; ERWIN VG, 1966, J BIOL CHEM, V241, P3533; Ferrier IN, 1999, BRIT J PSYCHIAT, V175, P246, DOI 10.1192/bjp.175.3.246; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Goodwin FK, 1900, MANIC DEPRESSIVE ILL; Gualtieri CT, 2008, J CLIN PSYCHIAT, V69, P1122, DOI 10.4088/JCP.v69n0712; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HARADA S, 1981, LANCET, V2, P982; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hua M, 2005, CHINESE GUIDE; Huang SY, 2004, ALCOHOL CLIN EXP RES, V28, P374, DOI 10.1097/01.ALC.0000117832.62901.61; Irons DE, 2012, ALCOHOL CLIN EXP RES, V36, P1882, DOI 10.1111/j.1530-0277.2012.01809.x; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Kauer-Sant'Anna M, 2007, CAN J PSYCHIAT, V52, P175, DOI 10.1177/070674370705200309; Keung WM, 1998, P NATL ACAD SCI USA, V95, P2198, DOI 10.1073/pnas.95.5.2198; Kim JM, 2004, NEUROBIOL AGING, V25, P295, DOI 10.1016/S0197-4580(03)00114-3; Kim SW, 2014, J AFFECT DISORDERS, V166, P243, DOI 10.1016/j.jad.2014.05.017; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; MacQueen GM, 2003, BIPOLAR DISORD, V5, P349, DOI 10.1034/j.1399-5618.2003.00048.x; Manning JS, 1997, COMPR PSYCHIAT, V38, P102; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Milham MP, 2005, BIOL PSYCHIAT, V57, P961, DOI 10.1016/j.biopsych.2005.01.038; Neria Y, 2010, J TRAUMA STRESS, V23, P322, DOI 10.1002/jts.20522; Perugi G, 1999, J PSYCHIATR RES, V33, P53, DOI 10.1016/S0022-3956(98)00044-2; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rihmer Z, 2001, J AFFECT DISORDERS, V67, P175, DOI 10.1016/S0165-0327(01)00309-3; Rosa-Neto P, 2005, NEUROIMAGE, V25, P868, DOI 10.1016/j.neuroimage.2004.11.031; Silverstein B, 1999, AM J PSYCHIAT, V156, P480; Simeonova DI, 2009, PSYCHIAT RES-NEUROIM, V173, P113, DOI 10.1016/j.pscychresns.2009.01.004; Simon NM, 2004, AM J PSYCHIAT, V161, P2222, DOI 10.1176/appi.ajp.161.12.2222; Simonsen C, 2008, BIPOLAR DISORD, V10, P245, DOI 10.1111/j.1399-5618.2007.00492.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Torrent C, 2006, BRIT J PSYCHIAT, V189, P254, DOI 10.1192/bjp.bp.105.017269; Vaglini F, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00071; Vieta E, 2000, COMPR PSYCHIAT, V41, P339, DOI 10.1053/comp.2000.9011; Wang YS, 2014, EUR PSYCHIAT, V29, P142, DOI 10.1016/j.eurpsy.2013.05.001; Wechsler D., 1945, WECHSLER MEMORY SCAL; Wozniak J, 2002, J CHILD ADOL PSYCHOP, V12, P101, DOI 10.1089/104454602760219144; Wu HI, 2011, PROG NEURO-PSYCHOPH, V35, P1841, DOI 10.1016/j.pnpbp.2011.07.013; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yu RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30424	69	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192229	10.1371/journal.pone.0192229	http://dx.doi.org/10.1371/journal.pone.0192229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV6OL	29425204	Green Published, gold, Green Submitted			2022-12-26	WOS:000424700800019
J	Seo, D; Lee, DH; Choi, N; Sudrajad, P; Lee, SH; Lee, JH				Seo, Dongwon; Lee, Doo Ho; Choi, Nuri; Sudrajad, Pita; Lee, Seung-Hwan; Lee, Jun-Heon			Estimation of linkage disequilibrium and analysis of genetic diversity in Korean chicken lines	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; NATIVE CHICKENS; GENOME SEQUENCE; DISCRIMINATION; TRAITS; EXTENT; NORTH; MTDNA	The development of genetic markers for animal breeding is an effective strategy to reduce the time and cost required to improve economically important traits. To implement genomic selection in the multibreed chicken population of Korea, an understanding of the linkage disequilibrium (LD) status of the target population is essential. In this study, we performed population genetic analyses to investigate LD decay, the effective population size, and breed diversity using 600 K high-density single nucleotide polymorphism genotypes of 189 native chickens in 14 lines (including Korean native chicken, imported and adapted purebred and commercial chickens). The results indicated that commercial native chickens have less calculated LD (average, r(2) = 0.13-0.26) and purebred native chickens have more calculated LD (average, r(2) = 0.24-0.37) across the entire genome. The effective population sizes of the examined lines showed patterns opposite to those of population LD. The phylogeny and admixture analyses showed that commercial and purebred chickens were well distinguished, except for Rhode Island Red (RIR) purebred lines of NC (NIAS_RIR_C) and ND (NIAS_RIR_D). These lines are difficult to distinguish clearly because they originated from the same respective breeds. The results of this study may provide important information for the development of genetic markers that can be used in breeding to improve the economic traits of native chickens.	[Seo, Dongwon; Lee, Doo Ho; Choi, Nuri; Lee, Seung-Hwan; Lee, Jun-Heon] Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea; [Sudrajad, Pita] Minist Agr, Indonesian Agcy Agr Res & Dev, South Jakarta, Indonesia	Chungnam National University; Indonesian Agency for Agricultural Research & Development	Lee, JH (corresponding author), Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea.	junheon@cnu.ac.kr		Lee, Jun Heon/0000-0003-3996-9209; Sudrajad, Pita/0000-0001-8148-9095; Lee, Seung Hwan/0000-0003-1508-4887	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA) [213010-05-1-SB250]; "Cooperative Research Program for Agriculture Science & Technology Development" [PJ012820052017]; Rural Development Administration, Republic of Korea; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries through the Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs [213010-05-2-SB250]; "Cooperative Research Program for Agriculture Science & Technology Development" of the Rural Development Administration, Republic of Korea [PJ012820052018]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA); "Cooperative Research Program for Agriculture Science & Technology Development"(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries through the Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs; "Cooperative Research Program for Agriculture Science & Technology Development" of the Rural Development Administration, Republic of Korea	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA) (213010-05-1-SB250) and "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ012820052017)", Rural Development Administration, Republic of Korea, and thanks to Hanhyup commercial native chicken company which provided chicken resources and background information.; This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries through the Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (213010-05-2-SB250) and the "Cooperative Research Program for Agriculture Science & Technology Development (project no. PJ012820052018)" of the Rural Development Administration, Republic of Korea. The authors thank the Hanhyup commercial native chicken company and Professor Jung-Min Heo's laboratory members at Chungnam National University, who provided chicken resources and background information.	Aerts J, 2007, CYTOGENET GENOME RES, V117, P338, DOI 10.1159/000103196; Ahn Dong-Hyun, 2002, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V31, P547; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Cho ChangYeon, 2011, Korean Journal of Poultry Science, V38, P5, DOI 10.5536/KJPS.2011.38.1.005; Choe JH, 2010, KOREAN J FOOD SCI AN, V30, P13, DOI 10.5851/kosfa.2010.30.1.13; Choi Nu Ri, 2015, Journal of Animal Science and Technology, V57, P5, DOI 10.1186/s40781-015-0044-6; Fu W. X., 2015, Genetics, Selection, Evolution, V47; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; HEDRICK PW, 1987, GENETICS, V117, P331; Heidaritabar M, 2016, J ANIM BREED GENET, V133, P167, DOI 10.1111/jbg.12199; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hogue MR, 2013, ASIAN AUSTRAL J ANIM, V26, P157, DOI 10.5713/ajas.2012.12459; Hoque MR, 2011, ASIAN AUSTRAL J ANIM, V24, P1637, DOI 10.5713/ajas.2011.11144; Islam MA, 2009, WORLD POULTRY SCI J, V65, P125, DOI 10.1017/S0043933909000010; Jayasena DD, 2013, ASIAN AUSTRAL J ANIM, V26, P1038, DOI 10.5713/ajas.2012.12684; Jeon HJ, 2010, KOREAN J FOOD SCI AN, V30, P171, DOI 10.5851/kosfa.2010.30.2.171; Jin S, 2017, WORLD POULTRY SCI J, V73, P163, DOI 10.1017/S004393391600088X; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Khatkar MS, 2007, GENETICS, V176, P763, DOI 10.1534/genetics.106.069369; Kong HS, 2006, ASIAN AUSTRAL J ANIM, V19, P1546, DOI 10.5713/ajas.2006.1546; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lee SH, 2011, ASIAN AUSTRAL J ANIM, V24, P1660, DOI 10.5713/ajas.2011.11165; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lu Duc, 2012, Frontiers in Genetics, V3, P152, DOI 10.3389/fgene.2012.00152; Menge E. O., 2005, International Journal of Poultry Science, V4, P827; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ros G, 2015, FRONT GENET, V173, P6; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Seo DW, 2013, ASIAN AUSTRAL J ANIM, V26, P316, DOI 10.5713/ajas.2012.12469; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Sharma A, 2015, ASIAN AUSTRAL J ANIM, V28, P1371, DOI 10.5713/ajas.14.0715; SVED J A, 1971, Theoretical Population Biology, V2, P125; Team RC, 2015, R LANG ENV STAT COMP, V2015; Zhao H, 2007, GENET RES, V89, P1, DOI 10.1017/S0016672307008634; 박미나, 2010, [Korean Journal of Poultry Science, 한국가금학회지], V37, P347	40	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192063	10.1371/journal.pone.0192063	http://dx.doi.org/10.1371/journal.pone.0192063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425208	Green Published, gold, Green Submitted			2022-12-26	WOS:000424700800012
J	Egea, LG; Jimenez-Ramos, R; Hernandez, I; Bouma, TJ; Brun, FG				Egea, Luis G.; Jimenez-Ramos, Rocio; Hernandez, Ignacio; Bouma, Tjeerd J.; Brun, Fernando G.			Effects of ocean acidification and hydrodynamic conditions on carbon metabolism and dissolved organic carbon (DOC) fluxes in seagrass populations	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CO2 ENRICHMENT; ATMOSPHERIC CO2; CLIMATE-CHANGE; THALASSIA-TESTUDINUM; LIGHT AVAILABILITY; GROWTH; PHOTOSYNTHESIS; AMMONIUM; SEAWATER	Global change has been acknowledged as one of the main threats to the biosphere and its provision of ecosystem services, especially in marine ecosystems. Seagrasses play a critical ecological role in coastal ecosystems, but their responses to ocean acidification (OA) and climate change are not well understood. There have been previous studies focused on the effects of OA, but the outcome of interactions with co-factors predicted to alter during climate change still needs to be addressed. For example, the impact of higher CO2 and different hydrodynamic regimes on seagrass performance remains unknown. We studied the effects of OA under different current velocities on productivity of the seagrass Zostera noltei, using changes in dissolved oxygen as a proxy for the seagrass carbon metabolism, and release of dissolved organic carbon (DOC) in a four-week experiment using an open-water outdoor mesocosm. Under current pH conditions, increasing current velocity had a positive effect on productivity, but this depended on shoot density. However, this positive effect of current velocity disappeared under OA conditions. OA conditions led to a significant increase in gross production rate and respiration, suggesting that Z. noltei is carbon-limited under the current inorganic carbon concentration of seawater. In addition, an increase in non-structural carbohydrates was found, which may lead to better growing conditions and higher resilience in seagrasses subjected to environmental stress. Regarding DOC flux, a direct and positive relationship was found between current velocity and DOC release, both under current pH and OA conditions. We conclude that OA and high current velocity may lead to favourable growth scenarios for Z. noltei populations, increasing their productivity, non-structural carbohydrate concentrations and DOC release. Our results add new dimensions to predictions on how seagrass ecosystems will respond to climate change, with important implications for the resilience and conservation of these threatened ecosystems.	[Egea, Luis G.; Jimenez-Ramos, Rocio; Hernandez, Ignacio; Brun, Fernando G.] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Cadiz, Spain; [Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res NIOZ, Dept Estuarine & Delta Syst, Yerseke, Netherlands	Universidad de Cadiz; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Egea, LG (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Cadiz, Spain.	gonzalo.egea@uca.es	Jiménez-Ramos, Rocío/AAT-8081-2020; Brun, Fernando G. G/L-1346-2014; Hernandez, Ignacio/N-2942-2013; Egea, Luis G./AAT-7290-2020	Jiménez-Ramos, Rocío/0000-0003-1705-1149; Brun, Fernando G. G/0000-0002-6313-9531; Hernandez, Ignacio/0000-0002-8024-2813; Egea, Luis G./0000-0002-2233-3426; Bouma, Tjeerd/0000-0001-7824-7546	Junta de Andalucia Excellence Project [RNM-P12-3020]; Spanish Ministry of Science and Innovation [CTM2011-24482]; Spanish Ministry of Science and Innovation; Spanish Ministry of Economy and Competitiveness	Junta de Andalucia Excellence Project(Junta de Andalucia); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Junta de Andalucia Excellence Project RNM-P12-3020 (PRODESCA) and by the Spanish Project Sea-Live (CTM2011-24482) from the Spanish Ministry of Science and Innovation. LGE holds a FPU fellowship from the Spanish Ministry of Science and Innovation. RJ holds a FPI fellowship from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre A, 2012, ECOL EVOL, V2, P2620, DOI 10.1002/ece3.333; [Anonymous], 2013, LIMNOL OCEANOGR FLUI; [Anonymous], 1989, BIOL SEAGRASSES TREA, P635; Bal KD, 2011, FUNCT ECOL, V25, P1197, DOI 10.1111/j.1365-2435.2011.01909.x; Barron C, 2006, ESTUAR COAST, V29, P417, DOI 10.1007/BF02784990; Barron C, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00042; Barron C, 2009, MAR ECOL PROG SER, V374, P75, DOI 10.3354/meps07715; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; BEER S, 1980, J EXP BOT, V31, P1019, DOI 10.1093/jxb/31.4.1019; BOTO KG, 1989, MAR ECOL PROG SER, V51, P243, DOI 10.3354/meps051243; Boudreau B.P., 2001, BENTHIC BOUNDARY LAY; Bouma TJ, 2005, HYDROBIOLOGIA, V540, P259, DOI 10.1007/s10750-004-7149-0; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brun FG, 2008, MAR ECOL PROG SER, V365, P67, DOI 10.3354/meps07512; Brun FG, 2003, MAR ECOL PROG SER, V265, P85, DOI 10.3354/meps265085; Brun FG, 2002, MAR ECOL PROG SER, V225, P177, DOI 10.3354/meps225177; Burke MK, 1996, MAR ECOL PROG SER, V137, P195, DOI 10.3354/meps137195; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Campbell JE, 2013, MAR BIOL, V160, P1465, DOI 10.1007/s00227-013-2199-3; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chipman L, 2010, LIMNOL OCEANOGR, V55, P857, DOI 10.4319/lo.2009.55.2.0857; Ciais Philippe, 2013, CLIMATE CHANGE 2013, P472, DOI [10.1017/CBO9781107415324.015, DOI 10.1017/CB09781107415324.015]; Cooley SR, 2009, OCEANOGRAPHY, V22, P172, DOI 10.5670/oceanog.2009.106; Corbett DR, 2010, BIOGEOSCIENCES, V7, P3289, DOI 10.5194/bg-7-3289-2010; Cornelisen CD, 2004, J MARINE SYST, V49, P177, DOI 10.1016/j.jmarsys.2003.05.008; Cornwall CE, 2016, ICES J MAR SCI, V73, P572, DOI 10.1093/icesjms/fsv118; Dafher EV, 2002, J ENVIRON MONITOR, V4, P55, DOI 10.1039/b107279j; de los Santos CB, 2010, MAR ECOL PROG SER, V398, P127, DOI 10.3354/meps08343; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duarte C. M., 2010, GLOBAL BIOGEOCHEM CY, V24, pG; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gonzalez-Ortiz V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104949; Govers LL, 2015, ECOL INDIC, V49, P53, DOI 10.1016/j.ecolind.2014.10.002; Hansell D.A., 2001, OCEANOGRAPHY, V14, P41, DOI DOI 10.5670/OCEANOG.2001.05; Hansell DA, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P1; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harris LA, 2006, ESTUAR COAST, V29, P340, DOI 10.1007/BF02782002; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI 10.1017/CBO9780511525551; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hurlbert SH, 2013, AGRON J, V105, P412, DOI 10.2134/agronj2012.0392; Invers O, 2001, J EXP MAR BIOL ECOL, V265, P203, DOI 10.1016/S0022-0981(01)00332-X; Jiang ZJ, 2010, J INTEGR PLANT BIOL, V52, P904, DOI 10.1111/j.1744-7909.2010.00991.x; Kane RP, 1996, J ATMOS TERR PHYS, V58, P1673, DOI 10.1016/0021-9169(95)00193-X; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kennish MJ, 2001, J COASTAL RES, V17, P731; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; KOCH EW, 1994, MAR BIOL, V118, P767, DOI 10.1007/BF00347527; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Laffoley D., 2009, MANAGEMENT NATURAL C; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; MADSEN TV, 1991, AQUAT BOT, V41, P5, DOI 10.1016/0304-3770(91)90037-6; Maher DT, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001433; Massel S. R., 1999, FLUID MECH MARINE EC; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Morris EP, 2008, LIMNOL OCEANOGR, V53, P1531, DOI 10.4319/lo.2008.53.4.1531; Navarro N, 2004, AQUAT MICROB ECOL, V37, P47, DOI 10.3354/ame037047; Nellemann C., 2009, BLUE CARBON RAPID RE; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; PAI SC, 1993, MAR CHEM, V41, P343, DOI 10.1016/0304-4203(93)90266-Q; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Peralta G, 2006, MAR ECOL PROG SER, V327, P135, DOI 10.3354/meps327135; Prinn R, 2011, CLIMATIC CHANGE, V104, P515, DOI [10.1007/s10584-009-9792-y, 10.1007/s10584-009-9792-v]; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Roland F, 1999, LIMNOL OCEANOGR, V44, P1148, DOI 10.4319/lo.1999.44.4.1148; Sabine CL, 2004, GREENH GAS SINK, P31; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Silva J, 2005, J EXP MAR BIOL ECOL, V317, P87, DOI 10.1016/j.jembe.2004.11.010; SMITH RD, 1984, PLANT PHYSIOL, V74, P1055, DOI 10.1104/pp.74.4.1055; Tokoro T, 2014, GLOBAL CHANGE BIOL, V20, P1873, DOI 10.1111/gcb.12543; Villazan B, 2016, MAR ECOL PROG SER, V545, P109, DOI 10.3354/meps11631; Watanabe K, 2015, GLOBAL CHANGE BIOL, V21, P2612, DOI 10.1111/gcb.12924; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219; Ziegler S, 1999, MAR ECOL PROG SER, V180, P149, DOI 10.3354/meps180149; Zimmerman RC, 1997, PLANT PHYSIOL, V115, P599, DOI 10.1104/pp.115.2.599; ZIMMERMAN RC, 1995, AQUAT BOT, V51, P67, DOI 10.1016/0304-3770(95)00472-C; ZIMMERMAN RC, 1995, PLANT PHYSIOL, V108, P1665, DOI 10.1104/pp.108.4.1665	92	13	13	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192402	10.1371/journal.pone.0192402	http://dx.doi.org/10.1371/journal.pone.0192402			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420625	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900070
J	Ishii, S; Kawai, M; Ishiwata, S; Suzuki, M				Ishii, Shuya; Kawai, Masataka; Ishiwata, Shin'ichi; Suzuki, Madoka			Estimation of actomyosin active force maintained by tropomyosin and troponin complex under vertical forces in the in vitro motility assay system	PLOS ONE			English	Article							QUASI-ELASTIC SCATTERING; SINGLE MYOSIN MOLECULE; CROSS-BRIDGE CYCLE; THIN-FILAMENTS; TEMPERATURE-CHANGE; ELEMENTARY STEPS; F-ACTIN; FLEXIBILITY; CYTOSKELETON; NUCLEOTIDE	The interaction between actin filaments and myosin molecular motors is a power source of a variety of cellular functions including cell division, cell motility, and muscular contraction. In vitro motility assay examines actin filaments interacting with myosin molecules that are adhered to a substrate (e.g., glass surface). This assay has been the standard method of studying the molecular mechanisms of contraction under an optical microscope. While the force generation has been measured through an optically trapped bead to which an actin filament is attached, a force vector vertical to the glass surface has been largely ignored with the in vitro motility assay. The vertical vector is created by the gap (distance) between the trapped bead and the glass surface. In this report, we propose a method to estimate the angle between the actin filament and the glass surface by optically determining the gap size. This determination requires a motorized stage in a standard epi-fluorescence microscope equipped with optical tweezers. This facile method is applied to force measurements using both pure actin filaments, and thin filaments reconstituted from actin, tropomyosin and troponin. We find that the angle-corrected force per unit filament length in the active condition (pCa = 5.0) decreases as the angle between the filament and the glass surface increases; i.e. as the force in the vertical direction increases. At the same time, we demonstrate that the force on reconstituted thin filaments is approximately 1.5 times larger than that on pure actin filaments. The range of angles we tested was between 11 degrees and 36 degrees with the estimated measurement error less than 6 degrees. These results suggest the ability of cytoplasmic tropomyosin isoforms maintaining actomyosin active force to stabilize cytoskeletal architecture.	[Ishii, Shuya; Ishiwata, Shin'ichi] Waseda Univ, Fac Sci & Engn, Dept Phys, Tokyo, Japan; [Kawai, Masataka] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Suzuki, Madoka] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Kawaguchi, Japan; [Suzuki, Madoka] Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan; [Suzuki, Madoka] Osaka Univ, Inst Prot Res, Osaka, Japan	Waseda University; University of Iowa; Japan Science & Technology Agency (JST); Waseda University; Osaka University	Suzuki, M (corresponding author), Japan Sci & Technol Agcy JST, PRESTO, Saitama, Kawaguchi, Japan.; Suzuki, M (corresponding author), Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan.; Suzuki, M (corresponding author), Osaka Univ, Inst Prot Res, Osaka, Japan.	suzu_mado@protein.osaka-u.ac.jp	Suzuki, Madoka/E-5420-2013	Suzuki, Madoka/0000-0002-3270-1755; Kawai, Masataka/0000-0002-3219-3527; Ishii, Shuya/0000-0002-1222-623X	US National Institutes of Health [HL070041]; US American Heart Association [13GRNT16810043]; JSPS KAKENHI [22227005]; Japan Science and Technology Agency [JPMJPR15F5]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US American Heart Association; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants from the US National Institutes of Health (https://www.nih.gov) HL070041 and US American Heart Association (http://www.heart.org/HEARTORG/) 13GRNT16810043 (to MK), and JSPS KAKENHI (https//www.jsps.go.jp/english/index.html) Grant Number 22227005 (to Slshiwata), and by The Japan Science and Technology Agency (http//www.jst.go.jp/EN/) Grant Number JPMJPR15F5 (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. P. B. Chase (Florida State University) for providing alpha-Tropomyosin (Tpm) WT, Dr. M. Miyazaki (Waseda University) for providing the LabView program, Dr. Y. Arai (Osaka University) for ImageJ plugin, Prof. K. Yasuda (Waseda University) for valuable advice and discussion, and members of the Yasuda lab for encouragements. This work was supported by grants from the US National Institutes of Health HL070041 and US American Heart Association 13GRNT16810043 (to MK), and JSPS KAKENHI Grant Number 22227005 (to SIshiwata), and by The Japan Science and Technology Agency Grant Number JPMJPR15F5 (to MS). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the funding organizations.	ASHKIN A, 1992, BIOPHYS J, V61, P569, DOI 10.1016/S0006-3495(92)81860-X; Capitanio M, 2013, BIOPHYS J, V105, P1293, DOI 10.1016/j.bpj.2013.08.007; Capitanio M, 2012, NAT METHODS, V9, P1013, DOI [10.1038/nmeth.2152, 10.1038/NMETH.2152]; Deufel C, 2006, BIOPHYS J, V90, P657, DOI 10.1529/biophysj.105.065458; Dutra RS, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.053848; ELLIOTT A, 1978, J MOL BIOL, V123, P505, DOI 10.1016/0022-2836(78)90204-8; Evangelista AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011209; FELGNER H, 1995, APPL OPTICS, V34, P977, DOI 10.1364/AO.34.000977; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Fish K.N., 2009, CURR PROTOC CYTOM; FUJIME S, 1971, J MOL BIOL, V62, P251, DOI 10.1016/0022-2836(71)90144-6; Fujita H, 2004, J PHYSIOL-LONDON, V556, P637, DOI 10.1113/jphysiol.2003.059956; Fujita H, 2002, BIOPHYS J, V82, P915, DOI 10.1016/S0006-3495(02)75453-2; Fujita H, 1996, BIOPHYS J, V71, P2307, DOI 10.1016/S0006-3495(96)79465-1; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gordon AM, BIOPHYS J; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Greulich KO, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/80/2/026601; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HIGASHIFUJIME S, 1986, CELL MOTIL CYTOSKEL, V6, P159, DOI 10.1002/cm.970060214; Homsher E, 2000, J PHYSIOL-LONDON, V524, P233, DOI 10.1111/j.1469-7793.2000.00233.x; Hundt N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20554; Inoue A S, 1997, VIDEO MICROSCOPY FUN; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; ISHIWATA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P77, DOI 10.1016/0005-2795(73)90150-5; ISHIWATA S, 1972, J MOL BIOL, V68, P511, DOI 10.1016/0022-2836(72)90103-9; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kawai M, 2000, BIOPHYS J, V78, P3112, DOI 10.1016/S0006-3495(00)76848-2; Kawai M, 2006, J PHYSIOL-LONDON, V574, P877, DOI 10.1113/jphysiol.2006.111708; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Li T., 2013, FUNDAMENTAL TESTS PH; Liu LL, 2014, P NATL ACAD SCI USA, V111, pE5609, DOI 10.1073/pnas.1422178112; Lodish H., 1999, MOL CELL BIOL; Martini N, 2002, J MICROSC-OXFORD, V206, P146, DOI 10.1046/j.1365-2818.2002.01016.x; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Miyazaki M, 2015, NAT CELL BIOL, V17, P480, DOI 10.1038/ncb3142; Murrell M, 2015, NAT REV MOL CELL BIO, V16, P486, DOI 10.1038/nrm4012; National Astronomical Observatory of Japan, 2016, CHR SCI TABL; Nieminen TA, 2007, J OPT A-PURE APPL OP, V9, pS196, DOI 10.1088/1464-4258/9/8/S12; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Oguchi Y, 2011, J MOL BIOL, V414, P667, DOI 10.1016/j.jmb.2011.10.026; Pollari R, 2015, OPT EXPRESS, V23, P28857, DOI 10.1364/OE.23.028857; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Schoffstall B, 2006, J PHYSIOL-LONDON, V577, P935, DOI 10.1113/jphysiol.2006.120105; Spudich James A, 2011, Cold Spring Harb Protoc, V2011, P1305, DOI 10.1101/pdb.top066662; Suzuki M, 2005, BIOPHYS J, V89, P321, DOI 10.1529/biophysj.104.054957; Suzuki M, 2011, BIOPHYS J, V101, P2740, DOI 10.1016/j.bpj.2011.10.040; Suzuki N, 1996, BIOPHYS J, V70, P401, DOI 10.1016/S0006-3495(96)79583-8; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Toyoshima Y Y, 1993, Adv Exp Med Biol, V332, P259; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Wu PY, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108101; Yehoshua S, 2015, BIOPHYS J, V108, P2759, DOI 10.1016/j.bpj.2015.05.014	66	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192558	10.1371/journal.pone.0192558	http://dx.doi.org/10.1371/journal.pone.0192558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420610	gold, Green Published, Green Submitted			2022-12-26	WOS:000424517900094
J	Chang, WY; Wu, YL; Su, PL; Yang, SC; Lin, CC; Su, WC				Chang, Wei-Yuan; Wu, Yi-Lin; Su, Po-Lan; Yang, Szu-Chun; Lin, Chien-Chung; Su, Wu-Chou			The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATION; OPEN-LABEL; 1ST-LINE TREATMENT; EXON 19; RADIATION-THERAPY; CIGARETTE-SMOKING; NEVER-SMOKERS; ADENOCARCINOMA	Previous studies have demonstrated the association between EGFR mutations and distant metastasis. However, the association for subsequent brain metastasis (BM) in stages I-III non-small cell lung cancer (NSCLC) patients remains inconclusive. We conducted a retrospective analysis to clarify the impact of EGFR mutations on the incidence of BM and associated survival in patients with stage I-III NSCLC. A total of 491 patients screened for EGFR mutations were retrospectively enrolled. Brain MRI or CT was used to detect the BM. Cumulative incidence of subsequent BM and overall survival (OS) after diagnosis of BM were estimated by the Kaplan-Meier method and compared using log-rank test. We performed Cox proportional hazard regression for predictors of subsequent BM and determinants of OS after BM. The cumulative incidence of BM seemed higher in patients harboring EGFR mutations than those without EGFR mutations although it did not reach statistical significance (hazard ratio [HR] = 1.75, 95% confidence interval [CI] = 0.731 similar to.81). After adjusting possible confounders, including age, smoking, stage, and tumor size, EGFR mutation became one of the predictors for subsequent BM (HR = 1.89, 95% CI = 1.12 similar to 3.17, p = 0.017). Though there was no statistical difference in survival after BM between patients with EGFR mutations and wild-type EGFR (median survival: 17.8 vs. 12.2 months, HR = 0.79, 95% CI = 0.45-1.40), patients with EGFR 19 deletion (Del) tended to have a longer survival after BM than the non-EGFR 19 Del group (median survival: 29.4 vs. 14.3 months, HR 0.58, 95% CI = 0.32-1.09, p = 0.089). In conclusion, our data suggested EGFR mutation to be one of the predictors for subsequent BM in stage I-III patients. Given the small sample size, more studies are warranted to corroborate our results.	[Chang, Wei-Yuan; Su, Po-Lan; Yang, Szu-Chun; Lin, Chien-Chung; Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Chang, Wei-Yuan; Lin, Chien-Chung; Su, Wu-Chou] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Inst Clin Med, Coll Med, Tainan, Taiwan; [Wu, Yi-Lin] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Nursing, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Yang, SC; Lin, CC (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan.; Lin, CC (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Inst Clin Med, Coll Med, Tainan, Taiwan.	yangszuchun@gmail.com; joshcclin@gmail.com.tw	Lin, Chien-Chung/T-1496-2019	Lin, Chien-Chung/0000-0002-4739-5631; Su, Po-Lan/0000-0002-8470-6590; Su, Wu-Chou/0000-0003-2953-4105	Ministry of Science and Technology, Taiwan [MOST 104-2314-B-006-046-MY3, MOST105-2314-B-076-MY2]; National Cheng Kung University Hospital [NCKUH-10605004]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This work was supported by MOST 104-2314-B-006-046-MY3 and MOST105-2314-B-076-MY2 from the Ministry of Science and Technology, Taiwan, and NCKUH-10605004 from the National Cheng Kung University Hospital.	Abrams JA, 2008, CANCER EPIDEM BIOMAR, V17, P2707, DOI 10.1158/1055-9965.EPI-08-0232; Akamatsu H, 2014, AM J CLIN ONCOL-CANC, V37, P144, DOI 10.1097/COC.0b013e31826e04f9; [Anonymous], 2013, J NEUROONCOL, V112, P461; Baek MY, 2018, KOREAN J INTERN MED, V33, P168, DOI 10.3904/kjim.2015.158; Bajard A, 2004, LUNG CANCER, V45, P317, DOI 10.1016/j.lungcan.2004.01.025; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Barlesi F, 2011, ANN ONCOL, V22, P2466, DOI 10.1093/annonc/mdr003; Batevik R, 2005, LUNG CANCER, V47, P173, DOI 10.1016/j.lungcan.2004.08.014; Breindel JL, 2013, CANCER RES, V73, P5053, DOI 10.1158/0008-5472.CAN-12-3775; Broniscer A, 2007, CLIN CANCER RES, V13, P1511, DOI 10.1158/1078-0432.CCR-06-2372; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Chen Y., 2014, ABST APPL ANAL, V2014, P7, DOI DOI 10.1016/J.C0MPEDU.2014.07.004; Chen Y, 2013, LUNG CANCER, V82, P313, DOI 10.1016/j.lungcan.2013.08.013; Dempke WCM, 2015, ANTICANCER RES, V35, P5797; Des Guetz G, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3570; Eichler AF, 2010, NEURO-ONCOLOGY, V12, P1193, DOI 10.1093/neuonc/noq076; Enomoto Y, 2013, RESPIR INVESTIG, V51, P153, DOI 10.1016/j.resinv.2013.02.004; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gounant V, 2007, LUNG CANCER, V58, P425, DOI 10.1016/j.lungcan.2007.07.010; Gridelli C, 2007, J THORAC ONCOL, V2, P758, DOI 10.1097/JTO.0b013e3180cc25b0; Guan J, 2016, MED ONCOL, V33, DOI 10.1007/s12032-015-0714-8; Han G, 2016, ONCOTARGET, V7, P56998, DOI 10.18632/oncotarget.10933; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Hsu CH, 2016, ONCOTARGET, V7, P46628, DOI 10.18632/oncotarget.9338; Hsu F, 2016, LUNG CANCER, V96, P101, DOI 10.1016/j.lungcan.2016.04.004; Huang QY, 2016, CHEST, V149, P1384, DOI 10.1016/j.chest.2015.12.017; Hubbs JL, 2010, CANCER-AM CANCER SOC, V116, P5038, DOI 10.1002/cncr.25254; Iuchi T, 2013, EUR J CANCER, V49, pS787; Jeon JH, 2015, EUR J CARDIO-THORAC, V47, P556, DOI 10.1093/ejcts/ezu177; Ji Z, 2014, INT J RADIAT ONCOL, V89, P330, DOI 10.1016/j.ijrobp.2014.02.025; Ke EE, 2017, J THORAC ONCOL, V12, P1368, DOI 10.1016/j.jtho.2017.05.018; Kim JE, 2009, LUNG CANCER, V65, P351, DOI 10.1016/j.lungcan.2008.12.011; Lai CSL, 2006, THORAX, V61, P91, DOI 10.1136/thx.2005.052233; Langer CJ, 2005, J CLIN ONCOL, V23, P6207, DOI 10.1200/JCO.2005.03.145; Li B, 2015, J NEURO-ONCOL, V124, P79, DOI 10.1007/s11060-015-1776-3; Lin JJ, 2016, J THORAC ONCOL, V11, P556, DOI 10.1016/j.jtho.2015.12.103; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Matsumoto S, 2006, INT J CANCER, V119, P1491, DOI 10.1002/ijc.21940; Midha A, 2015, AM J CANCER RES, V5, P2892; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Monaco EA, 2013, CANCER-AM CANCER SOC, V119, P226, DOI 10.1002/cncr.27504; Murin S, 2001, CHEST, V119, P1635, DOI 10.1378/chest.119.6.1635; Nie F, 2012, CANCER-AM CANCER SOC, V118, P5198, DOI 10.1002/cncr.27553; Owen S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00248; Popat S, 2007, LUNG CANCER, V56, P135, DOI 10.1016/j.lungcan.2006.11.009; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sacher AG, 2016, JAMA ONCOL, V2, P313, DOI 10.1001/jamaoncol.2015.4482; Sekine A, 2012, LUNG CANCER, V77, P64, DOI 10.1016/j.lungcan.2011.12.017; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Singh M, 2015, ONCOTARGET, V6, P27461, DOI 10.18632/oncotarget.4742; Socinski MA, 2013, CHEST, V143, pE341, DOI 10.1378/chest.12-2361; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; SORENSEN JB, 1988, J CLIN ONCOL, V6, P1474, DOI 10.1200/JCO.1988.6.9.1474; Stanic K, 2014, RADIOL ONCOL, V48, P173, DOI 10.2478/raon-2014-0016; Stish BJ, 2016, J CLIN ONCOL, V34, P3864, DOI 10.1200/JCO.2016.68.3425; Tanaka K, 2015, J THORAC ONCOL, V10, P1720, DOI 10.1097/JTO.0000000000000675; Venur Vyshak A, 2016, Am Soc Clin Oncol Educ Book, V35, pe123, DOI 10.14694/EDBK_100006; Wei F, 2014, AM J RESP CRIT CARE, V190, P1117, DOI 10.1164/rccm.201406-1003OC; Welsh JW, 2013, J CLIN ONCOL, V31, P895, DOI 10.1200/JCO.2011.40.1174; Wu SG, 2017, ERJ OPEN RES, V3; Wu YL, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.8500; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yagishita S, 2015, INT J RADIAT ONCOL, V91, P140, DOI 10.1016/j.ijrobp.2014.08.344; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yohena Tomofumi, 2004, Ann Thorac Cardiovasc Surg, V10, P347; Zhang YC, 2014, IEEE INT CONF ELECTR, P9; Zheng Z, 2017, J CANCER, V8, P597, DOI 10.7150/jca.16959; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu JQ, 2008, CANCER LETT, V265, P307, DOI 10.1016/j.canlet.2008.02.064	71	21	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192161	10.1371/journal.pone.0192161	http://dx.doi.org/10.1371/journal.pone.0192161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447182	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900023
J	Gergen, J; Coulon, F; Creneguy, A; Elain-Duret, N; Gutierrez, A; Pinkenburg, O; Verhoeyen, E; Anegon, I; Nguyen, TH; Halary, FA; Haspot, F				Gergen, Janina; Coulon, Flora; Creneguy, Alison; Elain-Duret, Nathan; Gutierrez, Alejandra; Pinkenburg, Olaf; Verhoeyen, Els; Anegon, Ignacio; Tuan Huy Nguyen; Halary, Franck Albert; Haspot, Fabienne			Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS REPLICATION; INHIBIT HIV-1 REPLICATION; TRANSPLANT RECIPIENTS; MOUSE CYTOMEGALOVIRUS; HEMATOPOIETIC STEM; ANTIVIRAL DRUGS; CAS9 NUCLEASES; BONE-MARROW; GENOME; INFECTION	Anti-HCMV treatments used in immunosuppressed patients reduce viral replication, but resistant viral strains can emerge. Moreover, these drugs do not target latently infected cells. We designed two anti-viral CRISPR/Cas9 strategies to target the UL122/123 gene, a key regulator of lytic replication and reactivation from latency. The singleplex strategy contains one gRNA to target the start codon. The multiplex strategy contains three gRNAs to excise the complete UL122/123 gene. Primary fibroblasts and U-251 MG cells were transduced with lentiviral vectors encoding Cas9 and one or three gRNAs. Both strategies induced mutations in the target gene and a concomitant reduction of immediate early (IE) protein expression in primary fibroblasts. Further detailed analysis in U-251 MG cells showed that the singleplex strategy induced 50% of indels in the viral genome, leading to a reduction in IE protein expression. The multiplex strategy excised the IE gene in 90% of all viral genomes and thus led to the inhibition of IE protein expression. Consequently, viral genome replication and late protein expression were reduced by 90%. Finally, the production of new viral particles was nearly abrogated. In conclusion, the multiplex anti-UL122/123 CRISPR/Cas9 system can target the viral genome efficiently enough to significantly prevent viral replication.	[Gergen, Janina; Coulon, Flora; Creneguy, Alison; Elain-Duret, Nathan; Anegon, Ignacio; Tuan Huy Nguyen; Halary, Franck Albert; Haspot, Fabienne] Univ Nantes, INSERM, Ctr Rech Transplantat & Immunol, UMR 1064, Nantes, France; [Gergen, Janina; Coulon, Flora; Creneguy, Alison; Elain-Duret, Nathan; Anegon, Ignacio; Tuan Huy Nguyen; Halary, Franck Albert; Haspot, Fabienne] CHU Nantes, ITUN, Nantes, France; [Gergen, Janina; Elain-Duret, Nathan; Anegon, Ignacio; Haspot, Fabienne] LabEx Immunograft Oncol LABEX IGO, Nantes, France; [Gutierrez, Alejandra; Verhoeyen, Els] Univ Lyon, Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon,Team EVIR, CIRI Int Ctr Infectiol Res,INSERM,CNRS,UMR5308,U1, Lyon, France; [Pinkenburg, Olaf] Univ Marburg, Inst Med Mikrobiol, Hans Meerwein Str 2, Marburg, Germany; [Pinkenburg, Olaf] Univ Marburg, Krankenhaushyg, Hans Meerwein Str 2, Marburg, Germany; [Verhoeyen, Els] INSERM, Ctr Mediterrane Med Mol C3M, Equipe Controle Metab Morts Cellulaires, U1065, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Haspot, F (corresponding author), Univ Nantes, INSERM, Ctr Rech Transplantat & Immunol, UMR 1064, Nantes, France.; Haspot, F (corresponding author), CHU Nantes, ITUN, Nantes, France.; Haspot, F (corresponding author), LabEx Immunograft Oncol LABEX IGO, Nantes, France.	fabienne.haspot@univ-nantes.fr	Anegon, Ignacio/I-7760-2018; halary, franck/AAR-9437-2020; Anegon, Ignacio/I-7498-2018; Halary, Franck/B-3782-2017; Huy, Nguyen Tien/B-2573-2010; Verhoeyen, Els/H-6360-2016; HASPOT, Fabienne/AAD-5698-2021; Verhoeyen, Els/AAW-4853-2021	halary, franck/0000-0003-0336-9615; Halary, Franck/0000-0003-0336-9615; Huy, Nguyen Tien/0000-0002-9543-9440; Verhoeyen, Els/0000-0001-9224-5491; Haspot, Fabienne/0000-0003-0513-1387	Labex IGO project - <<Investissements d'Avenir>> French Government program [ANR-11-LABX-0016-01]; Fondation Centaure; European Society of clinical Microbiology and Infectious Diseases (ESCMID); European Society of Organ transplantation (ESOT)	Labex IGO project - <<Investissements d'Avenir>> French Government program(French National Research Agency (ANR)); Fondation Centaure; European Society of clinical Microbiology and Infectious Diseases (ESCMID); European Society of Organ transplantation (ESOT)	This work was supported by the Labex IGO project (no ANR-11-LABX-0016-01) funded by the << Investissements d'Avenir >> French Government program, managed by the French National Research Agency (ANR) (http://www.labex-igo.com/); a grant from the Fondation Centaure(http://www.fondation-centaure.org/); a research grant from the European Society of clinical Microbiology and Infectious Diseases (ESCMID) (https://www.escmid.org/), a Junior basic grant from the European Society of Organ transplantation (ESOT) (http://www.esot.org/).	Angulo A, 2000, J VIROL, V74, P11129, DOI 10.1128/JVI.74.23.11129-11136.2000; Awasthi S, 2004, J VIROL, V78, P8191, DOI 10.1128/JVI.78.15.8191-8200.2004; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bellec J, 2015, CURR GENE THER, V15, P447; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Castillo JP, 2000, J VIROL, V74, P8028, DOI 10.1128/JVI.74.17.8028-8037.2000; Chenouard V, 2016, J GENET GENOMICS, V43, P341, DOI 10.1016/j.jgg.2016.04.005; Chou SW, 1997, J INFECT DIS, V176, P786, DOI 10.1086/517302; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; FDA, 1998, PROJ INF PERSPECT, V7; Gawn JM, 2002, J VIROL, V76, P4441, DOI 10.1128/JVI.76.9.4441-4455.2002; Glass M, 2009, NAT METHODS, V6, P577, DOI 10.1038/nmeth.1346; Gustems M, 2006, J VIROL, V80, P9899, DOI 10.1128/JVI.00640-06; Hamilton ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097231; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hsu PD, 2014, DNA TARGETING SPECIF, V31, P827; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968; Lilleri D, 2016, IMMUNOTHERAPY-UK, V8, P1135, DOI 10.2217/imt-2015-0028; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; MEYERS JD, 1986, J INFECT DIS, V153, P478, DOI 10.1093/infdis/153.3.478; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; Mousavi-Jazi M, 2001, J CLIN VIROL, V23, P1, DOI 10.1016/S1386-6532(01)00160-3; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Revello MG, 2001, J GEN VIROL, V82, P1429, DOI 10.1099/0022-1317-82-6-1429; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; RINGDEN O, 1986, J ANTIMICROB CHEMOTH, V17, P373, DOI 10.1093/jac/17.3.373; SCHMIDT GM, 1991, NEW ENGL J MED, V324, P1005, DOI 10.1056/NEJM199104113241501; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Slobedman B, 1999, J VIROL, V73, P4806, DOI 10.1128/JVI.73.6.4806-4812.1999; SNOECK R, 1988, ANTIMICROB AGENTS CH, V32, P1839, DOI 10.1128/AAC.32.12.1839; STAMMINGER T, 1991, J VIROL, V65, P2273, DOI 10.1128/JVI.65.5.2273-2282.1991; Stone D, 2016, HUM GENET, V135, P1071, DOI 10.1007/s00439-016-1686-2; SULLIVAN V, 1991, J INFECT DIS, V164, P781, DOI 10.1093/infdis/164.4.781; Tang QY, 2003, J VIROL, V77, P1357, DOI 10.1128/JVI.77.2.1357-1367.2003; Tarrant-Elorza M, 2014, CELL HOST MICROBE, V16, P43, DOI 10.1016/j.chom.2014.06.006; Taylor RT, 2006, J VIROL, V80, P920, DOI 10.1128/JVI.80.2.920-928.2006; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; Wang G, 2016, CELL REP, V17, P2819, DOI 10.1016/j.celrep.2016.11.057; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; White EA, 2004, J VIROL, V78, P1817, DOI 10.1128/JVI.78.4.1817-1830.2004; WROBLEWSKA Z, 1981, J MED VIROL, V8, P245, DOI 10.1002/jmv.1890080405	52	21	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192602	10.1371/journal.pone.0192602	http://dx.doi.org/10.1371/journal.pone.0192602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447206	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900041
J	Ishikawa, S; Naito, S; Iimori, S; Takahashi, D; Zeniya, M; Sato, H; Nomura, N; Sohara, E; Okado, T; Uchida, S; Rai, T				Ishikawa, Seiko; Naito, Shotaro; Iimori, Soichiro; Takahashi, Daiei; Zeniya, Moko; Sato, Hidehiko; Nomura, Naohiro; Sohara, Eisei; Okado, Tomokazu; Uchida, Shinichi; Rai, Tatemitsu			Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease	PLOS ONE			English	Article							MUSCLE MASS; VITAMIN-D; PREVALENCE; STRENGTH; HEALTH; POPULATION; ETIOLOGY; THERAPY; OBESITY; IMPACT	Introduction Sarcopenia, the age-related loss of muscle mass and function, frequently accompanies chronic kidney disease. The aim of this study was to clarify the prevalence and the risk factors for sarcopenia among patients with non-dialysis-dependent chronic kidney disease (NDD-CKD), focusing on the use of drugs. Methods We conducted a cross-sectional analysis on a cohort of 260 patients with NDD-CKD in a university hospital, recruited between June 2016 and March 2017. We extracted data on patient gender, age, cause of chronic kidney disease, use of drugs, and comorbidities that could potentially affect the prevalence of sarcopenia. Sarcopenia was diagnosed using the criteria of the Asian Working Group for Sarcopenia. Logistic regression analysis was performed to analyze the association of each factor on the prevalence of sarcopenia. Results 25.0% of our study subjects had sarcopenia. Multivariable analysis revealed that an increased risk of sarcopenia was significantly associated with age, male gender, body mass index, diabetes mellitus, and loop diuretic use (odds ratio, 4.59: 95% confidence interval, 1.81-11.61: P-value 0.001). Conclusions In our cohort, the prevalence of sarcopenia in patients with NDD-CKD was high, and diuretics use, particularly loop diuretic use, was suggested to be a risk factor of sarcopenia. Although loop diuretics are commonly used in patients with CKD, careful consideration of the risk of sarcopenia may be necessary.	[Ishikawa, Seiko; Naito, Shotaro; Iimori, Soichiro; Nomura, Naohiro; Sohara, Eisei; Okado, Tomokazu; Uchida, Shinichi; Rai, Tatemitsu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nephrol, Tokyo, Japan; [Takahashi, Daiei] Tokyo Metropolitan Otsuka Hosp, Dept Nephrol, Tokyo, Japan; [Zeniya, Moko] Tohto Bunkyo Hosp, Dept Internal Med, Tokyo, Japan; [Sato, Hidehiko] Nitobe Mem Nakano Gen Hosp, Dept Nephrol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Naito, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nephrol, Tokyo, Japan.	snaito.kid@tmd.ac.jp	Rai, Tatemitsu/K-7165-2019		Japan Society for the Promotion of Science [16K09642]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by Grants-in-Aid for Scientific Research (C) (16K09642) to TR from the Japan Society for the Promotion of Science. (https://www.jsps.go.jp/english/e-grants/index.html) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avin KG, 2015, CURR OSTEOPOROS REP, V13, P173, DOI 10.1007/s11914-015-0261-4; Beveridge LA, 2013, AGE AGEING, V42, P400, DOI 10.1093/ageing/aft046; Bouchi R, 2017, J DIABETES COMPLICAT, V31, P992, DOI 10.1016/j.jdiacomp.2017.02.021; Cetrone M, 2014, CURR DIABETES REV, V10, P231, DOI 10.2174/1573399810666140918121022; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Derbre F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046668; Di Bari M, 2004, J AM GERIATR SOC, V52, P961, DOI 10.1111/j.1532-5415.2004.52265.x; Fahal IH, 2014, NEPHROL DIAL TRANSPL, V29, P1655, DOI 10.1093/ndt/gft070; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Gordon PL, 2007, J RENAL NUTR, V17, P397, DOI 10.1053/j.jrn.2007.06.001; Harada K, 2017, AM J CARDIOL, V119, P1275, DOI 10.1016/j.amjcard.2017.01.003; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Kim JE, 2014, OSTEOPOROSIS INT, V25, P2189, DOI 10.1007/s00198-014-2745-y; Kim JK, 2014, CLIN NUTR, V33, P64, DOI 10.1016/j.clnu.2013.04.002; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Konig M, 2018, J GERONTOL A-BIOL, V73, P117, DOI 10.1093/gerona/glx074; Konishi M, 2015, J CACHEXIA SARCOPENI, V6, P174, DOI 10.1002/jcsm.12017; Levey AS, 2014, CLIN CHEM, V60, P916, DOI 10.1373/clinchem.2014.225383; Mandai S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46369; Molina P, 2017, J CACHEXIA SARCOPENI, V8, P686, DOI 10.1002/jcsm.12218; Moon SH, 2008, GUT LIVER, V2, P1, DOI 10.5009/gnl.2008.2.1.1; Morley JE, 2014, J CACHEXIA SARCOPENI, V5, P253, DOI 10.1007/s13539-014-0161-y; Onder G, 2002, LANCET, V359, P926, DOI 10.1016/S0140-6736(02)08024-8; Patel SS, 2013, J CACHEXIA SARCOPENI, V4, P19, DOI 10.1007/s13539-012-0079-1; Pereira RA, 2015, NEPHROL DIAL TRANSPL, V30, P1718, DOI 10.1093/ndt/gfv133; Petta S, 2017, ALIMENT PHARM THER, V45, P510, DOI 10.1111/apt.13889; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Ren HQ, 2016, RENAL FAILURE, V38, P364, DOI 10.3109/0886022X.2015.1132173; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P433, DOI 10.1007/BF02982704; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Sato E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36618; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Sharma D, 2014, CLIN J AM SOC NEPHRO, V9, P2079, DOI 10.2215/CJN.02140214; Taskapan H, 2011, CLIN NEPHROL, V76, P110, DOI 10.5414/CN107160; Wang TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep38937; Yamada M, 2013, J AM MED DIR ASSOC, V14, P911, DOI 10.1016/j.jamda.2013.08.015; Yang RR, 2016, DIABETES RES CLIN PR, V118, P121, DOI 10.1016/j.diabres.2016.06.023; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074	40	23	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192990	10.1371/journal.pone.0192990	http://dx.doi.org/10.1371/journal.pone.0192990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447254	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900088
J	Han, KE; Baek, SH; Kim, SH; Lim, KH				Han, Kyung Eun; Baek, Seung-Hee; Kim, Seung-Hyun; Lim, Key Hwan		Korean Ophthalmological Soc	Prevalence and risk factors of strabismus in children and adolescents in South Korea: Korea National Health and Nutrition Examination Survey, 2008-2011	PLOS ONE			English	Article							SINGAPOREAN CHINESE CHILDREN; ELEMENTARY-SCHOOL-CHILDREN; REFRACTIVE ERROR; CYCLOPLEGIC AUTOREFRACTION; INTERMITTENT EXOTROPIA; MANIFEST REFRACTIONS; CHILDHOOD STRABISMUS; VISUAL IMPAIRMENT; RECTUS RECESSION; AMBLYOPIA	Purpose To evaluate the prevalence and risk factors associated with horizontal strabismus in children and adolescents in South Korea. Methods A total of 5,935 children and adolescents 5-18 years of age who participated in the fourth and fifth Korean National Health and Nutrition Examination Survey (KNHANES IV-V) from July 2008 to December 2011 were evaluated and the prevalence of horizontal strabismus was estimated. Univariate and multivariate logistic regression analyses were conducted to determine the association between demographic, socioeconomic and clinical risk factors and clinically significant exodeviation (>= 15 prism diopters [PD]) and esodeviation (>= 10 PD). Results Among 5,935 eligible subjects, 84 subjects had clinically significant exodeviation and 13 had clinically significant esodeviation. The overall prevalence of clinically significant horizontal strabismus was 1.6% (95% confidence interval [CI], 1.2-2.1): 1.3% (95% CI, 1.0-1.7) for clinically significant exodeviation and 0.3% (95% CI, 0.1-0.6) for clinically significant esodeviation. Clinically significant exodeviation was associated with amblyopia (adjusted odds ratio [aOR], 6.45; 95% CI, 2.14-19.44), family history of strabismus (aOR, 4.91; 95% CI, 1.71-14.08) and astigmatism >= 1.0 D (aOR, 1.84; 95% CI, 1.13-2.98). Clinically significant esodeviation was associated with hyperopia (aOR, 12.16; 95% CI, 1.31-113.04) and amblyopia (aOR, 4.70; 95% CI, 1.12-19.81). Other demographic, socioeconomic, and clinical variables were not associated with strabismus. Conclusion This study provides data on the prevalence and independent risk factors for clinically significant exodeviation and esodeviation in a representative population of children and adolescents in South Korea.	[Han, Kyung Eun; Lim, Key Hwan] Ewha Womans Univ, Coll Med, Mok Dong Hosp, Dept Ophthalmol, Seoul, South Korea; [Baek, Seung-Hee] Konyang Univ, Coll Med, Dept Ophthalmol, Kims Eye Hosp, Seoul, South Korea; [Kim, Seung-Hyun] Korea Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Ewha Womans University; Konyang University; Konyang University Hospital; Korea University; Korea University Medicine (KU Medicine)	Lim, KH (corresponding author), Ewha Womans Univ, Coll Med, Mok Dong Hosp, Dept Ophthalmol, Seoul, South Korea.	limkh@ewha.ac.kr	Kim, Seung-Hyun/F-7394-2015	Lim, Key Hwan/0000-0001-6711-3948				Abrahamsson M, 1999, ACTA OPHTHALMOL SCAN, V77, P653, DOI 10.1034/j.1600-0420.1999.770609.x; Asakuma T, 2012, OPHTHALMOLOGY, V119, P1760, DOI 10.1016/j.ophtha.2012.02.034; Bez Y, 2009, J AAPOS, V13, P249, DOI 10.1016/j.jaapos.2009.02.010; Chen XP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/241983; CHEW E, 1994, ARCH OPHTHALMOL-CHIC, V112, P1349, DOI 10.1001/archopht.1994.01090220099030; Chia A, 2013, OPHTHAL EPIDEMIOL, V20, P138, DOI 10.3109/09286586.2013.767354; Chia A, 2010, INVEST OPHTH VIS SCI, V51, P3411, DOI 10.1167/iovs.09-4461; CHRISTENSEN AM, 1991, INVEST OPHTH VIS SCI, V32, P2143; Cotter SA, 2011, OPHTHALMOLOGY, V118, P2251, DOI 10.1016/j.ophtha.2011.06.032; CRISWELL MH, 1983, AM J OPTOM PHYS OPT, V60, P250; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Fu J, 2014, OPHTHAL EPIDEMIOL, V21, P197, DOI 10.3109/09286586.2014.904371; Hashemi H, 2016, BRIT J OPHTHALMOL, V100, P1122, DOI 10.1136/bjophthalmol-2015-307871; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; HOLT D, 1991, STATISTICIAN, V40, P333, DOI 10.2307/2348286; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kim H, 2016, AM J OPHTHALMOL, V166, P141, DOI 10.1016/j.ajo.2016.03.047; Lim HT, 2004, BRIT J OPHTHALMOL, V88, P929, DOI 10.1136/bjo.2003.029066; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Ma YY, 2016, INVEST OPHTH VIS SCI, V57, P6188, DOI 10.1167/iovs.16-20243; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Matsuo T, 2005, OPHTHAL EPIDEMIOL, V12, P31, DOI 10.1080/09286580490907805; Matsuo T, 2007, ACTA MED OKAYAMA, V61, P329; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Mojon-Azzi SM, 2008, BRIT J OPHTHALMOL, V92, P765, DOI 10.1136/bjo.2007.128884; Mojon-Azzi SM, 2009, ACTA OPHTHALMOL, V87, P784, DOI 10.1111/j.1755-3768.2008.01352.x; Mojon-Azzi SM, 2011, BRIT J OPHTHALMOL, V95, P473, DOI 10.1136/bjo.2010.185793; NAYAK BK, 1987, BRIT J OPHTHALMOL, V71, P73, DOI 10.1136/bjo.71.1.73; Pathai S, 2010, ARCH PEDIAT ADOL MED, V164, P250, DOI 10.1001/archpediatrics.2009.297; Podgor MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P739, DOI 10.1001/archopht.1996.01100130731018; Robaei D, 2006, OPHTHALMOLOGY, V113, P1146, DOI 10.1016/j.ophtha.2006.02.019; Robaei D, 2006, ARCH OPHTHALMOL-CHIC, V124, P878, DOI 10.1001/archopht.124.6.878; Rotsos T, 2009, CLIN OPHTHALMOL, V3, P429; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Stack RR, 2003, J AAPOS, V7, P263, DOI 10.1016/S1091-8531(03)00117-4; Torp-Pedersen T, 2010, INT J EPIDEMIOL, V39, P1229, DOI 10.1093/ije/dyq092; Walsh LA, 2000, J AAPOS, V4, P154, DOI 10.1016/S1091-8531(00)70005-X; Wang LH, 2010, J PEDIAT OPHTH STRAB, V47, P242, DOI 10.3928/01913913-20091019-12; Weissberg E, 2004, OPTOMETRY VISION SCI, V81, P505, DOI 10.1097/00006324-200407000-00011; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Williams C, 2008, BRIT J OPHTHALMOL, V92, P723, DOI 10.1136/bjo.2007.136051; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3; Zhu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120720	45	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191857	10.1371/journal.pone.0191857	http://dx.doi.org/10.1371/journal.pone.0191857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444106	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500036
J	Hanawa, S; Mitsuhashi, A; Shozu, M				Hanawa, Shinsuke; Mitsuhashi, Akira; Shozu, Makio			Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer	PLOS ONE			English	Article							DIABETES-MELLITUS; INSULIN-RESISTANCE; PP2A INHIBITION; BREAST-CANCER; IN-VIVO; CELLS; PROLIFERATION; CYTOTOXICITY; PATHWAY; COHORT	Objective Metformin, an antidiabetic drug, inhibits the endometrial cancer cell growth in vivo by improving the insulin resistance; however, its mechanism of action is not completely understood. Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase associated with insulin resistance and type 2 diabetes, and its inhibition restores the insulin resistance. This study investigated the antitumor effect of metformin on endometrial cancer with a focus on PP2A. Methods Metformin (1,500-2,250 mg/day) was preoperatively administered to patients with endometrial cancer for 4 to 6 weeks. Expression of the PP2A regulatory subunits, 4 (PPP2R4) and B (PP2A-B), was evaluated using real-time polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC) using paired specimens obtained before and after metformin treatment. The effect of PPP2R4 inhibition with small interfering RNA was evaluated in the endometrial cancer cell lines HEC265 and HEC1B. P values of < .05 were considered statistically significant. Results Preoperative metformin treatment significantly reduced the expression of PP2A-B, as determined using IHC, and the mRNA expression of PPP2R4, as determined using RT-PCR, in the patients with endometrial cancer. However, metformin could not directly alter the PPP2R4 mRNA levels in the endometrial cancer cell lines in vitro. PPP2R4 knockdown reduced the proliferation and induced the apoptosis by activating caspases 3/7 in HEC265 and HEC1B cells. Conclusions Downregulation of the PP2A-B subunit, including PPP2R4, is an important indirect target of metformin. Inhibition of PP2A may be an option for the treatment of endometrial cancer patients with insulin resistance.	[Hanawa, Shinsuke; Mitsuhashi, Akira; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan	Chiba University	Mitsuhashi, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan.	antira@faculty.chiba-u.jp		mitsuhashi, akira/0000-0003-3948-9256	Japan Society for the Promotion of Science [15K10702, 21592123, 24592504]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants No. 15K10702, 21592123, and 24592504 (all to AM) from the Japan Society for the Promotion of Science. The funding source had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Azam S, 2007, APOPTOSIS, V12, P1243, DOI 10.1007/s10495-006-0050-8; Bai XL, 2014, MOL CANCER THER, V13, P2062, DOI 10.1158/1535-7163.MCT-13-0800; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Bonanni B, 2012, J CLIN ONCOL, V30, P2593, DOI 10.1200/JCO.2011.39.3769; Chang KE, 2015, MOL CANCER THER, V14, P90, DOI 10.1158/1535-7163.MCT-14-0496; Duong FHT, 2014, CARCINOGENESIS, V35, P114, DOI 10.1093/carcin/bgt258; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Fuentes-Mattei E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju158; Galbo T, 2013, AGING-US, V5, P770, DOI 10.18632/aging.100611; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Goodwin PJ, 2011, BREAST, V20, pS31, DOI 10.1016/S0960-9776(11)70291-0; Guo F, 2014, CELL RES, V24, P190, DOI 10.1038/cr.2013.138; Haesen D, 2016, CANCER RES, V76, P5719, DOI 10.1158/0008-5472.CAN-15-3342; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Ho WS, 2016, ONCOTARGET, V7, P12447, DOI 10.18632/oncotarget.6970; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jeong AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27391; Kaemmerer D, 2012, INT J CLIN EXP PATHO, V5, P187; Kiely M, 2015, CANCERS, V7, P648, DOI 10.3390/cancers7020648; Kok SH, 2003, ORAL ONCOL, V39, P19, DOI 10.1016/S1368-8375(01)00129-4; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li J, 2014, INT J CLIN EXP PATHO, V7, P1147; Liao CY, 2014, GYNECOL ONCOL, V135, P163, DOI 10.1016/j.ygyno.2014.07.095; Liu SJ, 2011, CANCER BIOL THER, V12, P1005, DOI 10.4161/cbt.12.11.18380; Luo DJ, 2014, J NEUROCHEM, V130, P816, DOI 10.1111/jnc.12761; McDermott MSJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-157; Mitsuhashi A, 2014, CANCER-AM CANCER SOC, V120, P2986, DOI 10.1002/cncr.28853; Nagendra DC, 2012, MOL CARCINOGEN, V51, P826, DOI 10.1002/mc.20850; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11836; Shen Q, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-64; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sivalingam VN, 2016, BRIT J CANCER, V114, P281, DOI 10.1038/bjc.2015.453; Tian RH, 2016, CLIN TRANSL ONCOL, V18, P641, DOI 10.1007/s12094-015-1412-x; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wu MY, 2014, ONCOL REP, V32, P513, DOI 10.3892/or.2014.3266; Xian L, 2015, AGING-US, V7, P223, DOI 10.18632/aging.100725; Zhang ZH, 2013, INT J GYNECOL CANCER, V23, P294, DOI 10.1097/IGC.0b013e31827b8430	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192759	10.1371/journal.pone.0192759	http://dx.doi.org/10.1371/journal.pone.0192759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444159	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500087
J	Pushpanathan, ME; Loftus, AM; Gasson, N; Thomas, MG; Timms, CF; Olaithe, M; Bucks, RS				Pushpanathan, Maria E.; Loftus, Andrea M.; Gasson, Natalie; Thomas, Meghan G.; Timms, Caitlin F.; Olaithe, Michelle; Bucks, Romola S.			Beyond factor analysis: Multidimensionality and the Parkinson's Disease Sleep Scale-Revised	PLOS ONE			English	Article							NONMOTOR SYMPTOMS; GENDER-DIFFERENCES; BEHAVIOR DISORDER; PERSONALITY; INSOMNIA; VERSION; COMMON; LIFE; AGE; PD	Many studies have sought to describe the relationship between sleep disturbance and cognition in Parkinson's disease (PD). The Parkinson's Disease Sleep Scale (PDSS) and its variants (the Parkinson's disease Sleep Scale-Revised; PDSS-R, and the Parkinson's Disease Sleep Scale-2; PDSS-2) quantify a range of symptoms impacting sleep in only 15 items. However, data from these scales may be problematic as included items have considerable conceptual breadth, and there may be overlap in the constructs assessed. Multidimensional measurement models, accounting for the tendency for items to measure multiple constructs, may be useful more accurately to model variance than traditional confirmatory factor analysis. In the present study, we tested the hypothesis that a multidimensional model (a bifactor model) is more appropriate than traditional factor analysis for data generated by these types of scales, using data collected using the PDSS-R as an exemplar. 166 participants diagnosed with idiopathic PD participated in this study. Using PDSS-R data, we compared three models: a unidimensional model; a 3-factor model consisting of sub-factors measuring insomnia, motor symptoms and obstructive sleep apnoea (OSA) and REM sleep behaviour disorder (RBD) symptoms; and, a confirmatory bifactor model with both a general factor and the same three sub-factors. Only the confirmatory bifactor model achieved satisfactory model fit, suggesting that PDSS-R data are multidimensional. There were differential associations between factor scores and patient characteristics, suggesting that some PDSS-R items, but not others, are influenced by mood and personality in addition to sleep symptoms. Multidimensional measurement models may also be a helpful tool in the PDSS and the PDSS-2 scales and may improve the sensitivity of these instruments.	[Pushpanathan, Maria E.; Olaithe, Michelle; Bucks, Romola S.] Univ Western Australia, Sch Psychol Sci, Crawley, WA, Australia; [Loftus, Andrea M.; Gasson, Natalie; Timms, Caitlin F.] Curtin Univ, Sch Psychol & Speech Pathol, Bentley, WA, Australia; [Thomas, Meghan G.] Edith Cowan Univ, Sch Med Sci, Joondalup, WA, Australia	University of Western Australia; Curtin University; Edith Cowan University	Pushpanathan, ME (corresponding author), Univ Western Australia, Sch Psychol Sci, Crawley, WA, Australia.	maria.pushpanathan@uwa.edu.au	Bucks, Romola Starr/B-9164-2011	Bucks, Romola Starr/0000-0002-4207-4724; Pushpanathan, Maria/0000-0001-9115-1848; Olaithe, Michelle/0000-0002-9539-5716				Ancoli-Israel S, 2008, HARVARD REV PSYCHIAT, V16, P279, DOI 10.1080/10673220802432210; Bower JH, 2010, MOVEMENT DISORD, V25, P2105, DOI 10.1002/mds.23230; Chaudhuri KR, 2012, EUR J NEUROL, V19, P105, DOI 10.1111/j.1468-1331.2011.03442.x; Chaudhuri KR, 2002, J NEUROL NEUROSUR PS, V73, P629, DOI 10.1136/jnnp.73.6.629; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Dhawan V, 2006, J NEUROL SCI, V248, P158, DOI 10.1016/j.jns.2006.05.004; Dorsey CM, 1997, BIOL PSYCHIAT, V41, P209, DOI 10.1016/0006-3223(95)00659-1; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; Gunn DG, 2010, J GERIATR PSYCH NEUR, V23, P131, DOI 10.1177/0891988709358591; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Honig H, 2009, MOVEMENT DISORD, V24, P1468, DOI 10.1002/mds.22596; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iranzo A, 2005, NEUROLOGY, V65, P247, DOI 10.1212/01.wnl.0000168864.97813.e0; Kovacs N, 2016, SLEEP BIOL RHYTHMS, V14, P63, DOI 10.1007/s41105-015-0024-8; Lee AH, 2012, MOVEMENT DISORD, V27, P858, DOI 10.1002/mds.25003; Lee I. A., 2013, CALCULATION TEST DIF; Lin CM, 2008, SLEEP MED REV, V12, P481, DOI 10.1016/j.smrv.2007.11.003; Loftus AM, 2015, J INT NEUROPSYCH SOC, V21, P137, DOI 10.1017/S1355617715000041; Martin J, 2000, CLIN PSYCHOL REV, V20, P783, DOI 10.1016/S0272-7358(99)00063-X; Martinez-Martin P, 2008, MOVEMENT DISORD, V23, P1681, DOI 10.1002/mds.22110; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Morin AJS, 2016, STRUCT EQU MODELING, V23, P116, DOI 10.1080/10705511.2014.961800; Neikrug AB, 2013, J CLIN SLEEP MED, V9, P1119, DOI 10.5664/jcsm.3148; Norlinah MI, 2009, PARKINSONISM RELAT D, V15, P670, DOI 10.1016/j.parkreldis.2009.02.012; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Olson EJ, 2000, BRAIN, V123, P331, DOI 10.1093/brain/123.2.331; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Sixel-Doring F, 2012, SLEEP MED, V13, P1178, DOI 10.1016/j.sleep.2012.06.009; Stefansdottir S, 2012, EUR J NEUROL, V19, P1575, DOI 10.1111/j.1468-1331.2012.03791.x; Trenkwalder C, 2011, MOVEMENT DISORD, V26, P644, DOI 10.1002/mds.23476; Trenkwalder C, 2011, MOVEMENT DISORD, V26, P90, DOI 10.1002/mds.23441; Tse W, 2005, PARKINSONISM RELAT D, V11, P317, DOI 10.1016/j.parkreldis.2005.02.006; van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116; Verbaan D, 2008, MOVEMENT DISORD, V23, P35, DOI 10.1002/mds.21727; Vorderwuelbecke B. J., 2014, 22 C EUR SLEEP RES S, P2649; Wang J., 2020, STRUCTURAL EQUATION, DOI [DOI 10.1002/, DOI 10.1002/9781118356258]	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192394	10.1371/journal.pone.0192394	http://dx.doi.org/10.1371/journal.pone.0192394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432463	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300023
J	Esquirol, L; Peat, TS; Wilding, M; Lucent, D; French, NG; Hartley, CJ; Newman, J; Scott, C				Esquirol, Lygie; Peat, Thomas S.; Wilding, Matthew; Lucent, Del; French, Nigel G.; Hartley, Carol J.; Newman, Janet; Scott, Colin			Structural and biochemical characterization of the biuret hydrolase (BiuH) from the cyanuric acid catabolism pathway of Rhizobium leguminasorum bv. viciae 3841	PLOS ONE			English	Article							ALLOPHANATE HYDROLASE; ATRAZINE CHLOROHYDROLASE; CATALYTIC MECHANISM; RUT PATHWAY; EVOLUTION; ENZYME; NICOTINAMIDASE; PURIFICATION; DEGRADATION; TRZN	Biuret deamination is an essential step in cyanuric acid mineralization. In the well-studied atrazine degrading bacterium Pseudomonas sp. strain ADP, the amidase AtzE catalyzes this step. However, Rhizobium leguminosarum bv. viciae 3841 uses an unrelated cysteine hydrolase, BiuH, instead. Herein, structures of BiuH, BiuH with bound inhibitor and variants of BiuH are reported. The substrate is bound in the active site by a hydrogen bonding network that imparts high substrate specificity. The structure of the inactive Cys175Ser BiuH variant with substrate bound in the active site revealed that an active site cysteine (Cys175), aspartic acid (Asp36) and lysine (Lys142) form a catalytic triad, which is consistent with biochemical studies of BiuH variants. Finally, molecular dynamics simulations highlighted the presence of three channels from the active site to the enzyme surface: a persistent tunnel gated by residues Val218 and Gln215 forming a potential substrate channel and two smaller channels formed by Val28 and a mobile loop (including residues Phe41, Tyr47 and Met51) that may serve as channels for co-product (ammonia) or co-substrate (water).	[Esquirol, Lygie; French, Nigel G.; Hartley, Carol J.; Scott, Colin] CSIRO Biocatalysis & Synthet Biol, Canberra, ACT, Australia; [Esquirol, Lygie; Wilding, Matthew] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Peat, Thomas S.; Wilding, Matthew; Newman, Janet] CSIRO Biomed Mfg, Melbourne, Vic, Australia; [Lucent, Del] Wilkes Univ, Dept Elect Engn & Phys, Wilkes Barre, PA 18766 USA	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Wilkes University	Scott, C (corresponding author), CSIRO Biocatalysis & Synthet Biol, Canberra, ACT, Australia.	colin.scott@csiro.au	Peat, Thomas S/F-9817-2010; Scott, Colin/A-4682-2009; Wilding, Matthew A/D-4173-2012; Newman, Janet M/D-1857-2011; Hartley, Carol J/C-2255-2008	Peat, Thomas S/0000-0002-6488-0831; Scott, Colin/0000-0001-6110-6982; Wilding, Matthew A/0000-0002-3921-7771; Newman, Janet M/0000-0003-2666-3219; Hartley, Carol J/0000-0002-1927-8040; Esquirol, Lygie/0000-0002-4887-3260	SIEF funds	SIEF funds	We thank the beamline scientists of the MX beamlines of the Australian Synchrotron for help during data collection, and acknowledge the contribution of SIEF funds to enable access to the synchrotron. Crystallization experiments were performed in the CSIRO Collaborative Crystallisation Centre. We would also like to thank Drs Sarah Rottet and Andrew Warden for their constructive comments during the preparation of this manuscript.	Achor DS, 2005, J AM SOC HORTIC SCI, V130, P667, DOI 10.21273/JASHS.130.5.667; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2015, PYMOL MOL GRAPH SYST; Balotra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137700; Balotra S, 2015, APPL ENVIRON MICROB, V81, P470, DOI 10.1128/AEM.02783-14; BoundyMills KL, 1997, APPL ENVIRON MICROB, V63, P916, DOI 10.1128/AEM.63.3.916-923.1997; Cameron SM, 2011, ACS CATAL, V1, P1075, DOI 10.1021/cs200295n; Cameron SM, 2011, ABSTR PAP AM CHEM S, V241; Case D. A., 2017, AMBER 2017; Cheng G, 2005, APPL ENVIRON MICROB, V71, P4437, DOI 10.1128/AEM.71.8.4437-4445.2005; COOK AM, 1981, J AGR FOOD CHEM, V29, P1135, DOI 10.1021/jf00108a009; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eastman P, 2013, J CHEM THEORY COMPUT, V9, P461, DOI 10.1021/ct300857j; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; French JB, 2010, BIOCHEMISTRY-US, V49, P8803, DOI 10.1021/bi1012436; Frothingham R, 1996, ANTIMICROB AGENTS CH, V40, P1426, DOI 10.1128/AAC.40.6.1426; Fruchey I, 2003, APPL ENVIRON MICROB, V69, P3653, DOI 10.1128/AEM.69.6.3653-3657.2003; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jimenez JI, 2011, ENVIRON MICROBIOL, V13, P1718, DOI 10.1111/j.1462-2920.2011.02471.x; Jackson CJ, 2014, APPL ENVIRON MICROB, V80, P4003, DOI 10.1128/AEM.00916-14; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; JUTZI K, 1981, EXPERIENTIA, V37, P1231; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kincaid VA, 2012, BIOCHEMISTRY-US, V51, P545, DOI 10.1021/bi201347n; Mac Mahon S, 2012, J CHROMATOGR A, V1220, P101, DOI 10.1016/j.chroma.2011.11.066; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen H, 2013, J CHEM THEORY COMPUT, V9, P2020, DOI 10.1021/ct3010485; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Parales RE, 2010, J BACTERIOL, V192, P4086, DOI 10.1128/JB.00573-10; Pavelka A, 2016, IEEE ACM T COMPUT BI, V13, P505, DOI 10.1109/TCBB.2015.2459680; Pavelka A, 2009, NUCLEIC ACIDS RES, V37, pW376, DOI 10.1093/nar/gkp410; Peat TS, 2015, ACTA CRYSTALLOGR D, V71, P710, DOI 10.1107/S1399004715000619; Peat TS, 2013, MOL MICROBIOL, V88, P1149, DOI 10.1111/mmi.12249; Peat TS, 2017, APPL ENV MICROBIOLOG, V83, P13; Radian A, 2015, MBIO, V6, DOI 10.1128/mBio.01477-15; Rosa N, 2015, J BIOMOL SCREEN, V20, P898, DOI 10.1177/1087057115584059; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; Scherer MK, 2015, J CHEM THEORY COMPUT, V11, P5525, DOI 10.1021/acs.jctc.5b00743; Scott C, 2010, J ENVIRON MANAGE, V91, P2075, DOI 10.1016/j.jenvman.2010.05.007; Scott C, 2009, APPL ENVIRON MICROB, V75, P2184, DOI 10.1128/AEM.02634-08; Seabrook SA, 2013, ACS COMB SCI, V15, P387, DOI 10.1021/co400013v; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Seffernick JL, 2001, J BACTERIOL, V183, P2405, DOI 10.1128/JB.183.8.2405-2410.2001; Shapir N, 2006, APPL ENVIRON MICROB, V72, P2491, DOI 10.1128/AEM.72.4.2491-2495.2006; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Shapir N, 2005, APPL ENVIRON MICROB, V71, P2214, DOI 10.1128/AEM.71.5.2214-2220.2005; Shapir N, 2006, J BACTERIOL, V188, P5859, DOI 10.1128/JB.00517-06; SHEN RC, 1959, J AGR FOOD CHEM, V7, P762, DOI 10.1021/jf60105a002; Skubak P, 2013, NATURE COMMUNICATION, V4, P6; Sugrue E, 2016, BIOCHEMISTRY-US, V55, P6304, DOI 10.1021/acs.biochem.6b00731; Udikovic-Kolic N, 2012, APPL MICROBIOL BIOT, V96, P1175, DOI 10.1007/s00253-012-4495-0; Wackett LP, 2009, CURR OPIN MICROBIOL, V12, P244, DOI 10.1016/j.mib.2009.05.001; Wackett LP, 2005, ABSTR PAP AM CHEM S, V230, pU2153; Wackett LP, 2004, ACS SYM SER, V863, P37; Wackett LP, 2001, BIOCHEMISTRY-US, V40, P8636; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yeom S, 2015, APPL ENVIRON MICROB, V81, P6660, DOI 10.1128/AEM.02175-15; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	63	7	8	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192736	10.1371/journal.pone.0192736	http://dx.doi.org/10.1371/journal.pone.0192736			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425231	gold, Green Submitted, Green Published			2022-12-26	WOS:000424700800039
J	Wenzel, K; Schulze-Rothe, S; Muller, J; Wallukat, G; Haberland, A				Wenzel, Katrin; Schulze-Rothe, Sarah; Mueller, Johannes; Wallukat, Gerd; Haberland, Annekathrin			Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DILATED CARDIOMYOPATHY; DISEASE; BLOOD; SERUM; 1ST	Cell-based analytics for the detection of the beta1-adrenoceptor autoantibody (beta1-AAB) are functional, yet difficult to handle, and should be replaced by easily applicable, routine lab methods. Endeavors to develop solid-phase-based assays such as ELISA to exploit epitope moieties for trapping autoantibodies are ongoing. These solid-phase-based assays, however, are often unreliable when used with human patient material, in contrast to animal derived autoantibodies. We therefore tested an immunogen peptide-based ELISA for the detection of beta1-AAB, and compared commercially available goat antibodies against the 2nd extracellular loop of human beta1-adrenoceptor (ADRB1-AB) to autoantibodies enriched from patient material. The functionality of these autoantibodies was tested in a cell based assay for comparison and their structural appearance was investigated using 2D gel electrophoresis. The ELISA showed a limit of detection for ADRB1-AB of about 1.5 nmol antibody/L when spiked in human control serum and only about 25 nmol/L when spiked in species identical (goat) matrix material. When applied to samples of human origin, the ELISA failed to identify the specific beta1-AABs. A low concentration of beta1-AAB, together with structural inconsistency of the patient originated samples as seen from the 2D Gel appearance, might contribute to the failure of the peptide based ELISA technology to detect human beta1-AABs.	[Wenzel, Katrin; Schulze-Rothe, Sarah; Mueller, Johannes; Wallukat, Gerd; Haberland, Annekathrin] Berlin Cures GmbH, Berlin, Germany		Haberland, A (corresponding author), Berlin Cures GmbH, Berlin, Germany.	haberland@berlincures.de			Berlin Cures Holding AG	Berlin Cures Holding AG	Berlin Cures GmbH, the employer of KW, SSR, JM, GW, and AH is funded by the Berlin Cures Holding AG. Berlin Cures Holding AG develops BC007 for future therapeutic purpose. The funder provided support in the form of salaries for KW, SSR, JM, GW, AH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bornholz B, 2016, INT J CARDIOL, V202, P728, DOI 10.1016/j.ijcard.2015.10.068; Bornholz B, 2014, AUTOIMMUN REV, V13, P954, DOI 10.1016/j.autrev.2014.08.021; GREENBAUM CJ, 1992, J CLIN ENDOCR METAB, V74, P1040, DOI 10.1210/jc.74.5.1040; Haberland A, 2016, EUR J PHARMACOL, V789, P37, DOI 10.1016/j.ejphar.2016.06.061; Haberland A, 2011, CIRC RES, V109, P986, DOI 10.1161/CIRCRESAHA.111.253849; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 2015, CARDIOLOGY, V131, P149, DOI 10.1159/000376546; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HL, 2015, J INTERV CARD ELECTR, V44, P205, DOI 10.1007/s10840-015-0063-8; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Muller J, 2000, CIRCULATION, V101, P385, DOI 10.1161/01.CIR.101.4.385; Nagatomo Y, 2017, J AM COLL CARDIOL, V69, P968, DOI 10.1016/j.jacc.2016.11.067; Nakatake N, 2006, THYROID, V16, P1077, DOI 10.1089/thy.2006.16.1077; Patel PA, 2013, EUR J HEART FAIL, V15, P724, DOI 10.1093/eurjhf/hft065; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P397, DOI 10.1016/S0022-2828(08)80036-3; Wallukat G, 2014, SEMIN IMMUNOPATHOL, V36, P351, DOI 10.1007/s00281-014-0425-9; Wallukat G, 2012, CIRC J, V76, P2449, DOI 10.1253/circj.CJ-12-0212; Wallukat G, 2010, J AM COLL CARDIOL, V55, P463, DOI 10.1016/j.jacc.2009.06.064; Xia Y, 2011, EXPERT REV CLIN IMMU, V7, P659, DOI [10.1586/ECI.11.56, 10.1586/eci.11.56]; Ziegler AG, 2016, DIABETES TECHNOL THE, V18, P687, DOI 10.1089/dia.2016.0199	22	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192615	10.1371/journal.pone.0192615	http://dx.doi.org/10.1371/journal.pone.0192615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425252	Green Submitted, Green Published, gold			2022-12-26	WOS:000424700800032
J	Borek, A; Sokolowska-Wedzina, A; Chodaczek, G; Otlewski, J				Borek, Aleksandra; Sokolowska-Wedzina, Aleksandra; Chodaczek, Grzegorz; Otlewski, Jacek			Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; POTENT ANTITUMOR-ACTIVITY; ADVANCED GASTRIC-CANCER; K-SAM; AMPLIFICATION; REVEALS; INHIBITORS; CONJUGATE; SEGMENTS; THERAPY	Fibroblast growth factor receptors (FGFRs) are promising targets for antibody-based cancer therapies, as their substantial overexpression has been found in various tumor cells. Aberrant activation of FGF receptor 2 (FGFR2) signaling through overexpression of FGFR2 and/or its ligands, mutations, or receptor amplification has been reported in multiple cancer types, including gastric, colorectal, endometrial, ovarian, breast and lung cancer. In this paper, we describe application of the phage display technology to produce a panel of high affinity single chain variable antibody fragments (scFvs) against the extracellular ligand-binding domain of FGFR2 (ECD_FGFR2). The binders were selected from the human single chain variable fragment scFv phage display libraries Tomlinson I + J and showed high specificity and binding affinity towards human FGFR2 with nanomolar K-D values. To improve the affinity of the best binder selected, scFvF7, we reformatted it to a bivalent diabody format, or fused it with the Fc region (scFvF7-Fc). The scFvF7-Fc antibody construct presented the highest affinity for FGFR2, with a K-D of 0.76 nM, and was selectively internalized into cancer cells overexpressing FGFR2, Snu-16 and NCI-H716. Finally, we prepared a conjugate of scFvF7-Fc with the cytotoxic drug monomethyl-auristatin E (MMAE) and evaluated its cytotoxicity. The conjugate delivered MMAE selectively to FGFR2-positive tumor cells. These results indicate that scFvF7-Fc-vcMMAE is a highly potent molecule for the treatment of cancers with FGFR2 overexpression.	[Borek, Aleksandra; Sokolowska-Wedzina, Aleksandra; Otlewski, Jacek] Univ Wroclaw, Fac Biotechnol, Dept Prot Engn, Wroclaw, Poland; [Chodaczek, Grzegorz] Wroclaw Res Ctr EIT, Wroclaw, Poland	University of Wroclaw	Otlewski, J (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Prot Engn, Wroclaw, Poland.	jacek.otlewski@uwr.edu.pl	Chodaczek, Grzegorz/G-4073-2014; Chodaczek, Grzegorz/AFL-9576-2022; Chodaczek, Grzegorz/AAH-1681-2022	Otlewski, Jacek/0000-0001-8630-2891; Sokolowska-Wedzina, Aleksandra/0000-0001-9208-2450	National Science Centre, Poland [2011/02/A/NZ1/00066]; Wroclaw Research Centre EIT+ from European Regional Development Fund (Operational Programme Innovative Economy) [POIG 01.01.02-02-003/08-00, 1.1.2]	National Science Centre, Poland(National Science Centre, Poland); Wroclaw Research Centre EIT+ from European Regional Development Fund (Operational Programme Innovative Economy)	This work was supported by the National Science Centre, Poland (grant 2011/02/A/NZ1/00066). Confocal microscopy experiments were supported by Wroclaw Research Centre EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed" (POIG 01.01.02-02-003/08-00) financed from the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-1489; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; COX JPL, 1994, EUR J IMMUNOL, V24, P827, DOI 10.1002/eji.1830240409; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Ducry L., 2013, METHOD MOL BIOL, V1045, P1064; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Grygielewicz P, 2016, GASTRIC CANCER, V19, P53, DOI 10.1007/s10120-014-0444-1; Hara T, 1998, LAB INVEST, V78, P1143; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; HATTORI Y, 1990, P NATL ACAD SCI USA, V87, P5983, DOI 10.1073/pnas.87.15.5983; Huston J S, 1996, Q J Nucl Med, V40, P320; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Mathur A, 2010, P 101 ANN M AM ASS C; Mathur A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098515; MOR O, 1993, CANCER GENET CYTOGEN, V65, P111, DOI 10.1016/0165-4608(93)90217-A; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; NAKATANI H, 1990, JPN J CANCER RES, V81, P707, DOI 10.1111/j.1349-7006.1990.tb02631.x; Ochenduszko SL, 2010, ANTI-CANCER DRUG, V21, P737, DOI 10.1097/CAD.0b013e32833cfc99; Okeley NM, 2010, CLIN CANCER RES, V16, P888, DOI 10.1158/1078-0432.CCR-09-2069; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pettit G R, 1997, Fortschr Chem Org Naturst, V70, P1; Roukos DH, 2010, ANN SURG ONCOL, V17, P14, DOI 10.1245/s10434-009-0766-0; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shoji H, 2015, ANTICANCER RES, V35, P5055; Sokolowska-Wedzina A, 2017, MOL CANCER RES, V15, P1040, DOI 10.1158/1541-7786.MCR-16-0136; Sokolowska-Wedzina A, 2014, PROTEIN EXPRES PURIF, V99, P50, DOI 10.1016/j.pep.2014.03.012; Sommer A, 2016, CANCER RES, V76, P6331, DOI 10.1158/0008-5472.CAN-16-0180; Takeda M, 2007, CLIN CANCER RES, V13, P3051, DOI 10.1158/1078-0432.CCR-06-2743; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Viti F, 2000, METHOD ENZYMOL, V326, P480; Wang XH, 2011, CANCER RES, V71, P7410, DOI 10.1158/0008-5472.CAN-10-1134; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wong H, 2013, THER ADV GASTROENTER, V6, P15, DOI 10.1177/1756283X12453636; Xiang M, 2011, CHIN GER J CLIN ONCO, V10, P380; Xynos Ioannis D, 2013, ISRN Gastroenterol, V2013, P490578, DOI 10.1155/2013/490578; YOSHIDA T, 1993, SEMIN CANCER BIOL, V4, P33	41	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192194	10.1371/journal.pone.0192194	http://dx.doi.org/10.1371/journal.pone.0192194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420662	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900050
J	Li, FX; Li, Q; Wu, XH				Li, Fengxi; Li, Qian; Wu, Xianghua			Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; CELL-PROLIFERATION; DOWN-REGULATION; GASTRIC-CANCER; WILMS-TUMOR; LNCRNA; ASSOCIATION; TRANSCRIPTS; PROGRESSION; MIGRATION	Long non-coding RNA (IncRNA) has been confirmed to act as a key regulatory molecule in different types of cancers and play a significant role in tumors initiation and progression. LncRNA can be as acompeting endogenous RNA(ceRNA) to regulate the expression of targeted genes by sponging miRNA. In the present study, we explore the functional roles and regulatory mechanisms of IncRNAs as ceRNAs in colon cancer and their potential implications for prognosis. The IncRNAs, miRNAs and mRNAs expression profiles of 341 colon cancer tissues and 27 non-tumor colon tissues were downloaded from The Cancer Genome Atlas (TCGA) database. Differential expression of RNAs was identified using the "DESeq" bioconductor package in R. PPI network of differentially expressed genes was constructed using the STRING database. Survival analysis was estimated based on Kaplan-Meier curve analysis. We used KOBAS 3.0 to analyze the KEGG pathway of DEGs. The dysregulated IncRNA-associated ceRNA network was constructed in colon cancer based on bioinformatics generated from miRanda, PicTar, TargetScan, miRDB and miRcode. A total of 791 DEIncRNAs and 200 DEmiRNAs were identified in colon cancer compared with matched normal tissues with thresholds of vertical bar log2foldChange(FC)vertical bar >3.0 and adjusted P value<0.05. Twenty DEIncRNAs were identified, may be related to tumorigenesis and/or progression of colon cancer. Nine out of 20 dysregulated IncRNA were found to be significantly associated with overall survival (P value<0.05). Finally, we successfully constructed colon cancer-associated ceRNA network, including 9 colon cancer-specific IncRNAs, 13 miRNAS and 70 mRNAs. In conclusion, our study will contribute to improve the understanding of ceRNA network regulatory mechanisms in colon cancer. These identified novel IncRNAs can be as candidate prognostic biomarkers or potential therapeutic targets.	[Li, Fengxi; Wu, Xianghua] Guangxi Med Univ, Affiliated Hosp 1, Dept Surg, Nanning, Guangxi, Peoples R China; [Li, Qian] Guangxi Med Univ, Affiliated Hosp 1, Dept Gynaecol & Obstet, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Wu, XH (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Surg, Nanning, Guangxi, Peoples R China.	xhwuone@163.com						Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Chen DL, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0420-1; Dai QS, 2015, ONCOL LETT, V10, P2683, DOI 10.3892/ol.2015.3698; Dallosso AR, 2007, RNA, V13, P2287, DOI 10.1261/rna.562907; Du T, 2016, BBA-MOL BASIS DIS, V1862, P12, DOI 10.1016/j.bbadis.2015.10.001; Fedoriw AM, 2012, G3-GENES GENOM GENET, V2, P1521, DOI 10.1534/g3.112.004226; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Gong C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6406; Guo YW, 2013, FEBS J, V280, P4531, DOI 10.1111/febs.12417; Hou P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.249; Hu Y, 2017, BIOCH BIOPHYSICAL RE; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Jin X, 2017, CELL PHYSIOL BIOCHEM, V42, P295, DOI 10.1159/000477330; Kanduri C, 2011, SEMIN CELL DEV BIOL, V22, P343, DOI 10.1016/j.semcdb.2011.02.020; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Moorwood K, 1998, J PATHOL, V185, P352, DOI 10.1002/(SICI)1096-9896(199808)185:4<352::AID-PATH119>3.0.CO;2-#; Muers M, 2011, NAT REV GENET, V12, DOI 10.1038/nrg3088; Parks SK, 2015, J CELL PHYSIOL, V230, P1954, DOI 10.1002/jcp.24930; Peeters M, 2012, CANCER TREAT REV, V38, P397, DOI 10.1016/j.ctrv.2011.08.002; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Song J, 2017, BIOCH BIOPHYSICAL RE; Song MX, 2014, PROTEIN CELL, V5, P851, DOI 10.1007/s13238-014-0093-5; Song XD, 2014, J CELL MOL MED, V18, P991, DOI 10.1111/jcmm.12243; Stewart B, 2014, INT J MOL SCI; Sunamura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20690; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wei G, 2017, FRONTIERS CELLULAR N, P11; Xiao K, 2016, J CANCER, V7, P214, DOI 10.7150/jca.13150; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yarmishyn AA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00145; Yoshizawa S, 2015, INT J ONCOL, V47, P115, DOI 10.3892/ijo.2015.3018; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Zhang F, 2016, TUMOR BIOL, V37, P163, DOI 10.1007/s13277-015-4445-4; Zhou P, 2016, PATHOLOGY ONCOLOGY R, V22, P1	43	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192494	10.1371/journal.pone.0192494	http://dx.doi.org/10.1371/journal.pone.0192494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420609	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900083
J	Pournosrat, R; Kaya, S; Shaaf, S; Kilian, B; Ozkan, H				Pournosrat, Reza; Kaya, Selma; Shaaf, Salar; Kilian, Benjamin; Ozkan, Hakan			Geographical and environmental determinants of the genetic structure of wild barley in southeastern Anatolia	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; POPULATION-STRUCTURE; HORDEUM-SPONTANEUM; MOLECULAR CHAPERONES; DIVERSITY; ASSOCIATIONS; ADAPTATION; STRESS; LANDSCAPE; DOMESTICATION	Despite the global value of barley, compared to its wild progenitor, genetic variation in this crop has been drastically reduced due to the process of domestication, selection and improvement. In the medium term, this will negatively impact both the vulnerability and yield stability of barley against biotic and abiotic stresses under climate change. Returning to the crop wild relatives (CWR) as sources of new and beneficial alleles is a clear option for enhancing the resilience of diversity and adaptation to climate change. Southeastern Anatolia constitutes an important part of the natural distribution of wild barley in the Fertile Crescent where important crops were initially domesticated. In this study, we investigated genetic diversity in a comprehensive collection of 281 geo-referenced wild barley individuals from 92 collection sites with sample sizes ranging from 1 to 9 individuals per site, collected from southeastern Anatolia and 131 domesticated genotypes from 49 different countries using 40 EST-SSR markers. A total of 375 alleles were detected across entire collection, of which 283 were carried by domesticated genotypes and 316 alleles were present in the wild gene pool. The number of unique alleles in the wild and in the domesticated gene pool was 92 and 59, respectively. The population structure at K = 3 suggested two groups of wild barley namely G1-W consisting wild barley genotypes from the western part and G1-E comprising those mostly from the eastern part of the study area, with a sharp separation from the domesticated gene pool. The geographic and climatic factors jointly showed significant effects on the distribution of wild barley. Using a Latent Factor Mixed Model, we identified four candidate loci potentially involved in adaptation of wild barley to three environmental factors: temperature seasonality, mean temperature of driest quarter, and precipitation of coldest quarter. These loci are probably the targets of genomic regions, with potential roles against abiotic stresses.	[Pournosrat, Reza; Shaaf, Salar] Islamic Azad Univ, Coll Agr & Nat Resources, Dept Agron & Plant Breeding, Sanandaj Branch, Sanandaj, Iran; [Kaya, Selma; Ozkan, Hakan] Univ Cukurova, Dept Field Crops, Fac Agr, Adana, Turkey; [Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Genebank Dept, Genome Divers Grp, Seeland, Germany; [Kilian, Benjamin] Global Crop Divers Trust, Bonn, Germany	Islamic Azad University; Cukurova University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Shaaf, S (corresponding author), Islamic Azad Univ, Coll Agr & Nat Resources, Dept Agron & Plant Breeding, Sanandaj Branch, Sanandaj, Iran.; Ozkan, H (corresponding author), Univ Cukurova, Dept Field Crops, Fac Agr, Adana, Turkey.; Kilian, B (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Genebank Dept, Genome Divers Grp, Seeland, Germany.; Kilian, B (corresponding author), Global Crop Divers Trust, Bonn, Germany.	salarshaaf@gmail.com; benjamin.kilian@croptrust.org; hozkan@cu.edu.tr	ÖZKAN, Hakan/C-8510-2011; Shaaf, Salar/H-5521-2019	ÖZKAN, Hakan/0000-0003-3530-2626; Shaaf, Salar/0000-0002-0992-8273; Kilian, Benjamin/0000-0002-9145-6980	Scientific and Technological Research Council of Turkey [107O315]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the Scientific and Technological Research Council of Turkey; 107O315; www.tubitak.gov.tr.	Abebe TD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00813; Andrew RL, 2012, MOL ECOL, V21, P2078, DOI 10.1111/j.1365-294X.2012.05454.x; Ayyappan V, 2017, PLANT CELL REP, V36, P129, DOI 10.1007/s00299-016-2065-0; Bedada G, 2014, HEREDITY, V112, P646, DOI 10.1038/hdy.2014.2; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Castillo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-266; Civan P, 2017, NEW PHYTOL, V214, P468, DOI 10.1111/nph.14377; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Dai F, 2014, P NATL ACAD SCI USA, V111, P13403, DOI 10.1073/pnas.1414335111; Dempewolf H, 2017, CROP SCI, V57, P1070, DOI 10.2135/cropsci2016.10.0885; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Forster BP, 1997, NEW PHYTOL, V137, P141, DOI 10.1046/j.1469-8137.1997.00816.x; Francois O, 2016, MOL ECOL, V25, P454, DOI 10.1111/mec.13513; Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382; Graner A, 2003, DEV PL GEN, V7, P121, DOI 10.1016/S0168-7972(03)80009-9; Guo J, 2012, ANN BOT-LONDON, V110, P777, DOI 10.1093/aob/mcs142; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Haseneyer G, 2010, PLANT BREEDING, V129, P271, DOI 10.1111/j.1439-0523.2009.01725.x; He QX, 2013, EVOLUTION, V67, P3386, DOI 10.1111/evo.12159; Hubner S, 2013, J EVOLUTION BIOL, V26, P163, DOI 10.1111/jeb.12043; Huebner S., 2009, MOL ECOL, V18, P1523, DOI DOI 10.1111/J.1365-294X.2009.04106.X; Ivandic V, 2002, PLANT MOL BIOL, V48, P511, DOI 10.1023/A:1014875800036; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; KHALIL HB, 2014, BMC GENOMICS, V15, DOI DOI 10.1093/PCP/PCR039; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Kim YY, 2011, PLANT CELL PHYSIOL, V52, P874, DOI 10.1093/pcp/pcr039; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lazrek F, 2009, GENETICA, V135, P391, DOI 10.1007/s10709-008-9285-3; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Lei YK, 2015, BIOCHEM SYST ECOL, V59, P63, DOI 10.1016/j.bse.2015.01.009; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LONGLEY PA, 2005, GEOGRAPHIC INFORM SY, DOI DOI 10.1093/BIOINFORMATICS/BTS460; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Meszaros K, 2007, S AFR J BOT, V73, P43, DOI 10.1016/j.sajb.2006.06.006; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Moriuchi KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150350; Nevo E, 2005, BIOL J LINN SOC, V84, P205, DOI 10.1111/j.1095-8312.2005.00425.x; NEVO E, 1979, EVOLUTION, V33, P815, DOI 10.2307/2407648; NEVO E, 1986, GENETICA, V68, P203, DOI 10.1007/BF02424444; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL; Ozkan H, 2005, THEOR APPL GENET, V112, P12, DOI 10.1007/s00122-005-0067-3; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Parra-Quijano M, 2012, SPAN J AGRIC RES, V10, P419, DOI [10.5424/sjar/2011102-303-11, 10.5424/sjar/2012102-303-11]; Parra-Quijano M., 2008, P249, DOI 10.1079/9781845930998.0249; Pasam RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116164; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2016, R LANG ENV STAT COMP; REN J, 2013, BMC EVOL BIOL, V13, DOI DOI 10.1093/BIOINFORMATICS/BTI282; Russell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086021; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sayed MA, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1809-9; Shaaf S, 2014, GENET RESOUR CROP EV, V61, P1565, DOI 10.1007/s10722-014-0131-4; SHRESTHA B, 2014, BMC PLANT BIOL, V14, DOI DOI 10.1111/J.1365-313X.2004.02311.X; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thormann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160745; Truman W, 2013, PLANT PHYSIOL, V163, P1741, DOI 10.1104/pp.113.227108; Turpeinen T, 2001, MOL ECOL, V10, P1577, DOI 10.1046/j.1365-294X.2001.01281.x; Varshney RK, 2010, MOL BREEDING, V26, P229, DOI 10.1007/s11032-009-9373-9; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Zeng HQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00600; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	70	6	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192386	10.1371/journal.pone.0192386	http://dx.doi.org/10.1371/journal.pone.0192386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420597	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900068
J	Esposito, D; Gunster, RA; Martino, L; El Omari, K; Wagner, A; Thurston, TLM; Rittinger, K				Esposito, Diego; Gunster, Regina A.; Martino, Luigi; El Omari, Kamel; Wagner, Armin; Thurston, Teresa L. M.; Rittinger, Katrin			Structural basis for the glycosyltransferase activity of the Salmonella effector SseK3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosyltransferase; Salmonella enterica; protein structure; enzyme mechanism; bacterial toxin; X-ray crystallography; arginine modification; bacterial effectors; glycosyltransferase type-A; SseK3; UDP-GlcNAc; GT-A family; structural analysis	CLOSTRIDIUM-DIFFICILE TOXIN; III SECRETION; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN; DOMAIN; HOST; SYSTEM; IDENTIFICATION	The Salmonella-secreted effector SseK3 translocates into host cells, targeting innate immune responses, including NF-B activation. SseK3 is a glycosyltransferase that transfers an N-acetylglucosamine (GlcNAc) moiety onto the guanidino group of a target arginine, modulating host cell function. However, a lack of structural information has precluded elucidation of the molecular mechanisms in arginine and GlcNAc selection. We report here the crystal structure of SseK3 in its apo form and in complex with hydrolyzed UDP-GlcNAc. SseK3 possesses the typical glycosyltransferase type-A (GT-A)-family fold and the metal-coordinating DXD motif essential for ligand binding and enzymatic activity. Several conserved residues were essential for arginine GlcNAcylation and SseK3-mediated inhibition of NF-B activation. Isothermal titration calorimetry revealed SseK3's preference for manganese coordination. The pattern of interactions in the substrate-bound SseK3 structure explained the selection of the primary ligand. Structural rearrangement of the C-terminal residues upon ligand binding was crucial for SseK3's catalytic activity, and NMR analysis indicated that SseK3 has limited UDP-GlcNAc hydrolysis activity. The release of free N-acetyl -d-glucosamine, and the presence of the same molecule in the SseK3 active site, classified it as a retaining glycosyltransferase. A glutamate residue in the active site suggested a double-inversion mechanism for the arginine N-glycosylation reaction. Homology models of SseK1, SseK2, and the Escherichia coli orthologue NleB1 reveal differences in the surface electrostatic charge distribution, possibly accounting for their diverse activities. This first structure of a retaining GT-A arginine N-glycosyltransferase provides an important step toward a better understanding of this enzyme class and their roles as bacterial effectors.	[Esposito, Diego; Martino, Luigi; Rittinger, Katrin] Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England; [Gunster, Regina A.; Thurston, Teresa L. M.] Imperial Coll London, Microbiol Sect, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [El Omari, Kamel; Wagner, Armin] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England	Francis Crick Institute; Imperial College London; Diamond Light Source	Rittinger, K (corresponding author), Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England.; Thurston, TLM (corresponding author), Imperial Coll London, Microbiol Sect, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	t.thurston@imperial.ac.uk; katrin.rittinger@crick.ac.uk	Thurston, Teresa/AAZ-9938-2020; Rittinger, Katrin/N-3344-2019	Thurston, Teresa/0000-0001-6139-3723; Rittinger, Katrin/0000-0002-7698-4435; Martino, Luigi/0000-0001-5871-3124; Guenster, Regina/0000-0003-1280-3006; Esposito, Diego/0000-0003-4042-8856	Francis Crick Institute [FC001142]; Cancer Research UK; UK Medical Research Council; Wellcome Trust; MRC [MC_U117565398, MR/P028225/1, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117565398, MC_U117533887] Funding Source: researchfish; The Francis Crick Institute [10029, 10142] Funding Source: researchfish	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	The work was supported by Grant FC001142 from the Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albesa-Jove D, 2016, CURR OPIN STRUC BIOL, V40, P23, DOI 10.1016/j.sbi.2016.07.007; Ardevol A, 2016, BIOCHEM SOC T, V44, P51, DOI 10.1042/BST20150177; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; D'Urzo N, 2012, FEBS J, V279, P3085, DOI 10.1111/j.1742-4658.2012.08688.x; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; El Qaidi S, 2017, J BIOL CHEM, V292, P11423, DOI 10.1074/jbc.M117.790675; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Gunster RA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00010-17; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JAFFE EK, 1978, BIOCHEMISTRY-US, V17, P652, DOI 10.1021/bi00597a014; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karavolos MH, 2005, J BACTERIOL, V187, P1559, DOI 10.1128/JB.187.5.1559-1567.2005; Krafczyk R, 2017, MBIO, V8, DOI 10.1128/mBio.01412-17; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Li WQ, 2014, ACTA CRYSTALLOGR D, V70, P40, DOI 10.1107/S1399004713024619; Lu W, 2010, J MOL BIOL, V396, P321, DOI 10.1016/j.jmb.2009.11.044; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Pan M, 2014, ANGEW CHEM INT EDIT, V53, P14517, DOI 10.1002/anie.201407824; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Roslund MU, 2008, CARBOHYD RES, V343, P101, DOI 10.1016/j.carres.2007.10.008; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott NE, 2017, J BIOL CHEM, V292, P17337, DOI 10.1074/jbc.M117.805036; Shi WW, 2014, J BIOL CHEM, V289, P20898, DOI 10.1074/jbc.M114.581934; SINGH DG, 1995, FEBS LETT, V376, P61, DOI 10.1016/0014-5793(95)01247-6; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wagner A, 2016, ACTA CRYSTALLOGR D, V72, P430, DOI 10.1107/S2059798316001078; Yao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004522; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	58	33	38	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5064	5078		10.1074/jbc.RA118.001796	http://dx.doi.org/10.1074/jbc.RA118.001796			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449376	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000429409300014
J	Qu, C; Yan, M; Yang, SM; Wang, LB; Yin, Q; Liu, Y; Chen, YG; Li, JS				Qu, Chao; Yan, Meng; Yang, Suming; Wang, Lingbo; Yin, Qi; Liu, Yuan; Chen, Yeguang; Li, Jinsong			Haploid embryonic stem cells can be enriched and maintained by simple filtration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; CRISPR; Cas; cell sorting; cell biology; embryo; diploidization; FACS; filtration; haploid embryonic stem cells; haploidy	GENETICALLY-MODIFIED MICE; EFFICIENT GENERATION; CYTO-TOXICITY; MOUSE; GENOME; DERIVATION; HOECHST-33342; TECHNOLOGY; SYSTEMS; HALF	Mammalian haploid embryonic stem cells (haESCs) serve as a powerful tool for genetic analyses at both the cellular and organismal levels. However, spontaneous diploidization of haESCs limits their use in these analyses. Addition of small molecules to the culture medium to control the cell cycle can slow down diploidization, but cell-sorting methods such as FACS are still required to enrich haploid cells for long-term maintenance in vitro. Here, acting on our observation that haploid and diploidized cells differ in diameter, we developed a simplified filtration method to enrich haploid cells from cultured haESCs. We found that regular cell filtration with this system reliably maintained the haploidy of mouse haESCs for over 30 passages. Importantly, CRISPR/Cas9-mediated knockout and knockin were successfully achieved in the filtered cells, leading to stable haploid cell lines carrying the desired gene modifications. Of note, by injecting haESCs into metaphase II oocytes, we efficiently obtained live mice with the expected genetic traits, indicating that regular filtration maintained the functional integrity of haESCs. Moreover, this filtration system was also feasible for derivation of mouse haESCs from parthenogenetic haploid blastocysts and for human haESC maintenance. In conclusion, we have identified a reliable, efficient, and easy-to-handle technique for countering diploidization of haploid cells, a major obstacle in haESC applications.	[Qu, Chao; Yan, Meng; Yang, Suming; Wang, Lingbo; Yin, Qi; Li, Jinsong] Chinese Acad Sci, Shanghai Key Lab Mol Androl, State Key Lab Cell Biol, Inst Biochem & Cell Biol,Univ Chinese Acad Sci,Ct, Shanghai 200031, Peoples R China; [Liu, Yuan; Chen, Yeguang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tsinghua University	Li, JS (corresponding author), Chinese Acad Sci, Shanghai Key Lab Mol Androl, State Key Lab Cell Biol, Inst Biochem & Cell Biol,Univ Chinese Acad Sci,Ct, Shanghai 200031, Peoples R China.	jsli@sibcb.ac.cn		Wang, Lingbo/0000-0002-0962-8457; Yin, Qi/0000-0001-5628-5015; li, jin song/0000-0003-3456-662X	Ministry of Science and Technology of China [2014CB964803]; National Natural Science Foundation of China [31530048, 81672117, 31730062]; Chinese Academy of Sciences [XDB19010204, OYZDJ-SSW-SMC023, KJZD-EW-L13]; Facility-Based Open Research Program; Shanghai Municipal Commission for Science and Technology [16JC1420500, 17JC1400900, 17JC1420102, 17411954900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Facility-Based Open Research Program; Shanghai Municipal Commission for Science and Technology	This study was supported by Ministry of Science and Technology of China Grant 2014CB964803; National Natural Science Foundation of China Grants 31530048, 81672117, and 31730062; Chinese Academy of Sciences Grants XDB19010204, OYZDJ-SSW-SMC023, and KJZD-EW-L13 and the Facility-Based Open Research Program; and Shanghai Municipal Commission for Science and Technology Grants 16JC1420500, 17JC1400900, 17JC1420102, and 17411954900. The authors declare that they have no conflicts of interest with the contents of this article.	Bai M, 2016, J INTERN MED, V280, P236, DOI 10.1111/joim.12503; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Elling U, 2017, NATURE, V550, P114, DOI 10.1038/nature24027; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Freimann R, 2017, BIOMICROFLUIDICS, V11, DOI 10.1063/1.5006326; Guo A, 2017, STEM CELL REP, V8, P1124, DOI 10.1016/j.stemcr.2017.03.025; He ZQ, 2017, CELL REP, V20, P2227, DOI 10.1016/j.celrep.2017.07.081; Jin LF, 2016, ZOOL RES, V37, P205, DOI 10.13918/j.issn.2095-8137.2016.4.205; Kokubu C, 2014, CELL STEM CELL, V14, P265, DOI 10.1016/j.stem.2014.02.001; Kumar D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186977; Leeb M, 2012, DEVELOPMENT, V139, P3301, DOI 10.1242/dev.083675; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13471-4; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Sagi I, 2016, NATURE, V532, P107, DOI 10.1038/nature17408; Shi LY, 2012, PROTEIN CELL, V3, P806, DOI 10.1007/s13238-012-2096-4; Takahashi S, 2014, DEVELOPMENT, V141, P3842, DOI 10.1242/dev.110726; Vaitheesvaran B, 2014, METABOLOMICS, V10, P920, DOI 10.1007/s11306-014-0639-9; Wei LX, 2017, J GENET GENOMICS, V44, P461, DOI 10.1016/j.jgg.2017.07.004; WIEZOREK C, 1984, HISTOCHEMISTRY, V81, P493, DOI 10.1007/BF00489756; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Yilmaz A, 2016, CELL STEM CELL, V19, P569, DOI 10.1016/j.stem.2016.10.009; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao HL, 2015, BIOCHEM BIOPH RES CO, V464, P1163, DOI 10.1016/j.bbrc.2015.07.098; Zhong CQ, 2017, METHODS MOL BIOL, V1498, P121, DOI 10.1007/978-1-4939-6472-7_8; Zhong CQ, 2016, CELL RES, V26, P743, DOI 10.1038/cr.2016.59; Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005	34	4	8	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5230	5235		10.1074/jbc.RA118.002029	http://dx.doi.org/10.1074/jbc.RA118.002029			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449377	Green Published, hybrid			2022-12-26	WOS:000429409300027
J	Crook, Z; Booth, T; Cox, SR; Corley, J; Dykiert, D; Redmond, P; Pattie, A; Taylor, AM; Harris, SE; Starr, JM; Deary, IJ				Crook, Zander; Booth, Tom; Cox, Simon R.; Corley, Janie; Dykiert, Dominika; Redmond, Paul; Pattie, Alison; Taylor, Adele M.; Harris, Sarah E.; Starr, John M.; Deary, Ian J.			Apolipoprotein E genotype does not moderate the associations of depressive symptoms, neuroticism and allostatic load with cognitive ability and cognitive aging in the Lothian Birth Cohort 1936	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; MULTISYSTEM BIOLOGICAL RISK; GENOME-WIDE ASSOCIATION; PHYSIOLOGICAL DYSREGULATION; ALZHEIMER-DISEASE; EPSILON-4 ALLELE; APOE VARIATION; LATER LIFE; DECLINE; PERSONALITY	Objectives In this replication-and-extension study, we tested whether depressive symptoms, neuroticism, and allostatic load (multisystem physiological dysregulation) were related to lower baseline cognitive ability and greater subsequent cognitive decline in older adults, and whether these relationships were moderated by the E4 allele of the apolipoprotein E (APOE) gene. We also tested whether allostatic load mediated the relationships between neuroticism and cognitive outcomes. Methods We used data from the Lothian Birth Cohort 1936 (n at Waves 1-3: 1,028 [M age = 69.5 y]; 820 [M duration since Wave 1 = 2.98 y]; 659 [M duration since Wave 1 = 6.74 y]). We fitted latent growth curve models of general cognitive ability (modeled using five cognitive tests) with groups of APOE E4 non-carriers and carriers. In separate models, depressive symptoms, neuroticism, and allostatic load predicted baseline cognitive ability and subsequent cognitive decline. In addition, models tested whether allostatic load mediated relationships between neuroticism and cognitive outcomes. Results Baseline cognitive ability had small-to-moderate negative associations with depressive symptoms (beta range = -0.20 to -0.17), neuroticism (beta range = -0.27 to -0.23), and allostatic load (beta range = -0.11 to 0.09). Greater cognitive decline was linked to baseline allostaticload (beta range = -0.98 to -0.83) and depressive symptoms (beta range = -1.00 to -0.88). However, APOE E4 allele possession did not moderate the relationships of depressive symptoms, neuroticism and allostatic load with cognitive ability and cognitive decline. Additionally, the associations of neuroticism with cognitive ability and cognitive decline were not mediated through allostatic load. Conclusions Our results suggest that APOE E4 status does not moderate the relationships of depressive symptoms, neuroticism, and allostatic load with cognitive ability and cognitive decline in healthy older adults. The most notable positive finding in the current research was the strong association between allostatic load and cognitive decline.	[Crook, Zander; Booth, Tom; Cox, Simon R.; Corley, Janie; Dykiert, Dominika; Redmond, Paul; Pattie, Alison; Taylor, Adele M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Cox, Simon R.; Corley, Janie; Dykiert, Dominika; Harris, Sarah E.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.] Univ Edinburgh, Inst Genet & Mol Med, Med Res Council, Med Genet Sect,Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Dept Psychol, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Edinburgh	Crook, Z (corresponding author), Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.	zander.crook@ed.ac.uk	Deary, Ian J/C-6297-2009; Cox, Simon R./HDN-8568-2022	Deary, Ian J/0000-0002-1733-263X; Cox, Simon R./0000-0003-4036-3642	Age UK (Disconnected Mind project grant); UK Medical Research Council [G0701120, G0700704, G1001245, MR/M013111/1]; UK Biotechnology and Biological Science Research Council; University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross-council Lifelong Health and Wellbeing Initiative [MR/K026992/1]; UK Economic and Social Research Council; MRC [MR/R024065/1] Funding Source: UKRI; Medical Research Council [MR/K026992/1] Funding Source: researchfish	Age UK (Disconnected Mind project grant); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross-council Lifelong Health and Wellbeing Initiative; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge LBC1936 funding to IJD from Age UK (the Disconnected Mind project grant; http://www.ageuk.org.uk/), the UK Medical Research Council (grant numbers G0701120, G0700704, G1001245 and MR/M013111/1; https://www.mrc.ac.uk/) and the UK Biotechnology and Biological Science Research Council (http://www.bbsrc.ac.uk/) to IJD. LBC1936 work is conducted in the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross-council Lifelong Health and Wellbeing Initiative (grant MR/K026992/1 awarded to IJD; http://www.rcuk.ac.uk/). ZC is supported by a UK Economic and Social Research Council (http://www.esrc.ac.uk/) Advanced Quantitative Methods PhD award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckie TM, 2012, BIOL RES NURS, V14, P311, DOI 10.1177/1099800412455688; Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Blazer DG, 2005, COGNITIVE AGING PROG; Booth T, 2015, NEUROBIOL AGING, V36, P1390, DOI 10.1016/j.neurobiolaging.2014.12.020; Booth T, 2013, AM J HUM BIOL, V25, P538, DOI 10.1002/ajhb.22406; Bryer J, 2014, BIOL PSYCHIAT, V75, P18; Burke SL, 2016, INT PSYCHOGERIATR, V28, P1409, DOI 10.1017/S1041610216000405; Chapman BP, 2017, INT J GERIAT PSYCHIA; Corsentino EA, 2009, AM J GERIAT PSYCHIAT, V17, P155, DOI 10.1097/JGP.0b013e31818f3a6b; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Crook Z, 2017, PSYCHOSOM MED, V79, P117, DOI 10.1097/PSY.0000000000000415; Dar-Nimrod I, 2012, AM J GERIAT PSYCHIAT, V20, P1026, DOI 10.1097/JGP.0b013e318267016b; Dar-Nimrod I, 2012, INT J GERIATR PSYCH, V27, P1147, DOI 10.1002/gps.3759; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Davies G, 2014, MOL PSYCHIATR, V19, P76, DOI 10.1038/mp.2012.159; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Dotson VM, 2008, AM J GERIAT PSYCHIAT, V16, P318, DOI 10.1097/JGP.0b013e3181662a9c; Enders C. K., 2010, APPL MISSING DATA AN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geda YE, 2006, ARCH NEUROL-CHICAGO, V63, P435, DOI 10.1001/archneur.63.3.435; Gerritsen L, 2011, NEUROBIOL AGING, V32, P1615, DOI 10.1016/j.neurobiolaging.2009.09.007; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Harrington KD, 2015, AUST NZ J PSYCHIAT, V49, P36, DOI 10.1177/0004867414557161; Huppert Felicia A, 2005, BMC Geriatr, V5, P7, DOI 10.1186/1471-2318-5-7; Irie F, 2008, ARCH GEN PSYCHIAT, V65, P906, DOI 10.1001/archpsyc.65.8.906; Johnson W, 2011, HEALTH PSYCHOL, V30, P1, DOI 10.1037/a0021834; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kantarci K, 2012, NEUROLOGY, V78, P232, DOI 10.1212/WNL.0b013e31824365ab; Karlamangla AS, 2014, NEUROBIOL AGING, V35, P387, DOI 10.1016/j.neurobiolaging.2013.07.028; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Karlsson IK, 2015, NEUROBIOL AGING, V36, P1751, DOI 10.1016/j.neurobiolaging.2015.01.008; Kim JM, 2011, INT J GERIATR PSYCH, V26, P893, DOI 10.1002/gps.2621; Kobrosly RW, 2013, INT J GERIATR PSYCH, V28, P718, DOI 10.1002/gps.3878; Kohler S, 2010, J AM GERIATR SOC, V58, P873, DOI 10.1111/j.1532-5415.2010.02807.x; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Lee BK, 2008, AM J PSYCHIAT, V165, P1456, DOI 10.1176/appi.ajp.2008.07091532; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Luchetti M, 2016, J GERONTOL B-PSYCHOL, V71, P591, DOI 10.1093/geronb/gbu184; Luciano M, 2015, PSYCHOSOM MED, V77, P480, DOI 10.1097/PSY.0000000000000190; Luciano M, 2009, PSYCHOL AGING, V24, P129, DOI 10.1037/a0014780; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mitchell A.J., 2013, COGNITIVE SCREENING, P15, DOI DOI 10.1007/978-1-4471-2452-8_2; Muthen B., 2010, MPLUS USERS GUIDE; Niti M, 2009, J GERONTOL A-BIOL, V64, P306, DOI 10.1093/gerona/gln013; Phillips AC, 2010, J PSYCHOSOM RES, V69, P193, DOI 10.1016/j.jpsychores.2010.01.016; Portella MJ, 2005, AM J PSYCHIAT, V162, P807, DOI 10.1176/appi.ajp.162.4.807; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; R Core Team, 2013, R LANG ENV STAT COMP; Rajan KB, 2014, PSYCHOSOM MED, V76, P101, DOI 10.1097/PSY.0000000000000029; Reynolds CA, 2016, BEHAV GENET, V46, P4, DOI 10.1007/s10519-015-9761-3; Ritchie SJ, 2016, INTELLIGENCE, V59, P115, DOI 10.1016/j.intell.2016.08.007; Ritchie SJ, 2015, DEV PSYCHOL, V51, P573, DOI 10.1037/a0038981; Ritchie SJ, 2014, CURR BIOL, V24, pR681, DOI 10.1016/j.cub.2014.06.012; Sachs-Ericsson N, 2011, AM J GERIAT PSYCHIAT, V19, P23, DOI 10.1097/JGP.0b013e3181f61ae8; Sapkota S, 2016, INT J GERIATR PSYCH, V31, P502, DOI 10.1002/gps.4355; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Scottish Council for Research in Education, 1949, TREND SCOTT INT COMP; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Seeman T, 2010, AM J HUM BIOL, V22, P463, DOI 10.1002/ajhb.21018; Seplaki CL, 2005, EXP GERONTOL, V40, P438, DOI 10.1016/j.exger.2005.03.002; Stephan Y, 2016, PSYCHOSOM MED, V78, P302, DOI 10.1097/PSY.0000000000000281; Sutin AR, 2010, PSYCHOL MED, V40, P1485, DOI 10.1017/S0033291709992029; Sutin AR, 2010, AGE, V32, P513, DOI 10.1007/s11357-010-9153-9; Thompson B., 1996, ANN M MIDS ED RES AS; Wang LJ, 2008, MULTIVAR BEHAV RES, V43, P476, DOI 10.1080/00273170802285941; Wechsler D, 1998, WAIS 3 UK ADM SCORIN; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wiley JF, 2016, PSYCHOSOM MED, V78, P290, DOI 10.1097/PSY.0000000000000288; Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P126; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192604	10.1371/journal.pone.0192604	http://dx.doi.org/10.1371/journal.pone.0192604			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW5PR	29451880	Green Submitted, Green Published, gold			2022-12-26	WOS:000425369800017
J	Limirio, PHJO; da Rocha, HA; de Morais, RB; Hiraki, KRN; Balbi, APC; Soares, PBF; Dechichi, P				Justino Oliveira Limirio, Pedro Henrique; da Rocha Junior, Huberth Alexandre; de Morais, Richarlisson Borges; Nakamura Hiraki, Karen Renata; Coelho Balbi, Ana Paula; Ferreira Soares, Priscilla Barbosa; Dechichi, Paula			Influence of hyperbaric oxygen on biomechanics and structural bone matrix in type 1 diabetes mellitus rats	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; THERAPY; TISSUE; IRRADIATION; MANAGEMENT; GLYCATION; MARKERS; STRESS	Background The aim of this study was to evaluate the biomechanics and structural bone matrix in diabetic rats subjected to hyperbaric oxygen therapy (HBO). Methods Twenty-four male rats were divided into the following groups: Control; Control + HBO; Diabetic, and Diabetic + HBO. Diabetes was induced with streptozotocin (STZ) in the diabetic Groups. After 30 days, HBO was performed every 48h in HBO groups and all animals were euthanized 60 days after diabetic induction. The femur was submitted to a biomechanical (maximum strength, energy-to-failure and stiffness) and Attenuated Total Reflectance Fourier transform infrared (ATR-FTIR) analyses (crosslink ratio, crystallinity index, matrix-to-mineral ratio: Amide I + II/Hydroxyapatite (M:MI) and Amide III + Collagen/HA (M:MIII)). Results In biomechanical analysis, diabetic animals showed lower values of maximum strength, energy and stiffness than non-diabetic animals. However, structural strength and stiffness were increased in groups with HBO compared with non-HBO. ATR-FTIR analysis showed decreased collagen maturity in the ratio of crosslink peaks in diabetic compared with the other groups. The bone from the diabetic groups showed decreased crystallinity compared with non-diabetic groups. M: MI showed no statistical difference between groups. However, M: MIII showed an increased matrix mineral ratio in diabetic+HBO and control+HBO compared with control and diabetic groups. Correlations between mechanical and ATR-FTIR analyses showed significant positive correlation between collagen maturity and stiffness. Conclusions Diabetes decreased collagen maturation and the mineral deposition process, thus reducing biomechanical properties. Moreover, the study showed that HBO improved crosslink maturation and increased maximum strength and stiffness in the femur of T1DM animals.	[Justino Oliveira Limirio, Pedro Henrique; da Rocha Junior, Huberth Alexandre; Nakamura Hiraki, Karen Renata; Dechichi, Paula] Univ Fed Uberlandia, Dept Histol, Uberlandia, MG, Brazil; [de Morais, Richarlisson Borges] Univ Fed Mato Grosso, Fac Nursing, Cuiaba, Mato Grosso, Brazil; [Coelho Balbi, Ana Paula] Univ Fed Uberlandia, Dept Physiol, Uberlandia, MG, Brazil; [Ferreira Soares, Priscilla Barbosa] Univ Fed Uberlandia, Dept Periodontol & Implantol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Mato Grosso; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Dechichi, P (corresponding author), Univ Fed Uberlandia, Dept Histol, Uberlandia, MG, Brazil.	pauladechichi@ufu.br	Soares, Priscilla Barbosa Ferreira/AAK-5851-2020; de Morais, Richarlisson Borges/AAJ-9350-2021; Dechichi, Paula/AAK-8881-2020	Soares, Priscilla Barbosa Ferreira/0000-0002-4492-8957; de Morais, Richarlisson Borges/0000-0003-0009-1750; Hiraki, Karen/0000-0002-9382-4548	Higher Level Personnel Improvement Commission (CAPES/Brazil); Research Support Foundation of the State of Minas Gerais (FAPEMIG/Brazil)	Higher Level Personnel Improvement Commission (CAPES/Brazil); Research Support Foundation of the State of Minas Gerais (FAPEMIG/Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was funded with Higher Level Personnel Improvement Commission (CAPES/Brazil) and Research Support Foundation of the State of Minas Gerais (FAPEMIG/Brazil) to PD assuring independent research and publication of the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hadi H, 2015, J DENT, V43, P382, DOI 10.1016/j.jdent.2014.10.006; Armas LAG, 2012, BONE, V50, P91, DOI 10.1016/j.bone.2011.09.055; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Benetti C, 2015, APPL SPECTROSC, V69, P1496, DOI 10.1366/14-07726; Black E, 2003, ARCH SURG-CHICAGO, V138, P34, DOI 10.1001/archsurg.138.1.34; Boyar H, 2004, ANAL BIOANAL CHEM, V379, P433, DOI 10.1007/s00216-004-2589-y; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1271, DOI [10.1359/JBMR.090201, 10.1359/jbmr.090201]; Gunczler P, 2001, J PEDIATR ENDOCR MET, V14, P525; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Jing D, 2018, BONE, V106, P11, DOI 10.1016/j.bone.2017.10.001; Kanter M, 2004, ANAT REC PART A, V279A, P685, DOI 10.1002/ar.a.20056; Kanter M, 2007, CELL BIOCHEM FUNCT, V25, P747, DOI 10.1002/cbf.1397; Kawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072603; Korres N, 2013, WORLD J ORTHOP, V4, P124, DOI 10.5312/wjo.v4.i3.124; LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P; Levesque C, 2017, NURS CLIN N AM, V52, P589, DOI 10.1016/j.cnur.2017.07.008; Londahl M, 2013, MED CLIN N AM, V97, P957, DOI 10.1016/j.mcna.2013.04.004; Londahl M, 2011, CURR DIABETES REP, V11, P285, DOI 10.1007/s11892-011-0194-y; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Paschalis EP, 2011, CLIN ORTHOP RELAT R, V469, P2170, DOI 10.1007/s11999-010-1751-4; Poundarik AA, 2015, J MECH BEHAV BIOMED, V52, P120, DOI 10.1016/j.jmbbm.2015.08.012; Rocha FS, 2015, OR SURG OR MED OR PA, V120, P581, DOI 10.1016/j.oooo.2015.06.039; Rubin MR, 2017, ANN NY ACAD SCI, V1402, P18, DOI 10.1111/nyas.13463; Saito M, 2015, CALCIFIED TISSUE INT, V97, P242, DOI 10.1007/s00223-015-9985-5; Schwartz Ann V, 2007, Curr Osteoporos Rep, V5, P105; Sunkari VG, 2015, WOUND REPAIR REGEN, V23, P98, DOI 10.1111/wrr.12253; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Tyndall WA, 2003, CLIN ORTHOP RELAT R, P319, DOI 10.1097/01.blo.0000048138.30533.e2; Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62; Wang XF, 2017, ENVIRON POLLUT, V229, P168, DOI 10.1016/j.envpol.2017.04.086; Zhang H, 2017, ALGORITHMS, V10, DOI 10.3390/a10010027	35	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0191694	10.1371/journal.pone.0191694	http://dx.doi.org/10.1371/journal.pone.0191694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451877	gold, Green Published, Green Submitted			2022-12-26	WOS:000425369800006
J	Wang, B; Li, T; Niu, Y; Xiang, J; Cheng, JJ; Liu, B; Zhang, H; Yan, TY; Kanazawa, S; Wu, JL				Wang, Bin; Li, Ting; Niu, Yan; Xiang, Jie; Cheng, Junjie; Liu, Bo; Zhang, Hui; Yan, Tianyi; Kanazawa, Susumu; Wu, Jinglong			Differences in neural responses to ipsilateral stimuli i(n) wide-view fields between face- and house-selective areas	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; CORPUS-CALLOSUM; ORGANIZATION; CONNECTIVITY; REGIONS; REPRESENTATION; INFORMATION; LOCATION; MAPS; MT	Category-selective brain areas exhibit varying levels of neural activity to ipsilaterally presented stimuli. However, in face-and house-selective areas, the neural responses evoked by ipsilateral stimuli in the peripheral visual field remain unclear. In this study, we displayed face and house images using a wide-view visual presentation system while performing functional magnetic resonance imaging (fMRI). The face-selective areas (fusiform face area (FFA) and occipital face area (OFA)) exhibited intense neural responses to ipsilaterally presented images, whereas the house-selective areas (parahippocampal place area (PPA) and transverse occipital sulcus (TOS)) exhibited substantially smaller and even negative neural responses to the ipsilaterally presented images. We also found that the category preferences of the contralateral and ipsilateral neural responses were similar. Interestingly, the face-and house-selective areas exhibited neural responses to ipsilateral images that were smaller than the responses to the contralateral images. Multi-voxel pattern analysis (MVPA) was implemented to evaluate the difference between the contralateral and ipsilateral responses. The classification accuracies were much greater than those expected by chance. The classification accuracies in the FFA were smaller than those in the PPA and TOS. The closer eccentricities elicited greater classification accuracies in the PPA and TOS. We propose that these ipsilateral neural responses might be interpreted by interhemispheric communication through intrahemispheric connectivity of white matter connection and interhemispheric connectivity via the corpus callosum and occipital white matter connection. Furthermore, the PPA and TOS likely have weaker interhemispheric communication than the FFA and OFA, particularly in the peripheral visual field.	[Wang, Bin; Li, Ting; Niu, Yan; Xiang, Jie; Cheng, Junjie] Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan, Shanxi, Peoples R China; [Wang, Bin; Liu, Bo; Zhang, Hui] Shanxi Med Univ, Hosp 1, Dept Radiol, Taiyuan, Shanxi, Peoples R China; [Yan, Tianyi] Beijing Inst Technol, Sch Life Sci, Beijing, Peoples R China; [Kanazawa, Susumu] Okayama Univ, Grad Sch Med, Dent, Pharmaceut Sci, Okayama, Japan; [Wu, Jinglong] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Wu, Jinglong] Beijing Inst Technol, Minist Educ, Key Lab Biomimet Robots & Syst, Beijing, Peoples R China	Taiyuan University of Technology; Shanxi Medical University; Beijing Institute of Technology; Okayama University; Okayama University; Beijing Institute of Technology	Wang, B (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan, Shanxi, Peoples R China.; Wang, B; Zhang, H (corresponding author), Shanxi Med Univ, Hosp 1, Dept Radiol, Taiyuan, Shanxi, Peoples R China.; Yan, TY (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing, Peoples R China.; Wu, JL (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.; Wu, JL (corresponding author), Beijing Inst Technol, Minist Educ, Key Lab Biomimet Robots & Syst, Beijing, Peoples R China.	wangbin01@tyut.edu.cn; zhanghui_mr@163.com; yantianyi@bit.edu.cn; wu@mech.okayama-u.ac.jp	闫, 天翼/ABC-7229-2021	Wang, Bin/0000-0001-7771-5360	National Natural Science Foundation of China [61503272, 61305142, 81471752, 81471652, 81771824]; Natural Science Foundation of Shanxi [2015021090]; China Postdoctoral Science Foundation [2016M601287]; Scientific Research Foundation for Returned Overseas Chinese Scholars; State Education Ministry; Japan Society for the Promotion of Science (JSPS), KAKENHI [25249026, 25303013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was supported by the National Natural Science Foundation of China (61503272, 61305142, 81471752, 81471652, and 81771824), the Natural Science Foundation of Shanxi (2015021090), a project funded by the China Postdoctoral Science Foundation (2016M601287), and the Scientific Research Foundation for Returned Overseas Chinese Scholars, the State Education Ministry, the Japan Society for the Promotion of Science (JSPS), KAKENHI (25249026 and 25303013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the National Natural Science Foundation of China (61503272, 61305142, 81471752, 81471652, and 81771824), the Natural Science Foundation of Shanxi (2015021090), a project funded by the China Postdoctoral Science Foundation (2016M601287), and the Scientific Research Foundation for Returned Overseas Chinese Scholars, the State Education Ministry, the Japan Society for the Promotion of Science (JSPS), and KAKENHI (25249026 and 25303013).	Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; Axelrod V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117126; Berlucchi G, 2014, CORTEX, V56, P1, DOI 10.1016/j.cortex.2013.02.001; Choi US, 2013, NEUROREPORT, V24, P53, DOI 10.1097/WNR.0b013e32835c369a; Cichy RM, 2011, NEUROIMAGE, V54, P2297, DOI 10.1016/j.neuroimage.2010.09.044; Davies-Thompson J, 2012, J NEUROPHYSIOL, V108, P3087, DOI 10.1152/jn.01171.2011; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Dougherty RF, 2005, P NATL ACAD SCI USA, V102, P7350, DOI 10.1073/pnas.0500003102; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fischer E, 2012, CEREB CORTEX, V22, P865, DOI 10.1093/cercor/bhr154; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Golomb J., 2010, J VIS, V10, P950, DOI [10.1167/10.7.950, DOI 10.1167/10.7.950]; Golomb JD, 2011, CEREB CORTEX, V21, P2094, DOI [10.1093/cercor/bhq292, 10.1093/cercor/bhr357]; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Gschwind M, 2012, CEREB CORTEX, V22, P1564, DOI 10.1093/cercor/bhr226; Hanson SJ, 2011, NEUROIMAGE, V54, P1715, DOI 10.1016/j.neuroimage.2010.08.028; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Huk AC, 2002, J NEUROSCI, V22, P7195; Jack AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000452; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kay KN, 2015, CURR BIOL, V25, P595, DOI 10.1016/j.cub.2014.12.050; Kovacs G, 2008, NEUROIMAGE, V43, P156, DOI 10.1016/j.neuroimage.2008.06.042; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; MacEvoy SP, 2007, J NEUROPHYSIOL, V98, P2089, DOI 10.1152/jn.00438.2007; Minnebusch DA, 2009, BEHAV BRAIN RES, V198, P179, DOI 10.1016/j.bbr.2008.10.041; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Pyles JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061611; Quigley M, 2003, AM J NEURORADIOL, V24, P208; Saenz M, 2010, NEUROIMAGE, V52, P1224, DOI 10.1016/j.neuroimage.2010.05.060; Sayres R, 2010, J VIS, V9, P734; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shigihara Y, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00901; Shimono M, 2012, CEREB CORTEX, V22, P337, DOI 10.1093/cercor/bhr108; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072728; Werner NS, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00189; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Witthoft N, VISUAL FIELD COVERAG; Wu JL, 2013, J NEUROSCI METH, V214, P126, DOI 10.1016/j.jneumeth.2013.01.021; Wu JL, 2012, HUM BRAIN MAPP, V33, P1727, DOI 10.1002/hbm.21324	52	0	1	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192532	10.1371/journal.pone.0192532	http://dx.doi.org/10.1371/journal.pone.0192532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451872	gold, Green Published, Green Submitted			2022-12-26	WOS:000425369800016
J	Wen, HB; Jin, W; Ma, XY; Zheng, BQ; Xu, P; Xu, L; Hua, D; Yuan, XH; Gu, RB				Wen, Hai Bo; Jin, Wu; Ma, Xue Yan; Zheng, Bing Qing; Xu, Pao; Xu, Liang; Hua, Dan; Yuan, Xin Hua; Gu, Ruo Bo			Vitro culture of axe-head glochidia in pink heelsplitter Potamilus alatus and mechanism of its high host specialists	PLOS ONE			English	Article							UTTERBACKIA-IMBECILLIS BIVALVIA; POLYUNSATURATED FATTY-ACIDS; WATER MUSSEL GLOCHIDIA; IN-VITRO; HYRIOPSIS-MYERSIANA; METAMORPHOSIS; UNIONIDAE; FISH; PLASMA	The basal media M199 or MEM was utilized in the classical method of vitro culture of glochidia where 1-5% CO2 was required to maintain stable physiological pH for completion of non-parasitic metamorphosis. The classical method encounters a great challenge to those glochidia which undergo development of visceral tissue but significantly increase in size during metamorphosis. The improved in vitro culture techniques and classical methods were firstly compared for non-parasitic metamorphosis and development of glochidia in pink heelsplitter. Based on the improved method, the optimal vitro culture media was further selected from 14 plasmas or sera, realizing the non-parasitic metamorphosis of axe-head glochidia for the first time. The results showed that addition of different plasma (serum) had significant effect on glochidial metamorphosis in pink heelsplitter. Only glochidia in the skewband grunt and red drum groups could complete metamorphosis, the metamorphosis rate in skewband grunt was 93.3 +/- 3.1% at 24 +/- 0.5 degrees C, significantly higher than in marine and desalinated red drum. Heat-inactivated treatment on the plasma of yellow catfish and Barbus capito had significant effect on glochidia survival and shell growth. The metamorphosis rate also varied among different gravid period, and generally decreased with gravid time. Further comparison of free amino acid and fatty acid indicated that the taurine of high concentration was the only amino acid that might promote the rapid growth of glochidial shell, and the lack of adequate DPA and DHA might be an important reason leading to the abnormal foot and visceral development. Combined with our results of artificial selection of host fish, we tentatively established the mechanism of its host specialists in pink heelsplitter for the first time. This is the first report on non-parasite metamorphosis of axe-head glochidia based on our improved vitro culture method, which should provide important reference to fundamental theory research of glochidia metamorphosis and also benefit for better understand of mechanism of host specialists and generalists of Unionidae species.	[Wen, Hai Bo; Ma, Xue Yan; Xu, Pao; Xu, Liang; Yuan, Xin Hua; Gu, Ruo Bo] Nanjing Agr Univ, Wuxi Fishery Coll, Wuxi, Jiangsu, Peoples R China; [Wen, Hai Bo; Jin, Wu; Ma, Xue Yan; Xu, Pao; Yuan, Xin Hua; Gu, Ruo Bo] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Genet Breeding & Aquaculture Biol Freshwa, Wuxi, Jiangsu, Peoples R China; [Wen, Hai Bo; Jin, Wu; Ma, Xue Yan; Zheng, Bing Qing; Xu, Pao; Xu, Liang; Hua, Dan; Yuan, Xin Hua; Gu, Ruo Bo] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, SinoUS Cooperat Int Lab Germplasm Conservat & Uti, Wuxi, Jiangsu, Peoples R China; [Hua, Dan] Tennessee Wildlife Resources Agcy, Cumberland River Aquat Ctr, Nashville, TN USA	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS	Xu, P; Gu, RB (corresponding author), Nanjing Agr Univ, Wuxi Fishery Coll, Wuxi, Jiangsu, Peoples R China.; Xu, P; Gu, RB (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Genet Breeding & Aquaculture Biol Freshwa, Wuxi, Jiangsu, Peoples R China.; Xu, P; Gu, RB (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, SinoUS Cooperat Int Lab Germplasm Conservat & Uti, Wuxi, Jiangsu, Peoples R China.	xup@ffrc.cn; gurb@ffrc.cn			Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2016GH10]; Special Scientific Research Funds for Central Non-profit Institutes of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences [2017JBFM03, 2015JBFM02]; Natural Science Foundation of Jiangsu Province, China [BK20161145]	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences; Special Scientific Research Funds for Central Non-profit Institutes of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This study was supported by the Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (Grant number: 2016GH10), Special Scientific Research Funds for Central Non-profit Institutes of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences (Grant number: 2017JBFM03, 2015JBFM02) and Natural Science Foundation of Jiangsu Province, China (Grant number: BK20161145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arey LB, 1932, J MORPHOL, V53, P201, DOI 10.1002/jmor.1050530108; Brady T, 2004, ELLIPSARIA, V6, P15; Chumnanpuen P, 2011, INVERTEBR REPROD DEV, V55, P40, DOI 10.1080/07924259.2010.548643; Davis Donald Edward, 2000, THERE ARE MOUNTAINS; Fisher GR, 2002, J MOLLUS STUD, V68, P159, DOI 10.1093/mollus/68.2.159; Fisher GR, 2002, INVERTEBR BIOL, V121, P126; Forsyth JS, 2001, CURR OPIN CLIN NUTR, V4, P123, DOI 10.1097/00075197-200103000-00007; Fox TR, 2014, THESIS; Fritts MW, 2013, J MOLLUS STUD, V79, P163, DOI 10.1093/mollus/eyt008; FUKUHARA S, 1990, Venus the Japanese Journal of Malacology, V49, P54; Howells R. G., 1996, FRESHWATER MUSSELS T; Hua D., 2005, THESIS; Hua D, 2007, N AM J AQUACULT, V69, P147, DOI 10.1577/A05-108.1; ISOM BG, 1984, J PARASITOL, V70, P318, DOI 10.2307/3281890; ISOM BG, 1982, NAUTILUS, V96, P147; KanayasuToyoda T, 1996, PROSTAG LEUKOTR ESS, V54, P319, DOI 10.1016/S0952-3278(96)90045-9; KAT PW, 1984, BIOL REV, V59, P189, DOI 10.1111/j.1469-185X.1984.tb00407.x; KELLER AE, 1990, ENVIRON TOXICOL CHEM, V9, P1291, DOI 10.1002/etc.5620091008; Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001; Lima P, 2012, HYDROBIOLOGIA, V691, P21, DOI 10.1007/s10750-012-1078-0; Ma XY, 2017, HYDROBIOLOGIA, P1; MEYERS TR, 1980, J PARASITOL, V66, P274, DOI 10.2307/3280818; Owen C. T., 2009, THESIS; Owen CT, 2010, INVERTEBR REPROD DEV, V54, P187, DOI 10.1080/07924259.2010.9652332; Parmalee P., 1998, FRESHWATER MUSSELS T; Phang M, 2009, PROSTAG LEUKOTR ESS, V81, P35, DOI 10.1016/j.plefa.2009.05.001; Rogers-Lowery CL, 2007, DEV COMP IMMUNOL, V31, P143, DOI 10.1016/j.dci.2006.05.011; Scott W.B., 1973, Bulletin Fish Res Bd Canada, V184, P1; Sietman BE, 2009, ELLIPSARIA, V11, P18; Uthaiwan K, 2002, AQUACULTURE, V209, P197, DOI 10.1016/S0044-8486(01)00870-5; Uthaiwan K, 2001, AQUACULTURE, V195, P61, DOI 10.1016/S0044-8486(00)00541-X; WALLER DL, 1989, DIS AQUAT ORGAN, V6, P81, DOI 10.3354/dao006081; Watters GT, 1997, CAN J ZOOL, V75, P505, DOI 10.1139/z97-062; Watters GT, 1998, AM MIDL NAT, V139, P49; Wen HB, 2015, J MORPHOL, V276, P1273, DOI 10.1002/jmor.20406; Wen Hai-Bo, 2009, Chinese Journal of Zoology, V44, P92; Wen Haibo, 2011, Journal of Wuhan University (Natural Science Edition), V57, P57; Wen HB, 2018, ACTA HYDROB IN PRESS; Xie MQ, 2003, MODERN PARASITOLOGY	39	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192292	10.1371/journal.pone.0192292	http://dx.doi.org/10.1371/journal.pone.0192292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447194	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900027
J	Ramalho, CE; Ottewell, KM; Chambers, BK; Yates, CJ; Wilson, BA; Bencini, R; Barrett, G				Ramalho, Cristina E.; Ottewell, Kym M.; Chambers, Brian K.; Yates, Colin J.; Wilson, Barbara A.; Bencini, Roberta; Barrett, Geoff			Demographic and genetic viability of a medium-sized ground-dwelling mammal in a fire prone, rapidly urbanizing landscape	PLOS ONE			English	Article							SOUTHERN BROWN BANDICOOT; ISOODON-OBESULUS; POPULATION VIABILITY; WESTERN-AUSTRALIA; HABITAT FRAGMENTATION; CONSERVATION BIOLOGY; EXTINCTION RISK; VULPES-VULPES; BIODIVERSITY; MANAGEMENT	The rapid and large-scale urbanization of peri-urban areas poses major and complex challenges for wildlife conservation. We used population viability analysis (PVA) to evaluate the influence of urban encroachment, fire, and fauna crossing structures, with and without accounting for inbreeding effects, on the metapopulation viability of a medium-sized ground-dwelling mammal, the southern brown bandicoot (Isoodon obesulus), in the rapidly expanding city of Perth, Australia. We surveyed two metapopulations over one and a half years, and parameterized the PVA models using largely field-collected data. The models revealed that spatial isolation imposed by housing and road encroachment has major impacts on I. obesulus. Although the species is known to persist in small metapopulations at moderate levels of habitat fragmentation, the models indicate that these populations become highly vulnerable to demographic decline, genetic deterioration, and local extinction under increasing habitat connectivity loss. Isolated metapopulations were also predicted to be highly sensitive to fire, with large-scale fires having greater negative impacts on population abundance than small-scale ones. To reduce the risk of decline and local extirpation of I. obesulus and other small-to medium-sized ground-dwelling mammals in urbanizing, fire prone landscapes, we recommend that remnant vegetation and vegetated, structurally-complex corridors between habitat patches be retained. Well-designed road underpasses can be effective to connect habitat patches and reduce the probability of inbreeding and genetic differentiation; however, adjustment of fire management practices to limit the size of unplanned fires and ensure the retention of long unburnt vegetation will also be required to ensure persistence. Our study supports the evidence that in rapidly urbanizing landscapes, a pro-active conservation approach is required that manages species at the metapopulation level and that prioritizes metapopulations and habitat with greater long-term probability of persistence and conservation capacity, respectively. This strategy may help us prevent future declines and local extirpations, and currently relatively common species from becoming rare.	[Ramalho, Cristina E.; Ottewell, Kym M.; Yates, Colin J.; Wilson, Barbara A.; Barrett, Geoff] Western Australian Dept Biodivers Conservat & Att, Perth, WA, Australia; [Ramalho, Cristina E.] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia; [Chambers, Brian K.; Bencini, Roberta] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia; [Wilson, Barbara A.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic, Australia	University of Western Australia; University of Western Australia; Deakin University	Ramalho, CE (corresponding author), Western Australian Dept Biodivers Conservat & Att, Perth, WA, Australia.; Ramalho, CE (corresponding author), Univ Western Australia, Sch Biol Sci, Perth, WA, Australia.	cristina.ramalho@uwa.edu.au	Kym, Ottewell/I-9875-2019; Chambers, Brian/P-7320-2019	Kym, Ottewell/0000-0002-4273-3224; Bencini, Roberta/0000-0002-6927-5198; Ramalho, Cristina/0000-0001-6538-2060	Main Roads Western Australia; National Environmental Science Program - Clean Air and Urban Landscapes Hub; Clean Air and Urban Landscapes Hub of the National Environmental Science Program	Main Roads Western Australia; National Environmental Science Program - Clean Air and Urban Landscapes Hub; Clean Air and Urban Landscapes Hub of the National Environmental Science Program	This work was supported by Main Roads Western Australia. During part of the writing of this manuscript, CER was supported by the National Environmental Science Program - Clean Air and Urban Landscapes Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Main Roads Western Australia for providing financial and logistical support, the City of Mandurah, Western Power and the Western Australian Department of Biodiversity, Conservation and Attractions for granting approval to conduct this research on their land. We are also grateful for the help provided by a large number of volunteers in conducting the fieldwork. During part of the writing of this manuscript, CER was supported by the Clean Air and Urban Landscapes Hub of the National Environmental Science Program.	Akcakaya H. R., 2005, APPL BIOMATHEMATICS; Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Arthur AD, 2012, AUSTRAL ECOL, V37, P958, DOI 10.1111/j.1442-9993.2011.02355.x; Australian Bureau of Statistics, 2015, 3218 0 D REG POP GRO; BAMFORD MJ, 1992, WILDLIFE RES, V19, P169, DOI 10.1071/WR9920169; Ben-Ami Dror, 2006, Urban Ecosystems, V9, P227, DOI 10.1007/s11252-006-9353-3; Bolger DT, 1997, ECOL APPL, V7, P552, DOI 10.1890/1051-0761(1997)007[0552:RORTHF]2.0.CO;2; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Brito D, 2000, ANIM CONSERV, V3, P201; Brook BW, 2002, CONSERV ECOL, V6; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; BROUGHTON SK, 1991, AUST J ECOL, V16, P71, DOI 10.1111/j.1442-9993.1991.tb01482.x; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Catling PC, 2001, WILDLIFE RES, V28, P555, DOI 10.1071/WR00041; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chambers B, 2015, ANIM CONSERV, V18, P424, DOI 10.1111/acv.12189; Claridge AW, 2010, FOREST ECOL MANAG, V260, P822, DOI 10.1016/j.foreco.2010.05.041; Claridge AW, 2000, AUSTRAL ECOL, V25, P676, DOI 10.1111/j.1442-9993.2000.tb00074.x; Coates T. D., 2003, Australian Mammalogy, V25, P107; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dowle M, 2009, EUR J WILDLIFE RES, V55, P45, DOI 10.1007/s10344-008-0212-9; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Fischer JD, 2012, BIOSCIENCE, V62, P809, DOI 10.1525/bio.2012.62.9.6; FitzGibbon SI, 2007, LANDSCAPE ECOL, V22, P1513, DOI 10.1007/s10980-007-9139-x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Griffiths AD, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00519.1; Griffiths AD, 2015, BIOL CONSERV, V186, P337, DOI 10.1016/j.biocon.2015.03.021; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Harris IM, 2010, WILDLIFE RES, V37, P127, DOI 10.1071/WR09040; Hillman A, 2016, AUST MAMMAL, V38, P253, DOI 10.1071/AM15045; Hillman AE, 2017, SCI TOTAL ENVIRON, V607, P1466, DOI 10.1016/j.scitotenv.2017.07.086; Hone J, 2010, J APPL ECOL, V47, P507, DOI 10.1111/j.1365-2664.2010.01812.x; Howard K. H., 2014, REPORT PREPARED WWF; Johnson CN, 2009, AUSTRAL ECOL, V34, P35, DOI 10.1111/j.1442-9993.2008.01878.x; Kelly LT, 2015, CONSERV BIOL, V29, P473, DOI 10.1111/cobi.12384; Kelly LT, 2011, DIVERS DISTRIB, V17, P462, DOI 10.1111/j.1472-4642.2011.00754.x; Lacy R.C., 2014, VORTEX STOCHASTIC SI; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Li Y, 2015, CONSERV GENET, V16, P331, DOI 10.1007/s10592-014-0661-5; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Lizee MH, 2011, ECOL INDIC, V11, P353, DOI 10.1016/j.ecolind.2010.06.003; Magle SB, 2009, ANIM CONSERV, V12, P192, DOI 10.1111/j.1469-1795.2009.00237.x; McCarthy MA, 2001, ANIM CONSERV, V4, P351, DOI 10.1017/S136794300100141X; McCarthy MA, 2000, J ANIM ECOL, V69, P599, DOI 10.1046/j.1365-2656.2000.00415.x; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; National Health and Medical Research Council (NHMRC) Nh, 2013, AUSTR COD CAR US AN; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Ottewell K, 2014, BIOL CONSERV, V171, P209, DOI 10.1016/j.biocon.2014.01.012; PAULL D, 1995, WILDLIFE RES, V22, P585, DOI 10.1071/WR9950585; Paull D. J., 2008, MAMMALS AUSTR, P180; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; Ramalho CE, 2014, ECOLOGY, V95, P2466, DOI 10.1890/13-1239.1; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; Rayner L, 2015, DIVERS DISTRIB, V21, P428, DOI 10.1111/ddi.12293; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rose RW, 1997, J ZOOL, V243, P523, DOI 10.1111/j.1469-7998.1997.tb02798.x; Saito MU, 2015, ACTA OECOL, V67, P34, DOI 10.1016/j.actao.2015.06.002; Sawaya MA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1705; Soanes K, 2018, J APPL ECOL, V55, P129, DOI 10.1111/1365-2664.12966; Southwell DM, 2008, CONSERV BIOL, V22, P1045, DOI 10.1111/j.1523-1739.2008.00934.x; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; STODDART DM, 1979, J ANIM ECOL, V48, P165, DOI 10.2307/4107; Sunnucks P, 2015, HANDBOOK OF ROAD ECOLOGY, P110; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Taylor BD, 2014, AUST MAMMAL, V36, P178, DOI 10.1071/AM13034; Taylor BD, 2009, ECOL SOC, V14; Thomas L.N., 1990, P335; THOMPSON MB, 1989, AUST WILDLIFE RES, V16, P117, DOI 10.1071/WR9890117; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; van der Ree R, 2005, ANIM CONSERV, V8, P309, DOI 10.1017/S1367943005002258; van der Ree R, 2009, ECOL SOC, V14; Vellend M, 2013, ANIM CONSERV, V16, P14, DOI 10.1111/acv.12023; Villasenor NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097036; White GC, 1997, PROGRAM MARK MARK RE; Wolf KM, 2017, JOURNAL OF APPLIED E	82	11	11	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191190	10.1371/journal.pone.0191190	http://dx.doi.org/10.1371/journal.pone.0191190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444118	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500013
J	Ahn, SY; Goo, JM; Lee, KH; Ha, S; Paeng, JC				Ahn, Su Yeon; Goo, Jin Mo; Lee, Kyung Hee; Ha, Seunggyun; Paeng, Jin Chul			Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; DCE-MRI; THERAPY; ENDOSTATIN; PHOSPHATE; RAT	Objectives To determine whether the CKD-516 produces a significant change in vascular and metabolic parameters in PET/MRI Materials and methods With institutional Animal Care and Use Committee approval, 18 VX2 carcinoma tumors implanted in bilateral back muscles of 9 rabbits were evaluated. Serial PET/MRI were performed before, 4 hours after and 1-week after vascular disrupting agent, CKD-516 at a dose of 0.7 mg/kg (treated group, n = 10) or saline (control group, n = 8) administration. PET/MRI-derived parameters and their interval changes were compared between the treated and control group by using the linear mixed model. Each parameter within each group was also compared by using the linear mixed model. Results Changes of the volume transfer coefficient (K-trans) and the initial area under the gadolinium concentration-time curve until 60 seconds (iAUC) in the treated group were significantly larger compared with those in the control group at 4-hour follow-up (mean, -39.91% vs. -6.04%, P = 0.018; and -49.71% vs. + 6.23%, P = 0.013). Change of metabolic tumor volume (MTV) in the treated group was significantly smaller compared with that in the control group at 1-week follow-up (mean, + 118.34% vs. + 208.87%, P = 0.044). Serial measurements in the treated group revealed that K trans and iAUC decreased at 4-hour follow-up (P < 0.001) and partially recovered at 1-week follow-up (P = 0.001 and 0.024, respectively). MTV increased at a 4-hour follow-up (P = 0.038) and further increased at a 1-week follow-up (P < 0.001), while total lesion glycolysis (TLG) did not show a significant difference between the time points. SUVmax and SUVmean did not show significant interval changes between time points (P > 0.05). Conclusions PET/MRI is able to monitor the changes of vascular and metabolic parameters at different time points simultaneously, and confirmed that vascular changes precede the metabolic changes by VDA, CKD-516.	[Ahn, Su Yeon; Goo, Jin Mo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ahn, Su Yeon; Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Goo, Jin Mo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Kyung Hee] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea; [Ha, Seunggyun; Paeng, Jin Chul] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Goo, JM (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Goo, JM (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Goo, JM (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	jmgoo@plaza.snu.ac.kr		Goo, Jin Mo/0000-0003-1791-7942	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2063746]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2063746).	Chen FX, 2012, ITAL J PURE APPL MAT, P7; Desar IME, 2009, CANCER TREAT REV, V35, P309, DOI 10.1016/j.ctrv.2008.12.001; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Emir E, 2005, EUR J CANCER, V41, P799, DOI 10.1016/j.ejca.2005.01.001; Galbraith SM, 2003, J CLIN ONCOL, V21, P2831, DOI 10.1200/JCO.2003.05.187; Herbst RS, 2002, J CLIN ONCOL, V20, P3804, DOI 10.1200/JCO.2002.05.102; Joo I, 2016, RADIOLOGY, V278, P104, DOI 10.1148/radiol.2015141974; Joo I, 2014, RADIOLOGY, V272, P417, DOI 10.1148/radiol.14131165; Kidd JG, 1940, J EXP MED, V71, P813, DOI 10.1084/jem.71.6.813; Kim KW, 2013, INVEST NEW DRUG, V31, P1097, DOI 10.1007/s10637-012-9915-6; Lee J, 2010, J MED CHEM, V53, P6337, DOI 10.1021/jm1002414; Lee KH, 2017, ANTICANCER RES, V37, P1139, DOI 10.21873/anticanres.11427; Liang WJ, 2016, ONCOTARGET, V7, P15444, DOI 10.18632/oncotarget.6999; Liu YJ, 2012, ONCOL LETT, V4, P685, DOI 10.3892/ol.2012.819; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Moon J, 2016, J APPL CLIN MED PHYS, V17, P418, DOI 10.1120/jacmp.v17i5.6314; Mross K, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-5; Mullamitha SA, 2007, CLIN CANCER RES, V13, P2128, DOI 10.1158/1078-0432.CCR-06-2779; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Pichler BJ, 2010, J NUCL MED, V51, P333, DOI 10.2967/jnumed.109.061853; Shiomi Masashi, 2009, P49, DOI 10.1007/978-90-481-2227-1_7; Spear MA, 2011, CURR DRUG TARGETS, V12, P2009; Thoeny HC, 2005, RADIOLOGY, V237, P492, DOI 10.1148/radiol.2372041638; Thomas JP, 2003, J CLIN ONCOL, V21, P223, DOI 10.1200/JCO.2003.12.120; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Van de Wiele C, 2013, EUR J NUCL MED MOL I, V40, P290, DOI 10.1007/s00259-012-2280-z; Wang HJ, 2010, EUR RADIOL, V20, P2013, DOI 10.1007/s00330-010-1743-5; Wehrl HF, 2009, EUR J NUCL MED MOL I, V36, P56, DOI 10.1007/s00259-009-1078-0	30	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192706	10.1371/journal.pone.0192706	http://dx.doi.org/10.1371/journal.pone.0192706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438381	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400045
J	Li, J; Piermattei, A; Wang, P; Kang, SW; Xiao, MY; Tang, B; Liao, XF; Xin, X; Grusio, M; Orlandini, LC				Li, Jie; Piermattei, Angelo; Wang, Pei; Kang, Shengwei; Xiao, Mingyong; Tang, Bin; Liao, Xiongfei; Xin, Xin; Grusio, Mattia; Orlandini, Lucia Clara			Setup in a clinical workflow and impact on radiotherapy routine of an in vivo dosimetry procedure with an electronic portal imaging device	PLOS ONE			English	Article							EPID DOSIMETRY; EXPERIENCE; VERIFICATION; SYSTEM; IMRT	High conformal techniques such as intensity-modulated radiation therapy and volumetric-modulated arc therapy are widely used in overloaded radiotherapy departments. In vivo dosimetric screening is essential in this environment to avoid important dosimetric errors. This work examines the feasibility of introducing in vivo dosimetry (IVD) checks in a radiotherapy routine. The causes of dosimetric disagreements between delivered and planned treatments were identified and corrected during the course of treatment. The efficiency of the corrections performed and the added workload needed for the entire procedure were evaluated. The IVD procedure was based on an electronic portal imaging device. A total of 3682 IVD tests were performed for 147 patients who underwent head and neck, abdomen, pelvis, breast, and thorax radiotherapy treatments. Two types of indices were evaluated and used to determine if the IVD tests were within tolerance levels: the ratio R between the reconstructed and planned isocentre doses and a transit dosimetry based on the gamma-analysis of the electronic portal images. The causes of test outside tolerance level were investigated and corrected and IVD test was repeated during subsequent fraction. The time needed for each step of the IVD procedure was registered. Pelvis, abdomen, and head and neck treatments had 10% of tests out of tolerance whereas breast and thorax treatments accounted for up to 25%. The patient setup was the main cause of 90% of the IVD tests out of tolerance and the remaining 10% was due to patient morphological changes. An average time of 42 min per day was sufficient to monitor a daily workload of 60 patients in treatment. This work shows that IVD performed with an electronic portal imaging device is feasible in an overloaded department and enables the timely realignment of the treatment quality indices in order to achieve a patient's final treatment compliant with the one prescribed.	[Li, Jie; Wang, Pei; Kang, Shengwei; Xiao, Mingyong; Tang, Bin; Liao, Xiongfei; Xin, Xin; Orlandini, Lucia Clara] Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China; [Piermattei, Angelo; Grusio, Mattia] Fdn Policlin Univ Agostino Gemelli, UOC Fis Sanit, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Wang, P (corresponding author), Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China.	dengwangpei@163.com						Andreo P, 2000, REPORT NEWSMAGAZ OCT, V11; British Institute of Radiology IoPaEiM Society an College of Radiographers The Royal College of Radiologists, 2008, IMPL VIV DOS; Celi S, 2016, J APPL CLIN MED PHYS, V17, P262, DOI 10.1120/jacmp.v17i3.6070; Cilia S, 2007, PHYS MEDICA, V23, P25, DOI 10.1016/j.ejmp.2006.12.001; Cilla S, 2016, PHYS MEDICA, V32, P52, DOI 10.1016/j.ejmp.2015.09.007; Dunlop A, 2015, STRAHLENTHER ONKOL, V191, P970, DOI 10.1007/s00066-015-0890-7; Fidanzio A, 2016, RADIOTHER ONCOL, V119, pS852, DOI 10.1016/S0167-8140(16)33068-7; Fidanzio A, 2014, MED PHYS, V41, DOI 10.1118/1.4875685; Ford EC, 2012, INT J RADIAT ONCOL, V84, pE263, DOI 10.1016/j.ijrobp.2012.04.036; Francois P, 2011, PHYS MEDICA, V27, P1, DOI 10.1016/j.ejmp.2010.06.002; Fuangrod T, 2017, INT J HEALTH CARE Q, V30, P90, DOI 10.1108/IJHCQA-03-2016-0028; Fuangrod T, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0682-y; Hansen EK, 2006, INT J RADIAT ONCOL, V64, P355, DOI 10.1016/j.ijrobp.2005.07.957; Hartford AC, 2012, AM J CLIN ONCOL-CANC, V35, P612, DOI 10.1097/COC.0b013e31826e0515; Holm L, 2000, 20004 SSI; Klein EE, 2009, MED PHYS, V36, P4197, DOI 10.1118/1.3190392; Kruse JJ, 2010, MED PHYS, V37, P2516, DOI 10.1118/1.3425781; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Mans A, 2010, MED PHYS, V37, P2638, DOI 10.1118/1.3397807; McCowan PM, 2017, INT J RADIAT ONCOL, V97, P1077, DOI 10.1016/j.ijrobp.2017.01.227; McDermott LN, 2007, INT J RADIAT ONCOL, V67, P1568, DOI 10.1016/j.ijrobp.2006.11.047; McKenzie EM, 2014, MED PHYS, V41, DOI 10.1118/1.4899177; Mijnheer B, 2013, MED PHYS, V40, DOI 10.1118/1.4811216; Mijnheer BJ, 2015, PRACT RADIAT ONCOL, V5, pE679, DOI 10.1016/j.prro.2015.07.001; Piermattei A, 2015, NUCL INSTRUM METH A, V796, P93, DOI 10.1016/j.nima.2015.02.024; Piermattei A, 2006, MED PHYS, V33, P4414, DOI 10.1118/1.2360014; Piermattei A, 2012, NUCL INSTRUM METH B, V274, P42, DOI 10.1016/j.nimb.2011.12.004; Piermattei A, 2009, MED PHYS, V36, P2206, DOI 10.1118/1.3129158; Ricketts K, 2016, INT J RADIAT ONCOL, V95, P1513, DOI 10.1016/j.ijrobp.2016.03.021; Yorke E AR, 2005, MED PHYS, V87; [No title captured]	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192686	10.1371/journal.pone.0192686	http://dx.doi.org/10.1371/journal.pone.0192686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432473	Green Published, Green Submitted, gold			2022-12-26	WOS:000424814300036
J	Madugundu, R; Al-Gaadi, KA; Tola, E; Hassaballa, AA; Kayad, AG				Madugundu, Rangaswamy; Al-Gaadi, Khalid A.; Tola, ElKamil; Hassaballa, Abdalhaleem A.; Kayad, Ahmed G.			Utilization of Landsat-8 data for the estimation of carrot and maize crop water footprint under the arid climate of Saudi Arabia	PLOS ONE			English	Article							VIRTUAL WATER; CONSUMPTION; GREEN; BLUE; RESOURCES; NATIONS; TRADE	The crop Water Footprint (WF) can provide a comprehensive knowledge of the use of water through the demarcation of the amount of the water consumed by different crops. The WF has three components: green (WFg), blue (WFb) and grey (WFgr) water footprints. The WFg refers to the rainwater stored in the root zone soil layer and is mainly utilized for agricultural, horticultural and forestry production. The WFb, however, is the consumptive use of water from surface or groundwater resources and mainly deals with irrigated agriculture, industry, domestic water use, etc. While the WFgr is the amount of fresh water required to assimilate pollutants resulting from the use of fertilizers/agrochemicals. This study was conducted on six agricultural fields in the Eastern region of Saudi Arabia, during the period from December 2015 to December 2016, to investigate the spatiotemporal variation of the WF of silage maize and carrot crops. The WF of each crop was estimated in two ways, namely agro-meteorological (WFAgro) and remote sensing (WFRS) methods. The blue, green and grey components of WFAgro were computed with the use of weather station/Eddy covariance measurements and field recorded crop yield datasets. The WFRS estimated by applying surface energy balance principles on Landsat-8 imageries. However, due to non-availability of Landsat-8 data on the event of rainy days, this study was limited to blue component (WFRS-b). The WFAgro of silage maize was found to range from 3545 m(3) t(-1) to 4960 m(3) t(-1); on an average, the WFAgro-g, WFAgro-b, and WFAgro-gr are composed of < 1%, 77%, and 22%, respectively. In the case of carrot, the WFAgro ranged between 297 m(3) t(-1) and 502 m(3) t(-1). The WFAgro-g of carrot crop was estimated at < 1%, while WFAgro-b and WFAgro-gr was 67% and 32%, respectively. The WFAgro-b is occupied as a major portion in WF of silage maize (77%) and carrot (68%) crops. This is due to the high crop water demand combined with a very erratic rainfall, the irrigation is totally provided using groundwater delivered by center pivot irrigation systems. On the other hand, the WFRS-b estimated using Landsat-8 data was varied from 276 (+/- 73) m(3) t(-1) (carrot) and 2885 (+/- 441) m(3) t(-1) (silage maize). The variation (RMSE) between WFRS-b and WFAgro-b was about 17% and 14% for silage maize and carrot crops, respectively.	[Madugundu, Rangaswamy; Al-Gaadi, Khalid A.; Tola, ElKamil; Hassaballa, Abdalhaleem A.; Kayad, Ahmed G.] King Saud Univ, Precis Agr Res, Riyadh, Saudi Arabia; [Al-Gaadi, Khalid A.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Hassaballa, Abdalhaleem A.] Univ Khartoum, Dept Agr Engn, Fac Engn, Khartoum, Sudan	King Saud University; King Saud University; University of Khartoum	Madugundu, R (corresponding author), King Saud Univ, Precis Agr Res, Riyadh, Saudi Arabia.	rmadugundu@ksu.edu.sa	Tola, ElKamil/AAX-8777-2021; Hassaballa, Abdalhaleem/AAV-4851-2021; Tola, ElKamil/E-8523-2017; Madugundu, Rangaswamy/N-9214-2013; Kayad, Ahmed/E-7601-2017; Hassaballa, Abdalhaleem/AAB-7566-2022; Hassaballa, Abdalhaleem/AGG-0578-2022	Tola, ElKamil/0000-0003-0927-9688; Madugundu, Rangaswamy/0000-0002-5326-4785; Kayad, Ahmed/0000-0003-3396-938X; Hassaballa, Abdalhaleem/0000-0001-5881-7273; 	King Saud University, Riyadh, Saudi Arabia; Deanship of Scientific Research, King Saud University	King Saud University, Riyadh, Saudi Arabia(King Saud University); Deanship of Scientific Research, King Saud University(King Saud University)	This study was financially supported by Vice Deanship of Research Chairs, King Saud University, Riyadh, Saudi Arabia. Todhia Arable Farm (TAF) has provided the support in the form of making the field (the study area), sharing data on agricultural practices. However, both the TAF and funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; The authors are grateful to the Deanship of Scientific Research, King Saud University for funding through the Vice Deanship of Scientific Research Chairs. The unstinted cooperation and support extended by the staff of the Todhia Arable Farm, Saudi Arabia in carrying out the field research work are gratefully acknowledged.	Al-Zeid AA, 1988, CROP WATER REQUIREME; Aldaya MM, 2008, VALUE WATER RES REPO; Allan JA, 1998, GROUND WATER, V36, P545, DOI 10.1111/j.1745-6584.1998.tb02825.x; Allen R.G., 1998, FAO IRRIGATION DRAIN, DOI DOI 10.1016/J.EJA.2010.12.001; Allen RG, 2005, ASCE STANDARDIZED RE; Bulsink F, 2010, HYDROL EARTH SYST SC, V14, P119, DOI 10.5194/hess-14-119-2010; Cao XC, 2014, WATER RESOUR MANAG, V28, P2213, DOI 10.1007/s11269-014-0607-1; Chapagain A., 2008, UK WATER FOOTPRINT I, V1; Chapagain AK, 2006, ECOL ECON, V60, P186, DOI 10.1016/j.ecolecon.2005.11.027; Chapagain AM, 2011, ECOL ECON, V70, P749, DOI 10.1016/j.ecolecon.2010.11.012; Chowdhury S, 2013, J WATER REUSE DESAL, V3, P297, DOI 10.2166/wrd.2013.082; Fader M, 2011, HYDROL EARTH SYST SC, V15, P1641, DOI 10.5194/hess-15-1641-2011; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE; Hoekstra AY, 2005, GLOBAL ENVIRON CHANG, V15, P45, DOI 10.1016/j.gloenvcha.2004.06.004; Jury WA, 2005, P NATL ACAD SCI USA, V102, P15715, DOI 10.1073/pnas.0506467102; Kuo SF, 2006, AGR WATER MANAGE, V82, P433, DOI 10.1016/j.agwat.2005.08.002; Liu JG, 2010, J HYDROL, V384, P187, DOI 10.1016/j.jhydrol.2009.11.024; Ma J, 2006, PHILOS T R SOC B, V361, P835, DOI 10.1098/rstb.2005.1644; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Multsch S, 2017, INT J WATER RESOUR D, V33, P292, DOI 10.1080/07900627.2016.1168286; Multsch S, 2013, GEOSCI MODEL DEV, V6, P1043, DOI 10.5194/gmd-6-1043-2013; Multsch S, 2011, P 19 INT C MOD SIM P; Oki T, 2004, WATER SCI TECHNOL, V49, P203, DOI 10.2166/wst.2004.0456; Rajeshwari A., 2014, INT J RES ENG TECHNO, V3, P122, DOI [10.15623/ijret.2014.0305025, DOI 10.15623/IJRET.2014.0305025]; Romaguera M, 2010, REMOTE SENS-BASEL, V2, P1177, DOI 10.3390/rs2041177; Rosegrant M.W., 2002, GLOBAL WATER OUTLOOK; Savva A, 2002, IRRIGATION MANUAL PL, VIV, P82; Senay GB, 2013, J AM WATER RESOUR AS, V49, P577, DOI 10.1111/jawr.12057; Shrestha S, 2013, WATER RESOUR MANAG, V27, P5223, DOI 10.1007/s11269-013-0464-3; Srinivasan V, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011087; Struzik P, 2014, PROC SPIE, V9229, DOI 10.1117/12.2066093; Tampouratizi VL, 2015, P 14 INT C ENV SCI T; Tuninetti M, 2015, WATER RESOUR RES, V51, P8257, DOI 10.1002/2015WR017148; USGS, 2013, US USGS LANDS 8 PROD; van Oel PR, 2009, ECOL ECON, V69, P82, DOI 10.1016/j.ecolecon.2009.07.014; Verma S, 2009, PHYS CHEM EARTH, V34, P261, DOI 10.1016/j.pce.2008.05.002; WEF, 2016, GLOB RISKS REP 2016; Yang H, 2006, HYDROL EARTH SYST SC, V10, P443, DOI 10.5194/hess-10-443-2006; Zimmer D., 2003, VALUE WATER RES REPO, V12, P1	40	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192830	10.1371/journal.pone.0192830	http://dx.doi.org/10.1371/journal.pone.0192830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV8DE	29432446	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300050
J	Moroni, F; Magnoni, M; Vergani, V; Ammirati, E; Camici, PG				Moroni, Francesco; Magnoni, Marco; Vergani, Vittoria; Ammirati, Enrico; Camici, Paolo G.			Fractal analysis of plaque border, a novel method for the quantification of atherosclerotic plaque contour irregularity, is associated with pro-atherogenic plasma lipid profile in subjects with non-obstructive carotid stenoses	PLOS ONE			English	Article							ISCHEMIC-STROKE; SURFACE-MORPHOLOGY; HDL-CHOLESTEROL; RISK; RATIO; TRIGLYCERIDES	Background and aims Plaque border irregularity is a known imaging characteristic of vulnerable plaques, but its evaluation heavily relies on subjective evaluation and operator expertise. Aim of the present work is to propose a novel fractal-analysis based method for the quantification of atherosclerotic plaque border irregularity and assess its relation with cardiovascular risk factors. Methods and results Forty-two asymptomatic subjects with carotid stenosis underwent ultrasound evaluation and assessment of cardiovascular risk factors. Total, low-density lipoprotein (LDL), high-density lipoprotein (HDL) plasma cholesterol and triglycerides concentrations were measured for each subject. Fractal analysis was performed in all the carotid segments affected by atherosclerosis, i.e. 147 segments. The resulting fractal dimension (FD) is a measure of irregularity of plaque profile on long axis view of the plaque. FD in the severest stenosis (main plaque FD, mFD) was 1.136 +/- 0.039. Average FD per patient (global FD, gFD) was 1.145 +/- 0.039. FD was independent of other plaque characteristics. mFD significantly correlated with plasma HDL (r = -0.367, p = 0.02) and triglycerides-to-HDL ratio (r = 0.480, p = 0.002). Conclusions Fractal analysis is a novel, readily available, reproducible and inexpensive technique for the quantitative measurement of plaque irregularity. The correlation between low HDL levels and plaque FD suggests a role for HDL in the acquisition of morphologic features of plaque instability. Further studies are needed to validate the prognostic value of fractal analysis in carotid plaques evaluation.	[Moroni, Francesco; Magnoni, Marco; Vergani, Vittoria; Ammirati, Enrico; Camici, Paolo G.] Univ Vita Salute San Raffaele, Cardiothorac & Vasc Dept, Milan, Italy; [Moroni, Francesco; Magnoni, Marco; Vergani, Vittoria; Ammirati, Enrico; Camici, Paolo G.] Osped San Raffaele, Milan, Italy; [Ammirati, Enrico] Osped Niguarda Ca Granda, De Gasperis Cardio Ctr, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Moroni, F (corresponding author), Univ Vita Salute San Raffaele, Cardiothorac & Vasc Dept, Milan, Italy.; Moroni, F (corresponding author), Osped San Raffaele, Milan, Italy.	moroni.francesco@hsr.it	magnoni, marco/AAG-5312-2019; Camici, Paolo/AAN-1959-2020; Ammirati, Enrico/AAA-9961-2020	magnoni, marco/0000-0002-3748-2360; Camici, Paolo/0000-0001-5584-0750; Ammirati, Enrico/0000-0002-1676-5257; Moroni, Francesco/0000-0002-6101-1403	Italian Ministry of Health [GR-2009-1608780]; "Giovane Ricercatore Grant" from Italian Health Ministry [GR-2009-1608780]	Italian Ministry of Health(Ministry of Health, Italy); "Giovane Ricercatore Grant" from Italian Health Ministry	This work received support from GR-2009-1608780 by the Italian Ministry of Health (http://www.salute.gov.it/portale/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E.A. received funds by the "Giovane Ricercatore 2009 Grant" from Italian Health Ministry (project code GR-2009-1608780).	Ahammer H, 2004, CHAOS, V14, P183, DOI 10.1063/1.1638947; Ammirati E, 2016, ATHEROSCLEROSIS, V255, P171, DOI 10.1016/j.atherosclerosis.2016.10.004; Ammirati E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/718329; Boizel R, 2000, DIABETES CARE, V23, P1679, DOI 10.2337/diacare.23.11.1679; Brinjikji W, 2016, J NEUROSURG, V124, P27, DOI 10.3171/2015.1.JNS142452; Campbell S, 2013, EXPERT REV CARDIOVAS, V11, P343, DOI [10.1586/ERC.13.17, 10.1586/erc.13.17]; Captur G, 2017, NAT REV CARDIOL, V14, P56, DOI 10.1038/nrcardio.2016.161; Captur G, 2014, CIRC-CARDIOVASC GENE, V7, P241, DOI 10.1161/CIRCGENETICS.113.000362; Captur G, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-36; Chiu B, 2009, PHYS MED BIOL, V54, P1149, DOI 10.1088/0031-9155/54/5/004; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Gomory R, 2010, NATURE, V468, P378, DOI 10.1038/468378a; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; John AM, 2015, REV NEUROSCIENCE, V26, P633, DOI 10.1515/revneuro-2015-0011; Kanber B., 2013, CARDIOVASC ULTRASOUN, V11; Kim TN, 2010, CIRC-CARDIOVASC IMAG, V3, P142, DOI 10.1161/CIRCIMAGING.109.888909; Lennon FE, 2015, NAT REV CLIN ONCOL, V12, P664, DOI 10.1038/nrclinonc.2015.108; Millan-Nunez J, 2016, CURR PHARM DESIGN, V22, P365, DOI 10.2174/1381612822666151112150831; Moroni F, 2016, INT J CARDIOL, V223, P681, DOI 10.1016/j.ijcard.2016.08.234; Newby AC, 2016, EXP PHYSIOL, V101, P1327, DOI 10.1113/EP085567; Orlandi A, 2000, ARTERIOSCL THROM VAS, V20, P1123, DOI 10.1161/01.ATV.20.4.1123; Perez HA, 2016, ARCH MED SCI, V12, P513, DOI 10.5114/aoms.2016.59924; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; Pourcelot L, 1999, Minerva Cardioangiol, V47, P15; Prabhakaran S, 2006, STROKE, V37, P2696, DOI 10.1161/01.STR.0000244780.82190.a4; Prati P, 2011, CEREBROVASC DIS, V31, P300, DOI 10.1159/000320852; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062008; Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245; Rothwell PM, 2000, STROKE, V31, P615, DOI 10.1161/01.STR.31.3.615; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sigala F, 2010, J VASC SURG, V52, P704, DOI 10.1016/j.jvs.2010.03.047; Tegos TJ, 2001, AM J NEURORADIOL, V22, P1605; Teng ZZ, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003439; Tiozzo E, 2014, ATHEROSCLEROSIS, V237, P163, DOI 10.1016/j.atherosclerosis.2014.09.002; Urbina EM, 2013, PEDIATRICS, V131, pE1082, DOI 10.1542/peds.2012-1726	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192600	10.1371/journal.pone.0192600	http://dx.doi.org/10.1371/journal.pone.0192600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432486	gold, Green Submitted, Green Published			2022-12-26	WOS:000424814300031
J	Sanjo, H; Komeya, M; Sato, T; Abe, T; Katagiri, K; Yamanaka, H; Ino, Y; Arakawa, N; Hirano, H; Yao, T; Asayama, Y; Matsuhisa, A; Yao, M; Ogawa, T				Sanjo, Hiroyuki; Komeya, Mitsuru; Sato, Takuya; Abe, Takeru; Katagiri, Kumiko; Yamanaka, Hiroyuki; Ino, Yoko; Arakawa, Noriaki; Hirano, Hisashi; Yao, Tatsuma; Asayama, Yuta; Matsuhisa, Akio; Yao, Masahiro; Ogawa, Takehiko			In vitro mouse spermatogenesis with an organ culture method in chemically defined medium	PLOS ONE			English	Article							RETINOIC ACID; TESTIS TISSUES; VITAMIN-A; CELL DEVELOPMENT; SPERM; DIFFERENTIATION; SPERMATOGONIA; FERTILITY; SYSTEM; STRA8	We previously reported the successful induction and completion of mouse spermatogenesis by culturing neonatal testis tissues. The culture medium consisted of alpha-minimum essential medium (alpha-MEM),supplemented with Knockout serum replacement (KSR) or AlbuMAX, neither of which were defined chemically. In this study, we formulated a chemically defined medium (CDM) that can induce mouse spermatogenesis under organ culture conditions. It was found that bovine serum albumin (BSA) purified through three different procedures had different effects on spermatogenesis. We also confirmed that retinoic acid (RA) played crucial roles in the onset of spermatogonial differentiation and meiotic initiation. The added lipids exhibited weak promoting effects on spermatogenesis. Lastly, luteinizing hormone (LH), follicle stimulating hormone (FSH), triiodothyronine (T3), and testosterone (T) combined together promoted spermatogenesis until round spermatid production. The CDM, however, was not able to produce elongated spermatids. It was also unable to induce spermatogenesis from the very early neonatal period, before 2 days postpartum, leaving certain factors necessary for spermatogenic induction in mice unidentified. Nonetheless, the present study provided important basic information on testis organ culture and spermatogenesis in vitro.	[Sanjo, Hiroyuki; Komeya, Mitsuru; Yamanaka, Hiroyuki; Yao, Masahiro; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan; [Sato, Takuya; Abe, Takeru; Katagiri, Kumiko; Ogawa, Takehiko] Yokohama City Univ, Assoc Med Sci, Lab Biopharmaceut & Regenerat Sci, Inst Mol Med & Life Sci, Yokohama, Kanagawa, Japan; [Ino, Yoko; Arakawa, Noriaki; Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan; [Arakawa, Noriaki] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Yokohama, Kanagawa, Japan; [Yao, Tatsuma; Asayama, Yuta; Matsuhisa, Akio] Fuso Pharmaceut Ind Ltd, Ctr Res & Dev, Osaka, Japan; [Arakawa, Noriaki] Natl Inst Hlth Sci, Setagaya Ku, Tokyo, Japan	Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Fuso Pharmaceutical Industries, Ltd.; National Institute of Health Sciences - Japan	Ogawa, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan.; Ogawa, T (corresponding author), Yokohama City Univ, Assoc Med Sci, Lab Biopharmaceut & Regenerat Sci, Inst Mol Med & Life Sci, Yokohama, Kanagawa, Japan.	ogawa@yokohama-cu.ac.jp	Sato, Takuya/X-9143-2019; Sato, Takuya/F-8251-2017	Sato, Takuya/0000-0002-6198-2234; Sato, Takuya/0000-0002-6198-2234; Yao, Tatsuma/0000-0002-0974-0625	Strategic Research Promotion of Yokohama City University [IR2502]; Grant of Yamaguchi Endocrine Research Foundation; Yokohama Foundation for Advancement of Medical Science;  [25114007];  [24390371];  [SK2811]; Grants-in-Aid for Scientific Research [26713012] Funding Source: KAKEN	Strategic Research Promotion of Yokohama City University; Grant of Yamaguchi Endocrine Research Foundation; Yokohama Foundation for Advancement of Medical Science; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a Grant-in-Aid for Scientific Research on Innovative Areas, Mechanisms regulating gamete formation in animals 25114007 (to T.O.); Grant-in-Aid for Scientific Research (B) 24390371 (to T.O.); Strategic Research Promotion of Yokohama City University, No. IR2502 (to T.O.); Grant of Yamaguchi Endocrine Research Foundation (to M.K.); Yokohama Foundation for Advancement of Medical Science (to H.S.); Grant for 2016-2018 Strategic Research Promotion of Yokohama City University (SK2811) (to T.O.).; We thank Y. Koushige for her technical assistance. This study was funded by a Grant-in-Aid for Scientific Research on Innovative Areas, 'Mechanisms regulating gamete formation in animals' 25114007 (to T.O.); Grant-in-Aid for Scientific Research (B) 24390371 (to T.O.); Strategic Research Promotion of Yokohama City University, No.IR2502 (to T.O.); Grant of Yamaguchi Endocrine Research Foundation (to M.K.); Yokohama Foundation for Advancement of Medical Science (to H. S.); Grant for 2016-2018 Strategic Research Promotion of Yokohama City University (SK2811) (to T.O.). Fuso Pharmaceutical Industries, Ltd., did not play a role in the study design, data collection and analysis, decision to publish, or preparation	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Arkoun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116660; Brill JA, 2016, SEMIN CELL DEV BIOL, V59, P2, DOI 10.1016/j.semcdb.2016.06.010; Busada JT, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135145; Chapin RE, 2016, BIRTH DEFECTS RES B, V107, P225, DOI 10.1002/bdrb.21188; Dumont L, 2016, MOL HUM REPROD, V22, P819, DOI 10.1093/molehr/gaw063; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Holsberger DR, 2005, BIOL REPROD, V73, P396, DOI 10.1095/biolreprod.105.041426; Isoler-Alcaraz J, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0305-y; Jahnukainen K, 2012, J CLIN ENDOCR METAB, V97, P4341, DOI 10.1210/jc.2012-3065; Kojima K, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140277; Komeya M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21472; Koubova J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004541; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; Michael D., 2016, PHYSIOL REV, V96, P1; Nakamura N, 2017, BIRTH DEFECTS RES, V109, P465, DOI 10.1002/bdr2.1002; O'Shaughnessy PJ, 2014, SEMIN CELL DEV BIOL, V29, P55, DOI 10.1016/j.semcdb.2014.02.010; Ohta H, 2009, BIOL REPROD, V80, P511, DOI 10.1095/biolreprod.108.073270; Peters Jr T., 1995, ALL ALBUMIN, P285; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Reda A, 2016, MOL HUM REPROD, V22, P601, DOI 10.1093/molehr/gaw047; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Sato T., 2011, NAT COMMUN, V2; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Smith Lee B., 2015, PHYSL REPROD, V1, P642; Steinberger A, 1970, In Vitro, V5, P17, DOI 10.1007/BF02618371; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; Yao T, 2017, REPROD MED BIOL, V16, P99, DOI 10.1002/rmb2.12024; Yokonishi Tetsuhiro, 2016, Reproductive Medicine and Biology, V15, P21, DOI 10.1007/s12522-015-0218-4; Yokonishi Tetsuhiro, 2013, Methods Mol Biol, V927, P479; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795	35	32	32	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192884	10.1371/journal.pone.0192884	http://dx.doi.org/10.1371/journal.pone.0192884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432471	gold, Green Published, Green Submitted			2022-12-26	WOS:000424814300056
J	Shrestha, A; Dziwornu, AK; Ueda, Y; Wu, LB; Mathew, B; Frei, M				Shrestha, Asis; Dziwornu, Ambrose Kwaku; Ueda, Yoshiaki; Wu, Lin-Bo; Mathew, Boby; Frei, Michael			Genome-wide association study to identify candidate loci and genes for Mn toxicity tolerance in rice	PLOS ONE			English	Article							ORYZA-SATIVA L.; DIFFUSION FACILITATOR FAMILY; MANGANESE TOLERANCE; IRON TOXICITY; ACCUMULATION; ARABIDOPSIS; MECHANISMS; TRANSPORT; STRESS; GROWTH	Manganese (Mn) is an essential micro-nutrient for plants, but flooded rice fields can accumulate high levels of Mn2+ leading to Mn toxicity. Here, we present a genome-wide association study (GWAS) to identify candidate loci conferring Mn toxicity tolerance in rice (Oryza sativa L.). A diversity panel of 288 genotypes was grown in hydroponic solutions in a greenhouse under optimal and toxic Mn concentrations. We applied a Mn toxicity treatment (5 ppm Mn2+, 3 weeks) at twelve days after transplanting. Mn toxicity caused moderate damage in rice in terms of biomass loss and symptom formation despite extremely high shoot Mn concentrations ranging from 2.4 to 17.4 mg g(-1). The tropical japonica subpopulation was more sensitive to Mn toxicity than other subpopulations. Leaf damage symptoms were significantly correlated with Mn uptake into shoots. Association mapping was conducted for seven traits using 416741 single nucleotide polymorphism (SNP) markers using a mixed linear model, and detected six significant associations for the traits shoot manganese concentration and relative shoot length. Candidate regions contained genes coding for a heavy metal transporter, peroxidase precursor and Mn2+ ion binding proteins. The significant marker SNP-2.22465867 caused an amino acid change in a gene (LOC_Os02g37170) with unknown function. This study demonstrated significant natural variation in rice for Mn toxicity tolerance and the possibility of using GWAS to unravel genetic factors responsible for such complex traits.	[Shrestha, Asis; Dziwornu, Ambrose Kwaku; Ueda, Yoshiaki; Wu, Lin-Bo; Frei, Michael] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Nu, Bonn, Germany; [Shrestha, Asis; Mathew, Boby] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Br, Bonn, Germany; [Ueda, Yoshiaki] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan	University of Bonn; University of Bonn; University of Tokyo	Frei, M (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Nu, Bonn, Germany.	mfrei@uni-bonn.de	Wu, Linbo/AAW-6176-2021; Frei, Michael/K-5511-2013; Wu, Linbo/AAI-8777-2020; Shrestha, Asis/AAT-2000-2021	Frei, Michael/0000-0002-2474-6558; Wu, Linbo/0000-0001-5286-1994; Shrestha, Asis/0000-0003-4878-6965; Ueda, Yoshiaki/0000-0002-4304-368X	Deutsche Forschungsgemeinschaft [FR2952/1-1]; Bayer Science Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayer Science Foundation	This study was financially supported by Deutsche Forschungsgemeinschaft (FR2952/1-1) to MF and the Bayer Science Foundation (AS).	Al-Tamimi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13342; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker M, 2005, J PLANT NUTR SOIL SC, V168, P558, DOI 10.1002/jpln.200520504; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Che J, 2016, J EXP BOT, V67, P1535, DOI 10.1093/jxb/erv545; Chen ZJ, 2015, PLANT PHYSIOL, V167, P176, DOI 10.1104/pp.114.251017; Chen ZH, 2013, J EXP BOT, V64, P4375, DOI 10.1093/jxb/ert243; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Neto JBDA, 2017, J EXP BOT, V68, P687, DOI 10.1093/jxb/erw423; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; Dimkpa SON, 2016, J EXP BOT, V67, P1191, DOI 10.1093/jxb/erv470; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Edmond C, 2009, BIOCHEM J, V418, P145, DOI 10.1042/BJ20081814; Endelman JB, 2017, PACAKGE RRBLUP RIDGE; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fecht-Christoffers MM, 2006, PLANT PHYSIOL, V140, P1451, DOI 10.1104/pp.105.070474; Fecht-Christoffers MM, 2005, J PLANT NUTR SOIL SC, V168, P590, DOI 10.1002/jpln.200520515; Fecht-Christoffers MM, 2003, PLANT PHYSIOL, V133, P1935, DOI 10.1104/pp.103.029215; Fecht-Christoffers MM, 2003, PHYSIOL PLANTARUM, V117, P237, DOI 10.1034/j.1399-3054.2003.00022.x; Fernando DR, 2010, NEW PHYTOL, V188, P1014, DOI 10.1111/j.1469-8137.2010.03431.x; Fuhrs H, 2010, ANN BOT-LONDON, V105, P1129, DOI 10.1093/aob/mcq046; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Goussias C, 2002, PHILOS T R SOC B, V357, P1369, DOI 10.1098/rstb.2002.1134; GRANA X, 1995, COMP BIOCHEM PHYS B, V112, P287, DOI 10.1016/0305-0491(95)00076-3; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Hebbern CA, 2009, PHYSIOL PLANTARUM, V135, P307, DOI 10.1111/j.1399-3054.2008.01188.x; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; Horst WJ, 1999, J PLANT NUTR SOIL SC, V162, P263, DOI 10.1002/(SICI)1522-2624(199906)162:3&lt;263::AID-JPLN263&gt;3.0.CO;2-A; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; ISHIMARU Y, 2012, SCI REP UK, V2; JOLLIFFEE IT, 1986, PRINCIPAL COMPONENT; Lavres J, 2009, REV BRAS CIENC SOLO, V33, P395, DOI 10.1590/S0100-06832009000200017; Lee KO, 2002, BIOCHEM BIOPH RES CO, V296, P1152, DOI 10.1016/S0006-291X(02)02047-8; Li P, 2012, PLANT SOIL, V354, P407, DOI 10.1007/s11104-011-1076-4; Lidon FC, 2004, J PLANT PHYSIOL, V161, P1235, DOI 10.1016/j.jplph.2004.02.003; Matthus E, 2015, THEOR APPL GENET, V128, P2085, DOI 10.1007/s00122-015-2569-y; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Millaleo R, 2010, J SOIL SCI PLANT NUT, V10, P476, DOI 10.4067/S0718-95162010000200008; Mora MD, 2009, PLANT SOIL, V320, P79, DOI 10.1007/s11104-008-9872-1; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Pedas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113759; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Sasaki A, 2011, PLANT PHYSIOL, V157, P1832, DOI 10.1104/pp.111.186031; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Shakiba E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172133; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Team R core, LANG ENV STAT COMP; Ueda Y, 2015, J EXP BOT, V66, P293, DOI 10.1093/jxb/eru419; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Wang YX, 2002, PLANT SOIL, V238, P227, DOI 10.1023/A:1014487428033; WISSEMEIER AH, 1992, PLANT SOIL, V143, P299, DOI 10.1007/BF00007886; Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215; Xue SG, 2004, ENVIRON POLLUT, V131, P393, DOI 10.1016/j.envpol.2004.03.011; Yang M, 2014, J EXP BOT, V65, P4849, DOI 10.1093/jxb/eru259; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	67	14	14	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192116	10.1371/journal.pone.0192116	http://dx.doi.org/10.1371/journal.pone.0192116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425206	gold, Green Published, Green Submitted			2022-12-26	WOS:000424700800013
J	Thaler, A; Geuss, MN; Molbert, SC; Giel, KE; Streuber, S; Romero, J; Black, MJ; Mohler, BJ				Thaler, Anne; Geuss, Michael N.; Moelbert, Simone C.; Giel, Katrin E.; Streuber, Stephan; Romero, Javier; Black, Michael J.; Mohler, Betty J.			Body size estimation of self and others in females varying in BMI	PLOS ONE			English	Article							ANOREXIA-NERVOSA; WEIGHT STATUS; MASS INDEX; IMAGE; PERCEPTION; OBESITY; MISPERCEPTION; ADOLESCENTS; SENSITIVITY; INSTRUMENT	Previous literature suggests that a disturbed ability to accurately identify own body size may contribute to overweight. Here, we investigated the influence of personal body size, indexed by body mass index (BMI), on body size estimation in a non-clinical population of females varying in BMI. We attempted to disentangle general biases in body size estimates and attitudinal influences by manipulating whether participants believed the body stimuli (personalized avatars with realistic weight variations) represented their own body or that of another person. Our results show that the accuracy of own body size estimation is predicted by personal BMI, such that participants with lower BMI underestimated their body size and participants with higher BMI overestimated their body size. Further, participants with higher BMI were less likely to notice the same percentage of weight gain than participants with lower BMI. Importantly, these results were only apparent when participants were judging a virtual body that was their own identity (Experiment 1), but not when they estimated the size of a body with another identity and the same underlying body shape (Experiment 2a). The different influences of BMI on accuracy of body size estimation and sensitivity to weight change for self and other identity suggests that effects of BMI on visual body size estimation are self-specific and not generalizable to other bodies.	[Thaler, Anne; Geuss, Michael N.; Moelbert, Simone C.; Mohler, Betty J.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Thaler, Anne] Ctr Integrat Neurosci, Tubingen, Germany; [Thaler, Anne; Streuber, Stephan; Romero, Javier; Black, Michael J.; Mohler, Betty J.] Max Planck Inst Intelligent Syst, Tubingen, Germany; [Thaler, Anne; Moelbert, Simone C.] Univ Tubingen, Int Max Planck Res Sch, Grad Training Ctr Neurosci, Tubingen, Germany; [Moelbert, Simone C.; Giel, Katrin E.] Univ Tubingen, Dept Psychosomat Med, Tubingen, Germany; [Geuss, Michael N.] Human Res & Engn Directorate, Army Res Lab, Aberdeen Proving Ground, MD USA; [Mohler, Betty J.] Tech Univ Darmstadt, Darmstadt, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); Technical University of Darmstadt	Thaler, A (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.; Thaler, A (corresponding author), Ctr Integrat Neurosci, Tubingen, Germany.; Thaler, A (corresponding author), Max Planck Inst Intelligent Syst, Tubingen, Germany.; Thaler, A (corresponding author), Univ Tubingen, Int Max Planck Res Sch, Grad Training Ctr Neurosci, Tubingen, Germany.	anne.thaler@tuebingen.mpg.de	Thaler, Anne/ABD-2039-2020; Behrens, Simone/AAB-8890-2020; Streuber, Stephan/ABG-1550-2021	Behrens, Simone/0000-0002-0430-5245; Black, Michael/0000-0001-6077-4540	Centre for Integrative Neuroscience (CIN) Tubingen through the German Excellence Initiative [(EXC307) Pool-Projekt-2014-03]	Centre for Integrative Neuroscience (CIN) Tubingen through the German Excellence Initiative	This work was funded by the Centre for Integrative Neuroscience (CIN) Tubingen through the German Excellence Initiative (EXC307) Pool-Projekt-2014-03. The CIN had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaz AF, 1998, INT J EAT DISORDER, V23, P287, DOI 10.1002/(SICI)1098-108X(199804)23:3&lt;287::AID-EAT6&gt;3.0.CO;2-F; Boles DB, 2011, SOMATOSENS MOT RES, V28, P102, DOI 10.3109/08990220.2011.627068; BOWDEN PK, 1989, BRIT J PSYCHIAT, V155, P196, DOI 10.1192/bjp.155.2.196; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Clement U, 1996, PSYCHOTHER PSYCH MED, V46, P254; Collani G., 2003, Z DIFFERENTIELLE DIA, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Cornelissen KK, 2015, BODY IMAGE, V13, P75, DOI 10.1016/j.bodyim.2015.01.001; Cornelissen KK, 2016, BR J HLTH PSYCHOL, P1; Cornelissen PL, 2013, BODY IMAGE, V10, P103, DOI 10.1016/j.bodyim.2012.09.003; CRISP AH, 1974, BRIT J MED PSYCHOL, V47, P349, DOI 10.1111/j.2044-8341.1974.tb02300.x; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; GARDNER RM, 1987, J SOC BEHAV PERS, V2, P205; GARDNER RM, 1987, PSYCHOL MED, V17, P927, DOI 10.1017/S0033291700000738; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Grover SA, 2015, LANCET DIABETES ENDO, V3, P114, DOI 10.1016/S2213-8587(14)70229-3; Hashimoto T, 2013, EUR J NEUROSCI, V37, P1747, DOI 10.1111/ejn.12187; Herbert BM, 2014, EAT BEHAV, V15, P445, DOI 10.1016/j.eatbeh.2014.06.002; Hirshberg DA, 2012, LECT NOTES COMPUT SC, V7577, P242, DOI 10.1007/978-3-642-33783-3_18; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson SE, 2015, INT J OBESITY, V39, P1488, DOI 10.1038/ijo.2015.126; Johnson F, 2008, BMJ-BRIT MED J, V337, pa494, DOI DOI 10.1136/BMJ.A494; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kuchler F, 2003, INT J OBESITY, V27, P856, DOI 10.1038/sj.ijo.0802293; KUSKOWSKA-WOLK A, 1989, Scandinavian Journal of Primary Health Care, V7, P79, DOI 10.3109/02813438909088651; Longo MR, 2015, EUR PSYCHOL, V20, P6, DOI 10.1027/1016-9040/a000198; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Maximova K, 2008, INT J OBESITY, V32, P1008, DOI 10.1038/ijo.2008.15; Molbert SC, 2017, CLIN PSYCHOL REV, V57, P21, DOI 10.1016/j.cpr.2017.08.005; Molbert SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166826; Molbert SC, 2017, ASSESSING BODY IMAGE, P1; NORRIS DL, 1984, PSYCHOL MED, V14, P835, DOI 10.1017/S0033291700019802; Oldham M, 2015, J HEALTH PSYCHOL, P1; Paul T., 2005, EATING DISORDER INVE; Peirson Leslea, 2015, CMAJ Open, V3, pE47, DOI 10.9778/cmajo.20140050; PENNER LA, 1991, J ABNORM PSYCHOL, V100, P90, DOI 10.1037/0021-843X.100.1.90; Piryankova IV, 2014, ACM T APPL PERCEPT, V11, DOI 10.1145/2641568; Piryankova IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103428; PROCTOR L, 1986, BRIT J PSYCHIAT, V149, P113, DOI 10.1192/bjp.149.1.113; Puhl R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0552-6; Robinette K. M., 1999, Second International Conference on 3-D Digital Imaging and Modeling (Cat. No.PR00062), P380, DOI 10.1109/IM.1999.805368; Robinson E, 2014, INT J OBESITY, V38, P663, DOI 10.1038/ijo.2013.154; Rosenberg M., 1965, J RELIG HLTH DATABAS, DOI [10.1037/t01038-000, DOI 10.1037/T01038-000]; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Scarpina F, 2014, PSYCHIAT RES, V220, P960, DOI 10.1016/j.psychres.2014.08.020; SERDULA MK, 1993, ANN INTERN MED, V119, P667, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00008; THOMPSON JK, 1989, J CLIN PSYCHOL, V45, P473, DOI 10.1002/1097-4679(198905)45:3<473::AID-JCLP2270450320>3.0.CO;2-0; Tiggemann M, 2000, J ADOLESCENCE, V23, P645, DOI 10.1006/jado.2000.0350; Tovee MJ, 2000, P ROY SOC B-BIOL SCI, V267, P1987, DOI 10.1098/rspb.2000.1240; Tovee MJ, 2003, BRIT J PSYCHOL, V94, P501, DOI 10.1348/000712603322503060; Truesdale Kimberly P, 2008, N C Med J, V69, P188; Urdapilleta I, 2007, EAT WEIGHT DISORD-ST, V12, P140, DOI 10.1007/bf03327641; Wardle J, 2005, BEST PRACT RES CL EN, V19, P421, DOI 10.1016/j.beem.2005.04.006; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Willemsen P, 2008, PRESENCE-TELEOP VIRT, V17, P91, DOI 10.1162/pres.17.1.91; Wittchen H.-U., 1997, Z KLIN PSYCHOL PSYCH, V28, P68, DOI DOI 10.1026//0084-5345.28.1.68; Yang K, 2014, J SCHOOL HEALTH, V84, P654, DOI 10.1111/josh.12195	59	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192152	10.1371/journal.pone.0192152	http://dx.doi.org/10.1371/journal.pone.0192152			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV6OL	29425218	Green Published, Green Submitted, gold			2022-12-26	WOS:000424700800015
J	Yu, H; Jiao, BK; Lu, L; Wang, PF; Chen, SC; Liang, CZ; Liu, W				Yu, Hua; Jiao, Bingke; Lu, Lu; Wang, Pengfei; Chen, Shuangcheng; Liang, Chengzhi; Liu, Wei			NetMiner-an ensemble pipeline for building genome-wide and high-quality gene co-expression network using massive-scale RNA-seq samples	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; CIRCULAR RNAS; PLANT; RICE; BIOLOGY; TOPHAT; ANTHER	Accurately reconstructing gene co-expression network is of great importance for uncovering the genetic architecture underlying complex and various phenotypes. The recent availability of high-throughput RNA-seq sequencing has made genome-wide detecting and quantifying of the novel, rare and low-abundance transcripts practical. However, its potential merits in reconstructing gene co-expression network have still not been well explored. Using massive-scale RNA-seq samples, we have designed an ensemble pipeline, called NetMiner, for building genome-scale and high-quality Gene Co-expression Network (GCN) by integrating three frequently used inference algorithms. We constructed a RNA-seq-based GCN in one species of monocot rice. The quality of network obtained by our method was verified and evaluated by the curated gene functional association data sets, which obviously outperformed each single method. In addition, the powerful capability of network for associating genes with functions and agronomic traits was shown by enrichment analysis and case studies. In particular, we demonstrated the potential value of our proposed method to predict the biological roles of unknown protein-coding genes, long non-coding RNA (lncRNA) genes and circular RNA (circRNA) genes. Our results provided a valuable and highly reliable data source to select key candidate genes for subsequent experimental validation. To facilitate identification of novel genes regulating important biological processes and phenotypes in other plants or animals, we have published the source code of NetMiner, making it freely available at https://github.com/czllab/NetMiner.	[Yu, Hua; Wang, Pengfei; Chen, Shuangcheng; Liu, Wei] Nantong Univ, Nantong Med Coll, Nantong, Peoples R China; [Yu, Hua; Wang, Pengfei; Chen, Shuangcheng; Liu, Wei] Nantong Univ, Sch Pharm, Nantong, Peoples R China; [Yu, Hua; Jiao, Bingke; Liang, Chengzhi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Yu, Hua; Jiao, Bingke; Liang, Chengzhi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Lu] Nantong Polytech Coll, Nantong, Peoples R China; [Yu, Hua] Nantong Univ, Inst Reprod Med, Nantong Med Coll, Nantong, Peoples R China	Nantong University; Nantong University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nantong University	Yu, H; Liu, W (corresponding author), Nantong Univ, Nantong Med Coll, Nantong, Peoples R China.; Yu, H; Liu, W (corresponding author), Nantong Univ, Sch Pharm, Nantong, Peoples R China.; Yu, H; Liang, CZ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China.; Yu, H; Liang, CZ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Yu, H (corresponding author), Nantong Univ, Inst Reprod Med, Nantong Med Coll, Nantong, Peoples R China.	hyu200886@ntu.edu.cn; cliang@genetics.ac.cn; weiliu@ntu.edu.cn	WANG, Peng/GSN-5263-2022		Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08020302]; National Natural Science Foundation of China [21402101]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Our work is financially supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA08020302) and National Natural Science Foundation of China (Grant No. 21402101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is financially supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA08020302) and National Natural Science Foundation of China (Grant No. 21402101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Alipanahi B, 2013, NAT BIOTECHNOL, V31, P714, DOI 10.1038/nbt.2657; ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao PJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-17; Chabalier J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-235; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Gerstein MB, 2014, NATURE, V512, P445, DOI 10.1038/nature13424; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Gu HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-161; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hong SJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt145; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Jin J, 2013, NUCLEIC ACIDS RES; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lertampaiporn S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks878; Liu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm562; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Simoes RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033624; Strimmer K., 2001, J AM STAT ASSOC, V96, P1151, DOI [DOI 10.1198/016214501753382129, 10.1198/016214501753382129]; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Vandepoele K, 2009, PLANT PHYSIOL, V150, P535, DOI 10.1104/pp.109.136028; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wang Z, 2017, BMC BIOINFORMATICS, V18, DOI [10.1186/s12859-017-1647-3, 10.1093/bioinformatics/btx131]; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Yalamanchili HK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku577; Yang PY, 2010, CURR BIOINFORM, V5, P296, DOI 10.2174/157489310794072508; Ye CY, 2015, NEW PHYTOL, V208, P88, DOI 10.1111/nph.13585; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	67	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192613	10.1371/journal.pone.0192613	http://dx.doi.org/10.1371/journal.pone.0192613			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425247	gold, Green Published, Green Submitted			2022-12-26	WOS:000424700800031
J	Fung, V; Graetz, I; Reed, M; Jaffe, MG				Fung, Vicki; Graetz, Ilana; Reed, Mary; Jaffe, Marc G.			Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk	PLOS ONE			English	Article							MEDICARE-PART-D; DRUG COSTS; INTERVENTIONS; DISEASE; CARE; PREVENTION; RESPONSES; IMPLEMENTATION; BENEFICIARIES; NONADHERENCE	Background Patient reports of their adherence behaviors, concerns about statins, and perceptions of atherosclerotic cardiovascular disease (ASCVD) risk could inform approaches for improving adherence to statin therapy. We examined these factors and their associations with adherence. Methods We conducted telephone interviews among a stratified random sample of adults receiving statins within an integrated delivery system (N = 730, 81% response rate) in 2010. We sampled equal numbers of individuals in three clinical risk categories: those with 1) coronary artery disease; 2) diabetes or other ASCVD diagnosis; and 3) no diabetes or ASCVD diagnoses. We assessed 15 potential concerns about and barriers to taking statins, and perceived risk of having a heart attack in the next 10 years (0-10 scale). We calculated the proportion of days covered (PDC) by statins in the last 12 months using dispensing data and used multivariate logistic regression to examine the characteristics associated with non-adherence (PDC<80%). Analyses were weighted for sampling proportions. Results Sixty-one percent of patients with PDC<50% reported not filling a new prescription, splitting or skipping statins, or stopping refilling statins in the last 12 months vs. 15% of those with PDC >= 80% (p<0.05). The most commonly reported concerns about statins were preferring to lower cholesterol with lifestyle changes (66%), disliking medications in general (59%), and liver or kidney problems (31%); having trouble remembering to take statins (9%) was the most common reason for taking less than prescribed. In multivariate analyses, clinical risk categories were not significantly associated with odds of non-adherence; however, those with higher perceived risk of heart attack were less likely to be non-adherent. Conclusions Patient-reported medication-taking behaviors were correlated with statin PDC and those with lower perceived cardiovascular risk were less likely to be adherent. These findings highlight the importance of eliciting from and educating patients on their adherence behaviors and ASCVD risks.	[Fung, Vicki] Massachusetts Gen Hosp, Mongan Inst Hlth Policy Ctr, Boston, MA 02114 USA; [Fung, Vicki] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Graetz, Ilana] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Reed, Mary] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Jaffe, Marc G.] Resolve Save Lives, New York, NY USA; [Jaffe, Marc G.] Kaiser Permanente South San Francisco Med Ctr, Dept Endocrinol, San Francisco, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Tennessee System; University of Tennessee Health Science Center; Kaiser Permanente; Kaiser Permanente	Fung, V (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy Ctr, Boston, MA 02114 USA.; Fung, V (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	vfung@mgh.harvard.edu		Jaffe, Marc/0000-0002-5049-7815	Kaiser Permanente Community Benefit Program	Kaiser Permanente Community Benefit Program	The Kaiser Permanente Community Benefit Program provided the funding for this study to MGJ. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bermingham M, 2011, CLIN THER, V33, P1180, DOI 10.1016/j.clinthera.2011.07.007; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Calvert SB, 2012, AM HEART J, V163, P657, DOI 10.1016/j.ahj.2012.01.019; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Fung V, 2013, HEALTH SERV RES, V48, P1653, DOI 10.1111/1475-6773.12062; Fung Vicki, 2010, Perm J, V14, P4; Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02; Goff Jr DC, 2014, AM HEART ASS TASK S2, V129, DOI [DOI 10.1161/01.CIR.0000437741.48606.98, 10.1161/01.cir.0000437741.48606.98]; Ho PM, 2014, JAMA INTERN MED, V174, P186, DOI 10.1001/jamainternmed.2013.12944; Hsu J, 2008, JAMA-J AM MED ASSOC, V299, P1929, DOI 10.1001/jama.299.16.1929; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Karter AJ, 2017, HLTH SERV RES; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Kuntz JL, 2014, PATIENT EDUC COUNS, V97, P310, DOI 10.1016/j.pec.2014.08.021; Lewey J, 2015, AM J MANAG CARE, V21, P696; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Madden JM, 2009, JAMA-J AM MED ASSOC, V302, P1755, DOI 10.1001/jama.2009.1516; Maningat P, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0291-7; Martin SS, 2015, J AM COLL CARDIOL, V65, P1361, DOI 10.1016/j.jacc.2015.01.043; Misono AS, 2010, AM J MANAG CARE, V16, pSP82; Nair KV, 2011, PATIENT PREFER ADHER, V5, P195, DOI 10.2147/PPA.S18481; Patel MJ, 2007, AM HEART J, V154, P454, DOI 10.1016/j.ahj.2007.05.016; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Petr EJ, 2014, AM J CARDIOL, V114, P53, DOI 10.1016/j.amjcard.2014.04.006; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Rash JA, 2016, PREV MED, V90, P155, DOI 10.1016/j.ypmed.2016.07.006; Reed M, 2008, HEALTH SERV RES, V43, P785, DOI 10.1111/j.1475-6773.2007.00797.x; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Stone NJ, 2013, CIRCULATION; Ye X, 2007, CLIN THER, V29, P2748, DOI 10.1016/j.clinthera.2007.12.022; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	33	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191817	10.1371/journal.pone.0191817	http://dx.doi.org/10.1371/journal.pone.0191817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420613	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900024
J	Hui, DF; Yu, CL; Deng, Q; Dzantor, EK; Zhou, SP; Dennis, S; Sauve, R; Johnson, TL; Fay, PA; Shen, WJ; Luo, YQ				Hui, Dafeng; Yu, Chih-Li; Deng, Qi; Dzantor, E. Kudjo; Zhou, Suping; Dennis, Sam; Sauve, Roger; Johnson, Terrance L.; Fay, Philip A.; Shen, Weijun; Luo, Yiqi			Effects of precipitation changes on switchgrass photosynthesis, growth, and biomass: A mesocosm experiment	PLOS ONE			English	Article							LEAF LEVEL PHYSIOLOGY; WATER-USE EFFICIENCY; PANICUM-VIRGATUM L.; ALAMO SWITCHGRASS; SOIL RESPIRATION; CLIMATE EXTREMES; RESPONSES; NITROGEN; YIELD; PRODUCTIVITY	Climate changes, including chronic changes in precipitation amounts, will influence plant physiology and growth. However, such precipitation effects on switchgrass, a major bioenergy crop, have not been well investigated. We conducted a two-year precipitation simulation experiment using large pots (95 L) in an environmentally controlled greenhouse in Nashville, TN. Five precipitation treatments (ambient precipitation, and -50%, -33%, +33%, and +50% of ambient) were applied in a randomized complete block design with lowland "Alamo" switchgrass plants one year after they were established from tillers. The growing season progression of leaf physiology, tiller number, height, and aboveground biomass were determined each growing season. Precipitation treatments significantly affected leaf physiology, growth, and aboveground biomass. The photosynthetic rates in the wet (+50% and +33%) treatments were significantly enhanced by 15.9% and 8.1%, respectively, than the ambient treatment. Both leaf biomass and plant height were largely increased, resulting in dramatically increases in aboveground biomass by 56.5% and 49.6% in the +50% and +33% treatments, respectively. Compared to the ambient treatment, the drought (-33% and -50%) treatments did not influence leaf physiology, but the -50% treatment significantly reduced leaf biomass by 37.8%, plant height by 16.3%, and aboveground biomass by 38.9%. This study demonstrated that while switchgrass in general is a drought tolerant grass, severe drought significantly reduces Alamo's growth and biomass, and that high precipitation stimulates its photosynthesis and growth.	[Hui, Dafeng; Yu, Chih-Li; Deng, Qi; Johnson, Terrance L.] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Deng, Qi; Shen, Weijun] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management, Guangzhou, Guangdong, Peoples R China; [Dzantor, E. Kudjo; Zhou, Suping; Dennis, Sam; Sauve, Roger] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Fay, Philip A.] USDA, Grassland Soil & Water Res Lab, Temple, TX USA; [Luo, Yiqi] No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA	Tennessee State University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Tennessee State University; United States Department of Agriculture (USDA); Northern Arizona University	Hui, DF (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA.	dhui@tnstate.edu	Fay, Philip A./I-1853-2012	Fay, Philip A./0000-0002-8291-6316; Hui, Dafeng/0000-0002-5284-2897	USDA-Capacity Building Grant [2013-38821-21390]; Evans-Allen grant; National Science Foundation [1504886, 1623085]; Direct For Education and Human Resources [1504886, 1623085] Funding Source: National Science Foundation	USDA-Capacity Building Grant; Evans-Allen grant; National Science Foundation(National Science Foundation (NSF)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was supported by the USDA-Capacity Building Grant (2013-38821-21390) and Evans-Allen grant, and National Science Foundation (1504886, 1623085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi A A, 2013, Pak J Biol Sci, V16, P51, DOI 10.3923/pjbs.2013.51.58; Albaugh JM, 2014, AGROFOREST SYST, V88, P489, DOI 10.1007/s10457-014-9708-3; Barney JN, 2009, PLANT SCI, V177, P724, DOI 10.1016/j.plantsci.2009.09.003; Berdahl JD, 2005, AGRON J, V97, P549, DOI 10.2134/agronj2005.0549; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; COLLATZ GJ, 1992, AUST J PLANT PHYSIOL, V19, P519, DOI 10.1071/PP9920519; Cordero A, 2017, GCB BIOENERGY, V9, P144, DOI 10.1111/gcbb.12349; DeLucia EH, 2014, ENVIRON SCI TECHNOL, V48, P9471, DOI 10.1021/es502348e; Deng Q, 2017, AGR ECOSYST ENVIRON, V248, P29, DOI 10.1016/j.agee.2017.07.023; Deng Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041493, 10.1371/journal.pone.0038737]; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fay PA, 2003, OECOLOGIA, V137, P245, DOI 10.1007/s00442-003-1331-3; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Fike JH, 2006, BIOMASS BIOENERG, V30, P207, DOI 10.1016/j.biombioe.2005.10.008; Frank D, 2015, GLOBAL CHANGE BIOL, V21, P2861, DOI 10.1111/gcb.12916; Gao ZJ, 2015, PHOTOSYNTHETICA, V53, P489, DOI 10.1007/s11099-015-0108-3; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Haankuku C, 2015, AGRON J, V107, P287, DOI 10.2134/agronj14.0349; Hartman JC, 2013, GCB BIOENERGY, V5, P683, DOI 10.1111/j.1757-1707.2012.01204.x; Hartman JC, 2012, FUNCT PLANT BIOL, V39, P126, DOI 10.1071/FP11229; Haworth M, 2016, GCB BIOENERGY; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; HECKATHORN SA, 1994, ECOLOGY, V75, P1877, DOI 10.2307/1941592; Hui D., 1996, PRACTICAL SAS USAGE; Hui D., 2012, HDB CLIMATE CHANGE M, P433; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Hui DF, 2001, GLOBAL CHANGE BIOL, V7, P75, DOI 10.1046/j.1365-2486.2001.00391.x; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Irmak S, 2001, APPL ENG AGRIC, V17, P787; Kandel T. P., 2013, American Journal of Plant Sciences, V4, P1173, DOI 10.4236/ajps.2013.46145; KNAPP AK, 1984, OECOLOGIA, V65, P35, DOI 10.1007/BF00384460; Knapp AK, 2015, GLOBAL CHANGE BIOL, V21, P2624, DOI 10.1111/gcb.12888; Lemus R, 2014, SCI WORLD J, DOI 10.1155/2014/937594; Loik ME, 2007, PLANT ECOL, V191, P95, DOI 10.1007/s11258-006-9217-1; Long SP, 2013, ANNU REV PLANT BIOL, V64, P701, DOI 10.1146/annurev-arplant-050312-120033; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Medrano H, 2015, CROP J, V3, P220, DOI 10.1016/j.cj.2015.04.002; Mooney DF, 2009, AGRON J, V101, P1234, DOI 10.2134/agronj2009.0090; Muir JP, 2001, AGRON J, V93, P896, DOI 10.2134/agronj2001.934896x; Nippert JB, 2007, ENVIRON EXP BOT, V60, P412, DOI 10.1016/j.envexpbot.2006.12.012; O'Keefe K, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00339.1; Oliver RJ, 2009, GCB BIOENERGY, V1, P97, DOI 10.1111/j.1757-1707.2009.01011.x; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Pedroso GM, 2014, GCB BIOENERGY, V6, P704, DOI 10.1111/gcbb.12104; Perlack RD, 2005, IND TECHNICAL FEASIB; Sanderson MA, 2000, J RANGE MANAGE, V53, P221, DOI 10.2307/4003287; Sanderson MA, 1996, BIORESOURCE TECHNOL, V56, P83, DOI 10.1016/0960-8524(95)00176-X; Sanderson MA, 2006, CAN J PLANT SCI, V86, P1315, DOI 10.4141/P06-136; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Somleva MN, 2008, PLANT BIOTECHNOL J, V6, P663, DOI 10.1111/j.1467-7652.2008.00350.x; Tian S, 2016, ENVIRON MODELL SOFTW, V84, P226, DOI 10.1016/j.envsoft.2016.06.029; Tian SY, 2015, BIOMASS BIOENERG, V83, P233, DOI 10.1016/j.biombioe.2015.10.002; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Wang BX, 2016, ENVIRON EXP BOT, V122, P100, DOI 10.1016/j.envexpbot.2015.09.004; Wang BX, 2015, BIOMASS BIOENERG, V83, P493, DOI 10.1016/j.biombioe.2015.10.029; Wang D, 2010, GCB BIOENERGY, V2, P16, DOI 10.1111/j.1757-1707.2010.01035.x; Weaver JE, 1932, BOT GAZ, V93, P0113, DOI 10.1086/334244; Wilson DM, 2013, BIOENERG RES, V6, P103, DOI 10.1007/s12155-012-9240-0; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xu X, 2013, GLOBAL CHANGE BIOL, V19, P2753, DOI 10.1111/gcb.12248; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9657; Yu CL, 2017, PLANT SOIL, V420, P105, DOI 10.1007/s11104-017-3370-2; Zhang HJ, 2015, BIOMASS BIOENERG, V83, P393, DOI 10.1016/j.biombioe.2015.10.021; Zhou XH, 2012, ECOSYSTEMS, V15, P542, DOI 10.1007/s10021-012-9525-3; Zhu Y, 2014, CROP J, V2, P223, DOI 10.1016/j.cj.2014.04.005	67	20	21	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192555	10.1371/journal.pone.0192555	http://dx.doi.org/10.1371/journal.pone.0192555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420600	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900092
J	Xu, YY; Jiang, YQ; Li, C; He, MD; Rusyniak, WG; Annamdevula, N; Ochoa, J; Leavesley, SJ; Xu, JP; Rich, TC; Lin, MT; Zha, XM				Xu, Yuanyuan; Jiang, Yu-Qing; Li, Ce; He, Mindi; Rusyniak, W. George; Annamdevula, Naga; Ochoa, Juan; Leavesley, Silas J.; Xu, Jiangping; Rich, Thomas C.; Lin, Mike T.; Zha, Xiang-Ming			Human ASIC1a mediates stronger acid-induced responses as compared with mouse ASIC1a	FASEB JOURNAL			English	Article						acidosis; trafficking; neuronal injury; calcium	SENSING ION CHANNELS; SYNAPTIC PLASTICITY; ACTIVATED CURRENTS; PROTON RECEPTOR; INNATE FEAR; 1A; TRAFFICKING; CONTRIBUTES; AMYGDALA; NEUROPROTECTION	Acid-sensing ion channels (ASICs) are the major proton receptor in the brain and a key mediator of acidosis-induced neuronal injuries in disease. Most of published data on ASIC function came from studies performed in mice, and relatively little is known about potential differences between human and mouse ASICs (hASIC and mASIC, respectively). This information is critical for us to better interpret the functional importance of ASICs in human disease. Here, we examined the expression of ASICs in acutely resected human cortical tissue. Compared with mouse cortex, human cortical tissue showed a similar ratio of ASIC1a:ASIC2a expression, had reduced ASIC2b level, and exhibited a higher membrane:total ratio of ASIC1a. We further investigated the mechanism for higher surface trafficking of hASIC1a in heterologous cells. A single amino acid at position 285 was critical for increased N-glycosylation and surface expression of hASIC1a. Consistent with the changes in trafficking and current, cells expressing hASIC1a or mASIC1a S285P mutant had a higher acid-activated calcium increase and exhibited worsened acidotoxicity. These data suggest that ASICs are likely to have a larger impact on acidosis-induced neuronal injuries in humans than mice, and this effect is, at least in part, a result of more efficient trafficking of hASIC1a.Xu, Y., Jiang, Y.-Q., Li, C., He, M., Rusyniak, W. G., Annamdevula, N., Ochoa, J., Leavesley, S. J., Xu, J., Rich, T. C., Lin, M. T., Zha, X.-M. Human ASIC1a mediates stronger acid-induced responses as compared with mouse ASIC1a.	[Xu, Yuanyuan; Jiang, Yu-Qing; Li, Ce; He, Mindi; Lin, Mike T.; Zha, Xiang-Ming] Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA; [Rusyniak, W. George] Univ S Alabama, Coll Med, Dept Neurosurg, Mobile, AL 36688 USA; [Annamdevula, Naga; Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Ochoa, Juan] Univ S Alabama, Dept Neurol, Coll Med, Mobile, AL 36688 USA; [Leavesley, Silas J.] Univ S Alabama, Coll Engn, Chem & Biomol Engn, Mobile, AL 36688 USA; [Xu, Yuanyuan; Xu, Jiangping] Southern Med Univ, Sch Pharmaceut Sci, Dept Neuropharmacol & Drug Discovery, Guangzhou, Guangdong, Peoples R China; [Jiang, Yu-Qing] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Li, Ce] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai, Peoples R China	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; Southern Medical University - China; Hebei Medical University; Fudan University	Zha, XM (corresponding author), Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA.; Xu, JP (corresponding author), Southern Med Univ, Dept Neuropharmacol & Drug Discovery, Guangzhou, Guangdong, Peoples R China.	jpx@sum.edu.cn; zha@southalabama.edu	Xu, Jiangping/D-1456-2012	Zha, Xiangming/0000-0001-9490-2731	South Medical University; Third Hospital of Hebei Medical University; China Scholarship Council; American Heart Association (AHA) [16PRE27130004]; U.S. National Institutes of Health (NIH)/American Recovery and Reinvestment Act equipment grants [S10RR027535, S10OD020149]; National Natural Science Foundation of China [81773698]; NIH/National Institute of Neurological Disorders and Stroke [R01NS102495, R21NS093522]; AHA [13SDG13970009]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102495, R21NS093522] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020149] Funding Source: NIH RePORTER	South Medical University; Third Hospital of Hebei Medical University; China Scholarship Council(China Scholarship Council); American Heart Association (AHA)(American Heart Association); U.S. National Institutes of Health (NIH)/American Recovery and Reinvestment Act equipment grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AHA(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Lan Jing, Yufan Zhou, Nan Jiang, and Junjun Wu (all from the University of South Alabama) for assistance on pilot experiments. Y.X. was supported, in part, by a fellowship from South Medical University. Y.-Q.J. was supported by a fellowship from The Third Hospital of Hebei Medical University. C.L. was supported, in part, by a scholarship from the China Scholarship Council. N.A. was supported, in part, by a fellowship from the American Heart Association (AHA; 16PRE27130004). The Nikon A1R confocal microscope, FRET imaging, and analysis were funded by U.S. National Institutes of Health (NIH)/American Recovery and Reinvestment Act equipment grants (S10RR027535 and S10OD020149). This work was supported, in part, by the National Natural Science Foundation of China (Grant 81773698 to J.X.) and NIH/National Institute of Neurological Disorders and Stroke Grants R01NS102495 and R21NS093522, and AHA Grant 13SDG13970009 (to X.-M.Z.). The authors declare no conflicts of interest.	Annamdevula NS, 2013, SENSORS-BASEL, V13, P9267, DOI 10.3390/s130709267; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Chen XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021970; Chen XM, 2010, EUR J PHARMACOL, V648, P15, DOI 10.1016/j.ejphar.2010.09.005; Chiang PH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10143; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; FRENKEL C, 1993, BRIT J ANAESTH, V71, P15, DOI 10.1093/bja/71.1.15; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gonzalez-Inchauspe C, 2017, J NEUROSCI, V37, P2589, DOI 10.1523/JNEUROSCI.2566-16.2017; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Huang Y, 2015, NEUROPHARMACOLOGY, V94, P42, DOI 10.1016/j.neuropharm.2014.12.010; Jiang N, 2017, J CEREBR BLOOD F MET, V37, P528, DOI 10.1177/0271678X16630558; Jing Lan, 2011, PLoS One, V6, pe26909, DOI 10.1371/journal.pone.0026909; Jing L, 2012, J NEUROSCI, V32, P4080, DOI 10.1523/JNEUROSCI.5021-11.2012; Leavesley SJ, 2013, CYTOM PART A, V83, P898, DOI 10.1002/cyto.a.22340; Li MH, 2010, J PHYSIOL-LONDON, V588, P3883, DOI 10.1113/jphysiol.2010.192922; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lin SH, 2015, EUR J NEUROSCI, V41, P1553, DOI 10.1111/ejn.12905; Liu MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep23350; Meng QY, 2009, NEUROSCIENCE, V159, P1126, DOI 10.1016/j.neuroscience.2009.01.069; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ochoa JG, 2016, NEUROL RES INT, V2016, DOI 10.1155/2016/5380907; Petroff EY, 2008, P NATL ACAD SCI USA, V105, P3140, DOI 10.1073/pnas.0712280105; Pidoplichko VI, 2014, J NEUROSCI, V34, P3130, DOI 10.1523/JNEUROSCI.4009-13.2014; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Quintana P, 2015, J PHYSIOL-LONDON, V593, P4373, DOI 10.1113/JP270701; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; Wang YZ, 2015, ELIFE, V4, DOI 10.7554/eLife.05682; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wu JJ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0190-x; Wu JJ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0185-7; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072379; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	50	16	16	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3832	3843		10.1096/fj.201701367R	http://dx.doi.org/10.1096/fj.201701367R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29447005	Green Published			2022-12-26	WOS:000435104500029
J	Suire, CN; Nainar, S; Fazio, M; Kreutzer, AG; Paymozd-Yazdi, T; Topper, CL; Thompson, CR; Leissring, MA				Suire, Caitlin N.; Nainar, Sarah; Fazio, Michael; Kreutzer, Adam G.; Paymozd-Yazdi, Tara; Topper, Caitlyn L.; Thompson, Caroline R.; Leissring, Malcolm A.			Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; HUMAN-LUNG FIBROBLASTS; HUMAN-SKIN FIBROBLASTS; GROWTH-FACTOR-I; TOPICAL INSULIN; COLLAGEN-SYNTHESIS; PROLIFERATION; STIMULATION; VITRO; VIVO	Insulin-degrading enzyme (IDE) is an atypical zinc-metalloendopeptidase that hydrolyzes insulin and other intermediate-sized peptide hormones, many of which are implicated in skin health and wound healing. Pharmacological inhibitors of IDE administered internally have been shown to slow the breakdown of insulin and thereby potentiate insulin action. Given the importance of insulin and other IDE substrates for a variety of dermatological processes, pharmacological inhibitors of IDE suitable for topical applications would be expected to hold significant therapeutic and cosmetic potential. Existing IDE inhibitors, however, are prohibitively expensive, difficult to synthesize and of undetermined toxicity. Here we used phage display to discover novel peptidic inhibitors of IDE, which were subsequently characterized in vitro and in cell culture assays. Among several peptide sequences tested, a cyclic dodecapeptide dubbed P12-3A was found to potently inhibit the degradation of insulin (K-i = 2.5 +/- 0.31 mu M) and other substrates by IDE, while also being resistant to degradation, stable in biological milieu, and highly selective for IDE. In cell culture, P12-3A was shown to potentiate several insulin-induced processes, including the transcription, translation and secretion of alpha-1 type I collagen in primary murine skin fibroblasts, and the migration of keratino-cytes in a scratch wound migration assay. By virtue of its potency, stability, specificity for IDE, low cost of synthesis, and demonstrated ability to potentiate insulin-induced processes involved in wound healing and skin health, P12-3A holds significant therapeutic and cosmetic potential for topical applications.	[Suire, Caitlin N.; Paymozd-Yazdi, Tara; Topper, Caitlyn L.; Thompson, Caroline R.; Leissring, Malcolm A.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders UCI MI, Irvine, CA 92697 USA; [Suire, Caitlin N.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Nainar, Sarah; Fazio, Michael] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA; [Kreutzer, Adam G.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Leissring, MA (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders UCI MI, Irvine, CA 92697 USA.	m.leissring@uci.edu	Kreutzer, Adam/GVS-3816-2022; LEISSRING, MALCOLM/AAW-5361-2021; Kreutzer, Adam/GVS-8892-2022	LEISSRING, MALCOLM/0000-0001-7185-4255; Suire, Caitlin/0000-0001-5224-1330	National Institutes of Health [R01-GM115617]; American Diabetes Association [7-11-CD-13]; UCI Applied Innovation Technology Development Innovation Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); UCI Applied Innovation Technology Development Innovation Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported by grants from the National Institutes of Health (R01-GM115617; www.nih.gov), the American Diabetes Association (Career Development Award 7-11-CD-13; www.diabetes.org), and the UCI Applied Innovation Technology Development Innovation Fund (www.innovation.uci.edu) to MAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1990, AM REV RESPIR DIS, V142, pS7, DOI 10.1164/ajrccm/142.6_Pt_2.S7; Abdul-Hay SO, 2015, ACS CHEM BIOL, V10, P2716, DOI 10.1021/acschembio.5b00334; Abdul-Hay SO, 2013, J MED CHEM, V56, P2246, DOI 10.1021/jm301280p; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Apikoglu-Rabus S, 2010, CLIN EXP DERMATOL, V35, P180, DOI 10.1111/j.1365-2230.2009.03419.x; Aust MC, 2008, PLAST RECONSTR SURG, V121, P1421, DOI 10.1097/01.prs.0000304612.72899.02; Baltzis D, 2014, ADV THER, V31, P817, DOI 10.1007/s12325-014-0140-x; Bannister T, 2010, PROBE REPORTS NIH MO; BELFIELD WO, 1970, VET MED SM ANIM CLIN, V65, P455; Benoliel AM, 1997, J CELL SCI, V110, P2089; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; Charton J, 2015, EUR J MED CHEM, V90, P547, DOI 10.1016/j.ejmech.2014.12.005; Charton J, 2014, EUR J MED CHEM, V79, P184, DOI 10.1016/j.ejmech.2014.04.009; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COID DR, 1977, BRIT MED J, V2, P1063, DOI 10.1136/bmj.2.6094.1063-a; DelleDonne A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-39; Duckworth WC, 2004, J CLIN ENDOCR METAB, V89, P847, DOI 10.1210/jc.2003-031371; Durham TB, 2015, J BIOL CHEM, V290, P20044, DOI 10.1074/jbc.M115.638205; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fernandes Desmond, 2005, Oral Maxillofac Surg Clin North Am, V17, P51; GOLDSTEIN RH, 1989, ENDOCRINOLOGY, V124, P964, DOI 10.1210/endo-124-2-964; Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; Greenway S E, 1999, J Wound Care, V8, P526; Hanam S R, 1983, J Foot Surg, V22, P298; Hrynyk M, 2014, BURNS, V40, P1433, DOI 10.1016/j.burns.2014.03.020; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; KJELLSTROM T, 1984, HORM METAB RES, V16, P168, DOI 10.1055/s-2007-1014734; Krupsky M, 1996, CONNECT TISSUE RES, V34, P53, DOI 10.3109/03008209609028893; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; Leal MC, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1415, DOI 10.1016/B978-0-12-382219-2.00319-7; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2006, NATURE, V443, P761, DOI 10.1038/nature05210; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Liu Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-1; Madibally SV, 2003, J SURG RES, V109, P92, DOI 10.1016/S0022-4804(02)00036-7; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; MIRSKY IA, 1955, P SOC EXP BIOL MED, V88, P76; MIRSKY IA, 1955, SCIENCE, V122, P559, DOI 10.1126/science.122.3169.559; Monaco S, 2009, CELL CYCLE, V8, P2024, DOI 10.4161/cc.8.13.8813; Musselmann K, 2006, INVEST OPHTH VIS SCI, V47, P5260, DOI 10.1167/iovs.06-0612; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Rezvani O, 2009, OSTOMY WOUND MANAG, V55, P22; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V273, pE657, DOI 10.1152/ajpendo.1997.273.4.E657; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Singh Aashim, 2016, Indian Dermatol Online J, V7, P244, DOI 10.4103/2229-5178.185468; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Tang WJ, 2016, TRENDS ENDOCRIN MET, V27, P24, DOI 10.1016/j.tem.2015.11.003; Trevisan R, 1997, J AM SOC NEPHROL, V8, P1133; VILLEE DB, 1977, NATURE, V268, P156, DOI 10.1038/268156a0; WERINGER EJ, 1982, ACTA ENDOCRINOL-COP, V99, P101, DOI 10.1530/acta.0.0990101; Wertheimer E, 2000, J INVEST DERMATOL, V115, P24, DOI 10.1046/j.1523-1747.2000.00008.x; Wertheimer E, 2001, ENDOCRINOLOGY, V142, P1234, DOI 10.1210/en.142.3.1234; Wilson JM, 2008, ANN ROY COLL SURG, V90, P160, DOI 10.1308/003588408X261816	58	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193101	10.1371/journal.pone.0193101	http://dx.doi.org/10.1371/journal.pone.0193101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447281	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900112
J	Balsitis, S; Gali, V; Mason, PJ; Chaniewski, S; Levine, SM; Wichroski, MJ; Feulner, M; Song, YL; Granaldi, K; Loy, JK; Thompson, CM; Lesniak, JA; Brockus, C; Kishnani, N; Menne, S; Cockett, MI; Iyer, R; Mason, SW; Tenney, DJ				Balsitis, Scott; Gali, Volodymyr; Mason, Pamela J.; Chaniewski, Susan; Levine, Steven M.; Wichroski, Michael J.; Feulner, Michael; Song, Yunling; Granaldi, Karen; Loy, James K.; Thompson, Chris M.; Lesniak, Jacob A.; Brockus, Catherine; Kishnani, Narendra; Menne, Stephan; Cockett, Mark I.; Iyer, Renuka; Mason, Stephen W.; Tenney, Daniel J.			Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; T-CELL RESPONSES; VIRUS-INFECTION; VIRAL-HEPATITIS; NUCLEOS(T)IDE ANALOGS; PROGRAMMED DEATH-1; SURFACE-ANTIGEN; NEO-ANTIGENS; COMBINATION; MELANOMA	Immune clearance of Hepatitis B virus (HBV) is characterized by broad and robust antiviral T cell responses, while virus-specific T cells in chronic hepatitis B (CHB) are rare and exhibit immune exhaustion that includes programmed-death-1 (PD-1) expression on virus-specific T cells. Thus, an immunotherapy able to expand and activate virus-specific T cells may have therapeutic benefit for CHB patients. Like HBV-infected patients, woodchucks infected with woodchuck hepatitis virus (WHV) can have increased hepatic expression of PD-1-ligand-1 (PD-L1), increased PD-1 on CD8+ T cells, and a limited number of virus-specific T cells with substantial individual variation in these parameters. We used woodchucks infected with WHV to assess the safety and efficacy of anti-PD-L1 monoclonal antibody therapy (alpha PD-L1) in a variety of WHV infection states. Experimentally-infected animals lacked PD-1 or PD-L1 upregulation compared to uninfected controls, and accordingly, alpha PD-L1 treatment in lab-infected animals had limited antiviral effects. In contrast, animals with naturally acquired WHV infections displayed elevated PD-1 and PD-L1. In these same animals, combination therapy with alpha PD-L1 and entecavir (ETV) improved control of viremia and antigenemia compared to ETV treatment alone, but with efficacy restricted to a minority of animals. Pre-treatment WHV surface antigen (sAg) level was identified as a statistically significant predictor of treatment response, while PD-1 expression on peripheral CD8+ T cells, T cell production of interferon gamma (IFN-gamma) upon in vitro antigen stimulation (WHV ELI-SPOT), and circulating levels of liver enzymes were not. To further assess the safety of this strategy, alpha PD-L1 was tested in acute WHV infection to model the risk of liver damage when the extent of hepatic infection and antiviral immune responses were expected to be the greatest. No significant increase in serum markers of hepatic injury was observed over those in infected, untreated control animals. These data support a positive benefit/risk assessment for blockade of the PD-1:PD-L1 pathway in CHB patients and may help to identify patient groups most likely to benefit from treatment. Furthermore, the efficacy of alpha PD-L1 in only a minority of animals, as observed here, suggests that additional agents may be needed to achieve a more robust and consistent response leading to full sAg loss and durable responses through anti-sAg antibody seroconversion.	[Balsitis, Scott; Gali, Volodymyr; Mason, Pamela J.; Chaniewski, Susan; Levine, Steven M.; Wichroski, Michael J.; Feulner, Michael; Cockett, Mark I.; Mason, Stephen W.; Tenney, Daniel J.] Bristol Myers Squibb, Virol Discovery, Wallingford, CT 06492 USA; [Song, Yunling; Granaldi, Karen] Bristol Myers Squibb, Discovery Toxicol, Princeton, NJ USA; [Loy, James K.] Bristol Myers Squibb, Discovery Toxicol, Wallingford, CT USA; [Thompson, Chris M.; Lesniak, Jacob A.] Bristol Myers Squibb, Drug Safety Evaluat, Immunotoxicol, New Brunswick, NJ USA; [Brockus, Catherine] Bristol Myers Squibb, Bioanalyt Sci, Princeton, NJ USA; [Kishnani, Narendra] Bristol Myers Squibb, Pharmaceut Candidate Optimizat, Princeton, NJ USA; [Menne, Stephan] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA; [Iyer, Renuka] Roswell Pk Canc Inst, Liver & Pancreas Tumor Ctr, Buffalo, NY 14263 USA; [Balsitis, Scott] Gilead Sci, San Francisco, CA USA; [Gali, Volodymyr] Bristol Myers Squibb, Leads Discovery Optimizat, Wallingford, CT USA; [Mason, Pamela J.] 150 Humiston Dr, Bethany, CT USA; [Chaniewski, Susan] Bristol Myers Squibb, Clin Data Management, Wallingford, CT USA; [Levine, Steven M.; Wichroski, Michael J.; Tenney, Daniel J.] Bristol Myers Squibb, Immunooncol Discovery, Princeton, NJ 08540 USA; [Feulner, Michael] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA; [Brockus, Catherine] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Cockett, Mark I.] ViiV Healthcare, Wallingford, CT USA; [Mason, Stephen W.] Carogen, Farmington, CT USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Georgetown University; Roswell Park Cancer Institute; Gilead Sciences; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Boehringer Ingelheim; Eli Lilly	Tenney, DJ (corresponding author), Bristol Myers Squibb, Virol Discovery, Wallingford, CT 06492 USA.; Tenney, DJ (corresponding author), Bristol Myers Squibb, Immunooncol Discovery, Princeton, NJ 08540 USA.	daniel.tenney@bms.com		Mason, Stephen/0000-0002-6662-9624	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Bristol-Myers Squibb funded the research and had no role in the study design, data collection, analysis, decision to publish or manuscript preparation. The funder provided support in the form of salaries for authors (SB, VG, PJM, SC, SML, MJW, MF, YS, KG, CB, JKL, JAL, CMT, NK, SWM, MIC, and DJT) and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balsitis S, WOODCHUCK IGG UNPUB; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baudino L, 2008, J IMMUNOL, V181, P6664, DOI 10.4049/jimmunol.181.9.6664; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Boni C, 2012, GASTROENTEROLOGY, V143, P963, DOI 10.1053/j.gastro.2012.07.014; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Chen J, 2011, INFLAMM RES, V60, P47, DOI 10.1007/s00011-010-0233-1; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Colonno RJ, 2001, J INFECT DIS, V184, P1236, DOI 10.1086/324003; Cote Paul J., 1993, Viral Immunology, V6, P161, DOI 10.1089/vim.1993.6.161; Crettaz J, 2009, J VIROL, V83, P2663, DOI 10.1128/JVI.02384-08; Fisicaro P, 2012, GASTROENTEROLOGY, V143, P1576, DOI 10.1053/j.gastro.2012.08.041; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Gardiner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063818; Guidotti LG, 2015, CURR OPIN IMMUNOL, V36, P61, DOI 10.1016/j.coi.2015.06.016; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lampertico P, 2015, HEPATOLOGY, V61, P1459, DOI 10.1002/hep.27731; Liang XS, 2010, WORLD J GASTROENTERO, V16, P618, DOI 10.3748/wjg.v16.i5.618; Liaw YF, 2011, HEPATOLOGY, V54, pE1, DOI 10.1002/hep.24473; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Liu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003856; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Meng ZJ, 2016, ANTIVIR RES, V125, P14, DOI 10.1016/j.antiviral.2015.11.001; Menne S, 2005, ANTIMICROB AGENTS CH, V49, P2720, DOI 10.1128/AAC.49.7.2720-2728.2005; Menne S, 2007, J VIROL, V81, P10614, DOI 10.1128/JVI.00691-07; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; Park J-J, 2015, GASTROENTEROLOGY; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; Raziorrouh B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105703; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rehermann B, 2015, HEPATOLOGY, V61, P712, DOI 10.1002/hep.27323; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tzeng HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039179; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang BJ, 2011, WORLD J GASTROENTERO, V17, P3322, DOI 10.3748/wjg.v17.i28.3322; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Wong DKH, 2013, CLIN GASTROENTEROL H, V11, P1004, DOI 10.1016/j.cgh.2013.01.026; Zhang EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026196; Zhang WJ, 2013, HEPATOB PANCREAT DIS, V12, P394, DOI 10.1016/S1499-3872(13)60061-2; Zhang XN, 2016, J CLIN INVEST, V126, P1079, DOI 10.1172/JCI83339; Zhu D, 2016, J IMMUNOL	53	26	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0190058	10.1371/journal.pone.0190058	http://dx.doi.org/10.1371/journal.pone.0190058			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444087	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500005
J	Le, CT; Nguyen, G; Park, SY; Choi, DH; Cho, EH				Cong Thuc Le; Giang Nguyen; Park, So Young; Choi, Dae Hee; Cho, Eun-Hee			LY2405319, an analog of fibroblast growth factor 21 ameliorates alpha-smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; FGF21; ACTIVATION; LIVER; MECHANISMS; OBESITY	Fibroblast growth factor 21 (FGF21) is an important metabolic regulator expressed predominantly in the liver. In this study, we evaluated the role of LY2405319, an analogue of FGF21, in hepatic stellate cell (HSC) activation and in a methionine and choline-deficient (MCD)-diet induced mouse model of liver fibrosis. During liver injury, HSCs trans-differentiate into activated myofibroblasts which produce alpha-smooth muscle actin (alpha-SMA) and become a major cell type in hepatic fibrogenesis. Succinate and succinate receptor (GPR91) signaling has emerged as a regulator to promote alpha-SMA production in MCD diet-induced mice. Treatment with palmitate or MCD medium on LX-2 cells (HSCs) increased succinate concentration in the conditioned medium and cell lysate of LX-2 cells and increased production of GPR91 and alpha-SMA. However, LY2405319 administration ameliorates palmitate or MCD media-induced succinate production and decreases over-expression of GPR91 and alpha-SMA in LX2-cells. In an in vivo study, the MCD diet treatment caused increased steatohepatitis and liver fibrosis compared with the control diet in mice. Administration of LY2405319 improved steatohepatitis ameliorated GPR91 and alpha-SMA production in the liver, decreased succinate concentration in both liver and serum of MCD diet-induced mice. These results suggest that FGF21 reduces production of alpha-SMA by inhibiting the succinate-GPR91 pathway. We conclude that FGF21 acts as an inhibitor of the succinate-GPR91 pathway to control liver fibrosis. This suggests that FGF21 has therapeutic potential for treating liver fibrogenesis.	[Cong Thuc Le; Giang Nguyen; Park, So Young; Choi, Dae Hee; Cho, Eun-Hee] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea	Kangwon National University	Cho, EH (corresponding author), Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea.	ehcho@kangwon.ac.kr		CHO, EUN-HEE/0000-0002-1349-8894	Korean Diabetes Association;  [NRF-2016R1C1B2011968]	Korean Diabetes Association; 	This work was supported by NRF-2016R1C1B2011968 and a grant (E-H.C., 2014) from the Korean Diabetes Association to E-HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Adams Carolyn A, 2013, PLOS ONE, V8; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Combs TP, 2014, REV ENDOCR METAB DIS, V15, P137, DOI 10.1007/s11154-013-9280-6; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; Dong JQ, 2015, BRIT J CLIN PHARMACO, V80, P1051, DOI 10.1111/bcp.12676; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Giralt M, 2015, MOL CELL ENDOCRINOL, V418, P66, DOI 10.1016/j.mce.2015.09.018; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hebert SC, 2004, NATURE, V429, P143, DOI 10.1038/429143a; Jin LG, 2016, DIABETES METAB J, V40, P22, DOI 10.4093/dmj.2016.40.1.22; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Li YH, 2016, J BIOL CHEM, V291, P10277, DOI 10.1074/jbc.M115.692244; Li YH, 2015, BIOCHEM BIOPH RES CO, V463, P853, DOI 10.1016/j.bbrc.2015.06.023; Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; McCreath KJ, 2015, DIABETES, V64, P1154, DOI 10.2337/db14-0346; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rusli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30484; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu PF, 2016, TOXICOL APPL PHARM, V290, P43, DOI 10.1016/j.taap.2015.11.012; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	37	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192146	10.1371/journal.pone.0192146	http://dx.doi.org/10.1371/journal.pone.0192146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444136	gold, Green Submitted, Green Published			2022-12-26	WOS:000425183500055
J	Gjessing, MC; Aamelfot, M; Batts, WN; Benestad, SL; Dale, OB; Thoen, E; Weli, SC; Winton, JR				Gjessing, Mona C.; Aamelfot, Maria; Batts, William N.; Benestad, Sylvie L.; Dale, Ole B.; Thoen, Even; Weli, Simon C.; Winton, James R.			Development and characterization of two cell lines from gills of Atlantic salmon	PLOS ONE			English	Article							PRIMARY CULTURES; EPITHELIAL-CELLS; RAINBOW-TROUT; SALAR; EVOLUTION; POXVIRUS; DISEASE	Gill disease in Atlantic salmon, Salmo salar L., causes big losses in the salmon farming industry. Until now, tools to cultivate microorganisms causing gill disease and models to study the gill responses have been lacking. Here we describe the establishment and characterization of two cell lines from the gills of Atlantic salmon. Atlantic salmon gill cell ASG-10 consisted of cells staining for cytokeratin and e-cadherin and with desmosomes as seen by transmission electron microscopy suggesting the cells to be of epithelial origin. These structures were not seen in ASG-13. The cell lines have been maintained for almost 30 passages and both cell lines are fully susceptible to infection by infectious hematopoietic necrosis virus (IHNV), viral hemorrhagic septicemia virus (VHSV), infectious pancreatic necrosis virus (IPNV), Atlantic salmon reovirus TS (TSRV) and Pacific salmon paramyxovirus (PSPV). While infectious salmon anemia virus (ISAV) did not cause visible CPE, immunofluorescent staining revealed a sub-fraction of cells in both the ASG-10 and ASG-13 lines may be permissive to infection. ASG-10 is able to proliferate and migrate to close scratches in the monolayer within seven days in vitro contrary to ASG-13, which does not appear to do have the same proliferative and migratory ability. These cell lines will be useful in studies of gill diseases in Atlantic salmon and may represent an important contribution for alternatives to experimental animals and studies of epithelial-mesenchymal cell biology.	[Gjessing, Mona C.; Aamelfot, Maria; Benestad, Sylvie L.; Dale, Ole B.; Weli, Simon C.] Norwegian Vet Inst, Oslo, Norway; [Batts, William N.; Winton, James R.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Thoen, Even] Norwegian Univ Life Sci, Oslo, Norway	Norwegian Veterinary Institute; United States Department of the Interior; United States Geological Survey; Norwegian University of Life Sciences	Gjessing, MC (corresponding author), Norwegian Vet Inst, Oslo, Norway.	mona.gjessing@vetinst.no	Weli, Simon/G-9397-2019; Dale, Ole Bendik/ABB-6276-2021		Research Council of Norway [234037, 244110]	Research Council of Norway(Research Council of Norway)	Funded by 234037- https://www.forskningsradet.no/en/Home_page/1177315753906, The Research Council of Norway. MCG. 244110-https://www.forskningsradet.no/en/Home_page/1177315753906, The Research Council of Norway. MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn PA, 2005, BASIC HISTOLOGY, P66; AVELLA M, 1994, IN VITRO CELL DEV-AN, V30A, P41; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; Butler R, 2004, J FISH BIOL, V65, P1108, DOI 10.1111/j.0022-1112.2004.00521.x; Christiansen DH, 2017, J GEN VIROL, V98, P595, DOI 10.1099/jgv.0.000741; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; FERNANDES MN, 1995, J FISH BIOL, V47, P641, DOI 10.1006/jfbi.1995.0168; Freeman MA, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-58; Freshney R.I., 2010, CULTURE ANIMAL CELLS; Gjessing MC, 2015, J VIROL, V89, P9348, DOI 10.1128/JVI.01174-15; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koppang EO., 2015, MUCOSAL HLTH AQUACUL, V1, P93, DOI [DOI 10.1016/B978-0-12-417186-2.00005-4, 10.1016/B978-0-12-417186-2.00005-4]; Kvellestad A, 2005, DIS AQUAT ORGAN, V67, P47, DOI 10.3354/dao067047; Leoni G, 2015, MUCOSAL IMMUNOL, V8, P959, DOI 10.1038/mi.2015.63; McBeath A, 2015, J FISH DIS, V38, P3, DOI 10.1111/jfd.12253; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; NAITO N, 1980, AM J PHYSIOL, V238, pR165, DOI 10.1152/ajpregu.1980.238.3.R165; Nylund A, 2008, ARCH VIROL, V153, P1299, DOI 10.1007/s00705-008-0117-7; PART P, 1993, J EXP BIOL, V175, P219; REED L. J., 1938, AMER JOUR HYG, V27, P493; Steen JB, 1964, RESP FUNCTION TELEOS; Steinum T, 2008, J FISH DIS, V31, P205, DOI 10.1111/j.1365-2761.2007.00893.x; Steinum T, 2010, DIS AQUAT ORGAN, V91, P201, DOI 10.3354/dao02266; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; Wood CM, 1997, J EXP BIOL, V200, P1047; ZENKER WGE, 1987, COMP BIOCHEM PHYS A, V86, P423, DOI 10.1016/0300-9629(87)90518-4	29	8	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191792	10.1371/journal.pone.0191792	http://dx.doi.org/10.1371/journal.pone.0191792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444101	gold, Green Submitted, Green Published			2022-12-26	WOS:000425183500031
J	Kok, LM; Groenewegen, KA; Huisstede, BMA; Nelissen, RGHH; Rietveld, ABM; Haitjema, S				Kok, Laura M.; Groenewegen, Karlijn A.; Huisstede, Bionka M. A.; Nelissen, Rob G. H. H.; Rietveld, A. Boni M.; Haitjema, Saskia			The high prevalence of playing-related musculoskeletal disorders (PRMDs) and its associated factors in amateur musicians playing in student orchestras: A cross-sectional study	PLOS ONE			English	Article							AND/OR SHOULDER CANS; UPPER-EXTREMITY; RISK-FACTORS; COMPLAINTS; INJURIES; ARM; NECK; PAIN; CONSEQUENCES	Objective Despite the high number of amateur musicians in the general population, little is known about the musculoskeletal health of amateur musicians. Playing a musical instrument is supposed to be a risk factor for the development of musculoskeletal complaints. This study aimed to evaluate playing-related musculoskeletal disorders (PRMDs) among amateur musicians playing in student orchestras. Design A cross-sectional study. Participants 357 members of eleven Dutch student orchestras across the Netherlands were included in this study. Intervention A paper-based questionnaire on PRMDs was used. Outcome measures Sociodemographic characteristics and PRMDs were evaluated using an adaptation of the Nordic Musculoskeletal Questionnaire (NMQ) and the music module of the Disabilities of Shoulder and Hand (DASH) questionnaire. Results The year prevalence of PRMDs among amateur musicians was 67.8%. Female gender, younger age, higher BMI and playing a string instrument were independently associated with a higher prevalence of PRMDs. The left shoulder was affected more frequently in violinists and violists, whereas the right hand and wrist were more frequently affected in woodwind instrumentalists. Of the subjects with PRMDs during the last week, the score of the music module of the DASH was 18.8 (6.3-31.2) Discussion This study is the first to report on PRMDs and its associated factors in a large group of amateur musicians. The prevalence of PRMDs in amateur musicians is high, however the DASH scores reflect a confined impact of these PRMDs on their functioning as a musician. Preventive measures are needed aiming at reducing PRMDs among amateur musicians.	[Kok, Laura M.; Nelissen, Rob G. H. H.] Leiden Univ, Med Ctr, Dept Orthoped, Leiden, Netherlands; [Groenewegen, Karlijn A.] MC Slotervaart, Dept Geriatr, Amsterdam, Netherlands; [Huisstede, Bionka M. A.] Univ Utrecht, Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands; [Rietveld, A. Boni M.; Haitjema, Saskia] Haaglanden Med Ctr, Med Ctr Dancers & Musicians, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Slotervaart Hospital; Utrecht University; Utrecht University Medical Center; Haaglanden Medical Center	Kok, LM (corresponding author), Leiden Univ, Med Ctr, Dept Orthoped, Leiden, Netherlands.	Laura.m.kok@gmail.com	Nelissen, Rob/AAD-8134-2020	Nelissen, Rob/0000-0003-1228-4162				Ackermann B, 2012, MED PROBL PERFORM AR, V27, P181; Bizzini M, 2013, BR J SPORT MED; Buckley T, 2006, MED PROBL PERFORM AR, V21, P80; CHRISTMAN S, 1993, BRAIN COGNITION, V22, P266, DOI 10.1006/brcg.1993.1038; Dawson WJ, 2001, MED PROBL PERFORM AR, V16, P152; Edling CW, 2009, MED PROBL PERFORM AR, V24, P113; Engquist K, 2004, MED PROBL PERFORM AR, V19, P55; Hicks T, 2008, J CULT DIVERS; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Huisstede BMA, 2008, CLIN J PAIN, V24, P253, DOI 10.1097/AJP.0b013e318160a8b4; Kaufman-Cohen Y, 2011, OCCUP MED-OXFORD, V61, P90, DOI 10.1093/occmed/kqq196; Keller S, 2008, PREV MED, V46, P189, DOI 10.1016/j.ypmed.2007.09.008; Kok LM, 2017, PRINCIPLES OF GENDER-SPECIFIC MEDICINE: GENDER IN THE GENOMIC ERA, 3RD EDITION, P543, DOI 10.1016/B978-0-12-803506-1.00030-9; Kok LM, 2017, MED PROBL PERFORM AR, V32, P8, DOI 10.21091/mppa.2017.1003; Kok LM, 2016, INT ARCH OCC ENV HEA, V89, P373, DOI 10.1007/s00420-015-1090-6; Kok LM, 2015, MED PROBL PERFORM AR, V30, P163, DOI 10.21091/mppa.2015.3031; Kok LM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-9; Kok LM, 2016, PLOS ONE, P11; Kopiez R, 2012, PSYCHOL; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Leppanen M, 2014, SPORTS MED, V44, P473, DOI 10.1007/s40279-013-0136-8; MIDDLESTADT SE, 1989, MED PROBL PERFORM AR, V4, P41; NEWMARK J, 1987, MED PROBL PERFORM AR, V2, P142; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Roquelaure Y, 2009, ARTHRIT CARE RES, V61, P1425, DOI 10.1002/art.24740; Sadeghi S, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-35; Sataloff RT, 2013, SCI MED; van der Horst N, 2015, AM J SPORT MED, V43, P1316, DOI 10.1177/0363546515574057; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Volz L, 2014, FACTSHEET AMATEURKUN; Wiel A., 2010, NED TIJDSCHR GENEES, V154, P1; Wu SJ, 2007, MED PROBL PERFORM AR, V22, P43; Zaza C, 1998, SOC SCI MED, V47, P2013, DOI 10.1016/S0277-9536(98)00307-4; Zaza C, 1998, CAN MED ASSOC J, V158, P1019	34	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191772	10.1371/journal.pone.0191772	http://dx.doi.org/10.1371/journal.pone.0191772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444093	Green Published, gold			2022-12-26	WOS:000425183500030
J	Sarkar, J; Dwivedi, G; Chen, Q; Sheu, IE; Paich, M; Chelini, CM; D'Alessandro, PM; Burns, SP				Sarkar, Joydeep; Dwivedi, Gaurav; Chen, Qian; Sheu, Iris E.; Paich, Mark; Chelini, Colleen M.; D'Alessandro, Paul M.; Burns, Samuel P.			A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual	PLOS ONE			English	Article							FREE FATTY-ACIDS; RESTING METABOLIC-RATE; ADIPOSE-TISSUE LIPOLYSIS; LIFE-STYLE INTERVENTIONS; DE-NOVO LIPOGENESIS; SKELETAL-MUSCLE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; FOLLOW-UP	A computational model of the physiological mechanisms driving an individual's health towards onset of type 2 diabetes (T2D) is described, calibrated and validated using data from the Diabetes Prevention Program (DPP). The objective of this model is to quantify the factors that can be used for prevention of T2D. The model is energy and mass balanced and continuously simulates trajectories of variables including body weight components, fasting plasma glucose, insulin, and glycosylated hemoglobin among others on the time-scale of years. Modeled mechanisms include dynamic representations of intracellular insulin resistance, pancreatic beta-cell insulin production, oxidation of macronutrients, ketogenesis, effects of inflammation and reactive oxygen species, and conversion between stored and activated metabolic species, with body-weight connected to mass and energy balance. The model was calibrated to 331 placebo and 315 lifestyle-intervention DPP subjects, and one year forecasts of all individuals were generated. Predicted population mean errors were less than or of the same magnitude as clinical measurement error; mean forecast errors for weight and HbA1c were similar to 5%, supporting predictive capabilities of the model. Validation of lifestyle-intervention prediction is demonstrated by synthetically imposing diet and physical activity changes on DPP placebo subjects. Using subject level parameters, comparisons were made between exogenous and endogenous characteristics of subjects who progressed toward T2D (HbA1c > 6.5) over the course of the DPP study to those who did not. The comparison revealed significant differences in diets and pancreatic sensitivity to hyper-glycemia but not in propensity to develop insulin resistance. A computational experiment was performed to explore relative contributions of exogenous versus endogenous factors between these groups. Translational uses to applications in public health and personalized healthcare are discussed.	[Sarkar, Joydeep; Dwivedi, Gaurav; Chen, Qian; Sheu, Iris E.; Paich, Mark; Chelini, Colleen M.; D'Alessandro, Paul M.; Burns, Samuel P.] PricewaterhouseCoopers LLP, New York, NY USA		Burns, SP (corresponding author), PricewaterhouseCoopers LLP, New York, NY USA.	samuel.p.burns@pwc.com		Dwivedi, Gaurav/0000-0003-0681-0795	PricewaterhouseCoopers, LLP; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); General Clinical Research Center Program; National Institute of Child Health and Human Development (NICHD); National Institute on Aging (NIA); Office of Research on Women's Health; Office of Research on Minority Health; Centers for Disease Control and Prevention (CDC); American Diabetes Association; DPP	PricewaterhouseCoopers, LLP; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); General Clinical Research Center Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Diabetes Association(American Diabetes Association); DPP	This research was funded by PricewaterhouseCoopers, LLP. PricewaterhouseCoopers, LLP provided support in the form of salaries for all authors [JS, GD, QC, IS, MP, CC, PD, SB] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The Diabetes Prevention Program (DPP) was conducted by the DPP Research Group and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the General Clinical Research Center Program, the National Institute of Child Health and Human Development (NICHD), the National Institute on Aging (NIA), the Office of Research on Women's Health, the Office of Research on Minority Health, the Centers for Disease Control and Prevention (CDC), and the American Diabetes Association. The data [and samples] from the DPP were supplied by the NIDDK Central Repositories. This manuscript was not prepared under the auspices of the DPP and does not represent analyses or conclusions of the DPP Research Group, the NIDDK Central Repositories, or the NIH.	Abdel-Hamid TK, 2003, MED SCI SPORT EXER, V35, P400, DOI 10.1249/01.MSS.0000053659.32126.2D; AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056620; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; BALDWIN KM, 1975, PFLUG ARCH EUR J PHY, V354, P203, DOI 10.1007/BF00584644; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; BILD DE, 1989, DIABETES CARE, V12, P24, DOI 10.2337/diacare.12.1.24; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; BJORNTORP P, 1969, ACTA MED SCAND, V185, P351; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; CALLOWAY DH, 1954, AM J CLIN NUTR, V2, P405; CALLOWAY DH, 1975, J NUTR, V105, P914, DOI 10.1093/jn/105.7.914; Centers for Disease Control and Prevention, 2014, DIAB REP CARD 2014; Centers for Disease Control and Prevention, 2014, NATL DIAB STAT REP 2; Clark A, 2001, DIABETES, V50, pS169, DOI 10.2337/diabetes.50.2007.S169; Constable SH, 1987, AM J PHYSIOL-CELL PH, V253; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; De Berardis G, 2002, DIABETES CARE, V25, P284, DOI 10.2337/diacare.25.2.284; De Gaetano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1462, DOI 10.1152/ajpendo.90444.2008; de Winter W, 2006, J PHARMACOKINET PHAR, V33, P313, DOI 10.1007/s10928-006-9008-2; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Doyle F, 2008, IFAC P, DOI [10.3182/20080706-5-KR-1001.3822, DOI 10.3182/20080706-5-KR-1001.3822]; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dube S, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0605-6; Dufour Sylvie, 2009, Am J Physiol Endocrinol Metab, V297, pE231, DOI 10.1152/ajpendo.00222.2009; Dulloo AG, 1998, AM J CLIN NUTR, V68, P599, DOI 10.1093/ajcn/68.3.599; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; EATON RP, 1969, J CLIN INVEST, V48, P1560, DOI 10.1172/JCI106122; ELLIOT DL, 1989, AM J CLIN NUTR, V49, P93, DOI 10.1093/ajcn/49.1.93; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Fallah-Fini S, 2014, AM J PUBLIC HEALTH, V104, P1230, DOI 10.2105/AJPH.2014.301882; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Fischer Y, 1997, J BIOL CHEM, V272, P7085, DOI 10.1074/jbc.272.11.7085; Godoy-Matos AF, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-91; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Guo ZK, 2000, J APPL PHYSIOL, V89, P2057, DOI 10.1152/jappl.2000.89.5.2057; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Hernandez TL, 2010, AM J CLIN NUTR, V91, P578, DOI 10.3945/ajcn.2009.27909; Hindmarsh AC, 1983, SCI COMPUT, V1, P55; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; HORTON TJ, 1995, AM J CLIN NUTR, V62, P19, DOI 10.1093/ajcn/62.1.19; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Houstis NE, 2007, REACTIVE OXYGEN SPEC; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang TT, 2009, PREV CHRONIC DIS, V6; Hudgins LC, 2000, J LIPID RES, V41, P595; Janssen I, 2000, J APPL PHYSIOL, V89, P81; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Jones AP, 2006, AM J PUBLIC HEALTH, V96, P488, DOI 10.2105/AJPH.2005.063529; Jones E., SCIPY OPEN SOURCE SC; Jorgensen JOL, 1998, METABOLISM, V47, P1134, DOI 10.1016/S0026-0495(98)90289-X; Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892; Kannel W B, 1972, N Engl J Med, V287, P781, DOI 10.1056/NEJM197210192871601; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krogh A, 1920, BIOCHEM J, V14, P290, DOI 10.1042/bj0140290; Krudys KM, 2005, AM J PHYSIOL-ENDOC M, V288, pE1038, DOI 10.1152/ajpendo.00058.2004; Leguisamo NM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-100; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Liberopoulos EN, 2006, CURR DRUG TARGETS, V7, P211, DOI 10.2174/138945006775515419; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; LIVESEY G, 1988, AM J CLIN NUTR, V47, P608, DOI 10.1093/ajcn/47.4.608; Lustman, 1997, Semin Clin Neuropsychiatry, V2, P15; Marcovina S, 2007, CLIN CHEM, V53, P711, DOI 10.1373/clinchem.2006.082214; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; MCMENAMY RH, 1957, J CLIN INVEST, V36, P1672, DOI 10.1172/JCI103568; Meier JJ, 2013, DIABETES CARE, V36, pS113, DOI 10.2337/dcS13-2008; Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Nielsen S, 2000, INT J OBESITY, V24, P1153, DOI 10.1038/sj.ijo.0801317; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pandey KB, 2010, DIS MARKERS, V29, P31, DOI [10.1155/2010/964630, 10.3233/DMA-2010-0723]; PASQUET P, 1992, AM J CLIN NUTR, V56, P483, DOI 10.1093/ajcn/56.3.483; Phillips SM, 2014, SPORTS MED, V44, P71, DOI 10.1007/s40279-014-0152-3; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; RAND WM, 1976, AM J CLIN NUTR, V29, P639, DOI 10.1093/ajcn/29.6.639; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RICHIERI GV, 1995, J LIPID RES, V36, P229; RICHTER EA, 1982, AM J PHYSIOL, V242, pE25, DOI 10.1152/ajpendo.1982.242.1.E25; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; SAIFER A, 1961, J LIPID RES, V2, P268; Sakano N, 2009, J CLIN BIOCHEM NUTR, V44, P185, DOI 10.3164/jcbn.08-252; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Stein RJ, 2005, PUBLIC HEALTH REP, V120, P266, DOI 10.1177/003335490512000308; Stich V, 2000, J APPL PHYSIOL, V88, P1277, DOI 10.1152/jappl.2000.88.4.1277; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; TAY HL, 1995, CLIN OTOLARYNGOL, V20, P130, DOI 10.1111/j.1365-2273.1995.tb00029.x; Thomas Diana M., 2011, Journal of Biological Dynamics, V5, P579, DOI 10.1080/17513758.2010.508541; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Tuttolomondo A, 2008, NUTR METAB CARDIOVAS, V18, P152, DOI 10.1016/j.numecd.2007.02.003; van Loon LJC, 2005, DIABETOLOGIA, V48, P2097, DOI 10.1007/s00125-005-1889-x; Wadley GD, 2006, AM J PHYSIOL-ENDOC M, V290, pE694, DOI 10.1152/ajpendo.00464.2005; WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772; WHO, 1985, ENERGY PROTEIN REQUI; Widjaja A, 1999, CLIN CHEM, V45, P561; Wolfe RR, 1998, ADV EXP MED BIOL, V441, P147; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YOUNG DR, 1966, J APPL PHYSIOL, V21, P1047, DOI 10.1152/jappl.1966.21.3.1047; YOUNG VR, 1990, AM J CLIN NUTR, V51, P270, DOI 10.1093/ajcn/51.2.270; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	132	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192472	10.1371/journal.pone.0192472	http://dx.doi.org/10.1371/journal.pone.0192472			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444133	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500067
J	Chamie, G; Kato-Maeda, M; Emperador, DM; Wandera, B; Mugagga, O; Crandall, J; Janes, M; Marquez, C; Kamya, MR; Charlebois, ED; Havlir, DV				Chamie, Gabriel; Kato-Maeda, Midori; Emperador, Devy M.; Wandera, Bonnie; Mugagga, Olive; Crandall, John; Janes, Michael; Marquez, Carina; Kamya, Moses R.; Charlebois, Edwin D.; Havlir, Diane V.			Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda	PLOS ONE			English	Article							HIGH HIV PREVALENCE; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; COMMUNITY; AFRICA; METAANALYSIS; AREA	Introduction Incomplete understanding of TB transmission dynamics in high HIV prevalence settings remains an obstacle for prevention. Understanding where transmission occurs could provide a platform for case finding and interrupting transmission. Methods From 2012 +/- 2015, we sought to recruit all adults starting TB treatment in a Ugandan community. Participants underwent household (HH) contact investigation, and provided names of social contacts, sites of work, healthcare and socializing, and two sputum samples. Mycobacterium tuberculosis culture-positive specimens underwent 24-loci MIRU-VNTR and spoligotyping. We sought to identify epidemiologic links between genotype-matched cases by analyzing social networks and mapping locations where cases reported spending >= 12 hours over the one-month pre-treatment. Sites of spatial overlap (<= 100m) between genotype-matched cases were considered potential transmission sites. We analyzed social networks stratified by genotype clustering status, with cases linked by shared locations, and compared network density by location type between clustered vs. non-clustered cases. Results Of 173 adults with TB, 131 (76%) were enrolled, 108 provided sputum, and 84/131 (78%) were MTB culture-positive: 52% (66/131) tested HIV-positive. Of 118 adult HH contacts, 105 (89%) were screened and 3 (2.5%) diagnosed with active TB. Overall, 33 TB cases (39%) belonged to 15 distinct MTB genotype-matched clusters. Within each cluster, no cases shared a HH or reported shared non-HH contacts. In 6/15 (40%) clusters, potential epidemiologic links were identified by spatial overlap at specific locations: 5/6 involved health care settings. Genotype-clustered TB social networks had significantly greater network density based on shared clinics (p < 0.001) and decreased density based on shared marketplaces (p < 0.001), compared to non-clustered networks. Conclusions In this molecular epidemiologic study, links between MTB genotype-matched cases were only identifiable via shared locations, healthcare locations in particular, rather than named contacts. This suggests most transmission is occurring between casual contacts, and emphasizes the need for improved infection control in healthcare settings in rural Africa.	[Chamie, Gabriel; Emperador, Devy M.; Marquez, Carina; Havlir, Diane V.] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Kato-Maeda, Midori; Janes, Michael] Univ Calif San Francisco, Curry Int TB Ctr, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Wandera, Bonnie; Mugagga, Olive] MU UCSF Res Collaborat, Kampala, Uganda; [Crandall, John] Calif Dept Publ Hlth, Richmond, CA USA; [Kamya, Moses R.] Makerere Univ, Sch Med, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Charlebois, Edwin D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University; California Department of Public Health; Makerere University; University of California System; University of California San Francisco	Chamie, G (corresponding author), Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA.	Gabriel.Chamie@ucsf.edu		Emperador, Devy/0000-0002-8228-1824; Marquez, Carina/0000-0002-7622-6562	National Institute of Allergy and Infectious Diseases, National Institutes of Health [K23AI095034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI118592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by K23AI095034, National Institute of Allergy and Infectious Diseases, National Institutes of Health, awarded to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiimwe BB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-12; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Chamie G, 2015, IDENTIFYING LOCATION; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Glynn JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132840; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mears J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005636; Middelkoop K, 2014, J INFECT DIS; Middelkoop K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-221; Middelkoop K, 2009, J INFECT DIS, V200, P1207, DOI 10.1086/605930; Ministry of Health Uganda (MOH)., 2016, CONSOLIDATED GUIDELI; Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Saito S, 2016, JAIDS-J ACQ IMM DEF, V71, pe96, DOI 10.1097/QAI.0000000000000896; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Surie D, 2017, EMERG INFECT DIS, V23, P487, DOI 10.3201/eid2303.161183; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Tudo G, 2004, INT J TUBERC LUNG D, V8, P1458; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; Wilkinson D, 1997, TROP MED INT HEALTH, V2, P747, DOI 10.1046/j.1365-3156.1997.d01-386.x; World Health Organization, 2012, REC INV CONT PERS IN; Yuen CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099880; 2012, GLOB TUB REP 2013, P1	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192666	10.1371/journal.pone.0192666	http://dx.doi.org/10.1371/journal.pone.0192666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438413	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400039
J	Yetti, H; Naito, H; Yuan, Y; Jia, XF; Hayashi, Y; Tamada, H; Kitamori, K; Ikeda, K; Yamori, Y; Nakajima, T				Yetti, Husna; Naito, Hisao; Yuan, Yuan; Jia, Xiaofang; Hayashi, Yumi; Tamada, Hazuki; Kitamori, Kazuya; Ikeda, Katsumi; Yamori, Yukio; Nakajima, Tamie			Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; SEX-DIFFERENCES; FIBROTIC STEATOHEPATITIS; NUCLEAR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; CHENODEOXYCHOLIC ACID; X-RECEPTOR; DISEASE; EXPRESSION; GENDER	During middle age, women are less susceptible to nonalcoholic steatohepatitis (NASH) than men. Thus, we investigated the underlying molecular mechanisms behind these sexual differences using an established rat model of NASH. Mature female and male stroke-prone spontaneously hypertensive 5/Dmcr rats were fed control or high-fat-cholesterol (HFC) diets for 2, 8, and 14 weeks. Although HFC-induced hepatic fibrosis was markedly less severe in females than in males, only minor gender differences were observed in expression levels of cytochrome P450 enzymes (CYP)7A1, CYP8B1 CYP27A1, and CYP7B1, and multidrug resistance-associated protein 3, and bile salt export pump, which are involved in fibrosis-related bile acid (BA) kinetics. However, the BA detoxification-related enzymes UDP-glucuronosyltransferase (UGT) and sulfotransferase (SULT) 2A1, and the nuclear receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR), were strongly suppressed in HFC-fed males, and were only slightly changed in HFC-diet fed females. Expression levels of the farnesoid X receptor and its small heterodimer partner were similarly regulated in a gender-dependent fashion following HFC feeding. Hence, the pronounced female resistance to HFC-induced liver damage likely reflects sustained expression of the nuclear receptors CAR and PXR and the BA detoxification enzymes UGT and SULT.	[Yetti, Husna; Jia, Xiaofang; Hayashi, Yumi; Tamada, Hazuki] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Nagoya, Aichi, Japan; [Naito, Hisao] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan; [Yuan, Yuan; Nakajima, Tamie] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi, Japan; [Kitamori, Kazuya] Kinjo Gakuin Univ, Coll Human Life & Environm, Nagoya, Aichi, Japan; [Ikeda, Katsumi] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan; [Yetti, Husna] Andalas Univ, Dept Publ Hlth, Fac Med, Padang, Indonesia	Nagoya University; Fujita Health University; Chubu University; Mukogawa Women's University; Mukogawa Women's University; Universitas Andalas	Nakajima, T (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi, Japan.	tnasu23@med.nagoya-u.ac.jp		Nakajima, Tamie/0000-0002-0474-7019	Japan Society for the Promotion of Science [623390, B25H04788]; Medical Science Promotion Fund for the General Assembly of the Japan Medical Congress	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Science Promotion Fund for the General Assembly of the Japan Medical Congress	This study was supported in part by a Grant-in-Aid for Scientific Research (623390 and B25H04788) from the Japan Society for the Promotion of Science (http://www.mext.go.jp/en/) and Medical Science Promotion Fund for the General Assembly of the Japan Medical Congress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268; Anezaki Y, 2009, HEPATOL RES, V39, P609, DOI 10.1111/j.1872-034X.2009.00494.x; Aranha MM, 2008, EUR J GASTROEN HEPAT, V20, P519, DOI 10.1097/MEG.0b013e3282f4710a; Arrese M, 2010, CLIN PHARMACOL THER, V87, P473, DOI 10.1038/clpt.2010.2; Barbier O, 2009, MOL CELL BIOCHEM, V326, P3, DOI 10.1007/s11010-008-0001-5; Bock KW, 2010, BIOCHEM PHARMACOL, V80, P771, DOI 10.1016/j.bcp.2010.04.034; Bonkovsky HL, 1999, J HEPATOL, V31, P421, DOI 10.1016/S0168-8278(99)80032-4; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Comhair TM, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-4; Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; Dunn RT, 1998, DRUG METAB DISPOS, V26, P598; ENJOJI M, 2012, INT J HEPATOL, DOI DOI 10.1155/2012/925807; Erickson SK, 2009, J LIPID RES, V50, pS412, DOI 10.1194/jlr.R800089-JLR200; FARRELL GC, 1988, J CLIN INVEST, V81, P221, DOI 10.1172/JCI113299; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Galman C, 2011, J INTERN MED, V270, P580, DOI 10.1111/j.1365-2796.2011.02466.x; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Jia XF, 2014, DIGEST DIS SCI, V59, P1490, DOI 10.1007/s10620-014-3028-3; Jia XF, 2013, DIGEST DIS SCI, V58, P2212, DOI 10.1007/s10620-013-2747-1; Jia XF, 2012, LIFE SCI, V90, P934, DOI 10.1016/j.lfs.2012.04.029; Kashireddy PRV, 2004, EXP BIOL MED, V229, P158, DOI 10.1177/153537020422900204; Kitamori Kazuya, 2012, Environmental Health and Preventive Medicine, V17, P173, DOI 10.1007/s12199-011-0235-9; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Lamba V, 2003, J PHARMACOL EXP THER, V307, P906, DOI 10.1124/jpet.103.054866; Li GD, 2015, ACTA PHARM SIN B, V5, P93, DOI 10.1016/j.apsb.2015.01.005; Lopez-Velazquez JA, 2012, J LIPIDS, V2012, DOI 10.1155/2012/139875; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Moriya Takashi, 2012, Environmental Health and Preventive Medicine, V17, P444, DOI 10.1007/s12199-012-0273-y; Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002; Naito H, 2016, ENVIRON HEALTH PREV, V21, P368, DOI 10.1007/s12199-016-0539-x; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Rando G, 2011, BBA-MOL BASIS DIS, V1812, P964, DOI 10.1016/j.bbadis.2010.12.023; RUNGEMORRIS M, 1991, BIOCHEM BIOPH RES CO, V175, P1051, DOI 10.1016/0006-291X(91)91671-X; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Spruss A, 2012, MOL MED, V18, P1346, DOI 10.2119/molmed.2012.00223; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Suzuki Y, 2013, NAGOYA J MED SCI, V75, P57; Swanson HI, 2013, DRUG METAB DISPOS, V41, P1, DOI 10.1124/dmd.112.048694; Tamada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145939; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Uppal H, 2005, HEPATOLOGY, V41, P168, DOI 10.1002/hep.20512; Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883; Yatsuji S, 2007, HEPATOL RES, V37, P1034, DOI 10.1111/j.1872-034X.2007.00156.x; Yetti H, 2013, LIFE SCI, V93, P673, DOI 10.1016/j.lfs.2013.09.013; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200	53	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192863	10.1371/journal.pone.0192863	http://dx.doi.org/10.1371/journal.pone.0192863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438418	Green Submitted, gold, Green Published			2022-12-26	WOS:000425083400061
J	DeVries, ZC; Santangelo, RG; Barbarin, AM; Schal, C				DeVries, Zachary C.; Santangelo, Richard G.; Barbarin, Alexis M.; Schal, Coby			Histamine as an emergent indoor contaminant: Accumulation and persistence in bed bug infested homes	PLOS ONE			English	Article							CIMEX-LECTULARIUS; ATOPIC-DERMATITIS; LOW-INCOME; SKIN BARRIER; EXPOSURE; DUST; ALLERGEN; ASTHMA; REACTIVITY; FRANCE	Histamine is used in bronchial and dermal provocation, but it is rarely considered an environmental risk factor in allergic disease. Because bed bugs defecate large amounts of histamine as a component of their aggregation pheromone, we sought to determine if histamine accumulates in household dust in bed bug infested homes, and the effects of bed bug eradication with spatial heat on histamine levels in dust. We collected dust in homes and analyzed for histamine before, and up to three months after bed bug eradication. Histamine levels in bed bug infested homes were remarkably high (mean = 54.6 +/- 18.9 mu g/100 mg of sieved household dust) and significantly higher than in control homes not infested with bed bugs (mean < 2.5 +/- 1.9 mu g/100 mg of sieved household dust). Heat treatments that eradicated the bed bug infestations failed to reduce histamine levels, even three months after treatment. We report a clear association between histamine levels in household dust and bed bug infestations. The high concentrations, persistence, and proximity to humans during sleep suggest that bed bug-produced histamine may represent an emergent contaminant and pose a serious health risk in the indoor environment.	[DeVries, Zachary C.; Santangelo, Richard G.; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [DeVries, Zachary C.; Schal, Coby] North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Barbarin, Alexis M.] NC Dept Hlth & Human Serv, Communicable Dis Branch, Raleigh, NC USA; [Schal, Coby] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	DeVries, ZC (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; DeVries, ZC (corresponding author), North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA.	zcdevrie@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; DeVries, Zachary/0000-0003-0050-7269	Blanton J. Whitmire Endowment at North Carolina State University; US Department of Housing and Urban Development Healthy Homes program [NCHHU0017-13]; Alfred P. Sloan Foundation; National Institute of Environmental Health Sciences grant [P30ES025128]; Foundation for Agromedicine and Toxicology; Pi Chi Omega; Entomological Society of America	Blanton J. Whitmire Endowment at North Carolina State University; US Department of Housing and Urban Development Healthy Homes program; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institute of Environmental Health Sciences grant; Foundation for Agromedicine and Toxicology; Pi Chi Omega; Entomological Society of America	Funding for this study was provided by the Blanton J. Whitmire Endowment at North Carolina State University, the US Department of Housing and Urban Development Healthy Homes program (NCHHU0017-13) to CS, Alfred P. Sloan Foundation (2013-5-35 MBE) to CS and a National Institute of Environmental Health Sciences grant to the Center for Human Health and the Environment (CHHE, P30ES025128). ZCD received the David R. Nimocks Jr. Fellowship and scholarship awards from the Foundation for Agromedicine and Toxicology, Pi Chi Omega, and the Entomological Society of America.	Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V112, P339, DOI 10.1067/mai.2003.1597; ARLIAN LG, 1992, J ALLERGY CLIN IMMUN, V90, P292, DOI 10.1016/S0091-6749(05)80006-5; Baldacci S, 2015, RESP MED, V109, P1089, DOI 10.1016/j.rmed.2015.05.017; Bassil KL, 2007, CAN FAM PHYSICIAN, V53, P1705; Bencheton AL, 2011, J EUR ACAD DERMATOL, V25, P599, DOI 10.1111/j.1468-3083.2010.03804.x; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Cooper R.A., 2011, HDB PEST CONTROL, P586; CURRY JJ, 1946, J CLIN INVEST, V25, P785, DOI 10.1172/JCI101764; De Benedetto A, 2015, J CLIN MED, V4, P741, DOI 10.3390/jcm4040741; deBlay F, 1997, J ALLERGY CLIN IMMUN, V99, P107, DOI 10.1016/S0091-6749(97)70307-5; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Faundez EI, 2014, J MED ENTOMOL, V51, P1073, DOI 10.1603/ME13206; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; Gries R., 2015, ANGEW CHEM, V127, P1151, DOI [DOI 10.1002/ANGE.201409890, DOI 10.1073/pnas.1635049100]; Gries R, CAN J CHEM IN PRESS; Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HEYER G, 1989, J INVEST DERMATOL, V93, P492, DOI 10.1111/1523-1747.ep12284051; How YF, 2010, J VECTOR ECOL, V35, P89, DOI 10.1111/j.1948-7134.2010.00033.x; Kullman GJ, 1998, AM IND HYG ASSOC J, V59, P403, DOI 10.1080/15428119891010668; Leulmi H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003789; Mollet JA, 1997, J MED ENTOMOL, V34, P307, DOI 10.1093/jmedent/34.3.307; Moreland D., 2011, HDB PEST CONTROL, V10th, P11; MOSSMAN BT, 1989, NEW ENGL J MED, V320, P1721, DOI 10.1056/NEJM198906293202604; Potter Michael F., 2011, American Entomologist, V57, P14; Price JB, 2012, J ALLERGY CLIN IMMUN, V129, P863, DOI 10.1016/j.jaci.2012.01.034; Rudblad S, 2002, ALLERGY, V57, P1029, DOI 10.1034/j.1398-9995.2002.23682.x; Saillenfait AM, 2015, INT J HYG ENVIR HEAL, V218, P281, DOI 10.1016/j.ijheh.2015.01.002; Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483; Schaltegger CA, 2011, HANDBOOK ON THE SHADOW ECONOMY, P150; SCHWARTZ J, 1994, ENVIRON RES, V66, P105, DOI 10.1006/enrs.1994.1048; Sever ML, 2007, J ALLERGY CLIN IMMUN, V120, P849, DOI 10.1016/j.jaci.2007.07.003; Shalaby AR, 1996, FOOD RES INT, V29, P675, DOI 10.1016/S0963-9969(96)00066-X; SIEGEL PD, 1992, SCAND J WORK ENV HEA, V18, P60; SIEGEL PD, 1991, SCAND J WORK ENV HEA, V17, P276, DOI 10.5271/sjweh.1702; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stander S, 2002, EXP DERMATOL, V11, P12, DOI 10.1034/j.1600-0625.2002.110102.x; STEWART GA, 1995, CLIN REV ALLERG IMMU, V13, P135; TAYLOR AN, 1977, LANCET, V2, P847; U. S. Food and Drug Administration (USFDA), 2011, FISH FISH PROD HAZ C; van der Valk JPM, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0092-0; Wang Changlu, 2011, Insects, V2, P83, DOI 10.3390/insects2020083; Wang CL, 2011, J ECON ENTOMOL, V104, P274, DOI 10.1603/EC10141; WOOLCOCK AJ, 1984, AM REV RESPIR DIS, V130, P71	46	20	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192462	10.1371/journal.pone.0192462	http://dx.doi.org/10.1371/journal.pone.0192462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432483	Green Submitted, gold, Green Published			2022-12-26	WOS:000424814300026
J	Mathur, D; Mehta, A; Firmal, P; Bedi, G; Sood, C; Gautam, A; Raghava, GPS				Mathur, Deepika; Mehta, Ayesha; Firmal, Priyanka; Bedi, Gursimran; Sood, Charu; Gautam, Ankur; Raghava, Gajendra P. S.			TopicalPdb: A database of topically delivered peptides	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; INTRANASAL DELIVERY; SEQUENCE ALIGNMENT; FUTURE-DIRECTIONS; BRAIN DELIVERY; DRUG-DELIVERY; PROTEINS	TopicalPdb (http://crdd.osdd.net/raghava/topicalpdb/) is a repository of experimentally verified topically delivered peptides. Data was manually collected from research articles. The current release of TopicalPdb consists of 657 entries, which includes peptides delivered through the skin (462 entries), eye (173 entries), and nose (22 entries). Each entry provides comprehensive information related to these pep-tides like the source of origin, nature of peptide, length, N- and C-terminal modifications, mechanism of penetration, type of assays, cargo and biological properties of peptides, etc. In addition to natural peptides, TopicalPdb contains information of peptides having non-natural, chemically modified residues and D-amino acids. Besides this primary information, TopicalPdb stores predicted tertiary structures as well as peptide sequences in SMILE format. Tertiary structures of peptides were predicted using state-of-art method PEPstrMod. In order to assist users, a number of web-based tools have been integrated that includes keyword search, data browsing, similarity search and structural similarity. We believe that TopicalPdb is a unique database of its kind and it will be very useful in designing peptides for non-invasive topical delivery.	[Mathur, Deepika; Mehta, Ayesha; Firmal, Priyanka; Bedi, Gursimran; Sood, Charu; Gautam, Ankur; Raghava, Gajendra P. S.] CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Raghava, Gajendra P. S.] Indraprastha Inst Informat Technol, Computat Biol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Indraprastha Institute of Information Technology Delhi	Raghava, GPS (corresponding author), CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.; Raghava, GPS (corresponding author), Indraprastha Inst Informat Technol, Computat Biol, New Delhi, India.	raghava@imtech.res.in	Mathur, Deepika/ABE-2195-2021; Mathur, Deepika/O-6963-2014; Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022	Mathur, Deepika/0000-0002-2591-4170; Raghava, Gajendra P.S./0000-0002-8902-2876	Council of Scientific and Industrial Research [GENESIS BSC0121]; Department of Biotechnology (project BTISNET), Govt. of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (project BTISNET), Govt. of India	The authors are thankful to funding agencies Council of Scientific and Industrial Research (project Open Source Drug discovery and GENESIS BSC0121) and Department of Biotechnology (project BTISNET), Govt. of India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are thankful to funding agencies Council of Scientific and Industrial Research (project Open Source Drug discovery and GENESIS BSC0121) and Department of Biotechnology (project BTISNET), Govt. of India for financial support.	[Anonymous], 2018, PHYS ACTIVITY, V55, P273, DOI [10.1016/j, DOI 10.1186/1479]; Bruno BJ, 2013, THER DELIV, V4, P1443, DOI [10.4155/TDE.13.104, 10.4155/tde.13.104]; Campbell C, 2012, THER DELIV, V3, P557, DOI 10.4155/TDE.12.12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fortuna A, 2014, EUR J PHARM BIOPHARM, V88, P8, DOI 10.1016/j.ejpb.2014.03.004; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; GILBARD JP, 1990, INVEST OPHTH VIS SCI, V31, P1381; Gill JC, 2002, J PEDIATR-US, V140, P595, DOI 10.1067/mpd.2002.123626; Jitendra, 2011, INDIAN J PHARM SCI, V73, P367, DOI 10.4103/0250-474X.95608; Kamei N, 2015, J CONTROL RELEASE, V197, P105, DOI 10.1016/j.jconrel.2014.11.004; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; KROOTILA K, 1988, EXP EYE RES, V47, P307, DOI 10.1016/0014-4835(88)90013-9; Lin TT, 2016, ACTA PHARM SIN B, V6, P352, DOI 10.1016/j.apsb.2016.04.001; Lopes LB, 2005, PHARM RES-DORDR, V22, P750, DOI 10.1007/s11095-005-2591-x; Lopes LB, 2015, CURR PHARM DESIGN, V21, P2814, DOI 10.2174/1381612821666150428143243; Meredith ME, 2015, AAPS J, V17, P780, DOI 10.1208/s12248-015-9719-7; Nasrollahi SA, 2012, CHEM BIOL DRUG DES, V80, P639, DOI 10.1111/cbdd.12008; Pescina S, 2016, MOL PHARMACEUT, V13, P3876, DOI 10.1021/acs.molpharmaceut.6b00658; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Singh S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0103-4; Witting M, 2015, BIOTECHNOL ADV, V33, P1355, DOI 10.1016/j.biotechadv.2015.01.010; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yavuz B, 2016, OCULAR DRUG DELIVERY; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177	24	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0190134	10.1371/journal.pone.0190134	http://dx.doi.org/10.1371/journal.pone.0190134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432422	Green Submitted, gold, Green Published			2022-12-26	WOS:000424814300003
J	Volpe, MS; Naves, JM; Ribeiro, GG; Ruas, G; Tucci, MR				Volpe, Marcia S.; Naves, Juliane M.; Ribeiro, Gabriel G.; Ruas, Gualberto; Tucci, Mauro R.			Effects of manual hyperinflation, clinical practice versus expert recommendation, on displacement of mucus simulant: A laboratory study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; MECHANICAL VENTILATION; EXTUBATION OUTCOMES; SECRETION MOVEMENT; INTENSIVE-CARE; COUGH STRENGTH; PHYSIOTHERAPY; CLEARANCE; PERFORMANCE; SETTINGS	Introduction Manual hyperinflation (MH), a maneuver applied in mechanically ventilated patients to facilitate secretion removal, has large variation in its performance. Effectiveness of MH is usually evaluated by its capacity to generate an expiratory flow bias. The aim of this study was to compare the effects of MH-and its resulting flow bias D applied according to clinical practice versus according to expert recommendation on mucus movement in a lung model simulating a mechanically ventilated patient. Methods Twelve physiotherapists were asked to apply MH, using a self-inflating manual resuscitator, to a test lung as if to remove secretions under two conditions: according to their usual clinical practice (pre-instruction phase) and after verbal instruction to perform MH according to expert recommendation was given (post-instruction phase). Mucus simulant movement was measured with a photodensitometric technique. Peak inspiratory flow (PIF), peak inspiratory pressure (P-IP), inspiratory time (T-INSP), tidal volume (V-T) and peak expiratory flow (PEF) were measured continuously. Results It was found that MH performed post-instruction delivered a smaller VT (643.1 +/- 57.8 ml) at a lower P-IP (15.0 +/- 1.5 cmH(2)O), lower PIF (38.0 +/- 9.6 L/min), longer T-INSP (1.84 +/- 0.54 s) and lower PEF (65.4 +/- 6.7L/min) compared to MH pre-instruction. In the pre-instruction phase, MH resulted in a mean PIF/PEF ratio of 1.73 +/- 0.38 and mean PEF-PIF difference of -54.6 +/- 28.3 L/min, both out of the range for secretion removal. In the post-instruction phase both indexes were in the adequate range. Consequently, the mucus simulant was moved outward when MH was applied according to expert recommendation and towards the test lung when it was applied according to clinical practice. Conclusions Performance of MH during clinical practice with PIF higher than PEF was ineffective to clear secretion in a lung model simulating a mechanically ventilated patient. In order to remove secretion, MH should result in an adequate expiratory flow bias.	[Volpe, Marcia S.] Univ Fed Sao Paulo, Dept Human Movement Sci, Sao Paulo, Brazil; [Naves, Juliane M.; Ribeiro, Gabriel G.; Ruas, Gualberto] Univ Fed Triangulo Mineiro, Dept Appl Physiotherapy, Uberaba, MG, Brazil; [Tucci, Mauro R.] Univ Sao Paulo, Sch Med, Lab Med Res 09, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo	Volpe, MS (corresponding author), Univ Fed Sao Paulo, Dept Human Movement Sci, Sao Paulo, Brazil.	marciasvolpe@gmail.com						Ambrosino N, 2011, REV PORT PNEUMOL, V17, P283, DOI 10.1016/j.rppneu.2011.06.004; [Anonymous], PHYSIOTHERAPY; BENJAMIN RG, 1989, CHEST, V95, P658, DOI 10.1378/chest.95.3.658; Bennett BG, 2015, RESP CARE, V60, P1449, DOI 10.4187/respcare.04066; Boussarsar M, 2002, INTENS CARE MED, V28, P406, DOI 10.1007/s00134-001-1178-1; Denehy L, 1999, EUR RESPIR J, V14, P958, DOI 10.1034/j.1399-3003.1999.14d38.x; Duan J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1493-0; França Eduardo Ériko Tenório de, 2012, Rev. bras. ter. intensiva, V24, P6; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Hanekom S, 2011, J EVAL CLIN PRACT, V17, P801, DOI 10.1111/j.1365-2753.2010.01480.x; Hodgson C, 1999, AUST J PHYSIOTHER, V45, P185, DOI 10.1016/S0004-9514(14)60349-4; Hodgson C, 2000, ANAESTH INTENS CARE, V28, P255, DOI 10.1177/0310057X0002800302; Jham K, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.06.008; Jones AM, 2009, HEART LUNG, V38, P513, DOI 10.1016/j.hrtlng.2009.06.002; Jones AYM, 2002, RESP PHYSIOL NEUROBI, V132, P321, DOI 10.1016/S1569-9048(02)00071-X; KIM CS, 1987, J APPL PHYSIOL, V62, P959, DOI 10.1152/jappl.1987.62.3.959; Bassi GL, 2011, CURR OPIN CRIT CARE, V17, P57, DOI 10.1097/MCC.0b013e3283428b31; LIBASSI G, 2012, CRIT CARE MED, V40, P895, DOI DOI 10.1097/CCM.00013e318236efb5; Maxwell L, 2002, ANAESTH INTENS CARE, V30, P283, DOI 10.1177/0310057X0203000304; Maxwell LJ, 2007, ANAESTHESIA, V62, P27, DOI 10.1111/j.1365-2044.2006.04898.x; Maxwell LJ, 2003, AUST J PHYSIOTHER, V49, P31, DOI 10.1016/S0004-9514(14)60186-0; Ortiz TD, 2013, J BRAS PNEUMOL, V39, P205, DOI 10.1590/S1806-37132013000200012; Paulus F, 2012, CRIT CARE, V16, DOI 10.1186/cc11457; Paulus F, 2016, NURS CRIT CARE, V21, P36, DOI 10.1111/nicc.12068; Paulus Frederique, 2009, Intensive Crit Care Nurs, V25, P199, DOI 10.1016/j.iccn.2009.04.003; Redfern J, 2001, AUST J PHYSIOTHER, V47, P121, DOI 10.1016/S0004-9514(14)60303-2; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Shah S, 2005, CHEST, V128, P3699, DOI 10.1378/chest.128.5.3699; Sigera PC, 2016, PHYS THER, V96, P933, DOI 10.2522/ptj.20150363; Smailes ST, 2013, BURNS, V39, P236, DOI 10.1016/j.burns.2012.09.028; Smina M, 2003, CHEST, V124, P262, DOI 10.1378/chest.124.1.262; Stiller K, 2013, CHEST, V144, P825, DOI 10.1378/chest.12-2930; Thomas PJ, 2015, ANAESTH INTENS CARE, V43, P81, DOI 10.1177/0310057X1504300112; Turki Mohamed, 2005, Respir Care, V50, P340; Volpe MS, 2008, RESP CARE, V53, P1287	35	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191787	10.1371/journal.pone.0191787	http://dx.doi.org/10.1371/journal.pone.0191787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432468	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300011
J	Ayala, MN; Henriques, DYP				Ayala, Maria N.; Henriques, Denise Y. P.			Context-dependent concurrent adaptation to static and moving targets	PLOS ONE			English	Article							OPPOSING VISUOMOTOR ROTATIONS; MOTOR MEMORIES; VISUAL DISTORTIONS; INTERNAL-MODELS; MOVEMENTS; DYNAMICS; HAND; TRANSFORMATIONS; TASK; LIMB	Is the neural control of movements towards moving targets independent to that of static targets? In the following experiments, we used a visuomotor rotation adaptation paradigm to examine the extent to which adapting arm movements to static targets generalize to that of moving targets (i.e. pursuit or tracking). In the first and second experiments, we showed that adaptation to perturbed tracking movements generalizes to reaching movements; reach aftereffects following perturbed tracking were about half the size (approximate to 9 degrees) of those produced following reach training (similar to 19 degrees). Given these findings, in the final experiment we associated opposing perturbations (-30 degrees and +30 degrees) with either reaching or tracking movements and presented them within the same experimental block to determine whether these contexts allow for dual adaptation. We found that the group that experienced opposing perturbations was able to reduce both reaching and tracking errors, as well as produce reach aftereffects following dual training of approximate to 7 degrees, which were substantially smaller than those produced when reach training was not concurrent with tracking training. This reduction in reach aftereffects is consistent with the extent of the interference from tracking training as measured by the reach aftereffects produced when only that condition was performed. These results suggest partial, but not complete, overlap in the learning processes involved in the acquisition of tracking and reaching movements.	[Ayala, Maria N.; Henriques, Denise Y. P.] York Univ, Dept Psychol, Toronto, ON, Canada; [Ayala, Maria N.; Henriques, Denise Y. P.] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Henriques, Denise Y. P.] York Univ, Dept Kinesiol & Hlth Sci, Toronto, ON, Canada	York University - Canada; York University - Canada; York University - Canada	Ayala, MN (corresponding author), York Univ, Dept Psychol, Toronto, ON, Canada.; Ayala, MN (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.	mayala@yorku.ca		Henriques, Denise/0000-0003-2789-0472	NSERC Operating grant; Ontario Graduate Scholarship; Canada First Research Excellence Fund (VISTA); Natural Sciences and Engineering Research Council	NSERC Operating grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canada First Research Excellence Fund (VISTA); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the NSERC Operating grant (to DYPH), the Ontario Graduate Scholarship (to MNA), and the Canada First Research Excellence Fund (VISTA) (to MNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Priyanka Sharma for her assistance with data collection. This work was supported by the Natural Sciences and Engineering Research Council (Denise Y. P. Henriques) and the Ontario Graduate Scholarship (Maria N. Ayala).	Ames KC, 2014, NEURON, V81, P438, DOI 10.1016/j.neuron.2013.11.003; Ayala MN, 2015, EXP BRAIN RES, V233, P3433, DOI 10.1007/s00221-015-4411-9; Baldeo R, 2013, EXP BRAIN RES, V227, P231, DOI 10.1007/s00221-013-3503-7; Bock O, 2005, EXP BRAIN RES, V162, P513, DOI 10.1007/s00221-005-2222-0; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Dionne JK, 2008, J VISION, V8, DOI 10.1167/8.15.2; Donchin O, 2002, J NEUROPHYSIOL, V88, P2114, DOI 10.1152/jn.2002.88.4.2114; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; Galea JM, 2006, EXP BRAIN RES, V175, P676, DOI 10.1007/s00221-006-0585-5; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Green AM, 2015, EXP BRAIN RES, V233, P2961, DOI 10.1007/s00221-015-4366-x; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Herzfeld DJ, 2014, SCIENCE, V345, P1349, DOI 10.1126/science.1253138; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Howard IS, 2015, CURR BIOL, V25, P397, DOI 10.1016/j.cub.2014.12.037; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Hwang EJ, 2003, PLOS BIOL, V1, P209, DOI 10.1371/journal.pbio.0000025; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kitazawa S, 1997, J NEUROSCI, V17, P1481; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Modchalingam S., 2017, NEUROSCIENCE M PLANN; Morehead JR, 2014, NEUROSCIENCE M PLANN; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Nozaki D, 2009, EXP BRAIN RES, V194, P451, DOI 10.1007/s00221-009-1720-x; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Rand MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164602; Rentsch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109819; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Sheahan HR, 2016, NEURON, V92, P773, DOI 10.1016/j.neuron.2016.10.017; Simani MC, 2007, J NEUROPHYSIOL, V98, P2827, DOI 10.1152/jn.00290.2007; Spape MM, 2010, BEHAV BRAIN RES, V213, P313, DOI 10.1016/j.bbr.2010.05.029; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2012, ANN NY ACAD SCI, V1251, P1, DOI 10.1111/j.1749-6632.2011.06430.x; Thompson AKB, 2010, EXP BRAIN RES, V202, P543, DOI 10.1007/s00221-010-2155-0; Tong C, 2003, J NEUROPHYSIOL, V90, P578, DOI 10.1152/jn.01087.2002; Wang L, 2014, PSYCHOL RES-PSYCH FO, V78, P453, DOI 10.1007/s00426-013-0500-1; Werner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123321; Woolley DG, 2011, EXP BRAIN RES, V212, P213, DOI 10.1007/s00221-011-2720-1	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192476	10.1371/journal.pone.0192476	http://dx.doi.org/10.1371/journal.pone.0192476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420650	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900079
J	Koutsouveli, V; Taboada, S; Moles, J; Cristobo, J; Rios, P; Bertran, A; Sola, J; Avila, C; Riesgo, A				Koutsouveli, Vasiliki; Taboada, Sergi; Moles, Juan; Cristobo, Javier; Rios, Pilar; Bertran, Andrea; Sola, Joan; Avila, Conxita; Riesgo, Ana			Insights into the reproduction of some Antarctic dendroceratid, poecilosclerid, and haplosclerid demosponges	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; PROTEIN-SYNTHESIS; SPONGE; PORIFERA; RECRUITMENT; SEA; ECOLOGY; LARVA; WATER; PATTERNS	Sponges are a dominant element of the Antarctic benthic communities, posing both high species richness and large population densities. Despite their importance in Antarctic ecosystems, very little is known about their reproductive patterns and strategies. In our study, we surveyed the tissue of six different species for reproductive elements, namely, Dendrilla antarctica Topsent, 1905 (order Dendroceratida), Phorbas areolatus (Thiele, 1905), Kirkpatrickia variolosa (Kirkpatrick, 1907), and Isodictya kerguelenensis (Ridley & Dendy, 1886) (order Poecilosclerida), and Hemigellius pilosus (Kirkpatrick, 1907) and Haliclona penicillata (Topsent, 1908) (Haplosclerida). Samples of these six species containing various reproductive elements were collected in Deception Island and were processed for both light and transmission electron microscopy (TEM). Even though we were not able to monitor the entire reproductive cycle, due to time and meteorological conditions, we report important aspects of the reproduction of these species. This includes oocyte and embryo morphology and cell ultrastructure, follicular structures and nurse cell activity, as well as vitellogenesis. All species were brooding their embryos within their mesohyl. Both oocytes and embryos were registered in the majority of the studied species, and a single sperm cell being carried to an egg for fertilization was observed in H. penicillata. While the reproductive periods of all species coincided temporally, some of them seemed to rely on a single spawning event, this being suggested by the synchronic oogenesis and embryogenesis occurrence of D. antarctica, P. areolatus and I. kerguelenensis. In contrast, K. variolosa had an asynchronous embryo development, which suggests several larval release events. Our results suggest that differences in the reproductive strategies and morphological traits might succeed in the coexistence of these species at the same habitat avoiding the direct competition between them.	[Koutsouveli, Vasiliki; Taboada, Sergi; Riesgo, Ana] Nat Hist Museum London, Dept Life Sci, Invertebrate Div, London, England; [Moles, Juan; Bertran, Andrea; Sola, Joan; Avila, Conxita] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Fac Biol, Barcelona, Catalonia, Spain; [Moles, Juan; Bertran, Andrea; Sola, Joan; Avila, Conxita] Univ Barcelona, IRBio Biodivers Res Inst, Barcelona, Catalonia, Spain; [Cristobo, Javier; Rios, Pilar] IEO, Gijon, Spain	Natural History Museum London; University of Barcelona; University of Barcelona	Riesgo, A (corresponding author), Nat Hist Museum London, Dept Life Sci, Invertebrate Div, London, England.	A.Riesgo@nhm.ac.uk	Taboada, Sergi/AAB-9390-2021; Rios, Pilar/L-1293-2014; Riesgo, Ana/E-3341-2014; Moles, Juan/H-4786-2018; Cristobo, Javier/M-1949-2014; Avila, Conxita/B-9466-2008	Taboada, Sergi/0000-0003-1669-1152; Rios, Pilar/0000-0001-9710-9114; Riesgo, Ana/0000-0002-7993-1523; Moles, Juan/0000-0003-4511-4055; Cristobo, Javier/0000-0002-7725-4055; Avila, Conxita/0000-0002-5489-8376	Spanish Ministry of Economy and Competitivity [ACTIQUIM-II CGL2010-17415/ANT, DISTANTCOM CTM2013-42667/ANT]; European Union's Horizon research and innovation program [679849]; DIF grant of the Natural History Museum of London [SDF14032]	Spanish Ministry of Economy and Competitivity(Spanish Government); European Union's Horizon research and innovation program; DIF grant of the Natural History Museum of London	This work was carried out within two research grants from the Spanish Ministry of Economy and Competitivity, http.//www.idi.mineco.gob.es/ (ACTIQUIM-II CGL2010-17415/ANT, and DISTANTCOM CTM2013-42667/ANT) to CA, a grant from the European Union's Horizon 2020 research and innovation program under Grant Agreement No. 679849 ('SponGES') to AR and JC, and a DIF grant of the Natural History Museum of London, www.nhm.ac.uk (SDF14032) to AR.	AYLING AL, 1980, BIOL BULL, V158, P271, DOI 10.2307/1540854; Bergquist Patricia R., 1996, New Zealand Oceanographic Institute Memoir, V107, P1; Burton M., 1934, Great Barrier Reef Expedition 1928-9, V4, P513; Burton M., 1934, FURTHER ZOOLOGICAL R, P1; Campos M, 2007, REV BRAS ZOOL, V24, P742, DOI 10.1590/S0101-81752007000300027; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Dayton P, 2016, J EXP MAR BIOL ECOL, V482, P38, DOI 10.1016/j.jembe.2016.05.001; Efremova SM, 1987, PECULIARITIES EMBRYO, P162; ELVIN DW, 1976, BIOL BULL-US, V151, P108, DOI 10.2307/1540709; Ereskovsky A. V., 1999, RUSS J MAR BIOL, V25, P361; Ereskovsky A.V., 2005, COMP EMBRYOLOGY SPON; Ereskovsky AV, 2007, J MAR BIOL ASSOC UK, V87, P1379, DOI 10.1017/S0025315407058109; Ereskovsky AV, 2008, ZOOMORPHOLOGY, V127, P175, DOI 10.1007/s00435-008-0061-9; Ereskovsky AV, 2010, COMPARATIVE EMBRYOLOGY OF SPONGES, P1, DOI 10.1007/978-90-481-8575-7; Ereskovsky AV, 2000, BIOL BULL, V198, P77, DOI 10.2307/1542805; Ereskovsky AV, 1985, ORGANISM ONTO PHYLOG, P35; Fell P.E., 1974, pUnpaginated; Fell P.E., 1983, P1; FELL PE, 1976, BIOL BULL-US, V150, P200, DOI 10.2307/1540468; FELL PE, 1969, J MORPHOL, V127, P133, DOI 10.1002/jmor.1051270202; Fromont J, 1999, CORAL REEFS, V18, P340, DOI 10.1007/s003380050209; FROMONT J, 1994, CORAL REEFS, V13, P127, DOI 10.1007/BF00300773; FROMONT J, 1994, SPONGES IN TIME AND SPACE, P307; Heras H, 2000, LIPIDS, V35, P645, DOI 10.1007/s11745-000-0569-z; Ilan M, 2004, SARSIA, V89, P388, DOI 10.1080/00364820410002659; ILAN M, 1990, MAR BIOL, V105, P25, DOI 10.1007/BF01344267; Janussen Dorte, 2014, P94; Kasyanov VL, 2001, REPROD STRATEGY MARI; Lendenfeld RV, 1889, MONOGRAPH HORNY SPON, P1; Levi C., 1956, Archives de Zoologie Experimentale et Generale, V93, P1; Liaci L.S., 1975, Pubblicazioni Staz zool Napoli, V139, P307; Lindquist N, 1996, ECOL MONOGR, V66, P431, DOI 10.2307/2963489; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; Maldonado M, 2009, BIOL J LINN SOC, V97, P427, DOI 10.1111/j.1095-8312.2009.01202.x; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; Moles J, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3143-8; Moran AL, 2012, J EXP BIOL, V215, P1995, DOI 10.1242/jeb.067066; Morrow C, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0099-8; Nakamura Yuko, 1998, P179; Pace DA, 2007, BIOL BULL-US, V212, P115, DOI 10.2307/25066589; Perez-Porro AR, 2012, HYDROBIOLOGIA, V687, P315, DOI 10.1007/s10750-011-0919-6; Redmond NE, 2013, INTEGR COMP BIOL, V53, P388, DOI 10.1093/icb/ict078; Riesgo A, 2007, MAR FRESHWATER RES, V58, P398, DOI 10.1071/MF06052; Riesgo A, 2015, PLOS ONE, V10, P1; Riesgo A., 2013, ZOOLOGICA SCRIPTA, V43, P101, DOI DOI 10.1111/ZSC.12031; Riesgo A, 2008, INVERTEBR BIOL, V127, P357, DOI 10.1111/j.1744-7410.2008.00128.x; SALLER U, 1985, ZOOMORPHOLOGY, V105, P367, DOI 10.1007/BF00312280; Sara A, 2002, POLAR BIOL, V25, P425, DOI 10.1007/s00300-002-0360-4; SARA M, 1992, POLAR BIOL, V12, P559; Scalera Liaci L, 1973, Riv Biol, V66, P135; SCISCIOLI M, 1991, MOL REPROD DEV, V28, P346, DOI 10.1002/mrd.1080280406; SCISCIOLI M, 1994, CAH BIOL MAR, V35, P471; Simpson TL, 1984, CELL BIOL SPONGES, P341, DOI DOI 10.1007/978-1-4612-5214-6_7; Stephens KM, 2013, J MORPHOL, V274, P1263, DOI 10.1002/jmor.20177; Tokina DB, 1985, ORGANISM ONTO PHYLOG; TUZET O, 1970, CR ACAD SCI D NAT, V270, P955; Tuzet O, 1970, Annls Sci. nat. (Zool.), V12, P27; Uriz MJ, 1998, MAR ECOL PROG SER, V167, P137, DOI 10.3354/meps167137; Wapstra M., 1987, NATO ASI Series Series G Ecological Sciences, V13, P281; Watanabe Y., 1978, Natural Science Report of the Ochanomizu University, V29, P71; Whalan S, 2005, MAR BIOL, V146, P425, DOI 10.1007/s00227-004-1466-8; Whiteley NM, 2001, COMP BIOCHEM PHYS A, V128, P595, DOI 10.1016/S1095-6433(00)00337-8; Witte U, 1996, MAR BIOL, V124, P571, DOI 10.1007/BF00351038; Witte U, 1994, SPONGES TIME SPACE, Vi-xviii, P297; WOOLLACOTT RM, 1989, T AM MICROSC SOC, V108, P410, DOI 10.2307/3226272; Woollacott RM, 1996, INV BIOL, V115	67	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192267	10.1371/journal.pone.0192267	http://dx.doi.org/10.1371/journal.pone.0192267			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420669	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900059
J	Nacher, M; Adriouch, L; Van Melle, A; Parriault, MC; Adenis, A; Couppie, P				Nacher, Mathieu; Adriouch, Leila; Van Melle, Astrid; Parriault, Marie-Claire; Adenis, Antoine; Couppie, Pierre			Country of infection among HIV-infected patients born abroad living in French Guiana	PLOS ONE			English	Article							PREVENTION; MIGRATION; MIGRANTS	Background Over 75% of patients in the HIV cohort in French Guiana are of foreign origin. Our objective was to estimate what proportion of the migrant population of HIV-infected patients in Cayenne had been infected in French Guiana. Methods We included patients of known foreign origin who were followed in Cayenne, for whom the year of arrival in French Guiana was known and the initial CD4 count at the time of diagnosis was available. The time between seroconversion and time at diagnosis was estimated using the formula [square root (CD4 at seroconversion)-square root(CD4 at HIV diagnosis)] / slope of CD4 decline. CD4 counts at the time of infection and the slope were computed in an age and ethnicity-dependent variable. Results The median estimated time between infection and diagnosis was 4.5 years (IQR = 0.2-9.2). Overall, using a median estimate of CD4 count at the time of infection, it was estimated that 53.2% (95% CI = 48.3-58%) of HIV infected foreign patients had acquired HIV after having arrived in French Guiana. Patients having arrived in French Guiana before and during the 1990s and those receiving their HIV diagnosis before 2010 were more likely to have been infected in French Guiana. Conclusions Contrary to widespread belief suggesting that most migrants are already HIV-infected when they arrive in French Guiana, a large proportion of foreign HIV patients seem acquire the virus in French Guiana. There is still much to do in terms of primary prevention and testing among migrants.	[Nacher, Mathieu; Van Melle, Astrid; Parriault, Marie-Claire; Adenis, Antoine] INSERM, CIC 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana; [Nacher, Mathieu; Adriouch, Leila] Ctr Hosp Andree Rosemon, Coordinat Reg VIH COREVIH Guyane, Cayenne, French Guiana; [Couppie, Pierre] Ctr Hosp Andree Rosemon, Serv Dermatol Venereol, Cayenne, French Guiana	Institut National de la Sante et de la Recherche Medicale (Inserm)	Nacher, M (corresponding author), INSERM, CIC 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana.; Nacher, M (corresponding author), Ctr Hosp Andree Rosemon, Coordinat Reg VIH COREVIH Guyane, Cayenne, French Guiana.	mathieu.nacher66@gmail.com	nacher, mathieu/AAH-4796-2021; Adenis, Antoine/AAI-1059-2021	nacher, mathieu/0000-0001-9397-3204; Adenis, Antoine/0000-0003-4000-4981				Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Cabie A, 2005, B EPIDEMIOL HEBD, V46, P238; Cambrezy L, 2015, IMMIGRATION STAT GUY, P193; Cazein F., 2015, B EPIDEMIOL HEBD, V9, P152; Cobat A, 2008, REV EPIDEMIOL SANTE, V56, P143, DOI 10.1016/j.respe.2008.03.118; Desgrees-du-Lou A, 2015, EUROSURVEILLANCE, V20, P31, DOI 10.2807/1560-7917.ES.2015.20.46.30065; Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9; Halfen S., 2006, CONNAISSANCES ATTITU; Infections HPACf, 2008, LONG AN TRAJ CD4 CEL; Nacher M, 2007, HIV MED, V8, P472, DOI 10.1111/j.1468-1293.2007.00492.x; Nacher M, 2010, INT J STD AIDS, V21, P359, DOI 10.1258/ijsa.2010.009570; Piantoni F, 2016, TRENTE ANS IMMIGRATI; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Scherhag K, 2016, HAITIENS GUYANE	16	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192564	10.1371/journal.pone.0192564	http://dx.doi.org/10.1371/journal.pone.0192564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420591	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900095
J	Ohde, T; Dadou, I				Ohde, Thomas; Dadou, Isabelle			Seasonal and annual variability of coastal sulphur plumes in the northern Benguela upwelling system	PLOS ONE			English	Article							HYDROGEN-SULFIDE ERUPTIONS; ATLANTIC-OCEAN; INTERANNUAL VARIABILITY; FRONTAL ZONE; LARGE-SCALE; SULFATE REDUCTION; NAMIBIAN SHELF; WATER; OXYGEN; ANGOLA	We investigated the seasonal and annual variability of surface sulphur plumes in the northern Benguela upwelling system off Namibia because of their significant impacts on the marine ecosystem, fishing industry, aquaculture farming and tourism due to their toxic properties. We identified the sulphur plumes in ocean colour satellite data of the medium resolution imaging spectrometer (MERIS) for the 2002-2012 time period using the differences in the spectral properties of Namibian Benguela optical water types. The sulphur events have a strong seasonal cycle with pronounced main and off-seasons forced by local and remote-driven processes. The main peak season is in late austral summer and early austral autumn at the beginning of the annual upwelling cycle caused by increasing equatorwards along-shore winds. The sulphur plume activity is high between February and April during the seasonal oxygen minimum associated with the seasonal reduction of cross-shore ventilation of the bottom waters, the seasonal southernmost position of the Angola Benguela Frontal Zone, the seasonal maximum of water mass fractions of South Atlantic and Angola Gyre Central Waters as well as the seasonal arrival of the downwelling coastal trapped waves. The off-season is in austral spring and early austral summer during increased upwelling intensity and enhanced oxygen supply. The annual variability of sulphur events is characterized by very high activities in years 2004, 2005 and 2010 interrupted by periods of lower activity in years 2002 to 2003, 2006 to 2009 and 2011 to 2012. This result can be explained by the relative contributions or adding effects of local and remote-driven forces (from the equatorial area). The probability for the occurrence of sulphur plumes is enhanced in years with a lower annual mean of upwelling intensity, decreased oxygen supply associated with decreased lateral ventilation of bottom waters, more southern position of the Angola Benguela Frontal Zone, increased mass fraction of South Atlantic Central Water and stronger downwelling coastal trapped waves. Understanding of the variability and forcing processes of the toxic sulphur events will help in the future to monitor and forecast them as well as to manage their social and economic consequences in the northern Benguela upwelling system off Namibia.	[Ohde, Thomas; Dadou, Isabelle] Univ Toulouse, UPS, IRD, CNRS,CNES,LEGOS, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales	Ohde, T (corresponding author), Univ Toulouse, UPS, IRD, CNRS,CNES,LEGOS, Toulouse, France.	Thomas.Ohde@legos.obs-mip.fr	Ohde, Thomas/J-4926-2015	Ohde, Thomas/0000-0001-8117-814X	European Union's Horizon research and innovation program under Marie Sklodowska-Curie grant [706426]; host institute OMP/LEGOS (Observatoire Midi-Pyrenees/Laboratoire d'Etudes en Geophysique et Oceanographie Spatiales) in France; NASA/HQ; NASA	European Union's Horizon research and innovation program under Marie Sklodowska-Curie grant; host institute OMP/LEGOS (Observatoire Midi-Pyrenees/Laboratoire d'Etudes en Geophysique et Oceanographie Spatiales) in France; NASA/HQ; NASA(National Aeronautics & Space Administration (NASA))	This study has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 706426. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 706426. The authors thank the host institute OMP/LEGOS (Observatoire Midi-Pyrenees/Laboratoire d'Etudes en Geophysique et Oceanographie Spatiales) in France for their support. This investigation was mainly based on satellite data of different sources. The MERIS and MSI data were kindly provided by ESA. We acknowledge the use of MODIS data from LANCE FIRMS operated by the NASA/GSFC/Earth Science Data and Information System (ESDIS) with funding provided by NASA/HQ. Data products of the Ocean Biology Processing Group (OBPG) were used (HICO, VIIRS, MODIS). TMI, QuikScat, ASCAT and CCMP data were produced by Remote Sensing Systems (RSS) and sponsored by NASA. RSS TMI data are available at www.remss.com. We are grateful to NASA Goddard Space Flight Center for providing access to TMI TDR files. The Ssalto/Duacs altimeter SLA product was produced and distributed by the Copernicus Marine and Environment Monitoring Service (CMEMS) (http://www.marine.copernicus.eu). The CARS climatology was developed by CSIRO Marine and Atmospheric Research. The software packages IDL (https://www.harrisgeospatial.com), SeaDAS (https:// seadas.gsfc.nasa.gov), SNAP (http://step.esa.int/main/toolboxes/snap/) and ACOLITE (https://odnature.naturalsciences.be/remsem/software-and-data/acolite) were taken for the processing of satellite data. Some of the analyses used in this paper were produced with the online data systems of GIOVANNI (https://giovanni.sci.gsfc.nasa.gov) and Asia-Pacific Data Research Center (http://apdrc.soest.hawaii.edu).	Ahmed S, 2011, PROC SPIE, V8030, DOI 10.1117/12.884674; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Antoine D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004472; Atlas R, 2011, B AM METEOROL SOC, V92, P157, DOI 10.1175/2010BAMS2946.1; Bachelery ML, 2016, GEOPHYS RES LETT, V43, P8617, DOI 10.1002/2016GL070288; Bachelery ML, 2016, J GEOPHYS RES-OCEANS, V121, P284, DOI 10.1002/2015JC011168; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; BAILEY G W, 1985, South African Journal of Marine Science, P197; Bourassa MA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001028; Bourg L, 2012, MERIS 3 DATA REPROCE; BOYD AJ, 1987, S AFR J MARINE SCI, V5, P107, DOI 10.2989/025776187784522577; Bremner J. M., 1978, THESIS; Bremner JM, 1983, COASTAL UPWELLING B; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Bruchert V, 2003, GEOCHIM COSMOCHIM AC, V67, P4505, DOI 10.1016/S0016-7037(03)00275-8; Bruchert V, 2009, PROG OCEANOGR, V83, P169, DOI 10.1016/j.pocean.2009.07.017; BUBNOV VA, 1972, OCEANOLOGY-USSR, V12, P193; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CHAPMAN P, 1987, S AFR J MARINE SCI, V5, P85, DOI 10.2989/025776187784522162; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chelton DB, 2005, MON WEATHER REV, V133, P409, DOI 10.1175/MWR-2861.1; Li CC, 2006, TERR ATMOS OCEAN SCI, V17, P447; Classen T, 1930, PALAEBIOLOGICA, V111, P13; Colberg F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027463; Copenhagen, 1953, INVESTIGATIONAL REPO, V14, P1; Dogliotti AI, 2009, INT J REMOTE SENS, V30, P251, DOI 10.1080/01431160802311133; Ebuchi N, 2002, J ATMOS OCEAN TECH, V19, P2049, DOI 10.1175/1520-0426(2002)019<2049:EOWVOB>2.0.CO;2; Ekman VW., 1905, ARKIV MAT ASTRON FIZ, V2, P1; Emeis KC, 2004, CONT SHELF RES, V24, P627, DOI 10.1016/j.csr.2004.01.007; EVANS CL, 1967, Q J EXP PHYSIOL CMS, V52, P231, DOI 10.1113/expphysiol.1967.sp001909; Feng H, 2008, INT J REMOTE SENS, V29, P4479, DOI 10.1080/01431160801918599; Ferdelman TG, 1999, LIMNOL OCEANOGR, V44, P650, DOI 10.4319/lo.1999.44.3.0650; Findlay AJ, 2017, LIMNOL OCEANOGR, V62, P1853, DOI 10.1002/lno.10539; Findlay AJ, 2014, GEOCHIM COSMOCHIM AC, V142, P334, DOI 10.1016/j.gca.2014.07.032; Flohr A, 2014, BIOGEOSCIENCES, V11, P885, DOI 10.5194/bg-11-885-2014; Florenchie P, 2004, J CLIMATE, V17, P2318, DOI 10.1175/1520-0442(2004)017<2318:EOIWAC>2.0.CO;2; Florenchie P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017172; Galan A, 2014, LIMNOL OCEANOGR, V59, P1865, DOI 10.4319/lo.2014.59.6.1865; Gentemann CL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002092; Ghanea M, 2016, ADV SPACE RES, V57, P127, DOI 10.1016/j.asr.2015.10.040; GILL AE, 1974, DEEP-SEA RES, V21, P325, DOI 10.1016/0011-7471(74)90038-2; GORDON AL, 1995, DEEP-SEA RES PT I, V42, P1, DOI 10.1016/0967-0637(94)00032-N; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Gutknecht E, 2013, BIOGEOSCIENCES, V10, P3559, DOI 10.5194/bg-10-3559-2013; Hagen E, 2001, OCEANOL ACTA, V24, P557, DOI 10.1016/S0399-1784(01)01173-2; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Hamukuaya H, 1994, SURVEY JUVENILE HAKE; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Jorgensen B. B, 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_8; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; Junker T, 2017, J MARINE SYST, V165, P36, DOI 10.1016/j.jmarsys.2016.09.003; Kostianoy AG, 1999, J GEOPHYS RES-OCEANS, V104, P20963, DOI 10.1029/1999JC900017; Lamont T, 2017, J MARINE SYSTEMS; Lass HU, 2005, CONT SHELF RES, V25, P1473, DOI 10.1016/j.csr.2005.04.012; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lee MA, 2010, TERR ATMOS OCEAN SCI, V21, P727, DOI 10.3319/TAO.2009.09.07.01(Oc); Louw DC, 2016, J MARINE SYST, V157, P124, DOI 10.1016/j.jmarsys.2016.01.009; Lucke RL, 2011, APPL OPTICS, V50, P1501, DOI 10.1364/AO.50.001501; Lubbecke JF, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005964; MAIER S, 1984, INT J SYST BACTERIOL, V34, P414, DOI 10.1099/00207713-34-4-414; MEEUWIS JM, 1990, S AFR J MARINE SCI, V9, P261; Mendonca A, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3328872; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Mohrholz V, 2001, S AFR J SCI, V97, P199; Monteiro PMS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026234; Monteiro PMS, 2006, LAR MAR ECOSYST, V14, P71; Monteiro PMS, 2005, CONT SHELF RES, V25, P1864, DOI 10.1016/j.csr.2005.06.012; MOROSHKIN KV, 1970, OCEANOLOGY-USSR, V10, P27; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; Oesch DC, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002857; Ohde T, 2007, INT J REMOTE SENS, V28, P609, DOI 10.1080/01431160600972961; Ohde T, 2007, CONT SHELF RES, V27, P744, DOI 10.1016/j.csr.2006.11.016; Ohde T, 2011, INT J REMOTE SENS, V32, P9327, DOI 10.1080/01431161.2011.554455; Ohde T, 2009, CENT EUR J GEOSCI, V1, P340, DOI 10.2478/v10085-009-0020-9; Polo I, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004495; Poole R, 1999, DEEP-SEA RES PT I, V46, P1895, DOI 10.1016/S0967-0637(99)00025-4; Ricciardulli L, 2016, ASCAT METOP A DATA P; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rouault M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052099; Schmidt M, 2016, PROG OCEANOGR, V149, P145, DOI 10.1016/j.pocean.2016.09.004; Schouten MW, 2005, DEEP-SEA RES PT I, V52, P477, DOI 10.1016/j.dsr.2004.10.007; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; Schunck H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068661; Senan R, 200129 CAOS; Shannon L.V., 1996, S ATLANTIC PRESENT C; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; SHANNON LV, 1986, J MAR RES, V44, P495, DOI 10.1357/002224086788403105; Shillington FA, 2006, LAR MAR ECOSYST, V14, P49; Shillington FA, 1998, SEA; Urquhart EA, 2013, REMOTE SENS ENVIRON, V135, P167, DOI 10.1016/j.rse.2013.03.034; van der Plas AK, 2007, AFR J MAR SCI, V29, P37, DOI 10.2989/AJMS.2007.29.1.3.68; Vanhellemont Q, 2014, REMOTE SENS ENVIRON, V145, P105, DOI 10.1016/j.rse.2014.01.009; Veitch JA, 2006, INT J REMOTE SENS, V27, P987, DOI 10.1080/01431160500127914; Veitch J, 2009, PROG OCEANOGR, V83, P296, DOI 10.1016/j.pocean.2009.07.008; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Wentz F. J., 2015, REMOTE SENSING SYSTE	99	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192140	10.1371/journal.pone.0192140	http://dx.doi.org/10.1371/journal.pone.0192140			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420587	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900042
J	Shakeel, M; Irfan, M; Khan, IA				Shakeel, Muhammad; Irfan, Muhammad; Khan, Ishtiaq Ahmad			Estimating the mutational load for cardiovascular diseases in Pakistani population	PLOS ONE			English	Article							OF-FUNCTION VARIANTS; GENETIC-VARIATION; BLOOD-PRESSURE; LOW-FREQUENCY; RISK-FACTORS; MISSENSE MUTATIONS; NATURAL-SELECTION; CODING VARIANTS; HUMAN PHENOTYPE; COMPLEX TRAITS	The deleterious genetic variants contributing to certain diseases may differ in terms of number and allele frequency from population to population depending on their evolutionary background. Here, we prioritize the deleterious variants from Pakistani population in manually curated gene list already reported to be associated with common, Mendelian, and congenital cardiovascular diseases (CVDs) using the genome/exome sequencing data of Pakistani individuals publically available in 1000 Genomes Project (PJL), and Exome Aggregation Consortium (ExAC) South Asia. By applying a set of tools such as Combined Annotation Dependent Depletion (CADD), ANNOVAR, and Variant Effect Predictor (VEP), we highlighted 561 potentially detrimental variants from PJL data, and 7374 variants from ExAC South Asian data. Likewise, filtration from ClinVar for CVDs revealed 03 pathogenic and 02 likely pathogenic variants from PJL and 112 pathogenic and 42 likely pathogenic variants from ExAC South Asians. The comparison of derived allele frequencies (DAF) revealed many of these prioritized variants having two fold and higher DAF in Pakistani individuals than in other populations. The highest number of deleterious variants contributing to common CVDs in descending order includes hypertension, atherosclerosis, heart failure, aneurysm, and coronary heart disease, and for Mendelian and congenital CVDs cardiomyopathies, cardiac arrhythmias, and atrioventricular septal defects.	[Shakeel, Muhammad; Irfan, Muhammad; Khan, Ishtiaq Ahmad] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Jamil ur Rahman Ctr Genome Res, Karachi, Pakistan	University of Karachi	Khan, IA (corresponding author), Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Jamil ur Rahman Ctr Genome Res, Karachi, Pakistan.	ishtiaqchemist@gmail.com		Khan, Ishtiaq Ahmad/0000-0003-2421-2625; Shakeel, Muhammad/0000-0003-2472-3222	Higher Education Comission, Pakistan [PIN: 213-54240-2BM2-123]	Higher Education Comission, Pakistan	This work was supported by Higher Education Comission, Pakistan, www.hec.gov.pk, PIN: 213-54240-2BM2-123 (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], INT J VASC MED, DOI DOI 10.1155/2013/786801); Awan ZA, 2011, J POSTGRADUATE MED I, V19; Ayub Qasim, 2009, Briefings in Functional Genomics & Proteomics, V8, P395, DOI 10.1093/bfgp/elp015; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Casals F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003815; Chen C, 2012, CLIN ENDOCRINOL, V76, P506, DOI 10.1111/j.1365-2265.2011.04178.x; Coventry A, 2010, NATURE COMMUNICATION, V1, P1; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Deng HW, 1996, GENETICS, V144, P349; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Furutama D, 2010, J CLIN NEUROSCI, V17, P408, DOI 10.1016/j.jocn.2009.06.010; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Haq FU, 2011, ANN PEDIAT CARDIOL, V4, P117, DOI 10.4103/0974-2069.84641; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Herrero J, 2016, DATABASE-OXFORD, DOI [10.1093/database/bav096, 10.1093/database/baw053]; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Jafar TH, 2008, HEART, V94, P408, DOI 10.1136/hrt.2007.120774; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Karafet TM, 2015, EUR J HUM GENET, V23, P1405, DOI 10.1038/ejhg.2014.299; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lettre G, 2014, J MED GENET, V51, P705, DOI 10.1136/jmedgenet-2014-102437; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; Misra A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1420; Moran AE, 2014, GLOB HEART, V9, P91, DOI 10.1016/j.gheart.2013.12.007; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; Pabalan N, 2017, GENET TEST MOL BIOMA, V21, P24, DOI 10.1089/gtmb.2016.0054; Panoutsopoulou K, 2013, HUM MOL GENET, V22, pR16, DOI 10.1093/hmg/ddt376; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peischl S, 2015, MOL ECOL, V24, P2084, DOI 10.1111/mec.13154; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Santoro D, 2015, CLIN BIOCHEM, V48, P1028, DOI 10.1016/j.clinbiochem.2015.05.009; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Suwazono Y, 2006, LIFE SCI, V78, P2475, DOI 10.1016/j.lfs.2005.10.001; Swapna N, 2011, Indian J Hum Genet, V17, P201, DOI 10.4103/0971-6866.92104; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; The World Bank, 2016, WORLD BANK DAT WORLD; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Wain LV, 2014, BRIEF FUNCT GENOMICS, V13, P384, DOI 10.1093/bfgp/elu010; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO, 2016, CARD DIS CVDS FACT S; WHO, 2016, HLTH STAT INF SYST; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049686; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zaidi S, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1645; Zaman MJS, 2012, TREND UROL MENS HEAL, V3, P11, DOI 10.1002/tre.262; Zlotorynski E, 2015, NAT REV MOL CELL BIO, V16, P578, DOI 10.1038/nrm4057	70	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192446	10.1371/journal.pone.0192446	http://dx.doi.org/10.1371/journal.pone.0192446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420653	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900075
J	Benforte, FC; Colonnella, MA; Ricardi, MM; Venero, ECS; Lizarraga, L; Lopez, NI; Tribelli, PM				Benforte, Florencia C.; Colonnella, Maria A.; Ricardi, Martiniano M.; Solar Venero, Esmeralda C.; Lizarraga, Leonardo; Lopez, Nancy I.; Tribelli, Paula M.			Novel role of the LPS core glycosyltransferase WapH for cold adaptation in the Antarctic bacterium Pseudomonas extremaustralis	PLOS ONE			English	Article							ESCHERICHIA-COLI; LOW-TEMPERATURE; BIOFILM FORMATION; CELL-ENVELOPE; POLYMYXIN-B; STRESS; LIPOPOLYSACCHARIDES; FLUORESCENS; RESISTANCE; SYRINGAE	Psychrotroph microorganisms have developed cellular mechanisms to cope with cold stress. Cell envelopes are key components for bacterial survival. Outer membrane is a constituent of Gram negative bacterial envelopes, consisting of several components, such as lipopolysaccharides (LPS). In this work we investigated the relevance of envelope characteristics for cold adaptation in the Antarctic bacterium Pseudomonas extremaustralis by analyzing a mini Tn5 wapH mutant strain, encoding a core LPS glycosyltransferase. Our results showed that wapH strain is impaired to grow under low temperature but not for cold survival. The mutation in wapH, provoked a strong aggregative phenotype and modifications of envelope nanomechanical properties such as lower flexibility and higher turgor pressure, cell permeability and surface area to volume ratio (S/V). Changes in these characteristics were also observed in the wild type strain grown at different temperatures, showing higher cell flexibility but lower turgor pressure under cold conditions. Cold shock experiments indicated that an acclimation period in the wild type is necessary for cell flexibility and S/V ratio adjustments. Alteration in cell-cell interaction capabilities was observed in wapH strain. Mixed cells of wild type and wapH strains, as well as those of the wild type strain grown at different temperatures, showed a mosaic pattern of aggregation. These results indicate that wapH mutation provoked marked envelope alterations showing that LPS core conservation appears as a novel essential feature for active growth under cold conditions.	[Benforte, Florencia C.; Lopez, Nancy I.; Tribelli, Paula M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Colonnella, Maria A.; Lizarraga, Leonardo] Consejo Nacl Invest Cient & Tecn, Ctr Invest Bionanociencias, Buenos Aires, DF, Argentina; [Ricardi, Martiniano M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina; [Solar Venero, Esmeralda C.; Lopez, Nancy I.; Tribelli, Paula M.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lopez, NI; Tribelli, PM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.; Lopez, NI; Tribelli, PM (corresponding author), Consejo Nacl Invest Cient & Tecn, IQUIBICEN, Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar; paulatrib@qb.fcen.uba.ar		Ricardi, Martiniano/0000-0002-7904-6305; Tribelli, Paula Maria/0000-0001-9558-6275; Solar Venero, Esmeralda/0000-0003-3516-8535; Lizarraga, Leonardo/0000-0003-3476-495X	Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo [BID-PICT 2259]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2014-2017]; Universidad de Buenos Aires [Codigo 20020130100451BA]; Agencia Nacional de Promocion Cientifica y Tecnologica [PRH-2013-0017-PICT 2015-0031]; CONICET; UBA	Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBA(University of Buenos Aires)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo BID-PICT 2259. NIL, PMT, ESV; Consejo Nacional de Investigaciones Cientificas y Tecnicas. PIP 2014-2017. NIL. PMT, ESV; Universidad de Buenos Aires.Codigo 20020130100451BA. NIL, PMT, ESV, FCB and the Agencia Nacional de Promocion Cientifica y Tecnologica (grant PRH-2013-0017-PICT 2015-0031). LL, ESV and MAC have a graduate student fellowship from CONICET. FCB has an undergraduate student fellowship from UBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MMR, LL, PMT, and NIL are career investigators from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). ESV and MAC have a graduate student fellowship from CONICET. FCB has an undergraduate student fellowship from UBA.	Ansari MA, 2014, J APPL MICROBIOL, V116, P772, DOI 10.1111/jam.12423; Appanna VD, 2001, MICROBIOS, V106, P19; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Batchelor E, 2005, J BACTERIOL, V187, P5723, DOI 10.1128/JB.187.16.5723-5731.2005; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Cefali E, 2002, SCANNING, V24, P274, DOI 10.1002/sca.4950240601; Chalabaev S, 2014, MBIO, V5, DOI 10.1128/mBio.01116-14; Chattopadhyay MK, 2011, CURR MICROBIOL, V62, P544, DOI 10.1007/s00284-010-9742-y; Corsaro MM, 2008, CHEM-EUR J, V14, P9368, DOI 10.1002/chem.200800117; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Fondi M, 2014, ENV MICROBIOL; Fonseca P, 2011, ENV MICROBIOL REP, V3, P329, DOI 10.1111/j.1758-2229.2010.00229.x; Francius G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020066; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Gaboriaud F, 2008, COLLOID SURFACE B, V62, P206, DOI 10.1016/j.colsurfb.2007.10.004; Godin-Roulling A, 2015, ENVIRON MICROBIOL, V17, P2407, DOI 10.1111/1462-2920.12707; Guyard-Nicodeme M, 2008, J PROTEOME RES, V7, P1218, DOI 10.1021/pr070539x; Harris LK, 2016, CELL, V165, P1479, DOI 10.1016/j.cell.2016.05.045; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Kiran MD, 2005, EXTREMOPHILES, V9, P117, DOI 10.1007/s00792-005-0435-6; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kumar GS, 2002, J BACTERIOL, V184, P6746, DOI 10.1128/JB.184.23.6746-6749.2002; Lam JS, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00118; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Loffhagen N, 2004, BIOSCI BIOTECH BIOCH, V68, P317, DOI 10.1271/bbb.68.317; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Moreno R, 2014, ENV MICROBIOL REP, V6, P417, DOI 10.1111/1758-2229.12150; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; Iustman LJR, 2015, EXTREMOPHILES, V19, P207, DOI 10.1007/s00792-014-0700-7; RAY MK, 1994, J BACTERIOL, V176, P4243, DOI 10.1128/jb.176.14.4243-4249.1994; Reuhs BL, 1998, APPL ENVIRON MICROB, V64, P4930; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Stokes JM, 2016, CELL CHEM BIOL, V23, P267, DOI 10.1016/j.chembiol.2015.12.011; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Tribelli PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145353; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; Tribelli PM, 2013, PLOS ONE, P8; Wang HB, 2015, ACS APPL MATER INTER, V7, P13007, DOI 10.1021/acsami.5b03041; Wang HB, 2013, SOFT MATTER, V9, P7560, DOI 10.1039/c3sm51325d	54	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192559	10.1371/journal.pone.0192559	http://dx.doi.org/10.1371/journal.pone.0192559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415056	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300086
J	Huber, L; Giguere, S; Berghaus, LJ; Hanafi, A; Vitosh-Sillman, S; Czerwinski, SL				Huber, Laura; Giguere, Steeve; Berghaus, Londa J.; Hanafi, Amanda; Vitosh-Sillman, Sarah; Czerwinski, Sarah L.			Development of septic polysynovitis and uveitis in foals experimentally infected with Rhodococcus equi	PLOS ONE			English	Article							AQUEOUS-HUMOR; PCR ASSAY; HORSES; RESISTANCE; PNEUMONIA; DIAGNOSIS; ARTHRITIS; RIFAMPIN	Rhodococcus equi is one of the most important causes of disease in foals. Infection is typically characterized by pyogranulomatous pneumonia although extrapulmonary infections occur occasionally. Uveitis and polysynovitis have been reported in foals naturally infected with R. equi and are thought to be the result of an immune-mediated process. However, the pathogenesis of these conditions is poorly understood. The objectives of this study were to document the occurrence of uveitis and polysynovitis after experimental infection with R. equi and to determine if these disorders are the direct result of infection at these sites. Foals between 3 and 4 weeks of age were infected intratracheally with virulent R. equi using inocula of 1x10(8) CFU (high inoculum; n = 16) or 1x10(7) CFU (low inoculum; n = 12). Foals were monitored twice daily and necropsy was performed 14 days post-infection. Aqueous humor and synovial fluid were collected aseptically and the percentage of affected lung was calculated. The mean (+/- SD) percentage of affected lung was significantly higher with the high inoculum (31.8 +/- 14.6%) than with the low inoculum (14.4 +/- 11.4%). Fourteen of 25 foals developed uveitis and 20 of 28 foals developed polysynovitis. R. equi was cultured from the aqueous humor of 11 foals and from the synovial fluid of 14 foals. The risk of development of polysynovitis and protein concentration in the aqueous humor were significantly higher in foals that received the high inoculum. These results indicate that polysynovitis and uveitis are septic complications associated with the severity of lung disease.	[Huber, Laura; Giguere, Steeve; Berghaus, Londa J.; Hanafi, Amanda] Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA; [Vitosh-Sillman, Sarah] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Czerwinski, Sarah L.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA	University System of Georgia; University of Georgia; University of Nebraska System; University of Nebraska Lincoln; University System of Georgia; University of Georgia	Giguere, S (corresponding author), Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA.	gigueres@uga.edu		Huber, Laura/0000-0002-5138-0336	Merck Animal Health; Hodgson Equine Research Endowment of the University of Georgia	Merck Animal Health(Merck & Company); Hodgson Equine Research Endowment of the University of Georgia	This work was supported by the Merck Animal Health to SG and the Hodgson Equine Research Endowment of the University of Georgia to SG. The funders participated in study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotti M, 1996, SCAND J INFECT DIS, V28, P463, DOI 10.3109/00365549609037941; Cohen N.D., 2006, COMPENDIUM ON CONTIN, V1, P14; Donisi A, 1996, AIDS, V10, P359, DOI 10.1097/00002030-199604000-00002; Elmas CR, 2013, CAN J VET RES, V77, P211; Faber NA, 2000, J CLIN MICROBIOL, V38, P2731, DOI 10.1128/JCM.38.7.2731-2733.2000; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 2010, JAVMA-J AM VET MED A, V237, P74, DOI 10.2460/javma.237.1.74; KENNEY DG, 1994, EQUINE VET J, V26, P246, DOI 10.1111/j.2042-3306.1994.tb04379.x; KROHNE SG, 1995, J AM VET MED ASSOC, V206, P1167; Ladron N, 2003, J CLIN MICROBIOL, V41, P3241, DOI 10.1128/JCM.41.7.3241-3245.2003; LEADON D, 1988, VET REC, V123, P279, DOI 10.1136/vr.123.10.279-a; MADISON JB, 1988, J AM VET MED ASSOC, V192, P1581; Rankin AJ, 2002, AM J VET RES, V63, P750, DOI 10.2460/ajvr.2002.63.750; Reuss SM, 2009, J AM MED VET ASS, V235, P855, DOI DOI 10.2460/JAVMA.235.7.855; SCHNEIDER RK, 1992, EQUINE VET J, V24, P436, DOI 10.1111/j.2042-3306.1992.tb02873.x; SWEENEY CR, 1987, VET MICROBIOL, V14, P329, DOI 10.1016/0378-1135(87)90120-9; Wilkes EJA, 2016, EQUINE VET EDUC, V28, P186, DOI 10.1111/eve.12469; Yamshchikov AV, 2010, LANCET INFECT DIS, V10, P350, DOI 10.1016/S1473-3099(10)70068-2	18	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192655	10.1371/journal.pone.0192655	http://dx.doi.org/10.1371/journal.pone.0192655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415076	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300091
J	Antenucci, L; Hytonen, VP; Ylanne, J				Antenucci, Lina; Hytonen, Vesa P.; Ylanne, Jari			Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MOUSE PLATELETS; SH2 DOMAINS; SYK; ADHESION; BINDING; ALPHA(IIB)BETA(3); NEUTROPHILS; LYMPHOMA; P72(SYK)	Spleen tyrosine kinase (Syk) is involved in cellular adhesion and also in the activation and development of hematopoietic cells. Syk activation induced by genomic rearrangement has been linked to certain T-cell lymphomas, and Syk inhibitors have been shown to prolong survival of patients with B-cell lineage malignancies. Syk is activated either by its interaction with a double-phosphorylated immunoreceptor tyrosine-based activation motif (pITAM), which induces rearrangements in the Syk structure, or by the phosphorylation of specific tyrosine residues. In addition to its immunoreceptor function, Syk is activated downstream of integrin pathways, and integrins bind to the same region in Syk as does pITAM. However, it is unknown whether integrins and pITAM use the same mechanism to activate Syk. Here, using purified Syk protein and fluorescence-based enzyme assay we investigated whether interaction of the integrin beta(3) cytoplasmic domain with the Syk regulatory domain causes changes in Syk activity similar to those induced by pITAM peptides. We observed no direct Syk activation by soluble integrin peptide, and integrin did not compete with pITAM-induced activation even though at high concentrations, the integrin cytoplasmic domain peptide competed with Syk's substrate. However, clustered integrin peptides induced Syk activation, presumably via a transphosphorylation mechanism. Moreover, the clustered integrins also activated a Syk variant in which tyrosines were replaced with phenylalanine (Y348F/Y352F), indicating that clustered integrin-induced Syk activation involved other phosphorylation sites. In conclusion, integrin cytoplasmic domains do not directly induce Syk conformational changes and do not activate Syk via the same mechanism as pITAM.	[Antenucci, Lina; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, Survontie 9 C, Jyvaskyla 40014, Finland; [Antenucci, Lina; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, Survontie 9 C, Jyvaskyla 40014, Finland; [Hytonen, Vesa P.] Univ Tampere, Fac Med & Life Sci, Tampere 33014, Finland; [Hytonen, Vesa P.] Univ Tampere, BioMediTech, Tampere 33014, Finland; [Hytonen, Vesa P.] Fimlab Labs, Tampere 33014, Finland	University of Jyvaskyla; University of Jyvaskyla; Tampere University; Tampere University	Antenucci, L (corresponding author), Univ Jyvaskyla, Survontie 9 C,POB 35, Jyvaskyla 40014, Finland.	lina.antenucci@jyu.fi	Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480; Antenucci, Lina/0000-0003-1201-9342; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [278668, 290506]; Jenny and Antti Wihuri Foundation	Academy of Finland(Academy of Finland); Jenny and Antti Wihuri Foundation	This work was supported by Academy of Finland Grants 278668 (to J. Y.) and 290506 (to V. P. H.) and a research sabbatical grant from the Jenny and Antti Wihuri Foundation (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Hughes CE, 2015, BLOOD, V125, P144, DOI 10.1182/blood-2014-05-579375; Krisenko MO, 2015, BBA-MOL CELL RES, V1853, P254, DOI 10.1016/j.bbamcr.2014.10.022; Law DA, 1999, BLOOD, V93, P2645, DOI 10.1182/blood.V93.8.2645.408k13_2645_2652; Liu DL, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0512-1; Maartens AP, 2015, DEV BIOL, V401, P62, DOI 10.1016/j.ydbio.2014.12.038; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Shults MD, 2005, NAT METHODS, V2, P277, DOI 10.1038/NMETH747; Shults MD, 2006, ANAL BIOCHEM, V352, P198, DOI 10.1016/j.ab.2006.03.003; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yan SR, 1997, J IMMUNOL, V158, P1902; YANG C, 1994, EUR J BIOCHEM, V221, P973, DOI 10.1111/j.1432-1033.1994.tb18813.x; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Yuan YF, 2001, CANCER RES, V61, P5558	39	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4591	4602		10.1074/jbc.RA117.000660	http://dx.doi.org/10.1074/jbc.RA117.000660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29440271	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000428848300001
J	Curtis, G; Argo, CM; Jones, D; Grove-White, D				Curtis, G.; Argo, C. McGregor; Jones, D.; Grove-White, D.			The impact of early life nutrition and housing on growth and reproduction in dairy cattle	PLOS ONE			English	Article							AD-LIBITUM MILK; MANAGEMENT-PRACTICES; CRYPTOSPORIDIUM-PARVUM; DISEASE INCIDENCE; FEEDING-BEHAVIOR; CALF NUTRITION; RISK-FACTORS; WEIGHT-GAIN; CALVES; HEALTH	Contentious issues in calf rearing include milk feeding practices and single versus group housing. The current study was performed on a high producing 170 Holstein cow dairy farm, to investigate the impact of nutrition and housing on growth and reproduction. Heifer calves (n = 100) were allocated in birth order to one of two commonly used management strategies. All calves received 3 +/- 4 litres of dam specific colostrum within 6 hours of birth. Group A calves were group housed from birth and fed milk replacer (MR) ad libitum via a computerised machine utilising a single teat, with weaning commencing at 63 days of age. Group R calves were initially housed in individual pens and received 2.5 litres of MR twice daily via a bucket until 21 days of age when they were group housed and fed 3 litres of MR twice daily via a group trough with weaning commencing at 56 days. From 12 weeks of age onwards, calves in both dietary groups were subject to common nutritional and husbandry protocols. All breeding of heifers was via artificial insemination with no hormonal intervention. Calves were weighed, body condition scored and morphometric measures recorded weekly up till 12 weeks of age then monthly until conception. Pre-weaning growth rates (kg/day) were significantly higher in Group A calves compared to Group R (0.89, 95% CI 0.86-0.93 vs 0.57, 95% CI 0.54-0.6 kg/day P < 0.001) with the most marked differences observed during the first three weeks of life (0.72, 95% CI 0.61-0.82 vs 0.17, 95% CI 0.08-0.26 P < 0.001). Whilst Group A calves gained body condition score (BCS) throughout the pre-weaning phase, Group R calves lost BCS during the first 4 weeks of life. Data suggested that Group R calves supported skeletal growth during this period by catabolising body tissue. Group A calves had a greater risk of disease than group R calves during the pre-weaning phase (diarrhoea: odds ratio 3.86, 95% CI 1.67-8.9; pneumonia: odds ratio 5.80, 95% CI 2.33-14.44) although no calves died during this period. Whilst pneumonia had a significant impact on growth during the study duration (P = 0.008), this was not the case for diarrhoea. Whilst univariate analysis failed to show any statistically significant group differences (P > 0.050) in any of the mean values of measured reproductive parameters, multivariable Cox regression suggested that there was a weak trend (P = 0.072) for Group A animals to achieve first service earlier than their Group R counterparts (62.6 weeks versus 65.3 weeks). Irrespective of dietary group, the hazard for achievement of all measured reproductive parameters, apart from time to puberty, was 20-40% less for heifers borne from multiparous dams compared to heifers from primiparous dams.	[Curtis, G.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Leahurst Campus, Wirral, Merseyside, England; [Argo, C. McGregor] Univ Surrey, Sch Vet Med, Guildford, England; [Jones, D.; Grove-White, D.] Univ Liverpool, Inst Vet Sci, Leahurst Campus, Wirral, Merseyside, England	University of Liverpool; University of Surrey; University of Liverpool	Grove-White, D (corresponding author), Univ Liverpool, Inst Vet Sci, Leahurst Campus, Wirral, Merseyside, England.	daigw@liv.ac.uk		Grove-White, Dai/0000-0002-5969-5535	Tesco Plc [KTP 7995]; University of Liverpool [KTP 7995]; Biotechnology and Biological Sciences Research Council; Innovate UK; Tesco Plc. Volac, For Farmers	Tesco Plc; University of Liverpool; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Tesco Plc. Volac, For Farmers	This work was supported by KTP 7995, Knowledge Transfer Partnership between Tesco Plc and University of Liverpool; Funders: Biotechnology and Biological Sciences Research Council, Innovate UK and Tesco Plc. Volac, For Farmers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA HO, 1988, J ANIM SCI, V66, P2687; Amburgh M. E. van, 2011, Proceedings of the 44th Annual Conference of the American Association of Bovine Practitioners, St. Louis, Missouri, USA, 22-24 September, 2011, P79; Anderson N. G., 2011, Proceedings of the 44th Annual Conference of the American Association of Bovine Practitioners, St. Louis, Missouri, USA, 22-24 September, 2011, P88; Appleby MC, 2001, APPL ANIM BEHAV SCI, V74, P191, DOI 10.1016/S0168-1591(01)00171-X; Babu LK, 2009, ANIM SCI J, V80, P149, DOI 10.1111/j.1740-0929.2008.00620.x; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; Bermingham M, 2006, CHANGE CONFORMATION; Brickell JS, 2009, THERIOGENOLOGY, V72, P408, DOI 10.1016/j.theriogenology.2009.03.015; Costa JHC, 2016, J DAIRY SCI, V99, P2453, DOI 10.3168/jds.2015-10144; Curtis GC, 2016, VET REC, V179, P512, DOI 10.1136/vr.103895; Da Silva P, 2003, PLACENTA, V24, P248, DOI 10.1053/plac.2002.0897; Dairy A, 2016, CALF MANAGEMENT; Dairy A, 2010, HEIFER REARING MYTHS; Dairy C, 2011, PD FERTILITY HDB FAR; [DEFRA DEFRA], 2006, AN WELF ACT; Drackley JK, 2007, J DAIRY SCI, V90, P614; Drackley JK, 2008, VET CLIN N AM-FOOD A, V24, P55, DOI 10.1016/j.cvfa.2008.01.001; Eastham N, 2017, ASS AGE 1 CALVING SU; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Ettema JF, 2004, J DAIRY SCI, V87, P2730, DOI 10.3168/jds.S0022-0302(04)73400-1; Faber S. N., 2005, Professional Animal Scientist, V21, P420; Gabler MT, 2000, J DAIRY SCI, V83, P1104, DOI 10.3168/jds.S0022-0302(00)74975-7; Grove-White D, 2010, CATTLE PRACT, V18, P220; Gulliksen SM, 2009, J DAIRY SCI, V92, P2782, DOI 10.3168/jds.2008-1807; Hanninen L, 2002, ACTA AGR SCANDINAV A, V53; Haworth GM, 2008, VET REC, V162, P643, DOI 10.1136/vr.162.20.643; Heinrichs AJ, 2005, RUMEN DEV DAIRY CALF, p53 ; Hepola H, 2003, APPL ANIM BEHAV SCI, V80, P233, DOI 10.1016/S0168-1591(02)00214-9; Jasper J, 2002, J DAIRY SCI, V85, P3054, DOI 10.3168/jds.S0022-0302(02)74391-9; Jensen MB, 2006, J DAIRY SCI, V89, P4778, DOI 10.3168/jds.S0022-0302(06)72527-9; Johnson KF, 2017, ANIMAL, V1 -11; Khan MA, 2016, J DAIRY SCI, V99, P885, DOI 10.3168/jds.2015-9975; Kiezebrink DJ, 2015, J DAIRY SCI, V98, P349, DOI 10.3168/jds.2014-7959; Kirkwood BR, 2003, ESSENTIAL MED STAT; Klein-Jobstl D, 2014, J DAIRY SCI, V97, P5110, DOI 10.3168/jds.2013-7695; Lammers BP, 1999, J DAIRY SCI, V82, P1746, DOI 10.3168/jds.S0022-0302(99)75405-6; Lawrence TLJ, 2012, GROWTH FARM ANIMALS; Lima FS, 2013, J DAIRY SCI, V96, P7054, DOI 10.3168/jds.2013-7093; Lima SF, 2017, J DAIRY SCI, V100, P3031, DOI 10.3168/jds.2016-11604; Losinger WC, 1997, J DAIRY RES, V64, P1, DOI 10.1017/S0022029996001999; MAATJE K, 1993, VET REC, V133, P266, DOI 10.1136/vr.133.11.266; MacFarlane JA, 2014, VET REC, V174, DOI 10.1136/vr.102228; Marsh S, 2009, HEIFER MANAGEMENT HA; McGuirk SM, 2008, VET CLIN N AM-FOOD A, V24, P139, DOI 10.1016/j.cvfa.2007.10.003; Morrison SJ, 2012, ANIMAL, V6, P909, DOI 10.1017/S1751731111002163; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Ollivett TL, 2012, JAVMA-J AM VET MED A, V241, P1514, DOI 10.2460/javma.241.11.1514; Pedersen RE, 2009, LIVEST SCI, V121, P215, DOI 10.1016/j.livsci.2008.06.007; Pirlo G, 2000, J DAIRY SCI, V83, P603, DOI 10.3168/jds.S0022-0302(00)74919-8; QUIGLEY JD, 1991, J DAIRY SCI, V74, P250, DOI 10.3168/jds.S0022-0302(91)78167-8; Quigley JD, 2006, J DAIRY SCI, V89, P207, DOI 10.3168/jds.S0022-0302(06)72085-9; Soberon F, 2012, J DAIRY SCI, V95, P783, DOI 10.3168/jds.2011-4391; Soberon F, 2013, J ANIMAL SCI; Swali A, 2007, ANIM REPROD SCI, V102, P122, DOI 10.1016/j.anireprosci.2006.10.012; TANNER JM, 1981, BRIT MED BULL, V37, P233, DOI 10.1093/oxfordjournals.bmb.a071708; Trotz-Williams LA, 2008, PREV VET MED, V83, P11, DOI 10.1016/j.prevetmed.2007.03.001; Trotz-Williams LA, 2007, PREV VET MED, V82, P12, DOI 10.1016/j.prevetmed.2007.05.003; Walker SL, 2008, HORM BEHAV, V53, P493, DOI 10.1016/j.yhbeh.2007.12.003; WALTNERTOEWS D, 1986, CAN J VET RES, V50, P314; WARNICK VD, 1977, J DAIRY SCI, V60, P947, DOI 10.3168/jds.S0022-0302(77)83968-4; Wathes DC, 2008, ANIMAL, V2, P1135, DOI 10.1017/S1751731108002322; Webster AJF, 2001, VET J, V161, P229, DOI 10.1053/tvjl.2000.0563; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x	63	25	27	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191687	10.1371/journal.pone.0191687	http://dx.doi.org/10.1371/journal.pone.0191687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444092	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500027
J	Franca, UL; McManus, ML				Franca, Urbano L.; McManus, Michael L.			Frequency, trends, and antecedents of severe maternal depression after three million US births	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; DISORDERS; PREGNANCY; SYMPTOMS	Background Postpartum depression carries adverse consequences for mothers and children, so widespread screening during primary care visits is recommended. However, the rates, timing, and factors associated with significant depressive episodes are incompletely understood. Methods and findings We examined the Healthcare Cost and Utilization Project (HCUP) State Inpatient, Emergency Department, and Ambulatory Surgery and Services Databases from California (2005-2011) and Florida (2005-2012). Within 203 million records, we identified 3,213,111 births and all mothers who had hospital encounters for severe depression within 40 weeks following delivery. We identified 15,806 episodes of postpartum depression after 11,103 deliveries among 10,883 unique women, and calculated an overall rate of 36.7 depression-associated hospital visits per 10,000 deliveries. Upward trends were observed in both states, with combined five-year increases of 34%. First depressive events were most common within 30 days of delivery, but continued for the entire observation period. About half (1,661/3,325) of PPD first episodes occurred within 34 days of delivery, 70% (2,329/3,325) by the end of the second month, and 87% (2,893/3,325) before four-months of the delivery. Women with private insurance were less likely to have hospital encounters for depression than women with public insurance and women with depression were much more likely to have had some kind of hospital encounter at some time during their pregnancies. Rates of depression increased with the number of prenatal hospital encounters in a "dose-dependent" fashion: the rate of depression was 17.2/10,000 for women with no pre-natal hospital visits, doubling for women with at least one encounter (34.9/10,000), and increasing 7-fold to 126/10,000 for women with three or more encounters during their pregnancies. Conclusions Our findings suggest that (1) hospital encounters for post-partum depression are increasing, (2) screening should begin very early and continue for the first year after delivery, and (3) added attention should be given to women who had hospital encounters during their pregnancies.	[Franca, Urbano L.; McManus, Michael L.] Boston Childrens Hosp, Div Crit Care, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA; [Franca, Urbano L.; McManus, Michael L.] Harvard Med Sch, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	McManus, ML (corresponding author), Boston Childrens Hosp, Div Crit Care, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.; McManus, ML (corresponding author), Harvard Med Sch, Boston, MA USA.	michael.mcmanus@childrens.harvard.edu	Franca, Urbano/AAY-6698-2020	Franca, Urbano/0000-0001-8388-3731				Center on the Developing Child at Harvard University, 2009, 8 CTR DEV CHILD HARV, P1; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Earls MF, 2010, PEDIATRICS, V126, P1032, DOI 10.1542/peds.2010-2348; HCUP National Inpatient Sample (NIS) and the Nationwide Inpatient Sample, 2005, HEALTHC COST UT PROJ; Josefsson A, 2001, ACTA OBSTET GYN SCAN, V80, P251; Ko JY, 2017, MMWR MORBIDITY MORTA; Myers ER, 2013, AHRQ PUBLICATION, V13-EHC064-EF; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; ORR ST, 1995, EPIDEMIOL REV, V17, P165, DOI 10.1093/oxfordjournals.epirev.a036172; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Perkel JM, 2015, NATURE, V518, P125, DOI 10.1038/518125a; Raisanen S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004047; Savitz DA, 2011, ANN EPIDEMIOL, V21, P399, DOI 10.1016/j.annepidem.2011.03.003; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Stewart DE, 2016, NEW ENGL J MED, V375, P2177, DOI 10.1056/NEJMcp1607649; Wachino V., 2016, CMCS INFORM B, P1; Xu FL, 2016, BJPSYCH OPEN, V2, P233, DOI 10.1192/bjpo.bp.116.002790; Xu FL, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-119	18	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192854	10.1371/journal.pone.0192854	http://dx.doi.org/10.1371/journal.pone.0192854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444165	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500098
J	Schmidt, KE; Kuepper, JM; Schumak, B; Alferink, J; Hofmann, A; Howland, SW; Renia, L; Limmer, A; Specht, S; Hoerauf, A				Schmidt, Kim E.; Kuepper, Janina M.; Schumak, Beatrix; Alferink, Judith; Hofmann, Andrea; Howland, Shanshan W.; Renia, Laurent; Limmer, Andreas; Specht, Sabine; Hoerauf, Achim			Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators	PLOS ONE			English	Article							T-CELLS; DENDRITIC CELLS; MATRIX METALLOPROTEINASES; PLASMODIUM INFECTION; GRANZYME-B; PATHOGENESIS; EXPRESSION; BRAIN; ADHESION; MICE	Malaria ranks among the most important infectious diseases worldwide and affects mostly people living in tropical countries. Mechanisms involved in disease progression are still not fully understood and specific treatments that might interfere with cerebral malaria (CM) are limited. Here we show that administration of doxycycline (DOX) prevented experimental CM (ECM) in Plasmodium berghei ANKA (PbA)-infected C57BL/6 wildtype (WT) mice in an IL-10-independent manner. DOX-treated mice showed an intact blood-brain barrier (BBB) and attenuated brain inflammation. Importantly, if WT mice were infected with a 20-fold increased parasite load, they could be still protected from ECM if they received DOX from day 4 +/- 6 post infection, despite similar parasitemia compared to control-infected mice that did not receive DOX and developed ECM. Infiltration of T cells and cytotoxic responses were reduced in brains of DOX-treated mice. Analysis of brain tissue by RNA-array revealed reduced expression of chemokines and tumour necrosis factor (TNF) in brains of DOX-treated mice. Furthermore, DOX-administration resulted in brains of the mice in reduced expression of matrix metalloproteinase 2 (MMP2) and granzyme B, which are both factors associated with ECM pathology. Systemic interferon gamma production was reduced and activated peripheral T cells accumulated in the spleen in DOX-treated mice. Our results suggest that DOX targeted inflammatory processes in the central nervous system (CNS) and prevented ECM by impaired brain access of effector T cells in addition to its anti-parasitic effect, thereby expanding the understanding of molecular events that underlie DOX-mediated therapeutic interventions.	[Schmidt, Kim E.; Kuepper, Janina M.; Schumak, Beatrix; Hofmann, Andrea; Specht, Sabine; Hoerauf, Achim] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Alferink, Judith] Univ Hosp Muenster, Dept Psychiat & Psychotherapy, Munster, Germany; [Howland, Shanshan W.; Renia, Laurent] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Limmer, Andreas] Univ Hosp Essen, Clin Anaesthesiol & Intens Care, Essen, Germany; [Limmer, Andreas] Univ Hosp Bonn, Inst Mol Med, Bonn, Germany; [Limmer, Andreas] Univ Hosp Bonn, Inst Expt Immunol, Bonn, Germany	University of Bonn; University of Munster; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Duisburg Essen; University of Bonn; University of Bonn	Schumak, B (corresponding author), Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.	bschumak@uni-bonn.de	Renia, Laurent/E-2117-2011; Howland, Shanshan W/I-2245-2014	Renia, Laurent/0000-0003-0349-1557; Howland, Shanshan W/0000-0003-4794-1564; Kuehlwein, Janina M./0000-0003-3648-2649; Schumak, Beatrix/0000-0003-0749-3170; alferink, judith/0000-0002-3251-6584	intramural funding (BONFOR program) of the Medical Faculty of the Friedrich-Wilhelms University Bonn; German Centre for Infection Research (Deutsches Zentrum fuer Infektionsforschung, DZIF); Singapore's Agency for Science, Technology and Research (A*STAR)	intramural funding (BONFOR program) of the Medical Faculty of the Friedrich-Wilhelms University Bonn; German Centre for Infection Research (Deutsches Zentrum fuer Infektionsforschung, DZIF); Singapore's Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was financially supported by intramural funding (BONFOR program) of the Medical Faculty of the Friedrich-Wilhelms University Bonn to SS, BS and JK (www.ukb.unibonn.de/bonfor/) and also by the German Centre for Infection Research (Deutsches Zentrum fuer Infektionsforschung, DZIF, www.dzif.de). Part of this work was supported by an intramural grant from Singapore's Agency for Science, Technology and Research (A*STAR). BS and AH are members of the Bonn Excellence Cluster "Immunosensation" EXC1023.	Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; Batty KT, 2007, ANTIMICROB AGENTS CH, V51, P4477, DOI 10.1128/AAC.00529-07; Bauer PR, 2002, MICROCIRCULATION, V9, P463, DOI 10.1038/sj.mn.7800159; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Castro JEZ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/370872; Chang WL, 2003, INFECT IMMUN, V71, P1911, DOI 10.1128/IAI.71.4.1911-1918.2003; Costa GD, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3694714; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; D'Orlando O, 2013, EUR J IMMUNOL, V43, P194, DOI 10.1002/eji.201142343; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Draper MP, 2013, ANTIMICROB AGENTS CH; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Enose-Akahata Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-16; Geurts N, 2012, PHARMACOL THERAPEUT, V133, P257, DOI 10.1016/j.pharmthera.2011.11.008; Gu Y, 2010, FEMS IMMUNOL MED MIC, V58, P218, DOI 10.1111/j.1574-695X.2009.00625.x; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Hirako IC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13277; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Howland SW, 2015, SEMIN IMMUNOPATHOL; Huang XQ, 2014, INT IMMUNOPHARMACOL, V22, P266, DOI 10.1016/j.intimp.2014.07.001; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Krakauer T, 2003, ANTIMICROB AGENTS CH, V47, P3630, DOI 10.1128/AAC.47.11.3630-3633.2003; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074108; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Mairuae N, 2011, NEUROSCI LETT, V500, P36, DOI 10.1016/j.neulet.2011.06.001; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Miranda AS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-388; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Piva L, 2012, J IMMUNOL, V189, P1128, DOI 10.4049/jimmunol.1201171; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Ramos TN, 2013, J BIOL CHEM, V288, P10962, DOI 10.1074/jbc.C113.457028; Randall LM, 2010, EXP PARASITOL, V126, P326, DOI 10.1016/j.exppara.2010.04.016; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Sarto BY, 2004, ANN TROP MED PARASIT, V98, P297, DOI 10.1179/000349804225003271; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Shaw TN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005210; SMITH JR, 1994, INFLAMMATION, V18, P193, DOI 10.1007/BF01534560; Stevenson MM, 2006, PARASITE IMMUNOL, V28, P5, DOI 10.1111/j.1365-3024.2006.00772.x; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285; Tauber S C, 2008, Curr Mol Pharmacol, V1, P68; Van den Steen PE, 2006, LAB INVEST, V86, P873, DOI 10.1038/labinvest.3700454; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wang ZH, 2012, J MOL NEUROSCI, V47, P89, DOI 10.1007/s12031-011-9689-x; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHO, 2016, WORLD MAL REP 2016; WHO, 2010, GUID TREATM MAL, V2nd; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602; World Health Organization, 2015, GUID TREATM MAL, Vthird; Yang YN, 2012, OPHTHALMIC RES, V48, P165, DOI 10.1159/000338819; Yang Z, 2012, CURR MED CHEM, V19, P4541, DOI 10.2174/092986712803251575	68	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192717	10.1371/journal.pone.0192717	http://dx.doi.org/10.1371/journal.pone.0192717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438386	Green Submitted, gold, Green Published			2022-12-26	WOS:000425083400047
J	Su, H; Song, SR; Yan, X; Fang, LM; Zeng, B; Zhu, YL				Su, Hu; Song, Shurui; Yan, Xin; Fang, Limin; Zeng, Bin; Zhu, Youlin			Endogenous salicylic acid shows different correlation with baicalin and baicalein in the medicinal plant Scutellaria baicalensis Georgi subjected to stress and exogenous salicylic acid	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; SYSTEMIC ACQUIRED-RESISTANCE; ISOCHORISMATE SYNTHASE; ARABIDOPSIS; BIOSYNTHESIS; DEFENSE; GROWTH; PHOTOSYNTHESIS; CULTURES; PATHWAY	Salicylic acid (SA) is synthesized via the phenylalanine lyase (PAL) and isochorismate synthase (ICS) pathways and can influence the stress response in plants by regulating certain secondary metabolites. However, the association between SA and particular secondary metabolites in the Chinese medicinal plant Scutellaria baicalensis Georgi is unclear. To elucidate the association between SA and the secondary metabolites baicalin and baicalein, which constitute the primary effective components of S. baicalensis, we subjected seedlings to drought and salt stress and exogenous SA treatment in a laboratory setting and tested the expression of PAL and ICS, as well as the content of free SA (FSA), total SA (TSA), baicalin, and baicalein. We also assessed the correlation of FSA and TSA with PAL and ICS, and with baicalin and baicalein accumulation, respectively. The results indicated that both FSA and TSA were positively correlated with PAL, ICS, and baicalin, but negatively correlated with baicalein. The findings of this study improve our understanding of the manner in which SA regulates secondary metabolites in S. baicalensis.	[Su, Hu; Yan, Xin; Zhu, Youlin] Nanchang Univ, Life Sci Dept, Nanchang, Jiangxi, Peoples R China; [Su, Hu; Song, Shurui; Fang, Limin; Zeng, Bin] Jiangxi Sci & Technol Normal Univ, Life Sci Dept, Nanchang, Jiangxi, Peoples R China	Nanchang University; Jiangxi Science & Technology Normal University	Zhu, YL (corresponding author), Nanchang Univ, Life Sci Dept, Nanchang, Jiangxi, Peoples R China.	ylzhu1999@aliyun.com		Su, Hu/0000-0002-9672-944X	National Natural Science Foundation of China [81102803]; "555 talent project" of Jiangxi Province; Jiangxi Key Laboratory of Bioprocess Engineering [31171731]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "555 talent project" of Jiangxi Province; Jiangxi Key Laboratory of Bioprocess Engineering	This work was supported by the National Natural Science Foundation of China [Grant no. 81102803] and "555 talent project" of Jiangxi Province, Jiangxi Key Laboratory of Bioprocess Engineering [Grant no. 31171731]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China [Grant no. 81102803] and "555 talent project" of Jiangxi Province, Jiangxi Key Laboratory of Bioprocess Engineering [Grant no. 31171731].	Anand A, 2008, PLANT PHYSIOL, V146, P703, DOI 10.1104/pp.107.111302; Bai XY, 2015, PLANT GROWTH REGUL, V75, P695, DOI 10.1007/s10725-014-9971-3; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; El-Esawi MA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00716; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Janda T, 2014, ACTA PHYSIOL PLANT, V36, P2537, DOI 10.1007/s11738-014-1620-y; Kahn MIR, 2015, FRONT PLANT SCI, P6; Kovacik J, 2012, J PLANT PHYSIOL, V169, P1317, DOI 10.1016/j.jplph.2012.04.008; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahdavian K, 2008, BIOL PLANTARUM, V52, P170, DOI 10.1007/s10535-008-0037-0; Marsh Z, 2014, PHYTOCHEMISTRY, V107, P50, DOI 10.1016/j.phytochem.2014.08.020; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; Ogawa D, 2007, PLANTA, V226, P1277, DOI 10.1007/s00425-007-0556-5; Rangel-Sanchez G, 2014, J PLANT PHYSIOL, V171, P189, DOI 10.1016/j.jplph.2013.07.004; Shine MB, 2016, NEW PHYTOL, V212, P627, DOI 10.1111/nph.14078; Su H, 2016, ACTA PHYSIOL PLANT, V38, DOI [10.1007/s11738-016-2193-8, 10]; Su H, 2015, J PLANT BIOCHEM BIOT, V24, P34, DOI 10.1007/s13562-013-0233-7; Sudha G, 2002, PLANT CELL TISS ORG, V71, P181, DOI 10.1023/A:1020336626361; Szalai G, 2011, J PLANT PHYSIOL, V168, P213, DOI 10.1016/j.jplph.2010.07.029; Wang YD, 2007, CELL BIOL INT, V31, P1179, DOI 10.1016/j.cellbi.2007.03.038; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xue LJ, 2013, PLANT CELL, V25, P2714, DOI 10.1105/tpc.113.112839; YOUNG IG, 1969, BIOCHIM BIOPHYS ACTA, V177, P401, DOI 10.1016/0304-4165(69)90302-X; Zhao JM, 1996, PLANT CELL, V8, P2235, DOI 10.1105/tpc.8.12.2235; Zhao QC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501729; Zhou N, 1998, PLANT CELL, V10, P1021, DOI 10.1105/tpc.10.6.1021	28	17	18	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192114	10.1371/journal.pone.0192114	http://dx.doi.org/10.1371/journal.pone.0192114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438420	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400012
J	Zhao, Y; Liu, RH; Zhang, X; Whiteing, A				Zhao, Yi; Liu, Ronghui; Zhang, Xi; Whiteing, Anthony			A chance-constrained stochastic approach to intermodal container routing problems	PLOS ONE			English	Article							SERVICE NETWORK DESIGN; FREIGHT TRANSPORTATION; MODEL; TIME; ALGORITHM	We consider a container routing problem with stochastic time variables in a sea-rail intermodal transportation system. The problem is formulated as a binary integer chance-constrained programming model including stochastic travel times and stochastic transfer time, with the objective of minimising the expected total cost. Two chance constraints are proposed to ensure that the container service satisfies ship fulfilment and cargo on-time delivery with pre-specified probabilities. A hybrid heuristic algorithm is employed to solve the binary integer chance-constrained programming model. Two case studies are conducted to demonstrate the feasibility of the proposed model and to analyse the impact of stochastic variables and chance-constraints on the optimal solution and total cost.	[Zhao, Yi; Zhang, Xi] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Zhao, Yi; Liu, Ronghui; Whiteing, Anthony] Univ Leeds, Inst Transport Studies, Leeds, W Yorkshire, England	Beijing Jiaotong University; University of Leeds	Liu, RH (corresponding author), Univ Leeds, Inst Transport Studies, Leeds, W Yorkshire, England.	r.liu@its.leeds.ac.uk		Liu, Ronghui/0000-0003-0627-3184	China Scholarship Council; UK Rail Safety and Standards Board [T1071]	China Scholarship Council(China Scholarship Council); UK Rail Safety and Standards Board	China Scholarship Council (http://en.csc.edu.cn/) sponsored a visiting scholarship to YZ (the first author) which enabled him to spend a year visiting the University of Leeds where he was supervised by RL and AEW and conducted the research reported in this paper. UK Rail Safety and Standards Board (https://www.rssb.co.uk/) Project T1071 provided financial support to RL and AEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apivatanagul P., 2008, THESIS; Ayar B, 2012, COMPUT OPTIM APPL, P1; Barnhart C., 1993, J BUS LOGIST, V14, P205; Bowden R. O., 2004, VIRTUAL INTERMODAL T; Cao CX, 2012, EUR J OPER RES, V217, P214, DOI 10.1016/j.ejor.2011.08.023; Caris A, 2013, COMPUT IND, V64, P105, DOI 10.1016/j.compind.2012.12.001; Chang TS, 2008, COMPUT OPER RES, V35, P2877, DOI 10.1016/j.cor.2006.12.025; CHARNES A, 1959, MANAGE SCI, V6, P73, DOI 10.1287/mnsc.6.1.73; Cho JH, 2012, APPL INTELL, V36, P529, DOI 10.1007/s10489-010-0223-6; CRAINIC TG, 1986, TRANSPORT RES B-METH, V20, P225, DOI 10.1016/0191-2615(86)90019-6; CRAINIC TG, 1990, TRANSPORT SCI, V24, P1, DOI 10.1287/trsc.24.1.1; Crainic TG, 2000, EUR J OPER RES, V122, P272, DOI 10.1016/S0377-2217(99)00233-7; Demir E, 2016, TRANSPORT RES B-METH, V93, P789, DOI 10.1016/j.trb.2015.09.007; Dong JX, 2015, TRANSPORT RES B-METH, V78, P404, DOI 10.1016/j.trb.2015.05.005; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Hvattum LM, 2009, J HEURISTICS, V15, P527, DOI 10.1007/s10732-008-9076-0; Kauczynski WE, 2012, PROCEEDINGS OF THE ASME 31ST INTERNATIONAL CONFERENCE ON OCEAN, OFFSHORE AND ARCTIC ENGINEERING, 2012, VOL 5, P195; Kim H. - J., 2008, MARIT POLICY MANAG, V35, P103, DOI DOI 10.1080/03088830701849084; Li JQ, 2015, TRANSPORT RES C-EMER, V60, P397, DOI 10.1016/j.trc.2015.09.010; Li MS, 2017, J APPL STAT, V44, P715, DOI 10.1080/02664763.2016.1182134; Li SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168526; Liu B., 2009, THEORY PRACTICE UNCE; Meng Q, 2014, TRANSPORT SCI, V48, P265, DOI 10.1287/trsc.2013.0461; Meng Q, 2012, TRANSPORT RES REC, P42, DOI 10.3141/2269-05; Meng Q, 2012, EUR J OPER RES, V223, P96, DOI 10.1016/j.ejor.2012.06.025; Meng QC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125939; MIN H, 1991, TRANSPORT RES A-POL, V25, P351, DOI 10.1016/0191-2607(91)90013-G; Moccia L, 2011, NETWORKS, V57, P53, DOI 10.1002/net.20383; Pagnoncelli BK, 2009, J OPTIMIZ THEORY APP, V142, P399, DOI 10.1007/s10957-009-9523-6; ROUSH WB, 1994, INTERFACES, V24, P53, DOI 10.1287/inte.24.2.53; SteadieSeifi M, 2014, EUR J OPER RES, V233, P1, DOI 10.1016/j.ejor.2013.06.055; van Riessen B, 2015, INT J SHIP TRANS LOG, V7, P457, DOI 10.1504/IJSTL.2015.069683; Wang TS, 2013, TRANSPORT RES E-LOG, V60, P1, DOI 10.1016/j.tre.2013.09.001; Yang LX, 2011, ENG OPTIMIZ, V43, P1289, DOI 10.1080/0305215X.2010.550286; Yang XJ, 2011, J TRANSP GEOGR, V19, P515, DOI 10.1016/j.jtrangeo.2010.05.007; YEN JY, 1971, MANAGE SCI, V17, P712, DOI 10.1287/mnsc.17.11.712; Ziliaskopoulos A, 2000, EUR J OPER RES, V125, P486, DOI 10.1016/S0377-2217(99)00388-4	38	20	21	13	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192275	10.1371/journal.pone.0192275	http://dx.doi.org/10.1371/journal.pone.0192275			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW1TV	29438389	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400020
J	Ikoma, M; Gantt, S; Casper, C; Ogata, Y; Zhang, Q; Basom, R; Dyen, MR; Rose, TM; Barcy, S				Ikoma, Minako; Gantt, Soren; Casper, Corey; Ogata, Yuko; Zhang, Qing; Basom, Ryan; Dyen, Michael R.; Rose, Timothy M.; Barcy, Serge			KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; EPSTEIN-BARR-VIRUS; KAPOSIS-SARCOMA; TUMOR-SUPPRESSOR; PERIPHERAL-BLOOD; HERPESVIRUS-INFECTION; VIRAL REPLICATION; SMALL RNAS; HUMAN-HERPESVIRUS-8; MICRORNAS	Kaposi's sarcoma herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS). Both KSHV and HIV infections are endemic in Uganda, where KS is among the most common cancers in HIV-infected individuals. Recent studies examined the use of small RNAs as biomarkers of disease, including microRNAs (miRNAs), with viral and tumor-derived miRNAs being detected in exosomes from individuals with KSHV-associated malignancies. In the current study, the host and viral extracellular mature miRNA expression profiles were analyzed in blood of KS-negative individuals in Uganda, comparing those with or without KSHV detectable from the oropharynx. We observed increased levels of cellular oncogenic miRNAs and decreased levels of tumor-suppressor miRNAs in plasma of infected individuals exhibiting oral KSHV shedding. These changes in host oncomiRs were exacerbated in people co-infected with HIV, and partially reversed after 2 years of anti-retroviral therapy. We also detected KSHV miRNAs in plasma of KSHV infected individuals and determined that their expression levels correlated with KSHV plasma viremia. Deep sequencing revealed an expected profile of small cellular RNAs in plasma, with miRNAs constituting the major RNA biotype. In contrast, the composition of small RNAs in exosomes was highly atypical with high levels of YRNA and low levels of miRNAs. Mass spectrometry analysis of the exosomes revealed eleven different peptides derived from the malaria parasite, Plasmodium falciparum, and small RNA sequencing confirmed widespread plasmodium co-infections in the Ugandan cohorts. Proteome analysis indicated an exosomal protein profile consistent with erythrocyte and keratinocyte origins for the plasma exosomes. A strong correlation was observed between the abundance of Plasmodium proteins and cellular markers of malaria. As Plasmodium falciparum is an endemic pathogen in Uganda, our study shows that co-infection with other pathogens, such as KSHV, can severely impact the small RNA repertoire, complicating the use of exosome miRNAs as biomarkers of disease.	[Ikoma, Minako; Dyen, Michael R.; Rose, Timothy M.; Barcy, Serge] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA; [Gantt, Soren] Univ British Columbia, BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Casper, Corey] Infect Dis Res Inst, Seattle, WA USA; [Casper, Corey] Univ Washington, Dept Med & Global Hlth, Seattle, WA 98195 USA; [Ogata, Yuko] Fred Hutchinson Canc Res Ctr, Prote, 1124 Columbia St, Seattle, WA 98104 USA; [Zhang, Qing; Basom, Ryan] Fred Hutchinson Canc Res Ctr, Genom, 1124 Columbia St, Seattle, WA 98104 USA; [Rose, Timothy M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ogata, Yuko] Just Biotherapeut All, Seattle, WA USA; [Dyen, Michael R.] King Cty Environm Lab, Dept Nat Resources & Pk, Seattle, WA USA	Seattle Children's Hospital; BC Childrens Hospital; University of British Columbia; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Barcy, S (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.	serge.barcy@seattlechildrens.org		Oda, Minako/0000-0003-3379-0881; Gantt, Soren/0000-0001-5743-3606	NIH; NIH/National Institute of Dental and Craniofacial Research; Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations [1P01 DE021954]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE021954] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by an NIH funded program, NIH/National Institute of Dental and Craniofacial Research, Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations, 1P01 DE021954. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2002, BLOOD, V99, P649, DOI 10.1182/blood.V99.2.649; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Boshoff C, 1998, BLOOD, V91, P1671, DOI 10.1182/blood.V91.5.1671.1671_1671_1679; Bruce AG, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6010011; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Campbell TB, 2000, AIDS, V14, P2109, DOI 10.1097/00002030-200009290-00006; Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327; Casper C, 2004, JAIDS-J ACQ IMM DEF, V35, P233, DOI 10.1097/00126334-200403010-00003; Casper C, 2007, J INFECT DIS, V195, P30, DOI 10.1086/509621; Chen CYA, 2016, NUCLEIC ACIDS RES, V44, P3772, DOI 10.1093/nar/gkw205; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Chen Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0786-2; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; CHO W, 2007, MOL CANCER, V6; Chohan BH, 2004, J CLIN VIROL, V30, P137, DOI 10.1016/j.jcv.2003.08.017; Choi HS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005255; Christov CP, 2006, MOL CELL BIOL, V26, P6993, DOI 10.1128/MCB.01060-06; Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Dhahbi JM, 2013, PHYSIOL GENOMICS, V45, P990, DOI 10.1152/physiolgenomics.00129.2013; Di Bartolo DL, 2008, BLOOD, V111, P4731, DOI 10.1182/blood-2007-09-110544; DiMaio TA, 2014, J VIROL, V88, P14301, DOI 10.1128/JVI.01696-14; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Feng JL, 2014, J CELL MOL MED, V18, P2125, DOI 10.1111/jcmm.12398; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Forte E, 2015, J VIROL, V89, P2333, DOI 10.1128/JVI.03317-14; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Fuentes-Mattei E, 2017, EBIOMEDICINE, V20, P182, DOI 10.1016/j.ebiom.2017.04.018; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gantt S, 2015, ADV VIROL, V2015, DOI 10.1155/2015/687162; Gantt S, 2014, J CLIN VIROL, V60, P127, DOI 10.1016/j.jcv.2014.03.002; Gantt S, 2011, CURR OPIN INFECT DIS, V24, P295, DOI 10.1097/QCO.0b013e3283486d04; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00165; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Haderk F, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5509; Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884; Hammond SM, 2006, CANCER CHEMOTH PHARM, V58, pS63, DOI 10.1007/s00280-006-0318-2; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Hernandez-Ramirez RU, 2017, LANCET HIV, V4, pE495, DOI 10.1016/S2352-3018(17)30125-X; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Hizir Z, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.429; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Hoshina S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162574; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; Ignacio RAB, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0052-2; International Agency for Research on Cancer, 2003, IARC Sci Publ, P1; ITOH Y, 1990, CLIN EXP IMMUNOL, V81, P45; Johnston C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004222; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; Koga K, 2015, DIABETOLOGIA, V58, P2169, DOI 10.1007/s00125-015-3642-4; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI 10.1016/j.biocel.2015.07.003; Lee MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004412; Lei XF, 2010, VIRULENCE, V1, P433, DOI 10.4161/viru.1.5.12966; Li P, 2014, FEBS LETT, V588, P705, DOI 10.1016/j.febslet.2014.01.007; Li W, 2016, ONCOTARGET, V7, P32286, DOI 10.18632/oncotarget.8591; Lin XZ, 2012, J VIROL, V86, P12717, DOI 10.1128/JVI.01473-12; Liu SX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101770; Liu YH, 2012, J VIROL, V86, P1372, DOI 10.1128/JVI.06245-11; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manzano M, 2013, J VIROL, V87, P11821, DOI 10.1128/JVI.01692-13; MARSCHANG P, 1994, INT ARCH ALLERGY IMM, V103, P113, DOI 10.1159/000236616; Mathema VB, 2015, ASIAN PAC J TROP MED, V8, P253, DOI 10.1016/S1995-7645(14)60327-8; Meng J, 2015, PEERJ, V3, DOI 10.7717/peerj.971; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nalwoga A, 2015, TROP MED INT HEALTH, V20, P665, DOI 10.1111/tmi.12464; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; O'Hara AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000389; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; OBRIEN CA, 1990, EMBO J, V9, P3683, DOI 10.1002/j.1460-2075.1990.tb07580.x; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okuno T, 2002, VIRUS RES, V90, P77, DOI 10.1016/S0168-1702(02)00142-9; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; PHANUPHAK P, 1985, CLIN EXP IMMUNOL, V59, P571; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; Purushothaman P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070198; Qin ZQ, 2014, VIRUSES-BASEL, V6, P4571, DOI 10.3390/v6114571; Qiu J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004561; Qu Y, 2016, TUMOR BIOL, V37, P5275, DOI 10.1007/s13277-015-4389-8; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Repetto E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0489-y; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Semeere AS, 2012, CURR OPIN ONCOL, V24, P522, DOI 10.1097/CCO.0b013e328355e14b; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Simpson DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008822; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suffert G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002405; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Tedeschi R, 2001, J CLIN MICROBIOL, V39, P4269, DOI 10.1128/JCM.39.12.4269-4273.2001; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Tomita M, 2004, ONCOGENE, V23, P8272, DOI 10.1038/sj.onc.1208059; Trivedi P, 2004, BLOOD, V103, P313, DOI 10.1182/blood-2003-05-1710; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang YH, 2017, EUR J CANCER PREV, V26, P144, DOI 10.1097/CEJ.0000000000000221; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wenisch C, 1996, CLIN EXP IMMUNOL, V105, P74, DOI 10.1046/j.1365-2249.1996.d01-723.x; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; Yin SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11012; Yogev O, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006524; Zhang Y, 2012, NUCLEIC ACIDS RES, V40, P9286, DOI 10.1093/nar/gks667; Zhou SJ, 2017, BRIT J CANCER, V117, P233, DOI 10.1038/bjc.2017.164; Zuo LL, 2017, VIROL SIN, V32, P175, DOI 10.1007/s12250-017-3996-5	121	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192659	10.1371/journal.pone.0192659	http://dx.doi.org/10.1371/journal.pone.0192659			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425228	gold, Green Published, Green Submitted			2022-12-26	WOS:000424700800034
J	Pradhan, S; Hedberg, J; Rosenqvist, J; Jonsson, CM; Wold, S; Blomberg, E; Wallinder, IO				Pradhan, Sulena; Hedberg, Jonas; Rosenqvist, Jorgen; Jonsson, Caroline M.; Wold, Susanna; Blomberg, Eva; Wallinder, Inger Odnevall			Influence of humic acid and dihydroxy benzoic acid on the agglomeration, adsorption, sedimentation and dissolution of copper, manganese, aluminum and silica nanoparticles - A tentative exposure scenario	PLOS ONE			English	Article							AGGREGATION KINETICS; SILVER NANOPARTICLES; OXIDE NANOPARTICLES; ZNO NANOPARTICLES; METAL-OXIDES; ATR-FTIR; PH; TOXICITY; BEHAVIOR; DISAGGREGATION	This work focuses on kinetic aspects of stability, mobility, and dissolution of bare Cu, Al and Mn, and SiO2 NPs in synthetic freshwater (FW) with and without the presence of natural organic matter (NOM). This includes elucidation of particle and surface interactions, metal dissolution kinetics, and speciation predictions of released metals in solution. Dihydroxy benzoic acid (DHBA) and humic acid adsorbed rapidly on all metal NPs (< 1 min) via multiple surface coordinations, followed in general by rapid agglomeration and concomitant sedimentation for a large fraction of the particles. In contrast, NOM did not induce agglomeration of the SiO2 NPs during the test duration (21 days). DHBA in concentrations of 0.1 and 1 mM was unable to stabilize the metal NPs for time periods longer than 6 h, whereas humic acid, at certain concentrations (20 mg/L) was more efficient (> 24 h). The presence of NOM increased the amount of released metals into solution, in particular for Al and Cu, whereas the effect for Mn was minor. At least 10% of the particle mass was dissolved within 24 h and remained in solution for the metal NPs in the presence of NOM. Speciation modeling revealed that released Al and Cu predominantly formed complexes with NOM, whereas less complexation was seen for Mn. The results imply that potentially dispersed NPs of Cu, Al and Mn readily dissolve or sediment close to the source in freshwater of low salinity, whereas SiO2 NPs are more stable and therefore more mobile in solution.	[Pradhan, Sulena; Hedberg, Jonas; Blomberg, Eva; Wallinder, Inger Odnevall] KTH Royal Inst Technol, Dept Chem, Div Surface & Corros Sci, Stockholm, Sweden; [Rosenqvist, Jorgen; Jonsson, Caroline M.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Wold, Susanna] KTH Royal Inst Technol, Dept Chem, Div Appl Phys Chem, Stockholm, Sweden; [Blomberg, Eva] RISE Res Inst Sweden, Div Biosci & Mat, Stockholm, Sweden	Royal Institute of Technology; University of Gothenburg; Royal Institute of Technology; RISE Research Institutes of Sweden	Hedberg, J (corresponding author), KTH Royal Inst Technol, Dept Chem, Div Surface & Corros Sci, Stockholm, Sweden.	jhed@kth.se	Wallinder, Inger Odnevall/Q-6875-2017; Hedberg, Jonas/H-4226-2019; Jonsson, Caroline M/F-2469-2010	Jonsson, Caroline M/0000-0001-9491-322X; Odnevall, Inger/0000-0003-2206-0082; /0000-0003-2100-8864	Swedish Foundation for Strategic Environmental Research (MISTRA)	Swedish Foundation for Strategic Environmental Research (MISTRA)(Swedish Foundation for Strategic Research)	This work has been performed within the framework of the Mistra Environment Nanosafety program, a consortium between Chalmers University of Technology, Gothenburg University, Karolinska Institutet, KTH Royal Institute of Technology, Lund University and AkzoNobel AB, funded by the Swedish Foundation for Strategic Environmental Research (MISTRA) to IOW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been performed within the framework of the Mistra Environment Nanosafety program, a consortium between Chalmers University of Technology, Gothenburg University, Karolinska Institutet, KTH Royal Institute of Technology, Lund University and AkzoNobel AB, funded by the Swedish foundation for strategic environmental research (MISTRA). We acknowledge Sara Isaksson for AAS measurements. We thank Assoc. Prof. A. Y. Godymchuk, Tomsk University, Russia, for providing Cu NPs, AkzoNobel AB for providing the SiO<INF>2</INF> NPs and technical support, and Rickard Frost (Chalmers University of Technology) for the SEM images of the SiO<INF>2</INF> NPs.	Akaighe N, 2012, SCI TOTAL ENVIRON, V441, P277, DOI 10.1016/j.scitotenv.2012.09.055; Akaighe N, 2011, ENVIRON SCI TECHNOL, V45, P3895, DOI 10.1021/es103946g; AMAL R, 1992, J COLLOID INTERF SCI, V151, P244, DOI 10.1016/0021-9797(92)90255-K; [Anonymous], 2001, ENVJMMONO20019 OECD, V9; Averett R. C., 1994, HUMIC SUBSTANCES SUW; Baalousha M, 2009, SCI TOTAL ENVIRON, V407, P2093, DOI 10.1016/j.scitotenv.2008.11.022; Bauerlein PS, 2017, SCI TOTAL ENVIRON, V576, P273, DOI 10.1016/j.scitotenv.2016.09.206; Bhattacharjee S, 2016, J CONTROL RELEASE, V235, P337, DOI 10.1016/j.jconrel.2016.06.017; Bian SW, 2011, LANGMUIR, V27, P6059, DOI 10.1021/la200570n; Bournel F, 1996, SURF SCI, V352, P228, DOI 10.1016/0039-6028(95)01138-2; Christian P, 2008, ECOTOXICOLOGY, V17, P326, DOI 10.1007/s10646-008-0213-1; Cohen JM, 2015, NANOMEDICINE-UK, V10, P3015, DOI 10.2217/nnm.15.129; de Allison JD, 2011, VISUAL MINTEQ VER 3, V4, P1991; Erhayem M, 2014, SCI TOTAL ENVIRON, V470, P92, DOI 10.1016/j.scitotenv.2013.09.063; Gandhi N, 2010, ENVIRON SCI TECHNOL, V44, P5195, DOI 10.1021/es903317a; Ghosh S, 2008, LANGMUIR, V24, P12385, DOI 10.1021/la802015f; Gottschalk F, 2013, ENVIRON POLLUT, V181, P287, DOI 10.1016/j.envpol.2013.06.003; Guan XH, 2006, CHEMOSPHERE, V65, P2074, DOI 10.1016/j.chemosphere.2006.06.048; Gulley-Stahl H, 2010, ENVIRON SCI TECHNOL, V44, P4116, DOI 10.1021/es902040u; Hansen SF, 2016, ENVIRON SCI-NANO, V3, P169, DOI 10.1039/c5en00182j; Hay MB, 2007, GEOCHIM COSMOCHIM AC, V71, P3518, DOI 10.1016/j.gca.2007.03.038; Hedberg J, 2017, ENVIRON SCI-NANO, V4, P886, DOI 10.1039/c6en00645k; Hedberg J, 2016, COLLOID SURFACE B, V141, P291, DOI 10.1016/j.colsurfb.2016.01.052; Hedberg Y, 2013, J MATER SCI-MATER M, V24, P1015, DOI 10.1007/s10856-013-4859-8; Hedberg YS, 2016, ELECTROCHIM ACTA, V212, P360, DOI 10.1016/j.electacta.2016.07.017; Hendren CO, 2015, SCI TOTAL ENVIRON, V536, P1029, DOI 10.1016/j.scitotenv.2015.06.100; Huangfu XL, 2013, ENVIRON SCI TECHNOL, V47, P10285, DOI 10.1021/es4003247; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; KERNDORFF H, 1980, GEOCHIM COSMOCHIM AC, V44, P1701, DOI 10.1016/0016-7037(80)90221-5; Kim JY, 2013, ECOTOX ENVIRON SAFE, V92, P57, DOI 10.1016/j.ecoenv.2013.02.004; Loosli F, 2013, WATER RES, V47, P6052, DOI 10.1016/j.watres.2013.07.021; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e; May PM, 2015, APPL GEOCHEM, V55, P3, DOI 10.1016/j.apgeochem.2014.11.023; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Mudunkotuwa IA, 2015, ENVIRON SCI-NANO, V2, P429, DOI 10.1039/c4en00215f; Nakamoto K., 2009, INFRARED RAMAN SPECT, V6th; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Omar FM, 2014, SCI TOTAL ENVIRON, V468, P195, DOI 10.1016/j.scitotenv.2013.08.044; OMELIA CR, 1980, ENVIRON SCI TECHNOL, V14, P1052, DOI 10.1021/es60169a601; Pradhan S, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-016-3597-5; Pu YB, 2016, ENVIRON SCI TECHNOL, V50, P9370, DOI 10.1021/acs.est.5b06300; Quik JTK, 2011, ENVIRON INT, V37, P1068, DOI 10.1016/j.envint.2011.01.015; Schmidt J, 2006, J PHYS CHEM B, V110, P3955, DOI 10.1021/jp0553611; Schneckenburger T, 2012, ORG GEOCHEM, V47, P132, DOI 10.1016/j.orggeochem.2012.03.014; SCHNYDER B, 1992, J ELECTROANAL CHEM, V339, P167, DOI 10.1016/0022-0728(92)80450-I; Shi J, 2012, ACTA BIOMATER, V8, P3478, DOI 10.1016/j.actbio.2012.04.024; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Stumm W, 2012, AQUATIC CHEM CHEM EQ, DOI [10.1016/j.scitotenv.2013.08.044, DOI 10.1016/J.SCITOTENV.2013.08.044]; Stumm W, 1995, INNER SPHERE SURFACE; Sun TY, 2017, ENVIRON SCI TECHNOL, V51, P2854, DOI 10.1021/acs.est.6b05702; Van Hoecke K, 2011, ENVIRON POLLUT, V159, P970, DOI 10.1016/j.envpol.2010.12.010; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234; Volk C. J., 2001, METHODS ENZYMOLOGY M; Wang LF, 2015, WATER RES, V68, P12, DOI 10.1016/j.watres.2014.09.031; Wang X, 2014, LANGMUIR, V30, P13877, DOI 10.1021/la503170x; Wang ZY, 2016, ENVIRON SCI-NANO, V3, P240, DOI [10.1039/c5en00230c, 10.1039/C5EN00230C]; Xing B., 2016, ENG NANOPARTICLES EN; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P2661, DOI 10.1021/es304013r	61	17	17	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192553	10.1371/journal.pone.0192553	http://dx.doi.org/10.1371/journal.pone.0192553			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420670	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900091
J	Zeinert, R; Martinez, E; Schmitz, J; Senn, K; Usman, B; Anantharaman, V; Aravind, L; Waters, LS				Zeinert, Rilee; Martinez, Eli; Schmitz, Jennifer; Senn, Katherine; Usman, Bakhtawar; Anantharaman, Vivek; Aravind, L.; Waters, Lauren S.			Structure-function analysis of manganese exporter proteins across bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; STREPTOCOCCUS-PNEUMONIAE; BACILLUS-SUBTILIS; PSI-BLAST; METAL; HOMEOSTASIS; TRANSPORT; SYSTEM; STRESS	Manganese (Mn) is an essential trace nutrient for organisms because of its role in cofactoring enzymes and providing protection against reactive oxygen species (ROS). Many bacteria require manganese to form pathogenic or symbiotic interactions with eukaryotic host cells. However, excess manganese is toxic, requiring cells to have manganese export mechanisms. Bacteria are currently known to possess two widely distributed classes of manganese export proteins, MntP and MntE, but other types of transporters likely exist. Moreover, the structure and function of MntP is not well understood. Here, we characterized the role of three structurally related proteins known or predicted to be involved in manganese transport in bacteria from the MntP, UPF0016, and TerC families. These studies used computational analysis to analyze phylogeny and structure, physiological assays to test sensitivity to high levels of manganese and ROS, and inductively coupled plasma-mass spectrometry (ICP-MS) to measure metal levels. We found that MntP alters cellular resistance to ROS. Moreover, we used extensive computational analyses and phenotypic assays to identify amino acids required for MntP activity. These negatively charged residues likely serve to directly bind manganese and transport it from the cytoplasm through the membrane. We further characterized two other potential manganese transporters associated with a Mn-sensing riboswitch and found that the UPF0016 family of proteins has manganese export activity. We provide here the first phenotypic and biochemical evidence for the role of Alx, a member of the TerC family, in manganese homeostasis. It does not appear to export manganese, but rather it intriguingly facilitates an increase in intracellular manganese concentration. These findings expand the available knowledge about the identity and mechanisms of manganese homeostasis proteins across bacteria and show that proximity to a Mn-responsive riboswitch can be used to identify new components of the manganese homeostasis machinery.	[Zeinert, Rilee; Martinez, Eli; Schmitz, Jennifer; Senn, Katherine; Usman, Bakhtawar; Waters, Lauren S.] Univ Wisconsin, Dept Chem, Oshkosh, WI 54901 USA; [Anantharaman, Vivek; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Zeinert, Rilee] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	University of Wisconsin System; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Massachusetts System; University of Massachusetts Amherst	Waters, LS (corresponding author), Univ Wisconsin, Dept Chem, Oshkosh, WI 54901 USA.; Aravind, L (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.	aravind@ncbi.nlm.nih.gov; watersl@uwosh.edu	Anantharaman, Vivek/ABB-9991-2021	Anantharaman, Vivek/0000-0001-8395-0009	Intramural Research Program of the National Library of Medicine, National Institutes of Health; Research Corporation for Scientific Advancement [22658, 23595]; Department of Education TRIO McNair Scholars Program at the University of Wisconsin, Oshkosh; University of Wisconsin, Oshkosh	Intramural Research Program of the National Library of Medicine, National Institutes of Health; Research Corporation for Scientific Advancement(Research Corporation for Science Advancement); Department of Education TRIO McNair Scholars Program at the University of Wisconsin, Oshkosh; University of Wisconsin, Oshkosh	This work was supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health (to V. A. and L. A.), Grants 22658 and 23595 from the Research Corporation for Scientific Advancement (to L. S. W.), the Department of Education TRIO McNair Scholars Program at the University of Wisconsin, Oshkosh (to R. Z. and E. M.), and University of Wisconsin, Oshkosh, Faculty Development funds (to L. S. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleshin VV, 1999, TRENDS BIOCHEM SCI, V24, P133, DOI 10.1016/S0968-0004(99)01367-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; BINGHAM RJ, 1990, J BACTERIOL, V172, P2184, DOI 10.1128/jb.172.4.2184-2186.1990; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cubillas C, 2014, METALLOMICS, V6, P1808, DOI 10.1039/c4mt00135d; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dambach M, 2015, MOL CELL, V57, P1099, DOI 10.1016/j.molcel.2015.01.035; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Fisher CR, 2016, J BACTERIOL, V198, P2810, DOI 10.1128/JB.00215-16; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Hohle TH, 2014, MOL MICROBIOL, V93, P736, DOI 10.1111/mmi.12687; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang XJ, 2017, MOL MICROBIOL, V103, P253, DOI 10.1111/mmi.13554; Imlay JA, 2014, J BIOL CHEM, V289, P28121, DOI 10.1074/jbc.R114.588814; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021983; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; Martin JE, 2017, MOL MICROBIOL, V104, P334, DOI 10.1111/mmi.13630; Martin JE, 2016, J BACTERIOL, V198, P1066, DOI 10.1128/JB.00975-15; Martin JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004977; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Neyrolles O, 2015, IMMUNOL REV, V264, P249, DOI 10.1111/imr.12265; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P11334, DOI 10.1074/jbc.M112.448175; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Price IR, 2015, MOL CELL, V57, P1110, DOI 10.1016/j.molcel.2015.02.016; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Turner AG, 2015, MBIO, V6, DOI 10.1128/mBio.00278-15; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Yamamoto K, 2011, J BACTERIOL, V193, P1477, DOI 10.1128/JB.01230-10; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	58	20	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5715	5730		10.1074/jbc.M117.790717	http://dx.doi.org/10.1074/jbc.M117.790717			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29440394	Green Published, hybrid			2022-12-26	WOS:000430044100031
J	Sowers, CR; Wang, R; Bourne, RA; McGrath, BC; Hu, JJ; Bevilacqua, SC; Paton, JC; Paton, AW; Collardeau-Frachon, S; Nicolino, M; Cavener, DR				Sowers, Carrie R.; Wang, Rong; Bourne, Rebecca A.; McGrath, Barbara C.; Hu, Jingjie; Bevilacqua, Sarah C.; Paton, James C.; Paton, Adrienne W.; Collardeau-Frachon, Sophie; Nicolino, Marc; Cavener, Douglas R.			The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; endoplasmic reticulum (ER); insulin secretion; intracellular trafficking; protein aggregation; BiP; PERK; beta cells	PANCREATIC BETA-CELLS; MESSENGER-RNA TRANSLATION; DISULFIDE-ISOMERASE; GLUCOSE-HOMEOSTASIS; PERK EIF2AK3; SUBTILASE CYTOTOXIN; DIABETES-MELLITUS; ESCHERICHIA-COLI; ADP-RIBOSYLATION; BINDING-PROTEIN	Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones.	[Sowers, Carrie R.; Wang, Rong; Bourne, Rebecca A.; McGrath, Barbara C.; Hu, Jingjie; Bevilacqua, Sarah C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Collardeau-Frachon, Sophie] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Hop Femme Mere Enfant, Dept Pathol, F-69677 Bron, France; [Collardeau-Frachon, Sophie] INSERM, Unit U1060, F-69677 Bron, France; [Nicolino, Marc] Hosp Civils Lyon, Serv Endocrinol & Dabetol Pediat & Malad Herediat, Hop Femme Mere Enfant, F-69677 Bron, France; [Sowers, Carrie R.] MedImmune LLC, Gaithersburg, MD 20878 USA; [Wang, Rong] Atila Biosyst, Mountain View, CA 94043 USA; [Bevilacqua, Sarah C.] CALTECH, Pasadena, CA 91125 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Adelaide; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; AstraZeneca; Medimmune; California Institute of Technology	Cavener, DR (corresponding author), 109 Life Sci Bldg, University Pk, PA 16802 USA.	drc9@psu.edu	Wang, Rong/M-4503-2019; Carmen, Team1/Y-7382-2019; wang, meng/GWZ-9558-2022; FRACHON, Sophie COLLARDEAU/H-2000-2014	Carmen, Team1/0000-0003-4234-1746; FRACHON, Sophie COLLARDEAU/0000-0001-8604-1089; Lab, Carmen/0000-0002-5935-3236	National Institutes of Health [R01 DK88140]; Huck Graduate Research Dissertation Award from the Huck Institutes of the Life Sciences at Penn State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Graduate Research Dissertation Award from the Huck Institutes of the Life Sciences at Penn State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK88140 and a Huck Graduate Research Dissertation Award (to C. R. S.) from the Huck Institutes of the Life Sciences at Penn State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Alarcon C, 2002, AV DIABETOL, V18, P168; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Collardeau-Frachon S, 2015, PEDIATR DIABETES, V16, P510, DOI 10.1111/pedi.12201; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Fabrizio G, 2015, CELL MOL LIFE SCI, V72, P1209, DOI 10.1007/s00018-014-1745-6; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Greeley SAW, 2011, CURR DIABETES REP, V11, P519, DOI 10.1007/s11892-011-0234-7; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Kim MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/509437; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Laitusis AL, 1999, J BIOL CHEM, V274, P486, DOI 10.1074/jbc.274.1.486; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NAGAMATSU S, 1987, ENDOCRINOLOGY, V120, P1225, DOI 10.1210/endo-120-4-1225; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Norez C, 2008, EUR J PHARMACOL, V592, P33, DOI 10.1016/j.ejphar.2008.06.103; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; RESENDEZ E, 1985, MOL CELL BIOL, V5, P1212, DOI 10.1128/MCB.5.6.1212; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; Shankar RK, 2013, PEDIATR DIABETES, V14, P174, DOI 10.1111/pedi.12003; Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005; Teodoro T, 2012, AM J PHYSIOL-CELL PH, V302, pC992, DOI 10.1152/ajpcell.00160.2011; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Tiwari A, 2013, J CELL SCI, V126, P1962, DOI 10.1242/jcs.117374; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; van Vliet AR, 2017, MOL CELL, V65, P885, DOI 10.1016/j.molcel.2017.01.020; Vishnu N, 2014, MOL BIOL CELL, V25, P368, DOI 10.1091/mbc.E13-07-0433; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zito E, 2010, J CELL BIOL, V189, P769, DOI 10.1083/jcb.20091108620100423c	71	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5134	5149		10.1074/jbc.M117.813790	http://dx.doi.org/10.1074/jbc.M117.813790			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29444822	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000429409300019
J	Han, D; Wegrzyn, J; Bi, H; Wei, RH; Zhang, B; Li, XR				Han, Ding; Wegrzyn, Jana; Bi, Hua; Wei, Ruihua; Zhang, Bin; Li, Xiaorong			Practice makes the deficiency of global motion detection in people with pattern-related visual stress more apparent	PLOS ONE			English	Article							INCREASED CORTICAL HYPEREXCITABILITY; HEMODYNAMIC-RESPONSE; GAZE STABILITY; MIGRAINE; DISCOMFORT; PERCEPTION; GLARE; SENSITIVITY; POPULATION; HEADACHE	Aims Pattern-related visual stress (PRVS) refers to the perceptual difficulties experienced by some individuals when exposed to high contrast striped patterns. People with PRVS were reported to have reduced sensitivity to global motion at baseline testing and the difference disappears at a second estimate. The present study was to investigate the effect of practice on global motion threshold in adults with and without PRVS. Methods A total of 101 subjects were recruited and the Wilkins & Evans Pattern Glare Test was used to determine if a subject had PRVS. The threshold to detect global motion was measured with a random dot kinematogram. Each subject was measured 5 times at the first visit and again a month later. Receiver operating characteristic (ROC) curve analysis was applied to show the agreement between the two tests. Results Twenty-nine subjects were classified as having PRVS and 72 were classified as normal. At baseline, the threshold to detect global motion was significantly higher in subjects with PRVS (0.832 +/- 0.098 vs. 0.618 +/- 0.228, p < 0.001). After 5 sessions, the difference between the normal and subjects with PRVS increased (0.767 +/- 0.170 vs. 0.291 +/- 0.149, p < 0.001). In ROC analysis, the area under the curve (AUC) improved from 0.792 at baseline to 0.964 at the fifth session. After a one-month break, the difference between normal and subjects with PRVS was still significant (0.843 +/- 0.169 vs. 0.407 +/- 0.216, p < 0.001) and the AUC was 0.875. Conclusion The ability to detect global motion is impaired in persons with PRVS and the difference increased after additional sessions of practice.	[Han, Ding; Wei, Ruihua; Li, Xiaorong] Tianjin Med Univ Eye Hosp, Sch Optometry & Ophthalmol, Tianjin, Peoples R China; [Wegrzyn, Jana; Bi, Hua; Zhang, Bin] Nova Southeastern Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA	Tianjin Medical University; Nova Southeastern University	Li, XR (corresponding author), Tianjin Med Univ Eye Hosp, Sch Optometry & Ophthalmol, Tianjin, Peoples R China.; Zhang, B (corresponding author), Nova Southeastern Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA.	bz52@nova.edu; lixiaorong@tmu.edu.cn	bi, huaqiang/GYJ-5005-2022; Zhang, Bin/GOH-1376-2022					Allen PM, 2012, PERCEPTION, V41, P1458, DOI 10.1068/p7390; Antal A, 2005, CEPHALALGIA, V25, P788, DOI 10.1111/j.1468-2982.2005.00949.x; Astle A.T., 2015, J VISION, V15, P16, DOI [10.1167/15.10.16, DOI 10.1167/15.10.16]; Astle AT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01158; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braithwaite JJ, 2015, CORTEX, V69, P1, DOI 10.1016/j.cortex.2015.03.023; Braithwaite JJ, 2013, COGN NEUROPSYCHIATRY, V18, P549, DOI 10.1080/13546805.2013.768176; Conlon E, 2001, VISION RES, V41, P3063, DOI 10.1016/S0042-6989(01)00204-8; Conlon E, 1998, PERCEPTION, V27, P21, DOI 10.1068/p270021; Conlon EG, 2009, NEUROPSYCHOLOGIA, V47, P907, DOI 10.1016/j.neuropsychologia.2008.12.037; Evans B., 2016, J OPTOMETRY, V10, P161, DOI [10.1016/j.optom.2016.08.002., DOI 10.1016/J.OPTOM.2016.08.002]; Evans BJW, 2008, OPHTHAL PHYSL OPT, V28, P295, DOI 10.1111/j.1475-1313.2008.00578.x; Evans BJW, 2002, OPHTHAL PHYSL OPT, V22, P535, DOI 10.1046/j.1475-1313.2002.00071.x; Evans Bruce J W, 2016, J Optom, V9, P205, DOI 10.1016/j.optom.2016.04.002; Fahle M, 1996, INVEST OPHTH VIS SCI, V37, P869; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Gilchrist JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00449; Gregory R. L., 1993, P ROYAL SOC B, V253, P1336; Hadad B, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00049; Haigh SM, 2015, NEUROIMAGE, V111, P379, DOI 10.1016/j.neuroimage.2015.02.034; Haigh SM, 2013, VISION RES, V89, P47, DOI 10.1016/j.visres.2013.07.003; Harle DE, 2004, OPHTHAL PHYSL OPT, V24, P369, DOI 10.1111/j.1475-1313.2004.00212.x; Harle DE, 2006, HEADACHE, V46, P1431, DOI 10.1111/j.1526-4610.2006.00585.x; Hermens F, 2012, I-PERCEPTION, V3, P282, DOI 10.1068/i0457aap; Hess RF, 2007, VISION RES, V47, P1682, DOI 10.1016/j.visres.2007.02.005; Hibbard PB, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140535; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Khalil NM, 2011, CEPHALALGIA, V31, P213, DOI 10.1177/0333102410378050; MARCUS DA, 1989, ARCH NEUROL-CHICAGO, V46, P1129, DOI 10.1001/archneur.1989.00520460125024; McKendrick AM, 2006, CEPHALALGIA, V26, P1131, DOI 10.1111/j.1468-2982.2006.01182.x; McKendrick AM, 2004, CEPHALALGIA, V24, P363, DOI 10.1111/j.1468-2982.2004.00679.x; Narasimhan S, 2012, VISION RES, V62, P102, DOI 10.1016/j.visres.2012.02.016; NULTY DD, 1987, PSYCHOL MED, V17, P705, DOI 10.1017/S0033291700025940; O'Hare L, 2017, EUR J NEUROSCI, V45, P410, DOI 10.1111/ejn.13479; O'Hare L, 2013, J VISION, V13, DOI 10.1167/13.5.7; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penacchio O, 2015, VISION RES, V108, P1, DOI 10.1016/j.visres.2014.12.013; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Simmers AJ, 2001, INVEST OPHTH VIS SCI, V42, P879; Wattam-Bell J, 2010, CURR BIOL, V20, P411, DOI 10.1016/j.cub.2009.12.020; WILKINS A, 1984, BRAIN, V107, P989, DOI 10.1093/brain/107.4.989; Wilkins AJ, 2012, VISUAL ASPECTS DYSLE, P63; Zanker JM, 2003, PERCEPTION, V32, P1037, DOI 10.1068/p5128	49	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193215	10.1371/journal.pone.0193215	http://dx.doi.org/10.1371/journal.pone.0193215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447280	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900120
J	Zhang, HM; Liu, P; Jiang, C; Jin, XQ; Liu, RN; Li, SQ; Zhao, Y				Zhang, Hong-Mei; Liu, Pei; Jiang, Cheng; Jin, Xiao-Qing; Liu, Rui-Ning; Li, Shun-Qing; Zhao, Yan			Notch signaling inhibitor DAPT provides protection against acute craniocerebral injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GAMMA-SECRETASE; NEUROGENESIS; APOPTOSIS; AUTOPHAGY; ISCHEMIA; MOUSE; DEATH	Notch signaling pathway is involved in many physiological and pathological processes. The gamma-secretase inhibitor DAPT inhibits Notch signaling pathway and promotes nerve regeneration after cerebral ischemia. However, neuroprotective effects of DAPT against acute craniocerebral injury remain unclear. In this study, we established rat model of acute craniocerebral injury, and found that with the increase of damage grade, the expression of Notch and downstream protein Hes1 and Hes5 expression gradually increased. After the administration of DAPT, the expression of Notch, Hes1 and Hes5 was inhibited, apoptosis and oxidative stress decreased, neurological function and cognitive function improved. These results suggest that Notch signaling can be used as an indicator to assess the severity of post-traumatic brain injury. Notch inhibitor DAPT can reduce oxidative stress and apoptosis after acute craniocerebral injury, and is a potential drug for the treatment of acute craniocerebral injury.	[Zhang, Hong-Mei; Jiang, Cheng; Jin, Xiao-Qing; Liu, Rui-Ning; Li, Shun-Qing; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan, Hubei, Peoples R China; [Liu, Pei] Hubei Univ Med, Taihe Hosp, Dept Intens Care Unit, Wuhan, Hubei, Peoples R China	Wuhan University; Hubei University of Medicine	Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan, Hubei, Peoples R China.	doctoryanzhao@163.com			Emergency Diagnostic & Therapeutic Center of Central China	Emergency Diagnostic & Therapeutic Center of Central China	This study was financially supported by the "Emergency Diagnostic & Therapeutic Center of Central China." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Xian-Long Zhou for reviewing the manuscript. This study was financially supported by the "Emergency Diagnostic & Therapeutic Center of Central China".	Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fazio C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.408; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Huang M, 2014, CHINESE MED J-PEKING, V127, P924, DOI 10.3760/cma.j.issn.0366-6999.20132366; Li SY, 2012, NEUROL SCI, V33, P1257, DOI 10.1007/s10072-012-0948-6; Li ZX, 2016, TRANSL STROKE RES, V7, P132, DOI 10.1007/s12975-015-0441-7; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Pazos MC, 2017, MOL CELL ENDOCRINOL, V440, P125, DOI 10.1016/j.mce.2016.11.025; Pei HF, 2015, FREE RADICAL BIO MED, V82, P114, DOI 10.1016/j.freeradbiomed.2015.02.002; RINK A, 1995, AM J PATHOL, V147, P1575; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang ZX, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-56; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang GS, 2013, CNS NEUROSCI THER, V19, P53, DOI 10.1111/cns.12032; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037	25	21	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193037	10.1371/journal.pone.0193037	http://dx.doi.org/10.1371/journal.pone.0193037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447233	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900100
J	Zhang, L; Shi, L; Xiao, ZP; Qiu, H; Peng, P; Zhang, MS				Zhang, Lu; Shi, Lei; Xiao, Zhiping; Qiu, Hong; Peng, Ping; Zhang, Mingsheng			Coaxial technique-promoted diagnostic accuracy of CT-guided percutaneous cutting needle biopsy for small and deep lung lesions	PLOS ONE			English	Article							CHEST TUBE PLACEMENT; RISK-FACTORS; PULMONARY NODULES; ASPIRATION BIOPSY; CORE BIOPSY; PNEUMOTHORAX; CANCER; YIELD	Coaxial technique is extensively applied to facilitate percutaneous lung lesion biopsy. However, the impact of coaxial technique on diagnostic accuracy remains undecided. We reviewed 485 patients who underwent percutaneous CT-guided needle biopsies of lung lesions in our hospital. All of these biopsies were performed using either a cutting needle alone (n = 268) or a cutting needle combined with a coaxial needle (n = 217). The diagnostic accuracy and complications resulting from the two techniques were then compared. The diagnostic accuracies of the two techniques were comparably high, at 98.2% (with coaxial technique) and 95.9% (without coaxial technique), p = 0.24. Subgroup analysis discovered that for patients with lesions measuring <1.5 cm and needle path length >= 4 cm, the coaxial technique achieved a higher diagnostic accuracy (95.5% vs. 72.7%, p = 0.023). The biopsy was well tolerated in all of the patients. Pneumothorax occurred less often in patients who were biopsied with the coaxial technique (19 versus 43, p = 0.024). Thus, the application of the coaxial technique could improve diagnostic accuracy in patients with small and deep lung lesions, and could reduce the risk of pneumothorax. The combined use of cutting needles with coaxial needles is the preferred technique for performing percutaneous CT-guided lung biopsies.	[Zhang, Lu; Shi, Lei; Xiao, Zhiping; Qiu, Hong; Peng, Ping; Zhang, Mingsheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Qiu, H; Zhang, MS (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Hubei, Peoples R China.	tjqiuhong@163.com; zms75@163.com		Zhang, Mingsheng/0000-0002-8929-9349	National Natural Science Foundation of China [81441087, 81372664]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China [no. 81441087 to LZ, 81372664 to HQ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviram G, 2005, CLIN RADIOL, V60, P370, DOI 10.1016/j.crad.2004.09.006; Beslic S, 2012, RADIOL ONCOL, V46, P19, DOI 10.2478/v10019-012-0004-4; Geraghty PR, 2003, RADIOLOGY, V229, P475, DOI 10.1148/radiol.2291020499; Heyer CM, 2008, ACAD RADIOL, V15, P1017, DOI 10.1016/j.acra.2008.02.018; Hiraki T, 2010, AM J ROENTGENOL, V194, P809, DOI 10.2214/AJR.09.3224; Hiraki T, 2009, CHEST, V136, P1612, DOI 10.1378/chest.09-0370; Kaira K, 2011, AM J TRANSL RES, V3, P383; Kucuk CU, 2004, RESPIROLOGY, V9, P392, DOI 10.1111/j.1440-1843.2004.00607.x; Laspas F, 2008, J MED IMAG RADIAT ON, V52, P458, DOI 10.1111/j.1440-1673.2008.01990.x; Laurent F, 2000, CARDIOVASC INTER RAD, V23, P266, DOI 10.1007/s002700010067; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Nour-Eldin NEA, 2016, CARDIOVASC INTER RAD, V39, P261, DOI 10.1007/s00270-015-1167-3; Ohno Y, 2003, AM J ROENTGENOL, V180, P1665, DOI 10.2214/ajr.180.6.1801665; Popper HH, 2014, TRANSL LUNG CANCER R, V3, P291, DOI 10.3978/j.issn.2218-6751.2014.10.01; Priola AM, 2007, RADIOL MED, V112, P1142, DOI 10.1007/s11547-007-0212-y; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; Wehrschuetz M, 2010, CLIN MED INSIGHTS-CI, V4, P9; WESTCOTT JL, 1988, RADIOLOGY, V169, P593, DOI 10.1148/radiology.169.3.3055026; Yeow KM, 2001, J VASC INTERV RADIOL, V12, P1305, DOI 10.1016/S1051-0443(07)61556-5	19	13	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192920	10.1371/journal.pone.0192920	http://dx.doi.org/10.1371/journal.pone.0192920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447239	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900073
J	Nishio, M; Tanaka, Y				Nishio, Mizuho; Tanaka, Yutaka			Heterogeneity in pulmonary emphysema: Analysis of CT attenuation using Gaussian mixture model	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; AIR-FLOW LIMITATION; COMPUTED-TOMOGRAPHY; LUNG-FUNCTION; DISEASE; COPD; SMOKERS; DIMENSIONS; VOLUMES	Purpose To utilize Gaussian mixture model (GMM) for the quantification of chronic obstructive pulmonary disease (COPD) and to evaluate the combined use of multiple types of quantification. Materials and methods Eighty-seven patients (67 men, 20 women; age, 67.4 +/- 11.0 years) who had undergone computed tomography (CT) and pulmonary function test (PFT) were included. The heterogeneity of CT attenuation in emphysema (HC) was obtained by analyzing a distribution of CT attenuation with GMM. The percentages of low-attenuation volume in the lungs (LAV), wall area of bronchi (WA), and the cross-sectional area of small pulmonary vessels (CSA) were also calculated. The relationships between COPD quantifications and the PFT results were evaluated by Pearson's correlation coefficients and through linear models, with the best models selected using Akaike information criterion (AIC). Results The correlation coefficients with FEV1 were as follows: LAV, -0.505; HC, -0.277; CSA, 0.384; WA, -0.196. The correlation coefficients with FEV1/FVC were: LAV, -0.640; HC, -0.136; CSA, 0.288; WA, -0.131. For predicting FEV1, the smallest AIC values were obtained in the model with LAV, HC, CSA, and WA. For predicting FEV1/FVC, the smallest AIC values were obtained in the model with LAV and HC. In both models, the coefficient of HC was statistically significant (P-values = 0.000880 and 0.0441 for FEV1 and FEV1/FVC, respectively). Conclusion GMM was applied to COPD quantification. The results of this study show that COPD severity was associated with HC. In addition, it is shown that the combined use of multiple types of quantification made the evaluation of COPD severity more reliable.	[Nishio, Mizuho] Clin PET Ctr, Inst Biomed Res & Innovat, Chuo Ku, Minatojimaminamimachi, Kobe, Hyogo, Japan; [Nishio, Mizuho] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Kawahara Cho, Kyoto, Kyoto, Japan; [Nishio, Mizuho] Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Sakyo Ku, 53 Kawahara Cho, Kyoto, Kyoto, Japan; [Tanaka, Yutaka] Chibune Gen Hosp, Dept Radiol, Nishi Yodogawa Ku, Osaka, Osaka, Japan	Institute for Biomedical Research & Innovation (IBRI); Kyoto University; Kyoto University	Nishio, M (corresponding author), Clin PET Ctr, Inst Biomed Res & Innovat, Chuo Ku, Minatojimaminamimachi, Kobe, Hyogo, Japan.; Nishio, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Kawahara Cho, Kyoto, Kyoto, Japan.; Nishio, M (corresponding author), Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Sakyo Ku, 53 Kawahara Cho, Kyoto, Kyoto, Japan.	jurader@yahoo.co.jp	Nishio, Mizuho/ACC-0897-2022		JSPS KAKENHI [JP16K19883]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant Number JP16K19883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by JSPS KAKENHI (Grant Number JP16K19883).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aristophanous M, 2007, MED PHYS, V34, P4223, DOI 10.1118/1.2791035; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Coxson HO, 2014, AM J RESP CRIT CARE, V190, P135, DOI 10.1164/rccm.201402-0256PP; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gierada DS, 2011, RADIOLOGY, V261, P950, DOI 10.1148/radiol.11110542; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Greenspan H, 2006, IEEE T MED IMAGING, V25, P1233, DOI 10.1109/TMI.2006.880668; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hersh CP, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-42; Ju JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113320; Lee YK, 2008, LUNG, V186, P157, DOI 10.1007/s00408-008-9071-0; Matsuoka S, 2010, ACAD RADIOL, V17, P93, DOI 10.1016/j.acra.2009.07.022; Mets OM, 2012, EUR RADIOL, V22, P120, DOI 10.1007/s00330-011-2237-9; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakaya T, 2000, ENVIRON PLANN A, V32, P91, DOI 10.1068/a31145; Nishio M, 2015, ACAD RADIOL, V22, P330, DOI 10.1016/j.acra.2014.09.011; Nishio M, 2014, AM J ROENTGENOL, V202, pW453, DOI 10.2214/AJR.13.10781; Subramanian DR, 2012, AM J RESP CRIT CARE, V186, P1125, DOI 10.1164/rccm.201201-0051OC; Tanabe N, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-31; Turino GM, 2008, THORAX, V63, P1032, DOI 10.1136/thx.2008.105957; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285	25	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192892	10.1371/journal.pone.0192892	http://dx.doi.org/10.1371/journal.pone.0192892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444178	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500102
J	Al-Bustan, SA; Al-Serri, A; Annice, BG; Alnaqeeb, MA; Al-Kandari, WY; Dashti, M				Al-Bustan, Suzanne A.; Al-Serri, Ahmad; Annice, Babitha G.; Alnaqeeb, Majed A.; Al-Kandari, Wafa Y.; Dashti, Mohammed			A novel LPL intronic variant: g. 18704C>A identified by re-sequencing Kuwaiti Arab samples is associated with high-density lipoprotein, very low-density lipoprotein and triglyceride lipid levels	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIPASE GENE; POPULATION; POLYMORPHISMS; HYPERTRIGLYCERIDEMIA; CHOLESTEROL; ADOLESCENTS; METABOLISM; CONTRIBUTE; MUTATIONS	The role interethnic genetic differences play in plasma lipid level variation across populations is a global health concern. Several genes involved in lipid metabolism and transport are strong candidates for the genetic association with lipid level variation especially lipoprotein lipase (LPL). The objective of this study was to re-sequence the full LPL gene in Kuwaiti Arabs, analyse the sequence variation and identify variants that could attribute to variation in plasma lipid levels for further genetic association. Samples (n = 100) of an Arab ethnic group from Kuwait were analysed for sequence variation by Sanger sequencing across the 30 Kb LPL gene and its flanking sequences. A total of 293 variants including 252 single nucleotide polymorphisms (SNPs) and 39 insertions/deletions (InDels) were identified among which 47 variants (32 SNPs and 15 InDels) were novel to Kuwaiti Arabs. This study is the first to report sequence data and analysis of frequencies of variants at the LPL gene locus in an Arab ethnic group with a novel "rare" variant (LPL:g.18704C>A) significantly associated to HDL (B = -0.181; 95% CI (-0.357, -0.006); p = 0.043), TG (B = 0.134; 95% CI (0.004-0.263); p = 0.044) and VLDL (B = 0.131; 95% CI (-0.001-0.263); p = 0.043) levels. Sequence variation in Kuwaiti Arabs was compared to other populations and was found to be similar with regards to the number of SNPs, InDels and distribution of the number of variants across the LPL gene locus and minor allele frequency (MAF). Moreover, comparison of the identified variants and their MAF with other reports provided a list of 46 potential variants across the LPL gene to be considered for future genetic association studies. The findings warrant further investigation into the association of g.18704C>A with lipid levels in other ethnic groups and with clinical manifestations of dyslipidemia.	[Al-Bustan, Suzanne A.; Annice, Babitha G.; Alnaqeeb, Majed A.; Al-Kandari, Wafa Y.] Kuwait Univ, Dept Biol Sci, Fac Sci, Kuwait, Kuwait; [Al-Serri, Ahmad] Kuwait Univ, Dept Pathol, Unit Human Genet, Fac Med, Hawalli Governate, Kuwait; [Dashti, Mohammed] Minist Hlth, Kuwait Med Genet Ctr, Kuwait, Kuwait	Kuwait University; Kuwait University	Al-Bustan, SA (corresponding author), Kuwait Univ, Dept Biol Sci, Fac Sci, Kuwait, Kuwait.	s.albustan@ku.edu.kw		Al-Bustan, Suzanne/0000-0002-1260-4632; Alnaqeeb, Majed/0000-0002-1828-3024	Kuwait University Research Sector [SL04/11];  [GS01/02]	Kuwait University Research Sector; 	This research was funded totally by Kuwait University Research Sector, Project SL04/11.; The authors would like to extend their appreciation and gratitude to Kuwait University Research Sector and to the technical staff of Al-Amiri hospital for providing the samples and lipid profiles of the Biotechnology centre for their assistance with the use of the general Real-time and sequencing facility (Project GS01/02), namely Dr. Betsy Sheena Cherian, Mrs. Sheela Thankakkon and Mr. Philip Koshy. The authors would also like to acknowledge the assistance of Dr. Hussein Behbehani for the estimates of frequency differences used for the selection of the variants to be validated. Finally, the authors extend their gratitude to all the participants in this study for providing consent and relevant information.	Al-Bustan SA, 2005, HUM BIOL, V77, P487, DOI 10.1353/hub.2005.0058; Al-Bustan SA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-157; Al-Bustan SA, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-90; Ariza MJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-66; Askari G, 2016, SAO PAULO MED J, V134, P121, DOI 10.1590/1516-3180.2015.00792608; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Ayyappa KA, 2017, NUTR METAB, V14, DOI 10.1186/s12986-016-0155-1; Bentley AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004190; Cho YS, 2008, EXP MOL MED, V40, P523, DOI 10.3858/emm.2008.40.5.523; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; DEEB SS, 1989, BIOCHEMISTRY-US, V28, P4132, DOI 10.1021/bi00436a001; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Deveci M, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-74, 10.1186/1471-2105-15-73]; Evans D, 2011, ATHEROSCLEROSIS, V214, P386, DOI 10.1016/j.atherosclerosis.2010.11.026; Evans D, 2013, J CLIN LIPIDOL, V7, P610, DOI 10.1016/j.jacl.2013.09.006; Gao RR, 2015, EXP PHYSIOL, V100, P698, DOI 10.1113/EP085127; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; KIRCHGESSNER TG, 1989, P NATL ACAD SCI USA, V86, P9647, DOI 10.1073/pnas.86.24.9647; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Lu YC, 2008, J LIPID RES, V49, P2582, DOI 10.1194/jlr.M800232-JLR200; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Pirim D, 2015, EUR J HUM GENET, V23, P1244, DOI 10.1038/ejhg.2014.268; Pirim D, 2014, J LIPID RES, V55, P85, DOI 10.1194/jlr.M043265; R Core Team, 2013, R LANG ENV STAT COMP; Rabacchi C, 2015, ATHEROSCLEROSIS, V241, P79, DOI 10.1016/j.atherosclerosis.2015.04.815; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richardson K, 2013, AM J HUM GENET, V92, P5, DOI 10.1016/j.ajhg.2012.10.020; Rodrigues R, 2016, J CLIN LIPIDOL, V10, P394, DOI 10.1016/j.jacl.2015.12.015; Shahid SU, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0419-4; Shetty PB, 2015, CIRC-CARDIOVASC GENE, V8, P106, DOI 10.1161/CIRCGENETICS.114.000481; Smith AJP, 2010, HUM MOL GENET, V19, P3936, DOI 10.1093/hmg/ddq308; Wood AC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-143; Yang Yuhong, 2007, Journal of Genetics and Genomics, V34, P381, DOI 10.1016/S1673-8527(07)60041-1; Yue YH, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0491-9	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192617	10.1371/journal.pone.0192617	http://dx.doi.org/10.1371/journal.pone.0192617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438437	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400033
J	Jia, XN; Xu, SX; Bai, J; Wang, YF; Nie, ZH; Zhu, CC; Wang, Y; Cai, YX; Zou, JX; Zhou, XM				Jia, Xin-nan; Xu, Shu-xin; Bai, Jun; Wang, Yi-fan; Nie, Zong-heng; Zhu, Chun-chao; Wang, Yan; Cai, Yi-xiong; Zou, Jie-xin; Zhou, Xian-min			The complete mitochondrial genome of Somanniathelphusa boyangensis and phylogenetic analysis of Genus Somanniathelphusa (Crustacea: Decapoda: Parathelphusidae)	PLOS ONE			English	Article							DIVERGENCE TIME-ESTIMATION; TRANSFER-RNA GENES; FRESH-WATER CRAB; SEQUENCE; BRACHYURA; EVOLUTION; PROGRAM	In this study, the authors first obtained the mitochondrial genome of Somanniathelphusa boyangensis. The results showed that the mitochondrial genome is 17,032bp in length, included 13 protein-coding genes, 2 rRNAs genes, 22 tRNAs genes and 1 putative control region, and it has the characteristics of the metazoan mitochondrial genome A+T bias. All tRNA genes display the typical clover-leaf secondary structure except tRNA(Ser(AGN)), which has lost the dihydroxyuridine arm. The GenBank database contains the mitochondrial genomes of representatives of approximately 22 families of Brachyura, comprising 56 species, including 4 species of freshwater crab. The authors established the phylogenetic relationships using the maximum likelihood and Bayesian inference methods. The phylogenetic relationship indicated that the molecular taxonomy of S. boyangensis is consistent with current morphological classification, and Parathelphusidae and Potamidae are derived within the freshwater clade or as part of it. In addition, the authors used the COX1 sequence of Somanniathelphusa in GenBank and the COX1 sequence of S. boyangensis to estimated the divergence time of this genus. The result displayed that the divergence time of Somanniathelphusa qiongshanensis is consistent with the separation of Hainan Island from mainland China in the Beibu Gulf, and the divergence time for Somanniathelphusa taiwanensis and Somanniathelphusa amoyensis is consistent with the separation of Taiwan Province from Mainland China at Fujian Province. These data indicate that geologic events influenced speciation of the genus Somanniathelphusa.	[Jia, Xin-nan; Xu, Shu-xin; Bai, Jun; Nie, Zong-heng; Zhu, Chun-chao; Zou, Jie-xin] Nanchang Univ, Sch Basic Med Sci, Res Lab Freshwater Crustacean Decapoda & Paragoni, Nanchang, Jiangxi, Peoples R China; [Wang, Yi-fan] Jiangxi Acad Med Sci, Inst Pathogen Biol, Nanchang, Jiangxi, Peoples R China; [Wang, Yan; Zhou, Xian-min] Nanchang Univ, Key Lab Poyang Lake Environm & Resource Utilizat, Minist Educ, Nanchang, Jiangxi, Peoples R China; [Cai, Yi-xiong] Natl Pk Board, Natl Biodivers Ctr, Singapore, Singapore	Nanchang University; Nanchang University	Zou, JX (corresponding author), Nanchang Univ, Sch Basic Med Sci, Res Lab Freshwater Crustacean Decapoda & Paragoni, Nanchang, Jiangxi, Peoples R China.; Zhou, XM (corresponding author), Nanchang Univ, Key Lab Poyang Lake Environm & Resource Utilizat, Minist Educ, Nanchang, Jiangxi, Peoples R China.	jxzou@ncu.edu.cn; zhouxmjxmu@126.com		Zou, Jiexin/0000-0002-5549-2167	National Science Foundation of China [81260257, 31460156, 31560179]; Natural Science Foundation of Jiangxi Province [20171BAB205108]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work is supported by the National Science Foundation of China http://www.nsfc.gov.cn/ (No. 81260257, 31460156, 31560179). Received by XMZ, National Sharing Service Platform for Parasite Resources http://www.tdrc.org.cn/ (TDRC-22) and the Natural Science Foundation of Jiangxi Province http://www.jxstc.gov.cn/ (No. 20171BAB205108), Received by JXZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bai J, 2018, GENE, V646, P217, DOI 10.1016/j.gene.2018.01.015; Bakel BWM van, 2012, ZOOTAXA, V3215, P1; Burland T G, 2000, Methods Mol Biol, V132, P71; Chen JJ, 2015, FUNGAL DIVERS, V71, P185, DOI 10.1007/s13225-014-0317-2; Dai A.-Y., 1999, FAUNA SINICA ARTHROP; Dai AY, 1994, ACTA ZOOTAXONOMICA S; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Feldmann Rodney M., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P183; Hertweck KL, 2015, BOT J LINN SOC, V178, P375, DOI 10.1111/boj.12260; Igawa T, 2008, GENE, V407, P116, DOI 10.1016/j.gene.2007.10.001; Isaka Y, 2014, ENTOMOL SCI, V17, P435, DOI 10.1111/ens.12080; Ivey JL, 2007, GENE, V394, P35, DOI 10.1016/j.gene.2007.01.009; JAA N, 2008, MRMODELTEST 2 3 READ; Jing HU, 2006, ENTOMOTAXONOMIA; Jondeung A, 2012, MOL BIOL REP, V39, P10921, DOI 10.1007/s11033-012-1992-2; Karasawa H, 2008, J CRUSTACEAN BIOL, V28, P82, DOI 10.1651/07-2882R.1; Karasawa H, 2011, J CRUSTACEAN BIOL, V31, P523, DOI 10.1651/10-3423.1; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Ki JS, 2009, COMP BIOCHEM PHYS D, V4, P290, DOI 10.1016/j.cbd.2009.07.002; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Liang G.H., 2013, ACTA GEOL SIN-ENGL, V87, P73; Liu YA, 2010, MOL BIOL REP, V37, P2559, DOI 10.1007/s11033-009-9773-2; Lopez-Lopez A, 2015, ZOOL SCR, V44, P437, DOI 10.1111/zsc.12113; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma HY, 2013, GENE, V519, P120, DOI 10.1016/j.gene.2013.01.028; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Nie Rui-E, 2014, Acta Entomologica Sinica, V57, P860; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Schweitzer CE, 2000, J PALEONTOL, V74, P636, DOI 10.1666/0022-3360(2000)074<0636:NFPFWU>2.0.CO;2; Segawa RD, 2005, GENE, V355, P28, DOI 10.1016/j.gene.2005.05.020; Shen X, 2007, GENE, V403, P98, DOI 10.1016/j.gene.2007.06.021; Shi GH, 2015, MAR GENOM, V21, P53, DOI 10.1016/j.margen.2015.02.002; Shih HT, 2011, MOL PHYLOGENET EVOL, V58, P427, DOI 10.1016/j.ympev.2010.11.013; Shih HT, 2007, INVERTEBR SYST, V21, P484; Sun HY, 2005, GENE, V349, P207, DOI 10.1016/j.gene.2004.12.036; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang Xian-hua, 2002, Dixue Qianyuan, V9, P465; Tsang LM, 2014, MOL BIOL EVOL, V31, P1173, DOI 10.1093/molbev/msu068; Vazquez G. E., 2001, Advances in Engineering Software, V32, P37, DOI 10.1016/S0965-9978(00)00073-9; Wang Y, 2016, MITOCHONDRIAL DNA B, V1, P750, DOI 10.1080/23802359.2016.1209094; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yamauchi MM, 2003, GENE, V311, P129, DOI 10.1016/S0378-1119(03)00582-1; Yang EC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21361; Zhang ZQ, 2015, GENE, V560, P15, DOI 10.1016/j.gene.2014.12.026; Zhaobing Z, 1982, J APPL OCEANOGRAPHY, P24	48	19	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192601	10.1371/journal.pone.0192601	http://dx.doi.org/10.1371/journal.pone.0192601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438407	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400030
J	Negi, S; Tak, H; Ganapathi, TR				Negi, Sanjana; Tak, Himanshu; Ganapathi, T. R.			Xylem specific activation of 5 ' upstream regulatory region of two NAC transcription factors (MusaVND6 and MusaVND7) in banana is regulated by SNBE-like sites	PLOS ONE			English	Article							SECONDARY WALL SYNTHESIS; VASCULAR-RELATED NAC-DOMAIN7; FUNCTIONAL-CHARACTERIZATION; VESSEL FORMATION; MULTIPLE CLASSES; DIRECT TARGET; CELL-DEATH; ARABIDOPSIS; DIFFERENTIATION; SND1	Deposition of secondary cell wall in the xylem elements is controlled by a subgroup of NAC (NAM, ATAF, CUC) family, known as vascular-related NAC transcription factors (VNDs). In the present study, we analyzed the 5' upstream regulatory region of two banana NAC transcription factors (MusaVND6 and MusaVND7) for tissue specific expression and presence of 19-bp secondary-wall NAC binding element (SNBE)-like motifs. Transgenic banana plants of Musa cultivar Rasthali harboring either P-MusaVND7::GUS or P-MusaVND6::GUS showed specific GUS (beta-D-Glucuronidase) activity in cells of the xylem tissue. Approximately 1.2kb promoter region of either MusaVND6 or MusaVND7 showed presence of at least two SNBE-like motifs. This 1.2kb promoter region was retarded in a gel shift assay by three banana VND protein (VND1, VND2 and VND3). The banana VND1-VND3 could also retard the mobility of isolated SNBE-like motifs of MusaVND6 or MusaVND7 in a gel shift assay. Transcript levels of MusaVND6 and MusaVND7 were elevated in transgenic banana overexpressing either banana VND1, VND2 or VND3. Present study suggested a probable regulation of banana VND6 and VND7 expression through direct interaction of banana VND1-VND3 with SNBE-like motifs. Our study also indicated two promoter elements for possible utilization in cell wall modifications in plants especially banana, which is being recently considered as a potential biofuel crop.	[Negi, Sanjana; Tak, Himanshu; Ganapathi, T. R.] Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India; [Negi, Sanjana; Tak, Himanshu; Ganapathi, T. R.] Homi Bhabha Natl Inst, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute	Ganapathi, TR (corresponding author), Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India.; Ganapathi, TR (corresponding author), Homi Bhabha Natl Inst, Bombay, Maharashtra, India.	trgana@barc.gov.in			Department of Atomic Energy, Govt. of India	Department of Atomic Energy, Govt. of India(Department of Atomic Energy (DAE))	Department of Atomic Energy, Govt. of India funded the study. The funder had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscript.	Clarke WP, 2008, WASTE MANAGE, V28, P527, DOI 10.1016/j.wasman.2007.01.012; Endo H, 2015, PLANT CELL PHYSIOL, V56, P242, DOI 10.1093/pcp/pcu134; Eudes A, 2015, PLANT BIOTECHNOL J, V13, P1241, DOI 10.1111/pbi.12310; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Ingale S, 2014, BRAZ J MICROBIOL, V45, P885, DOI 10.1590/S1517-83822014000300018; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Li XJ, 2009, PLANT MOL BIOL, V69, P685, DOI 10.1007/s11103-008-9448-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Negi S, 2015, PROTOPLASMA; Negi S, 2017, PLANT SCI, V265, P70, DOI 10.1016/j.plantsci.2017.09.018; Negi S, 2015, TRANSGENIC RES, V24, P571, DOI 10.1007/s11248-014-9860-6; Negi S, 2015, PLANT BIOTECHNOL REP, V9, P47, DOI 10.1007/s11816-015-0342-y; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Ona T, 2001, WOOD SCI TECHNOL, V35, P229, DOI 10.1007/s002260100090; Ookawa T, 2010, PLANT PROD SCI, V13, P58, DOI 10.1626/pps.13.58; Rodgers JT, 2000, ANAL BIOCHEM, V277, P254, DOI 10.1006/abio.1999.4394; Sharma P., 2015, INT J SCI ENG TECHNO, V3, P1015; Soyano T, 2008, PLANT CELL, V20, P3359, DOI 10.1105/tpc.108.061796; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yamaguchi M, 2010, PLANT BIOTECHNOL, V27, P237, DOI 10.5511/plantbiotechnology.27.237; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	36	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192852	10.1371/journal.pone.0192852	http://dx.doi.org/10.1371/journal.pone.0192852			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438404	Green Submitted, gold, Green Published			2022-12-26	WOS:000425083400060
J	Ramirez, F; Rodriguez, C; Seoane, J; Figuerola, J; Bustamante, J				Ramirez, Francisco; Rodriguez, Carlos; Seoane, Javier; Figuerola, Jordi; Bustamante, Javier			How will climate change affect endangered Mediterranean waterbirds?	PLOS ONE			English	Article							LONG-TERM CHANGES; HABITAT CHARACTERISTICS; GLOSSY IBIS; WETLANDS; CONSERVATION; COMMUNITY; SALINITY; DONANA; BIODIVERSITY; CONSEQUENCES	Global warming and direct anthropogenic impacts, such as water extraction, largely affect water budgets in Mediterranean wetlands, thereby increasing wetland salinities and isolation, and decreasing water depths and hydroperiods (duration of the inundation period). These wetland features are key elements structuring waterbird communities. However, the ultimate and net consequences of these dynamic conditions on waterbird assemblages are largely unknown. We combined regular sampling of waterbird presence through one annual cycle with in-situ data on relevant environmental predictors of waterbird distribution to model habitat selection for 69 species in a typical Mediterranean wetland network in southwestern Spain. Species associations with environmental features were subsequently used to predict changes in habitat suitability for each species under three climate change scenarios (encompassing changes in environmental predictors that ranged from 10% to 50% change as predicted by regional climatic models). Waterbirds distributed themselves unevenly throughout environmental gradients and water salinity was the most important gradient structuring the distribution of the community. Environmental suitability for the guilds of diving birds and vegetation gleaners will decline in future climate scenarios, while many small wading birds will benefit from changing conditions. Resident species and those that breed in this wetland network will also be more negatively impacted than those using this area for wintering or stopover. We provide a tool that can be used in a horizon-scanning framework to identify emerging issues in waterbird conservation and to anticipate suitable management actions.	[Ramirez, Francisco; Figuerola, Jordi; Bustamante, Javier] CSIC, Estn Biol Donana, Dept Wetland Ecol, C Amer Vespucio 26, Seville, Spain; [Ramirez, Francisco] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Fac Biol, Avda Diagonal 643, Barcelona, Spain; [Rodriguez, Carlos] CSIC, Estn Biol Donana, Dept Conservat Biol, C Amer Vespucio 26, Seville, Spain; [Seoane, Javier] Univ Autonoma Madrid, Dept Ecol, Terr Ecol Grp, Madrid, Spain; [Bustamante, Javier] CSIC, Estn Biol Donana, Remote Sensing & GIS Lab LAST EBD, C Amer Vespucio 26, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Ramirez, F (corresponding author), CSIC, Estn Biol Donana, Dept Wetland Ecol, C Amer Vespucio 26, Seville, Spain.; Ramirez, F (corresponding author), Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Fac Biol, Avda Diagonal 643, Barcelona, Spain.	ramirez@ebd.csic.es	Bustamante, Javier/C-2735-2008; Ramírez, Francisco/I-3553-2014; Bustamante, Javier/AAA-7273-2019; Figuerola, Jordi/B-7917-2008; Seoane Pinilla, Javier/B-6833-2008	Bustamante, Javier/0000-0001-7515-0677; Ramírez, Francisco/0000-0001-9670-486X; Bustamante, Javier/0000-0001-7515-0677; Figuerola, Jordi/0000-0002-4664-9011; Seoane Pinilla, Javier/0000-0001-9975-4846	European Union (EU) Horizon research and innovation program [641762]; Autoridad Portuaria de Sevilla; ECOPOTENTIAL; Subprograma Juan de la Cierva-Incorporacion; Ministerio de Economia, Industria y Competitividad [IJCI-2015-24531]	European Union (EU) Horizon research and innovation program; Autoridad Portuaria de Sevilla; ECOPOTENTIAL; Subprograma Juan de la Cierva-Incorporacion; Ministerio de Economia, Industria y Competitividad	The study was supported by the European Union (EU) Horizon 2020 research and innovation program under grant agreement No. 641762 to ECOPOTENTIAL project. Field data were collected under the project "Propuesta metodologica para diagnosticar y pronosticar las consecuencias de las actuaciones humanas en el estuario del Guadalquivir" financed by Autoridad Portuaria de Sevilla. F. Ramirez was partially funded by ECOPOTENTIAL and "Subprograma Juan de la Cierva-Incorporacion; Ministerio de Economia, Industria y Competitividad" (IJCI-2015-24531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Carlos Gutierrez-ExpOsito and Andrew J. Green for their help in the analyses and interpretation of results. The study was supported by the European Union (EU) Horizon 2020 research and innovation program under grant agreement No. 641762 to ECOPOTENTIAL project. Field data were collected under the project "Propuesta metodolOgica para diagnosticar y pronosticar las consecuencias de las actuaciones humanas en el estuario del Guadalquivir" financed by Autoridad Portuaria de Sevilla. F. Ramirez was partially funded by ECOPOTENTIAL and "Subprograma Juan de la Cierva-Incorporacion; Ministerio de Economia, Industria y Competitividad" (IJCI-2015-24531).	Alexander BW, 2014, WATERBIRDS, V37, P274, DOI 10.1675/063.037.0306; Amat J.A., 1982, Wildfowl, V33, P94; Amat JA, 1982, DATOS SELECCION HABI; Amat JA, 1982, ACTA VERTEBR, V9, P251; Bustamante J, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100867; Cappelle J, 2010, ECOHEALTH, V7, P283, DOI 10.1007/s10393-010-0347-5; Cherkaoui SI, 2016, ARDEOLA, V63, P295, DOI 10.13157/arla.63.2.2016.ra5; Colwell MA, 2000, WATERBIRDS, V23, P45; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Diaz-Delgado R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090775; Dronova I, 2015, REMOTE SENS-BASEL, V7, P6380, DOI 10.3390/rs70506380; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EULISS NH, 1989, CONDOR, V91, P803, DOI 10.2307/1368063; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Galewski T, 2011, BIOL CONSERV, V144, P1392, DOI 10.1016/j.biocon.2010.10.030; Garcia Novo F, 2006, DONANA WATER BIOSPHE, DOI [10.1111/j.2006.0906-7590.04596.x, DOI 10.1111/J.2006.0906-7590.04596.X]; Brandolin PG, 2016, ARDEOLA, V63, P329, DOI 10.13157/arla.63.2.2016.ra7; Gilbert NI, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0070-0; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gonzalez-Gajardo A, 2009, WATERBIRDS, V32, P225, DOI 10.1675/063.032.0203; Green AJ, 1996, CONSERV BIOL, V10, P1435, DOI 10.1046/j.1523-1739.1996.10051435.x; Green AJ, 2002, BIOL CONSERV, V104, P71, DOI 10.1016/S0006-3207(01)00155-0; Green AJ, 2017, FRONT ECOL ENVIRON, V15, P99, DOI 10.1002/fee.1459; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Guadagnin DL, 2007, BIODIVERS CONSERV, V16, P1231, DOI 10.1007/s10531-006-9127-5; Gutierrez JS, 2012, FUNCT ECOL, V26, P236, DOI 10.1111/j.1365-2435.2011.01929.x; Hannam KM, 2003, WATERBIRDS, V26, P119, DOI 10.1675/1524-4695(2003)026[0119:IOSOGA]2.0.CO;2; Holm TE, 2006, BIODIVERS CONSERV, V15, P4399, DOI 10.1007/s10531-005-4384-2; Hughes RG, 2004, IBIS, V146, P21, DOI 10.1111/j.1474-919X.2004.00324.x; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Junk WJ, 2013, AQUAT SCI, V75, P113, DOI 10.1007/s00027-012-0253-8; Kagalou I, 2008, J ENVIRON MANAGE, V87, P497, DOI 10.1016/j.jenvman.2007.01.039; Kingsford RT, 2004, ECOLOGY, V85, P2478, DOI 10.1890/03-0470; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; LOMAN J, 1991, CONSERV BIOL, V5, P176, DOI 10.1111/j.1523-1739.1991.tb00122.x; Ma ZJ, 2010, WETLANDS, V30, P15, DOI 10.1007/s13157-009-0001-6; Macias M, 2004, WATERBIRDS, V27, P234, DOI 10.1675/1524-4695(2004)027[0234:TDOTGI]2.0.CO;2; Marchowski D, 2017, PEERJ, V5, DOI 10.7717/peerj.3604; Marquez-Ferrando R, 2014, BIOL CONSERV, V171, P127, DOI 10.1016/j.biocon.2014.01.022; Martinez-Abrain A, 2016, ARDEOLA, V63, P79, DOI 10.13157/arla.63.1.2016.rp4; Monastersky R, 2014, NATURE, V516, P159, DOI 10.1038/516158a; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nassauer JI, 2004, WETLANDS, V24, P756, DOI 10.1672/0277-5212(2004)024[0756:MTSOMW]2.0.CO;2; Navarro J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159974; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Papazoglou C, 2004, BIRDS EUROPEAN UNION; Paracuellos M, 2004, WATERBIRDS, V27, P446, DOI 10.1675/1524-4695(2004)027[0446:FATDOA]2.0.CO;2; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Pickens BA, 2014, ECOL MODEL, V285, P1, DOI 10.1016/j.ecolmodel.2014.04.013; Prado P, 2014, ESTUAR COAST SHELF S, V139, P1, DOI 10.1016/j.ecss.2013.12.013; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez F, 2015, MAR ECOL PROG SER, V527, P221, DOI 10.3354/meps11282; Ramirez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047551; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Ridgeway G., 2007, GEN BOOSTED MODELS G; Romo S, 2005, FRESHWATER BIOL, V50, P1706, DOI 10.1111/j.1365-2427.2005.01432.x; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Schallenberg M, 2003, MAR ECOL PROG SER, V251, P181, DOI 10.3354/meps251181; Sebastian-Gonzalez E, 2014, RESTOR ECOL, V22, P311, DOI 10.1111/rec.12078; Seoane J, 2004, ECOL MODEL, V171, P209, DOI 10.1016/j.ecolmodel.2003.08.006; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Serrano L, 2008, AQUAT CONSERV, V18, P261, DOI 10.1002/aqc.830; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Sutherland WJ, 2011, TRENDS ECOL EVOL, V26, P10, DOI 10.1016/j.tree.2010.11.002; Tablado Z, 2010, CONSERV BIOL, V24, P1230, DOI 10.1111/j.1523-1739.2010.01483.x; Takekawa JY, 2001, HYDROBIOLOGIA, V466, P317, DOI 10.1023/A:1014546524957; Tavares DC, 2015, BIOL CONSERV, V186, P12, DOI 10.1016/j.biocon.2015.02.027; Toral GM, 2012, BIOL CONSERV, V148, P19, DOI 10.1016/j.biocon.2012.02.001; Tyre AJ, 2001, ECOL APPL, V11, P1722, DOI 10.2307/3061091; Verboom J, 2001, BIOL CONSERV, V100, P89, DOI 10.1016/S0006-3207(00)00210-X; Warnock N, 2002, WATERBIRDS, V25, P79; Waterkeyn A, 2008, FRESHWATER BIOL, V53, P1808, DOI 10.1111/j.1365-2427.2008.02005.x; Wauchope HS, 2017, GLOBAL CHANGE BIOL, V23, P1085, DOI 10.1111/gcb.13404; Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x	76	24	25	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192702	10.1371/journal.pone.0192702	http://dx.doi.org/10.1371/journal.pone.0192702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438428	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400044
J	Taieb, F; Hong, TT; Ho, HT; Thanh, BN; Phuong, TP; Ta, DV; Hong, NLT; Pham, HB; Nguyen, LTH; Nguyen, HT; Nguyen, TT; Tuaillon, E; Delaporte, E; Le Thi, H; Bich, HTT; Nguyen, TA; Madec, Y				Taieb, Fabien; Tram Tran Hong; Hien Thi Ho; Binh Nguyen Thanh; Tram Pham Phuong; Dung Viet Ta; Nhung Le Thi Hong; Hien Ba Pham; Lan Thi Huong Nguyen; Huong Thi Nguyen; Thu Trang Nguyen; Tuaillon, Edouard; Delaporte, Eric; Huong Le Thi; Hau Tran Thi Bich; Tuan Anh Nguyen; Madec, Yoann			First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam	PLOS ONE			English	Article							VIRAL LOAD; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; DRUG-RESISTANCE; SCALE-UP; AFRICA; PLASMA; COHORT; ADULTS; ASSAY	Background Viral load (VL) monitoring of HIV-infected patients in decentralized areas is limited due to logistic constraints. Dried Blood Spots (DBS) offer the opportunity to collect samples in remote area which can be easily transferred and tested at a central laboratory. The MOVIDA (Monitoring Of Viral load In Decentralized Area) project evaluated the performance of VL measurements on DBS using the new CE marked optimized Abbott protocol. Methods HIV-1 infected adults from three outpatient clinics in Hanoi (Vietnam) were enrolled into the study between 1 March and 13 April 2017. VL was measured on DBS using the optimized protocol provided by the manufacturer and compared to plasma VL as reference method on the Abbott m2000rt RealTime HIV-1 platform. Sensitivity was defined as the ability for DBS samples to correctly identify VL failure at the threshold of 1000 copies/mL of plasma, while specificity represented the ability to identify patients with a plasma HIV-RNA VL of <1000 copies/mL. Results A total of 203 patients were enrolled in the study, of which 152 (75%) were male. Median age was 38 [inter quartile range: 34-43] years. Of these patients, 37 were untreated, 38 on ART for <6 months and 117 were on ART for >= 6 months. A strong correlation between VL results in plasma and from DBS was observed (rho = 0.95; p< 0.001). Plasma VL was >= 1000 copies/mL in 71 patients. The sensitivity of DBS was 90.1% (95% confidence interval [CI]: 80.7-95.9) and the specificity was 96.2% (95% CI: 91.4-98.8). Conclusions The new optimized Abbott DBS protocol performed well in this study, meeting the WHO performance criteria for the use of DBS for HIV VL monitoring. Scaling up VL monitoring using DBS can be used to reach the last 90 in the UNAIDS targets of 90-90-90 to help end the AIDS epidemics. However, sensitivity remains the main challenge for manufacturers to prevent maintaining patients in virological failure on inefficient ART.	[Taieb, Fabien; Madec, Yoann] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Taieb, Fabien] Inst Pasteur, Ctr Translat Res, Paris, France; [Tram Tran Hong; Binh Nguyen Thanh; Tram Pham Phuong; Nhung Le Thi Hong; Tuan Anh Nguyen] Natl Inst Hyg & Epidemiol, Virol Lab, HIV AIDS Dept, Hanoi, Vietnam; [Hien Thi Ho; Dung Viet Ta] Hanoi Univ Publ Hlth, HIV AIDS Prevent & Control Dept, Hanoi, Vietnam; [Hien Ba Pham; Lan Thi Huong Nguyen] Dong Da Gen Hosp, Outpatient Clin, Hanoi, Vietnam; [Huong Thi Nguyen] Dong Anh Outpatient Clin, Hanoi, Vietnam; [Thu Trang Nguyen] Nam Tu Liem Outpatient Clin, Hanoi, Vietnam; [Tuaillon, Edouard] Montpellier Univ Hosp, INSERM, Unit Pathogenesis & Control Chron Infect, U1058, Montpellier, France; [Delaporte, Eric] IRD, UMI TransVIHMI 233, Montpellier, France; [Delaporte, Eric] Univ Montpellier I, Montpellier, France; [Huong Le Thi] Vietnam Adm HIV AIDS Control, Hanoi, Vietnam; [Hau Tran Thi Bich] Prov AIDS Ctr Hanoi, Hanoi, Vietnam	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institute of Hygiene & Epidemiology (NIHE); Hanoi University of Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Madec, Y (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.	yoann.madec@pasteur.fr	Delaporte, Eric/J-5397-2018	Delaporte, Eric/0000-0002-1822-9853; Tuaillon, Edouard/0000-0001-5866-9530; HO, Assoc. Prof. Hien/0000-0002-1181-7580	Abbott company	Abbott company	This work was funded by Abbott company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; [Anonymous], 2016, CONGUID UANT DRU; [Anonymous], 2016, PUBL REP; [Anonymous], 2014, 90 90 90 AMBITIOUS T; Arredondo M, 2012, J CLIN MICROBIOL, V50, P569, DOI 10.1128/JCM.00418-11; Bertagnolio S, 2010, AIDS REV, V12, P195; Braun P, 2007, CLIN CHEM LAB MED, V45, P93, DOI 10.1515/CCLM.2007.008; Tran DA, 2014, SEX TRANSM INFECT, V90, P538, DOI 10.1136/sextrans-2013-051353; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Goel N, 2017, J VIROL METHODS, V244, P39, DOI 10.1016/j.jviromet.2017.03.001; Gous N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168244; Gunda Daniel W, 2017, BMC Res Notes, V10, P45, DOI 10.1186/s13104-016-2334-6; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Laprise C, 2013, CLIN INFECT DIS, V57, P1489, DOI 10.1093/cid/cit529; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; Makadzange AT, 2017, J CLIN MICROBIOL; Monleau M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-395; Monleau M, 2014, J CLIN MICROBIOL, V52, P578, DOI 10.1128/JCM.02860-13; Pannus P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005475; Rangarajan S, 2016, J VIRUS ERAD, V2, P94; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rottinghaus E, 2013, J CLIN MICROBIOL, V51, P55, DOI 10.1128/JCM.02002-12; Schmitz ME, 2017, JAIDS-J ACQ IMM DEF, V74, P399, DOI [10.1097/QAI.0000000000001275, 10.1097/qai.0000000000001275]; Sollis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085869; Taieb F, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw142; UNITAID, 2015, HIV AIDS DIAGN TECHN; Vandenhende MA, 2015, AIDS, V29, P373, DOI 10.1097/QAD.0000000000000544; Vidya M, 2012, J VIROL METHODS, V181, P177, DOI 10.1016/j.jviromet.2012.02.006; Waruru A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158881; Zida S, 2016, J CLIN MICROBIOL, V54, P1641, DOI 10.1128/JCM.03372-15	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0191920	10.1371/journal.pone.0191920	http://dx.doi.org/10.1371/journal.pone.0191920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425216	Green Published, gold, Green Submitted			2022-12-26	WOS:000424700800010
J	Engleder, M; Horvat, M; Emmerstorfer-Augustin, A; Wriessnegger, T; Gabriel, S; Strohmeier, G; Weber, H; Muller, M; Kaluzna, I; Mink, D; Schurmann, M; Pichler, H				Engleder, Matthias; Horvat, Melissa; Emmerstorfer-Augustin, Anita; Wriessnegger, Tamara; Gabriel, Stefanie; Strohmeier, Gernot; Weber, Hansjoerg; Mueller, Monika; Kaluzna, Iwona; Mink, Daniel; Schurmann, Martin; Pichler, Harald			Recombinant expression, purification and biochemical characterization of kievitone hydratase from Nectria haematococca	PLOS ONE			English	Article							F-SP PHASEOLI; AMINO-ACID-SEQUENCE; ENZYMATIC-SYNTHESIS; PICHIA-PASTORIS; TERTIARY ALCOHOLS; FUSARIUM; PROTEINS; DETOXIFICATION; PHYTOALEXIN; XANTHOHUMOL	Kievitone hydratase catalyzes the addition of water to the double bond of the prenyl moiety of plant isoflavonoid kievitone and, thereby, forms the tertiary alcohol hydroxy-kievitone. In nature, this conversion is associated with a defense mechanism of fungal pathogens against phytoalexins generated by host plants after infection. As of today, a gene sequence coding for kievitone hydratase activity has only been identified and characterized in Fusarium solani f. sp. phaseoli. Here, we report on the identification of a putative kievitone hydratase sequence in Nectria haematococca (NhKHS), the teleomorph state of F. solani, based on in silico sequence analyses. After heterologous expression of the enzyme in the methylotrophic yeast Pichia pastoris, we have confirmed its kievitone hydration activity and have assessed its biochemical properties and substrate specificity. Purified recombinant NhKHS is obviously a homodimeric glycoprotein. Due to its good activity for the readily available chalcone derivative xanthohumol (XN), this compound was selected as a model substrate for biochemical studies. The optimal pH and temperature for hydratase activity were 6.0 and 35 degrees C, respectively, and apparent V-max and K-m values for hydration of XN were 7.16 mu mol min(-1) mg(-1) and 0.98 +/- 0.13 mM, respectively. Due to its catalytic properties and apparent substrate promiscuity, NhKHS is a promising enzyme for the biocatalytic production of tertiary alcohols.	[Engleder, Matthias; Horvat, Melissa; Emmerstorfer-Augustin, Anita; Wriessnegger, Tamara; Strohmeier, Gernot; Pichler, Harald] Acib Austrian Ctr Ind Biotechnol, Graz, Austria; [Engleder, Matthias; Horvat, Melissa; Gabriel, Stefanie; Pichler, Harald] Graz Univ Technol, Inst Mol Biotechnol, NAWI Graz, BioTechMed Graz, Graz, Austria; [Strohmeier, Gernot; Weber, Hansjoerg] Graz Univ Technol, Inst Organ Chem, NAWI Graz, Graz, Austria; [Mueller, Monika; Kaluzna, Iwona; Mink, Daniel; Schurmann, Martin] DSM Ahead R&D Innovat Synth, Geleen, Netherlands; [Mueller, Monika; Kaluzna, Iwona; Mink, Daniel; Schurmann, Martin] InnoSyn BV, Geleen, Netherlands	Austrian Centre of Industrial Biotechnology; Graz University of Technology; Graz University of Technology; DSM NV	Pichler, H (corresponding author), Acib Austrian Ctr Ind Biotechnol, Graz, Austria.; Pichler, H (corresponding author), Graz Univ Technol, Inst Mol Biotechnol, NAWI Graz, BioTechMed Graz, Graz, Austria.	harald.pichler@tugraz.at	Pichler, Harald/B-5398-2013	Pichler, Harald/0000-0001-6043-2137; Schurmann, Martin/0000-0003-3286-122X; Engleder, Matthias/0000-0002-1064-1018; Emmerstorfer-Augustin, Anita/0000-0002-3392-8839	Das Land Steiermark; Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; Government of Lower Austria; Business Agency Vienna through the COMET Funding Program	Das Land Steiermark; Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; Government of Lower Austria; Business Agency Vienna through the COMET Funding Program	This work has been supported by Das Land Steiermark, the Federal Ministry of Science, Research and Economy (BMWFW), the Federal Ministry of Traffic, Innovation and Technology (bmvit), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol, the Government of Lower Austria and Business Agency Vienna through the COMET Funding Program managed by the Austrian Research Promotion Agency FFG. The co-funder, InnoSyn B.V. provided support in the form of salaries for authors [MM, IK, DM, MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All coauthors with industrial affiliation, i.e. MM, IK, DM, MS, approved of the publication, like all the other authors. The specific roles of all authors are articulated in the 'author contributions' section. The industrial affiliation of MM, IK, DM, MS, did not have any influence whatsoever on the scientific layout of this manuscript.	Albrecht M, 1997, J BIOTECHNOL, V58, P177, DOI 10.1016/S0168-1656(97)00151-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CLEVELAND TE, 1983, PHYSIOL PLANT PATHOL, V22, P129; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Engleder M, 2015, CHEMBIOCHEM, V16, P1730, DOI 10.1002/cbic.201500269; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Faber K., 2011, BIOTRANSFORMATIONS O, V6th; Gerhauser C, 2002, MOL CANCER THER, V1, P959; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; Jahic M, 2006, BIOTECHNOL PROGR, V22, P1465, DOI 10.1021/bp060171t; Jin JF, 2011, CHEM COMMUN, V47, P2502, DOI 10.1039/c0cc04153j; Jo YS, 2014, J AGR FOOD CHEM, V62, P6736, DOI 10.1021/jf501081z; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Kourist R, 2008, CHEMBIOCHEM, V9, P491, DOI 10.1002/cbic.200700688; Kourist R, 2011, APPL MICROBIOL BIOT, V91, P505, DOI 10.1007/s00253-011-3418-9; KUHN PJ, 1979, PHYSIOL PLANT PATHOL, V14, P179, DOI 10.1016/0048-4059(79)90006-7; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; LI DX, 1995, MOL PLANT MICROBE IN, V8, P388, DOI 10.1094/MPMI-8-0388; Liese A., 2006, IND BIOTRANSFORMATIO; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Muller M, 2014, CHEMBIOENG REV, V1, P14, DOI 10.1002/cben.201300005; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Resch V, 2015, CATAL SCI TECHNOL, V5, P1385, DOI 10.1039/c4cy00692e; SANDMANN G, 1994, EUR J BIOCHEM, V223, P7, DOI 10.1111/j.1432-1033.1994.tb18961.x; SMITH DA, 1982, PHYTOPATHOLOGY, V72, P1319, DOI 10.1094/Phyto-72-1319; Song JW, 2013, ANGEW CHEM INT EDIT, V52, P2534, DOI 10.1002/anie.201209187; Tronina T, 2013, BIOORGAN MED CHEM, V21, P2001, DOI 10.1016/j.bmc.2013.01.026; TURBEK CS, 1992, FEMS MICROBIOL LETT, V94, P187, DOI 10.1111/j.1574-6968.1992.tb05312.x; TURBEK CS, 1990, PHYTOCHEMISTRY, V29, P2841, DOI 10.1016/0031-9422(90)87088-C; VONHEIJNE G, 1986, J MOL BIOL, V189, P239, DOI 10.1016/0022-2836(86)90394-3; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wriessnegger T, 2014, METAB ENG, V24, P18, DOI 10.1016/j.ymben.2014.04.001	34	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192653	10.1371/journal.pone.0192653	http://dx.doi.org/10.1371/journal.pone.0192653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420618	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900103
J	Melouane, A; Carbonell, A; Yoshioka, M; Puymirat, J; St-Amand, J				Melouane, Aicha; Carbonell, Antoine; Yoshioka, Mayumi; Puymirat, Jack; St-Amand, Jonny			Implication of SPARC in the modulation of the extracellular matrix and mitochondrial function in muscle cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; COLLAGEN TYPE-I; SKELETAL-MUSCLE; MYOBLAST DIFFERENTIATION; MYOGENIN EXPRESSION; CALCIUM-BINDING; TRANSFORMING GROWTH-FACTOR-BETA-1; ENDOTHELIAL-CELLS; PROCOLLAGEN-I; NULL MICE	Secreted protein, acidic and rich in cysteine (SPARC) is differentially associated with cell proliferation and extracellular matrix (ECM) assembly. We show here the effect of exogenous SPARC inhibition/induction on ECM and mitochondrial proteins expression and on the differentiation of C2C12 cells. The cells were cultured in growth medium (GM) supplemented with different experimental conditions. The differentiation of myoblasts was studied for 5 days, the expressions of ECM and mitochondrial proteins were measured and the formation of the myotubes was quantified after exogenous induction/inhibition of SPARC. The results indicate that the addition of recombinant SPARC protein (rSPARC) in cell culture medium increased the differentiation of C2C12 myoblasts and myogenin expression during the myotube formation. However, the treatment with antibody specific for SPARC (anti-SPARC) prevented the differentiation and decreased myogenin expression. The induction of SPARC in the proliferating and differentiating C2C12 cells increased collagen 1a1 protein expression, whereas the inhibition decreased it. The effects on fibronectin protein expression were opposite. Furthermore, the addition of rSPARC in C2C12 myoblast increased the expression of mitochondrial proteins, ubiquinol-cytochrome c reductase core protein II (UQCRC2) and succinate dehydrogenase iron-sulfur subunit (SDHB), whereas the anti-SPARC decreased them. During the differentiation, only the anti-SPARC had the effects on mitochondrial proteins, NADH dehydrogenase ubiquinone 1 beta subcomplex subunit 8 (NADHB8), SDHB and cytochrome c oxidase 1 (MTCO1). Thus, SPARC plays a crucial role in the proliferation and differentiation of C2C12 and may be involved in the link between the ECM remodeling and mitochondrial function.	[Melouane, Aicha; Yoshioka, Mayumi; St-Amand, Jonny] CHU Quebec Res Ctr, CREMI, Quebec City, PQ, Canada; [Melouane, Aicha; St-Amand, Jonny] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada; [Carbonell, Antoine; Puymirat, Jack] CHU Quebec, Res Ctr, Human Genet Unit, Quebec City, PQ, Canada; [Carbonell, Antoine; Puymirat, Jack] Laval Univ, Fac Med, Dept Med, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	St-Amand, J (corresponding author), CHU Quebec Res Ctr, CREMI, Quebec City, PQ, Canada.; St-Amand, J (corresponding author), Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada.	jonny.st-amand@crchudequebec.ulaval.ca			Canadian Institute of Health Research [133669]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research 133669 to JS and JP, http://www.cihr-irsc.gc.ca/e/37788. html<https://webmail.chuq.qc.ca/owa/redir.aspx? C=bc30cc15bf6a41a68308331095652a6f&URL=http%3a%2f%2fwww.cihr-irsc.gc.ca%2fe%2f37788.html>.	AMPHLETT GW, 1983, BIOCHEM BIOPH RES CO, V111, P1045, DOI 10.1016/0006-291X(83)91405-5; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Bassuk JA, 1999, EXP EYE RES, V68, P321, DOI 10.1006/exer.1998.0608; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P163, DOI 10.1007/s12079-009-0069-z; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Brown Karen E., 1995, Seminars in Developmental Biology, V6, P69, DOI 10.1016/S1044-5781(06)80016-2; BRUNETTI A, 1990, J BIOL CHEM, V265, P5960; Cachaco AS, 2005, DEV DYNAM, V232, P1069, DOI 10.1002/dvdy.20280; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; CHEN LB, 1977, CELL, V10, P393, DOI 10.1016/0092-8674(77)90026-5; Cho WJ, 2000, BIOCHEM BIOPH RES CO, V271, P630, DOI 10.1006/bbrc.2000.2682; CHUNG CY, 1990, J CELL PHYSIOL, V142, P392, DOI 10.1002/jcp.1041420224; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; de Cavanagh EMV, 2009, AM J PHYSIOL-HEART C, V296, pH550, DOI 10.1152/ajpheart.01176.2008; Dourdin N, 1997, EXP CELL RES, V235, P385, DOI 10.1006/excr.1997.3684; Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002; Emerson CP, 1990, CURR OPIN CELL BIOL, V2, P1065, DOI 10.1016/0955-0674(90)90157-A; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; Eslami Anna, 2010, J Vis Exp, DOI 10.3791/2359; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; HAUSCHKA SD, 1966, P NATL ACAD SCI USA, V55, P119, DOI 10.1073/pnas.55.1.119; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211; Hjorth M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12473; Huynh MH, 1999, DEV GROWTH DIFFER, V41, P407; IruelaArispe ML, 1996, DEV DYNAM, V207, P171, DOI 10.1002/(SICI)1097-0177(199610)207:2<171::AID-AJA5>3.0.CO;2-E; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jorgensen LH, 2009, J HISTOCHEM CYTOCHEM, V57, P29, DOI 10.1369/jhc.2008.951954; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Katz BZ, 1997, BIOCHIMIE, V79, P467, DOI 10.1016/S0300-9084(97)82738-1; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Levene CI, 1971, P ROY SOC MED, V64, P240; Liu YP, 2013, GUT, V62, P810, DOI 10.1136/gutjnl-2012-303235; Lund DK, 2013, FEBS J, V280, P4089, DOI 10.1111/febs.12171; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; MCDONALD JA, 1988, ANNU REV CELL BIOL, V4, P183, DOI 10.1146/annurev.cb.04.110188.001151; MCLENNAN IS, 1993, DEV DYNAM, V197, P281, DOI 10.1002/aja.1001970406; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Mercurius KO, 1998, CIRC RES, V82, P548, DOI 10.1161/01.RES.82.5.548; Milasincic DJ, 1996, MOL CELL BIOL, V16, P5964; MOON KY, 1994, J BIOL CHEM, V269, P7651; Motamed K, 2002, J CELL BIOCHEM, V84, P759, DOI 10.1002/jcb.10095; MURPHYULLRICH JE, 1995, J CELL BIOCHEM, V57, P341, DOI 10.1002/jcb.240570218; NANDAN D, 1990, J CELL BIOL, V110, P1673, DOI 10.1083/jcb.110.5.1673; Ono Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182040; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; PODLESKI TR, 1979, EXP CELL RES, V122, P317, DOI 10.1016/0014-4827(79)90308-2; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Riedl I, 2010, EXP GERONTOL, V45, P896, DOI 10.1016/j.exger.2010.08.014; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAITOH O, 1992, EXP CELL RES, V200, P70, DOI 10.1016/S0014-4827(05)80072-2; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Song HY, 2010, BIOCHEM BIOPH RES CO, V396, P961, DOI 10.1016/j.bbrc.2010.05.033; Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Taylor SC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/361590; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Velleman SG, 1999, DEV GROWTH DIFFER, V41, P153; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zamurs LK, 2015, J BIOL CHEM, V290, P4272, DOI 10.1074/jbc.M114.632208	76	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192714	10.1371/journal.pone.0192714	http://dx.doi.org/10.1371/journal.pone.0192714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420632	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900109
J	Steiniger, BS; Ulrich, C; Berthold, M; Guthe, M; Lobachev, O				Steiniger, Birte S.; Ulrich, Christine; Berthold, Moritz; Guthe, Michael; Lobachev, Oleg			Capillary networks and follicular marginal zones in human spleens. Three-dimensional models based on immunostained serial sections	PLOS ONE			English	Article							SPLENIC WHITE PULP; B-CELLS; LYMPHOID ORGANS; RECONSTRUCTION; MIGRATION; ANTIGEN; NORMALIZATION; HETEROGENEITY; COMPARTMENTS; RESPONSES	We have reconstructed small parts of capillary networks in the human splenic white pulp using serial sections immunostained for CD34 alone or for CD34 and CD271. The three-dimensional (3D) models show three types of interconnected networks: a network with very few long capillaries inside the white pulp originating from central arteries, a denser network surrounding follicles plus periarterial T-cell regions and a network in the red pulp. Capillaries of the perifollicular network and the red pulp network have open ends. Perifollicular capillaries form an arrangement similar to a basketball net located in the outer marginal zone. The marginal zone is defined by MAdCAM-1(+) marginal reticular stromal cells. Perifollicular capillaries are connected to red pulp capillaries surrounded by CD271(+) stromal capillary sheath cells. The scarcity of capillaries inside the splenic white pulp is astonishing, as non-polarised germinal centres with proliferating B-cells occur in adult human spleens. We suggest that specialized stromal marginal reticular cells form a barrier inside the splenic marginal zone, which together with the scarcity of capillaries guarantees the maintenance of gradients necessary for positioning of migratory B-and T-lymphocytes in the human splenic white pulp.	[Steiniger, Birte S.] Univ Marburg, Inst Anat & Cell Biol, Marburg, Germany; [Ulrich, Christine] Univ Marburg, Inst Psychol, Marburg, Germany; [Berthold, Moritz; Guthe, Michael; Lobachev, Oleg] Univ Bayreuth, Inst Comp Sci, Bayreuth, Germany	Philipps University Marburg; Philipps University Marburg; University of Bayreuth	Steiniger, BS (corresponding author), Univ Marburg, Inst Anat & Cell Biol, Marburg, Germany.; Lobachev, O (corresponding author), Univ Bayreuth, Inst Comp Sci, Bayreuth, Germany.	steinigb@staff.uni-marburg.de; oleg.lobachev@uni-bayreuth.de	Lobachev, Oleg/F-2843-2012	Lobachev, Oleg/0000-0002-7193-6258; Steiniger, Birte/0000-0002-3602-7331	DFG; University Bayreuth; Philipps-University Marburg	DFG(German Research Foundation (DFG)); University Bayreuth; Philipps-University Marburg	We shall receive funding of open access publication by a joint programme of of DFG, University Bayreuth and Philipps-University Marburg. At present, the study is not specifically funded.	Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; Bradski G., 2008, LEARNING OPENCV COMP; Carata L., 2011, P 27 SPRING C COMPUT, P103; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Egger J, 2017, PLOS ONE, V12, P1; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363, DOI 10.1007/3-540-45103-x_50; Fasnacht N, 2014, J EXP MED, V211, P2265, DOI 10.1084/jem.20132528; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; GRAY D, 1984, IMMUNOLOGY, V52, P659; Hammad H, 2017, NAT IMMUNOL, V18, P313, DOI 10.1038/ni.3657; Ju T, 2004, ACM T GRAPHIC, V23, P888, DOI 10.1145/1015706.1015815; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Khan AM, 2014, IEEE T BIO-MED ENG, V61, P1729, DOI 10.1109/TBME.2014.2303294; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Kusumi S, 2015, BIOMED RES-TOKYO, V36, P195, DOI 10.2220/biomedres.36.195; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Lobachev O, 2017, SPRING C CO IN PRESS; Lobachev O, 2017, MED IMAGE ANAL, V35, P288, DOI 10.1016/j.media.2016.07.010; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Ma B, 2008, MICRON, V39, P967, DOI 10.1016/j.micron.2007.10.007; NIEUWENHUIS P, 1976, CELL IMMUNOL, V23, P254, DOI 10.1016/0008-8749(76)90191-X; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; OLAH I, 1982, AM J ANAT, V165, P445, DOI 10.1002/aja.1001650408; OLAH I, 1984, J LEUKOCYTE BIOL, V35, P501; Olah I, 2008, AVIAN IMMUNOLOGY, P13, DOI 10.1016/B978-012370634-8.50005-6; Onder D, 2014, APPL IMMUNOHISTO M M, V22, P713, DOI 10.1097/PAI.0000000000000003; Reinhard E, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.946629; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SNOOK T, 1964, ANAT RECORD, V148, P149, DOI 10.1002/ar.1091480205; Steiniger B, 2003, J HISTOCHEM CYTOCHEM, V51, P655, DOI 10.1177/002215540305100511; Steiniger B, 2005, IMMUNOLOGY, V116, P429, DOI 10.1111/j.1365-2567.2005.02242.x; Steiniger B, 2000, MICROANATOMY FUNCTIO, P15; Steiniger B, 2007, HISTOCHEM CELL BIOL, V128, P391, DOI 10.1007/s00418-007-0320-8; Steiniger B, 2006, HISTOCHEM CELL BIOL, V126, P641, DOI 10.1007/s00418-006-0210-5; Steiniger B, 2011, J HISTOCHEM CYTOCHEM, V59, P639, DOI 10.1369/0022155411408315; Steiniger BS, 2015, IMMUNOLOGY, V145, P334, DOI 10.1111/imm.12469; Steiniger BS, 2014, IMMUNOLOGY, V143, P462, DOI 10.1111/imm.12325; Steiniger BS, 2014, HISTOCHEM CELL BIOL, V141, P507, DOI 10.1007/s00418-013-1172-z; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Turner VM, 2017, IMMUNOLOGY, V151, P349, DOI 10.1111/imm.12737; Ulrich C., 2014, WSCG 2014 COMM PAP P, P361; Ulrich C., 2014, P 4 EUROGRAPHICS WOR, P69, DOI DOI 10.2312/VCBM.20141185; VEERMAN AJP, 1975, CELL TISSUE RES, V156, P417, DOI 10.1007/BF00225103	54	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191019	10.1371/journal.pone.0191019	http://dx.doi.org/10.1371/journal.pone.0191019			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420557	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900009
J	de Leon, MJ; Pirraglia, E; Osorio, RS; Glodzik, L; Saint-Louis, L; Kim, HJ; Fortea, J; Fossati, S; Laska, E; Siegel, C; Butler, T; Li, Y; Rusinek, H; Zetterberg, H; Blennow, K				de Leon, Mony J.; Pirraglia, Elizabeth; Osorio, Ricardo S.; Glodzik, Lidia; Saint-Louis, Les; Kim, Hee-Jin; Fortea, Juan; Fossati, Silvia; Laska, Eugene; Siegel, Carole; Butler, Tracy; Li, Yi; Rusinek, Henry; Zetterberg, Henrik; Blennow, Kaj		Alzheimer's Dis Neuroimaging; Natl Alzheimer's Coordinating Ctr	The nonlinear relationship between cerebrospinal fluid A beta(42) and tau in preclinical Alzheimer's disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; HYPOTHETICAL MODEL; DYNAMIC BIOMARKERS; CSF BIOMARKERS; AGE; DEPOSITION; A-BETA-42; ADULTS; STANDARDIZATION; CLEARANCE	Cerebrospinal fluid (CSF) studies consistently show that CSF levels of amyloid-beta 1-42 (A beta(42)) are reduced and tau levels increased prior to the onset of cognitive decline related to Alzheimer's disease (AD). However, the preclinical prediction accuracy for low CSF A beta(42) levels, a surrogate for brain A beta(42) deposits, is not high. Moreover, the pathology data suggests a course initiated by tauopathy contradicting the contemporary clinical view of an A beta initiated cascade. CSF A beta(42) and tau data from 3 normal aging cohorts (45-90 years) were combined to test both cross-sectional (n = 766) and longitudinal (n = 651) hypotheses: 1) that the relationship between CSF levels of A beta(42) and tau are not linear over the adult life-span; and 2) that non-linear models improve the prediction of cognitive decline. Supporting the hypotheses, the results showed that a u-shaped quadratic fit (A beta(2)) best describes the relationship for CSF A beta(42) with CSF tau levels. Furthermore we found that the relationship between A beta(42) and tau changes with age-between 45 and 70 years there is a positive linear association, whereas between 71 and 90 years there is a negative linear association between A beta(42) and tau. The quadratic effect appears to be unique to A beta(42), as A beta(38) and A beta(40) showed only positive linear relationships with age and CSF tau. Importantly, we observed the prediction of cognitive decline was improved by considering both high and low levels of A beta(42). Overall, these data suggest an earlier preclinical stage than currently appreciated, marked by CSF elevations in tau and accompanied by either elevations or reductions in A beta(42). Future studies are needed to examine potential mechanisms such as failing CSF clearance as a common factor elevating CSF A beta(xx) analyte levels prior to A beta(42) deposition in brain.	[de Leon, Mony J.; Pirraglia, Elizabeth; Osorio, Ricardo S.; Glodzik, Lidia; Fossati, Silvia; Laska, Eugene; Siegel, Carole; Butler, Tracy; Li, Yi] NYU Med Ctr, Dept Psychiat, Ctr Brain Hlth, New York, NY 10016 USA; [Pirraglia, Elizabeth] NYU Med Ctr, Dept Populat Hlth, Div Biostat, New York, NY 10016 USA; [Osorio, Ricardo S.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Glodzik, Lidia; Rusinek, Henry] NYU Med Ctr, Dept Radiol, New York, NY 10016 USA; [Saint-Louis, Les] Lennox Hill Radiol, New York, NY USA; [Kim, Hee-Jin] Hanyang Univ, Dept Neurol, Memory Unit, Seoul, South Korea; [Fortea, Juan] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Univ Hosp, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UK Dementia Res Inst, London, England	New York University; New York University; Nathan Kline Institute for Psychiatric Research; New York University; Hanyang University; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of London; University College London	de Leon, MJ (corresponding author), NYU Med Ctr, Dept Psychiat, Ctr Brain Hlth, New York, NY 10016 USA.	Mony.deLeon@nyumc.org	Kim, Hee-Jin/P-1903-2015; Fortea, Juan/AFU-3179-2022; de Leon, Mony/AAP-7890-2021	Kim, Hee-Jin/0000-0001-7880-690X; Fortea, Juan/0000-0002-1340-638X; Pirraglia, Elizabeth/0000-0003-0419-559X; de Leon, Mony/0000-0003-2245-4380; Fossati, Silvia/0000-0002-2047-222X; Siegel, Carole/0000-0002-7460-788X; li, yi/0000-0002-3875-3513; Laska, Eugene/0000-0001-6799-1361	National Institutes of Health [AG13616, AG022374, AG12101, AG057570, AG032554, HL118624, AG049348, HL111724]; National Institute on Aging [U01 AG024904, W81XWH 12 2 0012]; National Institute of Biomedical Imaging and Bioengineering [U01 AG024904, W81XWH 12 2 0012]; AbbVie [U01 AG024904, W81XWH 12 2 0012]; Alzheimer's Association [U01 AG024904, W81XWH 12 2 0012]; Alzheimer's Drug Discovery Foundation [U01 AG024904, W81XWH 12 2 0012]; Araclon Biotech [U01 AG024904, W81XWH 12 2 0012]; BioClinica, Inc. [U01 AG024904, W81XWH 12 2 0012]; Biogen [U01 AG024904, W81XWH 12 2 0012]; Bristol Myers Squibb Company [U01 AG024904, W81XWH 12 2 0012]; CereSpir, Inc. [U01 AG024904, W81XWH 12 2 0012]; Cogstate [U01 AG024904, W81XWH 12 2 0012]; Eisai Inc. [U01 AG024904, W81XWH 12 2 0012]; Elan Pharmaceuticals, Inc.; [U01 AG024904, W81XWH 12 2 0012]; Eli Lilly and Company [U01 AG024904, W81XWH 12 2 0012]; Eurolmmun [U01 AG024904, W81XWH 12 2 0012]; F. Hoffmann La Roche Ltd [U01 AG024904, W81XWH 12 2 0012]; Genentech, Inc. [U01 AG024904, W81XWH 12 2 0012]; Fujirebio [U01 AG024904, W81XWH 12 2 0012]; GE Healthcare [U01 AG024904, W81XWH 12 2 0012]; IXICO Ltd. [U01 AG024904, W81XWH 12 2 0012]; Janssen Alzheimer I mmunotherapy Research & Development, LLC. [U01 AG024904, W81XWH 12 2 0012]; Johnson & Johnson Pharmaceutical Research & Development LLC. [U01 AG024904, W81XWH 12 2 0012]; Lumosity [U01 AG024904, W81XWH 12 2 0012]; Lundbeck [U01 AG024904, W81XWH 12 2 0012]; Merck Co., Inc. [U01 AG024904, W81XWH 12 2 0012]; Meso Scale Diagnostics, LLC. [U01 AG024904, W81XWH 12 2 0012]; NeuroRx Research [U01 AG024904, W81XWH 12 2 0012]; Neurotrack Technologies [U01 AG024904, W81XWH 12 2 0012]; Novartis Pharmaceuticals Corporation [U01 AG024904, W81XWH 12 2 0012]; Pfizer Inc. [U01 AG024904, W81XWH 12 2 0012]; Piramal Imaging [U01 AG024904, W81XWH 12 2 0012]; Servier [U01 AG024904, W81XWH 12 2 0012]; Takeda Pharmaceutical Company [U01 AG024904, W81XWH 12 2 0012]; Transition Therapeutics [U01 AG024904, W81XWH 12 2 0012]; Canadian Institutes of Health Research; NIA/NIH Grant [U01 AG016976]; Swedish Research Council [2017-00915, 2013-2546]; Swedish Alzheimer Foundation [AF 553101]; Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences LUA/ALF VGR project [ALFGBG-715986]; European Research Council [681712]; Knut and Alice Wallenberg Foundation [2013HZ]; NIA [P30 AG019610, P30, AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146];  [P50 AG005134];  [P50 AG016574];  [P50];  [AG005138];  [P30 AG008051];  [AG013854];  [P30 AG008017];  [AG010161];  [P50 AG047366];  [P30 AG010129];  [P50 AG016573];  [P50 AG016570];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]; NATIONAL INSTITUTE ON AGING [P30AG008051, U01AG016976, R01AG022374, R21AG049348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.;; Eli Lilly and Company(Eli Lilly); Eurolmmun; F. Hoffmann La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIA/NIH Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Alzheimer Foundation; Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences LUA/ALF VGR project; European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The NYU study was supported by National Institutes of Health (https://urldefense. proofpoint.com/v2/url?u=https-3A_www.nih.gov_&d=DwlGaQ&c=j5oPp00e8H1iio48Dtsedb OBGma15iFiLigvtN2r4ell&r=pgURDIMRVf FwMnUonrj4ZXYtKgxaWlxc-LhDyy62ZY&m=0awcrQ4Elao5w1T8t14JaTKdfOlcYFIzbq3 DM0qkasC8&s=f6hj-5HuGxw-GZ0d2LM6hs ZWXmo865oZPLb1OvKITLs&e=) grants AG13616 (MdeL), AG022374 (MdeL), AG12101 (MdeL), AG057570 (MdeL), AG032554 (MdeL), HL118624 (RSO), AG049348 (RSO), HL111724 (LG). The Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH 12 2 0012) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.friiii.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The NACC database is funded by NIA/NIH Grant U01 AG016976. Kaj Blennow and Henrik Zetterberg received funding from the Swedish Research Council grants 2017-00915 (KB) and 2013-2546 (HZ), the Swedish Alzheimer Foundation grant AF 553101 (KB), the Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences LUA/ALF VGR project ALFGBG-715986 (KB), the European Research Council grant 681712 (HZ), and the Knut and Alice Wallenberg Foundation grant 2013HZ (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NACC data are contributed by the NIA funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30, AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688, (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133, (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134, (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50, AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30, AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30, AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI Marie Francoise Chesselet, MD, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), and P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Blennow K, 2013, MED CLIN N AM, V97, P369, DOI 10.1016/j.mcna.2012.12.012; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Braak H, 2013, ACTA NEUROPATHOL; de Leon MJ, 2017, J NUCL MED, V58, P1471, DOI 10.2967/jnumed.116.187211; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glodzik-Sobanska L, 2009, NEUROBIOL AGING, V30, P672, DOI 10.1016/j.neurobiolaging.2007.08.019; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P51, DOI 10.1001/archneurol.2011.235; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kakuda N, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0477-x; Lauridsen C, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00210; Maia LF, 2015, EMBO MOL MED, V7, P895, DOI 10.15252/emmm.201505026; Mattsson N, 2015, JAMA NEUROL, V72, P554, DOI 10.1001/jamaneurol.2014.4530; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Paternico D, 2012, ALZHEIMERS DEMENT, V8, P520, DOI 10.1016/j.jalz.2011.10.003; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; REISBERG B, 1993, AM J PSYCHIAT, V150, P680; Roe CM, 2013, NEUROLOGY, V80, P1784, DOI 10.1212/WNL.0b013e3182918ca6; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shoji M, 2001, NEUROBIOL AGING, V22, P209, DOI 10.1016/S0197-4580(00)00229-3; Sjogren M, 2001, CLIN CHEM, V47, P1776; Spiegel J, 2016, J ALZHEIMERS DIS, V49, P93, DOI 10.3233/JAD-150167; Sutphen CL, 2015, JAMA NEUROL, V72, P1029, DOI 10.1001/jamaneurol.2015.1285; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Tijms BM, 2017, ANN NEUROL, V81, P749, DOI 10.1002/ana.24921; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3	36	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191240	10.1371/journal.pone.0191240	http://dx.doi.org/10.1371/journal.pone.0191240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415068	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300018
J	Raynor, EJ; Powell, LA; Schacht, WH				Raynor, Edward J.; Powell, Larkin A.; Schacht, Walter H.			Present and future thermal environments available to Sharp-tailed Grouse in an intact grassland	PLOS ONE			English	Article							EVAPORATIVE COOLING CAPACITY; OPERATIVE TEMPERATURE; VEGETATION STRUCTURE; HABITAT SELECTION; CLIMATE-CHANGE; WATER-LOSS; THERMOREGULATION; BEHAVIOR; ECOLOGY; TOLERANCE	Better understanding animal ecology in terms of thermal habitat use has become a focus of ecological studies, in large part due to the predicted temperature increases associated with global climate change. To further our knowledge on how ground-nesting endotherms respond to thermal landscapes, we examined the thermal ecology of Sharp-tailed Grouse (Tympanuchus phasianellus) during the nesting period. We measured site-specific iButton temperatures (T-iB) and vegetation characteristics at nest sites, nearby random sites, and landscape sites to assess thermal patterns at scales relevant to nesting birds. We asked if microhabitat vegetation characteristics at nest sites matched the characteristics that directed macrohabitat nest-site selection. Grouse selected sites sheltered by dense vegetation for nesting that moderated TiB on average up to 2.7 degrees C more than available landscape sites. Successful nests were positioned in a way that reduced exposure to thermal extremes by as much as 4 degrees C relative to failed nests with an overall mean daytime difference (+/- SE) of 0.4 +/- 0.03 degrees C. We found that macrohabitat nest-site selection was guided by dense vegetation cover and minimal bare ground as also seen at the microhabitat scale. Global climate projections for 2080 suggest that TiB at nest sites may approach temperatures currently avoided on the landscape, emphasizing a need for future conservation plans that acknowledge fine-scale thermal space in climate change scenarios. These data show that features of grassland landscapes can buffer organisms from unfavorable microclimatic conditions and highlight how thermal heterogeneity at the individual-level can drive decisions guiding nest site selection.	[Raynor, Edward J.; Powell, Larkin A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Raynor, Edward J.; Schacht, Walter H.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Raynor, EJ (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.; Raynor, EJ (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	edwardraynor@gmail.com	Raynor, Edward/J-8717-2015; Powell, Larkin A/G-4570-2010	Raynor, Edward/0000-0003-2483-4694; 	Nebraska Game & Parks Commission	Nebraska Game & Parks Commission	LAP and WHS received funding from Nebraska Game & Parks Commission for this project.	Albright TP, 2017, P NATL ACAD SCI USA, V114, P2283, DOI 10.1073/pnas.1613625114; Anderson DB, 1936, ECOLOGY, V17, P277, DOI 10.2307/1931468; Angilletta MJ, 2009, ECOLOGY, V90, P2933, DOI 10.1890/08-2224.1; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beever EA, 2015, CONSERVATION LETT; Beever EA, 2013, ECOLOGY, V94, P1563, DOI 10.1890/12-2174.1; Bleed AS, 1998, ATLAS SAND HILLS CON; Bragg T. B, 1996, PRAIRIE CONSERVATION, P53; BUHNERKEMPE JE, 1984, WILDLIFE SOC B, V12, P382; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carroll JM, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00163.1; Carroll JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118467; Connelly J. W., 1998, BIRDS N AM; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Dallmann Josiah D., 2016, Great Plains Research, V26, P117; Deeming C., 2002, AVIAN INCUBATION BEH; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Elmore RD, 2017, WILDLIFE SOC B, V41, P183, DOI 10.1002/wsb.772; EVANS KE, 1975, CONDOR, V77, P160, DOI 10.2307/1365786; Gillis H, 2012, CAN J ZOOL, V90, P694, DOI 10.1139/Z2012-035; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Grisham BA, 2016, CONDOR, V118, P728, DOI 10.1650/CONDOR-16-38.1; Grisham BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068225; Gunderson AR, 2012, FUNCT ECOL, V26, P783, DOI 10.1111/j.1365-2435.2012.01987.x; Guthery FS, 2005, WILDLIFE MONOGR, P1; Hamerstrom F, 1957, GUIDE PRAIRIE CHICKE; Hansell MH, 2002, OX ORN SER, V13, P8; Hepp GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047777; Hovick TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00340.1; Huey R.B., 1991, American Naturalist, V137, P91; HUEY RB, 1974, SCIENCE, V184, P1001, DOI 10.1126/science.184.4140.1001; JOHNSON DB, 1988, J WILDLIFE MANAGE, V52, P464, DOI 10.2307/3801592; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; KOBRIGER GERALD D., 1965, J WILDLIFE MANAGE, V29, P788, DOI 10.2307/3798555; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Long RA, 2014, ECOL MONOGR, V84, P513, DOI 10.1890/13-1273.1; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Matthews TW, 2013, J WILDLIFE MANAGE, V77, P1202, DOI 10.1002/jwmg.564; McKechnie AE, 2016, J EXP BIOL, V219, P2137, DOI 10.1242/jeb.139733; Melin M, 2014, GLOBAL CHANGE BIOL, V20, P1115, DOI 10.1111/gcb.12405; Monteith J., 2007, PRINCIPLES ENV PHYS; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Noakes MJ, 2016, J EXP BIOL, V219, P859, DOI 10.1242/jeb.132001; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Powell LA, 2014, EC305; Prose BL., 1987, HABITAT SUITABILITY; R Core Team, 2021, R LANGUAGE ENV STAT; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; RICHARDS SA, 1976, J AGR SCI, V87, P527, DOI 10.1017/S002185960003313X; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Rowe JW, 2014, J THERM BIOL, V40, P9, DOI 10.1016/j.jtherbio.2013.12.002; Sato CF, 2014, J APPL ECOL, V51, P13, DOI 10.1111/1365-2664.12168; Sauer JR, 2017, N AM BREEDING BIRD S; SCHROEDER MA, 1991, J FIELD ORNITHOL, V62, P378; Sliwinski MS, 2017, MANAGING WILDLIFE HA; Sliwinski MS, 2017, THESIS; Sohl TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112251; Street GM, 2016, LANDSCAPE ECOL, V31, P1939, DOI 10.1007/s10980-016-0372-z; Swinehart JB., 1990, ATLAS SAND HILLS RES, P43; Tanner EP, 2016, GLOBAL CHANGE BIOL; Therneau T., 2015, PACKAGE SURVIVAL ANA; Tuff KT, 2016, ECOL LETT, V19, P361, DOI 10.1111/ele.12579; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Vaudo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061907; Walsberg GE, 1996, J THERM BIOL, V21, P275, DOI 10.1016/S0306-4565(96)00017-4; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Wiebe KL, 2000, BEHAV ECOL SOCIOBIOL, V48, P463; Wiens J.A., 1985, P169; Winder VL, 2018, J WILDLIFE MANAGE, V82, P113, DOI 10.1002/jwmg.21331; Winder VL, 2016, J ORNITHOL, V157, P733, DOI 10.1007/s10336-016-1330-x; Wolf BO, 1996, J EXP BIOL, V199, P451	79	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191233	10.1371/journal.pone.0191233	http://dx.doi.org/10.1371/journal.pone.0191233			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415080	gold, Green Published			2022-12-26	WOS:000424325300017
J	Akuffo, AA; Alontaga, AY; Metcalf, R; Beatty, MS; Becker, A; McDaniel, JM; Hesterberg, RS; Goodheart, WE; Gunawan, S; Ayaz, M; Yang, Y; Karim, MR; Orobello, ME; Daniel, K; Guida, W; Yoder, JA; Rajadhyaksha, AM; Schonbrunn, E; Lawrence, HR; Lawrence, NJ; Epling-Burnette, PK				Akuffo, Afua A.; Alontaga, Aileen Y.; Metcalf, Rainer; Beatty, Matthew S.; Becker, Andreas; McDaniel, Jessica M.; Hesterberg, Rebecca S.; Goodheart, William E.; Gunawan, Steven; Ayaz, Muhammad; Yang, Yan; Karim, Md Rezaul; Orobello, Morgan E.; Daniel, Kenyon; Guida, Wayne; Yoder, Jeffrey A.; Rajadhyaksha, Anjali M.; Schonbrunn, Ernst; Lawrence, Harshani R.; Lawrence, Nicholas J.; Epling-Burnette, Pearlie K.			Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA CELLS; UBIQUITIN LIGASE; ANTITUMOR-ACTIVITY; MYELODYSPLASTIC SYNDROMES; THALIDOMIDE ANALOGS; DATA-BANK; T-CELLS; LENALIDOMIDE; TARGET; POMALIDOMIDE	Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereblon (CRBN) promotes proteosomal destruction by engaging the DDB1-CUL4A-Roc1-RBX1 E3 ubiquitin ligase in human cells but not in mouse cells, suggesting that sequence variations in CRBN may cause its inactivation. Therapeutically, CRBN engagers have the potential for broad applications in cancer and immune therapy by specifically reducing protein expression through targeted ubiquitin-mediated degradation. To examine the effects of defined sequence changes on CRBN's activity, we performed a comprehensive study using complementary theoretical, biophysical, and biological assays aimed at understanding CRBN's nonprimate sequence variations. With a series of recombinant thalidomide-binding domain (TBD) proteins, we show that CRBN sequence variants retain their drug-binding properties to both classical immunomodulatory drugs and dBET1, a chemical compound and targeting ligand designed to degrade bromodomain-containing4(BRD4) via a CRBN-dependent mechanism. We further show that dBET1 stimulates CRBN's E3 ubiquitin-conjugating function and degrades BRD4 in both mouse and humancells. This insight paves the way for studies of CRBN-dependent proteasome-targeting molecules in nonprimate models and provides a new understanding of CRBN's substrate-recruiting function.	[Akuffo, Afua A.; Alontaga, Aileen Y.; Beatty, Matthew S.; McDaniel, Jessica M.; Hesterberg, Rebecca S.; Goodheart, William E.; Orobello, Morgan E.; Epling-Burnette, Pearlie K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Becker, Andreas; Yang, Yan; Lawrence, Harshani R.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL 33612 USA; [Gunawan, Steven; Ayaz, Muhammad; Karim, Md Rezaul; Schonbrunn, Ernst; Lawrence, Nicholas J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Metcalf, Rainer; Daniel, Kenyon; Guida, Wayne] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Akuffo, Afua A.; Hesterberg, Rebecca S.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA; [Yoder, Jeffrey A.] North Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27607 USA; [Rajadhyaksha, Anjali M.] Weill Cornell Med, Grad Program Neurosci, Brain & Mind Res Inst, Pediat Neurol,Pediat,Mol & Dev Neurosci Lab, New York, NY 10065 USA; [McDaniel, Jessica M.] Celgene Corp, 556 Morris Ave, Summit, NJ 07901 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of North Carolina; North Carolina State University; Cornell University; Bristol-Myers Squibb; Celgene Corporation	Epling-Burnette, PK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, SRB 23033, Tampa, FL 33612 USA.	Pearlie.Burnette@moffitt.org	Karim, Rezaul M./H-7930-2016	Karim, Rezaul M./0000-0002-0424-127X; Schonbrunn, Ernst/0000-0002-3589-3510; Hesterberg, Rebecca/0000-0003-0472-7517; Yoder, Jeffrey/0000-0002-6083-1311	NCI (National Institutes of Health)-designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [R50CA211447, P30CA076292] Funding Source: NIH RePORTER	NCI (National Institutes of Health)-designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	hCRBN-DDB1 protein complex and the antiCRBN antibody were generous gifts from Celgene Corp. (San Diego, CA). Multiple myeloma cell lines were provided by Drs. Kenneth Shain and Connor Lynch (Moffitt Cancer Center). Wealso thank John Cleveland, Ph.D. (Moffitt Cancer Center) for his expert opinion and assistance with manuscript preparation. The Chemical Biology Core Facility at the H. Lee Moffitt Cancer Center and Research Institute, is an NCI (National Institutes of Health)-designated Comprehensive Cancer Center (Grant P30-CA076292).	Arora M, 2016, THER ADV HEMATOL, V7, P209, DOI 10.1177/2040620716652861; Bargagna-Mohan P, 2005, BIOORG MED CHEM LETT, V15, P2724, DOI 10.1016/j.bmcl.2005.04.008; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bjorklund CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.66; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Diggle GE, 2001, INT J CLIN PRACT, V55, P627; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Fang J, 2016, NAT MED, V22, P727, DOI 10.1038/nm.4127; Fionda C, 2015, ONCOTARGET, V6, P23609, DOI 10.18632/oncotarget.4603; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; FRATTA ID, 1965, TOXICOL APPL PHARM, V7, P268, DOI 10.1016/0041-008X(65)90095-5; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Gopalakrishnan R, 2016, ONCOGENE, V35, P1797, DOI 10.1038/onc.2015.245; Hagner PR, 2015, BLOOD, V126, P779, DOI 10.1182/blood-2015-02-628669; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lebraud H, 2016, ACS CENTRAL SCI, V2, P927, DOI 10.1021/acscentsci.6b00280; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Lindner S, 2016, J MOL MED, V94, P1327, DOI 10.1007/s00109-016-1450-z; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mailloux AW, 2012, J IMMUNOL, V189, P3198, DOI 10.4049/jimmunol.1200602; Martin MP, 2012, CHEMBIOCHEM, V13, P2128, DOI 10.1002/cbic.201200316; McDaniel JM, 2012, LEUKEMIA, V26, P1425, DOI 10.1038/leu.2011.359; Min Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.226; O'Brien S, 2014, J IMMUNOL, V192, P5118, DOI 10.4049/jimmunol.1301992; Otahal P, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1115940; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Rajadhyaksha AM, 2012, BEHAV BRAIN RES, V226, P428, DOI 10.1016/j.bbr.2011.09.039; Robak T, 2016, SEMIN ONCOL, V43, P280, DOI 10.1053/j.seminoncol.2016.02.010; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Saenz DT, 2017, LEUKEMIA, V31, P1951, DOI 10.1038/leu.2016.393; Sakamoto KM, 2010, PEDIATR RES, V67, P505, DOI 10.1203/PDR.0b013e3181d35017; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Sun YP, 2015, BLOOD, V125, P2724, DOI 10.1182/blood-2014-08-598037; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang X, 2016, BIOCHEM PHARMACOL, V116, P200, DOI 10.1016/j.bcp.2016.07.017; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Zeldis JB, 1999, CLIN THER, V21, P319, DOI 10.1016/S0149-2918(00)88289-2; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhou B, 2018, J MED CHEM, V61, P462, DOI 10.1021/acs.jmedchem.6b01816	55	23	28	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6187	6200		10.1074/jbc.M117.816868	http://dx.doi.org/10.1074/jbc.M117.816868			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29449372	Green Published, hybrid			2022-12-26	WOS:000430497300034
J	Eom, H; Park, Y; Kim, J; Yang, JS; Kang, H; Kim, K; Chun, BC; Park, O; Hong, JI				Eom, HyeEun; Park, YoungJoon; Kim, JooWhee; Yang, Jeong-Sun; Kang, HaeJi; Kim, Kisoon; Chun, Byung Chul; Park, Ok; Hong, Jeong Ik			Occurrence of measles in a country with elimination status: Amplifying measles infection in hospitalized children due to imported virus	PLOS ONE			English	Article							UNITED-STATES; SOUTH-KOREA; OUTBREAK; EPIDEMIOLOGY; ERADICATION	The Republic of Korea declared measles elimination in 2006. However, a measles outbreak occurred in 2013. This study aimed to identify the epidemiological characteristics of the sources of infection and the pattern of measles transmission in 2013 in South Korea. We utilized surveillance data, epidemiological data, immunization registry data, and genetic information. We describe the epidemiological characteristics of all measles case patients (sex, age distribution, vaccination status, sources of infection) as well as details of the outbreak (the pattern of transmission, duration, mean age of patients, and generation time). In 2013, a total of 107 measles cases were notified. Most patients were infants (43.0%) and unvaccinated individuals (60.7%). We identified 4 imported and 103 import-related cases. A total of 105 cases were related to four outbreaks that occurred in Gyeongnam, northern Gyeonggi, southern Gyeonggi, and Seoul. The predominant circulating genotype was B3 type, which was identified in the Gyeongnam, northern Gyeonggi, and southern Gyeonggi outbreaks. The B3 type had not been in circulation in South Korea in the previous 3 years; virologic evidence suggests that these outbreaks were import-related. Most measles cases in South Korea have been associated with imported measles virus. Although Korea has maintained a high level of herd immunity, clustering of susceptible people can cause such measles outbreaks.	[Eom, HyeEun; Park, YoungJoon; Kim, JooWhee; Park, Ok; Hong, Jeong Ik] Korea Ctr Dis Control & Prevent, Div Vaccine Preventable Dis Control, Cheongju, Chungcheongbuk, South Korea; [Eom, HyeEun; Park, YoungJoon; Kim, JooWhee; Park, Ok; Hong, Jeong Ik] Korea Ctr Dis Control & Prevent, Natl Immunizat Program, Cheongju, Chungcheongbuk, South Korea; [Yang, Jeong-Sun; Kang, HaeJi; Kim, Kisoon] Korea Natl Inst Hlth, Div Resp Viruses, Cheongju, Chungcheongbuk, South Korea; [Chun, Byung Chul] Korea Univ, Med Coll, Dept Prevent Med, Seoul, South Korea; [Kim, Kisoon] Korea Natl Inst Hlth, Div Influenza Virus, Cheongju, Chungcheongbuk, South Korea; [Park, Ok] Div HIV AIDS & TB Control, Cheongju, Chungcheongbuk, South Korea; [Hong, Jeong Ik] Korea Ctr Dis Control & Prevent, Div Publ Hlth Preparedness & Response, Cheongju, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea University; Korea University Medicine (KU Medicine); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea Centers for Disease Control & Prevention (KCDC)	Chun, BC (corresponding author), Korea Univ, Med Coll, Dept Prevent Med, Seoul, South Korea.	Chun@korea.ac.kr	Chun, Byung Chul/AGO-1458-2022; Chun, Byung Chul/AGO-1390-2022	Chun, Byung Chul/0000-0001-6576-8916; Chun, Byung Chul/0000-0001-6576-8916				Andrus JK, 2011, VACCINE, V29, pD91, DOI 10.1016/j.vaccine.2011.04.059; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P118; [Anonymous], OECD HLTH DAT; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Choe YJ, 2012, JPN J INFECT DIS, V65, P371, DOI 10.7883/yoken.65.371; Choi WS, 2011, J INFECT DIS S1, pS483; Eom HS, 2013, PHWR, V6, P41; Fiebelkorn AP, 2010, J INFECT DIS, V202, P1520, DOI 10.1086/656914; Kim ES, 2012, VACCINE, V30, P3355, DOI 10.1016/j.vaccine.2012.03.073; Klinkenberg D, 2011, J THEOR BIOL, V284, P52, DOI 10.1016/j.jtbi.2011.06.015; Korea Centers for Disease Control and Prevention Chungnam National University, 2013, REP 2013 KOR NAT IMM; Lee J-K, 2007, Morbidity and Mortality Weekly Report, V56, P304; Lee KY, 2007, J INFECTION, V54, P167, DOI 10.1016/j.jinf.2006.02.016; Leuridan E, 2010, BMJ, V340, pc1626, DOI 10.1136/bmj.c1626; Levin A, 2011, J INFECT DIS, V204, pS98, DOI 10.1093/infdis/jir096; McLean Huong, 2012, Morbidity and Mortality Weekly Report, V61, P253; Oster NV, 2004, J INFECT DIS, V189, pS48, DOI 10.1086/374854; Park YJ, 2013, JPN J INFECT DIS, V66, P6, DOI 10.7883/yoken.66.6; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; World Health Organization, 4 W PAC COUNTR AR 1; World Health Organization Regional Office for the Western Pacific, 2013, GUID VER MEASL EL W; Yip FY, 2004, J INFECT DIS, V189, pS54, DOI 10.1086/379377; 이호동, 2002, Infection and Chemotherapy, V34, P89; 이호동, 2002, Infection and Chemotherapy, V34, P94	24	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0188957	10.1371/journal.pone.0188957	http://dx.doi.org/10.1371/journal.pone.0188957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447169	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900002
J	Janssen, R; Moisik, SR; Dediu, D				Janssen, Rick; Moisik, Scott R.; Dediu, Dan			Modelling human hard palate shape with Bezier curves	PLOS ONE			English	Article							CLEFT-LIP; NORMAL INDIVIDUALS; VOCAL-TRACT; SOFT PALATE; POPULATION; DIMENSIONS; HEIGHT; MORPHOLOGY; GENETICS; DISTANCE	People vary at most levels, from the molecular to the cognitive, and the shape of the hard palate (the bony roof of the mouth) is no exception. The patterns of variation in the hard palate are important for the forensic sciences and (palaeo) anthropology, and might also play a role in speech production, both in pathological cases and normal variation. Here we describe a method based on Bezier curves, whose main aim is to generate possible shapes of the hard palate in humans for use in computer simulations of speech production and language evolution. Moreover, our method can also capture existing patterns of variation using few and easy-to-interpret parameters, and fits actual data obtained from MRI traces very well with as little as two or three free parameters. When compared to the widely-used Principal Component Analysis (PCA), our method fits actual data slightly worse for the same number of degrees of freedom. However, it is much better at generating new shapes without requiring a calibration sample, its parameters have clearer interpretations, and their ranges are grounded in geometrical considerations.	[Janssen, Rick; Moisik, Scott R.; Dediu, Dan] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Moisik, Scott R.] Nanyang Technol Univ, Linguist & Multilingual Studies, Singapore, Singapore; [Dediu, Dan] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Max Planck Society; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Radboud University Nijmegen	Dediu, D (corresponding author), Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands.; Dediu, D (corresponding author), Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	Dan.Dediu@mpi.nl	Dediu, Dan/E-3279-2012; Moisik, Scott/AAF-9003-2020	Dediu, Dan/0000-0002-0704-6365; Moisik, Scott/0000-0003-1540-1790	Netherlands Organisation for Scientific Research (NWO) VIDI grant [276-70-022]	Netherlands Organisation for Scientific Research (NWO) VIDI grant(Netherlands Organization for Scientific Research (NWO))	This work is part of the "Genetic biases in language and speech project" funded by the Netherlands Organisation for Scientific Research (NWO; http://www.nwo.nl) VIDI grant 276-70-022 to DD and hosted by the Max Planck Institute for Psycholinguistics, Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the ArtiVarK participants, David Norris and Paul Gaalman (Donders Institute for Brain, Cognition and Behaviour, Nijmegen) for access to the Avanto 1.5T MRI scanner and help with piloting, Carly Jaques for participant recruitment and management, and Sabine Kooijman for assistance with obtaining the ethical approval. This work is part of the G[3]bils (Genetic biases in language and speech) project funded by the Netherlands Organisation for Scientific Research (NWO) VIDI grant 276-70-022 to DD.	[Anonymous], BEZ CURV; Banzhaf W., 1997, GENETIC PROGRAMMING; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; Bates TC, 2011, BEHAV GENET, V41, P50, DOI 10.1007/s10519-010-9402-9; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Birkholz P., 2005, 3D ARTIKULATORISCHE; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Bourdiol P, 2010, J ORAL REHABIL, V37, P100, DOI 10.1111/j.1365-2842.2009.02024.x; Brunner J., 2006, P 7 INT SEM SPEECH P, P247; Brunner J, 2009, J ACOUST SOC AM, V125, P3936, DOI 10.1121/1.3125313; Bugaighis I, 2010, EUROPEAN J ORTHODONT; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Byers SN, 1997, J FORENSIC SCI, V42, P3; Chovalopoulou ME, 2013, ANTHROPOL ANZ, V70, P407, DOI 10.1127/0003-5548/2013/0363; D'Souza AS, 2012, BIOMED RES-INDIA, V23, P173; Dediu D, 2016, LANGUAGE COMMUNICATI; Dediu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045198; Dellavia C, 2007, EUR J ORTHODONT, V29, P417, DOI 10.1093/ejo/cjm026; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Durand C, 2013, NAT REV ENDOCRINOL, V9, P171, DOI 10.1038/nrendo.2012.251; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Farin G., 2002, HDB COMPUTER AIDED G; Ferrario Virgilio F, 2002, Int J Adult Orthodon Orthognath Surg, V17, P51; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fuchs S., 2005, ZAS PAP, V42, P43, DOI [10.21248/zaspil.42.2005.273, DOI 10.21248/ZASPIL.42.2005.273]; Gick B., 2013, ARTICULATORY PHONETI; HARSHMAN R, 1977, J ACOUST SOC AM, V62, P693, DOI 10.1121/1.381581; HASSANALI J, 1984, ANAT REC, V209, P273, DOI 10.1002/ar.1092090213; HIKI S, 1986, SPEECH COMMUN, V5, P141, DOI 10.1016/0167-6393(86)90004-X; Jobling M, 2014, HUMAN EVOLUTIONARY GENETICS, SECOND EDITION, P1; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kaifu Y, 2003, YEARB PHYS ANTHROPOL, V46, P47, DOI 10.1002/ajpa.10329; Kumar DK, 2011, J CLIN DIAGN RES, V5, P1310; Lammert A., 2011, 12 ANN C INT SPEECH; Lammert A, 2011, P 9 INT SEM SPEECH P; Lammert A, 2013, J SPEECH LANG HEAR R, V56, P521, DOI 10.1044/1092-4388(2012/12-0059); Leslie EJ, 2013, AM J MED GENET C, V163, P246, DOI 10.1002/ajmg.c.31381; Lloyd J., 2012, SOFT ISSUE BIOMECHAN, P355, DOI DOI 10.1002/hed.23909; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; MANTEL N, 1967, CANCER RES, V27, P209; MATLAB, 2012, MATLAB STAT TOOLB RE; Moisik SR, J LANGUAGE IN PRESS; Online Mendelian Inheritance in Man OMIM, 2015, ONL MEND INH MAN OMI; Panchal G., 2010, INT J COMPUT APPL, V1, P41, DOI DOI 10.5120/126-242; Patel SR, 2008, EUR RESPIR J, V32, P1304, DOI 10.1183/09031936.00029808; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Praveen B, 2011, WORLD J DENT, V2, P207; Python Software Foundation, PYTH LANG REF VERS 2; R Core Team, 2013, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; REYNOSO MC, 1986, HUM GENET, V74, P200, DOI 10.1007/BF00282095; RIQUELME A, 1970, ANGLE ORTHOD, V40, P71; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rstudio Team, 2015, RSTUDIO INT DEV R; RStudio Team, 2011, MAN INT PLOTS RSTUDI; Schabenberger O., 2005, STAT METHODS SPATIAL; Stanier P, 2004, HUM MOL GENET, V13, pR73, DOI 10.1093/hmg/ddh052; Tiede M.K., 2004, J ACOUST SOC AM, V115, P2633, DOI [10.1121/1.4784878, DOI 10.1121/1.4784878]; Tiede Mark K, 2005, J ACOUST SOC AM, V117, P2568, DOI DOI 10.1121/1.4788555; Townsend G C, 1990, J Forensic Odontostomatol, V8, P3; van Reenen J F, 1987, J Dent Assoc S Afr, V42, P489; von Cramon-Taubadel N, 2011, P NATL ACAD SCI USA, V108, P19546, DOI 10.1073/pnas.1113050108; Vorperian HK, 1999, INT J PEDIATR OTORHI, V49, P197, DOI 10.1016/S0165-5876(99)00208-6; Weirich M., 2010, LINGUIST, V52, P19; Weirich M., 2011, P ISSP, P251; WINKLER EM, 1993, HUM BIOL, V65, P139; You M, 2008, DENTOMAXILLOFAC RAD, V37, P344, DOI 10.1259/dmfr/55898096; YOUNES S, 1995, J ORAL REHABIL, V22, P391, DOI 10.1111/j.1365-2842.1995.tb00790.x; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zhou X., 2007, INTERSPEECH, P54	71	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191557	10.1371/journal.pone.0191557	http://dx.doi.org/10.1371/journal.pone.0191557			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447175	Green Published, gold			2022-12-26	WOS:000425283900015
J	Kong, JS; Lee, YK; Kim, MK; Choi, MK; Heo, YR; Hyun, T; Kim, SM; Lyu, ES; Oh, SY; Park, HR; Rhee, MY; Ro, HK; Song, MK				Kong, Ji-Sook; Lee, Yeon-Kyung; Kim, Mi Kyung; Choi, Mi-Kyeong; Heo, Young-Ran; Hyun, Taisun; Kim, Sun Mee; Lyu, Eun-Soon; Oh, Se-Young; Park, Hae-Ryun; Rhee, Moo-Yong; Ro, Hee-Kyong; Song, Mi Kyung			Estimation model for habitual 24-hour urinary-sodium excretion using simple questionnaires from normotensive Koreans	PLOS ONE			English	Article							SALT INTAKE; POTASSIUM EXCRETION; BLOOD-PRESSURE; ADULTS; HEALTH; VALIDATION; CREATININE; SPECIMEN; JAPANESE; SAMPLES	This study was conducted to develop an equation for estimation of 24-h urinary-sodium excretion that can serve as an alternative to 24-h dietary recall and 24-h urine collection for normotensive Korean adults. In total, data on 640 healthy Korean adults aged 19 to 69 years from 4 regions of the country were collected as a training set. In order to externally validate the equation developed from that training set, 200 subjects were recruited independently as a validation set. Due to heterogeneity by gender, we constructed a gender-specific equation for estimation of 24-h urinary-sodium excretion by using a multivariable linear regression model and assessed the performance of the developed equation in validation set. The best model consisted of age, body weight, dietary behavior ('eating salty food', 'Kimchi consumption', 'Korean soup or stew consumption', 'soy sauce or red pepper paste consumption'), and smoking status in men, and age, body weight, dietary behavior ('salt preference', 'eating salty food', 'checking sodium content for processed foods', 'nut consumption'), and smoking status in women, respectively. When this model was tested in the external validation set, the mean bias between the measured and estimated 24-h urinary-sodium excretion from Bland-Altman plots was -1.92 (95% CI: -113, 110) mmol/d for men and -1.51 (95% CI: -90.6, 87.6) mmol/d for women. The cut-points of sodium intake calculated based on the equations were >= 4,000 mg/d for men and >= 3,500 mg/d for women, with 89.8 and 76.6% sensitivity and 29.3 and 64.2% specificity, respectively. In this study, a habitual 24-hour urinary-sodium-excretion-estimation model of normotensive Korean adults based on anthropometric and lifestyle factors was developed and showed feasibility for an asymptomatic population.	[Kong, Ji-Sook; Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Prevent, Goyang, Gyeonggi, South Korea; [Lee, Yeon-Kyung] Kyungpook Natl Univ, Dept Food Sci & Nutr, Daegu, South Korea; [Choi, Mi-Kyeong] Kongju Natl Univ, Div Food Sci, Yesan, South Korea; [Heo, Young-Ran] Chonnam Natl Univ, Dept Food & Nutr, Gwangju, South Korea; [Hyun, Taisun] Chungbuk Natl Univ, Dept Food & Nutr, Cheongju, South Korea; [Kim, Sun Mee] Korea Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Lyu, Eun-Soon] Pukyong Natl Univ, Dept Food Sci & Nutr, Busan, South Korea; [Oh, Se-Young] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea; [Park, Hae-Ryun] Myongji Univ, Dept Food & Nutr, Yongin, South Korea; [Rhee, Moo-Yong] Dongguk Univ Ilsan Hosp, Cardiovasc Ctr, Goyang, Gyeonggi, South Korea; [Ro, Hee-Kyong] Dongshin Univ, Dept Food & Nutr, Naju, South Korea; [Song, Mi Kyung] Natl Canc Ctr, Biometr Res Branch, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Goyang, South Korea; [Song, Mi Kyung] Natl Canc Ctr, Biostat Collaborat Unit, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Goyang, South Korea; [Song, Mi Kyung] Natl Canc Ctr, Goyang, Gyeonggi, South Korea	National Cancer Center - Korea (NCC); Kyungpook National University; Kongju National University; Chonnam National University; Chungbuk National University; Korea University; Korea University Medicine (KU Medicine); Pukyong National University; Kyung Hee University; Myongji University; Dongguk University; Dongshin University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol & Prevent, Goyang, Gyeonggi, South Korea.	alrud@ncc.re.kr		Kong, Ji-Sook/0000-0002-4085-2158	Ministry of Food and Drug Safety, Korea [14162MFDS136]; National Cancer Center, Korea [1610210]	Ministry of Food and Drug Safety, Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Cancer Center, Korea	The present study was financially supported by a grant (14162MFDS136) from the Ministry of Food and Drug Safety, Korea, and by a grant (1610210) from the National Cancer Center, Korea. The authors received no specific funding for this work.	Allen NB, 2017, AM J EPIDEMIOL, V186, P149, DOI 10.1093/aje/kwx056; Alles B, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040225; [Anonymous], 1988, BMJ, V297, P319; Bates CJ, 1999, EUR J CLIN NUTR, V53, P694, DOI 10.1038/sj.ejcn.1600834; Blackburn G L, 1977, JPEN J Parenter Enteral Nutr, V1, P11, DOI 10.1177/014860717700100111; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2013, AM J EPIDEMIOL, V177, P1180, DOI 10.1093/aje/kwt066; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Centers for Disease Control, 2010, MMWR-MORBID MORTAL W, V59, P746; Cianciaruso B, 1998, MINER ELECTROL METAB, V24, P296, DOI 10.1159/000057385; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; FORTE JG, 1989, J HUM HYPERTENS, V3, P179; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Hashimoto T, 2008, INTERNAL MED, V47, P399, DOI 10.2169/internalmedicine.47.0622; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Itoh R, 1999, EUR J CLIN NUTR, V53, P886, DOI 10.1038/sj.ejcn.1600871; Jeong YeonSeon, 2014, Korean Journal of Community Nutrition, V19, P537, DOI 10.5720/kjcn.2014.19.6.537; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kim HJ, 2007, ASIA PAC J CLIN NUTR, V16, P122; Kim HyunHee, 2012, Korean Journal of Community Nutrition, V17, P38; Koo HS, 2014, J KOREAN MED SCI, V29, pS97, DOI 10.3346/jkms.2014.29.S2.S97; Korea Centers for Disease Control and Prevention, 2015, 6 KOR NAT HLTH NUTR; Lee H, 2016, BRIT J NUTR, V115, P666, DOI 10.1017/S0007114515004717; LIU K, 1979, AM J EPIDEMIOL, V110, P219, DOI 10.1093/oxfordjournals.aje.a112806; Mage DT, 2008, J EXPO SCI ENV EPID, V18, P360, DOI 10.1038/sj.jes.7500614; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; Melse-Boonstra A, 1999, EUR J CLIN NUTR, V53, P281, DOI 10.1038/sj.ejcn.1600723; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Ortega RM, 2011, BRIT J NUTR, V105, P787, DOI 10.1017/S000711451000423X; Peng YG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149655; Rhee MY, 2014, NUTRIENTS, V6, P2360, DOI 10.3390/nu6062360; Rhodes DG, 2013, AM J CLIN NUTR, V97, P958, DOI 10.3945/ajcn.112.044982; SCHACHTER J, 1980, HYPERTENSION, V2, P695, DOI 10.1161/01.HYP.2.5.695; Son SookMee, 2007, Korean Journal of Community Nutrition, V12, P838; Son SookMee, 2005, Korean Journal of Community Nutrition, V10, P677; Son SookMee, 2007, Korean Journal of Community Nutrition, V12, P545; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Uechi K, 2017, ASIA PAC J CLIN NUTR, V26, P769, DOI 10.6133/apjcn.092016.05; WHO, 2012, GUID SOD INT AD CHIL; World Health Organization, 2006, RED SALT INT POP REP; Yang BG, 2013, 11135215900031301 KO; 신은경, 2008, Journal of Nutrition and Health, V41, P184	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192588	10.1371/journal.pone.0192588	http://dx.doi.org/10.1371/journal.pone.0192588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447201	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900037
J	Svefors, P; Selling, KE; Shaheen, R; Khan, AI; Persson, LA; Lindholm, L				Svefors, Pernilla; Selling, Katarina Ekholm; Shaheen, Rubina; Khan, Ashraful Islam; Persson, Lars-Ake; Lindholm, Lars			Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting: Analysis of data from the MINIMat randomized trial, Bangladesh	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; CHILD UNDERNUTRITION; FOLIC-ACID; SUPPLEMENTATION; IRON; PREGNANCY; OUTCOMES; WEIGHT	Introduction Nutrition interventions may have favourable as well as unfavourable effects. The Maternal and Infant Nutrition Interventions in Matlab (MINIMat), with early prenatal food and micronutrient supplementation, reduced infant mortality and were reported to be very cost-effective. However, the multiple micronutrients (MMS) supplement was associated with an increased risk of stunted growth in infancy and early childhood. This unfavourable outcome was not included in the previous cost-effectiveness analysis. The aim of this study is to evaluate whether the MINIMat interventions remain cost-effective in view of both favourable (decreased under-five-years mortality) and unfavourable (increased stunting) outcomes. Method Pregnant women in rural Bangladesh, where food insecurity still is prevalent, were randomized to early (E) or usual (U) invitation to be given food supplementation and daily doses of 30 mg, or 60 mg iron with 400 mu g of folic acid, or MMS with 15 micronutrients including 30 mg iron and 400 mu g of folic acid. E reduced stunting at 4.5 years compared with U, MMS increased stunting at 4.5 years compared with Fe60, while the combination EMMS reduced infant mortality compared with UFe60. The outcome measure used was disability adjusted life years (DALYs), a measure of overall disease burden that combines years of life lost due to premature mortality (under five-year mortality) and years lived with disability (stunting). Incremental cost effectiveness ratios were calculated using cost data from already published studies. Results By incrementing UFe60 (standard practice) to EMMS, one DALY could be averted at a cost of US$24. Conclusion When both favourable and unfavourable outcomes were included in the analysis, early prenatal food and multiple micronutrient interventions remained highly cost effective and seem to be meaningful from a public health perspective.	[Svefors, Pernilla; Selling, Katarina Ekholm; Shaheen, Rubina; Persson, Lars-Ake] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden; [Khan, Ashraful Islam] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Persson, Lars-Ake] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Lindholm, Lars] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Uppsala University; International Centre for Diarrhoeal Disease Research (ICDDR); University of London; London School of Hygiene & Tropical Medicine; Umea University	Svefors, P (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden.	pernilla.svefors@kbh.uu.se		Svefors, Pernilla/0000-0003-2612-2973; Persson, Lars Ake/0000-0003-0710-7954	icddr,b; Swedish International Development Cooperation Agency (Sida); UK Medical Research Council; Swedish Research Council; Department for International Development (DFID); Japan Society for the Promotion of Science; Child Health and Nutrition Research Initiative (CHNRI); Uppsala University; United States Agency for International Development (USAID); United Nations Children's Fund (UNICEF)	icddr,b; Swedish International Development Cooperation Agency (Sida); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Department for International Development (DFID); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Child Health and Nutrition Research Initiative (CHNRI); Uppsala University; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); United Nations Children's Fund (UNICEF)	The MINIMat research study was funded by icddr,b, United Nations Children's Fund (UNICEF), Swedish International Development Cooperation Agency (Sida), UK Medical Research Council, Swedish Research Council, Department for International Development (DFID), Japan Society for the Promotion of Science, Child Health and Nutrition Research Initiative (CHNRI), Uppsala University and United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2015, ANN HUM BIOL, V15, P1; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Borghi J, 2005, LANCET, V366, P1882, DOI 10.1016/S0140-6736(05)67758-6; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; de Onis M, 2006, WHO IRIS WHO CHILD G; Devakumar D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0633-3; Ekstrom EC, 2016, INT J EPIDEMIOL, V45, P1656, DOI 10.1093/ije/dyw199; Fall CHD, 2009, FOOD NUTR BULL, V30, pS533, DOI 10.1177/15648265090304S408; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Haider BA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub4; Haider BA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S19; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S17; International Centre for Diarrhoeal Disease Research Bangladesh (ICDDR B), 2003, HLTH DEM SURV SYST M; International Centre for Diarrhoeal Disease Research Bangladesh (ICDDR B), 2010, HLTH DEM SURV SYST M; Khan AI, 2015, MATERN CHILD NUTR, V11, P385, DOI 10.1111/mcn.12021; Khan MM, 2003, PUBLIC HEALTH NUTR, V6, P19, DOI 10.1079/PHN2002359; Kramer MS, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000032; LeFevre AE, 2013, B WORLD HEALTH ORGAN, V91, P736, DOI 10.2471/BLT.12.117127; Margetts BM, 2009, FOOD NUTR BULL, V30, pS517, DOI 10.1177/15648265090304S406; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Menon P, 2016, MATERN CHILD NUTR, V12, P169, DOI 10.1111/mcn.12257; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2011, BANGL DEM HLTH SURV; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Persson LA, 2017, FASEB J, V31; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; Puett C, 2013, HEALTH POLICY PLANN, V28, P386, DOI 10.1093/heapol/czs070; Rahman S, 2016, PUBLIC HEALTH NUTR, V19, P1862, DOI 10.1017/S1368980015003651; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Shaheen R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-5; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; Stein AD, 2005, MATERN CHILD NUTR, V1, P177, DOI 10.1111/j.1740-8709.2005.00021.x; Svefors P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149700; The World Bank, 2015, CONS PRIC IND 1986 2; Tiwari AKM, 2011, CLIN NUTR, V30, P188, DOI 10.1016/j.clnu.2010.08.001; WHO, 2016, WHO TECH REP SER, V997, P1; WHO, 2012, WHO GUID DAIL IR FOL; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2008, The global burden of disease: 2004 update; Ziaei S, 2016, J NUTR, V146, P2520, DOI 10.3945/jn.116.235994	43	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191260	10.1371/journal.pone.0191260	http://dx.doi.org/10.1371/journal.pone.0191260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447176	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000425283900011
J	Tilahun, M; Ameni, G; Desta, K; Zewude, A; Yamuah, L; Abebe, M; Aseffa, A				Tilahun, Melaku; Ameni, Gobena; Desta, Kassu; Zewude, Aboma; Yamuah, Lawrence; Abebe, Markos; Aseffa, Abraham			Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis estrains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia	PLOS ONE			English	Article							RESISTANCE; STRAINS	Introduction Tuberculosis (TB) is caused by M. tuberculosis complex and remains a major global public health problem. The epidemic remains a threat to sub-Saharan Africa, including Ethiopia, with further emergence of drug resistant TB. We investigated the drug sensitivity pattern and molecular epidemiology of mycobacterial strains isolated from pulmonary TB patients in and around Ambo town in Oromia Region, Central Ethiopia. Methods A cross-sectional study was conducted involving 105 consecutive new smear positive pulmonary TB patients diagnosed at Ambo Hospital and surrounding Health Centers between May 2014 and March 2015 upon informed consent. Sputum samples were cultured on Low wenstein-Jensen (LJ) media using standard techniques to isolate mycobacteria. Region of difference 9 (RD9)-based polymerase chain reaction (PCR) and spoligotyping was employed for the identification of the isolates at species and strain levels. The spoligotype patterns were entered into the SITVIT database to determine Octal and SIT (Spoligotyping International Typing) numbers for each strain. The sensitivity of the isolates to isoniazid (INH), rifampicin (RIF), ethambutol (ETB) and streptomycin (STM) was evaluated on LJ-medium with the indirect proportion method. Results Cultures were positive in 86/105 (82%) of newly diagnosed smear positive pulmonary TB cases. All of the 86 isolates were confirmed as M. tuberculosis. The majority (76.7%) of them were clustered into seven groups while the rest (23.3%) appeared unique. The most predominant Spoligotypes were SIT53 and SIT149, consisting of 24.4% and 20.9% of the isolates, respectively. Assigning of the isolates to family using SPOTCLUST software revealed that 45.3% of the isolates belonged to T1, 23.3% to T3 and 13% to CAS family. The majority (76.7%) of the M. tuberculosis isolates were susceptible to all the four drugs. Any resistance to any one of the four drugs was detected in 23.3% of the isolates. The highest proportion of any resistance was observed against isoniazid (9.3%) and ethambutol (7%). There was only a single case (1.2%) of multidrug resistant/rifampicin resistant (MDR/RR) TB. Conclusion The majority of the isolates were clustered suggesting on-going active transmission in the study area. Mono resistance is relatively prevalent while the magnitude of MDR/RR-TB was found to be lower than in previous studies.	[Tilahun, Melaku; Zewude, Aboma; Yamuah, Lawrence; Abebe, Markos; Aseffa, Abraham] AHRI, Addis Ababa, Ethiopia; [Tilahun, Melaku; Desta, Kassu] Addis Ababa Univ, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Ameni, Gobena] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Tilahun, M (corresponding author), AHRI, Addis Ababa, Ethiopia.; Tilahun, M (corresponding author), Addis Ababa Univ, Dept Med Lab Sci, Addis Ababa, Ethiopia.	melatila@yahoo.com	Kempker, Russell/F-5776-2017; Aseffa, Abraham/J-3248-2016; Ameni, Gobena/AAR-4201-2020; zewude, Aboma/AAE-3970-2021	Aseffa, Abraham/0000-0002-8028-1150; Ameni, Gobena/0000-0003-3987-0671; zewude, Aboma/0000-0001-6087-0129; Tilahun, Melaku/0000-0002-3101-3926	AHRI core budget; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	AHRI core budget; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work is supported by AHRI core budget. AHRI Receives core support from Sida, Norad and the Government of Ethiopia.	Abate Dereje, 2012, BMC Res Notes, V5, P462, DOI 10.1186/1756-0500-5-462; Abebe Gemeda, 2012, BMC Res Notes, V5, P225, DOI 10.1186/1756-0500-5-225; Adane K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1933-9; Belay M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238532; Deribew A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-54; Esmael A, 2014, J CLIN DIAGN RES, V2, P102; Garedew L, 2013, INT J TUBERC LUNG D, V17, P1076, DOI 10.5588/ijtld.12.0854; Gebremedhin Gebrezgabiher, 2015, Asian Pacific Journal of Tropical Disease, V5, P329, DOI 10.1016/S2222-1808(14)60792-1; Getahun M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2105-7; Hussein B, 2013, AFRI J MICROBIOL RES, V7, P791; Kamal M, 2015, PAKISTAN J CHEST MED, V19; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lukoye D, 2014, ANTIMICROBIAL AGENTS; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Magana-Arachchi DN, 2013, EPIDEMIOLOGY MULTIDR; Maru M, 2015, TUBERCULOSIS RES TRE, V2015, P1; Massi MN, 2011, INT J TUBERC LUNG D, V15, P489, DOI 10.5588/ijtld.09.0730; Mbugi EV, 2014, TUBERCULOSIS; Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235; Mihret A, 2013, AFR HEALTH SCI, V12, P339; Minstry of Health, 2014, GUID PROGR MAN DRUG; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Seyoum B, 2014, TUBERCULOSIS RES TRE, V2014; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sougakoff W, 2011, CLIN MICROBIOL INFEC, V17, P800, DOI 10.1111/j.1469-0691.2011.03577.x; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Tessema B, 2012, INT J TUBERC LUNG D, V16, P805, DOI 10.5588/ijtld.11.0522; Tessema B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-37; TESSIERSHERMAN B, 2013, BMC INFECT DIS, V13, P96863, DOI DOI 10.1186/1471-2458-13-51; Uzoewulu N, 2014, J MED MICROB DIAGN, V3; Villa-Rosas C, 2015, SALUD PUBLICA MEXICO, V57, P177; Wedajo Wassihun, 2014, BMC Res Notes, V7, P512, DOI 10.1186/1756-0500-7-512; Weldegebreal S, 2017, INT J TUBERC LUNG D, V21, P18, DOI 10.5588/ijtld.16.0286; WHO, 2003, GUID SURV DRUG RES T; World Health Organization, GLOB TUB REP 2016; World Health organization, 2014, GLOB LAB IN ADV TB D	36	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193083	10.1371/journal.pone.0193083	http://dx.doi.org/10.1371/journal.pone.0193083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447273	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900110
J	Markle, CE; Chow-Fraser, G; Chow-Fraser, P				Markle, Chantel E.; Chow-Fraser, Gillian; Chow-Fraser, Patricia			Long-term habitat changes in a protected area: Implications for herpetofauna habitat management and restoration	PLOS ONE			English	Article							ELAPHE-OBSOLETA-OBSOLETA; FRESH-WATER TURTLES; SNAKES; SELECTION; FRAGMENTATION; ECOLOGY; CANADA; THERMOREGULATION; CONSERVATION; POPULATIONS	Point Pelee National Park, located at the southern-most tip of Canada's mainland, historically supported a large number of herpetofauna species; however, despite nearly a century of protection, six snake and five amphibian species have disappeared, and remaining species- at-risk populations are thought to be in decline. We hypothesized that long-term changes in availability and distribution of critical habitat types may have contributed to the disappearance of herpetofauna. To track habitat changes we used aerial image data spanning 85 years (1931 +/- 2015) and manually digitized and classified image data using a standardized framework. Change-detection analyses were used to evaluate the relative importance of proportionate loss and fragmentation of 17 habitat types. Marsh habitat diversity and aquatic connectivity has declined since 1931. The marsh matrix transitioned from a graminoid and forb shallow marsh interspersed with water to a cattail dominated marsh, altering critical breeding, foraging, and overwintering habitat. Reduced diversity of marsh habitats appears to be linked to the expansion of invasive Phragmites australis, which invaded prior to 2000. Loss of open habitats such as savanna and meadow has reduced availability of high quality thermoregulation habitat for reptiles. Restoration of the northwestern region and tip of Point Pelee National Park to a mixed landscape of shallow wetlands (cattail, graminoid, forb, open water) and eradication of dense Phragmites stands should improve habitat diversity. Our results suggest that long-term landscape changes resulting from habitat succession and invasive species can negatively affect habitat suitability for herpetofauna and protection of land alone does not necessarily equate to protection of sensitive herpetofauna.	[Markle, Chantel E.; Chow-Fraser, Gillian; Chow-Fraser, Patricia] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Chow-Fraser, Gillian] Univ Victoria, Sch Environm Studies, Victoria, BC, Canada	McMaster University; University of Victoria	Markle, CE (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	marklece@mcmaster.ca		Markle, Chantel/0000-0002-1703-0201	Natural Sciences and Engineering Research Council of Canada, Alexander Graham Bell Canada Doctoral Graduate Scholarship; Highway Infrastructure and Improvement Program from the Ontario Ministry of Transportation	Natural Sciences and Engineering Research Council of Canada, Alexander Graham Bell Canada Doctoral Graduate Scholarship; Highway Infrastructure and Improvement Program from the Ontario Ministry of Transportation	We acknowledge partial funding from the Natural Sciences and Engineering Research Council of Canada, Alexander Graham Bell Canada Doctoral Graduate Scholarship (http://www.nserccrsng.gc.ca) to CEM and a grant to PC-F from the Highway Infrastructure and Improvement Program from the Ontario Ministry of Transportation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouin-Demers G, 2001, J ANIM ECOL, V70, P1006, DOI 10.1046/j.0021-8790.2001.00554.x; Blouin-Demers G, 2001, ECOLOGY, V82, P2882, DOI 10.1890/0012-9658(2001)082[2882:HUBBRS]2.0.CO;2; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bolton RM, 2010, CHELONIAN CONSERV BI, V9, P238, DOI 10.2744/CCB-0793.1; Brown JH, 1998, BIOGEOGRAPHY SUNDERL; Browne CL, 2007, BIOL CONSERV, V138, P421, DOI 10.1016/j.biocon.2007.05.008; Burke VJ, 1995, CONSERV BIOL, V9, P1365, DOI 10.1046/j.1523-1739.1995.09061365.x; Catling PM, 2011, CAN FIELD NAT, V125, P95, DOI 10.22621/cfn.v125i2.1187; Colombo SJ, 2007, CCRR05 MIN NAT RES F; Cooper JE, 2008, HYDROBIOLOGIA, V601, P41, DOI 10.1007/s10750-007-9265-0; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Dougan & Associates, 2007, POINT PEL NAT PARK E; Environment Canada, 2016, REC STRAT SPOTT TURT; ERNST C H, 1976, Journal of Herpetology, V10, P25, DOI 10.2307/1562924; Ernst CH, 2009, TURTLES US CANADA; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Gibbons JW, 2003, WETLANDS, V23, P630, DOI 10.1672/0277-5212(2003)023[0630:THAVCF]2.0.CO;2; Greenberg DA, 2013, CONSERV BIOL, V27, P1049, DOI 10.1111/cobi.12078; Harvey DS, 2006, J HERPETOL, V40, P66, DOI 10.1670/89-05A.1; Hecnar S. J., 2004, Aquatic Ecosystem Health & Management, V7, P289, DOI 10.1080/14634980490461542; Hecnar SJ, 1998, BIOL CONSERV, V85, P213, DOI 10.1016/S0006-3207(98)00014-7; Hecnar SJ, 2010, P PARKS RES FOR ONT; Hecnar SJ, 2004, HECNAR DR FEASIBILIT; Hecnar SJ, 2011, J HERPETOL, V45, P478, DOI 10.1670/10-219.1; Hessburg PF, 2000, FOREST ECOL MANAG, V136, P53, DOI 10.1016/S0378-1127(99)00263-7; Hobbs RJ, 2014, FRONT ECOL ENVIRON, V12, P557, DOI 10.1890/130300; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Juffe-Bignoli D, 2016, AQUAT CONSERV, V26, P133, DOI 10.1002/aqc.2638; Kjoss VA, 2001, BIOL CONSERV, V98, P285, DOI 10.1016/S0006-3207(00)00167-1; Litzgus JD, 2004, COPEIA, P804; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; McGarigal K., 2012, TECH REP; Parks Canada, 2004, POINT PEL NAT PARK E; Parsons DJ, 1999, ECOL APPL, V9, P1177, DOI 10.1890/1051-0761(1999)009[1177:UALOHV]2.0.CO;2; Pike DA, 2011, ECOL APPL, V21, P274, DOI 10.1890/09-2394.1; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Rhemtulla JM, 2002, CAN J FOREST RES, V32, P2010, DOI 10.1139/X02-112; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Row JR, 2006, ECOSCIENCE, V13, P443, DOI 10.2980/1195-6860(2006)13[443:TQIHSA]2.0.CO;2; Row JR, 2012, J HERPETOL, V46, P94, DOI 10.1670/10-262; Row JR, 2006, OECOLOGIA, V148, P1, DOI 10.1007/s00442-005-0350-7; Russell R. W., 1999, PARKS PROTECTED AREA, V1999, P371; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Smith M., 2002, MAPPING CRITICAL RED; Stow D, 1980, P INT S REM SENS ENV; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Todd BD, 2008, CONSERV BIOL, V22, P753, DOI 10.1111/j.1523-1739.2008.00916.x; ULTSCH GR, 1989, BIOL REV, V64, P435, DOI 10.1111/j.1469-185X.1989.tb00683.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilcox DA, 2008, J GREAT LAKES RES, V34, P301, DOI 10.3394/0380-1330(2008)34[301:CIOGMI]2.0.CO;2; WILLIS EO, 1974, ECOL MONOGR, V44, P153, DOI 10.2307/1942309	53	10	10	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192134	10.1371/journal.pone.0192134	http://dx.doi.org/10.1371/journal.pone.0192134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444129	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500053
J	Piao, YL; Jin, KN; He, Y; Liu, JX; Liu, S; Li, XN; Piao, ZY				Piao, Yinglan; Jin, Kaining; He, Ying; Liu, Jiaxiu; Liu, Shuang; Li, Xiaonan; Piao, Zhongyun			Genome-wide identification and role of MKK and MPK gene families in clubroot resistance of Brassica rapa	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; WRKY TRANSCRIPTION FACTORS; PLANT-DISEASE RESISTANCE; INNATE IMMUNITY; ARABIDOPSIS-THALIANA; MAPK CASCADES; PLASMODIOPHORA-BRASSICAE; EXPRESSION ANALYSIS; CELL-DEATH; DEFENSE	Mitogen-activated protein kinase (MAPK or MPK) cascades play key roles in responses to various biotic stresses, as well as in plant growth and development. However, the responses of MPK and MPK kinase (MKK) in Chinese cabbage (Brassica rapa ssp. pekinensis) to Plasmodiophora brassicae, a causal agent of clubroot disease in Brassica crops, are still not clear. In the present study, a total of 11 B. rapa MKK (BraMKK) and 30 BraMPK genes were identified and unevenly distributed in 6 and 10 chromosomes, respectively. The synteny analysis indicated that these genes experienced whole-genome triplication and segmental and tandem duplication during or after the divergence of B. rapa, accompanied by the loss of three MKK and two MPK orthologs of Arabidopsis. The BraMKK and BraMPK genes were classified into four groups with similar intron/exon structures and conserved motifs in each group. A quantitative PCR analysis showed that the majority of BraMKK and BraMPK genes were natively expressed in roots, hypocotyls, and leaves, whereas 5 BraMKK and 16 BraMPK genes up-regulated in the roots upon P. brassicae infection. Additionally, these 5 BraMKK and 16 BraMPK genes exhibited a significantly different expression pattern between a pair of clubroot-resistant/susceptible near-isogenic lines (NILs). Furthermore, the possible modules of MKK-MPK involved in B. rapa-P. brassicae interaction are also discussed. The present study will provide functional clues for further characterization of the MAPK cascades in B. rapa.	[Piao, Yinglan; Jin, Kaining; He, Ying; Liu, Jiaxiu; Liu, Shuang; Li, Xiaonan; Piao, Zhongyun] Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Li, XN; Piao, ZY (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China.	gracesleexn@163.com; zypiaosau@163.com		Piao, Zhongyun/0000-0003-4574-4647	National Key Research and Development Program of China [2016YFD0100202-19, 2017YFD0101802]; earmarked fund for China Agriculture Research System [CARS-12]; National Natural Science Foundation of China [31471882]	National Key Research and Development Program of China; earmarked fund for China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (Grant No. 2016YFD0100202-19 and No.2017YFD0101802), the earmarked fund for China Agriculture Research System (CARS-12), and National Natural Science Foundation of China (Grant No. 31471882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Key Research and Development Program of China (Grant No. 2016YFD0100202-19 and No. 2017YFD0101802), the earmarked fund for China Agriculture Research System (CARS-12), and National Natural Science Foundation of China (Grant No. 31471882).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen JJ, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01183; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chu M, 2013, ACTA HORTIC, V1005, P599; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; INGRAM DS, 1972, PROC R SOC SER B-BIO, V180, P103, DOI 10.1098/rspb.1972.0008; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Knoth C, 2008, PLANT J, V55, P53, DOI 10.1111/j.1365-313X.2008.03486.x; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Lemarie S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00539; Liang WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-392; Liu QP, 2007, PLANT PHYSIOL BIOCH, V45, P6, DOI 10.1016/j.plaphy.2006.12.011; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Liu ZQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00780; Lu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132051; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; NAIKI T, 1987, T BRIT MYCOL SOC, V89, P569, DOI 10.1016/S0007-1536(87)80091-8; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Piao ZhongYun, 2010, Acta Horticulturae Sinica, V37, P1264; Piao ZY, 2009, J PLANT GROWTH REGUL, V28, P252, DOI 10.1007/s00344-009-9093-8; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Reyna NS, 2006, MOL PLANT MICROBE IN, V19, P530, DOI 10.1094/MPMI-19-0530; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Ueno H, 2012, PLANT MOL BIOL, V80, P621, DOI 10.1007/s11103-012-9971-5; Underwood W, 2007, PLANT J, V52, P658, DOI 10.1111/j.1365-313X.2007.03262.x; Wang G, 2014, AUST J GRAPE WINE R, V20, P255, DOI 10.1111/ajgw.12081; Wang XL, 2015, INT J ELECTROCHEM SC, V10, P93; Xie DW, 2015, J GENET, V94, P55, DOI 10.1007/s12041-015-0495-z; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Xu J, 2015, TRENDS PLANT SCI, V20, P56, DOI 10.1016/j.tplants.2014.10.001; YAN Y, 2016, FRONT PLANT SCI, V7; Yang TB, 2010, PLANT SIGNAL BEHAV, V5, P991, DOI [10.4161/psb.5.8.12225, 10.1074/jbc.M109.035659]; Yang ZY, 2015, RICE, V8, DOI 10.1186/s12284-014-0038-x; Yoo SJ, 2014, PLANT PATHOLOGY J, V30, P168, DOI 10.5423/PPJ.OA.10.2013.0106; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang ZB, 2012, CELL HOST MICROBE, V11, P253, DOI 10.1016/j.chom.2012.01.015	60	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191015	10.1371/journal.pone.0191015	http://dx.doi.org/10.1371/journal.pone.0191015			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444111	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500012
J	Rusjan, PM; Knezevic, D; Boileau, I; Tong, JC; Mizrahi, R; Wilson, AA; Houle, S				Rusjan, Pablo M.; Knezevic, Dunja; Boileau, Isabelle; Tong, Junchao; Mizrahi, Romina; Wilson, Alan A.; Houle, Sylvain			Voxel level quantification of [C-11]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; COMPARTMENTAL-MODELS; PARAMETER-ESTIMATION; PET; STRATEGY; PF-04457845; BINDING; TRACER; VOLUME	[ C-11] CURB is a novel irreversible radioligand for imaging fatty acid amide hydrolase in the human brain. In the present work, we validate an algorithm for generating parametric map images of [C-11] CURB acquired with a high resolution research tomograph (HRRT) scanner. This algorithm applies the basis function method on an irreversible two-tissue compartment model (k(4) = 0) with arterial input function, i.e., BAFPIC. Monte Carlo simulations are employed to assess bias and variability of the binding macroparameters (K-i and k(3)) as a function of the voxel noise level and the range of basis functions. The results show that for a [C-11] CURB time activity curve with noise levels corresponding to a voxel of an image acquired with the HRRT and reconstructed with the filtered back projection algorithm, the implementation of BAFPIC requires the use of a constant vascular fraction of tissue (5%) and a cutoff for slow frequencies (0.06 min(-1)). With these settings, BAFPIC maintains the probabilistic distributions of the binding macroparameters with approximately Gaussian shape and minimizes the bias and variability for large physiological ranges of the rate constants of [C-11] CURB. BAFPIC reduces the variability of Ki to a third of that given by Patlak plot, the standard graphical method for irreversible radioligands. Application to real data demonstrated an excellent correlation between region of interest and BAFPIC parametric data and agreed with the simulations results. Therefore, BAFPIC with a constant vascular fraction can be used to generate parametric maps of [C-11] CURB images acquired with an HRRT provided that the limits of the basis functions are carefully selected.	[Rusjan, Pablo M.; Knezevic, Dunja; Boileau, Isabelle; Tong, Junchao; Mizrahi, Romina; Wilson, Alan A.; Houle, Sylvain] CAMH Campbell Family Mental Hlth Res Inst, Res Imaging Ctr, Toronto, ON, Canada; [Rusjan, Pablo M.; Boileau, Isabelle; Tong, Junchao; Mizrahi, Romina; Wilson, Alan A.; Houle, Sylvain] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto	Rusjan, PM (corresponding author), CAMH Campbell Family Mental Hlth Res Inst, Res Imaging Ctr, Toronto, ON, Canada.; Rusjan, PM (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.	pablo.rusjan@camhpet.ca		Rusjan, Pablo/0000-0003-0075-2918; Houle, Sylvain/0000-0002-4231-6316; Mizrahi, Romina/0000-0001-6667-7928				Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; ALPERT NM, 1984, J CEREBR BLOOD F MET, V4, P28, DOI 10.1038/jcbfm.1984.4; Bencherif B, 2004, J NUCL MED, V45, P402; Boileau I, 2015, J CEREBR BLOOD F MET, V35, P1827, DOI 10.1038/jcbfm.2015.133; Boileau I, 2015, J CEREBR BLOOD F MET, V35, P1237, DOI 10.1038/jcbfm.2015.119; CUNNINGHAM VJ, 1993, J CEREBR BLOOD F MET, V13, P15, DOI 10.1038/jcbfm.1993.5; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Gunn RN, 2002, J CEREBR BLOOD F MET, V22, P1425, DOI 10.1097/01.wcb.0000045042.03034.42; Gunn RN, 2001, J CEREBR BLOOD F MET, V21, P635, DOI 10.1097/00004647-200106000-00002; Hammers A, 2007, NEUROIMAGE, V38, P82, DOI 10.1016/j.neuroimage.2007.06.035; Hong YT, 2011, J CEREBR BLOOD F MET, V31, P648, DOI 10.1038/jcbfm.2010.141; Hong YT, 2010, NEUROIMAGE, V51, P164, DOI 10.1016/j.neuroimage.2010.02.013; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Innis RB, 2007, EUR J NUCL MED MOL I, V34, P1239, DOI 10.1007/s00259-007-0481-7; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; Johnson DS, 2011, ACS MED CHEM LETT, V2, P91, DOI 10.1021/ml100190t; KOEPPE RA, 1985, J CEREBR BLOOD F MET, V5, P224, DOI 10.1038/jcbfm.1985.29; Koeppe RA, 1999, J CEREBR BLOOD F MET, V19, P1150, DOI 10.1097/00004647-199910000-00012; Lammertsma AA, 2012, HDB PARTICLE DETECTI, P1065; Logan J, 2001, J CEREBR BLOOD F MET, V21, P307, DOI 10.1097/00004647-200103000-00014; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Rizzo G, 2012, NEUROIMAGE, V59, P2485, DOI 10.1016/j.neuroimage.2011.08.101; Rusjan PM, 2014, J CEREBR BLOOD F MET, V34, P883, DOI 10.1038/jcbfm.2014.34; Rusjan PM, 2013, J CEREBR BLOOD F MET, V33, P407, DOI 10.1038/jcbfm.2012.180; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; YU DC, 1995, PHYS MED BIOL, V40, P1243, DOI 10.1088/0031-9155/40/7/007	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192410	10.1371/journal.pone.0192410	http://dx.doi.org/10.1371/journal.pone.0192410			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444138	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500065
J	Aklilu, E; Abbasi, I; Gebresilassie, A; Yared, S; Kindu, M; Kirstein, OD; Moncaz, A; Tekie, H; Balkew, M; Warburg, A; Hailu, A; Gebre-Michael, T				Aklilu, Esayas; Abbasi, Ibrahim; Gebresilassie, Araya; Yared, Solomon; Kindu, Mizan; Kirstein, Oscar David; Moncaz, Aviad; Tekie, Habte; Balkew, Meshesha; Warburg, Alon; Hailu, Asrat; Gebre-Michael, Teshome			Some aspects of entomological determinants of Phlebotomus orientalis in highland and lowland visceral leishmaniasis foci in northwestern Ethiopia	PLOS ONE			English	Article							SAND FLIES; CUTANEOUS LEISHMANIASIS; HOST PREFERENCES; DIPTERA PSYCHODIDAE; FEEDING PREFERENCE; BLOODMEAL SOURCES; KALA-AZAR; IDENTIFICATION; SANDFLIES; LUTZOMYIA	Visceral leishmaniasis (VL) is one of the major public health problems in northwest Ethiopia, mainly in Libo-Kemkem and Metema districts, where Phlebotomus orientalis is the most probable vector of the disease. The aim of this study was to determine the physiological age, host preference and vectorial potential of P. orientalis in the highland and lowland foci of the region. Sand flies were collected using CDC light traps between May 2011 and April 2012 in Libo-Kemkem and October 2012 and September 2013 in Metema from household compounds, farm field and mixed forest. Females belonging to Phlebotomus were dissected for physiological age determination and Leishmania detection and isolation. Leishmania infections in sand flies were investigated using molecular methods. Freshly fed Phlebotomus females were tested to identify blood meal sources using PCR-RLB and ELISA. A total of 1149 (936 from Libo-Kemkem and 213 from Metema) blood unfed female P. orientalis were dissected for age determination. The parity rate was 45.6% and 66.2% in Libo-Kemkem and Metema, respectively. None of 798 female P. orientalis dissected (578 from Libo-Kemkem and 220 from Metema) was infected with Leishmania parasites. A total of 347 P. orientalis specimens collected from Libo-Kemkem were processed using PCR, of which 10 (2.8%) specimens were found with DNA of Leishmania spp. Of a total 491 freshly fed female P. orientalis analyzed for blood meal origins by RLB-PCR and ELISA, 57.6% (67.8% from Libo-Kemkem and 49.8% from Metema) were found to contain bovine blood while 4.9% (3.7% from Libo-Kemkem and 5.7% from Metema) were of human blood. In conclusion, the present study showed parity difference between the two populations of P. orientalis and that both populations have strong zoophilic behavior. Based on the presented evidences, the species is strongly implicated as a vector of kala-azar in both areas. Therefore, vector control should be a component of a strategy to manage visceral leishmaniasis in both study areas.	[Aklilu, Esayas] Mada Walabu Univ, Dept Biol, Bale Robe, Ethiopia; [Abbasi, Ibrahim; Kirstein, Oscar David; Moncaz, Aviad; Warburg, Alon] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada, Kuvin Ctr Study Infect & Trop Dis,Fac Med,Hadassa, Jerusalem, Israel; [Gebresilassie, Araya; Yared, Solomon] Jigjiga Univ, Dept Biol, Jigjiga, Ethiopia; [Kindu, Mizan] Mada Walabu Univ, Sch Med Parasitol Microbiol & Immunol, Bale Robe, Ethiopia; [Tekie, Habte] Addis Ababa Univ, Dept Zool Sci, Addis Ababa, Ethiopia; [Balkew, Meshesha; Gebre-Michael, Teshome] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Hailu, Asrat] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia	Hebrew University of Jerusalem; Addis Ababa University; Addis Ababa University; Addis Ababa University	Aklilu, E (corresponding author), Mada Walabu Univ, Dept Biol, Bale Robe, Ethiopia.	reyeesayas@gmail.com	Hailu, Asrat/AAM-6982-2020; Yared, Solomon/AAX-2429-2021; Abbasi, Ibrahim/AAB-2738-2019; Warburg, Alon/ABE-9946-2020	Warburg, Alon/0000-0001-7929-3114; Yared, Solomon/0000-0003-1510-8316; Maasho, Habte Tekie/0000-0003-2228-5249	Bill and Melinda Gates Foundation Global Health Program [OPPGH5336]	Bill and Melinda Gates Foundation Global Health Program(Bill & Melinda Gates Foundation)	Authors are grateful to the people of Libo-Kemkem and Metema districts for their support during the study. We also thank our field and laboratory assistants, particularly Mr. Gashaw Mihiret for his helps in carrying out this study. The Bill and Melinda Gates Foundation Global Health Program (grant number OPPGH5336) provided financial support.; The authors received funding from The Bill and Melinda Gates Foundation Global Health Program (grant number OPPGH5336).	Abbasi I, 2009, VECTOR-BORNE ZOONOT, V9, P79, DOI 10.1089/vbz.2008.0064; Abbasi I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-153; Aklilu E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175308; Alvar J, 2007, AM J TROP MED HYG, V77, P275; ANEZ N, 1994, ANN TROP MED PARASIT, V88, P279, DOI 10.1080/00034983.1994.11812868; Ashford R W, 1973, Ethiop Med J, V11, P259; ASHFORD RW, 1992, T ROY SOC TROP MED H, V86, P379, DOI 10.1016/0035-9203(92)90229-6; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; BLACKWELL A, 1994, MED VET ENTOMOL, V8, P20, DOI 10.1111/j.1365-2915.1994.tb00378.x; Bongiorno G, 2003, ACTA TROP, V88, P109, DOI 10.1016/S0001-706X(03)00190-6; BOREHAM PFL, 1975, J TROP MED HYG, V78, P83; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; CHRISTENSEN HA, 1980, J MED ENTOMOL, V17, P522, DOI 10.1093/jmedent/17.6.522; COLEMAN R E, 1987, Bulletin of the Society of Vector Ecologists, V12, P539; Courtenay O, 2009, MED VET ENTOMOL, V23, P245, DOI 10.1111/j.1365-2915.2009.00815.x; DHANDA V, 1982, INDIAN J MED RES, V76, P840; Elnaiem DA, 1998, ANN TROP MED PARASIT, V92, P229, DOI 10.1080/00034989860085; FOSTER WA, 1972, ANN TROP MED PARASIT, V66, P433, DOI 10.1080/00034983.1972.11686845; Gadisa E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0987-y; Garlapati RB, 2012, J MED ENTOMOL, V49, P515, DOI 10.1603/ME11115; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gebre-Michael T, 2007, ANN TROP MED PARASIT, V101, P367, DOI 10.1179/136485907X176382; Gebre-Michael T, 2004, T ROY SOC TROP MED H, V98, P64, DOI 10.1016/S0035-9203(03)00008-7; Gebre-Michael T, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-6; GEBREMICHAEL T, 1993, T ROY SOC TROP MED H, V87, P10, DOI 10.1016/0035-9203(93)90399-B; Gebresilassie A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0883-5; GUY MW, 1984, ANN PARASIT HUM COMP, V59, P449, DOI 10.1051/parasite/1984595449; HAILU A, 1995, ACTA TROP, V60, P15, DOI 10.1016/0001-706X(95)00093-T; Hassan MM, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-26; Jaouadi K, 2013, ANN ENTOMOL SOC AM, V106, P79, DOI 10.1603/AN11186; KILLICKKENDRICK R, 1978, ACTA TROP, V35, P297; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lane R. P., 1993, P78; LEWIS DJ, 1971, B WORLD HEALTH ORGAN, V44, P535; LEWIS DJ, 1970, B ENTOMOL RES, V60, P209, DOI 10.1017/S0007485300040736; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Mamo H., 1999, THESIS; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Mascari TM, 2008, J AM MOSQUITO CONTR, V24, P323, DOI 10.2987/5678.1; MENGESHA B, 1978, TROP GEOGR MED, V30, P199; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; NGUMBI PM, 1992, MED VET ENTOMOL, V6, P385, DOI 10.1111/j.1365-2915.1992.tb00638.x; OGUSUKU E, 1994, ANN TROP MED PARASIT, V88, P329, DOI 10.1080/00034983.1994.11812873; Oshaghi MA, 2009, AM J TROP MED HYG, V81, P572, DOI 10.4269/ajtmh.2009.08-0469; QUINNELL RJ, 1992, MED VET ENTOMOL, V6, P195, DOI 10.1111/j.1365-2915.1992.tb00606.x; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; Seblova V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002187; Svobodova M, 2003, AM J TROP MED HYG, V68, P6, DOI 10.4269/ajtmh.2003.68.6; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; 2010, WHO TECHN REP SER, V949, P1	52	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192844	10.1371/journal.pone.0192844	http://dx.doi.org/10.1371/journal.pone.0192844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438419	Green Submitted, gold, Green Published			2022-12-26	WOS:000425083400059
J	Ayub, Q; Ngadi, A; Rashid, S; Habib, HA				Ayub, Qaisar; Ngadi, Asri; Rashid, Sulma; Habib, Hafiz Adnan			Priority Queue Based Reactive Buffer Management Policy for Delay Tolerant Network under City Based Environments	PLOS ONE			English	Article							CONNECTED MOBILE NETWORKS; PROTOCOL; STRATEGY; DROP; TIME	Delay Tolerant Network (DTN) multi-copy routing protocols are privileged to create and transmit multiple copies of each message that causes congestion and some messages are dropped. This process is known as reactive drop because messages were dropped reactively to overcome buffer overflows. The existing reactive buffer management policies apply a single metric to drop source, relay and destine messages. Hereby, selection to drop a message is dubious because each message as source, relay or destine may have consumed dissimilar magnitude of network resources. Similarly, DTN has included time to live (ttl) parameter which defines lifetime of message. Hence, when ttl expires then message is automatically destroyed from relay nodes. However, time-to-live (ttl) is not applicable on messages reached at their destinations. Moreover, nodes keep replicating messages till ttl expires even-though large number of messages has already been dispersed. In this paper, we have proposed Priority Queue Based Reactive Buffer Management Policy (PQB-R) for DTN under City Based Environments. The PQB-R classifies buffered messages into source, relay and destine queues. Moreover, separate drop metric has been applied on individual queue. The experiment results prove that proposed PQB-R has reduced number of messages transmissions, message drop and increases delivery ratio.	[Ayub, Qaisar; Habib, Hafiz Adnan] Univ Engn & Technol Taxila, Dept Comp Sci, Rawalpindi, Pakistan; [Ngadi, Asri] Univ Technol Malaysia, Dept Comp Sci, Johor Baharu, Johor, Malaysia; [Rashid, Sulma] COMSATS Inst Informat Technol, Dept Comp Sci, Wah Cantt, Rawalpindi, Pakistan	Universiti Teknologi Malaysia; COMSATS University Islamabad (CUI)	Ayub, Q (corresponding author), Univ Engn & Technol Taxila, Dept Comp Sci, Rawalpindi, Pakistan.	qaisar.ayyub@uettaxila.edu.pk	Rashid, Sulma/ABA-6004-2020; NGADI, ASRI/G-3174-2011	NGADI, ASRI/0000-0003-4907-6359	Universiti Teknologi Malaysia [Q. J130000.21A2.02E63]	Universiti Teknologi Malaysia	This work was supported by Postdoctoral Research University Grant (Q. J130000.21A2.02E63) from Universiti Teknologi Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Postdoctoral Research University Grant (Q.J130000.21A2.02E63) from Universiti Teknologi Malaysia.	[Anonymous], INT C HET NETW QUAL; [Anonymous], 2003, ACM SIGMOBILE, DOI DOI 10.1145/961268.961272; Anzaldi D, 2010, ORWAR DELAY TOLERANT; Ayub Q, 2014, CLUSTER COMPUT, V17, P1465, DOI 10.1007/s10586-013-0331-2; Ayub Q, 2014, J NETW COMPUT APPL, V39, P302, DOI 10.1016/j.jnca.2013.07.011; Cerf V, 2007, IRTF DTN RES GROUP, V2, P1; Erramilli V, 2008, MOBIHOC'08: PROCEEDINGS OF THE NINTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P251; Fall K, 2003, ACM SIGCOMM COMP COM, V33, P27; Han B, 2012, IEEE T MOBILE COMPUT, V11, P821, DOI 10.1109/TMC.2011.101; Hui P, 2011, IEEE T MOBILE COMPUT, V10, P1576, DOI 10.1109/TMC.2010.246; Jain S, 2016, INT J COMMUN SYST, V29, P1820, DOI 10.1002/dac.2796; Jiang GX, 2014, J NETW COMPUT APPL, V44, P92, DOI 10.1016/j.jnca.2014.05.004; Kim EH, 2014, 2014 INTERNATIONAL CONFERENCE ON INFORMATION NETWORKING (ICOIN 2014), P412, DOI 10.1109/ICOIN.2014.6799715; Krifa A, 2008, P WOWMOM, P1, DOI DOI 10.1109/WOWMOM.2008.4594889; Krifa A, 2012, IEEE T MOBILE COMPUT, V11, P1470, DOI 10.1109/TMC.2011.163; Lakkakorpi J, 2010, ACM S MODEL ANAL SIM, P101; Li QP, 2010, INT ASIA CONF INFORM, P1, DOI 10.1109/CAR.2010.5456895; Li Y., 2009, P INT C ONWIRELESS C, P457; Lindgren Anders, 2006, P 1 INT C COMM SYST, P1; Mankin A., 1990, Computer Communication Review, V20, P1, DOI 10.1145/99517.99521; Pan DR, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-103; Prodhan AT, 2011, J NETW COMPUT APPL, V34, P1660, DOI 10.1016/j.jnca.2011.05.005; Pujol JM, 2009, IEEE INFOCOM SER, P837, DOI 10.1109/INFCOM.2009.5061993; Radenkovic M., 2011, 2011 Eighth International Conference on Wireless On-demand Network Systems and Services (WONS 2011), P60, DOI 10.1109/WONS.2011.5720201; Rashid Sulma, 2010, International Journal of Computer and Network Security, V2, P118; Rashid S., 2011, INT J COMPUTER APPL, P118; Rashid S, 2013, J NETW COMPUT APPL, V36, P1395, DOI 10.1016/j.jnca.2013.02.030; Settawatcharawanit T, 2013, INT JOINT CONF COMP, P116; Shin K, 2011, IET COMMUN, V5, P753, DOI 10.1049/iet-com.2010.0422; Shin K, 2012, J NETW COMPUT APPL, V35, P1762, DOI 10.1016/j.jnca.2012.07.001; Soares VNGJ, 2009, INT CONF PARA PROC, P344, DOI 10.1109/ICPPW.2009.33; Sok P, 2013, 2013 INTERNATIONAL CONFERENCE ON ICT CONVERGENCE (ICTC 2013): FUTURE CREATIVE CONVERGENCE TECHNOLOGIES FOR NEW ICT ECOSYSTEMS, P159, DOI 10.1109/ICTC.2013.6675329; Spyropoulos T, 2008, IEEE ACM T NETWORK, V16, P63, DOI 10.1109/TNET.2007.897962; Vahdat A., 2000, EPIDEMIC ROUTING PAR; Wilson J., 2007, TECHNICAL REPORT; Zhang XL, 2007, COMPUT NETW, V51, P2867, DOI 10.1016/j.comnet.2006.11.028	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0191580	10.1371/journal.pone.0191580	http://dx.doi.org/10.1371/journal.pone.0191580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438438	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400006
J	Lee, SP; Kao, CY; Chang, SC; Chiu, YL; Chen, YJ; Chen, MHG; Chang, CC; Lin, YW; Chiang, CP; Wang, JK; Lin, CY; Johnson, MD				Lee, Shiao-Pieng; Kao, Chen-Yu; Chang, Shun-Cheng; Chiu, Yi-Lin; Chen, Yen-Ju; Chen, Ming-Hsing G.; Chang, Chun-Chia; Lin, Yu-Wen; Chiang, Chien-Ping; Wang, Jehng-Kang; Lin, Chen-Yong; Johnson, Michael D.			Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin	PLOS ONE			English	Article							FACTOR ACTIVATOR INHIBITOR-1B; EPIDERMAL BARRIER FUNCTION; SERINE-PROTEASE INHIBITOR; ZYMOGEN ACTIVATION; EPITHELIAL-CELLS; PROTEOLYTIC CASCADE; MOLECULAR-CLONING; EXPRESSION; COMPLEX; CANCER	The membrane-bound serine proteases prostasin and matriptase and the Kunitz-type protease inhibitors HAI-1 and HAI-2 are all expressed in human skin and may form a tightly regulated proteolysis network, contributing to skin pathophysiology. Evidence from other systems, however, suggests that the relationship between matriptase and prostasin and between the proteases and the inhibitors can be context-dependent. In this study the in vivo zymogen activation and protease inhibition status of matriptase and prostasin were investigated in the human skin. Immunohistochemistry detected high levels of activated prostasin in the granular layer, but only low levels of activated matriptase restricted to the basal layer. Immunoblot analysis of foreskin lysates confirmed this in vivo zymogen activation status and further revealed that HAI-1 but not HAI-2 is the prominent inhibitor for prostasin and matriptase in skin. The zymogen activation status and location of the proteases does not support a close functional relation between matriptase and prostasin in the human skin. The limited role for HAI-2 in the inhibition of matriptase and prostasin is the result of its primarily intracellular localization in basal and spinous layer keratinocytes, which probably prevents the Kunitz inhibitor from interacting with active prostasin or matriptase. In contrast, the cell surface expression of HAI-1 in all viable epidermal layers renders it an effective regulator for matriptase and prostasin. Collectively, our study suggests the importance of tissue distribution and subcellular localization in the functional relationship between proteases and protease inhibitors.	[Lee, Shiao-Pieng] Natl Def Med Ctr, Sch Dent, Taipei, Taiwan; [Lee, Shiao-Pieng] Triserv Gen Hosp, Dept Dent, Taipei, Taiwan; [Kao, Chen-Yu] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei, Taiwan; [Kao, Chen-Yu] Natl Def Med Ctr, Dept Biomed Engn, Taipei, Taiwan; [Chang, Shun-Cheng] Shuang Ho Hosp, Div Plast Surg, Dept Surg, Taipei, Taiwan; [Chang, Shun-Cheng] Taipei Med Univ, Sch Med, Dept Surg, Taipei, Taiwan; [Chiu, Yi-Lin; Chen, Yen-Ju; Lin, Yu-Wen; Chiang, Chien-Ping; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Chiu, Yi-Lin; Lin, Yu-Wen] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Chen, Ming-Hsing G.; Chang, Chun-Chia] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chiang, Chien-Ping; Lin, Chen-Yong; Johnson, Michael D.] Triserv Gen Hosp, Dept Dermatol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Taiwan University of Science & Technology; National Defense Medical Center; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Defense Medical Center; Georgetown University; National Defense Medical Center; Tri-Service General Hospital	Chiang, CP (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.; Chiang, CP (corresponding author), Triserv Gen Hosp, Dept Dermatol, Taipei, Taiwan.	cppchiang@gmail.com	Lin, Chen/GRR-2799-2022; Chiu, Yilin/ABC-3746-2021	Chiu, Yilin/0000-0002-1827-6924; johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) [R01 CA 123223]; Ministry of National Defense, Taiwan [MAB106-070, MAB-105-139, MAB-105-140]; Tri-Service General Hospital, Taiwan [TSGH-C106-013]; Lombardi Comprehensive Cancer Center support grant (NIH/NCI) [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of National Defense, Taiwan; Tri-Service General Hospital, Taiwan; Lombardi Comprehensive Cancer Center support grant (NIH/NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant R01 CA 123223 (to M. D. Johnson and C. -Y. Lin), Grant (MAB106-070) from the Ministry of National Defense, Taiwan (to J. -K. Wang), Grant (TSGH-C106-013) from the Tri-Service General Hospital, Taiwan (to S. -P. Lee and C. -Y. Kao), Grant (MAB-105-139) from the Ministry of National Defense, Taiwan (to C. -P. Chiang), and Grant (MAB-105-140) from the Ministry of National Defense, Taiwan (to S. -P. Lee). We also acknowledge the assistance provided by the Histopathology and Tissue Shared Resource and the Microscopy and Imaging Shared Resource which are supported in part by the Lombardi Comprehensive Cancer Center support grant (NIH/NCI grant P30-CA051008). We acknowledge the assistance provided by the Microscopy and Imaging Shared Resource, which is supported in part by the Lombardi Comprehensive Cancer Center support grant (NIH/NCI grant P30-CA051008). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Carattino MD, 2014, AM J PHYSIOL-RENAL, V307, pF1080, DOI 10.1152/ajprenal.00157.2014; Chang HHD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120489; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen YW, 2016, J INVEST DERMATOL, V136, P1210, DOI 10.1016/j.jid.2016.01.029; Chen YW, 2014, J INVEST DERMATOL, V134, P405, DOI 10.1038/jid.2013.320; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chen YW, 2010, AM J PATHOL, V176, P2986, DOI 10.2353/ajpath.2010.090665; Chu L, 2014, 2014 TENTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING (IIH-MSP 2014), P9, DOI 10.1109/IIH-MSP.2014.10; Crisante G, 2014, FASEB J, V28, P4792, DOI 10.1096/fj.14-253781; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lai CH, 2016, BIOL OPEN, V5, P1380, DOI 10.1242/bio.019745; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152904; Lai YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139044; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Shiao F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170944; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Su HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167894; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096899; Wu BY, 2014, J HISTOCHEM CYTOCHEM, V62, P50, DOI 10.1369/0022155413505599; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192632	10.1371/journal.pone.0192632	http://dx.doi.org/10.1371/journal.pone.0192632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438412	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400037
J	Puig, CG; Reigosa, MJ; Valentao, P; Andrade, PB; Pedrol, N				Puig, Carolina G.; Reigosa, Manuel J.; Valentao, Patricia; Andrade, Paula B.; Pedrol, Nuria			Unravelling the bioherbicide potential of Eucalyptus globulus Labill: Biochemistry and effects of its aqueous extract	PLOS ONE			English	Article							XANTHOPHYLL CYCLE; SEEDLING GROWTH; ALLELOCHEMICALS; GERMINATION; PHOTOSYNTHESIS; LEAVES; WEEDS; WATER; PHYTOTOXICITY; FLUORESCENCE	In the worldwide search for new strategies in sustainable weed management, the use of plant species able to produce and release phytotoxic compounds into the environment could be an effective alternative to synthetic herbicides. Eucalyptus globulus Labill. is known to be a source of biologically active compounds responsible for its phytotoxic and allelopathic properties. Our previous results demonstrated the bioherbicide potential of eucalyptus leaves incorporated into the soil as a green manure, probably through the release of phytotoxins into the soil solution. Thus, the aims of this study were to understand the phytotoxicity of the eucalyptus leaves aqueous extract applied in pre- and post-emergence, and to identify and quantify its potentially phytotoxic water-soluble compounds. The effects were tested on the germination and early growth of the model target species Lactuca sativa and Agrostis stolonifera, and on physiological parameters of L. sativa adult plants after watering or spraying application. Dose-response curves and ED50 and ED80 values for eucalyptus aqueous extracts revealed pre-emergence inhibitory effects on both target species, effects being comparable to the herbicide metolachlor. While spraying treatment reduced the aerial and root biomass and increased the dry weight/fresh weight ratio of lettuce adult plants, watering application reduced protein contents and chlorophyll concentrations with respect to control, reflecting different modes of action depending on the site of phytotoxin entry. Via HPLC analyses, a total of 8 phenolic compounds (chlorogenic, two.-coumaric derivatives, ellagic, hyperoside, rutin, quercitrin, and kaempferol 3-O-glucoside) and other 5 low weight organic acids (citric, malic, shikimic, succinic and fumaric acids) were obtained from aqueous extract, the latter being identified for the first time in E. globulus. Despite some phytotoxic effects were found on lettuce adult plants, the use of eucalyptus aqueous extract would be discarded in post-emergence, whereas it was promising as a pre-emergence bioherbicide.	[Puig, Carolina G.; Reigosa, Manuel J.; Pedrol, Nuria] Univ Vigo, Dept Plant Biol & Soil Sci, Vigo, Spain; [Valentao, Patricia; Andrade, Paula B.] Univ Porto, Dept Chem, Lab Pharmacognosy, REQUIMTE LAQV, Porto, Portugal	Universidade de Vigo; Universidade do Porto	Puig, CG (corresponding author), Univ Vigo, Dept Plant Biol & Soil Sci, Vigo, Spain.	cgpuig@uvigo.es	Roger, Manuel Joaquín Reigosa/O-4438-2019; Reigosa, Manuel J/K-3551-2013; Valentão, Patrícia/D-4818-2013; Pedrol, Nuria/I-6228-2019; Puig, Carolina G./O-4708-2019; Andrade, Paula/A-5900-2008	Roger, Manuel Joaquín Reigosa/0000-0003-0527-1849; Reigosa, Manuel J/0000-0003-0527-1849; Valentão, Patrícia/0000-0002-0740-4396; Pedrol, Nuria/0000-0001-6725-373X; Puig, Carolina G./0000-0002-4596-8571; Andrade, Paula/0000-0002-9764-3920	Spanish Ministry of Education [AP2009-4809]; Spanish Ministry of Economy and Competitiveness (BIOINPUT) [CGL2016-78660-R]	Spanish Ministry of Education(Spanish Government); Spanish Ministry of Economy and Competitiveness (BIOINPUT)	This work was supported by the Spanish Ministry of Education for the FPU grant AP2009-4809 (CGP) and by the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/; BIOINPUT (CGL2016-78660-R)) (NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta G, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P285, DOI 10.1007/1-4020-4280-9_13; Almeida IF, 2009, J MED FOOD, V12, P175, DOI 10.1089/jmf.2008.0046; Alvarez-Iglesias L, 2014, ALLELOPATHY J, V34, P299; Amakura Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1060, DOI 10.1271/bbb.80832; An M, 2001, J CHEM ECOL, V27, P383, DOI 10.1023/A:1005640708047; [Anonymous], 2005, P 20 AS PAC WEED SCI; Babu RC, 1997, J AGRON CROP SCI, V179, P123, DOI 10.1111/j.1439-037X.1997.tb00507.x; Bagavathy S, 2007, ALLELOPATHY J, V20, P395; Batish DR, 2008, FOREST ECOL MANAG, V256, P2166, DOI 10.1016/j.foreco.2008.08.008; Batish DR, 2004, CROP PROT, V23, P1209, DOI 10.1016/j.cropro.2004.05.009; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Boulekbache-Makhlouf L, 2013, PHYTOCHEM ANALYSIS, V24, P162, DOI 10.1002/pca.2396; Chiapusio G, 1997, J CHEM ECOL, V23, P2445, DOI 10.1023/B:JOEC.0000006658.27633.15; Chon SU, 2003, WEED RES, V43, P444, DOI 10.1046/j.0043-1737.2003.00361.x; Cordeau S, 2016, CROP PROT, V87, P44, DOI 10.1016/j.cropro.2016.04.016; Dayan FE, 2000, J CHEM ECOL, V26, P2079, DOI 10.1023/A:1005512331061; Dayan FE, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P63, DOI 10.1007/1-4020-4280-9_3; Dejam M., 2014, INT J FARMING ALLIED, V3, P81; DEMMIGADAMS B, 1995, AUST J PLANT PHYSIOL, V22, P249, DOI 10.1071/PP9950249; Dezsi S, 2015, MOLECULES, V20, P4720, DOI 10.3390/molecules20034720; Djanaguiraman M., 2005, International Journal of Agriculture and Biology, V7, P35; Efeoglu B, 2009, S AFR J BOT, V75, P34, DOI 10.1016/j.sajb.2008.06.005; Einhellig FA, 2004, ALLELOPATHY: CHEMISTRY AND MODE OF ACTION OF ALLELOCHEMICALS, P217; El-Rokiek K. G., 2011, Journal of Applied Sciences Research, P1793; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GERIG TM, 1989, J CHEM ECOL, V15, P2403, DOI 10.1007/BF01020371; Golisz A, 2007, WEED BIOL MANAG, V7, P164, DOI 10.1111/j.1445-6664.2007.00252.x; Grana E, 2013, WEED SCI, V61, P469, DOI 10.1614/WS-D-12-00159.1; Gullon B, 2017, IND CROP PROD, V108, P649, DOI 10.1016/j.indcrop.2017.07.014; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hoagland RE, 2004, ALLELOPATHY: CHEMISTRY AND MODE OF ACTION OF ALLELOCHEMICALS, P315; Inderjit, 1996, BOT REV, V62, P186, DOI 10.1007/BF02857921; Jatoba LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161670; JAYAKUMAR M, 1990, COMP PHYSIOL ECOL, V15, P109; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; KRAUSE GH, 1982, BIOCHIM BIOPHYS ACTA, V679, P116, DOI 10.1016/0005-2728(82)90262-6; Macias FA, 2000, J AGR FOOD CHEM, V48, P2512, DOI 10.1021/jf9903051; Macias FA, 2007, PEST MANAG SCI, V63, P327, DOI 10.1002/ps.1342; Mayer AM, 1963, GERMINATION SEEDS; MERSIE W, 1993, J CHEM ECOL, V19, P1293, DOI 10.1007/BF00984876; Morsi M. M., 2016, Australian Journal of Crop Science, V10, P1551; Oliveira AP, 2009, FOOD CHEM TOXICOL, V47, P2841, DOI 10.1016/j.fct.2009.09.004; Padhy B, 2000, ALLELOPATHY J, V7, P69; Pedrol N, 2000, J PLANT PHYSIOL, V157, P383, DOI 10.1016/S0176-1617(00)80023-1; Puig CG, 2013, WEED SCI, V61, P154, DOI 10.1614/WS-D-12-00056.1; Qin B, 2006, PLANT SIGNAL BEHAV, V1, P323, DOI 10.4161/psb.1.6.3563; Reigosa MJ, 2007, J CHEM ECOL, V33, P1456, DOI 10.1007/s10886-007-9318-x; Reigosa MJ, 1999, PLANT GROWTH REGUL, V28, P83, DOI 10.1023/A:1006269716762; Rice E.L., 1984, ALLELOPATHY, P189, DOI 10.1016/B978-0-08-092539-4.50010-1; Seigler DS, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P11, DOI 10.1007/1-4020-4280-9_2; Silva IR, 2004, TREE PHYSIOL, V24, P1267, DOI 10.1093/treephys/24.11.1267; SOUTO XC, 1994, J CHEM ECOL, V20, P3005, DOI 10.1007/BF02098405; Souza L.S., 2003, Planta daninha, V21, P343, DOI 10.1590/S0100-83582003000300001; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Xuan TD, 2005, CROP PROT, V24, P197, DOI 10.1016/j.cropro.2004.08.004; Yamagushi MQ, 2011, SEMIN-CIENC AGRAR, V32, P1361, DOI 10.5433/1679-0359.2011v32n4p1361; Zhang JB, 2010, ALLELOPATHY J, V25, P313; [张志忠 Zhang Zhizhong], 2013, [生态学报, Acta Ecologica Sinica], V33, P4591; Zhou YH, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P127, DOI 10.1007/1-4020-4280-9_6	60	32	34	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192872	10.1371/journal.pone.0192872	http://dx.doi.org/10.1371/journal.pone.0192872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438430	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400063
J	Duleba, W; Teodoro, AC; Debenay, JP; Martins, MVA; Gubitoso, S; Pregnolato, LA; Lerena, LM; Prada, SM; Bevilacqua, JE				Duleba, Wania; Teodoro, Andreia C.; Debenay, Jean-Pierre; Alves Martins, Maria Virginia; Gubitoso, Silas; Pregnolato, Leonardo Antonio; Lerena, Laura Misailidis; Prada, Silvio Miranda; Bevilacqua, Jose Eduardo			Environmental impact of the largest petroleum terminal in SE Brazil: A multiproxy analysis based on sediment geochemistry and living benthic foraminifera	PLOS ONE			English	Article							SAO SEBASTIAO CHANNEL; HEAVY-METAL POLLUTION; RIO-DE-JANEIRO; GUANABARA BAY; AROMATIC-HYDROCARBONS; COASTAL SEDIMENTS; SURFACE SEDIMENTS; NE SECTOR; PHOSPHORUS; MARINE	The Dutos e Terminais do Centro Sul (DTCS) is one of the largest petroleum terminals of the South America located in the Sao Sebastiao Channel (SSC) on the southeastern Brazilian coast. The aims of this study were to compare the sediment quality near the DTCS with that of several sites in the SSC region including the Araca (AR) domestic sewage outfall and to assess the efficiency of the DTCS wastewater treatment plant. To achieve these goals, tex-tural, geochemical, and living benthic foraminifera results were analyzed for the DTCS, AR, and SSC regions. Sediments in the DTCS area were silty with high concentrations of total organic carbon (1.7-2.4%), total nitrogen (0.2-0.3%), total sulfur (0.4-0.6%), and total (0.12-0.18%) and inorganic phosphorous (0.07-0.11%). These values were higher than those in sediments collected in the SSC and Araca regions. The sediments concentrations of As, Cd, Cr, Cu, Hg, Ni, Pb, and Zn in the SSC and AR regions were lower than their corresponding probable effect levels (PELs). However, sediments near the DTCS were enriched with As, Cu, and Ni, whose concentrations exceeded their corresponding threshold effect levels (TELs). Around the DTCS outfall diffusers, living foraminiferal densities and diversities were lower than those for the other areas studied. In the DTCS area, it was necessary to search 50 to 190 cm(3) of sediment to find 100 live specimens. In the SSC and Araca areas, a maximum of 40 cm(3) of sediment was enough to locate 100 live specimens. The lower density and diversity of living foraminifera around the DTCS than around the other areas illustrates the impact of the environmental stress caused by the presence of pollutants. These results indicate that the waste-water treatment plant efficiency is low and its discharge of pollutants from petrochemical waste liquids affects the benthic fauna around the DTCS in a potentially harmful manner.	[Duleba, Wania; Pregnolato, Leonardo Antonio; Lerena, Laura Misailidis] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Rua Arlindo Bettio, Sao Paulo, SP, Brazil; [Teodoro, Andreia C.; Gubitoso, Silas] Univ Sao Paulo, Inst Geociencias, R Lago, Sao Paulo, SP, Brazil; [Debenay, Jean-Pierre] Ctr IRD France Nord, IPSL LOCEAN, UMR 7159, Bondy, France; [Alves Martins, Maria Virginia] Univ Estado Rio de Janeiro, Dept Estratig & Paleontol, Fac Geol, Av Sao Francisco Xavier, Rio De Janeiro, RJ, Brazil; [Alves Martins, Maria Virginia] Univ Aveiro, GeoBioTec, Dept Geociencias, Campus Santiago, Aveiro, Portugal; [Prada, Silvio Miranda; Bevilacqua, Jose Eduardo] UNIFIEO Ctr Univ FIEO, Ctr Estudos Quim, Av Franz Voegeli,Bloco Branco,4 Andar, Osasco, SP, Brazil; [Bevilacqua, Jose Eduardo] Companhia Ambiental Estado Sao Paulo CETESB, Av Prof Frederico Hermann Jr, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universidade do Estado do Rio de Janeiro; Universidade de Aveiro; Centro Universitario Fieo	Duleba, W (corresponding author), Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Rua Arlindo Bettio, Sao Paulo, SP, Brazil.	wduleba@usp.br	Prada, Silvio Miranda/S-6703-2019; Martins, Maria Virginia Alves/O-2893-2013; Alves Martins, Maria Virginia/AAD-3531-2021	Prada, Silvio Miranda/0000-0002-3568-2641; Martins, Maria Virginia Alves/0000-0001-8348-8862; Alves Martins, Maria Virginia/0000-0001-8348-8862	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/51031-8, 02/02611-2]; CETESB; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CETESB; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 09/51031-8, 02/02611-2, Prof Wania Duleba; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 02/02611-2, Dr Andreia C Teodoro; and CETESB.; The authors would like to thank the Editor and the reviewers for their collaboration in improving work. They would also like to thank Claudia Conde A Lamparelli and Debora Moura Ogler for their generous support during the project. This work was supported by FAPESP and CETESB.	Abrahim GMS, 2008, ENVIRON MONIT ASSESS, V136, P227, DOI 10.1007/s10661-007-9678-2; ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; ALVE E, 1991, J FORAMIN RES, V21, P1, DOI 10.2113/gsjfr.21.1.1; Martins MVA, 2016, J SEDIMENT ENVIRON, V1, P411, DOI 10.12957/jse.2016.26875; Martins MVA, 2016, J SEDIMENT ENVIRON, V1, P393, DOI 10.12957/jse.2016.26872; Martins MVA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118077; ASTON SR, 1977, ESTUAR COAST MAR SCI, V5, P243, DOI 10.1016/0302-3524(77)90020-2; Baird C., 1998, ENVIRON CHEM, V1a; Bandy O.L., 1965, LIMNOLOGY OCEANOGRAP, V10, P314, DOI DOI 10.4319/LO.1965.10.3.0314; BANDY OL, 1964, LIMNOL OCEANOGR, V9, P124, DOI 10.4319/lo.1964.9.1.0124; Baturin GN, 2003, LITHOL MINER RESOUR+, V38, P101, DOI 10.1023/A:1023499908601; Bergin F, 2006, ESTUAR COAST SHELF S, V66, P368, DOI 10.1016/j.ecss.2005.09.013; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; Bicego MC, 2008, OCEANOGRAFIA ECOSSIS, P123; BMD C-F., 1990, B I OCEANOGR MONACO, V38, P111, DOI [10.1590/S0373-55241990000200002, DOI 10.1590/S0373-55241990000200002]; Bohrer-Morel MB, 2004, BASES TOXICOLOGICAS, P221; Bouchet VMP, 2007, MAR ENVIRON RES, V64, P358, DOI 10.1016/j.marenvres.2007.02.007; Boyes SJ, 2016, MAR POLLUT BULL, V111, P18, DOI 10.1016/j.marpolbul.2016.06.079; Buosi C, 2010, PRESENT ENV SUSTAINA, V4, P92; Burone L, 2006, MAR POLLUT BULL, V52, P61, DOI 10.1016/j.marpolbul.2005.08.007; Canadian Council of Ministers of the Environment, 1999, CAN ENV QUAL GUID; Carreira RS, 1998, MAR POLLUT BULL, V36, P818, DOI 10.1016/S0025-326X(98)00062-9; Castro B., 1998, REV BRAS OCEANOGR, V46, P111; CCME, CAN ENV QUAL GUID SU; Cetecioglu Z, 2009, MAR POLLUT BULL, V58, P384, DOI 10.1016/j.marpolbul.2008.10.009; CETESB, 2005, REL QUAL AG LIT EST; CETESB Relatorio de monitoramento de emissario submarino, 2007, SER REL; da Silva DAM, 2010, MAR ENVIRON RES, V69, P277, DOI 10.1016/j.marenvres.2009.11.007; Datta DK, 1999, ORG GEOCHEM, V30, P75, DOI 10.1016/S0146-6380(98)00203-4; Debenay JP, 2009, MAR POLLUT BULL, V59, P311, DOI 10.1016/j.marpolbul.2009.09.014; Debenay JP, 2001, J FORAMIN RES, V31, P152, DOI 10.2113/0310152; Debenay JP, 2001, MAR MICROPALEONTOL, V43, P75, DOI 10.1016/S0377-8398(01)00023-8; Delavy FP, 2016, J SEDIMENT ENVIRON, V1, P360, DOI 10.12957/jse.2016.26281; Donnici S, 2002, MAR MICROPALEONTOL, V44, P93, DOI 10.1016/S0377-8398(01)00043-3; Donnici S, 2012, MAR POLLUT BULL, V64, P2015, DOI 10.1016/j.marpolbul.2012.06.024; du Chatelet EA, 2004, ENVIRON POLLUT, V127, P27, DOI 10.1016/S0269-7491(03)00256-2; Duleba N, 2003, J FORAMIN RES, V33, P62; Duleba W, 2007, SERIE RELATORIO, P71; Fatela F, 2002, MAR MICROPALEONTOL, V45, P169, DOI 10.1016/S0377-8398(02)00021-X; FDEP Approach to the Assessment of Sediment Quality in Florida Coastal Waters, 1994, DEV EV SED QUAL ASS, VI; Ferraro L, 2006, ENVIRON POLLUT, V142, P274, DOI 10.1016/j.envpol.2005.10.026; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; Fortis RM, 2007, REV BRASILEIRA RECUR, V12, P117; Frontalini Fabrizio, 2011, Revue de Micropaleontologie, V54, P115, DOI 10.1016/j.revmic.2011.03.001; Furtado V.V., 2008, OCEANOGRAFIA ECOSSIS, P141; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; GESAMP, 1993, REP STUD GESAMP, V59, P180; Giles HN, 2003, AM SOC TESTING MAT I, V5, P51; Gross M.G., 1971, PROCEDURES SEDIMENTA, P573; Guerra R.C., 2009, Arq. Inst. Biol., V76, P259, DOI 10.1590/1808-1657v76p2592009; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Horton BP, 1999, MAR MICROPALEONTOL, V36, P205, DOI 10.1016/S0377-8398(99)00003-1; Jackson RE, 2007, ENVIRON SCI TECHNOL, V41, P5953, DOI 10.1021/es062504o; Jain CK, 1998, HYDROLOG SCI J, V43, P379, DOI 10.1080/02626669809492133; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Kennish M.J., 1992, ECOLOGY ESTUARIES AN; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Lai DYF, 2008, MAR POLLUT BULL, V57, P349, DOI 10.1016/j.marpolbul.2008.01.038; Lamparelli C.C., 2007, EMISSARIOS SUBMARINO; LEGG J. O., 1955, SOIL SCI SOC AMER PROC, V19, P139; Liang A, 2015, ENVIRON SCI POLLUT R, V22, P16067, DOI 10.1007/s11356-015-4825-8; Liu QT, 2003, ENVIRON POLLUT, V122, P51, DOI 10.1016/S0269-7491(02)00286-5; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Ludwig JA, 1988, STAT ECOLOGY; Marins RV, 2007, QUIM NOVA, V30, P1208, DOI 10.1590/S0100-40422007000500029; Martinez-Colon M, 2009, J FORAMIN RES, V39, P278, DOI 10.2113/gsjfr.39.4.278; Martins MVA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137250; Martins V, 2011, J IBER GEOL, V37, P231, DOI 10.5209/rev_JIGE.2011.v37.n2.10; Clemente IMMM, 2015, J COASTAL RES, V31, P1190, DOI 10.2112/JCOASTRES-D-14-00104.1; Matschullat J, 2000, SCI TOTAL ENVIRON, V249, P297, DOI 10.1016/S0048-9697(99)00524-0; McTeir M.D.K., 1993, SOC PETR ENG INT S O; Mitsch W.J., 1986, WETLANDS; Mojtahid M, 2008, MAR POLLUT BULL, V56, P42, DOI 10.1016/j.marpolbul.2007.08.018; MULLER G, 1979, UMSCHAU, V79, P778; Murray J. W., 1991, ECOLOGY PALEOECOLOGY; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Murray JW, 2003, J FORAMIN RES, V33, P101, DOI 10.2113/0330101; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; NAGY J, 1987, MAR MICROPALEONTOL, V12, P109, DOI 10.1016/0377-8398(87)90017-X; Neff J.M., 1987, P531; Nigam R, 2006, ENVIRON INT, V32, P273, DOI 10.1016/j.envint.2005.08.024; Osamor AF, 1978, OIL WATER SEPARATION; Osorio VKL, 2001, QUIM NOVA, V24, P700, DOI 10.1590/S0100-40422001000500019; Pereira EDM, 2006, J COASTAL RES, P1395; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Roig N, 2011, ENVIRON INT, V37, P671, DOI 10.1016/j.envint.2011.01.007; Romano E, 2009, MAR POLLUT BULL, V59, P245, DOI 10.1016/j.marpolbul.2009.09.017; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; Saulnier I, 2000, APPL GEOCHEM, V15, P191, DOI 10.1016/S0883-2927(99)00034-7; Schintu M, 2016, MAR POLLUT BULL, V111, P45, DOI 10.1016/j.marpolbul.2016.07.029; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; SCHRODER CJ, 1987, J FORAMIN RES, V17, P101, DOI 10.2113/gsjfr.17.2.101; Scott DB, 2005, J FORAMIN RES, V35, P65, DOI 10.2113/35.1.65; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SOMERVILLE HJ, 1987, MAR POLLUT BULL, V18, P549, DOI 10.1016/0025-326X(87)90539-X; Steckbauer A, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/025003; Stein R, 1991, ACCUMULATION ORGANIC, P217, DOI DOI 10.1007/BFB0010382; STOFFERS P, 1986, NEW ZEAL J MAR FRESH, V20, P495, DOI 10.1080/00288330.1986.9516169; Sutherland RA, 2000, ARCH ENVIRON CON TOX, V38, P428, DOI 10.1007/s002449910057; Tankere-Muller S, 2007, MAR CHEM, V106, P192, DOI 10.1016/j.marchem.2006.04.005; Teodoro AC, 2010, MAR POLLUT BULL, V60, P536, DOI 10.1016/j.marpolbul.2009.11.011; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tessier E, 2011, MAR POLLUT BULL, V62, P2075, DOI 10.1016/j.marpolbul.2011.07.022; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vorenhout M, 2004, J ENVIRON QUAL, V33, P1562, DOI 10.2134/jeq2004.1562; WALTON WILLIAM R., 1952, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V3, P56; Wang H, 2003, CHEMOSPHERE, V50, P557, DOI 10.1016/S0045-6535(02)00484-8; Wellman DE, 1999, J SOIL CONTAM, V8, P329, DOI 10.1080/10588339991339360; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wilhelm SM, 2000, FUEL PROCESS TECHNOL, V63, P1, DOI 10.1016/S0378-3820(99)00068-5; YANKO V, 1994, J FORAMIN RES, V24, P1, DOI 10.2113/gsjfr.24.1.1; Yanko V, 1999, MODERN FORAMINIFERA, P217; ZALESNY EMIL R., 1959, MICROPALEONTOLOGY, V5, P101, DOI 10.2307/1484158; Zanardi E, 1999, MAR POLLUT BULL, V38, P410, DOI 10.1016/S0025-326X(97)00194-X; Zoumis T, 2001, SCI TOTAL ENVIRON, V266, P195, DOI 10.1016/S0048-9697(00)00740-3	115	19	19	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191446	10.1371/journal.pone.0191446	http://dx.doi.org/10.1371/journal.pone.0191446			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432425	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300005
J	Pavanello, C; Zanaboni, AM; Gaito, S; Botta, M; Mombelli, G; Sirtori, CR; Ruscica, M				Pavanello, Chiara; Zanaboni, Anna Maria; Gaito, Sabrina; Botta, Margherita; Mombelli, Giuliana; Sirtori, Cesare R.; Ruscica, Massimiliano			Influence of body variables in the development of metabolic syndrome-A long term follow-up study	PLOS ONE			English	Article							RISK-FACTORS; SCIENTIFIC STATEMENT; OBESITY; RATIO; ASSOCIATION; CHOLESTEROL; MANAGEMENT; ADIPOSITY; DIAGNOSIS	Objectives The body variable associated with the diagnosis of Metabolic Syndrome (MetS) is an elevated waist circumference (WC), although a number of other variables have been suggested. Among these, an elevated waist-to-height ratio (WHtR), ie a value higher than 0.5, that may identify abnormality, independently from height. An elevated WHtR provided the best correlation with MetS in a prior study in a large Italian population. In order to assess the validity of this conclusion, a long-term follow-up study re-examined this population, also in order to detect possible associations with cardiovascular (CV) risk. Methods and results 1,071 subjects with a complete follow-up of over 6 years were evaluated with a comparative assessment of the three anthropometric variables, namely WHtR, WC and body mass index (BMI). WHtR >= 0.5 had the highest sensitivity for the identification of MetS, both in males and females (94.1% and 86.7% respectively). WHtR was of reduced specificity, occurring, yet less frequently (17.7% in males and 30% in females), in patients without MetS. By contrast, enlarged WC occurred with a lower frequency in male patients who developed MetS (30.2%) whereas in females, frequency was higher than in males (69.3%). Finally, a BMI >= 25 kg/m(2) had intermediate sensitivity and specificity regardless of gender. WC showed the highest odds ratio (2.62, 95% CI: 1.18 +/- 5.78) for the prediction of CV occurrence. Conclusion The present study confirms WHtR as an excellent screening tool in identifying MetS carriers, but, different from reports in other countries, it shows a lower specificity in our population.	[Pavanello, Chiara] Univ Milan, Ctr E Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Zanaboni, Anna Maria; Gaito, Sabrina] Univ Milan, Dipartimento Informat, Milan, Italy; [Botta, Margherita; Ruscica, Massimiliano] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Mombelli, Giuliana; Sirtori, Cesare R.] ASST Grande Osped Metropolitano Niguarda, Dyslipidemia Ctr, Milan, Italy	University of Milan; University of Milan; University of Milan	Sirtori, CR (corresponding author), ASST Grande Osped Metropolitano Niguarda, Dyslipidemia Ctr, Milan, Italy.	cesare.sirtori@icloud.it	Ruscica, Massimiliano/K-7133-2012; Pavanello, Chiara/AAE-5530-2021; Ruscica, Massimiliano/AAP-8672-2020	Ruscica, Massimiliano/0000-0002-0195-7061; Ruscica, Massimiliano/0000-0002-0195-7061; PAVANELLO, CHIARA/0000-0001-5892-9857				Akbaraly TN, 2010, J CLIN ENDOCR METAB, V95, pE327, DOI 10.1210/jc.2010-0153; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; FRANCESCHINI G, 1994, ARTERIOSCLER THROMB, V14, P1569, DOI 10.1161/01.ATV.14.10.1569; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hopps E, 2010, NUTR METAB CARDIOVAS, V20, P72, DOI 10.1016/j.numecd.2009.06.002; Kagawa M, 2008, BRIT J NUTR, V100, P1135, DOI 10.1017/S0007114508966095; Lee JJ, 2016, J AM COLL CARDIOL, V68, P1509, DOI 10.1016/j.jacc.2016.06.067; Mancia G, 2007, HYPERTENSION, V49, P40, DOI 10.1161/01.HYP.0000251933.22091.24; Mason C, 2009, AM J CARDIOL, V103, P1716, DOI 10.1016/j.amjcard.2009.02.018; Mombelli G, 2017, CURR VASC PHARM; Mombelli G, 2009, ATHEROSCLEROSIS, V206, P340, DOI 10.1016/j.atherosclerosis.2009.02.036; Mombelli G, 2009, METAB SYNDR RELAT D, V7, P477, DOI 10.1089/met.2008.0101; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rana JS, 2016, J AM COLL CARDIOL, V67, P2118, DOI 10.1016/j.jacc.2016.02.055; Roos V, 2017, METAB SYNDR RELAT D, V15, P36, DOI 10.1089/met.2016.0082; Ruscica M, 2014, EUR J INTERN MED, V25, P401, DOI 10.1016/j.ejim.2014.03.003; Salazar MR, 2014, AM J MED, V127, P152, DOI 10.1016/j.amjmed.2013.10.012; Salminen M, 2010, DIABETES METAB, V36, P437, DOI 10.1016/j.diabet.2010.05.002; Schmidt C, 2012, METAB SYNDR RELAT D, V10, P394, DOI 10.1089/met.2012.0048; Sirtori CR, 2001, CIRCULATION, V103, P1949; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Vishnu A, 2015, ATHEROSCLEROSIS, V243, P278, DOI 10.1016/j.atherosclerosis.2015.09.025; Wang GS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156243	29	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192751	10.1371/journal.pone.0192751	http://dx.doi.org/10.1371/journal.pone.0192751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432480	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300043
J	Sailer, V; Charpentier, A; Dietrich, J; Vogt, TJ; Franzen, A; Bootz, F; Dietrich, D; Schroeck, A				Sailer, Verena; Charpentier, Arthur; Dietrich, Joern; Vogt, Timo J.; Franzen, Alina; Bootz, Friedrich; Dietrich, Dimo; Schroeck, Andreas			Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas	PLOS ONE			English	Article							COMPREHENSIVE GENOMIC CHARACTERIZATION; POSITIVE BREAST-CANCER; HUMAN-PAPILLOMAVIRUS; PROSTATE-CANCER; SURVIVAL; RISK; CHEMOTHERAPY; STATISTICS; RECURRENCE; EXPRESSION	Background Patients with squamous cell cancer of the head and neck region (HNSCC) are at risk for disease recurrence and metastases, even after initial successful therapy. A tissue-based biomarker could be beneficial to guide treatment as well as post-treatment surveillance. Gene methylation status has been recently identified as powerful prognostic biomarker in HNSCC. We therefore evaluated the methylation status of the homeobox gene PITX1 and the adjacent long intergenic non-coding RNA (lincRNA) C5orf66-AS1 in publicly available datasets. Methods Gene methylation and expression data from 528 patients with HNSCC included in The Cancer Genome Atlas (TCGA, there obtained by using the Infinium HumanMethylation450 BeadChip Kit) were evaluated and methylation and expression levels of PITX1 and lincRNA C5orf66-AS1 was correlated with overall survival and other parameters. Thus, ten beads targeting PITX1 exon 3 and three beads targeting lincRNA C5orf66-AS1 were identified as significant candidates. The mean methylation of these beads was used for further correlation and the median was employed for dichotomization. Results Both PITX1 exon 3 and lincRNA C5orf66-AS1 were significantly higher methylated in tumor tissue than in normal adjacent tissue (NAT) (PITX1 exon 3: tumor tissue 58.1%, NAT: 31.7%, p<0.001; lincRNA C5orf66-AS1: tumor tissue: 27.4%, NAT: 18.9%, p<0.001). In a univariate analysis, hypermethylation of both loci was significantly associated with the risk of death (univariate: exon 3: Hazard ratio (HR): 4.97 [1.78-16.71], p = 0.010, lincRNA C5orf66-AS1: Hazard ratio (HR): 12.23 [3.01-49.74], p<0.001). PITX1 exon 3 and lincRNA C5orf66-AS1 methylation was also significantly correlated with tumor localization, T category, human papilloma virus (HPV)-negative and p16-negative tumors and tumor grade. Kaplan-Meier analysis showed, that lincRNA C5orf66-AS1 hypomethylation was significantly associated with overall survival (p = 0.001) in the entire cohort as well in a subgroup of HPV-negative tumors (p = 0.003) and in patients with laryngeal tumors (p = 0.022). Conclusion Methylation status of PITX1 and even more so of lincRNA C5orf66-AS1 is a promising prognostic biomarker in HNSCC, in particular for HPV-negative patients. Further prospective evaluation is warranted.	[Sailer, Verena] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Sailer, Verena] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA; [Charpentier, Arthur; Dietrich, Joern; Vogt, Timo J.; Franzen, Alina; Bootz, Friedrich; Dietrich, Dimo; Schroeck, Andreas] Univ Hosp Bonn, Dept Otolaryngol Head & Neck Surg, Bonn, Germany	Cornell University; Cornell University; University of Bonn	Dietrich, D (corresponding author), Univ Hosp Bonn, Dept Otolaryngol Head & Neck Surg, Bonn, Germany.	dimo.dietrich@gmail.com						Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Bell A, 2011, CANCER-AM CANCER SOC, V117, P2898, DOI 10.1002/cncr.25818; Blasco MA, 2017, LARYNGOSCOPE; Bossi P, 2016, CLIN CANCER RES, V22, P3961, DOI 10.1158/1078-0432.CCR-15-2547; Brennan K, 2017, EBIOMEDICINE, V17, P223, DOI 10.1016/j.ebiom.2017.02.025; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Crawford MJ, 1997, MAMM GENOME, V8, P841, DOI 10.1007/s003359900589; Dietrich D, 2013, J MOL DIAGN, V15, P270, DOI 10.1016/j.jmoldx.2012.11.002; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Enzenhofer E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167665; Feng L, 2017, ONCOTARGET, V8, P31521, DOI 10.18632/oncotarget.16358; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gatta G, 2015, EUR J CANCER, V51, P2130, DOI 10.1016/j.ejca.2015.07.043; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goltz D, 2017, LEUKEMIA, V31, P738, DOI 10.1038/leu.2016.328; Goltz D, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1221555; Graham A, 1999, CURR BIOL, V9, pR368, DOI 10.1016/S0960-9822(99)80229-2; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hartmann O, 2009, CLIN CANCER RES, V15, P315, DOI 10.1158/1078-0432.CCR-08-0166; Huang SH, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0484-y; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jouhi L, 2017, CURR OPIN OTOLARYNGO, V25, P108, DOI 10.1097/MOO.0000000000000341; Juodzbalys G, 2016, CANCER BIOMARK, V17, P487, DOI 10.3233/CBM-160666; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kondo Y, 2017, CANCER SCI, V108, P1927, DOI 10.1111/cas.13342; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Meller S, 2016, EPIGENETICS, P1; Mennen U, 2014, J HAND SURG-EUR VOL, V39, P919, DOI 10.1177/1753193413502162; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Sailer V, 2016, ONCOTARGET; Sailer V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179412; Schatz P, 2010, J MOL DIAGN, V12, P345, DOI 10.2353/jmoldx.2010.090088; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Tai WT, 2016, HEPATOLOGY, V63, P1528, DOI 10.1002/hep.28478; Takenobu M, 2016, MOL CLIN ONCOL, V5, P89, DOI 10.3892/mco.2016.880; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Uhl B, 2017, J MOL DIAGN, V19, P107, DOI 10.1016/j.jmoldx.2016.08.008; Uhl B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165769; Wei GF, 2015, ONCOTARGET, V6, P17065, DOI 10.18632/oncotarget.4185; Wei JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9699; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang SYF, 2016, OTOLARYNG HEAD NECK, V155, P416, DOI 10.1177/0194599816642436; ZHANG C, 2017, BMC GENOMICS, V18, P8634; Zhao D, 2011, HUM PATHOL, V42, P1514, DOI 10.1016/j.humpath.2010.03.012	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192742	10.1371/journal.pone.0192742	http://dx.doi.org/10.1371/journal.pone.0192742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425237	Green Published, gold, Green Submitted			2022-12-26	WOS:000424700800041
J	Ahn, KB; Baik, JE; Park, OJ; Yun, CH; Han, SH				Ahn, Ki Bum; Baik, Jung Eun; Park, Ok-Jin; Yun, Cheol-Heui; Han, Seung Hyun			Lactobacillus plantarum lipoteichoic acid inhibits biofilm formation of Streptococcus mutans	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NITRIC-OXIDE PRODUCTION; STAPHYLOCOCCUS-AUREUS; TEICHOIC-ACIDS; ANTIMICROBIAL PEPTIDES; MURINE MACROPHAGES; DENTAL-CARIES; RESISTANCE; RECEPTOR; PROTEIN	Dental caries is a biofilm-dependent oral disease and Streptococcus mutans is the known primary etiologic agent of dental caries that initiates biofilm formation on tooth surfaces. Although some Lactobacillus strains inhibit biofilm formation of oral pathogenic bacteria, the molecular mechanisms by which lactobacilli inhibit bacterial biofilm formation are not clearly understood. In this study, we demonstrated that Lactobacillus plantarum lipoteichoic acid (Lp.LTA) inhibited the biofilm formation of S. mutans on polystyrene plates, hydroxyapatite discs, and dentin slices without affecting the bacterial growth. Lp.LTA interferes with sucrose decomposition of S. mutans required for the production of exopolysaccharide, which is a main component of biofilm. Lp.LTA also attenuated the biding of fluorescein isothiocyanate-conjugated dextran to S. mutans, which is known to have a high affinity to exopolysaccharide on S. mutans. Dealanylated Lp.LTA did not inhibit biofilm formation of S. mutans implying that D-alanine moieties in the Lp.LTA structure were crucial for inhibition. Collectively, these results suggest that Lp.LTA attenuates S. mutans biofilm formation and could be used to develop effective anticaries agents.	[Ahn, Ki Bum; Baik, Jung Eun; Park, Ok-Jin; Han, Seung Hyun] Seoul Natl Univ, Sch Dent, Dept Oral Microbiol & Immunol, DRI, Seoul, South Korea; [Ahn, Ki Bum; Baik, Jung Eun; Park, Ok-Jin; Han, Seung Hyun] Seoul Natl Univ, Sch Dent, Plus Program Bk21, Seoul, South Korea; [Ahn, Ki Bum] Korea Atom Energy Res Inst, Res Div Biotechnol, Jeongeup, South Korea; [Yun, Cheol-Heui] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Yun, Cheol-Heui] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Atomic Energy Research Institute (KAERI); Seoul National University (SNU); Seoul National University (SNU)	Han, SH (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Microbiol & Immunol, DRI, Seoul, South Korea.; Han, SH (corresponding author), Seoul Natl Univ, Sch Dent, Plus Program Bk21, Seoul, South Korea.	shhan-mi@snu.ac.kr	YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887; Han, Seung Hyun/0000-0001-9418-9278; Ahn, Ki Bum/0000-0003-4445-5720	National Research Foundation of Korea - Korean government [NRF-2015R1D1A1A09056592, NRF-2015M2A2A6A01044894]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C1377]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by grants from the National Research Foundation of Korea (http://www.nrf.re.kr), which is funded by the Korean government (NRF-2015R1D1A1A09056592 to OJP and NRF-2015M2A2A6A01044894 to SHH), and by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (http://www.khidi.or.kr), funded by the Ministry of Health & Welfare (HI17C1377 to OJK), Republic of Korea.	Ahn SJ, 2012, ACTA ODONTOL SCAND, V70, P504, DOI 10.3109/00016357.2011.640277; Anunthawan T, 2015, BBA-BIOMEMBRANES, V1848, P1352, DOI 10.1016/j.bbamem.2015.02.021; Balakrishnan M, 2000, AUST DENT J, V45, P235, DOI 10.1111/j.1834-7819.2000.tb00257.x; Botelho JN, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0052; Claes IJJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-161; COURTNEY HS, 1991, INFECT IMMUN, V59, P1661, DOI 10.1128/IAI.59.5.1661-1666.1991; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Dong D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131806; Egland PG, 2004, P NATL ACAD SCI USA, V101, P16917, DOI 10.1073/pnas.0407457101; Elshikh M, 2017, NEW BIOTECHNOL, V36, P26, DOI 10.1016/j.nbt.2016.12.009; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gao QX, 2016, FISH SHELLFISH IMMUN, V54, P573, DOI 10.1016/j.fsi.2016.05.013; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; HAJISHENGALLIS G, 1992, INFECT IMMUN, V60, P5057, DOI 10.1128/IAI.60.12.5057-5064.1992; Hatano S, 2015, INT IMMUNOPHARMACOL, V25, P321, DOI 10.1016/j.intimp.2015.02.011; Haukioja A., 2010, EUROPEAN J DENT, V4, P348; James KM, 2016, J MED MICROBIOL, V65, P328, DOI 10.1099/jmm.0.000226; Jang KS, 2011, BIOCHEM BIOPH RES CO, V407, P823, DOI 10.1016/j.bbrc.2011.03.107; Kang SS, 2016, ARCH PHARM RES, V39, P1519, DOI 10.1007/s12272-016-0804-y; Kang SS, 2011, MOL IMMUNOL, V48, P2170, DOI 10.1016/j.molimm.2011.07.009; Kim HG, 2008, J IMMUNOL, V180, P2553, DOI 10.4049/jimmunol.180.4.2553; Kim HG, 2011, MOL IMMUNOL, V48, P382, DOI 10.1016/j.molimm.2010.07.011; Kim NJ, 2015, MOL IMMUNOL, V65, P17, DOI 10.1016/j.molimm.2014.12.016; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; KURAMITSU HK, 1980, INFECT IMMUN, V29, P376; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Noh SY, 2015, MOL IMMUNOL, V64, P183, DOI 10.1016/j.molimm.2014.11.014; Ou MZ, 2017, MOL MED REP, V15, P210, DOI 10.3892/mmr.2016.5979; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Pitts NB, 2017, NAT REV DIS PRIMERS, V3, P1, DOI 10.1038/nrdp.2017.30; Raisanen L, 2007, J BACTERIOL, V189, P4135, DOI 10.1128/JB.00078-07; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rivardo F, 2009, APPL MICROBIOL BIOT, V83, P541, DOI 10.1007/s00253-009-1987-7; Ryu YH, 2009, INT IMMUNOPHARMACOL, V9, P127, DOI 10.1016/j.intimp.2008.10.014; Sedgley CM, 2008, J ENDODONT, V34, P570, DOI 10.1016/j.joen.2008.02.014; Sekhon KK, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-49; Shah DSH, 2004, MICROBIOL-SGM, V150, P1947, DOI 10.1099/mic.0.26955-0; Shiratsuchi A, 2010, IMMUNOLOGY, V129, P268, DOI 10.1111/j.1365-2567.2009.03168.x; Skucaite N, 2010, J ENDODONT, V36, P1611, DOI 10.1016/j.joen.2010.04.009; Soderling EM, 2011, CURR MICROBIOL, V62, P618, DOI 10.1007/s00284-010-9752-9; Tahmourespour A, 2011, BIOFOULING, V27, P385, DOI 10.1080/08927014.2011.575458; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Velusamy P, 2016, TOX RESEARCH, V32, P95, DOI 10.5487/TR.2016.32.2.095; Ward OP, 2010, ADV EXP MED BIOL, V672, P65; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; WICKEN AJ, 1980, BIOCHIM BIOPHYS ACTA, V604, P1, DOI 10.1016/0304-4157(80)90002-7; Wong Sook-San, 2013, BMC Res Notes, V6, P135, DOI 10.1186/1756-0500-6-135; Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027; You GE, 2013, J MICROBIOL BIOTECHN, V23, P1357, DOI 10.4014/jmb.1306.06026; Zhang A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03364; Zhang PB, 2017, ACS APPL MATER INTER, V9, P16934, DOI 10.1021/acsami.7b05227	57	44	47	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192694	10.1371/journal.pone.0192694	http://dx.doi.org/10.1371/journal.pone.0192694			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420616	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900106
J	Guaricci, AI; Carita, P; Lorenzoni, V; Casavecchia, G; Rabbat, M; Ieva, R; Brunetti, ND; Andreini, D; Di Biase, M; Marenzi, G; Bartorelli, A; Pepi, M; Pontone, G				Guaricci, Andrea Igoren; Carita, Patrizia; Lorenzoni, Valentina; Casavecchia, GraziaPia; Rabbat, Mark; Ieva, Riccardo; Brunetti, Natale Daniele; Andreini, Daniele; Di Biase, Matteo; Marenzi, Giancarlo; Bartorelli, Antonio; Pepi, Mauro; Pontone, Gianluca			QT-interval evaluation in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction for prediction of myocardial salvage index	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; END-SYSTOLIC VOLUME; RECOVERY; SIZE; PROLONGATION; ANGIOPLASTY; OUTCOMES; CMR	Assessing the efficacy of revascularization therapy in patients with ST-segment elevation myocardial infarction (STEMI) is extremely important in order to guide subsequent management and assess prognosis. We aimed to determine the relationship between corrected QT-interval (QTc) changes on standard sequential ECG and myocardial salvage index in anterior STEMI patients after successful primary percutaneous coronary intervention. Fifty anterior STEMI patients treated by primary percutaneous coronary intervention underwent quantitative ECG analysis and cardiac magnetic resonance. For each patient the difference (Delta QTc) between the QTc of ischemic myocardium (maximum QTc in anterior leads) versus remote myocardium (minimum QTc in inferior leads) during the first six days after STEMI was measured. The QTc in anterior leads was significantly longer than QTc in inferior leads (p<0.0001). At multivariate analysis, Delta QT(C) and peak troponin I were the only independent predictors for late gadolium enhancement while Delta QTc and left ventricular ejection fraction were independent predictors of myocardial salvage index < 60%. The receiver operative curve of Delta QTc showed an area under the curve of 0.77 to predict a myocardial salvage index < 0.6. In conclusion, in a subset of patients with a first occurrence of early revascularized anterior STEMI, Delta QTc is inversely correlated with CMR-derived myocardial salvage index and may represent a useful parameter for assessing efficacy of reperfusion therapy.	[Guaricci, Andrea Igoren] Univ Hosp Policlin Bari, Dept Emergency & Organ Transplantat, Inst Cardiovasc Dis, Bari, Italy; [Guaricci, Andrea Igoren; Casavecchia, GraziaPia; Ieva, Riccardo; Brunetti, Natale Daniele; Di Biase, Matteo] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Carita, Patrizia] Univ Hosp P Giaccone, Dept Cardiol, Palermo, Italy; [Lorenzoni, Valentina] Scuola Super Sant Anna, Florence, Italy; [Rabbat, Mark] Loyola Univ, Chicago, IL 60611 USA; [Rabbat, Mark] Edward Hines Jr VA Hosp, Hines, IL USA; [Andreini, Daniele; Marenzi, Giancarlo; Bartorelli, Antonio; Pepi, Mauro; Pontone, Gianluca] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Andreini, Daniele] Univ Milan, Dept Cardiovasc Sci & Community Hlth, Milan, Italy; [Bartorelli, Antonio] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy	Universita degli Studi di Bari Aldo Moro; University of Foggia; University of Palermo; Policlinico Paolo Giaccone; Scuola Superiore Sant'Anna; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; Luigi Sacco Hospital	Pontone, G (corresponding author), IRCCS, Ctr Cardiol Monzino, Milan, Italy.	gianluca.pontone@ccfm.it	Brunetti, Natale Daniele/S-9131-2019; Andreini, Daniele/ABG-9647-2020; Rabbat, Mark/AAS-9710-2021; Bartorelli, Antonio/K-3955-2018; Lorenzoni, Valentina/K-5306-2018; Bartorelli, Antonio Luca/ABG-9593-2020	Brunetti, Natale Daniele/0000-0001-9610-7408; Lorenzoni, Valentina/0000-0002-9948-0301; Pontone, Gianluca/0000-0002-1339-6679; Marenzi, Giancarlo/0000-0003-4410-4461				Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; Bonnemeier H, 2001, J AM COLL CARDIOL, V37, P44, DOI 10.1016/S0735-1097(00)01061-5; Brunetti ND, 2016, AM J THER, V23, pE1057, DOI 10.1097/MJT.0000000000000301; Dall'Armellina E, 2011, CIRC-CARDIOVASC IMAG, V4, P228, DOI 10.1161/CIRCIMAGING.111.963421; de Waha S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-249; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Francone M, 2009, J AM COLL CARDIOL, V54, P2145, DOI 10.1016/j.jacc.2009.08.024; Galluzzo A, 2015, J CARDIOVASC MED, V16, P1; Greupner J, 2012, J AM COLL CARDIOL, V59, P1897, DOI 10.1016/j.jacc.2012.01.046; Guaricci AI, 2015, J CARDIOVASC MED, V16, P653, DOI 10.2459/JCM.0000000000000267; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Larose E, 2010, J AM COLL CARDIOL, V55, P2459, DOI 10.1016/j.jacc.2010.02.033; Maffei E, 2012, EUR RADIOL, V22, P1041, DOI 10.1007/s00330-011-2345-6; Masci PG, 2010, JACC-CARDIOVASC IMAG, V3, P45, DOI 10.1016/j.jcmg.2009.06.016; Pontone G, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004956; Pontone G, 2016, EUR RADIOL, V26, P2155, DOI 10.1007/s00330-015-4064-x; Pontone G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/297696; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Wu E, 2008, HEART, V94, P730, DOI 10.1136/hrt.2007.122622; Zimarino M, 2011, HEART, V97, P466, DOI 10.1136/hrt.2010.206003	23	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192220	10.1371/journal.pone.0192220	http://dx.doi.org/10.1371/journal.pone.0192220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420570	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900054
J	Bamorovat, M; Sharifi, I; Aflatoonian, MR; Sharifi, H; Karamoozian, A; Sharifi, F; Khosravi, A; Hassanzadeh, S				Bamorovat, Mehdi; Sharifi, Iraj; Aflatoonian, Mohammad Reza; Sharifi, Hamid; Karamoozian, Ali; Sharifi, Fatemeh; Khosravi, Ahmad; Hassanzadeh, Saeid			Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; MORPHINE; DIAGNOSIS; PROVINCE; DRUGS	Cutaneous leishmaniasis (CL) is a serious health challenge at the global level due to Leishmania tropica. This study was conducted to evaluate the risk factors associated with anthroponotic CL (ACL) in unresponsive (patient who does not heal and remains with an active lesion, despite receiving two courses of intra-lesional Glucantime along with cryotherapy and one cycle of systemic Glucantime) and responsive patients in a major focus in southeastern Iran. A case-control study was conducted from April 2015 to October 2016 in the southeast of Iran. Patients were recruited in a major ACL focus from unresponsive and responsive cases. These patients were compared for environmental, clinical, and demographic characteristic factors. Twenty-five risk related factors were analyzed using multivariate logistic regression and backward elimination stepwise models. P<0.05 was defined to be statistically significant. In general, 340 patients with ACL comprising 72 (21.2%) unresponsive cases and 268 (78.8%) responsive cases with active lesions or scars were analyzed by estimating odds ratio (OR). All isolates from 15 responsive and 15 unresponsive patients were characterized as Leishmania tropica based on the BLAST and phylogenic analyses by PCR sequences of the Hsp70 and ITS1 loci. Among the 25 variables, 4 major risk factors including poor interior housing conditions (OR = 1.99, confidence interval (CI) = 1-3.93, P<0.04), history of chronic diseases (OR = 6.22, CI = 2.51-15.44, P <= 0.001), duration of lesion in the patients referred >= 13 months (OR = 74.99, CI = 17.24-326.17, P <= 0.001), and 5 +/- 12 months (OR=7.42,CI = 3.07-17.92, P <= 0.001) than lesions with <= 4 months of age and age groups >= 51 years (OR = 3.85, CI = 1.04-14.22, P<0.04) than those <= 7 years, were significantly associated with unresponsive forms. Improving interior house construction protecting high risk individuals and those with debilitating diseases from being bitten by sand flies, together with the early detection and effective treatment of older age groups with history of chronic diseases are highly important measures for preventing unresponsive forms in patients with ACL in southeastern Iran.	[Bamorovat, Mehdi; Sharifi, Iraj; Khosravi, Ahmad] Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran; [Aflatoonian, Mohammad Reza] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran; [Sharifi, Hamid] Kerman Univ Med Sci, Inst Futures Studies Hlth, HIV STI Surveillance Res Ctr, Kerman, Iran; [Sharifi, Hamid] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Karamoozian, Ali] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran; [Sharifi, Fatemeh] Kerman Univ Med Sci, Inst Neuropharmacol, Pharmaceut Res Ctr, Kerman, Iran; [Hassanzadeh, Saeid] Shahid Bahonar Univ Kerman, Dept Pathobiol, Fac Vet Med, Kerman, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Shahid Bahonar University of Kerman (SBUK)	Sharifi, I (corresponding author), Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran.	iraj.sharifi@yahoo.com	Sharifi, Fatemeh/AAA-3666-2019; Sharifi, Hamid/B-5493-2019; Karamoozian, Ali/AAX-7523-2021; Khosravi, Ahmad/AAA-5264-2019; Sharifi, Iraj/AAY-8267-2020; Bamorovat, Mehdi/AAD-3051-2021; Reza, Aflatoonian Mohammad/Y-2246-2018	Sharifi, Fatemeh/0000-0003-1711-0540; Sharifi, Hamid/0000-0002-9008-7618; Bamorovat, Mehdi/0000-0002-4900-4278; Reza, Aflatoonian Mohammad/0000-0002-2148-6690; Karamoozian, Ali/0000-0002-1677-2852; Sharifi, Iraj/0000-0002-6894-6834	Kerman University of Medical Sciences, Kerman, Iran [94.621, IR.KMU.REC.1394.115]	Kerman University of Medical Sciences, Kerman, Iran	This study was supported by the Vice-Chancellor for Research, Kerman University of Medical Sciences (ethic no. IR.KMU.REC.1394.115, contract no. 94.621), Kerman, Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Vice-Chancellor for Research, Kerman University of Medical Sciences (contract no. 94.621), Kerman, Iran. We thank Mrs S. Nikpoor for editing the manuscript and Mr M.A. Mohammadi for his help in molecular examinations.	Aflatoonian B., 2016, IRANIAN J EPIDEMIOLO, V12, P28; Aflatoonian MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089043; Allahverdiyev AM, 2005, AM J TROP MED HYG, V73, P276, DOI 10.4269/ajtmh.2005.73.276; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; BUSSIERE JL, 1992, IMMUNOPHARM IMMUNOT, V14, P657, DOI 10.3109/08923979209005416; Desjeux P, 2001, MED MICROBIOL IMMUN, V190, P77, DOI 10.1007/s004300100085; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Dujardin JC, 2006, TRENDS PARASITOL, V22, P4, DOI 10.1016/j.pt.2005.11.004; Chaves LF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-164; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Gkolfinopoulou K, 2013, Euro Surveill, V18, P20532, DOI 10.2807/1560-7917.ES2013.18.29.20532; Gouya M. M., 2010, NATL GUIDELINES CUTA, P1; Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Karimi A, 2014, ACTA TROP, V132, P131, DOI 10.1016/j.actatropica.2014.01.004; Khazaei S, 2015, ARCH CLIN INFECT DIS, V10, DOI 10.5812/archcid.28511; Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042; Lysle DT, 2000, IMMUNOPHARMACOLOGY, V46, P181, DOI 10.1016/S0162-3109(99)00172-1; Malaviya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106771; Membrive NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047050; MOLITOR TW, 1992, J PHARMACOL EXP THER, V260, P581; Mostafavi R., 2013, ARCH HYG SCI, V2, P48; Murback Nathalia Dias Negrão, 2011, An. Bras. Dermatol., V86, P55, DOI 10.1590/S0365-05962011000100007; Natera S, 2007, INT J ANTIMICROB AG, V29, P637, DOI 10.1016/j.ijantimicag.2007.01.004; Norouzinezhad F, 2016, ASIAN PAC J TROP BIO, V6, P614, DOI 10.1016/j.apjtb.2016.05.005; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; PETERSON PK, 1987, J IMMUNOL, V138, P3907; Reithinger R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000639; Sacerdote P, 1997, BRIT J PHARMACOL, V121, P834, DOI 10.1038/sj.bjp.0701138; Sarkari B, 2012, IRAN J PUBLIC HEALTH, V41, P94; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Sharifi I, 2015, IRAN J PUBLIC HEALTH, V44, P299; SISON JP, 1995, CLIN INFECT DIS, V20, P1207, DOI 10.1093/clinids/20.5.1207; Van der Auwera G, 2013, EUROSURVEILLANCE, V18, P40, DOI 10.2807/1560-7917.ES2013.18.30.20543; van der Auwera G, 2015, CLIN MICROBIOL REV, V28, P265, DOI 10.1128/CMR.00104-14; Van der Auwera G, 2014, J CLIN MICROBIOL, V52, P1098, DOI 10.1128/JCM.02936-13; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; World Health Organization, 2010, CONTR LEISHM REP M W; World Health Organization, 2016, WEEKL EP REC REL EP; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Zampieri RA, 2016, PLOS NEGLECT TROP D, V10, P1	41	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192236	10.1371/journal.pone.0192236	http://dx.doi.org/10.1371/journal.pone.0192236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415078	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300061
J	Ramadan, S; Nowier, AM; Hori, Y; Inoue-Murayama, M				Ramadan, Sherif; Nowier, Amira M.; Hori, Yusuke; Inoue-Murayama, Miho			The association between glutamine repeats in the androgen receptor gene and personality traits in dromedary camel (Camelus dromedarius)	PLOS ONE			English	Article							LENGTH POLYMORPHISM; PANIC DISORDER; FEAR REACTIONS; DAIRY-COWS; BEHAVIOR; CAG; RESPONSIVENESS; TEMPERAMENT; ANXIETY; STRESS	Temperament traits such as fearfulness are important as they define an animal's responses to its environment and handling. The increasing automation of daily tasks and growing population limits contact between camels and humans. Such limitations contribute to fear of humans and changes in physical environment. Monoamine oxidase A (MAOA) and androgen receptor (AR) genes are important candidates associated with mammal personality. In our analysis, MAOA exon 15 showed no polymorphism but a novel polymorphism was seen in the camel AR exon 1; 16, 17, 18, and 19 glutamine repeats were detected. We genotyped 138 camels belonging to four Egyptian breeds: Maghrabi (n = 90), Sudani (n = 15), Somali (n = 23), and Baladi (n = 10) for AR. Out of the 90 genotyped Maghrabi camels, we evaluated responses of 33 and 32 mature females to a novel object and exposure to an unfamiliar person, respectively. AR gene showed a significant association based on the principal component (PC) score, which indicated the fear of human touch, and the PC score indicates fear during interaction with novel objects. Individuals carrying a shorter genotype in homozygote (S/S) were found to be more fearful. Furthermore, we found that Sudani and Somali breeds had a higher frequency of shorter genotype (S/S), which was associated with increased fearfulness. These findings reflect the behavioral tendency and consequently, affect the use of this breed. This is the first report showing the role of AR glutamine repeats influencing a behavioral trait in dromedary camels and leading to inter-breed differences. Fear-related traits reported here are important because camels cope with various types of stresses and fear, resulting from the demands of intensive production systems and racing events. However, further studies, employing functional genomics and linkage analysis are necessary for confirming the relationship between fearfulness and genetic variation.	[Ramadan, Sherif; Hori, Yusuke; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Ramadan, Sherif] Benha Univ, Fac Vet Med, Moshtohor, Egypt; [Nowier, Amira M.] Anim Prod Res Inst, Biotechnol Res Dept, Dokki, Egypt; [Hori, Yusuke] Kyoto Univ, Grad Sch Letters, Kyoto, Japan; [Inoue-Murayama, Miho] Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan	Kyoto University; Egyptian Knowledge Bank (EKB); Benha University; Kyoto University; National Institute for Environmental Studies - Japan	Inoue-Murayama, M (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.; Inoue-Murayama, M (corresponding author), Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan.	mmurayama@wrc.kyoto-u.ac.jp	Ramadan, Sherif/AAY-5228-2020; ramadann, sherif/AAX-4992-2020	ramadann, sherif/0000-0001-5151-5520	JSPS KAKENHI [25290082]; Kyoto University Supporting program for interaction-based initiative team studies (SPIRITS); Egyptian Ministry of Higher Education; Grants-in-Aid for Scientific Research [16H05801] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyoto University Supporting program for interaction-based initiative team studies (SPIRITS); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by JSPS KAKENHI Grant Number 25290082 to MI-M, Kyoto University Supporting program for interaction-based initiative team studies (SPIRITS) to MI-M, and the Egyptian Ministry of Higher Education to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aluja A, 2011, PSYCHIAT GENET, V21, P229, DOI 10.1097/YPG.0b013e328345465e; Benhajali H, 2010, J ANIM SCI, V88, P3529, DOI 10.2527/jas.2010-3132; BOISSY A, 1994, HORM BEHAV, V28, P66, DOI 10.1006/hbeh.1994.1006; Bouissou MF, 1996, HORM BEHAV, V30, P93, DOI 10.1006/hbeh.1996.0013; Butovskaya ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136208; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Crabbe P, 2007, J CLIN ENDOCR METAB, V92, P3604, DOI 10.1210/jc.2007-0117; D'Eath RB, 2010, ANIM WELFARE, V19, P17; Fatnassi M, 2014, TROP ANIM HEALTH PRO, V46, P861, DOI 10.1007/s11250-014-0577-6; Faye B, 2012, P 3 ISOCARD C 29 JAN, P2; Gauly M, 2002, J ANIM BREED GENET, V119, P379, DOI 10.1046/j.1439-0388.2002.00360.x; Gibbons J, 2009, APPL ANIM BEHAV SCI, V116, P163, DOI 10.1016/j.applanim.2008.08.009; Gong PY, 2017, PSYCHONEUROENDOCRINO, V80, P74, DOI 10.1016/j.psyneuen.2017.03.008; Grandinson K, 2005, LIVEST PROD SCI, V93, P43, DOI 10.1016/j.livprodsci.2004.11.005; Gutierrez-Gil B, 2008, J HERED, V99, P629, DOI 10.1093/jhered/esn060; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hedlund L., 2013, MS THESIS; Hedlund L, 2015, J DAIRY SCI, V98, P5819, DOI 10.3168/jds.2014-8667; Hong KW, 2006, PRIMATES, V47, P248, DOI 10.1007/s10329-005-0174-4; Hong KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022144; Hori Y, 2016, ANIM GENET, V47, P62, DOI 10.1111/age.12384; Idris A, 2015, EFFECT MANAGEMENT SY; Ito H, 2015, META GENE, V5, P120, DOI 10.1016/j.mgene.2015.06.006; Kis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083993; Konno A, 2011, BIOL LETTERS, V7, P658, DOI 10.1098/rsbl.2011.0087; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Nenonen H, 2010, MOL HUM REPROD, V16, P153, DOI 10.1093/molehr/gap097; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Rushen J, 2001, APPL ANIM BEHAV SCI, V73, P1, DOI 10.1016/S0168-1591(01)00105-8; Sheppard RL, 2011, PHYSIOL GENOMICS, V43, P1135, DOI 10.1152/physiolgenomics.00049.2011; Shih J. C., 1999, Neurobiology (Budapest), V7, P235; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Tadic A, 2003, AM J MED GENET B, V117B, P1, DOI 10.1002/ajmg.b.10013; Turner SP, GENES ANIMAL BEHAV, P3537; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Honk J, 2005, BIOL PSYCHIAT, V58, P218, DOI 10.1016/j.biopsych.2005.04.003; VANDENHEEDE M, 1993, HORM BEHAV, V27, P435, DOI 10.1006/hbeh.1993.1032; Wardeh M. F., 1991, Proceedings of the International Conference on Camel Production and Improvement, 10-13 December, 1990, Tobruk, Libya., P78; Wu HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6188; Yasui S, 2013, ZOO BIOL, V32, P70, DOI 10.1002/zoo.21045; Ziegler C, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.41	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191119	10.1371/journal.pone.0191119	http://dx.doi.org/10.1371/journal.pone.0191119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415053	Green Submitted, gold, Green Published			2022-12-26	WOS:000424325300016
J	Caja, L; Tzavlaki, K; Dadras, MS; Tan, EJ; Hatem, G; Maturi, NP; Moren, A; Wik, L; Watanabe, Y; Savary, K; Kamali-Moghaddan, M; Uhrbom, L; Heldin, CH; Moustakas, A				Caja, Laia; Tzavlaki, Kalliopi; Dadras, Mahsa S.; Tan, E-Jean; Hatem, Gad; Maturi, Naga P.; Moren, Anita; Wik, Lotta; Watanabe, Yukihide; Savary, Katia; Kamali-Moghaddan, Masood; Uhrbom, Lene; Heldin, Carl-Henrik; Moustakas, Aristidis			Snail regulates BMP and TGF beta pathways to control the differentiation status of glioma-initiating cells	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; STEM-CELLS; MESENCHYMAL TRANSITION; SELF-RENEWAL; GLIOBLASTOMA; BONE; MAINTENANCE; INDUCTION; PROGNOSIS; INTERACTS	Glioblastoma multiforme is a brain malignancy characterized by high heterogeneity, invasiveness, and resistance to current therapies, attributes related to the occurrence of glioma stem cells (GSCs). Transforming growth factor beta (TGF beta) promotes self-renewal and bone morphogenetic protein (BMP) induces differentiation of GSCs. BMP7 induces the transcription factor Snail to promote astrocytic differentiation in GSCs and suppress tumor growth in vivo. We demonstrate that Snail represses stemness in GSCs. Snail interacts with SMAD signaling mediators, generates a positive feedback loop of BMP signaling and transcriptionally represses the TGFB1 gene, decreasing TGF beta 1 signaling activity. Exogenous TGF beta 1 counteracts Snail function in vitro, and in vivo promotes proliferation and re-expression of Nestin, confirming the importance of TGFB1 gene repression by Snail. In conclusion, novel insight highlights mechanisms whereby Snail differentially regulates the activity of the opposing BMP and TGF beta pathways, thus promoting an astrocytic fate switch and repressing stemness in GSCs.	[Caja, Laia; Tzavlaki, Kalliopi; Dadras, Mahsa S.; Hatem, Gad; Maturi, Naga P.; Moren, Anita; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Biomed Ctr, Box 582, SE-75123 Uppsala, Sweden; [Caja, Laia; Tzavlaki, Kalliopi; Dadras, Mahsa S.; Hatem, Gad; Maturi, Naga P.; Moren, Anita; Watanabe, Yukihide; Savary, Katia; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Canc Res, Sci Life Lab, Biomed Ctr, Box 595, SE-75124 Uppsala, Sweden; [Tan, E-Jean; Maturi, Naga P.; Uhrbom, Lene] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, SE-75185 Uppsala, Sweden; [Wik, Lotta; Kamali-Moghaddan, Masood] Uppsala Univ, Biomed Ctr, Dept Immunol Genet & Pathol, Sci Life Lab, Box 815, S-75108 Uppsala, Sweden; [Watanabe, Yukihide] Univ Tsukuba, Dept Expt Pathol, Fac Med, Tsukuba, Ibaraki, Japan; [Savary, Katia] Univ Reims, UMR CNRS MEDyC 7369, Reims, France	Uppsala University; Uppsala University; Uppsala University; Uppsala University; University of Tsukuba; Universite de Reims Champagne-Ardenne	Caja, L; Moustakas, A (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Biomed Ctr, Box 582, SE-75123 Uppsala, Sweden.; Caja, L; Moustakas, A (corresponding author), Uppsala Univ, Ludwig Canc Res, Sci Life Lab, Biomed Ctr, Box 595, SE-75124 Uppsala, Sweden.	laja.caja@imbim.uu.se; aris.moustakas@imbim.uu.se	Tan, E-Jean/J-3425-2019; Caja, Laia/J-4618-2019	Tan, E-Jean/0000-0002-4631-174X; Caja, Laia/0000-0002-8786-8763; Maturi, Nagaprathyusha/0000-0002-7726-8617	Ludwig Cancer Research; Swedish Cancer Society [CAN 2012/438, CAN 2015/438, CAN 2012/1186]; Swedish Research Council [K2013-66X-14936-10-5, 2015-02757]; Lisa Erikssons minnesfond	Ludwig Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lisa Erikssons minnesfond	This work was supported by: Ludwig Cancer Research; Swedish Cancer Society (CAN 2012/438, CAN 2015/438 to ArM); and Swedish Research Council (K2013-66X-14936-10-5 to ArM, 2015-02757 to C-HH). LC was supported by postdoctoral fellowships from Lisa Erikssons minnesfond (2013) and Swedish Cancer Society (CAN 2012/1186).	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caja L, 2015, FEBS LETT, V589, P1588, DOI 10.1016/j.febslet.2015.04.058; Caja L, 2012, CURR PHARM DESIGN, V18, P4072, DOI 10.2174/138161212802430459; Caren H, 2015, STEM CELL REP, V5, P829, DOI 10.1016/j.stemcr.2015.09.014; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Floratos A, 2010, BIOINFORMATICS, V26, P1779, DOI 10.1093/bioinformatics/btq282; Gonzalez-Gomez P, 2015, ONCOTARGET, V6, P10950, DOI 10.18632/oncotarget.3459; Haar CP, 2012, NEUROCHEM RES, V37, P1192, DOI 10.1007/s11064-011-0701-1; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ikushima H, 2011, J BIOL CHEM, V286, P41434, DOI 10.1074/jbc.M111.300863; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Larssen P, 2017, MOL CELL PROTEOMICS, V16, P502, DOI [10.1074/mcp.M116.064725, 10.1074/mcp.A116.064725]; Mahabir R, 2014, NEURO-ONCOLOGY, V16, P671, DOI 10.1093/neuonc/not239; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Nguyen DH, 2013, CANCERINCYTES, V2, DOI DOI 10.1038/PROTEX.2013.097; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Savary K, 2013, ONCOGENE, V32, P5409, DOI 10.1038/onc.2013.67; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Tan EJ, 2015, NUCLEIC ACIDS RES, V43, P162, DOI 10.1093/nar/gku1293; Tate CM, 2012, CELL DEATH DIFFER, V19, P1644, DOI 10.1038/cdd.2012.44; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Villagrasa P, 2012, ONCOGENE, V31, P4022, DOI 10.1038/onc.2011.562; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Watanabe Y, 2016, J BIOL CHEM, V291, P12706, DOI 10.1074/jbc.M116.729699; Whissell G, 2014, NAT CELL BIOL, V16, P695, DOI 10.1038/ncb2992; Yan K, 2014, GENE DEV, V28, P1085, DOI 10.1101/gad.235515.113; Yan K, 2013, CURR OPIN NEUROL, V26, P701, DOI 10.1097/WCO.0000000000000032; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301	45	26	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19					2515	2531		10.1038/s41388-018-0136-0	http://dx.doi.org/10.1038/s41388-018-0136-0			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29449696	Green Published, hybrid			2022-12-26	WOS:000431873400005
J	Suginta, W; Sritho, N; Ranok, A; Bulmer, DM; Kitaoku, Y; van den Berg, B; Fukamizo, T				Suginta, Wipa; Sritho, Natchanok; Ranok, Araya; Bulmer, David Michael; Kitaoku, Yoshihito; van den Berg, Bert; Fukamizo, Tamo			Structure and function of a novel periplasmic chitooligosaccharide-binding protein from marine Vibrio bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; structure-function; isothermal titration calorimetry (ITC); carbohydrate processing; prokaryotic signal-transduction; chitin recycling; glycoside hydrolase; nutrient transport; solute-binding protein; sugar-protein interactions	CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; CHITIN; HARVEYI; HETERODISACCHARIDE; PURIFICATION; CHITOPORIN; RECEPTORS; CHOLERAE; MALTOSE	Periplasmic solute-binding proteins in bacteria are involved in the active transport of nutrients into the cytoplasm. In marine bacteria of the genus Vibrio, a chitooligosaccharide-binding protein (CBP) is thought to be the major solute-binding protein controlling the rate of chitin uptake in these bacteria. However, the molecular mechanism of the CBP involvement in chitin metabolism has not been elucidated. Here, we report the structure and function of a recombinant chitooligosaccharide-binding protein from Vibrio harveyi, namely VhCBP, expressed in Escherichia coli. Isothermal titration calorimetry revealed that VhCBP strongly binds shorter chitooligosaccharides ((GlcNAc)(n), where n = 2, 3, and 4) with affinities that are considerably greater than those for glycoside hydrolase family 18 and 19 chitinases but does not bind longer ones, including insoluble chitin polysaccharides. We also found that VhCBP comprises two domains with flexible linkers and that the domain-domain interface forms the sugar-binding cleft, which is not long extended but forms a small cavity. (GlcNAc)(2) bound to this cavity, apparently triggering a closed conformation of VhCBP. Trp-363 and Trp-513, which stack against the two individual GlcNAc rings, likely make a major contribution to the high affinity of VhCBP for (GlcNAc)(2). The strong chitobiose binding, followed by the conformational change of VhCBP, may facilitate its interaction with an active-transport system in the inner membrane of Vibrio species.	[Suginta, Wipa; Sritho, Natchanok; Fukamizo, Tamo] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Ranok, Araya] Rajamangala Univ Technol Isan, Nakhon Ratchasima 30000, Thailand; [Bulmer, David Michael; van den Berg, Bert] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kitaoku, Yoshihito; Fukamizo, Tamo] Kindai Univ, Dept Adv Biosci, Nara 6318505, Japan	Suranaree University of Technology; Rajamangala University of Technology; Newcastle University - UK; Kindai University (Kinki University)	Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Sch Chem, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th	Fukamizo, Tamo/AAY-7251-2020	Bulmer, David/0000-0003-0157-9790; van den Berg, Bert/0000-0003-1966-8804	Suranaree University of Technology; Office of the Higher Education Commission under National Research University Project of Thailand [FtR. 12/2558]; Thailand Research Fund; Suranaree University of Technology through Basic Research Grant [BRG578001]; Suranaree University of Technology Grant [SUT1-102-58-36-10]	Suranaree University of Technology; Office of the Higher Education Commission under National Research University Project of Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology through Basic Research Grant; Suranaree University of Technology Grant	This work was supported by Suranaree University of Technology and by Office of the Higher Education Commission under National Research University Project of Thailand Contract FtR. 12/2558 (to W. S. and T. F.), by Thailand Research Fund and Suranaree University of Technology through Basic Research Grant BRG578001 (to W. S.), and by Suranaree University of Technology Grant SUT1-102-58-36-10 (to W. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chumjan W, 2015, J BIOL CHEM, V290, P19184, DOI 10.1074/jbc.M115.660530; Cockerell SR, 2014, MICROBIOL-SGM, V160, P832, DOI 10.1099/mic.0.075903-0; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Hall JA, 1997, J BIOL CHEM, V272, P17615, DOI 10.1074/jbc.272.28.17615; Hamre AG, 2015, J PHYS CHEM B, V119, P9601, DOI 10.1021/acs.jpcb.5b03817; Hirano T, 2009, GLYCOBIOLOGY, V19, P1046, DOI 10.1093/glycob/cwp088; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Kadokura K, 2007, APPL MICROBIOL BIOT, V75, P357, DOI 10.1007/s00253-006-0831-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Li XB, 2007, GLYCOBIOLOGY, V17, P1377, DOI 10.1093/glycob/cwm096; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Magnusson U, 2002, J BIOL CHEM, V277, P14077, DOI 10.1074/jbc.M200514200; Meekrathok P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149228; Meekrathok P, 2015, ACTA CRYSTALLOGR F, V71, P427, DOI 10.1107/S2053230X1500415X; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ohnuma T, 2011, FEBS J, V278, P3991, DOI 10.1111/j.1742-4658.2011.08301.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Shilton BH, 1996, J MOL BIOL, V264, P350, DOI 10.1006/jmbi.1996.0645; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Sritho N, 2012, APPL BIOCHEM BIOTECH, V166, P1192, DOI 10.1007/s12010-011-9504-8; Suginta W, 2016, INT J BIOL MACROMOL, V93, P1111, DOI 10.1016/j.ijbiomac.2016.09.066; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2012, BIOSCI BIOTECH BIOCH, V76, P2275, DOI 10.1271/bbb.120559; Suginta Wipa, 2009, J Chem Biol, V2, P191, DOI 10.1007/s12154-009-0021-y; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	38	8	9	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5150	5159		10.1074/jbc.RA117.001012	http://dx.doi.org/10.1074/jbc.RA117.001012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29444825	hybrid, Green Published			2022-12-26	WOS:000429409300020
J	Lai, Q; Wang, HY; Li, AG; Xu, YH; Tang, L; Chen, Q; Zhang, CF; Gao, Y; Song, JF; Du, ZZ				Lai, Qi; Wang, Haiyong; Li, Angui; Xu, Yinhui; Tang, Liang; Chen, Qiang; Zhang, Chunfang; Gao, Yang; Song, Jianfei; Du, Zhenzong			Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN/PD-L1 signal of lung cancer cells	ONCOGENE			English	Article							PD-L1 EXPRESSION; GENE-EXPRESSION; IFN-GAMMA; IMMUNOTHERAPY; PATHWAY	IFN-gamma-induced PD-L1 expression represents the existence of tumor-specific T cells, which predicts high-response rate to anti-PD-1/L1 therapy, but loss-of-function of IFN signals (e.g., JAK mutation) induces adaptive immune resistance in patients with low-response rate. Interferon regulatory factors (IRF) are frequently epigenetic silenced in carcinogenesis, while the role of methylation in anti-PD-1/L1 therapy remains unclear. We here investigated the methylation status of IFN-gamma related genes IRF1/8 and IFN-alpha/beta-related genes IRF3/7 in lung cancer tissues and found that only highly methylated IRF1 and 7 negatively correlated to cd274 (coding PD-L1) expression, similar to JAK mutation. Interestingly, decitibine (DAC) as methylation inhibitor could hypomethylate IRF1/7 to restore PD-L1 level. Meanwhile, IRF7 enhanced constitutive PD-L1 expression, which was independent of IFN-gamma though directly promote transcription of PD-L1, leading to abrogating cytotoxic T lymphocytes (CTLs) generation which could be restored by anti-PD-L1 antibody, or siRNA-IRF7. The supplement of DAC to anti-PD-1 therapy in vivo improve the efficiency of anti-tumor with less methylated IRF1/7, more interferon-related genes expression (e.g., CXCL9) and IFN-gamma/CD8+ T-cells infiltrations, suggesting that additional treatment of DAC could rescue the ability to response to IFN in lung cancer patients with anti-PD-1/L1 therapy resistance.	[Lai, Qi; Zhang, Chunfang; Gao, Yang; Du, Zhenzong] Cental South Univ, Dept Thorac Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Lai, Qi] Southwest Med Univ, Dept Thorac Surg, Affiliated Tradit Med Hosp, Luzhou, Sichuan, Peoples R China; [Wang, Haiyong; Li, Angui] Guilin Med Univ, Affiliated Hosp, Dept Thorac & Cardiovasc Surg, Guilin, Peoples R China; [Xu, Yinhui; Tang, Liang; Du, Zhenzong] Guilin Med Univ, Affiliated Nanxi Shan Hosp, Dept Cardiothorac Surg, Guilin, Guangxi, Peoples R China; [Xu, Yinhui; Tang, Liang; Du, Zhenzong] Nanxi Shan Hosp Guangxi Zhuang Autonomous Reg, Guilin, Guangxi, Peoples R China; [Chen, Qiang; Song, Jianfei] Guilin Med Univ, Affiliated Hosp 2, Dept Thorac & Cardiovasc Surg, Guilin, Peoples R China	Central South University; Southwest Medical University; Guilin Medical University; Guilin Medical University; Guilin Medical University	Du, ZZ (corresponding author), Cental South Univ, Dept Thorac Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China.; Du, ZZ (corresponding author), Guilin Med Univ, Affiliated Nanxi Shan Hosp, Dept Cardiothorac Surg, Guilin, Guangxi, Peoples R China.; Du, ZZ (corresponding author), Nanxi Shan Hosp Guangxi Zhuang Autonomous Reg, Guilin, Guangxi, Peoples R China.; Song, JF (corresponding author), Guilin Med Univ, Affiliated Hosp 2, Dept Thorac & Cardiovasc Surg, Guilin, Peoples R China.	guilinsjf@163.com; duzhenzong@sina.com			Natural Science Foundation of Guangxi [2016GXNSFAA380138]; Science Research and Technology Development Plan of Guangxi [2015BC12007]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Science Research and Technology Development Plan of Guangxi	This work was supported by the Natural Science Foundation of Guangxi (2016GXNSFAA380138) and Science Research and Technology Development Plan of Guangxi (2015BC12007).	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Breugom AJ, 2015, LANCET ONCOL, V16, P200, DOI 10.1016/S1470-2045(14)71199-4; Ding L, 2017, MOL CANCER THER, V16, P1068, DOI 10.1158/1535-7163.MCT-16-0454; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Ma D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06331; McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638; Mehta A, 2015, CANCER METAST REV, V34, P229, DOI 10.1007/s10555-015-9563-3; Naylor EC, 2016, SURG ONCOL CLIN N AM, V25, P601, DOI 10.1016/j.soc.2016.02.011; Ortmann CA, 2005, NUCLEIC ACIDS RES, V33, P6895, DOI 10.1093/nar/gki1001; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Ribas A, 2016, J EXP MED, V213, P2835, DOI 10.1084/jem.20161462; Sacher AG, 2016, JAMA ONCOL, V2, P1217, DOI 10.1001/jamaoncol.2016.0639; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Socinski MA, 2016, J THORAC ONCOL, V11, P1411, DOI 10.1016/j.jtho.2016.05.024; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Yamashita M, 2010, CANCER SCI, V101, P1708, DOI 10.1111/j.1349-7006.2010.01581.x; Yang H, 2014, LEUKEMIA, V28, P1280, DOI 10.1038/leu.2013.355; Zhang Z, 2017, LEUKEMIA LYMPHOMA, V58, P969, DOI 10.1080/10428194.2016.1219903	22	38	40	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2302	2312		10.1038/s41388-018-0125-3	http://dx.doi.org/10.1038/s41388-018-0125-3			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29422611				2022-12-26	WOS:000431100200007
J	Hakala, M; Kalimeri, M; Enkavi, G; Vattulainen, I; Lappalainen, P				Hakala, Markku; Kalimeri, Maria; Enkavi, Giray; Vattulainen, Ilpo; Lappalainen, Pekka			Molecular mechanism for inhibition of twinfilin by phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN-FILAMENT; CAPPING PROTEIN; MEDIATED ENDOCYTOSIS; MEMBRANE DYNAMICS; PLASMA-MEMBRANE; CELL REGULATION; BUDDING YEAST; FORCE-FIELD	Membrane phosphoinositides control organization and dynamics of the actin cytoskeleton by regulating the activities of several key actin-binding proteins. Twinfilin is an evolutionarily conserved protein that contributes to cytoskeletal dynamics by interacting with actin monomers, filaments, and the heterodimeric capping protein. Twinfilin also binds phosphoinositides, which inhibit its interactions with actin, but the underlying mechanism has remained unknown. Here, we show that the high-affinity binding site of twinfilin for phosphoinositides is located at the C-terminal tail region, whereas the two actin-depolymerizing factor (ADF)/cofilin-like ADF homology domains of twinfilin bind phosphoinositides only with low affinity. Mutagenesis and biochemical experiments combined with atomistic molecular dynamics simulations reveal that the C-terminal tail of twinfilin interacts with membranes through a multivalent electrostatic interaction with a preference toward phosphatidylinositol 3,5-bisphosphate (PI(3,5)P-2), PI(4,5)P-2, and PI(3,4,5)P-3. This initial interaction places the actin-binding ADF homology domains of twinfilin in close proximity to the membrane and subsequently promotes their association with the membrane, thus leading to inhibition of the actin interactions. In support of this model, a twinfilin mutant lacking the C-terminal tail inhibits actin filament assembly in a phosphoinositide-insensitive manner. Our mutagenesis data also reveal that the phosphoinositide-and capping protein-binding sites overlap in the C-terminal tail of twinfilin, suggesting that phosphoinositide binding additionally inhibits the interactions of twinfilin with the heterodimeric capping protein. The results demonstrate that the conserved C-terminal tail of twinfilin is a multifunctional binding motif, which is crucial for interaction with the heterodimeric capping protein and for tethering twinfilin to phosphoinositide-rich membranes.	[Hakala, Markku; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, POB 56, FI-00014 Helsinki, Finland; [Enkavi, Giray; Vattulainen, Ilpo] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Kalimeri, Maria; Vattulainen, Ilpo] Tampere Univ Technol, Lab Phys, FI-33101 Tampere, Finland; [Vattulainen, Ilpo] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense, Denmark	University of Helsinki; University of Helsinki; Tampere University; University of Southern Denmark	Lappalainen, P (corresponding author), Univ Helsinki, Inst Biotechnol, POB 56, FI-00014 Helsinki, Finland.	pekka.lappalainen@helsinki.fi	Vattulainen, Ilpo T/G-4224-2014	Hakala, Markku/0000-0002-3485-6080; Lappalainen, Pekka/0000-0001-6227-0354; Vattulainen, Ilpo/0000-0001-7408-3214; Kalimeri, Maria/0000-0002-6569-7553	ProLipids Centre of Excellence from the Academy of Finland [272130, 307415]; Doctoral School in Health Sciences; European Research Council Advanced Grant CROWDED-PRO-LIPIDS [290974]	ProLipids Centre of Excellence from the Academy of Finland; Doctoral School in Health Sciences; European Research Council Advanced Grant CROWDED-PRO-LIPIDS	This work was supported by ProLipids Centre of Excellence Grants 272130 and 307415 from the Academy of Finland (to P. L. and I. V.), a fellowship from the Doctoral School in Health Sciences (to M. H.), and European Research Council Advanced Grant CROWDED-PRO-LIPIDS (Grant 290974; to I. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bockhorn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2393; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johnston AB, 2015, NAT CELL BIOL, V17, P1504, DOI 10.1038/ncb3252; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lehtimaki J, 2017, HANDB EXP PHARMACOL, V235, P123, DOI 10.1007/164_2016_28; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; MELCHIONNA S, 1993, MOL PHYS, V78, P533, DOI 10.1080/00268979300100371; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Nevalainen EM, 2009, BIOCHEM J, V417, P593, DOI 10.1042/BJ20080608; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Paavilainen VO, 2002, J BIOL CHEM, V277, P43089, DOI 10.1074/jbc.M208225200; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Pleskot R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002765; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Schink KO, 2016, ANNU REV CELL DEV BI, V32, P143, DOI 10.1146/annurev-cellbio-111315-125349; Senju Y, 2017, P NATL ACAD SCI USA, V114, pE8977, DOI 10.1073/pnas.1705032114; Stritt S, 2017, BLOOD, V130, P1746, DOI 10.1182/blood-2017-02-770768; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; YONEZAWA N, 1991, J BIOL CHEM, V266, P17218; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; Zhao HX, 2012, MOL BIOL CELL, V23, P2823, DOI 10.1091/mbc.E11-07-0645; Zhao HX, 2010, BIOPHYS J, V98, P2327, DOI 10.1016/j.bpj.2010.01.046	68	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4818	4829		10.1074/jbc.RA117.000484	http://dx.doi.org/10.1074/jbc.RA117.000484			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29425097	Green Published, hybrid			2022-12-26	WOS:000428848300022
J	Park, MJ; Shen, HL; Spaeth, JM; Tolvanen, JH; Failor, C; Knudtson, JF; McLaughlin, J; Halder, SK; Yang, QW; Bulun, SE; Al-Hendy, A; Schenken, RS; Aaltonen, LA; Boyer, TG				Park, Min Ju; Shen, Hailian; Spaeth, Jason M.; Tolvanen, Jaana H.; Failor, Courtney; Knudtson, Jennifer F.; McLaughlin, Jessica; Halder, Sunil K.; Yang, Qiwei; Bulun, Serdar E.; Al-Hendy, Ayman; Schenken, Robert S.; Aaltonen, Lauri A.; Boyer, Thomas G.			Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTERINE FIBROIDS; KINASE MODULE; TARGET GENES; COMPLEX; REVEALS; IDENTIFICATION; TRANSCRIPTION; LEIOMYOMAS; GENOMICS; FAMILY	Somatic mutations in exon 2 of the RNA polymerase II transcriptional Mediator subunit MED12 occur at high frequency in uterine fibroids (UFs) and breast fibroepithelial tumors as well as recurrently, albeit less frequently, in malignant uterine leimyosarcomas, chronic lymphocytic leukemias, and colorectal cancers. Previously, we reported that UF-linked mutations in MED12 disrupt its ability to activate cyclin C (CycC)-dependent kinase 8 (CDK8) in Mediator, implicating impaired Mediator-associated CDK8 activity in the molecular pathogenesis of these clinically significant lesions. Notably, the CDK8 paralog CDK19 is also expressed in myometrium, and both CDK8 and CDK19 assemble into Mediator in a mutually exclusive manner, suggesting that CDK19 activity may also be germane to the pathogenesis of MED12 mutation-induced UFs. However, whether and how UF-linked mutations in MED12 affect CDK19 activation is unknown. Herein, we show that MED12 allosterically activates CDK19 and that UF-linked exon 2 mutations in MED12 disrupt its CDK19 stimulatory activity. Furthermore, we find that within the Mediator kinase module, MED13 directly binds to the MED12 C terminus, thereby suppressing an apparent UF mutation-induced conformational change in MED12 that otherwise disrupts its association with CycCCDK8/19. Thus, in the presence of MED13, mutant MED12 can bind, but cannot activate, CycC-CDK8/19. These findings indicate that MED12 binding is necessary but not sufficient for CycC-CDK8/19 activation and reveal an additional step in the MED12-dependent activation process, one critically dependent on MED12 residues altered by UF-linked exon 2 mutations. These findings confirm that UF-linked mutations in MED12 disrupt composite Mediator-associated kinase activity and identify CDK8/19 as prospective therapeutic targets in UFs.	[Park, Min Ju; Shen, Hailian; Spaeth, Jason M.; Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Failor, Courtney; Knudtson, Jennifer F.; McLaughlin, Jessica; Schenken, Robert S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Tolvanen, Jaana H.; Aaltonen, Lauri A.] Univ Helsinki, Haartman Inst, Genome Scale Biol Program, Biomedicum, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland; [Tolvanen, Jaana H.; Aaltonen, Lauri A.] Univ Helsinki, Haartman Inst, Dept Med Genet, Biomedicum, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland; [Halder, Sunil K.; Yang, Qiwei; Al-Hendy, Ayman] Augusta Univ, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Bulun, Serdar E.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Spaeth, Jason M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Helsinki; University of Helsinki; University System of Georgia; Augusta University; Northwestern University; Feinberg School of Medicine; Vanderbilt University	Boyer, TG (corresponding author), 8210 Floyd Curl Dr,Mail Code 8257 STRF, San Antonio, TX 78229 USA.	boyer@uthscsa.edu	Al-hendy, Ayman/J-9324-2019; Aaltonen, Lauri/A-5375-2010; Yang, Qiwei/AAI-7414-2021; Kaukomaa, Jaana/G-1040-2016	Aaltonen, Lauri/0000-0001-6839-4286; Kaukomaa, Jaana/0000-0003-1183-4943; Spaeth, Jason/0000-0002-1945-4323; , Qiwei Yang/0000-0001-7131-8946	U.S. Dept. of Health and Human Services, National Institute of Health [R01HD087417]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR001120]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD094378, R01HD087417, P01HD057877] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002646, UL1TR001120] Funding Source: NIH RePORTER	U.S. Dept. of Health and Human Services, National Institute of Health; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by U.S. Dept. of Health and Human Services, National Institute of Health Grant R01HD087417 (to T. G. B.) and the National Center for Advancing Translational Sciences, National Institutes of Health, through the Clinical and Translational Science Award (CTSA) UL1 TR001120. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hendy A, 2017, ENDOCRINOLOGY, V158, P592, DOI 10.1210/en.2016-1097; Alderton G. K., 2014, NAT REV CANCER, V14, P382; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Audetat KA, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00626-16; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Clark AD, 2015, CRIT REV BIOCHEM MOL, V50, P393, DOI 10.3109/10409238.2015.1064854; Daniels D., 2013, J PROTEOM BIOINFORM, V2, P004, DOI DOI 10.4172/JPB.S2-004; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Eychenne T, 2017, TRANSCR-AUSTIN, V8, P328, DOI 10.1080/21541264.2017.1329000; Harper T. M., 2017, J BIOL CHEM; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Islam MS, 2013, J CLIN ENDOCR METAB, V98, P921, DOI 10.1210/jc.2012-3237; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Janody F, 2011, DEV DYNAM, V240, P2051, DOI 10.1002/dvdy.22705; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Kampjarvi K, 2015, ONCOTARGET, V6, P1884; Kampjarvi K, 2014, HUM MUTAT, V35, P1136, DOI 10.1002/humu.22612; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Levy G, 2012, J ASSIST REPROD GEN, V29, P703, DOI 10.1007/s10815-012-9784-0; Lim WK, 2014, NAT GENET, V46, P877, DOI 10.1038/ng.3037; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin J, 2013, CARDIOVASC INTER RAD, V36, P395, DOI 10.1007/s00270-012-0505-y; Mehine M, 2016, P NATL ACAD SCI USA, V113, P1315, DOI 10.1073/pnas.1518752113; Mehine M, 2014, FERTIL STERIL, V102, P621, DOI 10.1016/j.fertnstert.2014.06.050; Mittal P, 2015, J CLIN INVEST, V125, P3280, DOI 10.1172/JCI81534; Moravek MB, 2015, CURR OPIN OBSTET GYN, V27, P276, DOI 10.1097/GCO.0000000000000185; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Parsanezhad ME, 2010, FERTIL STERIL, V93, P192, DOI 10.1016/j.fertnstert.2008.09.064; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Tan J, 2015, NAT GENET, V47, P1341, DOI 10.1038/ng.3409; Tsai KL, 2017, NATURE, V544, P196, DOI 10.1038/nature21393; Tsai KL, 2014, CELL, V158, P463, DOI 10.1016/j.cell.2014.06.036; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Tsutsui T, 2008, GENES CELLS, V13, P817, DOI 10.1111/j.1365-2443.2008.01208.x; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; Turunen M, 2014, CELL REP, V7, P654, DOI 10.1016/j.celrep.2014.03.047; van der Kooij SM, 2012, CURR OPIN OBSTET GYN, V24, P368, DOI 10.1097/GCO.0b013e328359f10a; Xu W, 2011, J GENET GENOMICS, V38, P439, DOI 10.1016/j.jgg.2011.09.002; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19763, DOI 10.1073/pnas.1121120109	53	31	31	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4870	4882		10.1074/jbc.RA118.001725	http://dx.doi.org/10.1074/jbc.RA118.001725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29440396	hybrid, Green Published			2022-12-26	WOS:000428848300026
J	Grandahl, M; Paek, SC; Grisurapong, S; Sherer, P; Tyden, T; Lundberg, P				Grandahl, Maria; Paek, Seung Chun; Grisurapong, Siriwan; Sherer, Penchan; Tyden, Tanja; Lundberg, Pranee			Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; DECISION-MAKING; PROVIDER COMMUNICATION; ADOLESCENT GIRLS; YOUNG-WOMEN; ACCEPTABILITY; CANCER; DAUGHTERS; ATTITUDES; MOTHERS	Thailand has one of the world's highest prevalence of cervical cancer, mainly caused by the human papillomavirus (HPV). HPV infections can successfully be prevented by vaccination, which is available at a cost but not yet implemented in the national vaccination program. Parents play a critical role in deciding whether to vaccinate their child against HPV. Thus, the aim was to examine the association between parents' knowledge, beliefs, and acceptance of the HPV vaccination for their daughters, considering their socio-demographics and religious beliefs. A cross-sectional design was used among three schools in Thailand: Nakorn Phatom province (suburban) and Bangkok (urban). Parents of 9-12-year-old daughters completed the questionnaires, guided by the Health Belief Model. In total, 359 parents completed the questionnaires; of those, 301 were included in the final analyses. The ordinary least squares (OLS) regression analysis showed that background knowledge of HPV and the HPV vaccine was positively related to knowledge of HPV and cervical cancer. For beliefs, knowledge was positively associated with susceptibility (i.e., parents' perceived risk of an HPV infection/related disease), severity, and benefit. However, knowledge was not significantly related to barriers. For acceptance, higher susceptibility and benefit were related to higher acceptance, and greater knowledge was associated with higher acceptance. Thus, we found associations between parents' knowledge, beliefs, and acceptance of the HPV vaccination for their daughters, considering their socio-demographics and religious beliefs. Parents, who reported religion as important, as opposed to those who did not, were more favorable toward the HPV vaccination. Four out of ten mothers had never undergone a cervical cancer screening, but most had accepted previous childhood vaccinations for their daughters. The overall acceptance of the vaccine was high, and we believe our results are promising for future implementation of the HPV vaccination in the national childhood vaccination program in Thailand.	[Grandahl, Maria; Tyden, Tanja] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Paek, Seung Chun; Grisurapong, Siriwan; Sherer, Penchan] Mahidol Univ, Dept Soc & Hlth, Salaya Campus, Bangkok, Thailand; [Lundberg, Pranee] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Mahidol University; Uppsala University	Grandahl, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	maria.grandahl@kbh.uu.se		Paek, Seung Chun/0000-0002-9483-5572; Grandahl, Maria/0000-0002-4553-6656	Swedish Foundation for International Cooperation in Research and Higher Education (STINT) [IB2014-5900]	Swedish Foundation for International Cooperation in Research and Higher Education (STINT)	This work was supported by [The Swedish Foundation for International Cooperation in Research and Higher Education (STINT)] grant number [IB2014-5900]. The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2008, WMA DECL HELS ETH PR; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Champion VL., 2008, HLTH BEHAV HLTH ED T, P45; Chesson HW, 2014, SEX TRANSM DIS, V41, P660, DOI 10.1097/OLQ.0000000000000193; D'Hauwers KWM, 2013, VACCINE, V31, P5843, DOI 10.1016/j.vaccine.2013.09.068; Das A, 2010, VACCINE, V28, P1440, DOI 10.1016/j.vaccine.2009.11.041; Dempsey AF, 2009, ANN EPIDEMIOL, V19, P531, DOI 10.1016/j.annepidem.2009.03.011; Dube E, 2015, VACCINE, V33, P4191, DOI 10.1016/j.vaccine.2015.04.041; Farias CC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1677-y; Fu LDY, 2017, VACCINE, V35, P802, DOI 10.1016/j.vaccine.2016.12.045; Gilkey MB, 2016, HUM VACC IMMUNOTHER, V12, P1454, DOI 10.1080/21645515.2015.1129090; Gilkey MB, 2016, VACCINE, V34, P1187, DOI 10.1016/j.vaccine.2016.01.023; Gordon D, 2011, VACCINE, V29, P7350, DOI 10.1016/j.vaccine.2011.07.083; Gottvall M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014255; Gottvall M, 2013, UPSALA J MED SCI, V118, P263, DOI 10.3109/03009734.2013.809039; Grandahl M, 2017, J SCHOOL HEALTH, V87, P62, DOI 10.1111/josh.12470; Grandahl M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009875; Grandahl M, 2014, ACTA PAEDIATR, V103, P436, DOI 10.1111/apa.12545; Griffioen AM, 2012, CLIN PEDIATR, V51, P560, DOI 10.1177/0009922812443732; Hansen BT, 2015, PREV MED, V77, P4, DOI 10.1016/j.ypmed.2015.04.024; Jaspers L, 2011, VACCINE, V29, P7785, DOI 10.1016/j.vaccine.2011.07.107; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juntasopeepun P, 2012, INT J GYNECOL OBSTET, V118, P247, DOI 10.1016/j.ijgo.2012.04.015; Juntasopeepun P, 2011, NURS HEALTH SCI, V13, P475, DOI 10.1111/j.1442-2018.2011.00642.x; Krakow MM, 2015, WOMEN HEALTH ISS, V25, P105, DOI 10.1016/j.whi.2014.11.006; Krawczyk A, 2015, HUM VACC IMMUNOTHER, V11, P322, DOI 10.1080/21645515.2014.1004030; La Vincente SF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2579-3; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Lundberg PC, 2001, CANCER NURS, V24, P469, DOI 10.1097/00002820-200112000-00008; Lundberg PC, 2013, J CLIN NURS, V22, P1907, DOI 10.1111/jocn.12130; Madhivanan P, 2014, PREV MED, V64, P69, DOI 10.1016/j.ypmed.2014.04.002; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mortensen GL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1863-6; Muangchana C, 2010, VACCINE, V28, pA104, DOI 10.1016/j.vaccine.2010.02.043; Mupandawana ET, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0209-x; Nielson CM, 2010, J INFECT DIS, V202, P445, DOI 10.1086/653708; Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270; Oscarsson MG, 2012, SEX REPROD HEALTHC, V3, P141, DOI 10.1016/j.srhc.2012.10.002; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel H, 2016, SEX TRANSM INFECT, V92, P474, DOI 10.1136/sextrans-2015-052341; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Schreiber SMS, 2015, J ADOLESCENT HEALTH, V56, P402, DOI 10.1016/j.jadohealth.2014.12.008; Shelton RC, 2013, J RELIG HEALTH, V52, P1120, DOI 10.1007/s10943-011-9553-x; Spencer AM, 2014, J EPIDEMIOL COMMUN H, V68, P571, DOI 10.1136/jech-2013-202629; The PLOS Medicine Editors, 2014, PLOS MED, V11; Thomas T, 2015, ADV NURS SCI, V38, pE1, DOI 10.1097/ANS.0000000000000094; Thomas TL, 2013, J ADOLESCENT HEALTH, V52, pS60, DOI 10.1016/j.jadohealth.2012.08.011; Tung ILY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161846; Underwood NL, 2016, J PEDIATR ADOL GYNEC, V29, P617, DOI 10.1016/j.jpag.2016.05.003; Vielot NA, 2017, PAPILLOMAVIRUS RES, V3, P126, DOI 10.1016/j.pvr.2017.04.001; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; World Health Organization (WHO), 2013, WORLD HLTH REP RES U; Yu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146741; Zhang SK, 2015, ANN EPIDEMIOL, V25, P231, DOI 10.1016/j.annepidem.2014.12.009; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	57	33	33	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193054	10.1371/journal.pone.0193054	http://dx.doi.org/10.1371/journal.pone.0193054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447271	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900104
J	Kakoschky, B; Pleli, T; Schmithals, C; Zeuzem, S; Brune, B; Vogl, TJ; Korf, HW; Weigert, A; Piiper, A				Kakoschky, Bianca; Pleli, Thomas; Schmithals, Christian; Zeuzem, Stefan; Bruene, Bernhard; Vogl, Thomas J.; Korf, Horst-Werner; Weigert, Andreas; Piiper, Albrecht			Selective targeting of tumor associated macrophages in different tumor models	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER; POLARIZATION; PROGRESSION; SORAFENIB; ANGIOGENESIS; ACTIVATION; PLASTICITY; PHENOTYPE; GROWTH	Tumor progression largely depends on the presence of alternatively polarized (M2) tumor-associated macrophages (TAMs), whereas the classical M1-polarized macrophages can promote anti-tumorigenic immune responses. Thus, selective inhibition of M2-TAMs is a desirable anti-cancer approach in highly resistant tumor entities such as hepatocellular carcinoma (HCC) or breast cancer. We here examined whether a peptide that selectively binds to and is internalized by in vitro-differentiated murine M2 macrophages as compared to M1 macrophages, termed M2pep, could be used to selectively target TAMs in HCC and breast carcinoma. We confirmed selectivity of M2pep for in vitro M2 polarized macrophages. Upon incubation of suspended mixed 4T1 tumor cells with M2pep, high amounts of the TAMs were found to be associated with M2pep, whereas in mixed tumor cell suspensions from two HCC mouse models, M2pep showed only low-degree binding to TAMs. M2pep also showed low-degree targeting of liver macrophages. This indicates that the TAMs in different tumor entities show different targeting of M2pep and that M2pep is a very promising approach to develop selective M2-TAM-targeting in tumor entities containing M2-TAMs with significant amounts of the so far elusive M2pep receptor(s).	[Kakoschky, Bianca; Pleli, Thomas; Schmithals, Christian; Zeuzem, Stefan; Piiper, Albrecht] Univ Hosp Frankfurt, Dept Med 1, Frankfurt, Germany; [Bruene, Bernhard; Weigert, Andreas] Goethe Univ Frankfurt, Inst Biochem 1, Frankfurt, Germany; [Vogl, Thomas J.] Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Frankfurt, Germany; [Korf, Horst-Werner] Univ Hosp Frankfurt, Inst Anat 2, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Piiper, A (corresponding author), Univ Hosp Frankfurt, Dept Med 1, Frankfurt, Germany.	piiper@med.uni-frankfurt.de	Korf, Horst/ACX-9860-2022; Zeuzem, Stefan/AAE-7435-2019; Weigert, Andreas/E-6540-2010	Korf, Horst/0000-0002-5051-0303; Weigert, Andreas/0000-0002-7529-1952; Piiper, Albrecht/0000-0003-0131-3669	DFG, Germany [GRK1172]; University Hospital Frankfurt (estate of Maria Christine Held and Erika Hecker, Germany)	DFG, Germany(German Research Foundation (DFG)); University Hospital Frankfurt (estate of Maria Christine Held and Erika Hecker, Germany)	The work was supported by grants from GRK1172 (DFG, Germany) and from the University Hospital Frankfurt (estate of Maria Christine Held and Erika Hecker, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer C, 2016, NAT CELL BIOL, V18, P790, DOI 10.1038/ncb3371; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Cieslewicz M, 2013, P NATL ACAD SCI USA, V110, P15919, DOI 10.1073/pnas.1312197110; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Haupenthal J, 2012, NEOPLASIA, V14, P410, DOI 10.1596/neo.111366; Ibrahim AA, 2017, CLIN CANCER RES, V23, P3896, DOI 10.1158/1078-0432.CCR-16-1762; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Leek RD, 1996, CANCER RES, V56, P4625; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; MURAKAMI H, 1993, CANCER RES, V53, P1719; Ngambenjawong C, 2016, THERANOSTICS, V6, P1403, DOI 10.7150/thno.15394; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Scheiermann P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08521; Schmithals C, 2015, CANCER RES, V75, P3147, DOI 10.1158/0008-5472.CAN-15-0395; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sprinzl MF, 2015, J HEPATOL, V62, P863, DOI 10.1016/j.jhep.2014.11.011; Sun YY, 2017, SCAND J IMMUNOL, V85, P166, DOI 10.1111/sji.12468; Waidmann O, 2013, J HEPATOL, V59, P769, DOI 10.1016/j.jhep.2013.06.008; Watcharin W, 2015, J CONTROL RELEASE, V199, P63, DOI 10.1016/j.jconrel.2014.11.023; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zheng X, 2017, ONCOTARGET, V8, P48436, DOI 10.18632/oncotarget.17061	28	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193015	10.1371/journal.pone.0193015	http://dx.doi.org/10.1371/journal.pone.0193015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447241	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900096
J	Kouyoumdjian, FG; Patel, A; To, MJ; Kiefer, L; Regenstreif, L				Kouyoumdjian, Fiona G.; Patel, Alexandra; To, Matthew J.; Kiefer, Lori; Regenstreif, Leonora			Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey	PLOS ONE			English	Article							MEDICATION-ASSISTED TREATMENT; DRUG-USE; HEPATITIS-C; SUBSTITUTION TREATMENT; UNITED-STATES; SUBSTANCE USE; RISK; HIV; INMATES; PRISON	Background Substance use and substance use disorders are common in people who experience detention or incarceration in Canada, and opioid agonist treatment (OAT) may reduce the harms associated with substance use disorders. We aimed to define current physician practice in provincial correctional facilities in Ontario with respect to prescribing OAT and to identify potential barriers and facilitators to prescribing OAT. Methods We invited all physicians practicing in the 26 provincial correctional facilities for adults in Ontario to participate in an online survey. Results Twenty-seven physicians participated, with representation from most correctional facilities in Ontario. Of participating physicians, 52% reported prescribing methadone and 48% reported prescribing buprenorphine/naloxone to patients in provincial correctional facilities. Nineteen percent of participants reported initiating methadone treatment and 11% reported initiating buprenorphine/naloxone for patients in custody. Participants identified multiple barriers to initiating OAT in provincial correctional facilities including concerns about medication diversion and safety, concerns about initiating treatment in patients who are not currently using opioids, lack of linkage with community-based providers and the Ministry of Community Safety and Correctional Services policy. Identified facilitators to initiating OAT were support from institutional health care staff and administrative staff, adequate resources for program delivery and access to linkage with community-based OAT providers. Conclusions This study identifies opportunities to improve OAT programs and to improve access to OAT for persons in provincial correctional facilities in Ontario.	[Kouyoumdjian, Fiona G.; Regenstreif, Leonora] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Kouyoumdjian, Fiona G.; To, Matthew J.] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Patel, Alexandra] Univ Toronto, Toronto, ON, Canada; [To, Matthew J.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Kiefer, Lori] Ontario Minist Community Safety & Correct Serv, Toronto, ON, Canada; [Kiefer, Lori] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Dalhousie University; University of Toronto	Kouyoumdjian, FG (corresponding author), McMaster Univ, Dept Family Med, Hamilton, ON, Canada.; Kouyoumdjian, FG (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.	kouyouf@mcmaster.ca		Kouyoumdjian, Fiona/0000-0002-6869-7516; Regenstreif, Leonora Julie/0000-0001-7161-1712	Canadian Institutes of Health Research; Royal College of Physicians and Surgeons of Canada Regional Professional Development Grant	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Royal College of Physicians and Surgeons of Canada Regional Professional Development Grant	Fiona Kouyoumdjian received salary support from a Fellowship from the Canadian Institutes of Health Research and from a Royal College of Physicians and Surgeons of Canada Regional Professional Development Grant. The The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Can J Public Health, V95 Suppl 1, pS9; [Anonymous], 2004, HIV AIDS Policy Law Rev, V9, P45; [Anonymous], 2011, METH MAINT TREATM PR; Beaudette J, 2013, PREVALENCE MENTAL HL; Bell A, 2004, NEEDS ASSESSMENT FED; Bland RC, 1998, INT J LAW PSYCHIAT, V21, P273, DOI 10.1016/S0160-2527(98)00005-3; Boutwell Amy E, 2007, J Opioid Manag, V3, P328; Brink JH, 2001, INT J LAW PSYCHIAT, V24, P339, DOI 10.1016/S0160-2527(01)00071-1; Burchell AN, 2003, JAIDS-J ACQ IMM DEF, V32, P534, DOI 10.1097/00126334-200304150-00011; Buxton JA, 2009, CAN J PUBLIC HEALTH, V100, P121, DOI 10.1007/BF03405520; Calzavara LM, 2003, ADDICTION, V98, P1257, DOI 10.1046/j.1360-0443.2003.00466.x; Carrieri MP, 2006, CLIN INFECT DIS, V43, pS197, DOI 10.1086/508184; Connery HS, 2015, HARVARD REV PSYCHIAT, V23, P63, DOI 10.1097/HRP.0000000000000075; Crocker AG, 2007, J INTELLECT DEV DIS, V32, P143, DOI 10.1080/13668250701314053; Cropsey KL, 2012, J NATL MED ASSOC, V104, P487, DOI 10.1016/S0027-9684(15)30214-5; DeBeck K, 2009, ADDICTION, V104, P69, DOI 10.1111/j.1360-0443.2008.02387.x; Degenhardt L, 2014, ADDICTION, V109, P1306, DOI 10.1111/add.12536; Derkzen DM, 2012, ASSESSMENT ABORIGINA; Dufour A, 1996, AIDS, V10, P1009, DOI 10.1097/00002030-199610090-00012; Elgar FJ, 2003, CAN J PSYCHIAT, V48, P633, DOI 10.1177/070674370304800911; Farrell S., 2010, PREVALENCE INJECTION; Ford PM, 2000, QJM-MON J ASSOC PHYS, V93, P113, DOI 10.1093/qjmed/93.2.113; Fullerton CA, 2014, PSYCHIAT SERV, V65, P146, DOI 10.1176/appi.ps.201300235; Gordon AJ, 2011, PSYCHOL ADDICT BEHAV, V25, P215, DOI 10.1037/a0022776; Government of Canada, 2017, METH PROGR 2017; Grant B, 2004, HIGH INTENSITY SUBST; Grant BA., 2005, INTENSIVE SUPPORT UN; Groot E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157512; Hopley AAB, 2012, ADDICT BEHAV, V37, P947, DOI 10.1016/j.addbeh.2012.03.031; Johnson S, 2011, CHARACTERISTICS PART; Johnson S, 2010, ASSESSING IMPACT ENH; Kelsey CM, 2017, MATERN CHILD HLTH J, V21, P1260, DOI 10.1007/s10995-016-2224-5; Kiefer L., 2017, E COMMUNICATION, V13; Kitson A, 2011, IDENTIFYING KNOWLEDG; Kouyoumdjian Fiona G, 2016, CMAJ Open, V4, pE153, DOI 10.9778/cmajo.20150098; Kouyoumdjian FG, 2014, CAN J PUBLIC HEALTH, V105, pE198, DOI 10.17269/cjph.105.4193; Kunic D., 2006, COMPUTERIZED ASSESSM; Legare F., 2017, ASSESSING BARRIERS F; Marsden J, 2017, ADDICTION, V112, P1408, DOI 10.1111/add.13779; Martin RE, 2005, CAN J PUBLIC HEALTH, V96, P97, DOI 10.1007/BF03403669; Martin RE, 2008, CAN J PUBLIC HEALTH, V99, P262, DOI 10.1007/BF03403751; Mattick R, 2003, COCHRANE DATABASE SY; Methadone Treatment and Services Advisory Committee, 2016, METH TREATM SERV ADV; Mullins P., 2012, OFFENDER SUBSTANCE U; Murphy A, 2005, TIME OUT 2 PROFILE B; Nicholls T., 2004, INT J FORENSIC MENT, V3, P167, DOI [DOI 10.1080/14999013.2004.10471205, 10.1080/14999013.2004.10471205]; Nosyk B, 2013, HEALTH AFFAIR, V32, P1462, DOI 10.1377/hlthaff.2012.0846; Nunn A, 2009, DRUG ALCOHOL DEPEN, V105, P83, DOI 10.1016/j.drugalcdep.2009.06.015; Perry AE, 2015, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD010862.PUB2; Plourde C, 2002, SUBST USE MISUSE, V37, P47, DOI 10.1081/JA-120001496; Plourde C, 2012, PRISON J, V92, P506, DOI 10.1177/0032885512457555; Poulin C, 2007, CAN MED ASSOC J, V177, P252, DOI 10.1503/cmaj.060760; Power J, 2011, 250 CORR SERV CAN; Reitano J., 2017, ADULT CORRECTIONAL S; Rezansoff SN, 2013, PSYCHOL PUBLIC POL L, V19, P443, DOI 10.1037/a0033907; Robinson D., 1996, SUMMARY FINDINGS 199; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Smith A, 2013, TIME OUT 3 PROFILE B; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; Springer Sandra A, 2008, J Opioid Manag, V4, P81; Thompson J, 2011, ABORIGINAL MEN SUMMA; United Nations Human Rights, 1990, BAS PRINC TREATM PRI; United Nations Office on Drugs and Crime, 2006, HIV AIDS PREV CAR TR; Wakeman SE, 2017, J ADDICT MED, V11, P1, DOI 10.1097/ADM.0000000000000275; Walley AY, 2008, J GEN INTERN MED, V23, P1393, DOI 10.1007/s11606-008-0686-x; Young L., 2017, GLOBAL NEWS     0731; Zakaria D, 2012, RELATIONSHIPS LIFETI; Zakaria D., 2010, SUMMARY EMERGING FIN	68	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192431	10.1371/journal.pone.0192431	http://dx.doi.org/10.1371/journal.pone.0192431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447177	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900034
J	Mahdavi, M; Vissers, J; Elkhuizen, S; van Dijk, M; Vanhala, A; Karampli, E; Faubel, R; Forte, P; Coroian, E; van de Klundert, J				Mahdavi, Mahdi; Vissers, Jan; Elkhuizen, Sylvia; van Dijk, Mattees; Vanhala, Antero; Karampli, Eleftheria; Faubel, Raquel; Forte, Paul; Coroian, Elena; van de Klundert, Joris			The relationship between context, structure, and processes with outcomes of 6 regional diabetes networks in Europe	PLOS ONE			English	Article							QUALITY-OF-CARE; HEALTH-CARE; SYSTEMATIC ANALYSIS; EFFECTIVE COVERAGE; GLYCEMIC CONTROL; SERVICE QUALITY; SATISFACTION; LIFE; ADHERENCE; MELLITUS	Background While health service provisioning for the chronic condition Type 2 Diabetes (T2D) often involves a network of organisations and professionals, most evidence on the relationships between the structures and processes of service provisioning and the outcomes considers single organisations or solo practitioners. Extending Donabedian's Structure-Process-Outcome (SPO) model, we investigate how differences in quality of life, effective coverage of diabetes, and service satisfaction are associated with differences in the structures, processes, and context of T2D services in six regions in Finland, Germany, Greece, Netherlands, Spain, and UK. Methods Data collection consisted of: a) systematic modelling of provider network's structures and processes, and b) a cross-sectional survey of patient reported outcomes and other information. The survey resulted in data from 1459 T2D patients, during 2011-2012. Stepwise linear regression models were used to identify how independent cumulative proportion of variance in quality of life and service satisfaction are related to differences in context, structure and process. The selected context, structure and process variables are based on Donabedian's SPO model, a service quality research instrument (SERVQUAL), and previous organization and professional level evidence. Additional analysis deepens the possible bidirectional relation between outcomes and processes. Results The regression models explain 44% of variance in service satisfaction, mostly by structure and process variables (such as human resource use and the SERVQUAL dimensions). The models explained 23% of variance in quality of life between the networks, much of which is related to contextual variables. Our results suggest that effectiveness of A1c control is negatively correlated with process variables such as total hours of care provided per year and cost of services per year. Conclusions While the selected structure and process variables explain much of the variance in service satisfaction, this is less the case for quality of life. Moreover, it appears that the effect of the clinical outcome A1c control on processes is stronger than the other way around, as poorer control seems to relate to more service use, and higher cost. The standardized operational models used in this research prove to form a basis for expanding the network level evidence base for effective T2D service provisioning.	[Mahdavi, Mahdi] Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran; [Mahdavi, Mahdi; Vissers, Jan; Elkhuizen, Sylvia; van de Klundert, Joris] Univ Rotterdam, Inst Hlth Policy & Management, Rotterdam, Netherlands; [van Dijk, Mattees] Hook Holland, Rotterdam, Netherlands; [Vanhala, Antero] Aalto Univ, HEMA Inst, Aalto, Finland; [Karampli, Eleftheria] Natl Sch Publ Hlth, Athens, Greece; [Faubel, Raquel] Joint Res Unit ICT Appl Healthcare Proc Reengn eR, Valencia, Spain; [Faubel, Raquel] Univ Valencia, Valencia, Spain; [Forte, Paul] Balance Care Grp, London, England; [Coroian, Elena] Friedrich Alexander Univ Nuremberg Erlangen, Inst Learning Innovat, Nurnberg, Germany	Tehran University of Medical Sciences; Erasmus University Rotterdam; Aalto University; National & Kapodistrian University of Athens; University of Valencia; University of Erlangen Nuremberg	Mahdavi, M (corresponding author), Univ Rotterdam, Inst Hlth Policy & Management, Rotterdam, Netherlands.	Mahdavi@sina.tums.ac.ir	Karampli, Eleftheria/AAP-5186-2021; van de klundert, joris/AAF-6545-2021; Mahdavi/O-8616-2019	Karampli, Eleftheria/0000-0001-7678-2510; van de klundert, joris/0000-0003-4151-5089; Mahdavi/0000-0002-7383-3455	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	Over the years 2011-2014, the cost of contributions of all researchers have been fully covered by the European Commission 7th Framework Programme for Research and Technological Development, project Managed Outcomes. This also holds true for the cost of the private organization 'Balance of Care'. Cost from 2015 onwards for the final analysis and writing of this manuscript have been covered by the employer organisations of the researchers involved. The funder provided support in the form of salaries for all authors and material costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adeleye JO, 2017, NIGER J CLIN PRACT, V20, P221, DOI 10.4103/1119-3077.187310; [Anonymous], 2013, DISCOVERING STAT USI, P297; Bago T, 2007, MEASUREMENT HORIZONT; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; BOWERS MR, 1994, HEALTH CARE MANAGE R, V19, P49, DOI 10.1097/00004010-199401940-00006; Collins MM, 2009, DIABETES CARE, V32, P603, DOI 10.2337/dc08-1169; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dean Alison M, 2008, HLTH MARKETING Q, V16, P1; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Donker GA, 2004, FAM PRACT, V21, P364, DOI 10.1093/fampra/cmh404; Fichman M, 2003, ORGAN RES METHODS, V6, P282, DOI 10.1177/1094428103255532; Foster EM, 2007, EVALUATION REV, V31, P261, DOI 10.1177/0193841X07299247; Gorter KJ, 2010, PRIM CARE DIABETES, V4, P17, DOI 10.1016/j.pcd.2010.01.004; Guisasola FA, 2008, DIABETES OBES METAB, V10, P25, DOI 10.1111/j.1463-1326.2008.00882.x; Joy SM, 2013, PHARMACOECONOMICS, V31, P877, DOI 10.1007/s40273-013-0089-7; Juran, 1998, JURANS QUALITY CONTR; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kirkman MS, 2015, DIABETES CARE, V38, P604, DOI 10.2337/dc14-2098; Kodner Dennis L, 2002, Int J Integr Care, V2, pe12; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lopez-Lopez E, 2012, INT J QUAL HEALTH C, V24, P619, DOI 10.1093/intqhc/mzs056; Mahdavi M., 2015, THESIS; Mahdavi M, 2013, SOCIO-ECON PLAN SCI, V47, P271, DOI 10.1016/j.seps.2013.07.002; Montenegro H, 2011, J INTEGR CARE, V19, P5, DOI 10.1108/14769011111176707; Montori VM, 2002, DIABETES CARE, V25, P1952, DOI 10.2337/diacare.25.11.1952; Narayan KMV, 2003, J NATL MED ASSOC, V95, P64; Parasuraman A., 2002, RETAILING CRITICAL C, V64, P140; Prentice JC, 2012, HEALTH SERV RES, V47, P46, DOI 10.1111/j.1475-6773.2011.01307.x; Senic V, 2013, INT J CONSUM STUD, V37, P312, DOI 10.1111/j.1470-6431.2012.01132.x; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shojania KG, 2004, CLOSING QUALITY GAP, P1; Smith JJ, 2015, J AM BOARD FAM MED, V28, P28, DOI 10.3122/jabfm.2015.01.130329; Stone MA, 2013, DIABETES CARE, V36, P2628, DOI 10.2337/dc12-1759; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; TRIAD Study Grp, 2010, DIABETES CARE, V33, P940, DOI 10.2337/dc09-1802; van Raak A, 1999, INT J HEALTH PLAN M, V14, P235; Vinagre MH, 2008, INT J HEALTH CARE Q, V21, P87, DOI 10.1108/09526860810841183; Vrijhoef HJM, 2002, INT J NURS STUD, V39, P441, DOI 10.1016/S0020-7489(01)00046-3; Williams A., 2005, EQ 5D CONCEPTS METHO, P1, DOI DOI 10.1007/1-4020-3712-0_1	40	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192599	10.1371/journal.pone.0192599	http://dx.doi.org/10.1371/journal.pone.0192599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447220	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900040
J	Verani, JR; Massora, S; Acacio, S; dos Santos, RT; Vubil, D; Pimenta, F; Moura, I; Whitney, CG; Costa, MH; Macete, E; Matsinhe, MB; Carvalho, MD; Sigauque, B				Verani, Jennifer R.; Massora, Sergio; Acacio, Sozinho; dos Santos, Rita Teresa; Vubil, Delfino; Pimenta, Fabiana; Moura, Iaci; Whitney, Cynthia G.; Costa, Maria Helena; Macete, Eusebio; Matsinhe, Maria Benigna; Carvalho, Maria da Gloria; Sigauque, Betuel			Nasopharyngeal carriage of Streptococcus pneumoniae leamong HIV-infected and - uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; DISEASE; IMPACT; SUSCEPTIBILITY; KILIFI	Nasopharyngeal carriage is a precursor for pneumococcal disease and can be useful for evaluating pneumococcal conjugate vaccine (PCV) impact. We studied pre-PCV pneumococcal carriage among HIV-infected and -uninfected children in Mozambique. Between October 2012 and March 2013, we enrolled HIV-infected children age <5 years presenting for routine care at seven HIV clinics in 3 sites, including Maputo (urban-south), Nampula (urban-north), and Manhica (rural-south). We also enrolled a random sample of HIV-uninfected children <5 years old from a demographic surveillance site in Manhica. A single nasopharyngeal swab was obtained and cultured following enrichment in Todd Hewitt broth with yeast extract and rabbit serum. Pneumococcal isolates were serotyped by Quellung reaction and multiplex polymerase chain reaction. Factors associated with pneumococcal carriage were examined using logistic regression. Overall pneumococcal carriage prevalence was 80.5% (585/727), with similar prevalences among HIV-infected (81.5%, 339/416) and HIV-uninfected (79.1%, 246/311) children, and across age strata. Among HIV-infected, after adjusting for recent antibiotic use and hospitalization, there was no significant association between study site and colonization: Maputo (74.8%, 92/123), Nampula (83.7%, 82/98), Manhic E a (84.6%, 165/195). Among HIV-uninfected, report of having been born to an HIV-infected mother was not associated with colonization. Among 601 pneumococcal isolates from 585 children, serotypes 19F (13.5%), 23F (13.1%), 6A (9.2%), 6B (6.2%) and 19A (5.2%) were most common. The proportion of serotypes included in the 10- and 13-valent vaccines was 44.9% and 61.7%, respectively, with no significant differences by HIV status or age group. Overall 36.9% (n = 268) of children were colonized with a PCV10 serotype and 49.7% (n = 361) with a PCV13 serotype. Pneumococcal carriage was common, with little variation by geographic region, age, or HIV status. PCV10 was introduced in April 2013; ongoing carriage studies will examine the benefits of PCV10 among HIV-infected and-uninfected children.	[Verani, Jennifer R.; Pimenta, Fabiana; Moura, Iaci; Whitney, Cynthia G.; Carvalho, Maria da Gloria] Ctr Dis Control & Prevent, Resp Dis Branch, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Massora, Sergio; Acacio, Sozinho; Vubil, Delfino; Macete, Eusebio; Sigauque, Betuel] Fundacao Manhica, Ctr Invest Saude Manhica, Manhica, Mozambique; [Acacio, Sozinho; Sigauque, Betuel] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [dos Santos, Rita Teresa] Minist Saude, Hosp Cent Nampula, Nampula, Mozambique; [Costa, Maria Helena] Minist Saude, Hosp Gen Mavalane, Manhica, Mozambique; [Matsinhe, Maria Benigna] Minist Saude, Manhica, Mozambique	Centers for Disease Control & Prevention - USA; Centro de Investigacao em Saude de Manhica	Verani, JR (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA.; Sigauque, B (corresponding author), Fundacao Manhica, Ctr Invest Saude Manhica, Manhica, Mozambique.; Sigauque, B (corresponding author), Minist Saude, Inst Nacl Saude, Maputo, Mozambique.	jverani@cdc.gov; betuel.sigauque@manhica.net			USAID Missionin Mozambique: Fixed Obligation Grant (FOG) [AID-656-F-12-00001, RFA-656-12-000003]; Surveillance for Pediatric Pneumonia and Invasive Pneumococcal Disease in Mozambique; Spanish Agency for International Development Cooperation (AECI-Ministry of Foreign Affairs, Spain)	USAID Missionin Mozambique: Fixed Obligation Grant (FOG)(United States Agency for International Development (USAID)); Surveillance for Pediatric Pneumonia and Invasive Pneumococcal Disease in Mozambique; Spanish Agency for International Development Cooperation (AECI-Ministry of Foreign Affairs, Spain)	The work was supported by the following: USAID Missionin Mozambique: Fixed Obligation Grant (FOG) No. AID-656-F-12-00001, under RFA-656-12-000003, Surveillance for Pediatric Pneumonia and Invasive Pneumococcal Disease in Mozambique. The core funding of CISM povided by the Spanish Agency for International Development Cooperation (AECI-Ministry of Foreign Affairs, Spain), partially contributed to support the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293; Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brandileone MCD, 2016, VACCINE, V34, P5604, DOI 10.1016/j.vaccine.2016.09.027; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; CLSI, 2013, PERFORMANCE STANDARD; Cohen C, 2017, LANCET GLOB HEALTH, V5, pE359, DOI 10.1016/S2214-109X(17)30043-8; Cohen C, 2014, CLIN INFECT DIS, V59, P808, DOI 10.1093/cid/ciu431; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Fleming-Dutra KE, 2014, PEDIATR INFECT DIS J, V33, pS152, DOI 10.1097/INF.0000000000000083; Ginsburg AS, 2013, INT J ANTIMICROB AG, V42, P482, DOI 10.1016/j.ijantimicag.2013.08.012; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kobayashi M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2103-0; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS161, DOI 10.1097/INF.0000000000000084; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; Nyandiko W M, 2007, East Afr Med J, V84, P156; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Prymula R, 2009, EXPERT REV VACCINES, V8, P1479, DOI 10.1586/ERV.09.113; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; Vesikari T, 2016, J PEDIAT INF DIS SOC, V5, P237, DOI 10.1093/jpids/piw010; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; WHO, 2012, VACCINE; World Health Organization, 2008, EST HIB PNEUM DEATHS	35	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191113	10.1371/journal.pone.0191113	http://dx.doi.org/10.1371/journal.pone.0191113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447196	Green Published, gold			2022-12-26	WOS:000425283900007
J	Lucca, K; Pospisil, J; Sommerville, JA				Lucca, Kelsey; Pospisil, Jacqueline; Sommerville, Jessica A.			Fairness informs social decision making in infancy	PLOS ONE			English	Article							OBJECT PERMANENCE; RECIPROCITY; KNOWLEDGE; EVENTS; INEQUITY; CHILDREN	The ability to reason about fairness plays a defining role in the development of morality. Thus, researchers have long been interested in understanding when and how a sensitivity to fairness first develops. Here, we examined infants' ability to use fairness information in selecting social partners. Using a novel experimental paradigm that combined pre-recorded stimuli with an active behavioral measure, we tested whether infants preferred to socially engage with an individual they had previously seen behave fairly or unfairly. After viewing an individual distribute goods to third parties either equally (i.e., 3:3 distribution) or unequally (i.e., 5:1 distribution), both 13- and 17-month-old infants selectively chose to engage in a social interaction with (i.e., take a toy from) an individual who distributed resources equally. The use of a novel paradigm to assess infants' fairness preferences demonstrates that infants' previously established fairness preferences extend across different, more demanding paradigms, and may therefore be more enduring in nature. Together, these findings provide new insights into the nature of infants' fairness representations, and fill in key gaps in the developmental timeline of infants' ability to use fairness information in their consideration of potential social partners. In sum, these findings build on previous research by demonstrating that infants not only hold an expectation that resources should be distributed fairly, they also preferentially interact with those who have previously done so. The early-emerging ability to both reason about and use fairness information may play an influential role in the development of complex prosocial behaviors related to morality more broadly.	[Lucca, Kelsey; Pospisil, Jacqueline; Sommerville, Jessica A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Lucca, K (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	klucca@uw.edu			National Institute of Child Health and Development; NIH [R01-HD076949-01]; John Templeton Foundation	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation	Author JS received funding from the National Institute of Child Health and Development; NIH R01-HD076949-01; www.nichd.nih.gov, and from John Templeton Foundation; https://www.templeton.org/grant/developmental-changes-and-individual-differerces-in-fairness-concerns-and-altruistic-behavior-in-intancy-and-early-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLARGEON R, 1991, CHILD DEV, V62, P1227, DOI 10.2307/1130803; Berthier NE, 2006, EXP BRAIN RES, V169, P507, DOI 10.1007/s00221-005-0169-9; Berthier NE, 2000, DEV PSYCHOL, V36, P394, DOI 10.1037/0012-1649.36.3.394; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Bloom L., 1973, ONE WORD TIME USE SI; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Burns MP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00093; Carpenter M., 1998, MONOGRAPHS SOC RES C, V63; Casstevens R.M., 2007, JHAB JAVA HABITUATIO; DesChamps T. D., 2015, INFANCY, V21, P1; DEUTSCH M, 1975, J SOC ISSUES, V31, P137, DOI 10.1111/j.1540-4560.1975.tb01000.x; Enright E, 2017, COGNITION, P1; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E., 1999, Q J EC; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Hamlin JK, 2007, NATURE, V63, P219; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hood B, 2000, CHILD DEV, V71, P1540, DOI 10.1111/1467-8624.00247; Keen R, 2003, CURR DIR PSYCHOL SCI, V12, P79, DOI 10.1111/1467-8721.01234; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kuhlmeier VA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00836; Meristo M, 2016, INFANCY, V21, P353, DOI 10.1111/infa.12124; Meristo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110553; Meristo M, 2013, COGNITION, V129, P102, DOI 10.1016/j.cognition.2013.06.006; Munakata Y, 1997, PSYCHOL REV, V104, P686, DOI 10.1037/0033-295X.104.4.686; Munakata Y, 2001, TRENDS COGN SCI, V5, P309, DOI 10.1016/S1364-6613(00)01682-X; Page T, 2005, ECON J, V115, P1032, DOI 10.1111/j.1468-0297.2005.01031.x; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Rochat P, 2009, FAIRNESS DISTRIBUTIV, P416; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Shaw A, 2012, J EXP PSYCHOL GEN, V141, P382, DOI 10.1037/a0025907; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Smith CE, 2013, PLOS ONE, P8; Sommerville JA, ATLAS MORAL PSYCHOL, P1; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Ulber J, 2017, J EXP CHILD PSYCHOL, V155, P48, DOI 10.1016/j.jecp.2016.10.013; Ulber J, 2015, J EXP CHILD PSYCHOL, V140, P228, DOI 10.1016/j.jecp.2015.07.009; Xu J, 2016, DEV PSYCHOL, V52, P1732, DOI 10.1037/dev0000174; Ziv T, 2016, CHILD DEV, P1	41	33	33	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192848	10.1371/journal.pone.0192848	http://dx.doi.org/10.1371/journal.pone.0192848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444166	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500097
J	Shi, B; Wang, Y; Zhao, RZ; Long, XP; Deng, WW; Wang, ZL				Shi, Bei; Wang, Yan; Zhao, Ranzhun; Long, Xianping; Deng, Wenwen; Wang, Zhenglong			Bone marrow mesenchymal stem cell-derived exosomal miR-21 protects C-kit(+) cardiac stem cells from oxidative injury through the PTEN/PI3K/Akt axis	PLOS ONE			English	Article							PROGENITOR CELLS; PTEN; CARDIOMYOCYTES; MICROVESICLES; PROLIFERATION; ACTIVATION; MICRORNAS; APOPTOSIS; SURVIVAL; GROWTH	Stem cell (SC) therapy for ischemic cardiomyopathy is hampered by poor survival of the implanted cells. Recently, SC-derived exosomes have been shown to facilitate cell proliferation and survival by transporting various proteins and non-coding RNAs (such as microRNAs and lncRNAs). In this study, miR-21 was highly enriched in exosomes derived from bone marrow mesenchymal stem cells (MSCs). Interestingly, exosomes collected from hydrogen peroxide (H2O2)-treated MSCs (H-Exo) contained higher levels of miR-21 than exosomes released from MSCs under normal conditions (N-Exo). The pre-treatment of C-kit(+) cardiac stem cells (CSCs) with H-Exos resulted in significantly increased levels of miR-21 and phosphor-Akt (pAkt) and decreased levels of PTEN, which is a known target of miR-21. AnnexinV-FITC/PI analysis further demonstrated that the degree of oxidative stress-induced apoptosis was markedly lower in H-Exo-treated C-kit(+) CSCs than that in N-Exo-treated cells. These protective effects could be blocked by both a miR-21 inhibitor and the PI3K/Akt inhibitor LY294002. Therefore, exosomal miR-21 derived from H2O2-treated MSCs could be transported to C-kit(+) cardiac stem cells to functionally inhibit PTEN expression, thereby activating PI3K/AKT signaling and leading to protection against oxidative stress-triggered cell death. Thus, exosomes derived from MSCs could be used as a new therapeutic vehicle to facilitate C-kit(+) CSC therapies in the ischemic myocardium.	[Shi, Bei; Wang, Yan; Zhao, Ranzhun; Long, Xianping; Deng, Wenwen; Wang, Zhenglong] Zunyi Med Coll, Affiliated Hosp, Dept Cardiol, Zunyi, Peoples R China	Zunyi Medical University	Shi, B (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Cardiol, Zunyi, Peoples R China.	shibei2147@163.com	Shi, Bei/GWQ-3749-2022	Shi, Bei/0000-0001-5316-2351	National Natural Science Foundation of China [81360021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (Grant No. 81360021).	Bai HT, 2011, FEBS LETT, V585, P402, DOI 10.1016/j.febslet.2010.12.027; Bai YN, 2014, BIOCHEM BIOPH RES CO, V443, P802, DOI 10.1016/j.bbrc.2013.12.047; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5; Bobis-Wozowicz S, 2015, STEM CELLS, V33, P2748, DOI 10.1002/stem.2078; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Cai CX, 2015, STEM CELLS, V33, P3596, DOI 10.1002/stem.2198; Cervio E, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/482171; Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034; Cho JA, 2009, CANCER LETT, V275, P256, DOI 10.1016/j.canlet.2008.10.021; Ciuffreda Ludovica, 2014, Advances in Biological Regulation, V56, P66, DOI 10.1016/j.jbior.2014.07.002; Deng W., 2016, ATMOS CHEM PHYS DISC, V2016, P1, DOI DOI 10.1155/2016/5389181; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Fang S, 2016, STEM CELL TRANSL MED, V5, P1425, DOI 10.5966/sctm.2015-0367; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hesheng Ou YL, 2014, PLOS ONE, V9; Hong KU, 2014, CURRENT TREATMENT OP, V16, P24; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Hu GW, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt546; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liwak-Muir U DC, 2015, ONCOTARGET, V32, P1439; Lv C, 2016, J CLIN NEUROSCI, V27, P154, DOI 10.1016/j.jocn.2015.07.029; Lv GW, 2014, J CELL BIOCHEM, V115, P93, DOI 10.1002/jcb.24636; Mayfield AE, 2014, CAN J CARDIOL, V30, P1288, DOI 10.1016/j.cjca.2014.03.018; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Mohsin S, 2012, J AM COLL CARDIOL, V60, P1278, DOI 10.1016/j.jacc.2012.04.047; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Ou HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109929; Panigrahi AR, 2004, J PATHOL, V204, P93, DOI 10.1002/path.1611; Qi W, 2015, LAB INVEST, V95, P1258, DOI 10.1038/labinvest.2015.109; Richart A, 2014, STEM CELLS, V32, P2908, DOI 10.1002/stem.1789; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Safinur Ataya CG-T, 2011, EXP CELL RES, V317, P1192; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Schwartzbauer G, 2001, J BIOL CHEM, V276, P35786, DOI 10.1074/jbc.M102479200; Shi B, 2017, PEERJ, V5, DOI 10.7717/peerj.2859; Shi B, 2014, EXP BIOL MED, V239, P356, DOI 10.1177/1535370213517619; Sluijter JPG, 2014, CARDIOVASC RES, V102, P302, DOI 10.1093/cvr/cvu022; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Taghavi S, 2015, CTS-CLIN TRANSL SCI, V8, P425, DOI 10.1111/cts.12251; Tang XL, 2016, CIRC RES, V118, P1091, DOI 10.1161/CIRCRESAHA.115.307647; Teng L, 2016, J BIOL CHEM, V291, P9733, DOI 10.1074/jbc.M115.687806; van Kranenburg M, 2014, JACC-CARDIOVASC IMAG, V7, P930, DOI 10.1016/j.jcmg.2014.05.010; Wei C, 2014, FREE RADICAL RES, V48, P282, DOI 10.3109/10715762.2013.865839; Wu DN, 2006, NEUROSCI LETT, V404, P98, DOI 10.1016/j.neulet.2006.05.018; Wu TT, 2015, STEM CELLS, V33, P3281, DOI 10.1002/stem.2081; Xiao J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.181; Xu LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103698; Yang P, 2006, INVEST OPHTH VIS SCI, V47, P4598, DOI 10.1167/iovs.06-0140; Yu B, 2015, INT J CARDIOL, V182, P349, DOI 10.1016/j.ijcard.2014.12.043; Zhang ZW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002856; Zhou X, 2014, ONCOL REP, V31, P2173, DOI 10.3892/or.2014.3114	65	79	84	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191616	10.1371/journal.pone.0191616	http://dx.doi.org/10.1371/journal.pone.0191616			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444190	gold, Green Submitted, Green Published			2022-12-26	WOS:000425183500025
J	Cala, MP; Aldana, J; Medina, J; Sanchez, J; Guio, J; Wist, J; Meesters, RJW				Cala, Monica P.; Aldana, Julian; Medina, Jessica; Sanchez, Julian; Guio, Jose; Wist, Julien; Meesters, Roland J. W.			Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women	PLOS ONE			English	Article							CHOLINE PHOSPHOLIPID-METABOLISM; FATTY-ACID SYNTHASE; PROTEIN-KINASE-C; MASS-SPECTROMETRY; PHOSPHATIDIC-ACID; NMR-SPECTROSCOPY; HUMAN URINE; SERUM; PROFILES; CELLS	Breast cancer (BC) is a highly heterogeneous disease associated with metabolic reprogramming. The shifts in the metabolome caused by BC still lack data from Latin populations of Hispanic origin. In this pilot study, metabolomic and lipidomic approaches were performed to establish a plasma metabolic fingerprint of Colombian Hispanic women with BC. Data from 1 H-NMR, GC-MS and LC-MS were combined and compared. Statistics showed discrimination between breast cancer and healthy subjects on all analytical platforms. The differentiating metabolites were involved in glycerolipid, glycerophospholipid, amino acid and fatty acid metabolism. This study demonstrates the usefulness of multiplatform approaches in metabolic/lipid fingerprinting studies to broaden the outlook of possible shifts in metabolism. Our findings propose relevant plasma metabolites that could contribute to a better understanding of underlying metabolic shifts driven by BC in women of Colombian Hispanic origin. Particularly, the understanding of the up-regulation of long chain fatty acyl carnitines and the down-regulation of cyclic phosphatidic acid (cPA). In addition, the mapped metabolic signatures in breast cancer were similar but not identical to those reported for non-Hispanic women, despite racial differences.	[Cala, Monica P.; Aldana, Julian; Meesters, Roland J. W.] Univ Los Andes, Dept Chem, Grp Invest Quim Analit & Bioanalit GABIO, Bogota, DC, Colombia; [Medina, Jessica; Wist, Julien] Univ Valle, Dept Chem, Cali, Colombia; [Sanchez, Julian; Guio, Jose] Liga Canc Secc Bogota, Bogota, Colombia; [Meesters, Roland J. W.] MLM Med Labs GmbH, Monchengladbach, Germany	Universidad de los Andes (Colombia); Universidad del Valle	Meesters, RJW (corresponding author), Univ Los Andes, Dept Chem, Grp Invest Quim Analit & Bioanalit GABIO, Bogota, DC, Colombia.; Meesters, RJW (corresponding author), MLM Med Labs GmbH, Monchengladbach, Germany.	rjwmeesters@gmail.com	Wist, Julien/J-4254-2018; Meesters, Roland J.W./B-3259-2008	Wist, Julien/0000-0002-3416-2572; Cala, Monica/0000-0002-8198-726X; Meesters, Roland J.W./0000-0002-8946-2329; Aldana, Julian/0000-0001-6378-1201; Sanchez Castillo, Julian/0000-0003-3327-4158; Medina, Jessica/0000-0001-6123-3068	Proyecto Semilla from the Faculty of Sciences of Universidad de los Andes, Bogota D.C., Colombia [2015-1]	Proyecto Semilla from the Faculty of Sciences of Universidad de los Andes, Bogota D.C., Colombia	This study was financially supported by the Proyecto Semilla (Call for funding 2015-1, doctoral candidates) from the Faculty of Sciences of Universidad de los Andes, Bogota D.C., Colombia to MPCM.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Abu-Bedair FA, 2003, JPN J CLIN ONCOL, V33, P278, DOI 10.1093/jjco/hyg059; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Alonso A, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00023; Arana VA, 2015, FOOD CHEM, V175, P500, DOI 10.1016/j.foodchem.2014.11.160; Armitage EG, METABOLOMICS CANC BI; Armitage EG, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1093-7; Asiago VM, 2010, CANCER RES, V70, P8309, DOI 10.1158/0008-5472.CAN-10-1319; Barnes T, PLASMA AMINO ACID PR; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; Bhat S.A., 2013, J INVEST BIOCH, V2, P26, DOI DOI 10.5455/JIB.20121125075314; Budczies J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-334; Sanabria MC, 2009, BIOMEDICA, V29, P61, DOI 10.7705/biomedica.v29i1.42; Chen XL, 2016, ONCOTARGET, V7, P36622, DOI 10.18632/oncotarget.9124; Ciborowski M, 2010, J PROTEOME RES, V9, P4131, DOI 10.1021/pr100331j; Cui M, 2016, BIOMED CHROMATOGR, V30, P42, DOI 10.1002/bmc.3556; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039; Dowling P, 2015, METABOLOMICS, V11, P620, DOI 10.1007/s11306-014-0723-1; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Fan Y, 2016, ONCOTARGET, V7, P9925, DOI 10.18632/oncotarget.7155; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; Furstenberger G, WHAT ARE CYCLOOXYGEN; Garcia A, 2011, METHODS MOL BIOL, V708, P191, DOI 10.1007/978-1-61737-985-7_11; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Geck Renee C., 2016, Advances in Biological Regulation, V62, P11, DOI 10.1016/j.jbior.2016.01.001; Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Godzien J, 2015, METABOLOMICS, V11, P518, DOI 10.1007/s11306-014-0712-4; Gong Y, 2014, EUR REV MED PHARMACO, V18, P2808; Gu Y, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0408-1; Gunther UL, 2015, PATHOBIOLOGY, V82, P153, DOI 10.1159/000430844; Hammad LA, 2009, RAPID COMMUN MASS SP, V23, P863, DOI 10.1002/rcm.3947; He MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11298; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Jobard E, 2014, CANCER LETT, V343, P33, DOI 10.1016/j.canlet.2013.09.011; Kapil U, 2013, J BREAST CANCER, V16, P129, DOI 10.4048/jbc.2013.16.1.129; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Kim H, 2009, ANAL BIOANAL CHEM, V393, P1649, DOI 10.1007/s00216-009-2621-3; Kim HY, 2016, ONCOTARGET, V7, P67111, DOI 10.18632/oncotarget.11560; Kim IC, 2013, ANTICANCER RES, V33, P2467; KOKOGLU E, 1994, CANCER LETT, V82, P175, DOI 10.1016/0304-3835(94)90008-6; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Lai HS, 2005, SEMIN CANCER BIOL, V15, P267, DOI 10.1016/j.semcancer.2005.04.003; Leach MO, 1998, NMR BIOMED, V11, P314, DOI 10.1002/(SICI)1099-1492(1998110)11:7<314::AID-NBM522>3.0.CO;2-Z; Li YL, 2007, ANAL CHEM, V79, P1569, DOI 10.1021/ac0615910; Liland KH, 2011, TRAC-TREND ANAL CHEM, V30, P827, DOI 10.1016/j.trac.2011.02.007; Linher-Melville K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-56; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu HL, 2008, MOL CANCER THER, V7, P263, DOI 10.1158/1535-7163.MCT-07-0445; Hernandez JEL, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-11; Louis E, 2015, METABOLOMICS, V11, P225, DOI 10.1007/s11306-014-0690-6; Doria ML, 2013, J CELL PHYSIOL, V228, P457, DOI 10.1002/jcp.24152; Lv WW, 2012, CLIN BIOCHEM, V45, P127, DOI 10.1016/j.clinbiochem.2011.10.011; Marcus JN, 1997, CANCER-AM CANCER SOC, V80, P543, DOI 10.1002/(SICI)1097-0142(19970801)80:3+<543::AID-CNCR4>3.3.CO;2-R; Mishra P, METABOLIC SIGNATURES; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; More TH, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-016-1138-y; Morse-Gaudio M, 1998, INT J ONCOL, V12, P1349; Mourtada-Maarabouni M, 2010, MOL PHARMACOL, V78, P19, DOI 10.1124/mol.110.064055; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Noh DY, 2000, CANCER LETT, V161, P207, DOI 10.1016/S0304-3835(00)00612-1; Noh DY, 1998, ANTICANCER RES, V18, P2643; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Oakman C, 2011, ANN ONCOL, V22, P1295, DOI 10.1093/annonc/mdq606; Park SJ, 2014, BIOMOL THER, V22, P129, DOI 10.4062/biomolther.2013.110; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; POTISCHMAN N, 1991, NUTR CANCER, V15, P205, DOI 10.1080/01635589109514128; Qiu YP, 2013, INT J MOL SCI, V14, P8047, DOI 10.3390/ijms14048047; Ray G, 2001, CLIN BIOCHEM, V34, P71, DOI 10.1016/S0009-9120(00)00200-9; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schrimpe-Rutledge AC, 2016, J AM SOC MASS SPECTR, V27, P1897, DOI 10.1007/s13361-016-1469-y; Sethi S, 2017, PROSTAG OTH LIPID M, V128, P8, DOI 10.1016/j.prostaglandins.2016.12.002; Shajahan-Haq AN, 2015, METABOLITES, V5, P100, DOI 10.3390/metabo5010100; Shen J, 2013, TRANSL ONCOL, V6, P757, DOI 10.1593/tlo.13619; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stewart DA, 2015, CANCER RES, P75; Stewart DA, 2016, J PROTEOME RES, V15, P3225, DOI 10.1021/acs.jproteome.6b00430; Tenori L, 2012, MOL ONCOL, V6, P437, DOI 10.1016/j.molonc.2012.05.003; Ting YLT, 1996, ANTICANCER RES, V16, P1381; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang Z, 2014, EVID-BASED COMPL ALT, V2014, P16; Warburg O, ORIGIN CANC CELLS; Wei SW, 2013, MOL ONCOL, V7, P297, DOI 10.1016/j.molonc.2012.10.003; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Whiley L, 2012, ANAL CHEM, V84, P5992, DOI 10.1021/ac300716u; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Wishart DS, 2016, METABOLITES, V6, DOI 10.3390/metabo6010010; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; YAMASHITA SI, 1994, BRIT J CANCER, V69, P1166, DOI 10.1038/bjc.1994.229; Yang L, 2015, ANAL BIOANAL CHEM, V407, P5065, DOI 10.1007/s00216-015-8484-x; Yin PY, 2014, J CHROMATOGR A, V1374, P1, DOI 10.1016/j.chroma.2014.11.050; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; You JC, 2015, PROG BIOCHEM BIOPHYS, V42, P563; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167; ZIELINSKI CC, 1988, J CANCER RES CLIN, V114, P514, DOI 10.1007/BF00391503	109	31	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0190958	10.1371/journal.pone.0190958	http://dx.doi.org/10.1371/journal.pone.0190958			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438405	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400005
J	Du, M; Li, N; Niu, BZ; Liu, YH; You, DJ; Jiang, DF; Ruan, CQ; Qin, ZQ; Song, TW; Wang, WT				Du, Min; Li, Na; Niu, Baozhen; Liu, Yanhong; You, Dongjing; Jiang, Defu; Ruan, Congquan; Qin, Zhengquan; Song, Taowen; Wang, Wentao			De novo transcriptome analysis of Bagarius yarrelli (Siluriformes: Sisoridae) and the search for potential SSR markers using RNA-Seq	PLOS ONE			English	Article							SEQUENCING TECHNOLOGIES; MICROSATELLITE MARKERS; GENERATION; PLATFORM; GENOMICS	Background The yellow sisorid catfish (Bagarius yarrelli) is a carnivorous freshwater fish that inhabits the Honghe River, Lanchangjiang River and Nujiang River of southern China and other Southeast Asian countries. However, the publicly available genomic data for B. yarrelli are limited. Methodology and principal findings Illumina Solexa paired-end technology produced 1,706,456 raw reads from muscle, liver and caudal fin tissues of B. yarrelli. Nearly 5 Gb of data were acquired, and de novo assembly generated 14,607 unigenes, with an N50 of 2006 bp. A total of 9093 unigenes showed significant similarities to known proteins in public databases: 4477 and 6391 of B. yarrelli unigenes were mapped to the Gene Ontology (GO) and Clusters of Orthologous Groups (COG) databases, respectively. Moreover, 9635 unigenes were assigned to 242 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. In addition, 8568 microsatellites (simple sequence repeats, SSRs) were detected, and 31 pairs of polymorphic primers were characterized using wild populations of B. yarrelli from the Nujiang River, Yunnan Province, China. Conclusion/Significance These sequences enrich the genomic resources for B. yarrelli and will benefit future investigations into the evolutionary and biological processes of this and related Bagarius species. The SSR markers developed in this study will facilitate construction of genetic maps, investigations of genetic structures and germplasm polymorphism assessments in B. yarrelli.	[Du, Min; Li, Na; Liu, Yanhong] Honghe Univ, Efficient Cultivat & Secur Control Crops Coll & U, Key Lab Qual, Mengzi, Yunnan, Peoples R China; [Niu, Baozhen; You, Dongjing; Jiang, Defu; Ruan, Congquan; Qin, Zhengquan; Song, Taowen; Wang, Wentao] Honghe Univ, Coll Life Sci & Technol, Mengzi, Yunnan, Peoples R China	Honghe University; Honghe University	Du, M; Liu, YH (corresponding author), Honghe Univ, Efficient Cultivat & Secur Control Crops Coll & U, Key Lab Qual, Mengzi, Yunnan, Peoples R China.	du2005min@126.com; liu41294777@126.com		du, Min/0000-0002-6741-2785	National Natural Science Foundation of China [31360638]; Young Academic Leaders of Reserve Talent project in Yunnan Province [2015HB059]; Science Research Fund of Yunnan Provincial Department of Education [ZD2013009]; Innovative Practice Teaching Reform project at Honghe University [CXSJ1340]; Young Academic Leaders of Reserve Talent project in Honghe University [2014HB0203]; Honghe University doctoral special project [14bs11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Academic Leaders of Reserve Talent project in Yunnan Province; Science Research Fund of Yunnan Provincial Department of Education; Innovative Practice Teaching Reform project at Honghe University; Young Academic Leaders of Reserve Talent project in Honghe University; Honghe University doctoral special project	This work is supported by the National Natural Science Foundation of China (no.31360638), Young Academic Leaders of Reserve Talent project in Yunnan Province (no.2015HB059), Science Research Fund of Yunnan Provincial Department of Education (no.ZD2013009), Innovative Practice Teaching Reform project at Honghe University (no.CXSJ1340), Young Academic Leaders of Reserve Talent project in Honghe University (no.2014HB0203), and Honghe University doctoral special project (no.14bs11).; This work was supported by the National Natural Science Foundation of China (no.31360638), Young Academic Leaders of Reserve Talent Project in Yunnan Province (no.2015HB059), Science Research Fund of Yunnan Provincial Department of Education (no.ZD2013009), Innovative Practice Teaching Reform Project at Honghe University (no.CXSJ1340), Young Academic Leaders of Reserve Talent Project in Honghe University (no.2014HB0203), and the Honghe University Doctoral Special Project (no.14bs11).	BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cheng Q., 1987, SYSTEMATIC SYNOPSIS, V1; Chu XL, 1989, FISH FAUNA OF YUNNAN, V1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du M, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028157; Du M, 2015, GENET MOL RES, V14, P16308, DOI 10.4238/2015.December.8.21; Du M, 2014, FRESHWATER FISHERIES, V44, P1; [杜民 Du Min], 2016, [上海海洋大学学报, Journal of Shanghai Ocean University], V25, P337; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Guo XG, 2004, CHINESE SCI BULL, V49, P1586, DOI 10.1360/04wc0176; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luo W, 2013, CONSERV GENET RESOUR, V5, P499, DOI 10.1007/s12686-012-9837-9; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102668; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Niu B Z, 2016, JIANGSU AGR SCI, V44, P62; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; [田树魁 TIAN Shu-kui], 2009, [淡水渔业, Freshwater Fisheries], V39, P73; Tian SK, 2009, J HYDROECOL, V2, P115; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WANG ZY, 2010, BMC GENOMICS, V0011; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; Xue C J, 2012, J HYDROECOLOGY, V33, P54; Zhang HL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-647	34	11	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0190343	10.1371/journal.pone.0190343	http://dx.doi.org/10.1371/journal.pone.0190343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425202	Green Published, Green Submitted, gold			2022-12-26	WOS:000424700800002
J	Bermudez-Aza, EH; Shetty, S; Ousley, J; Kyaw, NTT; Soe, TT; Soe, K; Mon, PE; Tun, KT; Ciglenecki, I; Cristofani, S; Fernandez, M				Bermudez-Aza, Elkin Hernaan; Shetty, Sharmila; Ousley, Janet; Nang Thu Thu Kyaw; Soe, Theint Thida; Soe, Kyipyar; Mon, Phyu Ei; Kyaw Tin Tun; Ciglenecki, Iza; Cristofani, Susanna; Fernandez, Marcelo			Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; RESOURCE-LIMITED SETTINGS; MIDDLE-INCOME COUNTRIES; TREATMENT PROGRAM; RISK-FACTORS; CARDIOVASCULAR-DISEASE; FOLLOW-UP; COHORT; PREVALENCE; MORTALITY	Objective To study the long-term clinical, immunological and virological outcomes among people living with HIV on antiretroviral therapy (ART) in Myanmar. Methods A retrospective analysis of people on ART for >9 years followed by a cross-sectional survey among the patients in this group who remained on ART at the time of the survey. Routinely collected medical data established the baseline clinical and demographic characteristics for adult patients initiating ART between 2004 and 2006. Patients remaining on ART between March-August 2015 were invited to participate in a survey assessing clinical, virological, immunological, and biochemical characteristics. Results Of 615 patients included in the retrospective analysis, 35 (6%) were lost-to-follow-up, 9 (1%) were transferred, 153 died (25%) and 418 (68%) remained active in care. Among deaths, 48 (31.4%) occurred within 3 months of ART initiation, and 81 (52.9%) within 12 months, 90.1% (n = 73) of which were initially classified as stage 3/4. Of 385 patients included in the survey, 30 (7.7%) were on second-line ART regimen; 373 (96.8%) had suppressed viral load (< 250 copies/ml). The mean CD4 count was 548 cells/mm3 (SD 234.1) after >= 9 years on treatment regardless of the CD4 group at initiation. Tuberculosis while on ART was diagnosed in 187 (48.5%); 29 (7.6%) had evidence of hepatitis B and 53 (13.9%) of hepatitis C infection. Conclusions Appropriate immunological and virological outcomes were seen among patients on ART for >= 9 years. However, for the complete initiating cohort, high mortality was observed, especially in the first year on ART. Concerning co-infections, tuberculosis and viral hepatitis were common among this population. Our results demonstrate that good long-term outcomes are possible even for patients with advanced AIDS at ART initiation.	[Bermudez-Aza, Elkin Hernaan; Shetty, Sharmila; Ousley, Janet; Nang Thu Thu Kyaw; Soe, Theint Thida; Soe, Kyipyar; Mon, Phyu Ei; Fernandez, Marcelo] MSF, Yangon, Myanmar; [Kyaw Tin Tun] Minist Hlth, Dawei, Myanmar; [Ciglenecki, Iza; Cristofani, Susanna] MSF, Geneva, Switzerland	Doctors Without Borders; Doctors Without Borders	Bermudez-Aza, EH (corresponding author), MSF, Yangon, Myanmar.	hache200@yahoo.com						Achhra AC, 2011, CURR OPIN HIV AIDS, V6, P258, DOI 10.1097/COH.0b013e3283476c72; [Anonymous], 2016, MYANMAR NATL STRATEG; Boender TS, 2015, CLIN INFECT DIS, V61, P1453, DOI 10.1093/cid/civ556; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Carriquiry G, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20016; Castelnuovo B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142722; Choo MKK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118422; Do TC, 2016, HIV MED, V17, P542, DOI 10.1111/hiv.12358; Easterbrook P, 2012, SEMIN LIVER DIS, V32, P147, DOI 10.1055/s-0032-1316476; Glass TR, 2006, HIV MED, V7, P404, DOI 10.1111/j.1468-1293.2006.00400.x; Grimsrud A, 2014, JAIDS-J ACQ IMM DEF, V67, pE55, DOI 10.1097/QAI.0000000000000268; Hirschhorn Lisa R, 2012, AIDS, V26 Suppl 1, pS65; Htet AS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3882-3; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Kyaw NTT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171780; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Ledergerber B, 2011, HIV MED, V12, P279, DOI 10.1111/j.1468-1293.2010.00880.x; Lodwick R, 2010, ARCH INTERN MED, V170, P410, DOI 10.1001/archinternmed.2009.472; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Mburu G, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20926; Meloni ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164030; Mizushima D, 2014, J INFECT CHEMOTHER, V20, P784, DOI 10.1016/j.jiac.2014.08.015; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; National AIDS Programme Department of Health Ministry of Health Myanmar, 2012, HIV SENT SER SURV SU; Neogi U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055421; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Nuesch R, 2006, J ANTIMICROB CHEMOTH, V58, P637, DOI 10.1093/jac/dkl313; Paisible AL, 2015, JAIDS-J ACQ IMM DEF, V68, P209, DOI 10.1097/QAI.0000000000000419; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Pierre S, 2016, NEW ENGL J MED, V374, P397, DOI 10.1056/NEJMc1508934; Protopopescu C, 2017, JAIDS-J ACQ IMM DEF, V74, P293, DOI 10.1097/qai.0000000000001249; Sabapathy K, 2012, JAIDS-J ACQ IMM DEF, V60, pE53, DOI 10.1097/QAI.0b013e31824d5689; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; So-Armah KA, 2016, JAIDS-J ACQ IMM DEF, V72, P206, DOI 10.1097/QAI.0000000000000954; Takebe Y, 2003, AIDS, V17, P2077, DOI 10.1097/00002030-200309260-00009; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; UNAIDS, HIV AS PAC; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; World Health Organization, 2003, SCAL ANT THER RES LT; Zaw SKK, 2013, TROP DOCT, V43, P113, DOI 10.1177/0049475513493416	42	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191695	10.1371/journal.pone.0191695	http://dx.doi.org/10.1371/journal.pone.0191695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420652	gold, Green Published, Green Submitted			2022-12-26	WOS:000424517900018
J	Dhooria, S; Agarwal, R; Sehgal, IS; Prasad, KT; Garg, M; Bal, A; Aggarwal, AN; Behera, D				Dhooria, Sahajal; Agarwal, Ritesh; Sehgal, Inderpaul Singh; Prasad, Kuruswamy Thurai; Garg, Mandeep; Bal, Amanjit; Aggarwal, Ashutosh Nath; Behera, Digambar			Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ILD-INDIA REGISTRY; FLEXIBLE CRYOPROBE; STATEMENT; EPIDEMIOLOGY; PIRFENIDONE; SARCOIDOSIS; BIOPSY; SPAIN	Background The spectrum of interstitial lung diseases (ILDs) have mainly been reported from the developed countries; data from developing countries is sparse and conflicting. The aim of this study is to describe the distribution of various ILDs from a developing country. Methods This is an analysis of prospectively collected clinical, radiological and histological data of consecutive subjects (age > 12 years) with ILDs from a single tertiary care medical center. The diagnosis of the specific subtype of ILD was made according to standard criteria for various ILDs. Results A total of 803 subjects (mean age, 50.6 years; 50.2% women) were enrolled between March 2015 to February 2017 of which 566 (70.5%) were diagnosed during the study period (incident cases). Sarcoidosis (42.2%), idiopathic pulmonary fibrosis (IPF, 21.2%), connective tissue disease (CTD)-related ILDs (12.7%), hypersensitivity pneumonitis (10.7%), and non-IPF idiopathic interstitial pneumonias (9.2%) were the most common ILDs. The spectrum of ILDs was not significantly different (p = 0.87) between incident and prevalent cases. A histopathological specimen was obtained in 49.9% of the subjects yielding a histologically confirmed diagnosis in 40.6%. A diagnostic procedure was not performed in 402 subjects; the most common reasons were presence of definite usual interstitial pneumonia pattern on high resolution computed tomography and patients' unwillingness to undergo the procedure. Conclusion Sarcoidosis, IPF and CTD-ILDs were the most common ILDs seen at a tertiary center in northern India similar to the spectrum reported from developed countries. More studies are required from developing countries to ascertain the spectrum of ILDs in different geographic locales.	[Dhooria, Sahajal; Agarwal, Ritesh; Sehgal, Inderpaul Singh; Prasad, Kuruswamy Thurai; Aggarwal, Ashutosh Nath; Behera, Digambar] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh, India; [Garg, Mandeep] Postgrad Inst Med Educ & Res, Dept Radiodiagnosis & Imaging, Chandigarh, India; [Bal, Amanjit] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Dhooria, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh, India.	sahajal@gmail.com	Agarwal, Ritesh/A-3063-2009; Sehgal, Inderpaul/AAA-8165-2021; Sehgal, Inderpaul/GYE-2441-2022	Agarwal, Ritesh/0000-0003-2547-7668; Sehgal, Inderpaul/0000-0002-6505-6019; Garg, Mandeep/0000-0002-4714-6299				Agostini C, 2001, Monaldi Arch Chest Dis, V56, P364; Alhamad EH, 2013, ANN THORAC MED, V8, P33, DOI 10.4103/1817-1737.105717; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Dhooria S, 2017, CLIN RESP J IN PRESS; Dhooria Sahajal, 2017, J Assoc Physicians India, V65, P30; Dhooria S, 2017, AM J RESP CRIT CARE, V195, P835, DOI 10.1164/rccm.201610-2023LE; Dhooria S, 2016, SARCOIDOSIS VASC DIF, V33, P258; Dhooria S, 2016, RESP CARE, V61, P700, DOI 10.4187/respcare.04488; Dhooria S, 2016, LUNG INDIA, V33, P248, DOI 10.4103/0970-2113.177463; Dhooria S, 2016, LUNG INDIA, V33, P64, DOI 10.4103/0970-2113.173066; Dhooria S, 2015, LUNG INDIA, V32, P4, DOI 10.4103/0970-2113.148396; Dhooria S, 2014, J THORAC CARDIOV SUR, V148, P662, DOI 10.1016/j.jtcvs.2014.01.028; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Hyldgaard C, 2014, RESP MED, V108, P793, DOI 10.1016/j.rmed.2013.09.002; Jindal S K, 1999, Curr Opin Pulm Med, V5, P287, DOI 10.1097/00063198-199909000-00004; Jindal S K, 2001, Curr Opin Pulm Med, V7, P272, DOI 10.1097/00063198-200109000-00004; Karakatsani A, 2009, RESP MED, V103, P1122, DOI 10.1016/j.rmed.2009.03.001; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kumar Raj, 2014, Pneumonol Alergol Pol, V82, P218, DOI 10.5603/PiAP.2014.0029; Kundu S, 2014, LUNG INDIA, V31, P354, DOI 10.4103/0970-2113.142115; Lopez-Campos JL, 2004, EUR J EPIDEMIOL, V19, P155, DOI 10.1023/B:EJEP.0000017660.18541.83; Madan K, 2017, AM J RESP CRIT CARE, V195, P836, DOI 10.1164/rccm.201610-2099LE; Maheshwari U, 2004, Indian J Chest Dis Allied Sci, V46, P23; Musellim B, 2014, CLIN RESPIR J, V8, P55, DOI 10.1111/crj.12035; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ryerson CJ, 2014, EUR RESPIR J, V44, P273, DOI 10.1183/09031936.00051914; Schweisfurth H, 2003, Pneumologie, V57, P373; Schweisfurth H, 1996, Pneumologie, V50, P899; Sen Tiyas, 2010, Indian J Chest Dis Allied Sci, V52, P207; Singh S, 2017, AM J RESP CRIT CARE, V195, P801, DOI 10.1164/rccm.201607-1484OC; Thomeer M, 2001, ACTA CLIN BELG, V56, P163, DOI 10.1179/acb.2001.026; Thomeer M, 2001, EUR RESPIR J, V32, P114, DOI DOI 10.1016/S1010-7940(01)00915-0; Tinelli C, 2005, SARCOIDOSIS VASC DIF, V22, pS4; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Udwadia ZF, 2017, AM J RESP CRIT CARE, V195, P714, DOI 10.1164/rccm.201610-2019ED; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P64	39	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191938	10.1371/journal.pone.0191938	http://dx.doi.org/10.1371/journal.pone.0191938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420550	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900033
J	Owa, C; Poulin, M; Yan, LY; Shioda, T				Owa, Chie; Poulin, Matthew; Yan, Liying; Shioda, Toshi			Technical adequacy of bisulfite sequencing and pyrosequencing for detection of mitochondria! DNA methylation: Sources and avoidance of false-positive detection	PLOS ONE			English	Article							NON-CPG METHYLATION; METHYLTRANSFERASE 1; EXPOSURE; PATTERN; MARKER; CELLS	The existence of cytosine methylation in mammalian mitochondrial DNA (mtDNA) is a controversial subject. Because detection of DNA methylation depends on resistance of 5'-modified cytosines to bisulfite-catalyzed conversion to uracil, examined parameters that affect technical adequacy of mtDNA methylation analysis. Negative control amplicons (NCAs) devoid of cytosine methylation were amplified to cover the entire human or mouse mtDNA by long-range PCR. When the pyrosequencing template amplicons were gel-purified after bisulfite conversion, bisulfite pyrosequencing of NCAs did not detect significant levels of bisulfite-resistant cytosines (brCs) at ND1 (7 CpG sites) or CYTB (8 CpG sites) genes (CI95 = 0%-0.94%); without gel-purification, significant false-positive brCs were detected from NCAs (CI95 = 4.2%-6.8%). Bisulfite pyrosequencing of highly purified, linearized mtDNA isolated from human iPS cells or mouse liver detected significant brCs (similar to 30%) in human ND1 gene when the sequencing primer was not selective in bisulfite-converted and unconverted templates. However, repeated experiments using a sequencing primer selective in bisulfite-converted templates almost completely (<0.8%) suppressed brC detection, supporting the false-positive nature of brCs detected using the non-selective primer. Bisulfite-seq deep sequencing of linearized, gel-purified human mtDNA detected 9.4%-14.8% brCs for 9 CpG sites in ND1 gene. However, because all these brCs were associated with adjacent non-CpG brCs showing the same degrees of bisulfite resistance, DNA methylation in this mtDNA-encoded gene was not confirmed. Without linearization, data generated by bisulfite pyrosequencing or deep sequencing of purified mtDNA templates did not pass the quality control criteria. Shotgun bisulfite sequencing of human mtDNA detected extremely low levels of CpG methylation (<0.65%) over non-CpG methylation (<0.55%). Taken together, our study demonstrates that adequacy of mtDNA methylation analysis using methods dependent on bisulfite conversion needs to be established for each experiment, taking effects of incomplete bisulfite conversion and template impurity or topology into consideration.	[Owa, Chie; Shioda, Toshi] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Poulin, Matthew; Yan, Liying] EpigenDx Inc, Hopkinton, MA USA; [Shioda, Toshi] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Shioda, T (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Shioda, T (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	tshioda@mgh.harvard.edu		Shioda, Toshihiro/0000-0002-9434-7835; Owa, Chie/0000-0002-5241-5414	NIEHS/NIH [R01ES023316, R21ES024861]; EpigenDx; NIEHS/NIH	NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EpigenDx; NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NIEHS/NIH grants R01ES023316 and R21ES024861 to TS. The NIEHS/NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MP and LY are affiliated with EpigenDx, Inc., a for-profit company specialized in DNA bisulfite pyrosequencing and methylation analysis (MP, Scientific Director; LY, President). MP and LY played supportive roles in study design and preparation of the manuscript. MP was also involved in data collection and analysis. EpigenDx provided financial support to MP and LY in the form of salaries. Costs of research performed by and at EpigenDx were paid by TS. CO and TS are affiliated with Massachusetts General Hospital Center for Caner Research, a non-profit research organization. TS is also affiliated with Harvard Medical School (Associate Professor of Medicine). CO and TS are supported by the abovementioned NIEHS/NIH grants for salaries and research expenses. No financial support, in any forms, was provided from EpigenDx to CO or TS. CO was involved in data collection and analysis, and manuscript preparation. TS played primary roles in study design and preparation of the manuscript. TS was exclusively responsible for decisions of contents to be published without being influenced by EpigenDx.	Baccarelli AA, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0078-0; Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; Byun Hyang-Min, 2015, Methods Mol Biol, V1265, P271, DOI 10.1007/978-1-4939-2288-8_19; Byun HM, 2014, HUM GENET, V133, P247, DOI 10.1007/s00439-013-1417-x; Byun HM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-18; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Delaney C, 2015, METHODS MOL BIOL, V1343, P249, DOI 10.1007/978-1-4939-2963-4_19; Fuso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118318; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Hong EE, 2013, MOL CELL BIOL, V33, P2683, DOI 10.1128/MCB.00220-13; Ichiyanagi T, 2013, NUCLEIC ACIDS RES, V41, P738, DOI 10.1093/nar/gks1117; Janssen BG, 2014, PLACENTA, V35, P665, DOI 10.1016/j.placenta.2014.06.371; Janssen BG, 2015, EPIGENETICS-US, V10, P536, DOI 10.1080/15592294.2015.1048412; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lakshmanan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035271; Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23421; Maekawa M, 2004, CLIN CHEM, V50, P1480, DOI 10.1373/clinchem.2004.035139; Maresca A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00090; POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811; Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077; REIS RJS, 1983, J BIOL CHEM, V258, P9078; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Wong M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00279	25	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192722	10.1371/journal.pone.0192722	http://dx.doi.org/10.1371/journal.pone.0192722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420656	Green Published, gold			2022-12-26	WOS:000424517900111
J	Perez-Brocal, V; Moya, A				Perez-Brocal, Vicente; Moya, Andres			The analysis of the oral DNA virome reveals which viruses are widespread and rare among healthy young adults in Valencia (Spain)	PLOS ONE			English	Article							MICROBIOTA; BACTERIOPHAGE; SALIVARY; ECOLOGY	We have analysed oral wash samples from 72 healthy young adults in Valencia ( Spain) for a metagenomic analysis through the construction of shotgun libraries and high-throughput-sequencing. The oral viral communities have been taxonomically characterised as well as and the gene content from the latter. The majority of viruses are found in few individuals, with single occurrences being the most widespread ones, whereas universally distributed viruses, while present, are relatively rare, with bacteriophages from families Siphoviridae and Myoviridae, and Streptococcus phages, as well as the eukaryotic viral family Herpesviridae amongst the most widespread viruses. No significant differences were found between females and males for either viruses and bacteria in abundance and alpha and beta diversity. The virome show similarities with other oral viromes previously reported for healthy individuals, suggesting the existence of a universal core of oral viruses, at least in the Western society, regardless of the geographical location.	[Perez-Brocal, Vicente; Moya, Andres] FISABIO Publ Hlth, Gen & Hlth, Valencia, Spain; [Perez-Brocal, Vicente; Moya, Andres] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Moya, Andres] Univ Valencia, Integrat Syst Biol Inst I2Sysbio, Valencia, Spain; [Moya, Andres] Spanish Res Council CSIC, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC)	Perez-Brocal, V (corresponding author), FISABIO Publ Hlth, Gen & Hlth, Valencia, Spain.; Perez-Brocal, V (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	perez_vicbro@gva.es	Moya, Andrés/A-8190-2008; Perez Brocal, Vicente/K-3627-2014	Moya, Andrés/0000-0002-2867-1119; Perez Brocal, Vicente/0000-0002-1927-9676	Spanish Ministry of Science and Competitiveness [SAF 2012-31187, SAF2013-49788-EXP, SAF2015-65878-R]; Carlos III Institute of Health [PIE14/00045, AC15/00022]; Generalitat Valenciana [Prometeoll/2014/065]; FEDER; Spanish Ministry of Science and Competitiveness [SAF 2012-31187, SAF2013-49788-EXP, SAF2015-65878-R]; Carlos III Institute of Health [PIE14/00045, AC15/00022]; Generalitat Valenciana [Prometeoll/2014/065]; FEDER	Spanish Ministry of Science and Competitiveness(Spanish Government); Carlos III Institute of Health(Instituto de Salud Carlos III); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); FEDER(European Commission); Spanish Ministry of Science and Competitiveness(Spanish Government); Carlos III Institute of Health(Instituto de Salud Carlos III); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); FEDER(European Commission)	This work was supported by grants to AM from the Spanish Ministry of Science and Competitiveness (projects SAF 2012-31187, SAF2013-49788-EXP, SAF2015-65878-R), Carlos III Institute of Health (projects PIE14/00045 and AC15/00022), Generalitat Valenciana (project Prometeoll/2014/065) and co-financed by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134941; Abeles SR, 2014, ISME J, V8, P1753, DOI 10.1038/ismej.2014.31; Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Bachrach G, 2003, LETT APPL MICROBIOL, V36, P50, DOI 10.1046/j.1472-765X.2003.01262.x; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Broecker F, 2017, GUT MICROBES, V8, P214, DOI 10.1080/19490976.2016.1265196; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112; Delgado S, 2013, MICROB ECOL, V65, P763, DOI 10.1007/s00248-013-0192-5; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edlund A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27423; Gillings MR, 2015, GENES-BASEL, V6, P841, DOI 10.3390/genes6030841; Haynes M, 2011, METAGENOMICS OF THE HUMAN BODY, P63, DOI 10.1007/978-1-4419-7089-3_4; Huang RJ, 2011, VIRULENCE, V2, P435, DOI 10.4161/viru.2.5.16140; Kowarsky M, 2017, P NATL ACAD SCI USA, V114, P9623, DOI 10.1073/pnas.1707009114; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Ly M, 2014, MBIO, V5, DOI 10.1128/mBio.01133-14; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; Naidu M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-175; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Pujara P, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0103-4; Robles-Sikisaka R, 2013, ISME J, V7, P1710, DOI 10.1038/ismej.2013.63; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wylie KM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0071-7; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	31	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191867	10.1371/journal.pone.0191867	http://dx.doi.org/10.1371/journal.pone.0191867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420668	gold, Green Published, Green Submitted			2022-12-26	WOS:000424517900027
J	Brummer, T; Pigoni, M; Rossello, A; Wang, HH; Noy, PJ; Tomlinson, MG; Blobel, CP; Lichtenthaler, SF				Brummer, Tobias; Pigoni, Martina; Rossello, Armando; Wang, Huanhuan; Noy, Peter J.; Tomlinson, Michael G.; Blobel, Carl P.; Lichtenthaler, Stefan F.			The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation	FASEB JOURNAL			English	Article						ADAM17; GI254023X; Alzheimer's; tetraspanin15; NrCAM	AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE ADAM10; CELL-ADHESION; DISINTEGRIN/METALLOPROTEINASE ADAM10; TSPANC8 TETRASPANINS; REGULATED PROTEOLYSIS; NOTCH ACTIVATION; N-CADHERIN; CLEAVAGE; TRAFFICKING	The transmembrane protein, ADAM10 (a disintegrin and metalloprotease 10), has key physiologic functionsfor example, during embryonic development and in the brain. During transit through the secretory pathway, immature ADAM10 (proADAM10) is converted into its proteolytically active, mature form (mADAM10). Increasing or decreasing the abundance and/or activity of mADAM10 is considered to be a therapeutic approach for the treatment of such diseases as Alzheimer's disease and cancer. Yet biochemical detection and characterization of mADAM10 has been difficult. In contrast, proADAM10 is readily detected-for example, in immunoblots-which suggests that mADAM10 is only a fraction of total cellular ADAM10. Here, we demonstrate that mADAM10, but not proADAM10, unexpectedly undergoes rapid, time-dependent degradation upon biochemical cell lysis in different cell lines and in primary neurons, which prevents the detection of the majority of mADAM10 in immunoblots. This degradation required the catalytic activity of ADAM10, was efficiently prevented by adding active site inhibitors to the lysis buffer, and did not affect proADAM10, which suggests that ADAM10 degradation occurred in an intramolecular and autoproteolytic manner. Inhibition of postlysis autoproteolysis demonstrated efficient cellular ADAM10 maturation with higher levels of mADAM10 than proADAM10. Moreover, a cycloheximide chase experiment revealed that mADAM10 is a long-lived protein with a half-life of approximately 12 h. In summary, our study demonstrates that mADAM10 autoproteolysis must be blocked to allow for the proper detection of mADAM10, which is essential for the correct interpretation of biochemical and cellular studies of ADAM10.-Brummer, T., Pigoni, M., Rossello, A., Wang, H., Noy, P. J., Tomlinson, M. G., Blobel, C. P., Lichtenthaler, S. F. The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.	[Brummer, Tobias; Pigoni, Martina; Wang, Huanhuan; Lichtenthaler, Stefan F.] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Brummer, Tobias; Pigoni, Martina; Lichtenthaler, Stefan F.] Klinikum Rechts Der Isar, Sch Med, Neuroprote, Munich, Germany; [Blobel, Carl P.; Lichtenthaler, Stefan F.] Tech Univ Munich, Inst Adv Study, Munich, Germany; [Rossello, Armando] Univ Pisa, Dept Pharm, Pisa, Italy; [Wang, Huanhuan] Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Noy, Peter J.; Tomlinson, Michael G.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Blobel, Carl P.] Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med, Dept Med, New York, NY USA; [Blobel, Carl P.] Weill Cornell Med, Dept Physiol Biophys & Syst Biol, New York, NY USA; [Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Technical University of Munich; University of Pisa; Hangzhou Normal University; University of Birmingham; Cornell University; Cornell University	Lichtenthaler, SF (corresponding author), DZNE, Feodor Lynen Str 17, D-81377 Munich, Germany.; Lichtenthaler, SF (corresponding author), TUM, Feodor Lynen Str 17, D-81377 Munich, Germany.	stefan.lichtenthaler@dzne.de	Rossello, Armando/S-7332-2019	Rossello, Armando/0000-0002-6795-8091; Pigoni, Martina/0000-0002-7896-6978; Tomlinson, Michael/0000-0002-1189-0091	Deutsche Forschungsgemeinschaft [FOR2290]; Centers of Excellence in Neurodegeneration; Helmholtz-Israel Program; Breuer foundation Alzheimer Award; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01-GM64750]; medical faculty of Technische Universitat Munchen (Klinikum Rechts der Isar); British Heart Foundation Project [PG/13/92/30587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centers of Excellence in Neurodegeneration; Helmholtz-Israel Program; Breuer foundation Alzheimer Award; U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); medical faculty of Technische Universitat Munchen (Klinikum Rechts der Isar); British Heart Foundation Project(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following funding agencies: Deutsche Forschungsgemeinschaft (FOR2290), the Centers of Excellence in Neurodegeneration, the Helmholtz-Israel Program and the Breuer foundation Alzheimer Award (to S.F.L.), and the U.S. National Institutes of Health, National Institute of General Medical Sciences (Grant R01-GM64750; to C.P.B.). T.B. was supported by a fellowship from the medical faculty of Technische Universitat Munchen (Klinikum Rechts der Isar). P.J.N. was funded by the British Heart Foundation Project (Grant PG/13/92/30587; to M.G.T.). The authors thank Linda Troeberg (University of Oxford, Oxford, England) for help with the calculation of K<INF>i</INF> values. The authors declare no conflicts of interest.	Alabi RO, 2016, CIRC RES, V119, P519, DOI 10.1161/CIRCRESAHA.115.307738; Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Camodeca C, 2016, EUR J MED CHEM, V111, P193, DOI 10.1016/j.ejmech.2016.01.053; Chen AC, 2015, J CELL BIOL, V211, P1157, DOI 10.1083/jcb.201502001; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Epis R, 2010, BRAIN, V133, P3323, DOI 10.1093/brain/awq217; Gaida MM, 2010, INT J MOL MED, V26, P281, DOI 10.3892/ijmm_00000463; Glomski K, 2011, BLOOD, V118, P1163, DOI 10.1182/blood-2011-04-348557; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hoffmann FS, 2015, J IMMUNOL, V194, P542, DOI 10.4049/jimmunol.1402070; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones JC, 2016, ANNU REV PHYSIOL, V78, P243, DOI 10.1146/annurev-physiol-021014-071720; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lopez-Perez E, 2001, J NEUROCHEM, V76, P1532, DOI 10.1046/j.1471-4159.2001.00180.x; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matthews AL, 2017, BIOCHEM SOC T, V45, P719, DOI 10.1042/BST20160290; Matthews AL, 2017, PLATELETS, V28, P333, DOI 10.1080/09537104.2016.1184751; Musardo S, 2014, NEURODEGENER DIS, V13, P72, DOI 10.1159/000354233; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagara Y, 2012, BIOCHEM BIOPH RES CO, V417, P462, DOI 10.1016/j.bbrc.2011.11.140; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Pasciuto E, 2015, NEURON, V87, P382, DOI 10.1016/j.neuron.2015.06.032; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prox J, 2013, J NEUROSCI, V33, P12915, DOI 10.1523/JNEUROSCI.5910-12.2013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Romi E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5058; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Saraceno C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.492; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Siney EJ, 2017, MOL NEUROBIOL, V54, P3893, DOI 10.1007/s12035-016-0053-6; Storey E, 1999, EUR J NEUROSCI, V11, P1779, DOI 10.1046/j.1460-9568.1999.00599.x; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Susuki K, 2013, NEURON, V78, P469, DOI 10.1016/j.neuron.2013.03.005; Taverna M, 2013, J ALZHEIMERS DIS, V37, P667, DOI 10.3233/JAD-130509; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Woods N, 2015, ONCOTARGET, V6, P35931, DOI 10.18632/oncotarget.5933; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084617; Zimmermann M, 2004, J NEUROCHEM, V90, P1489, DOI 10.1111/j.1471-4159.2004.02680.x; Zocchi MR, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1123367	66	16	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3560	3573		10.1096/fj.201700823RR	http://dx.doi.org/10.1096/fj.201700823RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29430990	Green Published			2022-12-26	WOS:000435104500007
J	Jayaraman, V; Suryavanshi, A; Kalale, P; Kunala, J; Balaram, H				Jayaraman, Vijay; Suryavanshi, Arpitha; Kalale, Pavithra; Kunala, Jyothirmai; Balaram, Hemalatha			Biochemical characterization and essentiality of Plasmodium fumarate hydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL CEREBRAL MALARIA; ESCHERICHIA-COLI K-12; QUINONE OXIDOREDUCTASE; SUCCINATED PROTEOME; CRYSTAL-STRUCTURE; LIFE-CYCLE; PURIFICATION; METABOLISM; FALCIPARUM; PARASITE	Plasmodium falciparum (Pf), the causative agent of malaria, has an iron-sulfur cluster-containing class I fumarate hydratase (FH) that catalyzes the interconversion of fumarate to malate, a well-known reaction in the tricarboxylic acid cycle. In humans, the same reaction is catalyzed by class II FH that has no sequence or structural homology with the class I enzyme from Plasmodium. Fumarate is generated in large quantities in the parasite as a by-product of AMP synthesis and is converted to malate by FH and then used in the generation of the key metabolites oxaloacetate, aspartate, and pyruvate. Previous studies have identified the FH reaction as being essential to P. falciparum, but biochemical characterization of PfFH that may provide leads for the development of specific inhibitors is lacking. Here, we report on the kinetic characterization of purified recombinant PfFH, functional complementation of fh deficiency in Escherichia coli, and mitochondrial localization in the parasite. We found that the substrate analog mercaptosuccinic acid is a potent PfFH inhibitor, with a K-i value in the nanomolar range. The fh gene could not be knocked out in Plasmodium berghei when transfectants were introduced into BALB/c mice; however, fh knockout was successful when C57BL/6 mice were used as host, suggesting that the essentiality of the fh gene to the parasite was mouse strain-dependent.	[Jayaraman, Vijay; Suryavanshi, Arpitha; Kalale, Pavithra; Kunala, Jyothirmai; Balaram, Hemalatha] JNCASR, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India; [Kunala, Jyothirmai] Biocon Res Ltd, Mol Characterizat Analyt Grp, SEZ Unit, Biocon Pk,Bommasandra Jigani Link Rd, Bengaluru 560099, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Biocon Limited	Balaram, H (corresponding author), JNCASR, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India.	hb@jncasr.ac.in			Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR11294/BRB/10/1291/2014, BT/PR13760/COE/34/42/2015]; Science and Engineering Research Board, Department of Science and Technology, Government of India [EMR/2014/001276]; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC)	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Science and Engineering Research Board, Department of Science and Technology, Government of India; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India)	This work was supported in part by Department of Biotechnology, Ministry of Science and Technology, Government of India, Grants BT/PR11294/BRB/10/1291/2014 and BT/PR13760/COE/34/42/2015; Science and Engineering Research Board, Department of Science and Technology, Government of India, Grant EMR/2014/001276, and Institutional funding from Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Council of Scientific and Industrial Research (CSIR) junior and senior research fellowships.; Recipient of University Grants Commission (UGC) junior and senior research fellowships.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amani V, 1998, INFECT IMMUN, V66, P4093; Antonkine ML, 2009, BBA-BIOENERGETICS, V1787, P995, DOI 10.1016/j.bbabio.2009.03.007; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BELL PJ, 1989, J BACTERIOL, V171, P3494, DOI 10.1128/jb.171.6.3494-3503.1989; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Brandt U, 2014, J BIOL CHEM, V289, P30800, DOI 10.1074/jbc.M114.579730; Brandt U, 2014, APPL MICROBIOL BIOT, V98, P6039, DOI 10.1007/s00253-014-5811-7; Bulusu V, 2011, MOL BIOCHEM PARASIT, V177, P1, DOI 10.1016/j.molbiopara.2011.01.001; Bulusu V, 2011, J BIOL CHEM, V286, P9236, DOI 10.1074/jbc.M110.173328; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Carey MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3905-1; Chan A, 2012, ANGEW CHEM INT EDIT, V51, P7711, DOI 10.1002/anie.201202261; Chen BS, 2015, BIOTECHNOL ADV, V33, P526, DOI 10.1016/j.biotechadv.2015.01.007; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Padua RAP, 2017, INT J BIOL MACROMOL, V102, P42, DOI 10.1016/j.ijbiomac.2017.03.099; ELING W, 1977, Z PARASITENKD, V54, P29, DOI 10.1007/BF00380634; Feliciano PR, 2016, P NATL ACAD SCI USA, V113, P9804, DOI 10.1073/pnas.1605031113; Feliciano PR, 2012, INT J BIOL MACROMOL, V51, P25, DOI 10.1016/j.ijbiomac.2012.04.025; FLINT DH, 1994, ARCH BIOCHEM BIOPHYS, V311, P509, DOI 10.1006/abbi.1994.1269; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gomes AR, 2015, CELL HOST MICROBE, V17, P404, DOI 10.1016/j.chom.2015.01.014; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; Hallee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138626; Hartig S.M., 2013, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1415-102, DOI 10.1002/0471142727.MB1415S102, DOI 10.1002/0471142727.MB1415-102]; Jacot D, 2016, TRENDS PARASITOL, V32, P56, DOI 10.1016/j.pt.2015.09.001; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; Kronen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145098; Kronen M, 2015, APPL ENVIRON MICROB, V81, P5632, DOI 10.1128/AEM.00822-15; Lloyd SJ, 1999, PROTEIN SCI, V8, P2655, DOI 10.1110/ps.8.12.2655; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Merkley ED, 2014, MASS SPECTROM REV, V33, P98, DOI 10.1002/mas.21382; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nakamaru-Ogiso E, 2002, J BIOL CHEM, V277, P1680, DOI 10.1074/jbc.M108796200; Niikura M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1898-5; Niikura M, 2013, BIOCHEM BIOPH RES CO, V432, P504, DOI 10.1016/j.bbrc.2013.02.004; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; de Padua RAP, 2014, ACTA CRYSTALLOGR F, V70, P120, DOI 10.1107/S2053230X13033955; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Resch V, 2015, CATAL SCI TECHNOL, V5, P1385, DOI 10.1039/c4cy00692e; ROTH E, 1990, BLOOD CELLS, V16, P453; Ruecker N, 2017, CELL CHEM BIOL, V24, P306, DOI 10.1016/j.chembiol.2017.01.005; Rug M, 2013, METHOD MOL BIOL, V923, P75, DOI [DOI 10.1007/978-1-62703-026-7_6, 10.1007/978-1-62703-026-7_6]; SACCHETTINI JC, 1986, J BIOL CHEM, V261, P5183; Sanderson T., 2017, Wellcome Open Research, V2, P45, DOI 10.12688/wellcomeopenres.11896.1; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shimoyama T, 2007, FEMS MICROBIOL LETT, V270, P207, DOI 10.1111/j.1574-6968.2007.00665.x; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; TEIPEL JW, 1968, J BIOL CHEM, V243, P5684; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UEDA Y, 1991, J BIOCHEM, V109, P728, DOI 10.1093/oxfordjournals.jbchem.a123448; van Vugt-Lussenburg BMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055549; van Vugt-Lussenburg BMA, 2009, MICROBIOL-SGM, V155, P3015, DOI 10.1099/mic.0.030320-0; Weaver T, 2005, ACTA CRYSTALLOGR D, V61, P1395, DOI [10.1107/S0907444905024194, 10.1107/S090744905024194]; Weaver T, 1998, J MOL BIOL, V280, P431, DOI 10.1006/jmbi.1998.1862; WEAVER TM, 1993, J MOL BIOL, V231, P141, DOI 10.1006/jmbi.1993.1264; Woo YH, 2015, ELIFE, V4, DOI 10.7554/eLife.06974; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yang M, 2014, METABOLITES, V4, P640, DOI 10.3390/metabo4030640	69	10	10	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5878	5894		10.1074/jbc.M117.816298	http://dx.doi.org/10.1074/jbc.M117.816298			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29449371	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000430497300011
J	Burchfield, JG; Kebede, MA; Meoli, CC; Stockli, J; Whitworth, PT; Wright, AL; Hoffman, NJ; Minard, AY; Ma, XQ; Krycer, JR; Nelson, ME; Tan, SX; Yau, B; Thomas, KC; Wee, NKY; Khor, EC; Enriquez, RF; Vissel, B; Biden, TJ; Baldock, PA; Hoehn, KL; Cantley, J; Cooney, GJ; James, DE; Fazakerley, DJ				Burchfield, James G.; Kebede, Melkam A.; Meoli, Christopher C.; Stockli, Jacqueline; Whitworth, P. Tess; Wright, Amanda L.; Hoffman, Nolan J.; Minard, Annabel Y.; Ma, Xiuquan; Krycer, James R.; Nelson, Marin E.; Tan, Shi-Xiong; Yau, Belinda; Thomas, Kristen C.; Wee, Natalie K. Y.; Khor, Ee-Cheng; Enriquez, Ronaldo F.; Vissel, Bryce; Biden, Trevor J.; Baldock, Paul A.; Hoehn, Kyle L.; Cantley, James; Cooney, Gregory J.; James, David E.; Fazakerley, Daniel J.			High dietary fat and sucrose result in an extensive and time-dependent deterioration in health of multiple physiological systems in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; BETA-CELL GROWTH; TERM HIGH-FAT; ALZHEIMERS-DISEASE; BONE MASS; GLUCOSE-HOMEOSTASIS; COGNITIVE FUNCTION; DIABETES-MELLITUS; SKELETAL-MUSCLE; CORTICAL BONE	Obesity is associated with metabolic dysfunction, including insulin resistance and hyperinsulinemia, and with disorders such as cardiovascular disease, osteoporosis, and neurodegeneration. Typically, these pathologies are examined in discrete model systems and with limited temporal resolution, and whether these disorders co-occur is therefore unclear. To address this question, here we examined multiple physiological systems in male C57BL/6J mice following prolonged exposure to a high-fat/high-sucrose diet (HFHSD). HFHSD-fed mice rapidly exhibited metabolic alterations, including obesity, hyperleptinemia, physical inactivity, glucose intolerance, peripheral insulin resistance, fasting hyperglycemia, ectopic lipid deposition, and bone deterioration. Prolonged exposure to HFHSD resulted in morbid obesity, ectopic triglyceride deposition in liver and muscle, extensive bone loss, sarcopenia, hyperinsulinemia, and impaired short-term memory. Although many of these defects are typically associated with aging, HFHSD did not alter telomere length in white blood cells, indicating that this diet did not generally promote all aspects of aging. Strikingly, glucose homeostasis was highly dynamic. Glucose intolerance was evident in HFHSD-fed mice after 1 week and was maintained for 24 weeks. Beyond 24 weeks, however, glucose tolerance improved in HFHSD-fed mice, and by 60 weeks, it was indistinguishable from that of chow-fed mice. This improvement coincided with adaptive beta-cell hyperplasia and hyperinsulinemia, without changes in insulin sensitivity in muscle or adipose tissue. Assessment of insulin secretion in isolated islets revealed that leptin, which inhibited insulin secretion in the chow-fed mice, potentiated glucose-stimulated insulin secretion in the HFHSD-fed mice after 60 weeks. Overall, the excessive calorie intake was accompanied by deteriorating function of numerous physiological systems.	[Burchfield, James G.; Kebede, Melkam A.; Meoli, Christopher C.; Stockli, Jacqueline; Hoffman, Nolan J.; Minard, Annabel Y.; Krycer, James R.; Nelson, Marin E.; Yau, Belinda; Thomas, Kristen C.; Cooney, Gregory J.; James, David E.; Fazakerley, Daniel J.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [Burchfield, James G.; Meoli, Christopher C.; Stockli, Jacqueline; Whitworth, P. Tess; Wright, Amanda L.; Hoffman, Nolan J.; Minard, Annabel Y.; Ma, Xiuquan; Krycer, James R.; Tan, Shi-Xiong; Thomas, Kristen C.; Wee, Natalie K. Y.; Khor, Ee-Cheng; Enriquez, Ronaldo F.; Vissel, Bryce; Biden, Trevor J.; Baldock, Paul A.; Hoehn, Kyle L.; Cantley, James; James, David E.; Fazakerley, Daniel J.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Cooney, Gregory J.; James, David E.] Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [Wright, Amanda L.] Macquarie Univ, Dept Biomed Sci, Ctr Motor Neuron Dis Res, Fac Med, Sydney, NSW 2109, Australia; [Hoffman, Nolan J.] Australian Catholic Univ, Ctr Exercise & Nutr, Mary MacKillop Inst Hlth Res, Melbourne, Vic 3000, Australia; [Minard, Annabel Y.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Tan, Shi-Xiong] Republ Polytech, Sch Appl Sci, Singapore 738964, Singapore; [Vissel, Bryce] Univ Technol Sydney, Ctr Neurosci & Regenerat Med, Fac Sci, Sydney, NSW 2007, Australia; [Hoehn, Kyle L.] Univ New South Wales, Sch Biotechnol & Biomed Sci, Sydney, NSW 2052, Australia; [Cantley, James] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 2JD, England	University of Sydney; Garvan Institute of Medical Research; University of Sydney; Macquarie University; Australian Catholic University; University of Iowa; University of Technology Sydney; University of New South Wales Sydney; University of Oxford	James, DE (corresponding author), Univ Sydney, D-17 Charles Perkins Ctr, Camperdown, NSW 2006, Australia.	david.james@sydney.edu.au	Stoeckli, Jacqueline/D-7053-2016; Biden, Trevor/AAW-2829-2021; Stoeckli, Jacqueline/Z-4443-2019; Nelson, Marin/AAG-6653-2021; Kebede, Melkam/AAJ-7444-2021; Burchfield, James/C-1779-2019; Baldock, Paul/B-3840-2012; Tan, Shi-Xiong/Y-3728-2019; Fazakerley, Daniel/J-2652-2019; Ma, Hugh/S-4266-2019; Wee, Natalie/AAF-2134-2019	Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; Kebede, Melkam/0000-0001-9686-7378; Burchfield, James/0000-0002-6609-6151; Fazakerley, Daniel/0000-0001-8241-2903; Ma, Hugh/0000-0001-7227-1289; Yau, Belinda/0000-0003-2303-7343; Nelson, Marin/0000-0001-7001-406X; Wee, Natalie/0000-0002-7314-2646; Tan, Shi-Xiong/0000-0002-0020-2572; Biden, Trevor/0000-0001-5211-0234; Hoehn, Kyle/0000-0002-0214-3238; Krycer, James/0000-0003-1536-7270; Wright, Amanda/0000-0001-7141-6212; Vissel, Bryce/0000-0001-8860-8050; Hoffman, Nolan/0000-0001-5168-7082; Minard, Annabel Yurie/0000-0003-0715-622X; Cooke, Kristen/0000-0002-3534-1660; Cantley, James/0000-0003-2509-1271; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia [1061122, 1086850, 1086851]; Australian post-graduate award; National Health and Medical Research Council of Australia Early Career Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian post-graduate award(Australian Government); National Health and Medical Research Council of Australia Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Project Grants 1061122, 1086850 and 1086851 (to D. E. J.) and an Australian post-graduate award (to C. C. M., P. T. W., A. Y. M., A. L. W., and N. K. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a National Health and Medical Research Council of Australia Early Career Fellowship.	Altunkaynak ME, 2008, J ANAT, V212, P845, DOI 10.1111/j.1469-7580.2008.00902.x; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Aslesen R, 2001, J APPL PHYSIOL, V91, P1237, DOI 10.1152/jappl.2001.91.3.1237; Ballard C, 1999, Curr Psychiatry Rep, V1, P49, DOI 10.1007/s11920-999-0010-4; Baquero AF, 2014, J NEUROSCI, V34, P9982, DOI 10.1523/JNEUROSCI.0933-14.2014; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Cao JJ, 2010, ANN NY ACAD SCI, V1192, P292, DOI 10.1111/j.1749-6632.2009.05252.x; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; CHEN C, 1994, J CLIN INVEST, V94, P399, DOI 10.1172/JCI117335; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Devlin MJ, 2014, ENDOCRINOLOGY, V155, P3806, DOI 10.1210/en.2014-1041; Dineley KT, 2014, NEUROBIOL DIS, V72, P92, DOI 10.1016/j.nbd.2014.09.001; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Groop L, 2000, INT J CLIN PRACT, P3; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamrick M.W., 2007, INT BONE MINER SCI B, V4, P99, DOI [10.1138/20070254, DOI 10.1138/20070254]; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kebede MA, 2014, J CLIN INVEST, V124, P4240, DOI 10.1172/JCI74072; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Klein GL, 2014, WORLD J DIABETES, V5, P14, DOI 10.4239/wjd.v5.i1.14; Kowalski GM, 2017, J ENDOCRINOL, V233, P269, DOI 10.1530/JOE-17-0004; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li J, 2014, DIABETOLOGIA, V57, P2173, DOI 10.1007/s00125-014-3312-y; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Murphy EA, 2015, CURR OPIN CLIN NUTR, V18, P515, DOI 10.1097/MCO.0000000000000209; Niswender KD, 2007, J CLIN INVEST, V117, P2753, DOI 10.1172/JCI33528; Oftadeh R, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029176; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rosenkranz SK, 2010, EUR J APPL PHYSIOL, V109, P499, DOI 10.1007/s00421-010-1390-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Stockli J, 2017, J BIOL CHEM, V292, P19135, DOI 10.1074/jbc.M117.818351; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Strachan MWJ, 2003, LANCET, V362, P1253, DOI 10.1016/S0140-6736(03)14615-6; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; VAAG A, 1992, DIABETOLOGIA, V35, P80, DOI 10.1007/BF00400856; van Himbergen TM, 2012, ARCH NEUROL-CHICAGO, V69, P594, DOI 10.1001/archneurol.2011.670; Wauman J, 2011, FRONT BIOSCI-LANDMRK, V16, P2771, DOI 10.2741/3885; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wong IPL, 2013, J BONE MINER RES, V28, P886, DOI 10.1002/jbmr.1786; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Wongdee K, 2015, WORLD J DIABETES, V6, P673, DOI 10.4239/wjd.v6.i5.673; Wright AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059586; Wu LE, 2014, MOL METAB, V3, P465, DOI 10.1016/j.molmet.2014.02.005; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhao AZ, 1998, J CLIN INVEST, V102, P869, DOI 10.1172/JCI3920	62	44	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5731	5745		10.1074/jbc.RA117.000808	http://dx.doi.org/10.1074/jbc.RA117.000808			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29440390	hybrid, Green Published			2022-12-26	WOS:000430044100032
J	Bowen, KE; Mathew, SO; Borgmann, K; Ghorpade, A; Mathew, PA				Bowen, Kelly E.; Mathew, Stephen O.; Borgmann, Kathleen; Ghorpade, Anuja; Mathew, Porunelloor A.			A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells	PLOS ONE			English	Article							KILLER-CELLS; HIV-1 INFECTION; MISSING SELF; RECOGNITION; EXPRESSION; OLIGODENDROCYTES; MECHANISM; DEMENTIA; LYSIS	NK cells play important role in immunity against pathogens and cancer. NK cell functions are regulated by inhibitory and activating receptors binding corresponding ligands on the surface of target cells. NK cells were shown to be recruited to the CNS following several pathological conditions. NK cells could impact CNS physiology by killing glial cells and by secreting IFN-gamma. Astrocytes are intimately involved in immunological and inflammatory events occurring in the CNS and reactive astrogliosis is a key feature in HIV-associated neurocognitive disorders. There is little data on NK-astrocyte interactions and ligands expressed on astrocytes that could impact NK cell function. Natural cytotoxicity receptors (NCRs) play a critical role in the cytolytic function of NK cells. Among the NCRs, NKp44 is unique in expression and signal transduction. NKp44 is expressed only upon activation of NK cells and it can mediate both activating and inhibitory signals to NK cells. Here, we have studied the expression and function of natural cytotoxicity receptor NKp44 upon NK-astrocytes interactions in the presence or absence of an HIV peptide (HIV-3S peptide) shown to induce NK cell killing of CD4+ T cells during HIV-infection. Using a fusion protein consisting of the extracellular domain of NKp44 fused to Fc portion of human IgG, we determined the expression of a novel ligand for NKp44 (NKp44L) on astrocytes. Incubation of astrocytes with HIV-3S peptide downregulated NKp44L expression on astrocytes implicating protection from NK mediated killing. Thus, our study showed that NKp44 have a protective effect on astrocytes from NK cell mediated killing during HIV infection and impact astrocyte role in HAND.	[Bowen, Kelly E.; Mathew, Stephen O.; Borgmann, Kathleen; Ghorpade, Anuja; Mathew, Porunelloor A.] Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Ft Worth, TX 76107 USA; [Bowen, Kelly E.] Bluebird Bio, Cambridge, MA USA	University of North Texas System; University of North Texas Denton	Mathew, PA (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Ft Worth, TX 76107 USA.	porunelloor.mathew@unthsc.edu	Borgmann, Kathleen/ABU-3329-2022; Mathew, Stephen/ABI-4945-2020	Borgmann, Kathleen/0000-0003-0897-390X; Mathew, Stephen/0000-0001-5784-224X	National Institute of Health [NS101481]; UNTHSC Seed Grant	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNTHSC Seed Grant	This work was supported by a grant from National Institute of Health (NS101481) and UNTHSC Seed Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; Giulian D, 1997, ANN NY ACAD SCI, V835, P91, DOI 10.1111/j.1749-6632.1997.tb48621.x; Hallett WHD, 2006, SEMIN CANCER BIOL, V16, P367, DOI 10.1016/j.semcancer.2006.07.003; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Horton NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059552; Karre K, 2008, NAT IMMUNOL, V9, P477, DOI 10.1038/ni0508-477; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lunemann A, 2008, J IMMUNOL, V181, P6170, DOI 10.4049/jimmunol.181.9.6170; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; Moodley K, 2011, J NEUROSCI METH, V200, P173, DOI 10.1016/j.jneumeth.2011.07.005; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Morse RHA, 2001, J NEUROIMMUNOL, V116, P107, DOI 10.1016/S0165-5728(01)00289-2; Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Rajagopalan S, 2013, BLOOD, V122, P2921, DOI 10.1182/blood-2013-09-523696; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Ryg-Cornejo V, 2013, IMMUNOBIOLOGY, V218, P263, DOI 10.1016/j.imbio.2012.05.018; Saikali P, 2007, J NEUROSCI, V27, P1220, DOI 10.1523/JNEUROSCI.4402-06.2007; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Sun JC, 2011, IMMUNOL CELL BIOL, V89, P327, DOI 10.1038/icb.2010.162; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	30	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193008	10.1371/journal.pone.0193008	http://dx.doi.org/10.1371/journal.pone.0193008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447242	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900092
J	Chen, ZL; Yao, YQ; Ma, PP; Wang, QS; Pan, YC				Chen, Zhenliang; Yao, Yunqiu; Ma, Peipei; Wang, Qishan; Pan, Yuchun			Haplotype-based genome-wide association study identifies loci and candidate genes for milk yield in Holsteins	PLOS ONE			English	Article							SOMATIC-CELL SCORE; PRODUCTION TRAITS; BUFFALO; CATTLE	Since milk yield is a highly important economic trait in dairy cattle, the genome-wide association study (GWAS) is vital to explain the genetic architecture underlying milk yield and to perform marker-assisted selection (MAS). In this study, we adopted a haplotype-based empirical Bayesian GWAS to identify the loci and candidate genes for milk yield. A total of 1 092 Holstein cows were sequenced by using the genotyping by genome reducing and sequencing (GGRS) method. After filtering, 164 312 high-confidence SNPs and 13 476 haplotype blocks were identified to use for GWAS. The results indicated that 17 blocks were significantly associated with milk yield. We further identified the nearest gene of each haplotype block and annotated the genes with milk-associated quantitative trait locus (QTL) intervals and ingenuity pathway analysis (IPA) networks. Our analysis showed that four genes, DLGAP1, AP2B1, ITPR2 and THBS4, have relationships with milk yield, while another three, ARHGEF4, TDRD1 and KIF19, were inferred to have potential relationships. Additionally, a network derived from the IPA containing one inferred (ARHGEF4) and all four confirmed genes likely regulates milk yield. Our findings add to the understanding of identifying the causal genes underlying milk production traits and could guide follow up studies for further confirmation of the associated genes, pathways and biological networks.	[Chen, Zhenliang; Yao, Yunqiu; Ma, Peipei; Wang, Qishan; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Anim Sci, Shanghai, Peoples R China; [Chen, Zhenliang; Ma, Peipei; Wang, Qishan; Pan, Yuchun] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wang, QS; Pan, YC (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Anim Sci, Shanghai, Peoples R China.; Wang, QS; Pan, YC (corresponding author), Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China.	wangqishan@sjtu.edu.cn; panyuchun1963@aliyun.com		Wang, Qishan/0000-0002-6475-0009	National Natural Science Foundation of China [31370043, 31672386]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31370043, 31672386) to Qishan Wang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathla S, 2015, J PROTEOMICS, V127, P193, DOI 10.1016/j.jprot.2015.05.026; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067500; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; Cremonesi P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-540; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; D'Alessandro A, 2011, MOL BIOSYST, V7, P579, DOI 10.1039/c0mb00027b; Fang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099544; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; He SS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8839; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Khatkar MS, 2007, GENETICS, V176, P763, DOI 10.1534/genetics.106.069369; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Le Guillou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045727; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JJ, 2018, J DAIRY SCI, V101, P433, DOI 10.3168/jds.2017-13246; Misztal I., 2002, P 7 WORLD C GEN APPL, V28, P7; Odegard J, 2003, J DAIRY SCI, V86, P4103, DOI 10.3168/jds.S0022-0302(03)74024-7; Schneider MR, 2011, PLOS ONE, V6; Venturini GC, 2014, GENET MOL RES, V13, P10256, DOI 10.4238/2014.December.4.20; Wang Q, 2016, J ANIM BREED GENET, V133, P253, DOI 10.1111/jbg.12191; WILMINK JBM, 1987, LIVEST PROD SCI, V16, P335, DOI 10.1016/0301-6226(87)90003-0; Yang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101025; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	24	22	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192695	10.1371/journal.pone.0192695	http://dx.doi.org/10.1371/journal.pone.0192695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447209	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900046
J	Masuike, Y; Tanaka, K; Makino, T; Yamasaki, M; Miyazaki, Y; Takahashi, T; Kurokawa, Y; Nakajima, K; Mori, M; Doki, Y				Masuike, Yasunori; Tanaka, Koji; Makino, Tomoki; Yamasaki, Makoto; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Mori, Masaki; Doki, Yuichiro			Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; SOMATIC MUTATIONS; MAMMALIAN-CELLS; GASTRIC-CANCER; DNA DEPLETION; PROGRESSION; TRANSITION; RESISTANCE; SURVIVAL	Alterations in mitochondrial DNA (mtDNA) copy numbers in various human cancers have been studied, but any such changes in esophageal squamous cell carcinoma (ESCC) are not established. In the present study, we investigated the correlation of mtDNA copy number with clinicopathologic features, prognosis, and malignant potential of ESCC. MtDNA copy numbers of resected specimens from 80 patients treated with radical esophagectomy were measured by quantitative real-time PCR analyses. Human ESCC cells, TE8 and TE11, were cultured, and depletion of mtDNA content was induced by knockdown of mitochondrial transcription factor A expression or treatment with ethidium bromide. The mRNA and protein expression, proliferation, invasion, and cell cycle were investigated. The results showed that the mtDNA copy number of cancerous portions was 56.0 (37.4-234.5) percent that of non-cancerous parts and significantly lower (p<0.01). Low mtDNA copy number in resected cancerous tissues was significantly correlated with pathological depth of tumor invasion (p = 0.045) and pathological stage (p = 0.025). Patients with lower mtDNA copy number had significantly poorer 5-year overall survival compared to patients with higher levels (p<0.01). The mtDNA-depleted TE8 and TE11 cells had morphological changes and proliferated more slowly than control cells under normoxia but proliferated at almost the same rate under hypoxic conditions. In mtDNA-depleted cells, E-cadherin mRNA expression was decreased, and N-cadherin, vimentin, zeb-1, and cd44 mRNA expression was increased. Immunoblotting and flow cytometry analysis also showed downregulated E-cadherin and upregulated N-cadherin and CD44 protein in mtDNA-depleted cells. Moreover, mtDNA-depleted cells had enhanced invasion, migration, and sphere formation abilities, and the cell cycle arrest at G0/G1 phase was induced in these cells. These results suggested that mtDNA-depleted ESCC cells had mesenchymal characteristics, cancer stemness, and tolerance to hypoxia, which played important role in cancer progression. In conclusion, a low copy number of mtDNA is associated with tumor progression in ESCC.	[Masuike, Yasunori; Tanaka, Koji; Makino, Tomoki; Yamasaki, Makoto; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Osaka, Japan	Osaka University	Tanaka, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Osaka, Japan.	ktanaka@gesurg.med.osaka-u.ac.jp			Grants-in-Aid for Scientific Research [17K16550] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Colvin H, 2017, ANN GASTROENT SURG, V1, P5, DOI 10.1002/ags3.12008; Cui HH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-110; Davies PCW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gray MW, 1998, NATURE, V396, P109, DOI 10.1038/24030; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Guha M, 2014, ONCOGENE, V33, P5238, DOI 10.1038/onc.2013.467; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Kabekkodu SP, 2014, MITOCHONDRION, V16, P73, DOI 10.1016/j.mito.2013.07.001; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lee W, 2008, EXP MOL MED, V40, P109, DOI 10.3858/emm.2008.40.1.109; Li H, 2018, ONCOL LETT, V15, P1014, DOI 10.3892/ol.2017.7416; Lin CS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060814; Lin CS, 2012, INT J MOL SCI, V13, P11228, DOI 10.3390/ijms130911228; Lin CS, 2010, J THORAC CARDIOV SUR, V139, P189, DOI 10.1016/j.jtcvs.2009.04.007; Liu Z, 2007, CHINA MED EQUIPMENT, V4, p29 ; Miyata H, 2009, CANCER, V115, P3324, DOI 10.1002/cncr.24390; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Okamoto K, 2016, ONCOL REP, V36, P3333, DOI 10.3892/or.2016.5133; Okon IS, 2015, J BIOL CHEM, V290, P9101, DOI 10.1074/jbc.M114.631580; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Qian X, 2016, ONCOTARGETS THER, V9, P2247, DOI 10.2147/OTT.S103179; Rasband WS, 2012, ASCL; Rassouli FB, 2013, TUMOR BIOL, V34, P2909, DOI 10.1007/s13277-013-0853-5; Rice TW, 2017, ANN CARDIOTHORAC SUR, V6, P119, DOI 10.21037/acs.2017.03.14; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Saitou M, 2009, ONCOL REP, V21, P199, DOI 10.3892/or_00000208; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Tachimori Y, 2017, ESOPHAGUS-TOKYO, V14, P189, DOI 10.1007/s10388-017-0578-4; Tan DJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-93; Thomas F, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700039; Tokarz P, 2014, ACTA BIOCHIM POL, V61, P671; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Usami Y, 2008, J PATHOL, V215, P330, DOI 10.1002/path.2365; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Osch FHM, 2015, CARCINOGENESIS, V36, P1502, DOI 10.1093/carcin/bgv151; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang D, 2017, SEMIN CANCER BIOL, V44, P60, DOI 10.1016/j.semcancer.2017.03.010; Wen J, 2016, ONCOTARGET, V7, P37581, DOI 10.18632/oncotarget.9036; Wen SL, 2013, ONCOL LETT, V6, P1098, DOI 10.3892/ol.2013.1492; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010; Yu M, 2009, EUR J CANCER PREV, V18, P445, DOI 10.1097/CEJ.0b013e32832f9bd6; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-155; Zhang YF, 2015, AM J CANCER RES, V5, P1207; Zhou PT, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0624-9	60	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193159	10.1371/journal.pone.0193159	http://dx.doi.org/10.1371/journal.pone.0193159			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447301	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900116
J	Tahmasebi, F; Longstaffe, FJ; Zazula, G				Tahmasebi, Farnoush; Longstaffe, Fred J.; Zazula, Grant			Nitrogen isotopes suggest a change in nitrogen dynamics between the Late Pleistocene and modern time in Yukon, Canada	PLOS ONE			English	Article							LATE-QUATERNARY VEGETATION; SOIL ORGANIC-MATTER; STABLE CARBON; BONE-COLLAGEN; LITTER DECOMPOSITION; GLOBAL PATTERNS; MAMMOTH-STEPPE; MUCK DEPOSITS; DAWSON TEPHRA; C-13	A magnificent repository of Late Pleistocene terrestrial megafauna fossils is contained in icerich loess deposits of Alaska and Yukon, collectively eastern Beringia. The stable carbon (delta C-13) and nitrogen (delta N-15) isotope compositions of bone collagen from these fossils are routinely used to determine paleodiet and reconstruct the paleoecosystem. This approach requires consideration of changes in C- and N-isotope dynamics over time and their effects on the terrestrial vegetation isotopic baseline. To test for such changes between the Late Pleistocene and modern time, we compared delta C-13 and delta N-15 for vegetation and bone collagen and structural carbonate of some modern, Yukon, arctic ground squirrels with vegetation and bones from Late Pleistocene fossil arctic ground squirrel nests preserved in Yukon loess deposits. The isotopic discrimination between arctic ground squirrel bone collagen and their diet was measured using modern samples, as were isotopic changes during plant decomposition; Over-wintering decomposition of typical vegetation following senescence resulted in a minor change (similar to 0 -1 parts per thousand) in delta C-13 of modern Yukon grasses. A major change (similar to 2-10 parts per thousand) in delta N-15 was measured for decomposing Yukon grasses thinly covered by loess. As expected, the collagen-diet C-isotope discrimination measured for modern samples confirms that modern vegetation delta C-13 is a suitable proxy for the Late Pleistocene vegetation in Yukon Territory, after correction for the Suess effect. The N-isotope composition of vegetation from the fossil arctic ground squirrel nests, however, is determined to be similar to 2.8 parts per thousand higher than modern grasslands in the region, after correction for decomposition effects. This result suggests a change in N dynamics in this region between the Late Pleistocene and modern time.	[Tahmasebi, Farnoush; Longstaffe, Fred J.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada; [Zazula, Grant] Govt Yukon, Dept Tourism & Culture, Yukon Palaeontol Program, Whitehorse, YT, Canada	Western University (University of Western Ontario)	Tahmasebi, F; Longstaffe, FJ (corresponding author), Univ Western Ontario, Dept Earth Sci, London, ON, Canada.	Tahmasebi.farnoush@gmail.com; flongsta@uwo.ca	Longstaffe, Fred J/A-6843-2008		Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Graduate Scholarship; Canada Foundation for Innovation; Ontario Research Fund	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund	Funding was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (FJL), an Ontario Graduate Scholarship (FT), the Canada Foundation for Innovation (FJL) and the Ontario Research Fund (FJL). Additional research time was provided through the Canada Research Chairs program (FJL).; We thank Kim Law, Li Huang and Tessa Plint of Laboratory for Stable Isotope Science at University of Western Ontario for technical assistance and Tessa Plint, Rachel Schwartz-Narbonne and Matthew Longstaffe for assistance with sampling. Modern bone samples were provided by Meghan Larivee from Animal Health Laboratory, Environment Yukon. Fossil nests were collected with the permission of the Yukon government paleontology program and Yukon First Nations (License No. 13-525&E). Greg Hodgins and staff at the NSF Arizona AMS Laboratory performed the radiocarbon dating. Funding was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (FJL), an Ontario Graduate Scholarship (FT), the Canada Foundation for Innovation (FJL) and the Ontario Research Fund (FJL). Additional research time was provided through the Canada Research Chairs program (FJL). We also thank Paul Sanborn and Marina Suarez, and the PLOS ONE editorial team, for thoughtful suggestions for improvement of an earlier version of this manuscript. This is Laboratory for Stable Isotope Science Contribution # 343.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ambrose S.H., 2002, BIOGEOCHEMICAL APPRO, P243, DOI DOI 10.1007/0-306-47194-9_12; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Andreeva DB, 2013, QUATERN INT, V290, P82, DOI 10.1016/j.quaint.2012.10.054; [Anonymous], 1979, ENVIRON INT, V2, P229; BENNER R, 1990, GEOCHIM COSMOCHIM AC, V54, P2003, DOI 10.1016/0016-7037(90)90268-P; Billings SA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002137; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bocherens H, 2011, QUATERN INT, V245, P249, DOI 10.1016/j.quaint.2011.02.023; Bostrom B, 2007, OECOLOGIA, V153, P89, DOI 10.1007/s00442-007-0700-8; Caputa K, 2013, BOTANY, V91, P631, DOI 10.1139/cjb-2013-0014; Connin SL, 2001, SOIL BIOL BIOCHEM, V33, P41, DOI 10.1016/S0038-0717(00)00113-9; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; de Freitas HA, 2001, QUATERNARY RES, V55, P39, DOI 10.1006/qres.2000.2192; Dearing MD, 1997, ECOLOGY, V78, P774, DOI 10.1890/0012-9658(1997)078[0774:TMOPTB]2.0.CO;2; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dijkstra P, 2008, ECOL LETT, V11, P389, DOI 10.1111/j.1461-0248.2008.01154.x; Dijkstra P, 2006, SOIL BIOL BIOCHEM, V38, P3257, DOI 10.1016/j.soilbio.2006.04.005; Dittberner PL., 1983, PLANT INFORM NETWORK, P786; Drucker DG, 2009, GEOL J, V44, P593, DOI 10.1002/gj.1170; Drucker DG, 2003, EARTH PLANET SC LETT, V216, P163, DOI 10.1016/S0012-821X(03)00514-4; Fahey TJ, 2013, ECOL APPL, V23, P1185, DOI 10.1890/12-1760.1; Faith JT, 2011, QUATERNARY SCI REV, V30, P1675, DOI 10.1016/j.quascirev.2011.03.011; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fernandez I, 2003, RAPID COMMUN MASS SP, V17, P2614, DOI 10.1002/rcm.1234; Fox-Dobbs K, 2008, PALAEOGEOGR PALAEOCL, V261, P30, DOI 10.1016/j.palaeo.2007.12.011; Francisquini MI, 2014, PALAEOGEOGR PALAEOCL, V415, P91, DOI 10.1016/j.palaeo.2014.03.032; Fraser TA, 1997, CAN J EARTH SCI, V34, P1333, DOI 10.1139/e17-106; Fritz M, 2012, QUATERNARY RES, V78, P549, DOI 10.1016/j.yqres.2012.07.007; Froese DG, 2009, GSA TODAY, V19, P4, DOI DOI 10.1130/GSATG54A.1; Froese DG, 2006, QUATERNARY SCI REV, V25, P1542, DOI 10.1016/j.quascirev.2006.01.028; Gaglioti BV, 2011, QUATERNARY RES, V76, P373, DOI 10.1016/j.yqres.2011.08.004; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; GLEIXNER G, 1993, PLANT PHYSIOL, V102, P1287, DOI 10.1104/pp.102.4.1287; Guthrie RD, 1990, FOZEN FAUNA MAMMOTH; Guthrie RD., 1982, PALEOECOLOGY BERINGI, P307, DOI [10.1016/b978-0-12-355860-2.50030-2, DOI 10.1016/B978-0-12-355860-2.50030-2, 10.1016/B978-0-12-355860-2.50030-2]; Harington CR, 2011, QUATERNARY SCI REV, V30, P2341, DOI 10.1016/j.quascirev.2011.05.020; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; Hedges REM, 2003, INT J OSTEOARCHAEOL, V13, P66, DOI 10.1002/oa.660; HERMAN WA, 1977, CAN J SOIL SCI, V57, P205, DOI 10.4141/cjss77-025; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Hoffecker JF, 2014, SCIENCE, V343, P979, DOI 10.1126/science.1250768; Hofle C, 2000, QUATERNARY RES, V53, P143, DOI 10.1006/qres.1999.2097; Houlton BZ, 2009, P NATL ACAD SCI USA, V106, P21713, DOI 10.1073/pnas.0912111106; Huang YS, 1996, ORG GEOCHEM, V24, P273, DOI 10.1016/0146-6380(96)00039-3; Iacumin P, 2000, PALAEOGEOGR PALAEOCL, V163, P33, DOI 10.1016/S0031-0182(00)00141-3; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; Koch P.L., 1994, P63; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kotler E, 2000, CAN J EARTH SCI, V37, P849, DOI 10.1139/e00-013; Kramer MG, 2003, ECOLOGY, V84, P2021, DOI 10.1890/02-3097; KRUEGER HW, 1984, ACS SYM SER, V258, P205; Krull ES, 2002, RADIOCARBON, V44, P93, DOI 10.1017/S0033822200064705; Laxton NF, 1996, ARCTIC, V49, P129; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; Lerch TZ, 2011, BIOGEOCHEMISTRY, V106, P5, DOI 10.1007/s10533-010-9432-7; Lopes-Lutz D, 2008, PHYTOCHEMISTRY, V69, P1732, DOI 10.1016/j.phytochem.2008.02.014; MacDonald GM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1881; Marsh J, 2006, CAN J BOT, V84, P717, DOI [10.1139/b06-026, 10.1139/B06-026]; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McLauchlan KK, 2013, NATURE, V495, P352, DOI 10.1038/nature11916; Metcalfe JZ, 2009, J ARCHAEOL SCI, V36, P110, DOI 10.1016/j.jas.2008.07.019; Metcalfe JZ, 2010, PALAEOGEOGR PALAEOCL, V298, P257, DOI 10.1016/j.palaeo.2010.09.032; Muhs D.R., 2003, MEGA END MEMBERS GEO, V370, P53; Pardo F, 1997, PLANT SOIL, V191, P89, DOI 10.1023/A:1004237305438; Pastor J, 2006, LARGE HERBIVORE ECOL, P298; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Qi HP, 2003, RAPID COMMUN MASS SP, V17, P2483, DOI 10.1002/rcm.1219; Reichmann LG, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00263.1; Richards MP, 2003, PALAEOGEOGR PALAEOCL, V193, P261, DOI 10.1016/S0031-0182(03)00229-3; Salazar S., 2012, Journal of Agricultural Science and Technology, B, V2, P312; Sanborn PT, 2006, QUATERNARY RES, V66, P147, DOI 10.1016/j.yqres.2006.02.008; Schweizer M, 1999, RAPID COMMUN MASS SP, V13, P1284, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1284::AID-RCM578>3.0.CO;2-0; SHEMESH A, 1990, GEOCHIM COSMOCHIM AC, V54, P2433, DOI 10.1016/0016-7037(90)90230-I; SINGH JS, 1977, BOT REV, V43, P499, DOI 10.1007/BF02860844; SPIERS GA, 1986, CAN J FOREST RES, V16, P983, DOI 10.1139/x86-172; Stevens RE, 2004, QUATERNARY SCI REV, V23, P977, DOI 10.1016/j.quascirev.2003.06.024; Stevens RE, 2008, PALAEOGEOGR PALAEOCL, V262, P32, DOI 10.1016/j.palaeo.2008.01.019; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Szpak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053763; Tahmasebi F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183016; Talley SM, 2002, J CHEM ECOL, V28, P2141, DOI 10.1023/A:1021037029684; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; VANDERMERWE NJ, 1982, AM SCI, V70, P596; VANDEWATER PK, 1994, SCIENCE, V264, P239, DOI 10.1126/science.264.5156.239; Vetter MA, 2000, GRASSLANDS AISHIHIK, P165; Wallander H, 2003, SOIL BIOL BIOCHEM, V35, P997, DOI 10.1016/S0038-0717(03)00121-4; Wang G, 2008, BIOGEOSCIENCES, V5, P1325, DOI 10.5194/bg-5-1325-2008; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Webb EC, 2014, J ARCHAEOL SCI, V50, P97, DOI 10.1016/j.jas.2014.07.001; Welsh SL, 1974, ANDERSONS FLORA ALAS; Westgate JA, 2008, QUATERN INT, V178, P183, DOI 10.1016/j.quaint.2007.03.009; White J, 2011, STABLE ISOTOPIC COMP; Williams JW, 2001, ECOLOGY, V82, P3346; Wolf B, 2010, NATURE, V464, P881, DOI 10.1038/nature08931; Wooller MJ, 2007, ARCT ANTARCT ALP RES, V39, P318, DOI 10.1657/1523-0430(2007)39[318:SCICOE]2.0.CO;2; Wooller MJ, 2011, J QUATERNARY SCI, V26, P746, DOI 10.1002/jqs.1497; Wright LE, 1996, J ARCHAEOL SCI, V23, P933, DOI 10.1006/jasc.1996.0087; Wynn JG, 2006, GEODERMA, V131, P89, DOI 10.1016/j.geoderma.2005.03.005; Zazula GD, 2005, QUATERNARY RES, V63, P189, DOI 10.1016/j.yqres.2004.11.003; Zazula GD, 2003, NATURE, V423, P603, DOI 10.1038/423603a; Zazula GD, 2006, QUATERN INT, V142, P2, DOI 10.1016/j.quaint.2005.03.010; Zazula GD, 2007, QUATERNARY SCI REV, V26, P979, DOI 10.1016/j.quascirev.2006.12.006; Zazula GD, 2006, PALAEOGEOGR PALAEOCL, V242, P253, DOI 10.1016/j.palaeo.2006.06.005; Zazula GD, 2011, QUATERNARY SCI REV, V30, P2220, DOI 10.1016/j.quascirev.2010.04.019	111	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192713	10.1371/journal.pone.0192713	http://dx.doi.org/10.1371/journal.pone.0192713			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447202	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900047
J	Castellano-Castillo, D; Denechaud, PD; Moreno-Indias, I; Tinahones, F; Fajas, L; Queipo-Ortuno, MI; Cardona, F				Castellano-Castillo, Daniel; Denechaud, Pierre-Damien; Moreno-Indias, Isabel; Tinahones, Francisco; Fajas, Lluis; Isabel Queipo-Ortuno, Maria; Cardona, Fernando			Chromatin immunoprecipitation improvements for the processing of small frozen pieces of adipose tissue	PLOS ONE			English	Article							HISTONE H3; DNA METHYLATION; TRANSCRIPTION; EXTRACTION; EXPRESSION; PROTOCOL	Chromatin immunoprecipitation (ChIP) has gained importance to identify links between the genome and the proteome. Adipose tissue has emerged as an active tissue, which secretes a wide range of molecules that have been related to metabolic and obesity-related disorders, such as diabetes, cardiovascular failure, metabolic syndrome, or cancer. In turn, epigenetics has raised the importance in discerning the possible relationship between metabolic disorders, lifestyle and environment. However, ChIP application in human adipose tissue is limited by several factors, such as sample size, frozen sample availability, high lipid content and cellular composition of the tissue. Here, we optimize the standard protocol of ChIP for small pieces of frozen human adipose tissue. In addition, we test ChIP for the histone mark H3K4m3, which is related to active promoters, and validate the performance of the ChIP by analyzing gene promoters for factors usually studied in adipose tissue using qPCR. Our improvements result in a higher performance in chromatin shearing and DNA recovery of adipocytes from the tissue, which may be useful for ChIP-qPCR or ChIP-seq analysis.	[Castellano-Castillo, Daniel; Moreno-Indias, Isabel; Tinahones, Francisco; Isabel Queipo-Ortuno, Maria; Cardona, Fernando] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Endocrinol & Nutr, Hosp Virgen de la Victoria, Malaga, Spain; [Castellano-Castillo, Daniel; Moreno-Indias, Isabel; Tinahones, Francisco; Isabel Queipo-Ortuno, Maria; Cardona, Fernando] CIBERobn, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Denechaud, Pierre-Damien; Fajas, Lluis] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Denechaud, Pierre-Damien] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Denechaud, Pierre-Damien] INSERM, Inst Malad Metab & Cardiovasc, UMR 1048, Toulouse, France	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Lausanne; University of Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Queipo-Ortuno, MI (corresponding author), Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Endocrinol & Nutr, Hosp Virgen de la Victoria, Malaga, Spain.; Queipo-Ortuno, MI (corresponding author), CIBERobn, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.	maribelqo@gmail.com	Cardona, Fernando/AAG-7835-2019; Tinahones, Francisco José/AAB-2882-2020; Ortuño, María Isabel Queipo/AAC-1238-2021; Moreno-Indias, Isabel/B-6595-2017; Castellano-Castillo, Daniel/AAA-8423-2021; Coll, Lluis Fajas/C-8567-2014; Denechaud, Pierre-Damien/M-5650-2016	Cardona, Fernando/0000-0003-4460-6824; Moreno-Indias, Isabel/0000-0002-6121-151X; Castellano-Castillo, Daniel/0000-0001-8041-8244; Denechaud, Pierre-Damien/0000-0003-3502-4814; Tinahones, Francisco J/0000-0001-6871-4403; QUEIPO ORTUNO, MARIA ISABEL/0000-0002-2867-0845; Fajas, Lluis/0000-0002-1283-9503	Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional-FEDER [PI08/1655, PI11/02518, PI14/00082, FPU13/04211, CP13/00065, CP16/00163, EST15/00657]; FPU, Ministerio de Educacion, Cultura y Deporte; Miguel Servet Tipo I program, Instituto de Salud Carlos III (ES); Programa Nicolas Monarde, Consejeria de Salud, Junta de Andalucia [C-0032-2016]; Estancias breves FPU, Ministerio de Educacion, Cultura y Deporte; "Centros de Investigacion en Red" [CIBER] of the "Instituto de Salud Carlos III" [CB06/03/0018]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional-FEDER(European Commission); FPU, Ministerio de Educacion, Cultura y Deporte(German Research Foundation (DFG)); Miguel Servet Tipo I program, Instituto de Salud Carlos III (ES); Programa Nicolas Monarde, Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Estancias breves FPU, Ministerio de Educacion, Cultura y Deporte; "Centros de Investigacion en Red" [CIBER] of the "Instituto de Salud Carlos III"	This work was supported by Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional- FEDER PI08/1655; PI11/02518; PI14/00082, Mr. Fernando Cardona; FPU, Ministerio de Educacion, Cultura y Deporte co-funded by the Fondo Europeo de Desarrollo Regional-FEDER FPU13/04211 Mr Daniel Castellano-Castillo; Miguel Servet Tipo I program, Instituto de Salud Carlos III (ES), co-Funded by the Fondo Europeo de Desarrollo Regional-FEDER CP13/00065, Dr Maria Isabel Queipo-Ortuno; Miguel Servet Tipo I program, Instituto de Salud Carlos III (ES), co-Funded by the Fondo Europeo de Desarrollo Regional-FEDER CP16/00163, Dr Isabel Moreno-Indias; Programa Nicolas Monarde, Consejeria de Salud, Junta de Andalucia C-0032-2016, Dr Fernando Cardona; Estancias breves FPU, Ministerio de Educacion, Cultura y Deporte co-funded by the Fondo Europeo de Desarrollo Regional-FEDER EST15/00657, Mr Daniel Castellano-Castillo. The research group belongs to the "Centros de Investigacion en Red" [CIBER, CB06/03/0018] of the "Instituto de Salud Carlos III". We thank Ian Johnstone for English language editing.	Abranches MV, 2015, NUTR RES REV, V28, P121, DOI 10.1017/S0954422415000098; Amour JB, 2015, AN ULTRA LOW INPUT N, P1; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Biase FH, 2002, GENET MOL BIOL, V25, P313, DOI 10.1590/S1415-47572002000300011; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Castellano-Castillo D, 2017, CLIN CHEM; Clemente-Postigo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024783; Das M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145789; Del Corno M, 2016, ONCOTARGET, V5; Denechaud PD, 2016, J CLIN INVEST, V126, P137, DOI 10.1172/JCI81542; Fujimoto S, 2011, BIOCHEM BIOPH RES CO, V404, P223, DOI 10.1016/j.bbrc.2010.11.097; Garach A, 2015, J CLIN ENDOCR METAB, V25; Gavrilov A, 2009, METHODS MOL BIOL, V567, P171, DOI 10.1007/978-1-60327-414-2_12; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gillberg L, 2014, METABOLISM, V63, P263, DOI 10.1016/j.metabol.2013.10.003; Gonzalez N, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0528-4; Haim Y, 2013, AM J PHYSIOL-ENDOC M, V305, pE1172, DOI 10.1152/ajpendo.00598.2012; Lai Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89729; Luo LP, 2016, J ENDOCRINOL, V231, pR77, DOI 10.1530/JOE-16-0211; Moreno-indias I, 2016, TRANSL RES; Nilsson M, 2007, NUCLEIC ACIDS RES, V35, P4858, DOI 10.1093/nar/gkm492; Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189; Oliva-Olivera W, 2017, METABOLISM, V71, P132, DOI 10.1016/j.metabol.2017.03.012; Oliva-Olivera W, 2017, J CLIN ENDOCR METAB, V102, P478, DOI 10.1210/jc.2016-2256; Pelosi M, NORMAL HUMAN ADIPOSE, P1; Petrus P, 2017, INT J OBESITY, V41, P1295, DOI 10.1038/ijo.2017.106; Ramlee MK, 2014, CELL CYCLE, V13, P3414, DOI 10.4161/15384101.2014.953424; Rna PN, 2012, METHODS, V809, P609; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schmidl C, 2016, EUROPE PMC FUNDERS G, V12, P963; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018	32	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192314	10.1371/journal.pone.0192314	http://dx.doi.org/10.1371/journal.pone.0192314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444131	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500063
J	Giacomet, V; Masetti, M; Nannini, P; Forlanini, F; Clerici, M; Zuccotti, GV; Trabattoni, D				Giacomet, Vania; Masetti, Michela; Nannini, Pilar; Forlanini, Federica; Clerici, Mario; Zuccotti, Gian Vincenzo; Trabattoni, Daria			Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; SURFACE-ANTIGEN; T-CELL; INDIVIDUALS; NONRESPONDERS; EFFICACY; COHORT; IMMUNIZATION	Objective HBV vaccine induces protective antibodies only in 23-56% of HIV-infected children. The aim of our study is to evaluate the immunologic effects of a booster dose of HBV vaccine in HIV-infected youth. Design 53 young HIV-infected patients in whom HBV vaccination did not elicit protective Ab titers were enrolled. All patients were on ART with optimal immunological and viral response. Method All patients received a booster dose of HBV vaccine (HBVAXPRO 10 mu g i.m.). HBV-specific Ab titer, viral load and CD4+ T cells were measured at baseline (T0), T1, T6 and T12 months. In a subgroup of 16 patients HBV-specific cell mediated immune responses were evaluated at baseline, at T1 and T6. Results The booster dose induced seroconversion in 51% of patients at T1, 57% at T6, and49% at T12; seroconversion rate was significantly correlated with CD4+ T cells at T0 and to the CD4 nadir. The booster dose induced HBV-specific cell mediated immunity at T6 mainly in Responders (Rs): Effector Memory CD8+ T cells, HBV-specific TNF alpha-, IFN gamma-, granzyme secreting CD8+ T cells and IL2-secreting CD4+ T cells were significantly increased in Rs compared to T0. In Non Responders (NRs), HBV-specific IL2-secreting CD4+ T cells, Central and Effector Memory CD8+ T cells were the only parameters modified at T6. Conclusions Seroconversion induced by a booster dose of vaccine correlates with the development of T cell immunological memory in HIV-infected patients who did not respond to the standard immunization. Alternate immunization schedules need to be considered in NRs.	[Giacomet, Vania; Nannini, Pilar; Forlanini, Federica; Zuccotti, Gian Vincenzo] Univ Milan, L Sacco Hosp, Dept Pediat, Milan, Italy; [Masetti, Michela; Trabattoni, Daria] Univ Milan, Dept Biomed & Clin Sci L Sacco, Chair Immunol, Milan, Italy; [Masetti, Michela; Clerici, Mario] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Forlanini, Federica; Zuccotti, Gian Vincenzo] Univ Milan, Dept Pediat, Osped Bambini V Buzzi, Milan, Italy; [Clerici, Mario] Don C Gnocchi Fdn ONLUS, IRCCS, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Milan; University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Giacomet, V (corresponding author), Univ Milan, L Sacco Hosp, Dept Pediat, Milan, Italy.	vania.giacomet@unimi.it	Giacomet, Vania/AAM-1411-2020; Masetti, Michela/D-1659-2015; giacomet, vania/M-5350-2017	Giacomet, Vania/0000-0002-0892-9039; Masetti, Michela/0000-0002-8922-526X; giacomet, vania/0000-0002-0892-9039; Forlanini, Federica/0000-0001-7812-6322				Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Castro P, 2009, AIDS RES HUM RETROV, V25, P1249, DOI 10.1089/aid.2009.0015; Catherine FX, 2017, HUM VACC IMMUNOTHER, V13, P1304, DOI 10.1080/21645515.2016.1277844; Chedid MG, 1997, HUM IMMUNOL, V58, P42, DOI 10.1016/S0198-8859(97)00209-7; Fernandez-Ibieta M, 2007, INT J STD AIDS, V18, P351, DOI 10.1258/095646207780749763; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Keating GM, 2003, DRUGS, V63, P1021, DOI 10.2165/00003495-200363100-00006; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lao-Araya M, 2007, VACCINE, V25, P5324, DOI 10.1016/j.vaccine.2007.05.006; Larsen CE, 2000, VACCINE, V18, P3021, DOI 10.1016/S0264-410X(00)00084-0; Launay O, 2016, JAMA INTERN MED, V176, P603, DOI 10.1001/jamainternmed.2016.0741; Laurence JC, 2005, AM J MED, V118, P75, DOI 10.1016/j.amjmed.2005.07.024; Lin CC, 2011, AM J INFECT CONTROL, V39, P408, DOI 10.1016/j.ajic.2010.07.010; Mast E. E., 2005, MMWR-MORBID MORTAL W, V31, p521 ; McGovern BH, 2007, ANTIVIR THER, V12, pH3; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Paris Robert M, 2017, Pathog Immun, V2, P66, DOI 10.20411/pai.v2i1.175; Rahman F, 2000, HEPATOLOGY; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; RUTSTEIN RM, 1994, AIDS, V8, P1281, DOI 10.1097/00002030-199409000-00010; Scolfaro C, 1996, AIDS, V10, P1169, DOI 10.1097/00002030-199609000-00017; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Shire NJ, 2006, VACCINE, V24, P272, DOI 10.1016/j.vaccine.2005.07.102; Siriaksorn S, 2006, VACCINE, V24, P3095, DOI 10.1016/j.vaccine.2006.01.045; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; Weihrauch MR, 2008, WORLD J GASTROENTERO, V14, P2529, DOI 10.3748/wjg.14.2529; Whitaker JA, 2012, LANCET INFECT DIS, V12, P966, DOI 10.1016/S1473-3099(12)70243-8; Zinna SS, 2011, HIV MED, V12, P447, DOI 10.1111/j.1468-1293.2010.00895.x	30	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192638	10.1371/journal.pone.0192638	http://dx.doi.org/10.1371/journal.pone.0192638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444185	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500080
J	Khan, MI; Su, YK; Zou, JH; Yang, LW; Chou, RH; Yu, C				Khan, Md. Imran; Su, Yu-Kai; Zou, Jinhao; Yang, Lee-Wei; Chou, Ruey-Hwang; Yu, Chin			S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HUMAN ARTICULAR CHONDROCYTES; CHEMICAL-SHIFT PERTURBATION; CA2+-BINDING PROTEIN S100A1; CEREBROSPINAL-FLUID S100B; ALZHEIMERS-DISEASE; CALCIUM-BINDING; CRYSTAL-STRUCTURE; CELL-SURFACE; HUMAN HEART	Ca2(+)-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca2+ binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V domain of RAGE is one of the most important target proteins for S100A1. It binds to the hydrophobic surface and triggers signaling transduction cascades that induce cell growth, cell proliferation, and tumorigenesis. We used nuclear magnetic resonance (NMR) spectroscopy to characterize the interaction between S100A1 and the RAGE V domain. We found that S100B could interact with S100A1 via NMR H-1-N-15 HSQC titrations. We used the HADDOCK program to generate the following two binary complexes based on the NMR titration results: S100A1-RAGE V domain and S100A1-S100B. After overlapping these two complex structures, we found that S100B plays a crucial role in blocking the interaction site between RAGE V domain and S100A1. A cell proliferation assay WST-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment.	[Khan, Md. Imran; Su, Yu-Kai; Yu, Chin] Natl Tsing Hua Univ, Chem Dept, Hsinchu, Taiwan; [Zou, Jinhao; Yang, Lee-Wei] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yang, Lee-Wei] Natl Tsing Hua Univ, Natl Ctr Theoret Sci, Phys Div, Hsinchu, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Chem Dept, Hsinchu, Taiwan.; Chou, RH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Chou, RH (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.; Chou, RH (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	rhchou@gmail.com; cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180; Zou, Jinhao/0000-0002-0710-9581	Ministry of Science and Technology (MOST) of Taiwan [103-2113-M-007-017-MY3, 106-2113-M-007-021]; Ministry of Science and Technology, Taiwan [105-2320-B-039-059-MY3, 105-2634-F-039-001]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was sponsored by the Ministry of Science and Technology (MOST) of Taiwan (Grant numbers 103-2113-M-007-017-MY3 and 106-2113-M-007-021), CY received the funding; and Ministry of Science and Technology, Taiwan 105-2320-B-039-059-MY3 and 105-2634-F-039-001 to Dr. Ruey-Hwang Chou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BB, 2001, FEBS LETT, V497, P95, DOI 10.1016/S0014-5793(01)02444-9; Afanador L, 2014, CELL CALCIUM, V56, P68, DOI 10.1016/j.ceca.2014.05.002; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Chen HY, 2014, AM J CANCER RES, V4, P89; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Deloulme JC, 2003, MICROSC RES TECHNIQ, V60, P560, DOI 10.1002/jemt.10298; DeRycke MS, 2009, AM J CLIN PATHOL, V132, P846, DOI 10.1309/AJCPTK87EMMIKPFS; Diaconescu DE, 2014, ROM J MORPHOL EMBRYO, V55, P1371; Diaz-Romero J, 2017, J CELL PHYSIOL, V232, P1559, DOI 10.1002/jcp.25682; Diaz-Romero J, 2014, J CELL PHYSIOL, V229, P1106, DOI 10.1002/jcp.24547; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Gandy S, 2011, NATURE, V475, pS15, DOI 10.1038/475S15a; Gelse K, 2012, OSTEOARTHR CARTILAGE, V20, P162, DOI 10.1016/j.joca.2011.12.004; Goddard TD., 2000, SPARKY 3; Gowder SM, 2014, SCI WORLD J, DOI 10.1155/2014/971258; Heizmann C. W., 2007, V45, P93; Holakovska B, 2012, J BIOL CHEM, V287, P16645, DOI 10.1074/jbc.M112.350686; Hutton M., 2011, NATURE, V475, pS44; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Jablonowska A, 2004, J MOL BIOL, V344, P1037, DOI 10.1016/j.jmb.2004.09.083; Kiewitz R, 2003, BIOCHEM BIOPH RES CO, V306, P550, DOI 10.1016/S0006-291X(03)00987-2; Kraus C, 2009, J MOL CELL CARDIOL, V47, P445, DOI 10.1016/j.yjmcc.2009.06.003; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P533, DOI [DOI 10.1016/J.CANLET.2011.08.028, 10.1016/j.canlet.2011.08.028]; LANE AN, 1994, METHOD ENZYMOL, V239, P596; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2015, BBA-MOL BASIS DIS, V1852, P2706, DOI 10.1016/j.bbadis.2015.09.022; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li G, 2007, HISTOPATHOLOGY, V50, P642, DOI 10.1111/j.1365-2559.2007.02655.x; Liang HS, 2011, CANCER LETT, V313, P91, DOI 10.1016/j.canlet.2011.08.028; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lopez-de-Ipina K, 2013, SENSORS-BASEL, V13, P6730, DOI 10.3390/s130506730; M9, 2006, COLD SPRING HARBOR P, V2006; Ma L, 2002, ONLINE 2002 STRUCTUR, DOI [10.1006/jmbi.2001.5421, DOI 10.1006/JMBI.2001.5421]; Machius M, 2001, J MOL BIOL, V310, P689, DOI 10.1006/jmbi.2001.4794; Maco B, 2001, PHYSIOL RES, V50, P567; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Mori M, 1998, HISTOCHEM CELL BIOL, V110, P579, DOI 10.1007/s004180050320; Moroz OV, 2002, ACTA CRYSTALLOGR D, V58, P407, DOI 10.1107/S0907444901021278; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Naim R, 2006, ONCOL REP, V16, P671; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nowakowski M, 2013, BIOCHEMISTRY-US, V52, P1149, DOI 10.1021/bi3015407; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Petzold A, 2003, NEUROSCI LETT, V336, P167, DOI 10.1016/S0304-3940(02)01257-0; Prosser BL, 2008, J BIOL CHEM, V283, P5046, DOI 10.1074/jbc.M709231200; Ramzy T., 2011, J APPL SCI RES, V7, P1411; Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3; Rintala-Dempsey AC, 2006, BIOCHEMISTRY-US, V45, P14695, DOI 10.1021/bi061754e; Rohde D, 2010, J CARDIOVASC TRANSL, V3, P525, DOI 10.1007/s12265-010-9211-9; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schrodinger L. L. C., 2015, THE PYMOL MOLECULAR; Selleck William, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0521s52; Smith SP, 1998, STRUCTURE, V6, P211, DOI 10.1016/S0969-2126(98)00022-7; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tesarova P, 2016, BIOMED PAP, V160, P1, DOI 10.5507/bp.2016.003; van Dijk ADJ, 2006, J BIOMOL NMR, V34, P237, DOI 10.1007/s10858-006-0024-8; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; van Zundert GCP, 2014, METHODS MOL BIOL, V1137, P163, DOI 10.1007/978-1-4939-0366-5_12; Vivian JP, 2003, BIOCHEM BIOPH RES CO, V310, P1096, DOI 10.1016/j.bbrc.2003.09.126; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; Yan SD, 2009, J ALZHEIMERS DIS, V16, P833, DOI 10.3233/JAD-2009-1030; Yatime L, 2013, FEBS J, V280, P6556, DOI 10.1111/febs.12556	84	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0190545	10.1371/journal.pone.0190545	http://dx.doi.org/10.1371/journal.pone.0190545			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444082	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500007
J	Menezes, JA; Confalonieri, U; Madureira, AP; Duval, ID; dos Santos, RB; Margonari, C				Menezes, Julia Alves; Confalonieri, Ulisses; Madureira, Ana Paula; Duval, Isabela de Brito; dos Santos, Rhavena Barbosa; Margonari, Carina			Mapping human vulnerability to climate change in the Brazilian Amazon: The construction of a municipal vulnerability index	PLOS ONE			English	Article							ADAPTIVE CAPACITY; DEFORESTATION; INSTITUTIONS; ASSESSMENTS; DROUGHTS; CONTEXT; BASIN	Vulnerability, understood as the propensity to be adversely affected, has attained importance in the context of climate change by helping to understand what makes populations and territories predisposed to its impacts. Conditions of vulnerability may vary depending on the characteristics of each territory studied-social, environmental, infrastructural, public policies, among others. Thus, the present study aimed to evaluate what makes the municipalities of the state of Amazonas, Brazil, vulnerable to climate change in the context of the largest tropical forest in the world, and which regions of the State are the most susceptible. A Municipal Vulnerability Index was developed, which was used to associate current socio-environmental characteristics of municipalities with climate change scenarios in order to identify those that may be most affected by climate change. The results showed that poor adaptive capacity and poverty had the most influence on current vulnerability of the municipalities of Amazonas with the most vulnerable areas being the southern, northern, and eastern regions of the state. When current vulnerability was related to future climate change projections, the most vulnerable areas were the northern, northeastern, extreme southern, and southwestern regions. From a socio-environmental and climatic point of view, these regions should be a priority for public policy efforts to reduce their vulnerability and prepare them to cope with the adverse aspects of climate change.	[Menezes, Julia Alves; Confalonieri, Ulisses; Duval, Isabela de Brito; dos Santos, Rhavena Barbosa] Fundacao Oswaldo Cruz, Inst Rene Rachou, Grp Estudos Transdisciplinares Saude & Ambiente, Belo Horizonte, MG, Brazil; [Madureira, Ana Paula] Univ Fed Sao Joao Del Rei, Dept Engn Biossistemas, Sao Joao Del Rei, MG, Brazil; [Margonari, Carina] Fundacao Oswaldo Cruz, Inst Rene Rachou, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Sao Joao del-Rei; Fundacao Oswaldo Cruz	Menezes, JA (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Grp Estudos Transdisciplinares Saude & Ambiente, Belo Horizonte, MG, Brazil.	menezes.jalves@gmail.com			National Fund for Climate Change (Fundo Clima) [02000.000134/2014-60]; FundoClima	National Fund for Climate Change (Fundo Clima); FundoClima	This research article was funded by the National Fund for Climate Change (Fundo Clima process number 02000.000134/2014-60), linked to the Brazilian Ministry of Environment, which financially supported the development of the main scientific project entitled: "Construction of Vulnerability Indices as an Input for the Elaboration of Adaptation Actions to Climate Change in Brazil". This main project is being conducted for six Brazilian states, including the state of Amazonas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the financial support provided by the FundoClima, linked to the Brazilian Ministry of Environment, to the Rene Rachou Institute for making its facilities available, and to the Post-Graduate Program in Public Health from Rene Rachou Institute. Many thanks to all those who participated in the vulnerability indicators main project, of which this research article is part of, and especially Chang Manyu and Maria Ines Nahas, for their help and support in the research project, and Giovanini Luigi, for providing the regionalized climate	Adger N.W., 2004, NEW INDICATORS VULNE; Adger W. N., 1999, MITIG ADAPT STRAT GL, V4, P253, DOI [DOI 10.1023/A:1009601904210, 10.1023/A:1009601904210]; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Agrawal A., W0813 U MICH INT FOR; Alencar Fernando Helio, 2008, Acta Amaz., V38, P701, DOI 10.1590/S0044-59672008000400013; Alencar Fernando Helio, 2002, Acta Amazonica, V32, P613, DOI 10.1590/1809-43922002324613; [Anonymous], 2010, CENS DEM 2010; ARA Articulacion Regional Amazonica, 2011, AM OBJ DES MIL, P99; Barata MMDL, 2011, 4 DEP ENV; BARBER A, 2011, MIGR CLIM CHANG CAM, V24, P49; Barbieri Alisson F., 2015, Rev. bras. estud. popul., V32, P461, DOI 10.1590/S0102-3098201500000028; Barbieri AF, 2010, POPUL ENVIRON, V31, P344, DOI 10.1007/s11111-010-0105-1; Barros V.R., 2014, CLIMATE CHANGE 2014, P1757; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Cannon T., 2003, SOCIAL VULNERABILITY; CEPAL-Comissao Economica para a America Latina e o Caribe, 2007, AN AMB SUST EST AM; Chou SC, 2012, CLIM DYNAM, V38, P635, DOI 10.1007/s00382-011-1002-8; Coe MT, 2009, J HYDROL, V369, P165, DOI 10.1016/j.jhydrol.2009.02.043; Confalonieri U., 2000, GLOB CHANG HUM HLTH, V1, P174, DOI DOI 10.1023/A:1010081206165; Confalonieri UEC, 2009, CLIM RES, V40, P175, DOI 10.3354/cr00808; Confalonieri UEC, 2014, CLIMATIC CHANGE, V127, P123, DOI 10.1007/s10584-013-0811-7; Confalonieri Ulisses E. C., 2005, Estud. av., V19, P221, DOI 10.1590/S0103-40142005000100014; Cutter SL, 2000, ANN ASSOC AM GEOGR, V90, P713, DOI 10.1111/0004-5608.00219; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; DeAlmeida AWB, 2004, REV BRASILEIRA ESTUD, V6, P9, DOI DOI 10.22296/2317-1529.2004v6n1p9; Debortoli NS, 2017, NAT HAZARDS, V86, P557, DOI 10.1007/s11069-016-2705-2; Deressa T., 2008, IFPRI - Discussion Papers; Donaghy MM, 2011, COMP POLIT, V44, P83, DOI 10.5129/001041510X13815229366606; Donaghy MM, 2013, CIVIL SOC PARTICIPAT, V5; Eakin H, 2006, ANNU REV ENV RESOUR, V31, P365, DOI 10.1146/annurev.energy.30.050504.144352; Edenhofer O., 2014, CONTRIBUTION WORKING; Engle NL, 2010, GLOBAL ENVIRON CHANG, V20, P4, DOI 10.1016/j.gloenvcha.2009.07.001; Fearnside Philip M., 2013, International Journal of Social Ecology and Sustainable Development, V4, P1, DOI 10.4018/jsesd.2013070101; Salazar LF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043538; Fussel H-M, 2010, REV QUANTITATIVE ANA, V34; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Gash JHC, 1997, B AM METEOROL SOC, V78, P823, DOI 10.1175/1520-0477(1997)078<0823:CEOADS>2.0.CO;2; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Katsuragawa Tony Hiroshi, 2008, Estud. av., V22, P111, DOI 10.1590/S0103-40142008000300008; Langerwisch F, 2013, HYDROL EARTH SYST SC, V17, P2247, DOI 10.5194/hess-17-2247-2013; Leichenko R. M., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P1, DOI 10.1023/A:1015860421954; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Llopart M, 2014, CLIMATIC CHANGE, V125, P111, DOI 10.1007/s10584-014-1140-1; Luiggi G., 2011, METODOLOGIA ANALISE; Marengo JA, 2016, INT J CLIMATOL, V36, P1033, DOI 10.1002/joc.4420; Marengo JA, 2009, INT J CLIMATOL, V29, P2241, DOI 10.1002/joc.1863; Marengo J.A., 2013, AM J CLIM CHANGE, V2, P87, DOI [10.4236/ajcc.2013.22009, DOI 10.4236/AJCC.2013.22009, https://doi.org/10.4236/ajcc.2013.22009]; Marengo JA., 2014, COPENHAGEN DENMARK C, V15, P66; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Marengo JA, 2012, THEOR APPL CLIMATOL, V107, P73, DOI 10.1007/s00704-011-0465-1; McCarty J.J., 2001, CLIMATE CHANGE 2001; Moss R. H., 2001, VULNERABILITY CLIMAT; Moura EAF, 2000, AN 12 ENC NAC AB; NOBRE CA, 1991, J CLIMATE, V4, P957, DOI 10.1175/1520-0442(1991)004<0957:ADARCC>2.0.CO;2; Nobre CA, 2016, P NATL ACAD SCI USA, V113, P10759, DOI 10.1073/pnas.1605516113; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; O'Brien K, 2004, WHATS WORD CONFLICTI, V4; O'Brien KL, 2000, GLOBAL ENVIRON CHANG, V10, P221, DOI 10.1016/S0959-3780(00)00021-2; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Pelling M, 2005, GLOBAL ENVIRON CHANG, V15, P308, DOI 10.1016/j.gloenvcha.2005.02.001; Pereira D. M., 2016, RAE GA ESPACO GEOGRA, V35, P68; Pereira DM, 2016, REV ANPEGE, V12, P167; Prates Rodolfo Coelho, 2011, Econ. soc., V20, P601, DOI 10.1590/S0104-06182011000300006; Preston BL, 2009, MITIG ADAPT STRAT GL, V14, P251, DOI 10.1007/s11027-008-9163-4; Preston BL, 2011, SUSTAIN SCI, V6, P177, DOI 10.1007/s11625-011-0129-1; Quintao AF, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/2821343; RAISg, 2012, AM SOB PRES; Reboita MS, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/376738; Ronchail J, 2016, HYDROLOGICAL EXTREME, P2; Sabelli A., 2011, SCALE COUNTS REV IND; SALATI E, 1984, SCIENCE, V225, P129, DOI 10.1126/science.225.4658.129; Sampaio G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030612; Silvestrini RA, 2011, ECOL APPL, V21, P1573, DOI 10.1890/10-0827.1; Soares-Filho Britaldo Silveira, 2005, Estud. av., V19, P137, DOI 10.1590/S0103-40142005000200008; Solman SA, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/504357; Sullivan C, 2005, WATER SCI TECHNOL, V51, P69, DOI 10.2166/wst.2005.0111; Szlafsztein CF, 2015, NAT HAZARDS, V76, P1745, DOI 10.1007/s11069-014-1567-8; Thornton P.K., 2006, REPORT DEP INT DEV; Tomasella J, 2013, CLIMATIC CHANGE, V116, P723, DOI 10.1007/s10584-012-0508-3; Torres RR, 2012, CLIMATIC CHANGE, V115, P597, DOI 10.1007/s10584-012-0461-1; Universidade Federal de Santa Catarina-UFSC Centro Universita A rio de Estudos e Pesquisas sobre Desastres-CEPED, 2013, ATL BRAS DES NAT 199, P104; Vincent K., 2004, CREATING INDEX SOCIA; Wampler B, 2004, COMP POLIT, V36, P291, DOI 10.2307/4150132; Wolf J, 2010, GLOBAL ENVIRON CHANG, V20, P44, DOI 10.1016/j.gloenvcha.2009.09.004; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Yusuf A., 2009, CLIMATE CHANGE VULNE, P1	90	26	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0190808	10.1371/journal.pone.0190808	http://dx.doi.org/10.1371/journal.pone.0190808			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444086	Green Submitted, gold, Green Published			2022-12-26	WOS:000425183500009
J	Yano, R; Inadomi, C; Luo, L; Goto, S; Hara, T; Li, TS				Yano, Rintaro; Inadomi, Chiaki; Luo, Lan; Goto, Shinji; Hara, Tetsuya; Li, Tao-Sheng			The effect of transient oxygenation on stem cell mobilization and ischemia/reperfusion heart injury	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MYOCARDIUM; GROWTH; RECRUITMENT; ISCHEMIA; HYPOXIA; GLIOMA; MODEL	For general anesthesia, pre-oxygenation is routinely performed prior to intubation. It is well-known that ischemic/hypoxic preconditioning induces stem cell mobilization and protects against ischemia/reperfusion (I/R) injury. In this study, we investigated the effect of transient oxygenation on stem cell mobilization and I/R injury of the heart. Mice were exposed to 100% oxygen for 5 or 20 minutes. We evaluated the number of c-kit + stem/progenitor cells and the levels of SDF-1 alpha and VEGF in peripheral blood at 1, 3, 6, and 24 hours after oxygenation. We also induced I/R injury of the heart at 3 hours post-oxygenation for 5 minutes and then examined stem cell recruitment and fibrotic changes in the heart 3 or 14 days later. The number of c-kit(+) cells in peripheral blood was significantly increased at 1 or 24 hours after oxygenation for either 5 or 20 minutes. Oxygenation for 5 or 20 minutes did not significantly change the SDF-1 alpha level measured in plasma. However, the plasma VEGF level was decreased at 3 hours post-oxygenation for 20 minutes (p = 0.051). Oxygenation for 5 minutes did not significantly alter the fibrotic area or cell apoptosis. Although oxygenation for 5 minutes increased the number of c-kit(+) cells in hearts damaged by I/R injury, this difference was not significant between groups due to large variation between individuals (p = 0.14). Although transient oxygenation induces stem cell mobilization, it does not appear to protect against I/R injury of the heart in mice.	[Yano, Rintaro; Inadomi, Chiaki; Hara, Tetsuya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Anesthesiol, 1-7-1 Sakamoto, Nagasaki, Japan; [Yano, Rintaro; Luo, Lan; Goto, Shinji; Li, Tao-Sheng] Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, 1-12-4 Sakamoto, Nagasaki, Japan	Nagasaki University; Nagasaki University	Inadomi, C (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Anesthesiol, 1-7-1 Sakamoto, Nagasaki, Japan.; Li, TS (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, 1-12-4 Sakamoto, Nagasaki, Japan.	inadomic@nagasaki-u.ac.jp; litaoshe@nagasaki-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873; Luo, Lan/0000-0001-7549-9852	Japan Society for the Promotion of Science [26462339]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Award Number:26462339 (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26462339/) to Cl. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballas CB, 2002, J CELL BIOCHEM, P20, DOI 10.1002/jcb.10127; De Kok IJ, 2003, CLIN ORAL IMPLAN RES, V14, P481, DOI 10.1034/j.1600-0501.2003.110770.x; Di Felice V, 2013, EUR J HISTOCHEM, V57, P83, DOI 10.4081/ejh.2013.e14; Edmark L, 2003, ANESTHESIOLOGY, V98, P28, DOI 10.1097/00000542-200301000-00008; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Koti RS, 2005, CLIN SCI, V108, P55, DOI 10.1042/CS20040130; KUZUYA T, 1993, CIRC RES, V72, P1293, DOI 10.1161/01.RES.72.6.1293; Lazaris AM, 2009, J SURG RES, V154, P267, DOI 10.1016/j.jss.2008.06.037; McCord J M, 1985, Adv Myocardiol, V5, P183; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Murakami J, 2009, INT J CANCER, V124, P1685, DOI 10.1002/ijc.24085; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pistollato F, 2009, STEM CELLS, V27, P7, DOI 10.1634/stemcells.2008-0402; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sheng T, 2005, CIRCULATION, V111, P2438, DOI 10.1161/01.CIR.0000167553.49133.81; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Tang XL, 1996, CIRC RES, V79, P424, DOI 10.1161/01.RES.79.3.424; Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192733	10.1371/journal.pone.0192733	http://dx.doi.org/10.1371/journal.pone.0192733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438409	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400050
J	Islam, Z; Jahan, I; Ahammad, RU; Shahnaij, M; Nahar, S; Mohammad, QD				Islam, Zhahirul; Jahan, Israt; Ahammad, Rijwan U.; Shahnaij, Mohammad; Nahar, Shamsun; Mohammad, Quazi D.			FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barre syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SOLUBLE FAS; CAMPYLOBACTER INFECTION; GENE POLYMORPHISMS; VALIDATION; ANTIBODIES; ORGAN	Guillain-Barre A syndrome (GBS) is an autoimmune disorder of the peripheral nervous system triggered by molecular mimicry between pathogen lipopolysaccharides and host nerve gangliosides. Polymorphisms in the Fas receptor (FAS) and Fas ligand (FASL) genes may potentially alter the elimination of autoreactive immune cells and affect disease susceptibility or disease severity in GBS. We detected single nucleotide polymorphisms (SNPs) in FAS (-1377G/A and -670A/G) and FASL (-843C/T) in a prospective cohort of 300 patients with GBS and 300 healthy controls from the Bangladeshi population. Genotype distributions were not significantly different between patients with GBS and healthy controls. The FAS -670 AG heterozygous (P = 0.0005, OR = 2.5, 95% CI = 1.5-4.2) and GG homozygous (P = 0.0048, OR = 2.6, 95% CI = 1.3-5.0) genotypes were more common in patients with anti-GM1 antibodies than patients without anti-GM1 antibodies. The FAS -670 G allele was more prevalent in anti-GM1 antibody-positive than -negative patients (P = 0.0002, OR = 1.9, 95% CI = 1.4-2.7) and also in patients with the axonal subtype than demyelinating subtype (P < 0.0001, OR = 4.8, 95% CI = 2.3-10.1). The 1377G/-670G GG haplotype was significantly associated with the axonal subtype (P < 0.0001) and anti-ganglioside antibody-positivity (P = 0.0008) in GBS. Serum sFas (237.5 pg/mL vs. 159.5 pg/mL; P < 0.0001) and sFasL (225.1 pg/mL vs. 183.4 pg/mL; P = 0.0069) were elevated in patients with GBS compared to healthy controls, and among patients with high serum sFas was associated with severe GBS (P = 0.0406). In conclusion, this study indicates FAS-FASL promoter SNPs may promote the production of cross-reactive anti-ganglioside antibodies in GBS.	[Islam, Zhahirul; Jahan, Israt; Ahammad, Rijwan U.; Shahnaij, Mohammad; Nahar, Shamsun] Int Ctr Diarrheal Dis Res Icddr B, Lab Sci & Serv Div, Dhaka, Bangladesh; [Ahammad, Rijwan U.] Nagoya Univ, Sch Med, Nagoya, Aichi, Japan; [Mohammad, Quazi D.] Natl Inst Neurosci & Hosp, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Nagoya University	Islam, Z (corresponding author), Int Ctr Diarrheal Dis Res Icddr B, Lab Sci & Serv Div, Dhaka, Bangladesh.	zislam@icddrb.org	Shahnaij, Mohammad/GMX-3978-2022	Islam, Dr. Zhahirul/0000-0003-0935-8079; Mohammad, Shahnaij/0000-0002-3693-7239	icddr,b; Government of Bangladesh	icddr,b; Government of Bangladesh	This research activity was supported by the icddr,b and the Government of Bangladesh. The icddr,b gratefully acknowledges the commitment and shows gratitude to the following donors: the Government of the People's Republic of Bangladesh, Global Affairs Canada (GAC), the Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID), for endowing with unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maini MH, 2000, LUPUS, V9, P132, DOI 10.1191/096120300678828145; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Araste JM, 2010, IMMUNOL INVEST, V39, P27, DOI 10.3109/08820130903401736; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Bolstad AI, 2000, J RHEUMATOL, V27, P2397; Geleijns K, 2005, J NEUROIMMUNOL, V161, P183, DOI 10.1016/j.jneuroim.2004.12.001; Hao JH, 2006, ARCH DERMATOL RES, V297, P329, DOI 10.1007/s00403-005-0616-2; Ishaque T, 2017, J PERIPHER NERV SYST, V22, P121, DOI 10.1111/jns.12215; Islam MB, 2016, J PERIPHER NERV SYST, V21, P345, DOI 10.1111/jns.12189; Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; Islam Z, 2011, EMERG INFECT DIS, V17, P1317, DOI [10.3201/eid1707.101999, 10.3201/eid1707.102031]; Kanemitsu S, 2002, J RHEUMATOL, V29, P1183; Kuijf ML, 2005, J NEUROL SCI, V239, P37, DOI 10.1016/j.jns.2005.07.009; Lambert C, 2003, APOPTOSIS, V8, P551, DOI 10.1023/A:1026113222478; Lee YH, 2001, J RHEUMATOL, V28, P2008; Luo J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5981432; Mahfoudh W, 2007, INT J IMMUNOGENET, V34, P209, DOI 10.1111/j.1744-313X.2007.00676.x; Mullighan CG, 2004, ANN RHEUM DIS, V63, P98, DOI 10.1136/ard.2003.006056; OWENSCHAUB LB, 1995, CANCER LETT, V94, P1, DOI 10.1016/0304-3835(95)03834-J; Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002; Shin MS, 1999, AM J PATHOL, V154, P1785, DOI 10.1016/S0002-9440(10)65434-X; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; TAUXE RV, 1992, CAMPLYLOBACTER JEJUNI, P9; Ueno T, 1999, CLIN CANCER RES, V5, P3529; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; van Veen T, 2002, J NEUROIMMUNOL, V128, P95, DOI 10.1016/S0165-5728(02)00163-7; Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO;2-R; Yamada Akiko, 2017, Front Immunol, V8, P403, DOI 10.3389/fimmu.2017.00403; Yuki N, 2012, J NEUROL, V259, P1181, DOI 10.1007/s00415-011-6330-4	30	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192703	10.1371/journal.pone.0192703	http://dx.doi.org/10.1371/journal.pone.0192703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432441	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300040
J	Nikitina, V; Astrelina, T; Nugis, V; Ostashkin, A; Karaseva, T; Dobrovolskaya, E; Usupzhanova, D; Suchkova, Y; Lomonosova, E; Rodin, S; Brunchukov, V; Lauk-Dubitskiy, S; Brumberg, V; Machova, A; Kobzeva, I; Bushmanov, A; Samoilov, A				Nikitina, Victoria; Astrelina, Tatiana; Nugis, Vladimir; Ostashkin, Aleksandr; Karaseva, Tatiana; Dobrovolskaya, Ekaterina; Usupzhanova, Dariya; Suchkova, Yulia; Lomonosova, Elena; Rodin, Sergey; Brunchukov, Vitaliy; Lauk-Dubitskiy, Stanislav; Brumberg, Valentin; Machova, Anastasia; Kobzeva, Irina; Bushmanov, Andrey; Samoilov, Aleksandr			Clonal chromosomal and genomic instability during human multipotent mesenchymal stromal cells long-term culture	PLOS ONE			English	Article							IN-VITRO CULTURE; ACUTE MYELOID-LEUKEMIA; BONE-MARROW; STEM-CELLS; CYTOGENETIC ANALYSIS; STABILITY; EXPANSION; GUIDELINES; TRISOMY-8; THERAPY	Background aims Spontaneous mutagenesis often leads to appearance of genetic changes in cells. Although human multipotent mesenchymal stromal cells (hMSC) are considered as genetically stable, there is a risk of genomic and structural chromosome instability and, therefore, side effects of cell therapy associated with long-term effects. In this study, the karyotype, genetic variability and clone formation analyses have been carried out in the long-term culture MSC from human gingival mucosa. Methods The immunophenotype of MSC has been examined using flow cytofluorometry and short tandem repeat (STR) analysis has been carried out for authentication. The karyotype has been examined using GTG staining and mFISH, while the assessment of the aneuploidy 8 frequency has been performed using centromere specific chromosome FISH probes in interphase cells. Results The immunophenotype and STR loci combination did not change during the process of cultivation. From passage 23 the proliferative activity of cultured MSCs was significantly reduced. From passage 12 of cultivation, clones of cells with stable chromosome aberrations have been identified and the biggest of these (12%) are tetrasomy of chromosome 8. The random genetic and structural chromosomal aberrations and the spontaneous level of chromosomal aberrations in the hMSC long-term cultures were also described. Conclusions The spectrum of spontaneous chromosomal aberrations in MSC long-term cultivation has been described. Clonal chromosomal aberrations have been identified. A clone of cells with tetrasomy 8 has been detected in passage 12 and has reached the maximum size by passage 18 before and decreased along with the reduction of proliferative activity of cell line by passage 26. At later passages, the MSC line exhibited a set of cells with structural variants of the karyotype with a preponderance of normal diploid cells. The results of our study strongly suggest a need for rigorous genetic analyses of the clone formation in cultured MSCs before use in medicine.	[Nikitina, Victoria; Astrelina, Tatiana; Nugis, Vladimir; Ostashkin, Aleksandr; Karaseva, Tatiana; Dobrovolskaya, Ekaterina; Usupzhanova, Dariya; Suchkova, Yulia; Lomonosova, Elena; Brunchukov, Vitaliy; Lauk-Dubitskiy, Stanislav; Brumberg, Valentin; Machova, Anastasia; Kobzeva, Irina; Bushmanov, Andrey; Samoilov, Aleksandr] Fed Med Biol Agcy Russia, Burnasyan Fed Med Biophys Ctr, State Res Ctr, Moscow, Russia; [Rodin, Sergey] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Burnazyan Federal Medical Biophysical Center; Karolinska Institutet	Nikitina, V (corresponding author), Fed Med Biol Agcy Russia, Burnasyan Fed Med Biophys Ctr, State Res Ctr, Moscow, Russia.	nikitinava@yandex.ru	Lomonosova, Elena/B-1102-2017; Karaseva, Tatiana/B-6493-2017; Astrelina, Tatiana/F-5439-2016; Brumberg, Valentin/AAS-1789-2021; Karaseva, Tatiana/GYU-0690-2022; Сучкова, Юлия/AAS-2531-2021; Брунчуков, Виталий/AAS-1708-2021; Dobrovolskaya, Ekaterina/AAS-2570-2021; Nikitina, Victoria/D-3116-2012	Lomonosova, Elena/0000-0003-3739-4261; Karaseva, Tatiana/0000-0001-7369-2931; Astrelina, Tatiana/0000-0003-3629-0372; Brumberg, Valentin/0000-0001-6053-1637; Сучкова, Юлия/0000-0001-9651-1937; Брунчуков, Виталий/0000-0002-5744-5524; Dobrovolskaya, Ekaterina/0000-0003-2003-0322; Nikitina, Victoria/0000-0002-3150-7686; Kobzeva, Irina/0000-0002-1499-8954; Rodin, Sergey/0000-0002-6954-1986				Bauer VL, 2010, GENES-BASEL, V1, P388, DOI 10.3390/genes1030388; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Bochkov NP, 2009, B EXP BIOL MED+, V148, P677, DOI 10.1007/s10517-010-0793-7; Borgonovo T, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0197-5; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Freshney RI, 2002, CYTOTECHNOLOGY, V39, P55, DOI 10.1023/A:1022949730029; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Kim SH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/904142; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Liu LH, 2006, STEM CELLS DEV, V15, P349, DOI 10.1089/scd.2006.15.349; Mamaeva SE, 1998, INT REV CYTOL, V178, P1; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Nikitina TV, 2004, RUSS J GENET+, V40, P800, DOI 10.1023/B:RUGE.0000036531.42364.e7; Nikitina VA, 2011, B EXP BIOL MED+, V150, P627, DOI 10.1007/s10517-011-1207-1; Robinson WP, 1999, AM J MED GENET, V84, P34, DOI 10.1002/(SICI)1096-8628(19990507)84:1<34::AID-AJMG8>3.3.CO;2-Z; Schaich M, 2007, HAEMATOLOGICA, V92, P763, DOI 10.3324/haematol.11100; Shaffer Lisa G, 2013, ISCN 2013 INT SYSTEM, P144; Soukup Tomas, 2006, Acta Medica (Hradec Kralove), V49, P27; Stultz BG, 2016, CYTOTHERAPY, V18, P336, DOI 10.1016/j.jcyt.2015.11.017; Wolman SR, 2002, BLOOD, V100, P29, DOI 10.1182/blood.V100.1.29; Zhang ZX, 2007, CELL BIOL INT, V31, P645, DOI 10.1016/j.cellbi.2006.11.025	22	16	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192445	10.1371/journal.pone.0192445	http://dx.doi.org/10.1371/journal.pone.0192445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432491	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300025
J	Ai, T; Tabe, Y; Takemura, H; Kimura, K; Takahashi, T; Yang, H; Tsuchiya, K; Konishi, A; Uchihashi, K; Horii, T; Ohsaka, A				Ai, Tomohiko; Tabe, Yoko; Takemura, Hiroyuki; Kimura, Konobu; Takahashi, Toshihiro; Yang, Haeun; Tsuchiya, Koji; Konishi, Aya; Uchihashi, Kinya; Horii, Takashi; Ohsaka, Akimichi			Novel flowcytometry-based approach of malignant cell detection in body fluids using an automated hematology analyzer	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; SYSMEX XN-1000; CYTOPATHOLOGY; LABORATORIES; MICROSCOPY; CYTOLOGY; MODE	Morphological microscopic examinations of nucleated cells in body fluid (BF) samples are performed to screen malignancy. However, the morphological differentiation is time-consuming and labor-intensive. This study aimed to develop a new flowcytometry-based gating analysis mode "XN-BF gating algorithm" to detect malignant cells using an automated hematology analyzer, Sysmex XN-1000. XN-BF mode was equipped with WDF white blood cell (WBC) differential channel. We added two algorithms to the WDF channel: Rule 1 detects larger and clumped cell signals compared to the leukocytes, targeting the clustered malignant cells; Rule 2 detects middle sized mononuclear cells containing less granules than neutrophils with similar fluorescence signal to monocytes, targeting hematological malignant cells and solid tumor cells. BF samples that meet, at least, one rule were detected as malignant. To evaluate this novel gating algorithm, 92 various BF samples were collected. Manual microscopic differentiation with the May-Grunwald Giemsa stain and WBC count with hemocytometer were also performed. The performance of these three methods were evaluated by comparing with the cytological diagnosis. The XN-BF gating algorithm achieved sensitivity of 63.0% and specificity of 87.8% with 68.0% for positive predictive value and 85.1% for negative predictive value in detecting malignant-cell positive samples. Manual microscopic WBC differentiation and WBC count demonstrated 70.4% and 66.7% of sensitivities, and 96.9% and 92.3% of specificities, respectively. The XN-BF gating algorithm can be a feasible tool in hematology laboratories for prompt screening of malignant cells in various BF samples.	[Ai, Tomohiko; Tabe, Yoko; Kimura, Konobu; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan; [Ai, Tomohiko; Tabe, Yoko; Yang, Haeun] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Takemura, Hiroyuki; Takahashi, Toshihiro; Tsuchiya, Koji; Horii, Takashi; Ohsaka, Akimichi] Juntendo Univ Hosp, Dept Clin Lab, Tokyo, Japan; [Kimura, Konobu; Konishi, Aya; Uchihashi, Kinya] Sysmex, Hematol Prod Engn, Prod Dev, Kobe, Hyogo, Japan; [Tsuchiya, Koji; Ohsaka, Akimichi] Juntendo Univ, Dept Transfus Med & Stem Cell Regulat, Grad Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Sysmex Corporation; Juntendo University	Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan.; Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan.	tabe@juntendo.ac.jp		Ai, Tomohiko/0000-0003-0376-0227	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan [S1311011]	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (C), Japan, and a Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan (to YT). We also state that the funder provided support in the form of salaries to authors [KK, AK, and KU], but did not have any judgmental roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEZRA J, 1994, AM J CLIN PATHOL, V102, P439, DOI 10.1093/ajcp/102.4.439; Cho YU, 2015, INT J LAB HEMATOL, V37, P346, DOI 10.1111/ijlh.12292; DEKKER A, 1978, AM J CLIN PATHOL, V70, P855; Doherty Carolynne M, 2014, Ulster Med J, V83, P93; Fleming C, 2016, AM J CLIN PATHOL, V145, P299, DOI [10.1093/AJCP/AQV093, 10.1093/ajcp/aqv093]; Fleming C, 2012, CLIN CHEM LAB MED, V50, P1791, DOI 10.1515/cclm-2011-0927; Franchini M, 2010, SEMIN THROMB HEMOST, V36, P388, DOI 10.1055/s-0030-1254048; Ho TY, 1997, CARCINOGENESIS, V18, P739, DOI 10.1093/carcin/18.4.739; Jerz JL, 2014, ARCH PATHOL LAB MED, V138, P651, DOI 10.5858/arpa.2013-0295-OA; Kendall B, 1997, ARCH PATHOL LAB MED, V121, P976; Labaere D, 2015, INT J LAB HEMATOL, V37, P715, DOI 10.1111/ijlh.12393; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Samani FS, 2014, CYTOTECHNOLOGY, V66, P555, DOI 10.1007/s10616-013-9609-8; Seghezzi M, 2016, CLIN CHIM ACTA, V462, P41, DOI 10.1016/j.cca.2016.08.018; Takemura Hiroyuki, 2010, Rinsho Byori, V58, P559	15	11	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0190886	10.1371/journal.pone.0190886	http://dx.doi.org/10.1371/journal.pone.0190886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425230	Green Submitted, gold, Green Published			2022-12-26	WOS:000424700800004
J	Jaiswal, P; Datta, S; Sardar, B; Chaudhuri, SJ; Maji, D; Ghosh, M; Saha, B; Mukhopadhyay, S				Jaiswal, Priyank; Datta, Souvik; Sardar, Bikash; Chaudhuri, Surya Jyoti; Maji, Dipankar; Ghosh, Manab; Saha, Bibhuti; Mukhopadhyay, Sumi			Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India	PLOS ONE			English	Article							AZAR DERMAL LEISHMANIASIS; LINKED-IMMUNOSORBENT-ASSAY; KALA-AZAR; VISCERAL LEISHMANIASIS; RHEUMATOID-ARTHRITIS; FIELD DIAGNOSIS; GLYCOSYLATION; ANTIBODIES; DONOVANI; ANTIGEN	Background Post Kala Azar Dermal Leishmaniasis (PKDL) occurs as dermal consequence of previous Visceral Leishmaniasis (VL) infection and serves as an important reservoir for transmission of VL. Diagnosis of PKDL is often challenging for its symptomatic resemblance to other coendemic diseases like Leprosy or Vitiligo. Parasitological examination by slit-skin smear and culture are the standard methods but lack high sensitivity. Thus, for efficient control of VL, reliable diagnostic and prognostic assay of PKDL are required. Objective Previously, glycoproteins (9-OAcSA) have been reported as promising biomarkers of Indian VL patients. However, till date, the status of glycans in Indian PKDL patients remains unexplored. Accordingly, in this study, the glyco-profile of PKDL Circulating Immune Complexes (CICs) as compared to other cross diseases like Vitiligo and Leprosyhas been investigated. Further, a novel Glyco CIC assay has been developed for efficient Indian PKDL patient diagnosis. Methods/principal finding In the present study, 90 PKDL patients were enrolled from 3 VL endemic districts of West Bengal during 2015 +/- 16. Glycosylation profile of isolated CICs from sera of PKDL patients were initially analyzed through gradient SDS gel electrophoresis followed by PAS silver double staining, which revealed the presence of several glycan rich PKDL specific proteins of varying molecular weights. To further characterize the glyco-profile of acid dissociated affinity purified immuno-reactive antigens present in the CICs, glycosylation was demonstrated in these purified CIC antigens by DIG glycan differentiation kit with or without glycosidase as well as neuraminidase treatment. Diagnostic evaluation of the newly developed colorimetric Glyco CIC assay through Receiver Operating Characteristic (ROC) curve analysis revealed excellent (0.99) AUC value as compared to other conventional serodiagnostic assays like PEG CIC, Parasite ELISA (IgG and IgM). Additionally, longitudinal monitoring of 18 PKDL patients further revealed its good prognostic utility. Conclusion These results highlight the glycosylation status of CICs among Indian PKDL patients present in all the studied endemic districts of West Bengal. These PKDL biomarkers were completely absent in cross diseases like Vitiligo and Leprosy. Further, the newly developed Glyco CIC assay had an improved sensitivity of 95.6%, specificity of 99.3%, NPV of 97.1% and PPV of 98.9%.	[Jaiswal, Priyank; Datta, Souvik; Mukhopadhyay, Sumi] Sch Trop Med, Dept Lab Med, Kolkata, W Bengal, India; [Sardar, Bikash; Ghosh, Manab; Saha, Bibhuti] Govt West Bengal, Sch Trop Med, Dept Trop Med, Howrah, W Bengal, India; [Chaudhuri, Surya Jyoti] Govt West Bengal, Ranaghat Sub Div Hosp, Nadia, W Bengal, India; [Maji, Dipankar] Govt West Bengal, Dept Hlth & Family Welf, Howrah, W Bengal, India	Calcutta School of Tropical Medicine (CSTM)	Mukhopadhyay, S (corresponding author), Sch Trop Med, Dept Lab Med, Kolkata, W Bengal, India.	drsumimukhopadhyay@gmail.com	DATTA, SOUVIK/AAF-7954-2021	Datta, Souvik/0000-0001-8274-2435; MUKHOPADHYAY, SUMI/0000-0003-1400-3715	Science and Engineering Research Board, Department of Science and Technology, Govt of India under the Young Scientist Scheme [YSS/2014/000934]; ICMR [5/8-7(96) V-2011-ECD-11]	Science and Engineering Research Board, Department of Science and Technology, Govt of India under the Young Scientist Scheme; ICMR(Indian Council of Medical Research (ICMR))	SM is grateful for the financial support by Science and Engineering Research Board, Department of Science and Technology, Govt of India under the Young Scientist Scheme (YSS/2014/000934) and also ICMR (file no: 5/8-7(96) V-2011-ECD-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Bandyopadhyay S, 2004, J INFECT DIS, V190, P2010, DOI 10.1086/425519; Bandyopadhyay S, 2004, DIAGN MICR INFEC DIS, V50, P15, DOI 10.1016/j.diagmicrobio.2004.04.014; Bandyopadhyay SMN, 2008, ADV EXP MED BIOL, V625, P87; Blum JJ, 2001, J EUKARYOT MICROBIOL, V48, P102, DOI 10.1111/j.1550-7408.2001.tb00421.x; BOND A, 1990, EUR J IMMUNOL, V20, P2229, DOI 10.1002/eji.1830201011; Chava AK, 2003, GLYCOCONJUGATE J, V20, P199, DOI 10.1023/B:GLYC.0000024251.30100.08; Chava AK, 2004, J INFECT DIS, V189, P1257, DOI 10.1086/382752; CREIGHTON WD, 1973, J IMMUNOL, V111, P1219; Das NK, 2011, AM J TROP MED HYG, V84, P688, DOI 10.4269/ajtmh.2011.10-0590; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Datta S, 2015, INDIAN J EXP BIOL, V53, P321; Descoteaux A, 1999, BBA-MOL BASIS DIS, V1455, P341, DOI 10.1016/S0925-4439(99)00065-4; Desjeux P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-196; EVANS TG, 1988, INFECT IMMUN, V56, P3139, DOI 10.1128/IAI.56.12.3139-3144.1988; Faleiro RJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002914; Fernandes R, 2006, BIOCHEM MOL BIOL EDU, V34, P294, DOI 10.1002/bmb.2006.494034042636; Ganguly S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004138; GUPTA RC, 1981, CLIN EXP IMMUNOL, V46, P9; Jamal F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182474; JAY GD, 1990, ANAL BIOCHEM, V185, P324, DOI 10.1016/0003-2697(90)90302-P; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOLLER HJ, 1995, ANAL BIOCHEM, V226, P371, DOI 10.1006/abio.1995.1238; Mukhopadhyay S, 2006, INDIAN J MED RES, V123, P203; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Parveen Sameena, 2010, Indian J Dent Res, V21, P10, DOI 10.4103/0970-9290.62800; Perry D, 2013, AM J TROP MED HYG, V88, P778, DOI 10.4269/ajtmh.12-0442; Phi NC, 1988, ACTA MED HUNG, V46, P109; Raja A, 2006, DIAGN MICR INFEC DIS, V56, P281, DOI 10.1016/j.diagmicrobio.2006.06.003; Ramesh V, 2007, TROP MED INT HEALTH, V12, P848, DOI 10.1111/j.1365-3156.2007.01854.x; Ramesh V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2424-8; RAMESH V, 1995, INT J DERMATOL, V34, P85, DOI 10.1111/j.1365-4362.1995.tb03584.x; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Saha P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005391; Saha S, 2005, J CLIN MICROBIOL, V43, P1269, DOI 10.1128/JCM.43.3.1269-1277.2005; Salotra P, 2003, J CLIN PATHOL, V56, P840, DOI 10.1136/jcp.56.11.840; Salotra P, 2002, CLIN DIAGN LAB IMMUN, V9, P370, DOI 10.1128/CDLI.9.2.370-373.2002; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Salotra P, 2001, BRIT J DERMATOL, V145, P630, DOI 10.1046/j.1365-2133.2001.04434.x; Salotra P., 2016, CONTAINING POSTKALA, P7; Salotra P, 2006, INDIAN J MED RES, V123, P295; Samanta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028169; SATA T, 1990, HISTOCHEMISTRY, V94, P1; Schomig VJ, 2016, RSC ADV, V6, P44932, DOI 10.1039/c6ra07424c; Senbagavalli P, 2012, CLIN VACCINE IMMUNOL, V19, P1965, DOI 10.1128/CVI.00437-12; Sharma M. C., 2000, Journal of Communicable Diseases, V32, P67; SINGH R P, 1968, Indian Journal of Dermatology and Venereology, V13, P59; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Singh S. K., 2005, American Journal of Immunology, V1, P96; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Thakur CP, 2016, INDIAN J MED RES, V144, P799, DOI 10.4103/ijmr.IJMR_335_16; Weissmann G, 2009, BULL HOSP JT DIS, V67, P251; WHO, 2010, WHO TECH REP SER, V949, P1; Zijlstra EE, 2000, BRIT J DERMATOL, V143, P136, DOI 10.1046/j.1365-2133.2000.03603.x; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	58	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192302	10.1371/journal.pone.0192302	http://dx.doi.org/10.1371/journal.pone.0192302			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420575	gold, Green Published, Green Submitted			2022-12-26	WOS:000424517900063
J	Zhang, QM; Xiao, KH; Liu, HD; Song, L; McGarvey, JC; Sneddon, WB; Bisello, A; Friedman, PA				Zhang, Qiangmin; Xiao, Kunhong; Liu, Hongda; Song, Lei; McGarvey, Jennifer C.; Sneddon, W. Bruce; Bisello, Alessandro; Friedman, Peter A.			Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; UBIQUITIN-DEPENDENT REGULATION; PROXIMAL TUBULAR CELLS; TISSUE GROWTH-FACTOR; MU-OPIOID RECEPTORS; BETA-ARRESTIN; DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; PTH/PTHRP RECEPTOR	Gprotein-coupled receptor (GPCR) signaling and trafficking are essential for cellular function and regulated by phosphorylation, beta-arrestin, and ubiquitination. The GPCR parathyroid hormone receptor (PTHR) exhibits time-dependent reversible ubiquitination. The exact ubiquitination sites in PTHR are unknown, but they extend upstream of its intracellular tail. Here, using tandem MS, we identified Lys(388) in the third loop and Lys(484) in the C-terminal tail as primary ubiquitination sites in PTHR. We found that PTHR ubiquitination requires beta-arrestin and does not display a preference for beta-arrestin1 or -2. PTH stimulated PTHR phosphorylation at Thr(387)/Thr(392) and within the Ser(489)-Ser(493) region. Such phosphorylation events may recruit beta-arrestin, and we observed that chemically or genetically blocking PTHR phosphorylation inhibits its ubiquitination. Specifically, Ala replacement at Thr(387)/Thr(392) suppressed beta-arrestin binding and inhibited PTHR ubiquitination, suggesting that PTHR phosphorylation and ubiquitination are interdependent. Of note, Lys-deficient PTHR mutants promoted normal cAMP formation, but exhibited differential mitogen-activated protein kinase (MAPK) signaling. Lys-deficient PTHR triggered early onset and delayed ERK1/2 signaling compared with wildtype PTHR. Moreover, ubiquitination of Lys(388) and Lys(484) in wildtype PTHR strongly decreased p38 signaling, whereas Lys-deficient PTHR retained signaling comparable to unstimulated wildtype PTHR. Lys-deficient, ubiquitination-refractory PTHR reduced cell proliferation and increased apoptosis. However, elimination of all 11 Lys residues in PTHR did not affect its internalization and recycling. These results pinpoint the ubiquitinated Lys residues in PTHR controlling MAPK signaling and cell proliferation and survival. Our findings suggest new opportunities for targeting PTHR ubiquitination to regulate MAPK signaling or manage PTHR-related disorders.	[Zhang, Qiangmin; Xiao, Kunhong; Liu, Hongda; Song, Lei; McGarvey, Jennifer C.; Sneddon, W. Bruce; Bisello, Alessandro; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15261 USA; [McGarvey, Jennifer C.] Heptares Therapeut, Welwyn Garden City AL7 3AX, Herts, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Heptares Therapeutics Ltd.	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E-1356 Thomas E Starzl Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; McGarvey, Jennifer/0000-0001-8782-267X; Liu, Hongda/0000-0002-5977-9130	National Institutes of Health [R01 DK105811-A1, R01 DK111427-A1, R01 HL136382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105811, R01DK069998, R01DK111427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK105811-A1 and R01 DK111427-A1 (to P.A.F.) and R01 HL136382 (to A.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Alonso V, 2011, J BONE MINER RES, V26, P2923, DOI 10.1002/jbmr.494; Arttamangkul S, 2012, MOL PHARMACOL, V81, P348, DOI 10.1124/mol.111.076208; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Blind E, 1996, J BONE MINER RES, V11, P578; BLIND E, 1995, ENDOCRINOLOGY, V136, P4271, DOI 10.1210/en.136.10.4271; Bohinc BN, 2012, MINI-REV MED CHEM, V12, P856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan ASM, 2016, MOL BIOL CELL, V27, P1367, DOI 10.1091/mbc.E15-12-0851; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Cheng YB, 2013, CANCER METAST REV, V32, P567, DOI 10.1007/s10555-013-9433-9; Cossa G, 2013, CURR PHARM DESIGN, V19, P883, DOI 10.2174/138161213804547187; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Flannery PJ, 2001, BIOCHEM PHARMACOL, V62, P1047, DOI 10.1016/S0006-2952(01)00749-3; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Friedman PA, 1999, ENDOCRINOLOGY, V140, P301, DOI 10.1210/en.140.1.301; Friedman PA, 2006, AM J PHYSIOL-RENAL, V290, pF975, DOI 10.1152/ajprenal.00336.2005; Gan L, 2006, PROTEIN EXPRES PURIF, V47, P296, DOI 10.1016/j.pep.2005.11.004; Gardella TJ, 2015, PHARMACOL REV, V67, P310, DOI 10.1124/pr.114.009464; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Guo YS, 2010, CHINESE MED J-PEKING, V123, P3671, DOI 10.3760/cma.j.issn.0366-6999.2010.24.029; Guo YS, 2011, NEPHROL DIAL TRANSPL, V26, P839, DOI 10.1093/ndt/gfq521; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hislop JN, 2011, J BIOL CHEM, V286, P40193, DOI 10.1074/jbc.M111.288555; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang DS, 2013, METHOD ENZYMOL, V521, P91, DOI 10.1016/B978-0-12-391862-8.00005-3; Kennedy JE, 2015, PROG MOL BIOL TRANSL, V132, P15, DOI 10.1016/bs.pmbts.2015.02.005; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maeda A, 2013, P NATL ACAD SCI USA, V110, P5864, DOI 10.1073/pnas.1301674110; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Marie PJ, 2012, CURR OSTEOPOROS REP, V10, P190, DOI 10.1007/s11914-012-0109-0; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Matsumoto Y, 2017, J CLIN INVEST, V127, P2612, DOI 10.1172/JCI92233; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McGarvey JC, 2016, J BIOL CHEM, V291, P10986, DOI 10.1074/jbc.M115.697045; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Ravingerova T, 2003, MOL CELL BIOCHEM, V247, P127, DOI 10.1023/A:1024119224033; Roy SJ, 2013, MOL ENDOCRINOL, V27, P1245, DOI 10.1210/me.2013-1091; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shirakawa J, 2016, CALCIFIED TISSUE INT, V98, P306, DOI 10.1007/s00223-015-0083-5; Skieterska K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050923; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Takeda AN, 2014, EMBO J, V33, P1784, DOI 10.15252/embj.201487808; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/nchembio.1611, 10.1038/NCHEMBIO.1611]; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou AT, 2000, BIOCHEMISTRY-US, V39, P6514, DOI 10.1021/bi992706f; Zindel D, 2016, BIOCHEM J, V473, P4173, DOI 10.1042/BCJ20160740	86	8	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5556	5571		10.1074/jbc.RA118.001737	http://dx.doi.org/10.1074/jbc.RA118.001737			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29444827	Green Published, hybrid			2022-12-26	WOS:000430044100018
J	Casas-Aparicio, GA; Leon-Rodriguez, I; Hernandez-Zenteno, RD; Castillejos-Lopez, M; Alvarado-de la Barrera, C; Ormsby, CE; Reyes-Teran, G				Alejandro Casas-Aparicio, Gustavo; Leon-Rodriguez, Isabel; de Jesus Hernandez-Zenteno, Rafael; Castillejos-Lopez, Manuel; Alvarado-de la Barrera, Claudia; Ormsby, Christopher E.; Reyes-Teran, Gustavo			Aggressive fluid accumulation is associated with acute kidney injury and mortality in a cohort of patients with severe pneumonia caused by influenza A H1N1 virus	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; BALANCE; SURVIVAL; RECOVERY; SEPSIS	Introduction Fluid accumulation is associated with adverse outcomes such as acute kidney injury (AKI) in critically ill patients. This study aimed to describe the factors associated with AKI in individuals with influenza A H1N1 severe pneumonia, and explore the relation of fluid accumulation with AKI and mortality. Material and methods We reviewed medical records of individuals with influenza A H1N1 severe pneumonia and no history of chronic kidney disease, attending a national referral center for respiratory diseases between November 2014 and May 2015. Demographic information, risk factors for AKI, physiologic and laboratory data, outcomes and information on fluid intake and output were recorded. Categorical variables were compared using the chi-square test. Quantitative variables were compared using the Mann-Whitney test. Factors associated with AKI and mortality were identified by binary logistic regression. Linear models of fluid accumulation rates for individuals and groups were estimated using segmented linear regression. Results Of 60 patients studied, 43 developed AKI (71.6%). Male gender was protective for AKI (p = 0.019). AKI was associated with nephrotoxic drugs (p = 0.016); PEEP>10 cm H2O on admission (p = 0.031); mortality (p = 0.037); and fluid accumulation >= 10% (fluid overload) at day 7 of hospitalization (p = 0.00026). Mortality was associated with older age (p = 0.009); nephrotoxic drugs (p = 0.034); and higher Pneumonia Severity Index score (112 vs. 76, p = 0.008) on admission. The Deceased-AKI group had a higher rate of fluid accumulation expressed as ml/kg/body weight) than the Survivors-No AKI group during the study period of 7 days (Survivors-No AKI = 13.31 vs. Deceased-AKI = 22.76, p = 0.019). During the highest phase of fluid accumulation, the Survivors-No AKI group had a slower rate of fluid accumulation than the Survivors-AKI group (14.91 vs. 28.49, p = 0.001). Conclusions A high rate of fluid accumulation was associated with AKI and mortality. We support the approach of resuscitation in acute illness, with an early transition to neutral and then negative fluid balances.	[Alejandro Casas-Aparicio, Gustavo; Leon-Rodriguez, Isabel; Alvarado-de la Barrera, Claudia; Ormsby, Christopher E.; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ctr Invest Enfermedades Infecciosas, Ciudad De Mexico, Mexico; [de Jesus Hernandez-Zenteno, Rafael] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Serv Clin 5, Ciudad De Mexico, Mexico; [Castillejos-Lopez, Manuel] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Epidemiol, Ciudad De Mexico, Mexico		Reyes-Teran, G (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ctr Invest Enfermedades Infecciosas, Ciudad De Mexico, Mexico.	gustavo.reyesteran@gmail.com		Reyes-Teran, Gustavo/0000-0002-4115-4888; Castillejos-Lopez, Manuel de Jesus/0000-0001-8689-9755				Abdulkader RCRM, 2010, CLIN J AM SOC NEPHRO, V5, P1916, DOI 10.2215/CJN.00840110; Alsous F, 2000, CHEST, V117, P1749, DOI 10.1378/chest.117.6.1749; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Barrantes F, 2008, CRIT CARE MED, V36, P1397, DOI 10.1097/CCM.0b013e318168fbe0; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Chittawatanarat K, 2015, THER CLIN RISK MANAG, V11, P1097, DOI 10.2147/TCRM.S86409; Chou YH, 2013, J FORMOS MED ASSOC, V112, P112, DOI 10.1016/j.jfma.2012.05.007; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cordemans C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S15; Abreu Krasnalhia Lívia Soares de, 2013, Rev. bras. ter. intensiva, V25, P130, DOI 10.5935/0103-507X.20130024; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Dennen P, 2010, CRIT CARE MED, V38, P261, DOI 10.1097/CCM.0b013e3181bfb0b5; FIRTH JD, 1988, LANCET, V1, P1033; Fulop T, 2010, ASAIO J, V56, P333, DOI 10.1097/MAT.0b013e3181de35e4; Garzotto F, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1355-9; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kute VB, 2011, SAUDI J KIDNEY DIS T, V22, P83; Liu KD, 2011, CRIT CARE MED, V39, P2665, DOI 10.1097/CCM.0b013e318228234b; Martin-Loeches I, 2011, CRIT CARE, V15, DOI [10.1186/cc10046, 10.1186/cc9486]; Muggeo V.M., 2008, R NEWS, V8, P20; Prowle JR, 2010, NAT REV NEPHROL, V6, P107, DOI 10.1038/nrneph.2009.213; Sood MM, 2010, AM J KIDNEY DIS, V55, P848, DOI 10.1053/j.ajkd.2010.01.011; Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484; de Oliveira FSV, 2015, J CRIT CARE, V30, P97, DOI 10.1016/j.jcrc.2014.09.002; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Zhang L, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.03.025	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192592	10.1371/journal.pone.0192592	http://dx.doi.org/10.1371/journal.pone.0192592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447205	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900038
J	Barre, T; Perignon, M; Gazan, R; Vieux, F; Micard, V; Amiot, MJ; Darmon, N				Barre, Tangui; Perignon, Marlene; Gazan, Rozenn; Vieux, Florent; Micard, Valerie; Amiot, Marie-Josephe; Darmon, Nicole			Integrating nutrient bioavailability and co-production links when identifying sustainable diets: How low should we reduce meat consumption?	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; SELF-SELECTED DIETS; ENVIRONMENTAL-IMPACT; VITAMIN-A; NUTRITIONAL QUALITY; IRON-ABSORPTION; BETA-CAROTENE; ENERGY-INTAKE; FOOD; HEALTHY	Background Reducing the consumption of meat and other animal-based products is widely advocated to improve the sustainability of diets in high-income countries. However, such reduction may impair nutritional adequacy, since the bioavailability of key nutrients is higher when they come from animal-vs plant-based foods. Meat reduction may also affect the balance between foods co-produced within the same animal production system. Objective The objective was to assess the impact of introducing nutrient bioavailability and co-production links considerations on the dietary changes needed -especially regarding meat - to improve diet sustainability. Methods Diet optimization with linear and non-linear programming was used to design, for each gender, three modeled diets departing the least from the mean observed French diet (OBS) while reducing by at least 30% the diet-related environmental impacts (greenhouse gas emissions, eutrophication, acidification): i) in the nutrition-environment (NE) model, the fulfillment of recommended dietary allowances for all nutrients was imposed; ii) in the NE-bioavailability (NEB) model, nutritional adequacy was further ensured by accounting for iron, zinc, protein and provitamin A bioavailability; iii) in the NEB-co-production (NEB-CP) model, two links between co-produced animal foods (milk +/- beef and blood sausage +/- pork) were additionally included into the models by proportionally co-constraining their respective quantities. The price and environmental impacts of individual foods were assumed to be constant. Results 'Fruit and vegetables' and 'Starches' quantities increased in all modeled diets compared to OBS. In parallel, total meat and ruminant meat quantities decreased. Starting from 110g/d women's OBS diet (168g/d for men), total meat quantity decreased by 78%, 67% and 32% for women (68%, 66% and 62% for men) in NE, NEB and NEB-CP diets, respectively. Starting from 36g/d women's OBS diet (54g/d for men), ruminant meat quantity dropped severely by 84% and 87% in NE and NEB diets for women (80% and 78% for men), whereas it only decreased by 27% in NEB-CP diets (38% for men). The share of energy and proteins of animal origin was similar for the 3 modeled diets (approximately 1/5 of total energy, and 1/2 of protein) and lower than in OBS diet (approximately 1/3 of total energy, and 2/3 of protein). Conclusions Decreasing meat content was strictly needed to achieve more sustainable diets for French adults, but the reduction was less severe when nutrient bioavailability and co-production links were taken into account.	[Barre, Tangui; Gazan, Rozenn; Amiot, Marie-Josephe] Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France; [Perignon, Marlene; Darmon, Nicole] Univ Montpellier, INRA, MOISA, CIRAD,CIHEAM IAMM,Montpellier SupAgro, Montpellier, France; [Gazan, Rozenn; Vieux, Florent] Fac Med Timone, MS Nutr, Marseille, France; [Micard, Valerie] Univ Montpellier, INRA, CIRAD, IATE,Montpellier SupAgro, Montpellier, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Darmon, N (corresponding author), Univ Montpellier, INRA, MOISA, CIRAD,CIHEAM IAMM,Montpellier SupAgro, Montpellier, France.	nicole.darmon@inra.fr	Amiot, Marie Josephe/M-1203-2017; AMIOT, MARIE JOSEPHE/N-8894-2019; Barré, Tangui/CAH-2871-2022	Amiot, Marie Josephe/0000-0003-4563-4587; AMIOT, MARIE JOSEPHE/0000-0003-4563-4587; Barré, Tangui/0000-0002-3439-8868	GAZA doctoral school at Montpellier University; Daniel & Nina Carasso Foundation; MS-Nutrition; ANRT (the French research and technology agency)	GAZA doctoral school at Montpellier University; Daniel & Nina Carasso Foundation; MS-Nutrition; ANRT (the French research and technology agency)	TB received financial support from GAZA doctoral school at Montpellier University. MP received financial support from the Daniel & Nina Carasso Foundation under the Avasun project. RG received financial support from MS-Nutrition and the ANRT (the French research and technology agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFNOR, PRINCIPES GE A NE A; AFNOR, 2011, PRINCIPES GE A NE A; AFSSA, 2006, SUMMARY OF THE INDIV; Agence nationale de se A curite A sanitaire de l'alimentation de l'environnement et du travail (ANSES), 2016, AVIS DE LANSES RAPPO; Armah SM, 2013, J NUTR, V143, P1136, DOI 10.3945/jn.112.169904; Bertoluci G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150617; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; BRESSON JL, 2015, EFSA J, V13; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Centre d'Information des Viandes INRA, 2009, VALEURS NUTRITIONNEL; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; de Pee S, 1998, AM J CLIN NUTR, V68, P1058, DOI 10.1093/ajcn/68.5.1058; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; FAO, 2016, SUSTAINABLE FOOD CON; Food and Agriculture Organization of the United Nations (FAO), 2010, PROCEEDINGS OF THE I; Galloway JN, 2001, WATER AIR SOIL POLL, V130, P17, DOI 10.1023/A:1012272431583; Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Gephart JA, 2016, SCI TOTAL ENVIRON, V553, P120, DOI 10.1016/j.scitotenv.2016.02.050; Gibson RS, 2007, FOOD NUTR BULL, V28, pS77, DOI 10.1177/15648265070281S108; Gilani GS, 2005, J AOAC INT, V88, P967; Green R, 2015, CLIMATIC CHANGE, V129, P253, DOI 10.1007/s10584-015-1329-y; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; Hallstrom E, 2014, FOOD POLICY, V47, P81, DOI 10.1016/j.foodpol.2014.04.002; Haskell MJ, 2012, AM J CLIN NUTR, V96, p1193S, DOI 10.3945/ajcn.112.034850; Heller MC, 2015, J IND ECOL, V19, P391, DOI 10.1111/jiec.12174; Hendrie GA, 2014, NUTRIENTS, V6, P289, DOI 10.3390/nu6010289; Horgan GW, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0370-1; Hunt JR, 1996, J NUTR, V126, pS2345; Hunt JR, 2003, AM J CLIN NUTR, V78, p633S, DOI 10.1093/ajcn/78.3.633S; HURRELL RF, 1989, AM J CLIN NUTR, V49, P546, DOI 10.1093/ajcn/49.3.546; Institut de l'e A levage, 2014, PRODUCTIONS BOVINES; International Network of Food Data Systems (INFOODS), WORLDFOOD DIETARY AS; International Standard, 2006, ISO 14040 2006 ENVIR; International Standard, 2006, ISO 14044 2006 ENVIR; Jensen JD, 2015, INT J ENV RES PUB HE, V12, P7370, DOI 10.3390/ijerph120707370; Kantar Worldpanel, 2015, CONSUMER PANELS D KA; Khan NC, 2007, AM J CLIN NUTR, V85, P1112, DOI 10.1093/ajcn/85.4.1112; Kongkachuichai R, 2002, J FOOD COMPOS ANAL, V15, P389, DOI 10.1006/jfca.2002.1080; Latvia and the European Commission, 2015, INTENDED NATIONALLY; Macdiarmid J, 2011, LIVEWELL A BALANCE O; Macdiarmid JI, 2016, APPETITE, V96, P487, DOI 10.1016/j.appet.2015.10.011; Macdiarmid JI, 2013, P NUTR SOC, V72, P13, DOI 10.1017/S0029665112002893; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Maillot M, 2011, AM J CLIN NUTR, V94, P1127, DOI 10.3945/ajcn.111.016501; Martin, APPORTS NUTRITIONNEL; Martin A, 2001, APPORTS NUTRITIONNEL; Masset G, 2014, AM J CLIN NUTR, V99, P1460, DOI 10.3945/ajcn.113.077958; Masset G, 2014, J ACAD NUTR DIET, V114, P862, DOI 10.1016/j.jand.2014.02.002; McNaughton S. J., 1994, BIODIVERSITY ECOSYST, P361, DOI [10.1007/978-3-642-58001-7_17, DOI 10.1007/978-3-642-58001-7_17]; Meier T, 2013, ENVIRON SCI TECHNOL, V47, P877, DOI 10.1021/es302152v; Metz B, 2007, CONTRIBUTION OF WORK; Miller LV, 2007, J NUTR, V137, P135, DOI 10.1093/jn/137.1.135; Monsivais P, 2015, AM J CLIN NUTR, V102, P138, DOI 10.3945/ajcn.114.090639; Muzhingi T, 2011, AM J CLIN NUTR, V94, P510, DOI 10.3945/ajcn.110.006486; Parker RS, 1999, P NUTR SOC, V58, P155, DOI 10.1079/PNS19990021; Payne CLR, 2016, PUBLIC HEALTH NUTR, V19, P2654, DOI 10.1017/S1368980016000495; Perignon M, 2018, FOOD CHEM, V238, P73, DOI 10.1016/j.foodchem.2016.12.070; Perignon M, 2017, NUTR REV, V75, P2, DOI 10.1093/nutrit/nuw043; Perignon M, 2016, PUBLIC HEALTH NUTR, V19, P2662, DOI 10.1017/S1368980016000653; Reddy MB, 2000, AM J CLIN NUTR, V71, P937; Risku-Norja Helmi, 2009, Progress in Industrial Ecology, V6, P340, DOI 10.1504/PIE.2009.032323; Roos E, 2013, ECOL INDIC, V24, P573, DOI 10.1016/j.ecolind.2012.08.004; Saxe H, 2013, CLIMATIC CHANGE, V116, P249, DOI 10.1007/s10584-012-0495-4; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Soussana JF, 2007, AGR ECOSYST ENVIRON, V121, P121, DOI 10.1016/j.agee.2006.12.022; Soussana JF, 2010, ANIMAL, V4, P334, DOI 10.1017/S1751731109990784; Tang GW, 2009, AM J CLIN NUTR, V89, P1776, DOI 10.3945/ajcn.2008.27119; Tang GW, 2005, AM J CLIN NUTR, V82, P821, DOI 10.1093/ajcn/82.4.821; Tang GW, 2003, AM J CLIN NUTR, V78, P259, DOI 10.1093/ajcn/78.2.259; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tom MS, 2015, ENV SYST DECIS; United States Department of Agriculture, USDA NATIONAL NUTRIE; van de Kamp ME, 2017, THE GREENHOUSE GAS E; van Dooren C, 2014, FOOD POLICY, V44, P36, DOI 10.1016/j.foodpol.2013.11.002; van Dooren C, 2015, SUSTAINABILITY-BASEL, V7, P12837, DOI 10.3390/su70912837; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; Wang Z., 2007, BRIT J NUTR, V91, P121; West CE, 2002, J NUTR, V132, p2920S, DOI 10.1093/jn/132.9.2920S; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; 2016, EFSA J, V14; 2007, WHO TECHN REP SER, V935, P1	82	38	38	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191767	10.1371/journal.pone.0191767	http://dx.doi.org/10.1371/journal.pone.0191767			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444098	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500029
J	Munier, B; Bendell, LI				Munier, B.; Bendell, L. I.			Macro and micro plastics sorb and desorb metals and act as a point source of trace metals to coastal ecosystems	PLOS ONE			English	Article								Nine urban intertidal regions in Burrard Inlet, Vancouver, British Columbia, Canada, were sampled for plastic debris. Debris included macro and micro plastics and originated from a wide diversity of uses ranging from personal hygiene to solar cells. Debris was characterized for its polymer through standard physiochemical characteristics, then subject to a weak acid extraction to remove the metals, zinc, copper, cadmium and lead from the polymer. Recently manufactured low density polyethylene (LDPE), nylon, polyethylene terephthalate (PET), polypropylene (PP), polystyrene (PS) and polyvinyl chloride (PVC) were subject to the same extraction. Data was statistically analyzed by appropriate parametric and non-parametric tests when needed with significance set at P < 0.05. Polymers identified in field samples in order of abundance were; PVC (39), LDPE (28), PS (18), polyethylene (PE, 9), PP (8), nylon (8), high density polyethylene (HDPE, 7), polycarbonate (PC, 6), PET (6), polyurethane (PUR, 3) and polyoxymethylene (POM, 2). PVC and LDPE accounted for 46% of all samples. Field samples of PVC, HDPE and LDPE had significantly greater amounts of acid extracted copper and HDPE, LDPE and PUR significantly greater amounts of acid extracted zinc. PVC and LDPE had significantly greater amounts of acid extracted cadmium and PVC tended to have greater levels of acid extracted lead, significantly so for HDPE. Five of the collected items demonstrated extreme levels of acid extracted metal; greatest concentrations were 188, 6667, 698,000 and 930 mu gg(-1) of copper, zinc, lead and cadmium respectively recovered from an unidentified object comprised of PVC. Comparison of recently manufactured versus field samples indicated that recently manufactured samples had significantly greater amounts of acid extracted cadmium and zinc and field samples significantly greater amounts of acid extracted copper and lead which was primarily attributed to metal extracted from field samples of PVC. Plastic debris will affect metals within coastal ecosystems by; 1) providing a sorption site (copper and lead), notably for PVC 2) desorption from the plastic i.e., the "inherent" load (cadmium and zinc) and 3) serving as a point source of acute trace metal exposure to coastal ecosystems. All three mechanisms will put coastal ecosystems at risk to the toxic effects of these metals.	[Munier, B.; Bendell, L. I.] Simon Fraser Univ, Dept Biol Sci, Ecotoxicol Res Grp, Burnaby, BC, Canada	Simon Fraser University	Bendell, LI (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ecotoxicol Res Grp, Burnaby, BC, Canada.	bendell@sfu.ca			National Science and Engineering Council of Canada [31-611307]; NSERC [31-611307]	National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Council of Canada, http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp, Discovery Grant Programme, 31-611307 to LB.; The authors gratefully acknowledge Dr. Tamara Kazmiruk for her scientific rigor and technical advice throughout the study. We also thank Ross Kukard for equipment technical support. This study was in part support by an NSERC Discovery grant, 31-611307 to LB.	Ashton K, 2010, MAR POLLUT BULL, V60, P2050, DOI 10.1016/j.marpolbul.2010.07.014; Brady JP, 2016, MAR POLLUT BULL, V106, P329, DOI 10.1016/j.marpolbul.2016.03.029; Experta, ID MAT PLAST; Hahladakis JN, 2018, J HAZARD MATER, V344, P179, DOI 10.1016/j.jhazmat.2017.10.014; Holmes LA, 2012, ENV POLLUTION; Imhof HK, 2016, WATER RES, V98, P64, DOI 10.1016/j.watres.2016.03.015; International Cadmium Association, CADM STAB; Parker L, WHOPPING 91 PLASTIC; Rochman C, 2014, LONG TERM SORPTION M; Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P2439, DOI 10.1021/es400748b; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Vethaak AD, 2016, ENVIRON SCI TECHNOL, V50, P6825, DOI 10.1021/acs.est.6b02569; Wang JD, 2017, CHEMOSPHERE, V171, P248, DOI 10.1016/j.chemosphere.2016.12.074; World Economic Forum, NEW PLAST EC RETH FU; Zalasiewicz J, 2016, ANTHROPOCENE, V13, P4, DOI 10.1016/j.ancene.2016.01.002	16	95	96	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191759	10.1371/journal.pone.0191759	http://dx.doi.org/10.1371/journal.pone.0191759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444103	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500028
J	Praktiknjo, M; Krabbe, V; Pohlmann, A; Sampels, M; Jansen, C; Meyer, C; Strassburg, CP; Trebicka, J; Carmona, MAG				Praktiknjo, Michael; Krabbe, Viktoria; Pohlmann, Alessandra; Sampels, Matthias; Jansen, Christian; Meyer, Carsten; Strassburg, Christian P.; Trebicka, Jonel; Gonzalez Carmona, Maria A.			Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma	PLOS ONE			English	Article							FOCAL LIVER-LESIONS; RADIOFREQUENCY ABLATION; CIRRHOTIC-PATIENTS; HEPATIC RESECTION; CT; CHEMOEMBOLIZATION; METAANALYSIS; GUIDELINES; EXPERIENCE; MANAGEMENT	Background Early information on treatment response of HCC to local ablative therapy is crucial. Elastography as a non-invasive method has recently been shown to play a potential role in distinguishing between benign and malignant liver lesions. Elastography of hepatocellular carcinoma (HCC) in early response to local ablative therapy has not been studied to date. Methods We prospectively included a cohort of 14 patients with diagnosis of HCC who were treated with local ablative therapy (transarterial chemoembolization, TACE and/or radiofrequency ablation, RFA). We used 2D shear-wave elastography (RT 2D-SWE) to examine stiffness of HCC lesion before and 3, 30 and 90 days after local ablative therapy. Contrast-enhanced imaging after 90 days was performed to evaluate treatment response. Primary endpoint was stiffness of HCC in response to local ablative therapy. Secondary end point was tumor recurrence. Results Stiffness of HCC nodules and liver showed no significant difference prior to local ablative therapy. As early as three days after treatment, stiffness of responding HCC was significantly higher compared to non-responding. Higher stiffness before treatment was significantly associated with tumor recurrence. Conclusion Nodule stiffness in general and RT 2D-SWE in particular could provide a useful tool for early prediction of HCC response to local ablative therapy.	[Praktiknjo, Michael; Krabbe, Viktoria; Pohlmann, Alessandra; Sampels, Matthias; Jansen, Christian; Strassburg, Christian P.; Trebicka, Jonel; Gonzalez Carmona, Maria A.] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Meyer, Carsten] Univ Bonn, Dept Radiol, Bonn, Germany; [Trebicka, Jonel] European Fdn Study Chron Liver Failure EF CLIF, Barcelona, Spain	University of Bonn; University of Bonn	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Trebicka, J (corresponding author), European Fdn Study Chron Liver Failure EF CLIF, Barcelona, Spain.	jonel.trebicka@ukbonn.de		Trebicka, Jonel/0000-0002-7028-3881	Deutsche Forschungsgemeinschaft [SFB TRR 57 P18]; H2020 European Institute of Innovation and Technology [668031]; Fundacion Cellex (PREDICT grant)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H2020 European Institute of Innovation and Technology; Fundacion Cellex (PREDICT grant)	This work was supported by the Deutsche Forschungsgemeinschaft (grant SFB TRR 57 P18), H2020 European Institute of Innovation and Technology (grant 668031), and Fundacion Cellex (PREDICT grant) to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CS, 2016, ONCOTARGET, V7, P7241, DOI 10.18632/oncotarget.6892; Conti CB, 2016, WORLD J GASTROENTERO, V22, P2647, DOI 10.3748/wjg.v22.i9.2647; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Frieser M, 2011, ULTRASCHALL MED, V32, P148, DOI 10.1055/s-0029-1245934; Grgurevic I, 2017, LIVER INT OFF J 1013, P506; Heimbach J, 2017, HEPATOL BALTIM  0128; Ho DWH, 2017, GUT, V66, P1496, DOI 10.1136/gutjnl-2016-312734; Jansen C, 2016, GUT; Jiao Y, 2017, MED ULTRASON, V19, P16, DOI 10.11152/mu-925; Kierans AS, 2010, AM J ROENTGENOL, V194, P523, DOI 10.2214/AJR.09.2621; Kim YJ, 2017, HISTOPATHOLOGY, V71, P217, DOI 10.1111/his.13219; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Marquez HP, 2017, CARDIOVASC INTER RAD, V40, P90, DOI 10.1007/s00270-016-1444-9; Minami Y, 2015, LIVER CANCER, V4, P106, DOI 10.1159/000367733; Minami Y, 2013, ONCOLOGY-BASEL, V84, P58, DOI 10.1159/000345891; Mitchell DG, 2015, HEPATOLOGY, V61, P1056, DOI 10.1002/hep.27304; Montorsi M, 2005, J GASTROINTEST SURG, V9, P62, DOI 10.1016/j.gassur.2004.10.003; Mueller S, 2016, WORLD J GASTROENTERO, V22, P10482, DOI 10.3748/wjg.v22.i48.10482; Nakashima Y, 2003, HEPATOL RES, V26, P142, DOI 10.1016/S1386-6346(03)00007-X; Ng KKC, 2017, BRIT J SURG, V104, P1775, DOI 10.1002/bjs.10677; Okusaka T, 2002, CANCER-AM CANCER SOC, V95, P1931, DOI 10.1002/cncr.10892; Tian WS, 2016, ULTRASOUND MED BIOL, V42, P2156, DOI 10.1016/j.ultrasmedbio.2016.05.002; Tripathi D, 2015, GUT, V64, P1680, DOI 10.1136/gutjnl-2015-309262; Wang J, 2014, ISRN HEPATOL, V2014; Ying L, 2012, EUR RADIOL, V22, P2798, DOI 10.1007/s00330-012-2540-0	26	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192897	10.1371/journal.pone.0192897	http://dx.doi.org/10.1371/journal.pone.0192897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444164	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500103
J	Sidorchuk, A; Goodman, A; Koupil, I				Sidorchuk, Anna; Goodman, Anna; Koupil, Ilona			Social class, social mobility and alcohol-related disorders in Swedish men and women: A study of four generations	PLOS ONE			English	Article							PERIOD-COHORT ANALYSIS; SUBSTANCE USE; SOCIOECONOMIC-STATUS; NATIONAL COHORT; LIFE-COURSE; ATTRIBUTABLE MORTALITY; SCHOOL PERFORMANCE; GENDER-DIFFERENCES; HEALTH; METAANALYSIS	Objectives To investigate whether and how social class and social mobility in grandparents and parents predict alcohol-related disorders (ARDs) in males and females aged 12+ years, and whether intergenerational social prediction of ARDs varies across time periods. Methods The study sample included four successive generations (G) of Swedish families from the Uppsala Birth Cohort Multigenerational Study: G0 born 1851-1912; G1 born 1915-1929; G2 born 1940-1964 and G3 born 1965-1989. Two study populations were created, each consisting of grandparents, parents and offspring: population I 'G0-G1-G2' (offspring n = 18 430) and population II 'G1-G2-G3' (offspring n = 26 469). Registers and archives provided data on ancestors' socio-demographic factors and ARD history, together with offspring ARD development between 1964-2008. Cox regression models examined the hazard of offspring ARD development according to grandparental social class and grandparental-to-parental social trajectories, controlling for offspring birth year, grandmother's and mother's marital status and parental ARDs. Results Disadvantaged grandparental social class predicted increased ARD risk in offspring in population I, although the effect attenuated and became non-significant in males after adjusting for parental characteristics (adjusted hazard ratio (HR) = 1.80 (95% CI; 1.07, 3.03) in females, HR = 1.32 (95% CI; 0.93, 1.89) in males). In population II, no increase in ARD risk by grandparental social was evident. In both populations, males were at the highest ARD risk if both parents and grandparents belonged to disadvantaged social class (population I: HR = 1.82 (95% CI; 1.22-2.72); population II: HR = 1.68 (95% CI; 1.02-2.76)). Conclusions Intergenerational social patterning of ARDs appears to be time-contextual and gender-specific. The role of grandparental social class in developing ARDs in grandchildren seems to decline over time, while persistent grandparental-to-parental social disadvantage remains associated with higher ARD risk in males. When targeting higher risk groups, continuity of familial social disadvantage, particularly among males, should be considered.	[Sidorchuk, Anna; Koupil, Ilona] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Sidorchuk, Anna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Goodman, Anna; Koupil, Ilona] Stockholm Unviers, Dept Publ Hlth Sci, Stockholm, Sweden; [Goodman, Anna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	Karolinska Institutet; Karolinska Institutet; University of London; London School of Hygiene & Tropical Medicine	Sidorchuk, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Sidorchuk, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	anna.sidorchuk@ki.se	Koupil, Ilona/AAC-9067-2020	Koupil, Ilona/0000-0002-7034-1922	Swedish Research Council (Vetenskapsradet) [2013-5104, 2013-5474]; Swedish Research Council for Health, Working Life and Welfare (FORTE) [2013-1084, 2014-2693, 2006-1518]; European Foundation for Alcohol Research (ERAB) [EA1305]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (CAN) [2013-0003]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Research Council for Health, Working Life and Welfare (FORTE); European Foundation for Alcohol Research (ERAB); Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (CAN)	This study was funded by the Swedish Research Council (Vetenskapsradet, https://www.vr.se/), grant number 2013-5104 to Ilona Koupil and 2013-5474 to Rignell-Hydbom; The Swedish Research Council for Health, Working Life and Welfare (FORTE, https://forte.se/), grant number 2013-1084 and 2014-2693 to Ilona Koupil, and 2006-1518 to Lundberg; The European Foundation for Alcohol Research (ERAB, https://erab.org/), grant number EA1305 to Anna Sidorchuk; and The Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (CAN, http://www.can.se/systembolagets-alkoholforskningsrad/), grant number 2013-0003 to Anna Sidorchuk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren-Moonga J, 2009, AM J EPIDEMIOL, V170, P566, DOI 10.1093/aje/kwp166; Alcohol Loring B., GUIDANCE ADDRESSING; Bailey JA, 2006, J ABNORM CHILD PSYCH, V34, P273, DOI 10.1007/s10802-006-9033-z; Bjorklund A, 1994, NBER WORKING PAPER S; Caria MP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-312; Chen ZY, 2008, J FAM ISSUES, V29, P1574, DOI 10.1177/0192513X08318968; Cheng TL, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2467; Conrod PJ, 2013, JAMA PSYCHIAT, V70, P334, DOI 10.1001/jamapsychiatry.2013.651; Corrao G, 1997, INT J EPIDEMIOL, V26, P100, DOI 10.1093/ije/26.1.100; Edwards AC, 2016, PSYCHOL MED, V46, P957, DOI 10.1017/S0033291715002457; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Engdahl B, 2011, EUR J PUBLIC HEALTH, V21, P432, DOI 10.1093/eurpub/ckq096; Gauffin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151755; Gauffin K, 2015, INT J EPIDEMIOL, V44, P919, DOI 10.1093/ije/dyv006; Gauffin K, 2013, J EPIDEMIOL COMMUN H, V67, P932, DOI 10.1136/jech-2013-202624; Goodman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106475; Goodman A, 2012, P ROY SOC B-BIOL SCI, V279, P4342, DOI 10.1098/rspb.2012.1415; Goodman A, 2010, LONGITUD LIFE COURSE, V1, P317; Grigsby TJ, 2016, J ADOLESCENCE, V48, P18, DOI 10.1016/j.adolescence.2016.01.006; Hensing G, 2012, SCAND J PUBLIC HEALT, V40, P211, DOI 10.1177/1403494812459608; Institute for Health Metrics and Evaluation (IHME), 2022, FIN GLOB HLTH VIS; Johnson JG, 1999, J ABNORM PSYCHOL, V108, P490, DOI 10.1037/0021-843X.108.3.490; Jones L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1720-7; Jonsson U, 2012, SOC PSYCH PSYCH EPID, V47, P1695, DOI 10.1007/s00127-012-0476-y; Katikireddi SV, 2017, LANCET PUBLIC HEALTH, V2, pE267, DOI 10.1016/S2468-2667(17)30078-6; Kendler KS, 2017, PSYCHOL MED, V47, P925, DOI 10.1017/S0033291716003032; Kendler KS, 2017, J STUD ALCOHOL DRUGS, V78, P186, DOI 10.15288/jsad.2017.78.186; King SM, 2004, ADDICTION, V99, P1548, DOI 10.1111/j.1360-0443.2004.00893.x; Knight KE, 2014, SUBST USE MISUSE, V49, P221, DOI 10.3109/10826084.2013.824478; Koupil I, 2007, J INTERN MED, V261, P426, DOI 10.1111/j.1365-2796.2007.01799.x; Kraus L, 2015, ADDICTION, V110, P1443, DOI 10.1111/add.12989; Kraus L, 2015, ALCOHOL ALCOHOLISM, V50, P319, DOI 10.1093/alcalc/agv013; Lindahl M, 2015, J HUM RESOUR, V50, P1; Linell A, 2013, SCAND J PUBLIC HEALT, V41, P3, DOI 10.1177/1403494812466989; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Makela P, 2006, ALCOHOL ALCOHOLISM, V41, pI8, DOI 10.1093/alcalc/agl071; Mare RD, 2014, RES SOC STRAT MOBIL, V35, P121, DOI 10.1016/j.rssm.2014.01.004; McVicar D, 2015, SOC SCI MED, V136, P89, DOI 10.1016/j.socscimed.2015.05.005; Melchior M, 2007, AM J EPIDEMIOL, V166, P966, DOI 10.1093/aje/kwm155; Modin B, 2008, SOC SCI MED, V66, P822, DOI 10.1016/j.socscimed.2007.11.001; Modin B, 2009, SOC SCI MED, V68, P1633, DOI 10.1016/j.socscimed.2009.02.019; Modin B, 2009, INT J EPIDEMIOL, V38, P733, DOI 10.1093/ije/dyp001; Moore GF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2244-x; Najman JM, 2004, SOC SCI MED, V58, P1147, DOI 10.1016/S0277-9536(03)00286-7; Norstrom T, 2006, ADDICTION, V101, P1543, DOI 10.1111/j.1360-0443.2006.01540.x; Osler M, 2006, AM J EPIDEMIOL, V163, P654, DOI 10.1093/aje/kwj084; Pfeffer FT, 2014, RES SOC STRAT MOBIL, V35, P1, DOI 10.1016/j.rssm.2014.01.001; Pillas D, 2014, PEDIATR RES, V76, P418, DOI 10.1038/pr.2014.122; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Probst C, 2015, DRUG ALCOHOL REV, V34, P267, DOI 10.1111/dar.12184; Probst C, 2014, INT J EPIDEMIOL, V43, P1314, DOI 10.1093/ije/dyu043; Raninen J, 2016, ADDICTION, V111, P1021, DOI 10.1111/add.13323; Rosen M, 2006, ADDICTION, V101, P835, DOI 10.1111/j.1360-0443.2006.01421.x; Rosenfield S, 2000, SOC PSYCHOL QUART, V63, P208, DOI 10.2307/2695869; Sidorchuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042083; Sjolund S, 2012, ADDICTION, V107, P89, DOI 10.1111/j.1360-0443.2011.03544.x; Statistics Sweden, 1984, REP STAT COORD, V1982, P4; Statistics Sweden, LONG INT DAT HLTH IN; Syden L, 2017, ADDICTION, V112, P1920, DOI 10.1111/add.13889; Thornberry TP, 2006, J DRUG ISSUES, V36, P1, DOI 10.1177/002204260603600101; Tiikkaja S, 2016, INT J SOC PSYCHIATR, V62, P156, DOI 10.1177/0020764015614594; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yap MBH, 2017, ADDICTION, V112, P1142, DOI 10.1111/add.13785	64	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191855	10.1371/journal.pone.0191855	http://dx.doi.org/10.1371/journal.pone.0191855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444095	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500035
J	Groves, K; Kennett, S; Gillmeister, H				Groves, Katie; Kennett, Steffan; Gillmeister, Helge			Early visual ERPs show stable body-sensitive patterns over a 4-week test period	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; ANOREXIA-NERVOSA; BRAIN POTENTIALS; EVOKED-RESPONSES; PERCEPTION; FACE; EXTRASTRIATE; AREA; REPRESENTATIONS; STIMULATION	Event-related potential (ERP) studies feature among the most cited papers in the field of body representation, with recent research highlighting the potential of ERPs as neuropsychiatric biomarkers. Despite this, investigation into how reliable early visual ERPs and body-sensitive effects are over time has been overlooked. This study therefore aimed to assess the stability of early body-sensitive effects and visual P1, N1 and VPP responses. Participants were asked to identify pictures of their own bodies, other bodies and houses during an EEG test session that was completed at the same time, once a week, for four consecutive weeks. Results showed that amplitude and latency of early visual components and their associated body-sensitive effects were stable over the 4-week period. Furthermore, correlational analyses revealed that VPP component amplitude might be more reliable than VPP latency and specific electrode sites might be more robust indicators of body-sensitive cortical activity than others. These findings suggest that visual P1, N1 and VPP responses, alongside body-sensitive N1/VPP effects, are robust indications of neuronal activity. We conclude that these components are eligible to be considered as electrophysiological biomarkers relevant to body representation.	[Groves, Katie; Kennett, Steffan; Gillmeister, Helge] Univ Essex, Dept Psychol, Colchester, Essex, England	University of Essex	Groves, K (corresponding author), Univ Essex, Dept Psychol, Colchester, Essex, England.	kegrov@essex.ac.uk		Gillmeister, Helge/0000-0001-5999-5303	University of Essex	University of Essex	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. K.G. was supported by a PhD Studentship funded by the University of Essex. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Bauser DAS, 2015, BRIT J PSYCHOL, V106, P414, DOI 10.1111/bjop.12101; Bauser DAS, 2013, CLIN NEUROPHYSIOL, V124, P686, DOI 10.1016/j.clinph.2012.09.030; Bauser DS, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00106; Brandman T, 2014, CEREB CORTEX, P1; Castellini G, 2013, EUR PSYCHIAT, V28, P427, DOI 10.1016/j.eurpsy.2012.06.006; Chan AWY, 2011, COGN NEUROSCI-UK, V2, P210, DOI 10.1080/17588928.2011.604723; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; David N, 2009, SOC NEUROSCI, V4, P40, DOI 10.1080/17470910801938023; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Downing PE, 2016, NEUROPSYCHOLOGIA, V83, P138, DOI 10.1016/j.neuropsychologia.2015.05.033; Downing PE, 2011, COGN NEUROSCI-UK, V2, P186, DOI 10.1080/17588928.2011.582945; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Fallgatter AJ, 2001, CLIN NEUROPHYSIOL, V112, P198, DOI 10.1016/S1388-2457(00)00505-8; Gaspar CM, 2011, NEUROIMAGE, V58, P620, DOI 10.1016/j.neuroimage.2011.06.052; Groves K, 2017, BIOL PSYCHOL, V123, P205, DOI 10.1016/j.biopsycho.2016.12.016; Hajra SG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00211; Hodzic A, 2009, NEUROIMAGE, V45, P1264, DOI 10.1016/j.neuroimage.2009.01.027; Howell DC., 2012, STAT METHODS PSYCHOL; Huffmeijer R, 2014, PHYSIOL BEHAV, V130, P13, DOI 10.1016/j.physbeh.2014.03.008; Ishizu T, 2010, NEUROSCI LETT, V481, P36, DOI 10.1016/j.neulet.2010.06.047; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Kompatsiari K, 2016, NEUROSCI LETT, V617, P166, DOI 10.1016/j.neulet.2016.02.012; KOOI KA, 1964, ANN NY ACAD SCI, V112, P254, DOI 10.1111/j.1749-6632.1964.tb26755.x; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Kuefner D, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.067.2009; Li W, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00301; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mai S, 2015, BIOL PSYCHOL, V108, P105, DOI 10.1016/j.biopsycho.2015.03.013; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Meeren HKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071408; Meeren HKM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003503; Minnebusch DA, 2010, NEUROIMAGE, V49, P2746, DOI 10.1016/j.neuroimage.2009.10.046; Minnebusch DA, 2009, J COGNITIVE NEUROSCI, V21, P865, DOI 10.1162/jocn.2009.21074; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pourtois G, 2007, NEUROPSYCHOLOGIA, V45, P2621, DOI 10.1016/j.neuropsychologia.2007.04.005; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Sadeh B, 2011, CURR BIOL, V21, P1894, DOI 10.1016/j.cub.2011.09.030; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Taylor JC, 2010, BRAIN COGNITION, V73, P153, DOI 10.1016/j.bandc.2010.04.001; Taylor MJ, 1999, CLIN NEUROPHYSIOL, V110, P910, DOI 10.1016/S1388-2457(99)00006-1; Tello C, 2010, DOC OPHTHALMOL, V120, P219, DOI 10.1007/s10633-010-9216-3; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; Urgesi C, 2007, J NEUROSCI, V27, P8023, DOI 10.1523/JNEUROSCI.0789-07.2007; van Heijnsbergen CCRJ, 2007, BRAIN RES, V1186, P233, DOI 10.1016/j.brainres.2007.09.093; Vocks S, 2010, COGN AFFECT BEHAV NE, V10, P422, DOI 10.3758/CABN.10.3.422; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475; World Eating Disorders Action Day, 2016, 9 GOALS TAK ACT EAT	59	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192583	10.1371/journal.pone.0192583	http://dx.doi.org/10.1371/journal.pone.0192583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW1TV	29438399	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000425083400028
J	Kim, S; Nguyen, QB; Wolyniak, MJ; Frechette, G; Lehman, CR; Fox, BK; Sundstrom, P				Kim, Samin; Quoc Bao Nguyen; Wolyniak, Michael J.; Frechette, Gregory; Lehman, Christian R.; Fox, Brandon K.; Sundstrom, Paula			Release of transcriptional repression through the HCR promoter region confers uniform expression of HWP1 on surfaces of Candida albicans germ tubes	PLOS ONE			English	Article							TRANSGLUTAMINASE SUBSTRATE; GENE-EXPRESSION; EFG1; VIRULENCE; RNA; MORPHOGENESIS; ACTIVATION; PROTEIN; TUP1	The mechanisms that fungi use to co-regulate subsets of genes specifically associated with morphogenic states represent a basic unsolved problem in fungal biology. Candida albicans is an important model of fungal differentiation both for rapid interconversion between yeast and hyphal growth forms and for white/opaque switching mechanisms. The Sundstrom lab is interested in mechanisms regulating hypha-specific expression of adhesin genes that are critical for C. albicans hyphal growth phenotypes and pathogenicity. Early studies on hyphaspecific genes such as HWP1 and ALS3 reported 5' intergenic regions that are larger than those typically found in an average promoter and are associated with hypha-specific expression. In the case of HWP1, activation and repression involves a 368 bp region, denoted the HWP1 control region (HCR), located 1410 bp upstream of its transcription start site. In previous work we showed that HCR confers developmental regulation to a heterologous ENO1 promoter, indicating that HCR by itself contains sufficient information to couple gene expression to morphology. Here we show that the activation and repression mediated by HCR are localized to distinct HCR regions that are targeted by the transcription factors Nrg1p and Efg1p. The finding that Efg1p mediates both repression via HCR under yeast morphological conditions and activation conditions positions Efg1p as playing a central role in coupling HWP1 expression to morphogenesis through the HCR region. These localization studies revealed that the 120 terminal base pairs of HCR confer Efg1p-dependent repressive activity in addition to the Nrg1p repressive activity mediated by DNA upstream of this subregion. The 120 terminal base pair subregion of HCR also contained an initiation site for an HWP1 transcript that is specific to yeast growth conditions (HCR-Y) and may function in the repression of downstream DNA. The detection of an HWP1 mRNA isoform specific to hyphal growth conditions (HWP1-H) showed that morphology-specific mRNA isoforms occur under both yeast and hyphal growth conditions. Similar results were found at the ALS3 locus. Taken together, these results, suggest that the long 5' intergenic regions upstream of hypha-specific genes function in generating mRNA isoforms that are important for morphology-specific gene expression. Additional complexity in the HWP1 promoter involving HCR-independent activation was discovered by creating a strain lacking HCR that exhibited variable HWP1 expression during hyphal growth conditions. These results show that while HCR is important for ensuring uniform HWP1 expression in cell populations, HCR independent expression also exists. Overall, these results elucidate HCR-dependent mechanisms for coupling HWP1-dependent gene expression to morphology uniformly in cell populations and prompt the hypothesis that mRNA isoforms may play a role in coupling gene expression to morphology in C. albicans.	[Kim, Samin; Quoc Bao Nguyen; Frechette, Gregory; Sundstrom, Paula] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Microbiol & Mol Pathogenesis Program, Hanover, NH USA; [Wolyniak, Michael J.; Lehman, Christian R.; Fox, Brandon K.] Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA; [Kim, Samin] Yongsan Int Sch Seoul, Seoul, South Korea; [Quoc Bao Nguyen] Nong Lam Univ, Res Inst Biotechnol & Environm, Ho Chi Minh City, Vietnam; [Frechette, Gregory] Mt Sinai Hosp, Icahn Sch Med, Dept Surg, New York, NY 10029 USA	Dartmouth College; Nong Lam University; Icahn School of Medicine at Mount Sinai	Sundstrom, P (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Microbiol & Mol Pathogenesis Program, Hanover, NH USA.	Paula.Sundstrom@Dartmouth.edu	Wolyniak, Michael/S-6451-2019	Sundstrom, Paula/0000-0002-9490-0370	National Institute of Allergy and Infectious Diseases [R01 AI46608]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research was provided to Paula Sundstrom by the National Institute of Allergy and Infectious Diseases (R01 AI46608) https"//www.niaid.nih.gov/ and by internal, institutional reserves. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Barelle CJ, 2003, EUKARYOT CELL, V2, P398, DOI 10.1128/EC.2.3.398-410.2003; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2000, GENETICS, V155, P57; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; BRUMMEL M, 1982, DEV BIOL, V89, P211, DOI 10.1016/0012-1606(82)90308-6; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; CHEUNG AL, 1994, ANAL BIOCHEM, V222, P511, DOI 10.1006/abio.1994.1528; Childers DS, 2014, MOL MICROBIOL, V92, P570, DOI 10.1111/mmi.12576; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Dwivedi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016218; Guan ZY, 2015, MOL MICROBIOL, V97, P125, DOI 10.1111/mmi.13014; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kadosh D, 2016, CELL MOL LIFE SCI, V73, P4265, DOI 10.1007/s00018-016-2294-y; Kim S, 2007, EUKARYOT CELL, V6, P693, DOI 10.1128/EC.00341-06; Kim S, 2014, INFECT IMMUN, V82, P4369, DOI 10.1128/IAI.02002-14; KIMURA LH, 1978, INFECT IMMUN, V21, P64, DOI 10.1128/IAI.21.1.64-68.1978; Lachke SA, 2003, MOL MICROBIOL, V48, P523, DOI 10.1046/j.1365-2958.2003.t01-1-03448.x; Lassak T, 2011, MOL MICROBIOL, V82, P602, DOI 10.1111/j.1365-2958.2011.07837.x; Li Y, 2007, EUKARYOT CELL, V6, P2112, DOI 10.1128/EC.00199-07; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lu Y, 2008, MOL BIOL CELL, V19, P4260, DOI 10.1091/mbc.E08-02-0173; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; Lu YQ, 2012, PLANT METHODS, V8, DOI [10.1186/1746-4811-8-9, 10.1371/journal.ppat.1002663]; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Motaung TE, 2015, J MICROBIOL METH, V115, P153, DOI 10.1016/j.mimet.2015.06.004; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Noffz CS, 2008, EUKARYOT CELL, V7, P881, DOI 10.1128/EC.00033-08; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; Staab JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080842; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Staab JF, 2003, MICROBIOL-SGM, V149, P2977, DOI 10.1099/mic.0.26445-0; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Staab JF, 1996, J BIOL CHEM, V271, P6298, DOI 10.1074/jbc.271.11.6298; Sundstrom P, 2002, J INFECT DIS, V185, P521, DOI 10.1086/338836; SUNDSTROM PM, 1984, INFECT IMMUN, V43, P850, DOI 10.1128/IAI.43.3.850-855.1984; Tuch BB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001070; Wang LQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003027; WENZEL RP, 1995, CLIN INFECT DIS, V20, P1531, DOI 10.1093/clinids/20.6.1531; Wolyniak MJ, 2007, EUKARYOT CELL, V6, P1824, DOI 10.1128/EC.00188-07; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	59	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192260	10.1371/journal.pone.0192260	http://dx.doi.org/10.1371/journal.pone.0192260			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438403	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400018
J	Sandmann, A; Sticht, H				Sandmann, Achim; Sticht, Heinrich			Probing the role of intercalating protein sidechains for kink formation in DNA	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MITOCHONDRIAL TRANSCRIPTION FACTOR; NUCLEIC-ACID DATABASE; PARTICLE MESH EWALD; DOUBLE HELIX; ARCHITECTURAL ROLE; CRYSTAL-STRUCTURE; INDIRECT READOUT; BINDING PROTEIN; A-TRACTS	Protein binding can induce DNA kinks, which are for example important to enhance the specificity of the interaction and to facilitate the assembly of multi protein complexes. The respective proteins frequently exhibit amino acid sidechains that intercalate between the DNA base steps at the site of the kink. However, on a molecular level there is only little information available about the role of individual sidechains for kink formation. To unravel structural principles of protein-induced DNA kinking we have performed molecular dynamics (MD) simulations of five complexes that varied in their architecture, function, and identity of intercalated residues. Simulations were performed for the DNA complexes of wildtype proteins (Sac7d, Sox-4, CcpA, TFAM, TBP) and for mutants, in which the intercalating residues were individually or combined replaced by alanine. The work revealed that for systems with multiple intercalated residues, not all of them are necessarily required for kink formation. In some complexes (Sox-4, TBP), one of the residues proved to be essential for kink formation, whereas the second residue has only a very small effect on the magnitude of the kink. In other systems (e.g. Sac7d) each of the intercalated residues proved to be individually capable of conferring a strong kink suggesting a partially redundant role of the intercalating residues. Mutation of the key residues responsible for kinking either resulted in stable complexes with reduced kink angles or caused conformational instability as evidenced by a shift of the kink to an adjacent base step. Thus, MD simulations can help to identify the role of individual inserted residues for kinking, which is not readily apparent from an inspection of the static structures. This information might be helpful for understanding protein-DNA interactions in more detail and for designing proteins with altered DNA binding properties in the future.	[Sandmann, Achim; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Bioinformat, Erlangen, Germany	University of Erlangen Nuremberg	Sticht, H (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Bioinformat, Erlangen, Germany.	heinrich.sticht@fau.de		Sticht, Heinrich/0000-0001-5644-045X	Deutsche Forschungsgemeinschaft [STI155/3-3]; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	We acknowledge support by Deutsche Forschungsgemeinschaft (project STI155/3-3) and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing to HS.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; ARNOTT S, 1980, NATURE, V283, P743, DOI 10.1038/283743a0; Aung-Hilbrich LM, 2002, J MOL BIOL, V319, P77, DOI 10.1016/S0022-2836(02)00245-0; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Case D.A., 2014, AMBER, V14, P29; Chen CY, 2005, NUCLEIC ACIDS RES, V33, P430, DOI 10.1093/nar/gki191; Chen L, 2015, PHYS CHEM CHEM PHYS, V17, P5704, DOI 10.1039/c4cp05413j; Chen L, 2012, J PHYS CHEM B, V116, P12415, DOI 10.1021/jp305860h; Chen SF, 2001, J MOL BIOL, V314, P75, DOI 10.1006/jmbi.2001.5090; Chin K, 1999, NAT STRUCT BIOL, V6, P1055; Churchill MEA, 2010, J MOL BIOL, V403, P88, DOI 10.1016/j.jmb.2010.08.031; Curuksu J, 2009, NUCLEIC ACIDS RES, V37, P3766, DOI 10.1093/nar/gkp234; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DIEKMANN S, 1989, J MOL BIOL, V205, P787, DOI 10.1016/0022-2836(89)90324-0; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Du Q, 2008, NUCLEIC ACIDS RES, V36, P1120, DOI 10.1093/nar/gkm1125; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hallberg BM, 2011, NAT STRUCT MOL BIOL, V18, P1179, DOI 10.1038/nsmb.2167; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Harteis S, 2014, INT J MOL SCI, V15, P12335, DOI 10.3390/ijms150712335; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; JAYARAM B, 1989, BIOPOLYMERS, V28, P975, DOI 10.1002/bip.360280506; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; LAVERY R, 1981, NUCLEIC ACIDS RES, V9, P6539, DOI 10.1093/nar/9.23.6539; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; LESLIE AGW, 1980, J MOL BIOL, V143, P49, DOI 10.1016/0022-2836(80)90124-2; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Mack DR, 2001, J MOL BIOL, V312, P1037, DOI 10.1006/jmbi.2001.4994; Mondal M, 2015, J COMPUT AID MOL DES, V29, P283, DOI 10.1007/s10822-014-9828-x; Narayanan BC, 2014, NUCLEIC ACIDS RES, V42, pD114, DOI 10.1093/nar/gkt980; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Nikolov DB, 1996, P NATL ACAD SCI USA, V93, P4862, DOI 10.1073/pnas.93.10.4862; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Priyakumar UD, 2010, J PHYS CHEM B, V114, P16548, DOI 10.1021/jp101583d; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Schumacher MA, 2011, NUCLEIC ACIDS RES, V39, P2931, DOI 10.1093/nar/gkq1177; SHAKKED Z, 1989, NATURE, V342, P456, DOI 10.1038/342456a0; SHAKKED Z, 1986, PROG BIOPHYS MOL BIO, V47, P159, DOI 10.1016/0079-6107(86)90013-1; Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099; Vologodskii A, 2013, NUCLEIC ACIDS RES, V41, P6785, DOI 10.1093/nar/gkt396; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Zhang Y, 2017, ACS CHEM NEUROSCI, V8, P578, DOI 10.1021/acschemneuro.6b00348; Zhang ZF, 2017, BIOCHEM J, V474, P1727, DOI 10.1042/BCJ20170036; Zhang ZF, 2010, MOL MICROBIOL, V76, P749, DOI 10.1111/j.1365-2958.2010.07136.x	61	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192605	10.1371/journal.pone.0192605	http://dx.doi.org/10.1371/journal.pone.0192605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432448	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300032
J	Munyua, P; Onyango, C; Mwasi, L; Waiboci, LW; Arunga, G; Fields, B; Mott, JA; Cardona, CJ; Kitala, P; Nyaga, PN; Njenga, MK				Munyua, Peninah; Onyango, Clayton; Mwasi, Lydia; Waiboci, Lilian W.; Arunga, Geoffrey; Fields, Barry; Mott, Joshua A.; Cardona, Carol J.; Kitala, Philip; Nyaga, Philip N.; Njenga, M. Kariuki			Identification and characterization of influenza A viruses in selected domestic animals in Kenya, 2010-2012	PLOS ONE			English	Article							SWINE; PIGS; SURVEILLANCE; REASSORTMENT; MORBIDITY; EVOLUTION; ASSAY	Background Influenza A virus subtypes in non-human hosts have not been characterized in Kenya. We carried out influenza surveillance in selected domestic animals and compared the virus isolates with isolates obtained in humans during the same period. Methods We collected nasal swabs from pigs, dogs and cats; oropharyngeal and cloacal swabs from poultry; and blood samples from all animals between 2010 and 2012. A standardized questionnaire was administered to farmers and traders. Swabs were tested for influenza A by rtRT-PCR, virus isolation and subtyping was done on all positive swabs. All sera were screened for influenza A antibodies by ELISA, and positives were evaluated by hemagglutination inhibition (HI). Full genome sequencing was done on four selected pig virus isolates. Results Among 3,798 sera tested by ELISA, influenza A seroprevalence was highest in pigs (15.9%; 172/1084), 1.2% (3/258) in ducks, 1.4% (1/72) in cats 0.6% (3/467) in dogs, 0.1% (2/1894) in chicken and 0% in geese and turkeys. HI testing of ELISA-positive pig sera showed that 71.5% had positive titers to A/California/04/2009(H1N1). Among 6,289 swabs tested by rRT-PCR, influenza A prevalence was highest in ducks [1.2%; 5/423] and 0% in cats and turkeys. Eight virus isolates were obtained from pig nasal swabs collected in 2011 and were determined to be A(H1N1) pdm09 on subtyping. On phylogenetic analysis, four hemagglutinin segments from pig isolates clustered together and were closely associated with human influenza viruses that circulated in Kenya in 2011. Conclusion Influenza A(H1N1)pdm09 isolated in pigs was genetically similar to contemporary human pandemic influenza virus isolates. This suggest that the virus was likely transmitted from humans to pigs, became established and circulated in Kenyan pig populations during the study period. Minimal influenza A prevalence was observed in the other animals studied.	[Munyua, Peninah; Onyango, Clayton; Waiboci, Lilian W.; Fields, Barry; Mott, Joshua A.; Njenga, M. Kariuki] United States Ctr Dis Control & Prevent Kenya, Div Global Hlth Protect, Nairobi, Kenya; [Munyua, Peninah; Kitala, Philip; Nyaga, Philip N.] Univ Nairobi, Fac Vet Med, Nairobi, Kenya; [Mwasi, Lydia; Arunga, Geoffrey] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Mott, Joshua A.] United States Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Cardona, Carol J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Nairobi; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; University of Minnesota System; University of Minnesota Twin Cities	Munyua, P (corresponding author), United States Ctr Dis Control & Prevent Kenya, Div Global Hlth Protect, Nairobi, Kenya.; Munyua, P (corresponding author), Univ Nairobi, Fac Vet Med, Nairobi, Kenya.	ikg2@cdc.gov	Munyua, Peninah/AAA-5922-2021		National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Core Funding of the Global Disease Detection Division of CDC; Department of Health and Human Services [HHSN266200700007C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Core Funding of the Global Disease Detection Division of CDC; Department of Health and Human Services	This work was funded with funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, contract no. HHSN266200700007C to CJC and Core Funding of the Global Disease Detection Division of CDC to PM. There was no additional external funding received for this study.; This work was funded with funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, Contract No. HHSN266200700007C and Core Funding of the Global Disease Detection Division of CDC.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; AOluwagbenga A, 2009, VET ITAL, V45, P393; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; COX NJ, 2008, AVIAN INFLUENZA, P453; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Food Agric. Organ, 2012, PIG SECT KEN; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harrington B., 2005, INKSCAPE 2005; Kirunda H, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-50; Kyriakis CS, 2010, EMERG INFECT DIS, V16, P96, DOI 10.3201/eid1601.091190; Meseko C, 2013, ZOONOSES PUBLIC HLTH; *MMWR, 2009, MMWR-MORBID MORTAL W, V58, P1143; Munyua PM, 2013, INFLUENZA OTHER RESP, V7, P113, DOI 10.1111/j.1750-2659.2012.00365.x; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Njabo KY, 2012, VET MICROBIOL, V156, P189, DOI 10.1016/j.vetmic.2011.09.003; OIE, 2008, MANUAL DIAGNOSTIC TE; Rajao DS, 2013, INFLUENZA OTHER RESP, V7, P783, DOI 10.1111/irv.12072; Richt JA, 2004, J VET DIAGN INVEST, V16, P367, DOI 10.1177/104063870401600501; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shope R E, 1931, J Exp Med, V54, P373, DOI 10.1084/jem.54.3.373; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Snoeck CJ, 2015, VET MICROBIOL, V176, P165, DOI 10.1016/j.vetmic.2014.12.022; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2002, WHO MAN INFL DIAGN S; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	28	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192721	10.1371/journal.pone.0192721	http://dx.doi.org/10.1371/journal.pone.0192721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425232	Green Submitted, Green Published, gold			2022-12-26	WOS:000424700800038
J	Lai, CY; Lin, FH; Chu, H; Ku, CH; Tsai, SH; Chung, CH; Chien, WC; Wu, CH; Chu, CM; Chang, CW				Lai, Chung-Yu; Lin, Fu-Huang; Chu, Hsin; Ku, Chih-Hung; Tsai, Shih-Hung; Chung, Chi-Hsiang; Chien, Wu-Chien; Wu, Chun-Hsien; Chu, Chi-Ming; Chang, Chi-Wen			Survival factors of hospitalized out-of-hospital cardiac arrest patients in Taiwan: A retrospective study	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; ONLY CARDIOPULMONARY-RESUSCITATION; RECOMMENDED GUIDELINES; UTSTEIN STYLE; LAY RESCUERS; OUTCOMES; CARE; MORTALITY; DISEASE; DEFIBRILLATION	The chain of survival has been shown to improve the chances of survival for victims of cardiac arrest. Post-cardiac arrest care has been demonstrated to significantly impact the survival of out-of-hospital cardiac arrest (OHCA). How post-cardiac arrest care influences the survival of OHCA patients has been a main concern in recent years. The objective of this study was to assess the survival outcome of hospitalized OHCA patients and determine the factors associated with improved survival in terms of survival to discharge. We conducted a retrospective observational study by analyzing records from the National Health Insurance Research Database of Taiwan from 2007 to 2013. We collected cases with an International Classification of Disease Clinical Modification, 9 th revision primary diagnosis codes of 427.41 (ventricular fibrillation, VF) or 427.5 (cardiac arrest) and excluded patients less than 18 years old, as well as cases with an unknown outcome or a combination of traumatic comorbidities. We then calculated the proportion of survival to discharge among hospitalized OHCA patients. Factors associated with the dependent variable were examined by logistic regression. Statistical analysis was conducted using SPSS 22 (IBM, Armonk, NY). Of the 11,000 cases, 2,499 patients (22.7%) survived to hospital discharge. The mean age of subjects who survived to hospital discharge and those who did not was 66.7 +/- 16.7 and 71.7 +/- 15.2 years, respectively. After adjusting for covariates, neurological failure, cardiac comorbidities, hospital level, intensive care unit beds, transfer to another hospital, and length of hospital stay were independent predictors of improved survival. Cardiac rhythm on admission was a strong factor associated with survival to discharge (VF vs. non-VF: adjusted odds ratio: 3.51; 95% confidence interval: 3.06 +/- 4.01). In conclusion, cardiac comorbidities, hospital volume, cardiac rhythm on admission, transfer to another hospital and length of hospital stay had a significant positive association with survival to discharge in hospitalized OHCA patients in Taiwan.	[Lai, Chung-Yu] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Fu-Huang; Ku, Chih-Hung; Chung, Chi-Hsiang; Chien, Wu-Chien; Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chu, Hsin] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Ku, Chih-Hung] Kainan Univ, Dept Hlth Ind Management, Taoyuan, Taiwan; [Tsai, Shih-Hung] Triserv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Wu, Chun-Hsien] Triserv Gen Hosp, Natl Def Med Ctr, Div Cardiol, Taipei, Taiwan; [Chu, Chi-Ming] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chu, Chi-Ming] Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan; [Chang, Chi-Wen] Chang Gung Univ, Sch Nursing, Coll Med, Taoyuan, Taiwan; [Chang, Chi-Wen] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Nan Kai University Technology; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; Fu Jen Catholic University; Chang Gung University; Chang Gung Memorial Hospital	Lin, FH; Chu, CM (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chu, CM (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Chu, CM (corresponding author), Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan.; Chang, CW (corresponding author), Chang Gung Univ, Sch Nursing, Coll Med, Taoyuan, Taiwan.; Chang, CW (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan.	noldling@ms10.hinet.net; chuchiming@web.de; cwchang@mail.cgu.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	Ku, Chih-Hung/0000-0003-4065-6066				American Heart Association, AB CARD ARR; [Anonymous], AM HEART ASS CIRC, DOI DOI 10.1161/01.CIR.95.8.2213; Arrich J, 2006, MEDICINE, V85, P288, DOI 10.1097/01.md.0000236954.72342.20; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Carr BG, 2009, INTENS CARE MED, V35, P505, DOI 10.1007/s00134-008-1335-x; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chinese Hospital Association, 2000, ICD 9 CM ENGL CHIN D; Chokengarmwong N, 2016, AM J EMERG MED, V34, P1595, DOI 10.1016/j.ajem.2016.05.060; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Cummins RO, 1997, RESUSCITATION, V34, P151, DOI 10.1016/S0300-9572(97)01112-X; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Dudas K, 2011, CIRCULATION, V123, P46, DOI 10.1161/CIRCULATIONAHA.110.964999; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; Fugate JE, 2012, CIRCULATION, V126, P546, DOI 10.1161/CIRCULATIONAHA.111.088807; Girotra S, 2016, CIRCULATION, V133, P2159, DOI 10.1161/CIRCULATIONAHA.115.018175; Iwami T, 2012, CIRCULATION, V126, P2844, DOI 10.1161/CIRCULATIONAHA.112.109504; JENNETT B, 1975, LANCET, V1, P480; Lin MH, 2012, RESUSCITATION, V83, P343, DOI 10.1016/j.resuscitation.2011.09.006; Merchant RM, 2008, RESUSCITATION, V79, P398, DOI 10.1016/j.resuscitation.2008.07.015; Myerburg RJ, 2015, HARRISONS PRINCIPLE, P1764; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Ong MEH, 2011, ACAD EMERG MED, V18, P890, DOI 10.1111/j.1553-2712.2011.01132.x; Panchal AR, 2013, RESUSCITATION, V84, P435, DOI 10.1016/j.resuscitation.2012.07.038; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Redpath C, 2010, AM HEART J, V159, P577, DOI 10.1016/j.ahj.2009.12.030; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saba S, 2009, PACE, V32, P1444, DOI 10.1111/j.1540-8159.2009.02509.x; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stromsoe A, 2015, EUR HEART J, V36, P863, DOI 10.1093/eurheartj/ehu240; Tagami T, 2012, CIRCULATION, V126, P589, DOI 10.1161/CIRCULATIONAHA.111.086173; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Wallmuller C, 2012, RESUSCITATION, V83, P1206, DOI 10.1016/j.resuscitation.2012.05.001; Wang HE, 2012, RESUSCITATION, V83, P1343, DOI 10.1016/j.resuscitation.2012.07.013; Wolbinski M, 2016, HEART LUNG CIRC, V25, P639, DOI 10.1016/j.hlc.2016.02.001; Wong MKY, 2014, CIRCULATION, V130, P1883, DOI 10.1161/CIRCULATIONAHA.114.010633	37	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191954	10.1371/journal.pone.0191954	http://dx.doi.org/10.1371/journal.pone.0191954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420551	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900034
J	Rahman, A; Yamazaki, D; Sufiun, A; Kitada, K; Hitomi, H; Nakano, D; Nishiyama, A				Rahman, Asadur; Yamazaki, Daisuke; Sufiun, Abu; Kitada, Kento; Hitomi, Hirofumi; Nakano, Daisuke; Nishiyama, Akira			A novel approach to adenine-induced chronic kidney disease associated anemia in rodents	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; VASCULAR CALCIFICATION; GENDER-DIFFERENCES; HEART-FAILURE; ANIMAL-MODELS; ERYTHROPOIETIN; RATS; GROWTH; DYSFUNCTION; PHOSPHATE	To date, good experimental animal models of renal anemia are not available. Therefore, the purpose of this study was to establish a novel approach to induce chronic kidney disease (CKD) with severe anemia by oral administration of adenine in rodents. Adenine was administered to 6-week-old male C57BL/6 mice (25 and 50 mg/kg body weight) by oral gavage daily for 28 days. Serum creatinine and BUN as well as hematocrit, hemoglobin (Hb) and plasma erythropoietin (EPO) levels were monitored to assess renal function and anemia, respectively. Adenine at 25 mg/kg for 28 days slightly increased plasma creatinine levels, but did not induce anemia. In contrast, 50 mg/kg of adenine daily for 28 days showed severe renal dysfunction (plasma creatinine 1.9 +/- 0.10 mg/dL) and anemia (hematocrit 36.5 +/- 1.0% and EPO 28 +/- 2.4 pg/mL) as compared with vehicle-treated mice (0.4 +/- 0.02 mg/dL, 49.6 +/- 1.6% and 61 +/- 4.0 pg/mL, respectively). At the end of experiment, level of Hb also significantly reduced in 50 mg/kg adenine administration group. Remarkable histological changes of kidney tissues characterized by interstitial fibrosis and cystic appearance in tubules were observed in 50 mg/kg of adenine treatment group. These results have demonstrated that oral dosing with adenine at 50 mg/kg for 28 days is suitable to induce a stable anemia associated with CKD in mice.	[Rahman, Asadur; Yamazaki, Daisuke; Sufiun, Abu; Kitada, Kento; Hitomi, Hirofumi; Nakano, Daisuke; Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Fac Med, Takamatsu, Kagawa, Japan; [Rahman, Asadur] Int Univ Hlth & Welf, Sch Med, Dept Pharmacol, Narita, Japan; [Kitada, Kento] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA	Kagawa University; International University of Health & Welfare; Vanderbilt University	Rahman, A (corresponding author), Kagawa Univ, Dept Pharmacol, Fac Med, Takamatsu, Kagawa, Japan.; Rahman, A (corresponding author), Int Univ Hlth & Welf, Sch Med, Dept Pharmacol, Narita, Japan.	rahmanma@med.kagawa-u.ac.jp	Hitomi, Hirofumi/ABA-2086-2021; Rahman, Asadur/A-2367-2017	Rahman, Asadur/0000-0002-9172-5343; Kitada, Kento/0000-0002-6738-1253; Nishiyama, Akira/0000-0001-5971-820X	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [26460343]; Hoansha Foundation	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hoansha Foundation(Hoansha Foundation)	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (26460343 to Akira Nishiyama) and the Hoansha Foundation (to Akira Nishiyama). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2014, J MOL MED, V92, P871, DOI 10.1007/s00109-014-1151-4; Akchurin O, 2016, AM J PHYSIOL-RENAL, V311, pF877, DOI 10.1152/ajprenal.00089.2016; Ali BH, 2014, PHYSIOL RES, V63, P351, DOI 10.33549/physiolres.932685; Ali BH, 2013, J PHARMACOL TOX MET, V68, P384, DOI 10.1016/j.vascn.2013.05.001; Artunc F, 2007, NEPHROL DIAL TRANSPL, V22, P2900, DOI 10.1093/ndt/gfm316; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Ataka K, 2003, AM J NEPHROL, V23, P315, DOI 10.1159/000072913; Becker GJ, 2013, NEPHROL DIAL TRANSPL, V28, P2432, DOI 10.1093/ndt/gft071; Bissinger R, 2016, KIDNEY BLOOD PRESS R, V41, P966, DOI 10.1159/000452600; Claramunt D, 2015, AM J PHYSIOL-RENAL, V309, pF57, DOI 10.1152/ajprenal.00051.2015; Diwan V, 2014, AM J PHYSIOL-RENAL, V307, pF1169, DOI 10.1152/ajprenal.00676.2013; Diwan V, 2013, J PHARMACOL TOX MET, V68, P197, DOI 10.1016/j.vascn.2013.05.006; Fong D, 2016, CLIN EXP PHARMACOL P, V43, P896, DOI 10.1111/1440-1681.12621; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Hung SC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001480; Hussien NI, 2016, ALEX J MED, V52, P325, DOI 10.1016/j.ajme.2015.12.001; Igarashi T, 2014, CLIN EXP NEPHROL, V18, P525, DOI 10.1007/s10157-014-0995-9; Jia T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-116; Kang KP, 2014, MOL MED REP, V9, P2061, DOI 10.3892/mmr.2014.2089; Lang F, 2017, KIDNEY BLOOD PRESS R, V42, P749, DOI 10.1159/000484215; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Macdougall IC, 2013, NEW ENGL J MED, V368, P320, DOI 10.1056/NEJMoa1203166; Morgera S., 1997, International Urology and Nephrology, V29, P245, DOI 10.1007/BF02551350; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Nishioka S, 2014, KIDNEY INT, V85, P871, DOI 10.1038/ki.2013.496; Ogino A, 2010, J AM COLL CARDIOL, V56, P1949, DOI 10.1016/j.jacc.2010.04.068; OKADA H, 1999, CLIN EXP NEPHROL, V3, P82, DOI DOI 10.1007/S101570050015; Okada YM Hideto, 2001, CLIN EXP NEPHROL, V5, P28; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Rafiq K, 2011, J HYPERTENS, V29, P290, DOI 10.1097/HJH.0b013e32834103a9; Rahman A, 2016, J HYPERTENS, V34, P893, DOI 10.1097/HJH.0000000000000871; Rosenberger C, 2005, KIDNEY INT, V67, P531, DOI 10.1111/j.1523-1755.2005.67110.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sun CC, 2013, NEPHROL DIAL TRANSPL, V28, P1733, DOI 10.1093/ndt/gfs584; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Virani SA, 2008, CAN J CARDIOL, V24, p22B, DOI 10.1016/S0828-282X(08)71026-2; Wang XY, 2015, J THORAC DIS, V7, P1951, DOI 10.3978/j.issn.2072-1439.2015.10.66; Yang C, 2015, INDIAN J PHARM SCI, V77, P103; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; YOKOZAWA T, 1984, J NUTR SCI VITAMINOL, V30, P245, DOI 10.3177/jnsv.30.245; Yokozawa T, 1985, Nihon Jinzo Gakkai Shi, V27, P371; Zhang ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22151	48	41	44	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192531	10.1371/journal.pone.0192531	http://dx.doi.org/10.1371/journal.pone.0192531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415057	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300084
J	Liu, F; Dai, M; Xu, QY; Zhu, XL; Zhou, Y; Jiang, SH; Wang, YH; Ai, ZH; Ma, L; Zhang, YL; Hu, LP; Yang, Q; Li, J; Zhao, SJ; Zhang, ZG; Teng, YC				Liu, Fei; Dai, Miao; Xu, Qinyang; Zhu, Xiaolu; Zhou, Yang; Jiang, Shuheng; Wang, Yahui; Ai, Zhihong; Ma, Li; Zhang, Yanli; Hu, Lipeng; Yang, Qin; Li, Jun; Zhao, Shujie; Zhang, Zhigang; Teng, Yincheng			SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-kappa B-CD47 axis	ONCOGENE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; INFLAMMATION; IDENTIFICATION; RESISTANCE; PATHWAY; EVENTS	High-risk human papillomavirus oncoproteins E6 and E7 are the major etiological factors of cervical cancer but are insufficient for malignant transformation of cervical cancer. Dysregulated alternative splicing, mainly ascribed to aberrant splicing factor levels and activities, contributes to most cancer hallmarks. However, do E6 and E7 regulate the expression of splicing factors? Does alternative splicing acts as an "accomplice" of E6E7 to promote cervical cancer progression? Here, we identified that the splicing factor SRSF10, which promotes tumorigenesis of cervix, was upregulated by E6E7 via E2F1 transcriptional activation. SRSF10 modulates the alternate terminator of interleukin-1 receptor accessory protein exon 13 to increase production of the membrane form of interleukin-1 receptor accessory protein. SRSF10-mediated mIL1RAP upregulates the expression of the "don't eat me" signal CD47 to inhibit macrophage phagocytosis by promoting nuclear factor-KB activation, which is pivotal in inflammatory, immune, and tumorigenesis processes. Altogether, these data reveal a close relationship among HPV infection, alternative splicing and tumor immune evasion, and also suggests that the SRSF10-mIL1RAP-CD47 axis could be an attractive therapeutic target for the treatment of cervical cancer.	[Liu, Fei; Dai, Miao; Xu, Qinyang; Zhu, Xiaolu; Zhou, Yang; Ai, Zhihong; Ma, Li; Teng, Yincheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gynecol & Obstet, Sch Med, Shanghai, Peoples R China; [Dai, Miao] Cent South Univ, Affiliated Canc Hosp, Hunan Canc Hosp, Xiangya Sch Med,Dept Gynecol Oncol, Changsha, Hunan, Peoples R China; [Jiang, Shuheng; Wang, Yahui; Zhang, Yanli; Hu, Lipeng; Yang, Qin; Li, Jun; Zhang, Zhigang] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China; [Zhao, Shujie] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Central South University; Shanghai Jiao Tong University; Nanjing Medical University	Zhang, ZG (corresponding author), Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China.	zzhang@shsci.org; ycteng@sjtu.edu.cn	Jiang, Shuheng/M-6584-2019	Jiang, Shuheng/0000-0001-8516-6234	National Natural Science Foundation of China [81372794, 81672565, 81502382]; Science and Technology Commission of Shanghai Municipality-Key Basic Research Foundation [13JC404502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality-Key Basic Research Foundation	We thank Dr. Xueli Zhang (State Key Laboratory for Oncogenes and Related Genes, Shanghai, China) for critical reading of manuscript; Experimental Animal Center of East China Normal University for animal feeding. This work was supported by grants from the National Natural Science Foundation of China (81372794; 81672565; 81502382), and the Science and Technology Commission of Shanghai Municipality-Key Basic Research Foundation (13JC404502).	Adamia S, 2013, CURR CANCER DRUG TAR, V13, P735, DOI 10.2174/15680096113139990083; Agerstam H, 2015, P NATL ACAD SCI USA, V112, P10786, DOI 10.1073/pnas.1422749112; Biewenga P, 2008, GYNECOL ONCOL, V108, P520, DOI 10.1016/j.ygyno.2007.11.024; Casey SC, 2015, SEMIN CANCER BIOL, V35, pS199, DOI 10.1016/j.semcancer.2015.02.007; Centers for Disease Control and Prevention, GLOB CANC STAT; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dai M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41404; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Feng Y, 2008, NAT STRUCT MOL BIOL, V15, P1040, DOI 10.1038/nsmb.1485; Gemma A, 2001, EUR J CANCER, V37, P1554, DOI 10.1016/S0959-8049(01)00154-X; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Gholamin S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf2968; Da Costa RMG, 2016, ANTICANCER RES, V36, P2073; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Iwata T, 2015, INT J CLIN ONCOL, V20, P126, DOI 10.1007/s10147-014-0680-8; Jabonowska- Fudziska D, 2014, PRZEGL LEK, V72, P103; Jensen LE, 2003, CELL SIGNAL, V15, P793, DOI 10.1016/S0898-6568(03)00039-1; Jensen LE, 2000, J IMMUNOL, V164, P5277, DOI 10.4049/jimmunol.164.10.5277; Jiang SH, 2017, GASTROENTEROLOGY, V153, P277, DOI 10.1053/j.gastro.2017.03.008; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kozlovski I, 2017, HUM GENET, V136, P1113, DOI 10.1007/s00439-017-1803-x; Landberg N, 2016, LEUKEMIA, V30, P253, DOI 10.1038/leu.2015.135; Li H, 2014, MOL CELL BIOL, V34, P2198, DOI 10.1128/MCB.01674-13; Liu R, 2017, ONCOTARGET, V8, P39021, DOI 10.18632/oncotarget.16547; Lo J, 2015, HEPATOLOGY, V62, P534, DOI 10.1002/hep.27859; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Mehta AM, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8913860; Munkley J, 2017, HUM GENET, V136, P1143, DOI 10.1007/s00439-017-1792-9; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Peng ZY, 2011, TUMOR BIOL, V32, P359, DOI 10.1007/s13277-010-0128-3; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Ryan M, 2016, NUCLEIC ACIDS RES, V44, pD1018, DOI 10.1093/nar/gkv1288; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Senapati R, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0107-4; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Tsai YS, 2015, ONCOTARGET, V6, P6825, DOI 10.18632/oncotarget.3145; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Waggoner SE, 2004, GYNAECOLOGIC CANC CO, P65; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wen SY, 2015, ONCOGENE, V34, P717, DOI 10.1038/onc.2014.9; WHO World Health Organization, HUM PAP HPV CERV CAN; Zeng DD, 2016, ONCOTARGET, V7, P83040, DOI 10.18632/oncotarget.13349; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Zhang R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44744; Zhang Wei, 2011, Zhejiang Da Xue Xue Bao Yi Xue Ban, V40, P540; Zhou XX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5581; Zhou XX, 2014, NUCLEIC ACIDS RES, V42, P4019, DOI 10.1093/nar/gkt1387	55	60	64	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2394	2409		10.1038/s41388-017-0119-6	http://dx.doi.org/10.1038/s41388-017-0119-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29429992	hybrid, Green Published			2022-12-26	WOS:000431386000004
J	Trillo-Muyo, S; Nilsson, HE; Recktenwald, CV; Ermund, A; Ridley, C; Meiss, LN; Bahr, A; Klymiuk, N; Wine, JJ; Koeck, PJB; Thornton, DJ; Hebert, H; Hansson, GC				Trillo-Muyo, Sergio; Nilsson, Harriet E.; Recktenwald, Christian V.; Ermund, Anna; Ridley, Caroline; Meiss, Lauren N.; Baehr, Andrea; Klymiuk, Nikolai; Wine, Jeffrey J.; Koeck, Philip J. B.; Thornton, David J.; Hebert, Hans; Hansson, Gunnar C.			Granule-stored MUC5B mucins are packed by the non-covalent formation of N-terminal head-to-head tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; GEL-FORMING-MUCIN; CYSTIC-FIBROSIS; SECRETION; RELEASE; MUCUS; BICARBONATE; PACKING; TUBULES; DOMAIN	Most MUC5B mucin polymers in the upper airways of humans and pigs are produced by submucosal glands. MUC5B forms N-terminal covalent dimers that are further packed into larger assemblies because of low pH and high Ca2+ in the secretory granule of the mucin-producing cell. We purified the recombinant MUC5B N-terminal covalent dimer and used single-particle electron microscopy to study its structure under intracellular conditions. We found that, at intragranular pH, the dimeric MUC5B organized into head-to-head noncovalent tetramers where the von Willebrand D1-D2 domains hooked into each other. These N-terminal tetramers further formed long linear complexes from which, we suggest, the mucin domains and their C termini project radially outwards. Using conventional and video microscopy, we observed that, upon secretion into the submucosal gland ducts, a flow of bicarbonate-rich fluid passes the mucin-secreting cells. We suggest that this unfolds and pulls out the MUC5B assemblies into long linear threads. These further assemble into thicker mucin bundles in the glandular ducts before emerging at the gland duct opening. We conclude that the combination of intracellular packing of the MUC5B mucin and the submucosal gland morphology creates an efficient machine for producing linear mucin bundles.	[Trillo-Muyo, Sergio; Nilsson, Harriet E.; Recktenwald, Christian V.; Ermund, Anna; Meiss, Lauren N.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Box 440, S-40530 Gothenburg, Sweden; [Nilsson, Harriet E.; Koeck, Philip J. B.; Hebert, Hans] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Nilsson, Harriet E.; Koeck, Philip J. B.; Hebert, Hans] KTH Royal Inst Technol, Sch Technol & Hlth, S-14157 Huddinge, Sweden; [Ridley, Caroline; Thornton, David J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Wellcome Trust Ctr Cell Matrix Res, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Baehr, Andrea; Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, Hackerstr 27, D-85764 Oberschleissheim, Germany; [Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA	University of Gothenburg; Karolinska Institutet; Royal Institute of Technology; University of Manchester; University of Munich; Stanford University	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, S-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019; Klymiuk, Nikolai/AAB-8345-2022; Koeck, Philip/AAG-5333-2020; Ermund, Anna/AAG-3160-2020	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Klymiuk, Nikolai/0000-0003-3532-1659; Nilsson, Harriet/0000-0001-7739-4405; Ridley, Caroline/0000-0002-5483-0320; Trillo-Muyo, Sergio/0000-0002-3135-9134; Recktenwald, Christian Viktor/0000-0003-1710-1863; Thornton, David/0000-0001-7148-1970; Ermund, Anna/0000-0002-3233-043X	Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Inga Britt and Arne Lundberg Foundation; Sahlgrenska University Hospital (ALF); Wilhelm and Martina Lundgren Foundation; NIAID, National Institutes of Health [U01AI095473]; Erica Lederhausen Foundation; Magnus Bergvall Foundation; Swedish Heart-Lung Foundation; Center for Innovative Medicine (Karolinska Institutet); Lederhausen Center for Cystic Fibrosis Research at the University of Gothenburg; Swedish Cystic Fibrosis Foundation; Cystic Fibrosis Foundation (CFFT) [Hansso14X0, Thornt077X0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga Britt and Arne Lundberg Foundation; Sahlgrenska University Hospital (ALF); Wilhelm and Martina Lundgren Foundation; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Erica Lederhausen Foundation; Magnus Bergvall Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Center for Innovative Medicine (Karolinska Institutet); Lederhausen Center for Cystic Fibrosis Research at the University of Gothenburg; Swedish Cystic Fibrosis Foundation; Cystic Fibrosis Foundation (CFFT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Swedish Research Council; the Swedish Cancer Foundation; the Knut and Alice Wallenberg Foundation; the Inga Britt and Arne Lundberg Foundation; Sahlgrenska University Hospital (ALF); the Wilhelm and Martina Lundgren Foundation; NIAID, National Institutes of Health Grant U01AI095473; the Erica Lederhausen Foundation; the Magnus Bergvall Foundation; the Swedish Heart-Lung Foundation; the Center for Innovative Medicine (Karolinska Institutet); the Lederhausen Center for Cystic Fibrosis Research at the University of Gothenburg; the Swedish Cystic Fibrosis Foundation; and the Cystic Fibrosis Foundation (CFFT, Hansso14X0, and Thornt077X0). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Anderson WH, 2015, AM J RESP CRIT CARE, V192, P182, DOI 10.1164/rccm.201412-2230OC; Ermund A, 2017, BIOCHEM BIOPH RES CO, V492, P331, DOI 10.1016/j.bbrc.2017.08.113; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; MEYRICK B, 1969, THORAX, V24, P729, DOI 10.1136/thx.24.6.729; Nilsson HE, 2014, J MOL BIOL, V426, P2567, DOI 10.1016/j.jmb.2014.04.027; Ostedgaard LS, 2017, P NATL ACAD SCI USA, V114, P6842, DOI 10.1073/pnas.1703228114; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Ridley C, 2014, J BIOL CHEM, V289, P16409, DOI 10.1074/jbc.M114.566679; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; SANDERSON MJ, 1981, J CELL SCI, V47, P331; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; Widdicombe JH, 2015, PHYSIOL REV, V95, P1241, DOI 10.1152/physrev.00039.2014; Zheng Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8858; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	26	34	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5746	5754		10.1074/jbc.RA117.001014	http://dx.doi.org/10.1074/jbc.RA117.001014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29440393	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000430044100033
J	Bogdan, D; Falcone, J; Kanjiya, MP; Park, SH; Carbonetti, G; Studholme, K; Gomez, M; Lu, Y; Elmes, MW; Smietalo, N; Yan, S; Ojima, I; Puopolo, M; Kaczocha, M				Bogdan, Diane; Falcone, Jerome; Kanjiya, Martha P.; Park, Sang Hoon; Carbonetti, Gregory; Studholme, Keith; Gomez, Maria; Lu, Yong; Elmes, Matthew W.; Smietalo, Norbert; Yan, Su; Ojima, Iwao; Puopolo, Michelino; Kaczocha, Martin			Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid binding protein; prostaglandin; inflammation; pain; NF-B; FABP; mPGES-1	PROLIFERATOR-ACTIVATED RECEPTORS; UNITED-STATES; CHRONIC PAIN; ENDOPLASMIC-RETICULUM; NUCLEAR RECEPTORS; E-2 PRODUCTION; MICE LACKING; OPIOID USE; EXPRESSION; PREVALENCE	Fatty acid-binding proteins (FABPs) are intracellular lipid carriers that regulate inflammation, and pharmacological inhibition of FABP5 reduces inflammation and pain. The mechanism(s) underlying the anti-inflammatory effects associated with FABP5 inhibition is poorly understood. Herein, we identify a novel mechanism through which FABP5 modulates inflammation. In mice, intraplantar injection of carrageenan induces acute inflammation that is accompanied by edema, enhanced pain sensitivity, and elevations in proinflammatory cytokines and prostaglandin E-2 (PGE(2)). Inhibition of FABP5 reduced pain, edema, cytokine, and PGE(2) levels. PGE(2) is a major eicosanoid that enhances pain in the setting of inflammation, and we focused on the mechanism(s) through which FABP5 modulates PGE(2) production. Cyclooxygenase 2 (COX-2) and microsomal prostaglandin E synthase 1 (mPGES-1) are enzymes up-regulated at the site of inflammation and account for the bulk of PGE(2) biosynthesis. Pharmacological or genetic FABP5 inhibition suppressed the induction of mPGES-1 but not COX-2 in carrageenan-injected paws, which occurred predominantly in macrophages. The cytokine interleukin 1 (IL-1) is a major inducer of mPGES-1 during inflammation. Using A549 cells that express FABP5, IL-1 stimulation up-regulated mPGES-1 expression, and mPGES-1 induction was attenuated in A549 cells bearing a knockdown of FABP5. IL-1 up-regulates mPGES-1 via NF-B, which activates the mPGES-1 promoter. Knockdown of FABP5 reduced the activation and nuclear translocation of NF-B and attenuated mPGES-1 promoter activity. Deletion of NF-B-binding sites within the mPGES-1 promoter abrogated the ability of FABP5 to inhibit mPGES-1 promoter activation. Collectively, these results position FABP5 as a novel regulator of mPGES-1 induction and PGE(2) biosynthesis during inflammation.	[Bogdan, Diane; Falcone, Jerome; Kanjiya, Martha P.; Park, Sang Hoon; Studholme, Keith; Gomez, Maria; Lu, Yong; Smietalo, Norbert; Puopolo, Michelino; Kaczocha, Martin] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Carbonetti, Gregory; Elmes, Matthew W.; Kaczocha, Martin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Yan, Su; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Yan, Su; Ojima, Iwao; Kaczocha, Martin] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Carbonetti, Gregory; Elmes, Matthew W.] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.; Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.; Kaczocha, M (corresponding author), SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	Martin.Kaczocha@Stonybrook.edu	Yan, Su/J-6988-2019	Yan, Su/0000-0002-9961-471X; Ojima, Iwao/0000-0002-3628-1161; studholme, keith/0000-0002-0037-514X; Falcone, Jerome/0000-0002-0672-1226	National Institutes of Health [DA035949, DA035923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035923, R01DA035949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01 (COX-1 and COX-2, respectively) followed by microsomal DA035949 and DA035923 (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Campbell G, 2015, PAIN MED, V16, P1745, DOI 10.1111/pme.12773; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Catley MC, 2003, FEBS LETT, V547, P75, DOI 10.1016/S0014-5793(03)00672-0; Chen LH, 2013, PROSTAG OTH LIPID M, V104, P58, DOI 10.1016/j.prostaglandins.2012.08.006; Dallaglio K, 2013, EXP DERMATOL, V22, P255, DOI 10.1111/exd.12111; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Deckmann K, 2010, BIOCHEM PHARMACOL, V80, P1365, DOI 10.1016/j.bcp.2010.07.032; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; GARRY MG, 1992, BRAIN RES, V582, P139, DOI 10.1016/0006-8993(92)90328-7; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Guay J, 2004, J BIOL CHEM, V279, P24866, DOI 10.1074/jbc.M403106200; Han R, 2002, J BIOL CHEM, V277, P16355, DOI 10.1074/jbc.M111246200; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Helledie T, 2000, J LIPID RES, V41, P1740; Hui XY, 2010, J BIOL CHEM, V285, P10273, DOI 10.1074/jbc.M109.097907; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Kaczocha M, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0056-8; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kane CD, 1996, BIOCHEMISTRY-US, V35, P2894, DOI 10.1021/bi952476e; Krug LT, 2007, PLOS PATHOG, V3, P97, DOI 10.1371/journal.ppat.0030011; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Leclerc P, 2013, PROSTAG OTH LIPID M, V107, P26, DOI 10.1016/j.prostaglandins.2013.09.001; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Mendez M, 2003, HYPERTENSION, V42, P844, DOI 10.1161/01.HYP.0000085332.69777.D1; Miller RE, 2014, CYTOKINE, V70, P185, DOI 10.1016/j.cyto.2014.06.019; Naraba H, 2002, J BIOL CHEM, V277, P28601, DOI 10.1074/jbc.M203618200; Noma T, 2016, BIOCHEM PHARMACOL, V116, P120, DOI 10.1016/j.bcp.2016.07.014; Ogawa E, 2011, J INVEST DERMATOL, V131, P604, DOI 10.1038/jid.2010.342; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Palmer RE, 2015, PAIN, V156, P1208, DOI 10.1097/j.pain.0000000000000145; Patel KV, 2013, PAIN, V154, P2649, DOI 10.1016/j.pain.2013.07.029; Peng XX, 2017, MOL PAIN, V13, DOI 10.1177/1744806917697007; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Schou WS, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0741-2; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sostres C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4175; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; Wobst I, 2008, BIOCHEM PHARMACOL, V76, P62, DOI 10.1016/j.bcp.2008.04.008; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang YW, 2015, IMMUNITY, V42, P953, DOI 10.1016/j.immuni.2015.04.016	51	30	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5295	5306		10.1074/jbc.RA118.001593	http://dx.doi.org/10.1074/jbc.RA118.001593			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440395	hybrid, Green Published			2022-12-26	WOS:000429409300033
J	Galizzi, N; Galli, L; Poli, A; Gianotti, N; Carini, E; Bigoloni, A; Tambussi, G; Nozza, S; Lazzarin, A; Castagna, A; Mancusi, D; Termini, R				Galizzi, Nadia; Galli, Laura; Poli, Andrea; Gianotti, Nicola; Carini, Elisabetta; Bigoloni, Alba; Tambussi, Giuseppe; Nozza, Silvia; Lazzarin, Adriano; Castagna, Antonella; Mancusi, Daniela; Termini, Roberta			Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load	PLOS ONE			English	Article							CLINICAL-PRACTICE; TENOFOVIR; NAIVE; EMTRICITABINE; EFAVIRENZ; REGIMEN; PHASE-3; THRIVE; TRIAL; ECHO	Introduction A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sparing of tenofovir and protease inhibitors. However, data on use of this combination as a strategy of switch are limited. Aims of the study were to assess the long-term efficacy and safety of this regimen. Methods Retrospective study on HIV-1 infected patients followed at the Infectious Disease Department of the San Raffaele Scientific Institute, HBsAg-negative, HLA B5701-negative, with no documented resistance to RPV, ABC and 3TC, with HIV-RNA<50 copies/mL who started RPV plus ABC/3TC from March 2013 to September 2015. The primary outcome was durability [no treatment failure (TF)]. Secondary objectives were to evaluate changes in immunological, metabolic and other safety parameters. TF was defined as the occurrence of virological failure (VF, 2 consecutive values >50 copies/mL) or discontinuation of any drug in the regimen for any reason. Patients' follow-up accrued from the date of RPV plus ABC/3TC initiation to the date of TF (VF or discontinuation of any drug in the regimen) or to the date of last available visit. Time to TF was evaluated by use of the Kaplan-Meier curves. Mixed linear models were applied to evaluate changes in immunological, metabolic and other safety parameters. Results and discussion In this analysis, 100 patients starting RPV plus ABC/3TC were included. By 12, 24 and 36 months after switching to RPV plus ABC/3TC, the proportions of individuals without TF were 88% [95% confidence interval (CI): 79%-93%], 82% (95% CI: 73%-89%) and 78% (95% CI: 68%-86%), respectively. Time to TF was not significantly influenced by CD4+ nadir (<= 200 vs >200 cells/mu l; log-rank test: p = 0.311) or pre-ART viral load (< 100000 vs >= 100000 copies/mL; log-rank test: p = 0.574) or the type of previous antiretroviral regimen ( PI+2NRTIs vs NNRTI+2NRTIs vs Other; log-rank test: p = 0.942). Over a median follow-up of 2.9 years ( IQR: 1.9 +/- 3.5), 26 subjects discontinued the treatment [10 due to toxicity, 7 for interactions with other drugs, 3 due to cardiovascular risk concern, 2 due to single viral blip, 1 due to VF, 1 for asthma, 1 patient's decision, 1 due to enrolment in a study protocol]. Conclusions In this retrospective study, long-term use of RPV plus ABC/3TC regimen is effective and safe. Efficacy of this regimen was not found to be affected by low CD4+ nadir or high preART viral load.	[Galizzi, Nadia; Galli, Laura; Poli, Andrea; Gianotti, Nicola; Carini, Elisabetta; Bigoloni, Alba; Tambussi, Giuseppe; Nozza, Silvia; Lazzarin, Adriano; Castagna, Antonella] IRCCS San Raffaele, Infect Dis, Milan, Italy; [Galizzi, Nadia; Lazzarin, Adriano; Castagna, Antonella] Univ Vita Salute San Raffaele, Milan, Italy; [Mancusi, Daniela; Termini, Roberta] Janssen Cilag SpA, Med Affairs, Cologno Monzese Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Johnson & Johnson; Janssen Pharmaceuticals	Galizzi, N (corresponding author), IRCCS San Raffaele, Infect Dis, Milan, Italy.; Galizzi, N (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	galizzi.nadia@hsr.it	Galli, Laura/B-1161-2016; Bigoloni, Alba/AAO-4767-2020; Castagna, Antonella/K-3280-2018; NOZZA, SILVIA/AAC-5445-2022; LAZZARIN, Adriano/K-3607-2018	Castagna, Antonella/0000-0002-8338-9714; LAZZARIN, Adriano/0000-0003-2551-7754; Tambussi, Giuseppe/0000-0002-0604-2960; Galli, Laura/0000-0001-8046-0290; Gianotti, Nicola/0000-0002-7182-5080	Jansen-Cilag Spa [TMC278HTX4002]	Jansen-Cilag Spa	The TMC278HTX4002 has been supported by Jansen-Cilag Spa (http://www.janssen.com/italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [DM, RT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors have been articulated in the 'author contributions' section.	Amiel C, 2014, J ANTIMICROB CHEMOTH, V69, P3335, DOI 10.1093/jac/dku294; Bernaud C, 2016, INFECT DIS-NOR, V48, P754, DOI 10.1080/23744235.2016.1194528; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Curran A, 2016, J ANTIMICROB CHEMOTH, V71, P3510, DOI 10.1093/jac/dkw347; Gianotti N, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20037; Lapadula G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162320; Casado JL, 2014, AIDS REV, V16, P172; Marshall N, 2016, HIV MED, V17, P19; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Nelson MR, 2013, HIV CLIN TRIALS, V14, P81, DOI 10.1310/hct1403-81; Palacios R, 2016, EUR J CLIN MICROBIOL, V35, P815, DOI 10.1007/s10096-016-2602-3; Troya J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164455; Wang H, 2016, INT J ELECTROCHEM, V2016, DOI 10.1155/2016/4261012; Yombi JC, 2014, AIDS, V28, P621, DOI 10.1097/QAD.0000000000000103	14	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0191300	10.1371/journal.pone.0191300	http://dx.doi.org/10.1371/journal.pone.0191300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451870	gold, Green Submitted, Green Published			2022-12-26	WOS:000425369800003
J	Arama, C; Diarra, I; Kouriba, B; Sirois, F; Fedoryak, O; Thera, MA; Coulibaly, D; Lyke, KE; Plowe, CV; Chretien, M; Doumbo, OK; Mbikay, M				Arama, Charles; Diarra, Issa; Kouriba, Bourema; Sirois, Francine; Fedoryak, Olesya; Thera, Mahamadou A.; Coulibaly, Drissa; Lyke, Kirsten E.; Plowe, Christopher V.; Chretien, Michel; Doumbo, Ogobara K.; Mbikay, Majambu			Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-ARTERY-DISEASE; SUBTILISIN/KEXIN TYPE 9; PLASMA LDL CHOLESTEROL; PROPROTEIN CONVERTASES; AFRICAN POPULATION; HEART-DISEASE; MUTATIONS; PROTEIN; INFLAMMATION	Aim Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a hepatic secretory protein which promotes the degradation of low-density lipoprotein receptors leading to reduced hepatic uptake of plasma cholesterol. Non-synonymous single-nucleotide polymorphisms in its gene have been linked to hypo-or hyper-cholesterolemia, depending on whether they decrease or increase PCSK9 activity, respectively. Since the proliferation and the infectivity of Plasmodium spp. partially depend on cholesterol from the host, we hypothesize that these PCSK9 genetic polymorphisms could influence the course of malaria infection in individuals who carry them. Here we examined the frequency distribution of one dominant (C679X) and two recessive (A443T, I474V) hypocholesterolemic polymorphisms as well as that of one recessive hypercholesterolemic polymorphism (E670G) among healthy and malaria-infected Malian children. Methods Dried blood spots were collected in Bandiagara, Mali, from 752 age, residence and ethnicity-matched children: 253 healthy controls, 246 uncomplicated malaria patients and 253 severe malaria patients. Their genomic DNA was extracted and genotyped for the above PCSK9 polymorphisms using Taqman assays. Associations of genotype distributions and allele frequencies with malaria were evaluated. Results The minor allele frequency of the A443T, I474V, E670G, and C679X polymorphisms in the study population sample was 0.12, 0.20, 0.26, and 0.02, respectively. For each polymorphism, the genotype distribution among the three health conditions was statistically insignificant, but for the hypercholesterolemic E670G polymorphism, a trend towards association of the minor allele with malaria severity was observed (P = 0.035). The association proved to be stronger when allele frequencies between healthy controls and severe malaria cases were compared (Odd Ratio: 1.34; 95% Confidence Intervals: 1.04-1.83); P = 0.031). Conclusions Carriers of the minor allele of the E670G PCSK9 polymorphism might be more susceptible to severe malaria. Further investigation of the cholesterol regulating function of PCSK9 in the pathophysiology of malaria is needed.	[Arama, Charles; Diarra, Issa; Kouriba, Bourema; Thera, Mahamadou A.; Coulibaly, Drissa; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Int Ctr Excellence Res, Malaria Res & Training Ctr, Bamako, Mali; [Sirois, Francine; Fedoryak, Olesya; Chretien, Michel; Mbikay, Majambu] Inst Rech Clin Montreal, Lab Proteolyse Fonct, Montreal, PQ, Canada; [Lyke, Kirsten E.; Plowe, Christopher V.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Inst Global Hlth, Baltimore, MD 21201 USA; [Lyke, Kirsten E.; Plowe, Christopher V.] Univ Maryland, Sch Med, Div Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA; [Chretien, Michel; Mbikay, Majambu] Ottawa Hosp, Res Hosp, Chron Dis Program, Ottawa, ON, Canada; [Chretien, Michel; Mbikay, Majambu] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Science & Technology of Bamako; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Doumbo, OK (corresponding author), Univ Sci Tech & Technol Bamako, Int Ctr Excellence Res, Malaria Res & Training Ctr, Bamako, Mali.; Mbikay, M (corresponding author), Inst Rech Clin Montreal, Lab Proteolyse Fonct, Montreal, PQ, Canada.; Mbikay, M (corresponding author), Ottawa Hosp, Res Hosp, Chron Dis Program, Ottawa, ON, Canada.; Mbikay, M (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	okd@icermali.org; majambu.mbikay@ircm.qc.ca	MBIKAY, Majambu/ABF-8356-2020	Thera, Mahamadou A/0000-0002-2679-035X; CHRETIEN, Michel/0000-0002-8588-4460	Institut Merieux; Richard and Edith Strauss Foundation; National Institute of Allergy and Infectious Diseases [N01AI85346, U19AI065683]; Fogarty International Center, National Institutes of Health, USA [D43TW001589]	Institut Merieux; Richard and Edith Strauss Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by grants from the Institut Merieux (www.institut-merieux.com) as well as the Richard and Edith Strauss Foundation to MC. The Bandiagara case/control study was supported by a contract N01AI85346 and a cooperative agreement U19AI065683 from the National Institute of Allergy and Infectious Diseases and grant D43TW001589 to OKD from the Fogarty International Center, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Anderson JM, 2014, J CLIN LIPIDOL, V8, P256, DOI 10.1016/j.jacl.2014.02.008; Baass A, 2009, CLIN CHEM, V55, P1637, DOI 10.1373/clinchem.2009.126987; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Brown WV, 2016, J CLIN LIPIDOL, V10, P5, DOI 10.1016/j.jacl.2015.12.004; Cai GJ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0154-7; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Dieye Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1965; Ding KY, 2008, PHARMACOGENET GENOM, V18, P169, DOI 10.1097/FPC.0b013e3282f44d99; Dormoi J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-302; Dwivedi DJ, 2016, SHOCK, V46, P672, DOI 10.1097/SHK.0000000000000682; Evans D, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-66; Everett BM, 2015, NEW ENGL J MED, V373, P1588, DOI 10.1056/NEJMp1508120; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Frankland S, 2006, EUKARYOT CELL, V5, P849, DOI 10.1128/EC.5.5.849-860.2006; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kumar GA, 2016, CHEM PHYS LIPIDS, V199, P179, DOI 10.1016/j.chemphyslip.2016.02.007; Labaied M, 2011, CELL MICROBIOL, V13, P569, DOI 10.1111/j.1462-5822.2010.01555.x; Lyke KE, 2003, AM J TROP MED HYG, V69, P253, DOI 10.4269/ajtmh.2003.69.253; Marijon E, 2007, J HUM HYPERTENS, V21, P411, DOI 10.1038/sj.jhh.1002146; Mayne J, 2007, BIOCHEM BIOPH RES CO, V361, P451, DOI 10.1016/j.bbrc.2007.07.029; Mayne J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-70; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; Mbikay M, 2007, MED HYPOTHESES, V69, P1010, DOI 10.1016/j.mehy.2007.03.018; Mbikay M, 2013, J DIABETES, V5, P391, DOI 10.1111/1753-0407.12064; MILLER M, 1992, CIRCULATION, V86, P1165, DOI 10.1161/01.CIR.86.4.1165; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Morin PA, 1999, BIOTECHNIQUES, V27, P538, DOI 10.2144/99273rr02; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sirois F, 2008, GENET TEST, V12, P377, DOI 10.1089/gte.2008.0013; Souraud JB, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-13; Sviridov D, 2014, CURR OPIN LIPIDOL, V25, P333, DOI 10.1097/MOL.0000000000000106; Tsai CW, 2015, J CLIN ENDOCR METAB, V100, pE345, DOI 10.1210/jc.2014-3340; Visser BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-442; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; World Health Organization, 2015, GUID TREATM MAL, Vthird; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	46	11	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192850	10.1371/journal.pone.0192850	http://dx.doi.org/10.1371/journal.pone.0192850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447211	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900061
J	Chen, KYH; Messina, N; Germano, S; Bonnici, R; Freyne, B; Cheung, M; Goldsmith, G; Kollmann, TR; Levin, M; Burgner, D; Curtis, N				Chen, Katherine Y. H.; Messina, Nicole; Germano, Susie; Bonnici, Rhian; Freyne, Bridget; Cheung, Michael; Goldsmith, Greta; Kollmann, Tobias R.; Levin, Michael; Burgner, David; Curtis, Nigel			Innate immune responses following Kawasaki disease and toxic shock syndrome	PLOS ONE			English	Article							CORONARY-ARTERY LESIONS; INFLAMMASOME ACTIVATION; CHILDREN; POLYMORPHISM; ASSOCIATION; MECHANISMS; MANAGEMENT; DIAGNOSIS; PARENTS; CELLS	The pathogenesis of Kawasaki disease (KD) remains unknown and there is accumulating evidence for the importance of the innate immune system in initiating and mediating the host inflammatory response. We compared innate immune responses in KD and toxic shock syndrome (TSS) participants more than two years after their acute illness with control participants to investigate differences in their immune phenotype. Toxic shock syndrome shares many clinical features with KD; by including both disease groups we endeavoured to explore changes in innate immune responses following acute inflammatory illnesses more broadly. We measured the in vitro production of interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6, IL-1 receptor antagonist (IL-1ra), and IL-10 following whole blood stimulation with toll-like receptor and inflammasome ligands in 52 KD, 20 TSS, and 53 control participants in a case-control study. Analyses were adjusted for age, sex, and unstimulated cytokine concentrations. Compared to controls, KD participants have reduced IL-1ra production in response to stimulation with double stranded RNA (geometric mean ratio (GMR) 0.37, 95% CI 0.15, 0.89, p = 0.03) and increased IL-6 production in response to incubation with Lyovec (TM) (GMR 5.48, 95% CI 1.77, 16.98, p = 0.004). Compared to controls, TSS participants have increased IFN-gamma production in response to peptidoglycan (GMR 4.07, 95% CI 1.82, 9.11, p = 0.001), increased IL-1 beta production to lipopolysaccharide (GMR 1.64, 95% CI 1.13, 2.38, p = 0.01) and peptidoglycan (GMR 1.61, 95% CI 1.11, 2.33, p = 0.01), and increased IL-6 production to peptidoglycan (GMR 1.45, 95% CI 1.10, 1.92, p = 0.01). Years following the acute illness, individuals with previous KD or TSS exhibit a pro-inflammatory innate immune phenotype suggesting a possible underlying immunological susceptibility or innate immune memory.	[Chen, Katherine Y. H.; Messina, Nicole; Germano, Susie; Bonnici, Rhian; Freyne, Bridget; Burgner, David; Curtis, Nigel] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Chen, Katherine Y. H.; Freyne, Bridget; Burgner, David; Curtis, Nigel] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Chen, Katherine Y. H.; Freyne, Bridget; Curtis, Nigel] Royal Childrens Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Chen, Katherine Y. H.; Freyne, Bridget; Curtis, Nigel] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic, Australia; [Cheung, Michael; Goldsmith, Greta] Royal Childrens Hosp, Murdoch Childrens Res Inst, Heart Res Grp, Melbourne, Vic, Australia; [Cheung, Michael; Goldsmith, Greta] Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic, Australia; [Kollmann, Tobias R.] Univ British Columbia, Div Infect Dis, Dept Pediat, Vancouver, BC, Canada; [Levin, Michael] Imperial Coll London, Div Med, Paediat Infect Dis Grp, London, England; [Burgner, David] Monash Univ, Dept Paediat, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of British Columbia; Imperial College London; Monash University	Curtis, N (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Curtis, N (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.; Curtis, N (corresponding author), Royal Childrens Hosp, Infect Dis Unit, Melbourne, Vic, Australia.; Curtis, N (corresponding author), Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic, Australia.	nigel.curtis@rch.org.au		Kollmann, Tobias/0000-0003-2403-9762; Freyne, Bridget/0000-0002-9542-1582; Messina, Nicole/0000-0001-8404-4462; Levin, Michael/0000-0003-2767-6919	Australian Government Research Training Program scholarship from The University of Melbourne; Postgraduate Health Research Scholarship from Murdoch Children's Research Institute; National Health and Medical Research Council (NHMRC) Senior Research Fellowship [APP1064629]; National Heart Foundation Future Leader Fellowship [100369]; NHMRC [1064408]; Victorian Government's Operational Infrastructure Support Program; Royal Children's Hospital Foundation [RCH1000]; Big W; Jam and Jelly Foundation	Australian Government Research Training Program scholarship from The University of Melbourne; Postgraduate Health Research Scholarship from Murdoch Children's Research Institute; National Health and Medical Research Council (NHMRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Future Leader Fellowship(National Heart Foundation of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Royal Children's Hospital Foundation; Big W; Jam and Jelly Foundation	KYHC holds an Australian Government Research Training Program scholarship from The University of Melbourne and a Postgraduate Health Research Scholarship from Murdoch Children's Research Institute. DB holds a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1064629) and an honorary National Heart Foundation Future Leader Fellowship (100369). NC is an investigator on NHMRC project grant 1064408. Research at Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. The Heart Research Group is supported by The RCH1000, The Royal Children's Hospital Foundation and Big W. The authors also wish to thank Jam and Jelly Foundation for their financial support for this research. These entities had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; or decision to submit the manuscript for publication.	Alphonse MP, 2016, J IMMUNOL, V197, P3481, DOI 10.4049/jimmunol.1600388; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Biezeveld MH, 2006, ARTHRITIS RHEUM-US, V54, P369, DOI 10.1002/art.21529; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Burns JC, 2017, ARTHRITIS RHEUMATOL, V69, P268, DOI 10.1002/art.39975; FUJITA Y, 1989, PEDIATRICS, V84, P666; FURUKAWA S, 1992, ARCH DIS CHILD, V67, P706, DOI 10.1136/adc.67.6.706; Hara T, 2016, CLIN EXP IMMUNOL, V186, P134, DOI 10.1111/cei.12832; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Huang YH, 2017, ONCOTARGET, V8, P11249, DOI 10.18632/oncotarget.14497; Jansen K, 2008, J IMMUNOL METHODS, V336, P183, DOI 10.1016/j.jim.2008.04.013; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kum WWS, 2001, INFECT IMMUN, V69, P7544, DOI 10.1128/IAI.69.12.7544-7549.2001; Lee Y, 2012, CIRCULATION, V125, P1542, DOI 10.1161/CIRCULATIONAHA.111.072769; Lin MT, 2011, PEDIATR INFECT DIS J, V30, P148, DOI 10.1097/INF.0b013e3181f43a4e; Llewelyn M, 2002, LANCET INFECT DIS, V2, P156, DOI 10.1016/S1473-3099(02)00222-0; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; Luan YY, 2014, J INTERF CYTOK RES, V34, P2, DOI 10.1089/jir.2013.0042; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Newburger JW, 2016, J AM COLL CARDIOL, V67, P1738, DOI 10.1016/j.jacc.2015.12.073; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Ogawa S, 2014, CIRC J, V78, P2521, DOI 10.1253/circj.CJ-66-0096; Onouchi Y, 2013, PHARMACOGENOMICS J, V13, P52, DOI 10.1038/tpj.2011.45; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145486; Orenstein JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038998; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Tremoulet AH, 2016, CONTEMP CLIN TRIALS, V48, P70, DOI 10.1016/j.cct.2016.04.002; Uehara R, 2004, ARCH PEDIAT ADOL MED, V158, P1166, DOI 10.1001/archpedi.158.12.1166; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Weng KP, 2010, CIRC J, V74, P544, DOI 10.1253/circj.CJ-09-0664; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Ye F, 2004, AM J CARDIOL, V94, P840, DOI 10.1016/j.amjcard.2004.05.076; Yim D, 2010, PEDIATR CARDIOL, V31, P1232, DOI 10.1007/s00246-010-9771-0; Yu Kyunghee, ANN LAB MED, V43, P120, DOI [10.3343/alm.2023.43.1.120, DOI 10.3343/ALM.2023.43.1.120, DOI 10.3343/ALM.2015.35.1.89]; Zhang YL, 2014, J PLANT ECOL, V7, P10, DOI 10.1093/jpe/rtt025	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191830	10.1371/journal.pone.0191830	http://dx.doi.org/10.1371/journal.pone.0191830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447181	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900019
J	Tanuseputro, P; Beach, S; Chalifoux, M; Wodchis, WP; Hsu, AT; Seow, H; Manuel, DG				Tanuseputro, Peter; Beach, Sarah; Chalifoux, Mathieu; Wodchis, Walter P.; Hsu, Amy T.; Seow, Hsien; Manuel, Douglas G.			Associations between physician home visits for the dying and place of death: A population-based retrospective cohort study	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE CARE; CANCER-PATIENTS; PEOPLE DIE; SITE; DETERMINANTS; INVOLVEMENT; HOSPICE	Background While most individuals wish to die at home, the reality is that most will die in hospital. Aim To determine whether receiving a physician home visit near the end-of-life is associated with lower odds of death in a hospital. Design Observational retrospective cohort study, examining location of death and health care in the last year of life. Setting/Participants Population-level study of Ontarians, a Canadian province with over 13 million residents. All decedents from April 1, 2010 to March 31, 2013 (n = 264,754) Results More than half of 264,754 decedents died in hospital: 45.7% died in an acute care hospital and 7.7% in complex continuing care. After adjustment for multiple factors-including patient illness, home care services, and days of being at home-receiving at least one physician home visit from anon-palliative care physician was associated with a 47% decreased odds (odds-ratio, 0.53; 95% CI: 0.51-0.55) of dying in a hospital. When a palliative care physician specialist was involved, the overall odds declined by 59% (odds ratio, 0.41; 95% CI: 0.39-0.43). The same model, adjusting for physician home visits, showed that receiving palliative home care was associated with a similar reduction (odds ratio, 0.49; 95% CI: 0.47-0.51). Conclusion Location of death is strongly associated with end-of-life health care in the home. Less than one-third of the population, however, received end-of-life home care or a physician visit in their last year of life, revealing large room for improvement.	[Tanuseputro, Peter; Manuel, Douglas G.] Bruyere Res Inst, Ottawa, ON, Canada; [Tanuseputro, Peter; Beach, Sarah; Hsu, Amy T.; Manuel, Douglas G.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Tanuseputro, Peter] Univ Ottawa, Div Palliat Care, Dept Med, Ottawa, ON, Canada; [Tanuseputro, Peter; Chalifoux, Mathieu; Wodchis, Walter P.; Hsu, Amy T.; Seow, Hsien; Manuel, Douglas G.] Inst Clin Evaluat Sci Populat Hlth & Primary Care, Ottawa, ON, Canada; [Wodchis, Walter P.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Seow, Hsien] McMaster Univ, Dept Oncol, Hamilton, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; McMaster University	Tanuseputro, P (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.; Tanuseputro, P (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Tanuseputro, P (corresponding author), Univ Ottawa, Div Palliat Care, Dept Med, Ottawa, ON, Canada.; Tanuseputro, P (corresponding author), Inst Clin Evaluat Sci Populat Hlth & Primary Care, Ottawa, ON, Canada.	peter.tanuseputro@mail.utoronto.ca	Seow, Hsien/AAQ-1438-2021; Manuel, Doug/D-7100-2014	Seow, Hsien/0000-0001-6701-1714; Beach, Sarah/0000-0002-4660-0509; wodchis, walter/0000-0003-2494-7031; Tanuseputro, Peter/0000-0002-4409-0795; Manuel, Doug/0000-0003-0912-0845	Ontario Ministry of Health and Long Term Care (MOHLTC) [06034]; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC; Bruyere Research Institute	Ontario Ministry of Health and Long Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC; Bruyere Research Institute	This research was supported by a research grant from the Ontario Ministry of Health and Long Term Care (MOHLTC) to the Health System Performance Research Network Grant (HSPRN #06034). This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario MOHLTC. PT is supported through the Bruyere Research Institute. The views expressed in this paper are the views of the authors and do not necessarily reflect those of the funder. The funders had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Aabom B, 2005, BRIT J GEN PRACT, V55, P684; Aabom B, 2005, J CLIN ONCOL, V23, P7411, DOI 10.1200/JCO.2005.16.493; Aabom B, 2006, PALLIATIVE MED, V20, P507, DOI 10.1191/0269216306pm1169oa; Ahmad S, 2005, QJM-INT J MED, V98, P865, DOI 10.1093/qjmed/hci138; [Anonymous], 2015, HIGHL NAT PALL MED S; Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Barbera L, 2015, CMAJ OPEN, V3; Barbera L, 2015, J ONCOL PRACT, V11, pE279, DOI 10.1200/JOP.2015.004416; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Blackmore S., 2011, PREDICTING DEATH EST; Bluebond-Langner M, 2013, PALLIATIVE MED, V27, P705, DOI 10.1177/0269216313483186; Brazil K, 2005, PALLIATIVE MED, V19, P492, DOI 10.1191/0269216305pm1050oa; Broad JB, 2013, INT J PUBLIC HEALTH, V58, P257, DOI 10.1007/s00038-012-0394-5; Costa V, 2014, Ont Health Technol Assess Ser, V14, P1; Fowler R, 2013, CLIN INVEST MED, V36, pE127; Fukui S, 2011, ANN ONCOL, V22, P2113, DOI 10.1093/annonc/mdq719; Fukui S, 2011, J PAIN SYMPTOM MANAG, V42, P882, DOI 10.1016/j.jpainsymman.2011.02.024; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Georghiou T, 2014, EXPLORING COSTS CARE, P1; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Goodridge D, 2010, RURAL REMOTE HEALTH, V10; House of Commons Public Accounts Committee, 2009, 19 HOUS COMM PUBL AC; Jayaraman J, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-19; Kimura T, 2015, GERIATR GERONTOL INT, V15, P465, DOI 10.1111/ggi.12297; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Menec V., 2004, PATTERNS HLTH CARE U; MOR V, 1983, J HEALTH SOC BEHAV, V24, P375, DOI 10.2307/2136403; Muggah E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-452; Nakamura S, 2010, GERIATR GERONTOL INT, V10, P154, DOI 10.1111/j.1447-0594.2009.00570.x; Neergaard MA, 2009, BRIT J GEN PRACT, V59, P671, DOI 10.3399/bjgp09X454133; Ontario Medical Association, 2014, PALL CAR BACKGR OMAS; Reich O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-116; Remington R, 2010, J GERONTOL NURS, V36, P16, DOI 10.3928/00989134-20100730-06; Seow H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3496; Statistics Canada, 2014, TABL 102 0540 DEATHS; Statistics Canada, 2013, TABL 102 0509 DEATHS; Tang ST, 2001, CANCER INVEST, V19, P165, DOI 10.1081/CNV-100000151; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Unwin BK, 2011, AM FAM PHYSICIAN, V83, P925	41	41	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191322	10.1371/journal.pone.0191322	http://dx.doi.org/10.1371/journal.pone.0191322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447291	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900012
J	Funkhouser, JA; Mayhew, JA; Mulcahy, JB				Funkhouser, Jake A.; Mayhew, Jessica A.; Mulcahy, John B.			Social network and dominance hierarchy analyses at Chimpanzee Sanctuary Northwest	PLOS ONE			English	Article							RELATIONSHIP QUALITY; WILD CHIMPANZEES; STEEPNESS; LINEARITY; STABILITY; BEHAVIOR; WELFARE	Different aspects of sociality bear considerable weight on the individual- and group-level welfare of captive nonhuman primates. Social Network Analysis (SNA) is a useful tool for gaining a holistic understanding of the dynamic social relationships of captive primate groups. Gaining a greater understanding of captive chimpanzees through investigations of centrality, preferred and avoided relationships, dominance hierarchy, and social network diagrams can be useful in advising current management practices in sanctuaries and other captive settings. In this study, we investigated the dyadic social relationships, group-level social networks, and dominance hierarchy of seven chimpanzees (Pan troglodytes) at Chimpanzee Sanctuary Northwest. We used focal-animal and instantaneous scan sampling to collect 106.75 total hours of associative, affiliative, and agonistic data from June to September 2016. We analyzed our data using SOCPROG to derive dominance hierarchies and network statistics, and we diagrammed the group's social networks in NetDraw. Three individuals were most central in the grooming network, while two others had little connection. Through agonistic networks, we found that group members reciprocally exhibited agonism, and the group's dominance hierarchy was statistically non-linear. One chimpanzee emerged as the most dominant through agonism but was least connected to other group members across affiliative networks. Our results indicate that the conventional methods used to calculate individuals' dominance rank may be inadequate to wholly depict a group's social relationships in captive sanctuary populations. Our results have an applied component that can aid sanctuary staff in a variety of ways to best ensure the improvement of group welfare.	[Funkhouser, Jake A.; Mayhew, Jessica A.; Mulcahy, John B.] Cent Washington Univ, Primate Behav & Ecol Program, Ellensburg, WA 98926 USA; [Mayhew, Jessica A.; Mulcahy, John B.] Cent Washington Univ, Dept Anthropol & Museum Studies, Ellensburg, WA USA; [Mulcahy, John B.] Chimpanzee Sanctuary Northwest, Cle Elum, WA USA	Central Washington University; Central Washington University	Funkhouser, JA (corresponding author), Cent Washington Univ, Primate Behav & Ecol Program, Ellensburg, WA 98926 USA.	funkhousej@cwu.edu			Central Washington University College of the Sciences SURE fellowship JAF; Central Washington University Department of Anthropology and Museum Studies Pete and Sandra Barlow Award; CWU's Department of Anthropology and Museum Studies; Debra and Arlen Prentice Award through the CWU Primate Behavior Program	Central Washington University College of the Sciences SURE fellowship JAF; Central Washington University Department of Anthropology and Museum Studies Pete and Sandra Barlow Award; CWU's Department of Anthropology and Museum Studies; Debra and Arlen Prentice Award through the CWU Primate Behavior Program	This work received support from the following sources: Central Washington University College of the Sciences SURE fellowship JAF, https:/www.cwu.edu/sciences/undergraduate-research-funding/COTS-summer-undergraduate research experience. This funder does not provide grant numbers. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Central Washington University Department of Anthropology and Museum Studies Pete and Sandra Barlow Award - JAF, https://www.cwu.edu/ anthropology/pete-and-sandra-barlow-award-2017. This funder does not provide grant numbers. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Central Washington University, Primate Behavior Program Debra and Arlen Prentice Award (to JAF); http://www.cwu.edu/primatet, This funder does not provide grant numbers. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lori Sheeran, Diana Goodrich, and Mary Radeke for their contributions to this project, as well as all CSNW staff and volunteers for their cooperation and tolerance during data collection. We also thank Allison Farley for her assistance in interobserver reliability and Kaitlin Wright for her comments on previous drafts. We also greatly appreciate the time, consideration, and comments of the academic editor and two anonymous reviewers. This manuscript has greatly benefitted from their input. J.A.F. was a Central Washington University (CWU) College of the Sciences SURE fellow for the duration of this study, received a Pete and Sandra Barlow Award from CWU's Department of Anthropology and Museum Studies, as well as support from the Debra and Arlen Prentice Award through the CWU Primate Behavior Program. This project was approved by the CWU IACUC (protocol no. A041604).	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Asher L, 2009, J R SOC INTERFACE, V6, P1103, DOI 10.1098/rsif.2009.0221; Association of Zoos and Aquariums, 2009, CHIMP PAN TROGL CAR; Bennett AJ, 2015, DEV PSYCHOBIOL, V57, P279, DOI 10.1002/dev.21294; Boesch C, 2000, CHIMPANZEES TAI FORE; Borgatti S. P., 2002, NETDRAW SOFTWARE NET; Borgatti SP, 2016, UCINET WINDOWS SOFTW; Brambell F.W.R, 1965, REPORT TECHNICAL COM; Bridge P.D., 1993, P219; Brown JL, 1975, EVOLUTION BEHAV; Bygott DJ, 1974, THESIS; Clark FE, 2011, AM J PRIMATOL, V73, P748, DOI 10.1002/ajp.20903; Clay AW, 2017, BEHAV PROCESSES; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; DEWAAL F, 1982, CHIMPANZEE POLITICS; Douglas PH, 2017, ANIM BEHAV, V123, P21, DOI 10.1016/j.anbehav.2016.10.014; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Freeman AF, 2014, PEERJ, V2; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; FWS DOI, 2015, FWS PUB L, V80; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Hanamura Shunkichi, 2015, P410; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Itoh N, 2015, MAHALE CHIMPANZEES 5; Jensvold MLA, 2008, ZOO BIOL, V27, P345, DOI 10.1002/zoo.20194; Kagan R, 2015, J APPL ANIM WELF SCI, V18, pS1, DOI 10.1080/10888705.2015.1075830; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Khalil JYB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00026; Klass K, 2011, BEHAV PROCESS, V88, P168, DOI 10.1016/j.beproc.2011.09.003; Koene Paul, 2014, Animals, V4, P93, DOI 10.3390/ani4010093; Koski SE, 2012, INT J PRIMATOL, V33, P905, DOI 10.1007/s10764-012-9623-2; Koski SE, 2011, BEHAV ECOL SOCIOBIOL, V65, P2161, DOI 10.1007/s00265-011-1224-0; Maple T.L., 1986, P479; Martin JE, 2002, ANIM WELFARE, V11, P419; Massen JJM, 2014, EVOL HUM BEHAV, V35, P1, DOI 10.1016/j.evolhumbehav.2013.08.008; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Nakamura M, 2003, J HUM EVOL, V44, P59, DOI 10.1016/S0047-2484(02)00194-X; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newton-Fisher NE, 2004, PRIMATES, V45, P81, DOI 10.1007/s10329-003-0064-6; Newton-Fisher NE, 2015, ANIMAL BEHAV PRO VER; Nieuwenhuijsen K., 1982, Zoo Biology, V1, P5, DOI 10.1002/zoo.1430010103; Paoli T, 2006, AM J PHYS ANTHROPOL, V130, P116, DOI 10.1002/ajpa.20345; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; Pruetz Jill D.E., 2001, Special Topics in Primatology, V2, P16; Sakamaki Tetsuya, 2015, P459; Schel AM, 2013, AM J PRIMATOL, V75, P254, DOI 10.1002/ajp.22101; Shimada M, 2014, AM J PRIMATOL, V76, P1025, DOI 10.1002/ajp.22289; Silk J, 2013, EVOL ANTHROPOL, V22, P213, DOI 10.1002/evan.21367; Stevens JMG, 2007, INT J PRIMATOL, V28, P1417, DOI 10.1007/s10764-007-9186-9; Stumpf R, 2011, PRIMATES PERSPECTIVE, P340; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; van Schaik CP., 1989, COMP SOCIOECOLOGY BE, P195; Videan EN, 2007, APPL ANIM BEHAV SCI, V102, P95, DOI 10.1016/j.applanim.2006.03.011; Wakefield ML, 2013, ANIM BEHAV, V85, P1303, DOI 10.1016/j.anbehav.2013.03.019; Webster J., 1995, ANIMAL WELFARE COOL; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	66	22	22	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191898	10.1371/journal.pone.0191898	http://dx.doi.org/10.1371/journal.pone.0191898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444112	Green Submitted, gold, Green Published			2022-12-26	WOS:000425183500041
J	Kim, SY; Lee, JK; Sim, S; Choi, HG				Kim, So Young; Lee, Joon Kyu; Sim, Songyong; Choi, Hyo Geun			Hearing impairment increases the risk of distal radius, hip, and spine fractures: A longitudinal follow-up study using a national sample cohort	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; FRAGILITY FRACTURES; FOREARM FRACTURES; COCHLEAR CAPSULE; ASSOCIATION; OTOSCLEROSIS; EPIDEMIOLOGY; DENSITOMETRY; ADULTS	Objective Hearing impairment has been suggested to increase the risk of falls. However, most previous studies were conducted in an older population without classification of the fracture regions. This study aimed to delineate the risk of each fracture type in all age populations. Methods The Korean National Health Insurance Service-National Sample Cohort was collected from 2002 to 2013. A total of 4,854 severe hearing-impaired and 1,354 profound hearing-impaired participants were matched for age, group, sex, income group, and region of residence with 19,416 and 5,416 control participants, respectively. The fracture diagnosis was based on the International Classification of Disease (ICD-10) codes as follows: distal radius fracture (S525), hip fracture (S720, S721, S722), and spine fracture (S220, S32). Crude (simple) and adjusted hazard ratios (HRs) for each fracture associated with severe or profound hearing impairment were analyzed using the Cox proportional hazard model. Results The severe hearing-impaired group had an increased risk of distal radius fracture, hip fracture, and spine fracture compared with the control group (adjusted HR = 1.67, 95% CI = 1.38-2.03, P < 0.001 for hip fracture). The profound hearing-impaired group had an increased risk of hip and spine fracture (adjusted HR = 2.21, 95% CI = 1.44-3.39, P < 0.001 for hip fracture). Conclusion The risk of distal radius fracture, hip fracture, and spine fracture was increased in the severe hearing-impaired group compared with the control group.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Lee, Joon Kyu] Hallym Univ, Coll Med, Dept Orthopaed Surg, Anyang, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation of Korea [NRF-2015-R1D1A1A01060860]; National Research Foundation (NRF); Korean government (MSIPMOHW) [2016M3A9E8941669]	National Research Foundation of Korea(National Research Foundation of Korea); National Research Foundation (NRF); Korean government (MSIPMOHW)(Korean Government)	This work was supported by National Research Foundation of Korea grant (NRF-2015-R1D1A1A01060860) and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) & funded by the Korean government (MSIP&MOHW) (2016M3A9E8941669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2015, OSTEOPOROSIS INT, V26, P67, DOI 10.1007/s00198-014-2831-1; Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Bessette L, 2008, OSTEOPOROSIS INT, V19, P79, DOI 10.1007/s00198-007-0426-9; Chen J, 2013, NEUROREPORT, V24, P313, DOI 10.1097/WNR.0b013e32835fa79c; Dimai HP, 2014, OSTEOPOROSIS INT, V25, P2297, DOI 10.1007/s00198-014-2766-6; Fechtenbaum J, 2005, OSTEOPOROSIS INT, V16, P2175, DOI 10.1007/s00198-005-2023-0; Greenspan SL, 2012, J AM GERIATR SOC, V60, P455, DOI 10.1111/j.1532-5415.2011.03854.x; Guerreiro MJS, 2017, NEUROBIOL AGING, V56, P180, DOI 10.1016/j.neurobiolaging.2017.05.001; Guneri EA, 1996, ANN OTO RHINOL LARYN, V105, P659; Harvey NC, 2017, J BONE MINER RES; HERNLUND E, 2013, ARCH OSTEOPOROS, V8, DOI DOI 10.1007/S11657-013-0136-1; HUIZING EH, 1987, ACTA OTO-LARYNGOL, V103, P464; Jerrhag D, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1596-z; Jiam NTL, 2016, LARYNGOSCOPE, V126, P2587, DOI 10.1002/lary.25927; Kanis JA, 2017, OSTEOPOROSIS INT, V28, P2023, DOI 10.1007/s00198-017-4009-0; Keller BK, 1999, J AM GERIATR SOC, V47, P1319, DOI 10.1111/j.1532-5415.1999.tb07432.x; Kim SH, 2002, OBSTET GYNECOL, V99, P726, DOI 10.1016/S0029-7844(02)01963-4; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lundgren SS, 2017, OSTEOPOROSIS INT, V28, P3373, DOI 10.1007/s00198-017-4203-0; Martin KL, 2013, J GERONTOL A-BIOL, V68, P1091, DOI 10.1093/gerona/glt010; Martini A, 2014, AUDIOL NEURO-OTOL, V19, P2, DOI 10.1159/000371593; Mendy A, 2014, ANN EPIDEMIOL, V24, P58, DOI 10.1016/j.annepidem.2013.10.012; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Peracino A, 2014, AUDIOL NEURO-OTOL, V19, P6, DOI 10.1159/000371595; Ratti C, 2013, AGING CLIN EXP RES, V25, pS13, DOI 10.1007/s40520-013-0071-4; Rosengren BE, 2017, OSTEOPOROS INT, DOI 10.1007/s00198-017-4203-0; Rumalla K, 2015, LARYNGOSCOPE, V125, P720, DOI 10.1002/lary.24974; Shayman CS, 2017, OTOL NEUROTOL, V38, P484, DOI 10.1097/MAO.0000000000001360; Swinnen FKR, 2012, LARYNGOSCOPE, V122, P401, DOI 10.1002/lary.22408; Tarantino U, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3213; Tsai KY, 2014, SCHIZOPHR RES, V159, P322, DOI 10.1016/j.schres.2014.09.032; Wang HW, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009138; Zuniga MG, 2012, OTOL NEUROTOL, V33, P1586, DOI 10.1097/MAO.0b013e31826bedbc	33	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192820	10.1371/journal.pone.0192820	http://dx.doi.org/10.1371/journal.pone.0192820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW1TV	29438391	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400057
J	Oka, T; Stoltzfus, GT; Zhu, C; Jung, K; Wang, QH; Saif, LJ				Oka, Tomoichiro; Stoltzfus, Garrett T.; Zhu, Chelsea; Jung, Kwonil; Wang, Qiuhong; Saif, Linda J.			Attempts to grow human noroviruses, a sapovirus, and a bovine norovirus in vitro	PLOS ONE			English	Article							PORCINE ENTERIC CALICIVIRUS; CELL-LINE; SERIAL PROPAGATION; CULTURE; REPLICATION; PATHOGENESIS; INFECTION; STRAIN; VIRUS; GASTROENTERITIS	Noroviruses (NoVs) and Sapoviruses (SaVs) are enteric caliciviruses that have been detected in multiple mammalian species, including humans. Currently, efficient cell culture systems have been established only for murine NoVs and porcine SaV Cowden strain. Establishment of an efficient in vitro cell culture system for other NoVs and SaVs remains challenging; however, human NoV (HuNoV) replication in 3D cultured Caco-2 cells and a clone of Caco-2 cells, C2BBe1, human enteroids and in human B cells has been reported. In this study, we tested various cells and culture conditions to grow HuNoVs and a human SaV (HuSaV) to test the possibility of the propagation in different cells and culture conditions. We also attempted to grow a bovine NoV (BoNoV) in ex vivo organ cultures. We did not observe significant RNA level increases for HuSaV and BoNoV under our test conditions. HuNoV RNA levels increased to a maximum of similar to 600-fold in long-term Caco-2 cells that were cultured for 1-2 months in multi-well plates and inoculated with HuNoV-positive and bacteria-free human stool suspensions using serum-free medium supplemented with the bile acid, GCDCA. However, this positive result was inconsistent. Our results demonstrated that HuNoVs, BoNoV and HuSaV largely failed to grow in vitro under our test conditions. Our purpose is to share our findings with other researchers with the goal to develop efficient, reproducible simplified and cost-effective culture systems for human and animal NoVs and SaVs in the future.	[Oka, Tomoichiro; Stoltzfus, Garrett T.; Zhu, Chelsea; Jung, Kwonil; Wang, Qiuhong; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA; [Oka, Tomoichiro] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	University System of Ohio; Ohio State University; National Institute of Infectious Diseases (NIID)	Wang, QH; Saif, LJ (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA.	wang.655@osu.edu; saif.2@osu.edu		Stoltzfus, Garrett/0000-0002-8371-3027	National Institute of Food and Agriculture [2011-68003-30395]; Ministry of Health, Labour, and Welfare, of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Ministry of Health, Labour, and Welfare, of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Institute of Food and Agriculture (https://nifa.usda.gov/) (Grant #2011-68003-30395, L.A. Jaykus, PD) to Drs. Qiuhong Wang and Linda J. Saif, and partially supported by funding from the Ministry of Health, Labour, and Welfare, of Japan and the Ministry of Education, Culture, Sports, Science and Technology of Japan to Dr. Tomoichiro Oka. Salaries and research support were provided by state and federal funds appropriated to OARDC, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; AUGERON C, 1984, CANCER RES, V44, P3961; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Chang KO, 2004, P NATL ACAD SCI USA, V101, P8733, DOI 10.1073/pnas.0401126101; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; CUBITT WD, 1984, J GEN VIROL, V65, P1123, DOI 10.1099/0022-1317-65-6-1123; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; FLYNN WT, 1988, J CLIN MICROBIOL, V26, P206, DOI 10.1128/JCM.26.2.206-212.1988; Ganova-Raeva L, 2004, VIRUS RES, V102, P207, DOI 10.1016/j.virusres.2004.01.033; Herbst-Kralovetz MM, 2013, EMERG INFECT DIS, V19, P431, DOI 10.3201/eid1903.121029; Iritani N, 2016, J MED VIROL, V88, P1187, DOI 10.1002/jmv.24451; Jones MK, 2015, NAT PROTOC, V10, P1939, DOI 10.1038/nprot.2015.121; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Jung K, 2014, VET MICROBIOL, V168, P202, DOI 10.1016/j.vetmic.2013.11.008; Jung K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041619; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Karandikar UC, 2016, J GEN VIROL, V97, P2291, DOI 10.1099/jgv.0.000545; Kitajima M, 2010, J VIROL METHODS, V169, P269, DOI 10.1016/j.jviromet.2010.07.018; KJELDSBERG E, 1977, ACTA PATH MICRO IM B, V85, P351; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lu ZY, 2016, J VIROL, V90, P1345, DOI 10.1128/JVI.02197-15; Martin-Alonso JM, 2005, VIROLOGY, V337, P373, DOI 10.1016/j.virol.2005.04.018; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Oka T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156373; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Oka T, 2014, VET MICROBIOL, V173, P258, DOI 10.1016/j.vetmic.2014.08.012; Oka T, 2012, ARCH VIROL, V157, P349, DOI 10.1007/s00705-011-1161-2; Olarte-Castillo XA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163548; Otto PH, 2011, J VIROL, V85, P12013, DOI 10.1128/JVI.05342-11; Papafragkou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063485; PARWANI AV, 1991, ARCH VIROL, V120, P115, DOI 10.1007/BF01310954; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Pinto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032739; Qu L, 2016, J VIROL, V90, P8906, DOI 10.1128/JVI.01425-16; Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Smiley JR, 2003, J CLIN MICROBIOL, V41, P3089, DOI 10.1128/JCM.41.7.3089-3099.2003; Souza M, 2008, J VIROL, V82, P1777, DOI 10.1128/JVI.01347-07; Straub TM, 2013, WATER SCI TECHNOL, V67, P863, DOI 10.2166/wst.2012.636; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Straub TM, 2011, J WATER HEALTH, V9, P225, DOI 10.2166/wh.2010.106; Takanashi S, 2014, ARCH VIROL, V159, P257, DOI 10.1007/s00705-013-1806-4; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; Vlasova AN, 2016, EUR J IMMUNOL, V46, P2426, DOI 10.1002/eji.201646498; Wang QH, 2012, APPL ENVIRON MICROB, V78, P3932, DOI 10.1128/AEM.06600-11; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	52	32	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0178157	10.1371/journal.pone.0178157	http://dx.doi.org/10.1371/journal.pone.0178157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438433	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400001
J	Rauber, P; Lammert, F; Grotemeyer, K; Appenrodt, B				Rauber, Philip; Lammert, Frank; Grotemeyer, Katharina; Appenrodt, Beate			Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; COUNT/SPLEEN DIAMETER RATIO; PREDICT ESOPHAGEAL-VARICES; RETICULATED PLATELETS; HEPATIC CIRRHOSIS; THROMBOCYTOPENIA; DISEASE; MARKER; BLOOD; PARAMETER	Background and aims Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to investigate the cause of thrombocytopenia in patients with liver cirrhosis by measuring IPF%, TPO and spleen size. In addition we examined the use of IPF% to evaluate the severity of cirrhosis and its complications. Methods Overall, we included 88 in-patients with cirrhosis in our study. The collected data comprises current health status, blood parameters, severity of cirrhosis evaluated by Child-Pugh score and MELD score, spleen diameter, ascites and esophageal varices. The IPF% was measured using an automatic hematology analyzer. TPO was measured with ELISA. Results IPF% (p = 0.003) and spleen diameter (p = 0.001) were significantly higher in patients with thrombocytopenia. There was no significant difference in TPO between patients with and without thrombocytopenia. The mean values of IPF% varied significantly (p = 0.044) in Child-Pugh stages. IPF% was significantly (p = 0.005) elevated in patients with esophageal varices. Moreover, IPF% higher than 3.85% displayed sensitivity of 76.6% and specificity of 52.4% with an area under receiver operating curve characteristics of 0.669 for the presence of esophageal varices. Conclusion On closer examination of the three compartments known to have an influence on platelet count splenomegaly seems to be the major cause of thrombocytopenia in patients with cirrhosis according to current knowledge. Higher IPF% in patients with thrombocytopenia indicates peripheral consumption of platelets. The relation between spleen diameter and platelet count indicates the spleen to be the major place of platelets' consumption. TPO did not differ between patients with and without thrombocytopenia. Furthermore, we cannot exclude an influence of impaired thrombopoietin synthesis on platelet counts. The association between IPF% and platelet count suggests that there is physiological regulation of platelets in patients with cirrhosis. In our study IPF% is associated with esophageal varices and the stage of cirrhosis. Further studies are needed to confirm these results.	[Rauber, Philip] Saarland Univ, Med Ctr, Dept Neurol, Homburg, Germany; [Lammert, Frank; Grotemeyer, Katharina; Appenrodt, Beate] Saarland Univ, Med Ctr, Dept Med 2, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Rauber, P (corresponding author), Saarland Univ, Med Ctr, Dept Neurol, Homburg, Germany.	philip.rauber@uks.eu						Abe Y, 2006, THROMB RES, V118, P463, DOI 10.1016/j.thromres.2005.09.007; Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; ASTER RH, 1966, J CLIN INVEST, V45, P645, DOI 10.1172/JCI105380; AULT KA, 1992, AM J CLIN PATHOL, V98, P637, DOI 10.1093/ajcp/98.6.637; BALLARD HS, 1989, ALCOHOL CLIN EXP RES, V13, P706, DOI 10.1111/j.1530-0277.1989.tb00408.x; Bashour FN, 2000, AM J GASTROENTEROL, V95, P2936, DOI 10.1016/S0002-9270(00)01117-5; Bleibel W, 2013, TRANSPL INT, V26, P435, DOI 10.1111/tri.12064; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Gana JC, 2011, GASTROENTEROLOGY, V141, P2009, DOI 10.1053/j.gastro.2011.08.049; de Mattos AZ, 2013, ANN HEPATOL, V12, P810, DOI 10.1016/S1665-2681(19)31324-9; Di Mario A, 2009, J INFECTION, V59, P201, DOI 10.1016/j.jinf.2009.07.007; Gerbes AL, 2011, Z GASTROENTEROL, V49, P749, DOI 10.1055/s-0031-1273405; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Gonzalez-Ojeda A, 2014, WORLD J GASTROENTERO, V20, P2079, DOI 10.3748/wjg.v20.i8.2079; Goulis J, 1999, GUT, V44, P754, DOI 10.1136/gut.44.5.754; Grove EL, 2009, THROMB HAEMOSTASIS, V101, P151, DOI 10.1160/TH08-03-0186; Grozovsky R, 2015, NAT MED, V21, P47, DOI 10.1038/nm.3770; Guarner C, 1999, GASTROENTEROLOGY, V117, P414, DOI 10.1053/gast.1999.0029900414; Hayashi H, 2014, WORLD J GASTROENTERO, V20, P2595, DOI 10.3748/wjg.v20.i10.2595; Herklotz R, 2006, Ther Umsch, V63, P5, DOI 10.1024/0040-5930.63.1.5; INGRAM M, 1969, BRIT J HAEMATOL, V17, P225, DOI 10.1111/j.1365-2141.1969.tb01366.x; Kawasaki T, 1999, AM J GASTROENTEROL, V94, P1918; Koike Y, 1998, THROMB HAEMOSTASIS, V79, P1106; KUTER DJ, 1995, BLOOD, V85, P2720, DOI 10.1182/blood.V85.10.2720.bloodjournal85102720; Ljubicic N, 2012, CROAT MED J, V53, P374, DOI 10.3325/cmj.2012.53.374; Mao W, 2015, CLIN RES HEPATOL GAS; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; Miyazaki K, 2015, HEMATOLOGY, V20, P587, DOI 10.1179/1607845415Y.0000000021; Nomura T, 2010, INT J LAB HEMATOL, V32, P299, DOI 10.1111/j.1751-553X.2009.01184.x; Nowatari T, 2014, HEPATOL RES, V44, P165, DOI 10.1111/hepr.12205; Panasiuk A, 2004, HEPATO-GASTROENTEROL, V51, P1124; PAQUET KJ, 1982, ENDOSCOPY, V14, P4, DOI 10.1055/s-2007-1021560; PeckRadosavljevic M, 1997, J HEPATOL, V27, P127, DOI 10.1016/S0168-8278(97)80291-7; PEREIRA J, 1995, AM J HEMATOL, V50, P173, DOI 10.1002/ajh.2830500305; Saigo K, 2007, SYSMEX J INT, V2, P81; Schoffski P, 2002, LIVER, V22, P114, DOI 10.1034/j.1600-0676.2002.01547.x; Tafarel JR, 2011, EUR J GASTROEN HEPAT, V23, P754, DOI 10.1097/MEG.0b013e3283488a88; Tana MM, 2015, THROMB RES, V135, P823, DOI 10.1016/j.thromres.2015.02.010; Temel T, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.18556; Wendling F, 1999, HAEMATOLOGICA, V84, P158; Yildiz R, 2005, J GASTROEN HEPATOL, V20, P1115, DOI 10.1111/j.1440-1746.2005.03906.x; Zucker ML, 2012, INT J LAB HEMATOL, V34, P525, DOI 10.1111/j.1751-553X.2012.01429.x	42	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192271	10.1371/journal.pone.0192271	http://dx.doi.org/10.1371/journal.pone.0192271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438423	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400019
J	Parto, S; Lartillot, N				Parto, Sahar; Lartillot, Nicolas			Molecular adaptation in Rubisco: Discriminating between convergent evolution and positive selection using mechanistic and classical codon models	PLOS ONE			English	Article							C-4 PHOTOSYNTHESIS; NUCLEOTIDE SUBSTITUTION; LIKELIHOOD; SEQUENCES; RICE; LINEAGES; PLANTS; SITES; RATES; GENE	Rubisco (Ribulose-1, 5-biphosphate carboxylase/oxygenase) is the most important enzyme on earth, catalyzing the first step of photosynthetic CO2 fixation. So, without it, there would be no storing of the sun's energy in plants. Molecular adaptation of Rubisco to C4 photosynthetic pathway has attracted a lot of attention. C4 plants, which comprise less than 5% of land plants, have evolved more efficient photosynthesis compared to C3 plants. Interestingly, a large number of independent transitions from C3 to C4 phenotype have occurred. Each time, the Rubisco enzyme has been subject to similar changes in selective pressure, thus providing an excellent model for convergent evolution at the molecular level. Molecular adaptation is often identified with positive selection and is typically characterized by an elevated ratio of non-synonymous to synonymous substitution rate (dN/dS). However, convergent adaptation is expected to leave a different molecular signature, taking the form of repeated transitions toward identical or similar amino acids. Here, we used a previously introduced codon-based differential-selection model to detect and quantify consistent patterns of convergent adaptation in Rubisco in eudicots. We further contrasted our results with those obtained by classical codon models based on the estimation of dN/dS. We found that the two classes of models tend to select distinct, although overlapping, sets of positions. This discrepancy in the results illustrates the conceptual difference between these models while emphasizing the need to better discriminate between qualitatively different selective regimes, by using a broader class of codon models than those currently considered in molecular evolutionary studies.	[Parto, Sahar] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada; [Lartillot, Nicolas] Univ Lyon 1, CNRS, UMR, Lab Biometrie & Biol Evolut, Lyon, France	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Parto, S (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada.	sahar.parto@umontreal.ca		Parto, Sahar/0000-0003-0873-9224				Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Christin PA, 2008, MOL BIOL EVOL, V25, P2361, DOI 10.1093/molbev/msn178; Christin PA, 2010, TRENDS ECOL EVOL, V25, P403, DOI 10.1016/j.tree.2010.04.007; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Ellis RJ, TRENDS BIOCH SCI, V4, P241; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gowik U, 2011, PLANT PHYSIOL, V155, P56, DOI 10.1104/pp.110.165308; Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Iida S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004633; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kapralov MV, 2013, MOL BIOL EVOL, V30, P1051, DOI 10.1093/molbev/mst013; Kapralov MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052974; Lartillot N, 2006, J COMPUT BIOL, V13, P1701, DOI 10.1089/cmb.2006.13.1701; Lartillot N, 2011, MOL BIOL EVOL, V28, P729, DOI 10.1093/molbev/msq244; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Liu Z, 2013, BIOLOGIA, V68, P577, DOI 10.2478/s11756-013-0191-5; Makino A, 2003, SOIL SCI PLANT NUTR, V49, P319, DOI 10.1080/00380768.2003.10410016; Monson RK, 2003, INT J PLANT SCI, V164, pS43, DOI 10.1086/368400; Murrell B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002507; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nielsen R, 1998, GENETICS, V148, P929; Parto S, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0979-y; Rodrigue N, 2010, P NATL ACAD SCI USA, V107, P4629, DOI 10.1073/pnas.0910915107; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sen L, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-29; Simpson MG, 2010, PLANT SYSTEMATICS, 2ND EDITION, P1; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Studer RA, 2014, P NATL ACAD SCI USA, V111, P2223, DOI 10.1073/pnas.1310811111; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tamuri AU, 2012, GENETICS, V190, P1101, DOI 10.1534/genetics.111.136432; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Taniguchi Y, 2008, J EXP BOT, V59, P1799, DOI 10.1093/jxb/ern016; Thiltgen G, 2017, J MOL EVOL, V84, P39, DOI 10.1007/s00239-016-9765-5; van Lun M, 2011, J MOL BIOL, V411, P1083, DOI 10.1016/j.jmb.2011.06.052; von Caemmerer S, 2010, PLANT PHYSIOL, V154, P589, DOI 10.1104/pp.110.160952; von Caemmerer Susanne, 2000, VVolume 9, P85; Wilke CO, 2015, MOL BIOL EVOLUTION; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	48	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192697	10.1371/journal.pone.0192697	http://dx.doi.org/10.1371/journal.pone.0192697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432438	Green Submitted, gold, Green Published			2022-12-26	WOS:000424814300037
J	Huang, CL; Zhang, L; Shi, Y; Yi, H; Zhao, YL; Chen, J; Pollock, CA; Chen, XM				Huang, Chunling; Zhang, Ling; Shi, Ying; Yi, Hao; Zhao, Yongli; Chen, Jason; Pollock, Carol A.; Chen, Xin-Ming			The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; GARDOS CHANNEL BLOCKER; MESENCHYMAL TRANSITION; TGF-BETA; INFLAMMATION; MECHANISMS; ICA-17043; FIBROSIS; FACTOR-BETA(1); HYPERTENSION	Despite optimal control of hyperglycaemia, hypertension, and dyslipidaemia, the number of patients with diabetic nephropathy (DN) continues to grow. Strategies to target various signaling pathways to prevent DN have been intensively investigated in animal models and many have been proved to be promising. However, targeting these pathways once kidney disease is established, remain unsatisfactory. The clinical scenario is that patients with diabetes mellitus often present with established kidney damage and need effective treatments to repair and reverse the kidney damage. In this studies, eNOS-/- mice were administered with streptozotocin to induce diabetes. At 24 weeks, at which time we have previously demonstrated albuminuria and pathological changes of diabetic nephropathy, mice were randomised to receive TRAM34 subcutaneously, a highly selective inhibitor of potassium channel KCa3.1 or DMSO (vehicle) for a further 14 weeks. Albuminuria was assessed, inflammatory markers (CD68, F4/80) and extracellular matrix deposition (type I collagen and fibronectin) in the kidneys were examined. The results clearly demonstrate that TRAM34 reduced albuminuria, decreased inflammatory markers and reversed extracellular matrix deposition in kidneys via inhibition of the TGF-beta 1 signaling pathway. These results indicate that KCa3.1 blockade effectively reverses established diabetic nephropathy in this rodent model and provides a basis for progressing to human studies.	[Huang, Chunling; Shi, Ying; Yi, Hao; Pollock, Carol A.; Chen, Xin-Ming] Univ Sydney, Royal North Shore Hosp, Sydney Med Sch Northern, Kolling Inst, St Leonards, NSW, Australia; [Zhang, Ling] Kunming Med Univ, Sch Pharmaceut Sci, Kuming, Peoples R China; [Zhang, Ling] Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Kuming, Peoples R China; [Zhao, Yongli] Dalian Med Univ, Hosp 2, Dept Pediat, Dalian, Liaoning, Peoples R China; [Chen, Jason] Royal North Shore Hosp, Dept Anat Pathol, Sydney, NSW, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Kunming Medical University; Kunming Medical University; Dalian Medical University; Royal North Shore Hospital	Pollock, CA (corresponding author), Univ Sydney, Royal North Shore Hosp, Sydney Med Sch Northern, Kolling Inst, St Leonards, NSW, Australia.	carol.pollock@sydney.edu.au	Chen, Xin-Ming/D-2923-2015	Chen, Xin-Ming/0000-0003-3212-7172; Huang, Chunling/0000-0002-5410-4935	Juvenile Diabetes Research Foundation International [2-SRA-2014-258-Q-R]; Australian National Health and Medical Research Council (NHMRC) Peter Doherty Early Career Fellowship [APP1110560]	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Australian National Health and Medical Research Council (NHMRC) Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Juvenile Diabetes Research Foundation International (2-SRA-2014-258-Q-R). Huang C is funded by Australian National Health and Medical Research Council (NHMRC) Peter Doherty Early Career Fellowship (APP1110560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicic RZ, 2017, CLIN J AM SOC NEPHRO; Ataga KI, 2008, BLOOD, V111, P3991, DOI 10.1182/blood-2007-08-110098; Ataga KI, 2006, PHARMACOTHERAPY, V26, P1557, DOI 10.1592/phco.26.11.1557; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chang AS, 2016, AM J PHYSIOL-RENAL, V310, pF689, DOI 10.1152/ajprenal.00502.2015; Chiang EY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14644; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Conserva F, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/7934504; Donate-Correa J, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/948417; Elhai M, 2016, P NATL ACAD SCI USA, V113, pE3901, DOI 10.1073/pnas.1523512113; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Hansen Lars Koch, 2014, Dan Med J, V61, pB4946; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Huang CY, 2014, ACM T MULTIM COMPUT, V10, DOI 10.1145/2537855; Huang CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23884; Huang CL, 2014, NEPHROL DIAL TRANSPL, V29, P313, DOI 10.1093/ndt/gft431; Huang CL, 2014, INT J BIOCHEM CELL B, V47, P1, DOI [10.1016/j.biocel.2013.11.017, 10.1016/j.bioce1.2013.11.017]; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Meng XM, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.402; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Qi W, 2006, KIDNEY INT, V69, P989, DOI 10.1038/sj.ki.5000189; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Qi W, 2006, AM J PHYSIOL-RENAL, V291, pF1070, DOI 10.1152/ajprenal.00013.2006; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Sharma D, 2017, DIABETES RES CLIN PR, V128, P91, DOI 10.1016/j.diabres.2017.04.010; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Xu RD, 2017, ARTERIOSCL THROM VAS, V37, P226, DOI 10.1161/ATVBAHA.116.308461; Yamout H, 2014, ADV CHRONIC KIDNEY D, V21, P281, DOI 10.1053/j.ackd.2014.03.005; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	42	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192800	10.1371/journal.pone.0192800	http://dx.doi.org/10.1371/journal.pone.0192800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425253	Green Submitted, Green Published, gold			2022-12-26	WOS:000424700800046
J	Guan, HJ; Dai, ZL; Zhao, AW; He, J				Guan, Hongjun; Dai, Zongli; Zhao, Aiwu; He, Jie			A novel stock forecasting model based on High-order-fuzzy-fluctuation Trends and Back Propagation Neural Network	PLOS ONE			English	Article							TIME-SERIES; ENERGY; SYSTEM	In this paper, we propose a hybrid method to forecast the stock prices called High-order-fuzzy-fluctuation-Trends-based Back Propagation(HTBP) Neural Network model. First, we compare each value of the historical training data with the previous day's value to obtain a fluctuation trend time series (FTTS). On this basis, the FTTS blur into fuzzy time series (FFTS) based on the fluctuation of the increasing, equality, decreasing amplitude and direction. Since the relationship between FFTS and future wave trends is nonlinear, the HTBP neural network algorithm is used to find the mapping rules in the form of self-learning. Finally, the results of the algorithm output are used to predict future fluctuations. The proposed model provides some innovative features:(1) It combines fuzzy set theory and neural network algorithm to avoid overfitting problems existed in traditional models. (2) BP neural network algorithm can intelligently explore the internal rules of the actual existence of sequential data, without the need to analyze the influence factors of specific rules and the path of action. (3) The hybrid modal can reasonably remove noises from the internal rules by proper fuzzy treatment. This paper takes the TAIEX data set of Taiwan stock exchange as an example, and compares and analyzes the prediction performance of the model. The experimental results show that this method can predict the stock market in a very simple way. At the same time, we use this method to predict the Shanghai stock exchange composite index, and further verify the effectiveness and universality of the method.	[Guan, Hongjun; Dai, Zongli; He, Jie] Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China; [Zhao, Aiwu] Jiangsu Univ, Sch Management, Zhenjiang, Jiangsu, Peoples R China	Shandong University of Finance & Economics; Jiangsu University	Zhao, AW (corresponding author), Jiangsu Univ, Sch Management, Zhenjiang, Jiangsu, Peoples R China.	aiwuzh@126.comor			National Natural Science Foundation of China [71471076]; Ministry of Education of Humanities and Social Sciences [14YJAZH025]; China Nation Tourism Administration [15TACK003]; Natural Science Foundation of Shandong Province [ZR2013GM003]; Foundation Program of Jiangsu University [16JDG005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of Humanities and Social Sciences; China Nation Tourism Administration; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation Program of Jiangsu University	This work was supported by the National Natural Science Foundation of China 71471076 to Aiwu Zhao; The Fund of the Ministry of Education of Humanities and Social Sciences 14YJAZH025 to Dr. Hongjun Guan; The Fund of the China Nation Tourism Administration 15TACK003 to Dr. Hongjun Guan; The Natural Science Foundation of Shandong Province ZR2013GM003 to Dr. Hongjun Guan and the Foundation Program of Jiangsu University 16JDG005 to Aiwu Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot J, 2017, ATMOS RES, V197, P289, DOI 10.1016/j.atmosres.2017.07.015; Aladag CH, 2009, EXPERT SYST APPL, V36, P4228, DOI 10.1016/j.eswa.2008.04.001; Badrzadeh H, 2013, J HYDROL, V507, P75, DOI 10.1016/j.jhydrol.2013.10.017; Bing Y., 2012, ADV ENG FORUM, V6-7, P1055; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Chen SM, 2013, IEEE T CYBERNETICS, V43, P1102, DOI 10.1109/TSMCB.2012.2223815; Chen SM, 2011, IEEE T FUZZY SYST, V19, P1, DOI 10.1109/TFUZZ.2010.2073712; Chen SM, 2010, INFORM SCIENCES, V180, P4772, DOI 10.1016/j.ins.2010.08.026; Chen SM, 2017, FUZZY FORECASTING BA; Chen SM, 2013, TAIEX FORECASTING BA; Cheng SH, 2016, INFORM SCIENCES, V327, P272, DOI 10.1016/j.ins.2015.08.024; Daut MAM, 2017, RENEW SUST ENERG REV, V70, P1108, DOI 10.1016/j.rser.2016.12.015; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng ZH, 2015, IEEE T FUZZY SYST, V23, P813, DOI 10.1109/TFUZZ.2014.2328014; Dumitru CD, 2017, PROCEDIA ENGINEER, V181, P829, DOI 10.1016/j.proeng.2017.02.474; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Friedman M, 1939, J AM STAT ASSOC, V34, P109, DOI 10.2307/2279169; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Guan HJ, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9090191; GUAN S, 2017, SYMMETRY-BASEL, V9, DOI DOI 10.3390/SYM9100207; Herrera F, 1996, FUZZY SET SYST, V78, P73, DOI 10.1016/0165-0114(95)00107-7; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; Jenkins GM., 1976, TIME SERIES ANAL FOR, P303; Jia JY, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9070124; Jiang YZ, 2017, IEEE T SYST MAN CY-S, V47, P145, DOI 10.1109/TSMC.2016.2577558; Kisi O, 2012, COMPUT GEOSCI-UK, V41, P169, DOI 10.1016/j.cageo.2011.08.027; Mishra D, 2015, ATMOS ENVIRON, V102, P239, DOI 10.1016/j.atmosenv.2014.11.050; Nemenyi P. B., 1963, THESIS; Ratnayaka RMKT, 2015, PROCEEDINGS OF 2015 IEEE INTERNATIONAL CONFERENCE ON BEHAVIORAL, ECONOMIC, SOCIO-CULTURAL COMPUTING (BESC), P54, DOI 10.1109/BESC.2015.7365958; Raza MQ, 2015, RENEW SUST ENERG REV, V50, P1352, DOI 10.1016/j.rser.2015.04.065; Sadaei HJ, 2017, INT J APPROX REASON, V83, P196, DOI 10.1016/j.ijar.2017.01.006; Song Q, 1993, FORECASTING ENROLL 1; Song Q., 1994, FUZZY SETS SYST; Song Q, 1993, FUZZY SETS SYST; Tu CC, 2012, EXPERT SYST APPL, V39, P2479, DOI 10.1016/j.eswa.2011.08.100; Wang JZ, 2011, EXPERT SYST APPL, V38, P14346, DOI 10.1016/j.eswa.2011.04.222; Wang LX, 2017, IEEE T FUZZY SYST, V25, P277, DOI 10.1109/TFUZZ.2016.2574911; Wu JM, 2016, J ADV CERAM, V5, P176, DOI 10.1007/s40145-016-0187-z; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7	40	19	21	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192366	10.1371/journal.pone.0192366	http://dx.doi.org/10.1371/journal.pone.0192366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420584	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900067
J	Oh, SY; Kim, M; Eimes, JA; Lim, YW				Oh, Seung-Yoon; Kim, Misong; Eimes, John A.; Lim, Young Woon			Effect of fruiting body bacteria on the growth of Tricholoma matsutake and its related molds	PLOS ONE			English	Article							HELPER BACTERIA; PSEUDOMONAS-FLUORESCENS; EWINGELLA-AMERICANA; ANTIFUNGAL ACTIVITY; IN-VITRO; SP NOV.; MUSHROOM; BODIES; FUNGI; IDENTIFICATION	Tricholoma matsutake (pine mushroom, PM) is a prized mushroom in Asia due to its unique flavor and pine aroma. The fruiting body of PM forms only in its natural habitat (pine forest), and little is known regarding the natural conditions required for successful generation of the fruiting bodies in this species. Recent studies suggest that microbial interactions may be associated with the growth of PM; however, there have been few studies of the bacterial effects on PM growth. In this study, we surveyed which bacteria can directly and indirectly promote the growth of PM by using co-cultures with PM and molds associated with the fruiting body. Among 16 bacterial species isolated from the fruiting body, some species significantly influenced the mycelial growth of PM and molds. Most bacteria negatively affected PM growth and exhibited various enzyme activities, which suggests that they use the fruiting body as nutrient source. However, growth-promoting bacteria belonging to the Dietzia, Ewingella, Pseudomonas, Paenibacillus, and Rodococcus were also found. In addition, many bacteria suppressed molds, which suggests an indirect positive effect on PM as a biocontrol agent. Our results provide important insights toward a better understanding of the microbial interactions in the fruiting body of PM, and indicate that growth-promoting bacteria may be an important component in successful cultivation of PM.	[Oh, Seung-Yoon; Kim, Misong; Lim, Young Woon] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Eimes, John A.] Sungkyunkwan Univ, Univ Coll, Suwon, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU)	Lim, YW (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	ywlim@snu.ac.kr	Oh, Seung-Yoon/H-4958-2018	Oh, Seung-Yoon/0000-0002-9745-1849				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amend A, 2010, CONSERV GENET, V11, P795, DOI 10.1007/s10592-009-9894-0; Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernas E, 2006, ACTA SCI POLON-TECHN, V5, P5; BOWEN GD, 1979, SOIL BIOL BIOCHEM, V11, P119, DOI 10.1016/0038-0717(79)90087-7; Brabcova V, 2016, NEW PHYTOL, V210, P1369, DOI 10.1111/nph.13849; Brick D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05739-6; Brule C, 2001, SOIL BIOL BIOCHEM, V33, P1683, DOI 10.1016/S0038-0717(01)00090-6; Chen HB, 2010, BIOCHEM ENG J, V49, P337, DOI 10.1016/j.bej.2010.01.008; Choi In-Young, 2010, Mycobiology, V38, P310, DOI 10.4489/MYCO.2010.38.4.310; Dahm H, 2003, B POL ACAD BIOL SCI, V3, P167; DANELL E, 1993, MYCOL RES, V97, P1148, DOI 10.1016/S0953-7562(09)80519-4; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DUPONNOIS R, 1991, ANN SCI FOREST, V48, P239, DOI 10.1051/forest:19910301; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; GARBAYE J, 1994, NEW PHYTOL, V128, P197, DOI 10.1111/j.1469-8137.1994.tb04003.x; Gazzanelli G, 1999, SYMBIOSIS, V26, P211; Guerin-Laguette Alexis, 2003, Mycological Progress, V2, P37, DOI 10.1007/s11557-006-0042-7; Hoster F, 2005, APPL MICROBIOL BIOT, V66, P434, DOI 10.1007/s00253-004-1664-9; Inglis PW, 1997, FEMS MICROBIOL LETT, V157, P189, DOI 10.1016/S0378-1097(97)00475-8; Inglis PW, 1996, MICROBIOL-UK, V142, P3253, DOI 10.1099/13500872-142-11-3253; Izo I., 1964, J JPN SOC NUTR FOOD, V17, P69; Ka Kang-Hyeon, 1999, Korean Journal of Mycology, V27, P345; KANG A-S, 1989, Korean Journal of Mycology, V17, P51; Kataoka R, 2012, J MICROBIOL, V50, P199, DOI 10.1007/s12275-012-1371-7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KAZANAS N, 1987, J FOOD PROTECT, V50, P933, DOI 10.4315/0362-028X-50.11.933; Kobayashi DY, 2002, APPL ENVIRON MICROB, V68, P1047, DOI 10.1128/AEM.68.3.1047-1054.2002; Kredics L., 2010, CURRENT RES TECHNOLO, P295; Kumari D, 2013, ANN MICROBIOL, V63, P845, DOI 10.1007/s13213-012-0535-3; LANYI B, 1987, METHOD MICROBIOL, V19, P1; Lee H, 2015, BIORESOURCES, V10, P8450; Lee Won-Ho, 2007, Mycobiology, V35, P54, DOI 10.4489/MYCO.2007.35.2.054; Leon M, 2009, Int J Microbiol, V2009, P572049, DOI 10.1155/2009/572049; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Li Q, 2016, MICROBIOLOGY+, V85, P531, DOI 10.1134/S0026261716050106; Li Q, 2016, J MICROBIOL BIOTECHN, V26, P89, DOI 10.4014/jmb.1505.05008; Liu G, 2010, J MED PLANTS RES, V4, P1222; Miles P.G., 1997, MUSHROOM BIOL CONCIS; 김인엽, 2005, [The Korean Journal of Mycology, 한국균학회지], V33, P22; Nagy A., 2012, IOBC/WPRS Bulletin, V78, P289; Nielsen MN, 1999, FEMS MICROBIOL ECOL, V30, P217, DOI 10.1111/j.1574-6941.1999.tb00650.x; OGAWA M, 1976, T MYCOL SOC JPN, V17, P492; Oh SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168573; ORDENTLICH A, 1988, PHYTOPATHOLOGY, V78, P84; Park MS, 2014, ANTON LEEUW INT J G, V106, P593, DOI 10.1007/s10482-014-0230-4; Pavic A, 2013, FUNGAL ECOL, V6, P527, DOI 10.1016/j.funeco.2013.05.006; Pent M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00836; RAINEY PB, 1991, MYCOL RES, V95, P699, DOI 10.1016/S0953-7562(09)80817-4; RAINEY PB, 1991, PHYSIOL MOL PLANT P, V39, P57, DOI 10.1016/0885-5765(91)90031-C; Ramirez-Bahena MH, 2015, INT J SYST EVOL MICR, V65, P2110, DOI 10.1099/ijs.0.000230; Rangel-Castro JI, 2002, MYCOLOGIA, V94, P190, DOI 10.2307/3761795; 유영현, 2011, [The Korean Journal of Mycology, 한국균학회지], V39, P223; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; RUDAKOV OL, 1978, MYCOLOGIA, V70, P150, DOI 10.2307/3758695; Sbrana C, 2000, CAN J MICROBIOL, V46, P259, DOI 10.1139/cjm-46-3-259; Schrey SD, 2005, NEW PHYTOL, V168, P205, DOI 10.1111/j.1469-8137.2005.01518.x; Someya Nobutaka, 2001, Journal of General Plant Pathology, V67, P312, DOI 10.1007/PL00013038; SONG H-S, 1991, Korean Journal of Mycology, V19, P109; Splivallo R, 2015, ENVIRON MICROBIOL, V17, P2647, DOI 10.1111/1462-2920.12521; Summerbell RC, 2005, STUD MYCOL, P191, DOI 10.3114/sim.53.1.191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng WL, 2001, CARBOHYD RES, V332, P305, DOI 10.1016/S0008-6215(01)00084-2; Tsukamoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P2201, DOI 10.1271/bbb.66.2201; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; Varese GC, 1996, SYMBIOSIS, V21, P129; Wang EunJin, 2016, Korean Journal of Mycology, V44, P166; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Williams J, 2003, APPL ENVIRON MICROB, V69, P4192, DOI 10.1128/AEM.69.7.4192-4199.2003; Yamada A, 2006, MYCORRHIZA, V16, P111, DOI 10.1007/s00572-005-0021-x; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zagriadskaia YA, 2013, BIOL BULL+, V40, P358, DOI 10.1134/S106235901304016X; Zagryadskaya YA, 2015, EURASIAN SOIL SCI+, V48, P620, DOI 10.1134/S1064229315060137	76	24	24	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0190948	10.1371/journal.pone.0190948	http://dx.doi.org/10.1371/journal.pone.0190948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420560	Green Submitted, gold, Green Published			2022-12-26	WOS:000424517900008
J	Kilvaer, TK; Rakaee, M; Hellevik, T; Ostman, A; Strell, C; Bremnes, RM; Busund, LT; Donnem, T; Martinez-Zubiaurre, I				Kilvaer, Thomas Karsten; Rakaee, Mehrdad; Hellevik, Turid; Ostman, Arne; Strell, Carina; Bremnes, Roy M.; Busund, Lill-Tove; Donnem, Tom; Martinez-Zubiaurre, Inigo			Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; PREDICTS POOR-PROGNOSIS; STROMAL CELLS; PODOPLANIN EXPRESSION; LYMPH-NODES; E-CADHERIN; IMPACT; ACTIVATION; MARKER; COMPARTMENT	Objectives Selective targeting of cancer-associated fibroblasts (CAFs) has been proposed to synergize with immune-checkpoint inhibitors. While the roles of CAFs in cancer development are well described, their immune-regulatory properties remain incompletely understood. This study investigates correlations between CAF and immune-markers in tumor stroma from non-small cell lung cancer (NSCLC) patients, and examines whether a combination of CAF and immune cell scores impact patient prognosis. Methods Tumor specimens from 536 primary operable stage I-III NSCLC patients were organized in tissue microarrays. Expression of protein-markers was evaluated by immunohistochemistry. Results Fibroblast and stromal markers PDGFR alpha, PDGFR beta, FAP-1 and vimentin showed weak correlations while alpha SMA, and Masson's trichrome did not correlate with any of the investigated markers. Hierarchical clustering indicated the existence of different CAF-subsets. No relevant correlations were found between any CAF-marker and the immune-markers CD3, CD4, CD8, CD20, CD68, CD1a, CD56, FoxP3 and CD45RO. High density of fibroblast-activation protein positive mesenchymal cells (CAF(FAP)) was associated with better prognosis in tumors with high infiltration of CD8 and CD3 T-lymphocytes. Conclusions The presented data suggest that CAFs, irrespective of identity, have low influence on the degree of tumor infiltration by inflammatory-and/or immune-cells. However, CAF(FAP) may exert immuno-adjuvant roles in NSCLC, and targeting CAFs should be cautiously considered.	[Kilvaer, Thomas Karsten; Hellevik, Turid; Bremnes, Roy M.; Donnem, Tom] Univ Hosp Northern Norway, Dept Oncol, Tromso, Norway; [Kilvaer, Thomas Karsten; Bremnes, Roy M.; Donnem, Tom; Martinez-Zubiaurre, Inigo] UiT Artic Univ Norway, Dept Clin Med, Tromso, Norway; [Rakaee, Mehrdad; Busund, Lill-Tove] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Ostman, Arne; Strell, Carina] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Busund, Lill-Tove] Univ Hosp Northern Norway, Dept Clin Pathol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Karolinska Institutet; UiT The Arctic University of Tromso; University Hospital of North Norway	Martinez-Zubiaurre, I (corresponding author), UiT Artic Univ Norway, Dept Clin Med, Tromso, Norway.	inigo.martinez@uit.no	Rakaee, Mehrdad/GMX-0729-2022; Kilvaer, Thomas/AAI-7418-2020	Rakaee, Mehrdad/0000-0002-9080-0153; Kilvaer, Thomas/0000-0003-1669-0117; Hellevik, Turid/0000-0002-7979-5189; Strell, Carina/0000-0002-3783-7256; Martinez, Inigo/0000-0001-5408-9088	Northern Norway Regional Health Authority [SPP1137-13, SFP1138-13]; Norwegian Cancer Society [9223]; Erna & Olav Aakre Foundation for Cancer Research; UiT The Arctic University of Norway	Northern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); Erna & Olav Aakre Foundation for Cancer Research; UiT The Arctic University of Norway	This work was supported by the Northern Norway Regional Health Authority with URL: https://helse-nord.no/ (grant no: SPP1137-13 to TH and SFP1138-13), the Norwegian Cancer Society with URL: https://kreftforeningen.no; (grant no: 9223 to IMZ) and Erna & Olav Aakre Foundation for Cancer Research to IMZ. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank pathologists Samer Al-Saad, Khalid Al-Shibli and Elin Richardsen for providing human lung tissue samples. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Al-Shibli K, 2009, HISTOPATHOLOGY, V55, P301, DOI 10.1111/j.1365-2559.2009.03379.x; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Barnas JL, 2010, CANCER MICROENVIRON, V3, P29, DOI 10.1007/s12307-010-0044-5; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Chen YB, 2014, TUMOR BIOL, V35, P6707, DOI 10.1007/s13277-014-1908-y; Cortez E, 2014, SEMIN CANCER BIOL, V25, P3, DOI 10.1016/j.semcancer.2013.12.010; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; De Boeck A, 2013, PROTEOMICS, V13, P379, DOI 10.1002/pmic.201200179; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Donnem T, 2010, ANN ONCOL, V21, P223, DOI 10.1093/annonc/mdp296; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Edlund K, 2012, INT J CANCER, V131, P2264, DOI 10.1002/ijc.27518; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Hellevik T, 2013, TRANSL ONCOL, V6, P66, DOI 10.1593/tlo.12349; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kilvaer TK, 2016, BRIT J CANCER, V114, P1145, DOI 10.1038/bjc.2016.92; Kilvaer TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134965; Kitano H, 2010, ARCH PATHOL LAB MED, V134, P1520, DOI 10.1043/2009-0114-OA.1; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Koriyama H, 2015, J CANCER RES CLIN, V141, P1163, DOI 10.1007/s00432-014-1891-0; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P623, DOI 10.14670/HH-17.623; Leinonen T, 2008, HISTOL HISTOPATHOL, V23, P693, DOI 10.14670/HH-23.693; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Mattsson JSM, 2015, CANCER LETT, V356, P837, DOI 10.1016/j.canlet.2014.10.032; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Neri S, 2012, ANN SURG ONCOL, V19, P3953, DOI 10.1245/s10434-012-2421-4; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ono S, 2013, CHEST, V143, P963, DOI 10.1378/chest.12-0913; Paulsen EE, 2015, NEOPLASIA, V17, P839, DOI 10.1016/j.neo.2015.11.004; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Rakaee M, 2016, ONCOTARGET, V7, P72184, DOI 10.18632/oncotarget.12360; Reid A, 2013, CHEST, V144, DOI 10.1378/chest.1662734; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shu H, 2012, NEOPLASMA, V59, P658, DOI 10.4149/neo_2012_083; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Takahashi A, 2015, ONCOTARGET, V6, P9531, DOI 10.18632/oncotarget.3371; Tchou J, 2013, HUM PATHOL, V44, P2549, DOI 10.1016/j.humpath.2013.06.016; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902	51	28	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192157	10.1371/journal.pone.0192157	http://dx.doi.org/10.1371/journal.pone.0192157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415055	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300054
J	Liu, YE; Tong, CC; Zhang, YB; Cong, PF; Shi, XY; Liu, Y; Shi, L; Tong, Z; Jin, HX; Hou, MX				Liu, Yun-En; Tong, Cang-Ci; Zhang, Yu-Biao; Cong, Pei-Fang; Shi, Xiu-Yun; Liu, Ying; Shi, Lin; Tong, Zhou; Jin, Hong-Xu; Hou, Ming-Xiao			Chitosan oligosaccharide ameliorates acute lung injury induced by blast injury through the DDAH1/ADMA pathway	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; OXIDATIVE STRESS; BIOLOGICAL-ACTIVITIES; INFLAMMATION; ACTIVATION; APOPTOSIS; CELLS; RATS; CHITOOLIGOSACCHARIDES; MITOCHONDRIA	Objective To investigate the protective effect of chitosan oligosaccharide (COS) on acute lung injury (ALI) caused by blast injury, and explore possible molecular mechanisms. Methods A mouse model of blast injury-induced ALI was established using a self-made explosive device. Thirty mice were randomly assigned to control, ALI and ALI + COS groups. An eight-channel physiological monitor was used to determine the mouse physiological index. Enzyme linked immunosorbent assay was used to measure serum inflammatory factors. Hematoxylin-eosin staining, terminal deoxynucleotidyl transferase dUTP nick end labeling assay, immunofluorescence staining, real time-polymerase chain reaction and western blot assay were used to detect inflammatory reactions, oxidative stress and apoptosis. Results Mice were sacrificed 24 hours after successful model induction. Compared with the ALI group, the heart rate, respiration and PCO2 were significantly lower, but the PO2, TCO2 and HCO3- were significantly higher in the ALI + COS group. Compared to ALI alone, COS treatment of ALI caused a significant decrease in the wet/dry lung weight ratio, indicating a reduction in lung edema, inflammatory cell infiltration, levels of tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-4, IL-6 and nuclear factor kappa B mRNA and protein expression were reduced and IL-10 mRNA and protein expression was increased (P<0.05). COS significantly inhibited reactive oxygen species, MDA5 and IRE alpha mRNA and protein expressions, cell apoptosis and Bax and Caspase-3 mRNA and protein expressions, and significantly increased superoxide dismutase-1 mRNA expression, and Bcl-2 and Caspase-8 mRNA and protein expression (all P<0.05). COS significantly increased dimethylarginine dimethylaminohydrolase 1 (DDAH1) protein expression, and reduced ADMA and p38 protein expression (P<0.05). Conclusion Blast injury causes inflammation, oxidative stress and apoptosis in the lung tissues of mice. COS has protective effects on blast injury-induced ALI, possibly by promoting DDAH1 expression and inhibiting ADMA and mitogen-activated protein kinase pathways.	[Liu, Yun-En; Tong, Cang-Ci; Zhang, Yu-Biao; Cong, Pei-Fang; Shi, Xiu-Yun; Liu, Ying; Shi, Lin; Tong, Zhou; Jin, Hong-Xu; Hou, Ming-Xiao] PLA, Emergency Med Dept, Gen Hosp Shenyang Mil Command, Lab Rescue,Ctr Severe Wound & Trauma, Shenyang, Liaoning, Peoples R China		Hou, MX (corresponding author), PLA, Emergency Med Dept, Gen Hosp Shenyang Mil Command, Lab Rescue,Ctr Severe Wound & Trauma, Shenyang, Liaoning, Peoples R China.	houmingxiao188@163.com	Yunen, Liu/X-4121-2019		Liaoning Province Key Scientific and Technological Project [2012125007, 2013225089, 20170540947]; PLA Foundation of China [CSY12J002, AMS14L008]	Liaoning Province Key Scientific and Technological Project; PLA Foundation of China	This work was supported by the grants of Liaoning Province Key Scientific and Technological Project (No. 2012125007; No. 2013225089; No. 20170540947), and PLA Foundation of China during the Twelfth Five-year Plan Period (No. CSY12J002; No. AMS14L008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekera AT, 2016, DIABETES METAB, V42, P378, DOI 10.1016/j.diabet.2016.05.002; Aminzadeh A, 2017, METAB BRAIN DIS, V32, P819, DOI 10.1007/s11011-017-9976-5; Bahmani P, 2010, CELL STRESS CHAPERON, V15, P395, DOI 10.1007/s12192-009-0154-5; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; Buhrer Steven, 2012, Air Med J, V31, P10, DOI 10.1016/j.amj.2011.10.005; Calabrese C, 2015, Minerva Med, V106, P9; Charytan DM, 2012, CIRCULATION, V126, pS164, DOI 10.1161/CIRCULATIONAHA.111.083568; Chou TC, 2003, BIOCHEM BIOPH RES CO, V308, P403, DOI 10.1016/S0006-291X(03)01407-4; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; Hewedy WA, 2016, PHARMACOL REP, V68, P1319, DOI 10.1016/j.pharep.2016.08.009; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Huang B, 2016, J AGR FOOD CHEM, V64, P245, DOI 10.1021/acs.jafc.5b05195; Huang HC, 2015, NEUROTOX RES, V27, P411, DOI 10.1007/s12640-014-9512-x; Jangale NM, 2016, J PHYSIOL BIOCHEM, V72, P327, DOI 10.1007/s13105-016-0482-8; Jia SL, 2016, INT J BIOL MACROMOL, V83, P416, DOI 10.1016/j.ijbiomac.2015.11.011; Kim HY, 2016, CYTOKINE, V77, P203, DOI 10.1016/j.cyto.2015.09.002; Kim JA, 2017, BMB REP, V50, P257, DOI 10.5483/BMBRep.2017.50.5.023; Kinker KG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085148; Kunanusornchai W, 2016, PHARMACOL RES, V113, P458, DOI 10.1016/j.phrs.2016.09.016; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Li CJ, 2016, GENE REGUL SYST BIO, V10, P1, DOI 10.4137/GRSB.S35607; Li KC, 2016, CARBOHYD POLYM, V139, P178, DOI 10.1016/j.carbpol.2015.12.016; Li TM, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/5602142; Lin YC, 2017, MOL IMMUNOL, V83, P82, DOI 10.1016/j.molimm.2017.01.009; Lind L, 2013, VASC MED, V18, P192, DOI 10.1177/1358863X13496488; Luneburg N, 2016, PULM MED, V2016, DOI 10.1155/2016/6578578; Matrozova J, 2016, INT J ENDOCRINOL MET, V14, DOI 10.5812/ijem.30324; Meng NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062723; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Muanprasat C, 2017, PHARMACOL THERAPEUT, V170, P80, DOI 10.1016/j.pharmthera.2016.10.013; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Seferian PG, 2000, VACCINE, V19, P661, DOI 10.1016/S0264-410X(00)00248-6; Wada-Hiraike O, 2006, BIOCHEM SOC T, V34, P1114, DOI 10.1042/BST0341114; Wang HY, 2016, BBA-GEN SUBJECTS, V1860, P2793, DOI 10.1016/j.bbagen.2016.03.022; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Xu W, 2010, BIOORG MED CHEM LETT, V20, P3084, DOI 10.1016/j.bmcl.2010.03.105; Zhang Jianfeng, 2017, BIOMED RES INT, V2017, P1, DOI DOI 10.1002/SMTD.201700258	39	22	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192135	10.1371/journal.pone.0192135	http://dx.doi.org/10.1371/journal.pone.0192135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415054	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300052
J	Huang, MZ; Wang, SY; Wang, H; Cui, DA; Yang, YJ; Liu, XW; Kong, XJ; Li, JY				Huang, Mei-Zhou; Wang, Sheng-Yi; Wang, Hui; Cui, Dong-An; Yang, Ya-Jun; Liu, Xi-Wang; Kong, Xiao-Jun; Li, Jian-Yong			Differences in the intestinal microbiota between uninfected piglets and piglets infected with porcine epidemic diarrhea virus	PLOS ONE			English	Article							SEQUENCING DATA; GENE-SEQUENCES; MICROFLORA; GUT; COMMUNITIES; HYPOTHESIS; DIVERSITY; CHINA; BOWEL	Porcine epidemic diarrhea, a disastrous gastrointestinal disease, causes great financial losses due to its high infectivity, morbidity and mortality in suckling piglets despite the development and application of various vaccines. In this study, high-throughput sequencing was used to explore differences in the intestinal microbiota between uninfected piglets and piglets infected with porcine epidemic diarrhea virus (PEDV). The results revealed that the small intestinal microbiota of suckling piglets infected with PEDV showed low diversity and was dominated by Proteobacteria (49.1%). Additionally, the composition of the small intestinal microbiota of sucking piglets infected with PEDV showed marked differences from that of the uninfected piglets. Some of the taxa showing differences in abundance between uninfected piglets and piglets infected with PEDV were associated with cellular transport and catabolism, energy metabolism, the biosynthesis of other secondary metabolites, and amino acid metabolism as determined through the prediction of microbial function based on the bacterial 16S rRNA gene. Therefore, adjusting the intestinal microbiota might be a promising method for the prevention or treatment of PEDV.	[Huang, Mei-Zhou; Wang, Sheng-Yi; Wang, Hui; Cui, Dong-An; Yang, Ya-Jun; Liu, Xi-Wang; Kong, Xiao-Jun; Li, Jian-Yong] Lanzhou Inst Husb & Pharmaceut Sci CAAS, Lanzhou, Gansu, Peoples R China; [Huang, Mei-Zhou; Wang, Sheng-Yi; Wang, Hui; Cui, Dong-An; Yang, Ya-Jun; Liu, Xi-Wang; Kong, Xiao-Jun; Li, Jian-Yong] Key Lab New Anim Drug Project Gansu Prov, Lanzhou, Gansu, Peoples R China; [Huang, Mei-Zhou; Wang, Sheng-Yi; Wang, Hui; Cui, Dong-An; Yang, Ya-Jun; Liu, Xi-Wang; Kong, Xiao-Jun; Li, Jian-Yong] Minist Agr, Key Lab Vet Pharmaceut Dev, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Li, JY (corresponding author), Lanzhou Inst Husb & Pharmaceut Sci CAAS, Lanzhou, Gansu, Peoples R China.; Li, JY (corresponding author), Key Lab New Anim Drug Project Gansu Prov, Lanzhou, Gansu, Peoples R China.; Li, JY (corresponding author), Minist Agr, Key Lab Vet Pharmaceut Dev, Lanzhou, Gansu, Peoples R China.	lijy1971@163.com		Huang, Mei-Zhou/0000-0003-2538-0217	science-technology innovation engineering of CAAS (CAAS-ASTIP-LIHPS); Special Fund for Agro-Scientific Research in the public Interest [201303040-18]; Science-Technology Innovation Engineering of CAAS (CAASASTIP-LIHPS)	science-technology innovation engineering of CAAS (CAAS-ASTIP-LIHPS); Special Fund for Agro-Scientific Research in the public Interest; Science-Technology Innovation Engineering of CAAS (CAASASTIP-LIHPS)	This work was supported by (1) science-technology innovation engineering of CAAS (CAAS-ASTIP-2014-LIHPS) http://www.caas.net.cn/index.html (2) the Special Fund for Agro-Scientific Research in the public Interest (No.201303040-18) http://www.most.gov.cn/.; The study was funded by the Special Fund for Agro-Scientific Research in the Public Interest (No. 201303040-18) and Science-Technology Innovation Engineering of CAAS (CAAS-ASTIP-2014-LIHPS).	Alverdy JC, 2008, J LEUKOCYTE BIOL, V83, P461, DOI 10.1189/jlb.0607372; Avershina E, 2013, MICROBES ENVIRON, V28, P211, DOI 10.1264/jsme2.ME12157; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Dee S, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0176-9; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Herich R, 2004, BERL MUNCH TIERARZTL, V117, P46; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; John J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0355-3; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li M, 2014, ISME J, V8, P1609, DOI 10.1038/ismej.2014.10; Liang J, 2014, J DIGEST DIS, V15, P641, DOI 10.1111/1751-2980.12211; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Parekh PJ, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00055; Rist VTS, 2014, ANAEROBE, V25, P72, DOI 10.1016/j.anaerobe.2013.10.003; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Song DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120310; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Yang Z, 2012, DRUG METAB DISPOS, V40, P1538, DOI 10.1124/dmd.111.044008; Zhang B, 2014, J GEN VIROL, V95, P1603, DOI 10.1099/vir.0.063743-0; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117441	34	22	23	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192992	10.1371/journal.pone.0192992	http://dx.doi.org/10.1371/journal.pone.0192992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447243	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900089
J	Lin, KB; Yang, NP; Lee, YH; Chan, CL; Wu, CH; Chen, HC; Chang, NT				Lin, Kai-Biao; Yang, Nan-Ping; Lee, Yi-Hui; Chan, Chien-Lung; Wu, Chi-Hsu; Chen, Hou-Chuan; Chang, Nien-Tzu			The incidence and factors of hip fractures and subsequent morbidity in Taiwan: An 11-year population-based cohort study	PLOS ONE			English	Article							MORTALITY; REHABILITATION; OUTCOMES; SURGERY; RATES; WOMEN	Hip fractures are a major problem to elder population, but subsequent morbidity is unclear about environmental factors and socioeconomic conditions. The study aims to investigate the incidence of hip fractures treated by the surgery; to compare the sequelae and temporal trends of hip fractures; to evaluate the seasonal effects in the subsequent short-term and long-term morbidities after hip fractures. A cohort study design is conducted using national health research datasets between 2000 and 2010. The ICD-9-CM diagnostic codes were utilized to investigate the incidence of hip fractures and the corresponding treatments. Hierarchical modeling was used to analyze the factors associated with various types of hip fractures. The results indicated that females had a lower incidence in the 30-44 age group, but a significantly higher incidence than males among those aged 60 years or older (adjusted rates 232.1 vs. 100.3 per 100,000 persons, p<0.001). The incidence of hip fractures in the low-income group showed no significant difference compared to that in the general population. There was a temporal trend of a 8.6% increase in the incidence of all types of hip fractures over the period of 2000-2010. A summer-winter variation is observed among the elderly. Hip fractures and subsequent morbidity are increasing in Taiwan's aging society. Older age, female gender, and time periods were independent risk factors for subsequent morbidities after surgical treatment. The result of this study is useful to the healthcare policy makers and to raise the public awareness of hip fractures.	[Lin, Kai-Biao] Xiamen Univ Technol, Sch Comp & Informat Engn, Xiamen, Peoples R China; [Lin, Kai-Biao; Chan, Chien-Lung] Yuan Ze Univ, Dept Informat Management, Taoyuan, Taiwan; [Yang, Nan-Ping] Keelung Hosp, Minist Hlth & Welf, Dept Surg & Orthoped, Keelung, Taiwan; [Yang, Nan-Ping; Chen, Hou-Chuan] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Yang, Nan-Ping; Chen, Hou-Chuan] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Lee, Yi-Hui; Chang, Nien-Tzu] Natl Taiwan Univ, Sch Nursing, Coll Med, Taipei, Taiwan; [Lee, Yi-Hui] Chang Gang Univ, Dept Nursing, Coll Med, Sch Nursing, Taoyuan, Taiwan; [Chan, Chien-Lung] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan; [Wu, Chi-Hsu] Univ Strathclyde, Dept Bioengn, Glasgow, Lanark, Scotland; [Chen, Hou-Chuan] Taoyuan Hosp, Minist Hlth & Welf, Dept Orthoped, Taoyuan, Taiwan	Xiamen University of Technology; Yuan Ze University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; Chang Gung University; Yuan Ze University; University of Strathclyde	Chang, NT (corresponding author), Natl Taiwan Univ, Sch Nursing, Coll Med, Taipei, Taiwan.	changnt@gmail.com	Chan, Chien-Lung/K-2086-2012	Chan, Chien-Lung/0000-0002-7486-7075; Chang, Nien-Tzu/0000-0001-7611-3843	Ministry of Health & Welfare in Taiwan [DOH103-HO-1008, 10501]	Ministry of Health & Welfare in Taiwan	This study was partially supported by Ministry of Health & Welfare in Taiwan (Grant No: DOH103-HO-1008 and 10501 to HC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by Ministry of Health & Welfare in Taiwan (Grant No: DOH103-HO-1008 and 10501). The authors also thank the National Health Research Institute for providing the data.	Ballane G, 2013, GEOGRAPHIC VARIABILI, P623; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Cheng SY, 2011, OSTEOPOROSIS INT, V22, P2575, DOI 10.1007/s00198-011-1596-z; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Dettori Joseph R, 2011, Evid Based Spine Care J, V2, P7, DOI 10.1055/s-0030-1267080; Dhanwal DK, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/757102; Dhanwal DK, 2011, INDIAN J ORTHOP, V45, P15, DOI 10.4103/0019-5413.73656; Diamantopoulos AP, 2012, AGE AGEING, V41, P86, DOI 10.1093/ageing/afr114; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Emaus N, 2011, OSTEOPOROSIS INT, V22, P2603, DOI 10.1007/s00198-010-1485-x; Guilley E, 2011, OSTEOPOROSIS INT, V22, P647, DOI 10.1007/s00198-010-1287-1; Hagino H, 2004, J ORTHOP SCI, V9, P1, DOI 10.1007/s00776-003-0741-8; Halbert J, 2007, J REHABIL MED, V39, P507, DOI 10.2340/16501977-0102; Hansen L, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0126-3; Hershkovitz A, 2012, DISABIL REHABIL, V34, P304, DOI 10.3109/09638288.2011.606346; Huang JW, 2017, CLIN INTERV AGING, V12, P97, DOI 10.2147/CIA.S119186; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Klop C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143800; Liou MJ, 2002, AGE AGEING, V31, P483, DOI 10.1093/ageing/31.6.483; Mnif H, 2009, ORTHOP TRAUMATOL-SUR, V95, P505, DOI 10.1016/j.otsr.2009.08.001; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; Mundi S, 2014, ACTA ORTHOP, V85, P54, DOI 10.3109/17453674.2013.878831; National Health Insurance Administration Ministry of Health & Welfare Taiwan, TAIW NHI INF PUBL ES; Nazrun AS, 2014, THER CLIN RISK MANAG, V10, P937, DOI 10.2147/TCRM.S72456; Rosengren BE, 2014, ACTA ORTHOP, V85, P234, DOI 10.3109/17453674.2014.916491; Shyu YIL, 2016, INT J NURS STUD, V56, P54, DOI 10.1016/j.ijnurstu.2015.12.005; WILLIAMS MA, 1994, RES NURS HEALTH, V17, P175, DOI 10.1002/nur.4770170305; Yang NP, 2006, HEALTH POLICY, V75, P329, DOI 10.1016/j.healthpol.2005.04.009	29	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192388	10.1371/journal.pone.0192388	http://dx.doi.org/10.1371/journal.pone.0192388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447190	gold, Green Accepted, Green Published			2022-12-26	WOS:000425283900030
J	Pearse, AT; Rabbe, M; Juliusson, LM; Bidwell, MT; Craig-Moore, L; Brandt, DA; Harrell, W				Pearse, Aaron T.; Rabbe, Matt; Juliusson, Lara M.; Bidwell, Mark T.; Craig-Moore, Lea; Brandt, David A.; Harrell, Wade			Delineating and identifying long-term changes in the whooping crane (Grus americana) migration corridor	PLOS ONE			English	Article							PRAIRIE POTHOLE REGION; CLIMATE-CHANGE; GREAT-PLAINS; NORTH-AMERICA; CONSERVATION; DISTRIBUTIONS; RESPONSES; SHIFTS; GEESE; USA	Defining and identifying changes to seasonal ranges of migratory species is required for effective conservation. Historic sightings of migrating whooping cranes (Grus americana) have served as sole source of information to define a migration corridor in the Great Plains of North America (i.e., Canadian Prairies and United States Great Plains) for this endangered species. We updated this effort using past opportunistic sightings from 1942-2016 (n = 5,055) and more recent (2010-2016) location data from 58 telemetered birds (n = 4,423) to delineate migration corridors that included 50%, 75%, and 95% core areas. All migration corridors were well defined and relatively compact, with the 95% core corridor averaging 294 km wide, although it varied approximately +/- 40% in width from 170 km in central Texas to 407 km at the international border of the United States and Canada. Based on historic sightings and telemetry locations, we detected easterly movements in locations over time, primarily due to locations west of the median shifting east. This shift occurred from northern Oklahoma to central Saskatchewan at an average rate of 1.2 km/year (0.3-2.8 km/year). Associated with this directional shift was a decrease in distance of locations from the median in the same region averaging -0.7 km/year (-0.3-1.3 km/year), suggesting a modest narrowing of the migration corridor. Changes in the corridor over the past 8 decades suggest that agencies and organizations interested in recovery of this species may need to modify where conservation and recovery actions occur. Whooping cranes showed apparent plasticity in their migratory behavior, which likely has been necessary for persistence of a wetland-dependent species migrating through the drought-prone Great Plains. Behavioral flexibility will be useful for whooping cranes to continue recovery in a future of uncertain climate and land use changes throughout their annual range.	[Pearse, Aaron T.; Brandt, David A.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA; [Rabbe, Matt] US Fish & Wildlife Serv, Nebraska Ecol Serv Field Off, Wood River, NE USA; [Juliusson, Lara M.] US Fish & Wildlife Serv, Lakewood, CO USA; [Bidwell, Mark T.; Craig-Moore, Lea] Environm & Climate Change Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada; [Harrell, Wade] US Fish & Wildlife Serv, Austwell, TX USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Environment & Climate Change Canada; Canadian Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Pearse, AT (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA.	apearse@usgs.gov		Pearse, Aaron/0000-0002-6137-1556	Canadian Wildlife Service; Crane Trust; U.S. Fish and Wildlife Service; U.S. Geological Survey; Platte River Recovery Implementation Program; Gulf Coast Bird Observatory; International Crane Foundation; Parks Canada	Canadian Wildlife Service; Crane Trust; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey); Platte River Recovery Implementation Program; Gulf Coast Bird Observatory; International Crane Foundation; Parks Canada	Financial support was provided by the Canadian Wildlife Service to Mark Bidwell, Crane Trust, U.S. Fish and Wildlife Service to Wade Harrell, U.S. Geological Survey to Aaron Pearse, and the Platte River Recovery Implementation Program to Aaron Pearse. The Crane Trust and Platte River Recovery Implementation Program had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The U.S. Fish and Wildlife Service, U.S. Geological Survey, and Canadian Wildlife Service contributed as described in author roles.; Logistic and administrative support was provided by the Canadian Wildlife Service, Crane Trust, U.S. Fish and Wildlife Service, U.S. Geological Survey, and the Platte River Recovery Implementation Program, with additional support from the Gulf Coast Bird Observatory, International Crane Foundation, and Parks Canada. F. Chavez-Ramirez, B. Strobel, M. Harner, G. Wright, and B. Hartup, were integral to the initiation and continuation of the telemetry aspects of this work. We thank the thousands of private citizens and professional biologists that submitted and confirmed whooping crane sightings for >8 decades and the U.S. Fish and Wildlife Service and Canadian Wildlife Service for managing these long-term databases.	ALISAUSKAS RT, 1992, J WILDLIFE MANAGE, V56, P43, DOI 10.2307/3808789; Allen R. P, 1952, THE WHOOPING CRANE; [Anonymous], 2010, MAPPING SPECIES DIST; Askins Robert A., 2007, Ornithological Monographs, V64, pi; Austin JE, 2005, PATTERNS HABITAT USE, V9, P79; Bauer S, 2008, J ANIM ECOL, V77, P654, DOI 10.1111/j.1365-2656.2008.01381.x; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; Chavez-Ramirez F, 2012, WETLANDS, V32, P11, DOI 10.1007/s13157-011-0250-z; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark JS, 2002, ECOLOGY, V83, P595, DOI 10.1890/0012-9658(2002)083[0595:DCALRT]2.0.CO;2; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hefley TJ, 2014, METHODS ECOL EVOL, V5, P207, DOI 10.1111/2041-210X.12144; Hefley TJ, 2013, ECOL EVOL, V3, P5225, DOI 10.1002/ece3.887; HEUSMANN HW, 1991, WILDLIFE SOC B, V19, P14; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Hovick TJ, 2016, BIODIVERS CONSERV, V25, P345, DOI 10.1007/s10531-016-1053-6; Johns B.W., 1992, P N AM CRAN WORKSH, P61; Johnston CA, 2013, WETLANDS, V33, P175, DOI 10.1007/s13157-012-0365-x; Jorgensen JG, 2017, WATERBIRDS, V40, P195, DOI 10.1675/063.040.0302; Krapu GL, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.1; Kuyt E., 1992, 74 CAN WILDL SERV; La Sorte FA, 2014, J BIOGEOGR, V41, P1685, DOI 10.1111/jbi.12328; Laubhan Murray K., 1997, Ecological Studies, V125, P20; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; Millett B, 2009, CLIMATIC CHANGE, V93, P243, DOI 10.1007/s10584-008-9543-5; Newbold S, 2004, ECOL APPL, V14, P1384, DOI 10.1890/03-5193; Niemuth ND, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P533, DOI 10.1016/B978-0-12-373631-4.00020-4; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearse A. T., 2017, 20161209 US GEOL SUR, DOI [10.3133/ofr20161209, DOI 10.3133/OFR20161209]; Pearse A. T., 2015, 20151166 US GEOL SUR, DOI [10.3133/ofr20151166, DOI 10.3133/OFR20151166]; Pearse AT, 2016, CONDOR, V118, P391, DOI 10.1650/CONDOR-15-99.1; Pearse AT, 2018, MAP WHOOPING CRANE M; Pearse AT, 2017, SPATIAL DATA ESTIMAT; Reynolds RE, 2006, WILDLIFE SOC B, V34, P963, DOI 10.2193/0091-7648(2006)34[963:TFBADP]2.0.CO;2; Ringelman J.K., 1989, P311; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; *SERV ARG INC, 2001, ARG US MAN; Stehn T.V., 2008, P N AM CRANE WORKSHO, V10, P25; Stevenson James O., 1946, CONDOR, V48, P160, DOI 10.2307/1363971; Sutherland WJ, 1998, J AVIAN BIOL, V29, P441, DOI 10.2307/3677163; Tacha M, 2010, P N AM CRAN WORKSH, V11, P98; US Fish and Wildlife Service Canadian Wildlife Service, 2007, INT REC PLAN WHOOP C; Vrtiska Mark P., 2009, Great Plains Research, V19, P147; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson S, 2016, BIOL CONSERV, V197, P1, DOI 10.1016/j.biocon.2016.02.022; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	50	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192737	10.1371/journal.pone.0192737	http://dx.doi.org/10.1371/journal.pone.0192737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447213	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900048
J	Sinclair, KJ; Friesen-Waldner, LJ; McCurdy, CM; Wiens, CN; Wade, TP; de Vrijer, B; Regnault, TRH; McKenzie, CA				Sinclair, Kevin J.; Friesen-Waldner, Lanette J.; McCurdy, Colin M.; Wiens, Curtis N.; Wade, Trevor P.; de Vrijer, Barbra; Regnault, Timothy R. H.; McKenzie, Charles A.			Quantification of fetal organ volume and fat deposition following in utero exposure to maternal Western Diet using MRI	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; ADIPOSE-TISSUE; GUINEA-PIG; DEVELOPMENTAL ORIGINS; METABOLIC SYNDROME; LIVER-DISEASE; FRUCTOSE; OBESITY; GROWTH; HYPERLIPEMIA	Purpose To examine the feasibility of using MRI to identify differences in liver size and fat deposition in fetal guinea pigs exposed to an in utero environment influenced by maternal consumption of a Western diet. Materials and methods Female guinea pigs fed either an energy-dense Western Diet (WD), comprised of increased saturated fats and simple sugars, or a Control Diet (CD) from weaning through pregnancy, underwent MR scanning near term (similar to 60 days; term similar to 69 days). Maternal weights were collected at mating and at MR scanning. T-1-weighted, T-2-weighted, and IDEAL water-fat images were acquired at 3 Tesla. The images were used to segment maternal adipose tissue, fetal liver, fetal brain, fetal adipose tissue, and total fetal volumes and to measure maternal and fetal hepatic fat fractions. Results Weights of WD sows were lower prior to pregnancy (P=.04), however their weight gain over pregnancy did not differ from the CD group (P=.98). The WD sows had less total adipose tissue (TAT) at MR scanning (P=.04), while hepatic fat content was significantly elevated (P=.04). When controlling for litter size, WD fetuses had larger livers (P=.02), smaller brains (P=.01), and increased total adipose tissue volume (P=.01) when normalized by fetal volume. The WD fetuses also had increased hepatic fat fractions compared to CD fetal livers (P<.001). Conclusion Maternal Western Diet consumption prior to and during pregnancy induces differences in maternal liver fat content, fetal liver volume and liver fat storage, as well as changes in fetal adipose tissue deposition that can be measured in utero using MRI.	[Sinclair, Kevin J.; Friesen-Waldner, Lanette J.; McCurdy, Colin M.; Wade, Trevor P.; McKenzie, Charles A.] Western Univ, Dept Med Biophys, London, ON, Canada; [Wiens, Curtis N.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Wade, Trevor P.; McKenzie, Charles A.] Western Univ, Robarts Res Inst, London, ON, Canada; [de Vrijer, Barbra; Regnault, Timothy R. H.] Western Univ, Dept Obstet & Gynaecol, London, ON, Canada; [de Vrijer, Barbra; Regnault, Timothy R. H.] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada; [de Vrijer, Barbra; Regnault, Timothy R. H.; McKenzie, Charles A.] Childrens Hlth Res Inst, London, ON, Canada; [de Vrijer, Barbra; Regnault, Timothy R. H.; McKenzie, Charles A.] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); University of Wisconsin System; University of Wisconsin Madison; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Sinclair, KJ (corresponding author), Western Univ, Dept Med Biophys, London, ON, Canada.	ksincl3@uwo.ca	Regnault, Timothy RH/AAE-3168-2021; McKenzie, Charles A/I-6014-2012; Regnault, Timothy/J-8902-2014; Regnault, Timothy RH/GVS-9382-2022	McKenzie, Charles A/0000-0002-9614-1582; Regnault, Timothy/0000-0003-1930-8358; Regnault, Timothy RH/0000-0003-1930-8358; Sinclair, Kevin/0000-0002-5203-7484; Friesen-Waldner, Lanette/0000-0001-9812-9766	Canada Research Chairs Program [950-228038]; Natural Sciences and Engineering Research Council of Canada [RGPIN-356310-2013]; Ontario Research Fund [RE03-051]; Canadian Institutes of Health Research [CIHR-MOP-209113]	Canada Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canada Research Chairs Program (CAM: #950-228038): http://www.chairs-chaires.gc.ca/home-accueii-eng.aspx; Natural Sciences and Engineering Research Council of Canada (CAM: RGPIN-356310-2013): http://www.nserc-crsng.gc.ca/Professors-professeurs/Grants-Subs/DGIGP-pSIGP_enp.asp; Ontario Research Fund (CAM: RE03-051): https:// www.ontario.ca/page/ontario-research-fund; and Canadian Institutes of Health Research (TRHR: CIHR-MOP-209113): http://www.cihr-irsc.gc.ca/e/37788.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1994, J LIPID RES, V35, P1490; Anblagan D, 2013, ULTRASOUND OBST GYN, V42, P335, DOI 10.1002/uog.12382; [Anonymous], METABOLIC SYNDROME C; BARON H, 1968, J NUTR, V94, P95, DOI 10.1093/jn/94.1.95; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; BOHMER T, 1975, J LIPID RES, V16, P454; BOHMER T, 1972, J LIPID RES, V13, P371; Bouanane S, 2010, METABOLISM, V59, P1701, DOI 10.1016/j.metabol.2010.04.003; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Brumbaugh DE, 2014, PEDIATR RES, V75, P140, DOI 10.1038/pr.2013.193; Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017; Cambri LT, 2010, NUTR RES, V30, P156, DOI 10.1016/j.nutres.2010.01.001; Casellas J, 2014, J ANIM SCI, V92, P64, DOI 10.2527/jas.2013-6677; Castaneda-Gutierrez E, 2011, AM J CLIN NUTR, V94, p1838S, DOI 10.3945/ajcn.110.000794; Chen CYO, 2010, EUR J NUTR, V49, P337, DOI 10.1007/s00394-009-0091-1; CHEVALIER MM, 1972, J NUTR, V102, P337, DOI 10.1093/jn/102.3.337; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Desai M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.025; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; ENGLE WA, 1986, PEDIATR RES, V20, P1156, DOI 10.1203/00006450-198611000-00023; Godfrey KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041759; Gueant JL, 2014, PFLUG ARCH EUR J PHY, V466, P833, DOI 10.1007/s00424-013-1339-4; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Hines CDG, 2010, RADIOLOGY, V254, P119, DOI [10.1148/radiol.09090131, 10.1148/radiol.2531090131]; Horton DM, 2016, J DEV ORIG HLTH DIS, V7, P548, DOI 10.1017/S2040174416000295; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Ishikawa M, 1998, MAGN RESON IMAGING, V16, P45, DOI 10.1016/S0730-725X(97)00221-X; Janevski M, 2012, FOOD FUNCT, V3, P141, DOI 10.1039/c1fo10111k; JONES CT, 1983, J PHYSIOL-LONDON, V343, P525, DOI 10.1113/jphysiol.1983.sp014907; Kind KL, 2006, REPROD BIOMED ONLINE, V12, P532, DOI 10.1016/S1472-6483(10)61178-9; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Misra Vijay Laxmi, 2009, Curr Gastroenterol Rep, V11, P50; Modi N, 2011, PEDIATR RES, V70, P287, DOI 10.1203/PDR.0b013e318225f9b1; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Paschos P, 2009, HIPPOKRATIA, V13, P9; Rajia S, 2010, J NEUROENDOCRINOL, V22, P905, DOI 10.1111/j.1365-2826.2010.02005.x; Saleem SN, 2014, J ADV RES, V5, P507, DOI 10.1016/j.jare.2013.06.001; Sarr O, 2016, J PHYSIOL-LONDON, V594, P1753, DOI 10.1113/JP271777; Siega-Riz AM, 2002, AM J OBSTET GYNECOL, V186, P480, DOI 10.1067/mob.2002.121078; Symonds ME, 2003, J ENDOCRINOL, V179, P293, DOI 10.1677/joe.0.1790293; Tchirikov M, 2001, PLACENTA, V22, P24, DOI 10.1053/plac.2000.0585; Thomas EL, 2008, ARCH DIS CHILD-FETAL, V93, pF382, DOI 10.1136/adc.2007.127431; Thompson JA, 2014, J PHYSIOL-LONDON, V592, P5429, DOI 10.1113/jphysiol.2014.275016; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; Visentin S, 2014, ATHEROSCLEROSIS, V237, P391, DOI 10.1016/j.atherosclerosis.2014.09.027; VRANA A, 1974, NUTR METAB, V17, P74, DOI 10.1159/000175521; Yu HZ, 2008, MAGN RESON MED, V60, P1122, DOI 10.1002/mrm.21737	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192900	10.1371/journal.pone.0192900	http://dx.doi.org/10.1371/journal.pone.0192900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447203	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900068
J	Wang, QQ; Guo, LL; Strawser, CJ; Hauser, LA; Hwang, WT; Snyder, NW; Lynch, DR; Mesaros, C; Blair, IA				Wang, QingQing; Guo, Lili; Strawser, Cassandra J.; Hauser, Lauren A.; Hwang, Wei-Ting; Snyder, Nathaniel W.; Lynch, David R.; Mesaros, Clementina; Blair, Ian A.			Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy	PLOS ONE			English	Article							HEART-FAILURE; CARDIAC-FUNCTION; DIABETIC CARDIOMYOPATHY; SMOKING-CESSATION; APOA-I; MATURATION; DISEASE; MOUSE; IRON; HDL	Friedreich's ataxia (FA) is an autosomal recessive neurodegenerative disorder, which results primarily from reduced expression of the mitochondrial protein frataxin. FA has an estimated prevalence of one in 50,000 in the population, making it the most common hereditary ataxia. Paradoxically, mortality arises most frequently from cardiomyopathy and cardiac failure rather than from neurological effects. Decreased high-density lipoprotein (HDL) and apolipoprotein A-I (ApoA-l) levels in the general population are associated with an increased risk of mortality from cardiomyopathy and heart failure. However, the pathophysiology of heart disease in FA is non-vascular and there are conflicting data on HDL-cholesterol in FA. Two studies have shown a decrease in HDL-cholesterol compared with controls and two have shown there was no difference between FA and controls. One also showed that there was no difference in serum Apo-A-I levels in FA when compared with controls. Using a highly specific stable isotope dilution mass spectrometry-based assay, we demonstrated a 21.6% decrease in serum ApoA-I in FA patients (134.8 mg/dL, n = 95) compared with non-affected controls (172.1 mg/dL, n = 95). This is similar to the difference in serum ApoA-I levels between nonsmokers and tobacco smokers. Knockdown of frataxin by > 70% in human hepatoma HepG2 cells caused a 20% reduction in secreted ApoA-I. Simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor caused a 200% increase in HMG-CoA in the control HepG2 cells with a similar increase in the frataxin knockdown HepG2 cells, back to levels found in the control cells. There was a concomitant 20% increase in secreted ApoA-I to levels found in the control cells that were treated with simvastatin. This study provides compelling evidence that ApoA-I levels are reduced in FA patients compared with controls and suggest that statin treatment would normalize the ApoA-I levels.	[Wang, QingQing; Strawser, Cassandra J.; Hauser, Lauren A.; Lynch, David R.; Mesaros, Clementina; Blair, Ian A.] Childrens Hosp Philadelphia, Penn CHOP Ctr Excellence Friedreichs Ataxia, Philadelphia, PA 19104 USA; [Wang, QingQing; Guo, Lili; Mesaros, Clementina; Blair, Ian A.] Univ Penn, Perelman Sch Med, Penn SRP Ctr, Philadelphia, PA 19104 USA; [Wang, QingQing; Guo, Lili; Mesaros, Clementina; Blair, Ian A.] Univ Penn, Perelman Sch Med, Ctr Excellence Environm Toxicol Ctr, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Strawser, Cassandra J.; Hauser, Lauren A.; Lynch, David R.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Hwang, Wei-Ting] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Snyder, Nathaniel W.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Drexel University	Blair, IA (corresponding author), Childrens Hosp Philadelphia, Penn CHOP Ctr Excellence Friedreichs Ataxia, Philadelphia, PA 19104 USA.; Blair, IA (corresponding author), Univ Penn, Perelman Sch Med, Penn SRP Ctr, Philadelphia, PA 19104 USA.; Blair, IA (corresponding author), Univ Penn, Perelman Sch Med, Ctr Excellence Environm Toxicol Ctr, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.	ianblair@upenn.edu		Snyder, Nathaniel/0000-0001-5643-8747; Blair, Ian/0000-0003-0366-8658	Hamilton family; Finneran family; National Institute of Environmental Health Sciences [P30ES013508]; Penn Medicine/Friedrichs Ataxia Research Alliance; National Center for Advancing Translational Science [5UL1TR001878]; National Institute of Child Health and Human Development [R03HD092630]; Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD092630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, K22ES026235] Funding Source: NIH RePORTER	Hamilton family; Finneran family; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Penn Medicine/Friedrichs Ataxia Research Alliance; National Center for Advancing Translational Science; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Hamilton and Finneran families, the National Institute of Environmental Health Sciences, https://www.niehs.nih.gov/ (grant P30ES013508) to IAB; Penn Medicine/Friedrichs Ataxia Research Alliance, http://www.curefa.org/to DRL and IAB; the National Center for Advancing Translational Science, https://ncats.nih.gov/ (grant 5UL1TR001878) to IAB and DRL; and the National Institute of Child Health and Human Development, https://www.nichd.nih.gov/ (grant R03HD092630) to NWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the financial support of Hamilton and Finneran families and Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence.	Ahmed AA, 2015, CIRC-HEART FAIL, V8, P694, DOI 10.1161/CIRCHEARTFAILURE.114.001885; Alrob OA, 2014, BIOCHEM SOC T, V42, P1043, DOI 10.1042/BST20140094; BALDOENZI G, 1990, EUR NEUROL, V30, P132, DOI 10.1159/000117329; Barter PJ, 2010, J LIPID RES, V51, P1546, DOI 10.1194/jlr.P002816; Bonn V, 2002, ATHEROSCLEROSIS, V163, P59; Bonsu KO, 2015, CARDIOVASC THER, V33, P338, DOI 10.1111/1755-5922.12150; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chen K., 2016, ELIFE, V5; Chistiakov DA, 2016, LAB INVEST, V96, P708, DOI 10.1038/labinvest.2016.56; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Deo SV, 2014, HEART LUNG CIRC, V23, P985, DOI 10.1016/j.hlc.2014.04.007; Dullens SPJ, 2007, NUTR METAB CARDIOVAS, V17, P616, DOI 10.1016/j.numecd.2007.05.001; Filla A, 1980, Acta Neurol (Napoli), V2, P382; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Freitas HFG, 2009, BRAZ J MED BIOL RES, V42, P420, DOI 10.1590/S0100-879X2009000500004; Guo L, 2017, ANAL CHEM; Guo LL, 2016, RAPID COMMUN MASS SP, V30, P1835, DOI 10.1002/rcm.7667; Henneman L, 2011, BBA-MOL CELL BIOL L, V1811, P227, DOI 10.1016/j.bbalip.2011.01.002; Kipps A, 2009, PEDIATR CARDIOL, V30, P306, DOI 10.1007/s00246-008-9305-1; Koeppen AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116396; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Lightwood J, 2001, J AM COLL CARDIOL, V37, P1683, DOI 10.1016/S0735-1097(01)01188-3; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Maeda K, 2003, PREV MED, V37, P283, DOI 10.1016/S0091-7435(03)00110-5; Maejima T, 2004, BIOCHEM BIOPH RES CO, V324, P835, DOI 10.1016/j.bbrc.2004.09.122; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Mesaros C, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9121-1; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Pandolfo M, 1999, SEMIN NEUROL, V19, P311, DOI 10.1055/s-2008-1040847; Patel R, 2001, CIRCULATION, V104, P317, DOI 10.1161/hc2801.094031; Payne RM, 2012, IRISH J MED SCI, V181, P569, DOI 10.1007/s11845-012-0808-7; Payne RM, 2012, J CHILD NEUROL, V27, P1179, DOI 10.1177/0883073812448535; Plasterer HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063958; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rajagopalan B, 2010, MOVEMENT DISORD, V25, P846, DOI 10.1002/mds.22864; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Raman SV, 2011, EUR HEART J, V32, P561, DOI 10.1093/eurheartj/ehq443; Reetz K, 2015, LANCET NEUROL, V14, P174, DOI 10.1016/S1474-4422(14)70321-7; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Spillmann Frank, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P132; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Strawser C, 2017, EXPERT REV NEUROTHER, V17, P895, DOI 10.1080/14737175.2017.1356721; Vuilleumier N, 2010, ARTHRITIS RHEUM-US, V62, P2640, DOI 10.1002/art.27546; Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554; WALKER JL, 1980, J NEUROL NEUROSUR PS, V43, P111, DOI 10.1136/jnnp.43.2.111; Wang QQ, 2015, BIOANALYSIS, V7, P2895, DOI 10.4155/bio.15.195; Weidemann F, 2013, J NEUROCHEM, V126, P88, DOI 10.1111/jnc.12217	47	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192779	10.1371/journal.pone.0192779	http://dx.doi.org/10.1371/journal.pone.0192779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447225	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900054
J	McCully, M; Conde, J; Baptista, PV; Mullin, M; Dalby, MJ; Berry, CC				McCully, Mark; Conde, Joao; Baptista, Pedro V.; Mullin, Margaret; Dalby, Matthew J.; Berry, Catherine C.			Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; BONE-MARROW; OSTEOBLAST DIFFERENTIATION; MICRORNA EXPRESSION; SATB2; PROLIFERATION; MECHANISMS; PHENOTYPE; INSIGHTS; RUNX2	Mesenchymal stem cells are multipotent adult stem cells capable of generating bone, cartilage and fat, and are thus currently being exploited for regenerative medicine. When considering osteogenesis, developments have been made with regards to chemical induction (e.g. differentiation media) and physical induction (e.g. material stiffness, nanotopography), targeting established early transcription factors or regulators such as runx2 or bone morphogenic proteins and promoting increased numbers of cells committing to osteo-specific differentiation. Recent research highlighted the involvement of microRNAs in lineage commitment and terminal differentiation. Herein, gold nanoparticles that confer stability to short single stranded RNAs were used to deliver MiR-31 antagomiRs to both pre-osteoblastic cells and primary human MSCs in vitro. Results showed that blocking miR-31 led to an increase in osterix protein in both cell types at day 7, with an increase in osteocalcin at day 21, suggesting MSC osteogenesis. In addition, it was noted that antagomiR sequence direction was important, with the 5 prime reading direction proving more effective than the 3 prime. This study highlights the potential that miRNA antagomiR-tagged nanoparticles offer as novel therapeutics in regenerative medicine.	[McCully, Mark; Dalby, Matthew J.; Berry, Catherine C.] Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland; [Conde, Joao] Harvard MIT, Div Hlth Sci & Technol, Inst Med Engn & Sci, MIT, Cambridge, MA USA; [Baptista, Pedro V.] Univ Nova Lisboa, UCIBIO, DCV, Fac Ciencias & Tecnol, Campus Caparica, Caparica, Portugal; [Mullin, Margaret] Univ Glasgow, Electron Microscopy Unit, Glasgow, Lanark, Scotland	University of Glasgow; Harvard University; Massachusetts Institute of Technology (MIT); Universidade Nova de Lisboa; University of Glasgow	McCully, M; Berry, CC (corresponding author), Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland.	markamccully@gmail.com; Catherine.berry@glasgow.ac.uk	Baptista, Pedro V/A-1237-2009; Berry, Catherine/AAE-4493-2021; McCully, Mark/D-3192-2018; Conde, João/F-2231-2011; Baptista, Pedro/P-3182-2019	Baptista, Pedro V/0000-0001-5255-7095; McCully, Mark/0000-0002-2005-1062; Conde, João/0000-0001-8422-6792; Dalby, Matthew/0000-0002-0528-3359	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L008661/1]; Unidade de Ciencias Biomoleculares Aplicadas-UCIBIO - national funds from Fundacao para a Ciencia e a Tecnologia / Ministerio da Educacao e Ciencia (FCT/MEC) [UID/Multi/04378/2013]; European Regional Development Fund (ERDF) [POCI-01-0145-FEDER-007728];  [PD/BD/105734/2014]; BBSRC [BB/G008868/1, BB/L023814/1, BB/L008661/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L008661/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unidade de Ciencias Biomoleculares Aplicadas-UCIBIO - national funds from Fundacao para a Ciencia e a Tecnologia / Ministerio da Educacao e Ciencia (FCT/MEC); European Regional Development Fund (ERDF)(European Commission); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The author CCB wishes to acknowledge funding from the Biotechnology and Biological Sciences Research Council (BBSRC); BB/L008661/1. (https://www.bbsrc.ac.uk/); PVB was supported by the Unidade de Ciencias Biomoleculares Aplicadas-UCIBIO, which is financed by national funds from Fundacao para a Ciencia e a Tecnologia / Ministerio da Educacao e Ciencia (FCT/MEC) (https://www.fct.pt/) (UID/Multi/04378/2013) and co-financed by the European Regional Development Fund (ERDF) (http://ec.europa.eu/regional_policy/en/funding/erdf/) under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728); PP for PD/BD/105734/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Bhushan R, 2013, INT J BIOCHEM CELL B, V45, P696, DOI 10.1016/j.biocel.2012.12.008; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054130; Chang KW, 2013, ORAL ONCOL, V49, P27, DOI 10.1016/j.oraloncology.2012.07.003; Child HW, 2015, NANOMEDICINE-UK, V10, P2513, DOI 10.2217/NNM.15.95; Conde J, 2012, ACS NANO, V6, P8316, DOI 10.1021/nn3030223; Demontiero O, 2012, THER ADV MUSCULOSKEL, V4, P61, DOI 10.1177/1759720X11430858; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042; Dong WJ, 2015, J CELL PHYSIOL, V230, P680, DOI 10.1002/jcp.24792; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Grigsby CL, 2010, J R SOC INTERFACE, V7, pS67, DOI 10.1098/rsif.2009.0260; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Heggebo J, 2014, ORTHOP REV, V6, P65, DOI 10.4081/or.2014.5242; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; McCully M, 2015, NANO RES, V8, P3281, DOI 10.1007/s12274-015-0828-5; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Weilner S, 2016, AGING CELL, V15, P744, DOI 10.1111/acel.12484; Xie Q, 2014, BIOCHEM BIOPH RES CO, V446, P98, DOI 10.1016/j.bbrc.2014.02.058; Xu CY, 2016, CURR STEM CELL RES T, V11, P247, DOI 10.2174/1574888X10666150723145707; Yang JL, 2014, ACS NANO, V8, P9941, DOI 10.1021/nn504767g	36	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192562	10.1371/journal.pone.0192562	http://dx.doi.org/10.1371/journal.pone.0192562			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444183	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000425183500072
J	Mugabe, VA; Ali, S; Chelene, I; Monteiro, VO; Guiliche, OL; Muianga, AF; Mula, F; Antonio, V; Chongo, I; Oludele, J; Falk, K; Paploski, IA; Reis, MG; Kitron, U; Kummerer, BM; Ribeiro, GS; Gudo, ES				Mugabe, Vanio Andre; Ali, Sadia; Chelene, Imelda; Monteiro, Vanessa Onofre; Guiliche, Onelia; Muianga, Argentina Felisbela; Mula, Flora; Antonio, Virgilio; Chongo, Inocencio; Oludele, John; Falk, Kerstin; Paploski, Igor A.; Reis, Mitermayer G.; Kitron, Uriel; Kuemmerer, Beate M.; Ribeiro, Guilherme S.; Gudo, Eduardo Samo			Evidence for chikungunya and dengue transmission in Quelimane, Mozambique: Results from an investigation of a potential outbreak of chikungunya virus	PLOS ONE			English	Article							SEROPREVALENCE	Background In January 2016, health authorities from Zambezia province, Mozambique reported the detection of some patients presenting with fever, arthralgia, and a positive result for chikungunya in an IgM-based Rapid Diagnostic Test (RDT). We initiated a study to investigate a potential chikungunya outbreak in the city of Quelimane. Methods/Principal findings From February to June 2016, we conducted a cross-sectional study enrolling febrile patients attending five outpatient health units in Quelimane. Serum from each patient was tested for CHIKV and DENV, using IgM and IgG ELISA and qRT-PCR. Patients were also tested for malaria by RDT. Entomological surveys were performed around patients' households, and we calculated the proportion of positive ovitraps and the egg density per trap. A total of 163 patients were recruited, of which 99 (60.7%) were female. The median age was 28 years. IgM and IgG anti-CHIKV antibodies were identified in 17 (10.4%) and 103 (63.2%) patients, respectively. Plaque reduction neutralization assay confirmed the presence of anti-CHIKV antibodies in a subset of 11 tested patients with positive IgG results. IgM anti-DENV antibodies were found in 1 (0.9%) of 104 tested patients. Malaria was diagnosed in 35 (21.5%) patients, 2 of whom were also IgM-positive for CHIKV. Older age and lower education level were independently associated with the prevalence of IgG anti-CHIKV antibodies. Immature forms of Aedes aegypti were collected in 16 (20.3%) of 79 surveyed households. We also found that 25.0% (16/64) of the traps were positive, with an average of 90.8 eggs per pallet. Conclusions Our investigation demonstrated that no CHIKV outbreak was ongoing in Quelimane; rather, endemic transmission of the virus has been ongoing. Aedes aegypti mosquitoes are abundant, but dengue cases occurred only sporadically. Further population-based cohort studies are needed to improve our understanding of aspects related to the dynamics of arboviral transmission in Mozambique, as well as in other parts of Sub-Saharan Africa.	[Mugabe, Vanio Andre; Paploski, Igor A.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Mugabe, Vanio Andre; Paploski, Igor A.; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil; [Mugabe, Vanio Andre] Univ Pedag Quelimane, Zambezia, Mozambique; [Ali, Sadia; Chelene, Imelda; Monteiro, Vanessa Onofre; Guiliche, Onelia; Muianga, Argentina Felisbela; Mula, Flora; Antonio, Virgilio; Chongo, Inocencio; Oludele, John; Gudo, Eduardo Samo] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Falk, Kerstin] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Falk, Kerstin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA; [Kuemmerer, Beate M.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Public Health Agency of Sweden; Karolinska Institutet; Universidade Federal da Bahia; Emory University; University of Bonn	Gudo, ES (corresponding author), Minist Saude, Inst Nacl Saude, Maputo, Mozambique.	esamogudojr@gmail.com	Reis, Mitermayer/AAO-9742-2020; Paploski, Igor AD/D-7015-2014; Kümmerer, Beate/HGV-0882-2022; Ribeiro, Guilherme/B-6624-2008	Reis, Mitermayer/0000-0002-3051-9060; Paploski, Igor AD/0000-0002-3689-2042; Ribeiro, Guilherme/0000-0002-6798-2059; Ali-Pereira, Sadia/0000-0001-5275-2659; Mugabe, Vanio/0000-0001-6676-4378; Kitron, Uriel/0000-0003-0493-2043	European Foundation Initiative into Neglected Tropical Disease [91 488]; U.S. Centers for Disease Control and Prevention [5NU14GH001237-03-00]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	European Foundation Initiative into Neglected Tropical Disease; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	ESG received funds from the European Foundation Initiative into Neglected Tropical Disease (Grant # 91 488) and by the U.S. Centers for Disease Control and Prevention through a cooperative agreement number 5NU14GH001237-03-00. The views expressed in this written publication do not necessarily reflect the official policies of the U.S. Department of Health and Human Services. VAM, IADP, UK and GSR received scholarships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly MM, 2017, BIOMED CENTRAL, P4; [Anonymous], WHO DIR GEN SUMM OUT; CDC, 2016, TRIOPL REAL TIM RI P; Dick GWA, 1952, ZIKA VIRUS, P46; Diop D, 2015, MOJ PUBLIC HLTH, V2, P43; Glasker S, 2013, VIRUS REPLICON PARTI, P1; GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280; Gudo ES, 2015, SEROLOGICAL EVIDENCE, P1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29; Hopkins H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1054; Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4; Kikuti M, 2015, SPATIAL DISTRIBUTION, P1; KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201; Kraemer MUG, 2015, GLOBAL DISTRIBUTION, P1; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003721; Lala A., 2013, ESTUDO BASE CONSELHO; Massangaie M, 2016, AM J TROP MED HYG, V94, P413, DOI 10.4269/ajtmh.15-0543; Messina JP, 2007, MAPPING GLOBAL ENV S, V2016, P1; Ministerio de Economia e Financas de Mocambique, 2016, POBR BEM EST MOC QUA, P87; Muianga A, 2016, INT J INFECT DIS, V45, P174, DOI 10.1016/j.ijid.2016.02.411; Nsoesie EO, 2015, GLOBAL DISTRIBUTION, P1; Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645; Rezza G, 2016, DENGUE CHIKUNGUNYA L, P7724; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROBINSON MC, 1955, EPIDEMIC VIRUS DIS S, P28; Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WORTH C. BROOKE, 1960, AN INST MED TROP, V17, P231; Yusoff AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-211	33	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192110	10.1371/journal.pone.0192110	http://dx.doi.org/10.1371/journal.pone.0192110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415070	Green Submitted, gold, Green Published			2022-12-26	WOS:000424325300050
J	Zhao, CH; Shen, X; Guo, MR				Zhao, Changhui; Shen, Xue; Guo, Mingruo			Stability of lutein encapsulated whey protein nano-emulsion during storage	PLOS ONE			English	Article							MACULAR PIGMENT; DELIVERY; CANCER; RISK; ANTIOXIDANTS; PRETREATMENT; CAROTENOIDS; TEMPERATURE; ULTRASOUND; PREVENTION	Lutein is a hydrophobic carotenoid that has multiple health functions. However, the application of lutein is limited due to its poor solubility in water and instability under certain conditions during storage. Hereby we generated lutein loaded nano-emulsions using whey protein isolate (WPI) or polymerized whey protein isolate (PWP) with assistance of high intensity ultrasound and evaluate their stability during storage at different conditions. We measured the particle size, zeta-potential, physical stability and lutein content change. Results showed that the PWP based nano-emulsion system was not stable in the tested Oil/Water/Ethanol system indicated by the appearance of stratification within only one week. The WPI based nano-emulsion system showed stable physiochemical stability during the storage at 4 degrees C. The lutein content of the system was reduced by only 4% after four weeks storage at 4 degrees C. In conclusion, our whey protein based nano-emulsion system provides a promising strategy for encapsulation of lutein or other hydrophobic bioactive molecules to expand their applications.	[Zhao, Changhui; Shen, Xue] Jilin Univ, Coll Food Sci & Engn, Changchun, Jilin, Peoples R China; [Shen, Xue] Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis, Changchun, Jilin, Peoples R China; [Guo, Mingruo] Northeast Agr Univ, Dept Food Sci, Harbin, Heilongjiang, Peoples R China; [Guo, Mingruo] Univ Vermont, Dept Nutr & Food Sci, Burlington, VT USA	Jilin University; Jilin University; Northeast Agricultural University - China; University of Vermont	Zhao, CH (corresponding author), Jilin Univ, Coll Food Sci & Engn, Changchun, Jilin, Peoples R China.	czhao@jlu.edu.cn	Zhao, Changhui/N-2378-2019	Zhao, Changhui/0000-0002-1882-7490	Fundamental Research Funds for Young Researchers [451160301317];  [419080500712]	Fundamental Research Funds for Young Researchers; 	The research was partly supported by the Fundamental Research Funds for Young Researchers (Grant No. 451160301317) and partly by Startup Funds to Overseas Doctorate Talents Plan B (Grant No. 419080500712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT J FOOD SCI TECHN; BANKS W, 1985, FOOD CHEM, V18, P139, DOI 10.1016/0308-8146(85)90137-2; BONE RA, 1988, INVEST OPHTH VIS SCI, V29, P843; Boon CS, 2010, CRIT REV FOOD SCI, V50, P515, DOI 10.1080/10408390802565889; Breithaupt DE, 2007, TRENDS FOOD SCI TECH, V18, P501, DOI 10.1016/j.tifs.2007.04.009; Chen C., 2015, FUNCTIONAL CHARACTER; Cooper DA, 1999, NUTR REV, V57, P201, DOI 10.1111/j.1753-4887.1999.tb06944.x; Davidov-Pardo G, 2016, FOOD CHEM, V196, P821, DOI 10.1016/j.foodchem.2015.10.018; De Stefani E, 1999, NUTR CANCER, V34, P100, DOI 10.1207/S15327914NC340114; Dickinson E, 2010, COLLOID SURFACE B, V81, P130, DOI 10.1016/j.colsurfb.2010.06.033; Frede K, 2014, J FUNCT FOODS, V8, P118, DOI 10.1016/j.jff.2014.03.011; Gale CR, 2003, INVEST OPHTH VIS SCI, V44, P2461, DOI 10.1167/iovs.02-0929; Gunasekaran S, 2007, J FOOD ENG, V83, P31, DOI 10.1016/j.jfoodeng.2006.11.001; Gunnerud U, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-83; Hadden WL, 1999, J AGR FOOD CHEM, V47, P4189, DOI 10.1021/jf990096k; Halliwell B, 2000, CARDIOVASC RES, V47, P410, DOI 10.1016/S0008-6363(00)00097-3; Helgason T, 2009, FOOD HYDROCOLLOID, V23, P2243, DOI 10.1016/j.foodhyd.2009.05.014; Hidalgo A, 2006, J CEREAL SCI, V44, P182, DOI 10.1016/j.jcs.2006.06.002; Hu H, 2015, J FUNCT FOODS, V19, P182, DOI 10.1016/j.jff.2015.09.023; Hu H, 2013, FOOD HYDROCOLLOID, V32, P303, DOI 10.1016/j.foodhyd.2013.01.016; Jaiswal M, 2015, 3 BIOTECH, V5, P123, DOI 10.1007/s13205-014-0214-0; Jin HY, 2009, CHINESE J CHEM ENG, V17, P672, DOI 10.1016/S1004-9541(08)60262-1; Joye IJ, 2014, TRENDS FOOD SCI TECH, V40, P168, DOI 10.1016/j.tifs.2014.08.006; Lam RSH, 2015, LWT-FOOD SCI TECHNOL, V60, P427, DOI 10.1016/j.lwt.2014.07.031; Landrum J T, 1997, Adv Pharmacol, V38, P537; Li DaJing, 2008, Jiangsu Journal of Agricultural Sciences, V24, P97; Liu D, 2017, JOURNAL OF FOOD PROC; Madadlou A, 2010, ULTRASON SONOCHEM, V17, P153, DOI 10.1016/j.ultsonch.2009.06.009; Marshall Keri, 2004, Altern Med Rev, V9, P136; Mitri K, 2011, INT J PHARMACEUT, V414, P267, DOI 10.1016/j.ijpharm.2011.05.008; Mozaffarieh M, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-20; Neuman I, 1999, ANN ALLERG ASTHMA IM, V82, P549, DOI 10.1016/S1081-1206(10)63165-1; Parlak M, 2017, THERMAL THERMOMECHAN; Pratheesh V. B., 2009, Modern Applied Science, V3, P19; Qv XY, 2011, FOOD HYDROCOLLOID, V25, P1596, DOI 10.1016/j.foodhyd.2011.01.006; Reddy L, 2003, PHARMACOL THERAPEUT, V99, P1, DOI 10.1016/S0163-7258(03)00042-1; RIGGS LK, 1955, J AGR FOOD CHEM, V3, P333, DOI 10.1021/jf60050a006; Shen X, 2016, INT J FOOD SCI TECH, P52; Shen X, 2017, ULTRASON SONOCHEM, V39, P810, DOI 10.1016/j.ultsonch.2017.05.039; Shen X, 2017, FOOD HYDROCOLLOID, V63, P668, DOI 10.1016/j.foodhyd.2016.10.003; Shi XM, 1997, NAHRUNG, V41, P38, DOI 10.1002/food.19970410110; Tavani A, 1999, EUR J CANCER, V35, P1361, DOI 10.1016/S0959-8049(99)00139-2; TYCZKOWSKI JK, 1986, POULTRY SCI, V65, P1526, DOI 10.3382/ps.0651526; TYCZKOWSKI JK, 1986, POULTRY SCI, V65, P1141, DOI 10.3382/ps.0651141; Wang YF, 2012, EUR FOOD RES TECHNOL, V234, P157, DOI 10.1007/s00217-011-1630-6; Weigel F, 2018, FOOD CHEM, V242, P395, DOI 10.1016/j.foodchem.2017.09.060; Xie YQ, 2016, INT J PHARMACEUT, V500, P110, DOI 10.1016/j.ijpharm.2016.01.032; Yi J, 2016, FOOD CHEM, V200, P91, DOI 10.1016/j.foodchem.2016.01.035; Yi J, 2014, J AGR FOOD CHEM, V62, P8900, DOI 10.1021/jf502639k; Yu HL, 2013, FOOD CHEM, V141, P29, DOI 10.1016/j.foodchem.2013.03.009; Zhang PP, 2016, ULTRASON SONOCHEM, V29, P380, DOI 10.1016/j.ultsonch.2015.10.014; Zhao CD, 2014, FOOD CHEM, V156, P123, DOI 10.1016/j.foodchem.2014.01.086	52	40	41	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192511	10.1371/journal.pone.0192511	http://dx.doi.org/10.1371/journal.pone.0192511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415071	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300082
J	Fahey, JM; Stancill, JS; Smith, BC; Girotti, AW				Fahey, Jonathan M.; Stancill, Jennifer S.; Smith, Brian C.; Girotti, Albert W.			Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; photodynamic therapy; nitric oxide; nitric-oxide synthase; NF-kB transcription factor; bromodomain-containing protein 4 (BRD4); acetylation	NF-KAPPA-B; MALIGNANT BRAIN-TUMORS; LUNG-CANCER CELLS; 5-AMINOLEVULINIC ACID; UP-REGULATION; IN-VITRO; CONVENTIONAL THERAPIES; SYNTHASE INHIBITION; SELECTIVE INHIBITOR; BREAST-CANCER	Endogenous nitric oxide (NO) generated by inducible NO synthase (iNOS) promotes glioblastoma cell proliferation and invasion and also plays a key role in glioblastoma resistance to chemotherapy and radiotherapy. Non-ionizing photodynamic therapy (PDT) has anti-tumor advantages over conventional glioblastoma therapies. Our previous studies revealed that glioblastoma U87 cells up-regulate iNOS after a photodynamic challenge and that the resulting NO not only increases resistance to apoptosis but renders surviving cells more proliferative and invasive. These findings were largely based on the effects of inhibiting iNOS activity and scavenging NO. Demonstrating now that iNOS expression in photostressed U87 cells is mediated by NF-B, we hypothesized that (i) recognition of acetylated lysine (acK) on NF-B p65/RelA by bromodomain and extra-terminal (BET) protein Brd4 is crucial; and (ii) by suppressing iNOS expression, a BET inhibitor (JQ1) would attenuate the negative effects of photostress. The following evidence was obtained. (i) Like iNOS, Brd4 protein and p65-acK levels increased severalfold in photostressed cells. (ii) JQ1 at minimally toxic concentrations had no effect on Brd4 or p65-acK up-regulation after PDT but strongly suppressed iNOS, survivin, and Bcl-xL up-regulation, along with the growth and invasion spurt of PDT-surviving cells. (iii) JQ1 inhibition of NO production in photostressed cells closely paralleled that of growth/invasion inhibition. (iv) Finally, at 1% the concentration of iNOS inhibitor 1400W, JQ1 reduced post-PDT cell aggressiveness to a far greater extent. This is the first evidence for BET inhibitor targeting of iNOS expression in cancer cells and how such targeting can markedly improve therapeutic efficacy.	[Fahey, Jonathan M.; Stancill, Jennifer S.; Smith, Brian C.; Girotti, Albert W.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Girotti, AW (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	agirotti@mcw.edu	Smith, Brian C/D-9949-2013; Girotti, Albert/AAF-6910-2020	Smith, Brian C/0000-0001-6330-2768; Stancill, Jennifer/0000-0002-1612-4695	National Institutes of Health from NCI [CA70823]; Advancing a Healthier Wisconsin Research and Education Program [5520347]; BSC from the MCW Cancer Center [3308238/9]; American Heart Association Scientist Development Grant [15SDG25830057]; American Cancer Society [14-247-29-IRG, 86-004-26-IRG]; Advancing a Healthier Wisconsin Endowment [5520310]; NATIONAL CANCER INSTITUTE [R01CA070823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134643] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Advancing a Healthier Wisconsin Research and Education Program; BSC from the MCW Cancer Center; American Heart Association Scientist Development Grant(American Heart Association); American Cancer Society(American Cancer Society); Advancing a Healthier Wisconsin Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant CA70823 from NCI (to A. W. G.). This work also was supported by Grant 5520347 from the Advancing a Healthier Wisconsin Research and Education Program (to A. W. G.), BSC Grant 3308238/9 from the MCW Cancer Center (to A. W. G.), American Heart Association Scientist Development Grant 15SDG25830057 (to B. C. S.), Institutional Research Grants 14-247-29-IRG and 86-004-26-IRG from the American Cancer Society (to B. C. S.), and Grant 5520310 from the Advancing a Healthier Wisconsin Endowment (to B. C. S.). The authors declare that they have no conflicts of interest with the contents of this publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Akaike T, 1996, METHOD ENZYMOL, V268, P211; Andrieu Guillaume, 2016, Drug Discov Today Technol, V19, P45, DOI 10.1016/j.ddtec.2016.06.004; Bechet D, 2014, CANCER TREAT REV, V40, P229, DOI 10.1016/j.ctrv.2012.07.004; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Benov L, 2015, MED PRIN PRACT, V24, P14, DOI 10.1159/000362416; Berenguer-Daize C, 2016, INT J CANCER, V139, P2047, DOI 10.1002/ijc.30256; Bhowmick R, 2014, CANCER LETT, V343, P115, DOI 10.1016/j.canlet.2013.09.025; Bhowmick R, 2013, FREE RADICAL BIO MED, V57, P39, DOI 10.1016/j.freeradbiomed.2012.12.005; Bhowmick R, 2011, PHOTOCHEM PHOTOBIOL, V87, P378, DOI 10.1111/j.1751-1097.2010.00877.x; Bhowmick R, 2010, FREE RADICAL BIO MED, V48, P1296, DOI 10.1016/j.freeradbiomed.2010.01.040; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Burke AJ, 2017, ANTIOXID REDOX SIGN, V26, P1078, DOI 10.1089/ars.2017.7004; Cekaite L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-273; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Fahey JM, 2017, NITRIC OXIDE-BIOL CH, V62, P52, DOI 10.1016/j.niox.2016.12.003; Fahey JM, 2016, PHOTOCHEM PHOTOBIOL, V92, P842, DOI 10.1111/php.12636; Fahey JM, 2015, NITRIC OXIDE-BIOL CH, V49, P47, DOI 10.1016/j.niox.2015.05.006; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fionda C, 2016, CURR MED CHEM, V23, P2618, DOI 10.2174/0929867323666160727105101; Fu LL, 2015, ONCOTARGET, V6, P5501, DOI 10.18632/oncotarget.3551; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Garg H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0326-1; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Henderson BW, 1999, PHOTOCHEM PHOTOBIOL, V70, P64, DOI 10.1562/0031-8655(1999)070<0064:POPTAA>2.3.CO;2; Hirst D, 2010, CURR PHARM DESIGN, V16, P411, DOI 10.2174/138161210790232185; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ishida CT, 2017, ONCOTARGET, V8, P29558, DOI 10.18632/oncotarget.16365; Kim RK, 2013, CANCER SCI, V104, P1172, DOI 10.1111/cas.12207; Kleszcz R, 2015, PHARMACOL REP, V67, P1068, DOI 10.1016/j.pharep.2015.03.021; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Korbelik M, 2000, BRIT J CANCER, V82, P1835, DOI 10.1054/bjoc.2000.1157; Kostourou V, 2011, BRIT J CANCER, V104, P83, DOI 10.1038/sj.bjc.6606034; Krishnan N, 2013, FEBS J, V280, P2830, DOI 10.1111/febs.12283; Li F, 2015, ARCH TOXICOL, V89, P711, DOI 10.1007/s00204-015-1470-4; Li WN, 2017, PHOTODIAGN PHOTODYN, V18, P83, DOI 10.1016/j.pdpdt.2017.02.001; LUNA MC, 1994, CANCER RES, V54, P1374; Marelli G, 2017, CURR OPIN PHARMACOL, V35, P57, DOI 10.1016/j.coph.2017.05.007; Matsunaga T, 2014, FREE RADICAL RES, V48, P1371, DOI 10.3109/10715762.2014.957694; Meloche J, 2015, CIRC RES, V117, P525, DOI 10.1161/CIRCRESAHA.115.307004; Olzowy B, 2002, J NEUROSURG, V97, P970, DOI 10.3171/jns.2002.97.4.0970; Pan L, 2017, LASER SURG MED, V49, P719, DOI 10.1002/lsm.22661; Peng Q, 1997, PHOTOCHEM PHOTOBIOL, V65, P235, DOI 10.1111/j.1751-1097.1997.tb08549.x; Perez-Salvia M, 2017, ONCOTARGET, V8, P51621, DOI 10.18632/oncotarget.18255; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Quirk BJ, 2015, PHOTODIAGN PHOTODYN, V12, P530, DOI 10.1016/j.pdpdt.2015.04.009; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; Reeves KJ, 2010, J PHOTOCH PHOTOBIO B, V101, P224, DOI 10.1016/j.jphotobiol.2010.07.007; Rollakanti KR, 2015, CANCER MED-US, V4, P633, DOI 10.1002/cam4.361; Sahni JM, 2016, J BIOL CHEM, V291, P23756, DOI 10.1074/jbc.M116.738666; Saleem W, 2011, CANCER SCI, V102, P2150, DOI 10.1111/j.1349-7006.2011.02095.x; Sanovic R, 2009, INT J ONCOL, V35, P921, DOI 10.3892/ijo_00000407; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shu SK, 2016, COLD SH Q B, V81, P123, DOI 10.1101/sqb.2016.81.030908; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Tetard MC, 2014, PHOTODIAGN PHOTODYN, V11, P319, DOI 10.1016/j.pdpdt.2014.04.004; Uzdensky A, 2012, BBA-GEN SUBJECTS, V1820, P795, DOI 10.1016/j.bbagen.2012.03.008; Vannini F, 2015, REDOX BIOL, V6, P334, DOI 10.1016/j.redox.2015.08.009; Wali VB, 2017, CANCER RES, V77, P566, DOI 10.1158/0008-5472.CAN-16-1901; Wang J, 2017, CANCER LETT, V391, P141, DOI 10.1016/j.canlet.2017.01.031; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Whelan HT, 2012, J NATL COMPR CANC NE, V10, pS31, DOI 10.6004/jnccn.2012.0171; Wienerroither S, 2014, MOL CELL BIOL, V34, P415, DOI 10.1128/MCB.01353-13; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Wink DA, 2008, NITRIC OXIDE-BIOL CH, V19, P65, DOI 10.1016/j.niox.2008.05.003; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zanca C, 2017, GENE DEV, V31, P1212, DOI 10.1101/gad.300079.117; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	77	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5345	5359		10.1074/jbc.RA117.000443	http://dx.doi.org/10.1074/jbc.RA117.000443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440272	Green Published, hybrid			2022-12-26	WOS:000429409300037
J	Lahusen, TJ; Kim, SJ; Miao, K; Huang, ZB; Xu, XL; Deng, CX				Lahusen, Tyler J.; Kim, Seung-Jin; Miao, Kai; Huang, Zebin; Xu, Xiaoling; Deng, Chu-Xia			BRCA1 function in the intra-S checkpoint is activated by acetylation via a pCAF/SIRT1 axis	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; CELL-CYCLE; HISTONE ACETYLTRANSFERASES; TRANSCRIPTIONAL REGULATION; PHASE CHECKPOINT; TUMOR-SUPPRESSOR; BREAST-CANCER; SIRT1; CHK1; PHOSPHORYLATION	Breast cancer associated gene 1 (BRCA1) function has been shown to be regulated by phosphorylation but the role of acetylation has not been determined. Therefore, we tested whether BRCA1 can be acetylated by the acetyltransferases P300/CBP-associated factor (pCAF), GCN5, and p300. p300 exhibited the highest level of BRCA1 acetylation; however, there was also a decrease in the total level of BRCA1. Therefore, we focused on pCAF and GCN5 because they both acetylated BRCA1 without affecting BRCA1 expression. Further analysis indicated that the acetylated form of BRCA1 is deacetylated by wild-type (WT) SIRT1, but not deacetylase mutant SIRT1, suggesting that SIRT1 is a specific deacetylase of BRCA1. We demonstrated that lysine 830 of BRCA1 is a preferential acetylation site by pCAF and tested its function in embryonic stem (ES) cells by changing lysine 830 to arginine using a transcription activator-like effector nuclease (TALEN) system. After exposure to DNA damage-inducing UV radiation, the viability of BRCA1 K830R mutant cells is greater than the WT ES cells. Further analysis using additional cell lines indicated that the BRCA1 K830R mutation impairs the intra-S checkpoint. Also, checkpoint kinase 1 (CHK1) phosphorylation was less in K830R cells as compared with WT cells after UV exposure. These data suggest that acetylation of BRCA1 on lysine 830 activates BRCA1 function at the intra-S checkpoint after DNA damage.	[Lahusen, Tyler J.; Kim, Seung-Jin; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, 10-9N105, Bethesda, MD 20892 USA; [Miao, Kai; Huang, Zebin; Xu, Xiaoling; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Macau, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Macau	Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, 10-9N105, Bethesda, MD 20892 USA.; Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Macau, Peoples R China.	cxdeng@umac.mo			Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA; Chair Professor Grant by University of Macau, Macau SAR, China [CPG2017-00026-FHS]; Macao Science and Technology Development Fund grants [065/2015/A2, 094/2015/A3]	Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA; Chair Professor Grant by University of Macau, Macau SAR, China; Macao Science and Technology Development Fund grants	We thank Dr. Zhen Xiao for BRCA1 acetylation analysis and the members of the Deng laboratory for helpful discussion. This work was supported by the Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA, and by the Chair Professor Grant (CPG2017-00026-FHS), granted to C.D. by University of Macau, Macau SAR, China; Macao Science and Technology Development Fund grants (065/2015/A2 and 094/2015/A3), granted to C.D.	Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Di LJ, 2010, NAT STRUCT MOL BIOL, V17, P1406, DOI 10.1038/nsmb.1941; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Kim HB, 2015, INT J BIOL SCI, V11, P923, DOI 10.7150/ijbs.10896; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Luo JY, 2016, INT J BIOL SCI, V12, P1500, DOI 10.7150/ijbs.16176; Masuda T, 2016, INT J BIOL SCI, V12, P133, DOI 10.7150/ijbs.14242; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Nielsen FC, 2016, NAT REV CANCER, V16, P599, DOI 10.1038/nrc.2016.72; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Park EY, 2016, INT J BIOL SCI, V12, P1555, DOI 10.7150/ijbs.13833; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang RH, 2014, INT J BIOL SCI, V10, P1193, DOI 10.7150/ijbs.11066; Warmerdam DO, 2013, J CELL SCI, V126, P1923, DOI 10.1242/jcs.118265; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zheng HP, 2017, SCI REP-UK, V7, DOI 10.1038/srep43517	30	13	13	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2343	2350		10.1038/s41388-018-0127-1	http://dx.doi.org/10.1038/s41388-018-0127-1			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29440709				2022-12-26	WOS:000431100200010
J	Blobner, BM; Wang, XP; Kashlan, OB				Blobner, Brandon M.; Wang, Xue-Ping; Kashlan, Ossama B.			Conserved cysteines in the finger domain of the epithelial Na+ channel alpha and gamma subunits are proximal to the dynamic finger-thumb domain interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; EXTRACELLULAR LOOP; INHIBITORY DOMAIN; ENAC; AMILORIDE; EXPRESSION; RESIDUES; PEPTIDE; BINDING; IDENTIFICATION	The epithelial Na+ channel (ENaC) is a member of the ENaC/degenerin family of ion channels. In the structure of a related family member, the "thumb" domain's base interacts with the pore, and its tip interacts with the divergent "finger" domain. Between the base and tip, the thumb domain is characterized by a conserved five-rung disulfide ladder holding together two anti-parallel alpha helices. The ENaC alpha and gamma subunits' finger domains harbor autoinhibitory tracts that can be proteolytically liberated to activate the channel and also host an ENaC-specific pair of cysteines. Using a crosslinking approach, we show that one of the finger domain cysteines in the alpha subunit (alpha Cys-263) and both of the finger domain cysteines in the gamma subunit (gamma Cys-213 and gamma Cys-220) lie near the dynamic finger-thumb domain interface. Our data suggest that the alpha Cys-256/alpha Cys-263 pair is not disulfide-bonded. In contrast, we found that the gamma Cys-213/gamma Cys-220 pair is disulfide-bonded. Our data also suggest that the gamma subunit lacks the terminal rung in the thumb domain disulfide ladder, suggesting asymmetry between the subunits. We also observed functional asymmetry between the alpha and gamma subunit finger-thumb domain interfaces; crosslinks bridging the alpha subunit finger-thumb interface only inhibited ENaC currents, whereas crosslinks bridging the gamma subunit finger-thumb interface activated or inhibited currents dependent on the length of the crosslinker. Our data suggest that reactive cysteines lie at the dynamic finger-thumb interfaces of the alpha and gamma subunits and may play a yet undefined role in channel regulation.	[Blobner, Brandon M.; Wang, Xue-Ping; Kashlan, Ossama B.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Kashlan, Ossama B.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashlan, OB (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	obk2@pitt.edu	Wang, Xueping/AAF-2215-2020	Wang, Xueping/0000-0003-1102-0392	National Institutes of Health [P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098204, T32DK061296, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Pittsburgh Center for Kidney Research was supported by Grant P30 DK079307 from the National Institutes of Health.	Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chen L, 2004, AM J PHYSIOL-RENAL, V286, pF1202, DOI 10.1152/ajprenal.00352.2003; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Downs CA, 2013, J BIOL CHEM, V288, P8136, DOI 10.1074/jbc.M112.389536; DuVall MD, 1998, AM J PHYSIOL-CELL PH, V274, pC1417, DOI 10.1152/ajpcell.1998.274.5.C1417; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haq IJ, 2016, THORAX, V71, P284, DOI 10.1136/thoraxjnl-2015-207588; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeggle P, 2015, BIOCHEM BIOPH RES CO, V464, P38, DOI 10.1016/j.bbrc.2015.05.091; Jensen JH, 2013, J CHEM EDUC, V90, P1093, DOI 10.1021/ed400164n; Kapoor N, 2011, AM J PHYSIOL-CELL PH, V300, pC1246, DOI 10.1152/ajpcell.00199.2010; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; KOCKERLING A, 1993, AM J PHYSIOL, V264, pC1285, DOI 10.1152/ajpcell.1993.264.5.C1285; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Ray EC, 2016, AM J PHYSIOL-RENAL, V311, pF908, DOI 10.1152/ajprenal.00426.2016; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Trac PT, 2017, AM J PHYSIOL-LUNG C, V312, pL797, DOI 10.1152/ajplung.00379.2016; Xu H, 2007, AM J PHYSIOL-LUNG C, V293, pL1454, DOI 10.1152/ajplung.00248.2007	45	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4928	4939		10.1074/jbc.M117.819367	http://dx.doi.org/10.1074/jbc.M117.819367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29425099	Green Published, hybrid			2022-12-26	WOS:000428848300031
J	Bintabara, D; Mpondo, BCT				Bintabara, Deogratius; Mpondo, Bonaventura C. T.			Preparedness of lower-level health facilities and the associated factors for the outpatient primary care of hypertension: Evidence from Tanzanian national survey	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NONCOMMUNICABLE DISEASES; RISK-FACTORS; BURDEN; PREVALENCE; MANAGEMENT; READINESS; AVAILABILITY; PREVENTION	Introduction Sub-Saharan Africa is experiencing a rapid rise in the burden of non-communicable diseases in both urban and rural areas. Data on health system preparedness to manage hypertension and other non-communicable diseases remains scarce. This study aimed to assess the preparedness of lower-level health facilities for outpatient primary care of hypertension in Tanzania. Methods This study used data from the 2014-2015 Tanzania Service Provision Assessment survey. The facility was considered as prepared for the outpatient primary care of hypertension if reported at least half (>= 50%) of the items listed from each of the three domains (staff training and guideline, basic diagnostic equipment, and basic medicines) as identified by World Health Organization-Service Availability and Readiness Assessment manual. Data were analyzed using Stata 14. An unadjusted logistic regression model was used to assess the association between outcome and explanatory variables. All variables with a P value < 0.2 were fitted into the multiple logistic regression models using a 5% significance level. Results Out of 725 health facilities involved in the current study, about 68% were public facilities and 73% located in rural settings. Only 28% of the assessed facilities were considered prepared for the outpatient primary care of hypertension. About 9% and 42% of the assessed facilities reported to have at least one trained staff and guidelines for hypertension respectively. In multivariate analysis, private facilities [AOR = 2.7, 95% CI; 1.2-6.1], urban location [AOR = 2.2, 95% CI; 1.2-4.2], health centers [AOR = 5.2, 95% CI; 3.1-8.7] and the performance of routine management meetings [AOR = 2.6, 95% CI; 1.1-5.9] were significantly associated with preparedness for the outpatient primary care of hypertension. Conclusion The primary healthcare system in Tanzania is not adequately equipped to cope with the increasing burden of hypertension and other non-communicable diseases. Rural location, public ownership, and absence of routine management meetings were associated with being not prepared. There is a need to strengthen the primary healthcare system in Tanzania for better management of chronic diseases and curb their rising impact on health outcomes.	[Bintabara, Deogratius] Univ Dodoma, Coll Hlth Sci, Dept Publ Hlth, Dodoma, Tanzania; [Mpondo, Bonaventura C. T.] Univ Dodoma, Coll Hlth Sci, Dept Internal Med, Dodoma, Tanzania		Bintabara, D (corresponding author), Univ Dodoma, Coll Hlth Sci, Dept Publ Hlth, Dodoma, Tanzania.	bintabaradeo@gmail.com		Bintabara, Deogratius/0000-0001-7877-870X				Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Agwanda A, 2009, ASSESSMENT FAMILY PL; Ali MK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005121; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Cooper RS, 1998, BMJ-BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Department of Health Statistics and Informatics, 2008, GLOB BURD DIS 2004 U; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Hancock C, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-23; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Minh HV, 2014, INT J HEALTH PLAN M, V29, pE159, DOI 10.1002/hpm.2179; Ifakara Health Institute (IHI) and Ministry of Health and Social Welfare (MOHSW), 2013, TANZ SERV AV READ AS; Jacobs B, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1286-9; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Leung C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3661-1; Marquez Patricio V, 2013, CHALLENGE NONCOMMUNI; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ministry of Health and Social Welfare (MoHSW) [Tanzania Mainland] Ministry of Health (MoH) [Zanzi- bar], 2008, NAT NONC DIS STRAT J; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) [Tanzania Mainland] Ministry of Health (MoH) [Zanzibar] National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2015, TANZ 2015 16 DEM HLT; Ministry of Labour Employment and Youth Development Tanzania, 2013, NAT FAM PLANN GUID S; Misganaw A, 2014, J HEALTH POPUL NUTR, V32, P1; Mohan V, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/409083; Munga MA, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-4; Musinguzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142312; Organization WH, 2016, GLOBAL STATUS REPORT; Oyekale AS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2112-8; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Pires JE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-90; Poulter NR, 2011, J HYPERTENS, V29, P1281, DOI 10.1097/HJH.0b013e328347f437; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Schroth RJ., 2016, SAUDI J DENT RES, V7, P118, DOI DOI 10.1016/J.SJDR.2016.04.006; Settumba SN, 2015, TROP MED INT HEALTH, V20, P781, DOI 10.1111/tmi.12487; Shemdoe A, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0098-7; Siering U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082915; Sikika, 2011, MED MED SUPPL AV REP; Sikika, 2015, HLTH SECT BUDG AN FI; Sivaramakrishnan K, 2012, AM J PUBLIC HEALTH, V102, P2010, DOI 10.2105/AJPH.2012.300768; Spasojevic Nada, 2015, Mater Sociomed, V27, P409, DOI 10.5455/msm.2015.27.409-411; Uddin MJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-547; Wang WJ, 2017, GLOB HEALTH-SCI PRAC, V5, P244, DOI 10.9745/GHSP-D-16-00311; Ward J, 2000, EUR J CANCER CARE, V9, P80; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wiedenmayer K., 2004, ACCESS MED MED SUPPL; World Health Organization, 2015, SERV AV READ ASS SAR	54	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192942	10.1371/journal.pone.0192942	http://dx.doi.org/10.1371/journal.pone.0192942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447231	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900079
J	de los Santos, DG; de los Santos, JRG; Gil-Turnes, C; Gaboardi, G; Silva, LF; Franca, R; Fernandes, CG; Conceicao, FR				de los Santos, Diego Gil; Gil de los Santos, Joao Rodrigo; Gil-Turnes, Carlos; Gaboardi, Giana; Silva, Luiza Fernandes; Franca, Rodrigo; Fernandes, Cristina Gevehr; Conceicao, Fabricio Rochedo			Probiotic effect of Pichia pastoris X-33 produced in parboiled rice effluent and YPD medium on broiler chickens	PLOS ONE			English	Article							GROWTH-PERFORMANCE; IMMUNE-RESPONSE; PREBIOTIC SUPPLEMENTATION; YEAST; WASTE; CULTIVATION; METABOLISM; MODULATION; BIOMASS	In a previous paper we showed that the yeast Pichia pastoris X-33 grown in parboiled rice effluent supplemented with glycerol byproduct from the biodiesel industry improved the quality of the effluent. In this paper we show the validation of this yeast (PPE) as probiotic for broilers. Its effect on feed efficiency and immunomodulation was compared with the same yeast grown in yeast peptone dextrose medium (PPY), with Saccharomyces boulardii (SBY) and with the controls fed unsupplemented feed (CON). One-day-old female chicks were vaccinated against infectious bursal disease (IBD) and the titers of anti-IBD antibodies were measured by ELISA. PPE group had the highest mean titres on days 14 and 28 (p<0,05), and at 28 days, 64% of the animals showed seroconvertion. The PPE group also showed the best weight gains at 42 days of age, that, on days 7, 14 and 21 were 19%, 15%, and 8.7% higher, respectively, than the control group. The best feed conversion, 8.2% higher than the control group, was obtained by PPY at 42 days. Histopathological studies did not detect any undesirable effects in the supplemented animals. We concluded that Pichia pastoris X-33 when grown in effluents of the rice parboiling industry supplemented with glycerol byproduct from the biodiesel has probiotic properties for poultry.	[de los Santos, Diego Gil; Gil-Turnes, Carlos; Gaboardi, Giana; Silva, Luiza Fernandes; Franca, Rodrigo; Conceicao, Fabricio Rochedo] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Pelotas, RS, Brazil; [de los Santos, Diego Gil] Inst Fed Sul Riograndense, Pelotas, RS, Brazil; [Gil de los Santos, Joao Rodrigo; Gil-Turnes, Carlos; Fernandes, Cristina Gevehr; Conceicao, Fabricio Rochedo] Univ Fed Pelotas, Fac Vet, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Instituto Federal Sul-Rio-Grandense (IFSul); Universidade Federal de Pelotas	de los Santos, DG (corresponding author), Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Pelotas, RS, Brazil.; de los Santos, DG (corresponding author), Inst Fed Sul Riograndense, Pelotas, RS, Brazil.	diegogil@pelotas.ifsul.edu.br	Gaboardi, Giana/ABB-8428-2021; Gil de los Santos, Diego/AAD-5139-2022		Mercolab Laboratories (Caxias do Sul, RS, Brazil) [476140/2012-9]; CAPES; FAPERGS	Mercolab Laboratories (Caxias do Sul, RS, Brazil); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by Mercolab Laboratories (Caxias do Sul, RS, Brazil) for performing the ELISA, to CNPq (grant 476140/2012-9) F.R.C., CAPES R.F. and FAPERGS G.G., L.F.S. for scholarships and IFSUL D.G.S. for laboratories analyses support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Mercolab Laboratories (Caxias do Sul, RS, Brazil) for performing the ELISA, to CNPq (grant 476140/2012-9), CAPES and FAPERGS for scholarships and IFSUL for laboratory analyses support.	Alltech, 2016, ALLT GLOB FEED SURV; Aluwong T, 2013, J VET MED SCI, V75, P291, DOI 10.1292/jvms.12-0368; BAAP-Brazilian Association of Animal Protein, 2017, ANN REPORT; Bai SP, 2013, POULTRY SCI, V92, P663, DOI 10.3382/ps.2012-02813; Bekatorou A, 2006, FOOD TECHNOL BIOTECH, V44, P407; Celik E, 2008, IND ENG CHEM RES, V47, P2985, DOI 10.1021/ie071613o; Choi MH, 2003, BIOMASS BIOENERG, V25, P221, DOI 10.1016/S0961-9534(02)00194-0; Choi MH, 1999, BIORESOURCE TECHNOL, V70, P231, DOI 10.1016/S0960-8524(99)00049-8; Conceic Eao FR, 2002, FOOD AGR IMMUNOL, V14, P133; Coppola MD, 2005, FOOD AGR IMMUNOL, V16, P213, DOI 10.1080/09540100500244138; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; de los Santos DG, 2012, SCI WORLD J, DOI 10.1100/2012/492925; De los Santos JRG, 2005, BRIT POULTRY SCI, V46, P494, DOI 10.1080/00071660500181461; Deepika G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-116; Franca RC, 2015, APPL MICROBIOL BIOT, V99, P7953, DOI 10.1007/s00253-015-6696-9; Gelinas P, 2007, BIORESOURCE TECHNOL, V98, P1138, DOI 10.1016/j.biortech.2006.04.021; de los Santos JRG, 2012, VET MICROBIOL, V156, P448, DOI 10.1016/j.vetmic.2011.11.019; Haghighi HR, 2006, CLIN VACCINE IMMUNOL, V13, P975, DOI 10.1128/CVI.00161-06; Haghighi HR, 2005, CLIN DIAGN LAB IMMUN, V12, P1387, DOI 10.1128/CDLI.12.12.1387-1392.2005; Hahn-Hagerdal B, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-31; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; Janardhana V, 2009, J NUTR, V139, P1404, DOI 10.3945/jn.109.105007; Kim GB, 2011, POULTRY SCI, V90, P75, DOI 10.3382/ps.2010-00732; Knoblich HV, 2000, AVIAN DIS, V44, P874, DOI 10.2307/1593060; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Mookiah S, 2014, J SCI FOOD AGR, V94, P341, DOI 10.1002/jsfa.6365; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; Murugesan GS, 2005, BIORESOURCE TECHNOL, V96, P1743, DOI 10.1016/j.biortech.2005.01.006; Ohimain E. I., 2012, International Journal of Animal and Veterinary Advances, V4, P135; Rodriguez-Lecompte JC, 2012, J ANIM SCI, V90, P2246, DOI 10.2527/jas.2011-4184; Roos TB, 2010, FOOD AGR IMMUNOL, V21, P113, DOI 10.1080/09540100903443691; Roos TB, 2012, VACCINE, V30, P2173, DOI 10.1016/j.vaccine.2012.01.007; Salim HM, 2013, POULTRY SCI, V92, P2084, DOI 10.3382/ps.2012-02947; Shanmugasundaram R, 2012, POULTRY SCI, V91, P107, DOI 10.3382/ps.2011-01732; Suntornsuk W, 2000, WORLD J MICROB BIOT, V16, P815, DOI 10.1023/A:1008926700452; Taklimi S. M. S. M., 2012, Agricultural Sciences, V3, P5, DOI 10.4236/as.2012.31002; United States Department of Agriculture. Foreign Agricultural Service, 2017, LIV POULTR WORLD MAR; Yadav R, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02116; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; Zhao X, 2013, APPL MICROBIOL BIOT, V97, P6477, DOI 10.1007/s00253-013-4970-2	40	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192904	10.1371/journal.pone.0192904	http://dx.doi.org/10.1371/journal.pone.0192904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447227	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900069
J	Li, GY; Lee, O; Rabitz, H				Li, Genyuan; Lee, Olivia; Rabitz, Herschel			High efficiency classification of children with autism spectrum disorder	PLOS ONE			English	Article							GLOBAL SENSITIVITY-ANALYSIS; INDEXES	Autism spectrum disorder (ASD) is a wide-ranging collection of developmental diseases with varying symptoms and degrees of disability. Currently, ASD is diagnosed mainly with psychometric tools, often unable to provide an early and reliable diagnosis. Recently, biochemical methods are being explored as a means to meet the latter need. For example, an increased predisposition to ASD has been associated with abnormalities of metabolites in folate-dependent one carbon metabolism (FOCM) and transsulfuration (TS). Multiple metabolites in the FOCM/TS pathways have been measured, and statistical analysis tools employed to identify certain metabolites that are closely related to ASD. The prime difficulty in such biochemical studies comes from (i) inefficient determination of which metabolites are most important and (ii) understanding how these metabolites are collectively related to ASD. This paper presents a new method based on scores produced in Support Vector Machine (SVM) modeling combined with High Dimensional Model Representation (HDMR) sensitivity analysis. The new method effectively and efficiently identifies the key causative metabolites in FOCM/TS pathways, ranks their importance, and discovers their independent and correlative action patterns upon ASD. Such information is valuable not only for providing a foundation for a pathological interpretation but also for potentially providing an early, reliable diagnosis ideally leading to a subsequent comprehensive treatment of ASD. With only tens of SVM model runs, the new method can identify the combinations of the most important metabolites in the FOCM/TS pathways that lead to ASD. Previous efforts to find these metabolites required hundreds of thousands of model runs with the same data.	[Li, Genyuan; Rabitz, Herschel] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Lee, Olivia] Peddie Sch, Hightstown, NJ 08520 USA	Princeton University	Rabitz, H (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	hrabitz@princeton.edu		Lee, Olivia/0000-0002-8131-6482	National Science Foundation [CHE-1464569]; Department of Energy [DE-FG02-02ER15344]	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE))	This study was supported by National Science Foundation grant CHE-1464569 to HR and Department of Energy Grant DE-FG02-02ER15344 to GL and HR. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Deth R, 2008, NEUROTOXICOLOGY, V29, P190, DOI 10.1016/j.neuro.2007.09.010; Durrande N, 2013, J MULTIVARIATE ANAL, V115, P57, DOI 10.1016/j.jmva.2012.08.016; Hansen BE, 2004, THESIS; Howsmon DP, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005385; Interactive Autism Network (IAN), IAN RES FIND REGR; Jin Y, 2015, HUM BRAIN MAPP, V36, P4880, DOI 10.1002/hbm.22957; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Krzywinski M, 2013, NAT METHODS, V10, P1041, DOI 10.1038/nmeth.2698; Kucherenko S, 2012, COMPUT PHYS COMMUN, V183, P937, DOI 10.1016/j.cpc.2011.12.020; Li GY, 2017, RELIAB ENG SYST SAFE, V167, P136, DOI 10.1016/j.ress.2017.05.038; Li GY, 2017, J MATH CHEM, V55, P278, DOI 10.1007/s10910-016-0690-z; Li GY, 2012, J MATH CHEM, V50, P99, DOI 10.1007/s10910-011-9898-0; Li GY, 2010, J PHYS CHEM A, V114, P6022, DOI 10.1021/jp9096919; Li Q, 2008, J BUS ECON STAT, V26, P423, DOI 10.1198/073500107000000250; Liu R, 2008, J NONPARAMETR STAT, V20, P661, DOI 10.1080/10485250802326391; Lord C., 2012, AUTISM DIAGNOSTIC OB; Mandy W, 2016, J CHILD PSYCHOL PSYC, V57, P271, DOI 10.1111/jcpp.12501; Mara TA, 2015, ENVIRON MODELL SOFTW, V72, P173, DOI 10.1016/j.envsoft.2015.07.010; Mika S., 1999, NEURAL NETWORKS SIGN, P41, DOI DOI 10.1109/NNSP.1999.788121; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Rellini E, 2004, J AUTISM DEV DISORD, V34, P703, DOI 10.1007/s10803-004-5290-2; ROSENBLATT M, 1952, ANN MATH STAT, V23, P470, DOI 10.1214/aoms/1177729394; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461	28	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192867	10.1371/journal.pone.0192867	http://dx.doi.org/10.1371/journal.pone.0192867			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447214	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900063
J	Saleem, AR; Brunetti, C; Khalid, A; Della Rocca, G; Raio, A; Emiliani, G; De Carlo, A; Mahmood, T; Centritto, M				Saleem, Aansa Rukya; Brunetti, Cecilia; Khalid, Azeem; Della Rocca, Gianni; Raio, Aida; Emiliani, Giovanni; De Carlo, Anna; Mahmood, Tariq; Centritto, Mauro			Drought response of Mucuna pruriens (L.) DC. inoculated with ACC deaminase and IAA producing rhizobacteria	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; PLANT-GROWTH; ISOPRENE EMISSION; CARBON ASSIMILATION; STRESS TOLERANCE; WATER-STRESS; ETHYLENE; BACTERIA; PHOTOSYNTHESIS; SOIL	Drought is one of the major constraints limiting agricultural production worldwide and is expected to increase in the future. Limited water availability causes significant effects to plant growth and physiology. Plants have evolved different traits to mitigate the stress imposed by drought. The presence of plant growth-promoting rhizobacteria (PGPR) could play an important role in improving plant performances and productivity under drought. These beneficial microorganisms colonize the rhizosphere of plants and increase drought tolerance by lowering ethylene formation. In the present study, we demonstrate the potential to improve the growth of velvet bean under water deficit conditions of two different strains of PGPR with ACCd (1-Aminocyclopropane-1-Carboxylate deaminase) activity isolated from rainfed farming system. We compared uninoculated and inoculated plants with PGPR to assess: a) photosynthetic performance and biomass; b) ACC content and ethylene emission from leaves and roots; c) leaf isoprene emission. Our results provided evidence that under drought conditions inoculation with PGPR containing the ACCd enzyme could improve plant growth compared to untreated plants. Ethylene emission from roots and leaves of inoculated velvet bean plants was significantly lower than uninoculated plants. Moreover, isoprene emission increased with drought stress progression and was higher in inoculated plants compared to uninoculated counterparts. These findings clearly illustrate that selected PGPR strains isolated from rainfed areas could be highly effective in promoting plant growth under drought conditions by decreasing ACC and ethylene levels in plants.	[Saleem, Aansa Rukya] Bahria Univ, Dept Earth & Environm Sci, Islamabad Campus, Islamabad, Pakistan; [Brunetti, Cecilia; Emiliani, Giovanni; De Carlo, Anna; Centritto, Mauro] Natl Res Council Italy, Tree & Timber Inst, Via Madonna Piano, Florence, Italy; [Brunetti, Cecilia] Univ Florence, Dipartimento Sci Prod Agroalimentari & Ambiente, Viale Idee Sesto Fiorentino, Florence, Italy; [Khalid, Azeem] Pir Mehr Ali Shah Arid & Agr Univ, Dept Environm Sci, Rawalpindi, Pakistan; [Della Rocca, Gianni; Raio, Aida] Natl Res Council Italy, Inst Sustainable Plant Protect, Via Madonna Piano, Florence, Italy; [Mahmood, Tariq] Islamic Educ Sci & Cultural Org, Rabat, Morocco	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); University of Florence; Arid Agriculture University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR)	Saleem, AR (corresponding author), Bahria Univ, Dept Earth & Environm Sci, Islamabad Campus, Islamabad, Pakistan.	rukayya583@gmail.com	Cecilia, Brunetti/Q-4724-2018; raio, aida/ABC-8055-2020; De Carlo, Anna/AAW-7321-2020; Khalid, Azeem/AAT-4594-2021; DE CARLO, ANNA/L-7928-2019; Della Rocca, Gianni/I-2541-2015; Brunetti, Cecilia/D-3439-2016; Emiliani, Giovanni/G-5023-2016	raio, aida/0000-0001-9007-4342; DE CARLO, ANNA/0000-0002-8969-7945; Della Rocca, Gianni/0000-0001-5888-2550; Brunetti, Cecilia/0000-0002-8531-6076; Emiliani, Giovanni/0000-0002-1264-8002	Higher Education Commission of Pakistan; Italian Ministry of Foreign Affairs-Directorate General for Cultural Promotion and Cooperation (SAWaM-Pak) [MAE/SEDE/DGCS 4015]; Italian Ministry of Education University and Research (Progetto Premiale "AQUA")	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Italian Ministry of Foreign Affairs-Directorate General for Cultural Promotion and Cooperation (SAWaM-Pak); Italian Ministry of Education University and Research (Progetto Premiale "AQUA")	Aansa Rukya Saleem was supported by the Higher Education Commission of Pakistan and Italian Ministry of Foreign Affairs-Directorate General for Cultural Promotion and Cooperation (SAWaM-Pak, MAE/SEDE/DGCS 4015), and by the Italian Ministry of Education University and Research (Progetto Premiale 2012 "AQUA"). The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2013, BRAZ J MICROBIOL, V44, P1341, DOI 10.1590/S1517-83822013000400045; Ali SZ, 2014, ANN MICROBIOL, V64, P493, DOI 10.1007/s13213-013-0680-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Armada E, 2015, APPL SOIL ECOL, V96, P306, DOI 10.1016/j.apsoil.2015.08.008; Arshad M, 2012, ETHYLENE AGR SOURCES, P342; Arshad M, 2007, TRENDS BIOTECHNOL, V25, P356, DOI 10.1016/j.tibtech.2007.05.005; Bal HB, 2013, J BASIC MICROB, V53, P972, DOI 10.1002/jobm.201200445; Bangash N, 2013, PAK J BOT, V45, P91; Belimov AA, 2005, SOIL BIOL BIOCHEM, V37, P241, DOI 10.1016/j.soilbio.2004.07.033; Belimov AA, 2009, NEW PHYTOL, V181, P413, DOI 10.1111/j.1469-8137.2008.02657.x; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Brilli F, 2013, J EXP BOT, V64, P519, DOI 10.1093/jxb/ers353; Bulens I, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-17; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Centritto M, 2011, ECOL STUD-ANAL SYNTH, V212, P31, DOI 10.1007/978-90-481-9834-4_3; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen L, 2013, PLANT CELL ENVIRON, V36, P1850, DOI 10.1111/pce.12094; Cheng WH, 2009, PLANT MOL BIOL, V71, P61, DOI 10.1007/s11103-009-9509-7; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cristescu SM, 2013, ANN BOT-LONDON, V111, P347, DOI 10.1093/aob/mcs259; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Dineen SM, 2010, J APPL MICROBIOL, V109, P1886, DOI 10.1111/j.1365-2672.2010.04816.x; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; Fini A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01281; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; GLICK BR, 1995, CAN J MICROBIOL, V41, P533, DOI 10.1139/m95-070; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; HARLEY PC, 1994, PLANT PHYSIOL, V105, P279, DOI 10.1104/pp.105.1.279; Kasim WA, 2013, J PLANT GROWTH REGUL, V32, P122, DOI 10.1007/s00344-012-9283-7; Kaushal M, 2016, AGR ECOSYST ENVIRON, V231, P68, DOI 10.1016/j.agee.2016.06.031; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Loreto F., 2010, TRENDS PLANT SCI, V15, P1360; Loreto F, 2008, PLANT BIOSYST, V142, P154, DOI 10.1080/11263500701872937; Madhaiyan M, 2006, PLANTA, V224, P268, DOI 10.1007/s00425-005-0211-y; Magnani F, 1996, PLANTA, V199, P296, DOI 10.1007/BF00196572; Mahmood T, 2015, INT J AGRIC BIOL, V17, P681, DOI 10.17957/IJAB/14.0026; Marino G, 2017, TREE PHYSIOL, V37, P1637, DOI 10.1093/treephys/tpx083; Marulanda A, 2006, MICROB ECOL, V52, P670, DOI 10.1007/s00248-006-9078-0; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; Morgan P. W., 1992, ETHYLENE PLANT BIOL, P414, DOI DOI 10.1016/0092-8674(93)90043-P; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; Ngumbi E, 2016, APPL SOIL ECOL, V105, P109, DOI 10.1016/j.apsoil.2016.04.009; Pachauri RK, 2014, CLIM CHANG SYNTH REP; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Pierik R, 2006, TRENDS PLANT SCI, V11, P176, DOI 10.1016/j.tplants.2006.02.006; Saleem AR, 2015, INT J AGRIC BIOL, V17, P663, DOI 10.17957/IJAB/17.3.14.788; Saleemi AR, 2016, PAK J BOT, V48, P1697; Shaharoona B, 2006, LETT APPL MICROBIOL, V42, P155, DOI 10.1111/j.1472-765X.2005.01827.x; Shahzad SM, 2010, EUR J SOIL BIOL, V46, P342, DOI 10.1016/j.ejsobi.2010.05.007; Siddhuraju P, 1996, J AGR FOOD CHEM, V44, P2636, DOI 10.1021/jf950776x; Stefan M, 2013, ANALELE STIINTIFICE, VXIV; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tattini M, 2014, PLANT CELL ENVIRON, V37, P1950, DOI 10.1111/pce.12350; Tsonev T, 2014, INT J AGRIC BIOL, V16, P335; Vacheron J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00356; Vadivel V, 2000, INT J FOOD SCI NUTR, V51, P279, DOI 10.1080/09637480050077167; Vickers CE, 2009, PLANT CELL ENVIRON, V32, P520, DOI 10.1111/j.1365-3040.2009.01946.x; Vurukonda SSKP, 2016, MICROBIOL RES, V184, P13, DOI 10.1016/j.micres.2015.12.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x	67	42	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191218	10.1371/journal.pone.0191218	http://dx.doi.org/10.1371/journal.pone.0191218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447189	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900010
J	Sugimoto, R; Ishibashi-Ohgo, N; Atsuji, K; Miwa, Y; Iwata, O; Nakashima, A; Suzuki, K				Sugimoto, Ryota; Ishibashi-Ohgo, Naoko; Atsuji, Kohei; Miwa, Yuko; Iwata, Osamu; Nakashima, Ayaka; Suzuki, Kengo			Euglena extract suppresses adipocyte-differentiation in human adipose-derived stem cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1; ACTIVATED RECEPTOR-GAMMA; HIGH-FAT DIET; PPAR-GAMMA; 3T3-L1 CELLS; ECTOPIC EXPRESSION; C/EBP-BETA; OBESE MICE; GRACILIS Z; ADIPOGENESIS	Euglena gracilis Z (Euglena) is a unicellular, photosynthesizing, microscopic green alga. It contains several nutrients such as vitamins, minerals, and unsaturated fatty acids. In this study, to verify the potential role of Euglena consumption on human health and obesity, we evaluated the effect of Euglena on human adipose-derived stem cells. We prepared a Euglena extract and evaluated its effect on cell growth and lipid accumulation, and found that cell growth was promoted by the addition of the Euglena extract. Interestingly, intracellular lipid accumulation was inhibited in a concentration-dependent manner. Quantitative real-time PCR analysis and western blotting analysis indicated that the Euglena extract suppressed adipocyte differentiation by inhibiting the gene expression of the master regulators peroxisome proliferator-activated receptor-gamma (PPAR gamma) and one of three CCAAT-enhancer-binding proteins (C/EBP alpha). Further Oil Red O staining experiments indicated that the Euglena extract inhibited the early stage of adipocyte-differentiation. Consistent with these results, we observed that down-regulation of gene expression was involved in the early stage of adipogenesis represented by the sterol regulatory element binding protein 1 c (SREBP1c), two of three CCAAT-enhancer-binding proteins (C/EBP beta, C/EBP delta), and the cAMP regulatory element-binding protein (CREB). Taken together, these data suggest that Euglena extract is a promising candidate for the development of a new therapeutic treatment for obesity.	[Sugimoto, Ryota; Ishibashi-Ohgo, Naoko; Atsuji, Kohei; Miwa, Yuko; Iwata, Osamu; Nakashima, Ayaka; Suzuki, Kengo] Euglena Co Ltd, Dept Res & Dev, Minato Ku, Tokyo, Japan		Nakashima, A (corresponding author), Euglena Co Ltd, Dept Res & Dev, Minato Ku, Tokyo, Japan.	nakashima@euglena.jp		Nakashima, Ayaka/0000-0001-7474-406X				Aji K, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1267480; ANDING C, 1971, EUR J BIOCHEM, V24, P259, DOI 10.1111/j.1432-1033.1971.tb19679.x; Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378; BRIAND J, 1980, J PHYCOL, V16, P234; Bruki F., 2014, COLD SPRING HARB PER, V6; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fajas L, 1999, MOL CELL BIOL, V19, P5495; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Ho CH, 2006, INT J EAT DISORDER, V39, P477, DOI 10.1002/eat.20271; Johnson MD, 1998, ANN PHARMACOTHER, V32, P337, DOI 10.1345/aph.17046; Kang MC, 2016, FOOD CHEM TOXICOL, V90, P36, DOI 10.1016/j.fct.2016.01.023; Kang SI, 2011, BIOCHEM BIOPH RES CO, V409, P769, DOI 10.1016/j.bbrc.2011.05.086; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim KM, 2016, YONSEI MED J, V57, P1038, DOI 10.3349/ymj.2016.57.4.1038; Lai CS, 2012, J AGR FOOD CHEM, V60, P1094, DOI 10.1021/jf204862d; Lee I, 2010, J NAT PROD, V73, P172, DOI 10.1021/np900578h; Lee JE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-29; Leibel RL, 2002, NUTR REV, V60, pS15, DOI 10.1301/002966402320634788; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda H, 2009, MOL MED REP, V2, P897, DOI 10.3892/mmr_00000189; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Ning HX, 2009, DIFFERENTIATION, V77, P172, DOI 10.1016/j.diff.2008.09.019; Panja S, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0330-5; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Shimada R, 2016, FOOD FUNCT, V7, P4655, DOI [10.1039/c6fo00606j, 10.1039/C6FO00606J]; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sugiyama A, 2010, J VET MED SCI, V72, P755, DOI 10.1292/jvms.09-0526; SUMIDA S, 1987, PLANT CELL PHYSIOL, V28, P1587; Sung YY, 2011, J KOREAN SOC APPL BI, V54, P388, DOI 10.3839/jksabc.2011.061; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Tran BX, 2013, COST EFFECT RESOUR A, V11, P1; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wu Z, 1999, MOL CELL, V3; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yamada T, 2010, J DERMATOL SCI, V58, P36, DOI 10.1016/j.jdermsci.2010.02.003; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	48	11	12	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192404	10.1371/journal.pone.0192404	http://dx.doi.org/10.1371/journal.pone.0192404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447191	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900031
J	Altes, HK; Kloet, S; Cobelens, F; Bootsma, M				Altes, Hester Korthals; Kloet, Serieke; Cobelens, Frank; Bootsma, Martin			Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; INCUBATION PERIOD; IMMIGRANTS; RISK	While tuberculosis (TB) represents a significant disease burden worldwide, low-incidence countries strive to reach the WHO target of pre-elimination by 2035. Screening for TB in immigrants is an important component of the strategy to reduce the TB burden in low-incidence settings. An important option is the screening and preventive treatment of latent TB infection (LTBI). Whether this policy is worthwhile depends on the extent of transmission within the country, and introduction of new cases through import. Mathematical transmission models of TB have been used to identify key parameters in the epidemiology of TB and estimate transmission rates. An important application has also been to investigate the consequences of policy scenarios. Here, we formulate a mathematical model for TB transmission within the Netherlands to estimate the size of the pool of latent infections, and to determine the share of importation-either through immigration or travel-versus transmission within the Netherlands. We take into account importation of infections due to immigration, and travel to the country of origin, focusing on the three ethnicities most represented among foreign-born TB cases (after exclusion of those overrepresented among asylum seekers): Moroccans, Turkish and Indonesians. We fit a system of ordinary differential equations to the data from the Netherlands Tuberculosis Registry on (extra-) pulmonary TB cases from 1995-2013. We estimate that about 27% of Moroccans, 25% of Indonesians, and 16% of Turkish, are latently infected. Furthermore, we find that for all three foreign-born communities, immigration is the most important source of LTBI, but the extent of within-country transmission is much lower (about half) for the Turkish and Indonesian communities than for the Moroccan. This would imply that contact investigation would have a greater yield in the latter community than in the former. Travel remains a minor factor contributing LTBI, suggesting that targeting returning travelers might be less effective at preventing LTBI than immigrants upon entry in the country.	[Altes, Hester Korthals; Kloet, Serieke] Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance, Ctr Infect Dis Control, Bilthoven, Netherlands; [Cobelens, Frank] Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Cobelens, Frank] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Bootsma, Martin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bootsma, Martin] Univ Utrecht, Dept Math, Fac Sci, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University	Altes, HK (corresponding author), Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance, Ctr Infect Dis Control, Bilthoven, Netherlands.	hester.korthals.altes@rivm.nl		Cobelens, Frank/0000-0002-4367-1133				[Anonymous], 2016, IMMI EN EMIGRATIE NA; [Anonymous], 1899, BEVOLKING HUISHOUDEN; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boere TM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01979-2016; Borgdorff MW, 2011, INT J EPIDEMIOL, V40, P964, DOI 10.1093/ije/dyr058; Borgdorff MW, 1998, AM J EPIDEMIOL, V147, P187; Davies PDO, 2015, INT J TUBERC LUNG D, V19, P876, DOI 10.5588/ijtld.15.0506; Diekmann O, 2012, MATH TOOLS UNDERSTAN, P139; Dowdy DW, 2013, INT J TUBERC LUNG D, V17, P866, DOI 10.5588/ijtld.12.0573; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Houben RMGJ, 2016, LANCET GLOB HEALTH, V4, pE806, DOI [10.1016/s2214-109x(16)30199-1, 10.1016/S2214-109X(16)30199-1]; Kik SV, 2011, INT J TUBERC LUNG D, V15, P38; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Mulder C, 2011, INT J TUBERC LUNG D, V15, P1630, DOI 10.5588/ijtld.11.0027; Mulder C, 2012, EUR RESPIR J, V40, P1443, DOI 10.1183/09031936.00010612; Netherlands Tuberculosis Registry (NTR), 2014, TB CAS PER 1993 2013; Pesut DP, 2012, VOJNOSANIT PREGL, V69, P227, DOI 10.2298/VSP1203227P; Ragonnet R, 2017, EPIDEMICS-NETH, V21, P39, DOI 10.1016/j.epidem.2017.06.002; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Slump E EC, 2015, TUBERCULOSE NEDERLAN; Slump E EC, 2014, TUBERCULOSE NEDERLAN; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; van Aart C, 2017, INT J TUBERC LUNG D, V21, P486, DOI 10.5588/ijtld.16.0548; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; WHO, 2014, TB BURD EST; World Health Organization, 2021, 10 THREATS GLOB HLTH	31	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192282	10.1371/journal.pone.0192282	http://dx.doi.org/10.1371/journal.pone.0192282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444122	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500059
J	Hall, MT; Simms, KT; Lew, JB; Smith, MA; Saville, M; Canfell, K				Hall, Michaela T.; Simms, Kate T.; Lew, Jie-Bin; Smith, Megan A.; Saville, Marion; Canfell, Karen			Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; WOMEN; PROGRAMS; SURVIVAL	Background Many countries are transitioning from cytology-based to longer-interval HPV screening. Trials comparing HPV-based screening to cytology report an increase in CIN2/3 detection at the first screen, and longer-term reductions in CIN3+; however, population level year-to-year transitional impacts are poorly understood. We undertook a comprehensive evaluation of switching to longer-interval primary HPV screening in the context of HPV vaccination. We used Australia as an example setting, since Australia will make this transition in December 2017. Methods Using a model of HPV vaccination, transmission, natural history and cervical screening, Policy-1-Cervix, we simulated the planned transition from recommending cytology every two years for sexually-active women aged 18-20 to 69, to recommending HPV screening every five years for women aged 25-74 years. We estimated rates of CIN2/3, cervical cancer incidence, and mortality for each year from 2005 to 2035, considering ranges for HPV test accuracy and screening compliance in the context of HPV vaccination (current coverage similar to 82% in females; similar to 76% in males). Findings Transient increases are predicted to occur in rates of CIN2/3 detection and invasive cervical cancer in the first two to three years following the screening transition (of 16-24% and 11-14% in respectively, compared to 2017 rates). However, by 2035, CIN2/3 and invasive cervical cancer rates are predicted to fall by 40-44% and 42-51%, respectively, compared to 2017 rates. Cervical cancer mortality rates are predicted to remain unchanged until similar to 2020, then decline by 34-45% by 2035. Over the period 2018-2035, switching to primary HPV screening in Australia is expected to avert 2,006 cases of invasive cervical cancer and save 587 lives. Conclusions Transient increases in detected CIN2/3 and invasive cancer, which may be detectable at the population level, are predicted following a change to primary HPV screening. This is due to improved test sensitivity bringing forward diagnoses, resulting in longer term reductions in both cervical cancer incidence and mortality. Fluctuations in health outcomes due to the transition to a longer screening interval are predicted to occur for 10-15 years, but cervical cancer rates will be significantly reduced thereafter due to the impact of HPV vaccination and HPV screening. In order to maintain confidence in primary HPV screening through the transitional phase, it is important to widely communicate that an initial increase in CIN2/3 and perhaps even invasive cervical cancer is expected after a national transition to primary HPV screening, that this phenomenon is due to increased prevalent disease detection, and that this effect represents a marker of screening success.	[Hall, Michaela T.; Simms, Kate T.; Lew, Jie-Bin; Smith, Megan A.; Canfell, Karen] Canc Council NSW, Canc Res Div, Sydney, NSW, Australia; [Smith, Megan A.; Canfell, Karen] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Saville, Marion] Victorian Cytol Serv Ltd, Melbourne, Vic, Australia; [Saville, Marion] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia	Cancer Council New South Wales; University of Sydney; University of Melbourne	Canfell, K (corresponding author), Canc Council NSW, Canc Res Div, Sydney, NSW, Australia.; Canfell, K (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia.	karen.canfell@nswcc.org.au	Hall, Michaela/S-1996-2019	Hall, Michaela/0000-0002-8989-1449; Canfell, Karen/0000-0002-6443-6618; Simms, Kate/0000-0003-2568-7956; Lew, Jie-Bin/0000-0003-2837-3565; Smith, Megan/0000-0002-0401-2653	National Health and Medical Research Council [APP1065892, APP440200, APP1007518]; Medical Services Advisory Committee; Department of Health Australia; Cancer Council Australia; Cancer Council NSW; New Zealand Ministry of Health; United Kingdom Health Technologies Assessment (HTA); National Health and Medical Research Council (NHMRC) Australia [CDF APP1082989]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Services Advisory Committee; Department of Health Australia; Cancer Council Australia(Cancer Council Australia); Cancer Council NSW(Cancer Council New South Wales); New Zealand Ministry of Health; United Kingdom Health Technologies Assessment (HTA); National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	The development of the model used in this evaluation was funded by a range of sources including the National Health and Medical Research Council (project grants APP1065892, APP440200 and APP1007518), the Medical Services Advisory Committee, Department of Health Australia, Cancer Council Australia and Cancer Council NSW, the New Zealand Ministry of Health and the United Kingdom Health Technologies Assessment (HTA). Karen Canfell also receives salary support from the National Health and Medical Research Council (NHMRC) Australia (CDF APP1082989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, BMJ-BRIT MED J, P346; Andrae B, 2012, BMJ-BRIT MED J, P344; Arbyn M, 2008, OBSTET GYNECOL, P111; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Australian Bureau of Statistics, 2019, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2013, 3222 0 POP PROJ; Australian Government Department of Health, 2017, OV REN; Australian Government Department of Health, 2017, NAT CERV SCREEN PROG; Australian Government Department of Health and Ageing, 2011, HUM PAP HPV; Australian Institute of Health and Welfare, 2014, AUSTR I HLTH WELF CA; Australian Institute of Health and Welfare, 2013, AUSTR I HLTH WELF CA; Australian Institute of Health and Welfare, 2017, AUSTR I HLTH WELF CA; Australian Institute of Health and Welfare, 2015, AUSTR I HLTH WELF CA; Bolger N, 2006, ACTA CYTOL, P50; Brisson M, 2016, LANCET PUBLIC HEALTH, P1; Brotherton J, 2011, COMMUN DIS INTELL, P35; Brotherton J, 2008, COMMUN DIS INTELL, P32; Brotherton JM, 2013, LANCET, P377; Brotherton JML, 2014, VACCINE, P32; Brotherton JML, 2017, INT J CANCER, V141, P1576, DOI 10.1002/ijc.30871; Brotherton JML, 2015, PAPILLOMAVIRUS RES, V1, P59, DOI 10.1016/j.pvr.2015.05.005; Budd AC, 2014, MED J AUSTRALIA, P201; Cancer Council Australia,, 2017, NAT CERV SCREEN PROG; Canfell K, 2004, BRIT J CANCER, P91; Canfell K, 2011, HLTH TECHNOLOGY ASSE, V15; Canfell K, 2011, VACCINE, P29; Canfell K, 2007, COST EFFECTIVENESS P; Chow EPF, 2017, LANCET INFECT DIS, V17, P68, DOI 10.1016/S1473-3099(16)30116-5; ClinicalTrials.gov, 2014, COMP RAND CONTR TRAI; Creighton P, 2010, BMC PUBLIC HEALTH, P10; Crowe E, 2014, BMJ-BRIT MED J, P348; Davey E, 2007, BMJ-BRIT MED J, P335; de Sanjose S, 2010, LANCET ONCOL, P11; Department of Health and Ageing, 2013, IMM AUSTR PROGR HUM; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Elfstrom KM, 2014, BMJ-BRIT MED J, P348; Garland SM, 2009, J INFECT DIS, P199; Garland SM, 2016, CLIN INFECT DIS; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Herweijer E, 2014, JAMA-J AM MED ASSOC, V311, P597, DOI 10.1001/jama.2014.95; Jew JB, 2014, MSAC APPL; Kang YJ, 2012, THESIS; Kreimer AR, 2011, LANCET ONCOL, P12; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Legood R, 2012, BMJ-BRIT MED J, P345; Lew J, 2013, NATL CERVICAL SCREEN; Lew JB, 2016, PLOS ONE, P11; Lew JB, 2012, BMC HEALTH SERV RES, P12; Lew JB, 2017, LANCET PUBLIC HEALTH, V2, pE96, DOI 10.1016/S2468-2667(17)30007-5; Li N, 2011, INT J CANCER, P128; Malagon T, 2012, LANCET INFECT DIS, P12; Medical Services Advisory Committee, 2013, MSAC APPL; Ministero della Salute, 2014, PIAN NAZ PREV 2014 2; National Health and Medical Research Council, 2005, SCREEN PREV CERV CAN; National HPV Vaccination Program Register, 2014, HPV VACC COV DAT; National HPV Vaccination Register, 2017, COV DAT; National Screening Unit, 2016, UPD GUID CERV SCREEN; Pharmaceutical Benefits Advisory Committee (PBAC), 2017, JUL 2017 PBAC M POS; Rijkaart DC, 2012, LANCET ONCOL, P13; Rijksinstituut voor Volksgezondheid en Milieu, 2014, POP SCREEN WILL CHAN; Ronco G, 2014, LANCET, P383; Simms K, 2015, COST EFFECTIVENESS N; Smith M, 2009, EC EVALUATION IMPACT; Smith MA, 2016, MED J AUSTRALIA, P204; Smith MA, 2015, J INFECT DIS, P211; Smith MA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1375-9; Statens Serum Institute, 2016, HUM PAP VACC HPV TAE; Tabrizi SN, 2014, LANCET INFECT DIS, P14; Tota JE, 2017, JNCI-J NATL CANCER I, P109; van der Aa MA, 2008, EUR J OBSTET GYN R B, V139, P204, DOI 10.1016/j.ejogrb.2007.10.017; Victorian Cervical Cytology Register, 2014, STAT REP 2013; Zucchetto A, 2013, PREV MED, V57, P220, DOI 10.1016/j.ypmed.2013.05.018	72	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0185332	10.1371/journal.pone.0185332	http://dx.doi.org/10.1371/journal.pone.0185332			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444073	Green Published, gold			2022-12-26	WOS:000425183500001
J	Tian, D; Tian, M; Zhang, LL; Zhao, P; Cui, YF; Li, JL				Tian, Dan; Tian, Miao; Zhang, Leilei; Zhao, Peng; Cui, Yunfeng; Li, Jinlong			High fat diet sensitizes fibromyalgia-like pain behaviors in mice via tumor necrosis factor alpha	PLOS ONE			English	Article							SENSING ION CHANNELS; BODY-MASS INDEX; TNF-ALPHA; MOLECULAR-MECHANISMS; POTENTIAL MECHANISM; INSULIN-RESISTANCE; OBESITY; EXPRESSION; MUSCLE; POPULATION	Fibromyalgia (FM) and obesity are closely related. However, little is known about how obesity contributes to FM. Importantly, adequate evidence has shown that tumor necrosis factor alpha (TNF-alpha) plays a critical role in obesity. Thus, we hypothesized that obesity-induced TNF-alpha release may potentiate FM-associated pain. To test this hypothesis, we investigated the role of TNF-alpha in the development of FM-like pain in a mouse model of acid saline injection-induced FM. Consistent with previous reports, we showed that repeated acid saline injections induced bilateral mechanical hyperalgesia, and this effect lasted for at least 4 days after acid saline injections. This phenomenon was associated with increased levels of TNF-alpha in plasma, muscles, and spinal cord. Furthermore, we found that 24 weeks of high fat diet treatment significantly potentiated acid saline-induced bilateral mechanical hyperalgesia. High fat diet-treated mice exhibited robustly increased levels of TNF-alpha in plasma, muscles, and spinal cord after acid saline injections compared with low fat diet-treated mice. Additionally, using immunofluorescence staining, we found that the number of TNF-alpha positive cells in dorsal root ganglion (DRG) was increased after acid saline injections, and high fat diet treatment further sensitized this increase. Finally, we reported that acid saline-induced FM-like pain behaviors were abolished in TNFRp55(-/-) mice, confirming the critical role of TNF-alpha in the development of FM-like pain. Taken together, our results suggested that high fat diet treatment may sensitize acid saline-induced FM-like pain via increasing TNF-alpha levels in plasma, muscles, and DRG.	[Tian, Dan; Zhang, Leilei; Zhao, Peng; Cui, Yunfeng] Jilin Univ, Hosp 2, Dept Anesthesiol, Changchun, Jilin, Peoples R China; [Tian, Miao] Jilin Univ, Hosp 2, Dept Gynecol, Changchun, Jilin, Peoples R China; [Li, Jinlong] Jilin Univ, Hosp 2, Dept Gastrointestinal Surg, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Li, JL (corresponding author), Jilin Univ, Hosp 2, Dept Gastrointestinal Surg, Changchun, Jilin, Peoples R China.	jinlonglucky@gmail.com			Second Hospital of Jilin University [JUI2016SC5]	Second Hospital of Jilin University(Jilin University)	This research was funded by intramural grant (JUI2016SC5) from Second Hospital of Jilin University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by intramural grant (JUI20165C5) from Second Hospital of Jilin University.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Arendt-Nielsen Lars, 2003, Curr Pain Headache Rep, V7, P355, DOI 10.1007/s11916-003-0034-0; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Bernstein MS, 2004, PREV MED, V38, P94, DOI 10.1016/j.ypmed.2003.09.032; Bjorntorp P, 1999, DIABETIC MED, V16, P373, DOI 10.1046/j.1464-5491.1999.00067.x; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen W. N., 2014, MOL PAIN, V10, P40; Chen WH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-82; Chen WK, 2010, J NEUROSCI, V30, P10360, DOI 10.1523/JNEUROSCI.1041-10.2010; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Cregg R, 2010, J PHYSIOL-LONDON, V588, P1897, DOI 10.1113/jphysiol.2010.187807; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; DeSantana JM, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4402; Elert J, 2001, J RHEUMATOL, V28, P1361; English B, 2014, PAIN MANAG NURS, V15, P530, DOI 10.1016/j.pmn.2012.07.009; Eslami V, 2017, GERONTOLOGY, V63, P3, DOI 10.1159/000446651; Fillingim R B, 2000, Curr Rev Pain, V4, P24; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Gilbert GJ, 2007, NEUROLOGY, V68, P241; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Khimich S, 1997, Acta Chir Hung, V36, P166; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Lake JK, 2000, J CLIN EPIDEMIOL, V53, P245, DOI 10.1016/S0895-4356(99)00155-9; Lin JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128037; Lin JZ, 2015, EUR MICROW CONF, P1371, DOI 10.1109/EuMC.2015.7346027; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Lin YT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-126; Mamet J, 2002, J NEUROSCI, V22, P10662; Mattsson P, 2007, CEPHALALGIA, V27, P877, DOI 10.1111/j.1468-2982.2007.01360.x; McLean SA, 2005, DISABIL REHABIL, V27, P659, DOI 10.1080/09638280400009048; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Neels JG, 2006, AM J PATHOL, V168, P435, DOI 10.2353/ajpath.2006.050699; Neumann L, 2008, CLIN RHEUMATOL, V27, P1543, DOI 10.1007/s10067-008-0966-1; Okifuji A, 2002, APPL PSYCHOPHYS BIOF, V27, P129, DOI 10.1023/A:1016243710507; Okifuji A, 2015, J PAIN RES, V8, P399, DOI 10.2147/JPR.S55598; Okifuji A, 2009, CLIN RHEUMATOL, V28, P475, DOI 10.1007/s10067-009-1094-2; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; Peres MFP, 2005, ARQ NEURO-PSIQUIAT, V63, P931, DOI 10.1590/S0004-282X2005000600005; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; Price RC, 2013, EUR J PAIN, V17, P1316, DOI 10.1002/j.1532-2149.2013.00315.x; RAMZAN I, 1993, PHYSIOL BEHAV, V54, P433, DOI 10.1016/0031-9384(93)90231-4; Rollman GB, 2001, CLIN J PAIN, V17, P20, DOI 10.1097/00002508-200103000-00004; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Salemi S, 2003, J RHEUMATOL, V30, P146; Schafers M, 2003, PAIN, V104, P579, DOI 10.1016/S0304-3959(03)00115-5; Schreyer SA, 1998, J CLIN INVEST, V102, P402, DOI 10.1172/JCI2849; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Staud R, 2011, BEST PRACT RES CL RH, V25, P155, DOI 10.1016/j.berh.2010.01.010; Torensma B, 2017, SURG OBES RELAT DIS, V13, P788, DOI 10.1016/j.soard.2017.01.015; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Vilin YY, 2012, FRONT PHARMACOL, P3; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wallace DJ, 2006, CURR PHARM DESIGN, V12, P17, DOI 10.2174/138161206775193208; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wood JN, 2006, HAND CLINIC, V81, P49, DOI 10.1016/S0072-9752(06)80009-6; Yen LT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46663; Yunus MB, 2002, SCAND J RHEUMATOL, V31, P27, DOI 10.1080/030097402317255336; ZAHORSKA-MARKIEWICZ B, 1988, Acta Physiologica Polonica, V39, P183; Zhang L, 2011, PAIN, V152, P419, DOI 10.1016/j.pain.2010.11.014	64	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0190861	10.1371/journal.pone.0190861	http://dx.doi.org/10.1371/journal.pone.0190861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444083	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500010
J	Zahid, M; Bais, A; Tian, X; Devine, W; Lee, DM; Yau, C; Sonnenberg, D; Beerman, L; Khalifa, O; Lo, CW				Zahid, Maliha; Bais, Abha; Tian, Xin; Devine, William; Lee, Dong Ming; Yau, Cyrus; Sonnenberg, Daniel; Beerman, Lee; Khalifa, Omar; Lo, Cecilia W.			Airway ciliary dysfunction and respiratory symptoms in patients with transposition of the great arteries	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; NITRIC-OXIDE; MOUSE MODEL; MUTATIONS; DEFECTS; NASAL; HETEROTAXY; CHILDREN; PREVALENCE; VARIANTS	Background Our prior work on congenital heart disease (CHD) with heterotaxy, a birth defect involving randomized left-right patterning, has shown an association of a high prevalence of airway ciliary dysfunction (CD; 18/43 or 42%) with increased respiratory symptoms. Furthermore, heterotaxy patients with ciliary dysfunction were shown to have more postsurgical pulmonary morbidities. These findings are likely a reflection of the common role of motile cilia in both airway clearance and left-right patterning. As CHD comprising transposition of the great arteries (TGA) is commonly thought to involve disturbance of left-right patterning, especially L-TGA with left-right ventricular inversion, we hypothesize CHD patients with transposition of great arteries (TGA) may have high prevalence of airway CD with increased respiratory symptoms. Methods and results We recruited 75 CHD patients with isolated TGA, 28% L and 72% D-TGA. Patients were assessed using two tests typically used for evaluating airway ciliary dysfunction in patients with primary ciliary dyskinesia (PCD), a recessive sinopulmonary disease caused by respiratory ciliary dysfunction. This entailed the measurement of nasal nitric oxide (nNO), which is typically low with PCD. We also obtained nasal scrapes and conducted videomicroscopy to assess respiratory ciliary motion (CM). We observed low nNO in 29% of the patients, and abnormal CM in 57%, with 22% showing both low nNO and abnormal CM. No difference was observed for the prevalence of either low nNO or abnormal ciliary motion between patients with D vs. L-TGA. Respiratory symptoms were increased with abnormal CM, but not low nNO. Sequencing analysis showed no compound heterozygous or homozygous mutations in 39 genes known to cause PCD, nor in CFTR, gene causing cystic fibrosis. As both are recessive disorders, these results indicate TGA patients with ciliary dysfunction do not have PCD or cystic fibrosis (which can cause low nNO or abnormal ciliary motion). Conclusions TGA patients have high prevalence of abnormal CM and low nNO, but ciliary dysfunction was not correlated with TGA type. Differing from PCD, respiratory symptoms were increased with abnormal CM, but not low nNO. Together with the negative findings from exome sequencing analysis, this would suggest TGA patients with ciliary dysfunction do not have PCD but nevertheless may suffer from milder airway clearance deficiency. Further studies are needed to investigate whether such ciliary dysfunction is associated with increased postsurgical complications as previously observed in CHD patients with heterotaxy.	[Zahid, Maliha; Bais, Abha; Lee, Dong Ming; Sonnenberg, Daniel; Khalifa, Omar; Lo, Cecilia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Tian, Xin] NHLBI, Off Biostat Res, Bldg 10, Bethesda, MD 20892 USA; [Devine, William] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Yau, Cyrus; Beerman, Lee] Univ Pittsburgh, Sch Med, Dept Pediat, Div Pediat Cardiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lo, CW (corresponding author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA.	cel36@pitt.edu		Zahid, Maliha/0000-0002-2986-9557; Lo, Cecilia/0000-0003-4314-3434	Department of Health of the Commonwealth of Pennsylvania [4100054875]; Department of Defense [W81XWH-15-1-0649]	Department of Health of the Commonwealth of Pennsylvania; Department of Defense(United States Department of Defense)	This study was supported by Department of Health of the Commonwealth of Pennsylvania, Award # 4100054875 and the Department of Defense Grant W81XWH-15-1-0649. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PS, 2015, RESP MED, V109, P1126, DOI 10.1016/j.rmed.2015.07.010; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Aune CN, 2008, PEDIATR RES, V63, P9, DOI 10.1203/PDR.0b013e31815b6926; Chhin B, 2007, HUM MUTAT, V28, P563, DOI 10.1002/humu.20480; Corbelli R, 2004, CHEST, V126, P1054, DOI 10.1378/chest.126.4.1054; Csoma Z, 2003, CHEST, V124, P633, DOI 10.1378/chest.124.2.633; De Luca A, 2010, HEART, V96, P673, DOI 10.1136/hrt.2009.181685; Edelbusch C, 2017, HUM MUTAT, V38, P964, DOI 10.1002/humu.23261; Eileen Stewart MD PS AD, 2017, J THORACIC CARDIOVAS; Francis RJB, 2012, AM J PHYSIOL-HEART C, V302, pH2102, DOI 10.1152/ajpheart.01118.2011; French VM, 2012, CIRC RES, V110, P1564, DOI 10.1161/CIRCRESAHA.112.269795; Garrod Andrea S, 2014, Ann Am Thorac Soc, V11, P1426, DOI 10.1513/AnnalsATS.201405-222OC; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Harden B, 2014, J THORAC CARDIOV SUR, V147, P1291, DOI 10.1016/j.jtcvs.2013.06.018; Karadag B, 1999, EUR RESPIR J, V13, P1402, DOI 10.1034/j.1399-3003.1999.13f28.x; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; Muncke N, 2003, CIRCULATION, V108, P2843, DOI 10.1161/01.CIR.0000103684.77636.CD; Nakhleh N, 2012, CIRCULATION, V125, P2232, DOI 10.1161/CIRCULATIONAHA.111.079780; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; Wren C, 2012, EUR J PEDIATR, V171, P281, DOI 10.1007/s00431-011-1525-3	27	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191605	10.1371/journal.pone.0191605	http://dx.doi.org/10.1371/journal.pone.0191605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444099	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500024
J	Kuroda, S; Ito, H; Sakamaki, K; Tabei, T; Kawahara, T; Fujikawa, A; Makiyama, K; Yao, M; Uemura, H; Matsuzaki, J				Kuroda, Shinnosuke; Ito, Hiroki; Sakamaki, Kentaro; Tabei, Tadashi; Kawahara, Takashi; Fujikawa, Atsushi; Makiyama, Kazuhide; Yao, Masahiro; Uemura, Hiroji; Matsuzaki, Junichi			A new prediction model for operative time of flexible ureteroscopy with lithotripsy for the treatment of renal stones	PLOS ONE			English	Article							SINGLE-CENTER EXPERIENCE; HOLMIUM LASER LITHOTRIPSY; URETERAL ACCESS SHEATH; SHOCK-WAVE LITHOTRIPSY; HOUNSFIELD UNITS; PERCUTANEOUS NEPHROLITHOTOMY; SEMIRIGID URETEROSCOPY; EAU GUIDELINES; COMPLICATIONS; TOMOGRAPHY	This study aimed to develop a prediction model for the operative time of flexible uretero-scopy (fURS) for renal stones. We retrospectively evaluated patients with renal stones who had been treated successfully and had stone-free status determined by non-contrast computed tomography (NCCT) 3 months after fURS and holmium laser lithotripsy between December 2009 and September 2014 at a single institute. Correlations between possible factors and the operative time were analyzed using Spearman's correlation coefficients and a multivariate linear regression model. The P value < 0.1 was used for entry of variables into the model and for keeping the variables in the model. Internal validation was performed using 10,000 bootstrap resamples. Flexible URS was performed in 472 patients, and 316 patients were considered to have stone-free status and were enrolled in this study. Spearman's correlation coefficients showed a significant positive relationship between the operation time and stone volume (rho = 0.417, p < 0.001), and between the operation time and maximum Hounsfield units (rho = 0.323, p < 0.001). A multivariate assessment with forced entry and stepwise selection revealed six factors to predict the operative time of fURS: pre-operative stenting, stone volume, maximum Hounsfield unit, surgeon experience, sex, and sheath diameter. Based on this finding, we developed a model to predict operative time of fURS. The coefficient of determination (R-2) in this model was 0.319; the mean R-2 value for the prediction model was 0.320 +/- 0.049. To our knowledge, this is the first report of a model for predicting the operative time of fURS treatment of renal stones. The model may be used to reliably predict operative time preoperatively based on patient characteristics and the surgeons' experience, plan staged URS, and avoid surgical complications.	[Kuroda, Shinnosuke; Ito, Hiroki; Tabei, Tadashi; Fujikawa, Atsushi; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kuroda, Shinnosuke; Kawahara, Takashi; Uemura, Hiroji] Yokohama City Univ, Dept Urol & Renal Transplantat, Med Ctr, Yokohama, Kanagawa, Japan; [Ito, Hiroki; Makiyama, Kazuhide; Yao, Masahiro] Yokohama City Univ Med, Dept Urol, Yokohama, Kanagawa, Japan; [Sakamaki, Kentaro] Yokohama City Univ, Grad Sch Med, Dept Biostat, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Ito, H (corresponding author), Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.; Ito, H (corresponding author), Yokohama City Univ Med, Dept Urol, Yokohama, Kanagawa, Japan.	pug_daikichi@yahoo.co.jp						Aboumarzouk OM, 2012, J ENDOUROL, V26, P1257, DOI 10.1089/end.2012.0217; Akman T, 2012, BJU INT, V109, P1384, DOI 10.1111/j.1464-410X.2011.10691.x; Breda A, 2016, CURR OPIN UROL, V26, P70, DOI 10.1097/MOU.0000000000000233; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; Chu L, 2011, J ENDOUROL, V25, P751, DOI 10.1089/end.2010.0400; Cohen J, 2013, BJU INT, V111, pE127, DOI 10.1111/j.1464-410X.2012.11352.x; Eijkemans MJC, 2010, ANESTHESIOLOGY, V112, P41, DOI 10.1097/ALN.0b013e3181c294c2; Fuganti PE, 2008, UROLOGY, V72, P770, DOI 10.1016/j.urology.2008.05.042; Geavlete P, 2006, J ENDOUROL, V20, P179, DOI 10.1089/end.2006.20.179; Guzelburc V, 2016, J LAPAROENDOSC ADV S, V26, P23, DOI 10.1089/lap.2015.0294; Hubert KC, 2005, J UROLOGY, V174, P1079, DOI 10.1097/01.ju.0000169130.80049.9c; Hyams ES, 2010, J ENDOUROL, V24, P1411, DOI 10.1089/end.2009.0645; Ito H, 2015, UROLITHIASIS, V43, P467, DOI 10.1007/s00240-015-0789-x; Ito H, 2015, BJU INT, V115, P446, DOI 10.1111/bju.12775; Ito H, 2012, J ENDOUROL, V26, P1125, DOI 10.1089/end.2012.0154; Ito H, 2012, UROLOGY, V80, P524, DOI 10.1016/j.urology.2012.04.001; Kawahara T, 2016, UROLITHIASIS, V44, P231, DOI 10.1007/s00240-015-0823-z; Kawahara T, 2012, INT J UROL, V19, P881, DOI 10.1111/j.1442-2042.2012.03046.x; Kuroda S, 2016, INT J UROL, V23, P69, DOI 10.1111/iju.12951; Michel MS, 2007, EUR UROL, V51, P899, DOI 10.1016/j.eururo.2006.10.020; Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033; Pareek G, 2005, UROLOGY, V65, P33, DOI 10.1016/j.urology.2004.08.004; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; Saw KC, 2000, J ENDOUROL, V14, P471, DOI 10.1089/end.2000.14.471; Seitz C, 2012, EUR UROL, V61, P146, DOI 10.1016/j.eururo.2011.09.016; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Sugihara T, 2013, BJU INT, V111, P459, DOI 10.1111/j.1464-410X.2012.11594.x; Torricelli FC, 2014, UROLOGY, V83, P278, DOI 10.1016/j.urology.2013.10.002; Turk C, 2016, EUR UROL, V69, P475, DOI 10.1016/j.eururo.2015.07.041	29	18	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192597	10.1371/journal.pone.0192597	http://dx.doi.org/10.1371/journal.pone.0192597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438410	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400029
J	Liu, TB; Hu, Y; Guo, SY; Tan, L; Zhan, Y; Yang, LC; Liu, W; Wang, ND; Li, YL; Zhang, YF; Liu, CY; Yang, Y; Adelstein, RS; Wang, AB				Liu, Tanbin; Hu, Yi; Guo, Shiyin; Tan, Lei; Zhan, Yang; Yang, Lingchen; Liu, Wei; Wang, Naidong; Li, Yalan; Zhang, Yingfan; Liu, Chengyu; Yang, Yi; Adelstein, Robert S.; Wang, Aibing			Identification and characterization of MYH9 locus for high efficient gene knock-in and stable expression in mouse embryonic stem cells	PLOS ONE			English	Article							SAFE-HARBOR LOCUS; MYOSIN II-B; MICE; GENOME; ROSA26; REPLACEMENT; INTEGRATION; TRANSGENESIS; GENERATION; DISTINCT	Targeted integration of exogenous genes into so-called safe harbors/friend sites, offers the advantages of expressing normal levels of target genes and preventing potentially adverse effects on endogenous genes. However, the ideal genomic loci for this purpose remain limited. Additionally, due to the inherent and unresolved issues with the current genome editing tools, traditional embryonic stem (ES) cell-based targeted transgenesis technology is still preferred in practical applications. Here, we report that a high and repeatable homologous recombination (HR) frequency (> 95%) is achieved when an approximate 6kb DNA sequence flanking the MYH9 gene exon 2 site is used to create the homology arms for the knockout/knock-in of diverse nonmuscle myosin II (NM II) isoforms in mouse ES cells. The easily obtained ES clones greatly facilitated the generation of multiple NM II genetic replacement mouse models, as characterized previously. Further investigation demonstrated that though the targeted integration site for exogenous genes is shifted to MYH9 intron 2 (about 500bp downstream exon 2), the high HR efficiency and the endogenous MYH9 gene integrity are not only preserved, but the expected expression of the inserted gene(s) is observed in a pre-designed set of experiments conducted in mouse ES cells. Importantly, we confirmed that the expression and normal function of the endogenous MYH9 gene is not affected by the insertion of the exogenous gene in these cases. Therefore, these findings suggest that like the commonly used ROSA26 site, the MYH9 gene locus may be considered a new safe harbor for high-efficiency targeted transgenesis and for biomedical applications.	[Liu, Tanbin; Hu, Yi; Tan, Lei; Yang, Lingchen; Liu, Wei; Li, Yalan; Wang, Aibing] Hunan Agr Univ HUNAU, Lab Anim Models & Funct Genom, Key Lab Anim Vaccine & Prot Engn, Coll Vet Med, Changsha, Hunan, Peoples R China; [Guo, Shiyin] HUNAU, Coll Food Sci & Technol, Changsha, Hunan, Peoples R China; [Zhan, Yang; Wang, Naidong; Yang, Yi] HUNAU, Lab Funct Prote, Key Lab Anim Vaccine & Prot Engn, Coll Vet Med, Changsha, Hunan, Peoples R China; [Zhang, Yingfan; Adelstein, Robert S.; Wang, Aibing] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wang, AB (corresponding author), Hunan Agr Univ HUNAU, Lab Anim Models & Funct Genom, Key Lab Anim Vaccine & Prot Engn, Coll Vet Med, Changsha, Hunan, Peoples R China.; Wang, AB (corresponding author), NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA.	bingaiwang@hunau.edu.cn		Zhang, Yingfan/0000-0001-5932-2440; Tan, Lei/0000-0002-9358-4898; WANG, AIBING/0000-0002-0470-8220; Liu, Wei/0000-0001-8257-0397	National Natural Science Foundation of China [31571432, 31270819]; Hunan Provincial Natural Science Foundation of China [2015JC3097]; NHLBI/NIH Division of Intramural Research [ZIA HL004228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005907, ZIAHL004223, ZIAHL004228] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); NHLBI/NIH Division of Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work received support from the General Program of National Natural Science Foundation of China (Grants No. 31571432 to AW and 31270819 to YY); Hunan Provincial Natural Science Foundation of China (Grant No. 2015JC3097 to AW). Support was also provided by the NHLBI/NIH Division of Intramural Research (ZIA HL004228 to RSA).	Andreadaki M, 2014, CELL MICROBIOL, V16, P751, DOI 10.1111/cmi.12274; Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Baudoin C, 1998, GENE DEV, V12, P1202, DOI 10.1101/gad.12.8.1202; Belizario JE, 2012, J APPL GENET, V53, P295, DOI 10.1007/s13353-012-0096-y; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carthon BC, 2005, MOL CELL BIOL, V25, P1081, DOI 10.1128/MCB.25.3.1081-1088.2005; Casola S, 2010, METHODS MOL BIOL, V667, P145, DOI 10.1007/978-1-60761-811-9_10; Chandra SHV, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1345; Chen TR, 2012, BIOCHEM BIOPH RES CO, V425, P189, DOI 10.1016/j.bbrc.2012.07.064; Cohen J, 2016, SCIENCE, V354, P538, DOI 10.1126/science.354.6312.538; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Coppola E, 2005, EMBO J, V24, P4392, DOI 10.1038/sj.emboj.7600897; Corrigan-Curay J, 2015, MOL THER, V23, P796, DOI 10.1038/mt.2015.54; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Eyquem J, 2013, BIOTECHNOL BIOENG, V110, P2225, DOI 10.1002/bit.24892; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gama-Norton L, 2010, HUM GENE THER, V21, P979, DOI 10.1089/hum.2009.089; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hohenstein Peter, 2008, Pathogenetics, V1, P3, DOI 10.1186/1755-8417-1-3; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/NMETH.3075, 10.1038/nmeth.3075]; Huang CY, 2017, J VIROL, V91, DOI 10.1128/JVI.01979-16; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Kong QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107945; Lee S, 2016, GENESIS, V54, P53, DOI 10.1002/dvg.22912; Lee YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43220; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Low BE, 2016, METHODS MOL BIOL, V1438, P19, DOI 10.1007/978-1-4939-3661-8_2; Ma Xuefei, 2014, Bioarchitecture, V4, P88, DOI 10.4161/bioa.29766; Mao LF, 2017, DIABETES, V66, P407, DOI 10.2337/db16-0343; Motojima M, 2016, MAMM GENOME, V27, P62, DOI 10.1007/s00335-015-9610-y; Nanchi I, 2015, TRANSGENIC RES, V24, P549, DOI 10.1007/s11248-015-9872-x; Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018; Piazzi M, 2015, ONCOTARGET, V6, P10924, DOI 10.18632/oncotarget.3454; Ruan JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14253; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Saposnik B, 2014, MOL GENET GENOM MED, V2, P297, DOI 10.1002/mgg3.68; Satyanarayana A, 2008, DEVELOPMENT, V135, P3389, DOI 10.1242/dev.024919; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Sibilia M, 2003, DEVELOPMENT, V130, P4515, DOI 10.1242/dev.00664; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Smithies O, 2001, NAT MED, V7, P1083, DOI 10.1038/nm1001-1083; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strathdee D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000004; Suzuki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071187; Tchorz JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030011; Torres R, 2014, GENE THER, V21, P343, DOI 10.1038/gt.2014.1; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Verver EJJ, 2016, EAR HEARING, V37, P112, DOI 10.1097/AUD.0000000000000198; Wang AB, 2011, BIOCHEM SOC T, V39, P1131, DOI 10.1042/BST0391131; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wijshake T, 2014, BBA-MOL BASIS DIS, V1842, P1942, DOI 10.1016/j.bbadis.2014.04.020; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	58	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192641	10.1371/journal.pone.0192641	http://dx.doi.org/10.1371/journal.pone.0192641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438440	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400038
J	Mutamiswa, R; Machekano, H; Chidawanyika, F; Nyamukondiwa, C				Mutamiswa, Reyard; Machekano, Honest; Chidawanyika, Frank; Nyamukondiwa, Casper			Thermal resilience may shape population abundance of two sympatric congeneric Cotesia species (Hymenoptera: Braconidae)	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENTS; CEREAL STEM BORERS; CLIMATE-CHANGE; FLAVIPES CAMERON; TEMPERATURE EXTREMES; NATURAL HABITATS; COLD-HARDINESS; TOLERANCE; EVOLUTIONARY; PARASITOIDS	Basal and plasticity of thermal tolerance determine abundance, biogeographical patterns and activity of insects over spatial and temporal scales. For coexisting stemborer parasitoids, offering synergistic impact for biological control, mismatches in thermal tolerance may influence their ultimate impact in biocontrol programs under climate variability. Using laboratory-reared congeneric parasitoid species Cotesia sesamiae Cameron and Cotesia flavipes Cameron (Hymenoptera: Braconidae), we examined basal thermal tolerance to understand potential impact of climate variability on their survival and limits to activity. We measured upper-and lower -lethal temperatures (ULTs and LLTs), critical thermal limits [CTLs] (CTmin and CTmax), supercooling points (SCPs), chill-coma recovery time (CCRT) and heat knock-down time (HKDT) of adults. Results showed LLTs ranging -5 to 5 degrees C and -15 to -1 degrees C whilst ULTs ranged 35 to 42 degrees C and 37 to 44 degrees C for C. sesamiae and C. flavipes respectively. Cotesia flavipes had significantly higher heat tolerance (measured as CTmax), as well as cold tolerance (measured as CTmin) relative to C. sesamiae (P<0.0001). While SCPs did not vary significantly (P>0.05), C. flavipes recovered significantly faster following chill-coma and had higher HKDT compared to C. sesamiae. The results suggest marked differential basal thermal tolerance responses between the two congeners, with C. flavipes having an advantage at both temperature extremes. Thus, under predicted climate change, the two species may differ in phenologies and biogeography with consequences on their efficacy as biological control agents. These results may assist in predicting spatio-temporal activity patterns which can be used in integrated pest management programs under climate variability.	[Mutamiswa, Reyard; Machekano, Honest; Nyamukondiwa, Casper] BIUST, Dept Biol & Biotechnol Sci, Palapye, Botswana; [Chidawanyika, Frank] Agr Res Council, Plant Protect Res, Weeds Div, Hilton, South Africa; [Chidawanyika, Frank] Univ KwaZulu Natal, Sch Lifesci, Pietermaritzburg, South Africa; [Nyamukondiwa, Casper] Univ Free State, Dept Zool & Entomol, Bloemfontein, South Africa	Agricultural Research Council of South Africa; University of Kwazulu Natal; University of the Free State	Nyamukondiwa, C (corresponding author), BIUST, Dept Biol & Biotechnol Sci, Palapye, Botswana.; Nyamukondiwa, C (corresponding author), Univ Free State, Dept Zool & Entomol, Bloemfontein, South Africa.	nyamukondiwac@biust.ac.bw	Chidawanyika, Frank/AAJ-7551-2020	Chidawanyika, Frank/0000-0002-4601-768X; Machekano, Honest/0000-0001-9660-8587	BIUST grant [BIUST/ds/RI/17/2016]	BIUST grant	This work was supported through BIUST grant number BIUST/ds/R&I/17/2016 to CN.	Alford L, 2016, ENTOMOL EXP APPL, V159, P61, DOI 10.1111/eea.12410; Andreadis SS, 2005, ENTOMOL EXP APPL, V117, P113, DOI 10.1111/j.1570-7458.2005.00337.x; Assefa Y, 2008, J ECON ENTOMOL, V101, P686, DOI 10.1603/0022-0493(2008)101[686:EOCFHB]2.0.CO;2; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bale JS, 1996, EUR J ENTOMOL, V93, P369; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Nguyen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087535; Chidawanyika F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169371; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Dejen Asmare, 2013, International Journal of Insect Science, V5, P9, DOI [10.4137/ijis.s11009, 10.4137/IJIS.S11009]; Dessalegn Obsi Gemeda, 2015, Journal of Ecology and the Natural Environment, V7, P256; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Findsen A, 2014, J EXP BIOL, V217, P1297, DOI 10.1242/jeb.098442; Findsen A, 2013, J EXP BIOL, V216, P1630, DOI 10.1242/jeb.081141; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harrison JF, 2012, ECOL ENVIRON PHYSIOL, P1, DOI 10.1093/acprof:oso/9780199225941.001.0001; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Karuppaiah V., 2012, World Journal of Agricultural Sciences, V8, P240; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Kleynhans E, 2014, ENTOMOL EXP APPL, V150, P113, DOI 10.1111/eea.12144; Le Lann C, 2011, PHYSIOL ENTOMOL, V36, P21, DOI 10.1111/j.1365-3032.2010.00758.x; Ma FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103279; Machekano H, 2017, BIOL CONTROL; Mailafiya DM, 2009, J APPL ENTOMOL, V133, P416, DOI 10.1111/j.1439-0418.2009.01381.x; Mailafiya DM, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0115; Mailafiya DM, 2010, BIOL CONTROL, V54, P1, DOI 10.1016/j.biocontrol.2009.11.008; Manjoo Suman, 2011, Journal of Biological Control, V25, P323; Milton CC, 2008, J INSECT PHYSIOL, V54, P32, DOI 10.1016/j.jinsphys.2007.08.001; Mochiah MB, 2001, BIOL CONTROL, V21, P285, DOI 10.1006/bcon.2001.0941; Muirhead KA, 2012, MOL PHYLOGENET EVOL, V63, P904, DOI 10.1016/j.ympev.2012.03.003; Mutamiswa R, 2017, PEST MANAGEMENT SCI; Mutamiswa R, 2017, INSECT SCI; Mutamiswa R, 2017, AGR FOREST ENTOMOL, V19, P344, DOI 10.1111/afe.12217; Nooten SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085987; Nyamukondiwa C, 2013, J INSECT PHYSIOL, V59, P1199, DOI 10.1016/j.jinsphys.2013.09.004; Nyamukondiwa C, 2010, PHYSIOL ENTOMOL, V35, P255, DOI 10.1111/j.1365-3032.2010.00736.x; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; OCHIENG RS, 1985, INSECT SCI APPL, V6, P425, DOI 10.1017/S1742758400004744; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; R Core Team, 2021, R LANGUAGE ENV STAT; Rice AD, 2009, AUST J ENTOMOL, V48, P282, DOI 10.1111/j.1440-6055.2009.00717.x; Romo CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058136; Sallam MN, 1999, B ENTOMOL RES, V89, P185, DOI 10.1017/S0007485399000279; Sallam MN, 2002, BIOCONTROL SCI TECHN, V12, P493, DOI 10.1080/09583150220146059; Sallam MN, 2001, INSECT SCI ITS APPL, V21, P397; Santos M, 2012, ECOL EVOL, V2, P2866, DOI 10.1002/ece3.385; Selvaraj S., 2013, International Journal of Biodiversity and Conservation, V5, P845; Sgro CM, 2016, ANNU REV ENTOMOL, V61, P433, DOI 10.1146/annurev-ento-010715-023859; Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003; Sorensen JG, 2014, CROP PROT, V38, P87; Stotter RL, 2009, J THERM BIOL, V34, P320, DOI 10.1016/j.jtherbio.2009.05.002; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Weldon CW, 2011, J THERM BIOL, V36, P479, DOI 10.1016/j.jtherbio.2011.08.005; Zhou GF, 2003, ECOL ENTOMOL, V28, P109, DOI 10.1046/j.1365-2311.2003.00477.x	59	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0191840	10.1371/journal.pone.0191840	http://dx.doi.org/10.1371/journal.pone.0191840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438408	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400007
J	Sall, A; Corbee, D; Vikstrom, S; Ottosson, F; Persson, H; Waldemarson, S				Sall, Anna; Corbee, Daniel; Vikstrom, Sara; Ottosson, Filip; Persson, Helena; Waldemarson, Sofia			Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range	PLOS ONE			English	Article							RECOMBINANT ANTIBODY FRAGMENTS; BIOMARKER DISCOVERY; MASS-SPECTROMETRY; PHAGE DISPLAY; SCFV FRAGMENTS; IMMOBILIZATION; PROTEOMICS; VERIFICATION; ENRICHMENT; SELECTION	There is a great need for targeted protein assays with the capacity of sensitive measurements in complex samples such as plasma or serum, not the least for clinical purposes. Proteomics keeps generating hundreds of biomarker candidates that need to be transferred towards true clinical application through targeted verification studies and towards clinically applicable analysis formats. The immunoaffinity assay AFFIRM (AFFInity sRM) combines the sensitivity of recombinant single chain antibodies (scFv) for targeted protein enrichment with a specific mass spectrometry readout through selected reaction monitoring (SRM) in an automated workflow. Here we demonstrate a 100 times improved detection capacity of the assay down to pg/ml range through the use of oriented antibody immobilization to magnetic beads. This was achieved using biotin-tagged scFv coupled to streptavidin coated magnetic beads, or utilizing the FLAG tag for coupling to anti-FLAG antibody coated magnetic beads. An improved multiplexing capacity with an 11-plex setup was also demonstrated compared to a previous 3-plex setup, which is of great importance for the analysis of panels of biomarker targets.	[Sall, Anna; Corbee, Daniel; Vikstrom, Sara; Ottosson, Filip; Persson, Helena; Waldemarson, Sofia] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Sall, Anna] Alligator Biosci, Lund, Sweden; [Corbee, Daniel] Camurus, Lund, Sweden; [Vikstrom, Sara] BioGaia AB, Lund, Sweden; [Ottosson, Filip] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Persson, Helena] KTH Royal Inst Technol, Sci Life Lab Drug Discovery & Dev Platform, Stockholm, Sweden; [Persson, Helena] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden	Lund University; Lund University; Royal Institute of Technology; Royal Institute of Technology	Waldemarson, S (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	sofia.waldemarson@immun.lth.se		Persson, Helena/0000-0002-2965-0395; Ottosson, Filip/0000-0002-8312-3545	Fru Berta Kamprads stiftelse, Sweden [BKS53/2015]; Fru Berta Kamprads stiftelse [BKS53/2015]	Fru Berta Kamprads stiftelse, Sweden; Fru Berta Kamprads stiftelse	This work has been financed by Fru Berta Kamprads stiftelse, Sweden. Grant no BKS53/2015 to SW. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from Fru Berta Kamprads stiftelse (BKS53/2015) to SW. There was no additional external funding received for this study. We would also like to thank Prof. Peter James for proteomics and mass spectrometry support and input, Karin Hansson and Mats Magard for help and support with the TSQ instrument, Dr. Fredrik Levander for bioinformatics help and Maria Walle for antibody support, Oladapo Olaleye for contributing the work of antigen recovery in different plasma concentrations vs. serum. The mass spectrometry SRM data have been deposited to The PeptideAtlas SRM Experiment Library (PASSEL) and can be accessed through hup://www.peptideat PASS00852:GE3523bm@fip.peptideatias.org/).	Abbatiello SE, 2015, MOL CELL PROTEOMICS, V14, P2357, DOI 10.1074/mcp.M114.047050; Abbatiello SE, 2013, MOL CELL PROTEOMICS, V12, P2623, DOI 10.1074/mcp.M112.027078; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Brockmann EC, 2005, J IMMUNOL METHODS, V296, P159, DOI 10.1016/j.jim.2004.11.008; Cho IH, 2007, ANAL BIOCHEM, V365, P14, DOI 10.1016/j.ab.2007.02.028; Cloutier SM, 2000, MOL IMMUNOL, V37, P1067, DOI 10.1016/S0161-5890(01)00023-2; Fuzery AK, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-13; Hu XJ, 2013, BIOMACROMOLECULES, V14, P153, DOI 10.1021/bm301518p; Huttenhain R, 2009, CURR OPIN CHEM BIOL, V13, P518, DOI 10.1016/j.cbpa.2009.09.014; JANDA KD, 1994, P NATL ACAD SCI USA, V91, P2532, DOI 10.1073/pnas.91.7.2532; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Kumada Y, 2014, BBA-PROTEINS PROTEOM, V1844, P1960, DOI 10.1016/j.bbapap.2014.07.007; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makaraviciute A, 2013, BIOSENS BIOELECTRON, V50, P460, DOI 10.1016/j.bios.2013.06.060; Paulovich AG, 2008, PROTEOM CLIN APPL, V2, P1386, DOI 10.1002/prca.200780174; Peluso P, 2003, ANAL BIOCHEM, V312, P113, DOI 10.1016/S0003-2697(02)00442-6; Razavi M, 2011, J IMMUNOL METHODS, V364, P50, DOI 10.1016/j.jim.2010.11.001; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sall A, 2016, PROTEIN ENG DES SEL, V29, P427, DOI 10.1093/protein/gzw042; Sall A, 2015, J PROTEOME RES, V14, P4704, DOI 10.1021/acs.jproteome.5b00585; Sall A, 2014, J PROTEOME RES, V13, P5837, DOI 10.1021/pr500757s; Schoenherr RM, 2010, J IMMUNOL METHODS, V353, P49, DOI 10.1016/j.jim.2009.11.017; Skates SJ, 2013, J PROTEOME RES, V12, P5383, DOI 10.1021/pr400132j; Stoevesandt O, 2012, NEW BIOTECHNOL, V29, P511, DOI 10.1016/j.nbt.2012.05.003; Want EJ, 2005, CHEMBIOCHEM, V6, P1941, DOI 10.1002/cbic.200500151; Weiss F, 2013, BIOCH BIOPHYS ACTA; Whiteaker JR, 2007, ANAL BIOCHEM, V362, P44, DOI 10.1016/j.ab.2006.12.023; Whiteaker JR, 2014, J PROTEOME RES, V13, P2187, DOI 10.1021/pr4009404; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Yang HM, 2015, ANAL CHIM ACTA, V872, P1, DOI 10.1016/j.aca.2015.03.005	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0189116	10.1371/journal.pone.0189116	http://dx.doi.org/10.1371/journal.pone.0189116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438379	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400002
J	Seeker, LA; Ilska, JJ; Psifidi, A; Wilbourn, RV; Underwood, SL; Fairlie, J; Holland, R; Froy, H; Bagnall, A; Whitelaw, B; Coffey, M; Nussey, DH; Banos, G				Seeker, Luise A.; Ilska, Joanna J.; Psifidi, Androniki; Wilbourn, Rachael V.; Underwood, Sarah L.; Fairlie, Jennifer; Holland, Rebecca; Froy, Hannah; Bagnall, Ainsley; Whitelaw, Bruce; Coffey, Mike; Nussey, Daniel H.; Banos, Georgios			Longitudinal changes in telomere length and associated genetic parameters in dairy cattle analysed using random regression models	PLOS ONE			English	Article							BODY ENERGY; EARLY-LIFE; RED DEER; LACTATION; AGE; HERITABILITY; DYNAMICS; SURVIVAL; TRAITS; BIOMARKER	Telomeres cap the ends of linear chromosomes and shorten with age in many organisms. In humans short telomeres have been linked to morbidity and mortality. With the accumulation of longitudinal datasets the focus shifts from investigating telomere length (TL) to exploring TL change within individuals over time. Some studies indicate that the speed of telomere attrition is predictive of future disease. The objectives of the present study were to 1) characterize the change in bovine relative leukocyte TL (RLTL) across the lifetime in Holstein Friesian dairy cattle, 2) estimate genetic parameters of RLTL over time and 3) investigate the association of differences in individual RLTL profiles with productive lifespan. RLTL measurements were analysed using Legendre polynomials in a random regression model to describe TL profiles and genetic variance over age. The analyses were based on 1,328 repeated RLTL measurements of 308 female Holstein Friesian dairy cattle. A quadratic Legendre polynomial was fitted to the fixed effect of age in months and to the random effect of the animal identity. Changes in RLTL, heritability and within-trait genetic correlation along the age trajectory were calculated and illustrated. At a population level, the relationship between RLTL and age was described by a positive quadratic function. Individuals varied significantly regarding the direction and amount of RLTL change over life. The heritability of RLTL ranged from 0.36 to 0.47 (SE = 0.05-0.08) and remained statistically unchanged over time. The genetic correlation of RLTL at birth with measurements later in life decreased with the time interval between samplings from near unity to 0.69, indicating that TL later in life might be regulated by different genes than TL early in life. Even though animals differed in their RLTL profiles significantly, those differences were not correlated with productive lifespan (p = 0.954).	[Seeker, Luise A.; Ilska, Joanna J.; Coffey, Mike; Banos, Georgios] SRUC, Anim & Vet Sci, Easter Bush, Midlothian, Scotland; [Seeker, Luise A.; Psifidi, Androniki; Whitelaw, Bruce; Banos, Georgios] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Seeker, Luise A.; Psifidi, Androniki; Whitelaw, Bruce; Banos, Georgios] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Psifidi, Androniki] Univ London, Royal Vet Coll, Hatfield, Herts, England; [Wilbourn, Rachael V.; Underwood, Sarah L.; Fairlie, Jennifer; Holland, Rebecca; Froy, Hannah; Nussey, Daniel H.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Bagnall, Ainsley] SRUC Crichton Royal Farm, Dumfries, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of London; University of London Royal Veterinary College; University of Edinburgh	Seeker, LA (corresponding author), SRUC, Anim & Vet Sci, Easter Bush, Midlothian, Scotland.; Seeker, LA (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.; Seeker, LA (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	seeker.luise@gmail.com	Nussey, Daniel H/F-4155-2010; Underwood, Sarah/GWD-1097-2022; Seeker, Luise/Z-1448-2019	Seeker, Luise/0000-0001-6375-6372; Banos, Georgios/0000-0002-7674-858X; Whitelaw, Bruce/0000-0002-2918-1605; Ilska, Joanna Jadwiga/0000-0002-1563-0174; Froy, Hannah/0000-0003-2965-3526	Scotland's Rural College; Biotechnology and Biological Sciences Research Council [BB/L007312/1]; Rural & Environment Science & Analytical Services Division of the Scottish Government; BBSRC [BBS/E/D/05251445, BBS/E/D/30002276, BB/L007312/1, BB/L008238/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L008238/1, BBS/E/D/05251445, BBS/E/D/30002275, BBS/E/D/30002276, BBS/E/D/10002070] Funding Source: researchfish	Scotland's Rural College; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rural & Environment Science & Analytical Services Division of the Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a PhD scholarship to the first author offered by Scotland's Rural College (http://www.sruc.ac.uk/) and the Biotechnology and Biological Sciences Research Council (BB/L007312/1 to GB; http://www.bbsrc.ac.uk/), and the Rural & Environment Science & Analytical Services Division of the Scottish Government.	Abdullahpour R, 2013, ARCH TIERZUCHT, V56, DOI 10.7482/0003-9438-56-048; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baerlocher GM, 2007, AGING CELL, V6, P121, DOI 10.1111/j.1474-9726.2006.00254.x; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Banos G, 2004, J DAIRY SCI, V87, P2669, DOI 10.3168/jds.S0022-0302(04)73393-7; Banos G, 2010, ANIMAL, V4, P189, DOI 10.1017/S1751731109991182; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bateson M, 2016, BIOESSAYS, V38, P201, DOI 10.1002/bies.201500127; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Brown DE, 2012, J DAIRY SCI, V95, P6384, DOI 10.3168/jds.2012-5593; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Englishby TM, 2016, J ANIM SCI, V94, P1354, DOI 10.2527/jas.2015-0246; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fairlie J, 2016, AGING CELL, V15, P140, DOI 10.1111/acel.12417; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013496; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Froy H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116415; Gall Blackburn, 1978, J MOL BIOL, P33; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Genolini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150738; Goglin SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160748; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Hayward AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001917; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Herborn KA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3151; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Horn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017199; Hornsby PJ, 2006, AGING CELL, V5, P577, DOI 10.1111/j.1474-9726.2006.00249.x; Hovatta I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034948; Issa JP, 2003, CLIN IMMUNOL, V109, P103, DOI 10.1016/S1521-6616(03)00203-1; Jamrozik J, 1997, J DAIRY SCI, V80, P762, DOI 10.3168/jds.S0022-0302(97)75996-4; Kim W, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000016; KIRKPATRICK M, 1994, GENET RES, V64, P57, DOI 10.1017/S0016672300032559; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Lansdorp PM, 2006, AGING CELL, V5, P583, DOI 10.1111/j.1474-9726.2006.00247.x; Laubenthal L, 2016, J DAIRY SCI, V99, P4881, DOI 10.3168/jds.2015-10095; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Miyashita N, 2002, BIOL REPROD, V66, P1649, DOI 10.1095/biolreprod66.6.1649; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Mrode R, 2008, J DAIRY SCI, V91, P794, DOI 10.3168/jds.2007-0506; Mrode RA, 2003, LIVEST PROD SCI, V79, P239, DOI 10.1016/S0301-6226(02)00169-0; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nussey DH, 2008, P ROY SOC B-BIOL SCI, V275, P745, DOI 10.1098/rspb.2007.0986; Oikonomou G, 2008, J DAIRY SCI, V91, P2814, DOI 10.3168/jds.2007-0965; Olsson MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027505; Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pooley KA, 2013, HUM MOL GENET, V22, P5056, DOI 10.1093/hmg/ddt355; Raymond AR, 2013, EUR J HEART FAIL, V15, P54, DOI 10.1093/eurjhf/hfs147; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Seeker LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164046; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; Van Der Werf J, 2001, NOTES; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VEERKAMP RF, 1994, LIVEST PROD SCI, V39, P229, DOI 10.1016/0301-6226(94)90202-X; Wilson AJ, 2007, EVOL ECOL, V21, P337, DOI 10.1007/s10682-006-9106-z; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743	69	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192864	10.1371/journal.pone.0192864	http://dx.doi.org/10.1371/journal.pone.0192864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438415	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000425083400062
J	De Cuyper, A; Clauss, M; Hesta, M; Cools, A; Bosch, G; Hendriks, WH; Janssens, GPJ				De Cuyper, Annelies; Clauss, Marcus; Hesta, Myriam; Cools, An; Bosch, Guido; Hendriks, Wouter H.; Janssens, Geert P. J.			Are carnivore digestive separation mechanisms revealed on structure-rich diets?: Faecal inconsistency in dogs (Canis familiaris) fed day old chicks	PLOS ONE			English	Article							END-PRODUCT CONCENTRATIONS; HUMAN INTESTINAL BACTERIA; CAPTIVE EXOTIC FELIDS; PARTICLE PASSAGE MARKERS; FATTY-ACID PRODUCTION; HEALTHY ADULT DOGS; TOTAL TRACT ENERGY; IN-VITRO ANALYSES; NUTRIENT DIGESTIBILITY; MACRONUTRIENT DIGESTIBILITY	Pronounced variations in faecal consistency have been described anecdotally for some carnivore species fed a structure-rich diet. Typically two faecal consistencies are distinguished, namely hard and firm versus liquid and viscous faeces. It is possible that a separation mechanism is operating in the carnivore digestive tract, as in many herbivore species. Six beagle dogs were fed two experimental diets in a cross-over design of 7 days. Test diets consisted of chunked day old chicks differing only in particle size (fine = 7.8 mm vs coarse = 13 mm) in order to vary dietary structure. Digestive retention time was measured using titanium oxide (TiO2) as marker. The total faecal output was scored for consistency and faecal fermentation profiles were evaluated through faecal short-chain fatty acid (SCFA) and ammonia (NH3) analyses. A total of 181 faecal samples were collected. Dietary particle size did not affect faecal consistency, fermentative end products nor mean retention time (MRT). However, a faecal consistency dichotomy was observed with firm faeces (score 2 +/- 2.5) and soft faeces (score 4 +/- 4.5) being the most frequently occurring consistencies in an almost alternating pattern in every single dog. Firm and soft faeces differed distinctively in fermentative profiles. Although the structure difference between diets did not affect the faecal dichotomy, feeding whole prey provoked the occurrence of the latter which raises suspicion of a digestive separation mechanism in the canine digestive tract. Further faecal characterisation is however required in order to unravel the underlying mechanism.	[De Cuyper, Annelies; Hesta, Myriam; Cools, An; Janssens, Geert P. J.] Univ Ghent, Lab Anim Nutr, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium; [Clauss, Marcus] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Bosch, Guido; Hendriks, Wouter H.] Wageningen Univ, Dept Anim Sci, Anim Nutr Grp, Wageningen, Netherlands; [Hendriks, Wouter H.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Ghent University; University of Zurich; Wageningen University & Research; Utrecht University	De Cuyper, A (corresponding author), Univ Ghent, Lab Anim Nutr, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium.	annelies.decuyper@ugent.be	Bosch, Guido/A-6912-2011; Janssens, Geert/C-2264-2008; Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008; Clauss, Marcus/GRR-7996-2022	Bosch, Guido/0000-0002-5714-9506; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; De Cuyper, Annelies/0000-0003-2057-8283; Hesta, Myriam/0000-0001-9423-9765	Institute for Promotion of Innovation through Science and Technology in Flanders (IWT) [131448]	Institute for Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Institute for Promotion of Innovation through Science and Technology in Flanders (IWT) (grant number 131448; URL: https://www.iwt.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan FJ, 1996, VET RADIOL ULTRASOUN, V37, P336, DOI 10.1111/j.1740-8261.1996.tb01238.x; [Anonymous], 1973, 14431973 ISO; [Anonymous], 2012, FERRETS RABBITS ANDR; Vazquez JA, 2013, MAR DRUGS, V11, P747, DOI 10.3390/md11030747; Awati A, 2006, J ANIM SCI, V84, P1110, DOI 10.2527/2006.8451110x; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; BANTA CA, 1979, J NUTR, V109, P1592, DOI 10.1093/jn/109.9.1592; Becker AAMJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-43; Bellosa ML, 2011, J PARASITOL, V97, P349, DOI 10.1645/GE-2475.1; Beloshapka AN, 2012, BRIT J NUTR, V108, P638, DOI 10.1017/S0007114511005927; Beloshapka AN, 2012, AM J VET RES, V73, P1016, DOI 10.2460/ajvr.73.7.1016; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BJORNHAG G, 1984, CAN J ANIM SCI, V64, P89; BJORNHAG G, 1989, J EXP ZOOL, P32, DOI 10.1002/jez.1402520506; BJORNHAG G, 1981, LIVEST PROD SCI, V8, P351, DOI 10.1016/0301-6226(81)90053-1; BOISEN S, 1995, ANIM FEED SCI TECH, V51, P29, DOI 10.1016/0377-8401(94)00686-4; Bosch G, 2008, J ANIM SCI, V86, P2979, DOI 10.2527/jas.2007-0819; Bosch G, 2009, BRIT J NUTR, V102, P318, DOI 10.1017/S0007114508149194; BOWLAND J M, 1991, Koedoe, V34, P37; Carre B., 2000, PROD ANIM, V13, P131; Cole JT, 1999, J ANIM SCI, V77, P917; Cools A., 2015, 8 EUR ZOO NUTR C ARN, P14; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; De Cuyper A, 2017, J ANIM PHYSL ANIM NU; Depauw S, 2013, J ANIM PHYSIOL AN N, V97, P146, DOI 10.1111/j.1439-0396.2011.01252.x; Depauw S, 2012, J ANIM SCI, V90, P2540, DOI 10.2527/jas.2011-4377; Diaz Tartera HO, 2017, NEUROGASTROENT MOTIL, V29, P1; Dittmann MT, 2015, J COMP PHYSIOL B, V185, P559, DOI 10.1007/s00360-015-0904-x; Ferguson LR, 1997, FOOD SCI TECHNOL-LEB, V30, P735, DOI 10.1006/fstl.1997.0260; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Frei S, 2017, COMP BIOCHEM PHYS A, V204, P219, DOI 10.1016/j.cbpa.2016.12.001; Frei S, 2015, AUK, V132, P119, DOI 10.1642/AUK-14-144.1; GASAWAY WC, 1975, CONDOR, V77, P467, DOI 10.2307/1366093; Goggin JM, 1998, AM J VET RES, V59, P388; Hady A.A.A., 2013, LIFE SCI J, V10, P3172; Hermansson G, 1996, DIGEST DIS SCI, V41, P1994, DOI 10.1007/BF02093602; Hernot DC, 2005, J ANIM PHYSIOL AN N, V89, P189, DOI 10.1111/j.1439-0396.2005.00544.x; Hervera M, 2007, J ANIM PHYSIOL AN N, V91, P205, DOI 10.1111/j.1439-0396.2007.00693.x; Hill RC, 2011, BRIT J NUTR, V106, pS202, DOI 10.1017/S0007114511000833; Hooda S, 2012, J ANIM SCI, V90, P4355, DOI 10.2527/jas.2012-5333; HOROWITZ M, 1985, BRIT J OBSTET GYNAEC, V92, P743, DOI 10.1111/j.1471-0528.1985.tb01458.x; HUTSON WR, 1989, GASTROENTEROLOGY, V96, P11, DOI 10.1016/0016-5085(89)90758-0; ISO, 2005, 59831 ISO; ISO (International Standards Organization), 1981, 54981981 ISO; ITOH T, 1986, J PHARM PHARMACOL, V38, P801, DOI 10.1111/j.2042-7158.1986.tb04498.x; Jethva BD, 2004, ZOO BIOL, V23, P513, DOI 10.1002/zoo.20030; Kerr KR, 2014, J ANIM SCI, V92, P3441, DOI 10.2527/jas.2014-6615; Kerr KR, 2013, J ANIM SCI, V91, P2199, DOI 10.2527/jas.2012-5702; Kerr KR, 2013, J ANIM SCI, V91, P225, DOI 10.2527/jas.2011-4835; Kerr KR, 2012, J ANIM SCI, V90, P515, DOI 10.2527/jas.2010-3266; Kerr KR, 2013, ZOO BIOL, V32, P510, DOI 10.1002/zoo.21084; Lumetsberger T, 2017, J ZOOL, V302, P201, DOI 10.1111/jzo.12449; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; Macfarlane S, 1998, FEMS MICROBIOL ECOL, V26, P231, DOI 10.1111/j.1574-6941.1998.tb00508.x; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; MAINKA SA, 1989, J ZOO WILDLIFE MED, V20, P39; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Matsuda I, 2015, PHYSIOL BEHAV, V149, P45, DOI 10.1016/j.physbeh.2015.05.020; McGrosky A, 2016, EUR J WILDLIFE RES, V62, P395, DOI 10.1007/s10344-016-1011-3; Moxham G., 2001, WALTHAM FOCUS, V11, P24; Muller DWH, 2011, COMP BIOCHEM PHYS A, V160, P207, DOI 10.1016/j.cbpa.2011.06.004; Myers WD, 2004, J ANIM SCI, V82, P179; NAKAE T, 1965, J DAIRY SCI, V48, P287, DOI 10.3168/jds.S0022-0302(65)88218-2; Nery J, 2010, J ANIM SCI, V88, P159, DOI 10.2527/jas.2008-1666; Nickel R., 2004, EINGEWEIDE, V9; NRC, 2006, NUTR REQ DOGS CATS; Peterson Rolf O., 2003, P104; PROSKY L, 1985, J ASSOC OFF ANA CHEM, V68, P677; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Rolfe VE, 2002, J SMALL ANIM PRACT, V43, P290, DOI 10.1111/j.1748-5827.2002.tb00075.x; Ruehe F, 2003, ACTA THERIOL, V48, P527, DOI 10.1007/BF03192498; SARNA SK, 1988, AM J PHYSIOL, V254, pG595, DOI 10.1152/ajpgi.1988.254.4.G595; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schlesinger DP, 2011, CAN VET J, V52, P50; SCHULTZ JE, 1979, APPL ENVIRON MICROB, V37, P1206, DOI 10.1128/AEM.37.6.1206-1210.1979; Schwarm A, 2008, COMP BIOCHEM PHYS A, V150, P32, DOI 10.1016/j.cbpa.2008.02.022; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V125, P525, DOI 10.1016/S1095-6433(00)00183-5; TAYLOR RJF, 1959, BRIT J NUTR, V13, P1, DOI 10.1079/BJN19590003; THIELEMANS MF, 1978, ANN BIOL ANIM BIOCH, V18, P237, DOI 10.1051/rnd:19780203; Vester BM, 2008, ZOO BIOL, V27, P126, DOI 10.1002/zoo.20172; Vester BM, 2010, ZOO BIOL, V29, P676, DOI 10.1002/zoo.20305; Wachter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038066; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; Weber MP, 2004, J ANIM PHYSIOL AN N, V88, P356, DOI 10.1111/j.1439-0396.2004.00494.x; Weber MP, 2002, AM J VET RES, V63, P677, DOI 10.2460/ajvr.2002.63.677; Wen J, 1995, AM J PHYSIOL-GASTR L, V269, pG945, DOI 10.1152/ajpgi.1995.269.6.G945; Wyse CA, 2003, J VET INTERN MED, V17, P609, DOI 10.1892/0891-6640(2003)017&lt;0609:AROMFA&gt;2.3.CO;2; Zentek J, 2004, J NUTR, V134, p2158S, DOI 10.1093/jn/134.8.2158S; ZENTEK J, 1995, J ANIM PHYSIOL AN N, V74, P43, DOI 10.1111/j.1439-0396.1995.tb00435.x	91	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192741	10.1371/journal.pone.0192741	http://dx.doi.org/10.1371/journal.pone.0192741			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432482	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000424814300042
J	Singh, KK; Madden, M; Gray, J; Meentemeyer, RK				Singh, Kunwar K.; Madden, Marguerite; Gray, Josh; Meentemeyer, Ross K.			The managed clearing: An overlooked land-cover type in urbanizing regions?	PLOS ONE			English	Article							HIGH-RESOLUTION DATA; RURAL LANDSCAPE; UNITED-STATES; CLASSIFICATION; ECOSYSTEMS; SERVICES	Urban ecosystem assessments increasingly rely on widely available map products, such as the U.S. Geological Service (USGS) National Land Cover Database (NLCD), and datasets that use generic classification schemes to detect and model large-scale impacts of land-cover change. However, utilizing existing map products or schemes without identifying relevant urban class types such as semi-natural, yet managed land areas that account for differences in ecological functions due to their pervious surfaces may severely constrain assessments. To address this gap, we introduce the managed clearings land-cover type-semi-natural, vegetated land surfaces with varying degrees of management practices-for urbanizing landscapes. We explore the extent to which managed clearings are common and spatially distributed in three rapidly urbanizing areas of the Charlanta megaregion, USA. We visually interpreted and mapped fine-scale land cover with special attention to managed clearings using 2012 U.S. Department of Agriculture (USDA) National Agriculture Imagery Program (NAIP) images within 150 randomly selected 1-km(2) blocks in the cities of Atlanta, Charlotte, and Raleigh, and compared our maps with National Land Cover Database (NLCD) data. We estimated the abundance of managed clearings relative to other land use and land cover types, and the proportion of land-cover types in the NLCD that are similar to managed clearings. Our study reveals that managed clearings are the most common land cover type in these cities, covering 28% of the total sampled land area-6.2% higher than the total area of impervious surfaces. Managed clearings, when combined with forest cover, constitutes 69% of pervious surfaces in the sampled region. We observed variability in area estimates of managed clearings between the NAIP-derived and NLCD data. This suggests using high-resolution remote sensing imagery (e.g., NAIP) instead of modifying NLCD data for improved representation of spatial heterogeneity and mapping of managed clearings in urbanizing landscapes. Our findings also demonstrate the need to more carefully consider managed clearings and their critical ecological functions in landscape-to regional-scale studies of urbanizing ecosystems.	[Singh, Kunwar K.; Gray, Josh; Meentemeyer, Ross K.] North Carolina State Univ, Ctr Geospatial Analyt, Raleigh, NC 27695 USA; [Singh, Kunwar K.; Gray, Josh; Meentemeyer, Ross K.] North Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Singh, Kunwar K.; Madden, Marguerite] Univ Georgia, Dept Geog, Ctr Geospatial Res, Athens, GA 30602 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia	Singh, KK (corresponding author), North Carolina State Univ, Ctr Geospatial Analyt, Raleigh, NC 27695 USA.; Singh, KK (corresponding author), North Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.; Singh, KK (corresponding author), Univ Georgia, Dept Geog, Ctr Geospatial Res, Athens, GA 30602 USA.	kksingh@ncsu.edu	Singh, Kunwar/K-4432-2017	Singh, Kunwar/0000-0002-9788-1822; Gray, Josh/0000-0003-4341-4353; Meentemeyer, Ross/0000-0002-1247-6212				[Anonymous], 1976, LAND USE LAND COVER; [Anonymous], 2011, NATIONAL LAND COVER; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Blaschke T, 2014, ISPRS J PHOTOGRAMM, V87, P180, DOI 10.1016/j.isprsjprs.2013.09.014; Breuste J, 2015, J URBAN PLAN DEV, V141, DOI 10.1061/(ASCE)UP.1943-5444.0000291; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Colding J, 2013, GLOBAL ENVIRON CHANG, V23, P1039, DOI 10.1016/j.gloenvcha.2013.05.006; Derkzen ML, 2015, J APPL ECOL, V52, P1020, DOI 10.1111/1365-2664.12469; Dougherty M, 2004, PHOTOGRAMM ENG REM S, V70, P1275, DOI 10.14358/PERS.70.11.1275; Gaston KJ, 2013, J APPL ECOL, V50, P830, DOI 10.1111/1365-2664.12087; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Julian JP, 2014, HYDROL PROCESS, V28, P1525, DOI 10.1002/hyp.9692; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; Lahouari B., 2015, ENVIRON RES LETT, V10; Lu DS, 2010, PHOTOGRAMM ENG REM S, V76, P1159, DOI 10.14358/PERS.76.10.1159; Maxwell SK, 2008, AGR ECOSYST ENVIRON, V127, P141, DOI 10.1016/j.agee.2008.03.012; McKee JJ, 2015, P NATL ACAD SCI USA, V112, P1344, DOI 10.1073/pnas.1405713112; Meentemeyer RK, 2013, ANN ASSOC AM GEOGR, V103, P785, DOI 10.1080/00045608.2012.707591; Nowak DJ, 2010, ENVIRON MANAGE, V46, P378, DOI 10.1007/s00267-010-9536-9; Qian YG, 2015, LANDSCAPE ECOL, V30, P1165, DOI 10.1007/s10980-015-0195-3; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Singh KK, 2012, ISPRS J PHOTOGRAMM, V74, P110, DOI 10.1016/j.isprsjprs.2012.09.009; Verburg PH, 2011, GLOBAL CHANGE BIOL, V17, P974, DOI 10.1111/j.1365-2486.2010.02307.x; Wells AG, 2012, APPL VEG SCI, V15, P560, DOI 10.1111/j.1654-109X.2012.01193.x; Wickham JD, 2010, REMOTE SENS ENVIRON, V114, P1286, DOI 10.1016/j.rse.2010.01.018; Zhou W, 2008, INT J REMOTE SENS, V29, P3119, DOI 10.1080/01431160701469065; Zhou WQ, 2010, LANDSCAPE ECOL, V25, P53, DOI 10.1007/s10980-009-9427-8; Zhou WQ, 2009, REMOTE SENS ENVIRON, V113, P1769, DOI 10.1016/j.rse.2009.04.007	28	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192822	10.1371/journal.pone.0192822	http://dx.doi.org/10.1371/journal.pone.0192822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432442	gold, Green Submitted, Green Published			2022-12-26	WOS:000424814300048
J	Wang, ZX; Lau, JTF; Fang, Y; Mary, I; Gross, DL				Wang, Zixin; Lau, Joseph T. F.; Fang, Yuan; Mary, Ip; Gross, Danielle L.			Prevalence of actual uptake and willingness to use pre-exposure prophylaxis to prevent HIV acquisition among men who have sex with men in Hong Kong, China	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; TRANSGENDER WOMEN; AUSTRALIAN GAY; INFECTION; PREP; ADHERENCE; TENOFOVIR; RISK; MSM	Objectives This study was to investigate the prevalence of actual uptake of pre-exposure prophylaxis (PrEP), willingness to use daily oral PrEP under two cost scenarios, and potential issues related to PrEP use among men who have sex with men (MSM) with HIV negative/unknown sero-status in Hong Kong, China. Factors associated with the two measures of willingness were also investigated. Methods 403 eligible MSM completed the anonymous venue-based face-to-face interview/telephone interview. Results Only 1% had ever used PrEP. After being briefed about some facts of PrEP, the prevalence of willingness to use daily oral PrEP was 7.7% if they could purchase PrEP at private hospitals/clinics at HK$8,000 (US$1,032)/month (market rate) and 45.2% if free PrEP was provided by public hospitals/clinics in Hong Kong (free PrEP). After adjusted for significant background variables, significant factors of these two measures of willingness included: (1) number of correct responses to knowledge on PrEP, (2) perceived risk of HIV infection in the next six months, and (3) constructs of the Theory of Planned Behavior: positive and negative attitudes toward PrEP, perceived their significant others would support them take PrEP (perceived subjective norm), perceived number of local MSM who were willing to take PrEP (perceived descriptive norm), and confidence in using PrEP under the two scenarios (perceived behavioral control). Among all participants, 9.7% and 25.1% would start and discontinue using PrEP without consulting doctors; 26.0% would not take PrEP daily if it was provided for free, and 42.4% would not take up HIV testing every 3 months after using PrEP. Conclusion Different strategies should be considered for promoting PrEP at market rate and if free PrEP is made available. Future promotion should increase their knowledge about PrEP, modify their perceptions related to HIV and PrEP, and address some potential issues related to PrEP use.	[Wang, Zixin; Lau, Joseph T. F.; Fang, Yuan; Mary, Ip; Gross, Danielle L.] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Wang, Zixin; Lau, Joseph T. F.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Zixin] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Community Res Program AIDS, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong	Wang, ZX; Lau, JTF (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.; Wang, ZX; Lau, JTF (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.; Wang, ZX (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Community Res Program AIDS, Hong Kong, Hong Kong, Peoples R China.	wangzx@cuhk.edu.hk; jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022	Fang, Yuan/0000-0003-1154-5076	Council for the AIDS Trust Fund, Hong Kong SAR [MSS239R]; AIDS Trust Fund [MSS239R]	Council for the AIDS Trust Fund, Hong Kong SAR; AIDS Trust Fund	Funding of this study was provided by Council for the AIDS Trust Fund, Hong Kong SAR (ref# MSS239R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This HIV/AIDS prevention part of project is sponsored by AIDS Trust Fund (ref# MSS239R). The content of this article represents the opinion of our organization only. It does not represent the position of the AIDS Trust Fund. AIDS Trust Fund is not responsible for any claims, demands or liabilities whatsoever arising from or in connection with the use of any information contained in this article or the participation of the sponsored project.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2016, CANADAS SOURCE HIV H; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2015, PRESENTED IN CONFERE; Centers for Disease Control and Prevention (CDC), 2015, PAYING PREP; Centers for Disease Control ROC (Taiwan), LIST HOSP PROV PREEX; Cheung Tony, 2015, S CHINA MORNING POST; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Colby D, 2016, AS PAC C AIDS COINF; Ding YY, 2016, BIOSCI TRENDS, V10, P113, DOI 10.5582/bst.2016.01035; Dolezal C, 2015, AIDS EDUC PREV, V27, P289, DOI 10.1521/aeap.2015.27.4.289; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Haire BG, 2015, HIV AIDS-RES PALLIAT, V7, P241, DOI 10.2147/HIV.S72419; Holt M, 2014, JAIDS-J ACQ IMM DEF, V67, P222, DOI 10.1097/QAI.0000000000000287; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Hong Kong Advisory Council on AIDS, 2017, REC HIV AIDS STRAT H; Kasaie P, 2017, J ACQUIRED IMMUNE DE; Kenyon CR, 2015, INT J STD AIDS, V26, P988, DOI 10.1177/0956462415584490; Kesler MA, 2016, AIDS CARE, V28, P1378, DOI 10.1080/09540121.2016.1178703; Ko NY, 2016, AIDS EDUC PREV, V28, P128, DOI 10.1521/aeap.2016.28.2.128; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Lau JTF, 2014, ARCH SEX BEHAV, V43, P789, DOI 10.1007/s10508-013-0172-3; Lebouche B, 2016, HIV MED, V17, P152, DOI 10.1111/hiv.12286; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Martin MT, 2015, PRESENTED IN CONFERE; McCormack S, 2017, 9 IAS C HIV SCI PAR; McCormack S, 2015, PRESENTED IN CONFERE; McCormack SM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21103; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; Merab E., 2017, KENYAN GOVT ROLL OUT; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Mitchell JW, 2015, LGBT HEALTH, V2, P35, DOI 10.1089/lgbt.2014.0092; Peng P, 2017, AIDS BEHAV IN PRESS; Peterson L, 2007, PLOS CLIN TRIALS, V2, pe27TN; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Snowden JM, 2017, SEX TRANSM INFECT, V93, P52, DOI 10.1136/sextrans-2015-052382; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2016, GLOB AIDS UPD; US Public Health Service, 2014, PREEXPOSURE PROPHYLA; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Virtual AIDS Office of Hong Kong, 2015, CHP REVIEWS LOCAL HI; Wang Chelsea Zi, 2017, THESIS; Wang ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149801; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; Wilton J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20777; World Health Organization, 2016, CONS GUID US ANT DRU; Zablotska IB, 2013, JAIDS-J ACQ IMM DEF, V62, P334, DOI 10.1097/QAI.0b013e31827e854a; Zhang Y, 2013, AIDS PATIENT CARE ST, V27, P137, DOI 10.1089/apc.2012.0412; Zhou FF, 2012, 2012 11TH IEEE INTERNATIONAL SYMPOSIUM ON NETWORK COMPUTING AND APPLICATIONS (NCA), P10, DOI 10.1109/NCA.2012.41	53	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191671	10.1371/journal.pone.0191671	http://dx.doi.org/10.1371/journal.pone.0191671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV8DE	29432470	gold, Green Published, Green Submitted			2022-12-26	WOS:000424814300010
J	Backryd, E; Persson, EB; Larsson, AI; Fischer, MR; Gerdle, B				Backryd, Emmanuel; Persson, Elisabeth B.; Larsson, Annelie Inghilesi; Fischer, Marcelo Rivano; Gerdle, Bjorn			Chronic pain patients can be classified into four groups: Clustering-based discriminant analysis of psychometric data from 4665 patients referred to a multidisciplinary pain centre (a SQRP study)	PLOS ONE			English	Article							LOW-BACK-PAIN; FEAR-AVOIDANCE MODEL; COGNITIVE-BEHAVIORAL THERAPY; PERIPHERAL NEUROPATHIC PAIN; QUALITY-OF-LIFE; MUSCULOSKELETAL-PAIN; FIBROMYALGIA PATIENTS; HEALTH-CARE; CEREBROSPINAL-FLUID; SUBGROUP-ANALYSIS	Objective To subgroup chronic pain patients using psychometric data and regress the variables most responsible for subgroup discrimination. Design Cross-sectional, registry-based study. Setting and subjects Chronic pain patients assessed at a multidisciplinary pain centre between 2008 and 2015. Methods Data from the Swedish quality registry for pain rehabilitation (SQRP) were retrieved and analysed by principal component analysis, hierarchical clustering analysis, and partial least squares-discriminant analysis. Results Four subgroups were identified. Group 1 was characterized by low "psychological strain", the best relative situation concerning pain characteristics (intensity and spreading), the lowest frequency of fibromyalgia, as well as by a slightly older age. Group 2 was characterized by high "psychological strain" and by the most negative situation with respect to pain characteristics (intensity and spreading). Group 3 was characterized by high "social distress", the longest pain durations, and a statistically higher frequency of females. The frequency of three neuropathic pain conditions was generally lower in this group. Group 4 was characterized by high psychological strain, low "social distress", and high pain intensity. Conclusions The identification of these four clusters of chronic pain patients could be useful for the development of personalized rehabilitation programs. For example, the identification of a subgroup characterized mainly by high perceived "social distress" raises the question of how to best design interventions for such patients. Differentiating between clinically important subgroups and comparing how these subgroups respond to interventions is arguably an important area for further research.	[Backryd, Emmanuel; Gerdle, Bjorn] Linkoping Univ, Pain & Rehabil Ctr, Linkoping, Sweden; [Backryd, Emmanuel; Gerdle, Bjorn] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Persson, Elisabeth B.; Fischer, Marcelo Rivano] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Persson, Elisabeth B.; Fischer, Marcelo Rivano] Skane Univ Hosp, Dept Pain Rehabil Med, Lund, Sweden; [Larsson, Annelie Inghilesi] Qual Stat AB, Umea, Sweden	Linkoping University; Linkoping University; Lund University; Lund University; Skane University Hospital	Backryd, E (corresponding author), Linkoping Univ, Pain & Rehabil Ctr, Linkoping, Sweden.; Backryd, E (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	emmanuel.backryd@regionostergotland.se		Backryd, Emmanuel/0000-0003-4420-418X	AFA Insurance, research-ALF (Linkoping University hospital); Swedish Association of Local Authorities and Regions (SALAR)	AFA Insurance, research-ALF (Linkoping University hospital); Swedish Association of Local Authorities and Regions (SALAR)	The present study was sponsored by research grants from AFA Insurance, research-ALF (Linkoping University hospital), and the Swedish Association of Local Authorities and Regions (SALAR). AFA Insurance is a commercial founder, which is owned by Sweden's labour market parties: the Confederation of Swedish Enterprise, the Swedish Trade Union Confederation (LO) and The Council for Negotiation and Co-operation (PTK). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit for publication. The authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Backryd E, 2017, PAIN, V158, P2487, DOI 10.1097/j.pain.0000000000001061; Backryd E, 2017, J PAIN RES, V10, DOI 10.2147/JPR.S128508; Backryd E, 2015, J PAIN RES, V8, P321, DOI 10.2147/JPR.S82970; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Baron R, 2017, PAIN, V158, P261, DOI 10.1097/j.pain.0000000000000753; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Beneciuk JM, 2012, CLIN J PAIN, V28, P658, DOI 10.1097/AJP.0b013e31824306ed; Bennett M, 2010, PAIN, V18, P1; Bergstrom G, 1998, PAIN, V75, P101, DOI 10.1016/S0304-3959(97)00210-8; Bernardes SF, 2017, PAIN, V158, P2066, DOI 10.1097/j.pain.0000000000001033; Borsbo B, 2009, DISABIL REHABIL, V31, P1605, DOI 10.1080/09638280903110079; Boersma K, 2006, CLIN J PAIN, V22, P160, DOI 10.1097/01.ajp.0000159582.37750.39; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; Borsbo B., 2008, THESIS; Borsbo B, 2008, J REHABIL MED, V40, P562, DOI 10.2340/16501977-0207; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Buitenhuis J, 2011, SPINE, V36, pS238, DOI 10.1097/BRS.0b013e3182388400; Burns JW, 2017, PAIN; Cherkin DC, 1996, SPINE, V21, P2900, DOI 10.1097/00007632-199612150-00023; Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022; Denison E, 2007, J PAIN, V8, P67, DOI 10.1016/j.jpain.2006.06.007; DERRY S, 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD012232.pub2; Dersh J, 2002, PSYCHOSOM MED, V64, P773, DOI 10.1097/01.PSY.0000024232.11538.54; Eccleston C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub2; Edwards RR, 2016, J PAIN, V17, pT70, DOI 10.1016/j.jpain.2016.01.001; Engel CC, 1996, PAIN, V65, P197, DOI 10.1016/0304-3959(95)00164-6; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub4; Eriksson L., 2013, MULTI MEGAVARIATE DA; Field A., 2013, DISCOVERING STAT USI; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gerdle B, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1346-7; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; Goldsmith KA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-54; Hall-Lord M L, 1999, Int J Nurs Pract, V5, P78, DOI 10.1046/j.1440-172x.1999.00157.x; Hazard RG, 2012, SPINE J, V12, P1132, DOI 10.1016/j.spinee.2012.09.003; Hill JC, 2011, PHYS THER, V91, P712, DOI 10.2522/ptj.20100280; Hirsch O, 2014, CLIN J PAIN, V30, P1023, DOI 10.1097/AJP.0000000000000080; Hurtig IM, 2001, CLIN J PAIN, V17, P316, DOI 10.1097/00002508-200112000-00005; Jakobsson U, 2003, J PAIN SYMPTOM MANAG, V26, P625, DOI 10.1016/S0885-3924(03)00145-3; Kroenke K, 2001, ANN INTERN MED, V134, P801, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00001; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linton SJ, 2011, SCAND J PAIN, V2, P47, DOI 10.1016/j.sjpain.2011.01.005; Linton SJ, 2011, EUR J PAIN, V15, P416, DOI 10.1016/j.ejpain.2010.08.009; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Melzack R, 1999, PAIN, pS121, DOI 10.1016/S0304-3959(99)00145-1; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Miller LR, 2009, J PAIN, V10, P619, DOI 10.1016/j.jpain.2008.12.007; Milton MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065483; Morley S, 2008, PAIN, V137, P670, DOI 10.1016/j.pain.2008.02.025; Nijs J, 2011, CLIN RHEUMATOL, V30, P927, DOI 10.1007/s10067-011-1712-7; NRS, SWED QUAL REG PAIN R; Ocanez KLS, 2010, DEPRESS ANXIETY, V27, P760, DOI 10.1002/da.20681; Olausson P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11894; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; PARMELEE PA, 1991, J GERONTOL, V46, pP15, DOI 10.1093/geronj/46.1.P15; Petersen KK, 2016, PAIN, V157, P1400, DOI 10.1097/j.pain.0000000000000531; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; SBU - Swedish Council on Health Technology Assessment, 2010, SYST LIT; Staud R, 2012, EXPERT REV NEUROTHER, V12, P577, DOI [10.1586/ern.12.41, 10.1586/ERN.12.41]; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Sullivan MJL, 2008, PAIN, V135, P151, DOI 10.1016/j.pain.2007.05.021; SULLIVAN MJL, 1992, PAIN, V50, P5, DOI 10.1016/0304-3959(92)90107-M; Svanberg M, 2017, J REHABIL MED, V49, P354, DOI 10.2340/16501977-2212; Tunks ER, 2008, CAN J PSYCHIAT, V53, P224, DOI 10.1177/070674370805300403; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; van Koulil S, 2008, PATIENT EDUC COUNS, V71, P308, DOI 10.1016/j.pec.2007.11.025; van Koulil S, 2011, ARTHRIT CARE RES, V63, P800, DOI 10.1002/acr.20445; van Koulil S, 2010, ARTHRIT CARE RES, V62, P1377, DOI 10.1002/acr.20268; Viniol A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-294; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Westman AE, 2011, CLIN J PAIN, V27, P567, DOI 10.1097/AJP.0b013e318219ab6c; Wheelock AM, 2013, MOL BIOSYST, V9, P2589, DOI 10.1039/c3mb70194h; Wicksell RK, 2009, EUR J PAIN, V13, P760, DOI 10.1016/j.ejpain.2008.09.003; Williams LS, 2004, NEUROLOGY, V63, P674, DOI 10.1212/01.WNL.0000134669.05005.95; Wilson HD, 2009, ARTHRIT RHEUM-ARTHR, V61, P527, DOI 10.1002/art.24163; Woolf CJ, 1998, PAIN, V77, P227, DOI 10.1016/S0304-3959(98)00099-2; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	89	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192623	10.1371/journal.pone.0192623	http://dx.doi.org/10.1371/journal.pone.0192623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420607	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900099
J	Kitasaka, H; Kawai, T; Hoque, SAM; Umehara, T; Fujita, Y; Shimada, M				Kitasaka, Hiroya; Kawai, Tomoko; Hoque, S. A. Masudul; Umehara, Takashi; Fujita, Youko; Shimada, Masayuki			Inductions of granulosa cell luteinization and cumulus expansion are dependent on the fibronectin-integrin pathway during ovulation process in mice	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SIGNAL-TRANSDUCTION PATHWAYS; STRESS FIBER FORMATION; EXTRACELLULAR-MATRIX; OOCYTE COMPLEXES; GENE-EXPRESSION; BOVINE OOCYTES; IN-VITRO; GROWTH; RHO	It has been known that EGF-like factor secreted from LH-stimulated granuloma cells acts on granulosa cells and cumulus cells to induce ovulation process. Granulosa cells are changed the morphology with differentiating cell functions to produce progesterone. Cumulus cells are detached to make a space between the cells to accumulate hyaluronan rich matrix. LH also changes extracellular matrix (ECM) components including fibronectin in the follicular walls and granulosa cell layers. EGF like factor and fibronectin synergistically play important roles in numerous cell functions, especially cancer cell migration, estimating that fibronectin would impact on granulosa cells and cumulus cells. To clear this hypothesis, the localizations of fibronectin and its receptor integrin were observed by immunofluorescence technique. The functions were monitored by the detection of downstream signaling pathway, focal adhesion kinase (FAK). The pharmacological approach in both in vivo and in vitro were used for analyzing the physiological roles of FAK during ovulation process. The immunofluorescence staining revealed that fibronectin and integrin were observed in granulosa cells, cumulus cells and the space between cumulus cells and oocyte at 4 and 8 h after hCG injection. Concomitantly with the changes of fibronectin-integrin localization, FAK was phosphorylated in periovulatory follicles. The injection of FAK inhibitor suppressed not only ovulation but also luteinization of granulosa cells and cumulus expansion. In cultured-granulosa cells, fibronectin-integrin synergistically activated FAK with amphiregulin (AREG). Such cooperative stimulations induced a morphological change in granulosa cells, which resulted in the maximum level of progesterone production via the induction of Hsd3b. When cumulusoocyte complexes (COCs) were cultured with AREG in the presence of serum, the maximum level of cumulus expansion was observed. The AREG-induced cumulus expansion was also suppressed by FAK inhibitor. Thus, it is concluded that fibronectin and AREG synergistically activate FAK not only in granulosa cells and cumulus cells to induce successful ovulation process.	[Kitasaka, Hiroya; Kawai, Tomoko; Hoque, S. A. Masudul; Umehara, Takashi; Shimada, Masayuki] Hiroshima Univ, Grad Sch Biosphere Sci, Lab Reprod Endocrinol, Higashihiroshima, Hiroshima, Japan; [Kitasaka, Hiroya] Asada Ladies Clin, Nagoya, Aichi, Japan; [Hoque, S. A. Masudul] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Gazipur 1706, Bangladesh; [Fujita, Youko] Womens Clin Oizumi Gakuenn, Higashi Oizumi, Tokyo, Japan	Hiroshima University; Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU)	Shimada, M (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Lab Reprod Endocrinol, Higashihiroshima, Hiroshima, Japan.	mashimad@hiroshima-u.ac.jp	Shimada, Masayuki/Q-3673-2016	Shimada, Masayuki/0000-0002-6500-2088; Hoque, S. A. Masudul/0000-0003-3537-5892	JSPS KAKENHI [JP24688028, JP16H05017]; Japan Agency for Medical Research and Development (AMED) [16gk0110015h0001]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by JSPS KAKENHI Grant Number JP24688028 and JP16H05017 (to M.S.) and the Japan Agency for Medical Research and Development (AMED) 16gk0110015h0001 (to M.S.).	AHARONI D, 1993, ENDOCRINOLOGY, V133, P1426, DOI 10.1210/en.133.3.1426; ASEM EK, 1992, ACTA ENDOCRINOL-COP, V127, P466, DOI 10.1530/acta.0.1270466; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Downs SM, 2006, MOL REPROD DEV, V73, P379, DOI 10.1002/mrd.20416; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fatehi AN, 2002, THERIOGENOLOGY, V57, P1347, DOI 10.1016/S0093-691X(01)00717-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HERMAN B, 1983, EUR J CELL BIOL, V31, P34; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Huet C, 2001, J ENDOCRINOL, V169, P347, DOI 10.1677/joe.0.1690347; Irving-Rodgers HF, 2010, CELL TISSUE RES, V339, P613, DOI 10.1007/s00441-009-0905-8; Karlsson AB, 2010, MOL ENDOCRINOL, V24, P1765, DOI 10.1210/me.2009-0487; Kawashima I, 2012, ENDOCRINOLOGY, V153, P3949, DOI 10.1210/en.2012-1059; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/135608; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIYANO T, 1995, J EXP ZOOL, V273, P70, DOI 10.1002/jez.1402730109; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; PINYOPUMMINTR T, 1991, BIOL REPROD, V45, P736, DOI 10.1095/biolreprod45.5.736; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Shimada M, 2007, MOL ENDOCRINOL, V21, P2487, DOI 10.1210/me.2007-0042; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Sliogeryte K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07307; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1	42	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192458	10.1371/journal.pone.0192458	http://dx.doi.org/10.1371/journal.pone.0192458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420611	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900077
J	Wu, D; Yang, HJ; Zhang, Y; Li, XE; Jia, YR; Wang, CM				Wu, Di; Yang, Hai Jing; Zhang, Yan; Li, Xiu E.; Jia, Yu Rong; Wang, Chun Mei			Prediction of loss to follow-up in long-term supportive periodontal therapy in patients with chronic periodontitis	PLOS ONE			English	Article							SELF-EFFICACY; ORAL HYGIENE; DIABETIC-PATIENTS; BEHAVIOR; COMPLIANT; INTERVENTION; DEFINITIONS; DISEASE; COHORT; RISK	Aim This study examined the predictors of loss to follow-up in long-term supportive periodontal therapy in patients with chronic periodontitis. Methods A total of 280 patients with moderate to severe chronic periodontitis in a tertiary care hospital in China were investigated and followed over the course of study. Questionnaires on clinical and demographic characteristics, self-efficacy for oral self-care and dental fear at baseline were completed. Participants were followed to determine whether they could adhere to long-term supportive periodontal therapy. Binary logistic regression analysis was used to examine the association between clinical and demographic characteristics, self-efficacy for oral self-care, dental fear and loss to follow-up in long-term supportive periodontal therapy. Results The loss to follow-up in long-term supportive periodontal therapy was significantly associated with age [adjusted OR = 1.042, 95% confidence interval (CI): 1.012-1.074, p = 0.006], severe periodontitis [adjusted OR = 4.892, 95% CI: 2.280-10.499, p<0.001], periodontal surgery [adjusted OR = 11.334, 95% CI: 2.235-57.472, p = 0.003], and middle and low-scoring of self-efficacy scale for self-care groups. The adjusted ORs of loss to follow-up for the middle- (54-59) and low-scoring groups (15-53) were 71.899 (95% CI: 23.926-216.062, p<0.001) and 4.800 (95% CI: 2.263-10.182, p<0.001), respectively, compared with the high-scoring SESS group (60-75). Conclusion Age, severity of periodontitis, periodontal surgery and the level of self-efficacy for self-care may be effective predictors of loss to follow-up in long-term supportive periodontal therapy in patients with chronic periodontitis.	[Wu, Di; Li, Xiu E.] Peking Univ, Sch & Hosp Stomatol, Dept Nursing, Beijing, Peoples R China; [Wu, Di; Li, Xiu E.] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Wu, Di; Li, Xiu E.] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China; [Yang, Hai Jing; Zhang, Yan; Wang, Chun Mei] Tianjin Med Univ, Sch Nursing, Tianjin, Peoples R China; [Jia, Yu Rong] Tianjin Med Univ, Sch Stomatol, Dept Periodontol, Tianjin, Peoples R China	Peking University; Tianjin Medical University; Tianjin Medical University	Wang, CM (corresponding author), Tianjin Med Univ, Sch Nursing, Tianjin, Peoples R China.	cmwang8543@126.com						ALOGNA M, 1980, DIABETES CARE, V3, P533, DOI 10.2337/diacare.3.4.533; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BADERSTEN A, 1985, J CLIN PERIODONTOL, V12, P351, DOI 10.1111/j.1600-051X.1985.tb00925.x; Bandura A., 1977, SELF EFFICACY UNIFYI, P191; Bao Xuan Zhe, 2008, ANAL INFLUENCING FAC; Barz Daniela Luminita, 2016, Clujul Med, V89, P32, DOI 10.15386/cjmed-530; BASS C C, 1948, New Orleans Med Surg J, V101, P52; Chen X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155592; Chen Xingcan, 2005, SEEKING ROOTS, P63; Delatola C, 2014, J CLIN PERIODONTOL, V41, P791, DOI 10.1111/jcpe.12271; Di Wu, 2015, CHINESE J NURSING, V6, P758; Editorial, 2014, CHINESE GEN PRACTIC, V17, P3033; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; FANG Ji-qian, 2001, CHINA CANC, V10, P9; Fardal Oystein, 2003, Oral Health Prev Dent, V1, P93; Gokulanathan S, 2014, J PHARM BIOALLIED SC, V6, P171, DOI 10.4103/0975-7406.137443; Graetz C, 2013, J CLIN PERIODONTOL, V40, P1087, DOI 10.1111/jcpe.12159; Guttersrud O, 2015, PUBLIC HEALTH NUTR, V18, P2565, DOI 10.1017/S1368980014003152; Kakudate N, 2010, ORAL DIS, V16, P747, DOI 10.1111/j.1601-0825.2010.01703.x; Kakudate N., 2007, J JAPANESE SOC PERIO, V49, P285; Kakudate N, 2008, J PERIODONTOL, V79, P1041, DOI [10.1902/jop.2008.070552, 10.1902/jop.2008.070552 ]; Kerry GJ, 1995, PERIODONTOL 2000, V9, P176, DOI 10.1111/j.1600-0757.1995.tb00064.x; Konig J, 2001, J CLIN PERIODONTOL, V28, P227, DOI 10.1034/j.1600-051x.2001.028003227.x; Li Juchao, 1976, PEOPLES MILITARY SUR, P31; Little SJ, 1997, J PERIODONTAL RES, V32, P315, DOI 10.1111/j.1600-0765.1997.tb00540.x; Ng MCH, 2011, J CLIN PERIODONTOL, V38, P499, DOI 10.1111/j.1600-051X.2011.01708.x; Novaes AB, 1999, J PERIODONTOL, V70, P679, DOI 10.1902/jop.1999.70.6.679; Ojima M, 2001, J CLIN PERIODONTOL, V28, P1091, DOI 10.1034/j.1600-051X.2001.281202.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Qi Xiao Qiu, 2008, 3 NATL ORAL HLTH EPI, P268; Ramseier CA, 2014, J CLIN PERIODONTOL, V41, P473, DOI 10.1111/jcpe.12242; Steeves EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052122; Stewart JE, 1997, COMMUNITY DENT ORAL, V25, P337, DOI 10.1111/j.1600-0528.1997.tb00951.x; Syrjala AMH, 1999, J CLIN PERIODONTOL, V26, P616, DOI 10.1034/j.1600-051X.1999.260909.x; TEDESCO LA, 1992, J PERIODONTOL, V63, P567, DOI 10.1902/jop.1992.63.7.567; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Woelber JP, 2015, J CLIN PERIODONTOL, V42, P142, DOI 10.1111/jcpe.12348; Wolfe GR, 1996, COMMUNITY DENT ORAL, V24, P37, DOI 10.1111/j.1600-0528.1996.tb00810.x; Yang Liping, 2013, STUDIES DESIGNING PH; Zhuo Wang, 2015, Hua Xi Kou Qiang Yi Xue Za Zhi, V33, P178	40	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192221	10.1371/journal.pone.0192221	http://dx.doi.org/10.1371/journal.pone.0192221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420586	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900055
J	McNerney, MW; Sheng, T; Nechvatal, JM; Lee, AG; Lyons, DM; Soman, S; Liao, CP; O'Hara, R; Hallmayer, J; Taylor, J; Ashford, JW; Yesavage, J; Adamson, MM				McNerney, M. Windy; Sheng, Tong; Nechvatal, Jordan M.; Lee, Alex G.; Lyons, David M.; Soman, Salil; Liao, Chun-Ping; O'Hara, Ruth; Hallmayer, Joachim; Taylor, Joy; Ashford, J. Wesson; Yesavage, Jerome; Adamson, Maheen M.			Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation	PLOS ONE			English	Article							POPULATION-BASED SURVEY; DNA METHYLATION; PSYCHOMETRIC PROPERTIES; GULF-WAR; DISORDER; VETERANS; BRAIN; PTSD; NEUROENDOCRINE; SEGMENTATION	Many Veterans exposed to physical and psychological trauma experience symptoms of posttraumatic stress disorder (PTSD). As the etiology of PTSD symptoms is complex, a better understanding of the underlying biological mechanisms may improve preventative care and treatment for PTSD. Recent findings from the fields of neuroimaging and epigenetics offer important insights into the potential brain structures and biochemical pathways of modified gene expression associated with PTSD. We combined neuroimaging and epigenetic measures to assess current PTSD symptoms by measuring overall hippocampal volume and methylation of the glucocorticoid receptor (GR) gene (promoter region). Multiple regression analyses indicated that the hippocampal volume/GR methylation interaction was a predictor of PTSD symptoms. Our findings suggest that neuroimaging and epigenetic measures contribute interactively to PTSD symptoms. Incorporation of these metrics may aid in the identification and treatment of PTSD patients.	[McNerney, M. Windy; Sheng, Tong; Nechvatal, Jordan M.; Lee, Alex G.; Lyons, David M.; O'Hara, Ruth; Hallmayer, Joachim; Taylor, Joy; Ashford, J. Wesson; Yesavage, Jerome; Adamson, Maheen M.] Stanford Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [McNerney, M. Windy; Sheng, Tong; Nechvatal, Jordan M.; Taylor, Joy; Ashford, J. Wesson] VA Palo Alto Hlth Care Syst, WRIISC, Palo Alto, CA 94304 USA; [Soman, Salil] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Liao, Chun-Ping; O'Hara, Ruth; Hallmayer, Joachim; Yesavage, Jerome] VA Palo Alto, MIRECC, Palo Alto, CA USA; [Adamson, Maheen M.] VA Palo Alto, DVBIC, Palo Alto, CA USA; [Adamson, Maheen M.] Stanford Sch Med, Dept Neurosurg, Stanford, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	McNerney, MW (corresponding author), Stanford Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; McNerney, MW (corresponding author), VA Palo Alto Hlth Care Syst, WRIISC, Palo Alto, CA 94304 USA.	windymc@stanford.edu	Ashford, J. Wesson/D-3929-2009; Sheng, Tong/C-6306-2019	Sheng, Tong/0000-0003-1067-7608; Adamson, Maheen/0000-0002-1534-4063	WRIISC at the VA Palo Alto	WRIISC at the VA Palo Alto	WRIISC at the VA Palo Alto supported this project (www.warrelatedillness.va.gov).	Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Braithwaite EC, 2015, EPIGENETICS-US, V10, P408, DOI 10.1080/15592294.2015.1039221; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daskalakis NP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00369; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Endler G, 1999, BONE MARROW TRANSPL, V24, P95, DOI 10.1038/sj.bmt.1701815; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hayes JP, 2017, J PSYCHIATR RES, V95, P247, DOI 10.1016/j.jpsychires.2017.09.007; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Lee RS, 2014, NEUROENDOCRINOLOGY, V100, P278, DOI 10.1159/000369585; Lee T, 2009, NEUROREPORT, V20, P1554, DOI 10.1097/WNR.0b013e328332bb09; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Na Kyoung-Sae, 2014, PLoS One, V9, pe85425, DOI 10.1371/journal.pone.0085425; Nelson MD, 2017, CNS SPECTRUMS, V22, P363, DOI 10.1017/S1092852916000833; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Romens Sarah E, 2015, Child Dev, V86, P303, DOI 10.1111/cdev.12270; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Schnurr PP, 1999, J NERV MENT DIS, V187, P353, DOI 10.1097/00005053-199906000-00004; Soper DS, 2017, EFFECT SIZE COHENSD; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Terri Tenielian LHJ, 2008, INVISIBLE WOUNDS WAR; Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170; Torrone DZ, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-3; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Veer IM, 2015, PSYCHIAT RES-NEUROIM, V233, P436, DOI 10.1016/j.pscychresns.2015.07.016; Vukojevic V, 2014, J NEUROSCI, V34, P10274, DOI 10.1523/JNEUROSCI.1526-14.2014; Vyas A, 2002, J NEUROSCI, V22, P6810; Wang Q, 2013, NEUROBIOL AGING, V34, P1662, DOI 10.1016/j.neurobiolaging.2012.11.019; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wren ME, 2015, CLIN THER, V37, P529, DOI 10.1016/j.clinthera.2015.02.022; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yehuda R, 2015, BIOL PSYCHIAT, V77, P356, DOI 10.1016/j.biopsych.2014.02.006; Yehuda R, 2013, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00118; Yehuda R, 2009, J TRAUMA STRESS, V22, P427, DOI 10.1002/jts.20448; Zovkic Iva B, 2013, Front Psychiatry, V4, P60, DOI 10.3389/fpsyt.2013.00060	59	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192222	10.1371/journal.pone.0192222	http://dx.doi.org/10.1371/journal.pone.0192222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415058	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300060
J	Guo, DK; Zhang, S; Sun, HY; Xu, XY; Hao, ZB; Mu, CC; Xu, XS; Wang, GH; Ren, HG				Guo, Dongkai; Zhang, Shun; Sun, Hongyang; Xu, Xingyun; Hao, Zongbing; Mu, Chenchen; Xu, Xingshun; Wang, Guanghui; Ren, Haigang			Tyrosine hydroxylase down-regulation after loss of Abelson helper integration site 1 (AHI1) promotes depression via the circadian clock pathway in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						depression; dopamine; circadian clock; Rev-ErbA alpha (NR1D1); biosynthesis; Abelson helper integration site 1; behavioral disorder; RAR-related orphan receptor alpha; transcriptional regulation; tyrosine hydroxylase	REV-ERB-ALPHA; GENE-MUTATIONS; RECEPTOR; BIPOLAR; TRANSCRIPTION; DOPAMINE; DISORDER; DYSREGULATION; METAANALYSIS; ASSOCIATION	Abelson helper integration site 1 (AHI1) is associated with several neuropsychiatric and brain developmental disorders, such as schizophrenia, depression, autism, and Joubert syndrome. Ahi1 deficiency in mice leads to behaviors typical of depression. However, the mechanisms by which AHI1 regulates behavior remain to be elucidated. Here, we found that down-regulation of expression of the rate-limiting enzyme in dopamine biosynthesis, tyrosine hydroxylase (TH), in the midbrains of Ahi1-knockout (KO) mice is responsible for Ahi1-deficiency-mediated depressive symptoms. We also found that Rev-Erb, a TH transcriptional repressor and circadian regulator, is up-regulated in the Ahi1-KO mouse midbrains and Ahi1-knockdown Neuro-2a cells. Moreover, brain and muscle Arnt-like protein 1 (BMAL1), the Rev-Erb transcriptional regulator, is also increased in the Ahi1-KO mouse midbrains and Ahi1-knockdown cells. Our results further revealed that AHI1 decreases BMAL1/Rev-Erb expression by interacting with and repressing retinoic acid receptor-related orphan receptor , a nuclear receptor and transcriptional regulator of circadian genes. Of note, Bmal1 deficiency reversed the reduction in TH expression induced by Ahi1 deficiency. Moreover, microinfusion of the Rev-Erb inhibitor SR8278 into the ventral midbrain of Ahi1-KO mice significantly increased TH expression in the ventral tegmental area and improved their depressive symptoms. These findings provide a mechanistic explanation for a link between AHI1-related behaviors and the circadian clock pathway, indicating an involvement of circadian regulatory proteins in AHI1-regulated mood and behavior.	[Guo, Dongkai; Zhang, Shun; Sun, Hongyang; Xu, Xingyun; Hao, Zongbing; Mu, Chenchen; Wang, Guanghui; Ren, Haigang] Soochow Univ, Coll Pharmaceut Sci, Lab Mol Neuropathol, Jiangsu Key Lab Neuropsychiat Disorders, Suzhou 215123, Jiangsu, Peoples R China; [Guo, Dongkai; Zhang, Shun; Sun, Hongyang; Xu, Xingyun; Hao, Zongbing; Mu, Chenchen; Wang, Guanghui; Ren, Haigang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Xingshun] Soochow Univ, Inst Neurosci, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Xingshun] Soochow Univ, Dept Neurol, Affiliated Hosp 2, Suzhou 215004, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Wang, GH; Ren, HG (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Lab Mol Neuropathol, Jiangsu Key Lab Neuropsychiat Disorders, Suzhou 215123, Jiangsu, Peoples R China.; Wang, GH; Ren, HG (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou 215123, Jiangsu, Peoples R China.	wanggh@suda.edu.cn; rhg@suda.edu.cn	Wang, Guanghui/U-3979-2017; Xu, Xingshun/AAF-8183-2020; Ren, Haigang/U-6034-2017	Wang, Guanghui/0000-0001-8551-6468; Ren, Haigang/0000-0001-8844-4754; Xu, Xingshun/0000-0003-0205-6342	National Natural Sciences Foundation of China [81761148024, 31330030, 31471012]; National Key Scientific R&D Program of China [2016YFC1306000, 2012CB947602]; Suzhou Clinical Research Center of Neurological Disease [Szzx201503]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific R&D Program of China; Suzhou Clinical Research Center of Neurological Disease; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Sciences Foundation of China Grants 81761148024, 31330030, and 31471012; National Key Scientific R&D Program of China Grants 2016YFC1306000 and 2012CB947602; Suzhou Clinical Research Center of Neurological Disease Grant Szzx201503; and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Albrecht U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00030; Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Ashok AH, 2017, MOL PSYCHIATR, V22, P666, DOI 10.1038/mp.2017.16; Barandas R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0637-2; Bellivier F, 2015, EXPERT OPIN THER TAR, V19, P747, DOI 10.1517/14728222.2015.1018822; Blier P, 2013, J CLIN PSYCHIAT, V74, P19, DOI 10.4088/JCP.12084su1c.04; Bunney BG, 2015, MOL PSYCHIATR, V20, P48, DOI 10.1038/mp.2014.138; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chung S, 2014, CELL, V157, P858, DOI 10.1016/j.cell.2014.03.039; Dallaspezia S, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0606-9; De Bundel D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00152; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fukuchi M, 2010, BRAIN RES, V1366, P18, DOI 10.1016/j.brainres.2010.10.034; Furlong RA, 1999, AM J MED GENET, V88, P88, DOI 10.1002/(SICI)1096-8628(19990205)88:1<88::AID-AJMG16>3.0.CO;2-J; Gu C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.250; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Jager J, 2014, MOL ENDOCRINOL, V28, P490, DOI 10.1210/me.2013-1351; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Karatsoreos IN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00162; Kondratova AA, 2010, AGING-US, V2, P285; Korshunov KS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00091; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lamont EW, 2010, ISR J PSYCHIATR REL, V47, P27; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; McCarthy MJ, 2012, J BIOL RHYTHM, V27, P339, DOI 10.1177/0748730412456367; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Meyer JH, 2008, SEMIN NUCL MED, V38, P287, DOI 10.1053/j.semnuclmed.2008.02.007; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Porcelli S, 2014, PSYCHIAT INVEST, V11, P481, DOI 10.4306/pi.2014.11.4.481; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ren LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093640; Rivero O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012254; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Serretti A, 1998, AM J MED GENET, V81, P127, DOI 10.1002/(SICI)1096-8628(19980328)81:2<127::AID-AJMG1>3.3.CO;2-X; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sidor MM, 2015, MOL PSYCHIATR, V20, P1406, DOI 10.1038/mp.2014.167; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Tekin I, 2014, J NEURAL TRANSM, V121, P1451, DOI 10.1007/s00702-014-1238-7; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Weng L, 2013, J NEUROSCI, V33, P8172, DOI 10.1523/JNEUROSCI.0119-13.2013; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xu XS, 2010, P NATL ACAD SCI USA, V107, P19126, DOI 10.1073/pnas.1013032107; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	52	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5090	5101		10.1074/jbc.RA117.000618	http://dx.doi.org/10.1074/jbc.RA117.000618			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449373	hybrid, Green Published			2022-12-26	WOS:000429409300016
J	Citterio, CE; Morishita, Y; Dakka, N; Veluswamy, B; Arvan, P				Citterio, Cintia E.; Morishita, Yoshiaki; Dakka, Nada; Veluswamy, Balaji; Arvan, Peter			Relationship between the dimerization of thyroglobulin and its ability to form triiodothyronine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINESTERASE-LIKE DOMAIN; THYROXINE FORMATION; HORMONE FORMATION; IODINATION; SITES; ACETYLCHOLINESTERASE; DONOR	Thyroglobulin (TG) is the most abundant thyroid gland protein, a dimeric iodoglycoprotein (660 kDa). TG serves as the protein precursor in the synthesis of thyroid hormones tetraiodothyronine (T-4) and triiodothyronine (T-3). The primary site for T-3 synthesis in TG involves an iodotyrosine acceptor at the antepenultimate Tyr residue (at the extreme carboxyl terminus of the protein). The carboxyl-terminal region of TG comprises a cholinesterase-like (ChEL) domain followed by a short unique tail sequence. Despite many studies, the monoiodotyrosine donor residue needed for the coupling reaction to create T-3 at this evolutionarily conserved site remains unidentified. In this report, we have utilized a novel, convenient immunoblotting assay to detect T-3 formation after protein iodination in vitro, enabling the study of T-3 formation in recombinant TG secreted from thyrocytes or heterologous cells. With this assay, we confirm the antepenultimate residue of TG as a major T-3-forming site, but also demonstrate that the side chain of this residue intimately interacts with the same residue in the apposed monomer of the TG dimer. T-3 formation in TG, or the isolated carboxyl-terminal region, is inhibited by mutation of this antepenultimate residue, but we describe the first substitution mutation that actually increases T-3 hormonogenesis by engineering a novel cysteine, 10 residues upstream of the antepenultimate residue, allowing for covalent association of the unique tail sequences, and that helps to bring residues Tyr(2744) from apposed monomers into closer proximity.	[Citterio, Cintia E.; Morishita, Yoshiaki; Dakka, Nada; Veluswamy, Balaji; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Citterio, Cintia E.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol & Biotecnol, Catedra Genet, Buenos Aires C1113AAD, Buenos Aires, DF, Argentina; [Citterio, Cintia E.] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Buenos Aires C1120AAR, Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Arvan, P (corresponding author), Brehm Tower Rm 5112,1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Morishita, Yoshiaki/GWQ-6726-2022; Morishita, Yoshiaki/AAX-6552-2021; Citterio, Cintia E./AAI-4888-2021	Morishita, Yoshiaki/0000-0003-4733-7981; Citterio, Cintia E./0000-0002-3547-5458; DAKKA, NADIA/0000-0002-8265-5689	National Institutes of Health [R01 DK40344]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK40344 (to P. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cetrangolo GP, 2014, BIOCHEM BIOPH RES CO, V450, P488, DOI 10.1016/j.bbrc.2014.05.144; CHANOINE JP, 1993, J CLIN INVEST, V91, P2709, DOI 10.1172/JCI116510; Citterio CE, 2017, J BIOL CHEM, V292, P15434, DOI 10.1074/jbc.M117.784447; Dedieu A, 2011, J BIOL CHEM, V286, P259, DOI 10.1074/jbc.M110.159483; DENHARTOG MT, 1995, EUR J ENDOCRINOL, V132, P611, DOI 10.1530/eje.0.1320611; Deshpande V, 1999, BBA-PROTEIN STRUCT M, V1430, P157, DOI 10.1016/S0167-4838(99)00015-1; Di Jeso B, 2016, ENDOCR REV, V37, P2, DOI 10.1210/er.2015-1090; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; DUNN JT, 1987, J BIOL CHEM, V262, P16948; EICHLER J, 1994, J BIOL CHEM, V269, P30093; FASSLER CA, 1988, J BIOL CHEM, V263, P17366; HERZOG V, 1992, J CELL BIOL, V118, P1071, DOI 10.1083/jcb.118.5.1071; Holzer G, 2016, J BIOL CHEM, V291, P16553, DOI 10.1074/jbc.M116.719047; KIM PS, 1991, J BIOL CHEM, V266, P12412; Klein M, 2000, BIOL CHEM, V381, P593, DOI 10.1515/BC.2000.076; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; LARSEN PR, 1975, J CLIN ENDOCR METAB, V41, P1098, DOI 10.1210/jcem-41-6-1098; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2011, J BIOL CHEM, V286, P33045, DOI 10.1074/jbc.M111.281337; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; LEONARDI A, 1994, BIOCHEM BIOPH RES CO, V202, P38, DOI 10.1006/bbrc.1994.1890; Liu XW, 2002, ARCH PHARM RES, V25, P485, DOI 10.1007/BF02976607; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; ROLLAND M, 1976, BIOCHIM BIOPHYS ACTA, V427, P696, DOI 10.1016/0005-2795(76)90213-0; SCHIMMEL M, 1977, ANN INTERN MED, V87, P760, DOI 10.7326/0003-4819-87-6-760; Siffo S., 2017, MOL CELL ENDOCRINOL, P30637; STERLING K, 1970, J AMER MED ASSOC, V213, P571, DOI 10.1001/jama.213.4.571; SUZUKI S, 1975, GEN COMP ENDOCR, V26, P59, DOI 10.1016/0016-6480(75)90215-4; Taurog AM, 2000, WERNER INGBARS THYRO, P61; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Woeber KA, 2006, THYROID, V16, P687, DOI 10.1089/thy.2006.16.687	32	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4860	4869		10.1074/jbc.RA118.001786	http://dx.doi.org/10.1074/jbc.RA118.001786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29440273	hybrid, Green Published			2022-12-26	WOS:000428848300025
J	Bahari, L; Bein, A; Yashunsky, V; Braslavsky, I				Bahari, Liat; Bein, Amir; Yashunsky, Victor; Braslavsky, Ido			Directional freezing for the cryopreservation of adherent mammalian cells on a substrate	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SURFACE-BASED CRYOPRESERVATION; INTERCELLULAR ICE PROPAGATION; RED-BLOOD-CELLS; ENDOTHELIAL-CELLS; SOLIDIFICATION; VITRIFICATION; CRYOBIOLOGY; MONOLAYERS; VIABILITY	Successfully cryopreserving cells adhered to a substrate would facilitate the growth of a vital confluent cell culture after thawing while dramatically shortening the post-thaw culturing time. Herein we propose a controlled slow cooling method combining initial directional freezing followed by gradual cooling down to -80 degrees C for robust preservation of cell monolayers adherent to a substrate. Using computer controlled cryostages we examined the effect of cooling rates and dimethylsulfoxide (DMSO) concentration on cell survival and established an optimal cryopreservation protocol. Experimental results show the highest post-thawing viability for directional ice growth at a speed of 30 mu m/sec (equivalent to freezing rate of 3.8 degrees C/min), followed by gradual cooling of the sample with decreasing rate of 0.5 degrees C/min. Efficient cryopreservation of three widely used epithelial cell lines: IEC-18, HeLa, and Caco-2, provides proof-of-concept support for this new freezing protocol applied to adherent cells. This method is highly reproducible, significantly increases the post-thaw cell viability and can be readily applied for cryopreservation of cellular cultures in microfluidic devices.	[Bahari, Liat; Bein, Amir; Yashunsky, Victor; Braslavsky, Ido] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel	Hebrew University of Jerusalem	Braslavsky, I (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel.	ido.braslavsky@mail.huji.ac.il	Braslavsky, Ido/O-1859-2013; Yashunsky, Victor/P-1456-2019	Braslavsky, Ido/0000-0001-8985-8211; Yashunsky, Victor/0000-0003-3175-3390	European Commission; Yissum The Hebrew University technology transfer company	European Commission(European CommissionEuropean Commission Joint Research Centre); Yissum The Hebrew University technology transfer company	This work was supported by a European Commission grants "FP7 Ideas" and "FP7 Nanosciences" and Yissumit grant from Yissum The Hebrew University technology transfer company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2001, BIOPHYS J, V81, P1389, DOI 10.1016/S0006-3495(01)75794-3; Angell CA, 2002, CHEM REV, V102, P2627, DOI 10.1021/cr000689q; Arav A, 2012, BIOPRESERV BIOBANK, V10, P386, DOI 10.1089/bio.2012.0021; Arav A, 2009, SEMIN REPROD MED, V27, P438, DOI 10.1055/s-0029-1241052; Armitage WJ, 2003, CRYOBIOLOGY, V46, P194, DOI 10.1016/S0011-2240(03)00017-8; Beier AFJ, 2011, CRYOBIOLOGY, V63, P175, DOI 10.1016/j.cryobiol.2011.06.003; Best BP, 2015, REJUV RES, V18, P422, DOI 10.1089/rej.2014.1656; Bogdanova Ance, 2014, J Stem Cells, V9, P135, DOI jsc.2014.9.3.135; Corsini J, 2005, BIOL PROCED ONLINE, V7, P26, DOI 10.1251/bpo102; CZLONKOWSKA M, 1985, J REPROD FERTIL, V75, P485, DOI 10.1530/jrf.0.0750485; Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003; Di Giuseppe F, 2014, STEM CELL REV REP, V10, P429, DOI 10.1007/s12015-014-9501-8; Diaferia GR, 2008, CYTOTECHNOLOGY, V58, P11, DOI 10.1007/s10616-008-9163-y; FARRANT J, 1965, NATURE, V205, P1284, DOI 10.1038/2051284a0; Graham B, 2017, ANGEW CHEM; Higgins AZ, 2013, BIOPHYS J, V105, P2006, DOI 10.1016/j.bpj.2013.09.028; Hornung J, 1996, CRYOBIOLOGY, V33, P260, DOI 10.1006/cryo.1996.0026; Hubel A, 2007, CRYOBIOLOGY, V55, P182, DOI 10.1016/j.cryobiol.2007.07.002; Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623; Irimia D, 2002, BIOPHYS J, V82, P1858, DOI 10.1016/S0006-3495(02)75536-7; ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Katkov II, 2006, CRYOBIOLOGY, V53, P194, DOI 10.1016/j.cryobiol.2006.05.005; Kondo E, 2016, BIOTECHNOL BIOENG, V113, P237, DOI 10.1002/bit.25704; Kopeika J, 2015, HUM REPROD UPDATE, V21, P209, DOI 10.1093/humupd/dmu063; KORBER C, 1983, INT J HEAT MASS TRAN, V26, P1241, DOI 10.1016/S0017-9310(83)80179-3; Li L, 2014, RSC ADV, V4, P34443, DOI 10.1039/c4ra06972b; Lindemann D, 2014, ARCH ORAL BIOL, V59, P970, DOI 10.1016/j.archoralbio.2014.04.008; Liu J, 2000, BIOL REPROD, V63, P1303, DOI 10.1095/biolreprod63.5.1303; Ma W, 2006, NEUROSCI LETT, V403, P84, DOI 10.1016/j.neulet.2006.04.064; Maffei S, 2014, HUM REPROD, V29, P114, DOI 10.1093/humrep/det377; Malpique R, 2012, BIOTECHNOL PROGR, V28, P1079, DOI 10.1002/btpr.1572; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; OHNO T, 1991, CYTOTECHNOLOGY, V5, P273, DOI 10.1007/BF00556297; Pasch J, 1999, CRYOBIOLOGY, V39, P158, DOI 10.1006/cryo.1999.2197; Pegg DE, 2002, CRYOBIOLOGY, V44, P46, DOI 10.1016/S0011-2240(02)00003-2; Qi B, 2014, INT J OPHTHALMOL-CHI, V7, P768, DOI 10.3980/j.issn.2222-3959.2014.05.05; Rabin Y, 2000, J MICROSC-OXFORD, V200, P42, DOI 10.1046/j.1365-2818.2000.00718.x; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rowley S D, 1992, J Hematother, V1, P233, DOI 10.1089/scd.1.1992.1.233; RUBINSKY B, 1985, CRYOBIOLOGY, V22, P55, DOI 10.1016/0011-2240(85)90008-2; Saragusty J, 2007, REPROD DOMEST ANIM, V42, P610, DOI 10.1111/j.1439-0531.2006.00831.x; Shoji R, 2000, CYTOTECHNOLOGY, V32, P147, DOI 10.1023/A:1008124228377; Sigma- Aldrich, PROT CRYOPR CELL LIN; Uemura M, 2015, CRYOBIOLOGY, V70, P122, DOI 10.1016/j.cryobiol.2015.01.006; Wagh V, 2011, STEM CELL REV REP, V7, P506, DOI 10.1007/s12015-011-9230-1; Windrum P, 2005, BONE MARROW TRANSPL, V36, P601, DOI 10.1038/sj.bmt.1705100; Zampolla T, 2011, CRYOLETTERS, V32, P525	49	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192265	10.1371/journal.pone.0192265	http://dx.doi.org/10.1371/journal.pone.0192265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447224	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900026
J	Diao, YF; Lin, T; Li, XX; Oqani, RK; Lee, JE; Kim, SY; Jin, DI				Diao, Yun Fei; Lin, Tao; Li, Xiaoxia; Oqani, Reza K.; Lee, Jae Eun; Kim, So Yeon; Jin, Dong Il			Dynamic changes of SETD2, a histone H3K36 methyltransferase, in porcine oocytes, IVF and SCNT embryos	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; H3 LYSINE-27 METHYLATION; IN-VITRO; TRIMETHYLATION; ARCHITECTURE; HYPB/SETD2; COMPLEX; CLONING; REPAIR; DOMAIN	SETD2 (SET domain containing protein 2) acts as a histone H3 lysine 36 (H3K36)-specific methyltransferase and may play important roles in active gene transcription in human cells. However, its expression and role in porcine oocytes and preimplantation embryos are not well understood. Here, we used immunofluorescence and laser scanning confocal microscopy to examine SETD2 expression in porcine fetal fibroblasts, oocytes, and preimplantation embryos derived from in vitro fertilization (IVF), parthenogenetic activation (PA), and somatic cell nuclear transfer (SCNT). In porcine fetal fibroblasts, SETD2 expression was detected in interphase cells, but not in M (mitotic)-phase cells. The SETD2 signal was observed in non-surrounded nucleolus (NSN)-stage oocytes, but not in surrounded nucleolus (SN)-, metaphase I (MI)-, or metaphase II (MII)-stage oocytes. The SETD2 signal was detectable in sperm, and undetectable immediately after fertilization, detectable at the 2-cell stage, and peaked at the 4-cell stage of IVF embryos in which porcine embryonic genome is activated. Similar to the pattern found in IVF embryos, the SETD2 signal was absent from PA embryos at the 1-cell stage, but it was detected at the 2-cell stage and thereafter maintained to the blastocyst stage. Interestingly, unlike the IVF and PA embryos, the SETD2 signal was detected throughout the development of SCNT embryos, including at the 1-cell stage. These data suggest that SETD2 may be functional for embryonic gene transcription in porcine preimplantation embryos. It is further speculated that the aberrant expression of SETD2 at the 1-cell stage of porcine SCNT embryos may be a factor in the low efficiency of cloning in pig.	[Diao, Yun Fei; Li, Xiaoxia] Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Changchun, Jilin, Peoples R China; [Lin, Tao; Oqani, Reza K.; Lee, Jae Eun; Kim, So Yeon; Jin, Dong Il] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Daejeon, South Korea	Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS; Chungnam National University	Jin, DI (corresponding author), Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Daejeon, South Korea.	dijin@cnu.ac.kr		Lin, Tao/0000-0001-9100-6042	Cooperative Research Program for Agriculture Science & Technology Development [PJ0118512016]; BioGreen 21 Program of the Rural Development Administration [PJ01119601]; Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [IPET312060-5]	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); BioGreen 21 Program of the Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This work was supported by the Cooperative Research Program for Agriculture Science & Technology Development (grant no. PJ0118512016), the BioGreen 21 Program (grant no. PJ01119601) of the Rural Development Administration, and the Bio-industry Technology Development Program (grant no. IPET312060-5) of the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea to DIJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Cooperative Research Program for Agriculture Science & Technology Development (grant no. PJ0118512016), the BioGreen 21 Program (grant no. PJ01119601) of the Rural Development Administration, and the Bio-industry Technology Development Program (grant no. IPET312060-5) of the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Diao YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100205; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Lin T, 2016, REPROD BIOL, V16, P269, DOI 10.1016/j.repbio.2016.10.003; Lin T, 2015, ANIM REPROD SCI, V152, P65, DOI 10.1016/j.anireprosci.2014.11.009; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shi LH, 2008, J ANIM SCI, V86, P1106, DOI 10.2527/jas.2007-0718; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tan JH, 2009, MOL HUM REPROD, V15, P1, DOI 10.1093/molehr/gan069; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Venkatesh S, 2013, WIRES DEV BIOL, V2, P685, DOI 10.1002/wdev.109; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang LJ, 2011, CELL REPROGRAM, V13, P431, DOI 10.1089/cell.2011.0024; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zuccotti M, 2005, MOL CELL ENDOCRINOL, V234, P11, DOI 10.1016/j.mce.2004.08.014; Zuccotti M, 2011, HUM REPROD UPDATE, V17, P525, DOI 10.1093/humupd/dmr009	37	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191816	10.1371/journal.pone.0191816	http://dx.doi.org/10.1371/journal.pone.0191816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447173	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900018
J	Cassol, H; Petre, B; Degrange, S; Martial, C; Charland-Verville, V; Lallier, F; Bragard, I; Guillaume, M; Laureys, S				Cassol, Helena; Petre, Benoit; Degrange, Sophie; Martial, Charlotte; Charland-Verville, Vanessa; Lallier, Francois; Bragard, Isabelle; Guillaume, Michele; Laureys, Steven			Qualitative thematic analysis of the phenomenology of near-death experiences	PLOS ONE			English	Article							CARDIAC-ARREST; HEALTH-CARE; SURVIVORS; FEATURES; STATE	Near-death experiences (NDEs) refer to profound psychological events that can have an important impact on the experiencers' (NDErs) lives. Previous studies have shown that NDEs memories are phenomenologically rich. In the present study, we therefore aimed to extract the common themes (referred to as "features" in the NDE literature) reported by NDErs by analyzing all the concepts stored in the narratives of their experiences. A qualitative thematic analysis has been carried out on 34 cardiac arrest survivors' NDE narratives. Our results shed the light on the structure of the narratives by identifying 10 "time-bounded" themes which refer to isolated events encountered during the NDE and 1 "transversal" theme which characterizes the whole narrative and generally appears as a retrospective comment of self-reflection on the experience. The division of narratives into themes provides us with detailed information about the vocabulary used by NDErs to describe their experience. This established thematic method enables a rigorous description of the phenomenon, ensuring the inclusion of all self-reported manifestations of themes in narratives.	[Cassol, Helena; Martial, Charlotte; Charland-Verville, Vanessa; Laureys, Steven] Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium; [Cassol, Helena; Martial, Charlotte; Charland-Verville, Vanessa; Laureys, Steven] Univ Hosp Liege, Liege, Belgium; [Petre, Benoit; Degrange, Sophie; Bragard, Isabelle; Guillaume, Michele] Univ Liege, Dept Publ Hlth, Liege, Belgium; [Lallier, Francois] Univ Reims, Dept Family Med, Reims, France	University of Liege; University of Liege; University of Liege; Universite de Reims Champagne-Ardenne	Cassol, H (corresponding author), Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium.; Cassol, H (corresponding author), Univ Hosp Liege, Liege, Belgium.	coma@chu.ulg.ac.be	Martial, Charlotte/O-6703-2016; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Martial, Charlotte/0000-0001-6291-3460; Laureys, Steven/0000-0002-3096-3807; Petre, Benoit/0000-0002-5344-4401; Cassol, Helena/0000-0001-6616-7688	University Hospital of Liege; Belgian National Funds for Scientific Research (FRS-FNRS); European Commission; Luminous [686764]; Center-TBI [602150]; Human Brain Project [720270]; James McDonnell Foundation [15040574-08]; European Space Agency [C4000105971]; Belspo; Fondazione Europea di Ricerca Biomedica; BIAL Foundation [503 323 055]; Wallonia Brussels Federation Concerted Research Action [ARC 12/17/01]; Mind Science Foundation	University Hospital of Liege; Belgian National Funds for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Luminous; Center-TBI; Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); James McDonnell Foundation; European Space Agency(European Space AgencyEuropean Commission); Belspo(Belgian Federal Science Policy Office); Fondazione Europea di Ricerca Biomedica; BIAL Foundation(Bial Foundation); Wallonia Brussels Federation Concerted Research Action; Mind Science Foundation	This research was funded by University and University Hospital of Liege (http://www.ulg.ac.be/), the Belgian National Funds for Scientific Research (FRS-FNRS) (http://www.fnrs.be/), the European Commission (https://ec.europa.eu/), Luminous (grant number: 686764; http://www. luminous-project.eu/), Center-TBI (grant number: 602150; https://www.center-tbi.eu/), Human Brain Project (grant number: 720270; https://www. humanbrainproject.eu/), the James McDonnell Foundation (grant number: 15040574-08; https://www.jsmf.org/), the European Space Agency (grant number: C4000105971; http://www.esa.int/ESA), Belspo (http://www.belspo.be/), the "Fondazione Europea di Ricerca Biomedica" (http://www.ferbonlus.com/), the BIAL Foundation (grant number: 503 323 055; https://www.bial.com/), the Wallonia Brussels Federation Concerted Research Action (grant number: ARC 12/17/01), and the Mind Science Foundation (https://www. mindscence.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CHARLANDVERVILLE V, 2014, FRONT HUM NEUROSCI, V8; Facco E, 2015, MED HYPOTHESES, V85, P85, DOI 10.1016/j.mehy.2015.04.004; Gabbard G. o., 1981, DO NEAR DEATH EXPERI, V169, P374; Gabbard G.O., 1991, J NEAR DEATH STUD, V10, P41, DOI DOI 10.1007/BF01073295; GREYSON B, 1992, PSYCHIATRY, V55, P95; Greyson B, 2003, GEN HOSP PSYCHIAT, V25, P269, DOI 10.1016/S0163-8343(03)00042-2; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B., 1987, J NEAR DEATH STUDIES, V6, P41, DOI DOI 10.1007/BF01073267; Greyson B, VARIETIES ANOMALOUS; Greyson B, 2007, RESUSCITATION, V73, P407, DOI 10.1016/j.resuscitation.2006.10.013; Hou YM, 2013, ANN INDIAN ACAD NEUR, V16, P75, DOI 10.4103/0972-2327.107715; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange R, 2004, BRIT J PSYCHOL, V95, P161, DOI 10.1348/000712604773952403; Lange R., 2015, Psychology of Consciousness, V2, P79, DOI DOI 10.1037/cns0000040; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Martial C, 2017, CONSCIOUS C IN PRESS; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Moody R.A., 1975, LIFE LIFE; Moore LE, 2017, CONSCIOUS COGN, V51, P116, DOI 10.1016/j.concog.2017.03.003; Nelson KR, 2006, NEUROLOGY, V66, P1003, DOI 10.1212/01.wnl.0000204296.15607.37; OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L; Palmieri A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00429; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148; Pope C., 2006, QUALITATIVE RES; Ring K, 1980, LIFE AT DEATH A SCIE; Schwaninger J., 2002, J NEAR DEATH STUD, V20, P215, DOI [10.1023/A:1015258818660, DOI 10.1023/A:1015258818660]; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Thonnard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057620; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8	35	44	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0193001	10.1371/journal.pone.0193001	http://dx.doi.org/10.1371/journal.pone.0193001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444184	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500107
J	Mukhopadhyay, N; Noble, JA; Govil, M; Marazita, ML; Greenberg, DA				Mukhopadhyay, Nandita; Noble, Janelle A.; Govil, Manika; Marazita, Mary L.; Greenberg, David A.			Identifying genetic risk loci for diabetic complications and showing evidence for heterogeneity of type 1 diabetes based on complications risk	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; LINKAGE ANALYSIS; SUSCEPTIBILITY; ASSOCIATION; THYROIDITIS	There is a growing body of evidence suggesting that type 1 diabetes (T1D) is a genetically heterogeneous disease. However, the extent of this heterogeneity, and what observations may distinguish different forms, is unclear. One indicator may be T1D-related microvascular complications (MVCs), which are familial, but occur in some families, and not others. We tested the hypothesis that T1D plus MVC is genetically distinct from T1D without MCV. We studied 415 families (2,462 individuals, 896 with T1D) using genome-wide linkage analysis, comparing families with and without MVC. We also tested for interaction between identified loci and alleles at the HLA-DRB1 locus. We found significant linkage scores at 1p36.12, 1q32.1, 8q21.3, 12p11.21 and 22q11.21. In all regions except 1p36.12, linkage scores differed between MVC-based phenotype groups, suggesting that families with MVCs express different genetic influences than those without. Our linkage results also suggested gene-gene interaction between the above putative loci and the HLA region; HLA-based strata produced significantly increased linkage scores in some strata, but not others within a phenotype group. We conclude that families with type 1 diabetes plus MVCs are genetically different from those with diabetes alone.	[Mukhopadhyay, Nandita; Govil, Manika; Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA; [Noble, Janelle A.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Marazita, Mary L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Greenberg, David A.] Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH USA; [Greenberg, David A.] Ohio State Univ, Dept Pediat, Wexner Med Ctr, Columbus, OH 43210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Mukhopadhyay, N (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA.	nandita@pitt.edu			Pennsylvania Department of Health's Commonwealth Universal Research Enhancement Program; State of Pennsylvania	Pennsylvania Department of Health's Commonwealth Universal Research Enhancement Program; State of Pennsylvania	This study was funded by the Pennsylvania Department of Health's Commonwealth Universal Research Enhancement Program (http://www.health.pa.gov/MyRecords/Health-Research/CURE/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Darel Finley for providing computer assistance, and Valerie Hager for her work developing linkage-based gene-gene interaction detection. We also want to thank Dr. Cristina Monti and Dr. Barbara Corso for their work organizing and data basing the family data used in this work. Lastly, we wish to thank Dr. John Lonsdale, formerly of the National Disease Resource Interchange for supporting all our T1D work over the past decade. This work was supported in part by the State of Pennsylvania.	Abreu PC, 2002, GENET EPIDEMIOL, V22, P156, DOI 10.1002/gepi.0155; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Corso B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093398; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; HODGE SE, 1983, AM J HUM GENET, V35, P1139; Hodge SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146240; Howson JMM, 2007, DIABETOLOGIA, V50, P741, DOI 10.1007/s00125-007-0603-6; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lipner EM, 2013, HUM IMMUNOL, V74, P538, DOI 10.1016/j.humimm.2013.01.013; Lipner EM, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/694107; Looker HC, 2007, DIABETES, V56, P1160, DOI 10.2337/db06-1299; Monti MC, 2007, J CLIN ENDOCR METAB, V92, P4650, DOI 10.1210/jc.2007-1185; Nagy KH, 2010, PEDIATR DIABETES, V11, P579, DOI 10.1111/j.1399-5448.2010.00676.x; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Ott J, 1999, VARIABILITY RECOMBIN; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Thorsen SU, 2017, CLIN IMMUNOL, V174, P18, DOI 10.1016/j.clim.2016.11.007	20	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192696	10.1371/journal.pone.0192696	http://dx.doi.org/10.1371/journal.pone.0192696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444168	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500084
J	Shah, MP; Dahl, RM; Parashar, UD; Lopman, BA				Shah, Minesh P.; Dahl, Rebecca M.; Parashar, Umesh D.; Lopman, Benjamin A.			Annual changes in rotavirus hospitalization rates before and after rotavirus vaccine implementation in the United States	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; GASTROENTERITIS HOSPITALIZATIONS; ACTIVE SURVEILLANCE; US CHILDREN; DECREASE; DIARRHEA; TRENDS; IMPACT	Background Hospitalizations for rotavirus and acute gastroenteritis (AGE) have declined in the US with rotavirus vaccination, though biennial peaks in incidence in children aged less than 5 years occur. This pattern may be explained by lower rotavirus vaccination coverage in US children (59% to 73% from 2010-2015), resulting in accumulation of susceptible children over two successive birth cohorts. Methods Retrospective cohort analysis of claims data of commercially insured US children aged <5 years. Age-stratified hospitalization rates for rotavirus and for AGE from the 2002-2015 rotavirus seasons were examined. Median age and rotavirus vaccination coverage for biennial rotavirus seasons during pre-vaccine (2002-2005), early post-vaccine (2008-2011) and late post-vaccine (2012-2015) years. Results Age-stratified hospitalization rates decreased from pre-vaccine to early post-vaccine and then to late post-vaccine years. The clearest biennial pattern in hospitalization rates is the early post-vaccine period, with higher rates in 2009 and 2011 than in 2008 and 2010. The pattern diminishes in the late post-vaccine period. For rotavirus hospitalizations, the median age and the difference in age between biennial seasons was highest during the early post-vaccine period; these differences were not observed for AGE hospitalizations. There was no significant difference in vaccination coverage between biennial seasons. Conclusions These observations provide conflicting evidence that incomplete vaccine coverage drove the biennial pattern in rotavirus hospitalizations that has emerged with rotavirus vaccination in the US. As this pattern is diminishing with higher vaccine coverage in recent years, further increases in vaccine coverage may reach a threshold that eliminates peak seasons in hospitalizations.	[Shah, Minesh P.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Publ Hlth Sci Serv, Atlanta, GA 30329 USA; [Shah, Minesh P.; Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Dahl, Rebecca M.] Maximus Fed, Atlanta, GA USA; [Lopman, Benjamin A.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Shah, MP (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Publ Hlth Sci Serv, Atlanta, GA 30329 USA.; Shah, MP (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA.	mpshah@cdc.gov		Shah, Minesh/0000-0001-9117-5006				Aliabadi N, 2015, MMWR-MORBID MORTAL W, V64, P337; [Anonymous], WHO VACC PREV DIS MO; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Bowen MD, 2016, J INFECT DIS, V214, P732, DOI 10.1093/infdis/jiw233; Cortes JE, 2011, NEW ENGL J MED, V365, P1108, DOI 10.1056/NEJMoa1000446; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Goldacre MJ, 2013, LANCET, V382, P308, DOI 10.1016/S0140-6736(13)61635-9; Hemming-Harlo M, 2016, PEDIATR INFECT DIS J, V35, P1304, DOI 10.1097/INF.0000000000001305; Hill Holly A, 2016, MMWR Morb Mortal Wkly Rep, V65, P1065, DOI 10.15585/mmwr.mm6539a4; Hsu VP, 2005, PEDIATRICS, V115, P78, DOI 10.1542/peds.2004-0860; Jayasinghe S, 2013, VACCINE, V31, P967, DOI 10.1016/j.vaccine.2012.11.099; Leshem E, 2015, JAMA-J AM MED ASSOC, V313, P2282, DOI 10.1001/jama.2015.5571; Leshem E, 2014, LANCET INFECT DIS, V14, P847, DOI 10.1016/S1473-3099(14)70832-1; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; Matson DO, 2012, J PAEDIATR CHILD H, V48, P698, DOI 10.1111/j.1440-1754.2012.02445.x; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Payne DC, 2011, CLIN INFECT DIS, V53, P245, DOI 10.1093/cid/cir307; Rha B, 2014, EXPERT REV VACCINES, V13, P365, DOI 10.1586/14760584.2014.877846; Sabbe M, 2016, EUROSURVEILLANCE, V21, P19, DOI 10.2807/1560-7917.ES.2016.21.27.30273; San Hong LL, 2013, LEXIS EXPANSION AGE; Shah MP, 2016, PEDIATR INFECT DIS J, V35, P782, DOI 10.1097/INF.0000000000001175; Tate JE, 2014, CLIN INFECT DIS, V59, P1291, DOI 10.1093/cid/ciu564; Truven Health, MARKETSCAN COMM CLAI; Zlamy M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-112	24	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191429	10.1371/journal.pone.0191429	http://dx.doi.org/10.1371/journal.pone.0191429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444124	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500018
J	Thakur, N; Kupani, M; Pandey, RK; Mannan, R; Pruthi, A; Mehrotra, S				Thakur, Nanamika; Kupani, Manu; Pandey, Rajeev Kumar; Mannan, Rashim; Pruthi, Archna; Mehrotra, Sanjana			Genetic association of-1562C > T polymorphism in the MMP9 gene with primary glaucoma in a north Indian population	PLOS ONE			English	Article							PRIMARY ANGLE-CLOSURE; SINGLE NUCLEOTIDE POLYMORPHISMS; GANGLION-CELL DEATH; MATRIX METALLOPROTEINASES; OPTIC-NERVE; INTRAOCULAR-PRESSURE; MATRIX-METALLOPROTEINASE-9; PREVALENCE; EXPRESSION; APOPTOSIS	MMP (Matrix metalloproteinase) 9 is reported to affect glaucoma pathogenesis by altering intraocular pressure (10P) through its role in remodeling the extracellular matrix (ECM) in the trabecular meshwork. A genetic variant at the promoter region in the MMP9 gene (-1562C>T) has a putative role in regulating its transcription rate and hence can affect genetic predisposition to primary glaucoma. The present study examined the association of -1562C>T promoter polymorphism in the MMP9 gene with Primary Open Angle Glaucoma (POAG) and Primary Angle Closure Glaucoma (PACG) in a north Indian population. A total of 729 subjects (POAG = 224, PACG = 138 and 367 controls) were recruited for the study. Genotyping for the promoter sequence variant was done with PCR-RFLP method. Genotypic and allelic frequency distribution of the POAG and PACG data sets were compared to that of controls by chi-square test and genetic association was tested under different genetic models as implemented under PLINK. Statistically significant difference was observed in the genotype frequencies between PACG cases and controls (p = 0.030). However, in the POAG cases, this difference was only borderline (p = 0.052). Genetic model analysis, under the dominant model revealed 1.6 and 1.4 fold increased susceptibility to PACG and POAG (p = 0.012, p = 0.032) respectively. A higher frequency of CT genotype was observed in PACG as well as POAG males as compared to female subjects. According to the dominant model, CT+TT genotype conferred 1.8 fold higher risk of developing PACG among male patients as compared to the control group (p = 0.048, OR = 1.87;1.00-3.50). Current findings suggest significant association of MMP9 -1562C>T polymorphism with primary glaucoma in the targeted north Indian population and warrant further replication of the findings in other populations.	[Thakur, Nanamika; Kupani, Manu; Mehrotra, Sanjana] Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India; [Pandey, Rajeev Kumar] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mannan, Rashim; Pruthi, Archna] Baba Deep Singh Charitable Hosp, Amritsar, Punjab, India	Guru Nanak Dev University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mehrotra, S (corresponding author), Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India.	sanjana.bhu@gmail.com		Pandey, Rajeev/0000-0002-7883-1854; Thakur, Dr. Nanamika/0000-0002-8160-1371	Department of Science and Technology, Science & Engineering Research Board (SERB) [SB/YS/LS-140/2014.2]; University Grants Commission-Special Assistance Programme; University Grants Commission - Start Up BSR-grant	Department of Science and Technology, Science & Engineering Research Board (SERB); University Grants Commission-Special Assistance Programme; University Grants Commission - Start Up BSR-grant	This work was supported by: 1. SM: Department of Science and Technology, Science & Engineering Research Board (SERB), Grant No. SB/YS/LS-140/2014.2. SM: University Grants Commission-Special Assistance Programme. 3. SM: University Grants Commission - Start Up BSR-grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are sincerely thankful to all study subjects, who participated in the study by donating their precious blood samples. The work was funded by Department of Science and Technology, Science & Engineering Research Board (SERB), Grant No. SB/YS/LS-140/2014, University Grants Commission-Special Assistance Programme and Start Up BSR-grant.	Abu-Amero K, 2015, INT J MOL SCI, V16, P28886, DOI 10.3390/ijms161226135; ADELI K, 1990, CLIN CHEM, V36, P261; Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Ahram DF, 2015, EYE, V29, P1251, DOI 10.1038/eye.2015.124; Aung T, 2008, J GLAUCOMA, V17, P257, DOI 10.1097/IJG.0b013e31815c3aa5; Awadalla MS, 2011, MOL VIS, V17, P1420; Casson J, 2007, BRIT J OPHTHALMOL, V91, P710, DOI 10.1136/bjo.2006.107573; Chen XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157093; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Cho HK, 2014, SURV OPHTHALMOL, V59, P434, DOI 10.1016/j.survophthal.2013.09.003; De Groef L, 2016, INVEST OPHTH VIS SCI, V57, P5984, DOI 10.1167/iovs.16-19734; De Groef L, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0176-y; Friedman DS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1625, DOI 10.1001/archopht.124.11.1625; Gao XJ, 2014, INT J OPHTHALMOL-CHI, V7, P397, DOI 10.3980/j.issn.2222-3959.2014.03.02; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Mali RS, 2005, INVEST OPHTH VIS SCI, V46, P2125, DOI 10.1167/iovs.04-1376; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Markiewicz L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/812503; Markiewicz L, 2013, ACTA OPHTHALMOL, V91, pE516, DOI 10.1111/aos.12149; Micheal S, 2013, MOL VIS, V19, P441; Mossbock G, 2010, MOL VIS, V16, P1764; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Robertson JV, 2013, MOL VIS, V19, P684; Rong SS, 2016, OPHTHALMOLOGY, V123, P1211, DOI 10.1016/j.ophtha.2015.12.027; Schlotzer-Schrehardt U, 2003, INVEST OPHTH VIS SCI, V44, P1117, DOI 10.1167/iovs.02-0365; Shi HH, 2013, MOL VIS, V19, P128; Singh D, 2015, FRONT MOL BIOSCI, V2, P9; Song WL, 2011, OPHTHALMOLOGY, V118, P1982, DOI 10.1016/j.ophtha.2011.02.050; Sun MH, 2011, CURR EYE RES, V36, P1053, DOI 10.3109/02713683.2011.606591; Suzuki T, 2005, CORNEA, V24, P1004, DOI 10.1097/01.ico.0000160973.04072.a5; Tamm ER, 2017, EXP EYE RES, V157, P5, DOI 10.1016/j.exer.2017.02.006; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; Vranka JA, 2015, EXP EYE RES, V133, P112, DOI 10.1016/j.exer.2014.07.014; Wang IJ, 2006, MOL VIS, V12, P1223; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wong TTL, 2002, SURV OPHTHALMOL, V47, P239, DOI 10.1016/S0039-6257(02)00287-4; Wu MY, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0442-2; Yadav SS, 2014, DNA CELL BIOL, V33, P816, DOI 10.1089/dna.2014.2511; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang X, 2004, NEUROSCI LETT, V356, P140, DOI 10.1016/j.neulet.2003.10.084	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192636	10.1371/journal.pone.0192636	http://dx.doi.org/10.1371/journal.pone.0192636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432439	Green Submitted, gold, Green Published			2022-12-26	WOS:000424814300035
J	Yuan, HY; Chen, V; Boisvert, M; Isaacs, C; Glazer, RI				Yuan, Hongyan; Chen, Vincent; Boisvert, Marc; Isaacs, Claudine; Glazer, Robert I.			PLAC1 as a serum biomarker for breast cancer	PLOS ONE			English	Article							TOMOSYNTHESIS; SURVIVAL; DELTA; GENE	Placental-specific protein 1 (PLAC1) is an X-linked trophoblast gene that is re-expressed in several malignancies, including breast cancer, and is therefore a potential biomarker to follow disease onset and progression. Sera from 117 preoperative/pretreatment breast cancer patients and 51 control subjects, including those with fibrocystic disease, were analyzed for the presence of PLAC1 protein as well as its expression by IHC in tumor biopsies in a subset of subjects. Serum PLAC1 levels exceeded the mean plus one standard deviation (mean+SD) of the level in control subjects in 67% of subjects with ductal carcinoma in situ (DCIS), 67% with HER2(+) tumors, 73% with triple-negative cancer and 73% with ER+/PR+ tumors. Greater sensitivity was achieved using the mean+ 2 SD of control PLAC1 serum values, where the false positive rate was 3% and was exceeded by 38%, 40%, 60% and 43% of subjects with DCIS, HER2(+), TNBC and ER+/PR+/HER2(-) tumors. PLAC1 was detected in 97% of tumor biopsies, but did not correlate quantitatively with serum levels. There was no significant correlation of serum PLAC1 levels with race, age at diagnosis, body mass index (BMI) or the presence of metastatic disease. It remains to be determined whether PLAC1 serum levels can serve as a diagnostic biomarker for the presence or recurrence of disease post-surgery and/or therapy.	[Yuan, Hongyan; Chen, Vincent; Isaacs, Claudine; Glazer, Robert I.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Yuan, Hongyan; Chen, Vincent; Isaacs, Claudine; Glazer, Robert I.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Boisvert, Marc] Washington Hosp Ctr, Washington, DC 20010 USA	Georgetown University; Georgetown University; MedStar Washington Hospital Center	Glazer, RI (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA.; Glazer, RI (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	glazerr@georgetown.edu		Glazer, Robert/0000-0001-6936-2980	Avon Foundation for Women [02-2015-019]; National Cancer Institute [1P30CA051008]	Avon Foundation for Women; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Avon Foundation for Women, grant no. 02-2015-019 to RIG; https://www.avon.com/ and the National Cancer Institute, grant no. 1P30CA051008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Concu M, 2005, FETAL DIAGN THER, V20, P27, DOI 10.1159/000081365; Devor EJ, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/807849; Dong XY, 2008, INT J CANCER, V122, P2038, DOI 10.1002/ijc.23341; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Greenberg JS, 2014, AM J ROENTGENOL, V203, P687, DOI 10.2214/AJR.14.12642; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Koslowski M, 2009, J BIOL CHEM, V284, P28607, DOI 10.1074/jbc.M109.031120; Lala PK, 2003, PLACENTA, V24, P575, DOI 10.1016/S0143-4004(03)00063-8; Liu FF, 2008, GASTROENTEROLOGY, V134, P998, DOI 10.1053/j.gastro.2008.01.029; Liu FF, 2014, J GASTROENTEROL, V49, P419, DOI 10.1007/s00535-013-0811-4; Matteo M, 2013, PLACENTA, V34, P335, DOI 10.1016/j.placenta.2013.01.006; McCourt CM, 2013, J CLIN PATHOL, V66, P58, DOI 10.1136/jclinpath-2012-201140; Old Lloyd J, 2007, Cancer Immun, V7, P19; Silva Wilson A Jr, 2007, Cancer Immun, V7, P18; Song MH, 2011, BIOCHEM BIOPH RES CO, V408, P195, DOI 10.1016/j.bbrc.2011.02.077; Wagner M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-570; Wang X, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-107; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004; Yin YZ, 2009, CANCER RES, V69, P687, DOI 10.1158/0008-5472.CAN-08-2446; Yin YZ, 2005, CANCER RES, V65, P3950, DOI 10.1158/0008-5472.CAN-04-3990; Yuan HY, 2013, CANCER RES, V73, P4349, DOI 10.1158/0008-5472.CAN-13-0322	24	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192106	10.1371/journal.pone.0192106	http://dx.doi.org/10.1371/journal.pone.0192106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432428	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300016
J	Garikipati, VNS; Singh, SP; Mohanram, Y; Gupta, AK; Kapoor, D; Nityanand, S				Garikipati, Venkata Naga Srikanth; Singh, Saurabh Pratap; Mohanram, Yamuna; Gupta, Ashwani Kumar; Kapoor, Deepa; Nityanand, Soniya			Isolation and characterization of mesenchymal stem cells from human fetus heart	PLOS ONE			English	Article							CARDIAC PROGENITOR CELLS; ISCHEMIC-HEART; STROMAL CELLS; FETAL; MARKERS; AKT	Background Mesenchymal stem cells (MSCs) are promising cells for cardiovascular regenerative medicine. However, their potential may be limited, because of their restricted cardiovascular differentiation potential and decline in their number and functional characteristics with increasing donor age. We have previously shown that rat fetus heart harbors primitive MSCs and administration of these cells improved left ventricular (LV) function after ischemia/reperfusion injury in rats. To evaluate their potential as a new cell type for clinical cardiovascular cell therapy, we have undertaken this study on the isolation and characterization of human fetal cardiac MSCs (hfC-MSCs). Methods MSCs were isolated from the heart of five 14-16-week-old aborted human fetuses and studied for their growth characteristics, karyotypic stability and senescence over successive passages, expression of mesenchymal and embryonal markers by flow cytometry and immunocytochemistry, constitutive expression of cardiovascular genes by RT-PCR, differentiation into cells of the cardiovascular lineage and their immunomodulatory properties. Results The hfC-MSCs grew as adherent monolayer with spindle shaped morphology and exhibited rapid proliferation with an average population doubling time of 34 hours and expansion to up to more than 80 population doublings with maintenance of a normal karyotype and without senescence. Immunophenotyping showed that they had similar phenotype as human bone marrow mesenchymal stem cells (hBM-MSCs) expressing CD73, CD90, CD105 and lacking expression of CD31, CD34, CD45, HLA-DR. However, hfC-MSCs expressed significantly higher levels of CD117 and SSEA-4 compared to hBM-MSCs. In addition, hfC-MSCs expressed the embryonal markers Oct-4, Nanog and Sox-2 as compared to hBM-MSCs. Further, hfC-MSCs had significantly higher expression of the cardiovascular genes viz. ISL-1, flk-1, GATA-4, NKX2.5 and MDR-1 as compared to hBM-MSCs, and could be differentiated into major cardiovascular cells (cardiomyocytes, endothelial cells, smooth muscle cells). Interestingly, hfC-MSCs markedly reduced T-lymphocyte proliferation with an increased secretion of TGF-beta and IL-10. Conclusions Our results show that human fetus heart is a novel source of primitive MSCs with cardiovascular commitment which may have a potential therapeutic application in cardiovascular regenerative medicine.	[Garikipati, Venkata Naga Srikanth; Singh, Saurabh Pratap; Mohanram, Yamuna; Gupta, Ashwani Kumar; Nityanand, Soniya] Sanjay Gandhi Postgrad Inst Med Sci, Dept Hematol, Stem Cell Res Facil, Lucknow, Uttar Pradesh, India; [Kapoor, Deepa] Sanjay Gandhi Postgrad Inst Med Sci, Gen Hosp, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Nityanand, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Hematol, Stem Cell Res Facil, Lucknow, Uttar Pradesh, India.	soniya_nityanand@yahoo.co.in	Gupta, Ashwani Kumar/AAS-1084-2021	Gupta, Ashwani Kumar/0000-0001-7069-5299	Department of Biotechnology, Government of India [BT/PR6519/MED/14/826/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by an extramural grant sanctioned by Department of Biotechnology, Government of India, to Dr S Nityanand (BT/PR6519/MED/14/826/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an extramural grant sanctioned by the Department of Biotechnology, Government of India, to Dr. Sonya Nityanand (BT/PR6519/MED/14/826/2005). The authors would also like to extend sincere thanks to Dr. M.M. Godbole, Prof. and Head, Department of Molecular Medicine, SGPGIMS, Lucknow, and his research group, for extending laboratory facilities to perform immunocytochemistry imaging.	Beigi F, 2013, CIRC RES, V113, P372, DOI 10.1161/CIRCRESAHA.113.301075; Carr CA, PLOS ONE, V6; Castaldi A, 2017, J PHYSIOL-LONDON, V595, P6249, DOI 10.1113/JP274775; Garikipati VNS, 2017, J PHYSIOL-LONDON, V595, P6221, DOI 10.1113/JP274989; Garikipati VNS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100982; Giuliani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019988; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2009, STEM CELLS, V27, P971, DOI 10.1002/stem.12; Gonzales C, TISSUE ENG A, V18, P198; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hodgkinson CP, 2016, CIRC RES, V118, P95, DOI 10.1161/CIRCRESAHA.115.305373; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Maurer MH, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/704256; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Rossini A, 2011, CARDIOVASC RES, V89, P650, DOI 10.1093/cvr/cvq290; Sharma S, 2017, CIRC RES, V120, P816, DOI 10.1161/CIRCRESAHA.116.309782; Srikanth Garikipati Venkata Naga, 2013, World J Stem Cells, V5, P26, DOI 10.4252/wjsc.v5.i1.26; Wang WE, 2013, CLIN SCI, V125, P319, DOI 10.1042/CS20130019; Wysoczynski M, 2017, J AM COLL CARDIOL, V69, P1824, DOI 10.1016/j.jacc.2017.01.048; Wysoczynski M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00078; Zheng CL, 2009, CELL TRANSPLANT, V18, P1093, DOI 10.3727/096368909X12483162197042	25	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192244	10.1371/journal.pone.0192244	http://dx.doi.org/10.1371/journal.pone.0192244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420637	Green Submitted, gold, Green Published			2022-12-26	WOS:000424517900056
J	Gim, HJ; Ho, CH; Kim, J; Lee, EJ				Gim, Hyeon-Ju; Ho, Chang-Hoi; Kim, Jinwon; Lee, Eun Ju			Urbanization may reduce the risk of frost damage to spring flowers: A case study of two shrub species in South Korea	PLOS ONE			English	Article							URBAN HEAT-ISLAND; CLIMATE-CHANGE; UNITED-STATES; TRENDS; TEMPERATURE; INTENSITY; PHENOLOGY; EUROPE; IMPACT; SEASON	Regional warming, owing to urbanization, leads to earlier spring phenological events and may expose plants to hard freeze damage. This study examined the influence of urbanization on the risk of frost damage to spring flowers in South Korea from 1973 to 2015. For the analysis period, we categorized 25 cities into two groups: those showing rapid population growth (rPG) >= 200,000, including 13 cities, and those showing no or decreased population growth (nPG), including 12 cities. We then investigated the time from the last frost dates (LFDs) in spring to the first flowering dates (FFDs) for each group. The rPG group experienced significant spring warming of 0.47 degrees C per decade, resulting in earlier LFDs and FFDs. For this group, the advancement of LFD was more rapid than that of FFD, and the days between these two dates increased from 0.42 to 0.47 days per decade, implying a reduced risk of frost damage. Spring warming and the advancement of FFDs and LFDs were relatively small for the nPG group, and the LFDs were rather delayed. Consequently, the days between LFDs and FFDs were reduced from -1.05 to -1.67 days per decade, indicating an increased risk of frost damage. The contrasting changes in the frost-damage risk between the two city groups can be attributed to distinct urban warming at night, which makes the LFDs substantially earlier in the rPG group. Therefore, this study suggests that the warming associated with urbanization may lessen the risk of spring frost damage to plants in rapidly growing urban areas.	[Gim, Hyeon-Ju; Ho, Chang-Hoi] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Kim, Jinwon] Natl Inst Meteorol Sci, Climate Res Div, Seogwipo Si, South Korea; [Lee, Eun Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Seoul National University (SNU); National Institute of Meteorological Sciences; Seoul National University (SNU)	Ho, CH (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	hoch@cpl.snu.ac.kr	Ho, Chang-Hoi/H-8354-2015	Ho, Chang-Hoi/0000-0002-1372-0037	Korea Meteorological Administration Research and Development Program [KMIPA2015-6110]; National Institute of Meteorological Sciences (NIMS) - Korea Meteorological Administration [NIMS-2016-3100]; Korea Meteorological Administration [KMIPA2015-6110]	Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA)); National Institute of Meteorological Sciences (NIMS) - Korea Meteorological Administration(Korea Meteorological Administration (KMA)); Korea Meteorological Administration(Korea Meteorological Administration (KMA))	Prof. Chang-Hoi Ho and Mr. Hyeon-Ju Gim were supported by Korea Meteorological Administration (http://www.kma.go.kr) with the grant numbers of KMIPA2015-6110, and Dr. Jinwon Kim was supported by Korea Meteorological Administration with the grant numbers of NIMS-2016-3100. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Korea Meteorological Administration Research and Development Program under Grant KMIPA2015-6110. The work by Jinwon Kim was supported by the National Institute of Meteorological Sciences (NIMS) - Korea Meteorological Administration (NIMS-2016-3100). We thank two reviewers, David Inouye and one anonymous reviewer, whose comments helped improve and clarify this manuscript.	Alizadeh-Choobari O, 2016, ATMOS RES, V170, P176, DOI 10.1016/j.atmosres.2015.12.001; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Atkinson BW, 2003, BOUND-LAY METEOROL, V109, P285, DOI 10.1023/A:1025820326672; Augspurger CK, 2013, ECOLOGY, V94, P41, DOI 10.1890/12-0200.1; Beaubien E, 2011, BIOSCIENCE, V61, P514, DOI 10.1525/bio.2011.61.7.6; Blanke M, 2009, ERWERBS-OBSTBAU, V51, P101, DOI 10.1007/s10341-009-0086-3; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chow WTL, 2006, INT J CLIMATOL, V26, P2243, DOI 10.1002/joc.1364; Chuine I, 1998, PLANT CELL ENVIRON, V21, P455, DOI 10.1046/j.1365-3040.1998.00299.x; Chung U, 2004, CLIMATIC CHANGE, V66, P127, DOI 10.1023/B:CLIM.0000043136.58100.ce; Cline B, 1998, BLUEBERRY FREEZE DAM; Comrie AC, 2000, B AM METEOROL SOC, V81, P2417, DOI 10.1175/1520-0477(2000)081<2417:MAWMUH>2.3.CO;2; COOTER EJ, 1995, INT J CLIMATOL, V15, P65, DOI 10.1002/joc.3370150108; Easterling DR, 2002, B AM METEOROL SOC, V83, P1327, DOI 10.1175/1520-0477(2002)083&lt;1327:RCIFDA&gt;2.3.CO;2; Field CB, 2008, ECOLOGICAL IMPACTS C; Fujibe F, 2009, INT J CLIMATOL, V29, P1811, DOI 10.1002/joc.1822; Garrett PM, 2011, ENVIRON RES LETT, V6; Gedzelman SD, 2003, THEOR APPL CLIMATOL, V75, P29, DOI 10.1007/s00704-002-0724-2; Grimmond S, 2007, GEOGR J, V173, P83, DOI 10.1111/j.1475-4959.2007.232_3.x; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; Hanninen H., 1987, Silva Fennica, V21, P279; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hufkens K, 2012, GLOBAL CHANGE BIOL, V18, P2365, DOI 10.1111/j.1365-2486.2012.02712.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Inouye DW, 2000, ECOL LETT, V3, P457, DOI 10.1046/j.1461-0248.2000.00165.x; Jeong JH, 2011, INT J CLIMATOL, V31, P1488, DOI 10.1002/joc.2178; Jeong S. J., 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI DOI 10.1111/J.1365-2486.2011.02397.X; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kataoka K, 2009, SCI TOTAL ENVIRON, V407, P3112, DOI 10.1016/j.scitotenv.2008.09.015; Kim MK, 2011, ATMOS ENVIRON, V45, P5778, DOI 10.1016/j.atmosenv.2011.07.028; Kim YH, 2004, THEOR APPL CLIMATOL, V79, P151, DOI 10.1007/s00704-004-0070-7; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; KRAMER K, 1994, J APPL ECOL, V31, P172, DOI 10.2307/2404609; Kug JS, 2013, ASIA-PAC J ATMOS SCI, V49, P151, DOI 10.1007/s13143-013-0016-z; Larcher W., 2003, PHYSL PLANT ECOLOGY, pXX; Lee SH, 2010, THEOR APPL CLIMATOL, V100, P227, DOI 10.1007/s00704-009-0247-1; Malcolm J.R., 2000, ECOSYSTEMS GLOBAL CL; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2000, INT J BIOMETEOROL, V44, P76, DOI 10.1007/s004840000054; Mohan M, 2015, SCI TOTAL ENVIRON, V506, P453, DOI 10.1016/j.scitotenv.2014.11.006; OKE TR, 1981, J CLIMATOL, V1, P237, DOI 10.1002/joc.3370010304; Peterson AG, 2014, GEOPHYS RES LETT, V41, P2156, DOI 10.1002/2014GL059266; Richardson Andrew D., 2009, P87, DOI 10.1007/978-1-4419-0026-5_4; Rigby JR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033955; Robeson SM, 2002, CLIMATIC CHANGE, V52, P219, DOI 10.1023/A:1013088011223; Ryu YH, 2012, J APPL METEOROL CLIM, V51, P842, DOI 10.1175/JAMC-D-11-098.1; Sarvas R., 1974, INVESTIGATIONS ANN C; Scheifinger H, 2003, THEOR APPL CLIMATOL, V74, P41, DOI 10.1007/s00704-002-0704-6; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Snyder RL., 2005, FROST PROTECT, V1, P87; Sun Y, 2016, NAT CLIM CHANGE, V6, P706, DOI [10.1038/nclimate2956, 10.1038/NCLIMATE2956]; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571	54	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191428	10.1371/journal.pone.0191428	http://dx.doi.org/10.1371/journal.pone.0191428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415073	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300027
J	Jones, T; Jones, PL				Jones, Takako; Jones, Peter L.			A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy	PLOS ONE			English	Article							MUSCLE REGENERATION; DNA REARRANGEMENTS; SKELETAL-MUSCLE; GENE-EXPRESSION; CANDIDATE GENE; MESSENGER-RNA; ANIMAL-MODELS; FSHD; MICE; FAMILY	The Double homeobox 4 (DUX4) gene is an important regulator of early human development and its aberrant expression is causal for facioscapulohumeral muscular dystrophy (FSHD). The DUX4-full length (DUX4-fl) mRNA splice isoform encodes a transcriptional activator; however, DUX4 and its unique DNA binding preferences are specific to old-world primates. Regardless, the somatic cytotoxicity caused by DUX4 expression is conserved when expressed in cells and animals ranging from fly to mouse. Thus, viable animal models based on DUX4-fl expression have been difficult to generate due in large part to overt developmental toxicity of low DUX4-fl expression from leaky transgenes. We have overcome this obstacle and here we report the generation and initial characterization of a line of conditional floxed DUX4-fl transgenic mice, FLExDUX4, that is viable and fertile. In the absence of cre, these mice express a very low level of DUX4-fl mRNA from the transgene, resulting in mild phenotypes. However, when crossed with appropriate cre-driver lines of mice, the double transgenic offspring readily express DUX4-fl mRNA, protein, and target genes with the spatiotemporal pattern of nuclear cre expression dictated by the chosen system. When cre is expressed from the ACTA1 skeletal muscle-specific promoter, the double transgenic animals exhibit a developmental myopathy. When crossed with tamoxifen-inducible cre lines, DUX4-mediated pathology can be induced in adult animals. Thus, the appearance and progression of pathology can be controlled to provide readily screenable phenotypes useful for assessing therapeutic approaches targeting DUX4-fl mRNA and protein. Overall, the FLExDUX4 line of mice is quite versatile and will allow new investigations into mechanisms of DUX4-mediated pathophysiology as well as much-needed pre-clinical testing of DUX4-targeted FSHD interventions in vivo.	[Jones, Takako; Jones, Peter L.] Univ Nevada, Dept Pharmacol, Ctr Mol Med, Reno Sch Med, Reno, NV 89557 USA; [Jones, Takako; Jones, Peter L.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Massachusetts System; University of Massachusetts Worcester	Jones, T; Jones, PL (corresponding author), Univ Nevada, Dept Pharmacol, Ctr Mol Med, Reno Sch Med, Reno, NV 89557 USA.; Jones, T; Jones, PL (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA.	takakojones@med.unr.edu; peterjones@med.unr.edu		Jones, Peter/0000-0003-4283-1016	Chris Carrino Foundation for FSHD; FSH Society [FSHS-22012-01]; Muscular Dystrophy Association [MDA383364]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR070432, R21AR070438]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070432, R21AR070438] Funding Source: NIH RePORTER	Chris Carrino Foundation for FSHD; FSH Society; Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by grants from the Chris Carrino Foundation for FSHD (http://chriscarrinofoundation.org/) to TJ, the FSH Society (FSHS-22012-01) (https://www.fshsociety.org/) to PLJ, the Muscular Dystrophy Association (MDA383364) (https://www.mda.org/) to PLJ, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR070432 and R21AR070438) (https://www.niams.nih.gov/) to PLJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ansseau E, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030093; ARAHATA K, 1995, MUSCLE NERVE, pS56; Bosnakovski D, 2017, DIS MODEL MECH, V10, P1211, DOI 10.1242/dmm.030064; Bosnakovski D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00730-1; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen TH, 2013, NEUROMUSCULAR DISORD, V23, P298, DOI 10.1016/j.nmd.2013.01.005; Dandapat A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151467; Dandapat A, 2014, CELL REP, V8, P1484, DOI 10.1016/j.celrep.2014.07.056; de Greef JC, 2017, HUM MOL GENET; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feng Q, 2015, ELIFE, V4, DOI 10.7554/eLife.04996; Ferreboeuf M, 2013, HUM MOL GENET; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Frisullo G, 2010, J CLIN IMMUNOL; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Himeda CL, 2015, ANTIOXID REDOX SIGN, V22, P1463, DOI 10.1089/ars.2014.6090; Himeda CL, 2014, MOL CELL BIOL, V34, P1942, DOI 10.1128/MCB.00149-14; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jones TI, 2017, NEUROMUSCULAR DISORD, V27, P221, DOI 10.1016/j.nmd.2016.12.007; Jones TI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0072-6; Jones TI, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-23; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Klinge L, 2006, NEUROMUSCULAR DISORD, V16, P553, DOI 10.1016/j.nmd.2006.06.008; Klingler Werner, 2012, Acta Myol, V31, P184; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krom YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003415; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Lek A, 2015, TRENDS MOL MED, V21, P295, DOI 10.1016/j.molmed.2015.02.011; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marsollier AC, 2016, HUM MOL GENET, V25, P1468, DOI 10.1093/hmg/ddw015; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nagy A, 2009, COLD SPRING HARB PRO, V4; Peart N, 2017, HUM GENET, V136, P1291, DOI 10.1007/s00439-017-1813-8; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Smith LR, 2014, AM J PHYSIOL-CELL PH, V306, pC889, DOI 10.1152/ajpcell.00383.2013; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Statland JM, 2015, MUSCLE NERVE, V52, P521, DOI 10.1002/mus.24621; Tasca G, 2017, MOL NEUROBIOLOGY; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, MOL THER, V19, P2048, DOI 10.1038/mt.2011.118; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wang JX, 2012, BLOOD, V120, P1489, DOI 10.1182/blood-2012-01-404046; Wang LH, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0667-0; Whiddon JL, 2017, NAT GENET, V49, P935, DOI 10.1038/ng.3846; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251	77	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192657	10.1371/journal.pone.0192657	http://dx.doi.org/10.1371/journal.pone.0192657			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415061	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300092
J	Yang, S; Chiu, APY; Lin, QY; Zeng, ZQ; Li, YF; Zhang, Y; Yang, ZR; Yang, L; He, DH				Yang, Shu; Chiu, Alice P. Y.; Lin, Qianying; Zeng, Ziqian; Li, Yafei; Zhang, Yao; Yang, Zhengrong; Yang, Lin; He, Daihai			HIV epidemics in Shenzhen and Chongqing, China	PLOS ONE			English	Article							MEN; SEX; PREVALENCE; SURVEILLANCE; AGE; MUNICIPALITY; INFECTION; SYPHILIS; BEHAVIOR; GROWTH	Objective Men who have sex with men (MSM) and heterosexuals are the populations with the fastest growing HIV infection rates in China. We characterize the epidemic growth and age patterns between these two routes from 2004 to 2015 in Chongqing and Shenzhen, China. Design and methods Data were downloaded from the National HIV/AIDS Comprehensive Response Information Management System. For the new HIV diagnoses of heterosexuals and MSM in both cities, we estimated the growth rates by fitting different sub-exponential models. Heat maps are used to show their age patterns. We used histograms to compare these patterns by birth cohort. Results The MSM epidemics grew significantly in both cities. Chongqing experienced quadratic growth in HIV reported cases with an estimated growth rate of 0.086 per week and a "deceleration rate" of 0.673. HIV reported cases of MSM in Shenzhen grew even more drastically with a growth rate of 0.033 per week and "deceleration rate" of 0.794. The new infections are mainly affecting the ages of 18 to 30 in Chongqing and ages of 20 to 35 in Shenzhen. They peaked in early 1990's and mid-1990's birth cohorts in Chongqing and Shenzhen respectively. The HIV epidemic among heterosexuals grew rapidly in both cities. The growth rates were estimated as 0.02 and 0.028 in Chongqing and Shenzhen respectively whereas the "deceleration rates" were 0.878 and 0.790 in these two places. It affected mostly aged 18 to 75 in males and 18 to 65 in females in Chongqing and aged 18 to 45 in males and 18 to 50 in females in Shenzhen in 2015. In Chongqing, the heterosexual female epidemics display two peaks in HIV diagnoses in the birth cohorts of early 1950's and early 1980's, with heterosexual male epidemics peaked in early 1940's and early 1960's. The heterosexual male and female epidemics display higher rates in the birth cohort 1940-1960, than the birth cohort 1960-1990. It peaked in birth cohorts of 1950's and 1980's in Shenzhen. Conclusions We revealed striking differences in epidemic growth and age patterns of the HIV epidemics in these two cities. Our results may be used to inform age-targeted public health policies to curb their epidemic growth.	[Yang, Shu; Zeng, Ziqian] Chengdu Med Coll, Chengdu, Sichuan, Peoples R China; [Chiu, Alice P. Y.; Lin, Qianying; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Kowloon, Hong Kong, Peoples R China; [Li, Yafei; Zhang, Yao] Third Mil Med Univ, Coll Prevent Med, Dept Epidemiol, Chongqing 400038, Peoples R China; [Yang, Zhengrong] Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	Chengdu Medical College; Hong Kong Polytechnic University; Army Medical University; Chinese Center for Disease Control & Prevention; Hong Kong Polytechnic University	He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Kowloon, Hong Kong, Peoples R China.	daihai.he@polyu.edu.hk	YANG, Lin/F-9601-2014; Lin, Qianying/ABD-8415-2021; He, Daihai/AAT-8735-2021	YANG, Lin/0000-0002-5964-3233; He, Daihai/0000-0003-3253-654X	Early Career Scheme from Hong Kong Research Grants Council [PolyU 251001/14M]; AIDS Trust Fund from Hong Kong Government [MSS 236 R]; Chongqing Government AIDS visual synthesized control and prevention platform [20141026]	Early Career Scheme from Hong Kong Research Grants Council; AIDS Trust Fund from Hong Kong Government; Chongqing Government AIDS visual synthesized control and prevention platform	DH is supported by the Early Career Scheme from Hong Kong Research Grants Council (PolyU 251001/14M). DH, AC, and LY are supported by the AIDS Trust Fund from Hong Kong Government (MSS 236 R). SY, YL and YZ are supported by a grant from Chongqing Government (20141026) AIDS visual synthesized control and prevention platform.; DH is supported by the Early Career Scheme from Hong Kong Research Grants Council (PolyU 251001/14M). DH, AC, and LY are supported by the AIDS Trust Fund from Hong Kong Government (MSS 236 R). SY, YL and YZ are supported by a grant from Chongqing Government (20141026) AIDS visualization synthesized control and prevention platform. We thank Professors Shui Shan Lee and Lewi Stone for helpful comments.	Altman D., 2004, SEX RES SOC POLICY, V1, P63, DOI [10.1525/srsp.2004.1.1.63, DOI 10.1525/SRSP.2004.1.1.63]; Chen Lin, 2008, Journal of Tropical Medicine (Guangzhou), V8, P175; Chen XS, 2012, SEX TRANSM DIS, V39, P226, DOI 10.1097/OLQ.0b013e31823d2cd3; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; *CHONGQ STAT BUR, 2010, CHONGQ STAT YB 2010; Chongqing Statistical Bureau Chongqing China, CHONGQ STAT YB 2015; Chowell G, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0659; COLGATE SA, 1989, P NATL ACAD SCI USA, V86, P4793, DOI 10.1073/pnas.86.12.4793; Crabtree-Ramirez B, 2015, AIDS BEHAV, V19, P1599, DOI 10.1007/s10461-014-0974-x; Davison AC, 1997, BOOTSTRAP METHODS TH; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; El-Hayek C, 2010, MED J AUSTRALIA, V193, P655, DOI 10.5694/j.1326-5377.2010.tb04095.x; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Guo WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070718; He HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170457; Huang Y, 2011, AIDS CARE, V23, P96; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Li Yu-yan, 2010, Fudan Xuebao (Yixueban), V37, P304; Liu L, 2007, J CHONGQING MED U, V32, P632; Luo QingShan, 2015, China Tropical Medicine, V15, P815; Ma DiHui, 2015, Journal of Third Military Medical University, V37, P689; National Health and Family Planning Commission of the People's Republic of China, 2015, 2015 CHIN AIDS RESP; National Health and Family Planning Commission of the PRC, 2015 REP CHIN MIGR P; NCAIDS China CDC, 2013, CHIN J AIDS STD, V2, P85; Qian SS, 2014, AIDS, V28, P1805, DOI 10.1097/QAD.0000000000000323; Shenzhen Statistical Bureau Shenzhen China, SHENZH STAT YB 2014; Shenzhen Statistical Bureau Shenzhen China, SHENZH STAT YB 2015; Shenzhen Statistical Bureau Shenzhen China, 2010, SHENZH STAT YB; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Tang WM, 2016, SEX TRANSM INFECT, V92, P508, DOI 10.1136/sextrans-2015-052469; Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002; Wang N, 2016, AIDS BEHAV; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Xiao ZW, 2011, AIDS CARE, V23, P105, DOI 10.1080/09540121.2010.532537; Xing JN, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu214; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang Wei, 2015, Modern Preventive Medicine, V42, P3272; Zhang X, 2016, HIV MED; Zhang YQ, 2012, SEX TRANSM INFECT, V88, P444, DOI 10.1136/sextrans-2011-050295; Zhang YZ, 2015, IEEE ANN INT CONF CY, P2006, DOI 10.1109/CYBER.2015.7288256; Zhao J, 2015, ARCH SEX BEHAV, V44, P2055, DOI 10.1007/s10508-014-0350-y; Zhou C, 2013, ARCH SEX BEHAV, V42, P1275, DOI 10.1007/s10508-012-0008-6; Zou HC, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20792	46	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192849	10.1371/journal.pone.0192849	http://dx.doi.org/10.1371/journal.pone.0192849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447229	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900060
J	Gillies, CL; McLeod, IM; Alleway, HK; Cook, P; Crawford, C; Creighton, C; Diggles, B; Ford, J; Hamer, P; Heller-Wagner, G; Lebrault, E; Le Port, A; Russell, K; Sheaves, M; Warnock, B				Gillies, Chris L.; McLeod, Ian M.; Alleway, Heidi K.; Cook, Peter; Crawford, Christine; Creighton, Colin; Diggles, Ben; Ford, John; Hamer, Paul; Heller-Wagner, Gideon; Lebrault, Emma; Le Port, Agnes; Russell, Kylie; Sheaves, Marcus; Warnock, Bryn			Australian shellfish ecosystems: Past distribution, current status and future direction	PLOS ONE			English	Article							OYSTER SACCOSTREA-GLOMERATA; REEF RESTORATION; WATER-QUALITY; BASE-LINE; HABITAT; CONSERVATION; DECLINE; MARINE	We review the status of marine shellfish ecosystems formed primarily by bivalves in Australia, including: identifying ecosystem-forming species, assessing their historical and current extent, causes for decline and past and present management. Fourteen species of bivalves were identified as developing complex, three-dimensional reef or bed ecosystems in intertidal and subtidal areas across tropical, subtropical and temperate Australia. A dramatic decline in the extent and condition of Australia's two most common shellfish ecosystems, developed by Saccostrea glomerata and Ostrea angasi oysters, occurred during the mid-1800s to early 1900s in concurrence with extensive harvesting for food and lime production, ecosystem modification, disease outbreaks and a decline in water quality. Out of 118 historical locations containing O. angasi-developed ecosystems, only one location still contains the ecosystem whilst only six locations are known to still contain S. glomerata-developed ecosystems out of 60 historical locations. Ecosystems developed by the introduced oyster Crasostrea gigas are likely to be increasing in extent, whilst data on the remaining 11 ecosystem-forming species are limited, preventing a detailed assessment of their current ecosystem-forming status. Our analysis identifies that current knowledge on extent, physical characteristics, biodiversity and ecosystem services of Australian shellfish ecosystems is extremely limited. Despite the limited information on shellfish ecosystems, a number of restoration projects have recently been initiated across Australia and we propose a number of existing government policies and conservation mechanisms, if enacted, would readily serve to support the future conservation and recovery of Australia's shellfish ecosystems.	[Gillies, Chris L.] Nat Conservancy Australia, Carlton, Vic, Australia; [McLeod, Ian M.; Creighton, Colin; Heller-Wagner, Gideon; Le Port, Agnes; Sheaves, Marcus] James Cook Univ, TropWATER Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia; [Alleway, Heidi K.] Primary Ind & Reg South Australia, Adelaide, SA, Australia; [Cook, Peter; Warnock, Bryn] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia; [Crawford, Christine] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Diggles, Ben] DigsFish Serv, Banksia Beach, Qld, Australia; [Ford, John] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Hamer, Paul] Victorian Fisheries Author, Queenscliff, Vic, Australia; [Lebrault, Emma; Russell, Kylie] NSW Dept Primary Ind, Fisheries NSW, Port Stephens, NSW, Australia; [Sheaves, Marcus] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia	James Cook University; University of Western Australia; University of Tasmania; University of Melbourne; NSW Department of Primary Industries; James Cook University	Gillies, CL (corresponding author), Nat Conservancy Australia, Carlton, Vic, Australia.	chris.gillies@tnc.org	Alleway, Heidi/X-2161-2019; Sheaves, Marcus J/G-4283-2012; McLeod, Ian/J-9062-2014	Alleway, Heidi/0000-0002-9322-5967; Sheaves, Marcus J/0000-0003-0662-3439; McLeod, Ian/0000-0001-5375-4402	Marine Biodiversity Hub through Australian Government's National Environmental Science Programme Marine Biodiversity Hub - NESP; Nature Conservancy's Great Southern Seascapes program; Thomas Foundation; NESP Marine Biodiversity Hub	Marine Biodiversity Hub through Australian Government's National Environmental Science Programme Marine Biodiversity Hub - NESP; Nature Conservancy's Great Southern Seascapes program; Thomas Foundation; NESP Marine Biodiversity Hub	This work was supported by the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Science Programme Marine Biodiversity Hub - NESP (http://www.nespmarine.edu.au/), The Nature Conservancy's Great Southern Seascapes program (http.//www.natureaustralia.org.au/our-impact/oceans/) and the Thomas Foundation (http://thomasfoundation.org.au/). All authors received a research grant from the NESP Marine Biodiversity Hub to carry out this research. All authors hold faculty/government positions in their respective institutions with the exception of BD (employed by Digsfish Services Pry Ltd) and GH, EL, BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was undertaken for the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Science Program (NESP) and The Nature Conservancy's Great Southern Seascapes program (generously supported by The Thomas Foundation). The Authors would like to thank Loren Coen, James Fitzsimons and three anonymous reviewers for reviewing early drafts and providing valuable improvements to this manuscript. We thank members of the Australian Shellfish Reef Restoration Network for contributing to early discussions and providing the initial impetus for this work.	Alleway HK, 2016, ICES J MAR SCI, V73, P1427, DOI 10.1093/icesjms/fsv191; Alleway HK, 2015, CONSERV BIOL, V29, P795, DOI 10.1111/cobi.12452; Anastas PT, 2003, ENVIRON SCI TECHNOL, V37, p94A, DOI 10.1021/es032373g; [Anonymous], TASMANIAN FISHERIES; [Anonymous], 1896, THE MERCURY; [Anonymous], 1879, THE W AUSTR, P3; [Anonymous], 2011, IND REP AUSTR GOV MI; [Anonymous], 1898, BRISBANE COURIER; [Anonymous], 1906, FISHERIES MORETON BA; [Anonymous], 1981, J ROYAL HIST SOC QUE; [Anonymous], [No title captured]; [Anonymous], 1845, MANNERS CUSTOMS ABOR; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Aronson J, 2013, RESTOR ECOL, V21, P293, DOI 10.1111/rec.12011; Attenbrow Val, 2010, SYDNEYS ABORIGINAL I, V2nd; Barton A, 2015, OCEANOGRAPHY, V28, P146, DOI 10.5670/oceanog.2015.38; Beck M. W., 2009, SHELLFISH REEFS RISK; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bishop MJ, 2010, MAR FRESHWATER RES, V61, P714, DOI 10.1071/MF09177; Butler Alan, 1994, Marine Life, V3, P37; Campbell JB, 1979, AUST ARCHAEOL, P18; Cochard R, 2008, PERSPECT PLANT ECOL, V10, P3, DOI 10.1016/j.ppees.2007.11.001; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Connell S, 2008, RECOVERING LOST BASE; Crawford C., PROTECTION REPAIR AU; Creighton C., 1984, KEPPEL ISLANDS ENV S; Crooks S., 2011, ENV DEP PAPER, V121, P2011; DAME RF, 1984, J EXP MAR BIOL ECOL, V83, P239, DOI 10.1016/S0022-0981(84)80003-9; Diggles BK, 2013, NEW ZEAL J MAR FRESH, V47, P561, DOI 10.1080/00288330.2013.781511; Dove MC, 2007, J SHELLFISH RES, V26, P519, DOI 10.2983/0730-8000(2007)26[519:IOEAOS]2.0.CO;2; Edgar GJ, 2004, CONSERV BIOL, V18, P1579, DOI 10.1111/j.1523-1739.2004.00191.x; Edwards PET, 2013, MAR POLICY, V38, P65, DOI 10.1016/j.marpol.2012.05.020; Ermgassen PSEZ, 2016, J APPL ECOL, V53, P596, DOI 10.1111/1365-2664.12576; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Flinders M., 1801, MATTHEW FLINDERS J I, V2, P25; Ford John R., 2016, Proceedings of the Royal Society of Victoria, V128, P87, DOI 10.1071/RS16008; Fu D, 2016, FISH RES, V183, P506, DOI 10.1016/j.fishres.2016.05.003; George H., 1873, AUSTRALASIAN SKETCHE; Gillanders BM, 2013, YOUNG SPENCER GULF E; Gillies C., 2015, SHELLF REEF HAB SYN; GODFREY M C S, 1989, Archaeology in Oceania, V24, P65; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hall J., 1982, COASTAL ARCHAEOLOGY, P79; Hall J., 1984, FISHING DOLPHINS AFF; Hannan H B B, 2010, W PORT FISHERMAN; Harrison AJ, 1997, HIST REC AUST SCI, V11, P419; Horrigan B, 1997, COMMERCIAL IMPLICATI; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones H., 2016, SMALL BIVALVE SURVEY; Kasoar T, 2015, MAR FRESHWATER RES, V66, P981, DOI 10.1071/MF14306; Kennedy VS, 2011, J SHELLFISH RES, V30, P719, DOI 10.2983/035.030.0312; Kerkhove R, 2013, QLD REV, V20, P144, DOI 10.1017/qre.2013.17; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; La Peyre M, 2014, OCEAN COAST MANAGE, V89, P20, DOI 10.1016/j.ocecoaman.2013.12.002; Lourandos H., 1968, PAPERS P ROYAL SOC T, V102, P40; Lowery J., 2007, HABITAT MANAGEMENT S, V8; MacKenzie Jr CL, 1997, 192 NOAA US DEP COMM, V2; McLeod IM, 2012, MAR FRESHWATER RES, V63, P78, DOI 10.1071/MF11083; Meehan B., 1982, SHELL BED SHELL MIDD; Meyer DL, 1997, RESTOR ECOL, V5, P93, DOI 10.1046/j.1526-100X.1997.09710.x; Nell J.A., 2001, MAR FISH REV, V63, P14; Ogburn DM, 2007, COAST MANAGE, V35, P271, DOI 10.1080/08920750601169618; Paul LJ, 2012, 94 NZ ENV BIOD; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Possingham HP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002052; Richards RG, 2015, ICES J MAR SCI, V72, P403, DOI 10.1093/icesjms/fsu119; Rogers K, 2016, MAR POLICY, V72, P139, DOI 10.1016/j.marpol.2016.06.025; Ross A., 1995, AUSTR ARCH 95 P 1995; ROSS A, 1996, AUSTR ARCHAEOLOGY 95, V6, P107; Rowland M.J., 1986, QUEENSLAND ARCHAEOLO, V3, P72; Saville-Kent W., 1893, THE W AUSTR; Saville-Kent W., 1891, AUSTRALASIAN ASS ADV, V3, P550; Schrack E., 2012, RESTORATION WORKS HI; Shefi D., 2006, DEV CUTTERS RELATION; Smith G., 1985, QUEENSLAND OYSTER FI; Spalding M, 2015, MANGROVES COASTAL DE; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stockton E.D., 1977, AUST ARCHAEOL, V7, P20; Sullivan ME, 1981, ARCHAEOL OCEAN, V16, P81; Todorova V, 2009, CR ACAD BULG SCI, V62, P871; Tolley SG, 2005, J SHELLFISH RES, V24, P1007; Ulm S, 2006, ARCHAEOLOGICAL LIFE; Ulm Sean, 2002, Proceedings of the Royal Society of Queensland, V110, P121; Ulm S, 2006, TERRA AUSTRALIS, V24; Vancouver G., 1798, VOYAGE DISCOVERY N P; Waldbusser GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128376; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wescott G., 2016, BIG BOLD BLUE LESSON; Wilkie EM, 2012, J EXP MAR BIOL ECOL, V420, P16, DOI 10.1016/j.jembe.2012.03.018; Winstanley R., 2013, RECONSTRUCTION LOST; zu Ermgassen P., 2006, SETTING OBJECTIVES O, P76	95	51	51	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0190914	10.1371/journal.pone.0190914	http://dx.doi.org/10.1371/journal.pone.0190914			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444143	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000425183500011
J	Law, BS; Chidel, M; Law, PR				Law, Bradley S.; Chidel, Mark; Law, Peter R.			Forest bat population dynamics over 14 years at a climate refuge: Effects of timber harvesting and weather extremes	PLOS ONE			English	Article							NEW-SOUTH-WALES; INSECTIVOROUS BATS; MODELING SURVIVAL; EUCALYPT FOREST; SPATIAL ECOLOGY; ADULT SURVIVAL; MARK-RECAPTURE; RAIN-FOREST; DROUGHT; CONSERVATION	Long-term data are needed to explore the interaction of weather extremes with habitat alteration; in particular, can 'refugia' buffer population dynamics against climate change and are they robust to disturbances such as timber harvesting. Because forest bats are good indicators of ecosystem health, we used 14 years (1999-2012) of mark-recapture data from a suite of small tree-hollow roosting bats to estimate survival, abundance and body condition in harvested and unharvested forest and over extreme El Nino and La Nina weather events in southeastern Australia. Trapping was replicated within an experimental forest, located in a climate refuge, with different timber harvesting treatments. We trapped foraging bats and banded 3043 with a 32% retrap rate. Mark-recapture analyses allowed for dependence of survival on time, species, sex, logging treatment and for transients. A large portion of the population remained resident, with a maximum time to recapture of nine years. The effect of logging history (unlogged vs 16-30 years post-logging regrowth) on apparent survival was minor and species specific, with no detectable effect for two species, a positive effect for one and negative for the other. There was no effect of logging history on abundance or body condition for any of these species. Apparent survival of residents was not strongly influenced by weather variation (except for the smallest species), unlike previous studies outside of refugia. Despite annual variation in abundance and body condition across the 14 years of the study, no relationship with extreme weather was evident. The location of our study area in a climate refuge potentially buffered bat population dynamics from extreme weather. These results support the value of climate refugia in mitigating climate change impacts, though the lack of an external control highlights the need for further studies on the functioning of climate refugia. Relatively stable population dynamics were not compromised by timber harvesting, suggesting ecologically sustainable harvesting may be compatible with climate refugia.	[Law, Bradley S.; Chidel, Mark] NSW Primary Ind, Forest Sci Unit, Sydney, NSW, Australia; [Law, Peter R.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Chidel, Mark] Hills Shire Council, Castle Hill, Sydney, NSW, Australia	NSW Department of Primary Industries; Nelson Mandela University	Law, BS (corresponding author), NSW Primary Ind, Forest Sci Unit, Sydney, NSW, Australia.	brad.law@dpi.nsw.gov.au		Law, Peter/0000-0003-3382-0286; Law, Bradley/0000-0002-3991-3865	NSW state government	NSW state government	This study was funded by the NSW state government. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; Adams RA, 2010, ECOLOGY, V91, P2437, DOI 10.1890/09-0091.1; [Anonymous], 1982, ESTIMATION ANIMAL AB; Baker GB, 2001, WILDLIFE RES, V28, P229, DOI 10.1071/WR99068; Barclay RMR, 2003, BAT ECOLOGY, P209; BELL HL, 1985, AUST J ECOL, V10, P207, DOI 10.1111/j.1442-9993.1985.tb00884.x; Bellard C, 2016, ENVIRON CONSERV, V43, P79, DOI 10.1017/S037689291500020X; Burles DW, 2009, CAN J ZOOL, V87, P132, DOI 10.1139/Z08-146; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butt N, 2013, ECOL EVOL, V3, P5011, DOI 10.1002/ece3.873; Campbell SP, 2007, CONSERV BIOL, V21, P1218, DOI 10.1111/j.1523-1739.2007.00768.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cooch E, 2012, PROGRAM MARK GENTLE; Cornish PM, 2001, J HYDROL, V242, P43, DOI 10.1016/S0022-1694(00)00384-X; Frick WF, 2007, ECOL APPL, V17, P1213, DOI 10.1890/06-1021; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gonsalves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064081; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Grosbois V, 2009, ECOLOGY, V90, P2922, DOI 10.1890/08-1657.1; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gullett P, 2014, OIKOS, V123, P389, DOI 10.1111/j.1600-0706.2013.00620.x; Hache S, 2016, FOREST ECOL MANAG, V359, P309, DOI 10.1016/j.foreco.2015.10.002; Hagger V, 2013, AUSTRAL ECOL, V38, P465, DOI 10.1111/j.1442-9993.2012.02437.x; Holmes E.E., 2012, ANAL MULTIVARIATE TI; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hoyle SD, 2001, AUSTRAL ECOL, V26, P80, DOI 10.1046/j.1442-9993.2001.01092.x; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Keppel G, 2015, FRONT ECOL ENVIRON, V13, P106, DOI 10.1890/140055; Lada H, 2013, AUSTRAL ECOL, V38, P581, DOI 10.1111/aec.12002; LaVal RK, 2004, J MAMMAL, V85, P237, DOI 10.1644/BWG-016; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; Law B, 2016, BATS ANTHROPOCENE CO; Law B, 2008, MAMMALS AUSTR, P567; Law B.S., 2008, AUSTRALASIAN BAT RES, V31, P19; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lentini PE, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0371; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; Mackey B, 2012, ECOL APPL, V22, P1852, DOI 10.1890/11-1479.1; Menzel MA, 2002, FOREST ECOL MANAG, V162, P209, DOI 10.1016/S0378-1127(01)00516-3; Milstead WB, 2007, J MAMMAL, V88, P1532, DOI 10.1644/16-MAMM-A-407R.1; Morelli TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159909; O'Shea TJ, 2011, J MAMMAL, V92, P433, DOI 10.1644/10-MAMM-A-162.1; Papadatou E, 2011, OECOLOGIA, V165, P925, DOI 10.1007/s00442-010-1771-5; Parrott ML, 2007, WILDLIFE RES, V34, P437, DOI 10.1071/WR07071; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Pavey CR, 2014, J MAMMAL, V95, P615, DOI 10.1644/13-MAMM-A-183; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pryde MA, 2005, BIOL CONSERV, V126, P175, DOI 10.1016/j.biocon.2005.05.006; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; RANSOME RD, 1994, ZOOL J LINN SOC-LOND, V112, P337, DOI 10.1006/zjls.1994.1046; Reside AE, 2014, AUSTRAL ECOL, V39, P887, DOI 10.1111/aec.12146; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Schaub M, 2007, CONSERV BIOL, V21, P945, DOI 10.1111/j.1523-1739.2007.00743.x; Schorcht W, 2009, J ANIM ECOL, V78, P1182, DOI 10.1111/j.1365-2656.2009.01577.x; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Selwood KE, 2015, GLOBAL ECOL BIOGEOGR, V24, P838, DOI 10.1111/geb.12305; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; Slade C, 2016, AUST ZOOL IN PRESS; Verdon-Kidd DC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041067; Webala PW, 2011, J APPL ECOL, V48, P398, DOI 10.1111/j.1365-2664.2010.01934.x; Webala PW, 2010, FOREST ECOL MANAG, V260, P1780, DOI 10.1016/j.foreco.2010.08.022; Webb AA, 2012, J HYDROL, V464, P412, DOI 10.1016/j.jhydrol.2012.07.034; White GC, 2005, WILDLIFE RES, V32, P211, DOI 10.1071/WR03123; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	69	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191471	10.1371/journal.pone.0191471	http://dx.doi.org/10.1371/journal.pone.0191471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444115	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500019
J	Gama, MCT; dos Reis, IGM; Sousa, FAD; Gobatto, CA				Traina Gama, Maria Carolina; Masselli dos Reis, Ivan Gustavo; de Barros Sousa, Filipe Antonio; Gobatto, Claudio Alexandre			The 3-min all-out test is valid for determining critical power but not anaerobic work capacity in tethered running	PLOS ONE			English	Article							HIGH-INTENSITY EXERCISE; DURATION RELATIONSHIP; TIME RELATIONSHIP; CYCLE ERGOMETRY; STEADY-STATE; SINGLE TEST; THRESHOLD; LACTATE; RELIABILITY; PARAMETERS	The purpose of the study was to investigate if the 3-min all-out test (3MT) is valid for obtaining critical power intensity (CP) and the amount of work that can be performed above CP (W') on non-motorized treadmills in tethered running. Eight physically active individuals (24 +/- 3 years; 78.3 +/- 8.7 kg; 179 +/- 5 cm; 9.0 +/- 2.5% body fat) performed four different efforts at constant intensity to exhaustion in order to determine CP and W'. The mechanical power values obtained were subsequently plotted with their corresponding time to exhaustion (limit time) for application of three mathematical models: power hyperbolic versus time limit (Hyp), linear power versus 1/time (P vs 1/t) and linear work versus time limit (vs t). The 3MT test was carried out on the last day to determine end power (EP) and anaerobic capacity (WEP) using this methodology. EP value of 181.7 +/- 52 was similar (p = 0.486) to 178.2 +/- 61 (CP Hyp), 191.4 +/- 55 (vs t) and 188.3 +/- 55 (P vs 1/t). WEP value of 17.9 +/- 4.8 was not similar (p = 0.000) to 50.2 +/- 15.3 (CP Hyp), 44.8 +/- 8.7 (vs t) and 45.5 +/- 8.4 (P vs 1/t). Positive results (r = 0.78 +/- 0.98 and ICC = 0.88 +/- 0.99) of Pearson correlation and intraclass correlation (ICC +/- absolute agreement) were found for aerobic applications of conventional CP and 3MT. For anaerobic data, only the three models of conventional CP were correlated (r = 0.76 +/- 0.93); however, W' from the three models was not correlated with WEP (r = 0.37 +/- 0.52). The results of this study suggest that 3MT in tethered running on non-motorized treadmills is a valid test for estimating CP aerobic parameters in a single day of application but not anaerobic parameters of W'.	[Traina Gama, Maria Carolina; Masselli dos Reis, Ivan Gustavo; de Barros Sousa, Filipe Antonio; Gobatto, Claudio Alexandre] Univ Campinas UNICAMP, Sch Appl Sci, Limeira, SP, Brazil	Universidade Estadual de Campinas	Gobatto, CA (corresponding author), Univ Campinas UNICAMP, Sch Appl Sci, Limeira, SP, Brazil.	claudio.gobatto@fca.unicamp.br	Gobatto, Claudio A/E-7388-2014; Sousa, Filipe A B/H-2444-2017; Gama, Maria CT/E-5404-2018; dos reis, ivan/AAL-4937-2020; reis, ivan GM dos/E-6889-2015	Gama, Maria CT/0000-0002-8118-1952; dos reis, ivan/0000-0002-8025-1357; reis, ivan GM dos/0000-0002-8025-1357	Coordination for Improvement of Higher Education Personnel (CAPES) [01P04517/2013]; State of Sao Paulo Research Foundation (FAPESP) [2009/08535-5]	Coordination for Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Coordination for Improvement of Higher Education Personnel (CAPES), process number 01P04517/2013, and State of Sao Paulo Research Foundation (FAPESP), process number 2009/08535-5 to CAG.; This study was funded by the Coordination for Improvement of Higher Education Personnel (CAPES), process number 01P04517/2013, and State of Sao Paulo Research Foundation (FAPESP), process number 2009/08535-5. The authors thank Espaco da Escrita-Coordenadoria Geral da Universidade-UNICAMP-for the language services provided.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Barta J., 2016, INT REV ELECTR ENG-I, V11, P1; Bergstrom HC, 2013, J ELECTROMYOGR KINES, V23, P349, DOI 10.1016/j.jelekin.2012.11.001; Bergstrom HC, 2012, J STRENGTH COND RES, V26, P656, DOI 10.1519/JSC.0b013e31822b7304; Billat VL, 2003, SPORTS MED, V33, P407, DOI 10.2165/00007256-200333060-00003; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Broxterman RM, 2013, RESP PHYSIOL NEUROBI, V185, P380, DOI 10.1016/j.resp.2012.08.024; Bull AJ, 2000, MED SCI SPORT EXER, V32, P526, DOI 10.1097/00005768-200002000-00040; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Cheng CF, 2012, EUR J APPL PHYSIOL, V112, P1251, DOI 10.1007/s00421-011-2081-2; Dassonville J, 1998, J SPORT MED PHYS FIT, V38, P39; de Aguiar RA, 2013, EUR J APPL PHYSIOL, V113, P941, DOI 10.1007/s00421-012-2508-4; Dekerle J, 2008, SCI SPORT, V23, P231, DOI 10.1016/j.scispo.2007.06.015; Dekerle J, 2003, EUR J APPL PHYSIOL, V89, P281, DOI 10.1007/s00421-002-0786-y; Dekerle J, 2014, J SCI MED SPORT, V17, P640, DOI 10.1016/j.jsams.2013.09.003; ENGEL PC, 1978, ANAL BIOCHEM, V88, P475, DOI 10.1016/0003-2697(78)90447-5; Flueck JL, 2015, INT J SPORTS MED, V36, P809, DOI 10.1055/s-0035-1548811; GAESSER GA, 1988, INT J SPORTS MED, V9, P417, DOI 10.1055/s-2007-1025043; Galbraith A, 2014, INT J SPORT PHYSIOL, V9, P931, DOI 10.1123/ijspp.2013-0507; Gama MCT, 2017, INT J SPORTS MED, V38, P613, DOI 10.1055/s-0035-1565238; HILL DW, 1993, SPORTS MED, V16, P237, DOI 10.2165/00007256-199316040-00003; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HOUSH DJ, 1989, ERGONOMICS, V32, P997, DOI 10.1080/00140138908966860; Karsten B, 2014, INT J SPORTS MED, V35, P304, DOI 10.1055/s-0033-1349093; Lakomy HK, 1993, ERGONOMICS, V28, P376; MONOD H, 1965, ERGONOMICS, V8, P329, DOI 10.1080/00140136508930810; MORITANI T, 1981, ERGONOMICS, V24, P339, DOI 10.1080/00140138108924856; NEBELSICKGULLETT LJ, 1988, ERGONOMICS, V31, P1413, DOI 10.1080/00140138808966785; Pereira VH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10489; Poole DC, 2016, MED SCI SPORT EXER, V48, P2320, DOI 10.1249/MSS.0000000000000939; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Simpson LP, 2015, INT J SPORTS MED, V36, P113, DOI 10.1055/s-0034-1389943; Simpson LP, 2012, EUR J APPL PHYSIOL, V112, P2467, DOI 10.1007/s00421-011-2214-7; Solomonson AA, 2016, J STRENGTH COND RES, V30, P1391, DOI 10.1519/JSC.0000000000001209; Triska C, 2015, INT J SPORTS MED, V36, P1063, DOI 10.1055/s-0035-1549958; Vanhatalo A, 2008, MED SCI SPORT EXER, V40, P1693, DOI 10.1249/MSS.0b013e318177871a; Vanhatalo A, 2007, MED SCI SPORT EXER, V39, P548, DOI 10.1249/mss.0b013e31802dd3e6; Zagatto AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172032; Zemkova E., 2004, KINESIOLOGY, V36, P165	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192552	10.1371/journal.pone.0192552	http://dx.doi.org/10.1371/journal.pone.0192552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444141	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500071
J	Chung, K; Ciompi, F; Scholten, ET; Goo, JM; Prokop, M; Jacobs, C; van Ginneken, B; Schaefer-Prokop, CM				Chung, Kaman; Ciompi, Francesco; Scholten, Ernst T.; Goo, Jin Mo; Prokop, Mathias; Jacobs, Colin; van Ginneken, Bram; Schaefer-Prokop, Cornelia M.			Visual discrimination of screen-detected persistent from transient subsolid nodules: An observer study	PLOS ONE			English	Article							GROUND-GLASS NODULES; THIN-SECTION CT; PULMONARY NODULES; LUNG-CANCER; CHEST CT; FLEISCHNER-SOCIETY; MANAGEMENT; OPACITY; ADENOCARCINOMAS; CLASSIFICATION	Purpose To evaluate whether, and to which extent, experienced radiologists are able to visually correctly differentiate transient from persistent subsolid nodules from a single CT examination alone and to determine CT morphological features to make this differentiation. Materials and methods We selected 86 transient and 135 persistent subsolid nodules from the National Lung Screening Trial (NLST) database. Four experienced radiologists visually assessed a predefined list of morphological features and gave a final judgment on a continuous scale (0-100). To assess observer performance, area under the receiver operating characteristic (ROC) curve was calculated. Statistical differences of morphological features between transient and persistent lesions were calculated using Chi-square. Inter-observer agreement of morphological features was evaluated by percentage agreement. Results Forty-nine lesions were excluded by at least 2 observers, leaving 172 lesions for analysis. On average observers were able to differentiate transient from persistent subsolid nodules >= 10 mm with an area under the curve of 0.75 (95% CI 0.67-0.82). Nodule type, lesion margin, presence of a well-defined border, and pleural retraction showed significant differences between transient and persistent lesions in two observers. Average pair-wise percentage agreement for these features was 81%, 64%, 47% and 89% respectively. Agreement for other morphological features varied from 53% to 95%. Conclusion The visual capacity of experienced radiologists to differentiate persistent and transient subsolid nodules is moderate in subsolid nodules larger than 10 mm. Performance of the visual assessment of CT morphology alone is not sufficient to generally abandon a short-term follow-up for subsolid nodules.	[Chung, Kaman; Ciompi, Francesco; Scholten, Ernst T.; Prokop, Mathias; Jacobs, Colin; van Ginneken, Bram; Schaefer-Prokop, Cornelia M.] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands; [Goo, Jin Mo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Schaefer-Prokop, Cornelia M.] Meander Med Ctr, Dept Radiol, Amersfoort, Netherlands	Radboud University Nijmegen; Seoul National University (SNU); Seoul National University (SNU); Meander Medisch Centrum	Chung, K (corresponding author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands.	kaman.chung10@gmail.com	Prokop, W.M./H-8081-2014; Ciompi, Francesco/P-5598-2015; Jacobs, Colin/P-6938-2015; van Ginneken, Bram/A-3728-2012	Ciompi, Francesco/0000-0001-8327-9606; Jacobs, Colin/0000-0003-1180-3805; van Ginneken, Bram/0000-0003-2028-8972; Prokop, Mathias/0000-0001-8157-8055	(Dutch Cancer Society (KWF Kankerbestrijding) [KUN 2013-6110]; National Lung Screening Trial [NLST-74]	(Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding); National Lung Screening Trial	(Dutch Cancer Society (KWF Kankerbestrijding) grant number: KUN 2013-6110 https://www.kwf.nl/english/pages/default.aspx "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."; The authors thank the National Cancer Institute for access to NCI's data collected by the National Lung Screening Trial (project no. NLST-74). The statements contained herein are solely those of the authors and do not represent or imply concurrence or endorsement by NCI.	American College of Radiology, 2015, LUNG CT SCREEN REP D; Callister MEJ, 2015, THORAX, V70, P1, DOI 10.1136/thoraxjnl-2015-207168; Felix L, 2011, EUR J RADIOL, V77, P410, DOI 10.1016/j.ejrad.2009.09.008; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Godoy MCB, 2013, SEMIN ROENTGENOL, V48, P295, DOI 10.1053/j.ro.2013.03.013; Goo JM, 2011, AM J ROENTGENOL, V196, P533, DOI 10.2214/AJR.10.5813; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Kim HY, 2007, RADIOLOGY, V245, P267, DOI 10.1148/radiol.2451061682; Lee HJ, 2009, EUR RADIOL, V19, P552, DOI 10.1007/s00330-008-1188-2; Lee SM, 2013, RADIOLOGY, V268, P265, DOI 10.1148/radiol.13120949; Lee SM, 2010, RADIOLOGY, V255, P242, DOI 10.1148/radiol.09090547; Lee S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/967462; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oh JY, 2007, LUNG CANCER, V55, P67, DOI 10.1016/j.lungcan.2006.09.009; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061; Ridge CA, 2015, RADIOLOGY; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; van Riel SJ, 2015, RADIOLOGY, V277, P863, DOI 10.1148/radiol.2015142700; Vazquez M, 2009, LUNG CANCER, V64, P148, DOI 10.1016/j.lungcan.2008.08.009; Yang PS, 2001, J KOREAN MED SCI, V16, P573, DOI 10.3346/jkms.2001.16.5.573	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0191874	10.1371/journal.pone.0191874	http://dx.doi.org/10.1371/journal.pone.0191874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438443	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400008
J	Kim, SC; Shah, NR; Rogers, JR; Bibbo, CF; Di Carli, MF; Solomon, DH				Kim, Seoyoung C.; Shah, Nishant R.; Rogers, James R.; Bibbo, Courtney F.; Di Carli, Marcelo F.; Solomon, Daniel H.			Assessment of coronary vascular function with cardiac PET in relation to serum uric acid	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MYOCARDIAL FLOW RESERVE; RB-82 PET; MENDELIAN RANDOMIZATION; ENDOTHELIAL DYSFUNCTION; METABOLIC SYNDROME; PROGNOSTIC VALUE; ARTERY-DISEASE; HEART-DISEASE; BLOOD-FLOW	Background Elevated serum uric acid (SUA) levels have been independently associated with cardiovascular disease. Stress myocardial perfusion positron emission tomography (PET) allows for measurement of absolute myocardial blood flow (MBF) and quantification of global left ventricular coronary flow reserve (CFR). A CFR < 2.0 is considered impaired coronary vascular function, and it is associated with increased cardiovascular risk. We evaluated the relationship between SUA and PET-measured markers of coronary vascular function. Methods We studied adults undergoing a stress myocardial perfusion PET on clinical grounds (1/2006-3/2014) who also had >= 1 SUA measurement within 180 days from the PET date. Multivariable linear regression estimated the association between SUA and PET-derived MBF and CFR. We also stratified analyses by diabetes status. Results We included 382 patients with mean (SD) age of 68.4 (12.4) years and mean (SD) SUA level of 7.2 (2.6) mg/dl. 36% were female and 29% had gout. Median [IQR] CFR was reduced at 1.6 [1.2, 2.0] and median [IQR] stress MBF was 1.5 [1.1, 2.1] ml/min/g. In the adjusted analysis, SUA was inversely associated with stress MBF (beta = -0.14, p = 0.01) but not with CFR. Among patients without diabetes (n = 215), SUA had a negative association with CFR (beta = -0.15, p = 0.02) and stress MBF (beta = -0.19, p = 0.01) adjusting for age, sex, extent of myocardial scar and ischemia, serum creatinine and gout. In diabetic patients (n = 167), SUA was not associated with either CFR or MBF. Conclusions In this cross-sectional study, higher SUA is modestly associated with worse CFR and stress MBF among patients without diabetes.	[Kim, Seoyoung C.; Rogers, James R.; Solomon, Daniel H.] Harvard Med Sch, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kim, Seoyoung C.; Solomon, Daniel H.] Harvard Med Sch, Div Rheumatol Immunol & Allergy, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Shah, Nishant R.; Bibbo, Courtney F.; Di Carli, Marcelo F.] Harvard Med Sch, Noninvas Cardiovasc Imaging Program, Heart & Vasc Inst,Dept Radiol,Brigham & Womens Ho, Div Cardiovasc Med,Dept Med,Div Nucl Med & Mol Im, Boston, MA USA; [Shah, Nishant R.] Brown Univ, Dept Med, Lifespan Cardiovasc Inst, Div Cardiovasc Med,Alpert Sch Med, Providence, RI 02912 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island	Kim, SC (corresponding author), Harvard Med Sch, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.; Kim, SC (corresponding author), Harvard Med Sch, Div Rheumatol Immunol & Allergy, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.	sykim@bwh.harvard.edu	Kim, Seoyoung/L-6561-2019	Kim, Seoyoung/0000-0002-2517-3579	NIH [R21 AR069271, K24 AR055989, P60 AR047782, U34 AR063911, R01 HL119718, K24 326 AR055989]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022998] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119718, T32HL094301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U34AR063911, K24AR055989, R21AR069271, P60AR047782] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	SCK is supported by a grant from the NIH R21 AR069271. DHS is supported by the NIH grants K24 AR055989, P60 AR047782, U34 AR063911, and R01 HL119718.; SCK is supported by a grant from the NIH R21 AR069271. DHS is supported by the NIH grants K24 326 AR055989, P60 AR047782, U34 AR063911, and R01 HL119718.	BEANLANDS RSB, 1995, J AM COLL CARDIOL, V26, P1465, DOI 10.1016/0735-1097(95)00359-2; Bjornstad P, 2014, ACTA DIABETOL, V51, P783, DOI 10.1007/s00592-014-0611-1; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; DICARLI M, 1995, CIRCULATION, V91, P1944, DOI 10.1161/01.CIR.91.7.1944; El Fakhri G, 2005, J NUCL MED, V46, P1264; El Fakhri G, 2009, J NUCL MED, V50, P1062, DOI 10.2967/jnumed.104.007831; Ertek S, 2011, ACTA DIABETOL, V48, P21, DOI 10.1007/s00592-010-0211-7; Fukushima K, 2011, J NUCL MED, V52, P726, DOI 10.2967/jnumed.110.081828; GOULD KL, 1995, JAMA-J AM MED ASSOC, V274, P894, DOI 10.1001/jama.274.11.894; Herzog BA, 2009, J AM COLL CARDIOL, V54, P150, DOI 10.1016/j.jacc.2009.02.069; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kim SC, 2015, ARTHRITIS RHEUMATOL, V67, P273, DOI 10.1002/art.38918; Krishnan E, 2013, QJM-INT J MED, V106, P721, DOI 10.1093/qjmed/hct093; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Machac Josef, 2006, J Nucl Cardiol, V13, pe121, DOI 10.1016/j.nuclcard.2006.08.009; Matheus ASD, 2011, DIABETIC MED, V28, P1188, DOI 10.1111/j.1464-5491.2011.03349.x; Murthy VL, 2012, CIRCULATION, V126, P1858, DOI 10.1161/CIRCULATIONAHA.112.120402; Murthy VL, 2011, CIRCULATION, V124, P2215, DOI 10.1161/CIRCULATIONAHA.111.050427; Ryu S, 2007, ANN EPIDEMIOL, V17, P245, DOI 10.1016/j.annepidem.2006.10.001; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Taqueti VR, 2015, CIRCULATION, V131, P528, DOI 10.1161/CIRCULATIONAHA.114.009716; Wang Y, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-26; White J, 2016, LANCET DIABETES ENDO, V4, P327, DOI 10.1016/S2213-8587(15)00386-1; Yoshinaga K, 2006, J AM COLL CARDIOL, V48, P1029, DOI 10.1016/j.jacc.2006.06.025; Ziadi MC, 2011, J AM COLL CARDIOL, V58, P740, DOI 10.1016/j.jacc.2011.01.065	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192788	10.1371/journal.pone.0192788	http://dx.doi.org/10.1371/journal.pone.0192788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438436	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400056
J	Yasukochi, Y; Yang, B; Fujimoto, T; Sahara, K; Matsuo, T; Ishikawa, Y				Yasukochi, Yuji; Yang, Bin; Fujimoto, Toshiaki; Sahara, Ken; Matsuo, Takashi; Ishikawa, Yukio			Conservation and lineage-specific rearrangements in the GOBP/PBP gene complex of distantly related ditrysian Lepidoptera	PLOS ONE			English	Article							PHEROMONE BINDING-PROTEINS; ANTENNAL TRANSCRIPTOME ANALYSIS; ODORANT-BINDING; OLFACTORY GENES; CHROMOSOMAL FUSIONS; CHILO-SUPPRESSALIS; MANDUCA-SEXTA; IDENTIFICATION; MOTH; EXPRESSION	General odorant binding proteins (GOBPs) and pheromone binding proteins (PBPs) form a monophyletic subfamily of insect odorant binding proteins (OBPs) specific for Lepidoptera, butterflies and moths. The GOBP/PBP genes include six subgroups (GOBP1-2, PBP-A-D) previously reported to form a complex arrayed in a conserved order in representative moths (superfamily Bombycoidea) and butterflies (Nymphalidae). Although our knowledge of lepidopteran genomes has increased greatly recently, the structure of the GOBP/PBP complex has been studied only for species that represent limited lineages of the highly diverged Ditrysia. To understand the evolution of this functionally important gene complex, we determined 69-149 kb genomic sequences that include GOBP2 and five PBP genes in three Ostrinia moths (Pyraloidea), O. nubilalis, O. furnacalis, and O. latipennis, using bacterial artificial chromosome (BAC) and fosmid clones. The structure of the GOBP2/PBP gene cluster was well conserved despite the different sex pheromone composition utilized by the three moths. Five expressed PBP genes in Ostrinia moths were the result of two duplications of PBP-A genes. Surprisingly, an allele containing a fusion gene between tandemly arrayed PBP-A genes was observed in O. nubilalis. We also revealed duplication and intra-chromosomal translocation of the GOBP1 gene in P. xylostella by fluorescence in situ hybridization (FISH) analysis. Additionally, we compared the structure of the GOBP/PBP gene complex of seventeen species covering six superfamilies and twelve families of the lepidopteran clade, Ditrysia, and found the gene order was basically conserved despite the frequent occurrence of lineage-specific gains, losses, inversions and translocations of these genes, compared with their neighboring genes. Our findings support the hypothesis that the structure of the GOBP/PBP gene complex was already established in the common ancestor of Ditrysia.	[Yasukochi, Yuji] NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Yang, Bin; Matsuo, Takashi; Ishikawa, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan; [Fujimoto, Toshiaki; Sahara, Ken] Iwate Univ, Fac Agr, Morioka, Iwate, Japan; [Yang, Bin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	National Agriculture & Food Research Organization - Japan; University of Tokyo; Iwate University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yasukochi, Y (corresponding author), NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	yaskoch@affrc.go.jp	Matsuo, Takashi/AAR-8291-2021; Ishikawa, Yukio/J-5676-2019	Matsuo, Takashi/0000-0002-4185-6740; Ishikawa, Yukio/0000-0003-3067-2513; Yasukochi, Yuji/0000-0003-1541-4057	JSPS KAKENHI [22380040, 23248008, 23380030, 25292204, 16H05050]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers, 22380040 (to YY), 23248008 (to TM), 23380030 (to KS), 25292204 (to YY), 16H05050 (to KS), http://www.jsps.go.jp/english/e-grants/index.html.	Ahola V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5737; Allen JE, 2011, INSECT BIOCHEM MOLEC, V41, P141, DOI 10.1016/j.ibmb.2010.10.005; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Challis R. J., 2016, LEPBASE LEPIDOPTERAN, P56994, DOI 10.1101/056994; Chang HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13093; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Forstner Maike, 2006, Invertebrate Neuroscience, V6, P177, DOI 10.1007/s10158-006-0032-0; Fujii T, 2015, INSECT BIOCHEM MOLEC, V61, P62, DOI 10.1016/j.ibmb.2015.04.007; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Jouraku A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-464; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kobayashi F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1803-y; Koutroumpa FA, 2016, P NATL ACAD SCI USA, V113, pE6401, DOI 10.1073/pnas.1610515113; KRIEGER J, 1991, BIOCHIM BIOPHYS ACTA, V1088, P277, DOI 10.1016/0167-4781(91)90064-S; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Merritt TJS, 1998, J MOL EVOL, V46, P272, DOI 10.1007/PL00006303; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nardi JB, 2003, CELL TISSUE RES, V313, P321, DOI 10.1007/s00441-003-0766-5; Picimbon JF, 2002, INSECT BIOCHEM MOLEC, V32, P839, DOI 10.1016/S0965-1748(01)00172-2; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058568, 10.1371/journal.pone.0072678]; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Sahara K, 2013, INSECT BIOCHEM MOLEC, V43, P644, DOI 10.1016/j.ibmb.2013.04.003; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; Sun MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062098; Tang WQ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bat087; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; Vogt RG, 2002, J EXP BIOL, V205, P719; Vogt RG, 2015, INSECT BIOCHEM MOLEC, V62, P142, DOI 10.1016/j.ibmb.2015.03.003; Willett CS, 1999, INSECT BIOCHEM MOLEC, V29, P277, DOI 10.1016/S0965-1748(99)00003-X; Yang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121261; Yasukochi Y, 2016, HEREDITY, V116, P75, DOI 10.1038/hdy.2015.72; Yasukochi Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165894; Yoshido A., 2014, PROTOCOLS CYTOGENETI, P219; Zeng FF, 2013, BIOCHEM BIOPH RES CO, V433, P463, DOI 10.1016/j.bbrc.2013.03.038; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076464	43	5	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192762	10.1371/journal.pone.0192762	http://dx.doi.org/10.1371/journal.pone.0192762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425254	Green Published, Green Submitted, gold			2022-12-26	WOS:000424700800042
J	Perez-Castillo, Y; Sanchez-Rodriguez, A; Tejera, E; Cruz-Monteagudo, M; Borges, F; Cordeiro, MNDS; Huong, LTT; Hai, PT				Perez-Castillo, Yunierkis; Sanchez-Rodriguez, Aminael; Tejera, Eduardo; Cruz-Monteagudo, Maykel; Borges, Fernanda; Cordeiro, M. Natalia D. S.; Huong Le-Thi-Thu; Hai Pham-The			A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents	PLOS ONE			English	Article							DRUG DISCOVERY; MULTIOBJECTIVE OPTIMIZATION; GASTRIC-CARCINOMA; QSAR; CLASSIFICATION; INHIBITORS; DESIGN; CELLS; ADENOCARCINOMA; PERFORMANCE	Gastric cancer is the third leading cause of cancer-related mortality worldwide and despite advances in prevention, diagnosis and therapy, it is still regarded as a global health concern. The efficacy of the therapies for gastric cancer is limited by a poor response to currently available therapeutic regimens. One of the reasons that may explain these poor clinical outcomes is the highly heterogeneous nature of this disease. In this sense, it is essential to discover new molecular agents capable of targeting various gastric cancer subtypes simultaneously. Here, we present a multi-objective approach for the ligand-based virtual screening discovery of chemical compounds simultaneously active against the gastric cancer cell lines AGS, NCI-N87 and SNU-1. The proposed approach relays in a novel methodology based on the development of ensemble models for the bioactivity prediction against each individual gastric cancer cell line. The methodology includes the aggregation of one ensemble per cell line using a desirability-based algorithm into virtual screening protocols. Our research leads to the proposal of a multi-targeted virtual screening protocol able to achieve high enrichment of known chemicals with anti-gastric cancer activity. Specifically, our results indicate that, using the proposed protocol, it is possible to retrieve almost 20 more times multi-targeted compounds in the first 1% of the ranked list than what is expected from a uniform distribution of the active ones in the virtual screening database. More importantly, the proposed protocol attains an outstanding initial enrichment of known multi-targeted anti-gastric cancer agents.	[Perez-Castillo, Yunierkis] Univ Las Amer, Escuela Ciencias Fis & Matemat, Quito, Ecuador; [Sanchez-Rodriguez, Aminael] Univ Tech Particular Loja, Dept Ciencias Biol, Loja, Ecuador; [Tejera, Eduardo] Univ Las Amer, Fac Ingn & Ciencias Agr, Quito, Ecuador; [Cruz-Monteagudo, Maykel; Borges, Fernanda] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, CIQUP, Oporto, Portugal; [Cruz-Monteagudo, Maykel; Cordeiro, M. Natalia D. S.] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, REQUIMTE, Oporto, Portugal; [Cruz-Monteagudo, Maykel] West Coast Univ, Dept Gen Educ, Miami Campus, Doral, FL USA; [Huong Le-Thi-Thu] Vietnam Natl Univ, VNU Sch Med & Pharm, Hanoi, Vietnam; [Hai Pham-The] Hanoi Univ Pharm, Hanoi, Vietnam	Universidad de Las Americas - Ecuador; Universidad Tecnica Particular de Loja; Universidad de Las Americas - Ecuador; Universidade do Porto; Universidade do Porto; Vietnam National University Hanoi; Hanoi University of Pharmacy	Perez-Castillo, Y (corresponding author), Univ Las Amer, Escuela Ciencias Fis & Matemat, Quito, Ecuador.; Hai, PT (corresponding author), Hanoi Univ Pharm, Hanoi, Vietnam.	yunierkis@gmail.com; hpham.phd@gmail.com	Perez-Castillo, Yunierkis/AAY-1756-2020; Cordeiro, Maria Natália D. S./A-7413-2012; Cruz-Monteagudo, Maykel/G-4814-2010; Pham-The, Hai/I-2049-2016; Pham-The, Hai/N-5028-2019; Pham-The, Hai/A-2561-2016; Borges, Fernanda/A-5200-2014	Perez-Castillo, Yunierkis/0000-0002-3710-0035; Cordeiro, Maria Natália D. S./0000-0003-3375-8670; Pham-The, Hai/0000-0003-4531-7223; Pham-The, Hai/0000-0003-4531-7223; Pham-The, Hai/0000-0003-4531-7223; Borges, Fernanda/0000-0003-1050-2402; Tejera, Eduardo/0000-0002-1377-0413; Le-Thi-Thu, Huong/0000-0002-3826-1279	National Foundation for Science and Technology Development of Vietnam (NAFOSTED) [108.05-2017.13]; Foundation for Science and Technology (FCT); FEDER/COMPETE [SFRH/BPD/90673/2012]	National Foundation for Science and Technology Development of Vietnam (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER/COMPETE(European Commission)	HP-T and HL-T-T were funded by the National Foundation for Science and Technology Development of Vietnam (NAFOSTED, grant number 108.05-2017.13). MC-M was supported by the Foundation for Science and Technology (FCT) and FEDER/COMPETE (grant SFRH/BPD/90673/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bansal Y, 2014, EUR J MED CHEM, V76, P31, DOI 10.1016/j.ejmech.2014.01.060; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARRANCO SC, 1983, CANCER RES, V43, P1703; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; CARNEIRO F, 1995, PATHOL RES PRACT, V191, P571, DOI 10.1016/S0344-0338(11)80878-2; ChemAxon, 2017, CHEM STAND; ChemAxon, 2017, JCHEM; ChemAxon, 2017, JCHEM FOR EXC; Cruz-Monteagudo M, 2008, J COMPUT CHEM, V29, P2445, DOI 10.1002/jcc.20994; Cruz-Monteagudo M, 2017, DRUG DISCOV TODAY, V22, P994, DOI 10.1016/j.drudis.2017.02.004; Cruz-Monteagudo M, 2012, MINI-REV MED CHEM, V12, P920, DOI 10.2174/138955712802762329; Cruz-Monteagudo M, 2010, MOL INFORM, V29, P303, DOI 10.1002/minf.200900047; Du F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118324; Fourches D, 2016, J CHEM INF MODEL, V56, P1243, DOI 10.1021/acs.jcim.6b00129; Fourches D, 2010, J CHEM INF MODEL, V50, P1189, DOI 10.1021/ci100176x; Gao J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-186; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gullo I, 2017, PATHOBIOL J IMMUNOPA; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508; Kirchmair J, 2008, J COMPUT AID MOL DES, V22, P213, DOI 10.1007/s10822-007-9163-6; Korcsmaros T, 2007, EXPERT OPIN DRUG DIS, V2, P799, DOI 10.1517/17460441.2.6.799; Kumar KLS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155419; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Ma XH, 2010, PHARM RES-DORDR, V27, P739, DOI 10.1007/s11095-010-0065-2; Helguera AM, 2016, CURR PHARM DESIGN, V22, P3082, DOI 10.2174/1381612822666160302103542; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; PARK JG, 1990, CANCER RES, V50, P2773; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perez-Castillo Y, 2014, MOL DIVERS, V18, P637, DOI 10.1007/s11030-014-9513-y; Perez-Castillo Y, 2012, J CHEM INF MODEL, V52, P2366, DOI 10.1021/ci300146h; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Sanchez-Rodriguez A, 2017, DRUG DISCOV TODAY, V22, P1489, DOI 10.1016/j.drudis.2017.05.008; Sheridan RP, 2001, J CHEM INF COMP SCI, V41, P1395, DOI 10.1021/ci0100144; Singh H, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0046-9; Soufan O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144426; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Varnek A, 2005, J COMPUT AID MOL DES, V19, P693, DOI 10.1007/s10822-005-9008-0; Varnek A, 2008, CURRENT COMPUTER AID; Vasaikar S, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4040027; von Manstein V, 2013, CURR SIGNAL TRANSD T, V8, P193; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037	45	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192176	10.1371/journal.pone.0192176	http://dx.doi.org/10.1371/journal.pone.0192176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420638	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900047
J	Fielding, AB; Concannon, M; Darling, S; Rusilowicz-Jones, EV; Sacco, JJ; Prior, IA; Clague, MJ; Urbe, S; Coulson, JM				Fielding, Andrew B.; Concannon, Matthew; Darling, Sarah; Rusilowicz-Jones, Emma V.; Sacco, Joseph J.; Prior, Ian A.; Clague, Michael J.; Urbe, Sylvie; Coulson, Judy M.			The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity	ONCOGENE			English	Article							CELL-CYCLE PROGRESSION; DEUBIQUITINATING ENZYMES; MAMMALIAN-CELLS; CANCER; STABILITY; LOCALIZATION; DECATENATION; CHECKPOINT; INHIBITORS; MITOSIS	Ubiquitin-specific protease 15 (USP15) is a widely expressed deubiquitylase that has been implicated in diverse cellular processes in cancer. Here we identify topoisomerase II (TOP2A) as a novel protein that is regulated by USP15. TOP2A accumulates during G2 and functions to decatenate intertwined sister chromatids at prophase, ensuring the replicated genome can be accurately divided into daughter cells at anaphase. We show that USP15 is required for TOP2A accumulation, and that USP15 depletion leads to the formation of anaphase chromosome bridges. These bridges fail to decatenate, and at mitotic exit form micronuclei that are indicative of genome instability. We also describe the cell cycle-dependent behaviour for two major isoforms of USP15, which differ by a short serine-rich insertion that is retained in isoform-1 but not in isoform-2. Although USP15 is predominantly cytoplasmic in interphase, we show that both isoforms move into the nucleus at prophase, but that isoform-1 is phosphorylated on its unique S229 residue at mitotic entry. The micronuclei phenotype we observe on USP15 depletion can be rescued by either USP15 isoform and requires USP15 catalytic activity. Importantly, however, an S229D phospho-mimetic mutant of USP15 isoform-1 cannot rescue either the micronuclei phenotype, or accumulation of TOP2A. Thus, S229 phosphorylation selectively abrogates this role of USP15 in maintaining genome integrity in an isoform-specific manner. Finally, we show that USP15 isoform-1 is preferentially upregulated in a panel of non-small cell lung cancer cell lines, and propose that isoform imbalance may contribute to genome instability in cancer. Our data provide the first example of isoform-specific deubiquitylase phospho-regulation and reveal a novel role for USP15 in guarding genome integrity.	[Fielding, Andrew B.; Concannon, Matthew; Darling, Sarah; Rusilowicz-Jones, Emma V.; Sacco, Joseph J.; Prior, Ian A.; Clague, Michael J.; Urbe, Sylvie; Coulson, Judy M.] Univ Liverpool, Inst Translat Med, Cellular & Mol Physiol, Liverpool, Merseyside, England	University of Liverpool	Coulson, JM (corresponding author), Univ Liverpool, Inst Translat Med, Cellular & Mol Physiol, Liverpool, Merseyside, England.	jcoulson@liverpool.ac.uk	Concannon, Matthew/ABG-5026-2021; Urbe, Sylvie/S-1433-2018; Clague, Michael J/A-7199-2008	Concannon, Matthew/0000-0001-8777-4786; Urbe, Sylvie/0000-0003-4735-9814; Clague, Michael J/0000-0003-3355-9479; Coulson, Judy/0000-0003-2191-2001; Prior, Ian/0000-0002-4055-5161; Fielding, Andrew/0000-0002-3170-9966	North West Cancer Research project [CR942]; Wellcome Trust [099793/Z/12/Z, 096567/Z/11/Z]	North West Cancer Research project; Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are supported by a North West Cancer Research project grant CR942 (ABF) and Wellcome Trust PhD studentships 099793/Z/12/Z (MC), and 096567/Z/11/Z (SD). We acknowledge the contribution of Ruth Owen and Bethan Gay towards experiments using the lung cell panel.	Baker RT, 1999, GENOMICS, V59, P264, DOI 10.1006/geno.1999.5879; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Broderick R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7572; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen MC, 2011, HEPATOLOGY, V53, P148, DOI 10.1002/hep.23964; Chen T, 2015, ONCOGENE, V34, P4019, DOI 10.1038/onc.2014.332; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Cornelissen T, 2014, HUM MOL GENET, V23, P5227, DOI 10.1093/hmg/ddu244; Darling S, 2017, BIOCHEM SOC T, V45, P1125, DOI 10.1042/BST20170087; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DOWNES CS, 1991, P NATL ACAD SCI USA, V88, P8895, DOI 10.1073/pnas.88.20.8895; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Faronato M, 2011, ATLAS GENET CYTOGENE, V15, P645; Faronato M, 2013, CELL CYCLE, V12, P1964, DOI 10.4161/cc.25035; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fournane Sadek, 2012, Genes Cancer, V3, P697, DOI 10.1177/1947601912473477; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; GORBSKY GJ, 1994, CANCER RES, V54, P1042; Gowher H, 2012, P NATL ACAD SCI USA, V109, P2370, DOI 10.1073/pnas.1121538109; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Guturi KKN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12638; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hayes SD, 2012, J BIOL CHEM, V287, P43007, DOI 10.1074/jbc.M112.386938; Heideker J, 2015, BIOCHEM J, V467, P191, DOI 10.1042/bj4670191; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Huang XH, 2009, J MOL BIOL, V391, P691, DOI 10.1016/j.jmb.2009.06.066; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep17873; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Kotani Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep44293; Lim KH, 2016, CELL MOL LIFE SCI, V73, P1439, DOI 10.1007/s00018-015-2129-2; Liu HL, 2015, CELL REP, V13, P93, DOI 10.1016/j.celrep.2015.08.056; Liu WT, 2017, ONCOGENE, V36, P2715, DOI 10.1038/onc.2016.424; Long L, 2014, J BIOL CHEM, V289, P8916, DOI 10.1074/jbc.M114.551754; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Moss AC, 2009, CLIN CANCER RES, V15, P274, DOI 10.1158/1078-0432.CCR-08-1163; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nagasaka K, 2016, NAT CELL BIOL, V18, P692, DOI 10.1038/ncb3353; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nielsen CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9962; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pinto-Fernandez A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00133; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Shinagawa H, 2008, ANTIOXID REDOX SIGN, V10, P939, DOI 10.1089/ars.2007.1851; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Srihari S, 2013, BIOINFORMATICS, V29, P1553, DOI 10.1093/bioinformatics/btt191; Thorne C, 2011, TRAFFIC, V12, P1563, DOI 10.1111/j.1600-0854.2011.01261.x; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Vlasschaert C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20039; Vos RM, 2009, J VIROL, V83, P8885, DOI 10.1128/JVI.00605-09; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Xu ML, 2009, BIOCHEM BIOPH RES CO, V388, P366, DOI 10.1016/j.bbrc.2009.08.015; Zou Q, 2014, NAT IMMUNOL, V15, P562, DOI 10.1038/ni.2885	67	19	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2326	2342		10.1038/s41388-017-0092-0	http://dx.doi.org/10.1038/s41388-017-0092-0			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29429988	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000431100200009
J	Bercker, S; Winkelmann, T; Busch, T; Laudi, S; Lindner, D; Meixensberger, J				Bercker, Sven; Winkelmann, Tanja; Busch, Thilo; Laudi, Sven; Lindner, Dirk; Meixensberger, Juergen			Hydroxyethyl starch for volume expansion after subarachnoid haemorrhage and renal function: Results of a retrospective analysis	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; SPECIAL WRITING GROUP; CEREBRAL-BLOOD-FLOW; ACUTE KIDNEY INJURY; CONSENSUS CONFERENCE; CRITICALLY-ILL; STROKE-COUNCIL; VASOSPASM; FLUID; RESUSCITATION	Background Hydroxyethyl starch (HES) was part of "triple-H" therapy for prophylaxis and therapy of vasospasm in patients with subarachnoid haemorrhage (SAH). The European Medicines Agency restricted the use of HES in 2013 due to an increase of renal failure in critically ill patients receiving HES compared to crystalloid fluids. The occurrence of renal insufficiency in patients with SAH due to HES is still uncertain. The purpose of our study was to evaluate whether there was an association with renal impairment in patients receiving HES after subarachnoid haemorrhage. Methods Medical records of all non-traumatic SAH patients treated at the Departments of Anaesthesiology and Neurosurgery, University Hospital of Leipzig, Germany, between January 2009 and December 2014 were analysed. Patients received either HES 6% and/or 10% (HES group, n = 183) or exclusively crystalloids for fluid therapy (Crystalloid group, n = 93). Primary outcome was the incidence of acute kidney injury. Results The study groups had similar characteristics except for initial SAPS scores, incidence of vasospasm and ICU length of stay. Patients receiving HES fulfilled significantly more often SIRS (systemic inflammatory response syndrome) criteria. 24.6% (45/183) of the patients in the HES group had acute kidney injury (KDIGO 1-3) at any time during their ICU stay compared to 26.9% (25/93) in the crystalloid group (p = 0.679). Only few patients needed renal replacement therapy with no significant difference between groups (Crystalloid group: 4.3%; HES group: 2.2%; p = 0.322). The incidence of vasospasm was increased in the HES group when compared to the crystalloid group (33.9% vs. 17.2%; p = 0.004). Conclusion In the presented series of patients with non-traumatic SAH we found no significant association between HES therapy and the incidence of acute kidney injury. Treatment without HES did not worsen patient outcome.	[Bercker, Sven; Winkelmann, Tanja; Busch, Thilo; Laudi, Sven] Univ Hosp Leipzig, Dept Anaesthesiol & Intens Care Med, Leipzig, Germany; [Lindner, Dirk; Meixensberger, Juergen] Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany	Leipzig University; Leipzig University	Bercker, S; Winkelmann, T (corresponding author), Univ Hosp Leipzig, Dept Anaesthesiol & Intens Care Med, Leipzig, Germany.	sven.bercker@medizin.uni-leipzig.de; tanja.winkelmann@medizin.uni-leipzig.de			University Hospital Leipzig; German Research Foundation (DFG); University of Leipzig	University Hospital Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig	Funding was received from the University Hospital Leipzig in using materials and collecting data during working hours. We also acknowledge support from the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the University Hospital Leipzig in using materials and collecting data during working hours. Special thank goes to our colleagues from the Departments of Intensive Care Medicine and Neurosurgery who assisted the research. We acknowledge support from the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dasenbrock HH, 2015, WORLD NEUROSURG, V88, P459; Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Festic E, 2014, NEUROCRIT CARE, V20, P375, DOI 10.1007/s12028-014-9960-4; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; He B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0833-9; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jabbarli R, 2013, J STROKE CEREBROVASC, V22, P1332, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.006; Kancir ASP, 2015, ANESTH ANALG, V120, P608, DOI 10.1213/ANE.0000000000000596; Kancir ASP, 2014, ANESTHESIOLOGY, V121, P948, DOI 10.1097/ALN.0000000000000413; KISTLER JP, 1983, NEUROLOGY, V33, P424, DOI 10.1212/WNL.33.4.424; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunze E, 2016, J NEUROSURG ANESTH, V28, P187, DOI 10.1097/ANA.0000000000000205; Leberle R, 2015, INJURY, V46, P105, DOI 10.1016/j.injury.2014.08.039; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Magder S, 2010, INTENS CARE MED, V36, pS378; Mascia L, 2003, INTENS CARE MED, V29, P1088, DOI 10.1007/s00134-003-1780-5; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Mutter TC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub3; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; ORIGITANO TC, 1990, NEUROSURGERY, V27, P729, DOI 10.1227/00006123-199011000-00010; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Raiman M, 2016, EUR J ANAESTH, V33, P42, DOI 10.1097/EJA.0000000000000328; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Tujjar O, 2017, J NEUROSURG ANESTH, V29, P140, DOI 10.1097/ANA.0000000000000270; Zacharia BE, 2009, STROKE, V40, P2375, DOI 10.1161/STROKEAHA.108.545210; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	38	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192832	10.1371/journal.pone.0192832	http://dx.doi.org/10.1371/journal.pone.0192832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447255	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000425283900058
J	Fujita, T; Kozuka-Hata, H; Hori, Y; Takeuchi, J; Kubo, T; Oyama, M				Fujita, Toshiyuki; Kozuka-Hata, Hiroko; Hori, Yutaro; Takeuchi, Jun; Kubo, Takeo; Oyama, Masaaki			Shotgun proteomics deciphered age/division of labor-related functional specification of three honeybee (Apis mellifera L.) exocrine glands	PLOS ONE			English	Article							CEPHALIC SALIVARY-GLANDS; SCAPTOTRIGONA-POSTICA HYMENOPTERA; AGE-DEPENDENT MORPHOLOGY; HYPOPHARYNGEAL-GLAND; DROSOPHILA-MELANOGASTER; METABOLIC PATHWAYS; PROTON PUMPS; LABIAL GLAND; H+-ATPASE; WORKER	The honeybee (Apis mellifera L.) uses various chemical signals produced by the worker exocrine glands to maintain the functioning of its colony. The roles of worker postcerebral glands (PcGs), thoracic glands (TGs), and mandibular glands (MGs) and the functional changes they undergo according to the division of labor from nursing to foraging are not as well studied. To comprehensively characterize the molecular roles of these glands in workers and their changes according to the division of labor of workers, we analyzed the proteomes of PcGs, TGs, and MGs from nurse bees and foragers using shotgun proteomics technology. We identified approximately 2000 proteins from each of the nurse bee or forager glands and highlighted the features of these glands at the molecular level by semiquantitative enrichment analyses of frequently detected, gland-selective, and labor-selective proteins. First, we found the high potential to produce lipids in PcGs and MGs, suggesting their relation to pheromone production. Second, we also found the proton pumps abundant in TGs and propose some transporters possibly related to the saliva production. Finally, our data unveiled candidate enzymes involved in labor-dependent acid production in MGs.	[Fujita, Toshiyuki; Hori, Yutaro; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Kozuka-Hata, Hiroko; Oyama, Masaaki] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Hori, Yutaro] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Takeuchi, Jun] Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo, Japan; [Fujita, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci TIIMS, Shinjuku Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Women's Medical University	Fujita, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.; Oyama, M (corresponding author), Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan.; Fujita, T (corresponding author), Tokyo Womens Med Univ, Inst Integrated Med Sci TIIMS, Shinjuku Ku, Tokyo, Japan.	fujita.toshiyuki@twmu.ac.jp; moyama@ims.u-tokyo.ac.jp	KUBO, TAKEO/G-4951-2014	Oyama, Masaaki/0000-0001-6478-3735; Hori, Yutaro/0000-0002-4163-4750; Kubo, Takeo/0000-0002-5914-5269; Kozuka-Hata, Hiroko/0000-0002-9286-6594	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26291068, 16H06578]; Japan Society for the Promotion of Science [11J10223]; Grants-in-Aid for Scientific Research [16H06578] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (B) (grant number: 26291068) and Scientific Research on Innovative Areas (grant number: 16H06578) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. T. F. was the recipient of a Grant-in-Aid from Japan Society for the Promotion of Science for young scientists (no. 11J10223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Hiroko Ao-Kondo for processing the large-scale proteome data. This work was supported by the Grant-in-Aid for Scientific Research (B) (grant number: 26291068) and Scientific Research on Innovative Areas (grant number: 16H06578) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. T. F. was a recipient of a Grant-in-Aid from Japan Society for the Promotion of Science for young scientists (grant number: 11J10223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVITABILE A, 1975, ANN ENTOMOL SOC AM, V68, P1079, DOI 10.1093/aesa/68.6.1079; BARKER SA, 1959, NATURE, V183, P996, DOI 10.1038/183996a0; Baumann O, 2012, J INSECT PHYSIOL, V58, P450, DOI 10.1016/j.jinsphys.2011.11.015; Berenbaum MR, 2015, CURR OPIN INSECT SCI, V10, P51, DOI 10.1016/j.cois.2015.03.005; Beyenbach KW, 2011, ACTA PHYSIOL, V202, P387, DOI 10.1111/j.1748-1716.2010.02195.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Buttstedt A, 2016, NATURE, V537, pE10, DOI 10.1038/nature19349; Chan QWT, 2013, GENOME RES, V23, P1951, DOI 10.1101/gr.155994.113; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Da Cruz-Landim Carminda, 2005, Insect Science, V12, P467, DOI 10.1111/j.1744-7917.2005.00059.x; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; Deseyn J, 2005, APIDOLOGIE, V36, P49, DOI 10.1051/apido:2004068; Deseyn J, 2004, BELG J ZOOL, V134, P55; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Faust JE, 2012, TRAFFIC, V13, P1378, DOI 10.1111/j.1600-0854.2012.01393.x; Feng M, 2013, J PROTEOMICS, V87, P1, DOI 10.1016/j.jprot.2013.05.021; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fujita T, 2013, J PROTEOME RES, V12, P404, DOI 10.1021/pr300700e; Fujita T, 2010, BIOCHEM BIOPH RES CO, V397, P740, DOI 10.1016/j.bbrc.2010.06.023; Furusawa T, 2008, J PROTEOME RES, V7, P3194, DOI 10.1021/pr800061j; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; Gilbert S. F., 2008, ECOLOGICAL DEV BIOL; Goodman L., 2003, FORM FUNCTION HONEY; Hasegawa M, 2009, INSECT BIOCHEM MOLEC, V39, P661, DOI 10.1016/j.ibmb.2009.08.001; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Ji T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-665; Kamakura M, 2016, NATURE, V537, pE13, DOI 10.1038/nature19350; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Katzav-Gozansky T, 2001, J CHEM ECOL, V27, P919, DOI 10.1023/A:1010330902388; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kucharski R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14070; Landis GN, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r8; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Li C, 2012, INSECT MOL BIOL, V21, P405, DOI 10.1111/j.1365-2583.2012.01147.x; Li JK, 2010, J PROTEOME RES, V9, P6578, DOI 10.1021/pr100768t; Magnusson CD, 2011, CHEM PHYS LIPIDS, V164, P315, DOI 10.1016/j.chemphyslip.2011.04.010; Malka O, 2014, INSECT BIOCHEM MOLEC, V47, P36, DOI 10.1016/j.ibmb.2014.01.001; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Narushima Y, 2016, MOL CELL PROTEOMICS, V15, P1017, DOI 10.1074/mcp.M115.049999; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Plettner E, 1998, INSECT BIOCHEM MOLEC, V28, P31, DOI 10.1016/S0965-1748(97)00079-9; Poiani SB, 2010, ZOOLOGIA-CURITIBA, V27, P979, DOI 10.1590/S1984-46702010000600021; Poiani SB, 2010, ZOOLOGIA-CURITIBA, V27, P961, DOI 10.1590/S1984-46702010000600018; Poiani SB, 2010, J BIOSCIENCES, V35, P249, DOI 10.1007/s12038-010-0029-z; Santos KS, 2005, INSECT BIOCHEM MOLEC, V35, P85, DOI 10.1016/j.ibmb.2004.10.003; SCHONITZER K, 1990, ZOOMORPHOLOGY, V109, P211, DOI 10.1007/BF00312472; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; SHEARER DA, 1965, NATURE, V206, P530, DOI 10.1038/206530a0; SIMPSON J, 1960, J INSECT PHYSIOL, V4, P107, DOI 10.1016/0022-1910(60)90073-1; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Tautz J., 2008, BUZZ BEES BIOL SUPER; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; WINSTON ML, 1991, J INSECT BEHAV, V4, P649, DOI 10.1007/BF01048076; Winston ML., 1986, BIOL HONEY BEE; Wu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04879-z; Zimmermann B, 2003, J EXP BIOL, V206, P1867, DOI 10.1242/jeb.00376	70	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191344	10.1371/journal.pone.0191344	http://dx.doi.org/10.1371/journal.pone.0191344			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447197	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900013
J	Totah, D; Ojeda, L; Johnson, DD; Gates, D; Provost, EM; Barton, K				Totah, Deema; Ojeda, Lauro; Johnson, Daniel D.; Gates, Deanna; Provost, Emily Mower; Barton, Kira			Low-back electromyography (EMG) data-driven load classification for dynamic lifting tasks	PLOS ONE			English	Article							PATTERN-RECOGNITION; MUSCLE; DESIGN; FATIGUE; WALKING; ASSIST; MODEL; PAIN; HAL	Objective Numerous devices have been designed to support the back during lifting tasks. To improve the utility of such devices, this research explores the use of preparatory muscle activity to classify muscle loading and initiate appropriate device activation. The goal of this study was to determine the earliest time window that enabled accurate load classification during a dynamic lifting task. Methods Nine subjects performed thirty symmetrical lifts, split evenly across three weight conditions (no-weight, 10-lbs and 24-lbs), while low-back muscle activity data was collected. Seven descriptive statistics features were extracted from 100 ms windows of data. A multinomial logistic regression (MLR) classifier was trained and tested, employing leave-one subject out cross-validation, to classify lifted load values. Dimensionality reduction was achieved through feature cross-correlation analysis and greedy feedforward selection. The time of full load support by the subject was defined as load-onset. Results Regions of highest average classification accuracy started at 200 ms before until 200 ms after load-onset with average accuracies ranging from 80% (+/- 10%) to 81% (+/- 7%). The average recall for each class ranged from 69-92%. Conclusion These inter-subject classification results indicate that preparatory muscle activity can be leveraged to identify the intent to lift a weight up to 100 ms prior to load-onset. The high accuracies shown indicate the potential to utilize intent classification for assistive device applications.	[Totah, Deema; Ojeda, Lauro; Barton, Kira] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Johnson, Daniel D.] Univ Michigan, Coll Engn, Ann Arbor, MI 48109 USA; [Gates, Deanna] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Provost, Emily Mower] Univ Michigan, Dept Comp Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Totah, D (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	deema@umich.edu		Provost, Emily/0000-0003-1870-6063	National Science Foundation (NSF) PFI Grant [1534003]; Rackham Graduate Student Research Grant; University of Michigan's Mechanical Engineering Department; NSF PFI Award [1534003]; Mechanical Engineering Department at The University of Michigan	National Science Foundation (NSF) PFI Grant(National Science Foundation (NSF)); Rackham Graduate Student Research Grant; University of Michigan's Mechanical Engineering Department; NSF PFI Award(National Science Foundation (NSF)); Mechanical Engineering Department at The University of Michigan	This study was supported by a National Science Foundation (NSF) PFI Grant # 1534003 [https://www.nsf.gov/] (received by KB), a Rackham Graduate Student Research Grant [http:// www.rackham.umich.edu] (received by DT), and start-up funds from the University of Michigan's Mechanical Engineering Department [http://me.engin.umich.edu/ (received by KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Anne Gu for her assistance in data collection and analysis. This work was supported through NSF PFI Award # 1534003, a Rackham Graduate Student Research Grant, and start-up funds from the Mechanical Engineering Department at The University of Michigan. The study sponsors had no involvement in the study design, collection, analysis, and interpretation of data, writing of the manuscript and the authors' decision to publish.	Ajiboye AB, 2005, IEEE T NEUR SYS REH, V13, P280, DOI 10.1109/TNSRE.2005.847357; Chan ADC, 2005, IEEE T BIO-MED ENG, V52, P121, DOI 10.1109/TBME.2004.836492; Davidson BS, 2004, EUR J APPL PHYSIOL, V93, P183, DOI 10.1007/s00421-004-1195-1; Geng YJ, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-102; Hou YF, 2004, IEEE IJCNN, P1935; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Kawabata T, 2009 IEEE INT C ROB; Kawamoto H, 2005, ADV ROBOTICS, V19, P717, DOI 10.1163/1568553054455103; Khokhar ZO, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-41; Kim J. Y., 1987, INT J IND ERGONOM, V1, P219, DOI DOI 10.1016/0169-8141(87)90016-3; Kim W, 2014, INT C CONTR AUTOMAT, P479, DOI 10.1109/ICCAS.2014.6988049; Laing AC, 2001, ELECTROMECHANICAL DE, P1; Lamoth CJC, 2006, EUR SPINE J, V15, P23, DOI 10.1007/s00586-004-0825-y; Lavender SA, 1998, HUM FACTORS, V40, P159, DOI 10.1518/001872098779480631; Lotters F, 2003, SCAND J WORK ENV HEA, V29, P431; Phinyomark A, 2013, EXPERT SYST APPL, V40, P4832, DOI 10.1016/j.eswa.2013.02.023; Phinyomark A, 2012, EXPERT SYST APPL, V39, P7420, DOI 10.1016/j.eswa.2012.01.102; Pransky J, 2014, IND ROBOT, V41, P329, DOI 10.1108/IR-05-2014-0334; Ragonesi D, 2011, IEEE ENG MED BIO, P3515, DOI 10.1109/IEMBS.2011.6090583; Sankai Y, 2010, SPRINGER TRAC ADV RO, V66, P25; Sano K, 2013, J ROBOT MECHATRON, V25, P923, DOI 10.20965/jrm.2013.p0923; Sartori M, 2016, IEEE T BIO-MED ENG, V63, P879, DOI 10.1109/TBME.2016.2538296; Sato M., 2011, SICE 2011 - 50th Annual Conference of the Society of Instrument and Control Engineers of Japan, P628; Schollhorn WI, 2004, CLIN BIOMECH, V19, P876, DOI 10.1016/j.clinbiomech.2004.04.005; Staudenmann D, 2005, J ELECTROMYOGR KINES, V15, P1, DOI 10.1016/j.jelekin.2004.06.008; Umer W, 2017, J CONSTRUCTION ENG M, V143; van Poppel MNM, 2000, SPINE, V25, P2103, DOI 10.1097/00007632-200008150-00016; VANDIEEN JH, 1991, EUR J APPL PHYSIOL O, V63, P216, DOI 10.1007/BF00233851; Wehner M., 2009, P ASME 2009 DYN SYST, DOI [10.1115/DSCC2009-2644, DOI 10.1115/DSCC2009-2644]; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wolbrecht ET, 2010, INT J ROBOT RES, V29, P23, DOI 10.1177/0278364909103787; Yagi E., 2009, INT J AUTO TECH-JPN, V3, P716; Young AJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056021; Young AJ, 2013, IEEE T BIO-MED ENG, V60, P1250, DOI 10.1109/TBME.2012.2232293; Yu SN, 2012, ADV ROBOTICS, V26, P561, DOI 10.1163/156855311X617506; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	36	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192938	10.1371/journal.pone.0192938	http://dx.doi.org/10.1371/journal.pone.0192938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447252	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900078
J	Fundaro, C; Giardini, A; Maestri, R; Traversoni, S; Bartolo, M; Casale, R				Fundaro, Cira; Giardini, Anna; Maestri, Roberto; Traversoni, Silvia; Bartolo, Michelangelo; Casale, Roberto			Motor and psychosocial impact of robot-assisted gait training in a real-world rehabilitation setting: A pilot study	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CHRONIC STROKE; COGNITIVE IMPAIRMENT; PARKINSON DISEASE; WALKING; DEVICES; EXOSKELETON; PEOPLE; SCALE	In the last decade robotic devices have been applied in rehabilitation to overcome walking disability in neurologic diseases with promising results. Robot assisted gait training (RAGT) using the Lokomat seems not only to improve gait parameters but also the perception of well-being. Data on the psychosocial patient-robot impact are limited, in particular in the real-world of RAGT, in the rehabilitation setting. During rehabilitation training, the Lokomat can be considered an "assistive device for movement". This allowed the use of the Psycho-social Impact of Assistive Device Scale-PIADS to describe patient interaction with the Lokomat. The primary aim of this pilot study was to evaluate the psychosocial impact of the Lokomat in an in-patient rehabilitation setting using the PIADS; secondary aims were to assess whether the psychosocial impact of RAGT is different between pathological subgroups and if the Lokomat influenced functional variables (Functional Independence Measure scale-FIM and parameters provided by the Lokomat itself). Thirty-nine consecutive patients (69% males, 54.0 +/- 18.0 years) eligible for Lokomat training, with etiologically heterogeneous walking disabilities (Parkinson's Disease, n = 10; Spinal Cord Injury, n = 21; Ictus Event, n = 8) were enrolled. Patients were assessed with the FIM before and after rehabilitation with Lokomat, and the PIADS was administered after the rehabilitative period with Lokomat. Overall the PIADS score was positive (35.8 +/- 21.6), as well as the three sub-scales, pertaining to "ability", "adaptability" and "self-esteem" (17.2 +/- 10.4, 8.9 +/- 5.5 and 10.1 +/- 6.6 respectively) with no between-group differences. All patients significantly improved in gait measure and motor FIM scale (difference after-before treatment values: 11.7 +/- 9.8 and 11.2 +/- 10.3 respectively), increased treadmill speed (0.4 +/- 0.2m/s), reduced body weight support (-14.0 +/- 9.5%) and guidance force (-13.1 +/- 10.7%). This pilot study indicates that Lokomat, in a real-world in-patient setting, may have a generalised approval, independent of disease, underlining the importance of the psycho-social framework for patients training with assistive robotic-devices.	[Fundaro, Cira] IRCSS, Ist Clin Sci Maugeri, Neurophysiopathol Unit, Montescano, PV, Italy; [Giardini, Anna; Traversoni, Silvia] IRCSS, Ist Clin Sci Maugeri, Psychol Unit, Montescano, PV, Italy; [Maestri, Roberto] IRCSS, Ist Clin Sci Maugeri, Dept Biomed Engn, Montescano, PV, Italy; [Bartolo, Michelangelo; Casale, Roberto] Habilita Care & Res Hosp, Neurorehabil Unit, Zingonia Di Ciserano, BG, Italy; [Bartolo, Michelangelo; Casale, Roberto] Habilita Care & Res Hosp, Dept Adv Technol, Rehabil Unit, Zingonia Di Ciserano, BG, Italy; [Bartolo, Michelangelo; Casale, Roberto] Habilita Care & Res Hosp, Dept Adv Technol, Pain Rehabil Unit, Zingonia Di Ciserano, BG, Italy	Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS	Fundaro, C (corresponding author), IRCSS, Ist Clin Sci Maugeri, Neurophysiopathol Unit, Montescano, PV, Italy.	cira.fundaro@icsmaugeri.it	Maestri, Roberto/J-8168-2016; Giardini, Anna/G-4359-2018; Maestri, Roberto/AAA-7585-2019; fundarò, cira/E-8284-2019; Giardini, Anna/ABI-7610-2020	Maestri, Roberto/0000-0002-2873-0430; Giardini, Anna/0000-0002-2845-347X; Maestri, Roberto/0000-0002-2873-0430; fundarò, cira/0000-0002-7810-8885; Giardini, Anna/0000-0002-2845-347X; TRAVERSONI, SILVIA/0000-0003-2908-9566				Andrich R, 2003, ASSISITIVE TECHNOLOG; Bang DH, 2016, NEUROREHABILITATION, V38, P343, DOI 10.3233/NRE-161325; Beckerle P, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00024; Bortole M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0048-y; Bragoni Maura, 2013, Am J Phys Med Rehabil, V92, pe16, DOI 10.1097/PHM.0b013e3182a20a34; Calabro RS, 2015, INT J REHABIL RES, V38, P219, DOI 10.1097/MRR.0000000000000114; Calabro RS, 2017, J NEUROL SCI, V377, P25, DOI 10.1016/j.jns.2017.03.047; Calabro RS, 2016, NEUROL SCI, V37, P503, DOI 10.1007/s10072-016-2474-4; Caligari M, 2013, AMYOTROPH LAT SCL FR, V14, P546, DOI 10.3109/21678421.2013.803576; Chisari C, 2015, EUR J PHYS REHAB MED, V51, P59; Day H, 2002, DISABIL REHABIL, V24, P31, DOI 10.1080/09638280110066343; Day H., 1996, CAN J REHABIL, V9, P159; Dundar U, 2014, TOP STROKE REHABIL, V21, P453, DOI 10.1310/tsr2106-453; Eicher C, 2017, ASSIST TECHNOL; Esclarin-Ruz A, 2014, ARCH PHYS MED REHAB, V95, P1023, DOI 10.1016/j.apmr.2013.12.017; Furnari A, 2017, INT J NEUROSCI, V13, p1 ; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Iosa M, 2016, J MED BIOL ENG, V36, P1, DOI 10.1007/s40846-016-0115-2; Jutai J., 2002, TECHNOL DISABIL, V14, P107, DOI [10.3233/TAD-2002-14305, DOI 10.3233/TAD-2002-14305]; Knaepen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140626; Koumpouros Y, 2016, J HEALTHC ENG, V2016, DOI 10.1155/2016/1048964; Lam T, 2015, J REHABIL RES DEV, V52, P113, DOI 10.1682/JRRD.2014.03.0090; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Mann G, 2011, NEUROREHAB NEURAL RE, V25, P774, DOI 10.1177/1545968310397200; Nam KY, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0232-3; Orellano-Colon EM, 2016, TECHNOLOGIES, V4, DOI 10.3390/technologies4030021; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pani D, 2017, J TELEMED TELECARE, V23, P292, DOI 10.1177/1357633X16632950; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Phelan SK, 2015, DISABIL REHABIL, V37, P2272, DOI 10.3109/09638288.2015.1019648; Picelli A, 2012, NEUROREHAB NEURAL RE, V26, P353, DOI 10.1177/1545968311424417; Pierobon A, 2014, AM J PHYS MED REHAB, V93, P764, DOI 10.1097/PHM.0000000000000092; Rose MH, 2013, ARCH PHYS MED REHAB, V94, P687, DOI 10.1016/j.apmr.2012.11.025; Salatino C, 2016, ASSIST TECHNOL, V28, P41, DOI 10.1080/10400435.2015.1074631; Schiavolin S, 2017, INT J REHABIL RES, V40, P112, DOI 10.1097/MRR.0000000000000216; Schwartz I, 2012, MULT SCLER J, V18, P881, DOI 10.1177/1352458511431075; Shin JC, 2014, ANN REHABIL MED-ARM, V38, P719, DOI 10.5535/arm.2014.38.6.719; Stampacchia G, 2016, NEUROREHABILITATION, V39, P277, DOI 10.3233/NRE-161358; van Kammen K, 2016, CLIN BIOMECH, V36, P65, DOI 10.1016/j.clinbiomech.2016.04.013; Watson GS, 2010, BRAIN PATHOL, V20, P640, DOI 10.1111/j.1750-3639.2010.00373.x; Wenke R, 2018, DISABIL REHABIL, V40, P1532, DOI 10.1080/09638288.2017.1300949; WHO, 2001, WHO INT CLASS FUNCT; Zhou DHD, 2005, NEUROEPIDEMIOLOGY, V24, P87, DOI 10.1159/000081055	43	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191894	10.1371/journal.pone.0191894	http://dx.doi.org/10.1371/journal.pone.0191894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444172	Green Submitted, gold, Green Published			2022-12-26	WOS:000425183500040
J	Guo, XZ; Hou, LA; Yin, YC; Wu, J; Zhao, F; Xia, LY; Cheng, XQ; Liu, Q; Liu, L; Xu, EM; Qiu, L				Guo, Xiuzhi; Hou, Li'an; Yin, Yicong; Wu, Jie; Zhao, Fang; Xia, Liangyu; Cheng, Xinqi; Liu, Qian; Liu, Li; Xu, Ermu; Qiu, Ling			Negative interferences by calcium dobesilate in the detection of five serum analytes involving Trinder reaction-based assays	PLOS ONE			English	Article							URIC-ACID; IN-VITRO; CREATININE; VIVO; RATS	Previously, we reported the strong negative interference of calcium dobesilate, a vasoprotective agent, in creatinine assays involving the Trinder reaction. It is hypothesized that a similar effect occurs in the detection of uric acid (UA), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C). The interferences of calcium dobesilate during the detection of the five serum analytes were investigated on automated systems/analysers, and the effects were compared among eight different assay systems for each analyte. A calcium dobesilate standard was added into two sets of the blank serum pools of each analyte at final concentrations of 0, 2, 4, 8, 16, 32, and 64 mu g/mL. The percentage deviation of each analyte value was calculated between each drug concentration and the drug-free samples. The clinically acceptable error levels for UA, TC, TG, HDL-C, and LDL-C were defined as +/- 4.87%, +/- 4.1%, +/- 9.57%, +/- 5.61%, and +/- 5.46%, respectively. The observed interference was concentration dependent for each analyte. In the presence of 16 mu g/mL calcium dobesilate, which was within the therapeutic range, all seven Trinder reaction-based UA assay systems, two TG assay systems, two HDL-C assay systems and one TC assay system exhibited negative drug interferences. Calcium dobesilate negatively interferes with the detection of UA, TG, TC, and HDLC in assay systems based on the Trinder reaction. The effect was most significant in UA and TG detection.	[Qiu, Ling] Chinese Acad Med Sci, Dept Lab Med, Peking Union Med Coll Hosp, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qiu, L (corresponding author), Chinese Acad Med Sci, Dept Lab Med, Peking Union Med Coll Hosp, Beijing, Peoples R China.	lingqiubj@aliyun.com						AOKI Y, 1992, CLIN CHEM, V38, P1350; BENAKIS A, 1974, THERAPIE, V29, P211; Cao, 2000, CHIN J CLIN PHARM, P295; Clinical and Laboratory Standards Institute (CLSI), 2005, CLIN LAB STANDARDS I, Vsecond; Dastych M, 2014, CLIN LAB, V60, P1373, DOI 10.7754/Clin.Lab.2013.130902; Genzen JR, 2016, CLIN BIOCHEM, V49, P100, DOI 10.1016/j.clinbiochem.2015.10.005; GUDER WG, 1986, J CLIN CHEM CLIN BIO, V24, P889; Guo XZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000905; Hall JF, 2013, GASTROENTEROL CLIN N, V42, P759, DOI 10.1016/j.gtc.2013.09.001; Jafarey M, 2014, IRAN J KIDNEY DIS, V8, P46; Javadzadeh A, 2013, MOL VIS, V19, P62; Martinello F, 2006, CLIN BIOCHEM, V39, P396, DOI 10.1016/j.clinbiochem.2005.11.011; Minchinela J, 2014, BIOL VARIATION DATAB; Rabe E, 2011, PHLEBOLOGY, V26, P162, DOI 10.1258/phleb.2010.010051; Seker A, 2016, EUR REV MED PHARMACO, V20, P2168; Tejerina T, 1998, GEN PHARMACOL-VASC S, V31, P357, DOI 10.1016/S0306-3623(98)00040-8; Zhang XQ, 2013, EXP THER MED, V5, P295, DOI 10.3892/etm.2012.755	17	6	6	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192440	10.1371/journal.pone.0192440	http://dx.doi.org/10.1371/journal.pone.0192440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432460	Green Submitted, gold, Green Published			2022-12-26	WOS:000424814300024
J	Makita, N; Kosugi, Y; Sakabe, A; Kanazawa, A; Ohkubo, S; Tani, M				Makita, Naoki; Kosugi, Yoshiko; Sakabe, Ayaka; Kanazawa, Akito; Ohkubo, Shinjiro; Tani, Makoto			Seasonal and diurnal patterns of soil respiration in an evergreen coniferous forest: Evidence from six years of observation with automatic chambers	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; CO2 EFFLUX; ROOT RESPIRATION; TEMPERATURE-DEPENDENCE; BIOPHYSICAL CONTROLS; WATER-CONTENT; TIME-LAG; PHOTOSYNTHESIS; COMPONENTS; DYNAMICS	Soil respiration (R-s) plays a key role in the carbon balance of forest ecosystems. There is growing evidence that R-s is strongly correlated with canopy photosynthesis; however, how R-s is linked to aboveground attributes at various phenological stages, on the seasonal and diurnal scale, remains unclear. Using an automated closed dynamic chamber system, we assessed the seasonal and diurnal patterns of R-s in a temperate evergreen coniferous forest from 2005 to 2010. High-frequency R-s rates followed seasonal soil temperature patterns but the relationship showed strong hysteresis. Predictions of R-s based on a temperature-response model underestimated the observed values from June to July and overestimated those from August to September and from January to April. The observed R-s was higher in early summer than in late summer and autumn despite similar soil temperatures. At a diurnal scale, the R-s pattern showed a hysteresis loop with the soil temperature trend during the seasons of high biological activity (June to October). In July and August, R-s declined after the morning peak from 0800 to 1400 h, although soil temperatures continued to increase. During that period, figure-eight-shaped diurnal R-s patterns were observed, suggesting that a midday decline in root physiological activity may have occurred in early summer. In September and October, R-s was higher in the morning than in the night despite consistently high soil temperatures. We have characterised the magnitude and pattern of seasonal and diurnal R-s in an evergreen forest. We conclude that the temporal variability of R-s at high resolution is more related to seasons across the temperature dependence.	[Makita, Naoki] Shinshu Univ, Fac Sci, Nagano, Japan; [Makita, Naoki; Kosugi, Yoshiko; Sakabe, Ayaka; Kanazawa, Akito; Ohkubo, Shinjiro; Tani, Makoto] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Kanazawa, Akito] Publ Works Res Inst, Tsukuba, Ibaraki, Japan; [Ohkubo, Shinjiro] NARO Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan; [Tani, Makoto] Univ Human Environm, Dept Environm & Conservat, Okazaki, Aichi, Japan	Shinshu University; Kyoto University; PWRI: Public Works Research Institute; National Agriculture & Food Research Organization - Japan	Makita, N (corresponding author), Shinshu Univ, Fac Sci, Nagano, Japan.; Makita, N (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	macky@shinshu-u.ac.jp	Kosugi, Yoshiko/GQP-3103-2022	Tani, Makoto/0000-0001-8458-8638; Makita, Naoki/0000-0002-8701-766X	Japanese Ministry of Education, Culture, Sports, Science, and Technology from the Japan Society for the Promotion of Science [23221009, 15H03845, 15K18719]; Coca-Cola Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology from the Japan Society for the Promotion of Science; Coca-Cola Foundation	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grants-in-Aid for Scientific Research (grant numbers 23221009, 15H03845, 15K18719)) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/) and by the Coca-Cola Foundation (http://www.coca-colacompany.com/).	Abramoff RZ, 2015, NEW PHYTOL, V205, P1054, DOI 10.1111/nph.13111; Bahn M, 2010, BIOGEOSCIENCES, V7, P2147, DOI 10.5194/bg-7-2147-2010; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Ben Keane J, 2017, BIOGEOSCIENCES, V14, P1181, DOI 10.5194/bg-14-1181-2017; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Bloemen J, 2014, NEW PHYTOL, V201, P897, DOI 10.1111/nph.12568; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Carbone MS, 2008, NEW PHYTOL, V177, P295; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Dannoura M, 2011, NEW PHYTOL, V190, P181, DOI 10.1111/j.1469-8137.2010.03599.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; DeForest JL, 2006, INT J BIOMETEOROL, V51, P135, DOI 10.1007/s00484-006-0046-7; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Epron D, 2012, TREE PHYSIOL, V32, P776, DOI 10.1093/treephys/tps057; Franco AC, 2002, OECOLOGIA, V131, P356, DOI 10.1007/s00442-002-0903-y; Gaumont-Guay D, 2008, TREE PHYSIOL, V28, P161, DOI 10.1093/treephys/28.2.161; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; Han GX, 2014, SOIL BIOL BIOCHEM, V68, P85, DOI 10.1016/j.soilbio.2013.09.024; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heinemeyer A, 2012, BIOGEOSCIENCES, V9, P79, DOI 10.5194/bg-9-79-2012; Heskel MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00120.1; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Irvine J, 2008, GLOBAL CHANGE BIOL, V14, P2848, DOI 10.1111/j.1365-2486.2008.01682.x; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Joslin JD, 2001, PLANT SOIL, V228, P201, DOI 10.1023/A:1004866705021; Kawamura A, 2013, PLANT ROOT, V7, P77, DOI 10.3117/plantroot.7.77; Kosugi Y, 2013, ECOL RES, V28, P373, DOI 10.1007/s11284-012-1019-4; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lee MS, 2008, ECOL RES, V23, P777, DOI 10.1007/s11284-007-0439-z; Liu Q, 2006, GLOBAL CHANGE BIOL, V12, P2136, DOI 10.1111/j.1365-2486.2006.01245.x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lynch DJ, 2013, NEW PHYTOL, V199, P420, DOI 10.1111/nph.12290; Makita N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117694; Makita N, 2014, J AGRIC METEOROL, V70, P151, DOI 10.2480/agrmet.D-14-00006; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; McCormack ML, 2012, NEW PHYTOL, V195, P823, DOI 10.1111/j.1469-8137.2012.04198.x; Medvigy D, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000812; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mitani T., 2006, Journal of the Japanese Forest Society, V88, P496, DOI 10.4005/jjfs.88.496; Moyano FE, 2012, BIOGEOSCIENCES, V9, P1173, DOI 10.5194/bg-9-1173-2012; Ohkubo S, 2007, AGR FOREST METEOROL, V142, P50, DOI 10.1016/j.agrformet.2006.11.004; Phillips CL, 2011, GLOBAL CHANGE BIOL, V17, P515, DOI 10.1111/j.1365-2486.2010.02250.x; Pumpanen J, 2004, AGR FOREST METEOROL, V123, P159, DOI 10.1016/j.agrformet.2003.12.001; Pumpanen J., 2009, SOIL CARBON DYNAMICS, P16; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Risk D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014002; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Ruehr NK, 2010, BIOGEOCHEMISTRY, V98, P153, DOI 10.1007/s10533-009-9383-z; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Sakabe A, 2015, J GEOPHYS RES-BIOGEO, V120, P585, DOI 10.1002/2014JG002851; Savage K, 2008, FUNCT ECOL, V22, P1000, DOI 10.1111/j.1365-2435.2008.01414.x; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Steinaker DF, 2010, GLOBAL CHANGE BIOL, V16, P2241, DOI 10.1111/j.1365-2486.2009.02065.x; Suzina NE, 2004, MICROBIOLOGY+, V73, P435, DOI 10.1023/B:MICI.0000036990.94039.af; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Tierney GL, 2003, GLOBAL CHANGE BIOL, V9, P670, DOI 10.1046/j.1365-2486.2003.00622.x; Trinder CJ, 2008, SOIL BIOL BIOCHEM, V40, P1622, DOI 10.1016/j.soilbio.2008.01.016; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263	67	22	22	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192622	10.1371/journal.pone.0192622	http://dx.doi.org/10.1371/journal.pone.0192622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432465	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300033
J	Tanaka, N; Sano, K; Rahman, MA; Miyata, R; Capi, G; Kawahara, S				Tanaka, Norifumi; Sano, Katsunari; Rahman, Md Ashrafur; Miyata, Ryota; Capi, Genci; Kawahara, Shigenori			Change in hippocampal theta oscillation associated with multiple lever presses in a bimanual two-lever choice task for robot control in rats	PLOS ONE			English	Article							FRONTAL-MIDLINE THETA; BEHAVIORAL-INHIBITION; EEG; MOVEMENTS; INTENTION; FREQUENCY; AMPLITUDE; RHYTHM	Hippocampal theta oscillations have been implicated in working memory and attentional process, which might be useful for the brain-machine interface (BMI). To further elucidate the properties of the hippocampal theta oscillations that can be used in BMI, we investigated hippocampal theta oscillations during a two-lever choice task. During the task body-restrained rats were trained with a food reward to move an e-puck robot towards them by pressing the correct lever, ipsilateral to the robot several times, using the ipsilateral forelimb. The robot carried food and moved along a semicircle track set in front of the rat. We demonstrated that the power of hippocampal theta oscillations gradually increased during a 6-s preparatory period before the start of multiple lever pressing, irrespective of whether the correct lever choice or forelimb side were used. In addition, there was a significant difference in the theta power after the first choice, between correct and incorrect trials. During the correct trials the theta power was highest during the first lever-releasing period, whereas in the incorrect trials it occurred during the second correct lever-pressing period. We also analyzed the hippocampal theta oscillations at the termination of multiple lever pressing during the correct trials. Irrespective of whether the correct forelimb side was used, the power of hippocampal theta oscillations gradually decreased with the termination of multiple lever pressing. The frequency of theta oscillation also demonstrated an increase and decrease, before and after multiple lever pressing, respectively. There was a transient increase in frequency after the first lever press during the incorrect trials, while no such increase was observed during the correct trials. These results suggested that hippocampal theta oscillations reflect some aspects of preparatory and cognitive neural activities during the robot controlling task, which could be used for BMI.	[Tanaka, Norifumi; Rahman, Md Ashrafur; Kawahara, Shigenori] Univ Toyama, Grad Sch Innovat Life Sci, Toyama, Toyama, Japan; [Sano, Katsunari; Kawahara, Shigenori] Univ Toyama, Grad Sch Sci & Engn, Toyama, Toyama, Japan; [Miyata, Ryota] Univ Ryukyus, Dept Mech Syst Engn, Nishihara, Okinawa, Japan; [Capi, Genci] Univ Toyama, Dept Elect & Elect Syst Engn, Toyama, Toyama, Japan; [Rahman, Md Ashrafur] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Capi, Genci] Hosei Univ, Dept Mech Engn, Tokyo, Japan	University of Toyama; University of Toyama; University of the Ryukyus; University of Toyama; North South University (NSU); Hosei University	Tanaka, N (corresponding author), Univ Toyama, Grad Sch Innovat Life Sci, Toyama, Toyama, Japan.	d1481101@ems.u-toyama.ac.jp	Capi, Genci/X-9985-2019	rahman, Md ashrafur/0000-0003-0146-5312				Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Belchior H, 2014, HIPPOCAMPUS, V24, P693, DOI 10.1002/hipo.22260; Bett D, 2012, FRONT BEHAV NEUROSCI, P6; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bland BH, 2006, HIPPOCAMPUS, V16, P673, DOI 10.1002/hipo.20210; BUNO W, 1977, PHYSIOL BEHAV, V19, P615, DOI 10.1016/0031-9384(77)90035-X; Corbit LH, 2000, J NEUROSCI, V20, P4233; CUPELLO A, 1978, EXP BRAIN RES, V31, P143; Endepols H, 2010, J NEUROSCI, V30, P9708, DOI 10.1523/JNEUROSCI.1202-10.2010; Guven M, 2003, INT J NEUROSCI, V113, P1675, DOI 10.1080/00207450390249258; Inanaga K, 1998, PSYCHIAT CLIN NEUROS, V52, P555, DOI 10.1046/j.1440-1819.1998.00452.x; Sburlea AI, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0087-4; Levcik D, 2013, HIPPOCAMPUS, V23, P153, DOI 10.1002/hipo.22076; Lever C, 2014, SPACE, TIME AND MEMORY IN THE HIPPOCAMPAL FORMATION, P303, DOI 10.1007/978-3-7091-1292-2_12; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Mano M, 2013, ROBOTICS, V2, P54, DOI 10.3390/robotics2020054; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Murray TK, 1999, BEHAV BRAIN RES, V99, P103, DOI 10.1016/S0166-4328(98)00077-1; Ohishi H, 2003, NEUROSCI LETT, V352, P5, DOI 10.1016/j.neulet.2003.08.012; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Sakimoto Y, 2014, FRONT BEHAV NEUROSCI, P8; Sakimoto Y, 2014, BEHAV BRAIN RES, V275, P183, DOI 10.1016/j.bbr.2014.08.063; Sakimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070756; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Smith ME, 2001, HUM FACTORS, V43, P366, DOI 10.1518/001872001775898287; Taylor AM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0149; Tokuda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112927; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; Vyazovskiy VV, 2008, J NEUROPHYSIOL, V99, P969, DOI 10.1152/jn.01154.2007; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; WHISHAW IQ, 1973, BEHAV BIOL, V8, P461, DOI 10.1016/S0091-6773(73)80041-0; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192593	10.1371/journal.pone.0192593	http://dx.doi.org/10.1371/journal.pone.0192593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432436	Green Published, Green Submitted, gold			2022-12-26	WOS:000424814300030
J	Bertoli, FMD; Bruzamolin, CD; Pizzatto, E; Losso, EM; Brancher, JA; de Souza, JF				de Paiva Bertoli, Fernanda Mara; Bruzamolin, Carolina Dea; Pizzatto, Eduardo; Losso, Estela Maris; Brancher, Joao Armando; de Souza, Juliana Feltrin			Prevalence of diagnosed temporomandibular disorders: A cross-sectional study in Brazilian adolescents	PLOS ONE			English	Article							PARAFUNCTIONAL HABITS; SYMPTOMS; CHILDREN; SIGNS; PAIN; DYSFUNCTION; RELIABILITY; HEADACHE; SOUNDS	Background The prevalence of signs and symptoms of temporomandibular disorders (TMD) increases during adolescence and adulthood. Few studies have examined TMD prevalence in Brazilian adolescents. Aim To investigate the prevalence of TMD in Brazilian adolescents. Methods A representative population-based sample of 934 adolescents (10 +/- 14-years-old) was examined. TMD screening was performed using a questionnaire by the American Academy of Orofacial Pain. TMD diagnoses used research diagnostic criteria for temporomandibular disorders (RDC/TMD-Axis-I). Examinations were performed by a single calibrated examiner (kappa > 0.80). Results The prevalence of TMD symptoms was 34.9%; the most frequently reported symptoms were headache and neck ache (20.9%), followed by joint sounds (18.5%). Myofascial pain was the most prevalent type (10.3%), followed by disc displacement with reduction (8.0%) and arthralgia (3.5%). There was a significant association between sex and TMD symptoms; prevalence was significantly higher in girls (RP = 1.37; 95% CI = 1.14 +/- 1.65; p = 0.001). Myofascial pain of TMD and displacement with reduction were more prevalent in girls (RP = 1.76; p = 0.007 and RP = 2.06; p = 0.004, respectively). Conclusion TMD symptoms were present in 34.9% of adolescents, with myofascial pain being the most prevalent type (10.3%). TMD was significantly more common in girls. Routine pediatric dental care should include a TMD screening.	[de Paiva Bertoli, Fernanda Mara; Bruzamolin, Carolina Dea; Pizzatto, Eduardo; Losso, Estela Maris; Brancher, Joao Armando] Positivo Univ, Grad Program Dent, Curitiba, Parana, Brazil; [de Souza, Juliana Feltrin] Univ Fed Parana, Sch Dent, Dept Stomatol, Curitiba, Parana, Brazil	Universidade Positivo; Universidade Federal do Parana	Brancher, JA (corresponding author), Positivo Univ, Grad Program Dent, Curitiba, Parana, Brazil.	brancher.1@gmail.com	Brancher, João Armando/AAQ-4858-2020; Brancher, João Armando/C-7758-2014; de Souza, Juliana Feltrin/G-4588-2012	Brancher, João Armando/0000-0002-8914-702X; Brancher, João Armando/0000-0002-8914-702X; de Souza, Juliana Feltrin/0000-0001-9969-3721				Adern B, 2014, ACTA ODONTOL SCAND, V72, P585, DOI 10.3109/00016357.2013.878390; Al-Khotani A, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0642-9; Barbosa TD, 2008, INT J PEDIATR OTORHI, V72, P299, DOI 10.1016/j.ijporl.2007.11.006; Bonjardim Leonardo Rigoldi, 2005, Braz. oral res., V19, P93, DOI 10.1590/S1806-83242005000200004; de Santis TO, 2014, J BODYW MOV THER, V18, P87, DOI 10.1016/j.jbmt.2013.05.018; Campos JADB, 2014, J ORAL FACIAL PAIN H, V28, P147, DOI 10.11607/ofph.1194; Weiler RME, 2010, INT J PEDIATR OTORHI, V74, P896, DOI 10.1016/j.ijporl.2010.05.007; Farsi NMA, 2003, J ORAL REHABIL, V30, P1200, DOI 10.1111/j.1365-2842.2003.01187.x; Fernandes G, 2015, J ORAL REHABIL, V42, P113, DOI 10.1111/joor.12238; Fernandes G, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0015; Franco AL, 2014, CLIN J PAIN, V30, P340, DOI 10.1097/AJP.0b013e31829ca62f; Franco-Micheloni AL, 2015, J ORAL FACIAL PAIN H, V29, P242, DOI 10.11607/ofph.1262; Franco-Micheloni AL, 2014, J APPL ORAL SCI, V22, P314, DOI 10.1590/1678-775720130694; Hongxing L, 2016, J ORAL REHABIL, V43, P241, DOI 10.1111/joor.12366; Karibe H, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-8; Kim TY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145002; Kobayashi FY, 2014, J ORAL REHABIL, V41, P496, DOI 10.1111/joor.12163; Kohler AA, 2009, EUR ARCH PAEDIATR DE, V10, P16; Lauriti L, 2013, J PHYS THER SCI, V25, P1331, DOI 10.1589/jpts.25.1331; LeResche L, 2005, PAIN, V118, P201, DOI 10.1016/j.pain.2005.08.011; Moyaho-Bernal Angeles, 2010, Acta odontol. latinoam., V23, P228; Paiva Bertoli FMD, 2007, ARQ NEURO-PSIQUIAT, V65, P251, DOI 10.1590/S0004-282X2007000200012; Rapkin Andrea J, 2006, J Pediatr Adolesc Gynecol, V19, P181, DOI 10.1016/j.jpag.2006.02.004; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Sena Marina Fernandes de, 2013, Rev. paul. pediatr., V31, P538, DOI 10.1590/S0103-05822013000400018; Sonmez H, 2001, J ORAL REHABIL, V28, P280, DOI 10.1111/j.1365-2842.2001.tb01678.x; Tecco S, 2011, CRANIO, V29, P71, DOI 10.1179/crn.2011.010; Torii K, 2011, HEAD FACE MED, V7, DOI 10.1186/1746-160X-7-17; Tuerlings V, 2004, EUR J ORTHODONT, V26, P311, DOI 10.1093/ejo/26.3.311; Wahlund K, 1998, J OROFAC PAIN, V12, P42; WANMAN A, 1990, ORAL SURG ORAL MED O, V69, P2, DOI 10.1016/0030-4220(90)90259-U; Wieckiewicz M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/469187	32	51	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192254	10.1371/journal.pone.0192254	http://dx.doi.org/10.1371/journal.pone.0192254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420573	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900057
J	Soong, WJ; Tsao, PC; Lee, YS; Yang, CF				Soong, Wen-Jue; Tsao, Pei-Chen; Lee, Yu-Sheng; Yang, Chia-Feng			Flexible endoscopy for pediatric tracheobronchial metallic stent placement, maintenance and long-term outcomes	PLOS ONE			English	Article							AIRWAY STENTS; CHILDREN; OBSTRUCTION; EXPERIENCE; MANAGEMENT; BRONCHOMALACIA; TRACHEOMALACIA; BRONCHOSCOPY; TRACHEAL; INFANTS	Objectives To assess the placement, surveillance management and long-term outcomes of the tracheobronchial (TB) balloon expandable metallic stent (BEMS) managed by therapeutic flexible endoscopy (TFE). Methods This is a retrospective review and analysis of all computerized medical records and related flexible endoscopy videos of pediatric patients who received TB BEMS during 20 years period, from January 1997 to December 2016. TFE techniques with forceps debridement, balloon dilatation and laser ablation were used to implant stents, perform regular surveillance, maintain their functions, and expand the diameters of BEMS. Short-length (30cm-36cm) endoscopes of OD 3.2mm to 5.0mm coupled with the noninvasive ventilation, without ventilation bag, mask or airway tube, supported the whole procedures. Results 146 BEMS were implanted in 87 consecutive children, including 84 tracheal, 15 carinal and 47 bronchial stents. At the time of placement, the mean age was 35.6 +/- 54.6 month-old (range 0.3-228) and the mean body weight was 13.9 +/- 10.6 kg (range 2.2-60). Surveillance period was 9.4 +/- 6.7 years (range, 0.3-18.0). Satisfactory clinical improvements were noted immediately in all but two patients. Seventy-two (82.8%) patients were still alive with stable respiratory status, except two patients necessitating TFE management every two months. Fifty-one stents, including 35 tracheal and 16 bronchial ones, were successfully retrieved mainly with rigid endoscopy. Implanted stents could be significantly (<.001) further expanded for growing TB lumens. The final stent diameters were positively correlated to the implanted duration. Altogether, 33 stents expired (15 patients), 51 were retrieved (40 patients), and 62 remained and functioning well (38 patients), with their mean duration of 7.4 +/- 9.5, 34.9 +/- 36.3 and 82.3 +/- 62.5 months, respectively. Conclusion In pediatric patients, TFE with short-length scopes coupled with this NIV support has provided a safe, feasible and effective modality in placing and subsequently managing TB BEMS with acceptable long-term outcomes.	[Soong, Wen-Jue; Tsao, Pei-Chen; Lee, Yu-Sheng; Yang, Chia-Feng] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Soong, Wen-Jue; Tsao, Pei-Chen; Yang, Chia-Feng] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Soong, Wen-Jue] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pediat, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Soong, WJ (corresponding author), Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan.; Soong, WJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan.; Soong, WJ (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Pediat, Taipei, Taiwan.	wjsoong@vghtpe.gov.tw			Ministry of Health and Welfare, Taiwan [112.2015]; Taipei-Veterans General Hospital [V104C-190]	Ministry of Health and Welfare, Taiwan; Taipei-Veterans General Hospital(Taipei Veterans General Hospital)	There are two grants to support this study. 1. "Ministry of Health and Welfare, Taiwan; No. 112.2015 to WJS. The Index System for Measurement of Hospital Quality Performance and Quality Improvement: the 2nd Stage Program". 2. "Taipei-Veterans General Hospital' (V104C-190).	Alazemi S, 2010, CHEST, V138, P350, DOI 10.1378/chest.09-2682; Anton-Pacheco JL, 2008, EUR J CARDIO-THORAC, V33, P1069, DOI 10.1016/j.ejcts.2008.01.034; Anton-Pacheco JL, 2016, PEDIATR PULM, V51, P607, DOI 10.1002/ppul.23340; BHUTANI VK, 1986, AM J DIS CHILD, V140, P449, DOI 10.1001/archpedi.1986.02140190059026; Doull IJM, 1997, ARCH DIS CHILD-FETAL, V76, pF203, DOI 10.1136/fn.76.3.F203; Filler RM, 1998, J PEDIATR SURG, V33, P304, DOI 10.1016/S0022-3468(98)90452-3; Furman RH, 1999, ARCH OTOLARYNGOL, V125, P203, DOI 10.1001/archotol.125.2.203; Jacobs JP, 2000, EUR J CARDIO-THORAC, V18, P505, DOI 10.1016/S1010-7940(00)00534-0; Kumar P, 2003, ANN THORAC SURG, V75, P1579, DOI 10.1016/S0003-4975(02)04891-9; Lim LHY, 2004, OTOLARYNG HEAD NECK, V131, P355, DOI 10.1016/j.otohns.2004.04.007; Maeda K, 2013, J PEDIATR SURG, V48, P293, DOI 10.1016/j.jpedsurg.2012.11.002; Nicolai T, 2008, PEDIATR PULM, V43, P330, DOI 10.1002/ppul.20790; Nicolai T, 2001, PEDIATR PULM, V31, P289, DOI 10.1002/ppul.1041; Novotny L, 2012, J THORAC CARDIOV SUR, V143, P437, DOI 10.1016/j.jtcvs.2011.08.002; Peng YY, 2011, PEDIATR PULM, V46, P1031, DOI 10.1002/ppul.21464; Ranu H, 2009, POSTGRAD MED J, V85, P682, DOI 10.1136/pgmj.2009.089011; SANTORO G, 1995, J THORAC CARDIOV SUR, V110, P1145, DOI 10.1016/S0022-5223(05)80188-6; Shultz D., 2005, FDA PUBLIC HLTH NOTI; Soong WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183078; Soong WJ, 2017, INT J PEDIATR OTORHI, V95, P109, DOI 10.1016/j.ijporl.2017.01.033; Soong WJ, 2015, INT J PEDIATR OTORHI, V79, P1484, DOI 10.1016/j.ijporl.2015.06.033; Soong WJ, 2015, PEDIATR PULM, V50, P568, DOI 10.1002/ppul.23028; Soong WJ, 2013, PEDIATR PULM, V48, P288, DOI 10.1002/ppul.22592; Soong WJ, 2011, INT J PEDIATR OTORHI, V75, P824, DOI 10.1016/j.ijporl.2011.03.016; Soong WJ, 2010, INT J PEDIATR OTORHI, V74, P1432, DOI 10.1016/j.ijporl.2010.08.019; Tsai HL, 2004, J PEDIATR SURG, V39, P1772, DOI 10.1016/j.jpedsurg.2004.08.025; Valerie EP, 2005, J PEDIATR SURG, V40, P904, DOI 10.1016/j.jpedsurg.2005.03.002; Vinograd I, 2005, J THORAC CARDIOV SUR, V130, P146, DOI 10.1016/j.jtcvs.2004.10.011; Wells WJ, 2004, ANN THORAC SURG, V77, P1420, DOI 10.1016/S0003-4975(03)00893-2; Yang CF, 2015, RESP CARE, V60, pE26, DOI 10.4187/respcare.03419	30	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192557	10.1371/journal.pone.0192557	http://dx.doi.org/10.1371/journal.pone.0192557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420596	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900093
J	Sun, MS; Zhang, FJ; Ouyang, BW; Wang, MM; Li, Y; Jiao, X; Zhang, L; Wang, NL				Sun, Mingshen; Zhang, Fengju; Ouyang, Bowen; Wang, Mengmeng; Li, Yu; Jiao, Xuan; Zhang, Li; Wang, Ningli			Study of retina and choroid biological parameters of rhesus monkeys eyes on scleral collagen cross-linking by riboflavin and ultraviolet A	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; INTRAOCULAR-PRESSURE; BIOMECHANICAL PROPERTIES; PATHOLOGICAL MYOPIA; PROGRESSIVE MYOPIA; AXIAL LENGTH; THICKNESS; RIBOFLAVIN/ULTRAVIOLET; KERATOCONUS; REINFORCEMENT	To evaluate ocular fundus biological changes after scleral collagen cross-linking (CXL) with riboflavin/ultraviolet A (UVA) on rhesus monkeys in vivo by analyzing retina and choroid biological parameters. Six 3-year-old male rhesus monkeys (12 eyes) were observed in this study, with scleral CXL procedures applied on superior temporal equatorial sclera on random eyes of all rhesus. Optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) examination were performed before and 1 week, 1 month, 3 months and 6 months after CXL. The thickness of retina and choroid and the flow density of retinal superficial vascular networks were analyzed respectively in different regions after CXL. As for retina thickness and flow density of retinal superficial vascular networks, no statistical difference was noted between CXL eyes and control eyes at 1 day, 1week, 1 month, 3 months and 6 months (P>0.05). Among choroid parameters, the choroidal thickness in 1500 mu m temporal to the fovea center of CXL eyes revealed a significant reduction in 1 week postoperatively (P<0.05), but it subsequently increased from 1 month postoperatively, and no statistical difference was found between two groups in the following periods (P>0.05). The choroidal thickness nearby crosslinked region may change temporarily following scleral CXL, and it might recover gradually after 1 month postoperatively. The vascular flow density and thickness of retina were not affected by scleral CXL. Further study should be performed to evaluate the potential adverse effects at the direct vicinity of the application site and the long-term effect of scleral CXL in clinical application.	[Sun, Mingshen; Zhang, Fengju; Ouyang, Bowen; Li, Yu; Jiao, Xuan; Zhang, Li; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Wang, Mengmeng] Hebeisheng Eye Hosp, Hebei Ophthalmol Key Lab, Xingtai, Hebei, Peoples R China	Capital Medical University	Zhang, FJ (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	wxw93@hotmail.com		Wang, Mengmeng/0000-0002-4939-611X	National Natural Science Foundation of China [81570877]; Beijing Health Government [2013-2-023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Health Government	This study was supported by Grants from the National Natural Science Foundation of China (No. 81570877) (http://www.nsfc.gov.cn/) and 215 High-level Talent Fund of Beijing Health Government (No. 2013-2-023) (http://www.bjchfp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey AM, 2015, OSLI RETINA, V46, P18, DOI 10.3928/23258160-20150101-03; Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618; Caporossi A, 2010, AM J OPHTHALMOL, V149, P585, DOI 10.1016/j.ajo.2009.10.021; Chen MJ, 2013, GRAEF ARCH CLIN EXP, V251, P2633, DOI 10.1007/s00417-013-2429-x; Chow VWS, 2015, SCI REP, V5, P1652; Clayson K, 2017, EXP EYE RES, V165, P29, DOI 10.1016/j.exer.2017.08.015; DAVID R, 1985, ARCH OPHTHALMOL-CHIC, V103, P1812; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Dotan A, 2014, EXP EYE RES, V127, P190, DOI 10.1016/j.exer.2014.07.019; Elsheikh A, 2013, OPHTHAL PHYSL OPT, V33, P385, DOI 10.1111/opo.12043; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Kimball EC, 2014, EXP EYE RES, V128, P129, DOI 10.1016/j.exer.2014.08.016; KUBOTA T, 1993, BRIT J OPHTHALMOL, V77, P430, DOI 10.1136/bjo.77.7.430; Kymionis GD, 2014, J REFRACT SURG, V30, P272, DOI 10.3928/1081597X-20140320-06; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Moramarco A, 2015, J CATARACT REFR SURG, V41, P2546, DOI 10.1016/j.jcrs.2015.04.033; QUINN GE, 1995, OPHTHALMOLOGY, V102, P180; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Rong S, 2017, EXP EYE RES, V162, P37, DOI 10.1016/j.exer.2017.07.002; Sepah YJJ, 2017, INVEST OPHTH VIS SCI, V58; Sergienko NM, 2012, GRAEF ARCH CLIN EXP, V250, P1009, DOI 10.1007/s00417-012-1973-0; Shahlaee A, 2016, AM J OPHTHALMOL, V165, P39, DOI 10.1016/j.ajo.2016.02.018; Ulusoy DM, 2017, EUR J OPHTHALMOL, V27, P319, DOI 10.5301/ejo.5000848; Wang MM, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0086-z; Wang MM, 2015, CLIN EXP OPHTHALMOL, V43, P156, DOI 10.1111/ceo.12392; Wang MM, 2012, J REFRACT SURG, V28, P723, DOI 10.3928/1081597X-20120921-08; Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2009, ACTA OPHTHALMOL, V87, P193, DOI 10.1111/j.1755-3768.2008.01229.x; Wong YL, 2016, ASIA-PAC J OPHTHALMO, V5, P394, DOI 10.1097/APO.0000000000000234; Wu PC, 2016, ASIA-PAC J OPHTHALMO, V5, P386, DOI 10.1097/APO.0000000000000236; Yang SJ, 2013, CLIN EXP OPTOM, V96, P494, DOI 10.1111/cxo.12056; Yuan YG, 2016, MAT SCI ENG C-MATER, V62, P233, DOI 10.1016/j.msec.2015.12.046; Zheng F, 2016, INVEST OPHTH VIS SCI, V57, P6256, DOI 10.1167/iovs.16-20161	35	6	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192718	10.1371/journal.pone.0192718	http://dx.doi.org/10.1371/journal.pone.0192718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420622	gold, Green Published, Green Submitted			2022-12-26	WOS:000424517900110
J	Debernardi, J; Hollville, E; Lipinski, M; Wiels, J; Robert, A				Debernardi, Justine; Hollville, Emilie; Lipinski, Marc; Wiels, Joelle; Robert, Aude			Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells	ONCOGENE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; CYTOCHROME-C; SHIGA TOXINS; HELA-CELLS; IN-VITRO; BAX; ACTIVATION; CRISTAE; GLOBOTRIAOSYLCERAMIDE; IDENTIFICATION	The globotriaosylceramide Gb3 is a glycosphingolipid expressed on a subpopulation of germinal center B lymphocytes which has been recognized as the B cell differentiation antigen CD77. Among tumoral cell types, Gb3/CD77 is strongly expressed in Burkitt's lymphoma (BL) cells as well as other solid tumors including breast, testicular and ovarian carcinomas. One known ligand of Gb3/CD77 is Verotoxin-1 (VT-1), a Shiga toxin produced in specific E. coli strains. Previously, we have reported that in BL cells, VT-1 induces apoptosis via a caspase-dependent and mitochondria-dependent pathway. Yet, the respective roles of various apoptogenic factors remained to be deciphered. Here, this apoptotic pathway was found to require cleavage of the BID protein by caspase-8 as well as activation of two other apoptogenic proteins, BAK and BAX. Surprisingly however, t-BID, the truncated form of BID resulting from caspase-8 cleavage, played no role in the conformational changes of BAK and BAX. Rather, their activation occurred under the control of full length BID (FL-BID). Indeed, introducing a non-cleavable form of BID (BID-D59A) into BID-deficient BL cells restored BAK and BAX activation following VT-1 treatment. Still, t-BID was involved along with FL-BID in the BAK-dependent and BAX-dependent cytosolic release of CYT C and SMAC/DIABLO from the mitochondrial intermembrane space: FL-BID was found to control the homo-oligomerization of both BAK and BAX, likely contributing to the initial release of CYT C and SMAC/DIABLO, while t-BID was needed for their hetero-oligomerization and ensuing release amplification. Together, our results reveal a functional cooperation between BAK and BAX during VT-1-induced apoptosis and, unexpectedly, that activation of caspase-8 and production of t-BID were not mandatory for initiation of the cell death process.	[Debernardi, Justine; Hollville, Emilie; Lipinski, Marc; Wiels, Joelle; Robert, Aude] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Gustave Roussy,UMR 8126, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Wiels, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Gustave Roussy,UMR 8126, F-94805 Villejuif, France.	joelle.wiels@gustaveroussy.fr	robert, aude/F-9584-2015; Hollville, Emilie/ABD-4798-2021; Hollville, Emilie/AAA-3597-2022; Hollville, Emilie/GQZ-8301-2022; Wiels, Joëlle/AGL-2319-2022	robert, aude/0000-0003-3095-4190; Hollville, Emilie/0000-0001-5711-8542; Wiels, Joëlle/0000-0002-3313-2937	Fondation de France [2014 00047509]; Ligue National Contre le Cancer; Fondation ARC	Fondation de France(Fondation de France); Ligue National Contre le Cancer(Ligue nationale contre le cancer); Fondation ARC	We thank Yann Lecluse (Imaging and Cytometry Platform, Institut Gustave Roussy) for expert technical assistance in performing flow cytometry analyses. We are very grateful to Hana Raslova and Julie Riviere (INSERM UMR 1170, Institut Gustave-Roussy) for their help in producing lentivirus and to Evelyne May and Martine Raphael (UMR 8126 CNRS) for helpful discussions and suggestions. This work was supported by grants from the Fondation de France 2014 00047509 (JW), the Ligue National Contre le Cancer (doctoral fellowship to JD) and the Fondation ARC (doctoral fellowship to EH).	Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Arab S, 1997, ONCOL RES, V9, P553; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Cabon L, 2012, CELL DEATH DIFFER, V19, P245, DOI 10.1038/cdd.2011.91; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Ching JCY, 2002, INFECT IMMUN, V70, P4669, DOI 10.1128/IAI.70.8.4669-4677.2002; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fujii J, 2003, INFECT IMMUN, V71, P2724, DOI 10.1128/IAI.71.5.2724-2735.2003; Garibal J, 2010, CELL SIGNAL, V22, P467, DOI 10.1016/j.cellsig.2009.10.018; Ghiotto F, 2010, CYTOM PART A, V77A, P11, DOI 10.1002/cyto.a.20819; Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389; Grosse L, 2016, EMBO J, V35, P402, DOI 10.15252/embj.201592789; Gupta V, 2012, J BIOL CHEM, V287, P37195, DOI 10.1074/jbc.M112.396390; Iyer S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11734; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Konig HG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-7; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee SY, 2005, INFECT IMMUN, V73, P5115, DOI 10.1128/IAI.73.8.5115-5126.2005; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Mark Xiang, 2015, F1000Prime Rep, V7, P42, DOI 10.12703/P7-42; MANGENEY M, 1991, EUR J IMMUNOL, V21, P1131, DOI 10.1002/eji.1830210507; NUDELMAN E, 1983, SCIENCE, V220, P509, DOI 10.1126/science.6836295; OHYAMA C, 1990, INT J CANCER, V45, P1040, DOI 10.1002/ijc.2910450610; Pei YH, 2007, APOPTOSIS, V12, P1681, DOI 10.1007/s10495-007-0091-7; Raemy E, 2016, CELL DEATH DIFFER, V23, P1165, DOI 10.1038/cdd.2015.166; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tesh VL, 2012, CELL MICROBIOL, V14, P1, DOI 10.1111/j.1462-5822.2011.01684.x; Tesh VL, 2010, FUTURE MICROBIOL, V5, P431, DOI 10.2217/FMB.10.4; Tetaud C, 2003, J BIOL CHEM, V278, P45200, DOI 10.1074/jbc.M303868200; Todt F, 2015, EMBO J, V34, P67, DOI 10.15252/embj.201488806; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Zheng JH, 2016, FEBS J, V283, P2690, DOI 10.1111/febs.13527	42	10	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2410	2421		10.1038/s41388-018-0123-5	http://dx.doi.org/10.1038/s41388-018-0123-5			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29440708	Green Published, hybrid			2022-12-26	WOS:000431386000005
J	von Muhlinen, N; Horikawa, I; Alam, F; Isogaya, K; Lissa, D; Vojtesek, B; Lane, DP; Harris, CC				von Muhlinen, Natalia; Horikawa, Izumi; Alam, Fatima; Isogaya, Kazunobu; Lissa, Delphine; Vojtesek, Borek; Lane, David P.; Harris, Curtis C.			p53 isoforms regulate premature aging in human cells	ONCOGENE			English	Article							DNA-DAMAGE RESPONSES; DEFECTIVE MATURATION; GENOMIC INSTABILITY; PROGERIA SYNDROMES; DOWN-REGULATION; SENESCENCE; RAD51; PROMOTES; PRELAMIN; ACCUMULATION	Cellular senescence is a hallmark of normal aging and aging-related syndromes, including the premature aging disorder Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic disorder caused by a single mutation in the LMNA gene that results in the constitutive expression of a truncated splicing mutant of lamin A known as progerin. Progerin accumulation leads to increased cellular stresses including unrepaired DNA damage, activation of the p53 signaling pathway and accelerated senescence. We previously established that the p53 isoforms Delta 133p53 and p53 beta regulate senescence in normal human cells. However, their role in premature aging is unknown. Here we report that p53 isoforms are expressed in primary fibroblasts derived from HGPS patients, are associated with their accelerated senescence and that their manipulation can restore the replication capacity of HGPS fibroblasts. We found that in near-senescent HGPS fibroblasts, which exhibit low levels of Delta 133p53 and high levels of p53 beta, restoration of Delta 133p53 expression was sufficient to extend replicative lifespan and delay senescence, despite progerin levels and abnormal nuclear morphology remaining unchanged. Conversely, Delta 133p53 depletion or p53 beta overexpression accelerated the onset of senescence in otherwise proliferative HGPS fibroblasts. Our data indicate that Delta 133p53 exerts its role by modulating full-length p53 (FLp53) signaling to extend the replicative lifespan and promotes the repair of spontaneous progerin-induced DNA double-strand breaks (DSBs). We showed that Delta 133p53 dominant-negative inhibition of FLp53 occurs directly at the p21/CDKN1A and miR-34a promoters, two p53 senescence-associated genes. In addition, Delta 133p53 expression increased the expression of DNA repair RAD51, likely through upregulation of E2F1, a transcription factor that activates RAD51, to promote repair of DSBs. In summary, our data indicate that Delta 133p53 modulates p53 signaling to repress progerin-induced early onset of senescence in HGPS cells. Therefore, restoration of Delta 133p53 expression may be a novel therapeutic strategy to treat aging-associated phenotypes of HGPS in vivo.	[von Muhlinen, Natalia; Horikawa, Izumi; Alam, Fatima; Isogaya, Kazunobu; Lissa, Delphine; Harris, Curtis C.] NCI, Lab Human Carcinogenesis, NIH, Bldg 37, Bethesda, MD 20892 USA; [Vojtesek, Borek] Masaryk Mem Canc Inst, Reg Ctr Appl & Mol Oncol, Brno, Czech Republic; [Lane, David P.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Masaryk Memorial Cancer Institute; Karolinska Institutet	Harris, CC (corresponding author), NCI, Lab Human Carcinogenesis, NIH, Bldg 37, Bethesda, MD 20892 USA.	harrisc@mail.nih.gov	Ponce, Richard/A-3109-2017	Ponce, Richard/0000-0001-5077-8417; Lane, David/0000-0003-0551-3545	National Cancer Institute, National Institutes of Health; Czech Science Foundation [P206/12/G151];  [MEYS - NPS I - LO1413]; NATIONAL CANCER INSTITUTE [ZIABC011496] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Czech Science Foundation(Grant Agency of the Czech Republic); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute, National Institutes of Health. B.V. was supported with project from Czech Science Foundation P206/12/G151 and project MEYS - NPS I - LO1413.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Aoubala M, 2011, CELL DEATH DIFFER, V18, P248, DOI 10.1038/cdd.2010.91; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Buchhop S, 1997, NUCLEIC ACIDS RES, V25, P3868, DOI 10.1093/nar/25.19.3868; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gong L, 2015, CELL RES, V25, P351, DOI 10.1038/cr.2015.22; Gonzalo S, 2015, CURR OPIN CELL BIOL, V34, P75, DOI 10.1016/j.ceb.2015.05.007; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Horikawa I, 2017, CELL DEATH DIFFER, V24, P1017, DOI 10.1038/cdd.2017.48; Horikawa I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5706; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Linke SP, 2003, CANCER RES, V63, P2596; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maki CG, 1996, CANCER RES, V56, P2649; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Musich PR, 2011, BIOCHEM SOC T, V39, P1764, DOI 10.1042/BST20110687; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Pereira S, 2008, MECH AGEING DEV, V129, P449, DOI 10.1016/j.mad.2008.04.003; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Soria-Valles C, 2015, NAT CELL BIOL, V17, P1004, DOI 10.1038/ncb3207; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Turnquist C, 2016, CELL DEATH DIFFER, V23, P1515, DOI 10.1038/cdd.2016.37; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vidak S, 2015, GENE DEV, V29, P2022, DOI 10.1101/gad.263939.115; Wei JX, 2012, P NATL ACAD SCI USA, V109, pE2543, DOI 10.1073/pnas.1205664109; Wu MH, 2014, MOL PHARMACOL, V85, P866, DOI 10.1124/mol.113.090688; Yanez RJ, 1999, GENE THER, V6, P1282, DOI 10.1038/sj.gt.3300945; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE2261, DOI 10.1073/pnas.1320843111	60	33	33	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2379	2393		10.1038/s41388-017-0101-3	http://dx.doi.org/10.1038/s41388-017-0101-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29429991	Green Accepted			2022-12-26	WOS:000431386000003
J	Markovitch, O; Krasnogor, N				Markovitch, Omer; Krasnogor, Natalio			Predicting species emergence in simulated complex pre-biotic networks	PLOS ONE			English	Article							PREBIOTIC CHEMISTRY; ORIGIN; RNA; EVOLUTION; LIFE; TAPE; MODELS; EVOLVABILITY; CONTINGENCY; REPLICATORS	An intriguing question in evolution is what would happen if one could "replay" life's tape. Here, we explore the following hypothesis: when replaying the tape, the details ("decorations") of the outcomes would vary but certain "invariants" might emerge across different life-tapes sharing similar initial conditions. We use large-scale simulations of an in silico model of pre-biotic evolution called GARD (Graded Autocatalysis Replication Domain) to test this hypothesis. GARD models the temporal evolution of molecular assemblies, governed by a rates matrix (i.e. network) that biases different molecules' likelihood of joining or leaving a dynamically growing and splitting assembly. Previous studies have shown the emergence of so called compotypes, i.e., species capable of replication and selection response. Here, we apply networks' science to ascertain the degree to which invariants emerge across different life-tapes under GARD dynamics and whether one can predict these invariant from the chemistry specification alone (i.e. GARD's rates network representing initial conditions). We analysed the (complex) rates' network communities and asked whether communities are related (and how) to the emerging species under GARD's dynamic, and found that the communities correspond to the species emerging from the simulations. Importantly, we show how to use the set of communities detected to predict species emergence without performing any simulations. The analysis developed here may impact complex systems simulations in general.	[Markovitch, Omer; Krasnogor, Natalio] Newcastle Univ, Sch Comp Sci, Interdisciplinary Comp & Complex Biosyst Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Markovitch, Omer] Univ Groningen, Stratingh Inst, Ctr Syst Chem, Groningen, Netherlands; [Markovitch, Omer] Blue Marble Space Inst Sci, Seattle, WA USA	Newcastle University - UK; University of Groningen	Krasnogor, N (corresponding author), Newcastle Univ, Sch Comp Sci, Interdisciplinary Comp & Complex Biosyst Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	natalio.krasnogor@newcastle.ac.uk	Markovitch, Omer/E-5083-2016	Markovitch, Omer/0000-0002-9706-5323	UK's Engineering and Physical Sciences Research Council (EPSRC) [EP/J004111/2, EP/N031962/1]; EPSRC [EP/J004111/2, EP/N031962/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N031962/1, EP/J004111/2] Funding Source: researchfish	UK's Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the UK's Engineering and Physical Sciences Research Council (EPSRC) under projects (EP/J004111/2) "Towards a Universal Biological-Cell Operating System (AUdACiOuS)" and (EP/N031962/1) "Synthetic Portabolomics: Leading the way at the crossroads of the Digital and the Bio Economies" (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anet FA, 2004, CURR OPIN CHEM BIOL, V8, P654, DOI 10.1016/j.cbpa.2004.10.005; Aono M, 2015, ORIGINS LIFE EVOL B, V45, P327, DOI 10.1007/s11084-015-9444-3; Armstrong DL, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066001; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Beatty J, 2006, J PHILOS, V103, P336, DOI 10.5840/jphil2006103716; Bedau M, 2002, LEONARDO, V35, P395, DOI 10.1162/002409402760181196; Benner SA, 2010, ASTROBIOLOGY, V10, P1021, DOI 10.1089/ast.2010.0524; Bernhardt HS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-23; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Chen IA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002170; Cleaves Henderson James II, 2013, Life-Basel, V3, P331, DOI 10.3390/life3020331; Cronin L, 2006, NAT BIOTECHNOL, V24, P1203, DOI 10.1038/nbt1006-1203; Dyson F., 1999, ORIGINS LIFE; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Filisetti A, 2012, THEOR BIOSCI, V131, P85, DOI 10.1007/s12064-011-0136-x; FONTANA W, 1994, P NATL ACAD SCI USA, V91, P757, DOI 10.1073/pnas.91.2.757; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gesteland FR, 1999, RNA WORLD; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Glaab E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-597; Gould, 1989, LIB J, V114, P214; Gross R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0265-1; Gutierrez JMP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6571; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Hayden EJ, 2006, CHEM BIOL, V13, P909, DOI 10.1016/j.chembiol.2006.06.014; Jain S, 1998, PHYS REV LETT, V81, P5684, DOI 10.1103/PhysRevLett.81.5684; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kauffman S., 1995, HOME UNIVERSE SEARCH; Kauffman S.A., 1993, ORIGINS ORDER; Kim Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016103; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lazcano A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002089; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Lobkovsky Alexander E., 2012, Frontiers in Genetics, V3, P246, DOI 10.3389/fgene.2012.00246; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Luisi PL, 1999, CURR OPIN COLLOID IN, V4, P33, DOI 10.1016/S1359-0294(99)00012-6; Markovitch O, 2016, ZENODO; Markovitch O, 2014, J THEOR BIOL, V357, P26, DOI 10.1016/j.jtbi.2014.05.005; Markovitch O, 2012, ORIGINS LIFE EVOL B, V42, P469, DOI 10.1007/s11084-012-9309-y; Markovitch O, 2012, ARTIF LIFE, V18, P243, DOI 10.1162/artl_a_00064; Maurer SE, 2009, ASTROBIOLOGY, V9, P979, DOI 10.1089/ast.2009.0384; Meyer CD., 2000, MATRIX ANAL APPL LIN, DOI [10.1137/1.9780898719512, DOI 10.1137/1.9780898719512]; Missa O, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0226; OPARIN AI, 1962, COMP BIOCHEM PHYSIOL, V4, P371, DOI 10.1016/0010-406X(62)90018-X; OPARIN AI, 1976, ORIGINS LIFE EVOL B, V7, P3, DOI 10.1007/BF01218509; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Orgogozo V, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0057; Powner MW, 2011, PHILOS T R SOC B, V366, P2870, DOI 10.1098/rstb.2011.0134; Rasmussen S., 2009, PROTOCELLS; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanassy D, 2015, ACS SYNTH BIOL, V4, P39, DOI 10.1021/sb5001406; Schilling CH, 1998, P NATL ACAD SCI USA, V95, P4193, DOI 10.1073/pnas.95.8.4193; Segre D, 2001, J THEOR BIOL, V213, P481, DOI 10.1006/jtbi.2001.2440; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112; Segre D, 2000, EMBO REP, V1, P217, DOI 10.1093/embo-reports/kvd063; Shapiro R, 2006, Q REV BIOL, V81, P105, DOI 10.1086/506024; Shenhav B, 2007, PHILOS T R SOC B, V362, P1813, DOI 10.1098/rstb.2007.2073; Shirt-Ediss Ben, 2015, Life-Basel, V5, P181, DOI 10.3390/life5010181; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; Szathmary E, 1997, J THEOR BIOL, V187, P555, DOI 10.1006/jtbi.1996.0389; SZATHMARY E, 1995, P ROY SOC B-BIOL SCI, V260, P279, DOI 10.1098/rspb.1995.0092; TAYLOR T, 1998, COM ADAP SY, P256; Theis M, 2009, ECCS06 ONL P P193 OX; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Trifonov EN, 2011, J BIOMOL STRUCT DYN, V29, P259, DOI 10.1080/073911011010524992; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vasas V, 2015, J THEOR BIOL, V381, P29, DOI 10.1016/j.jtbi.2015.06.047; Vasas V, 2010, P NATL ACAD SCI USA, V107, P1470, DOI 10.1073/pnas.0912628107; Vequi-Suplicy CC, 2010, BBA-BIOMEMBRANES, V1798, P1338, DOI 10.1016/j.bbamem.2009.12.023; Virgo N, 2016, ARTIF LIFE, V22, P138, DOI 10.1162/ARTL_a_00195; Wagenaar DA, 2004, ARTIF LIFE, V10, P181, DOI 10.1162/106454604773563603; Walker SI, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0869	84	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192871	10.1371/journal.pone.0192871	http://dx.doi.org/10.1371/journal.pone.0192871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447212	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900064
J	McKinney, P; Tokos, KS; Matsumoto, K				McKinney, Paul; Tokos, Kathy S.; Matsumoto, Katsumi			Modeling nearshore-offshore exchange in Lake Superior	PLOS ONE			English	Article							GREAT-LAKES; AMPHIPOD DIPOREIA; CISCO RECRUITMENT; TRANSPORT; SURFACE; ZOOPLANKTON; VARIABILITY; COASTAL; EDDIES; WATERS	Lake Superior's ecosystem includes distinct nearshore and offshore food webs linked by hydrodynamic processes that transport water and tracers along and across shore. The scales over which these processes occur and their sensitivity to increasing summer surface temperatures are not well understood. This study investigated horizontal mixing between nearshore and offshore areas of Lake Superior over the 10-year period from 2003 to 2012 using a realistically forced three-dimensional numerical model and virtual tracers. An age tracer was used to characterize the time scales of horizontal mixing between nearshore areas of the lake where water depth is less than 100 m and deeper areas. The age of water in nearshore areas increased and decreased in an annual cycle corresponding to the lake's dimictic cycle of vertical mixing and stratification. Interannual variability of mixing in the isothermal period was significantly correlated to average springtime wind speed, whereas variability during the stratified season was correlated to the average summer surface temperature. Dispersal of a passive tracer released from nine locations around the model lake's perimeter was more extensive in late summer when stratification was established lakewide than in early summer. The distribution of eddies resolved in the model reflected differences between the early and late summer dispersal patterns. In the eastern part of the lake dispersal was primarily alongshore, reflecting counterclockwise coastal circulation. In the western part of the lake, cross-shore mixing was enhanced by cross-basin currents.	[McKinney, Paul; Tokos, Kathy S.; Matsumoto, Katsumi] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [McKinney, Paul] US EPA, Midcontinent Ecol Div, Duluth, MN 55804 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Environmental Protection Agency	McKinney, P (corresponding author), Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA.; McKinney, P (corresponding author), US EPA, Midcontinent Ecol Div, Duluth, MN 55804 USA.	mckin366@umn.edu	Matsumoto, Katsumi/X-3706-2018	Matsumoto, Katsumi/0000-0002-5832-9592	NASA [NNX13AM85G]; NASA Physical Oceanography [NNX13AM85G]	NASA(National Aeronautics & Space Administration (NASA)); NASA Physical Oceanography	Model experiments were funded by NASA grant #NNX13AM85G. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NASA Physical Oceanography (NNX13AM85G to KM). Numerical computation was carried out using resources at the University of Minnesota Supercomputing Institute (MSI).	Assel R, 2003, CLIMATIC CHANGE, V57, P185, DOI 10.1023/A:1022140604052; Auer MT, 2013, J GREAT LAKES RES, V39, P33, DOI 10.1016/j.jglr.2012.12.020; Auer MT, 2010, INT VER THEOR ANGEW, V30, P1499; Auer MT, 2004, J GREAT LAKES RES, V30, P64, DOI 10.1016/S0380-1330(04)70378-0; Austin J, 2013, LIMNOL OCEANOGR, V58, P715, DOI 10.4319/lo.2013.58.2.0715; Austin JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029021; Austin JA, 2011, LIMNOL OCEANOGR, V56, P1141, DOI 10.4319/lo.2011.56.3.1141; Beletsky D, 1999, J GREAT LAKES RES, V25, P78, DOI 10.1016/S0380-1330(99)70718-5; Bennington V, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006261; Budd JW, 2004, J GREAT LAKES RES, V30, P467, DOI 10.1016/S0380-1330(04)70407-4; BUKATA RP, 1978, CAN J SPECTROSC, V23, P57; Chen CS, 2001, J PHYS OCEANOGR, V31, P379, DOI 10.1175/1520-0485(2001)031<0379:PMSOTK>2.0.CO;2; CHEN CTA, 1986, LIMNOL OCEANOGR, V31, P657, DOI 10.4319/lo.1986.31.3.0657; Cline TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062279; Desai AR, 2009, NAT GEOSCI, V2, P855, DOI 10.1038/ngeo693; Gorman OT, 2011, STATUS TRENDS PREY F; Hedstrom K.S., 2009, TECHNICAL MANUAL COU; Holt J, 2016, GEOSCI MODEL DEV DIS; Lake Superior Partnership, LAK SUP LAK ACT MAN; Lam D.C.L., 1978, J GREAT LAKES RES, V4, P343, DOI DOI 10.1016/S0380-1330(78)72203-3; Matsumoto K, 2015, GEOCHEM GEOPHY GEOSY, V16, P3097, DOI 10.1002/2015GC005916; McKinney P, 2012, J GREAT LAKES RES, V38, P786, DOI 10.1016/j.jglr.2012.09.023; Megard RO, 1997, LIMNOL OCEANOGR, V42, P827, DOI 10.4319/lo.1997.42.5.0827; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Myers JT, 2015, FISH RES, V165, P11, DOI 10.1016/j.fishres.2014.12.014; Nencioli F., 2010, ATMOS OCEANIC TECHNO, V27, P564; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Oyadomari JK, 2004, J GREAT LAKES RES, V30, P369, DOI 10.1016/S0380-1330(04)70398-6; Ralph EA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014654; Rao YR, 2007, J GREAT LAKES RES, V33, P202, DOI 10.3394/0380-1330(2007)33[202:TAMBTC]2.0.CO;2; Rook BJ, 2013, N AM J FISH MANAGE, V33, P1243, DOI 10.1080/02755947.2013.837122; Schertzer W.M., 2009, ECOVISION WORLD MONO, P3; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Sierszen ME, 2014, FRESHWATER BIOL, V59, P2122, DOI 10.1111/fwb.12415; Ullman D, 1998, J GREAT LAKES RES, V24, P753, DOI 10.1016/S0380-1330(98)70860-3; Watson N.H.F., 1978, Journal of Great Lakes Research, V4, P481; White B, 2012, J GREAT LAKES RES, V38, P504, DOI 10.1016/j.jglr.2012.05.001; White B, 2012, J GREAT LAKES RES, V38, P61, DOI 10.1016/j.jglr.2011.12.006; Yurista P, 2011, AQUAT ECOSYST HEALTH, V14, P345, DOI 10.1080/14634988.2011.624942; Yurista PM, 2009, J GREAT LAKES RES, V35, P337, DOI 10.1016/j.jglr.2009.03.004; Zhou M, 2001, LIMNOL OCEANOGR, V46, P679, DOI 10.4319/lo.2001.46.3.0679	41	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193183	10.1371/journal.pone.0193183	http://dx.doi.org/10.1371/journal.pone.0193183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447286	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900118
J	Sumi, C; Okamoto, A; Tanaka, H; Nishi, K; Kusunoki, M; Shoji, T; Uba, T; Matsuo, Y; Adachi, T; Hayashi, JI; Takenaga, K; Hirota, K				Sumi, Chisato; Okamoto, Akihisa; Tanaka, Hiromasa; Nishi, Kenichiro; Kusunoki, Munenori; Shoji, Tomohiro; Uba, Takeo; Matsuo, Yoshiyuki; Adachi, Takehiko; Hayashi, Jun-Ichi; Takenaga, Keizo; Hirota, Kiichi			Propofol induces a metabolic switch to glycolysis and cell death in a mitochondrial electron transport chain-dependent manner	PLOS ONE			English	Article							RAT-LIVER MITOCHONDRIA; GENERAL ANESTHETIC 2,6-DIISOPROPYLPHENOL; COMPLEX-I; INFUSION SYNDROME; HYDROGEN-PEROXIDE; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; METFORMIN; INHIBITION; APOPTOSIS	The intravenous anesthetic propofol (2,6-diisopropylphenol) has been used for the induction and maintenance of anesthesia and sedation in critical patient care. However, the rare but severe complication propofol infusion syndrome (PRIS) can occur, especially in patients receiving high doses of propofol for prolonged periods. In vivo and in vitro evidence suggests that the propofol toxicity is related to the impaired mitochondrial function. However, underlying molecular mechanisms remain unknown. Therefore, we investigated effects of propofol on cell metabolism and death using a series of established cell lines of various origins, including neurons, myocytes, and trans-mitochondrial cybrids, with defined mitochondrial DNA deficits. We demonstrated that supraclinical concentrations of propofol in not less than 50 mu M disturbed the mitochondrial function and induced a metabolic switch, from oxidative phosphorylation to glycolysis, by targeting mitochondrial complexes I, II and III. This disturbance in mitochondrial electron transport caused the generation of reactive oxygen species, resulting in apoptosis. We also found that a predisposition to mitochondrial dysfunction, caused by a genetic mutation or pharmacological suppression of the electron transport chain by biguanides such as metformin and phenformin, promoted propofol-induced caspase activation and cell death induced by clinical relevant concentrations of propofol in not more than 25 mu M. With further experiments with appropriate in vivo model, it is possible that the processes to constitute the molecular basis of PRIS are identified.	[Sumi, Chisato; Kusunoki, Munenori; Shoji, Tomohiro; Uba, Takeo] Kansai Med Univ, Dept Anesthesiol, Hirakata, Osaka, Japan; [Sumi, Chisato; Okamoto, Akihisa; Tanaka, Hiromasa; Nishi, Kenichiro; Kusunoki, Munenori; Shoji, Tomohiro; Uba, Takeo; Matsuo, Yoshiyuki; Hirota, Kiichi] Kansai Med Univ, Inst Biomed Sci, Dept Human Stress Response Sci, Hirakata, Osaka, Japan; [Adachi, Takehiko] Tazuke Kofukai Med Inst Kitano Hosp, Dept Anesthesiol, Osaka, Japan; [Hayashi, Jun-Ichi] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Takenaga, Keizo] Shimane Univ, Fac Med, Dept Life Sci, Izumo, Shimane, Japan	Kansai Medical University; Kansai Medical University; University of Tsukuba; Shimane University	Hirota, K (corresponding author), Kansai Med Univ, Inst Biomed Sci, Dept Human Stress Response Sci, Hirakata, Osaka, Japan.	hif1@mac.com	; Hirota, Kiichi/E-9181-2010	Matsuo, Yoshiyuki/0000-0002-3183-4871; Shoji, Tomohiro/0000-0002-4185-2010; Hirota, Kiichi/0000-0003-1110-0827	Japan Society for the Promotion of Science KAKENHI [26670693, 24592336, 25462457, 15K15577]; Katano Kai; Kansai Medical University; KMU consortium grant from Kansai Medical University; Japanese Society of Anesthesiologists (JSA) Pitch Contest	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Katano Kai; Kansai Medical University; KMU consortium grant from Kansai Medical University; Japanese Society of Anesthesiologists (JSA) Pitch Contest	This work was supported by the Japan Society for the Promotion of Science KAKENHI, Grants #26670693 and #24592336 to K.H., #25462457 to K.N., and #15K15577 to T.A., and by a research grant from Katano Kai to K.H. and A.O. This work was supported by the research grant B from Kansai Medical University to A.O., the KMU consortium grant from Kansai Medical University to K.H. and the research grant from Katano Kai to A.O. and K.H. This work was supported by the Japanese Society of Anesthesiologists (JSA) Pitch Contest 2017 to C.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bains R, 2009, ACTA ANAESTH SCAND, V53, P1354, DOI 10.1111/j.1399-6576.2009.02047.x; BRANCA D, 1991, ARCH BIOCHEM BIOPHYS, V290, P517, DOI 10.1016/0003-9861(91)90575-4; BRANCA D, 1991, BIOCHEM PHARMACOL, V42, P87, DOI 10.1016/0006-2952(91)90684-W; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Bray RJ, 1998, PAEDIATR ANAESTH, V8, P491; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cheng G, 2016, CANCER RES, V76, P3904, DOI 10.1158/0008-5472.CAN-15-2534; COHEN PJ, 1973, ANESTHESIOLOGY, V39, P153, DOI 10.1097/00000542-197308000-00007; Cray SH, 1998, CRIT CARE MED, V26, P2087, DOI 10.1097/00003246-199812000-00046; Cui WY, 2014, TUMOR BIOL, V35, P5213, DOI 10.1007/s13277-014-1677-7; Dawidowicz AL, 2006, CHEM-BIOL INTERACT, V159, P149, DOI 10.1016/j.cbi.2005.10.108; Drahota Z, 2014, PHYSIOL RES, V63, P1, DOI 10.33549/physiolres.932600; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Ferrannini E, 2014, NEW ENGL J MED, V371, P1547, DOI 10.1056/NEJMcibr1409796; Finsterer J, 2017, EPILEPSY RES, V136, P5, DOI 10.1016/j.eplepsyres.2017.07.003; Finsterer J, 2016, J CHILD NEUROL, V31, P1489, DOI 10.1177/0883073816661458; Forkink M, 2015, REDOX BIOL, V6, P607, DOI 10.1016/j.redox.2015.09.003; Fudickar A, 2009, MINERVA ANESTESIOL, V75, P339; GOTTLIEB A, 1962, NEW ENGL J MED, V267, P806, DOI 10.1056/NEJM196210182671604; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ishikawa K, 2010, ANN NY ACAD SCI, V1201, P40, DOI 10.1111/j.1749-6632.2010.05616.x; Kajimoto M, 2014, J CEREBR BLOOD F MET, V34, P514, DOI 10.1038/jcbfm.2013.229; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Konno A, 2016, INT J DEV NEUROSCI, V51, P42, DOI 10.1016/j.ijdevneu.2016.04.007; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Krajcova A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1112-5; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Ludbrook GL, 2002, ANESTHESIOLOGY, V97, P1363, DOI 10.1097/00000542-200212000-00006; Luengo A, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0082-4; Matsuzaki S, 2015, BIOCHEMISTRY-US, V54, P2011, DOI 10.1021/bi501473h; Meng C, 2017, ONCOL REP, V37, P841, DOI 10.3892/or.2016.5332; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Niezgoda J, 2013, PEDIATR ANESTH, V23, P785, DOI 10.1111/pan.12158; Okamoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03980-7; Okamoto A, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0273-3; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; RELMAN AS, 1978, NEW ENGL J MED, V298, P564, DOI 10.1056/NEJM197803092981009; Rigoulet M, 1996, EUR J BIOCHEM, V241, P280; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Tiefenthaler M, 2001, BRIT J HAEMATOL, V114, P574, DOI 10.1046/j.1365-2141.2001.02988.x; Uppala R, 2017, BIOCHEM BIOPH RES CO, V482, P346, DOI 10.1016/j.bbrc.2016.11.066; Vanlander AV, 2015, ANESTHESIOLOGY, V122, P343, DOI 10.1097/ALN.0000000000000484; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Yang N, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20165794, 10.1590/1414-431x20165794]; Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048; Zhang C, 2016, CELL PHYSIOL BIOCHEM, V39, P2173, DOI 10.1159/000447912	54	34	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192796	10.1371/journal.pone.0192796	http://dx.doi.org/10.1371/journal.pone.0192796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447230	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900057
J	Sun, S; He, MZ; Wang, YJ; Yang, H; Al-Abed, Y				Sun, Shan; He, Mingzhu; Wang, Yongjun; Yang, Huan; Al-Abed, Yousef			Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1:TLR4: MD-2 axes	PLOS ONE			English	Article							CYTOKINE ACTIVITY; ACCURATE DOCKING; METHOTREXATE; GLIDE; RELEASE; PROTEIN; SEARCH	High mobility group box 1 (HMGB1) is a damage-associated molecular pattern (DAMP) protein that mediates inflammatory responses after infection or injury. Previously, we reported a peptide inhibitor of HMGB1 (P5779) that acts by directly interrupting HMGB1/MD-2 binding. Here, fingerprint similarity search and docking studies suggest folic acid derived-drugs function as P5779 mimetopes. Molecular dynamic (MD) simulation studies demonstrate that folic acid mimics the binding of P5779 at the TLR4 and MD-2 intersection. In surface plasmon resonance (SPR) studies, these drugs showed direct binding to TLR4/MD-2 but not HMGB1. Furthermore, these P5779 mimetopes inhibit HMGB1 and MD-2 binding and suppress HMGB1-induced TNF release in human macrophages in the nanomolar range. We assert from our findings that their demonstrated anti-inflammatory effects may be working through TLR4-dependent signaling.	[Sun, Shan; He, Mingzhu; Al-Abed, Yousef] Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY 11030 USA; [Wang, Yongjun; Yang, Huan] Feinstein Inst Med Res, Dept Biomed Sci, Manhasset, NY USA	Northwell Health; Northwell Health	Sun, S; Al-Abed, Y (corresponding author), Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY 11030 USA.	ssun1@northwell.edu; yalabed@northwell.edu		Wang, Yongjun/0000-0003-3515-9137; Sun, Shan/0000-0001-8838-3226	Feinstein Institute for Medical Research; National Institutes of Health (NIH) Grant [1S100D012042-01]	Feinstein Institute for Medical Research; National Institutes of Health (NIH) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from the Feinstein Institute for Medical Research and National Institutes of Health (NIH) Grant 1S100D012042-01 (Former number 1S10 RR033072-01) to Y.A-A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sowyan NS, 2009, INT J PHARMACOL, V5, P208, DOI 10.3923/ijp.2009.208.214; Ballester PJ, 2007, J COMPUT CHEM, V28, P1711, DOI [10.1002/jcc.20681, 10.1002/JCC.20681]; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; BRODY M, 1993, EUR J CLIN CHEM CLIN, V31, P667; Cereto-Massague A, 2015, METHODS, V71, P58, DOI 10.1016/j.ymeth.2014.08.005; CRONSTEIN BN, 1991, P NATL ACAD SCI USA, V88, P2441, DOI 10.1073/pnas.88.6.2441; Czura CJ, 2001, J ENDOTOXIN RES, V7, P315, DOI 10.1177/09680519010070041401; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gargaro AR, 1998, J MOL BIOL, V277, P119, DOI 10.1006/jmbi.1997.1560; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuroiwa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063073; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Liu J, 2011, CELL MOL IMMUNOL, V8, P289, DOI 10.1038/cmi.2011.6; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Souza ACP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12558; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang H, 2015, J EXP MED, V212, P5, DOI 10.1084/jem.20141318; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389	27	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193028	10.1371/journal.pone.0193028	http://dx.doi.org/10.1371/journal.pone.0193028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447234	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900099
J	Hasani, HJ; Ganesan, A; Ahmed, M; Barakat, KH				Hasani, Horia Jalily; Ganesan, Aravindhan; Ahmed, Marawan; Barakat, Khaled H.			Effects of protein-protein interactions and ligand binding on the ion permeation in KCNQ1 potassium channel	PLOS ONE			English	Article							I-KS-CHANNEL; MOLECULAR-DYNAMICS SIMULATIONS; SELECTIVITY FILTER; PORE DIMENSIONS; SK CHANNELS; INACTIVATION; ACTIVATION; KCNE1; DETERMINANTS; OPTIMIZATION	The voltage-gated KCNQ1 potassium ion channel interacts with the type I transmembrane protein minK (KCNE1) to generate the slow delayed rectifier (I-Ks) current in the heart. Mutations in these transmembrane proteins have been linked with several heart-related issues, including long QT syndromes (LQTS), congenital atrial fibrillation, and short QT syndrome. Off-target interactions of several drugs with that of KCNQ1/KCNE1 ion channel complex have been known to cause fatal cardiac irregularities. Thus, KCNQ1/KCNE1 remains an important avenue for drug-design and discovery research. In this work, we present the structural and mechanistic details of potassium ion permeation through an open KCNQ1 structural model using the combined molecular dynamics and steered molecular dynamics simulations. We discuss the processes and key residues involved in the permeation of a potassium ion through the KCNQ1 ion channel, and how the ion permeation is affected by (i) the KCNQ1-KCNE1 interactions and (ii) the binding of chromanol 293B ligand and its derivatives into the complex. The results reveal that interactions between KCNQ1 with KCNE1 causes a pore constriction in the former, which in-turn forms small energetic barriers in the ion-permeation pathway. These findings correlate with the previous experimental reports that interactions of KCNE1 dramatically slows the activation of KCNQ1. Upon ligand-binding onto the complex, the energy-barriers along ion permeation path are more pronounced, as expected, therefore, requiring higher force in our steered-MD simulations. Nevertheless, pulling the ion when a weak blocker is bound to the channel does not necessitate high force in SMD. This indicates that our SMD simulations have been able to discern between strong and week blockers and reveal their influence on potassium ion permeation. The findings presented here will have some implications in understanding the potential off-target interactions of the drugs with the KCNQ1/KCNE1 channel that lead to cardiotoxic effects.	[Hasani, Horia Jalily; Ganesan, Aravindhan; Ahmed, Marawan; Barakat, Khaled H.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada; [Barakat, Khaled H.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Barakat, Khaled H.] Univ Alberta, Li Ka Shing Appl Virol Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Barakat, KH (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada.; Barakat, KH (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.; Barakat, KH (corresponding author), Univ Alberta, Li Ka Shing Appl Virol Inst, Edmonton, AB, Canada.	kbarakat@ualberta.ca		Barakat, Khaled/0000-0002-3567-7279	Natural Sciences and Engineering Research Council of Canada [2015-00055]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Natural Sciences and Engineering Research Council of Canada discovery grant #2015-00055 (http://www.nserc-crsng.gc.ca) received by KB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant. All computations were performed on the BGQ supercomputer at the SciNet HPC Consortium located at the University of Toronto.	Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Ahmed M, 2017, DRUG DES DEV THER, V11, P2301, DOI 10.2147/DDDT.S133944; Ain Q. U., 2015, REV COMPUT MOL SCI, V5, P405, DOI [10.1002/wcms.1225, DOI 10.1002/WCMS.1225]; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; [Anonymous], 2017, SCHROD REL 2017 2 LI; Anwar-Mohamed A, 2014, TOXICOL LETT, V230, P382, DOI 10.1016/j.toxlet.2014.08.007; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Barakat KH, 2013, J CHEM INF MODEL, V53, P3031, DOI 10.1021/ci4003969; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bett GCL, 2006, J PHYSIOL-LONDON, V576, P755, DOI 10.1113/jphysiol.2006.116012; Bleich M, 1997, PFLUG ARCH EUR J PHY, V434, P499, DOI 10.1007/s004240050427; Busch AE, 1996, PFLUG ARCH EUR J PHY, V432, P1094, DOI 10.1007/s004240050240; Ceccarini L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049017; Chung DY, 2009, P NATL ACAD SCI USA, V106, P743, DOI 10.1073/pnas.0811897106; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durrant JD, 2011, J CHEM INF MODEL, V51, P2897, DOI 10.1021/ci2003889; Fowler PW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2858; Ganesan A, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1306; Ganesan A, 2017, DRUG DISCOV TODAY, V22, P249, DOI 10.1016/j.drudis.2016.11.001; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gerlach U, 2001, J MED CHEM, V44, P3831, DOI 10.1021/jm0109255; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Hasani HJ, 2017, J MOL GRAPH MODEL, V78, P26, DOI 10.1016/j.jmgm.2017.09.019; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; Hu G, 2014, BIOINFORMATICS, V30, P3561, DOI 10.1093/bioinformatics/btu581; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Jongbloed RJE, 1999, HUM MUTAT, V13, P301, DOI 10.1002/(SICI)1098-1004(1999)13:4<301::AID-HUMU7>3.3.CO;2-M; Kalyaanamoorthy S, 2017, EXPERT OPIN DRUG DIS, P1; Kalyaanamoorthy S., 2017, MED RES REV; Kalyaanamoorthy S, 2014, PROG BIOPHYS MOL BIO, V114, P123, DOI 10.1016/j.pbiomolbio.2013.06.004; Kalyaanamoorthy S, 2014, PHYS CHEM CHEM PHYS, V16, P3777, DOI 10.1039/c3cp53511h; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Khamis MA, 2015, ARTIF INTELL MED, V63, P135, DOI 10.1016/j.artmed.2015.02.002; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Kona J, 2007, THEOR CHEM ACC, V117, P1121, DOI 10.1007/s00214-006-0226-x; Kutteh R, 2007, J PHYS CHEM B, V111, P1090, DOI 10.1021/jp066294d; Lee S, 2016, HUM EXP TOXICOL, V35, P501, DOI 10.1177/0960327115595683; Lee S, 2016, TOXICOL APPL PHARM, V296, P42, DOI 10.1016/j.taap.2016.01.015; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Linder T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003058; Liu SA, 2015, P NATL ACAD SCI USA, V112, P15096, DOI 10.1073/pnas.1510526112; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Macias A, 2010, J MOL CELL CARDIOL, V49, P984, DOI 10.1016/j.yjmcc.2010.09.012; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Monticelli L, 2004, FEBS LETT, V564, P325, DOI 10.1016/S0014-5793(04)00271-6; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Osteen JD, 2010, P NATL ACAD SCI USA, V107, P18751, DOI 10.1073/pnas.1014150107; Patel N, 2014, TOWARDS UNRAVELLING, V19; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramakrishnan V, 2004, BBA-BIOMEMBRANES, V1664, P1, DOI 10.1016/j.bbamem.2004.03.015; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Seebohm G, 2003, MOL PHARMACOL, V64, P70, DOI 10.1124/mol.64.1.70; Seebohm G, 2013, BIOPHYS J, V105, P2437, DOI 10.1016/j.bpj.2013.10.022; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Siebrands CC, 2006, ANESTHESIOLOGY, V105, P511, DOI 10.1097/00000542-200609000-00015; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith JA, 2007, BIOCHEMISTRY-US, V46, P14141, DOI 10.1021/bi701597s; Strutz-Seebohm N, 2013, CELL PHYSIOL BIOCHEM, V31, P968, DOI 10.1159/000350115; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; Suessbrich H, 1996, FEBS LETT, V396, P271, DOI 10.1016/0014-5793(96)01113-1; Sula A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14205; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Veerman CC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1002, DOI 10.1161/CIRCEP.113.000239; Wojcikowski M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46710; Xu Y, 2013, BIOPHYS J, V105, P2461, DOI 10.1016/j.bpj.2013.09.058; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	79	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191905	10.1371/journal.pone.0191905	http://dx.doi.org/10.1371/journal.pone.0191905			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444113	Green Submitted, gold, Green Published			2022-12-26	WOS:000425183500042
J	Riley, C; Garfinkel, D; Thanel, K; Esch, K; Workalemahu, E; Anyanti, J; Mpanya, G; Binanga, A; Pope, J; Longfield, K; Bertrand, J; Shaw, B				Riley, Christina; Garfinkel, Danielle; Thanel, Katherine; Esch, Keith; Workalemahu, Endale; Anyanti, Jennifer; Mpanya, Godefroid; Binanga, Arsene; Pope, Jen; Longfield, Kim; Bertrand, Jane; Shaw, Bryan		FPwatch Grp	Getting to FP2020: Harnessing the private sector to increase modern contraceptive access and choice in Ethiopia, Nigeria, and DRC	PLOS ONE			English	Article							FAMILY-PLANNING PROVISION	Background An estimated 214 million women have unmet need for family planning in developing regions. Improved utilization of the private sector is key to achieving universal access to a range of safe and effective modern contraceptive methods stipulated by FP2020 and SDG commitments. Until now, a lack of market data has limited understanding of the private sector's role in increasing contraceptive coverage and choice. Methods In 2015, the FPwatch Project conducted representative outlet surveys in Ethiopia, Nigeria, and DRC using a full census approach in selected administrative areas. Every public and private sector outlet with the potential to sell or distribute modern contraceptives was approached. In outlets with modern contraceptives, product audits and provider interviews assessed contraceptive market composition, availability, and price. Findings Excluding general retailers, 96% of potential outlets in Ethiopia, 55% in Nigeria, and 41% in DRC had modern contraceptive methods available. In Ethiopia, 41% of modern contraceptive stocking outlets were in the private sector compared with approximately 80% in Nigeria and DRC where drug shops were dominant. Ninety-five percent of private sector outlets in Ethiopia had modern contraceptive methods available; 37% had three or more methods. In Nigeria and DRC, only 54% and 42% of private sector outlets stocked modern contraceptives with 5% and 4% stocking three or more methods, respectively. High prices in Nigeria and DRC create barriers to consumer access and choice. Discussion There is a missed opportunity to provide modern contraception through the private sector, particularly drug shops. Subsidies and interventions, like social marketing and social franchising, could leverage the private sector's role in increasing access to a range of contraceptives. Achieving global FP2020 commitments depends on the expansion of national contraceptive policies that promote greater partnership and cooperation with the private sector and improvement of decisions around funding streams of countries with large populations and high unmet need like Ethiopia, Nigeria, and DRC.	[Riley, Christina; Garfinkel, Danielle; Thanel, Katherine; Esch, Keith; Pope, Jen; FPwatch Grp] Populat Serv Int, Washington, DC USA; [Workalemahu, Endale] Populat Serv Int Ethiopia, Addis Ababa, Ethiopia; [Anyanti, Jennifer] Soc Family Hlth, Abuja, Nigeria; [Mpanya, Godefroid] Assoc Sante Familiale, Kinshasa, DEM REP CONGO; [Binanga, Arsene] Tulane Int Kinshasa, Kinshasa, DEM REP CONGO; [Bertrand, Jane] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Shaw, Bryan] Georgetown Univ, Inst Reprod Hlth, Washington, DC USA	Tulane University; Georgetown University	Riley, C (corresponding author), Populat Serv Int, Washington, DC USA.	riley.christinam@gmail.com	Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525; Bates, Katie/0000-0002-3118-4637; Riley, Christina/0000-0002-6167-1284; Yadav, Prashant/0000-0001-7836-6641	Bill & Melinda Gates Foundation [OPP1112709]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors are grateful to the Bill & Melinda Gates Foundation (grant no. OPP1112709) for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.gatesfoundation.org/How-We-Work/ General-Information/Grant-Opportunities.	Akol A, 2014, GLOB HEALTH-SCI PRAC, V2, P472, DOI 10.9745/GHSP-D-14-00085; Ali M, 2014, B WORLD HEALTH ORGAN, V92, P93, DOI 10.2471/BLT.13.122242; [Anonymous], 2014, FAMILY PLANNING NATL; [Anonymous], 2011, RESPOND PROJ TECHN M; [Anonymous], 2012, GOMBE STATE FRAMEWOR; [Anonymous], 2017, PMA2020 JOHNS HOPK U; [Anonymous], FAM PLANN SUMM JUL 1; Asnake Mengistu, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe29, DOI 10.1016/j.ijgo.2013.07.003; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Campbell OMR, 2015, TROP MED INT HEALTH, V20, P1639, DOI 10.1111/tmi.12597; Drug Shops and Pharmacies, 2013, SOURC FAM PLANN COMM; Duvall S, 2014, GLOB HEALTH-SCI PRAC, V2, P72, DOI 10.9745/GHSP-D-13-00116; Ethiopia Ministry of Health, 2016, COST IMPL PLAN FAM P; Evidence Project, 2017, STRENGTH ROL PAT MED; FPwatch Group, 2016, FPWATCH DR CONG 2015; FPwatch Group, 2016, FPWATCH NIG 2015 OUT; Guttmacher Institute, 2017, ADD IT INV CONTR MAT; Leisher SH, 2016, QUALITY MEASUREMENT; Lemma Israel, COMMUNICATION; Levy JK, 2014, J URBAN HEALTH, V91, P186, DOI 10.1007/s11524-013-9841-8; Montagu D., 2011, PRIVATE VERSUS PUBLI; Mukaba T, 2015, GLOB HEALTH, V3, P163, DOI 10.9745/GHSP-D-14-00244; Ngo TD, 2016, MATERNAL CHILD HLTH; Olson DJ, 2013, STUD FAMILY PLANN, V44, P445, DOI 10.1111/j.1728-4465.2013.00369.x; Rattan J, 2016, GLOB HLTH SCI PRA S2, V4; Rutta E, 2015, J PHARM POLICY PRACT, V8, P1; Sharma Suneeta, 2005, Health Policy, V71, P347, DOI 10.1016/j.healthpol.2004.09.010; Shelton JD, 2016, GLOB HEALTH-SCI PRAC, V4, P179, DOI 10.9745/GHSP-D-16-00135; Tessema G. A., 2011, PLOS ONE, V11; Thurston S, 2015, GLOB HEALTH-SCI PRAC, V3, P180, DOI 10.9745/GHSP-D-15-00057; Tilahun Y, 2016, GLOBAL HLTH SCI PRAC, V4; Van Lith LM, 2013, GLOB HEALTH-SCI PRAC, V1, P97, DOI 10.9745/GHSP-D-12-00036; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Weinberger M, 2017, PRIVATE SECTOR KEY R; Weinberger M, 2017, PRIVATE SECTOR KEY A	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192522	10.1371/journal.pone.0192522	http://dx.doi.org/10.1371/journal.pone.0192522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444140	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500069
J	Tremocoldi, MA; Rosalen, PL; Franchin, M; Massarioli, AP; Denny, C; Daiuto, ER; Paschoal, JAR; Melo, PS; de Alencar, SM				Tremocoldi, Maria Augusta; Rosalen, Pedro Luiz; Franchin, Marcelo; Massarioli, Adna Prado; Denny, Carina; Daiuto, Erica Regina; Rizzato Paschoal, Jonas Augusto; Melo, Priscilla Siqueira; de Alencar, Severino Matias			Exploration of avocado by-products as natural sources of bioactive compounds	PLOS ONE			English	Article							REACTIVE OXYGEN; ANTIOXIDANT CAPACITIES; PHENOLIC-COMPOUNDS; EXTRACTION; OPTIMIZATION; FRUIT; POLAR; TNF; L.	This study aimed to evaluate the antioxidant, anti-inflammatory, and cytotoxic properties and phenolic composition of peel and seed of avocado varieties Hass and Fuerte using green solvents. Ethanol soluble compounds were identified in peel and seed of both varieties using HPLC-MS/MS and quantified using HPLC-DAD. Agro-industrial by-products of both varieties exhibited high radical scavenging activity against synthetic free radicals (DPPH and ABTS) and reactive oxygen species (peroxyl, superoxide, and hypochlorous acid) and high ability to reduce Fe3+ to Fe2+. The main compounds with significant contribution to the antioxidant activity determined by online HPLC-ABTS(center dot+) analyses were procyanidin B-2 and epicatechin in the peel and trans-5-O-caffeoyl-D-quinic acid, procyanidin B-1, catechin, and epicatechin in the seed. Peel of Fuerte significantly suppressed TNF-alpha and nitric oxide (NO) release (459.3 pg/mL and 8.5 mu M, respectively), possibly because of the high phenolic content and antioxidant activity detected. Avocado agro-industrial by-products can be used for food and pharmaceutical purposes due to their antioxidant and anti-inflammatory properties.	[Tremocoldi, Maria Augusta; Massarioli, Adna Prado; Melo, Priscilla Siqueira; de Alencar, Severino Matias] Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil; [Rosalen, Pedro Luiz; Franchin, Marcelo; Denny, Carina] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Daiuto, Erica Regina] State Univ Paulista Julio de Mesquita Filho, Sch Agr Sci, Rua Jose Barbosa de Barros, Botucatu, SP, Brazil; [Rizzato Paschoal, Jonas Augusto] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Phys & Chem, Vila Monte Alegre, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	de Alencar, SM (corresponding author), Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil.	smalencar@usp.br	Massarioli, Adna Prado/I-4840-2013; tremocoldi, maria/W-9304-2019; Paschoal, Jonas Augusto Rizzato/F-4260-2012; Rosalen, Pedro Luiz/I-3718-2012; Alencar, Severino Matias/B-7743-2012; Franchin, Marcelo/M-7636-2017; Melo, Priscilla/H-6694-2016	Massarioli, Adna Prado/0000-0002-2747-0788; Paschoal, Jonas Augusto Rizzato/0000-0002-7372-0936; Rosalen, Pedro Luiz/0000-0003-0812-4027; Alencar, Severino Matias/0000-0002-6637-7973; Franchin, Marcelo/0000-0001-5613-2756; Melo, Priscilla/0000-0002-8344-906X	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo [2010/52671-8]	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo	This work received support from Grant #2010/52671-8 - Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - to MAT, http://bv.fapesp.br/pt/bolsas/127450/caracterizacao-isolamento-e-identificacao-de-compostos-corn-atividade-antioxidante-de-abacates-das-c/ - APT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemimi A, 2015, MOLECULES, V20, P6611, DOI 10.3390/molecules20046611; Altemimi A, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-015-0113-4; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Cannizzo ES, 2011, J PROTEOMICS, V74, P2313, DOI 10.1016/j.jprot.2011.06.005; Chemat F, 2012, INT J MOL SCI, V13, P8615, DOI 10.3390/ijms13078615; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Figueroa JG, 2018, FOOD RES INT, V105, P752, DOI 10.1016/j.foodres.2017.11.082; Franchin M, 2017, EUR J MED C IN PRESS; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hurtado-Fernandez E, 2011, J AGR FOOD CHEM, V59, P2255, DOI 10.1021/jf104276a; Kong KW, 2012, FOOD CHEM, V134, P324, DOI 10.1016/j.foodchem.2012.02.150; Melgar B, 2018, IND CROP PROD, V111, P212, DOI 10.1016/j.indcrop.2017.10.024; Melo PS, 2015, FOOD CHEM, V181, P160, DOI 10.1016/j.foodchem.2015.02.087; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Murakami Y, 2015, IN VIVO, V29, P701; Okonogi S, 2007, FOOD CHEM, V103, P839, DOI 10.1016/j.foodchem.2006.09.034; Oldoni TLC, 2016, FOOD CHEM, V192, P306, DOI 10.1016/j.foodchem.2015.07.004; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Ribeiro AB, 2014, FOOD CHEM, V165, P140, DOI 10.1016/j.foodchem.2014.05.079; Rodrigues E, 2013, J AGR FOOD CHEM, V61, P3022, DOI 10.1021/jf3054214; Rodrigues NP, 2014, FOOD RES INT, V61, P228, DOI 10.1016/j.foodres.2013.09.028; Rodriguez-Carpena JG, 2011, J AGR FOOD CHEM, V59, P5625, DOI 10.1021/jf1048832; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; Silva DF, 2016, FITOTERAPIA, V113, P139, DOI 10.1016/j.fitote.2016.07.021; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tehranifar A, 2011, IND CROP PROD, V34, P1523, DOI 10.1016/j.indcrop.2011.05.007; Tiveron AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165588; Wang W, 2010, FOOD CHEM, V122, P1193, DOI 10.1016/j.foodchem.2010.03.114; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yahia EM, 2009, FRUIT VEGETABLE PHYT, P1	35	80	81	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192577	10.1371/journal.pone.0192577	http://dx.doi.org/10.1371/journal.pone.0192577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444125	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500074
J	McNees, AL; Harrigal, LJ; Kelly, A; Minard, CG; Wong, C; Butel, JS				McNees, Adrienne L.; Harrigal, Lindsay J.; Kelly, Aoife; Minard, Charles G.; Wong, Connie; Butel, Janet S.			Viral microRNA effects on persistent infection of human lymphoid cells by polyomavirus SV40	PLOS ONE			English	Article							LARGE T-ANTIGEN; SIMIAN-VIRUS-40 DNA-SEQUENCES; PERIPHERAL-BLOOD LEUKOCYTES; TONSILLAR STROMAL CELLS; PRIMARY B-LYMPHOCYTES; REGULATORY REGION; JC VIRUS; MOLECULAR-IDENTIFICATION; CONTINUOUS-CULTURE; LIFE-SPAN	Background Polyomaviruses, including simian virus 40 (SV40), display evidence of lymphotropic properties. This study analyzed the nature of SV40 +/- human lymphocyte interactions in established cell lines and in primary lymphocytes. The effects of viral microRNA and the structure of the viral regulatory region on SV40 persistence were examined. Results SV40 DNA was maintained in infected B cell and myeloid cell lines during cell growth for at least 28 days. Limiting dilution analysis showed that low amounts of SV40 DNA (similar to 2 copies per cell) were retained over time. Infected B cells remained viable and able to proliferate. Genome copies of the SV40 microRNA-null mutant persisted at higher levels than the DNA of wild-type viruses. Complex viral regulatory regions produced modestly higher DNA levels than simple regulatory regions. Viral large T-antigen protein was detected at low frequency and at low levels in infected B cells. Following infection of primary lymphocytes, SV40 DNA was detected in CD19(+) B cells and CD14(+) monocytes, but not in CD3(+) T cells. Rescue attempts using either lysates of SV40-infected B lymphocytes, coculture of live cells, or infectious center assays all showed that replication-competent SV40 could be recovered on rare occasions. SV40 infections altered the expression of several B cell surface markers, with more pronounced changes following infections with the microRNA-null mutant. Conclusion These findings indicate that SV40 can establish persistent infections in human B lymphocytes. The cells retain low copy numbers of viral DNA; the infections are nonproductive and noncytolytic but can occasionally produce infectious virus. SV40 microRNA negatively regulates the degree of viral effects on B cells. Significance Lymphocytes may serve as viral reservoirs and may function to disseminate polyomaviruses to different tissues in a host. To our knowledge, this report is the first extensive analysis of viral microRNA effects on SV40 infection of human lymphocytes.	[McNees, Adrienne L.; Harrigal, Lindsay J.; Kelly, Aoife; Wong, Connie; Butel, Janet S.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Minard, Charles G.] Baylor Coll Med, Inst Clin & Translat Res, Houston, TX 77030 USA; [Kelly, Aoife] Univ Manchester, Fac Biol Med & Hlth, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England	Baylor College of Medicine; Baylor College of Medicine; University of Manchester	Butel, JS (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	jbutel@bcm.edu		Kelly, Aoife/0000-0002-8101-3422	National Institutes of Health [R01 CA104818, T32 GM008231, T32 A1007471]; Irish governmental agency, FAS; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH [P30 AI036211, P30 CA125123, S10 RR024574]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irish governmental agency, FAS; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by research grant R01 CA104818 from the National Institutes of Health (JSB), by training grants T32 GM008231 and T32 A1007471 from the National Institutes of Health (LJH), and by the Irish governmental agency, FAS (AK). This project was also supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574) and by the expert assistance of Joel M. Sederstrom.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Alaribe FN, 2013, LEUKEMIA RES, V37, P681, DOI 10.1016/j.leukres.2013.02.003; Amara K, 2008, MODERN PATHOL, V21, P282, DOI 10.1038/modpathol.3800993; ATWOOD WJ, 1992, VIROLOGY, V190, P716, DOI 10.1016/0042-6822(92)90909-9; Azzi A, 1996, J NEUROVIROL, V2, P411, DOI 10.3109/13550289609146907; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; Bauman Y, 2016, ONCOTARGET, V7, P15369, DOI 10.18632/oncotarget.8085; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; BECKWITH M, 1990, J NATL CANCER I, V82, P501, DOI 10.1093/jnci/82.6.501; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Bofill-Mas S, 2004, VIROLOGY, V330, P1, DOI 10.1016/j.virol.2004.09.007; Broekema NM, 2013, P NATL ACAD SCI USA, V110, P8200, DOI 10.1073/pnas.1301907110; BRUGGE JS, 1975, J VIROL, V15, P619, DOI 10.1128/JVI.15.3.619-635.1975; Butel J. S., 2010, Viral oncology: basic science and clinical applications, P165; Butel JS, 2012, CURR OPIN VIROL, V2, P508, DOI 10.1016/j.coviro.2012.06.004; Butel JS, 2012, CURR CANCER RES, P377, DOI 10.1007/978-1-4614-0016-5_15; Butel JS, 1999, HUM PATHOL, V30, P1496, DOI 10.1016/S0046-8177(99)90173-9; Cantalupo P, 2005, J VIROL, V79, P13094, DOI 10.1128/JVI.79.20.13094-13104.2005; CARBONE M, 1989, CANCER RES, V49, P1565; Chapagain ML, 2010, J INFECT DIS, V202, P184, DOI 10.1086/653823; COE JE, 1975, J NATL CANCER I, V54, P269, DOI 10.1093/jnci/54.1.269; Comar M, 2011, J MED VIROL, V83, P1446, DOI 10.1002/jmv.22124; Comar M, 2010, J MED VIROL, V82, P1236, DOI 10.1002/jmv.21786; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Dang X, 2008, J NEUROPATH EXP NEUR, V67, P784, DOI 10.1097/NEN.0b013e318180f0d5; David H, 2001, CANCER LETT, V162, P57, DOI 10.1016/S0304-3835(00)00628-5; Davies ML, 2010, VIROLOGY, V400, P53, DOI 10.1016/j.virol.2010.01.002; DeCaprio JA, 2013, NAT REV MICROBIOL, V11, P264, DOI 10.1038/nrmicro2992; Delbue S, 2010, J CLIN VIROL, V47, P156, DOI 10.1016/j.jcv.2009.11.029; DIAMANDOPOULOS GT, 1972, SCIENCE, V176, P173, DOI 10.1126/science.176.4031.173; Doerries K, 2006, ADV EXP MED BIOL, V577, P102; Dolei A, 2000, J GEN VIROL, V81, P1967, DOI 10.1099/0022-1317-81-8-1967; Dorries K, 2003, J NEUROVIROL, V9, P81, DOI 10.1080/13550280390195379; DORRIES K, 1994, VIROLOGY, V198, P59, DOI 10.1006/viro.1994.1008; Dubois V, 1997, J CLIN MICROBIOL, V35, P2288, DOI 10.1128/JCM.35.9.2288-2292.1997; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; Feeney KM, 2009, P ROY SOC B-BIOL SCI, V276, P1535, DOI 10.1098/rspb.2008.1642; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Forsman ZH, 2004, J VIROL, V78, P9306, DOI 10.1128/JVI.78.17.9306-9316.2004; GOUDSMIT J, 1982, J MED VIROL, V10, P91, DOI 10.1002/jmv.1890100203; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; ILYINSKII PO, 1992, J VIROL, V66, P6353, DOI 10.1128/JVI.66.11.6353-6360.1992; Imperiale MJ, 2016, ANNU REV VIROL, V3, P517, DOI 10.1146/annurev-virology-110615-042226; KANKI T, 1994, HYBRIDOMA, V13, P327, DOI 10.1089/hyb.1994.13.327; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Lagatie O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-268; Lapin B. A., 2009, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P7; Lednicky JA, 1998, J VIROL, V72, P3980, DOI 10.1128/JVI.72.5.3980-3990.1998; Lednicky JA, 1997, J GEN VIROL, V78, P1697, DOI 10.1099/0022-1317-78-7-1697; Lednicky JA, 2002, J CLIN MICROBIOL, V40, P1056, DOI 10.1128/JCM.40.3.1056-1059.2002; LEDNICKY JA, 1995, VIROLOGY, V212, P710, DOI 10.1006/viro.1995.1529; Lednicky JA, 1998, DEV BIOL STAND, V94, P155; Lednicky JA, 2001, SEMIN CANCER BIOL, V11, P39, DOI 10.1006/scbi.2000.0345; LEDNICKY JA, 1995, VIRUS RES, V35, P143, DOI 10.1016/0168-1702(94)00093-R; Li RM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028249.06596.CF; Lieberman PM, 2013, NAT REV MICROBIOL, V11, P863, DOI 10.1038/nrmicro3135; Martelli F, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1927; Martini F, 1996, CANCER RES, V56, P4820; Mazzoni E, 2017, CANCER IMMUNOL IMMUN, V66, P1189, DOI 10.1007/s00262-017-2008-9; Mazzoni E, 2012, EXP HEMATOL, V40, P466, DOI 10.1016/j.exphem.2012.02.008; McBride AA, 2012, BBA-GENE REGUL MECH, V1819, P820, DOI 10.1016/j.bbagrm.2012.01.011; McNees AL, 2009, VIROLOGY, V384, P114, DOI 10.1016/j.virol.2008.10.035; McNees AL, 2005, J CLIN VIROL, V34, P52, DOI 10.1016/j.jcv.2004.12.018; Meneses A, 2005, HAEMATOLOGICA, V90, P1635; MENEZES J, 1975, BIOMEDICINE, V22, P276; Mertz KD, 2010, J INVEST DERMATOL, V130, P1146, DOI 10.1038/jid.2009.392; Monaco MCG, 1996, J VIROL, V70, P7004, DOI 10.1128/JVI.70.10.7004-7012.1996; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Newman JS, 1998, J NEUROVIROL, V4, P394, DOI 10.3109/13550289809114538; Pancaldi C, 2009, J INFECTION, V58, P53, DOI 10.1016/j.jinf.2008.10.014; Papa N, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0553-z; Paracchin V, 2005, MOL MED, V11, P48, DOI 10.2119/2005-00007.Taioli; Patel NC, 2008, J CLIN VIROL, V43, P66, DOI 10.1016/j.jcv.2008.04.011; Patel NC, 2009, VIROLOGY, V386, P94, DOI 10.1016/j.virol.2008.12.040; Peng J, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.08.028; Rascovan N, 2016, CLIN INFECT DIS, V62, P1419, DOI 10.1093/cid/ciw135; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; ROBB JA, 1973, EXP CELL RES, V81, P120, DOI 10.1016/0014-4827(73)90118-3; RYAN QC, 1992, EXP CELL RES, V199, P387, DOI 10.1016/0014-4827(92)90450-M; Sadeghi M, 2014, J CLIN VIROL, V59, P55, DOI 10.1016/j.jcv.2013.11.008; Salakova M, 2016, J MED VIROL, V88, P695, DOI 10.1002/jmv.24385; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Seo GJ, 2009, VIROLOGY, V383, P183, DOI 10.1016/j.virol.2008.11.001; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Shivapurkar N, 2002, LANCET, V359, P851, DOI 10.1016/S0140-6736(02)07921-7; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Siebrasse EA, 2014, VIROLOGY, V468, P178, DOI 10.1016/j.virol.2014.08.005; Sroller V, 2008, J VIROL, V82, P871, DOI 10.1128/JVI.01626-07; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Stewart AR, 1998, J NEUROVIROL, V4, P182; Sullivan CS, 2009, VIROLOGY, V387, P157, DOI 10.1016/j.virol.2009.02.017; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Theiss JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004974; Thomas LD, 2007, J INFECT DIS, V195, P442, DOI 10.1086/510625; Toracchio S, 2010, EMERG INFECT DIS, V16, P1702, DOI 10.3201/eid1611.100628; Toracchio S, 2009, J CLIN VIROL, V46, P154, DOI 10.1016/j.jcv.2009.06.023; TORNATORE C, 1992, ANN NEUROL, V31, P454, DOI 10.1002/ana.410310426; Tseng CE, 2014, EUR J CLIN MICROBIOL, V33, P665, DOI 10.1007/s10096-013-2010-x; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Vanchiere JA, 2005, J MED VIROL, V75, P447, DOI 10.1002/jmv.20287; Vanchiere JA, 2016, J PEDIAT INF DIS SOC, V5, P210, DOI 10.1093/jpids/piu101; Vanchiere JA, 2009, J CLIN MICROBIOL, V47, P2388, DOI 10.1128/JCM.02472-08; Vilchez RA, 2002, LANCET, V359, P817, DOI 10.1016/S0140-6736(02)07950-3; Vilchez RA, 2005, VIROLOGY, V342, P38, DOI 10.1016/j.virol.2005.06.053; Wei G, 2000, J NEUROVIROL, V6, P127, DOI 10.3109/13550280009013156; White MK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003206; Yamamoto H, 2000, BRIT J CANCER, V82, P1677; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; Zekri AR, 2007, LEUKEMIA LYMPHOMA, V48, P1828, DOI 10.1080/10428190701534408; Zhang SJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003912; Zhang SJ, 2005, J GEN VIROL, V86, P2721, DOI 10.1099/vir.0.81168-0	115	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192799	10.1371/journal.pone.0192799	http://dx.doi.org/10.1371/journal.pone.0192799			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432481	gold, Green Published, Green Submitted			2022-12-26	WOS:000424814300046
J	Montague, BT; John, B; Sammartino, C; Costa, M; Fukuda, D; Solomon, L; Rich, JD				Montague, Brian T.; John, Betsey; Sammartino, Cara; Costa, Michael; Fukuda, Dawn; Solomon, Liza; Rich, Josiah D.			Use of viral load surveillance data to assess linkage to care for persons with HIV released from corrections	PLOS ONE			English	Article							SEXUAL PARTNERSHIPS; INFECTED PRISONERS; INCARCERATION; OUTCOMES; ENROLLMENT; INMATES; STATE	Incarcerated people remain a priority group in efforts to control and reverse the HIV epidemic. Following release, social instability and reengagement in key transmission risk behaviors increase the risk of secondary transmission of HIV. Targeted programs have been developed to facilitate reengagement in care on reentry. Evaluation of the impact of these initiatives requires a systematic, confidential, framework for assessment of linkage to care for persons released from corrections. By linking HIV viral load surveillance data to corrections release data, the time to the first laboratory monitoring service in the community as well as the virologic status can be assessed. Using this method, we linked release data for sentenced individuals released from Massachusetts state correctional facilities in 2012 to HIV surveillance data from the Massachusetts HIV/AIDS Surveillance Program (MHASP) for the years 2012-2013. We identified 41 individuals with HIV released in 2012. Ninety-one percent had identified virologic assessments post release, 41% within 30 days. Thirty-three percent did not have a viral load assessed for more than 90 days and 31% had detectable virus at the time of their initial assessment. Persons with longer incarcerations (> 180 days) were more likely to have suppressed viral load at the time of follow-up (p = 0.05). This work demonstrates the important value of HIV laboratory surveillance data and correctional release data as a tool to assess linkage to care following release from corrections. We encourage jurisdictions to explore utilizing similar methodology to evaluate the effectiveness of the linkage to HIV care after release from incarceration.	[Montague, Brian T.] Univ Colorado, Denver Sch Med, Div Infect Dis, Dept Med, Aurora, CO 80045 USA; [John, Betsey; Fukuda, Dawn] Massachusetts Dept Publ Hlth, Bur Infect Dis & Lab Sci, Boston, MA 02111 USA; [Sammartino, Cara] Johnson & Wales Univ, Dept Hlth Sci, Providence, RI USA; [Costa, Michael; Solomon, Liza] Abt Associates Inc, Cambridge, MA USA; [Rich, Josiah D.] Miriam Hosp, Providence, RI 02906 USA; [Rich, Josiah D.] Brown Univ, Dept Med, Div Infect Dis, Warren Alpert Sch Med, Providence, RI 02912 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Massachusetts Department of Public Health; ABT Associates; Lifespan Health Rhode Island; Miriam Hospital; Brown University	Montague, BT (corresponding author), Univ Colorado, Denver Sch Med, Div Infect Dis, Dept Med, Aurora, CO 80045 USA.	brian.montague@ucdenver.edu; betsey.john@state.ma.us		Montague, Brian/0000-0003-1403-6955	NIDA [1R01DA030778]; NIH [2T32DA13911, K24DA022112, CFAR P30A1042853]; Massachusetts Department of Corrections; Massachusetts HIV/AIDS Surveillance Program within the Massachusetts Department of Health; LINCS advisory board	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Department of Corrections; Massachusetts HIV/AIDS Surveillance Program within the Massachusetts Department of Health; LINCS advisory board	The primary support for this research came from NIDA grant 1R01DA030778 with additional support provided by NIH grants 2T32DA13911, K24DA022112, and CFAR P30A1042853. The funders provided support in the form of salaries for authors BTM, MC, CS, LS, JDR but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We gratefully acknowledge the support of the Massachusetts Department of Corrections and the Massachusetts HIV/AIDS Surveillance Program within the Massachusetts Department of Health. We also would like to acknowledge the LINCS advisory board for its support of this work including Joanna Buffington, MD, Peter Leone, MD, A. T. Wall, JD.	Adams LM, 2013, AIDS BEHAV, V17, P2685, DOI 10.1007/s10461-011-9990-2; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Baillargeon JG, 2010, PUBLIC HEALTH REP, V125, P64, DOI 10.1177/00333549101250S109; Bandara SN, 2015, HEALTH AFFAIR, V34, P2044, DOI 10.1377/hlthaff.2015.0668; Begier EM, 2010, JAIDS-J ACQ IMM DEF, V54, P93, DOI 10.1097/QAI.0b013e3181c98fa8; Booker CA, 2013, AIDS BEHAV, V17, P128, DOI 10.1007/s10461-012-0354-3; Boutwell AE, 2014, HEALTH AFFAIR, V33, P482, DOI 10.1377/hlthaff.2013.1131; Braunstein SL, 2016, JAIDS; CDC, STAT LAB REP LAWS VI; Gordon MS, 2013, AIDS BEHAV, V17, P2022, DOI 10.1007/s10461-013-0456-6; Gutman R, 2015, STAT MED; HRSA HIV/AIDS Bureau DaRTT, ENCR UN CLIENT ID EU; Iroh PA, 2015, AM J PUBLIC HEALTH, V105, pE5, DOI 10.2105/AJPH.2015.302635; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Khan MR, 2008, J URBAN HEALTH, V85, P100, DOI 10.1007/s11524-007-9237-8; Kouyoumdjian FG, 2014, CAN J PUBLIC HEALTH, V105, pE198, DOI 10.17269/cjph.105.4193; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Maruschak L, 2012, BJS; Montague BT, 2012, VIRULENCE, V3, P319, DOI 10.4161/viru.20432; Montague BT, 2016, SYSTEMATIC ASSESSMEN; Policy OoNA, 2010, NAT HIV AIDS STRAT U; Riedel LE, 2016, J CORRECT HEALTH CAR, V22, P189, DOI 10.1177/1078345816653199; Rosen DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160085; Rosen DL, 2014, AM J PUBLIC HEALTH, V104, P418, DOI 10.2105/AJPH.2013.301563; Sabharwal CJ, 2014, JAIDS-J ACQ IMM DEF, V65, P571, DOI 10.1097/QAI.0000000000000077; Services MDoHaH, 2007, MASS HIV CAR CONT FA; Spaulding AC, 2013, AIDS BEHAV, V17, P203, DOI 10.1007/s10461-012-0341-8; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Terzian AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029679; Wiewel EW, 2015, JAIDS-J ACQ IMM DEF, V68, P217, DOI 10.1097/QAI.0000000000000424; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4; Zaller ND, 2008, J HEALTH CARE POOR U, V19, P522, DOI 10.1353/hpu.0.0030	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192074	10.1371/journal.pone.0192074	http://dx.doi.org/10.1371/journal.pone.0192074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV8DE	29432472	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300014
J	Chiha, W; LeVaillant, CJ; Bartlett, CA; Hewitt, AW; Melton, PE; Fitzgerald, M; Harvey, AR				Chiha, Wissam; LeVaillant, Chrisna J.; Bartlett, Carole A.; Hewitt, Alex W.; Melton, Phillip E.; Fitzgerald, Melinda; Harvey, Alan R.			Retinal genes are differentially expressed in areas of primary versus secondary degeneration following partial optic nerve injury	PLOS ONE			English	Article							GANGLION-CELLS; OXIDATIVE STRESS; INTRAOCULAR-PRESSURE; MICROARRAY ANALYSIS; BRAIN-INJURY; RAT RETINA; TRANSECTION; MODEL; DEATH; MECHANISMS	Background Partial transection (PT) of the optic nerve is an established experimental model of secondary degeneration in the central nervous system. After a dorsal transection, retinal ganglion cells (RGCs) with axons in ventral optic nerve are intact but vulnerable to secondary degeneration, whereas RGCs in dorsal retina with dorsal axons are affected by primary and secondary injuries. Using microarray, we quantified gene expression changes in dorsal and ventral retina at 1 and 7 days post PT, to characterize pathogenic pathways linked to primary and secondary degeneration. Results In comparison to uninjured retina Cryba1, Cryba2 and Crygs, were significantly downregulated in injured dorsal retina at days 1 and 7. While Ecel1, Timp1, Mt2A and CD74, which are associated with reducing excitotoxicity, oxidative stress and inflammation, were significantly upregulated. Genes associated with oxygen binding pathways, immune responses, cytokine receptor activity and apoptosis were enriched in dorsal retina at day 1 after PT. Oxygen binding and apoptosis remained enriched at day 7, as were pathways involved in extracellular matrix modification. Fewer changes were observed in ventral retina at day 1 after PT, most associated with the regulation of protein homodimerization activity. By day 7, apoptosis, matrix organization and signal transduction pathways were enriched. Discriminant analysis was also performed for specific functional gene groups to compare expression intensities at each time point. Altered expression of selected genes (ATF3, GFAP, Ecel1, TIMP1, Tp53) and proteins (GFAP, ECEL1 and ATF3) were semi-quantitatively assessed by qRT-PCR and immunohistochemistry respectively. Conclusion There was an acute and complex primary injury response in dorsal retina indicative of a dynamic interaction between neuroprotective and neurodegenerative events; ventral retina vulnerable to secondary degeneration showed a delayed injury response. Both primary and secondary injury resulted in the upregulation of numerous genes linked to RGC death, but differences in the nature of these changes strongly suggest that death occurred via different molecular mechanisms.	[Chiha, Wissam; Fitzgerald, Melinda; Harvey, Alan R.] Univ Western Australia, Expt & Regenerat Neurosci, Crawley, WA, Australia; [Chiha, Wissam; LeVaillant, Chrisna J.; Harvey, Alan R.] Univ Western Australia, Sch Human Sci, Crawley, WA, Australia; [Chiha, Wissam; Bartlett, Carole A.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia; [Hewitt, Alex W.] Univ Western Australia, Lions Eye Inst, Nedlands, WA, Australia; [Melton, Phillip E.] Univ Western Australia, Sch Biomed Sci, Curtin UWA Ctr Genet Origins Hlth & Dis, Bentley, WA, Australia; [Melton, Phillip E.] Curtin Univ, Bentley, WA, Australia; [Fitzgerald, Melinda; Harvey, Alan R.] Perron Inst Neurol & Translat Sci, QEII Med Ctr, Nedlands, WA, Australia; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia; Lions Eye Institute; University of Western Australia; University of Western Australia; Curtin University; University of Western Australia; Curtin University	Harvey, AR (corresponding author), Univ Western Australia, Expt & Regenerat Neurosci, Crawley, WA, Australia.; Harvey, AR (corresponding author), Univ Western Australia, Sch Human Sci, Crawley, WA, Australia.; Harvey, AR (corresponding author), Perron Inst Neurol & Translat Sci, QEII Med Ctr, Nedlands, WA, Australia.	alan.harvey@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Melton, Phillip/A-5012-2013	Fitzgerald, Melinda/0000-0002-4823-8179; Melton, Phillip/0000-0003-4026-2964; Hewitt, Alex/0000-0002-5123-5999; , Alan/0000-0002-2590-831X	National Health and Medical Research Council (NHMRC), Australia [APP1061791]; NHMRC [APP1087114]; WA Neurotrauma Research Programme	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); WA Neurotrauma Research Programme	This work was partially funded by the National Health and Medical Research Council (NHMRC), Australia, APP1061791; MF is supported by a NHMRC Career Development Fellowship APP1087114; WA Neurotrauma Research Programme to Alan R Harvey.	Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Agudo M, 2008, MOL VIS, V14, P1050; Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bidmon HJ, 1998, STROKE, V29, P203, DOI 10.1161/01.STR.29.1.203; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Chan KC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43124; CHOI DW, 1987, J NEUROSCI, V7, P369; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Levkovitch-Verbin H, 2011, GRAEF ARCH CLIN EXP, V249, P849, DOI 10.1007/s00417-010-1608-2; Levkovitch-Verbin H, 2010, EXP EYE RES, V91, P127, DOI 10.1016/j.exer.2009.11.014; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068881; Liang ZJ, 2007, J NEUROL NEUROSUR PS, V78, P581, DOI 10.1136/jnnp.2006.099077; Liedtke T, 2007, GLIA, V55, P189, DOI 10.1002/glia.20447; Martin LJ, 2010, BBA-MOL BASIS DIS, V1802, P186, DOI 10.1016/j.bbadis.2009.07.009; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; Munemasa Y, 2009, INVEST OPHTH VIS SCI, V50, P3869, DOI 10.1167/iovs.08-3138; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Panagis L, 2011, INVEST OPHTH VIS SCI, V52, P7807, DOI 10.1167/iovs.10-7063; Piri N, 2007, BRAIN RES, V1141, P1, DOI 10.1016/j.brainres.2006.11.095; Piri N, 2006, MOL VIS, V12, P1660; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sharma A, 2012, INVEST OPHTH VIS SCI, V53, P8367, DOI 10.1167/iovs.12-10799; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Weishaupt JH, 2001, RESTOR NEUROL NEUROS, V19, P19; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192348	10.1371/journal.pone.0192348	http://dx.doi.org/10.1371/journal.pone.0192348			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425209	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000424700800022
J	Saad, SI; da Silva, JM; Silva, MLN; Guimaraes, JLB; Sousa, WC; Figueiredo, RD; da Rocha, HR				Saad, Sandra Isay; da Silva, Jonathan Mota; Naves Silva, Marx Leandro; Bittencourt Guimaraes, Joao Luis; Sousa Junior, Wilson Cabral; Figueiredo, Ricardo de Oliveira; da Rocha, Humberto Ribeiro			Analyzing ecological restoration strategies for water and soil conservation	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; UNCERTAINTY ANALYSIS; FILTER STRIP; LAND-USE; SEDIMENT; FOREST; PRECIPITATION; STREAMFLOW; ENSEMBLE; PAYMENTS	The choice of areas for nature conservation involves the attempt to maximize the benefits, whether by carrying out an economic activity or by the provision of Ecosystem Services. Studies are needed to improve the understanding of the effect of the extent and position along the watershed of restored areas on soil and water conservation. This study aimed to understand how different restoration strategies might reflect in soil conservation and sediment retention. Using InVEST tool, sediment transport was simulated in a small 12 km(2) watershed (Posses River, in Southeast Brazil), where one of first Brazilian Payment for Ecosystem Services (PES) projects is being carried out, comparing different hypothetical restoration strategies. With 25% of restoration, sediment export decreased by 78% for riparian restoration, and 27% for the steepest slopes restoration. On the other hand, the decrease in soil loss was lower for riparian restoration, with a 16% decrease, while the steepest slopes restoration reduced it by 21%. This mismatch between the reduction of sediment export and soil loss was explained by the fact that forest not only reduces soil loss locally but also traps sediment arriving from the upper parts of the watershed. While the first mechanism is important to provide soil stability, decreasing the risk of landslip, and to maintain agricultural productivity, the second can improve water quality and decrease the risk of silting, with positive effects on the water reservoirs at the outlet of the watershed. This suggests that Riparian and the Steepest Slopes restoration strategies are complementary in the sense of preventing sediments from reaching the water bodies as well as protecting them at their origin (with the reduction of erosion), so it will be advisable to consider the two types of restoration.	[Saad, Sandra Isay] Univ Sao Paulo, Grad Program Environm Sci, Inst Energy & Environm, Sao Paulo, Brazil; [da Silva, Jonathan Mota] Univ Fed Rio Grande do Norte, Dept Atmospher & Climat Sci, Natal, RN, Brazil; [Naves Silva, Marx Leandro] Univ Fed Lavras, Dept Ciencia Solo, Lavras, Brazil; [Bittencourt Guimaraes, Joao Luis] Aquaflora Meio Ambiente, Curitiba, Parana, Brazil; [Sousa Junior, Wilson Cabral] Aeronaut Inst Technol, Dept Water Resources & Environm, Sao Jose Dos Campos, Brazil; [Figueiredo, Ricardo de Oliveira] Brazilian Agr Res Coorporat, Embrapa Environm, Jaguariuna, Brazil; [da Rocha, Humberto Ribeiro] Univ Sao Paulo, Inst Astron Geophys & Atmospher Sci, Dept Atmospher Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte; Universidade Federal de Lavras; Comando-Geral de Tecnologia Aeroespacial (CTA); Instituto Tecnologico de Aeronautica (ITA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Saad, SI (corresponding author), Univ Sao Paulo, Grad Program Environm Sci, Inst Energy & Environm, Sao Paulo, Brazil.	sandraisaad@gmail.com	Sousa Junior, Wilson/J-8576-2014; Saad, Sandra/N-9433-2019; SILVA, MARX LEANDRO NAVES/AAQ-2504-2021; Silva, Marx Leandro Naves/D-4934-2018; Figueiredo, Ricardo de Oliveira/A-6967-2013	Sousa Junior, Wilson/0000-0001-6176-2410; Silva, Marx Leandro Naves/0000-0001-5575-9549; Figueiredo, Ricardo de Oliveira/0000-0002-0933-4854; Mota da Silva, Jonathan/0000-0001-9995-8451; Saad, Sandra/0000-0002-4380-3175	National Council for Scientific and Technological Development (CNPq) [15936363/2012-8]; Project Fapesp ClimateWise [2015/50682-6]; Fapesp ECOFOR [2012/51872-5]; Project Fapesp ECOFOR [2012/51872-5]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Project Fapesp ClimateWise(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Fapesp ECOFOR(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Project Fapesp ECOFOR(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the National Council for Scientific and Technological Development (CNPq, Process 15936363/2012-8): doctoral fellowship and the Project Fapesp ClimateWise "Climate-Smart Watershed Investments in the Montane Tropics of South America" (2015/50682-6). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Fapesp ECOFOR "Biodiversity and Ecosystem Functioning in degraded and recovering Amazonian and Atlantic Forests" (2012/51872-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author JLBG is affiliated with the commercial company Aquaflora Meio Ambiente. The funder provided support in the form of salaries for JLBG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; The authors would like to thank Project Fapesp ClimateWise "Climate-Smart Watershed Investments in the Montane Tropics of South America" (2015/50682-6), and Project Fapesp ECOFOR "Biodiversity and Ecosystem Functioning in degraded and recovering Amazonian and Atlantic Forests" (2012/51872-5). The first author would like to thank The National Council for Scientific and Technological Development (CNPq, Process 15936363/2012-8) for a doctoral fellowship, The Nature Conservancy (TNC) and Eileen Andrea Acosta Porras and Chris Finney, Agencia Nacional das Aguas and Andrelina Laura dos Santos, Extrema City Council and Paulo Pereira, for data and information of Posses watershed, and Paulo Sinisgalli for the suggestions.	Adame MF, 2015, CONSERV BIOL, V29, P493, DOI 10.1111/cobi.12391; da Silva MA, 2014, CIENC AGROTEC, V38, P160, DOI 10.1590/S1413-70542014000200007; Avalos FAP, 2016, VARIABILIDADE ESPACI; Barnett A, 2016, BIOSCIENCE, VXX; Birch J.C., P NATL ACAD SCI; da Silva FDB, 2010, ENG SANIT AMBIENT, V15, P141, DOI 10.1590/S1413-41522010000200006; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Chirico GB, 2013, PROCEDIA ENVIRON SCI, V19, P932, DOI 10.1016/j.proenv.2013.06.103; CRAWFORD CG, 1991, J HYDROL, V129, P331, DOI 10.1016/0022-1694(91)90057-O; Cressman G.P., 1959, MON WEATHER REV, V87, P367, DOI [10.1175/1520-0493(1959)0872.0.CO;2, 10.1175/1520-0493(1959)087, DOI 10.1175/1520-0493(1959)0872.0.CO;2]; Crossman ND, 2009, ECOL ECON, V68, P654, DOI 10.1016/j.ecolecon.2008.05.003; Cruz J, 2003, LAND WATER MEET GUID; DASILVA M, 2016, REV BRAS CIENC DO, V40, P1, DOI DOI 10.1590/18069657RBCS20140331; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Desmet PJJ, 1996, J SOIL WATER CONSERV, V51, P427; Garcia LC, 2013, NAT CONSERVACAO, V11, P181, DOI 10.4322/natcon.2013.028; Goel Pradeep Kumar, 2004, POLLUTANTS REMOVAL V; Goldstein JH, 2008, CONSERV LETT, V1, P236, DOI 10.1111/j.1755-263X.2008.00031.x; Hamel P, 2015, HYDROL EARTH SYST SC, V19, P839, DOI 10.5194/hess-19-839-2015; Huisman JA, 2009, ADV WATER RESOUR, V32, P159, DOI 10.1016/j.advwatres.2008.06.009; Lima JEFW, 2008, 7 ENC NAC ENG SED CA, P1; Liu XM, 2008, J ENVIRON QUAL, V37, P1667, DOI 10.2134/jeq2007.0437; Lombardi Neto F, 1992, AGRONOMICAS, V51, P189; Lu H, 2006, ENVIRON MODELL SOFTW, V21, P1297, DOI 10.1016/j.envsoft.2005.04.021; Martins SG, 2010, SCI FOR SCI, P517; MEA, 2003, EC HUM WELL BEING FR, P1; Metzger JP, 2010, NAT CONSERVACAO, V8, P92, DOI 10.4322/natcon.00801017; Muniz D.H. De, 2011, 19 S BRAS REC HIDR, P13; Newton AC, 2012, J APPL ECOL, V49, P571, DOI 10.1111/j.1365-2664.2012.02140.x; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Park YS, 2011, WATER-SUI, V3, P819, DOI 10.3390/w3030819; Pereira PH, 2010, CONSERVADOR EXTREMA; Pradhan B, 2012, ENVIRON MONIT ASSESS, V184, P715, DOI 10.1007/s10661-011-1996-8; Richards RC, 2015, ECOSYST SERV, V16, P23, DOI 10.1016/j.ecoser.2015.09.002; Sanchez-Canales M, 2012, SCI TOTAL ENVIRON, V440, P140, DOI 10.1016/j.scitotenv.2012.07.071; Silva M. A. da, 2013, Revista Brasileira de Ciencias Agrarias (Agraria), V8, P316, DOI 10.5039/agraria.v8i2a2289; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Sparovek G, 2010, ENVIRON SCI TECHNOL, V44, P6046, DOI 10.1021/es1007824; Strauch M, 2013, J ENVIRON MANAGE, V127, pS24, DOI 10.1016/j.jenvman.2013.01.014; Strauch M, 2012, J HYDROL, V414, P413, DOI 10.1016/j.jhydrol.2011.11.014; Tallis H, 2011, INVEST 2 4 4 USERS G; Uddin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150494; White MJ, 2009, HYDROL PROCESS, V23, P1602, DOI 10.1002/hyp.7291; Wischmeier W.H., 1978, AGR HDB; Yuan YP, 2009, ECOHYDROLOGY, V2, P321, DOI 10.1002/eco.82; Zhang JJ, 2013, LAND DEGRAD DEV, V24, P236, DOI 10.1002/ldr.1120; Zolin CA, 2014, AGR WATER MANAGE, V137, P75, DOI 10.1016/j.agwat.2014.02.006	47	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192325	10.1371/journal.pone.0192325	http://dx.doi.org/10.1371/journal.pone.0192325			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425214	Green Published, gold			2022-12-26	WOS:000424700800021
J	Thorrington, D; van Rossum, L; Knol, M; de Melker, H; Rumke, H; Hak, E; van Hoek, AJ				Thorrington, Dominic; van Rossum, Leo; Knol, Mirjam; de Melker, Hester; Rumke, Hans; Hak, Eelko; van Hoek, Albert Jan			Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands	PLOS ONE			English	Article							CONJUGATE VACCINE; OLDER-ADULTS	Background Streptococcus pneumoniae causes morbidity and mortality among all ages in The Netherlands. To reduce this burden, infants in The Netherlands receive the 10-valent pneumococcal conjugated vaccine (PCV10), but older persons are not targeted. We assessed the impact and cost-effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine (PPV23) or 13-valent PCV (PCV13) among all those aged 60, 65 or 70 and/or in combination with replacing PCV10 with PCV13 in the infant vaccination programme. Methods A static cost-effectiveness model was parameterized including projected trends for invasive pneumococcal disease (IPD) and hospitalised community acquired pneumonia (CAP). The different strategies were evaluated using vaccine list prices and a 10-year time horizon. Incremental cost-effectiveness ratios (ICER) were calculated with the current strategy (infant vaccination program with PCV10) as reference. Results Compared to the reference, the largest impact on pneumococcal disease burden was projected with a combined use of PCV13 among infants and PPV23 at 60, 65 and 70 years, preventing 1,635 cases of IPD and 914 cases of CAP. The most cost-effective strategy was vaccinating with PPV23 at 70 years only with similar low ICERs at age 60 and 65. The impact of the use of PCV13 among infants depends strongly on the projected herd-immunity effect on serotype 19A. Vaccinating elderly with either PCV13 or PPV23 was dominated by PPV23 in all investigated scenarios, mainly due to the lower price of PPV23. Conclusion Under the current assumptions, the best value for money is the use of PPV23 for elderly, with a single dose or at five year increment between age 60 to age 70.	[Thorrington, Dominic] Publ Hlth England, Resp Dis Dept, London, England; [van Rossum, Leo] Hlth Council Netherlands, Vaccinat Comm, The Hague, Netherlands; [Knol, Mirjam; de Melker, Hester; van Hoek, Albert Jan] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Hak, Eelko] Univ Groningen, Groningen Res Inst Pharm, Groningen, Netherlands; [van Hoek, Albert Jan] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	Public Health England; Netherlands National Institute for Public Health & the Environment; University of Groningen; University of London; London School of Hygiene & Tropical Medicine	van Hoek, AJ (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.; van Hoek, AJ (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	albert.vanhoek@lshtm.ac.uk			I-Move+; H grant from the European Council [634446]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) [HPRU-2012-10096]	I-Move+; H grant from the European Council; National Institute for Health Research Health Protection Research Unit (NIHR HPRU)	DM was funded by I-Move+, a H2020 grant (#634446) from the European Council (http:// WWW.i-moveplus.eu/); AJvH was funded by National Institute for Health Research Health Protection Research Unit (NIHR HPRU #HPRU-2012-10096) in Immunisation at the London School of Hygiene & Tropical Medicine in partnership with Public Health England (PHE) (http://immunisation.hpru.nihr.ac.uk/). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the EU H2020, the Netherlands National Institute for Public Health and the Environment, the Dutch Health Council, the London School of Hygiene & Tropical Medicine, the Department of Health or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; [Anonymous], 2016, GUIDELINE CONDUCT EC; Blommaert A, 2016, VACCINE, V34, P2106, DOI 10.1016/j.vaccine.2016.03.003; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Chen JL, 2014, ADV THER, V31, P392, DOI 10.1007/s12325-014-0115-y; Dirmesropian S, 2017, VACCINE, V35, P4307, DOI 10.1016/j.vaccine.2017.06.085; Eilers R, 2017, VACCINE, V35, P2823, DOI 10.1016/j.vaccine.2017.04.014; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Falkenhorst G, 2016, BUNDESGESUNDHEITSBLA, V59, P1623, DOI 10.1007/s00103-016-2466-9; Falkenhorst G, 2017, PLOS ONE, P1; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Hanquet G, 2016, INDIRECT EFFECT 5 YE, P40; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; NIVEL, 2016, MON VACC NAT PROGR G; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Raeven VM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1641-9; Remschmidt C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2040-y; RIVM, 2017, LCI GUID; Rogoza RM, 2009, VACCINE, V27, P4776, DOI 10.1016/j.vaccine.2009.05.085; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; van Lier EA, 2017, VACCINATIEGRAAD JAAR, V2016, P56; Wagenvoort GHJ, 2016, VACCINE, V34, P1077, DOI 10.1016/j.vaccine.2015.12.066; Westra TA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-75; Zwaap J, 2015, KOSTENEFFECTIVITEIT, P64	25	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192640	10.1371/journal.pone.0192640	http://dx.doi.org/10.1371/journal.pone.0192640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425249	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000424700800033
J	Autilio, C; Echaide, M; De Luca, D; Perez-Gil, J				Autilio, Chiara; Echaide, Mercedes; De Luca, Daniele; Perez-Gil, Jesus			Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome	PLOS ONE			English	Article							INDUCED LUNG INJURY; PULMONARY SURFACTANT; PRETERM INFANTS; FILM FORMATION; MEMBRANES; CHOLESTEROL; VENTILATION; ADSORPTION; ENCEPHALOPATHY; TEMPERATURE	Background Whole-body hypothermia (WBH) is used to improve neurological outcomes in perinatal asphyxia. Recent studies suggested a beneficial effect of hypothermia for some types of acute respiratory failure. However, no data are available about the biophysical function of human surfactant during WBH. We investigated whether WBH improves surfactant biophysical properties in asphyxiated neonates with or without meconium aspiration syndrome (MAS). Methods Non-bronchoscopic bronchoalveolar lavage (BAL) has been collected from 10 asphyxiated neonates (2 with MAS, 8 with no lung disease (NLD)) at different time-points (pre-WBH, 24h, 48h, 72h of WBH and post-WBH). Surfactant was extracted and tested by captive bubble surfactometry (CBS) in triplicate, at 37 degrees C and 33.5 degrees C,through initial adsorption and dynamic compression-expansion cycling. Phosphatidylcholine and cholesterol were assayed using enzymatic methods. Clinical data were recorded in real-time. Results Minimum surface tension under dynamic testing was significantly improved as assessed at 33.5 degrees C compared with its behavior at 37 degrees C in NLD neonates: the difference was evident after at least 72h of WBH and remained significant at 6h after rewarming (72h: p = 0.009; rewarming: p = 0.040). Similar results were obtained in MAS patients whose surfactant activity improved already at 48h of hypothermia. Total cholesterol showed a trend to increase at the first 24-48h of hypothermia in NLD patients. Conversely, hypothermia seemed to reduce the excess of exogenous cholesterol in MAS surfactant. Conclusions Surfactant biophysical properties may improve after 48-72h of WBH in asphyxiated neonates and the improvement is maintained shortly after rewarming. Due to study limitations, further studies are warranted to better clarify the effects of hypothermia on surfactant activity.	[Autilio, Chiara; Echaide, Mercedes; Perez-Gil, Jesus] Univ Complutense Madrid, Fac Biol, Dept Biochem, Madrid, Spain; [Autilio, Chiara; Echaide, Mercedes; Perez-Gil, Jesus] Univ Complutense Madrid, Hosp Octubre 12, Res Inst, Madrid, Spain; [Autilio, Chiara] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Dept Lab Med, Lab Clin Mol Biol, Rome, Italy; [De Luca, Daniele] South Paris Univ Hosp, AP HP, A Beclere Med Ctr, Div Pediat & Neonatal Crit Care, Paris, France	Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Perez-Gil, J (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Biochem, Madrid, Spain.; Perez-Gil, J (corresponding author), Univ Complutense Madrid, Hosp Octubre 12, Res Inst, Madrid, Spain.	jperezgil@bio.ucm.es	ECHAIDE, MERCEDES/I-1649-2015; Perez-Gil, Jesus/H-3102-2019; Autilio, Chiara/A-6613-2018	ECHAIDE, MERCEDES/0000-0002-0836-0858; Perez-Gil, Jesus/0000-0003-3587-7147; Autilio, Chiara/0000-0003-3446-1692; De Luca, Daniele/0000-0002-3846-4834	Laerdal Foundation Grant; ADRN (Association pour le Developpement et la Recherche en Neonatologie) non-profit foundation; Spanish Ministry of Economy and Competitiveness [BIO2015-67930-R]; Regional Government of Madrid [P2013/MIT-2807]	Laerdal Foundation Grant; ADRN (Association pour le Developpement et la Recherche en Neonatologie) non-profit foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government); Regional Government of Madrid	The study has been funded by the Laerdal Foundation Grant 2014 (received by DLD), by a travel grant from ADRN (Association pour le Developpement et la Recherche en Neonatologie) non-profit foundation, and by grants from Spanish Ministry of Economy and Competitiveness (BIO2015-67930-R) and the Regional Government of Madrid (P2013/MIT-2807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinsoy C, 2014, J MATERN-FETAL NEO M, V27, P421, DOI 10.3109/14767058.2013.818115; Aslami H, 2012, TRANSL RES, V159, P110, DOI 10.1016/j.trsl.2011.10.005; Aslami H, 2010, RESUSCITATION, V81, P1723, DOI 10.1016/j.resuscitation.2010.09.006; Autilio C, 2017, THER HYPOTH IN PRESS; Autilio C, 2017, J PEDIATR-US, V182, P66, DOI 10.1016/j.jpeds.2016.11.057; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Ball MK, 2010, RESUSCITATION, V81, P749, DOI 10.1016/j.resuscitation.2009.12.007; de la Serna JB, 2013, FARADAY DISCUSS, V161, P535, DOI 10.1039/c2fd20096a; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Bernhard W, 2016, ANN ANAT, V208, P146, DOI 10.1016/j.aanat.2016.08.003; Bernhard W, 2011, J APPL PHYSIOL, V111, P449, DOI 10.1152/japplphysiol.00766.2010; Boet A, 2014, MINERVA ANESTESIOL, V80, P1345; BOYNTON BR, 1989, J APPL PHYSIOL, V66, P1343, DOI 10.1152/jappl.1989.66.3.1343; Casals O, 2012, BIOCHIM BIOPHYS ACTA, V1818, P2550; Dargaville PA, 1999, AM J RESP CRIT CARE, V160, P771, DOI 10.1164/ajrccm.160.3.9811048; Dargaville PA, 2011, J PEDIATR-US, V158, P383, DOI 10.1016/j.jpeds.2010.08.044; de Blic J, 2000, EUR RESPIR J, V15, P217; De Jaegere A, 2006, AM J RESP CRIT CARE, V174, P639, DOI 10.1164/rccm.200603-351OC; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; De Luca D, 2016, AM J RESP CRIT CARE, V194, P381, DOI 10.1164/rccm.201602-0422LE; De Luca D, 2014, EUR RESPIR J, V44, P1708, DOI 10.1183/09031936.00117714; De Luca D, 2013, CRIT CARE, V17, DOI 10.1186/cc12842; De Luca D, 2011, INTENS CARE MED, V37, P1158, DOI 10.1007/s00134-011-2243-z; Dhillon G, 2015, INDIAN J CRIT CARE M, V19, P353, DOI 10.4103/0972-5229.158278; DOYLE R, 1994, AM J RESP CRIT CARE, V149, P1619, DOI 10.1164/ajrccm.149.6.8004321; Duan M, 2011, RESP CARE, V56, P1956, DOI 10.4187/respcare.01211; Echaide M, 2017, BBA-BIOMEMBRANES, V1859, P1725, DOI 10.1016/j.bbamem.2017.03.015; Gille C, 2007, J LIPID RES, V48, P307, DOI 10.1194/jlr.M600451-JLR200; Griese M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117985; Gunasekara L, 2005, BBA-MOL CELL BIOL L, V1737, P27, DOI 10.1016/j.bbalip.2005.09.002; Hall NJ, 2010, PEDIATRICS, V125, pE300, DOI 10.1542/peds.2008-3211; HAWCO MW, 1981, J APPL PHYSIOL, V51, P509, DOI 10.1152/jappl.1981.51.2.509; Hobi N, 2014, BBA-BIOMEMBRANES, V1838, P1842, DOI 10.1016/j.bbamem.2014.02.015; Hong SB, 2005, CRIT CARE MED, V33, P2049, DOI 10.1097/01.CCM.0000178186.37167.53; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Keating E, 2007, BIOPHYS J, V93, P1391, DOI 10.1529/biophysj.106.099762; LEMPERT J, 1971, J APPL PHYSIOL, V31, P380, DOI 10.1152/jappl.1971.31.3.380; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; Lopez-Rodriguez E, 2011, BIOPHYS J, V100, P646, DOI 10.1016/j.bpj.2010.12.3715; Naito H K, 1984, Lab Res Methods Biol Med, V10, P1; NANJEE MN, 1991, CLIN CHEM, V37, P868; Nespeca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153328; NOTTER RH, 1980, J LIPID RES, V21, P10; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Parra E, 2015, CHEM PHYS LIPIDS, V185, P153, DOI 10.1016/j.chemphyslip.2014.09.002; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Piastra M, 2014, EARLY HUM DEV, V90, pS41, DOI 10.1016/S0378-3782(14)50011-4; Pietrini D, 2012, EUR J PEDIATR, V171, P1855, DOI 10.1007/s00431-012-1769-6; Pietrini D, 2012, CURR DRUG TARGETS, V13, P925, DOI 10.2174/138945012800675641; Ravasio A, 2008, J LIPID RES, V49, P2479, DOI 10.1194/jlr.D800029-JLR200; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Suri LNM, 2013, BBA-BIOMEMBRANES, V1828, P1707, DOI 10.1016/j.bbamem.2013.03.005; Suri LNM, 2012, BBA-BIOMEMBRANES, V1818, P1581, DOI 10.1016/j.bbamem.2012.02.021; YU SH, 1993, BIOCHIM BIOPHYS ACTA, V1167, P264, DOI 10.1016/0005-2760(93)90228-2	56	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192295	10.1371/journal.pone.0192295	http://dx.doi.org/10.1371/journal.pone.0192295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420583	Green Submitted, gold, Green Published			2022-12-26	WOS:000424517900062
J	Cappellano, G; Ploner, C; Lobenwein, S; Sopper, S; Hoertnagl, P; Mayerl, C; Wick, N; Pierer, G; Wick, G; Wolfram, D				Cappellano, Giuseppe; Ploner, Christian; Lobenwein, Susanne; Sopper, Sieghart; Hoertnagl, Paul; Mayerl, Christina; Wick, Nikolaus; Pierer, Gerhard; Wick, Georg; Wolfram, Dolores			Immunophenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfaces	PLOS ONE			English	Article							CAPSULAR CONTRACTURE; LYMPHOCYTE-ACTIVATION; MAMMARY IMPLANTS; AUGMENTATION; EXPRESSION; FIBROSIS; BIOCOMPATIBILITY; PROLIFERATION; RESPONSES; BIOFILM	The most common complication of silicone breast implants is capsular contracture (massive scar formation around the implant). We postulate that capsular contracture is always a sequel to inflammatory processes, with both innate and adaptive immune mechanisms participating. In general, fibroblasts and macrophages have been used as cell types to evaluate in vitro the biocompatibility of breast implant surfaces. Moreover, also T cells have been found at the implant site at the initial stage of fibrous capsule formation. However, only few studies have addressed the influence of surfaces with different textures on T-cell responses. The aim of the present study was to investigate the immune response of human peripheral blood mononuclear cells (PBMC) to commercially available silicone breast implants in vitro. PBMC from healthy female blood donors were cultured on each silicone surface for 4 days. Proliferation and phenotype of cultured cells were assessed by flow cytometry. Cytokine levels were determined by multiplex and real-time assay. We found that silicone surfaces do not induce T-cell proliferation, nor do they extensively alter the proportion of T cell subsets (CD4, CD8, naive, effector memory). Interestingly, cytokine profiling identified matrix specific differences, especially for IL-6 and TNF-alpha on certain surface topographies that could lead to increased fibrosis.	[Cappellano, Giuseppe; Ploner, Christian; Lobenwein, Susanne; Pierer, Gerhard; Wolfram, Dolores] Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg, Innsbruck, Austria; [Sopper, Sieghart] Med Univ Innsbruck, Dept Internal Med 5, Innsbruck, Austria; [Hoertnagl, Paul] Med Univ Innsbruck, Cent Inst Blood Transfus & Immunol Dept, Innsbruck, Austria; [Mayerl, Christina] Med Univ Innsbruck, Dept Internal Med Cardiol & Angiol 3, Innsbruck, Austria; [Wick, Nikolaus] Wick Lab, Innsbruck, Austria; [Wick, Georg] Med Univ Innsbruck, Ctr Biocalorimetry, Bioctr, Div Expt Pathophysiol & Immunol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Wolfram, D (corresponding author), Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg, Innsbruck, Austria.	dolores.wolfram@i-med.ac.at	Sopper, Sieghart/I-3155-2018; Cappellano, Giuseppe/ABE-4980-2020	Sopper, Sieghart/0000-0003-2265-1974; Ploner, Christian/0000-0002-0313-2960; Wolfram, Dolores/0000-0003-0920-7211; Cappellano, Giuseppe/0000-0001-5193-4688	Estabilishement Lab, Costa Rica	Estabilishement Lab, Costa Rica	This project has been supported by Estabilishement Lab, Costa Rica. The funder had no role in study design, in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Backovic A, 2007, EXP GERONTOL, V42, P713, DOI 10.1016/j.exger.2007.04.003; Barr S, 2017, J MECH BEHAV BIOMED, V75, P75, DOI 10.1016/j.jmbbm.2017.06.030; Barr S, 2009, Eplasty, V9, pe22; Brody GS, 2015, PLAST RECONSTR SURG, V135, P695, DOI 10.1097/PRS.0000000000001033; Buszko M, 2017, IMMUNOL LETT, V186, P1, DOI 10.1016/j.imlet.2017.04.002; Dolores W, 2004, J AUTOIMMUN, V23, P81, DOI 10.1016/j.jaut.2004.03.005; EMERY JA, 1994, MODERN PATHOL, V7, P728; Hall-Findlay EJ, 2011, PLAST RECONSTR SURG, V127, P56, DOI 10.1097/PRS.0b013e3181fad34d; Headon H, 2015, ARCH PLAST SURG-APS, V42, P532, DOI 10.5999/aps.2015.42.5.532; Hu HH, 2015, PLAST RECONSTR SURG, V135, P319, DOI 10.1097/PRS.0000000000000886; Jacombs A, 2014, PLAST RECONSTR SURG, V133, p471E, DOI 10.1097/PRS.0000000000000020; Johnson Marlene, 2013, Radiol Technol, V84, p439M; Kim B, 2011, PLAST RECONSTR SURG, V127, P2141, DOI 10.1097/PRS.0b013e3182172418; Kyle DJT, 2015, BIOMATERIALS, V52, P88, DOI 10.1016/j.biomaterials.2015.02.003; Liu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116071; Lowe DB, 2011, IMMUNOTHERAPY-UK, V3, P1265, DOI [10.2217/IMT.11.113, 10.2217/imt.11.113]; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Britez MEM, 2012, EUR J PLAST SURG, V35, P647, DOI 10.1007/s00238-012-0728-9; Nair N, 2012, PLAST RECONSTR SURG, V130, p128E, DOI 10.1097/PRS.0b013e318254b359; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Nava MB, 2017, GLAND SURG, V6, P210, DOI 10.21037/gs.2017.04.02; Otsuka H, 2006, EUR CELLS MATER, V12, P36, DOI 10.22203/eCM.v012a04; Rodriguez A, 2010, J BIOMED MATER RES A, V92A, P214, DOI 10.1002/jbm.a.32362; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; Steiert AE, 2013, MED DEVICES-EVID RES, V6, P211, DOI 10.2147/MDER.S49522; Valencia-Lazcano AA, 2013, J MECH BEHAV BIOMED, V21, P133, DOI 10.1016/j.jmbbm.2013.02.005; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Wolfram D, 2012, PLAST RECONSTR SURG, V129, p327E, DOI 10.1097/PRS.0b013e31823aeacf; Wong CH, 2006, PLAST RECONSTR SURG, V118, P1224, DOI 10.1097/01.prs.0000237013.50283.d2; Ye X, 2014, MUTAT RES-REV MUTAT, V762, P123, DOI 10.1016/j.mrrev.2014.08.002	35	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192108	10.1371/journal.pone.0192108	http://dx.doi.org/10.1371/journal.pone.0192108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420643	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900040
J	Khan, R; Roy, N; Choi, K; Lee, SW				Khan, Raees; Roy, Nazish; Choi, Kihyuck; Lee, Seon-Woo			Distribution of triclosan-resistant genes in major pathogenic microorganisms revealed by metagenome and genome-wide analysis	PLOS ONE			English	Article							PREDICTS ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; PSEUDOMONAS-AERUGINOSA; FUNCTIONAL ASSIGNMENTS; REDUCTASE FABI; BIOCIDE; TARGET; IDENTIFICATION; ENVIRONMENT; INHIBITION	The substantial use of triclosan (TCS) has been aimed to kill pathogenic bacteria, but TCS resistance seems to be prevalent in microbial species and limited knowledge exists about TCS resistance determinants in a majority of pathogenic bacteria. We aimed to evaluate the distribution of TCS resistance determinants in major pathogenic bacteria (N = 231) and to assess the enrichment of potentially pathogenic genera in TCS contaminated environments. A TCS-resistant gene (TRG) database was constructed and experimentally validated to predict TCS resistance in major pathogenic bacteria. Genome-wide in silico analysis was performed to define the distribution of TCS-resistant determinants in major pathogens. Microbiome analysis of TCS contaminated soil samples was also performed to investigate the abundance of TCS-resistant pathogens. We experimentally confirmed that TCS resistance could be accurately predicted using genome-wide in silico analysis against TRG database. Predicted TCS resistant phenotypes were observed in all of the tested bacterial strains (N = 17), and heterologous expression of selected TCS resistant genes from those strains conferred expected levels of TCS resistance in an alternative host Escherichia coli. Moreover, genome-wide analysis revealed that potential TCS resistance determinants were abundant among the majority of human-associated pathogens (79%) and soil-borne plant pathogenic bacteria (98%). These included a variety of enoyl-acyl carrier protein reductase (ENRs) homologues, AcrB efflux pumps, and ENR substitutions. FabI ENR, which is the only known effective target for TCS, was either co-localized with other TCS resistance determinants or had TCS resistance-associated substitutions. Furthermore, microbiome analysis revealed that pathogenic genera with intrinsic TCS-resistant determinants exist in TCS contaminated environments. We conclude that TCS may not be as effective against the majority of bacterial pathogens as previously presumed. Further, the excessive use of this biocide in natural environments may selectively enrich for not only TCS-resistant bacterial pathogens, but possibly for additional resistance to multiple antibiotics.	[Khan, Raees; Roy, Nazish; Choi, Kihyuck; Lee, Seon-Woo] Dong A Univ, Dept Appl Biosci, Busan, South Korea	Dong A University	Lee, SW (corresponding author), Dong A Univ, Dept Appl Biosci, Busan, South Korea.	seonlee@dau.ac.kr	Choi, Kihyuck/AAN-9759-2020; KHAN, RAEES/AAT-8621-2020	KHAN, RAEES/0000-0002-8324-5702; Choi, Kihyuck/0000-0002-7031-3075; Lee, Seon-Woo/0000-0001-6142-7612	Cooperative Research Program for Agricultural Science & Technology Development, Republic of Korea [PJ01093901]	Cooperative Research Program for Agricultural Science & Technology Development, Republic of Korea	This study was funded by the Cooperative Research Program for Agricultural Science & Technology Development (Under the grant number PJ01093901 to SWL), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FDA ISS FIN RUL SAF; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Bester K, 2003, WATER RES, V37, P3891, DOI 10.1016/S0043-1354(03)00335-X; Biswas S, 2008, INT J ANTIMICROB AG, V32, P207, DOI 10.1016/j.ijantimicag.2008.03.017; Butler E, 2012, ENVIRON POLLUT, V167, P101, DOI 10.1016/j.envpol.2012.03.036; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chong Chan-Eng, 2006, In Silico Biology, V6, P341; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Dinwiddie MT, 2014, INT J ENV RES PUB HE, V11, P2209, DOI 10.3390/ijerph110202209; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002; Fernando DM, 2014, ANTIMICROB AGENTS CH, V58, P6424, DOI 10.1128/AAC.03074-14; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Fraise AP, 2002, J ANTIMICROB CHEMOTH, V49, P11, DOI 10.1093/jac/49.1.11; Gao B, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0150-9; Halden RU, 2014, ENVIRON SCI TECHNOL, V48, P3603, DOI 10.1021/es500495p; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; JACKOWSKI S, 1989, J BIOL CHEM, V264, P7624; James M., 2015, FASEB J, V29, P622, DOI DOI 10.1096/FASEBJ.29.1_SUPPLEMENT.622.4; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Khan R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32322; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Macri D, 2017, CONTEMP CLIN DENT, V8, P7, DOI 10.4103/ccd.ccd_225_17; Marshall N., 2014, J IMMUNOL S, V192, P119; Marshall NB, 2015, TOXICOL SCI, V147, P127, DOI 10.1093/toxsci/kfv113; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; McMurry LM, 1999, ANTIMICROB AGENTS CH, V43, P711, DOI 10.1128/AAC.43.3.711; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Pal C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2153-5; Pal C, 2014, NUCLEIC ACIDS RES, V42, pD737, DOI 10.1093/nar/gkt1252; Parkpian P, 2002, J ENVIRON SCI HEAL A, V37, P1099, DOI 10.1081/ESE-120004526; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Rout S, 2015, J MICROBIOL METH, V109, P1, DOI 10.1016/j.mimet.2014.11.016; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Saleh S, 2011, LETT APPL MICROBIOL, V52, P87, DOI 10.1111/j.1472-765X.2010.02976.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Sippel KH, 2014, J BIOL CHEM, V289, P33287, DOI 10.1074/jbc.M114.608547; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Tyson GH, 2015, J ANTIMICROB CHEMOTH, V70, P2763, DOI 10.1093/jac/dkv186; Walsh F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00019; Walters GI, 2017, ANN ALLERG ASTHMA IM, V118, P370, DOI 10.1016/j.anai.2016.12.001; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Yee AL, 2016, SCIENCE, V353, P348, DOI 10.1126/science.aag2698; Yu BJ, 2010, J ANTIMICROB CHEMOTH, V65, P1171, DOI 10.1093/jac/dkq114; Yueh MF, 2016, ANNU REV PHARMACOL, V56, P251, DOI 10.1146/annurev-pharmtox-010715-103417; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao S, 2016, APPL ENVIRON MICROB, V82, P459, DOI 10.1128/AEM.02873-15; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	65	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192277	10.1371/journal.pone.0192277	http://dx.doi.org/10.1371/journal.pone.0192277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420585	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900060
J	Perciani, CT; Jaoko, W; Farah, B; Ostrowski, MA; Anzala, O; MacDonald, KS				Perciani, Catia T.; Jaoko, Walter; Farah, Bashir; Ostrowski, Mario A.; Anzala, Omu; MacDonald, Kelly S.		KAVI-ICR Team	alpha E beta 7, alpha 4 beta 7 and alpha 4 beta 1 integrin contributions to T cell distribution in blood, cervix and rectal tissues: Potential implications for HIV transmission	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIGHLY PATHOGENIC SIV; ULCERATIVE-COLITIS; GASTROINTESTINAL-TRACT; MAINTENANCE THERAPY; CROHNS-DISEASE; IN-VIVO; INFECTION; LYMPHOCYTES; INDUCTION	Cell surface expression of alpha 4 beta 7, alpha 4 beta 1 and alpha E beta 7 integrins play a key role in T cell distribution. Understanding the contribution of integrins to the density and ratios of CD4(+):CD4(neg)T cell at the portals of entry for HIV is of fundamental importance for the advance of more effective HIV prevention strategies. We therefore set out to characterize and compare the expression of alpha 4 beta 7, alpha 4 beta 1 and alpha E beta 7 integrins on systemic, cervical and rectal CD4(+) and CD4(neg) T cells isolated from a cohort of healthy Kenyan women at low risk for sexually transmitted infections (STI) (n = 45). Here we show that blood and cervix were enriched in alpha 4(+)beta 1(+)CD4(+)T cells and alpha 4(+)beta 7(hi)CD4(+)T cells, whereas the rectum had an equal frequency of alpha 4(+)beta 7(hi)CD4(+)T cells and alpha E+ss 7(hi)CD4(+)T cells. Most cervical and rectal alpha E+beta 7(hi) CD4(+)T cells expressed CCR5 as well as CD69. Interestingly, alpha E beta 7 was the predominant integrin expressed by CD4(neg)T cells in both mucosal sites, outnumbering alpha E+beta 7(hi) CD4(+)T cells approximately 2-fold in the cervix and 7-fold in the rectum. The majority of alpha E+beta 7(hi) CD4(neg)T cells expressed CD69 at the mucosa. Taken together, our results show unique tissue-specific patterns of integrin expression. These results can help in guiding vaccine design and also the use of therapeutically targeting integrin adhesion as a means to preventing HIV.	[Perciani, Catia T.; Ostrowski, Mario A.; MacDonald, Kelly S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Jaoko, Walter; Farah, Bashir; Anzala, Omu; KAVI-ICR Team] Inst Clin Res KAVI ICR, Kenyan AIDS Vaccine Initiat, Nairobi, Kenya; [Jaoko, Walter; Anzala, Omu] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Ostrowski, Mario A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [MacDonald, Kelly S.] Univ Manitoba, Max Rady Coll Med, Dept Internal Med, Sect Infect Dis, Winnipeg, MB, Canada	University of Toronto; University of Nairobi; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Manitoba	MacDonald, KS (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; MacDonald, KS (corresponding author), Univ Manitoba, Max Rady Coll Med, Dept Internal Med, Sect Infect Dis, Winnipeg, MB, Canada.	kelly.macdonald@umanitoba.ca	Jaoko, Walter/AAN-5048-2020; Perciani, Catia/S-9093-2019; MacDonald, Kelly S/L-3315-2019	Jaoko, Walter/0000-0002-7134-6581; Perciani, Catia/0000-0003-0377-1778	Canadian Institutes for Health Research (CIHR Team Grant) [THA:11960]; CIHR Vanier Canada Graduate Scholarship; Delta Kappa Gamma Society World Fellowship; Ontario Graduate Scholarship; Ontario HIV Treatment Network Senior Investigator Award; HE Sellers Research Chair	Canadian Institutes for Health Research (CIHR Team Grant); CIHR Vanier Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Delta Kappa Gamma Society World Fellowship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario HIV Treatment Network Senior Investigator Award; HE Sellers Research Chair	This study has been funded by the Canadian Institutes for Health Research (CIHR Team Grant - Research Operating THA:11960). CTP was supported by CIHR Vanier Canada Graduate Scholarship, The Delta Kappa Gamma Society World Fellowship and Ontario Graduate Scholarship. KSM was funded by an Ontario HIV Treatment Network Senior Investigator Award. KSM is currently supported by the HE Sellers Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Carnathan DG, 2014, P NATL ACAD SCI US; ERLE DJ, 1994, J IMMUNOL, V153, P517; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Fiorino G, 2016, THER ADV GASTROENTER, V9, P503, DOI 10.1177/1756283X16647935; Glennie ND, 2015, J EXP MED, V212, P1405, DOI 10.1084/jem.20142101; Goode D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004567; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Joag VR, 2015, MUCOSAL IMMUNOLOGY; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kelley CF, 2016, AIDS, V30, P1302, DOI 10.1097/QAD.0000000000001062; Krzysiek R, 2001, BLOOD, V98, P3169, DOI 10.1182/blood.V98.10.3169; Lamb CA, 2017, J CROHNS COLITIS, V11, P610, DOI 10.1093/ecco-jcc/jjw189; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Pauls K, 2001, J INVEST DERMATOL, V117, P569, DOI 10.1046/j.0022-202x.2001.01481.x; Perciani CT, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017391; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Sivro A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6354; Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105; Veazey R S, 1998, AIDS, V12 Suppl A, pS35; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vermeire S, 2014, LANCET, V384, P309, DOI 10.1016/S0140-6736(14)60661-9; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Woon HG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005799; Zundler S, 2016, GUT; Zundler S, 2017, INFLAMM BOWEL DIS, V23, P379, DOI 10.1097/MIB.0000000000001029	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192482	10.1371/journal.pone.0192482	http://dx.doi.org/10.1371/journal.pone.0192482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420608	Green Submitted, gold, Green Published			2022-12-26	WOS:000424517900081
J	Sardar, P; Kempken, F				Sardar, Puspendu; Kempken, Frank			Characterization of indole-3-pyruvic acid pathway-mediated biosynthesis of auxin in Neurospora crassa	PLOS ONE			English	Article							BACTERIAL BIOSYNTHESIS; EVOLUTIONARY PATTERNS; CONIDIAL GERMINATION; DATABASE RESOURCES; SALKOWSKI REAGENT; CRYSTAL-STRUCTURE; IAA BIOSYNTHESIS; NATIONAL-CENTER; YOUNG HYPHAE; IDENTIFICATION	Plants, bacteria and some fungi are known to produce indole-3-acetic acid (IAA) by employing various pathways. Among these pathways, the indole-3-pyruvic acid (IPA) pathway is the best studied in green plants and plant-associated beneficial microbes. While IAA production circuitry in plants has been studied for decades, little is known regarding the IAA biosynthesis pathway in fungal species. Here, we present the first data for IAA-producing genes and the associated biosynthesis pathway in a non-pathogenic fungus, Neurospora crassa. For this purpose, we used a computational approach to determine the genes and outlined the IAA production circuitry in N. crassa. We then validated these data with experimental evidence. Here, we describe the homologous genes that are present in the IPA pathway of IAA production in N. crassa. High-performance liquid chromatography and thin-layer chromatography unambiguously identified IAA, indole-3-lactic acid (ILA) and tryptophol (TOL) from cultures supplemented with tryptophan. Deletion of the gene (cfp) that encodes the enzyme indole-3-pyruvate decarboxylase, which converts IPA to indole-3-acetaldehyde (IAAld), results in an accumulation of higher levels of ILA in the N. crassa culture medium. A double knock-out strain (Delta cbs-3;Delta ahd-2) for the enzyme IAAld dehydrogenase, which converts IAAld to IAA, shows a many fold decrease in IAA production compared with the wild type strain. The Delta cbs-3;Delta ahd-2 strain also displays slower conidiation and produces many fewer conidiospores than the wild type strain.	[Sardar, Puspendu; Kempken, Frank] Univ Kiel, Bot Inst & Bot Garten, Abt Bot Genet & Mol Biol, Kiel, Germany	University of Kiel	Kempken, F (corresponding author), Univ Kiel, Bot Inst & Bot Garten, Abt Bot Genet & Mol Biol, Kiel, Germany.	fkempken@bot.uni-kiel.de	Sardar, Puspendu/W-6727-2019	Sardar, Puspendu/0000-0001-8011-2915; Kempken, Frank/0000-0002-7853-8009	Max-Planck-International-Research-School Evolutionary Biology	Max-Planck-International-Research-School Evolutionary Biology	The authors received no specific funding for this work. However PS received a stipend from the Max-Planck-International-Research-School Evolutionary Biology.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Basse CW, 1996, EUR J BIOCHEM, V242, P648, DOI 10.1111/j.1432-1033.1996.0648r.x; Bulfer SL, 2013, PROTEIN SCI, V22, P1417, DOI 10.1002/pro.2315; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cooke TJ, 2002, PLANT MOL BIOL, V49, P319, DOI 10.1023/A:1015242627321; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; EPSTEIN CJ, 1964, NATURE, V203, P1350, DOI 10.1038/2031350a0; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Fu SF, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1048052; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; GRUEN HE, 1959, ANNU REV PLANT PHYS, V10, P405, DOI 10.1146/annurev.pp.10.060159.002201; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUNASEKA.M, 1972, MYCOLOGIA, V64, P1180, DOI 10.2307/3758087; Hilbert M, 2012, NEW PHYTOL, V196, P520, DOI 10.1111/j.1469-8137.2012.04275.x; HUTTER R, 1986, ANNU REV MICROBIOL, V40, P55, DOI 10.1146/annurev.mi.40.100186.000415; Kollath-Leiss K, 2014, EUKARYOT CELL, V13, P1051, DOI 10.1128/EC.00061-14; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; LINDEGREN CARL C., 1932, BULL TORREY BOT CLUB, V59, P85, DOI 10.2307/2480556; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Manulis S, 1998, MOL PLANT MICROBE IN, V11, P634, DOI 10.1094/MPMI.1998.11.7.634; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; NAKAMURA T, 1978, PLANT CELL PHYSIOL, V19, P705; NAKAMURA T, 1988, PLANT GROWTH REGUL, V7, P201; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Normanly J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001594; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Phi QT, 2008, J MICROBIOL BIOTECHN, V18, P1235; Pietrzak I, 1995, Przegl Lek, V52, P522; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Robinson M, 1998, APPL ENVIRON MICROB, V64, P5030; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; SANDBERG G, 1984, PLANTA, V161, P398, DOI 10.1007/BF00394569; Schutz A, 2003, EUR J BIOCHEM, V270, P2312, DOI 10.1046/j.1432-1033.2003.03601.x; Sitbon F, 2000, PLANTA, V211, P715, DOI 10.1007/s004250000338; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Szkop M, 2013, ANTON LEEUW INT J G, V103, P683, DOI 10.1007/s10482-012-9838-4; Sztein AE, 2000, INT J PLANT SCI, V161, P849, DOI 10.1086/317566; TOMITA K, 1984, PLANT CELL PHYSIOL, V25, P355; TOMITA K, 1987, AGR BIOL CHEM TOKYO, V51, P2633; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P117, DOI 10.1134/S0003683806020013; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Tudzynski B, 2002, MYCOTA, V10, P183; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zuther K, 2008, MOL MICROBIOL, V68, P152, DOI 10.1111/j.1365-2958.2008.06144.x	56	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192293	10.1371/journal.pone.0192293	http://dx.doi.org/10.1371/journal.pone.0192293			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420579	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900061
J	Shin, DW; Chun, S; Kim, YI; Kim, SJ; Kim, JS; Chong, S; Park, YS; Song, SY; Lee, JH; Ahn, HK; Kim, EY; Yang, SH; Lee, MK; Cho, DG; Jang, TW; Son, JW; Ryu, JS; Cho, MJ				Shin, Dong Wook; Chun, Sohyun; Kim, Young Il; Kim, Seung Joon; Kim, Jung Soo; Chong, SeMin; Park, Young Sik; Song, Sang-Yun; Lee, Jin Han; Ahn, Hee Kyung; Kim, Eun Young; Yang, Sei Hoon; Lee, Myoung Kyu; Cho, Deog Gon; Jang, Tae Won; Son, Ji Woong; Ryu, Jeong-Seon; Cho, Moon-June			A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ATTITUDES; TRIAL; ASSOCIATION; VIGNETTES; SOCIETY	Lung cancer specialists play an important role in designing and implementing lung cancer screening. We aimed to describe their 1) attitudes toward low-dose lung computed tomography (LDCT) screening, 2) current practices and experiences of LDCT screening and 3) attitudes and opinions towards national lung cancer screening program (NLCSP). We conducted a national web-based survey of pulmonologists, thoracic surgeons, medical oncologists, and radiological oncologists who are members of Korean Association for Lung Cancer (N = 183). Almost all respondents agreed that LDCT screening increases early detection (100%), improves survival (95.1%), and gives a good smoking cessation counseling opportunity (88.6%). Most were concerned about its high false positive results (79.8%) and the subsequent negative effects. Less than half were concerned about radiation hazard (37.2%). Overall, most (89.1%) believed that the benefits outweigh the risks and harms. Most (79.2%) stated that they proactively recommend LDCT screening to those who are eligible for the current guidelines, but the screening propensity varied considerably. The majority (77.6%) agreed with the idea of NLCSP and its beneficial effect, but had concerns about the quality control of CT devices (74.9%), quality assurance of radiologic interpretation (63.3%), poor access to LDCT (56.3%), and difficulties in selecting eligible population using self-report history (66.7%). Most (79.2%) thought that program need to be funded by a specialized fund rather than by the National Health Insurance. The opinions on the level of copayment for screening varied. Our findings would be an important source for health policy decision when considering for NLCSP in Korea.	[Shin, Dong Wook] Sungkyunkwan Univ, Dept Family Med, SAIHST, Seoul, South Korea; [Shin, Dong Wook] Sungkyunkwan Univ, SAIHST, Support Care Ctr, Samsung Med Ctr,Dept Digital Hlth, Seoul, South Korea; [Chun, Sohyun] Samsung Med Ctr, Int Clin, Daejeon, South Korea; [Kim, Young Il; Cho, Moon-June] Chungnam Natl Univ, Sch Med, Dept Radiat Oncol, Daejeon, South Korea; [Kim, Seung Joon] Catholic Univ Korea, Coll Med, Seoul St Mary Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Jung Soo; Ryu, Jeong-Seon] Inha Univ, Coll Med, Inha Univ Hosp, Dept Internal Med, Incheon, South Korea; [Chong, SeMin] Chung Ang Univ, Coll Med, Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Young Sik] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Song, Sang-Yun] Chonnam Natl Univ, Med Sch, Hwasun Hosp, Dept Thorac & Cardiovasc Surg, Hwasun, South Korea; [Lee, Jin Han] Donga A Ilbo, Med Correspondent & Social Policy Desk, Seoul, South Korea; [Ahn, Hee Kyung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Kim, Eun Young] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Yang, Sei Hoon] Wonkwang Univ, Coll Med, Dept Internal Med, Iksan, South Korea; [Lee, Myoung Kyu] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Cho, Deog Gon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Thorac & Cardiovasc Surg, Suwon, South Korea; [Jang, Tae Won] Kosin Univ, Med Coll, Dept Internal Med, Pusan, South Korea; [Son, Ji Woong] Konyang Univ Hosp, Dept Internal Med, Daejeon, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Chungnam National University; Catholic University of Korea; Seoul St. Mary's Hospital; Inha University; Inha University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Chonnam National University; Gachon University; Gachon University; Wonkwang University; Yonsei University; Catholic University of Korea; Konyang University; Konyang University Hospital	Ryu, JS (corresponding author), Inha Univ, Coll Med, Inha Univ Hosp, Dept Internal Med, Incheon, South Korea.	jsryu@inha.ac.kr		KIM, YOUNG IL/0000-0003-3696-7187; Chong, Semin/0000-0002-7429-2566	Korean Ministry of Health and Welfare [HI15C0554, HI16C0286]	Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Korean Ministry of Health and Welfare (HI15C0554 and HI16C0286) for JSR. The funders had no role in study design, data.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Academy of Family Physicians, 2013, LUNG CANC; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Detterbeck FC, 2013, CHEST, V143, pE78, DOI 10.1378/chest.12-2350; Doria-Rose VP, 2012, CANCER EPIDEM BIOMAR, V21, P1049, DOI 10.1158/1055-9965.EPI-12-0343; Ersek JL, 2016, CANCER-AM CANCER SOC, V122, P2324, DOI 10.1002/cncr.29944; Field JK, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20400; Fucito LM, 2016, CANCER-AM CANCER SOC, V122, P1150, DOI 10.1002/cncr.29926; Goulart BHL, 2012, J NATL COMPR CANC NE, V10, P267, DOI 10.6004/jnccn.2012.0023; Heleno B, 2011, NEW ENGL J MED, V365, P2036, DOI 10.1056/NEJMc1110293; Henderson S, 2011, J COMMUN HEALTH, V36, P949, DOI 10.1007/s10900-011-9394-2; Hoffman RM, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150112; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Iaccarino JM, 2015, ANN AM THORAC SOC, V12, P1667, DOI 10.1513/AnnalsATS.201507-467OC; Infante M, 2015, AM J RESP CRIT CARE, V191, P1166, DOI 10.1164/rccm.201408-1475OC; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kanodra NM, 2016, ANN AM THORAC SOC, V13, P1977, DOI 10.1513/AnnalsATS.201604-286OC; Lewis JA, 2015, CANCER EPIDEM BIOMAR, V24, P664, DOI 10.1158/1055-9965.EPI-14-1241; Moyer V, 2014, ONCOLOGY-NY, V28, P449; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Oudkerk M, 2017, LANCET ONCOL, V18, pE754, DOI [10.1016/S1470-2045(17)30861-6, 10.1016/s1470-2045(17)30861-6]; Park ER, 2013, CANCER-AM CANCER SOC, V119, P1306, DOI 10.1002/cncr.27925; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Pedersen JH, 2017, EUR J CARDIO-THORAC, V51, P411, DOI 10.1093/ejcts/ezw418; Postmus PE, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx222; Quaife SL, LANCET, V384, pS16; Rampinelli C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j347; Shin DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172568; Shin DW, 2015, CANCER RES TREAT, V47, P600, DOI 10.4143/crt.2014.162; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Villanti AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071379; Wang ZX, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0221-8; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172	35	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192626	10.1371/journal.pone.0192626	http://dx.doi.org/10.1371/journal.pone.0192626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420619	gold, Green Published, Green Submitted			2022-12-26	WOS:000424517900100
J	Vinagre, C; Mendonca, V; Cereja, R; Abreu-Afonso, F; Dias, M; Mizrahi, D; Flores, AAV				Vinagre, Catarina; Mendonca, Vanessa; Cereja, Rui; Abreu-Afonso, Francisca; Dias, Marta; Mizrahi, Damian; Flores, Augusto A. V.			Ecological traps in shallow coastal waters-Potential effect of heat-waves in tropical and temperate organisms	PLOS ONE			English	Article							CRITICAL THERMAL MAXIMA; ROCKY INTERTIDAL POOLS; CLIMATE-CHANGE; DEPENDENT BIOGEOGRAPHY; ACCLIMATION CAPACITY; OXYGEN LIMITATION; REEF FISHES; TOLERANCE; IMPACTS; NURSERY	Mortality of fish has been reported in tide pools during warm days. That means that tide pools are potential ecological traps for coastal organisms, which happen when environmental changes cause maladaptive habitat selection. Heat-waves are predicted to increase in intensity, duration and frequency, making it relevant to investigate the role of tide pools as traps for coastal organisms. However, heat waves can also lead to acclimatization. If organisms undergo acclimatization prior to being trapped in tide pools, their survival chances may increase. Common tide pool species (46 species in total) were collected at a tropical and a temperate area and their upper thermal limits estimated. They were maintained for 10 days at their mean summer sea surface temperature +3 degrees C, mimicking a heat-wave. Their upper thermal limits were estimated again, after this acclimation period, to calculate each species' acclimation response. The upper thermal limits of the organisms were compared to the temperatures attained by tide pool waters to investigate if 1) tide pools could be considered ecological traps and 2) if the increase in upper thermal limits elicited by the acclimation period could make the organisms less vulnerable to this threat. Tropical tide pools were found to be ecological traps for an important number of common coastal species, given that they can attain temperatures higher than the upper thermal limits of most of those species. Tide pools are not ecological traps in temperate zones. Tropical species have higher thermal limits than temperate species, but lower acclimation response, that does not allow them to survive the maximum habitat temperature of tropical tide pools. This way, tropical coastal organisms seem to be, not only more vulnerable to climate warming per se, but also to an increase in the ecological trap effect of tide pools.	[Vinagre, Catarina; Mendonca, Vanessa; Cereja, Rui; Abreu-Afonso, Francisca; Dias, Marta] Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Mizrahi, Damian; Flores, Augusto A. V.] Univ Sao Paulo, Ctr Biol Marinha, Rod Manoel Hipolito Rego, Sao Sebastiao, SP, Brazil	Universidade de Lisboa; Universidade de Sao Paulo	Vinagre, C (corresponding author), Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.	cmvinagre@fc.ul.pt	Flores, Augusto A. V./B-7092-2011; Cereja, Rui/AAU-1264-2021; Vinagre, Catarina/G-1965-2015; Dias, Marta/ABE-3178-2020; Dias, Marta/O-4112-2015; Mizrahi, Damian/D-9435-2017; Mendonca, Vanessa/C-5774-2015	Flores, Augusto A. V./0000-0001-9347-8860; Cereja, Rui/0000-0001-7813-4592; Vinagre, Catarina/0000-0003-2146-7948; Dias, Marta/0000-0003-0447-6009; Mizrahi, Damian/0000-0003-4688-6698; Mendonca, Vanessa/0000-0002-3658-9502	Portuguese Foundation for Science and Technology [PTDC/MAR-EST/2141/2012]; "Investigador FCT" position;  [UID/MAR/04292/2013]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); "Investigador FCT" position(Portuguese Foundation for Science and Technology); 	This study had the support of the Portuguese Foundation for Science and Technology through the WarmingWebs project, PTDC/MAR-EST/2141/2012, the "Investigador FCT" position granted to C. Vinagre and the strategic project UID/MAR/04292/2013 granted to MARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara R, 2003, ESTUAR COAST SHELF S, V56, P807, DOI 10.1016/S0272-7714(02)00315-3; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chown SL, 2001, J INSECT PHYSIOL, V47, P649, DOI 10.1016/S0022-1910(00)00163-3; Clarke AP, 2000, MAR BIOL, V137, P447, DOI 10.1007/s002270000367; Collard M, 2016, ICES J MAR SCI, V73, P727, DOI 10.1093/icesjms/fsv018; Cuculescu M, 1998, J THERM BIOL, V23, P107, DOI 10.1016/S0306-4565(98)00008-4; DETHIER MN, 1982, BOT MAR, V25, P55, DOI 10.1515/botm.1982.25.2.55; DETHIER MN, 1984, ECOL MONOGR, V54, P99, DOI 10.2307/1942457; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dias M, 2014, J APPL ICHTHYOL, V30, P970, DOI 10.1111/jai.12450; Dias M, 2016, MAR BIOL RES, V12, P331, DOI 10.1080/17451000.2016.1143106; Diederich CM, 2013, MAR ECOL PROG SER, V486, P173, DOI 10.3354/meps10355; Donelson JM, 2011, GLOBAL CHANGE BIOL, V17, P1712, DOI 10.1111/j.1365-2486.2010.02339.x; Duarte H, 2012, GLOBAL CHANGE BIOL, V18, P412, DOI 10.1111/j.1365-2486.2011.02518.x; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Edenhofer O., 2014, CONTRIBUTION WORKING; Firth LB, 2016, MAR FRESHWATER RES, V67, P131, DOI 10.1071/MF14163; Firth LB, 2014, MAR ENVIRON RES, V102, P122, DOI 10.1016/j.marenvres.2014.03.016; Firth LB, 2009, GLOBAL CHANGE BIOL, V15, P1413, DOI 10.1111/j.1365-2486.2009.01863.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; Gunderson AR, 2015, P ROYAL SOC B, V282, P1471; Hale R, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2930; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hiatt R. H., 1960, Ecological Monographs, V30, P65, DOI 10.2307/1942181; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; HUEY RB, 1992, FUNCT ECOL, V6, P489, DOI 10.2307/2389288; Jost JA, 2012, MAR ECOL PROG SER, V444, P263, DOI 10.3354/meps09379; Kaspari M, 2015, GLOBAL CHANGE BIOL, V21, P1092, DOI 10.1111/gcb.12750; Kriska G, 1998, J EXP BIOL, V201, P2273; Kruck NC, 2009, MAR ECOL PROG SER, V384, P207, DOI 10.3354/meps07992; LASIAK TA, 1981, S AFR J SCI, V77, P388; Little C, 2009, BIOL ROCKY SHORES, P356; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Madeira D, 2012, J SEA RES, V70, P32, DOI 10.1016/j.seares.2012.03.002; Martins E. P., 2004, COMPARE VERSION 4 6B; Menge BA, 2008, ECOL LETT, V11, P151, DOI 10.1111/j.1461-0248.2007.01135.x; Mora C, 2001, MAR BIOL, V139, P765; Morley SA, 2014, J MAR BIOL ASSOC UK, V96, P1; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nguyen TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018889; Regil JN, 2015, J THERM BIOL, V53, P151, DOI 10.1016/j.jtherbio.2015.11.001; Overgaard J, 2014, GLOBAL CHANGE BIOL, V20, P1738, DOI 10.1111/gcb.12521; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Rastrick SPS, 2014, J EXP BIOL, V217, P2499, DOI 10.1242/jeb.089011; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Salas A, 2014, J SHELLFISH RES, V33, P239, DOI 10.2983/035.033.0123; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Somero GN, 2011, AM J PHYSIOL-REG I, V301, pR1, DOI 10.1152/ajpregu.00719.2010; Sorte CJB, 2010, OIKOS, V119, P1909, DOI 10.1111/j.1600-0706.2010.18663.x; Sorte CJB, 2005, MAR BIOL, V146, P985, DOI 10.1007/s00227-004-1508-2; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Trussell GC, 2004, OECOLOGIA, V139, P427, DOI 10.1007/s00442-004-1512-8; Vinagre C, 2016, ECOL INDIC, V62, P317, DOI 10.1016/j.ecolind.2015.11.010; Vinagre C, 2015, BIOLOGIA, V70, P372, DOI 10.1515/biolog-2015-0046; Vinagre C, 2015, J THERM BIOL, V47, P19, DOI 10.1016/j.jtherbio.2014.10.012; Vinagre C, 2013, J SEA RES, V81, P10, DOI 10.1016/j.seares.2013.03.011; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x	71	49	49	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192700	10.1371/journal.pone.0192700	http://dx.doi.org/10.1371/journal.pone.0192700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420657	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900107
J	Wagner, N; Dieteren, S; Franz, N; Kohler, K; Mors, K; Nicin, L; Schmidt, J; Perl, M; Marzi, I; Relja, B				Wagner, Nils; Dieteren, Scott; Franz, Niklas; Koehler, Kernt; Moers, Katharina; Nicin, Luka; Schmidt, Julia; Perl, Mario; Marzi, Ingo; Relja, Borna			Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SODIUM PYRUVATE; LIVER-INJURY; BASE DEFICIT; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS; TERMINAL KINASE; IN-VITRO; RESUSCITATION; RESPONSES	Background The treatment of patients with multiple trauma including blunt chest/thoracic trauma (TxT) and hemorrhagic shock (H) is still challenging. Numerous studies show detrimental consequences of TxT and HS resulting in strong inflammatory changes, organ injury and mortality. Additionally, the reperfusion (R) phase plays a key role in triggering inflammation and worsening outcome. Ethyl pyruvate (EP), a stable lipophilic ester, has anti-inflammatory properties. Here, the influence of EP on the inflammatory reaction and liver injury in a double hit model of TxT and H/R in rats was explored. Methods Female Lewis rats were subjected to TxT followed by hemorrhage/H (60 min, 35 +/- 3mm Hg) and resuscitation/R (TxT+H/R). Reperfusion was performed by either Ringer's lactated solution (RL) alone or RL supplemented with EP (50 mg/kg). Sham animals underwent all surgical procedures without TxT+H/R. After 2h, blood and liver tissue were collected for analyses, and survival was assessed after 24h. Results Resuscitation with EP significantly improved haemoglobin levels and base excess recovery compared with controls after TxT+H/R, respectively (p<0.05). TxT+H/R-induced significant increase in alanine aminotransferase levels and liver injury were attenuated by EP compared with controls (p<0.05). Local inflammation as shown by increased gene expression of IL-6 and ICAM-1, enhanced ICAM-1 and HMGB1 protein expression and infiltration of the liver with neutrophils were also significantly attenuated by EP compared with controls after TxT+H/R (p<0.05). EP significantly reduced TxT+H/R-induced p65 activation in liver tissue. Survival rates improved by EP from 50% to 70% after TxT+H/R. Conclusions These data support the concept that the pronounced local pro-inflammatory response in the liver after blunt chest trauma and hemorrhagic shock is associated with NF-kappa B. In particular, the beneficial anti-inflammatory effects of ethyl pyruvate seem to be regulated by the HMGB1/NF-kappa B axis in the liver, thereby, restraining inflammatory responses and liver injury after double hit trauma in the rat.	[Wagner, Nils; Dieteren, Scott; Franz, Niklas; Moers, Katharina; Nicin, Luka; Schmidt, Julia; Marzi, Ingo; Relja, Borna] Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Surg, Frankfurt, Germany; [Koehler, Kernt] Justus Liebig Univ Giessen, Inst Vet Pathol, Giessen, Germany; [Perl, Mario] BG Trauma Ctr Murnau, Murnau, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Justus Liebig University Giessen	Relja, B (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Surg, Frankfurt, Germany.	info@bornarelja.com	Relja, Borna/B-6642-2016	Relja, Borna/0000-0002-5625-8823; Nicin, Luka/0000-0002-3618-2438	DFG [RE 3304/5-1, PE 908/3-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG RE 3304/5-1 and PE 908/3-1. We thank Katrin Jurida, Kerstin Kontradowitz and Alexander Schaible for outstanding technical assistance. Grant support: The work was supported by grants from the DFG RE 3304/5-1 and PE 908/3-1.	Abt R, 2009, EUR J TRAUMA EMERG S, V35, P429, DOI 10.1007/s00068-009-8245-7; Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; DAVIS JW, 1988, J TRAUMA, V28, P1464, DOI 10.1097/00005373-198810000-00010; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Dong WH, 2010, SHOCK, V34, P205, DOI 10.1097/SHK.0b013e3181cc0c63; Esmer E, 2016, PREHOSPITAL ASSESSME; Fang R, 2016, ACTA NEUROCHIR, V158, P1069, DOI 10.1007/s00701-016-2795-3; Fink MP, 2008, CURR OPIN ANESTHESIO, V21, P160, DOI 10.1097/ACO.0b013e3282f63c2e; Han YS, 2005, J PHARMACOL EXP THER, V312, P1097, DOI 10.1124/jpet.104.079707; Hauser B, 2005, CRIT CARE MED, V33, P2034, DOI 10.1097/01.CCM.0000178177.03979.CE; Hietbrink F, 2006, World J Emerg Surg, V1, P15, DOI 10.1186/1749-7922-1-15; Horst K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154788; Huber-Lang M, 2016, SEMIN IMMUNOL, V28, P278, DOI 10.1016/j.smim.2016.04.005; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Kao RLC, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0030-7; Karmaniolou II, 2013, J ANESTH, V27, P447, DOI 10.1007/s00540-012-1543-y; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lehnert M, 2008, SHOCK, V30, P159, DOI 10.1097/SHK.0b013e31815dd623; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Liener UC, 2003, SHOCK, V20, P511, DOI 10.1097/01.shk.0000095057.62263.fb; Luan ZG, 2012, PANCREAS, V41, P729, DOI 10.1097/MPA.0b013e31823cd3ef; Maier M, 2009, EUR J TRAUMA EMERG S, V35, P463, DOI 10.1007/s00068-009-9123-z; Mongan PD, 1999, AM J PHYSIOL-HEART C, V277, pH2253, DOI 10.1152/ajpheart.1999.277.6.H2253; Mulier KE, 2005, SHOCK, V23, P248, DOI 10.1097/01.shk.0000153353.58341.ff; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; Partrick D A, 1996, New Horiz, V4, P194; Pierce A, 2014, CURR OPIN ANESTHESIO, V27, P246, DOI 10.1097/ACO.0000000000000047; Polito F, 2016, INT J IMMUNOPATH PH, V29, P504, DOI 10.1177/0394632016656187; Pulathan Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/857109; Relja B, 2016, INT J MOL MED, V37, P517, DOI 10.3892/ijmm.2015.2431; Relja B, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/983427; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Relja B, 2012, EUR J NUTR, V51, P311, DOI 10.1007/s00394-011-0216-1; Relja B, 2009, SHOCK, V32, P509, DOI 10.1097/SHK.0b013e3181a2530d; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; Sakran JV, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-64; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seitz DH, 2008, SHOCK, V30, P537, DOI 10.1097/SHK.0b013e31816a394b; Sharma P, 2010, SHOCK, V33, P532, DOI 10.1097/SHK.0b013e3181cc02b3; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/461536; Shen M., 2014, PLOS ONE, V2, P87977, DOI DOI 10.1371/J0URNAL.P0NE; Sileri P, 2001, TRANSPLANTATION, V72, P27, DOI 10.1097/00007890-200107150-00008; Sims CA, 2001, CRIT CARE MED, V29, P1513, DOI 10.1097/00003246-200108000-00003; Slovin PN, 2001, RESUSCITATION, V50, P109, DOI 10.1016/S0300-9572(01)00325-2; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tsung A, 2005, TRANSPLANTATION, V79, P196, DOI 10.1097/01.TP.0000151681.07474.2E; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Worlein JM, 2011, AM J PRIMATOL, V73, P98; Wutzler S, 2013, CHIRURG, V84, P753, DOI 10.1007/s00104-013-2477-0; Yang RK, 2003, J LAB CLIN MED, V142, P322, DOI 10.1016/S0022-2143(03)00138-0; Yang RK, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0144-1; Yang RK, 2009, J SURG RES, V153, P302, DOI 10.1016/j.jss.2008.04.004; Yu YF, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2607-5; Zeng JY, 2007, ANESTHESIOLOGY, V107, P630, DOI 10.1097/01.anes.0000281898.01966.1e; Zhang M, 2017, CLIN RES HEPATOLOGY	60	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192171	10.1371/journal.pone.0192171	http://dx.doi.org/10.1371/journal.pone.0192171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420582	gold, Green Published, Green Submitted			2022-12-26	WOS:000424517900045
J	Dzneladze, I; Woolley, JF; Rossell, C; Han, YQ; Rashid, A; Jain, M; Reimand, J; Minden, MD; Salmena, L				Dzneladze, Irakli; Woolley, John F.; Rossell, Carla; Han, Youqi; Rashid, Ayesha; Jain, Michael; Reimand, Juri; Minden, Mark D.; Salmena, Leonardo			SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; PHOSPHATASE; SGK3	Our previous studies demonstrated that INPP4B, a member of the PI3K/Akt signaling pathway, is overexpressed in a subset of AML patients and is associated with lower response to chemotherapy and shorter survival. INPP4B expression analysis in AML revealed a right skewed frequency distribution with 25% of patients expressing significantly higher levels than the majority. The 75% low/25% high cut-off revealed the prognostic power of INPP4B expression status in AML, which would not have been apparent with a standard median cutoff approach. Our identification of a clinically relevant non-median cut-off for INPP4B indicated a need for a generalizable non-median dichotomization approach to optimally study clinically relevant genes. To address this need, we developed Subgroup Identifier (SubID), a tool which examines the relationship between a continuous variable (e.g. gene expression), and a test parameter (e.g. CoxPH or Fisher's exact P values). In our study, Fisher's exact SubID was used to reveal EVI1 as a transcriptional regulator of INPP4B in AML; a finding which was validated in vitro. Next, we used CoxPH SubID to conduct a pan-cancer analysis of INPP4B's prognostic significance. Our analysis revealed that INPP4B low is associated with shorter survival in kidney clear cell, liver hepatocellular, and bladder urothelial carcinomas. Conversely, INPP4B low was shown to be associated with increased survival in pancreatic adenocarcinoma in three independent datasets. Overall, our study describes the development and application of a novel subgroup identification tool used to identify prognostically significant rare subgroups based upon gene expression, and for investigating the association between a gene with skewed frequency distribution and potentially important upstream and downstream genes that relate to the index gene.	[Dzneladze, Irakli; Woolley, John F.; Han, Youqi; Rashid, Ayesha; Jain, Michael; Minden, Mark D.; Salmena, Leonardo] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Dzneladze, Irakli; Rashid, Ayesha; Reimand, Juri; Minden, Mark D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Dzneladze, Irakli; Rossell, Carla; Reimand, Juri] Ontario Inst Canc Res, Toronto, ON, Canada; [Woolley, John F.; Salmena, Leonardo] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto	Minden, MD; Salmena, L (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Minden, MD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Salmena, L (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.	mark.minden@uhn.ca; leonardo.salmena@utoronto.ca	Reimand, Jüri/U-9264-2019; Jain, Michael/AAI-2741-2020	Reimand, Jüri/0000-0002-2299-2309; Jain, Michael/0000-0002-7789-1257; Salmena, Leonardo/0000-0003-4023-658X	Orsino Chair in Leukemia Research; Marvin and Linda Barnett leukemia Research Fund; Brian Steck Leukemia Research Fund; Canada Research Chair	Orsino Chair in Leukemia Research; Marvin and Linda Barnett leukemia Research Fund; Brian Steck Leukemia Research Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	MDM is a recipient of the Orsino Chair in Leukemia Research, the Marvin and Linda Barnett leukemia Research Fund, and the Brian Steck Leukemia Research Fund. LS is the recipient of a Tier II Canada Research Chair.	Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Chi MN, 2015, ONCOTARGET, V6, P39891, DOI 10.18632/oncotarget.5359; Dzneladze I, 2015, LEUKEMIA, V29, P1485, DOI 10.1038/leu.2015.51; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Guo ST, 2016, ONCOGENE, V35, P3049, DOI 10.1038/onc.2015.361; Hodgson MC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0061-y; Hsu IW, 2014, ONCOTARGET, V5, P7917, DOI 10.18632/oncotarget.1421; Kofuji S, 2015, CANCER DISCOV, V5, P730, DOI 10.1158/2159-8290.CD-14-1329; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; NORRIS FA, 1994, J BIOL CHEM, V269, P8716; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Perez-Lorenzo R, 2014, J INVEST DERMATOL, V134, P1359, DOI 10.1038/jid.2013.511; Rijal S, 2015, BLOOD, V125, P2815, DOI 10.1182/blood-2014-09-603555; Rodgers SJ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160432; Salmena L, 2015, EUR J GYNAECOL ONCOL, V36, P260; Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33; Tokunaga E, 2016, BREAST, V25, P62, DOI 10.1016/j.breast.2015.10.006; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Won JR, 2013, MODERN PATHOL, V26, P1438, DOI 10.1038/modpathol.2013.97; Woolley JF, 2015, TRENDS MOL MED, V21, P530, DOI 10.1016/j.molmed.2015.06.006; Zhang L, 2016, LIFE SCI, V155, P110, DOI 10.1016/j.lfs.2016.05.014	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191510	10.1371/journal.pone.0191510	http://dx.doi.org/10.1371/journal.pone.0191510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415082	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300030
J	Saera-Vila, A; Louie, KW; Sha, C; Kelly, RM; Kish, PE; Kahana, A				Saera-Vila, Alfonso; Louie, Ke'ale W.; Sha, Cuilee; Kelly, Ryan M.; Kish, Phillip E.; Kahana, Alon			Extraocular muscle regeneration in zebrafish requires late signals from Insulin-like growth factors	PLOS ONE			English	Article							FACTOR-I; SKELETAL-MUSCLE; IGF-I; SATELLITE CELLS; FIN REGENERATION; GENE-EXPRESSION; ADULT ZEBRAFISH; MULLER GLIA; DIFFERENTIATION; AUTOPHAGY	Insulin-like growth factors (Igfs) are key regulators of key biological processes such as embryonic development, growth, and tissue repair and regeneration. The role of Igf in myogenesis is well documented and, in zebrafish, promotes fin and heart regeneration. However, the mechanism of action of Igf in muscle repair and regeneration is not well understood. Using adult zebrafish extraocular muscle (EOM) regeneration as an experimental model, we show that Igf1 receptor blockage using either chemical inhibitors (BMS754807 and NVP-AEW541) or translation-blocking morpholino oligonucleotides (MOs) reduced EOM regeneration. Zebrafish EOMs regeneration depends on myocyte dedifferentiation, which is driven by early epigenetic reprogramming and requires autophagy activation and cell cycle reentry. Inhibition of Igf signaling had no effect on either autophagy activation or cell proliferation, indicating that Igf signaling was not involved in the early reprogramming steps of regeneration. Instead, blocking Igf signaling produced hypercellularity of regenerating EOMs and diminished myosin expression, resulting in lack of mature differentiated muscle fibers even many days after injury, indicating that Igf was involved in late re-differentiation steps. Although it is considered the main mediator of myogenic Igf actions, Akt activation decreased in regenerating EOMs, suggesting that alternative signaling pathways mediate Igf activity in muscle regeneration. In conclusion, Igf signaling is critical for re-differentiation of reprogrammed myoblasts during late steps of zebrafish EOM regeneration, suggesting a regulatory mechanism for determining regenerated muscle size and timing of differentiation, and a potential target for regenerative therapy.	[Saera-Vila, Alfonso; Louie, Ke'ale W.; Sha, Cuilee; Kelly, Ryan M.; Kish, Phillip E.; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Louie, Ke'ale W.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saera-Vila, A; Kahana, A (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	alfonsosaera@gmail.com; akahana@med.umich.edu	Kish, Phil E/H-6051-2011; Saera-Vila, Alfonso/O-7438-2017	Kahana, Alon/0000-0002-5667-2274; Kelly, Ryan/0000-0002-0328-8025; Saera-Vila, Alfonso/0000-0003-0106-2353	Alliance for Vision Research, a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB); NEI of the NIH [R01 EY022633]; RPB; Vision Research Core at the University of Michigan [P30 EY007003]; Cancer Center Research Core at the University of Michigan [P30 CA046592]; Michigan Diabetes Research Center at the University of Michigan [P30 DK020572]; A. Alfred Taubman Medical Research Institute; NIH NCRR [P40 RR012546]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY022633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER	Alliance for Vision Research, a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB); NEI of the NIH; RPB(Research to Prevent Blindness (RPB)); Vision Research Core at the University of Michigan; Cancer Center Research Core at the University of Michigan; Michigan Diabetes Research Center at the University of Michigan; A. Alfred Taubman Medical Research Institute; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Alliance for Vision Research, a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB), grant R01 EY022633 from the NEI of the NIH (AK), and an unrestricted grant from RPB to the Department of Ophthalmology and Visual Sciences. This research utilized the Vision Research Core (P30 EY007003), the Cancer Center Research Core (P30 CA046592), and the Michigan Diabetes Research Center (P30 DK020572) at the University of Michigan. AK is supported by the Mrs. William Davidson Emerging Scholar Award from the A. Alfred Taubman Medical Research Institute. The Zebrafish International Resource Center is supported by grant P40 RR012546 from the NIH NCRR. Funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Ayaso E, 2002, MOL CELL ENDOCRINOL, V191, P137, DOI 10.1016/S0303-7207(02)00083-7; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Berridge BR, 2013, HASCHEK AND ROUSSEAUX'S HANDBOOK OF TOXICOLOGIC PATHOLOGY, VOL 1-3, 3RD EDITION, P1567, DOI 10.1016/B978-0-12-415759-0.00046-7; Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chen J, 2004, INVEST OPHTH VIS SCI, V45, P3538, DOI 10.1167/iovs.04-0393; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Doherty JT, 2011, J BIOL CHEM, V286, P25903, DOI 10.1074/jbc.M111.243030; EDWALL D, 1989, ENDOCRINOLOGY, V124, P820, DOI 10.1210/endo-124-2-820; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Feng CY, 2011, GROWTH HORM IGF RES, V21, P228, DOI 10.1016/j.ghir.2011.06.001; Fischer MD, 2002, PHYSIOL GENOMICS, V9, P71, DOI 10.1152/physiolgenomics.00115.2001; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; GREENE EA, 1991, J ANIM SCI, V69, P146; Haddad F, 2004, J APPL PHYSIOL, V96, P203, DOI 10.1152/japplphysiol.00856.2003; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853; Krishan K, 1996, J MUSCLE RES CELL M, V17, P513, DOI 10.1007/BF00124351; Larkindale J, 2014, MUSCLE NERVE, V49, P431, DOI 10.1002/mus.23942; LEVINOVITZ A, 1992, MOL ENDOCRINOL, V6, P1227, DOI 10.1210/me.6.8.1227; Li T, 2010, INVEST OPHTH VIS SCI, V51, P2479, DOI 10.1167/iovs.09-4414; Louie KW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4236-y; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; MCFARLAND DC, 1993, GEN COMP ENDOCR, V89, P415, DOI 10.1006/gcen.1993.1049; McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P3866, DOI 10.1167/iovs.03-0223; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Onuma TA, 2011, J NEUROSCI, V31, P11814, DOI 10.1523/JNEUROSCI.6804-10.2011; Ovalle WK, 2007, NETTERS ESSENTIAL HI; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Renna M, 2013, HUM MOL GENET, V22, P4528, DOI 10.1093/hmg/ddt300; Saera-Vila A, 2016, AUTOPHAGY, V12, P1864, DOI 10.1080/15548627.2016.1207015; Saera-Vila A, 2016, CELL SIGNAL, V28, P1196, DOI 10.1016/j.cellsig.2016.06.001; Saera-Vila A, 2015, INVEST OPHTH VIS SCI, V56, P4977, DOI 10.1167/iovs.14-16103; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Shi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1040, DOI 10.1152/ajpcell.00475.2008; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; Troncoso R, 2013, IUBMB LIFE, V65, P593, DOI 10.1002/iub.1172; VANDENBURGH HH, 1991, AM J PHYSIOL, V260, pC475, DOI 10.1152/ajpcell.1991.260.3.C475; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Willoughby CL, 2012, INVEST OPHTH VIS SCI, V53, P68, DOI 10.1167/iovs.11-8356; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	58	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192214	10.1371/journal.pone.0192214	http://dx.doi.org/10.1371/journal.pone.0192214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415074	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300059
J	de Pina-Araujo, IIM; Spitz, N; Soares, CC; Niel, C; Lago, BV; Gomes, SA				de Pina-Araujo, Isabel Ines M.; Spitz, Natalia; Soares, Caroline C.; Niel, Christian; Lago, Barbara V.; Gomes, Selma A.			Hepatitis B virus genotypes A1, A2 and E in Cape Verde: Unequal distribution through the islands and association with human flows	PLOS ONE			English	Article							GENETIC DIVERSITY; NATURAL-HISTORY; HBV GENOTYPE; SLAVE-TRADE; AFRICA; SUBGENOTYPES; EPIDEMIOLOGY; INFERENCE; REVEALS; DISEASE	Hepatitis B virus (HBV) diversity has not been previously studied in Cape Verde. The archipelago was discovered in 1460 by Portuguese explorers, who brought African slaves to colonise the islands. In this study, we investigated the HBV characteristics from 183 HBsAg-positive Cape Verdean individuals. Phylogenetic analysis of the pre-S/S region and the full-length genomes revealed 54 isolates with HBV/A1 (57%), 21 with HBV/A2 (22%), 19 with HBV/E (20%), and one with HBV/D (1%). HBV genotypes and subgenotypes were unequally distributed through the islands. In Sao Vicente, the main northern island, most isolates (84%) belonged to the African-originated HBV/A1, with the remaining isolates belonging to HBV/A2, which is prevalent in Europe. Interestingly, the HBV/A1 isolates from Sao Vicente were closely related to Brazilian sequences into the Asian-American clade, which suggests the dissemination of common African ancestors through slave trade. In contrast, in Santiago and nearby southern islands, where a recent influx from different populations circulates, a higher diversity of HBV was observed: HBV/A1 (40%); HBV/E (32%); HBV/A2 (28%); and HBV/D (1%). HBV/E is a recent genotype disseminated in Africa that was absent in the era of the slave trade. African and European human flows at different times of the history may explain the HBV diversity in Cape Verde. The possible origin and specifics of each HBV genotype circulating in Cape Verde are discussed.	[de Pina-Araujo, Isabel Ines M.] Univ Cabo Verde, Fac Ciencia & Tecnol, Santiago, Cape Verde; [Spitz, Natalia; Soares, Caroline C.; Niel, Christian; Lago, Barbara V.; Gomes, Selma A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Mol, Rio De Janeiro, Brazil; [Lago, Barbara V.] Fiocruz MS, Inst Tecnol Imunobiol Biomanguinhos, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Gomes, SA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Mol, Rio De Janeiro, Brazil.	selma@ioc.fiocruz.br	Soares, Caroline Cordeiro/ABM-8961-2022	Monteiro de Pina Araujo, Isabel Ines/0000-0001-7766-1059; Spitz Toledo Dias, Natalia/0000-0003-4776-1758	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [466733/2014-3, 312427/2015-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was suppported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 466733/2014-3 and 312427/2015-8). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampah KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156864; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017; Araujo NM, 2004, ARCH VIROL, V149, P1383, DOI 10.1007/s00705-003-0269-4; Beachey R., 1976, SLAVE TRADE E AFRICA; Bottecchia M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-11; Bowyer SM, 1997, J GEN VIROL, V78, P1719, DOI 10.1099/0022-1317-78-7-1719; Brehm A, 2002, ANN HUM GENET, V66, P49, DOI 10.1017/S0003480001001002; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; Godinho V.M., 1965, DESCOBRIMENTOS EC MU, VI; Goncalves J., 2007, HEPATITE B ENTRE DOA; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUNTHER S, 1995, J VIROL, V69, P5437; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0; Hundie GB, 2017, J VIRAL HEPATITIS, V24, P163, DOI 10.1111/jvh.12631; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; IEP. Potencial do turismo internacional de Cabo Verde, 2014, THESIS; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105317; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092223; Loureiro CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118959; Marciano S, 2013, ANTIVIR THER, V18, P485, DOI 10.3851/IMP2604; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Msuya S E, 2006, East Afr Med J, V83, P91; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Pirillo MF, 2007, J MED VIROL, V79, P1797, DOI 10.1002/jmv.21007; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Rajoriya N, 2017, J HEPATOL, V67, P1281, DOI 10.1016/j.jhep.2017.07.011; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Sutcliffe S, 2002, JAIDS-J ACQ IMM DEF, V31, P90, DOI 10.1097/00126334-200209010-00012; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; van Houdt R, 2010, J VIRAL HEPATITIS, V17, P108, DOI 10.1111/j.1365-2893.2009.01158.x; World Health Organization, 2016, HEP B; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x; Zehender G, 2008, VIROLOGY, V380, P84, DOI 10.1016/j.virol.2008.07.009; Zehender G, 2015, INFECT GENET EVOL, V32, P361, DOI 10.1016/j.meegid.2015.03.009; Zehender G, 2014, WORLD J GASTROENTERO, V20, P7622, DOI 10.3748/wjg.v20.i24.7622	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192595	10.1371/journal.pone.0192595	http://dx.doi.org/10.1371/journal.pone.0192595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447232	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900039
J	Hu, P; Li, YP; Campos, H				Hu, Peter; Li, Yanping; Campos, Hannia			Fried food intake and risk of nonfatal acute myocardial infarction in the Costa Rica Heart Study	PLOS ONE			English	Article							DIETARY PATTERNS; PROPENSITY-SCORE; FATTY-ACIDS; OIL; CONSUMPTION; NUTRITION; COUNTRIES; WOMEN; PERFORMANCE; OXIDATION	Economic development in middle-income countries has led to a noticeable rise in the availability of commercial deep fried foods and lifestyles that require eating meals "on the go" and outside of the home. Yet, data from these countries where fried foods were traditionally prepared at home are scarce, despite several studies showing the potential adverse effects of fried food consumption on risk for heart disease. We aimed to examine whether consumption of fried foods inside or outside of the home is associated with an increased risk of myocardial infarction (MI) among Hispanic/Latinos living in Costa Rica. Participants were incident cases of a first acute MI (n = 2,154) and randomly selected controls matched for age, sex, and residence (n = 2,154). After adjustment for traditional cardiovascular risk factors, including history of diabetes, history of hypertension, smoking, abdominal obesity, income, educational years, occupation, alcohol intake, dietary intakes of saturated fatty acid, fiber intake, and total energy intake, the multivariable-adjusted odds ratio (OR, 95% CI) for risk of MI were 1.00 (reference), 1.02 (0.86-1.21), 1.26 (0.81-1.95), and 1.58 (1.08-2.30) for intake of fried foods outside of the home <1/week, 1-3/week, 4-6/week, and 1/day, respectively (P trend = 0.02); and 1.00, 0.81 (0.65-1.00), 0.81 (0.61-1.09), and 0.93 (0.72-1.19), respectively (P for trend = 0.65) for intake of fried foods inside the home. The data suggest that consumption of fried foods outside of the home, a practice that has been associated with economic development, could have adverse effects on cardiovascular disease.	[Hu, Peter; Li, Yanping; Campos, Hannia] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Peter] Cornell Univ, Coll Human Ecol, Ithaca, NY USA; [Campos, Hannia] Univ Hispanoameriana, Ctr Invest & Innovac Nutr Traslac & Salud CIINT, San Jose, Costa Rica	Harvard University; Harvard T.H. Chan School of Public Health; Cornell University	Campos, H (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Campos, H (corresponding author), Univ Hispanoameriana, Ctr Invest & Innovac Nutr Traslac & Salud CIINT, San Jose, Costa Rica.	hcampos@hsph.harvard.edu	Li, Yanping/H-6437-2011	Li, Yanping/0000-0002-0412-2748	National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (HC) [HL49086, HL60692]; CIINT Research Fund from Universidad Hispanoamericana de Costa Rica	National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (HC); CIINT Research Fund from Universidad Hispanoamericana de Costa Rica	This study was supported by grants HL49086 and HL60692 from the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (HC), and the CIINT Research Fund from Universidad Hispanoamericana de Costa Rica.	Andrikopoulos NK, 2002, INT J FOOD SCI NUTR, V53, P351, DOI 10.1080/09637480220138098; Ansorena D, 2010, J FOOD SCI, V75, pH62, DOI 10.1111/j.1750-3841.2009.01472.x; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Cahill LE, 2014, AM J CLIN NUTR, V100, P667, DOI 10.3945/ajcn.114.084129; Campos H, 2008, CIRCULATION, V118, P339, DOI 10.1161/CIRCULATIONAHA.107.762419; Cantor A, 2013, ECOL FOOD NUTR, V52, P479, DOI 10.1080/03670244.2013.824360; Casal S, 2010, FOOD CHEM TOXICOL, V48, P2972, DOI 10.1016/j.fct.2010.07.036; Flores-Alvarez MD, 2012, J FOOD SCI, V77, pC1136, DOI 10.1111/j.1750-3841.2012.02930.x; DiBello JR, 2008, AM J EPIDEMIOL, V168, P1433, DOI 10.1093/aje/kwn274; Donfrancesco C, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-53; Echarte M, 2001, J FOOD PROTECT, V64, P1062, DOI 10.4315/0362-028X-64.7.1062; Ferracane R, 2008, J AGR FOOD CHEM, V56, P8601, DOI 10.1021/jf800408w; Gadiraju TV, 2015, NUTRIENTS, V7, P8424, DOI 10.3390/nu7105404; Guallar-Castillon P, 2007, AM J CLIN NUTR, V86, P198, DOI 10.1093/ajcn/86.1.198; Guallar-Castillon P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e363; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Kabagambe EK, 2005, J NUTR, V135, P2674, DOI 10.1093/jn/135.11.2674; Kabagambe EK, 2003, EUR J CLIN NUTR, V57, P1447, DOI 10.1038/sj.ejcn.1601709; Kabagambe EK, 2001, AM J EPIDEMIOL, V154, P1126, DOI 10.1093/aje/154.12.1126; Koh E, 2015, FOOD CHEM, V174, P467, DOI 10.1016/j.foodchem.2014.11.087; Krishnan S, 2010, AM J CLIN NUTR, V91, P465, DOI 10.3945/ajcn.2009.28682; Li A, 2012, J AGR FOOD CHEM, V60, P10709, DOI 10.1021/jf3033599; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Martinez-Ortiz JA, 2006, EUR J CLIN NUTR, V60, P770, DOI 10.1038/sj.ejcn.1602381; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Popkin BM, 2014, FOOD POLICY, V47, P91, DOI 10.1016/j.foodpol.2014.05.001; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Soriguer F, 2003, AM J CLIN NUTR, V78, P1092, DOI 10.1093/ajcn/78.6.1092; World Health Organization, 1971, IHD REG REP 5 WORK G; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhou YJ, 2015, FOOD POLICY, V55, P92, DOI 10.1016/j.foodpol.2015.07.001	33	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192960	10.1371/journal.pone.0192960	http://dx.doi.org/10.1371/journal.pone.0192960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447246	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900083
J	Otto, S; Krohne, U; Richter, D				Otto, Siegmar; Kroehne, Ulf; Richter, David			The dominance of introspective measures and what this implies: The example of environmental attitude	PLOS ONE			English	Article							ECOLOGICAL BEHAVIOR; PARADIGM	The behavioral sciences, including most of psychology, seek to explain and predict behavior with the help of theories and models that involve concepts (e.g., attitudes) that are subsequently translated into measures. Currently, some subdisciplines such as social psychology focus almost exclusively on measures that demand reflection or even introspection when administered to persons. We argue that such a focus hinders progress in explaining behavior. One major reason is that such an exclusive focus on reflections results in common method bias, which then produces spurious relations, or in other words, low discriminant validity. Without the valid measurement of theoretical concepts, theoretical assumptions cannot be tested, and hence, theory development will be hampered. We argue that the use of a greater variety of methods would reduce these problems and would in turn foster theory building. Using a representative sample of N = 472 participants (age: M = 51.0, SD = 17.7; 54% female), we compared the validity of a classical introspective attitude measure (i.e., the New Ecological Paradigm) with that of an alternative attitude measure (i.e., the General Ecological Behavior scale). The latter measure, which was based on self-reported behavior, showed substantially better validity that we argue could aid theory development.	[Otto, Siegmar] Otto Von Guericke Univ, Magdeburg, Germany; [Otto, Siegmar] Univ Hohenheim, Stuttgart, Germany; [Kroehne, Ulf] German Inst Int Educ Res DIPF, Frankfurt, Germany; [Richter, David] DIW Berlin, Socioecon Panel Study, Berlin, Germany	Otto von Guericke University; University Hohenheim; German Institute for International Educational Research; DIW Berlin - Deutsches Institut fur Wirtschaftsforschung	Otto, S (corresponding author), Otto Von Guericke Univ, Magdeburg, Germany.; Otto, S (corresponding author), Univ Hohenheim, Stuttgart, Germany.	siegmar.otto@ovgu.de	Otto, Siegmar/AAS-2634-2020; Richter, David/D-9556-2011	Otto, Siegmar/0000-0001-9645-2586; Richter, David/0000-0003-2811-8652				Ajzen I, 2005, EBOOK ATTITUDES PERS; [Anonymous], 2005, HDB ATTITUDES, DOI DOI 10.4324/9781410612823; Arnold O, 2017, SUSTAINABLE TR UNPUB; Arnold O, ENV BEHAV IN PRESS; Baumeister R. F., 2009, THEN MIRACLE OCCURS, P12; Blake J., 1999, LOCAL ENVIRON, V4, P257, DOI [10.1080/13549839908725599, DOI 10.1080/13549839908725599]; Campbell D.T., 1963, PSYCHOL STUDY SCI IN, V6, P94, DOI [10.1037/10590-003, DOI 10.1037/10590-003]; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; COTE JA, 1987, J MARKETING RES, V24, P315, DOI 10.2307/3151642; de Groot JM, 2010, J ENVIRON PSYCHOL, V30, P368, DOI 10.1016/j.jenvp.2010.04.002; De Houwer J, 2013, EUR REV SOC PSYCHOL, V24, P252, DOI 10.1080/10463283.2014.892320; DEFLEUR ML, 1963, SOC FORCES, V42, P17, DOI 10.2307/2574941; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Eagly A. H., 1993, PSYCHOL ATTITUDES; Eid M., 2011, STAT FORSCHUNGSMETHO; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; GROB A, 1995, J ENVIRON PSYCHOL, V15, P209, DOI 10.1016/0272-4944(95)90004-7; Hawcroft LJ, 2010, J ENVIRON PSYCHOL, V30, P143, DOI 10.1016/j.jenvp.2009.10.003; Hines J.M., 1987, J ENVIRON EDUC, V18, P1, DOI [10.1080/00958964.1987.9943482, DOI 10.1080/00958964.1987.9943482]; Hinkle D.E., 2003, APPL STAT BEHAV SCI; Kaiser F.G., 2015, COMPR PSYCHOL, V4, P11, DOI [10.2466/49.CP.4.11, DOI 10.2466/49.CP.4.11]; Kaiser FG, 2004, PERS INDIV DIFFER, V36, P1531, DOI 10.1016/j.paid.2003.06.003; Kaiser FG, 2003, J ENVIRON PSYCHOL, V23, P11, DOI 10.1016/S0272-4944(02)00075-0; Kaiser FG, 2001, DIAGNOSTICA, V47, P88, DOI 10.1026//0012-1924.47.2.88; Kaiser FG, J ENV PSYCH IN PRESS; Kaiser FG, 2015, J SOC PSYCHOL, V155, P12, DOI 10.1080/00224545.2014.959884; Kaiser FG, 2010, PERS SOC PSYCHOL REV, V14, P351, DOI 10.1177/1088868310366452; Kingsbury G.G., 1989, APPL MEAS EDUC, V2, P359, DOI [10.1207/s15324818ame0204_6, DOI 10.1207/S15324818AME0204_6]; Kolen MJ, 2014, TEST EQUATING SCALIN; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Milfont TL, 2010, J ENVIRON PSYCHOL, V30, P80, DOI 10.1016/j.jenvp.2009.09.001; Otto S, 2016, SOC NATUR RESOUR, V29, P628, DOI 10.1080/08941920.2015.1037410; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Poortinga W, 2004, ENVIRON BEHAV, V36, P70, DOI 10.1177/0013916503251466; Rauschmayer F, 2013, J HUM DEV CAPABIL, V14, P1, DOI 10.1080/19452829.2012.751744; Raykov T, 2015, EDUC PSYCHOL MEAS, V75, P146, DOI 10.1177/0013164414526039; Richter D, 2012, SOEPPAPERS; Schultz PW, 1996, SOC PSYCHOL QUART, V59, P375, DOI 10.2307/2787078; STERN PC, 1994, J SOC ISSUES, V50, P65, DOI 10.1111/j.1540-4560.1994.tb02420.x; Tanner C, 2004, ENVIRON BEHAV, V36, P94, DOI 10.1177/0013916503251437; von Davier M, 2007, METHODOL EUROPEAN J, V3, P115, DOI DOI 10.1027/1614-2241.3.3.115; Wilson M., 2004, CONSTRUCTING MEASURE, DOI [https://doi.org/10.4324/9781410611697, DOI 10.4324/9781410611697]	42	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192907	10.1371/journal.pone.0192907	http://dx.doi.org/10.1371/journal.pone.0192907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447235	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900070
J	Woud, ML; Cwik, JC; Blackwell, SE; Kleim, B; Holmes, EA; Adolph, D; Zhang, H; Margraf, J				Woud, Marcella L.; Cwik, Jan C.; Blackwell, Simon E.; Kleim, Birgit; Holmes, Emily A.; Adolph, Dirk; Zhang, Hui; Margraf, Juergen			Does napping enhance the effects of Cognitive Bias Modification-Appraisal training? An experimental study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SLOW-WAVE SLEEP; INTRUSIVE MEMORIES; TRAUMA; CONSOLIDATION; REAPPRAISAL; IMPACT; VULNERABILITY; ATTENTION; MODEL	Posttraumatic Stress Disorder (PTSD) is characterised by dysfunctional appraisals of the trauma and its consequences including one's own symptoms. Experimental studies have shown that Cognitive Bias Modification-Appraisal (CBM-App) training can reduce dysfunctional interpretations and analog trauma symptoms. One important question is how to enhance the effects of CBM-App. Following work suggesting that sleep has beneficial effects on consolidation processes and can thus improve learning, the present study investigated whether a brief period of sleep (i.e., a nap) enhances the effects of CBM-App. All participants watched a stressful movie as an analogue trauma induction. After that, participants received either positive or negative CBM-App training. Within each training, half of the participants then had a 90-minute nap or watched a neutral movie. Results showed that the CBM training induced training-congruent appraisals. Sleep did not enhance this effect. Participants who slept, however, experienced fewer intrusive memories of the analogue trauma, but this effect was independent of the CBM condition. These results provide valuable information about the effects of sleep during a 90-minute nap period on encoding of analogue trauma and emotional learning in the context of appraisal, and highlight the importance of sleep as a focus for continued research.	[Woud, Marcella L.; Blackwell, Simon E.; Adolph, Dirk; Margraf, Juergen] Ruhr Univ Bochum, Dept Psychol, Mental Hlth Res & Treatment Ctr, Bochum, Germany; [Cwik, Jan C.] Univ Cologne, Clin Psychol & Psychotherapy, Cologne, Germany; [Kleim, Birgit] Univ Hosp Psychiat Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Holmes, Emily A.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Zhang, Hui] Ruhr Univ Bochum, Fac Psychol, Inst Cognit Neurosci, Dept Neuropsychol, Bochum, Germany	Ruhr University Bochum; University of Cologne; Karolinska Institutet; Ruhr University Bochum	Woud, ML (corresponding author), Ruhr Univ Bochum, Dept Psychol, Mental Hlth Res & Treatment Ctr, Bochum, Germany.	marcella.woud@rub.de	Kleim, Birgit/AAM-5309-2021; Cwik, Jan Christopher/O-7852-2016; Holmes, Emily/ABD-4367-2020; Margraf, Jürgen/A-6873-2008; Blackwell, Simon/AAG-4861-2021	Cwik, Jan Christopher/0000-0002-2290-353X; Holmes, Emily/0000-0001-7319-3112; Margraf, Jürgen/0000-0001-5207-7016; Blackwell, Simon/0000-0002-3313-7084; Woud, Marcella/0000-0002-4974-505X	Alexander von Humboldt Foundation [3.3-SCZ/1133999]; Daimler and Benz Foundation [32-12/4]; Deutsche Forschungsgemeinschaft (DFG) [WO2018/2-1, MA1116/13-1]; Karolinska Institutet; Wellcome Trust; Lupina Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Daimler and Benz Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Karolinska Institutet(Karolinska Institutet); Wellcome Trust(Wellcome TrustEuropean Commission); Lupina Foundation	The Alexander von Humboldt Foundation provided financial support for the present project (awarded to Prof. Margraf, grant number: 3.3-SCZ/1133999, https://www.humboldt-foundation.de/web/home.html). Further, these are additional grants of some of the authors: MLW is supported by a Post Doctoral scholarship of the Daimler and Benz Foundation (32-12/4, https://www.daimler-benz-stiftung.de/cms/en/foundation.html) and a grant of the Deutsche Forschungsgemeinschaft (DFG; WO2018/2-1, http://www.dfg.de/en/). EAH receives a salary from the Karolinska Institutet, and receives funding from The Wellcome Trust (https://wellcome.ac.uk/, the UK NIHR (https://www.nihr.ac.uk/), and the Lupina Foundation (http://www.lupina.ca/). JM is is supported by a grant of the Deutsche Forschungsgemeinschaft (DFG; MA1116/13-1, http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend R, 2014, CLIN PSYCHOL SCI, V2, P620, DOI 10.1177/2167702614526571; Abend R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062501; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Bryant RA, 2005, PSYCHOL SCI, V16, P749, DOI 10.1111/j.1467-9280.2005.01608.x; Bryant RA, 2007, J CONSULT CLIN PSYCH, V75, P812, DOI 10.1037/0022-006X.75.5.812; Buysse D J, 1989, Psychiatry Res, V28, P193; Cheung J, 2017, J BEHAV THER EXP PSY, V54, P108, DOI 10.1016/j.jbtep.2016.07.005; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; Diekelmann S, 2012, NEUROBIOL LEARN MEM, V98, P103, DOI 10.1016/j.nlm.2012.07.002; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A., 1999, POSTTRAUMATISCHE BEL; Ehring T, 2008, J CONSULT CLIN PSYCH, V76, P219, DOI 10.1037/0022-006X.76.2.219; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; FOA EB, 1995, CURR DIR PSYCHOL SCI, V4, P61, DOI 10.1111/1467-8721.ep10771786; Hautzinger M., 2006, BECK DEPRESSIONSINVE; Hertel PT, 2011, PERSPECT PSYCHOL SCI, V6, P521, DOI 10.1177/1745691611421205; Hofmann S., 2010, VOGELWELT WALDES; Holmes EA, 2004, J NERV MENT DIS, V192, P28, DOI 10.1097/01.nmd.0000105997.28152.4b; Holmes EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004153; Iber C., 2007, AASM MANUAL SCORING; James EL, 2016, CLIN PSYCHOL REV, V47, P106, DOI 10.1016/j.cpr.2016.04.010; Kleim B, 2014, PSYCHOL MED, V44, P1511, DOI 10.1017/S0033291713001748; Kleim B, 2016, SLEEP, V39, P2125, DOI 10.5665/sleep.6310; Koster EHW, 2009, J ABNORM PSYCHOL, V118, P1, DOI 10.1037/a0014379; Laux L, 1981, STATE TRAIT DAS STAT; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MacLeod C, 2012, ANNU REV CLIN PSYCHO, V8, P189, DOI 10.1146/annurev-clinpsy-032511-143052; Maercker A, 1998, DIAGNOSTICA, V44, P130; Nickerson A, 2017, CLIN PSYCHOL SCI, V5, P497, DOI 10.1177/2167702617690857; Pace-Schott EF, 2012, J PSYCHIATR RES, V46, P1036, DOI 10.1016/j.jpsychires.2012.04.015; Porcheret K, 2015, SLEEP, V38, P1017, DOI 10.5665/sleep.4802; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Schartau PES, 2009, J ABNORM PSYCHOL, V118, P15, DOI 10.1037/a0012906; Schichl M, 2012, HYPNOSIS, V13, P7; Schranz S, 2011, DIE NORDSEE VON OBEN; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Woud ML, 2017, CLIN PSYCHOL REV, V54, P81, DOI 10.1016/j.cpr.2017.04.003; Woud ML, 2014, ALCOHOL CLIN EXP RES, V38, P1151, DOI 10.1111/acer.12334; Woud ML, 2013, J BEHAV THER EXP PSY, V44, P312, DOI 10.1016/j.jbtep.2013.01.003; Woud ML, 2012, PSYCHOL ADDICT BEHAV, V26, P627, DOI 10.1037/a0029025; Woud ML, 2012, EMOTION, V12, P778, DOI 10.1037/a0024992	44	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192837	10.1371/journal.pone.0192837	http://dx.doi.org/10.1371/journal.pone.0192837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447217	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000425283900059
J	Cevallos, W; Fernandez-Soto, P; Calvopina, M; Buendia-Sanchez, M; Lopez-Aban, J; Vicente, B; Muro, A				Cevallos, William; Fernandez-Soto, Pedro; Calvopina, Manuel; Buendia-Sanchez, Maria; Lopez-Aban, Julio; Vicente, Belen; Muro, Antonio			Diagnosis of amphimeriasis by LAMPhimerus assay in human stool samples long-term storage onto filter paper	PLOS ONE			English	Article							DNA EXTRACTION; PCR METHODS; SPP.; INFECTION	Amphimeriasis, a fish-borne zoonotic disease caused by the liver fluke Amphimerus spp., has recently been reported as an emerging disease affecting an indigenous Ameridian group, the Chachi, living in Ecuador. The only method for diagnosing amphimeriasis was the microscopic detection of eggs from the parasite in patients' stool samples with very low sensitivity. Our group developed an ELISA technique for detection of anti-Amphimerus IgG in human sera and a molecular method based on LAMP technology (named LAMPhimerus) for specific and sensitive parasite DNA detection. The LAMPhimerus method showed to be much more sensitive than classical parasitological methods for amphimeriasis diagnosis using human stool samples for analysis. The objective of this work is to demonstrate the feasibility of using dried stool samples on filter paper as source of DNA in combination with the effectiveness of our previously designed LAMPhimerus assay for successfully Amphimerus sp. detection in clinical stool samples. A total of 102 untreated and undiluted stool samples collected from Chachi population were spread as thin layer onto common filter paper for easily transportation to our laboratory and stored at room temperature for one year until DNA extraction. When LAMPhimerus method was applied for Amphimerus sp. DNA detection, a higher number of positive results was detected (61/102; 59.80%) in comparison to parasitological methods (38/102; 37.25%), including 28/61 (45.90%) microscopy-confirmed Amphimerus sp. infections. The diagnostic parameters for the sensitivity and specificity werecalculated for our LAMPhimerus assay, which were 79.17% and 65.98%, respectively. We demonstrate, for the first time, that common filter paper is useful for easy collection and long-term storage of human stool samples for later DNA extraction and molecular analysis of human-parasitic trematode eggs. This simple, economic and easily handling method combined with the specific and sensible LAMPhimerus assay has the potential to beused as an effective molecular large-scale screening test for amphimeriasis-endemic areas.	[Cevallos, William] Univ Cent Ecuador, Ctr Biomed, Carrera Med, Quito, Ecuador; [Cevallos, William; Fernandez-Soto, Pedro; Buendia-Sanchez, Maria; Lopez-Aban, Julio; Vicente, Belen; Muro, Antonio] Univ Salamanca, Infect & Trop Dis Res Grp e INTRO, Biomed Res Inst Salamanca, Res Ctr Trop Dis,IBSAL CIETUS,Fac Pharm, Salamanca, Spain; [Calvopina, Manuel] UDLA, Carrera Med, Quito, Ecuador	Universidad Central del Ecuador; University of Salamanca; Universidad de Las Americas - Ecuador	Fernandez-Soto, P; Muro, A (corresponding author), Univ Salamanca, Infect & Trop Dis Res Grp e INTRO, Biomed Res Inst Salamanca, Res Ctr Trop Dis,IBSAL CIETUS,Fac Pharm, Salamanca, Spain.	pfsoto@usal.es; ama@usal.es	López-Abán, Julio/B-3557-2015	López-Abán, Julio/0000-0001-8509-0727; Muro, Antonio/0000-0003-0244-4740; Calvopina, Manuel/0000-0002-0286-0747; Cevallos, William/0000-0003-1519-7275	Universidad Central del Ecuador [CUP 91750000.0000.374072]; Japan Society for the Promotion of Science, JSPS (KAKENHI) [25305011]; Ministry of Health, Labor and Welfare of Japan [H23-Shinko-ippan-014, H26-Shinkoippan- 009]; Health Research Projects: Technological Development Project in Health [DTS16/00207]; Health Research Project of funding institution Instituto de Salud Carlos III [PI16/01784]	Universidad Central del Ecuador; Japan Society for the Promotion of Science, JSPS (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Health Research Projects: Technological Development Project in Health; Health Research Project of funding institution Instituto de Salud Carlos III	This study was funded by the grants from the Universidad Central del Ecuador (CUP 91750000.0000.374072) (to William F. Cevallos) (http://www.uce.edu.ec/) and in part by the Japan Society for the Promotion of Science, JSPS (KAKENHI: Grant No.25305011) to Manuel Calvopina and by grants for Research on Emerging and Re-emerging Infectious Diseases (H23-Shinko-ippan-014 and H26-Shinkoippan- 009) from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/). Additional funding was supported by the Health Research Projects: Technological Development Project in Health, grant number DTS16/00207 (to Antonio Muro) and Health Research Project, grant number PI16/01784 (to Pedro Fernandez-Soto) of funding institution Instituto de Salud Carlos III (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvopina M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003526; Calvopina M, 2011, EMERG INFECT DIS, V17, P2331, DOI 10.3201/eid1712.110373; Carnevale S, 2000, CLIN DIAGN LAB IMMUN, V7, P504, DOI 10.1128/CDLI.7.3.504-506.2000; Cevallos W, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005672; Cevallos W, 2017, MEM I OSWALDO CRUZ, V112, P364, DOI 10.1590/0074-02760160426; Crompton DW, 2010, WHO TECH REP SER; Johansen MV, 2010, ADV PARASIT, V73, P171, DOI 10.1016/S0065-308X(10)73007-4; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P2297, DOI 10.3748/wjg.14.2297; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nantavisai K, 2007, J CLIN MICROBIOL, V45, P581, DOI 10.1128/JCM.01823-06; Njiru ZK, 2010, PLOS NEGLECT TROP D, V6, pe1572; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; PENSE D B, 1972, Journal of Wildlife Diseases, V8, P221; Rajendram D, 2006, J MICROBIOL METH, V67, P582, DOI 10.1016/j.mimet.2006.05.010; ROTHENBACHER H, 1963, J AM VET MED ASSOC, V143, P1099; Seyer A, 2016, PARASITOL RES, V115, P4449, DOI 10.1007/s00436-016-5231-y; Smit PW, 2014, AM J TROP MED HYG, V90, P195, DOI 10.4269/ajtmh.13-0463; Subrungruang I, 2004, J CLIN MICROBIOL, V42, P3490, DOI 10.1128/JCM.42.8.3490-3494.2004; World Health Organization, 1992, BAS LAB METH MED PAR; Zhang XZ, 2014, BIOSENS BIOELECTRON, V61, P491, DOI 10.1016/j.bios.2014.05.039	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192637	10.1371/journal.pone.0192637	http://dx.doi.org/10.1371/journal.pone.0192637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444135	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500079
J	Hsieh, WC; Ramadesikan, S; Fekete, D; Aguilar, RC				Hsieh, Wen-Chieh; Ramadesikan, Swetha; Fekete, Donna; Aguilar, Ruben Claudio			Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; RENAL PROGENITOR CELLS; SYNDROME PROTEIN OCRL1; PRIMARY CILIA; OCULOCEREBRORENAL SYNDROME; TRANSCRIPTION FACTOR; 5-PHOSPHATASE; TRAFFICKING; DEFICIENCY; ACTIVATION	Lowe syndrome is an X-linked condition characterized by congenital cataracts, neurological abnormalities and kidney malfunction. This lethal disease is caused by mutations in the OCRL1 gene, which encodes for the phosphatidylinositol 5-phosphatase Ocrl1. While in the past decade we witnessed substantial progress in the identification and characterization of LS patient cellular phenotypes, many of these studies have been performed in knockeddown cell lines or patient's cells from accessible cell types such as skin fibroblasts, and not from the organs affected. This is partially due to the limited accessibility of patient cells from eyes, brain and kidneys. Here we report the preparation of induced pluripotent stem cells (iPSCs) from patient skin fibroblasts and their reprogramming into kidney cells. These reprogrammed kidney cells displayed primary cilia assembly defects similar to those described previously in cell lines. Additionally, the transcription factor and cap mesenchyme marker Six2 was substantially retained in the Golgi complex and the functional nuclear-localized fraction was reduced. These results were confirmed using different batches of differentiated cells from different iPSC colonies and by the use of the human proximal tubule kidney cell line HK2. Indeed, OCRL1 KO led to both ciliogenesis defects and Six2 retention in the Golgi complex. In agreement with Six2's role in the suppression of ductal kidney lineages, cells from this pedigree were over-represented among patient kidney-reprogrammed cells. We speculate that this diminished efficacy to produce cap mesenchyme cells would cause LS patients to have difficulties in replenishing senescent or damaged cells derived from this lineage, particularly proximal tubule cells, leading to pathological scenarios such as tubular atrophy.	[Hsieh, Wen-Chieh; Ramadesikan, Swetha; Fekete, Donna; Aguilar, Ruben Claudio] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Fekete, Donna; Aguilar, Ruben Claudio] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA; [Fekete, Donna; Aguilar, Ruben Claudio] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Fekete, Donna; Aguilar, Ruben Claudio] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Aguilar, RC (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.; Aguilar, RC (corresponding author), Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA.; Aguilar, RC (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.; Aguilar, RC (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	claudio@purdue.edu	Ramadesikan, Swetha/AGV-0594-2022	Ramadesikan, Swetha/0000-0002-8066-2500	National Institutes of Health; Lowe Syndrome Trust [1R01DK109398-01, BU/CO/2014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lowe Syndrome Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health and the Lowe Syndrome Trust under Grants 1R01DK109398-01 and BU/CO/2014 to RCA.; We thank members of the Aguilar lab for discussions and critical reading of the manuscript, and to Claudia B. Hanna for excellent technical assistance. This work was supported by the National Institutes of Health and the Lowe Syndrome Trust under Grants 1R01DK109398-01 and BU/CO/2014 to RCA.	Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Araoka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084881; Baxi K, 2017, GENETICS; Bockenhauer D, 2008, CLIN J AM SOC NEPHRO, V3, P1430, DOI 10.2215/CJN.00520108; Bokenkamp A, 2016, PEDIATR NEPHROL, V31, P2201, DOI 10.1007/s00467-016-3343-3; Brown KM, 2013, THER ADV PSYCHOPHARM, V3, P163, DOI 10.1177/2045125312471963; Bussolati B, 2015, NAT REV NEPHROL, V11, P695, DOI 10.1038/nrneph.2015.126; Chen LQ, 2017, CELL RES, V27, P748, DOI 10.1038/cr.2017.45; Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Coon BG, 2012, HUM MOL GENET, V21, P1835, DOI 10.1093/hmg/ddr615; Cui SS, 2010, AM J PHYSIOL-RENAL, V298, pF335, DOI 10.1152/ajprenal.00453.2009; Deane JA, 2012, INT REV CEL MOL BIO, V293, P169, DOI 10.1016/B978-0-12-394304-0.00011-7; Di Malta C, 2017, SCIENCE, V356, P1188, DOI 10.1126/science.aag2553; Fogelgren B, 2008, DEV DYNAM, V237, P1767, DOI 10.1002/dvdy.21587; Fogelgren B, 2009, AM J PHYSIOL-RENAL, V296, pF1166, DOI 10.1152/ajprenal.90550.2008; Gao J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.120; Gil S, 2006, DEV BIOL, V298, P201, DOI 10.1016/j.ydbio.2006.06.029; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; He GY, 2010, DEV BIOL, V344, P720, DOI 10.1016/j.ydbio.2010.05.509; Hilgendorf KI, 2016, CURR OPIN CELL BIOL, V39, P84, DOI 10.1016/j.ceb.2016.02.008; Hishikawa K, 2015, WORLD J STEM CELLS, V7, P490, DOI 10.4252/wjsc.v7.i2.490; Hu SY, 2008, BIOCHEMISTRY-US, V47, P3586, DOI 10.1021/bi702186s; Kleene SJ, 2014, BIOSCIENCE, V64, P1092, DOI 10.1093/biosci/biu181; Kleta R, 2008, CLIN J AM SOC NEPHRO, V3, P1244, DOI 10.2215/CJN.02880608; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lamani E, 2015, DEV GROWTH DIFFER, V57, P625, DOI 10.1111/dgd.12253; Lasne D, 2010, BRIT J HAEMATOL, V150, P685, DOI 10.1111/j.1365-2141.2010.08304.x; Lee Kristen L, 2015, Cilia, V4, P7, DOI 10.1186/s13630-015-0016-y; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Little MH, 2012, COLD SPRING HARB PER, V4; Liu JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020191; Loi M, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-16; Luo N, 2012, HUM MOL GENET, V21, P3333, DOI 10.1093/hmg/dds163; Madhivanan K, 2014, TRAFFIC, V15, P1031, DOI 10.1111/tra.12195; Madhivanan Kayalvizhi, 2012, Commun Integr Biol, V5, P641, DOI 10.4161/cib.21952; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meyer-Schwesinger C, 2016, NEPHRON, V132, P101, DOI 10.1159/000442180; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Nabar NR, 2017, YALE J BIOL MED, V90, P301; Nandez R, 2014, ELIFE, V3, DOI 10.7554/eLife.02975; Oltrabella F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005058; Prosseda PP, 2017, J CELL SCI, V130, P3447, DOI 10.1242/jcs.200857; Putoux A, 2012, PEDIATR NEPHROL, V27, P7, DOI 10.1007/s00467-010-1751-3; Rbaibi Y, 2012, TRAFFIC, V13, P1295, DOI 10.1111/j.1600-0854.2012.01387.x; Recker F, 2015, PEDIATR NEPHROL, V30, P931, DOI 10.1007/s00467-014-3013-2; Reiter JF, 2017, NAT REV MOL CELL BIO; Rivera-Serrano EE, 2017, VIROLOGY, V502, P133, DOI 10.1016/j.virol.2016.12.022; Schramm L, 2004, AM J KIDNEY DIS, V43, P538, DOI 10.1053/j.ajkd.2003.11.013; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Serretti A, 2009, CURR MED CHEM, V16, P1917, DOI 10.2174/092986709788186101; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Suzuki Etsu, 2016, World J Nephrol, V5, P43, DOI 10.5527/wjn.v5.i1.43; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takasato M, 2016, NATURE, V536, P238, DOI 10.1038/nature17982; Tanigawa S, 2016, DIFFERENTIATION, V91, P152, DOI 10.1016/j.diff.2016.01.007; Topaloglu R, 2013, TURKISH J PEDIATR, V55, P331; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; van Rahden VA, 2012, HUM MOL GENET, V21, P5019, DOI 10.1093/hmg/dds343; Vicinanza M, 2011, EMBO J, V30, P4970, DOI 10.1038/emboj.2011.354; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang HL, 2014, J INTEGR MED-JIM, V12, P469, DOI 10.1016/S2095-4964(14)60053-4; Wang SX, 2013, AM J PHYSIOL-RENAL, V305, pF1085, DOI 10.1152/ajprenal.00399.2013; Wang S, 2017, NAT IMMUNOL, V18, P733, DOI 10.1038/ni.3744; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wolf MTF, 2015, CURR OPIN PEDIATR, V27, P201, DOI 10.1097/MOP.0000000000000194; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xu QW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10777; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574; Zhu SA, 2015, ARTHRITIS RHEUMATOL, V67, P2154, DOI 10.1002/art.39174	71	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192635	10.1371/journal.pone.0192635	http://dx.doi.org/10.1371/journal.pone.0192635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444177	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500078
J	Pillai, RR; Wilson, AB; Premkumar, NR; Kattimani, S; Sagili, H; Rajendiran, S				Pillai, Raji Ramachandran; Wilson, Anand Babu; Premkumar, Nancy R.; Kattimani, Shivanand; Sagili, Haritha; Rajendiran, Soundravally			Low serum levels of High-Density Lipoprotein cholesterol (HDL-c) as an indicator for the development of severe postpartum depressive symptoms	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MAJOR DEPRESSION; PREGNANCY; DISORDER; WOMEN; RISK; LIPIDS; ANXIETY; OBESITY; PROFILE	Postpartum depression (PPD) is a psychiatric complication of childbirth affecting 10-20% of new mothers and has negative impact on both mother and infant. Serum lipid levels have been related to depressive disorders, but very limited literatures are available regarding the lipid levels in women with postpartum depression. The present study is aimed to examine the association of serum lipids with the development of postpartum depressive symptoms. This is a cross sectional study conducted at a tertiary care hospital in South India. Women who came for postpartum check-up at 6th week post-delivery were screened for PPD (September 2014-October 2015). Women with depressive symptoms were assessed using EPDS (Edinburgh Postnatal Depression Scale). The study involved 186 cases and 250 controls matched for age and BMI. Serum levels of lipid parameters were estimated through spectrophotometry and the atherogenic indices were calculated in all the subjects. Low serum levels of Total Cholesterol (TC) and High Density Lipoprotein cholesterol (HDL-c) were significantly low in PPD women with severe depressive symptoms. The study recorded a significant negative correlation between HDL-c and the EPDS score in PPD women (r = -0.140, p = 0.05). Interestingly, the study also observed a significant negative correlation between Body Mass Index (BMI) and EPDS scores in case group (r = -0.146, p = 0.047), whereas a positive correlation between the same in controls (r = 0.187, p = 0.004). Our study demonstrated that low levels of serum HDL-c is correlated with the development of severe depressive symptoms in postpartum women. Study highlights the role of lipids in the development of postpartum depressive symptoms.	[Pillai, Raji Ramachandran; Wilson, Anand Babu; Rajendiran, Soundravally] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Biochem, Pondicherry, India; [Premkumar, Nancy R.] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Medico Socio Serv, Pondicherry, India; [Kattimani, Shivanand] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Psychiat, Pondicherry, India; [Sagili, Haritha] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Obstet & Gynecol, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research	Rajendiran, S (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Biochem, Pondicherry, India.	soundy27@gmail.com		KATTIMANI, SHIVANAND/0000-0002-9481-2784	parent institute JIPMER, Puducherry, India; DST-SERB program; parent institute JIPMER; DST	parent institute JIPMER, Puducherry, India; DST-SERB program; parent institute JIPMER; DST(Department of Science & Technology (India))	This study was funded by the intramural grant of the parent institute JIPMER, Puducherry, India. In addition, the support provided by the DST-SERB program is also acknowledged.; Authors sincerely thank all postpartum mothers who actively participated in this study as well all the staff in the Department of Obstetrics & Gynecology, JIPMER for directing the mothers while screening to carry our study successfully. Special thanks to the 30 B lab facilities of JIPMER. We thank intramural grant of the parent institute JIPMER and DST research grant for funding this project.	Azorin JM, 2012, J AFFECT DISORDERS, V136, P710, DOI 10.1016/j.jad.2011.10.003; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bartels A, 2012, J OBSTET GYNAECOL, V32, P747, DOI 10.3109/01443615.2012.714017; Benjamin D, 2005, J OBSTET GYN INDIA, V55, P241; Beydoun MA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.4; Bodnar LM, 2009, J CLIN PSYCHIAT, V70, P1290, DOI 10.4088/JCP.08m04651; Bodnar-Deren S, 2016, J WOMENS HEALTH, V25, P1219, DOI 10.1089/jwh.2015.5346; Boury JM, 2004, WOMEN HEALTH, V39, P19, DOI 10.1300/J013v39n03_02; Brown HA, 2009, NAT CHEM BIOL, V5, P602, DOI 10.1038/nchembio0909-602; Buttner MM, 2012, ASSESSMENT, V19, P247, DOI 10.1177/1073191111429388; Carter AS, 2000, PSYCHOSOM MED, V62, P264, DOI 10.1097/00006842-200003000-00019; Chen CC, 2001, PSYCHIAT RES, V102, P153, DOI 10.1016/S0165-1781(01)00231-1; Cockerill GW, 2001, CIRCULATION, V103, P108; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Dong C, 2004, INT J OBESITY, V28, P790, DOI 10.1038/sj.ijo.0802626; Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Ertel KA, 2015, HEALTH PSYCHOL, V34, P19; Farias DR, 2016, BJOG-INT J OBSTET GY, V123, P570, DOI 10.1111/1471-0528.13293; FAUBEL M, 1989, J PSYCHOL, V123, P385, DOI 10.1080/00223980.1989.10542993; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Ghio A, 2011, ADV CLIN CHEM, V55, P133, DOI 10.1016/B978-0-12-387042-1.00007-1; Gupta A., 2013, IND MED GAZ, V147, P253; Henshaw C., 2003, ARCH WOMEN MENT HLTH, V6, P33; HIBBELN JR, 1995, AM J CLIN NUTR, V62, P1; HILLMAN L, 1975, METABOLISM, V24, P943, DOI 10.1016/0026-0495(75)90086-4; Horsten M, 1997, PSYCHOSOM MED, V59, P521, DOI 10.1097/00006842-199709000-00009; Howard BV, 2003, ENDOCRIN METAB CLIN, V32, P855, DOI 10.1016/S0889-8529(03)00073-2; Howard LM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-57; Huang TL, 2005, J AFFECT DISORDERS, V86, P75, DOI 10.1016/j.jad.2004.11.005; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; Kaplan JR, 1997, ANN NY ACAD SCI, V836, P57, DOI 10.1111/j.1749-6632.1997.tb52355.x; Krause KM, 2009, MATERN CHILD HLTH J, V13, P832, DOI 10.1007/s10995-008-0418-1; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Ledochowski M, 2003, CLIN CHEM LAB MED, V41, P821, DOI 10.1515/CCLM.2003.124; Lehto SM, 2010, PSYCHIAT CLIN NEUROS, V64, P279, DOI 10.1111/j.1440-1819.2010.02079.x; Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1; Linde JA, 2004, INT J OBESITY, V28, P418, DOI 10.1038/sj.ijo.0802570; Lippi G, 2007, CLIN LAB, V53, P173; Loraine KE, 2015, OBSTET GYNECOL, V125, P144; Maes M, 1997, ACTA PSYCHIAT SCAND, V95, P212, DOI 10.1111/j.1600-0447.1997.tb09622.x; Mahar I, 2014, NEUROSCI BIOBEHAV R, V38, P173, DOI 10.1016/j.neubiorev.2013.11.009; Mankuta D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-58; Mannie ZN, 2013, BRIT J PSYCHIAT, V203, P18, DOI 10.1192/bjp.bp.113.126987; Matyjaszek-Matuszek B, 2014, ANN AGR ENV MED, V21, P850, DOI 10.5604/12321966.1129945; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Ogura Kazuhiro, 2002, J Atheroscler Thromb, V9, P42; Olusi SO, 1996, BIOL PSYCHIAT, V40, P1128, DOI 10.1016/S0006-3223(95)00599-4; Paris R, 2009, ARCH WOMEN MENT HLTH, V12, P309, DOI 10.1007/s00737-009-0105-2; POTTER JM, 1979, AM J OBSTET GYNECOL, V133, P165, DOI 10.1016/0002-9378(79)90469-1; Qureshi I. A., 1999, Annals Academy of Medicine Singapore, V28, P217; Rabe-Jablonska J, 2000, Med Sci Monit, V6, P539; REBOUD P, 1963, AM J OBSTET GYNECOL, V86, P820; Rhee EJ, 2015, ENDOCRINOL METAB, V30, P263, DOI 10.3803/EnM.2015.30.3.263; Rice MC, 2010, AGING MENT HEALTH, V14, P405, DOI 10.1080/13607860903586185; Roberts RE, 2002, ANN BEHAV MED, V24, P169, DOI 10.1207/S15324796ABM2403_02; Roohafza H, 2005, ARYA ATHEROSCLER, V1, P15; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Savarimuthu RJS, 2010, INT J SOC PSYCHIATR, V56, P94, DOI 10.1177/0020764008097756; Seehusen DA, 2005, J AM BOARD FAM PRACT, V18, P104, DOI 10.3122/jabfm.18.2.104; Sharon JH, 2008, CHILDBIRTHOBESITY J, V16; Sit D, 2006, J WOMENS HEALTH, V15, P352, DOI 10.1089/jwh.2006.15.352; Terao T, 2000, ACTA PSYCHIAT SCAND, V101, P231; Udoh A. E., 1994, Acta Medica Hungarica, V50, P75; VANSTIPHOUT WAHJ, 1987, AM J EPIDEMIOL, V126, P922; Vargas HO, 2014, LIFE SCI, V102, P65, DOI 10.1016/j.lfs.2014.02.033; Vliegen N, 2014, HARVARD REV PSYCHIAT, V22, P1, DOI 10.1097/HRP.0000000000000013; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wulsin LR, 2005, PSYCHOSOM MED, V67, P697, DOI 10.1097/01.psy.0000181274.56785.28; Wysokinski A, 2015, DIABETES METAB SYND, V9, P168, DOI 10.1016/j.dsx.2015.04.004; Zhang J, 2005, J AFFECT DISORDERS, V89, P25, DOI 10.1016/j.jad.2005.05.021	73	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192811	10.1371/journal.pone.0192811	http://dx.doi.org/10.1371/journal.pone.0192811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444162	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500093
J	Wilson, SE; Chung, H; Schwartz, KL; Guttmann, A; Deeks, SL; Kwong, JC; Crowcroft, NS; Wing, L; Tu, K				Wilson, Sarah E.; Chung, Hannah; Schwartz, Kevin L.; Guttmann, Astrid; Deeks, Shelley L.; Kwong, Jeffrey C.; Crowcroft, Natasha S.; Wing, Laura; Tu, Karen			Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada	PLOS ONE			English	Article							ADMINISTRATIVE DATA; YOUNG-CHILDREN; INFLUENZA VACCINATION; IMMUNIZATION COVERAGE; IDENTIFY PATIENTS; COMPLETION; VALIDATION; CARE; GASTROENTERITIS; HOSPITALIZATION	Background In August 2011, Ontario, Canada introduced a rotavirus immunization program using Rotarix (TM) vaccine. No assessments of rotavirus vaccine coverage have been previously conducted in Ontario. Methods We assessed vaccine coverage (series initiation and completion) and factors associated with uptake using the Electronic Medical Record Administrative data Linked Database (EMRALD), a collection of family physician electronic medical records (EMR) linked to health administrative data. Series initiation (1 dose) and series completion (2 doses) before and after the program's introduction were calculated. To identify factors associated with series initiation and completion, adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) were calculated using logistic regression. Results A total of 12,525 children were included. Series completion increased each year of the program (73%, 79% and 84%, respectively). Factors associated with series initiation included high continuity of care (aOR = 2.15; 95% CI, 1.61-2.87), maternal influenza vaccination (aOR = 1.55; 95% CI, 1.24-1.93), maternal immmigration to Canada in the last five years (aOR = 1.47; 95% CI, 1.05-2.04), and having no siblings (aOR = 1.62; 95% CI, 1.30-2.03). Relative to the first program year, infants were more likely to initiate the series in the second year (aOR = 1.71; 95% CI 1.39-2.10) and third year (aOR = 2.02; 95% CI 1.56-2.61) of the program. Infants receiving care from physicians with large practices were less likely to initiate the series (aOR 0.91; 95% CI, 0.88-0.94, per 100 patients rostered) and less likely to complete the series (aOR 0.94; 95% CI, 0.91-0.97, per 100 patients rostered). Additional associations were identified for series completion. Conclusions Family physician delivery achieved moderately high coverage in the program's first three years. This assessment demonstrates the usefulness of EMR data for evaluating vaccine coverage. Important insights into factors associated with initiation or completion (i.e. high continuity of care, smaller roster sizes, rural practice location) suggest areas for research and potential program supports.	[Wilson, Sarah E.; Schwartz, Kevin L.; Deeks, Shelley L.; Kwong, Jeffrey C.; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Wilson, Sarah E.; Chung, Hannah; Schwartz, Kevin L.; Guttmann, Astrid; Kwong, Jeffrey C.; Wing, Laura; Tu, Karen] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Wilson, Sarah E.; Schwartz, Kevin L.; Deeks, Shelley L.; Kwong, Jeffrey C.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Guttmann, Astrid] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Guttmann, Astrid; Tu, Karen] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kwong, Jeffrey C.; Tu, Karen] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Wilson, SE (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Wilson, SE (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Wilson, SE (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	sarah.wilson@oahpp.ca		Wilson, Sarah/0000-0002-8239-0094; Tu, Karen/0000-0003-0883-4934	Public Health Ontario (PHO); Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); Department of Family and Community Medicine at the University of Toronto; Canadian Institutes for Health Research Applied Chair in Reproductive and Child Health Services and Policy Research	Public Health Ontario (PHO); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Department of Family and Community Medicine at the University of Toronto; Canadian Institutes for Health Research Applied Chair in Reproductive and Child Health Services and Policy Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Public Health Ontario (PHO). This study was also supported by the Institute for Clinical Evaluative Sciences (ICES). Both PHO and ICES are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Astrid Guttmann receives salary support from a Canadian Institutes for Health Research Applied Chair in Reproductive and Child Health Services and Policy Research. Karen Tu and Jeff Kwong are supported by Clinician Scientist Awards from the Department of Family and Community Medicine at the University of Toronto. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, PHO, or MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Canada Communicable Disease Report, V36, P1; [Anonymous], 2013, PROD MON; [Anonymous], 2016, PROD MON; BC Centre for Disease Control, IMM UPT CHILDR 2 BIR; Boulianne N., 2015, ENQUETE COUVERTURE V; Braeckman T, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.20.20806; Butt DA, 2014, NEUROEPIDEMIOLOGY, V43, P28, DOI 10.1159/000365590; Calnan M, 2016, HUM VACC IMMUNOTHER, V12, P1235, DOI 10.1080/21645515.2015.1136041; Campitelli MA, 2012, PEDIATRICS, V129, pE1421, DOI 10.1542/peds.2011-2441; Canadian Immunization Committee Public Health Agency of Canada, 2014, REC ROT IMM PROGR; Christakis DA, 2000, AM J PUBLIC HEALTH, V90, P962, DOI 10.2105/AJPH.90.6.962; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dennehy PH, 2006, PEDIATR INFECT DIS J, V25, P1123, DOI 10.1097/01.inf.0000243777.01375.5b; Eisenberg DF, 2013, HUM VACC IMMUNOTHER, V9, P389, DOI 10.4161/hv.22877; Falagas ME, 2008, CURR MED RES OPIN, V24, P1719, DOI 10.1185/03007990802085692; Feudtner C, 2000, PEDIATRICS, V106, P205; Foty RG, 2010, VACCINE, V28, P6518, DOI 10.1016/j.vaccine.2010.06.097; Gosselin V, 2016, CAN J PUBLIC HEALTH, V107, pE161, DOI [10.17269/cjph.107.5286, 10.17269/CJPH.107.5286]; Guttmann A, 2006, PEDIATRICS, V117, P595, DOI 10.1542/peds.2004-2784; Guttmann A, 2006, PRIMARY CARE ONTARIO, P35; Guttmann A, 2008, AMBUL PEDIATR, V8, P205, DOI 10.1016/j.ambp.2008.01.010; Jaakkimainen L, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-16; Krishnarajah G, 2015, VACCINE, V33, P479, DOI 10.1016/j.vaccine.2014.06.059; Krishnarajah G, 2012, VACCINE, V30, P3717, DOI 10.1016/j.vaccine.2011.12.077; Krysko KM, 2015, MULT SCLER J, V21, P217, DOI 10.1177/1352458514538334; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; National Advisory Committee on Immunization. An Advisory Committee Statement (ACS) update National Advisory Committee on Immunization MMWR Recomm Rep. (NACI), 2015, STAT ROT VACC INT; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Ontario Physician Human Resources Data Center, 2015, QUICK FACTS GLANC ON; Panozzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073825; Public Health Agency of Canada, 2014, CAN IMM GUID ROT VAC; Public Health Ontario, 2015, IMM COV REP SCH PUP; Sahni LC, 2015, PEDIATRICS, V135, pE432, DOI 10.1542/peds.2014-0208; Schwartz KL, 2015, HUM VACC IMMUNOTHER, V11, P1840, DOI 10.1080/21645515.2015.1043499; Senecal M, 2006, CAN PUBL HLTH ASS 97; Statistics Canada, 2016, POP YEAR PROV TERR; Statistics Canada, 2011 NAT HOUS DAT SU; Stumpf KA, 2013, PEDIATRICS, V132, pE662, DOI 10.1542/peds.2013-0291; Toback SL, 2012, CLIN PEDIATR, V51, P551, DOI 10.1177/0009922812443731; Tu K, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0195-x; Tu KR, 2014, AM J MANAG CARE, V20, pE15; Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676; Tu K, 2010, CAN J CARDIOL, V26, pE225, DOI 10.1016/S0828-282X(10)70412-8; Wilson SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154340; Zelman M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-908	46	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192809	10.1371/journal.pone.0192809	http://dx.doi.org/10.1371/journal.pone.0192809			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444167	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500091
J	Lo, D; Park, B				Lo, Derek; Park, Briton			Modeling the spread of the Zika virus using topological data analysis	PLOS ONE			English	Article								Zika virus (ZIKV), a disease spread primarily through the Aedes aegypti mosquito, was identified in Brazil in 2015 and was declared a global health emergency by the World Health Organization (WHO). Epidemiologists often use common state-level attributes such as population density and temperature to determine the spread of disease. By applying techniques from topological data analysis, we believe that epidemiologists will be able to better predict how ZIKV will spread. We use the Vietoris-Rips filtration on high-density mosquito locations in Brazil to create simplicial complexes, from which we extract homology group generators. Previously epidemiologists have not relied on topological data analysis to model disease spread. Evaluating our model on ZIKV case data in the states of Brazil demonstrates the value of these techniques for the improved assessment of vector-borne diseases.	[Lo, Derek; Park, Briton] Yale Univ, Dept Stat, New Haven, CT 06520 USA; [Lo, Derek] Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA; [Park, Briton] Yale Univ, Dept Math, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Lo, D (corresponding author), Yale Univ, Dept Stat, New Haven, CT 06520 USA.; Lo, D (corresponding author), Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.	derektlo@gmail.com						Andrew J, 2016, POTENTIAL IMPACTS 21, P1573; [Anonymous], 2014, IBGE EST EST RES POP; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Castro, 2016, BIORXIV056648; CDC, 2016, ZIK VIR; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; ECDC, 2016, CURR ZIK TRANSM; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; FAO, 2010, FAOCLIM NET X 203 MN; Fasy B, 2016, TDA STAT TOOLS TOPOL; Gao D., 2016, SCI REPORTS; Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Kraemer MUG, 2015, DRYAD DIGITAL REPOSI; NEWBOLD P, 1983, J FORECASTING, V2, P23, DOI 10.1002/for.3980020104; Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024; Zhang, 2016, BIORXIV066456	23	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192120	10.1371/journal.pone.0192120	http://dx.doi.org/10.1371/journal.pone.0192120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438377	Green Submitted, gold, Green Published			2022-12-26	WOS:000425083400013
J	Urosa, A; Tobal, IE; de la Granja, NP; Capitan, MC; Moro, RF; Marcos, IS; Garrido, NM; Sanz, F; Calle, E; Diez, D				Urosa, Aitor; Tobal, Ignacio E.; de la Granja, Ngela P.; Capitan, M. Carmen; Moro, R. F.; Marcos, Isidro S.; Garrido, Narciso M.; Sanz, Francisca; Calle, Emilio; Diez, David			Diastereoselective synthesis of chiral 1,3-cyclohexadienals	PLOS ONE			English	Article							BETA-BRANCHED ALPHA,BETA-ALKENALS; CATALYTIC ASYMMETRIC-SYNTHESIS; ALPHA,BETA-UNSATURATED ALDEHYDES; YLIDENEMALONIC ACIDS; SELF-CONDENSATION; UV-FILTERS; SUNSCREENS; ANNULATION; PROLINE; SOLVENT	A novel approach to the production of chiral 1,3-cyclohexadienals has been developed. The organocatalysed asymmetric reaction of different beta-disubstituted-alpha, beta-unsaturated aldehydes with a chiral a, beta -unsaturated aldehyde in the presence of a Jorgensen-Hayashi organocatalyst provides easy and stereocontrolled access to the cyclohexadienal backbone. This method allows for the synthesis of potential photoprotective chiral 1,3-cyclohexadienals and extra extended conjugation compounds in a simple manner.	[Urosa, Aitor; Tobal, Ignacio E.; de la Granja, Ngela P.; Capitan, M. Carmen; Moro, R. F.; Marcos, Isidro S.; Garrido, Narciso M.; Diez, David] Univ Salamanca, Fac Ciencias Quim, Dept Quim Organ, Salamanca, Spain; [Sanz, Francisca] Univ Salamanca, Serv Difracc Rayos X, Salamanca, Spain; [Calle, Emilio] Univ Salamanca, Fac Ciencias Quim, Dept Quim Fis, Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca	Diez, D (corresponding author), Univ Salamanca, Fac Ciencias Quim, Dept Quim Organ, Salamanca, Spain.	ddm@usal.es	Garrido, Narciso Martin/K-7771-2014; Díez, David/K-7580-2014; Tobal Salcedo, Ignacio E./C-6959-2017	Garrido, Narciso Martin/0000-0002-1704-8073; Díez, David/0000-0002-7261-8454; Tobal Salcedo, Ignacio E./0000-0001-8781-6245	Ministry of Economy and Competitiveness (MINECO) [CTQ2015-68175-R]; European Regional Development Fund (FEDER); Regional Government of Castile Leon [BIO/SA59/15, UIC21]; Universidad de Salamanca; Regional Government of Castile & Leon-European Social Fund (JCyL-FSE); Regional Government of Castile Leon	Ministry of Economy and Competitiveness (MINECO); European Regional Development Fund (FEDER)(European Commission); Regional Government of Castile Leon; Universidad de Salamanca; Regional Government of Castile & Leon-European Social Fund (JCyL-FSE); Regional Government of Castile Leon	Financial support for this work was provided by the Ministry of Economy and Competitiveness (MINECO) CTQ2015-68175-R, the European Regional Development Fund (FEDER), the Regional Government of Castile & Leon (BIO/SA59/15, UIC21) and the Universidad de Salamanca. AU thanks the Regional Government of Castile & Leon-European Social Fund (JCyL-FSE), IET thanks the Regional Government of Castile & Leon and MCC thanks the Universidad de Salamanca for their fellowships.; The authors gratefully acknowledge the help of J. Rodilla from the Universidade da Beira Interior and C. Raposo (MS) from the Universidad de Salamanca and S. S. Serra for her help in writing the manuscript. Financial support for this work was provided by the Ministry of Economy and Competitiveness (MINECO) CTQ2015-68175-R, the European Regional Development Fund (FEDER), the Regional Government of Castile & Leon (BIO/SA59/15, UIC21) and the Universidad de Salamanca. IET thanks the Regional Government of Castile & Leon for his fellowship, MCC thanks the Universidad de Salamanca for her fellowship and AU thanks the Regional Government of Castile & Leon-European Social Fund (JCyL-FSE).	Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; ASATO AE, 1992, TETRAHEDRON LETT, V33, P3105, DOI 10.1016/S0040-4039(00)79825-X; Bench BJ, 2008, BIOORGAN MED CHEM, V16, P7573, DOI 10.1016/j.bmc.2008.07.030; Bench BJ, 2006, J ORG CHEM, V71, P9458, DOI 10.1021/jo061763t; Bertelsen S, 2009, CHEM SOC REV, V38, P2178, DOI 10.1039/b903816g; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; Buchanan GS, 2011, ORG LETT, V13, P4402, DOI 10.1021/ol2017438; Chang MY, 2013, TETRAHEDRON, V69, P9616, DOI 10.1016/j.tet.2013.09.036; Chretien MN, 2010, PHOTOCHEM PHOTOBIOL, V86, P153, DOI 10.1111/j.1751-1097.2009.00644.x; Deng YH, 1998, J ORG CHEM, V63, P7789, DOI 10.1021/jo980861e; Diez Martin D, 2001, SYNTHESIS-STUTTGART, V2001, P1069; Dunlap NK, 2002, TETRAHEDRON LETT, V43, P3923, DOI 10.1016/S0040-4039(02)00661-5; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Freitas JV, 2015, INT J PHARMACEUT, V484, P131, DOI 10.1016/j.ijpharm.2015.02.062; Gong P, 2015, CHEM ENG J, V277, P97, DOI 10.1016/j.cej.2015.04.078; Gonzalez H, 2010, PHOTOCH PHOTOBIO SCI, V9, P482, DOI 10.1039/b9pp00149b; Gonzalez HG, 2002, CLIN EXP DERMATOL, V27, P691, DOI 10.1046/j.1365-2230.2002.01095.x; Grigalavicius M, 2016, ANTICANCER RES, V36, P1409; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; He J, 2017, BIOMED RES INT, V2017, P11; Hong BC, 2007, J ORG CHEM, V72, P8459, DOI 10.1021/jo701477v; Hong BC, 2007, TETRAHEDRON, V63, P2840, DOI 10.1016/j.tet.2007.01.039; Hong BC, 2006, ORG LETT, V8, P2217, DOI 10.1021/ol060486+; Krause M, 2012, INT J ANDROL, V35, P424, DOI 10.1111/j.1365-2605.2012.01280.x; Loupy A, 2004, TETRAHEDRON, V60, P1683, DOI 10.1016/j.tet.2003.11.042; Maciel E, 2017, PHOTOCH PHOTOBIO SCI, V16, P744, DOI 10.1039/c7pp00025a; Maruoka K, 2012, CHEM COMMUN, V48, P10703, DOI 10.1039/c2cc90327j; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Murphy JJ, 2011, ANGEW CHEM INT EDIT, V50, P5095, DOI 10.1002/anie.201100804; Nigmatov AG, 1996, RUSS CHEM B+, V45, P144, DOI 10.1007/BF01433750; Nigmatov AG, 1996, RUSS CHEM B+, V45, P623, DOI 10.1007/BF01435793; NIGMATOV AG, 1993, RUSS CHEM B+, V42, P213, DOI 10.1007/BF00700021; Osterwalder U, 2009, BRIT J DERMATOL, V161, P13, DOI 10.1111/j.1365-2133.2009.09506.x; Pena J, 2012, RSC ADV, V2, P8041, DOI 10.1039/c2ra21306k; Peters L, 2004, PLANTA MED, V70, P883, DOI 10.1055/s-2004-832610; Pezzati B, 2013, ORG LETT, V15, P2950, DOI 10.1021/ol401042b; Scheffler U, 2013, CHEM-EUR J, V19, P14346, DOI 10.1002/chem.201301996; Schuch AP, 2010, J PHOTOCH PHOTOBIO B, V99, P111, DOI 10.1016/j.jphotobiol.2010.03.004; Serebryakov EP, 2003, RUSS CHEM B+, V52, P734, DOI 10.1023/A:1023987613185; Serebryakov EP, 1998, RUSS CHEM B+, V47, P82, DOI 10.1007/BF02495513; Sydorenko N, 2006, ORG LETT, V8, P2611, DOI 10.1021/ol060932t; Urosa A, 2015, MAR DRUGS, V13, P2407, DOI 10.3390/md13042407; Wang ZY, 2013, ORG LETT, V15, P4980, DOI 10.1021/ol402288y; Watanabe Coran M. H., 2007, USA patent, Patent No. [US 20070232813 A1, 20070232813]; YAMADA S, 1973, TETRAHEDRON LETT, P381; Ye LW, 2009, CHEM COMMUN, P3092, DOI 10.1039/b900048h; Zeng S, 2015, PHARM RES-DORDR, V32, P2548, DOI 10.1007/s11095-015-1643-0	47	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192113	10.1371/journal.pone.0192113	http://dx.doi.org/10.1371/journal.pone.0192113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438416	gold, Green Submitted, Green Published			2022-12-26	WOS:000425083400011
J	Wallace, JC; Youngblood, JE; Port, JA; Cullen, AC; Smith, MN; Workman, T; Faustman, EM				Wallace, James C.; Youngblood, Jessica E.; Port, Jesse A.; Cullen, Alison C.; Smith, Marissa N.; Workman, Tomomi; Faustman, Elaine M.			Variability in metagenomic samples from the Puget Sound: Relationship to temporal and anthropogenic impacts	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; ANTIBIOTIC-RESISTANCE; PLANKTONIC BACTERIA; ADAPTATION; DIVERGENCE; WATER	Whole-metagenome sequencing (WMS) has emerged as a powerful tool to assess potential public health risks in marine environments by measuring changes in microbial community structure and function in uncultured bacteria. In addition to monitoring public health risks such as antibiotic resistance determinants, it is essential to measure predictors of microbial variation in order to identify natural versus anthropogenic factors as well as to evaluate reproducibility of metagenomic measurements. This study expands our previous metagenomic characterization of Puget Sound by sampling new nearshore environments including the Duwamish River, an EPA superfund site, and the Hood Canal, an area characterized by highly variable oxygen levels. We also resampled a wastewater treatment plant, nearshore and open ocean sites introducing a longitudinal component measuring seasonal and locational variations and establishing metagenomics sampling reproducibility. Microbial composition from samples collected in the open sound were highly similar within the same season and location across different years, while nearshore samples revealed multi-fold seasonal variation in microbial composition and diversity. Comparisons with recently sequenced predominant marine bacterial genomes helped provide much greater species level taxonomic detail compared to our previous study. Antibiotic resistance determinants and pollution and detoxification indicators largely grouped by location showing minor seasonal differences. Metal resistance, oxidative stress and detoxification systems showed no increase in samples proximal to an EPA superfund site indicating a lack of ecosystem adaptation to anthropogenic impacts. Taxonomic analysis of common sewage influent families showed a surprising similarity between wastewater treatment plant and open sound samples suggesting a low-level but pervasive sewage influent signature in Puget Sound surface waters. Our study shows reproducibility of metagenomic data sampling in multiple Puget Sound locations while establishing baseline measurements of antibiotic resistance determinants, pollution and detoxification systems. Combining seasonal and longitudinal data across these locations provides a foundation for evaluating variation in future studies.	[Wallace, James C.; Smith, Marissa N.; Workman, Tomomi; Faustman, Elaine M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Youngblood, Jessica E.] Amec Foster Wheeler, Environm Toxicol, Lynnwood, WA USA; [Port, Jesse A.] Stanford Univ, Ctr Ocean Solut, Monterey, CA USA; [Cullen, Alison C.] Univ Washington, Daniel J Evans Sch Publ Affairs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Stanford University; University of Washington; University of Washington Seattle	Faustman, EM (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	faustman@uw.edu		Faustman, Elaine/0000-0002-3085-6403	NIEHS [P50 ESO12762, 5 P30 ES007033]; NSF [OCE-0434087]; UCAR [S08-67883]; NOAA; UW Pacific Northwest Center for Human Health and Ocean Studies [NIEHS: P50 ESO12762, NSF: OCE-0434087]; National Oceanic and Atmospheric Administration [UCAR S08-67883]; Center for Ecogenetics and Environmental Health [NIEHS: 5 P30 ES007033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, P50ES012762] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NSF(National Science Foundation (NSF)); UCAR; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); UW Pacific Northwest Center for Human Health and Ocean Studies; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Center for Ecogenetics and Environmental Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS: P50 ESO12762, https://www.niehs.nih.gov/; NSF: OCE-0434087, https://www.nsf.gov/; UCAR: S08-67883, https://scied.ucar.edu/; NIEHS: 5 P30 ES007033, https://www.niehs.nih.gov/.; This project was supported by the NOAA-funded Pacific Northwest Consortium for Pre- and Post-doctoral Traineeships in Oceans and Human Health and was also supported by the UW Pacific Northwest Center for Human Health and Ocean Studies (NIEHS: P50 ESO12762 and NSF: OCE-0434087) and the National Oceanic and Atmospheric Administration (UCAR S08-67883) as well as the Center for Ecogenetics and Environmental Health (NIEHS: 5 P30 ES007033).	Aguilo-Ferretjans MM, 2008, SYST APPL MICROBIOL, V31, P231, DOI 10.1016/j.syapm.2008.04.003; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bengtsson-Palme J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-749; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; City of Seattle, 2013, PROTECTING SEATTLES; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crossett K, 2013, POPULATION TRENDS 19; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Ecker DJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-19; Environmental Protection Agency, LOW DUW WAT REC DEC; Galvez E, 2012, INT C INT SYST MOL B; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Henze M, 2008, BIOLOGICAL WASTEWATER TREATMENT: PRINCIPLES, MODELLING AND DESIGN, P1; Howarth R, 2000, ISSUES ECOLOGY, P15; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Kelly RP, 2016, PEERJ, V4, DOI 10.7717/peerj.2444; Levinton JS, 2003, P NATL ACAD SCI USA, V100, P9889, DOI 10.1073/pnas.1731446100; Li Z, 2012, INT J SYST EVOL MICR, V62, P1042, DOI 10.1099/ijs.0.029868-0; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Milici M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19054; Newton RJ, 2015, MBIO, V6, DOI 10.1128/mBio.02574-14; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009; Port JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048000; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Simon M, 2017, ISME J, V11, P1483, DOI 10.1038/ismej.2016.198; Spietz RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135731; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Tully BJ, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-34; United States Census Bureau, STAT COUNT QUICK FAC; van Tol HM, 2017, ISME J, V11, P31, DOI 10.1038/ismej.2016.112; Varela AR, 2013, ENV SCI POLLUTION RE; Voget S, 2015, ISME J, V9, P371, DOI 10.1038/ismej.2014.134; von Scheibner Markus, 2017, Front Microbiol, V8, P27, DOI 10.3389/fmicb.2017.00027; Wallace JC, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw165; Washington State Department of Ecology, SHELLF SAF INF; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299	58	8	8	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192412	10.1371/journal.pone.0192412	http://dx.doi.org/10.1371/journal.pone.0192412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438385	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400023
J	Kokhaei, P; Hojjat-Farsangi, M; Mozaffari, F; Moshfegh, A; Pak, F; Rashidy-Pour, A; Palma, M; Hansson, L; Osterborg, A; Mellstedt, H				Kokhaei, Parviz; Hojjat-Farsangi, Mohammad; Mozaffari, Fariba; Moshfegh, Ali; Pak, Fatemeh; Rashidy-Pour, Ali; Palma, Marzia; Hansson, Lotta; Osterborg, Anders; Mellstedt, Hakan			Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; GROWTH-FACTOR-BETA; B-CELLS; CANCER PROGRESSION; PROSTATE-CANCER; FUNCTIONAL-ROLE; CLL; SURVIVAL; REGULATOR; CARCINOMA	Crosstalk between leukemic cells and the tumor microenvironment is of importance in chronic lymphocytic leukemia (CLL). T cells seem to sustain the survival of CLL cells by various mechanisms. The Kruppel-like family of transcription factors (KLFs) are identified as regulators of proliferation and cell death. In the present study, we analyzed the expression of the wild type (WT) gene KLF6 and the oncogenic splice variant 1 (KLF6-SV1) at the mRNA level in subsets of T cells from CLL patients (n = 29), multiple myeloma patients (n = 6) and normal donors (n = 10). RNA Silencing was used for wtKLF6 and KLF6-SV1. Tumor cell apoptosis was measured. A significant overexpression of wtKLF6 and KLF6-SV1 in T cells of CLL patients compared to normal donors and myeloma patients was noted (p<0.002). Western blot showed that both wtKLF6 and KLF6-SV1 were expressed in purified T cells from CLL patients. KLF6-SV1 siRNA transfection induced a significant down-regulation of KLF6-SV1 in CLL T cells, which lost the capability to sustain the growth of leukemic cells. However, no such a significant effect was seen after wtKLF6 transfection of the autologous T cells. The results suggest that KLF6-SV1 may play a role in the regulation of survival CLL cells.	[Kokhaei, Parviz; Hojjat-Farsangi, Mohammad; Mozaffari, Fariba; Moshfegh, Ali; Palma, Marzia; Hansson, Lotta; Osterborg, Anders; Mellstedt, Hakan] Karolinska Inst, Immune & Gene Therapy Lab, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden; [Kokhaei, Parviz; Pak, Fatemeh] Semnan Univ Med Sci, Canc Res Ctr, Semnan, Iran; [Kokhaei, Parviz; Pak, Fatemeh] Semnan Univ Med Sci, Dept Immunol, Semnan, Iran; [Hojjat-Farsangi, Mohammad] Bushehr Univ Med Sci, Sch Med, Persian Gulf Marine Biotechnol Med Res Ctr, Bushehr, Iran; [Hojjat-Farsangi, Mohammad] Bushehr Univ Med Sci, Sch Med, Dept Immunol, Bushehr, Iran; [Rashidy-Pour, Ali] Semnan Univ Med Sci, Physiol Res Ctr, Semnan, Iran; [Rashidy-Pour, Ali] Semnan Univ Med Sci, Dept Physiol, Semnan, Iran; [Palma, Marzia; Hansson, Lotta; Osterborg, Anders] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden	Karolinska Institutet; Semnan University of Medical Sciences; Semnan University of Medical Sciences; Semnan University of Medical Sciences; Semnan University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital	Mellstedt, H (corresponding author), Karolinska Inst, Immune & Gene Therapy Lab, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden.	hakan.mellstedt@sll.se	Hojjat-Farsangi, Mohammad/E-8171-2018; Palma, Marzia/AGN-7362-2022; Rashidy-Pour, Ali/B-5696-2018	Hojjat-Farsangi, Mohammad/0000-0002-0589-5523; Rashidy-Pour, Ali/0000-0001-5006-1408; Mellstedt, Hakan/0000-0001-6756-0609	Swedish Cancer Society [160534]; Cancer Society in Stockholm [151313]; King Gustav Vth Jubilee Fund [144193]; AFA Forsakring [130054]; Cancer and Allergy Foundation [150420, 150122, 64]; Stockholm County Council [20120051, 20150070]; Karolinska Institute Foundation	Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; King Gustav Vth Jubilee Fund; AFA Forsakring; Cancer and Allergy Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institute Foundation(Karolinska Institutet)	This work was supported by The Swedish Cancer Society, https://www.cancerfonden.se/, Award Number: 160534, Recipient: AO; The Cancer Society in Stockholm, http://www.rahfo.se/om-oss/in-english/, Award Number: 151313, Recipient: AO; The King Gustav Vth Jubilee Fund, http://www.rahfo.se/om-oss/in-english/, Award Number: 144193, Recipient: AO; AFA Forsakring, https://www.afaforsakring.se/forskning/, Award Number: 130054, Recipient: AO; The Cancer and Allergy Foundation, http://cancerochallergifonden.se, Award Number: 150420, 150122, 64, Recipient: HM; The Stockholm County Council, https://forskningsstod.vmi.se/Ansokan/start.asp, Award Number: 20120051, 20150070, Recipient: AO; and The Karolinska Institute Foundation, http://ki.se/en/education/the-karolinska-institutet-foundation-scholarships, Award Number: None, Recipient: LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AO, 2008, ANN ONCOL, V19, P1172, DOI 10.1093/annonc/mdn017; Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Anvekar RA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.161; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Caligaris-Cappio F, 2014, SEMIN CANCER BIOL, V24, P43, DOI 10.1016/j.semcancer.2013.06.010; Chen H, 2011, GASTRIC CANCER, V14, P339, DOI 10.1007/s10120-011-0049-x; Choudhury A, 2010, BRIT J HAEMATOL, V151, P327, DOI 10.1111/j.1365-2141.2010.08362.x; Difeo A, 2008, CANCER RES, V68, P965, DOI 10.1158/0008-5472.CAN-07-2604; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Difeo A, 2009, CANCER RES, V69, P4733, DOI 10.1158/0008-5472.CAN-08-4282; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Douglas RS, 1997, BLOOD, V89, P941, DOI 10.1182/blood.V89.3.941; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Hatami R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004688; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Joshua D, 2016, CL LYMPH MYELOM LEUK, V16, P537, DOI 10.1016/j.clml.2016.08.003; Kiaii S, 2013, CANCER IMMUNOL IMMUN, V62, P51, DOI 10.1007/s00262-012-1300-y; Kokhaei P, 2004, LEUKEMIA, V18, P1810, DOI 10.1038/sj.leu.2403517; Kokhaei P, 2003, LEUKEMIA, V17, P894, DOI 10.1038/sj.leu.2402913; Kokhaei P, 2007, EXP HEMATOL, V35, P297, DOI 10.1016/j.exphem.2006.10.006; KREMER JP, 1992, BRIT J HAEMATOL, V80, P480, DOI 10.1111/j.1365-2141.1992.tb04561.x; Li J, 2014, INT J ENV RES PUB HE, V11, P2427, DOI 10.3390/ijerph110302427; Masoodi M, 2014, LEUKEMIA, V28, P1381, DOI 10.1038/leu.2014.10; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI200523409; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; Palma M, 2006, ANN ONCOL, V17, pX144, DOI 10.1093/annonc/mdl252; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Rossmann ED, 2002, EUR J HAEMATOL, V68, P299, DOI 10.1034/j.1600-0609.2002.01612.x; Sangodkar J, 2009, EUR J CANCER, V45, P666, DOI 10.1016/j.ejca.2008.11.009; Slinger E, 2016, HAEMATOLOGICA, V101, DOI 10.3324/haematol.2016.142323; ten Hacken E, 2014, PHARMACOL THERAPEUT, V144, P338, DOI 10.1016/j.pharmthera.2014.07.003; Teng MS, 2005, ARCH OTOLARYNGOL, V131, P407, DOI 10.1001/archotol.131.5.407; Vardi A, 2017, LEUKEMIA, V31, P1555, DOI 10.1038/leu.2016.362; Vetter D, 2012, HEPATOLOGY, V56, P1361, DOI 10.1002/hep.25810; Wait IW, 2007, WATER RES, V41, P2427, DOI 10.1016/j.watres.2007.02.057; Zhang W, 2011, CANCER BIOL THER, V11, P150, DOI 10.4161/cbt.11.2.14623	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192839	10.1371/journal.pone.0192839	http://dx.doi.org/10.1371/journal.pone.0192839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432497	Green Published, Green Submitted, gold			2022-12-26	WOS:000424814300052
J	Gutierrez-Fonseca, PE; Ramirez, A; Pringle, CM				Gutierrez-Fonseca, Pablo E.; Ramirez, Alonso; Pringle, Catherine M.			Large-scale climatic phenomena drive fluctuations in macroinvertebrate assemblages in lowland tropical streams, Costa Rica: The importance of ENSO events in determining long-term (15y) patterns	PLOS ONE			English	Article							FRESH-WATER MACROINVERTEBRATES; NINO-SOUTHERN-OSCILLATION; EL-NINO; CENTRAL-AMERICA; RAIN-FOREST; PHOSPHORUS LEVELS; TREE GROWTH; TEMPERATURE; DYNAMICS; DROUGHT	Understanding how environmental variables influence the distribution and density of organisms over relatively long temporal scales is a central question in ecology given increased climatic variability (e.g., precipitation, ENSO events). The primary goal of our study was to evaluate long-term (15y time span) patterns of climate, as well as environmental parameters in two Neotropical streams in lowland Costa Rica, to assess potential effects on aquatic macroinvertebrates. We also examined the relative effects of an 8y whole-stream P-enrichment experiment on macroinvertebrate assemblages against the backdrop of this long-term study. Climate, environmental variables and macroinvertebrate samples were measured monthly for 7y and then quarterly for an additional 8y in each stream. Temporal patterns in climatic and environmental variables showed high variability over time, without clear inter-annual or intra-annual patterns. Macroinvertebrate richness and abundance decreased with increasing discharge and was positively related to the number of days since the last high discharge event. Findings show that fluctuations in stream physicochemistry and macroinvertebrate assemblage structure are ultimately the result of large-scale climatic phenomena, such as ENSO events, while the 8y P-enrichment did not appear to affect macroinvertebrates. Our study demonstrates that Neotropical lowland streams are highly dynamic and not as stable as is commonly presumed, with high intra- and inter-annual variability in environmental parameters that change the structure and composition of freshwater macroinvertebrate assemblages.	[Gutierrez-Fonseca, Pablo E.] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00931 USA; [Ramirez, Alonso] Univ Puerto Rico Rio Piedras, Dept Environm Sci, San Juan, PR 00931 USA; [Pringle, Catherine M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; University System of Georgia; University of Georgia	Gutierrez-Fonseca, PE (corresponding author), Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00931 USA.	gutifp@gmail.com	Gutiérrez-Fonseca, Pablo E./X-8494-2018	Gutiérrez-Fonseca, Pablo E./0000-0003-0777-8889	National Science Foundation [DEB 1122389]	National Science Foundation(National Science Foundation (NSF))	This study was financed by National Science Foundation (DEB 1122389) to Catherine M. Pringle. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Angeler DG, 2012, ECOL APPL, V22, P1172, DOI 10.1890/11-1474.1; APHA American Public Health Association, 1992, STANDARD METHODS EXA; Ardon M, 2006, FRESHWATER BIOL, V51, P618, DOI 10.1111/j.1365-2427.2006.01515.x; Ardon M, 2013, SCI TOTAL ENVIRON, V443, P267, DOI 10.1016/j.scitotenv.2012.10.068; Arrington DA, 2006, J N AM BENTHOL SOC, V25, P126, DOI 10.1899/0887-3593(2006)25[126:HATSFP]2.0.CO;2; Ayon P, 2004, ICES J MAR SCI, V61, P478, DOI 10.1016/j.icesjms.2004.03.027; Beche LA, 2007, FRESHWATER BIOL, V52, P2317, DOI 10.1111/j.1365-2427.2007.01859.x; Beche LA, 2009, ECOGRAPHY, V32, P778, DOI 10.1111/j.1600-0587.2009.05612.x; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Blanco JF, 2003, B ECOTROPICA ECOSIST, V37; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; BOULTON AJ, 1992, HYDROBIOLOGIA, V241, P107, DOI 10.1007/BF00008263; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cai WJ, 2015, NAT CLIM CHANGE, V5, P132, DOI [10.1038/nclimate2492, 10.1038/NCLIMATE2492]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Covich AP, 2006, J N AM BENTHOL SOC, V25, P99, DOI 10.1899/0887-3593(2006)25[99:EODAHD]2.0.CO;2; Covich AP, 1996, STREAM COMMUNITY FOO; Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Dudgeon D., 2011, TROPICAL STREAM ECOL; Durance I, 2009, FRESHWATER BIOL, V54, P388, DOI 10.1111/j.1365-2427.2008.02112.x; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Faramarzi M, 2013, J HYDROL, V480, P85, DOI 10.1016/j.jhydrol.2012.12.016; Feio MJ, 2010, J N AM BENTHOL SOC, V29, P1397, DOI 10.1899/09-158.1; Field C.B.V., 2012, MANAGING RISKS EXTRE, P582; Foley JA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001872; FUGITA DK, 1969, STANDARD PROCEDURES; Gilbert B, 2008, CAN J FISH AQUAT SCI, V65, P890, DOI 10.1139/F08-057; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Gordon N.D., 2004, STREAM HYDROLOGY INT; Hanson P, 2010, REV BIOL TROP, V58, P3; Hart DD, 1999, ANNU REV ECOL SYST, V30, P363, DOI 10.1146/annurev.ecolsys.30.1.363; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hidalgo HG, 2013, J HYDROL, V495, P94, DOI 10.1016/j.jhydrol.2013.05.004; Holdridge LR, 1967, LIFE ZONE ECOLOGY; HYNES HBN, 1970, ANNU REV ENTOMOL, V15, P25, DOI 10.1146/annurev.en.15.010170.000325; IRONS JG, 1994, FRESHWATER BIOL, V32, P401, DOI 10.1111/j.1365-2427.1994.tb01135.x; Jackson JK, 2006, FRESHWATER BIOL, V51, P591, DOI 10.1111/j.1365-2427.2006.01503.x; JACKSON JK, 1995, J N AM BENTHOL SOC, V14, P115, DOI 10.2307/1467728; Jacobsen D, 2014, FRESHW SCI, V33, P32, DOI 10.1086/674745; Jassby A. D., 2015, WQ SOME TOOLS EXPLOR; Karmalkar AV, 2011, CLIM DYNAM, V37, P605, DOI 10.1007/s00382-011-1099-9; Kim DH, 2008, J WILDLIFE MANAGE, V72, P231, DOI 10.2193/2007-040; Lawrence JE, 2010, J N AM BENTHOL SOC, V29, P1424, DOI 10.1899/09-178.1; Lee T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044007; Liaw A., 2015, R PACKAGE VERSION, V4, P6; Magnusson WE, 2010, GLOBAL CHANGE BIOL, V16, P2401, DOI 10.1111/j.1365-2486.2009.02140.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Mascaro J, 2004, FOREST ECOL MANAG, V190, P3, DOI 10.1016/j.foreco.2003.10.002; Mazerolle MJ, 2016, AICCMODAVG MODEL SEL; McCune B., 2011, PC ORD MULTIVARIATE; McLeod AI, 2015, KENDAL KENDALL RANK; McMullen LE, 2012, ECOL APPL, V22, P2164, DOI 10.1890/11-1650.1; Mohseni O, 1999, J HYDROL, V218, P128, DOI 10.1016/S0022-1694(99)00034-7; Mol JH, 2000, ENVIRON BIOL FISH, V59, P429, DOI 10.1023/A:1026529200610; Mouthon J, 2006, GLOBAL CHANGE BIOL, V12, P441, DOI 10.1111/j.1365-2486.2006.01095.x; Negishi JN, 2006, J ANIM ECOL, V75, P118, DOI 10.1111/j.1365-2656.2005.01027.x; Nepstad D., 2004, Global Change Biology, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu OJ, 2007, AFR J ECOL, V46, P132; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; PRINGLE CM, 1990, HYDROBIOLOGIA, V206, P73, DOI 10.1007/BF00018971; PRINGLE CM, 1991, ECOLOGY, V72, P951, DOI 10.2307/1940596; PRINGLE CM, 1991, BIOTROPICA, V23, P523, DOI 10.2307/2388390; PRINGLE CM, 2000, STREAMS GROUND WATER, P167; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez A, 2006, J N AM BENTHOL SOC, V25, P108, DOI 10.1899/0887-3593(2006)25[108:TASPIS]2.0.CO;2; Ramirez A, 2006, LIMNOL OCEANOGR, V51, P189, DOI 10.4319/lo.2006.51.1.0189; Ramirez A, 1998, J N AM BENTHOL SOC, V17, P443, DOI 10.2307/1468365; Ramirez A, 2003, FRESHWATER BIOL, V48, P88, DOI 10.1046/j.1365-2427.2003.00973.x; Rauscher SA, 2011, J CLIMATE, V24, P2003, DOI 10.1175/2010JCLI3536.1; RESH VH, 1988, J N AM BENTHOL SOC, V7, P433, DOI 10.2307/1467300; Riascos JM, 2006, MAR BIOL, V148, P1283, DOI 10.1007/s00227-005-0165-4; Rosemond AD, 2002, LIMNOL OCEANOGR, V47, P278, DOI 10.4319/lo.2002.47.1.0278; Rosemond AD, 2001, ECOLOGY, V82, P2279, DOI 10.1890/0012-9658(2001)082[2279:ATOTDA]2.0.CO;2; Rueda-Delgado G, 2006, J N AM BENTHOL SOC, V25, P233, DOI 10.1899/0887-3593(2006)25[233:LDIAAF]2.0.CO;2; Sanford Jr RL, 1994, LA SELVA ECOLOGY NAT, P19; Schonher T, 1998, J CLIMATOL, V2, P1258; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Small GE, 2008, INT VER THEOR ANGEW, V30, P551; Small GE, 2012, ECOSYSTEMS, V15, P974, DOI 10.1007/s10021-012-9559-6; Small GE, 2011, LIMNOL OCEANOGR, V56, P268, DOI 10.4319/lo.2011.56.1.0268; Sponseller RA, 2010, GLOBAL CHANGE BIOL, V16, P2891, DOI 10.1111/j.1365-2486.2010.02200.x; Stallcup LA, 2006, FRESHWATER BIOL, V51, P1515, DOI 10.1111/j.1365-2427.2006.01588.x; Steinhoff DF, 2015, CLIM DYNAM, V44, P1329, DOI 10.1007/s00382-014-2196-3; Triska FJ, 2006, BIOGEOCHEMISTRY, V81, P131, DOI 10.1007/s10533-006-9026-6; Tuv E, 2009, J MACH LEARN RES, V10, P1341; Vaughan IP, 2012, GLOBAL CHANGE BIOL, V18, P2184, DOI 10.1111/j.1365-2486.2012.02662.x; Vecchi GA, 2010, WIRES CLIM CHANGE, V1, P260, DOI 10.1002/wcc.33; WALLACE JB, 1980, ANNU REV ENTOMOL, V25, P103, DOI 10.1146/annurev.en.25.010180.000535; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Warfe DM, 2011, FRESHWATER BIOL, V56, P2169, DOI 10.1111/j.1365-2427.2011.02660.x; Williams D.D., 1981, P155; Winemiller KO, 2014, ECOL MONOGR, V84, P621, DOI 10.1890/13-1822.1; Wohl E, 2017, FRONT EARTH SCI-PRC, V11, P447, DOI 10.1007/s11707-017-0647-y; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Woodward G, 2005, PHILOS T R SOC LON B, V365, P2093; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316; YU YS, 1993, J HYDROL, V150, P61, DOI 10.1016/0022-1694(93)90156-4; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Yule CM, 1996, ARCH HYDROBIOL, V137, P227; Zuur A, 2010, MIXED EFFECTS MODELS, P574	110	19	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191781	10.1371/journal.pone.0191781	http://dx.doi.org/10.1371/journal.pone.0191781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420548	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900022
J	Khan, MM; Mendes, A; Chalup, SK				Khan, Maryam Mahsal; Mendes, Alexandre; Chalup, Stephan K.			Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction	PLOS ONE			English	Article							CLASSIFIER; DIVERSITY; ALGORITHM	Wavelet Neural Networks are a combination of neural networks and wavelets and have been mostly used in the area of time-series prediction and control. Recently, Evolutionary Wavelet Neural Networks have been employed to develop cancer prediction models. The present study proposes to use ensembles of Evolutionary Wavelet Neural Networks. The search for a high quality ensemble is directed by a fitness function that incorporates the accuracy of the classifiers both independently and as part of the ensemble itself. The ensemble approach is tested on three publicly available biomedical benchmark datasets, one on Breast Cancer and two on Parkinson's disease, using a 10-fold cross-validation strategy. Our experimental results show that, for the first dataset, the performance was similar to previous studies reported in literature. On the second dataset, the Evolutionary Wavelet Neural Network ensembles performed better than all previous methods. The third dataset is relatively new and this study is the first to report benchmark results.	[Khan, Maryam Mahsal; Mendes, Alexandre; Chalup, Stephan K.] Univ Newcastle, Sch Elect Engn & Comp, IMLRG, Callaghan, NSW 2308, Australia	University of Newcastle	Khan, MM (corresponding author), Univ Newcastle, Sch Elect Engn & Comp, IMLRG, Callaghan, NSW 2308, Australia.	maryammahsal.khan@uon.edu.au	Chalup, Stephan/O-8914-2019; CHALUP, STEPHAN KONRAD/G-7560-2013; Mendes, Alexandre/C-1832-2013	Chalup, Stephan/0000-0002-7886-3653; Mendes, Alexandre/0000-0003-1759-3765	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	The first author would like to acknowledge the support through an Australian Government Research Training Program Scholarship.	Alexandridis AK, 2013, NEURAL NETWORKS, V42, P1, DOI 10.1016/j.neunet.2013.01.008; [Anonymous], LIV PARK DIS UPD OCT; [Anonymous], 2014, DIGITAL DATABASE SCR; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Astrom F, 2011, EXPERT SYST APPL, V38, P12470, DOI 10.1016/j.eswa.2011.04.028; Banfield R. E., 2005, Information Fusion, V6, P49, DOI 10.1016/j.inffus.2004.04.005; Bias Breiman L., 1996, 460 U CAL STAT DEP; Breiman L., 2001, MACH LEARN, V45, P5; CAGLAR M. F., 2010, J ENG SCI DESIGN, V1, P59; Caruana R., 2004, P 21 INT C MACHINE L, P18, DOI [10.1145/1015330.1015432, DOI 10.1145/1015330.1015432]; Cavalcanti GDC, 2016, PATTERN RECOGN LETT, V74, P38, DOI 10.1016/j.patrec.2016.01.029; Chalup SK, 2007, CONNECT SCI, V19, P183, DOI 10.1080/09540090701398017; Fan W, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P146; Gul A, 2018, ADV DATA ANAL CLASSI, V12, P827, DOI 10.1007/s11634-015-0227-5; Haque MZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154151; Heath M, 1998, COMP IMAG VIS, V13, P457; Heath M., 2001, P IWDM, V212, P218; HO TK, 1994, IEEE T PATTERN ANAL, V16, P66, DOI 10.1109/34.273716; Huang MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0161501; Huang YC, 2002, IEEE T POWER DELIVER, V17, P412, DOI 10.1109/61.997908; Khan MM, 2017, NEUROCOMPUTING, V247, P39, DOI 10.1016/j.neucom.2017.03.048; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Lang KJ., 1988, P 1988 CONN MOD SUMM, P52; Leod PMC, 2011, INT J COMPUT INTELL, V10, P481, DOI 10.1142/S1469026811003203; Liao G. C., 2012, AS PAC POW EN ENG C, P1, DOI DOI 10.1109/APPEEC.2012.6307573; Lichman M, 2014, UCI MACHINE LEARNING; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McLeod Peter, 2013, Neural Information Processing. 20th International Conference, ICONIP 2013. Proceedings: LNCS 8228, P525, DOI 10.1007/978-3-642-42051-1_65; Osowski S, 1996, NEURAL NETWORKS, V9, P1583, DOI 10.1016/S0893-6080(96)00029-9; Ozcift A, 2012, J MED SYST, V36, P2141, DOI 10.1007/s10916-011-9678-1; Partalas I, 2010, MACH LEARN, V81, P257, DOI 10.1007/s10994-010-5172-0; Partalas I, 2008, FRONT ARTIF INTEL AP, V178, P117, DOI 10.3233/978-1-58603-891-5-117; Pour S. G., 2012, P 2 AUSTR WORKSH ART, P55; Powers D. M, 2011, ARXIV201016061; Qiu FC, 2014, 2014 5TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING AND SERVICE SCIENCE (ICSESS), P1162, DOI 10.1109/ICSESS.2014.6933773; Sahoo D, 2006, P 11 MULT AN OPT C A, P1; Sakar BE, 2013, IEEE J BIOMED HEALTH, V17, P828, DOI 10.1109/JBHI.2013.2245674; Sakar CO, 2010, J MED SYST, V34, P591, DOI 10.1007/s10916-009-9272-y; Taghavi ZS, 2013, 2013 3RD JOINT CONFERENCE OF AI & ROBOTICS AND 5TH ROBOCUP IRAN OPEN INTERNATIONAL SYMPOSIUM (RIOS), P1; Tsoumakas G, 2009, STUD COMPUT INTELL, V245, P1, DOI 10.1007/978-3-642-03999-7_1; Vazquez LA, 2015, MATH PROBL ENG, V2015, P1; Verma B, 2010, EXPERT SYST APPL, V37, P3344, DOI 10.1016/j.eswa.2009.10.016; Verma B, 2009, PATTERN RECOGN, V42, P1845, DOI 10.1016/j.patcog.2009.02.009; Xu JH, 2006, LECT NOTES COMPUT SC, V4113, P286, DOI 10.1007/11816157_29; Yang HJ, 2016, OPTIK, V127, P8103, DOI 10.1016/j.ijleo.2016.06.017; Yao G, 2016, SOFT COMPUT, V20, P2995, DOI 10.1007/s00500-015-1927-7; ZAKI FW, 1988, PATTERN RECOGN, V21, P327, DOI 10.1016/0031-3203(88)90046-5; ZHANG J, 1995, IEEE T SIGNAL PROCES, V43, P1485, DOI 10.1109/78.388860; Zhang P, 2005, LECT NOTES ARTIF INT, V3614, P316; Zhang P, 2006, INT C COMP INT MOD C, P141, DOI DOI 10.1109/CIMCA.2006.46; ZHANG QG, 1992, IEEE T NEURAL NETWOR, V3, P889, DOI 10.1109/72.165591; Zhang Y, 2006, J MACH LEARN RES, V7, P1315; Zhao H, 2011, 3 INT WORKSH INT SYS, P1; Zhou Z.-H, 2012, ENSEMBLE METHODS FDN, DOI DOI 10.1201/B12207; Zhou ZH, 2003, LECT NOTES ARTIF INT, V2639, P476	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192192	10.1371/journal.pone.0192192	http://dx.doi.org/10.1371/journal.pone.0192192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420578	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900049
J	Kolivand, H; Fern, BM; Rahim, MSM; Sulong, G; Baker, T; Tully, D				Kolivand, Hoshang; Fern, Bong Mei; Rahim, Mohd Shafry Mohd; Sulong, Ghazali; Baker, Thar; Tully, David			An expert botanical feature extraction technique based on phenetic features for identifying plant species	PLOS ONE			English	Article							RECOGNITION	In this paper, we present a new method to recognise the leaf type and identify plant species using phenetic parts of the leaf; lobes, apex and base detection. Most of the research in this area focuses on the popular features such as the shape, colour, vein, and texture, which consumes large amounts of computational processing and are not efficient, especially in the Acer database with a high complexity structure of the leaves. This paper is focused on phenetic parts of the leaf which increases accuracy. Detecting the local maxima and local minima are done based on Centroid Contour Distance for Every Boundary Point, using north and south region to recognise the apex and base. Digital morphology is used to measure the leaf shape and the leaf margin. Centroid Contour Gradient is presented to extract the curvature of leaf apex and base. We analyse 32 leaf images of tropical plants and evaluated with two different datasets, Flavia, and Acer. The best accuracy obtained is 94.76% and 82.6% respectively. Experimental results show the effectiveness of the proposed technique without considering the commonly used features with high computational cost.	[Kolivand, Hoshang; Baker, Thar; Tully, David] Liverpool John Moores Univ, Dept Comp Sci, Liverpool, Merseyside, England; [Fern, Bong Mei] Univ Tunku Abdul Rahman, Jalan Sungai Long, Kajang, Selangor, Malaysia; [Rahim, Mohd Shafry Mohd] UTM, UTM IRDA Digital Media Ctr, Media & Games Innovat Ctr Excellence MaGIC X, UIRL,Inst Human Ctr, Skudai, Johor, Malaysia; [Sulong, Ghazali] Univ Malaysia Terengganu, Terengganu, Malaysia	Liverpool John Moores University; University of Liverpool; Universiti Tunku Abdul Rahman (UTAR); Universiti Teknologi Malaysia; Universiti Malaysia Terengganu	Kolivand, H (corresponding author), Liverpool John Moores Univ, Dept Comp Sci, Liverpool, Merseyside, England.	H.Kolivand@ljmu.ac.uk	Baker, Thar/H-6073-2019; Kolivand, Hoshang/B-2501-2016	Baker, Thar/0000-0002-5166-4873; Kolivand, Hoshang/0000-0001-5460-5679				AbJabal MF., 2013, J COMPUT SCI-NETH, V9, P1295, DOI [10.3844/jcssp.2013.1295.1304, DOI 10.3844/JCSSP.2013.1295.1304, DOI 10.3844/J.CSSP.2013.1295.1304]; An N, 2016, COMPUT ELECTRON AGR, V127, P376, DOI 10.1016/j.compag.2016.04.002; Arora A., 2012, CLEF ONLINE WORKING; Arun Priya C., 2012, Proceedings of the 2012 International Conference on Pattern Recognition, Informatics and Medical Engineering (PRIME), P428, DOI 10.1109/ICPRIME.2012.6208384; Cope JS, 2012, LECT NOTES COMPUT SC, V7517, P258, DOI 10.1007/978-3-642-33140-4_23; Corney DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042112; Fern BM, 2014, ADV SCI LETT, V20, P209, DOI 10.1166/asl.2014.5300; Goeau H, 2013, P 21 ACM INT C MULT, P423; Gouveia F, 1997, ISIE '97 - PROCEEDINGS OF THE IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, VOLS 1-3, P757, DOI 10.1109/ISIE.1997.648634; Hati S., 2013, INT J COMPUTER APPL, V62; Jelinkova H, 2014, TREES-STRUCT FUNCT, V28, P389, DOI 10.1007/s00468-013-0957-y; Larese M. G., 2014, EXPERT SYSTEMS APPL; Mallah C., 2013, SIGNAL PROCESS PATTE, V5, P45; Mouine S., 2013, P 3 ACM C INT C MULT, P127; Mouine S., 2012, P 2 ACM INT C MULT R, P49; Mouine S, 2013, P 3 ACM C INT C MULT, P309; Mouine S, 2013, LECT NOTES COMPUT SC, V7950, P205, DOI 10.1007/978-3-642-39094-4_24; Mzoughi O, 2013, IEEE IMAGE PROC, P3967, DOI 10.1109/ICIP.2013.6738817; Mzoughi O, 2012, IEEE IMAGE PROC, P1033, DOI 10.1109/ICIP.2012.6467039; Narayan V., 2014, RATIO, V13, P885; Pahalawatta K.K, 2008, THESIS U CANTERBURY; Petchsri S, 2012, SCIENCEASIA, V38, P1, DOI 10.2306/scienceasia1513-1874.2012.38.001; Pornpanomchai C., 2011, Kasetsart Journal, Natural Sciences, V45, P551; Pornpanomchai C., 2011, INT J ENG TECHNOLOGY, V3, P347, DOI DOI 10.7763/IJET.2011.V3.251; Prance GT, 2017, KEW BULL, V72, DOI 10.1007/S12225-017-9712-7; Sule Tekkesinoglu, 2014, Research Journal of Applied Sciences, Engineering and Technology, V7, P2447; Watchareeruetai U., 2015, COMP SCI ENG C ICSEC, P1; Yahiaoui I., 2012, 2012 IEEE International Conference on Multimedia and Expo (ICME), P254, DOI 10.1109/ICME.2012.130	28	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191447	10.1371/journal.pone.0191447	http://dx.doi.org/10.1371/journal.pone.0191447			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420568	Green Published, Green Accepted, gold			2022-12-26	WOS:000424517900014
J	Ceapa, CD; Vazquez-Hernandez, M; Rodriguez-Luna, SD; Vazquez, APC; Suarez, VJ; Rodriguez-Sanoja, R; Alvarez-Buylla, ER; Sanchez, S				Diana Ceapa, Corina; Vazquez-Hernandez, Melissa; Daniela Rodriguez-Luna, Stefany; Cruz Vazquez, Angelica Patricia; Jimenez Suarez, Veronica; Rodriguez-Sanoja, Romina; Alvarez-Buylla, Elena R.; Sanchez, Sergio			Genome mining of Streptomyces scabrisporus NF3 reveals symbiotic features including genes related to plant interactions	PLOS ONE			English	Article							SIGMA-FACTOR; AMPHIPTERYGIUM-ADSTRINGENS; ENDOPHYTIC STREPTOMYCES; SECONDARY METABOLISM; DISEASE-RESISTANCE; GROWTH PROMOTION; ROOT; PROTEIN; IDENTIFICATION; RESPONSES	Endophytic bacteria are wide-spread and associated with plant physiological benefits, yet their genomes and secondary metabolites remain largely unidentified. In this study, we explored the genome of the endophyte Streptomyces scabrisporus NF3 for discovery of potential novel molecules as well as genes and metabolites involved in host interactions. The complete genomes of seven Streptomyces and three other more distantly related bacteria were used to define the functional landscape of this unique microbe. The S. scabrisporus NF3 genome is larger than the average Streptomyces genome and not structured for an obligate endosymbiotic lifestyle; this and the fact that can grow in R2YE media implies that it could include a soil-living stage. The genome displays an enrichment of genes associated with amino acid production, protein secretion, secondary metabolite and antioxidants production and xenobiotic degradation, indicating that S. scabrisporus NF3 could contribute to the metabolic enrichment of soil microbial communities and of its hosts. Importantly, besides its metabolic advantages, the genome showed evidence for differential functional specificity and diversification of plant interaction molecules, including genes for the production of plant hormones, stress resistance molecules, chitinases, antibiotics and siderophores. Given the diversity of S. scabrisporus mechanisms for host upkeep, we propose that these strategies were necessary for its adaptation to plant hosts and to face changes in environmental conditions.	[Diana Ceapa, Corina; Vazquez-Hernandez, Melissa; Daniela Rodriguez-Luna, Stefany; Cruz Vazquez, Angelica Patricia; Rodriguez-Sanoja, Romina; Sanchez, Sergio] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City, DF, Mexico; [Cruz Vazquez, Angelica Patricia; Jimenez Suarez, Veronica; Alvarez-Buylla, Elena R.] Univ Nacl Autonoma Mexico, Inst Ecol, Lab Genet Mol Epigenet Desarrollo & Evoluc Planta, Mexico City, DF, Mexico; [Cruz Vazquez, Angelica Patricia] Inst Tecnol Tuxtla Gutierrez, Gutierrez, Chiapas, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ceapa, CD; Sanchez, S (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City, DF, Mexico.	corinaceapa@iibiomedicas.unam.mx; sersan@biomedicas.unam.mx	Vázquez-Hernández, Melissa/AAW-2013-2020; SUAREZ, VERONICA JIMENEZ/AAB-9313-2021; Ceapă, Corina-Diana/B-3241-2016; Romina, Rodríguez-Sanoja/C-5333-2009	Vázquez-Hernández, Melissa/0000-0003-2527-9135; Ceapă, Corina-Diana/0000-0001-8661-4211; Romina, Rodríguez-Sanoja/0000-0002-2722-5432; JIMENEZ, VERONICA/0000-0002-3078-8922; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473	Direccion general de asuntos del personal academic (DGAPA), UNAM; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA, UNAM [IN202216]; CONACYT [INFR-2017.279880]	Direccion general de asuntos del personal academic (DGAPA), UNAM(Universidad Nacional Autonoma de Mexico); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA, UNAM; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by a Direccion general de asuntos del personal academic (DGAPA), UNAM Postdoctoral Fellowship (http://dgapa.unam.mx/index.php/formacion-academica/posdoc) to C.D.C. and by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) (http://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit), DGAPA, UNAM (grant IN202216) awarded to S.S. The authors thank the support of CONACYT INFR-2017.279880 that allowed the acquisition of an UPLC masses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the support of CONACYT INFR-2017.279880 that allowed the acquisition of an UPLC masses. We thank Marco A. Ortiz for strain preservation studies, to Karol Rodriguez-Pena for critically reviewing the manuscript, to Betsabe Linares Ferrer for improving the figures and to Nidia Maldonado Carmona and Omar Jimenez Rodriguez for the extended discussions about the topic.	Agrawal N., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P429; Ardanov P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046802; Armada E, 2016, J PLANT PHYSIOL, V192, P1, DOI 10.1016/j.jplph.2015.11.007; Artzi L, 2017, NAT REV MICROBIOL, V15, P83, DOI 10.1038/nrmicro.2016.164; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Blumenstein K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01033; Brechenmacher L, 2010, PLANT PHYSIOL, V153, P1808, DOI 10.1104/pp.110.157800; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Card S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw114; Castillo-Juarez I, 2007, J ETHNOPHARMACOL, V114, P72, DOI 10.1016/j.jep.2007.07.022; Charousova I, 2017, J ADV PHARM TECHNOL, V8, P46, DOI 10.4103/japtr.JAPTR_161_16; Chaudhary AK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/968518; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; ECONOMOU A, 1990, EMBO J, V9, P349, DOI 10.1002/j.1460-2075.1990.tb08117.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Garay-Arroyo A, 2012, DEV DYNAM, V241, P1867, DOI 10.1002/dvdy.23878; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Cabanas CGL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00427; Gopalakrishnan S, 2015, 3 BIOTECH, V5, P799, DOI 10.1007/s13205-015-0283-8; Gopalakrishnan S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-574; Gregor AK, 2003, CAN J MICROBIOL, V49, P483, DOI 10.1139/W03-061; Han Y, 2015, GENET MOL RES, V14, P9412, DOI 10.4238/2015.August.14.5; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hjort K, 2010, FEMS MICROBIOL ECOL, V71, P197, DOI 10.1111/j.1574-6941.2009.00801.x; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Jaiswal AK, 2017, SCI REP-UK, V7, DOI 10.1038/srep44382; Jog R, 2012, J APPL MICROBIOL, V113, P1154, DOI 10.1111/j.1365-2672.2012.05417.x; Jones GH, 1997, MOL MICROBIOL, V23, P169, DOI 10.1046/j.1365-2958.1997.2001566.x; Joseph B, 2011, J PURE APPL MICROBIO, V5, P153; Kaul S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00955; Khan Z, 2014, ENVIRON SCI TECHNOL, V48, P12221, DOI 10.1021/es503880t; Kielak AM, 2013, APPL ENVIRON MICROB, V79, P263, DOI 10.1128/AEM.02546-12; Kudo F, 2015, CHEMBIOCHEM, V16, P909, DOI 10.1002/cbic.201500040; Kulkarni G, 2015, MBIO, V6, DOI 10.1128/mBio.01251-15; Kurth F, 2014, MOL PLANT MICROBE IN, V27, P891, DOI 10.1094/MPMI-10-13-0296-R; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lee KE, 2015, J MICROBIOL BIOTECHN, V25, P1467, DOI 10.4014/jmb.1502.02011; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li Y, 2013, PHYSIOL MOL PLANT P, V83, P51, DOI 10.1016/j.pmpp.2013.05.001; Lin L, 2012, PLANTA, V236, P1849, DOI 10.1007/s00425-012-1741-8; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Lopez-Fernandez S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00419; Maheshwari D.K., 2012, BACTERIA AGROBIOLOGY, DOI DOI 10.1007/978-3-662-45795-5_15; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Martin JF, 2017, J ANTIBIOT TOKYO, V15, P1; Min B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40432; Nah JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/549737; Navarrete A, 2005, J PHARM PHARMACOL, V57, P1629, DOI 10.1211/jpp.57.12.0013; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Nishizawa T, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00875-16; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Ortega AGO, 1999, J ETHNOPHARMACOL, V68, P109, DOI 10.1016/S0378-8741(99)00047-1; Otani H, 2013, MOL MICROBIOL, V87, P1223, DOI 10.1111/mmi.12160; Oviedo-Chavez I, 2004, PHYTOMEDICINE, V11, P436, DOI 10.1016/j.phymed.2003.05.003; Palacios OA, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw077; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ping X, 2004, INT J SYST EVOL MICR, V54, P577, DOI 10.1099/ijs.0.02692-0; Purushotham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036714; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Rathore Abhishek Singh, 2015, Enzyme Res, V2015, P791907, DOI 10.1155/2015/791907; Rey T, 2017, TRENDS PLANT SCI, V22, P30, DOI 10.1016/j.tplants.2016.10.008; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Rovenich H, 2014, CURR OPIN PLANT BIOL, V20, P96, DOI 10.1016/j.pbi.2014.05.001; Rylott EL, 2014, PLANT SOIL, V385, P389, DOI 10.1007/s11104-014-2296-1; Sadeghi A, 2012, WORLD J MICROB BIOT, V28, P1503, DOI 10.1007/s11274-011-0952-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salla TD, 2014, PLANT PHYSIOL BIOCH, V85, P14, DOI 10.1016/j.plaphy.2014.10.008; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Schouten A, 2004, MOL PLANT MICROBE IN, V17, P1201, DOI 10.1094/MPMI.2004.17.11.1201; Seipke RF, 2012, FEMS MICROBIOL REV, V36, P862, DOI 10.1111/j.1574-6976.2011.00313.x; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Sevcikova B, 2001, ARCH MICROBIOL, V177, P98, DOI 10.1007/s00203-001-0367-1; Shah AM, 2016, CHEM-BIOL INTERACT, V256, P198, DOI 10.1016/j.cbi.2016.06.032; Silipo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6106; Skinnider MA, 2015, NUCLEIC ACIDS RES, V43, P9645, DOI 10.1093/nar/gkv1012; Song YS, 2013, CARBOHYD POLYM, V92, P2276, DOI 10.1016/j.carbpol.2012.12.018; Straub D, 2013, J EXP BOT, V64, P4603, DOI 10.1093/jxb/ert276; Tan GY, 2017, ACS SYNTH BIOL, V6, P995, DOI 10.1021/acssynbio.6b00330; Tapia-Lopez R, 2008, PLANT PHYSIOL, V146, P1182, DOI 10.1104/pp.107.108647; Tarkka MT, 2008, PLANT SIGNAL BEHAV, V3, P917, DOI 10.4161/psb.5996; Tian BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17087; Tokala RK, 2002, APPL ENVIRON MICROB, V68, P2161, DOI 10.1128/AEM.68.5.2161-2171.2002; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; van Baarlen P, 2013, CURR OPIN MICROBIOL, V16, P270, DOI 10.1016/j.mib.2013.07.001; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Vazquez-Hernandez M, 2017, GENOME ANNOUNC, V5; Wang Q., 2015, JBM, V3, P56, DOI [10.4236/jbm.2015.33009, DOI 10.4236/JBM.2015.33009]; Wang XY, 2016, EUR J PLANT PATHOL, V144, P477, DOI 10.1007/s10658-015-0788-3; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Yakhin OI, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02049; Yang B, 2014, PLANT PHYSIOL BIOCH, V82, P172, DOI 10.1016/j.plaphy.2014.06.002; Yu X, 2017, J APPL MICROBIOL, V122, P987, DOI 10.1111/jam.13379; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97; Zhang C, 2009, J ANTIBIOT, V62, P55, DOI 10.1038/ja.2008.8	99	15	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192618	10.1371/journal.pone.0192618	http://dx.doi.org/10.1371/journal.pone.0192618			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447216	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900043
J	Gioia, M; Fasciglione, GF; Sbardella, D; Sciandra, F; Casella, M; Camerini, S; Crescenzi, M; Gori, A; Tarantino, U; Cozza, P; Brancaccio, A; Coletta, M; Bozzi, M				Gioia, Magda; Fasciglione, Giovanni Francesco; Sbardella, Diego; Sciandra, Francesca; Casella, MariaLuisa; Camerini, Serena; Crescenzi, Marco; Gori, Alessandro; Tarantino, Umberto; Cozza, Paola; Brancaccio, Andrea; Coletta, Massimo; Bozzi, Manuela			The enzymatic processing of alpha-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site	PLOS ONE			English	Article							BETA-DYSTROGLYCAN; MATRIX METALLOPROTEINASES; COLLAGEN-I; NEUTROPHIL COLLAGENASE; SKELETAL-MUSCLE; GELATINASE-A; HEMOPEXIN; CLEAVAGE; BINDING; ECTODOMAIN	Dystroglycan (DG) is a membrane receptor, belonging to the dystrophin-glycoprotein complex (DGC) and formed by two subunits, alpha-dystroglycan (alpha-DG) and beta-dystroglycan (beta - DG). The C-terminal domain of alpha-DG and the N-terminal extracellular domain of beta - DG are connected, providing a link between the extracellular matrix and the cytosol. Under pathological conditions, such as cancer and muscular dystrophies, DG may be the target of metalloproteinases MMP-2 and MMP-9, contributing to disease progression. Previously, we reported that the C-terminal domain alpha-DG (483-628) domain is particularly susceptible to the catalytic activity of MMP-2; here we show that the alpha-DG 621-628 region is required to carry out its complete digestion, suggesting that this portion may represent a MMP-2 anchoring site. Following this observation, we synthesized an alpha-DG based-peptide, spanning the (613-651) C-terminal region. The analysis of the kinetic and thermodynamic parameters of the whole and the isolated catalytic domain of MMP-2 (cdMMP-2) has shown its inhibitory properties, indicating the presence of (at least) two binding sites for the peptide, both located within the catalytic domain, only one of the two being topologically distinct from the catalytic active groove. However, the different behavior between whole MMP-2 and cdMMP-2 envisages the occurrence of an additional binding site for the peptide on the hemopexin-like domain of MMP-2. Interestingly, mass spectrometry analysis has shown that a-DG (613-651) peptide is cleavable even though it is a very poor substrate of MMP-2, a feature that renders this molecule a promising template for developing a selective MMP-2 inhibitor.	[Gioia, Magda; Fasciglione, Giovanni Francesco; Sbardella, Diego; Tarantino, Umberto; Cozza, Paola; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Gioia, Magda; Fasciglione, Giovanni Francesco; Sbardella, Diego; Coletta, Massimo] CIRCMSB, Bari, Italy; [Sciandra, Francesca; Brancaccio, Andrea; Bozzi, Manuela] CNR, Inst Mol Recognit, Rome, Italy; [Casella, MariaLuisa; Camerini, Serena; Crescenzi, Marco] Ist Super Sanita, Rome, Italy; [Gori, Alessandro] CNR, Inst Mol Recognit, Milan, Italy; [Brancaccio, Andrea] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Bozzi, Manuela] Catholic Univ, Inst Biochem & Clin Biochem, Rome, Italy	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); University of Bristol; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Gioia, M (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.; Gioia, M (corresponding author), CIRCMSB, Bari, Italy.; Bozzi, M (corresponding author), CNR, Inst Mol Recognit, Rome, Italy.; Bozzi, M (corresponding author), Catholic Univ, Inst Biochem & Clin Biochem, Rome, Italy.	magda.gioia@uniroma2.it; manuela.bozzi@unicatt.it	Gioia, Magda/ABF-8909-2020; Camerini, Serena/A-4637-2017; Gori, Alessandro/A-1357-2019; Coletta, Massimo/N-9049-2015; Casella, Marialuisa/AAA-9846-2021; Sciandra, Francesca/AAY-4650-2020; Crescenzi, Marco/J-3603-2018; Sbardella, Diego/N-9187-2015; Brancaccio, Andrea/C-5876-2009; Coletta, Massimiliano/GSN-5927-2022; Fasciglione, Giovanni Francesco/ABF-7738-2020; Gioia, Magda/AAD-4781-2022; SBARDELLA, Diego/K-7519-2016	Camerini, Serena/0000-0001-6131-4335; Casella, Marialuisa/0000-0003-0245-6709; Sciandra, Francesca/0000-0002-2123-1516; Crescenzi, Marco/0000-0003-0156-1494; Brancaccio, Andrea/0000-0003-4690-8826; COZZA, PAOLA/0000-0003-2663-8291; SBARDELLA, Diego/0000-0002-9924-7761; COLETTA, Massimiliano/0000-0002-5489-9467; Gioia, Magda/0000-0003-0352-3547	Italian Space Agency (ASI SMEMCO) [DC-DTE-2011-033]	Italian Space Agency (ASI SMEMCO)	This work has been supported by funds from the Italian Space Agency (ASI SMEMCO n. DC-DTE-2011-033 to U.T.).; This work has been supported by funds from the Italian Space Agency (ASI SMEMCO n. DC-DTE-2011-033 to U.T.).	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bozzi M, 2006, FEBS J, V273, P4929, DOI 10.1111/j.1742-4658.2006.05492.x; Bozzi M, 2015, MATRIX BIOL, V44-46, P130, DOI 10.1016/j.matbio.2015.02.005; Bozzi M, 2009, IUBMB LIFE, V61, P1143, DOI 10.1002/iub.273; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Court FA, 2011, J NEUROSCI, V31, P12208, DOI 10.1523/JNEUROSCI.0141-11.2011; De Rosa MC, 2011, J MOL GRAPH MODEL, V29, P1015, DOI 10.1016/j.jmgm.2011.04.008; Fukai Y, 2017, BIOCHEM BIOPH RES CO, V492, P199, DOI 10.1016/j.bbrc.2017.08.048; Gioia M, 2002, J BIOL CHEM, V277, P23123, DOI 10.1074/jbc.M110873200; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Gioia M, 2010, J BIOL INORG CHEM, V15, P1219, DOI 10.1007/s00775-010-0680-8; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Heng S, 2015, FASEB J, V29, P4011, DOI 10.1096/fj.14-269456; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Levin M, 2017, BBA-MOL CELL RES, V1864, P1927, DOI 10.1016/j.bbamcr.2017.06.009; Losasso C, 2000, FEBS LETT, V484, P194, DOI 10.1016/S0014-5793(00)02157-8; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Paggi P, 2006, J PHYSIOL-PARIS, V99, P119, DOI 10.1016/j.jphysparis.2005.12.004; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Rizzo R, 2013, MOL CELL BIOCHEM, V381, P243, DOI 10.1007/s11010-013-1708-5; Russo K, 2000, BIOCHEM BIOPH RES CO, V274, P93, DOI 10.1006/bbrc.2000.3103; Saito F, 2008, FEBS LETT, V582, P439, DOI 10.1016/j.febslet.2008.01.006; Sbardella D, 2015, MATRIX BIOL, V41, P2, DOI 10.1016/j.matbio.2014.11.007; Sbardella D, 2012, IUBMB LIFE, V64, P988, DOI 10.1002/iub.1095; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Sciandra F, 2013, CURR PROTEIN PEPT SC, V14, P626; Sgambato A, 2007, CANCER BIOL THER, V6, P1840, DOI 10.4161/cbt.6.12.4983; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Yamada H, 2001, HUM MOL GENET, V10, P1563, DOI 10.1093/hmg/10.15.1563	40	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192651	10.1371/journal.pone.0192651	http://dx.doi.org/10.1371/journal.pone.0192651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447293	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900044
J	Liu, C; Deb, S; Ferreira, VS; Xu, E; Baumgart, T				Liu, Chun; Deb, Sanghamitra; Ferreira, Vinicius S.; Xu, Eric; Baumgart, Tobias			Kinetics of PTEN-mediated PI(3,4,5)P3 hydrolysis on solid supported membranes	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; TUMOR-SUPPRESSOR; PROTEIN ADSORPTION; PLASMA-MEMBRANE; CELL-MIGRATION; IN-VITRO; BINDING; MODELS; PHOSPHATASE; ACTIVATION	Phosphatidylinositides play important roles in cellular signaling and migration. Phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) is an important phosphatidylinositide because it acts as a secondary messenger to trigger cell movement and proliferation. A high level of PI(3,4,5)P3 at the plasma membrane is known to contribute to tumorigenesis. One key enzyme that regulates PI(3,4,5)P3 levels at the plasma membrane is phosphatase and tensin homologue deleted on chromosome 10 (PTEN), which dephosphorylates PI(3,4,5)P3 through hydrolysis to form phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2). It has been reported that PI(4,5)P2 is involved in positive feedback in the PI(3,4,5)P3 hydrolysis by PTEN. However, how PI(3,4,5)P3 dephosphorylation by PTEN is regulated, is still under debate. How other PI(3,4,5)P3-binding proteins affect the dephosphorylation kinetics catalyzed by PTEN also remains unclear. Here, we develop a fluorescent-protein biosensor approach to study how PI(3,4,5)P3 dephosphorylation is regulated by PTEN as well as its membrane-mediated feedback mechanisms. Our observation of sigmoidal kinetics of the PI (3,4,5)P3 hydrolysis reaction supports the notion of autocatalysis in PTEN function. We developed a kinetic model to describe the observed reaction kinetics, which allowed us to i) distinguish between membrane-recruitment and allosteric activation of PTEN by PI(4,5)P2, ii) account for the influence of the biosensor on the observed reaction kinetics, and iii) demonstrate that all of these mechanisms contribute to the kinetics of PTEN-mediated catalysis.	[Liu, Chun; Deb, Sanghamitra; Ferreira, Vinicius S.; Xu, Eric; Baumgart, Tobias] Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Deb, Sanghamitra] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Ferreira, Vinicius S.] CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; California Institute of Technology	Baumgart, T (corresponding author), Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA.	baumgart@sas.upenn.edu		Ferreira, Vinicius/0000-0002-9522-2567	National Science Foundation (NSF) CAREER [CBET 1053857]; National Institutes of Health (NIH) [R01 97552]; NSF CAREER [CBET 1053857]; NIH [R01 97552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552, R01GM104867] Funding Source: NIH RePORTER	National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) CAREER grant CBET 1053857 and National Institutes of Health (NIH) grant R01 97552 (to TB).; We acknowledge help with enzyme purification from the labs of A. Ross and R. Marmorstein, thank L. Xinle, L. Chun-Wei, Z. Graber, and S. Wilner for helpful discussions, and acknowledge funding through NSF CAREER grant CBET 1053857 and NIH grant R01 97552.	Ades AE, 2003, RISK ANAL, V23, P1165, DOI 10.1111/j.0272-4332.2003.00386.x; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cassey P, 2016, PSYCHONOMIC B REV; Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gesztelyi R, 2012, ARCH HIST EXACT SCI, V66, P427, DOI 10.1007/s00407-012-0098-5; Goldstein B, 1999, J MOL RECOGNIT, V12, P293, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<293::AID-JMR472>3.0.CO;2-M; Harishchandra RK, 2015, METHODS, V77-78, P125, DOI 10.1016/j.ymeth.2015.02.004; Haugh JM, 2012, BIOPHYS J, V102, P2003, DOI 10.1016/j.bpj.2012.03.055; Hengl S, 2007, BIOINFORMATICS, V23, P2612, DOI 10.1093/bioinformatics/btm382; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Iversen L, 2014, SCIENCE, V345, P50, DOI 10.1126/science.1250373; Jennissen HP, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1990207; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Lai CL, 2013, J MOL BIOL, V425, P3073, DOI 10.1016/j.jmb.2013.05.026; Larsen J, 2011, J AM CHEM SOC, V133, P10685, DOI 10.1021/ja203984j; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li P, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-91; Liang F, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602991; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lionello A, 2005, LAB CHIP, V5, P1096, DOI 10.1039/b506009e; Lionello A, 2005, LAB CHIP, V5, P254, DOI 10.1039/b411179f; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Lumb CN, 2013, BIOPHYS J, V104, P613, DOI 10.1016/j.bpj.2012.12.002; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 1998, J BIOL CHEM, P273; Mak Lok Hang, 2010, J Chem Biol, V3, P157, DOI 10.1007/s12154-010-0041-7; Mason T, 1999, MATH BIOSCI, V159, P123, DOI 10.1016/S0025-5564(99)00023-1; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Miao B, 2012, ONCOGENE, V31, P4317, DOI 10.1038/onc.2011.593; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Panaiotov I, 1999, ENZYMATIC REACTIONS; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Shenoy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032591; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Spinelli L, 2015, METHODS, V77-78, P51, DOI 10.1016/j.ymeth.2014.11.003; Turner BM, 2013, PSYCHOL METHODS, V18, P368, DOI 10.1037/a0032222; Ullrich SJ, 2011, NAT CHEM BIOL, V7, P263, DOI 10.1038/nchembio.543; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; VERGER R, 1973, J BIOL CHEM, V248, P4023; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yasui M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003817; Yin LL, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4934802; Yin L, 2015, BIOSENS BIOELECTRON, V66, P412, DOI 10.1016/j.bios.2014.11.036	54	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192667	10.1371/journal.pone.0192667	http://dx.doi.org/10.1371/journal.pone.0192667			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447222	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000425283900045
J	Oh, NS; Joung, JY; Lee, JY; Kim, Y				Oh, Nam Su; Joung, Jae Yeon; Lee, Ji Young; Kim, Younghoon			Probiotic and anti-inflammatory potential of Lactobacillus rhamnosus 4B15 and Lactobacillus gasseri 4M13 isolated from infant feces	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; IN-VITRO; SELECTION; KOUMISS; STRAIN	A total of 22 Lactobacillus strains, which were isolated from infant feces were evaluated for their probiotic potential along with resistance to low pH and bile salts. Eight isolates (L. reuteri 3M02 and 3M03, L. gasseri 4M13, 4R22, 5R01, 5R02, and 5R13, and L. rhamnosus 4B15) with high tolerance to acid and bile salts, and ability to adhere to the intestine were screened from 22 strains. Further, functional properties of 8 Lactobacillus strains, such as anti-oxidation, inhibition of a-glucosidase activity, cholesterol-lowering, and anti-inflammation were evaluated. The properties were strain-specific. Particularly, two strains of L. rhamnosus, 4B15 (4B15) and L. gasseri 4M13 (4M13) showed considerably higher anti-oxidation, inhibition of alpha-glucosidase activity, and cholesterol-lowering, and greater inhibition of nitric oxide production than other strains. Moreover, the two selected strains substantially inhibited the release of inflammatory mediators such as TNF-alpha, IL-6, IL-1 beta, and IL-10 stimulated the treatment of RAW 264.7 macrophages with LPS. In addition, whole genome sequencing and comparative genomic analysis of 4B15 and 4M13 indicated them as novel genomic strains. These results suggested that 4B15 and 4M13 showed the highest probiotic potential and have an impact on immune health by modulating pro-inflammatory cytokines.	[Oh, Nam Su; Joung, Jae Yeon; Lee, Ji Young] Seoul Dairy Cooperat, R&D Ctr, Ansan, Kyunggi, South Korea; [Joung, Jae Yeon; Lee, Ji Young] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Kim, Younghoon] Chonbuk Natl Univ, Dept Anim Sci, Jeonju, South Korea; [Kim, Younghoon] Chonbuk Natl Univ, Inst Milk Genom, Jeonju, South Korea	Korea University; Jeonbuk National University; Jeonbuk National University	Kim, Y (corresponding author), Chonbuk Natl Univ, Dept Anim Sci, Jeonju, South Korea.; Kim, Y (corresponding author), Chonbuk Natl Univ, Inst Milk Genom, Jeonju, South Korea.	ykeys2584@jbnu.ac.kr	Joung, Jae Yeon/AAK-1202-2020	Lee, Ji Young/0000-0003-4838-6128	High Value-Added Food Technology Development Program of the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (iPET); Ministry for Food, Agriculture, Forestry and Fisheries of Republic of Korea [115006-03-2-SB010]; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning [2016M3C1B5907057]; R & D Center, Seoul Dairy Cooperative, Ansan, Kyunggi, South Korea	High Value-Added Food Technology Development Program of the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (iPET); Ministry for Food, Agriculture, Forestry and Fisheries of Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning; R & D Center, Seoul Dairy Cooperative, Ansan, Kyunggi, South Korea	This research was supported by the High Value-Added Food Technology Development Program of the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (iPET), and the Ministry for Food, Agriculture, Forestry and Fisheries of Republic of Korea (115006-03-2-SB010) and National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communications Technology (ICT) and Future Planning (2016M3C1B5907057). NSO, JYJ, and JYL received support in the form of salary from R & D Center, Seoul Dairy Cooperative, Ansan, Kyunggi, South Korea. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005; Bao Y, 2010, FOOD CONTROL, V21, P695, DOI 10.1016/j.foodcont.2009.10.010; Chon H, 2010, MICROBIOL IMMUNOL, V54, P228, DOI 10.1111/j.1348-0421.2010.00202.x; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Giraffa G, 2010, RES MICROBIOL, V161, P480, DOI 10.1016/j.resmic.2010.03.001; Guo CF, 2015, J FUNCT FOODS, V12, P294, DOI 10.1016/j.jff.2014.11.029; Jin LZ, 1998, LETT APPL MICROBIOL, V27, P183, DOI 10.1046/j.1472-765X.1998.00405.x; Kim JY, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0145-x; Kim SJ, 2008, LWT-FOOD SCI TECHNOL, V41, P493, DOI 10.1016/j.lwt.2007.03.025; Kirtzalidou E, 2011, ANAEROBE, V17, P440, DOI 10.1016/j.anaerobe.2011.05.007; Lacroix IME, 2013, J AGR FOOD CHEM, V61, P7500, DOI 10.1021/jf401000s; Lee J, 2014, J AGR FOOD CHEM, V62, P3954, DOI 10.1021/jf4038503; Lee J, 2010, APPL ENVIRON MICROB, V76, P4829, DOI 10.1128/AEM.02892-09; Lievin-Le Moal V, 2002, GUT, V50, P803, DOI 10.1136/gut.50.6.803; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Morita H, 2009, J BACTERIOL, V191, P7630, DOI 10.1128/JB.01287-09; Oh NS, 2014, J DAIRY SCI, V97, P3300, DOI 10.3168/jds.2013-7728; Oh NS, 2017, J AGR FOOD CHEM, V65, P4744, DOI 10.1021/acs.jafc.7b01339; Oh NS, 2016, APPL MICROBIOL BIOT, V100, P10095, DOI 10.1007/s00253-016-7863-3; Pereira DIA, 2003, APPL ENVIRON MICROB, V69, P4743, DOI 10.1128/AEM.69.8.4743-4752.2003; Philippe D, 2011, WORLD J GASTROENTERO, V17, P459, DOI 10.3748/wjg.v17.i4.459; Ramchandran L, 2009, DAIRY SCI TECHNOL, V89, P583, DOI 10.1051/dst/2009039; Rao SA, 2007, J CHROMATOGR B, V855, P166, DOI 10.1016/j.jchromb.2007.04.048; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Robbins KS, 2016, FOOD CHEM, V212, P681, DOI 10.1016/j.foodchem.2016.06.018; Ronka E, 2003, INT J FOOD MICROBIOL, V83, P63, DOI 10.1016/S0168-1605(02)00315-X; Ross RP, 2005, J APPL MICROBIOL, V98, P1410, DOI 10.1111/j.1365-2672.2005.02654.x; Roy MK, 2010, INT J FOOD SCI NUTR, V61, P109, DOI 10.3109/09637480903292601; Santosa S, 2006, NUTR REV, V64, P265, DOI [10.1111/j.1753-4887.2006.tb00209.x, 10.1301/nr.2006.jun.265-274]; Suskovic J, 2001, FOOD TECHNOL BIOTECH, V39, P227; TOBA T, 1991, LETT APPL MICROBIOL, V12, P228, DOI 10.1111/j.1472-765X.1991.tb00546.x; Verdenelli MC, 2009, EUR J NUTR, V48, P355, DOI 10.1007/s00394-009-0021-2; Wu R, 2009, J BASIC MICROB, V49, P318, DOI 10.1002/jobm.200800047; Zeng Z, 2016, J FUNCT FOODS, V20, P486, DOI 10.1016/j.jff.2015.11.030; Zielinska D, 2015, CURR MICROBIOL, V70, P183, DOI 10.1007/s00284-014-0699-0	35	99	104	14	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192021	10.1371/journal.pone.0192021	http://dx.doi.org/10.1371/journal.pone.0192021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444150	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500050
J	Goodin, DS; Khankhanian, P; Gourraud, PA; Vince, N				Goodin, Douglas S.; Khankhanian, Pouya; Gourraud, Pierre-Antoine; Vince, Nicolas			Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; DIAGNOSTIC-CRITERIA; MHC HAPLOTYPES; RISK; GUIDELINES; PATTERNS; FAMILIES; ALLELES; LOCI	Objective To determine the relationship between highly-conserved extended-haplotypes (CEHs) in the major histocompatibility complex (MHC) and MS-susceptibility. Background Among the similar to 200 MS-susceptibility regions, which are known from genome-wide analyses of single nucleotide polymorphisms (SNPs), the MHC accounts for roughly a third of the currently explained variance and the strongest MS-associations are for certain Class II alleles (e.g., HLA-DRB1*15:01; HLA-DRB1*03:01; and HLA-DRB1*13:03), which frequently reside on CEHs within the MHC. Design/Methods Autosomal SNPs (441,547) from 11,376 MS cases and 18,872 controls in the WTCCC dataset were phased. The most significant MS associated SNP haplotype was composed of 11 SNPs in the MHC Class II region surrounding the HLA-DRB1 gene. We also phased alleles at the HLA-A, HLA-C, HLA-B, HLA-DRB1, and HLA-DQB1 loci. This data was used to probe the relationship between CEHs and MS susceptibility. Results We phased a total of 59,884 extended haplotypes (HLA-A, HLA-C, HLA-B, HLA-DRB1, HLA-DQB1 and SNP haplotypes) from 29,942 individuals. Of these, 10,078 unique extended haplotypes were identified. The 10 most common CEHs accounted for 22% (13,302) of the total. By contrast, the 8,446 least common extended haplotypes also accounted for approximately 20% (12,298) of the total. This extreme frequency-disparity among extended haplotypes necessarily complicates interpretation of reported diseaseassociations with specific HLA alleles. In particular, the HLA motif HLA-DRB1*15:01 similar to HLA-DQB1*06:02 is strongly associated with MS risk. Nevertheless, although this motif is almost always found on the a1 SNP haplotype, it can rarely be found on others (e.g., a27 and a36), and, in these cases, it seems to have no apparent disease-association (OR = 0.7; CI = 0.3-1.3 and OR = 0.7; CI = 0.2-2.2, respectively). Furthermore, single copy carriers of the a1 SNP-haplotype without this HLA motif still have an increased disease risk (OR = 2.2; CI = 1.2-3.8). In addition, even among the set of CEHs, which carry the Class II motif of HLA-DRB1*15:01 similar to HLA-DQB1*06:02 similar to a1, different CEHs have differing strengths in their MS-associations. Conclusions The MHC in diverse human populations consists, primarily, of a very small collection of very highly-selected CEHs. Our findings suggest that the MS-association with the HLA-DRB1* 15: 01 similar to HLA-DQB1*06: 02 haplotype may be due primarily to the combined attributes of the CEHs on which this particular HLA-motif often resides.	[Goodin, Douglas S.; Gourraud, Pierre-Antoine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Khankhanian, Pouya] Univ Penn, Ctr Neuroengn & Therapeut, Philadelphia, PA 19104 USA; [Gourraud, Pierre-Antoine; Vince, Nicolas] Univ Nantes, Ctr Rech Transplantat & Immunol UMR 1064, INSERM, Nantes, France; [Gourraud, Pierre-Antoine; Vince, Nicolas] CHU Nantes, ITUN, Nantes, France	University of California System; University of California San Francisco; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu	Gourraud, Pierre-Antoine FD/O-3024-2015; Vince, Nicolas/K-5882-2019	Vince, Nicolas/0000-0002-3767-6210; Gourraud, Pierre-Antoine/0000-0003-1131-9554				Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bugawan TL, 2000, TISSUE ANTIGENS, V56, P392, DOI 10.1034/j.1399-0039.2000.560502.x; Chao MJ, 2008, P NATL ACAD SCI USA, V105, P13069, DOI 10.1073/pnas.0801042105; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Gillespie JH, 1998, POPULATION GENETICS; Goodin DS, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0575-6; Goodin DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090034; Gourraud PA, 2005, HUM IMMUNOL, V66, P563, DOI 10.1016/j.humimm.2005.01.011; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hofker MH, 2014, BBA-MOL BASIS DIS, V1842, P1889, DOI 10.1016/j.bbadis.2014.05.002; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Isobe N, 2016, JAMA NEUROL; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Khankhanian P, 2015, J MED GENET, V52, P587, DOI 10.1136/jmedgenet-2015-103071; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Link J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036779; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McElroy JP, 2010, HUM MOL GENET, V19, P3080, DOI 10.1093/hmg/ddq197; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pappas DJ, 2015, HUM IMMUNOL, V76, P374, DOI 10.1016/j.humimm.2015.01.029; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Paul P, 2016, DNA REPAIR, V40, P47, DOI 10.1016/j.dnarep.2016.02.005; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Sanchez-Mazas A, 2000, EUR J HUM GENET, V8, P33, DOI 10.1038/sj.ejhg.5200391; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Taylan F, 2012, IMMUNOGENETICS, V64, P839, DOI 10.1007/s00251-012-0644-y; Testi M, 2015, TISSUE ANTIGENS, V86, P285, DOI 10.1111/tan.12642; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; Vandiedonck Claire, 2009, Briefings in Functional Genomics & Proteomics, V8, P379, DOI 10.1093/bfgp/elp010; Wennerstrom A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079690; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zu J, 2013, PLOS ONE, V8	56	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0190043	10.1371/journal.pone.0190043	http://dx.doi.org/10.1371/journal.pone.0190043			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438392	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400003
J	Liu, JZ; Li, WF; Wu, JS; Liu, YH				Liu, Jianzheng; Li, Weifeng; Wu, Jiansheng; Liu, Yonghong			Visualizing the intercity correlation of PM2.5 time series in the Beijing-Tianjin-Hebei region using ground-based air quality monitoring data	PLOS ONE			English	Article							METEOROLOGICAL CONDITIONS; TEMPORAL PATTERNS; CHINA; PM10; PERSPECTIVE; TRANSPORT	The Beijing-Tianjin-Hebei area faces a severe fine particulate matter (PM2.5) problem. To date, considerable progress has been made toward understanding the PM2.5 problem, including spatial-temporal characterization, driving factors, and health effects. However, little research has been done on the dynamic interactions and relationships between PM2.5 concentrations in different cities in this area. To address the research gap, this study discovered a phenomenon of time-lagged intercity correlations of PM2.5 time series and proposed a visualization framework based on this phenomenon to visualize the interaction in PM2.5 concentrations between cities. The visualizations produced using the framework show that there are significant time-lagged correlations between the PM2.5 time series in different cities in this area. The visualizations also show that the correlations are more significant in colder months and between cities that are closer, and that there are seasonal changes in the temporal order of the correlated PM2.5 time series. Further analysis suggests that the timelagged intercity correlations of PM2.5 time series are most likely due to synoptic meteorological variations. We argue that the visualizations demonstrate the interactions of air pollution between cities in the Beijing-Tianjin-Hebei area and the significant effect of synoptic meteorological conditions on PM2.5 pollution. The visualization framework could help determine the pathway of regional transportation of air pollution and may also be useful in delineating the area of interaction of PM2.5 pollution for impact analysis.	[Liu, Jianzheng; Li, Weifeng] Univ Hong Kong, Fac Architecture, Dept Urban Planning & Design, Hong Kong, Hong Kong, Peoples R China; [Liu, Jianzheng; Li, Weifeng] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China; [Wu, Jiansheng] Peking Univ, Key Lab Human Environm Sci & Technol, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Wu, Jiansheng] Peking Univ, Coll Urban & Environm Sci, Key Lab Earth Surface Proc, Beijing, Peoples R China; [Liu, Yonghong] Sun Yat Sen Univ, Sch Engn, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Peking University; University Town of Shenzhen; Peking University; Sun Yat Sen University	Li, WF (corresponding author), Univ Hong Kong, Fac Architecture, Dept Urban Planning & Design, Hong Kong, Hong Kong, Peoples R China.; Li, WF (corresponding author), Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China.	wfli@hku.hk	LI, Weifeng/E-1478-2011; Liu, Jianzheng/F-2186-2015; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	LI, Weifeng/0000-0001-5386-3019; Liu, Jianzheng/0000-0003-0039-4786; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [41471370]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (Grant No. 41471370). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Natural Science Foundation of China (Grant No. 41471370).	Beech H., 2014, TIME; Chen W, 2015, ATMOS ENVIRON, V119, P21, DOI 10.1016/j.atmosenv.2015.08.040; Chen Z. Y., 2017, SCI REPORTS, V7; Chen ZY, 2016, ATMOS ENVIRON, V127, P303, DOI 10.1016/j.atmosenv.2015.12.011; Cheng YH, 2010, AEROSOL AIR QUAL RES, V10, P456, DOI 10.4209/aaqr.2010.04.0025; China Council for International Cooperation on Environment and Development, 2014, PERF EV ACT PLAN AIR; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Gan N., 2016, BEIJING PLANS VENTIL; Global Modeling and Assimilation Office, 2015, MERRA 2 TAVGM 2D SLV; He JJ, 2017, ENVIRON POLLUT, V223, P484, DOI 10.1016/j.envpol.2017.01.050; He JJ, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2930-z; Hinkle D.E., 2003, APPL STAT BEHAV SCI; Hu JL, 2014, ATMOS ENVIRON, V95, P598, DOI 10.1016/j.atmosenv.2014.07.019; Huang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141642; Jia YT, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010389; Kenny D. A., 1987, STAT SOCIAL BEHAV SC; Lin GZ, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0177-1; Liu JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32221; Liu XH, 2010, ATMOS ENVIRON, V44, P2415, DOI 10.1016/j.atmosenv.2010.03.035; Liu Y, 2016, ENV PLANNING B; Lu WZ, 2011, BUILD ENVIRON, V46, P577, DOI 10.1016/j.buildenv.2010.09.004; Luo J, 2017, SCI REPORTS, V7; Lv BL, 2015, AEROSOL AIR QUAL RES, V15, P1836, DOI 10.4209/aaqr.2015.04.0266; Molod A, 2015, GEOSCI MODEL DEV, V8, P1339, DOI 10.5194/gmd-8-1339-2015; Pearce JL, 2011, ATMOS ENVIRON, V45, P1328, DOI 10.1016/j.atmosenv.2010.11.051; Rhudy M, 2009, ASME 2009 INT MECH E; SCC [State Council of China], 2013, STAT COUNC ISS ACT P; Schwankert S., 2014, ITS YOUR FAULT NEW R; Stanway D., 2014, BEIJING SAYS ONE 3 I; Wang F, 2010, ENVIRON MODELL SOFTW, V25, P927, DOI 10.1016/j.envsoft.2010.02.004; Wang LL, 2015, ATMOS RES, V157, P37, DOI 10.1016/j.atmosres.2014.12.003; Wu D, 2015, J ENVIRON MANAGE, V149, P27, DOI 10.1016/j.jenvman.2014.09.032; Yang Y, 2015, ENVIRON SCI TECHNOL, V49, P13431, DOI 10.1021/acs.est.5b03614; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhang Y, 2005, COMP STUDY TIME DELA	36	13	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192614	10.1371/journal.pone.0192614	http://dx.doi.org/10.1371/journal.pone.0192614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438417	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400032
J	Ma, JJ; Ma, LY; Zhang, ZQ; Li, K; Wang, YQ; Chen, XM; Zhang, H				Ma, Jinju; Ma, Liyi; Zhang, Zhongquan; Li, Kai; Wang, Youqiong; Chen, Xiaoming; Zhang, Hong			In vivo evaluation of insect wax for hair growth potential	PLOS ONE			English	Article							WHITE WAX; POLICOSANOL; MINOXIDIL; EXTRACT	Insect wax is secreted by Ericerus pela Chavanness. It has been traditionally used to treat hair loss in China, but few reports have been published on the hair growth-promoting effect of insect wax. In this work, we examined the hair growth-promoting effects of insect wax on model animals. Different concentrations of insect wax were topically applied to the denuded backs of mice, and 5% minoxidil was applied topically as a positive control. We found that insect wax significantly promoted hair growth in a dose-dependent manner, 45% and 30% insect wax both induced hair to regrow, while less visible hair growth was observed in blank controls on the 16 th day. The experimental areas treated with 45% and 30% insect wax exhibited significant differences in hair scores compared to blank controls, and hair lengths in the 45% and 30% insect wax group was significantly longer than in blank controls on the 16 th and 20 th days. There were no new hair follicles forming in the treated areas, and the hair follicles were prematurely converted to the anagen phase from the telogen phase in experimental areas treated with 45% and 30% insect wax. Both 45% and 30% insect wax upregulated vascular endothelial growth factor expression. The results indicated that 45% and 30% insect wax showed hair growth-promoting potential approximately as potent as 5% minoxidil by inducing the premature conversion of telogen-to-anagen and by prolonging the mature anagen phase rather than increasing the number of hair follicles, which was likely related to the upregulation of VEGF expression. The dissociative policosanol in insect wax was considered the key ingredient most likely responsible for the hair growth promoting potential.	[Ma, Jinju; Ma, Liyi; Zhang, Zhongquan; Li, Kai; Wang, Youqiong; Chen, Xiaoming; Zhang, Hong] Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF	Ma, LY (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China.	linhuashi510@outlook.com			Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2018SY025]; National High Technology Research and Development Program of China (863 Program) [2014AA021801]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was financially supported by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (CAFYBB2018SY025), and National High Technology Research and Development Program of China (863 Program) (2014AA021801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the Fundamental Research Funds for the Central Nonprofit Research Institution of CAF (CAFYBB2018SY025), and National High Technology Research and Development Program of China (863 Program) (2014AA021801). We also acknowledge our sincere gratitude to all staff members of the department for their kind assistance.	Adhirajan N, 2003, J ETHNOPHARMACOL, V88, P235, DOI 10.1016/S0378-8741(03)00231-9; Alsantali A, 2011, CLIN COSMET INVESTI, V4, P107, DOI 10.2147/CCID.S22767; Anna Herman, 2016, FITOTERAPIA; Avram MR, 2002, DERMATOL SURG, V28, P894, DOI 10.1046/j.1524-4725.2002.02068.x; Bassino E, 2016, NAT PROD RES, V30, P2831, DOI 10.1080/14786419.2016.1154053; Chen XM, 2009, CHINESE WHITE WAX SC, P29; Cotsarelis G, 2001, TRENDS MOL MED, V7, P293, DOI 10.1016/S1471-4914(01)02027-5; Dastan M, 2016, BIOMED PHARMACOTHER, V84, P979, DOI 10.1016/j.biopha.2016.10.019; Datta K, 2009, J ETHNOPHARMACOL, V124, P450, DOI 10.1016/j.jep.2009.05.023; Dhanotia R, 2011, NAT PROD RES, V25, P1432, DOI 10.1080/14786410802632820; Gordon KA, 2011, CLIN COSMET INVESTI, V4, P101, DOI 10.2147/CCID.S10182; Han XH, 2001, PRELIMINARY STUDIES; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hou XY., 2011, J ANHUI AGR SCI, V39, P2817; Hunt N, 2005, BRIT MED J, V331, P951, DOI 10.1136/bmj.331.7522.951; Lachgar S, 1998, BRIT J DERMATOL, V138, P407; Lee GS, 2010, FITOTERAPIA, V81, P17, DOI 10.1016/j.fitote.2009.06.016; Lin L, 2017, SAUDI PHARM J, V25, P625, DOI 10.1016/j.jsps.2017.04.035; Ma LiYi, 2009, Chemistry and Industry of Forest Products, V29, P6; [马李一 MA Liyi], 2008, [食品工业科技, Science & Technology of Food Industry], V29, P179; Mysore V, 2016, INDIAN J DERMATOL VE, V82, P128, DOI 10.4103/0378-6323.177432; Ng CH, 2005, J AGR FOOD CHEM, V53, P6289, DOI 10.1021/jf051269a; Noa M, 2005, ARCH MED RES, V36, P441, DOI 10.1016/j.arcmed.2005.03.039; Park YO, 2013, TOX RESEARCH, V29, P241, DOI 10.5487/TR.2013.29.4.241; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Peters EMJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175904; Rho SS, 2005, J DERMATOL SCI, V38, P89, DOI 10.1016/j.jdermsci.2004.12.025; Seo SR, 2013, J IND ENG CHEM, V19, P1331, DOI 10.1016/j.jiec.2012.12.037; Shi-zhen L, 2006, COMPENDIUM MATERIA M; Stenn KS, 1996, DERMATOL CLIN, V14, P543, DOI 10.1016/S0733-8635(05)70383-1; Taylor JC, 2003, NUTRITION, V19, P192, DOI 10.1016/S0899-9007(02)00869-9; UNO H, 1993, J INVEST DERMATOL, V101, pS143, DOI 10.1111/1523-1747.ep12363275; Vesoulis ZA, 2014, PHARMACOTHERAPY, V34, pe341, DOI 10.1002/phar.1495; Wang ZD, 2017, BIOMED PHARMACOTHER, V89, P438, DOI 10.1016/j.biopha.2017.02.036; Yang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08141; Yang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035719; Yang P, 2011, AFR J MICROBIOL RES, V5, P1246; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Yingguo Wang YL, 2002, CHINA OILS FATS, V27, P54; Zhang RG, 2011, PROCEDIA ENGINEER, V18, DOI 10.1016/j.proeng.2011.11.016; Zhang Y, 2016, BIOMED PHARMACOTHER, V83, P641, DOI 10.1016/j.biopha.2016.07.022; Zheng H, 2009, NAT PROD RES DEV, V21, P313	42	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192612	10.1371/journal.pone.0192612	http://dx.doi.org/10.1371/journal.pone.0192612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438422	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400031
J	Seo, IS; Lee, HG; Koo, B; Koh, CS; Park, HY; Im, C; Shin, HC				Seo, In-Seok; Lee, Hwan-Gon; Koo, Bonkon; Koh, Chin Su; Park, Hae-Yong; Im, Changkyun; Shin, Hyung-Cheul			Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction	PLOS ONE			English	Article							PROSTATE-CANCER; SCENT DETECTION; DOGS; CARCINOMAS; ACCURACY; MELANOMA; URINE	Although several studies have been performed to detect cancer using canine olfaction, none have investigated whether canine olfaction trained to the specific odor of one cancer is able to detect odor related to other unfamiliar cancers. To resolve this issue, we employed breast and colorectal cancer in vitro, and investigated whether trained dogs to odor related to metabolic waste from breast cancer are able to detect it from colorectal cancer, and vice versa. The culture liquid samples used in the cultivation of cancerous cells (4T1 and CT26) were employed as an experimental group. Two different breeds of dogs were trained for the different cancer odor each other. The dogs were then tested using a double-blind method and cross-test to determine whether they could correctly detect the experimental group, which contains the specific odor for metabolic waste of familiar or unfamiliar cancer. For two cancers, both dogs regardless of whether training or non-training showed that accuracy was over 90%, and sensitivity and specificity were over 0.9, respectively. Through these results, it was verified that the superior olfactory ability of dogs can discriminate odor for metabolic waste of cancer cells from it of benign cells, and that the specific odor for metabolic waste of breast cancer has not significant differences to it of colorectal cancer. That is, it testifies that metabolic waste between breast and colorectal cancer have the common specific odor in vitro. Accordingly, a trained dogs for detecting odor for metabolic waste of breast cancer can perceive it of colorectal cancer, and vice versa. In order to the future work, we will plan in vivo experiment for the two cancers and suggest research as to what kind of cancers have the common specific odor. Furthermore, the relationship between breast and colorectal cancer should be investigated using other research methods.	[Seo, In-Seok; Koh, Chin Su; Park, Hae-Yong; Im, Changkyun; Shin, Hyung-Cheul] Hallym Univ, Coll Med, Chunchon, South Korea; [Seo, In-Seok] Gangwon Prov Police Agcy, Chunchon, South Korea; [Lee, Hwan-Gon] Hallym Univ, Dept Phys Educ, Chunchon, South Korea; [Koo, Bonkon] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea	Hallym University; Hallym University; Pohang University of Science & Technology (POSTECH)	Shin, HC (corresponding author), Hallym Univ, Coll Med, Chunchon, South Korea.	hcshin@hallym.ac.kr						Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Davies NJ, 2011, BRIT J CANCER, V105, pS52, DOI 10.1038/bjc.2011.423; Elliker KR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-22; Filipiak W, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-17; Foulkes WD, 1996, J MED GENET, V33, P534, DOI 10.1136/jmg.33.7.534; Gordon RT, 2008, J ALTERN COMPLEM MED, V14, P61, DOI 10.1089/acm.2006.6408; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Horvath G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-396; Keller A, 2017, SCIENCE, V355, P820, DOI 10.1126/science.aal2014; Kermen F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00206; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Moser E, 2010, J VET BEHAV, V5, P145, DOI 10.1016/j.jveb.2010.01.002; Newschaffer CJ, 2001, LANCET, V357, P837, DOI 10.1016/S0140-6736(00)04197-0; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; Prat A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03544; Pruitt SL, 2009, CANCER EPIDEM BIOMAR, V18, P2579, DOI 10.1158/1055-9965.EPI-09-0135; Schmidt Kamila, 2015, J Biomark, V2015, P981458, DOI 10.1155/2015/981458; Scott Rodney J, 2004, Hered Cancer Clin Pract, V2, P25, DOI 10.1186/1897-4287-2-1-25; Sell CS, 2006, ANGEW CHEM INT EDIT, V45, P6254, DOI 10.1002/anie.200600782; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Strauch M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03576; Taverna G, 2015, J UROLOGY, V193, P1382, DOI 10.1016/j.juro.2014.09.099; WILLIAMS H, 1989, LANCET, V1, P734; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712	25	14	14	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192629	10.1371/journal.pone.0192629	http://dx.doi.org/10.1371/journal.pone.0192629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438432	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400036
J	Brakenhoff, TB; van Smeden, M; Visseren, FLJ; Groenwold, RHH				Brakenhoff, Timo B.; van Smeden, Maarten; Visseren, Frank L. J.; Groenwold, Rolf H. H.			Random measurement error: Why worry? An example of cardiovascular risk factors	PLOS ONE			English	Article							BLOOD-PRESSURE-MEASUREMENT; MISCLASSIFICATION; EXPOSURE	With the increased use of data not originally recorded for research, such as routine care data (or 'big data'), measurement error is bound to become an increasingly relevant problem in medical research. A common view among medical researchers on the influence of random measurement error (i.e. classical measurement error) is that its presence leads to some degree of systematic underestimation of studied exposure-outcome relations (i.e. attenuation of the effect estimate). For the common situation where the analysis involves at least one exposure and one confounder, we demonstrate that the direction of effect of random measurement error on the estimated exposure-outcome relations can be difficult to anticipate. Using three example studies on cardiovascular risk factors, we illustrate that random measurement error in the exposure and/or confounder can lead to underestimation as well as overestimation of exposure-outcome relations. We therefore advise medical researchers to refrain from making claims about the direction of effect of measurement error in their manuscripts, unless the appropriate inferential tools are used to study or alleviate the impact of measurement error from the analysis.	[Brakenhoff, Timo B.; van Smeden, Maarten; Groenwold, Rolf H. H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Visseren, Frank L. J.] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Brakenhoff, TB (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	T.B.Brakenhoff-2@umcutrecht.nl	van Smeden, Maarten/Y-7034-2019	van Smeden, Maarten/0000-0002-5529-1541; Visseren, Frank/0000-0003-3951-5223; Groenwold, Rolf/0000-0001-9238-6999	Netherlands Organization for Scientific Research (NWO-Vidi project) [917.16.430]	Netherlands Organization for Scientific Research (NWO-Vidi project)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (https://www.nwo.nl/en) (NWO-Vidi project 917.16.430 granted to R.H.H.G.).	Ahrens W, 2013, HDB EPIDEMIOLOGY, DOI DOI 10.1007/978-0-387-09834-0; [Anonymous], 2014, R LANG ENV STAT COMP; Brakenhoff TB, 2018, MEASUREMENT ERROR ME; Campbell NRC, 2005, AM J HYPERTENS, V18, P1522, DOI 10.1016/j.amjhyper.2005.05.002; Carroll RJ, 2006, MEASUREMENT ERROR NO; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; Day NE, 2004, INT J EPIDEMIOL, V33, P1373, DOI 10.1093/ije/dyh138; Dosemeci M, 1990, AM J EPIDEMIOL, V132, P373; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Graves JW, 2004, AM J HYPERTENS, V17, P354, DOI 10.1016/j.amjhyper.2003.12.007; Gustafson P, 2004, INTER DISC; Heneghan C, 2007, BRIT J GEN PRACT, V57, P948, DOI 10.3399/096016407782604965; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Jurek AM, 2008, INT J EPIDEMIOL, V37, P382, DOI 10.1093/ije/dym291; Jurek AM, 2006, EUR J EPIDEMIOL, V21, P871, DOI 10.1007/s10654-006-9083-0; Keogh RH, 2014, STAT MED, V33, P2137, DOI 10.1002/sim.6095; Loken E, 2017, SCIENCE, V355, P584, DOI 10.1126/science.aal3618; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; MCADAMS J, 1986, AM J POLIT SCI, V30, P256, DOI 10.2307/2111304; Muff S, 2015, BIOMETRICAL J, V57, P1068, DOI 10.1002/bimj.201400157; Nicodeme R, 2009, ARCH CARDIOVASC DIS, V102, P477, DOI 10.1016/j.acvd.2009.02.013; Nitzan M, 2017, MED DEVICES-EVID RES, V10, P157, DOI 10.2147/MDER.S141599; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Spiegelman D, 1997, AM J CLIN NUTR, V65, P1179; van der Wel MC, 2011, ANN FAM MED, V9, P128, DOI 10.1370/afm.1211; Wong MY, 1999, STAT MED, V18, P2831, DOI 10.1002/(SICI)1097-0258(19991115)18:21<2831::AID-SIM282>3.3.CO;2-V; Zidek JV, 1996, ENVIRONMETRICS, V7, P441, DOI 10.1002/(SICI)1099-095X(199607)7:4<441::AID-ENV226>3.0.CO;2-V	31	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192298	10.1371/journal.pone.0192298	http://dx.doi.org/10.1371/journal.pone.0192298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425217	Green Published, gold, Green Submitted			2022-12-26	WOS:000424700800020
J	Sabljic, I; Tomin, M; Matovina, M; Sucec, I; Paic, AT; Tomic, A; Abramic, M; Tomic, S				Sabljic, Igor; Tomin, Marko; Matovina, Mihaela; Sucec, Iva; Paic, Ana Tomasic; Tomic, Antonija; Abramic, Marija; Tomic, Sanja			The first dipeptidyl peptidase III from a thermophile: Structural basis for thermal stability and reduced activity	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; WEB SERVER; MECHANISM; MOTION; WATER; REFINEMENT; PARAMETERS; SOFTWARE; BINDING; SYSTEM	Dipeptidyl peptidase III (DPP III) isolated from the thermophilic bacteria Caldithrix abyssi (Ca) is a two-domain zinc exopeptidase, a member of the M49 family. Like other DPPs III, it cleaves dipeptides from the N-terminus of its substrates but differently from human, yeast and Bacteroides thetaiotaomicron (mesophile) orthologs, it has the pentapeptide zinc binding motif (HEISH) in the active site instead of the hexapeptide (HEXXGH). The aim of our study was to investigate structure, dynamics and activity of CaDPP III, as well as to find possible differences with already characterized DPPs III from mesophiles, especially B. thetaiotaomicron. The enzyme structure was determined by X-ray diffraction, while stability and flexibility were investigated using MD simulations. Using molecular modeling approach we determined the way of ligands binding into the enzyme active site and identified the possible reasons for the decreased substrate specificity compared to other DPPs III. The obtained results gave us possible explanation for higher stability, as well as higher temperature optimum of CaDPP III. The structural features explaining its altered substrate specificity are also given. The possible structural and catalytic significance of the HEISH motive, unique to CaDPP III, was studied computationally, comparing the results of long MD simulations of the wild type enzyme with those obtained for the HEISGH mutant. This study presents the first structural and biochemical characterization of DPP III from a thermophile.	[Sabljic, Igor] Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia; [Tomin, Marko; Matovina, Mihaela; Sucec, Iva; Paic, Ana Tomasic; Tomic, Antonija; Abramic, Marija; Tomic, Sanja] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia	Rudjer Boskovic Institute; Rudjer Boskovic Institute	Tomic, S (corresponding author), Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia.	sanja.tomic@irb.hr	Matovina, Mihaela/P-7426-2019	Matovina, Mihaela/0000-0001-7647-3339; Sabljic, Igor/0000-0001-9044-2678; Sucec, Iva/0000-0002-1192-7800; Tomic, Sanja/0000-0002-0550-0878	Croatian Science Foundation [7235]; European Community's Seventh Framework Programme [283570]; Croatian Ministry of Science and Education funding [533-19]	Croatian Science Foundation; European Community's Seventh Framework Programme; Croatian Ministry of Science and Education funding	This work was supported by the Croatian Science Foundation, grant number: 7235 (http://www.hrzz.hr/default.aspx?ID=47), European Community's Seventh Framework Programme (FP7/2007-2013) (https://ec.europa.eu/research/fp7/index_en.cfm), BioStruct-X grant number: 283570, the Croatian Ministry of Science and Education funding (Bilateral project with Austria number 533-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2004, INT J BIOCHEM CELL B, V36, P434, DOI 10.1016/S1357-2725(03)00267-X; ABRAMIC M, 1992, BIOL CHEM H-S, V373, P375, DOI 10.1515/bchm3.1992.373.2.375; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertosa B, 2008, BIOPHYS J, V94, P27, DOI 10.1529/biophysj.107.109025; Bezerra GA, 2012, P NATL ACAD SCI USA, V109, P6525, DOI 10.1073/pnas.1118005109; Chen M, 2004, HDB PROTEOLYTIC ENZY; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Darden T., 2016, AMBER 2016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel M, 2017, PLOS ONE, V12; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; JAJCANINJOZIC N, 2011, BIOCH STRUCTURAL CHA; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karacic Z, 2017, BIOL CHEM, V398, P101, DOI 10.1515/hsz-2016-0141; Karaic Z., 2017, CURR TOP PEPT PROTEI, V18, P41; Klenk HP, 2010, SYST APPL MICROBIOL, V33, P175, DOI 10.1016/j.syapm.2010.03.003; Kublanov IV, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00195; Kumar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23787; Kumar V, 2014, J AMINO ACIDS, V2014; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mandrich L, 2009, PROTEIN PEPTIDE LETT, V16, P1189; Matovina M, 2017, RSC ADV, V7, P36326, DOI 10.1039/c7ra02642k; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P323, DOI 10.1099/ijs.0.02390-0; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pal SK, 2002, J PHYS CHEM B, V106, P12376, DOI 10.1021/jp0213506; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saelensminde G, 2009, EXTREMOPHILES, V13, P11, DOI 10.1007/s00792-008-0192-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheu SY, 2010, J PHYS CHEM B, V114, P16558, DOI 10.1021/jp105164t; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Spoljaric J, 2009, BIOORG CHEM, V37, P70, DOI 10.1016/j.bioorg.2009.03.002; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tomic A, 2016, PHYS CHEM CHEM PHYS, V18, P27245, DOI 10.1039/c6cp04580d; Tomic A, 2014, DALTON T, V43, P15503, DOI 10.1039/c4dt02003k; Tomic A, 2012, J CHEM INF MODEL, V52, P1583, DOI 10.1021/ci300141k; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vukelic B, 2012, BIOL CHEM, V393, P37, DOI 10.1515/BC-2011-193; wallner S, 2017, MOL BIOSYST, V13, P2407; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192488	10.1371/journal.pone.0192488	http://dx.doi.org/10.1371/journal.pone.0192488			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420664	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900082
J	Sambataro, M; Sambado, L; Trevisiol, E; Cacciatore, M; Furlan, A; Stefani, PM; Seganfreddo, E; Durante, E; Conte, S; Della Bella, S; Paccagnella, A; dei Tos, AP				Sambataro, Maria; Sambado, Luisa; Trevisiol, Enrica; Cacciatore, Matilde; Furlan, Anna; Stefani, Piero Maria; Seganfreddo, Elena; Durante, Elisabetta; Conte, Stefania; Della Bella, Silvia; Paccagnella, Agostino; dei Tos, Angelo Paolo			Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesions	FASEB JOURNAL			English	Article						type 2 diabetes; peripheral neurovascular; diabetic foot	NECROSIS-FACTOR-ALPHA; PERIPHERAL NEUROPATHY; FLOW-CYTOMETRY; GLUCOSE-TOLERANCE; T-CELLS; HYPERGLYCEMIA; DISEASE; MICE; INFLAMMATION; MANAGEMENT	Diabetic neuropathy is the most common complication of diabetes and is frequently associated with foot ischemia and infection, but its pathogenesis is controversial. We hypothesized that proinsulin expression in peripheral blood mononuclear cells is a process relevant to this condition and could represent a link among hyperglycemia, nerve susceptibility, and diabetic foot lesions. We assessed proinsulin expression by using flow cytometry in dendritic cells from control participants and patients with type 2 diabetes with or without peripheral neuropathy or accompanied by diabetic foot. Among 32 non-neuropathic and 120 neuropathic patients with type 2 diabetes, we performed leg electromyography and found average sensory sural nerve conduction velocities of 48 +/- 4 and 30 +/- 4 m/s, respectively (P < 0.03). Of those with neuropathy, 42 were without lesions, 39 had foot lesions, and 39 had neuroischemic foot lesions (allux oximetry <30 mmHg). In this well-defined diabetic population, but not in nondiabetic participants, a progressively increasing level of peripheral blood dendritic cell proinsulin expression was detected, which directly correlated with circulating TNF- levels (P < 0.002) and multiple conduction velocities of leg nerves (P < 0.05). These results are consistent with the hypothesis that, in type 2 diabetes, proinsulin-expressing blood cells, possibly via their involvement in innate immunity, may play a role in diabetic peripheral neuropathy and foot lesions.Sambataro, M., Sambado, L., Trevisiol, E., Cacciatore, M., Furlan, A., Stefani, P. M., Seganfreddo, E., Durante, E., Conte, S., Della Bella, S., Paccagnella, A., dei Tos, A. P. Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesions.	[Sambataro, Maria; Sambado, Luisa; Paccagnella, Agostino] Santa Maria di Ca Foncello Hosp, Endocrine Metab & Nutr Dis Unit, Treviso, Italy; [Cacciatore, Matilde; dei Tos, Angelo Paolo] Santa Maria di Ca Foncello Hosp, Dept Pathol, Treviso, Italy; [Furlan, Anna; Stefani, Piero Maria] Santa Maria di Ca Foncello Hosp, Hematol Unit, Treviso, Italy; [Seganfreddo, Elena; Durante, Elisabetta] Santa Maria di Ca Foncello Hosp, Immunohematol & Transfus Med Serv, Treviso, Italy; [Conte, Stefania] Santa Maria di Ca Foncello Hosp, Neurol Unit, Treviso, Italy; [Trevisiol, Enrica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Della Bella, Silvia] Univ Milan, Dept Biomed Technol & Translat Med, Milan, Italy; [Della Bella, Silvia] Humanitas Clin & Res Ctr, Lab Clin & Expt Immunol, Milan, Italy	ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; University of Padua; University of Milan	Sambataro, M (corresponding author), Osped Santa Maria di Ca Foncello, UOC Malattie Endocrine Metab & Nutr Clin, Piazza Osped 1, I-31100 Treviso, Italy.	maria.sambataro@aulss2.veneto.it	Dei Tos, Angelo/AAN-3244-2020; Sambado, Luisa/ABG-8001-2020; Furlan, Anna/AAV-2794-2021; Bella, Silvia Della/AAB-7904-2019; Furlan, Anna/AAV-6184-2021	Dei Tos, Angelo/0000-0002-1228-8940; Della Bella, Silvia/0000-0003-0818-5049; Sambataro, Maria/0000-0002-9259-8366	Italian Leukemia-Lymphoma-Myeloma Organizzazione non Lucrativa di Utilita' Sociale (ONLUS) Association, section of Treviso	Italian Leukemia-Lymphoma-Myeloma Organizzazione non Lucrativa di Utilita' Sociale (ONLUS) Association, section of Treviso	The authors thank Teresa Mariotto Pelos, former head of Associazione Italiana Leucemie-Linfomi e Mieloma (AIL) Treviso section (Santa Maria di Ca' Foncello Hospital, Treviso, Italy), for contributions to the project. This research was supported by the Italian Leukemia-Lymphoma-Myeloma Organizzazione non Lucrativa di Utilita' Sociale (ONLUS) Association, section of Treviso. The authors declare no conflicts of interest.	[Anonymous], 1991, Ophthalmology, V98, P786; Apelqvist J, 2008, DIABETES-METAB RES, V24, pS181, DOI 10.1002/dmrr.848; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Buras ED, 2015, FASEB J, V29, P3537, DOI 10.1096/fj.15-271452; Delisa J. A., 1994, MANUAL NERVE CONDUCT, P110; Della Bella S, 2008, J IMMUNOL METHODS, V339, P153, DOI 10.1016/j.jim.2008.09.009; Dopheide JF, 2012, THROMB HAEMOSTASIS, V108, P1198, DOI 10.1160/TH12-05-0327; DYCK PJ, 1986, ANN NEUROL, V19, P440, DOI 10.1002/ana.410190504; Elia AR, 2008, J LEUKOCYTE BIOL, V84, P1472, DOI 10.1189/jlb.0208082; Erbel C, 2011, EUR J MED RES, V16, P367, DOI 10.1186/2047-783X-16-8-367; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Hamid HS, 2014, ANN CLIN TRANSL NEUR, V1, P799, DOI 10.1002/acn3.119; Katagi M, 2014, FEBS LETT, V588, P1080, DOI 10.1016/j.febslet.2014.02.030; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lee CC, 2015, DIABETES CARE, V38, P793, DOI 10.2337/dc14-2585; Lu H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-80; Melzer S, 2015, CYTOM PART B-CLIN CY, V88, P270, DOI 10.1002/cyto.b.21234; Ogrin R, 2011, INT WOUND J, V8, P437, DOI 10.1111/j.1742-481X.2011.00784.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papanas N, 2011, NAT REV ENDOCRINOL, V7, P682, DOI 10.1038/nrendo.2011.113; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Portou MJ, 2015, VASC PHARMACOL, V71, P31, DOI 10.1016/j.vph.2015.02.007; Rao XQ, 2014, LIFE SCI, V116, P59, DOI 10.1016/j.lfs.2014.09.015; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sambataro M, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/589412; Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987; Santegoets SJAM, 2015, CANCER IMMUNOL IMMUN, V64, P1271, DOI 10.1007/s00262-015-1729-x; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Thrainsdottir S, 2003, DIABETES, V52, P2615, DOI 10.2337/diabetes.52.10.2615; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Urabe H, 2016, AM J PHYSIOL-ENDOC M, V310, pE269, DOI 10.1152/ajpendo.00381.2015; Urabe H, 2015, DIABETOLOGIA, V58, P402, DOI 10.1007/s00125-014-3440-4; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Zhu T, 2015, NEUROSCI LETT, V585, P28, DOI 10.1016/j.neulet.2014.11.020	41	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3742	3751		10.1096/fj.201701279RR	http://dx.doi.org/10.1096/fj.201701279RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29436863				2022-12-26	WOS:000435104500022
J	Ozdemir, AY; Rusanov, T; Kent, T; Siddique, LA; Pomerantz, RT				Ozdemir, Ahmet Y.; Rusanov, Timur; Kent, Tatiana; Siddique, Labiba A.; Pomerantz, Richard T.			Polymerase -helicase efficiently unwinds DNA and RNA-DNA hybrids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA enzyme; DNA repair; DNA polymerase; DNA damage; DNA damage response; DNA replication; alternative end-joining; double-strand break repair; microhomology-mediated end-joining; replication fork repair; helicase; polymerase	STRAND BREAK REPAIR; POL-THETA; HOMOLOGOUS-RECOMBINATION; HUMAN-CELLS; REPLICATION; PROTEIN; LESION; DOMAIN; MECHANISM; REVEALS	POLQ is a unique multifunctional replication and repair gene that encodes for a N-terminal superfamily 2 helicase and a C-terminal A-family polymerase. Although the function of the polymerase domain has been investigated, little is understood regarding the helicase domain. Multiple studies have reported that polymerase -helicase (Pol-helicase) is unable to unwind DNA. However, it exhibits ATPase activity that is stimulated by single-stranded DNA, which presents a biochemical conundrum. In contrast to previous reports, we demonstrate that Pol-helicase (residues 1-894) efficiently unwinds DNA with 3-5 polarity, including DNA with 3 or 5 overhangs, blunt-ended DNA, and replication forks. Pol-helicase also efficiently unwinds RNA-DNA hybrids and exhibits a preference for unwinding the lagging strand at replication forks, similar to related HELQ helicase. Finally, we find that Pol-helicase can facilitate strand displacement synthesis by Pol-polymerase, suggesting a plausible function for the helicase domain. Taken together, these findings indicate nucleic acid unwinding as a relevant activity for Pol in replication repair.	[Ozdemir, Ahmet Y.; Rusanov, Timur; Kent, Tatiana; Siddique, Labiba A.; Pomerantz, Richard T.] Temple Univ, Lewis Katz Sch Med, Dept Med Genet & Mol Biochem, Fels Inst Canc Res, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Pomerantz, RT (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Med Genet & Mol Biochem, Fels Inst Canc Res, Philadelphia, PA 19140 USA.	richard.pomerantz@temple.edu		KENT, Tatiana/0000-0001-8237-0184; Rusanov, Timur/0000-0002-4054-3611	National Institutes of Health [1R01GM115472-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM115472-01 (to R. T. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman CA, 2013, NATURE, V502, P381, DOI 10.1038/nature12565; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Black SJ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090067; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Campbell JL, 2017, NAT STRUCT MOL BIOL, V24, P1007, DOI 10.1038/nsmb.3510; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fernandez-Vidal A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5285; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guilliam TA, 2015, NUCLEIC ACIDS RES, V43, P6651, DOI 10.1093/nar/gkv625; Hogg M, 2011, J MOL BIOL, V405, P642, DOI 10.1016/j.jmb.2010.10.041; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Khadka P, 2016, DNA REPAIR, V37, P53, DOI 10.1016/j.dnarep.2015.11.005; Koole W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4216; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Marini F, 2002, J BIOL CHEM, V277, P8716, DOI 10.1074/jbc.M110271200; Mateos-Gomez PA, 2017, NAT STRUCT MOL BIOL, V24, P1116, DOI 10.1038/nsmb.3494; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Newman JA, 2015, STRUCTURE, V23, P2319, DOI 10.1016/j.str.2015.10.014; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Plosky BS, 2016, MOL CELL, V64, P643, DOI 10.1016/j.molcel.2016.11.010; Popuri V, 2013, NUCLEIC ACIDS RES, V41, P881, DOI 10.1093/nar/gks1134; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; Saito S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16112; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Tafel AA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228189; Takata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3338; Thyme SB, 2016, CELL REP, V15, P1611, DOI 10.1016/j.celrep.2016.04.089; Wood RD, 2016, DNA REPAIR, V44, P22, DOI 10.1016/j.dnarep.2016.05.003; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zelensky AN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00124-3; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	44	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5259	5269		10.1074/jbc.RA117.000565	http://dx.doi.org/10.1074/jbc.RA117.000565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29444826	hybrid, Green Published			2022-12-26	WOS:000429409300030
J	Takamine, Y; Ichinoseki-Sekine, N; Tsuzuki, T; Yoshihara, T; Naito, H				Takamine, Yuri; Ichinoseki-Sekine, Noriko; Tsuzuki, Takamasa; Yoshihara, Toshinori; Naito, Hisashi			Effects of voluntary running exercise on bone histology in type 2 diabetic rats	PLOS ONE			English	Article							HIGH-FAT DIET; FRACTURE RISK; INSULIN-RESISTANCE; MELLITUS; OSTEOPOROSIS; OBESITY; FRAGILITY; WOMEN; MODEL; ADIPONECTIN	The incidence of obesity in children and adolescents, which may lead to type 2 diabetes, is increasing. Exercise is recommended to prevent and improve diabetes. However, little is known about the bone marrow environment at the onset of diabetes in the young, and it is unclear whether exercise training is useful for maintaining bone homeostasis, such as mechanical and histological properties. Thus, this study clarified the histological properties of bone and whether exercise contributes to maintaining bone homeostasis at the onset of type 2 diabetes in rats. Four-week-old male Otsuka Long-Evans Tokushima Fatty (OLETF; n = 21) rats as a diabetic model and Long-Evans Tokushima Otsuka (LETO; n = 18) rats as a control were assigned randomly to four groups: the OLETF sedentary group (O-Sed; n = 11), OLETF exercise group (O-Ex; n = 10), LETO sedentary group (L-Sed; n = 9), and LETO exercise group (L-Ex; n = 9). All rats in the exercise group were allowed free access to a steel running wheel for 20 weeks (5-25 weeks of age). In the glucose tolerance test, blood glucose level was higher in the O-Sed group than that in the L-Sed and L-Ex groups, and was markedly suppressed by the voluntary running exercise of O-Ex rats. The energy to fracture and the two-dimensional bone volume at 25 weeks of age did not differ significantly among the groups, though the maximum breaking force and stiffness were lower in OLETF rats. However, bone marrow fat volume was greater in O-Sed than that in L-Sed and L-Ex rats, and was markedly suppressed by wheel running in the O-Ex rats. Our results indicate that exercise has beneficial effects not only for preventing diabetes but also on normal bone remodeling at an early age.	[Takamine, Yuri; Ichinoseki-Sekine, Noriko; Tsuzuki, Takamasa; Yoshihara, Toshinori; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba, Japan; [Ichinoseki-Sekine, Noriko] Open Univ Japan, Fac Liberal Arts, Chiba, Chiba, Japan	Juntendo University	Naito, H (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba, Japan.	hnaitou@juntendo.ac.jp	Naito, Hisashi/F-5655-2011; Yoshihara, Toshinori/M-3374-2019; Tsuzuki, Takamasa/S-3563-2019; Ichinoseki-Sekine, Noriko/F-9075-2011	Naito, Hisashi/0000-0002-0522-9512; Yoshihara, Toshinori/0000-0002-8465-5439; Tsuzuki, Takamasa/0000-0002-0241-1183; Ichinoseki-Sekine, Noriko/0000-0002-0467-3312	MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1101008]	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1101008) to H. Naito.	Ardisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Devlin MJ, 2013, J BONE MINER RES, V28, P1718, DOI 10.1002/jbmr.2013; Dobnig H, 2006, J CLIN ENDOCR METAB, V91, P3355, DOI 10.1210/jc.2006-0460; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Fajardo RJ, 2014, J BONE MINER RES, V29, P1025, DOI 10.1002/jbmr.2210; Halade GV, 2010, J NUTR BIOCHEM, V21, P1162, DOI 10.1016/j.jnutbio.2009.10.002; Hamilton CJ, 2013, METABOLISM, V62, P1401, DOI 10.1016/j.metabol.2013.05.004; Henriksen EJ, 2002, J APPL PHYSIOL, V93, P788, DOI 10.1152/japplphysiol.01219.2001; Hinton PS, 2015, METABOLISM, V64, P905, DOI 10.1016/j.metabol.2015.04.004; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang TH, 2008, J BONE MINER METAB, V26, P350, DOI 10.1007/s00774-007-0831-3; Hung YH, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12232; Ivers RQ, 2001, DIABETES CARE, V24, P1198, DOI 10.2337/diacare.24.7.1198; Kasumov T, 2015, OBESITY, V23, P1414, DOI 10.1002/oby.21117; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; Ma RF, 2017, CELL PHYSIOL BIOCHEM, V41, P55, DOI 10.1159/000455936; Menagh PJ, 2010, J BONE MINER RES, V25, P757, DOI 10.1359/jbmr.091015; Mikus CR, 1985, J APPL PHYSIOL, V2010, P1203; Minami A, 2002, ATHEROSCLEROSIS, V162, P85, DOI 10.1016/S0021-9150(01)00685-2; Minematsu A, 2017, J MUSCULOSKEL NEURON, V17, P433; Moseley KF, 2012, CURR OPIN ENDOCRINOL, V19, P128, DOI 10.1097/MED.0b013e328350a6e1; Patsch JM, 2013, J BONE MINER RES, V28, P1721, DOI 10.1002/jbmr.1950; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; SHIMA K, 1993, METABOLISM, V42, P971, DOI 10.1016/0026-0495(93)90009-D; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Shu L, 2015, CALCIFIED TISSUE INT, V96, P313, DOI 10.1007/s00223-015-9954-z; Styner M, 2014, BONE, V64, P39, DOI 10.1016/j.bone.2014.03.044; Tsuzuki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132029; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wongdee K, 2015, WORLD J DIABETES, V6, P673, DOI 10.4239/wjd.v6.i5.673; Yamaguchi T, 2011, ENDOCR J, V58, P613, DOI 10.1507/endocrj.EJ11-0063; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; Yuki A, 2010, EUR J APPL PHYSIOL, V109, P641, DOI 10.1007/s00421-010-1383-0	39	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193068	10.1371/journal.pone.0193068	http://dx.doi.org/10.1371/journal.pone.0193068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447298	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900108
J	Turkalo, AK; Wrege, PH; Wittemyer, G				Turkalo, Andrea K.; Wrege, Peter H.; Wittemyer, George			Demography of a forest elephant population	PLOS ONE			English	Article							LOXODONTA-AFRICANA POPULATION; NATIONAL-PARK; SURVIVAL; DYNAMICS	African forest elephants face severe threats from illegal killing for ivory and bushmeat and habitat conversion. Due to their cryptic nature and inaccessible range, little information on the biology of this species has been collected despite its iconic status. Compiling individual based monitoring data collected over 20 years from the Dzanga Bai population in Central African Republic, we summarize sex and age specific survivorship and female age specific fecundity for a cohort of 1625 individually identified elephants. Annual mortality (average = 3.5%) and natality (average = 5.3%) were lower and markedly less variable relative to rates reported for savanna elephant populations. New individuals consistently entered the study system, leading to a 2.5% average annual increase in the registered population. Calf sex ratios among known birth did not differ from parity. A weak seasonal signal in births was detected suggesting increased conceptions during the wet season. Inter-calf intervals and age of primiparity were longer relative to savanna elephant populations. Within the population, females between the ages of 25-39 demonstrated the shortest inter-calf intervals and highest fecundity, and previous calf sex had no influence on the interval. Calf survivorship was high (97%) the first two years after birth and did not differ by sex. Male and female survival began to differ by the age of 13 years, and males demonstrated significantly lower survival relative to females by the age of 20. It is suspected these differences are driven by human selection for ivory. Forest elephants were found to have one of the longest generation times recorded for any species at 31 years. These data provide fundamental understanding of forest elephant demography, providing baseline data for projecting population status and trends.	[Turkalo, Andrea K.] Wildlife Conservat Soc, Bangui, Cent Afr Republ; [Turkalo, Andrea K.; Wrege, Peter H.] Cornell Lab Ornithol, Bioacoust Res Program, Elephant Listening Project, Ithaca, NY USA; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO USA; [Wittemyer, George] Save Elephants, Nairobi, Kenya	Cornell University; Colorado State University	Wittemyer, G (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO USA.; Wittemyer, G (corresponding author), Save Elephants, Nairobi, Kenya.	g.wittemyer@colostate.edu	Wittemyer, George/AFQ-1840-2022		US Fish and Wildlife Service International Conservation Grant; Elephant Listening Project support	US Fish and Wildlife Service International Conservation Grant; Elephant Listening Project support	US Fish and Wildlife Service International Conservation Grant; Elephant Listening Project support.	Beaune D, 2013, BIODIVERS CONSERV, V22, P225, DOI 10.1007/s10531-012-0416-x; Beyers RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027129; Blake S, 2004, BIOTROPICA, V36, P392, DOI 10.1646/03215; Blake S., 2002, ECOLOGY FOREST ELEPH; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Brooks ME, 2016, J ANIM ECOL, V85, P318, DOI 10.1111/1365-2656.12465; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Douglas-Hamilton I., 1972, THESIS; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Foley CAH, 2010, ORYX, V44, P205, DOI 10.1017/S0030605309990706; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Ishida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020642; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Mayaux P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0300; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss CJ, 2011, FEMALE REPROD STRATE, P187; Roca AL, 2015, ANNU REV ANIM BIOSCI, V3, P139, DOI 10.1146/annurev-animal-022114-110838; Roff Derek A., 1992; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Stearns S.C., 1992, pi; Turkalo AK, 2017, J APPL ECOL, V54, P153, DOI 10.1111/1365-2664.12764; Turkalo AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085154; Turkalo AK, 2013, AFR J ECOL, V51, P501, DOI 10.1111/aje.12087; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wittemyer G, 2005, AFR J ECOL, V43, P44, DOI 10.1111/j.1365-2028.2004.00543.x; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111; Wittemyer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053726; Wrege PH, 2012, AFR J ECOL, V50, P176, DOI 10.1111/j.1365-2028.2011.01310.x	37	16	17	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192777	10.1371/journal.pone.0192777	http://dx.doi.org/10.1371/journal.pone.0192777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447207	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900053
J	Donovan, PD; Gonzalez, G; Higgins, DG; Butler, G; Ito, K				Donovan, Paul D.; Gonzalez, Gabriel; Higgins, Desmond G.; Butler, Geraldine; Ito, Kimihito			Identification of fungi in shotgun metagenomics datasets	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; ENTEROCYTOZOON-BIENEUSI; GENOME; PREVALENCE; ALIGNMENT; CLASSIFICATION; PROTEINS; SEQUENCE; REVEALS; NUCLEAR	Metagenomics uses nucleic acid sequencing to characterize species diversity in different niches such as environmental biomes or the human microbiome. Most studies have used 16S rRNA amplicon sequencing to identify bacteria. However, the decreasing cost of sequencing has resulted in a gradual shift away from amplicon analyses and towards shotgun metagenomic sequencing. Shotgun metagenomic data can be used to identify a wide range of species, but have rarely been applied to fungal identification. Here, we develop a sequence classification pipeline, FindFungi, and use it to identify fungal sequences in public metagenome datasets. We focus primarily on animal metagenomes, especially those from pig and mouse microbiomes. We identified fungi in 39 of 70 datasets comprising 71 fungal species. At least 11 pathogenic species with zoonotic potential were identified, including Candida tropicalis. We identified Pseudogymnoascus species from 13 Antarctic soil samples initially analyzed for the presence of bacteria capable of degrading diesel oil. We also show that Candida tropicalis and Candida loboi are likely the same species. In addition, we identify several examples where contaminating DNA was erroneously included in fungal genome assemblies.	[Donovan, Paul D.; Butler, Geraldine] Univ Coll Dublin, Sch Biomed & Biomol Sci, Dublin, Ireland; [Donovan, Paul D.; Butler, Geraldine] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Conway Inst, Dublin, Ireland; [Gonzalez, Gabriel; Ito, Kimihito] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Higgins, Desmond G.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Higgins, Desmond G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Ito, Kimihito] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan	University College Dublin; University College Dublin; Hokkaido University; University College Dublin; University College Dublin; Hokkaido University	Butler, G (corresponding author), Univ Coll Dublin, Sch Biomed & Biomol Sci, Dublin, Ireland.; Butler, G (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Conway Inst, Dublin, Ireland.	gbutler@ucd.ie	Gonzalez, Gabriel/T-8010-2018; Ito, Kimihito/E-9975-2012	Gonzalez, Gabriel/0000-0002-2180-2120; Ito, Kimihito/0000-0003-4986-1795; Donovan, Paul/0000-0002-3927-8961; Butler, Geraldine/0000-0002-1770-5301	Science Foundation Ireland [12/IA/1343]; Wellcome Trust [102406/Z/13/Z]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by an award from Science Foundation Ireland (grant number 12/IA/1343, https://www.fi.ie) to GB and from the Wellcome Trust (102406/Z/13/Z, https://wellcome.ac.uk) to GB and PDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson JP, 2016, MOL CELL PROTEOMICS, V15, P1188, DOI 10.1074/mcp.M115.054502; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Boissy RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095578; Botelho NS, 2012, ZOONOSES PUBLIC HLTH, V59, P16, DOI 10.1111/j.1863-2378.2011.01410.x; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cui LJ, 2013, GENOME MED, V5, DOI 10.1186/gm467; Dadi TH, 2017, PEERJ, V5, DOI 10.7717/peerj.3138; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fosso B, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0595-z; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gweon HS, 2015, METHODS ECOL EVOL, V6, P973, DOI 10.1111/2041-210X.12399; Hager CL, 2017, DIGEST LIVER DIS, V49, P1171, DOI 10.1016/j.dld.2017.08.025; Hall RA, 2017, CURR OPIN MICROBIOL, V40, P58, DOI 10.1016/j.mib.2017.10.020; Herr RA, 2001, J CLIN MICROBIOL, V39, P309, DOI 10.1128/JCM.39.1.309-314.2001; HOEBEN P, 1986, CURR GENET, V10, P371, DOI 10.1007/BF00418409; Hovmoller MS, 2008, MOL ECOL, V17, P3818, DOI 10.1111/j.1365-294X.2008.03886.x; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Hunter S, 2014, NUCLEIC ACIDS RES, V42, pD600, DOI 10.1093/nar/gkt961; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Iturrieta-Gonzalez IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109553; James SA, 2016, INT J SYST EVOL MICR, V66, P5046, DOI 10.1099/ijsem.0.001467; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Johnson LJAN, 2013, APPL ENVIRON MICROB, V79, P5465, DOI 10.1128/AEM.01429-13; Kim Grace K, 2009, J Clin Aesthet Dermatol, V2, P14; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-182; Laudencia-Chingcuanco D, 2012, COMP FUNCT GENOM, V2012; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; Li XG, 2017, INT J BIOCHEM CELL B, V87, P1, DOI 10.1016/j.biocel.2017.03.003; Maddela NR, 2015, WATER SCI TECHNOL, V71, P1554, DOI 10.2166/wst.2015.142; Maguire SL, 2013, MOL BIOL EVOL, V30, P1281, DOI 10.1093/molbev/mst042; Malouin F, 2003, ANTIMICROB AGENTS CH, V47, P658, DOI 10.1128/AAC.47.2.658-664.2003; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Marshall WA, 1998, MICROBIAL ECOL, V36, P212, DOI 10.1007/s002489900108; McTaggart AR, 2012, PERSOONIA, V29, P63, DOI 10.3767/003158512X660562; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Ng KP, 2012, EUKARYOT CELL, V11, P705, DOI 10.1128/EC.00081-12; Nunn MA, 2007, EMERG INFECT DIS, V13, P747, DOI 10.3201/eid1305.061179; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Palencia ER, 2010, TOXINS, V2, P399, DOI 10.3390/toxins2040399; Peay KG, 2016, NAT REV MICROBIOL, V14, P434, DOI 10.1038/nrmicro.2016.59; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; Quesada-Moraga E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089278; Reif JS, 2013, VECTOR-BORNE ZOONOT, V13, P689, DOI 10.1089/vbz.2012.1280; Roper M, 2011, CURR BIOL, V21, pR786, DOI 10.1016/j.cub.2011.06.042; Medina IR, 2017, REV IBEROAM MICOL, V34, P211, DOI 10.1016/j.riam.2017.03.001; Schafhauser T, 2015, J BIOTECHNOL, V211, P101, DOI 10.1016/j.jbiotec.2015.07.004; Schlegel M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3369-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seidl MF, 2015, MOL PLANT MICROBE IN, V28, P362, DOI 10.1094/MPMI-06-14-0173-R; Suzuki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103833; Tuli HS, 2014, 3 BIOTECH, V4, P1, DOI 10.1007/s13205-013-0121-9; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; White JR, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-6; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0; Yang Z, 2017, BIOTECHNOL ADV; Zhao W, 2014, APPL ENVIRON MICROB, V80, P3699, DOI 10.1128/AEM.00807-14	68	41	42	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192898	10.1371/journal.pone.0192898	http://dx.doi.org/10.1371/journal.pone.0192898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444186	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500104
J	Smolinska, E; Moskot, M; Jakobkiewicz-Banecka, J; Wegrzyn, G; Banecki, B; Szczerkowska-Dobosz, A; Purzycka-Bohdan, D; Gabig-Ciminska, M				Smolinska, Elwira; Moskot, Marta; Jakobkiewicz-Banecka, Joanna; Wegrzyn, Grzegorz; Banecki, Bogdan; Szczerkowska-Dobosz, Aneta; Purzycka-Bohdan, Dorota; Gabig-Ciminska, Magdalena			Molecular action of isoflavone genistein in the human epithelial cell line HaCaT	PLOS ONE			English	Article							NF-KAPPA-B; CYTOKINE PRODUCTION; PSORIASIS; EXPRESSION; INFLAMMATION; KERATINOCYTE; METHOTREXATE; METABOLISM; PATHWAYS; DIFFERENTIATION	Due to its strong proliferation-reducing effects on keratinocytes, and also anti-inflammatory properties, the isoflavone genistein has already been proposed as a possible antipsoriatic compound. As there is still no detailed information on this topic, we examined the effects of genistein by using an in vitro model of both, normal and "psoriasis-like" keratinocytes at this stage of our work exhaustively testing the selected flavonoid in a mono-treated experimental design. Gene expression studies revealed transcriptional changes that confirms known disease-associated pathways and highlights many psoriasis-related genes. Our results suggested that aberrant expression of genes contributing to the progress of psoriasis could be improved by the action of genistein. Genistein prevented "cytokine mix" as well as TNF-alpha-induced NF-kappa B nuclear translocation, with no effect on the PI3K signaling cascade, indicating the luck of turning this pathway into NF-kappa B activation. It could have attenuated TNF-alpha and LPS-induced inflammatory responses by suppressing ROS activation. Regardless of the type of keratinocyte stimulation used, reduction of cytokine IL-8, IL-20 and CCL2 production (both at RNA and protein level) following genistein treatment was visible. Because investigations of other groups supported our commentary on potential administration of genistein as a potential weapon in the armamentarium against psoriasis, it is believed that this paper should serve to encourage researchers to conduct further studies on this subject.	[Smolinska, Elwira; Moskot, Marta; Jakobkiewicz-Banecka, Joanna; Gabig-Ciminska, Magdalena] Univ Gdansk, Dept Med Biol & Genet, Gdansk, Poland; [Smolinska, Elwira] Med Univ Gdansk, Dept Physiol, Gdansk, Poland; [Moskot, Marta; Gabig-Ciminska, Magdalena] Polish Acad Sci, Inst Biochem & Biophys, Lab Mol Biol, Gdansk, Poland; [Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, Gdansk, Poland; [Banecki, Bogdan] Intercollegiate Fac Biotechnol UG MUG, Dept Mol & Cellular Biol, Gdansk, Poland; [Szczerkowska-Dobosz, Aneta; Purzycka-Bohdan, Dorota] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Gabig-Ciminska, M (corresponding author), Univ Gdansk, Dept Med Biol & Genet, Gdansk, Poland.; Gabig-Ciminska, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Lab Mol Biol, Gdansk, Poland.	m.gabig@biol.ug.edu.pl	Szczerkowska-Dobosz, Aneta/AAA-1535-2020; Gabig-Cimińska, Magdalena/E-3207-2018; Wegrzyn, Grzegorz/ABD-6699-2020; Wegrzyn, Grzegorz/AAL-1179-2020; Jakóbkiewicz-Banecka, Joanna/C-2365-2014; Moskot, Marta/R-5017-2018	Szczerkowska-Dobosz, Aneta/0000-0003-4040-0116; Gabig-Cimińska, Magdalena/0000-0002-2664-8724; Wegrzyn, Grzegorz/0000-0003-4042-7466; Moskot, Marta/0000-0002-7342-9372; Banecki, Bogdan/0000-0003-3286-2388; Jakobkiewicz-Banecka, Joanna/0000-0002-8846-5448; , Dorota/0000-0003-2804-0437	National Centre for Research and Development (Poland) [NCRD - PBS1/B7/7/2012]	National Centre for Research and Development (Poland)	This work was supported by National Centre for Research and Development (Poland) (project grant no. NCRD - PBS1/B7/7/2012). http://www.ncbr.gov.pl/en/. The funders had a role in the study design, data collection and analysis. This work was supported by National Centre for Research and Development (Poland) (project grant no. NCRD-PBS1/B7/7/2012).	Amigo M, 2006, LIFE SCI, V79, P2395, DOI 10.1016/j.lfs.2006.08.003; Bochenska K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122514; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bracke S, 2013, ARCH DERMATOL RES, V305, P501, DOI 10.1007/s00403-013-1379-9; Bu LH, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-13; Chan ESL, 2002, ARTHRITIS RES, V4, P266, DOI 10.1186/ar419; Chyou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032828; Coda AB, 2012, GENOMICS, V100, P18, DOI 10.1016/j.ygeno.2012.05.004; Cowden A, 2008, INTRODUCTION HISTORY, DOI [10.1056/NEJM197412052912301, DOI 10.1056/NEJM197412052912301]; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dowlatshahi EA, 2013, BRIT J DERMATOL, V169, P266, DOI 10.1111/bjd.12355; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; FARBER EM, 1992, J AM ACAD DERMATOL, V27, P640, DOI 10.1016/0190-9622(92)70232-5; Ge W, 2015, INT REV IMMUNOL, V34, P415, DOI 10.3109/08830185.2014.936587; Gerards AH, 2003, RHEUMATOLOGY, V42, P1189, DOI 10.1093/rheumatology/keg323; GREEN C, 1988, BRIT J DERMATOL, V119, P691, DOI 10.1111/j.1365-2133.1988.tb03489.x; Griffiths CEM, 2004, BRIT J DERMATOL, V150, P11, DOI 10.1111/j.0366-077X.2004.05949.x; Gu XL, 2015, ACTA DERM-VENEREOL, V95, P140, DOI 10.2340/00015555-1905; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Guo P, 2014, GENOMICS, V103, P48, DOI 10.1016/j.ygeno.2013.11.001; He Y, 2013, SCI SIGNAL, V4, pra44; ITO K, 1992, FOLIA PHARMACOL JPN, V99, P55, DOI 10.1254/fpj.99.55; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Jurzak M, 2013, ACTA POL PHARM, V70, P205; Kim J, 2016, J INVEST DERMATOL, V136, P2173, DOI 10.1016/j.jid.2016.04.032; Kim S, 2006, FASEB J, V20, pA612; Kloska A, 2011, METAB BRAIN DIS, V26, P1, DOI 10.1007/s11011-011-9233-2; KRAGBALLE K, 1988, BRIT J DERMATOL, V119, P223, DOI 10.1111/j.1365-2133.1988.tb03204.x; Kupper TS, 2003, NEW ENGL J MED, V349, P1987, DOI 10.1056/NEJMp038164; Li JC, 2014, DRUG DES DEV THER, V8, P315, DOI 10.2147/DDDT.S52354; Mahmood T, 2015, EXPERT OPIN EMERG DR, V20, P209, DOI 10.1517/14728214.2015.1010509; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; McClain RM, 2007, FOOD CHEM TOXICOL, V45, P1319, DOI 10.1016/j.fct.2007.01.009; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Moskot M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09378; Moskot M, 2014, J BIOL CHEM, V289, P17054, DOI 10.1074/jbc.M114.555300; Mozolewski P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43154; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; Pazyar N, 2015, JUNDISHAPUR J NAT PH, V10; Peairs A, 2009, CLIN EXP IMMUNOL, V156, P542, DOI 10.1111/j.1365-2249.2009.03924.x; Piotrowska E, 2006, EUR J HUM GENET, V14, P846, DOI 10.1038/sj.ejhg.5201623; Polkowski K, 2000, Acta Pol Pharm, V57, P135; Saelee C, 2011, MOLECULES, V16, P3908, DOI 10.3390/molecules16053908; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; SCHURER NY, 1993, J INVEST DERMATOL, V100, P82, DOI 10.1111/1523-1747.ep12354929; Semini G, 2014, BIOCHEM PHARMACOL, V87, P477, DOI 10.1016/j.bcp.2013.11.012; Shukla S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138710; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swindell WR, 2016, J INVEST DERMATOL, V136, P1820, DOI 10.1016/j.jid.2016.04.035; Swindell WR, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-27; Swindell WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-527; Tervaniemi MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22745; Wardwell PR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0824-x; WEINSTEIN GD, 1990, J INVEST DERMATOL, V95, pS49, DOI 10.1111/1523-1747.ep12505777; Weng ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090739; Yamauchi PS, 2015, J DRUGS DERMATOL, V14, P244; Zampetti A, 2009, INT J IMMUNOPATH PH, V22, P1067, DOI 10.1177/039463200902200423; Zweifach B.W., 2014, INFLAMMATORY PROCESS	62	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192297	10.1371/journal.pone.0192297	http://dx.doi.org/10.1371/journal.pone.0192297			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444128	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500061
J	Sparkman, A; Howe, S; Hynes, S; Hobbs, B; Handal, K				Sparkman, Amanda; Howe, Stephen; Hynes, Stephanie; Hobbs, Brooke; Handal, Karina			Parallel behavioral and morphological divergence in fence lizards on two college campuses	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; RAPID ENVIRONMENTAL-CHANGE; IBERIAN ROCK LIZARDS; SCELOPORUS-OCCIDENTALIS; LOCOMOTOR PERFORMANCE; ANTIPREDATOR BEHAVIOR; PHENOTYPIC PLASTICITY; ANOLIS-CAROLINENSIS; THAMNOPHIS-SIRTALIS; THERMAL PHYSIOLOGY	The spread of urban development has dramatically altered natural habitats, modifying community relationships, abiotic factors, and structural features. Animal populations living in these areas must perish, emigrate, or find ways to adjust to a suite of new selective pressures. Those that successfully inhabit the urban environment may make behavioral, physiological, and/or morphological adjustments that represent either evolutionary change and/or phenotypic plasticity. We tested for effects of urbanization on antipredator behavior and associated morphology across an urban-wild gradient in the western fence lizard (Sceloporus occidentalis) in two California counties, Santa Barbara and San Luis Obispo. We compared college campuses in both counties with adjacent rural habitats, conducting field trials that allowed us to characterize antipredator behavior in response to the acute stress of capture. We found notable divergence between campus and rural behavior, with campus lizards more frequently exhibiting diminished escape behavior, including tonic immobility, and lower sprint speeds. Furthermore, campus females had significantly shorter limbs, and while this did not explain variation in sprint speed, those with shorter limbs were more likely to show tonic immobility. We hypothesize that these parallel behavioral and morphological changes on both campuses reflect adjustment to a novel environment involving changes in predation and human presence.	[Sparkman, Amanda; Hynes, Stephanie; Hobbs, Brooke; Handal, Karina] Westmont Coll, Dept Biol, Santa Barbara, CA 93108 USA; [Howe, Stephen] Univ Akron, Dept Biol, Akron, OH 44325 USA	University System of Ohio; University of Akron	Sparkman, A (corresponding author), Westmont Coll, Dept Biol, Santa Barbara, CA 93108 USA.	sparkman@westmont.edu		Oppenhuizen, Brooke/0000-0001-5499-3122				Adams C.E., 2016, URBAN WILDLIFE MANAG, Vthird; Atwell JW, 2012, BEHAV ECOL, V23, P960, DOI 10.1093/beheco/ars059; Badyaev AV, 2008, EVOLUTION, V62, P1951, DOI 10.1111/j.1558-5646.2008.00428.x; BENNETT AF, 1978, ANNU REV PHYSIOL, V40, P447, DOI 10.1146/annurev.ph.40.030178.002311; Bokony V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036639; Bonenfant M, 1996, BEHAV ECOL, V7, P299, DOI 10.1093/beheco/7.3.299; Bonnet X, 2005, ETHOLOGY, V111, P573, DOI 10.1111/j.1439-0310.2005.01070.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brown CR, 2013, CURR BIOL, V23, pR233, DOI 10.1016/j.cub.2013.02.023; Buckley CR, 2010, BIOL J LINN SOC, V99, P84; Buckley CR, 2007, SCELOPORUS OCCIDENTA; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; CHISZAR D, 1976, ANIM LEARN BEHAV, V4, P273, DOI 10.3758/BF03214049; Cooper WE, 2007, BEHAVIOUR, V144, P1235, DOI 10.1163/156853907781890940; Cooper WE, 2007, ETHOLOGY, V113, P661, DOI 10.1111/j.1439-0310.2007.01363.x; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; CROWLEY SR, 1985, OECOLOGIA, V66, P219, DOI 10.1007/BF00379858; DILL LM, 1989, CAN J ZOOL, V67, P233, DOI 10.1139/z89-033; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Downes S, 2007, OECOLOGIA, V153, P775, DOI 10.1007/s00442-007-0775-2; DUNLAP KD, 1995, J EXP ZOOL, V271, P36, DOI 10.1002/jez.1402710105; Edelaar P, 2012, BEHAV ECOL, V23, P619, DOI 10.1093/beheco/ars006; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Fischer JD, 2012, BIOSCIENCE, V62, P809, DOI 10.1525/bio.2012.62.9.6; French SS, 2008, J COMP PHYSIOL B, V178, P997, DOI 10.1007/s00360-008-0290-8; Gil D, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P1; Gil D, 2013, AVIAN URBAN ECOLOGY, V69; Grolle Elizabeth K., 2014, Bulletin Southern California Academy of Sciences, V113, P42; HERZOG HA, 1986, J COMP PSYCHOL, V100, P372, DOI 10.1037/0735-7036.100.4.372; HUEY RB, 1990, PHYSIOL ZOOL, V63, P845, DOI 10.1086/physzool.63.5.30152617; HUEY RB, 1987, EVOLUTION, V41, P1116, DOI 10.1111/j.1558-5646.1987.tb05880.x; Irschick DJ, 2005, BIOL J LINN SOC, V85, P223, DOI 10.1111/j.1095-8312.2005.00487.x; Kolbe JJ, 2005, J HERPETOL, V39, P674, DOI 10.1670/87-05N.1; Langkilde T, 2009, ECOLOGY, V90, P208, DOI 10.1890/08-0355.1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lopez P, 2005, ANIM BEHAV, V69, P1, DOI 10.1016/j.anbehav.2004.05.010; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Majlath I, 2009, ACTA ETHOL, V12, P99, DOI 10.1007/s10211-009-0063-8; Marnocha E, 2011, EVOL APPL, V4, P388, DOI 10.1111/j.1752-4571.2010.00170.x; Martin J, 2009, ANIM BEHAV, V77, P1261, DOI 10.1016/j.anbehav.2009.02.004; Marx BP, 2008, CLIN PSYCHOL-SCI PR, V15, P74, DOI 10.1111/j.1468-2850.2008.00112.x; McGowan MM, 2014, ETHOLOGY, V120, P1081, DOI 10.1111/eth.12281; Moller AP, 2012, ANIM BEHAV, V84, P341, DOI 10.1016/j.anbehav.2012.04.030; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2010, BEHAV ECOLOGY; Moore IT, 2000, ANIM BEHAV, V59, P529, DOI 10.1006/anbe.1999.1344; Moule H, 2016, J ZOOL, V298, P103, DOI 10.1111/jzo.12288; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199563562.001.0001; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Prosser C, 2006, J HERPETOL, V40, P151, DOI 10.1670/38-05A.1; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Rodriguez-Prieto I, 2010, BEHAV ECOL SOCIOBIOL, V64, P1937, DOI 10.1007/s00265-010-1004-2; Rogers SM, CURRENT BIOL, V24, pR1031; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sih A, 2013, ANIM BEHAV, V85, P1077, DOI 10.1016/j.anbehav.2013.02.017; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; SINERVO B, 1994, ECOLOGY, V75, P776, DOI 10.2307/1941734; SINERVO B, 1991, J EXP BIOL, V155, P323; SINERVO B, 1990, OECOLOGIA, V83, P228, DOI 10.1007/BF00317757; SINERVO B, 1991, ECOLOGY, V72, P1225, DOI 10.2307/1941096; SNELL HL, 1988, EVOL ECOL, V2, P353, DOI 10.1007/BF02207566; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Trompeter WP, 2011, HORM BEHAV, V60, P152, DOI 10.1016/j.yhbeh.2011.04.001; TSUJI JS, 1989, EVOL ECOL, V3, P240, DOI 10.1007/BF02270725; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Winchell KM, 2016, EVOLUTION, V70, P1009, DOI 10.1111/evo.12925; Wong BBM, 2015, BEHAV ECOL, V26, P665, DOI 10.1093/beheco/aru183	72	13	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191800	10.1371/journal.pone.0191800	http://dx.doi.org/10.1371/journal.pone.0191800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444102	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500032
J	Ernst, AK; Putscher, A; Samatov, TR; Suling, A; Galatenko, VV; Shkurnikov, MY; Knyazev, EN; Tonevitsky, AG; Haalck, T; Lange, T; Maar, H; Schroder-Schwarz, J; Riecken, K; Schumacher, U; Wicklein, D				Ernst, Ann-Kathrin; Putscher, Annika; Samatov, Timur R.; Suling, Anna; Galatenko, Vladimir V.; Shkurnikov, Maxim Yu; Knyazev, Evgeny N.; Tonevitsky, Alexander G.; Haalck, Thomas; Lange, Tobias; Maar, Hanna; Schroeder-Schwarz, Jennifer; Riecken, Kristoffer; Schumacher, Udo; Wicklein, Daniel			Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; ADHESION MOLECULE L1; BREAST-CANCER; TUMOR-GROWTH; SCID MICE; EXPRESSION; PROGRESSION; PROTEINS; SURVIVAL; PATHWAY	Finding additional functional targets for combination therapy could improve the outcome for melanoma patients. In a spontaneous metastasis xenograft model of human melanoma a shRNA mediated knockdown of L1CAM more than sevenfold reduced the number of lung metastases after the induction of subcutaneous tumors for two human melanoma cell lines (MeWo, MV3). Whole genome expression arrays of the initially L1CAM high MeWo subcutaneous tumors revealed unchanged or downregulated genes involved in epithelial to mesenchymal transition (EMT) except an upregulation of Jagged 1, indicating a compensatory change in Notch signaling especially as Jagged 1 expression showed an increase in MeWo L1CAM metastases and Jagged 1 was expressed in metastases of the initially L1CAM low MV3 cells as well. Expression of 17 genes showed concordant regulation for L1CAM knockdown tumors of both cell lines. The changes in gene expression indicated changes in the EMT network of the melanoma cells and an increase in p53/p21 and p38 activity contributing to the reduced metastatic potential of the L1CAM knockdowns. Taken together, these data make L1CAM a highly interesting therapeutic target to prevent further metastatic spread in melanoma patients.	[Ernst, Ann-Kathrin; Putscher, Annika; Lange, Tobias; Maar, Hanna; Schroeder-Schwarz, Jennifer; Schumacher, Udo; Wicklein, Daniel] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany; [Samatov, Timur R.; Galatenko, Vladimir V.; Shkurnikov, Maxim Yu; Knyazev, Evgeny N.] SRC Bioclinicum, Moscow, Russia; [Samatov, Timur R.] Moscow State Univ Mech Engn, Moscow, Russia; [Suling, Anna] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Galatenko, Vladimir V.; Tonevitsky, Alexander G.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Galatenko, Vladimir V.] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Tonevitsky, Alexander G.] Natl Ctr Med Radiol Res, Dept Translat Oncol, Obninsk, Russia; [Haalck, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Dermatol, Outpatient Ctr, Hamburg, Germany; [Riecken, Kristoffer] Univ Med Ctr Hamburg Eppendorf, Res Dept Cell & Gene Therapy, Dept Stem Cell Transplantat, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Moscow Polytechnic University; Moscow State University of Mechanical Engineering; University of Hamburg; University Medical Center Hamburg-Eppendorf; Lomonosov Moscow State University; HSE University (National Research University Higher School of Economics); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wicklein, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany.	d.wicklein@uke.de	Galatenko, Vladimir/ABB-7514-2020; Lange, Tobias/K-8689-2015; Tonevitsky, Alexander/R-5596-2019; Riecken, Kristoffer/AAD-2371-2020; Galatenko, Vladimir V./E-5139-2014; Shkurnikov, Maxim Yu/C-7587-2014; Knyazev, Evgeny/E-2977-2014; Shkurnikov, Maxim/O-4234-2017	Galatenko, Vladimir/0000-0003-3029-3628; Riecken, Kristoffer/0000-0001-9050-6766; Galatenko, Vladimir V./0000-0003-3029-3628; Knyazev, Evgeny/0000-0002-9414-2573; Shkurnikov, Maxim/0000-0002-6668-5028	Russian Science Foundation [14-44-00051]; SRC Bioclinicum, Moscow	Russian Science Foundation(Russian Science Foundation (RSF)); SRC Bioclinicum, Moscow	This work was financially supported by the Russian Science Foundation (Grant 14-44-00051). This work was also funded by SRC Bioclinicum, Moscow: The funder provided support in the form of (part of) the salaries for authors T.S., V.G., M.S. and E.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This work was financially supported by the Russian Science Foundation (Grant 14-44-00051).; This work was also funded by SRC Bioclinicum, Moscow:; This funder provided support in the form of (part of) the salaries for authors T.S., V.G., M.S. and E.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Altevogt P, 2016, INT J CANCER, V138, P1565, DOI 10.1002/ijc.29658; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Colombo F, 2015, TRENDS PHARMACOL SCI, V36, P769, DOI 10.1016/j.tips.2015.08.004; Doberstein K, 2015, INT J CANCER, V136, pE326, DOI 10.1002/ijc.29222; Feng M, 2014, J CLIN INVEST, V124, P5291, DOI 10.1172/JCI76711; Gast D, 2005, INT J CANCER, V115, P658, DOI 10.1002/ijc.20869; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hoja-Lukowicz D, 2013, GLYCOCONJUGATE J, V30, P205, DOI 10.1007/s10719-012-9374-5; Jojovic M, 2000, CANCER LETT, V152, P151, DOI 10.1016/S0304-3835(99)00443-7; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Massi D, 2006, MODERN PATHOL, V19, P246, DOI 10.1038/modpathol.3800526; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Previs RA, 2015, CLIN CANCER RES, V21, P955, DOI 10.1158/1078-0432.CCR-14-0809; Samatov TR, 2016, PROG HISTOCHEM CYTOC; Shannan B, 2016, CANCER TREAT RES, V167, P1, DOI 10.1007/978-3-319-22539-5_1; Stein B, 1996, J BIOL CHEM, V271, P11427, DOI 10.1074/jbc.271.19.11427; Stubke K, 2012, CANCER LETT, V321, P89, DOI 10.1016/j.canlet.2012.02.019; Thies A, 2007, BRIT J CANCER, V96, P609, DOI 10.1038/sj.bjc.6603594; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3; Tian YJ, 2014, MELANOMA RES, V24, P335, DOI 10.1097/CMR.0000000000000080; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; van Zeijl M. C, 2016, EUR J SURG ONCOL; Weber K, 2010, GENE THER, V17, P511, DOI 10.1038/gt.2009.149; Wei WY, 2011, J CLIN INVEST, V121, P1263, DOI 10.1172/JCI57080; Wicklein Daniel, 2012, Methods Mol Biol, V878, P241, DOI 10.1007/978-1-61779-854-2_16; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xu SP, 2015, INT J CLIN EXP PATHO, V8, P4881; Xue Y, 2015, TUMOUR BIOL J INT SO	34	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192525	10.1371/journal.pone.0192525	http://dx.doi.org/10.1371/journal.pone.0192525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432466	Green Submitted, gold, Green Published			2022-12-26	WOS:000424814300027
J	Spaulding, K; Takaba, K; Collins, A; Faraji, F; Wang, GY; Aguayo, E; Ge, L; Saloner, D; Wallace, AW; Baker, AJ; Lovett, DH; Ratcliffe, MB				Spaulding, Kimberly; Takaba, Kiyoaki; Collins, Alexander; Faraji, Farshid; Wang, Guanying; Aguayo, Esteban; Ge, Liang; Saloner, David; Wallace, Arthur W.; Baker, Anthony J.; Lovett, David H.; Ratcliffe, Mark B.			Short term doxycycline treatment induces sustained improvement in myocardial infarction border zone contractility	PLOS ONE			English	Article							LEFT-VENTRICULAR ANEURYSM; MATRIX METALLOPROTEINASE-2; REPERFUSION INJURY; HEART; DYSFUNCTION; ISCHEMIA; TRIAL; INFLAMMATION; PREVENT; STRESS	Decreased contractility in the non-ischemic border zone surrounding a MI is in part due to degradation of cardiomyocyte sarcomeric components by intracellular matrix metalloproteinase-2 (MMP-2). We recently reported that MMP-2 levels were increased in the border zone after a MI and that treatment with doxycycline for two weeks after MI was associated with normalization of MMP-2 levels and improvement in ex-vivo contractile protein developed force in the myocardial border zone. The purpose of the current study was to determine if there is a sustained effect of short term treatment with doxycycline (Dox) on border zone function in a large animal model of antero-apical myocardial infarction (MI). Antero-apical MI was created in 14 sheep. Seven sheep received doxycycline 0.8 mg/kg/hr IV for two weeks. Cardiac MRI was performed two weeks before, and then two and six weeks after MI. Two sheep died prior to MRI at six weeks from surgical/anesthesia-related causes. The remaining 12 sheep completed the protocol. Doxycycline induced a sustained reduction in intracellular MMP-2 by Western blot (3649 +/- 643 MI+Dox vs 9236 +/- 114 MI relative intensity; p = 0.0009), an improvement in ex-vivo contractility (65.3 +/- 2.0 MI+Dox vs 39.7 +/- 0.8 MI mN/mm(2); p<0.0001) and an increase in ventricular wall thickness at end-systole 1.0 cm from the infarct edge (12.4 +/- 0.6 MI+Dox vs 10.0 +/- 0.5 MI mm; p = 0.0095). Administration of doxycycline for a limited two week period is associated with a sustained improvement in ex-vivo contractility and an increase in wall thickness at end-systole in the border zone six weeks after MI. These findings were associated with a reduction in intracellular MMP-2 activity.	[Spaulding, Kimberly; Takaba, Kiyoaki; Collins, Alexander; Faraji, Farshid; Wang, Guanying; Aguayo, Esteban; Ge, Liang; Saloner, David; Wallace, Arthur W.; Baker, Anthony J.; Lovett, David H.; Ratcliffe, Mark B.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Faraji, Farshid; Saloner, David] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Ge, Liang; Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Ge, Liang; Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Wallace, Arthur W.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA; [Baker, Anthony J.; Lovett, David H.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ratcliffe, MB (corresponding author), Vet Affairs Med Ctr, San Francisco, CA 94121 USA.; Ratcliffe, MB (corresponding author), Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA.; Ratcliffe, MB (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	Mark.Ratcliffe@va.gov	Wallace, Arthur W/D-5312-2019	Wallace, Arthur W/0000-0003-2809-5104; Saloner, David/0000-0002-6989-8547; Faraji, Farshid/0000-0003-3218-1347	NIH, National Heart, Lung and Blood Institute [5R01 HL063348-18]; Department of Veterans Affairs Merit Review Award [I01BX000740]; American Heart Association [14GRNT20380813, 15GRNT25550041]; National Heart, Lung and Blood Institute Grant [5R01 HL063348-18]; Veterans Affairs [I01BX000740] Funding Source: NIH RePORTER	NIH, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); American Heart Association(American Heart Association); National Heart, Lung and Blood Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the NIH, National Heart, Lung and Blood Institute Grant 5R01 HL063348-18 (MBR) (https://www.nhlbi.nih.gov/); Department of Veterans Affairs Merit Review Award I01BX000740 (AJB) (https://eur01.safelinks.protection.outlook.com/?url=www.research.va.gov & and American Heart Association Grant in Aid 14GRNT20380813 (DHL) and Grant in Aid 15GRNT25550041 (AJB) (https://eur01.safelinks.protection.outlook.com/?url=www.heart.org&data=02%7C01%7C%7C05fb4d1b9c8a463c101d08d568b95520%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636530068480923972&sdata=6VGj4%2Fj0zxzQyIFasA21Dy66ZsD11R8Vj1MzBs35uXA%3D&reserved=0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by National Heart, Lung and Blood Institute Grant 5R01 HL063348-18 (MBR), Department of Veterans Affairs Merit Review Award I01BX000740 (AJB), and the American Heart Association: Grant in Aid 14GRNT20380813 (DHL), and Grant in Aid 15GRNT25550041 (AJB).	Aikawa Y, 2001, AM HEART J, V141, P234, DOI 10.1067/mhj.2001.112237; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Bashir MR, 2015, J MAGN RESON IMAGING, V41, P884, DOI 10.1002/jmri.24691; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Cerisano G, 2014, EUR HEART J, V35, P184, DOI 10.1093/eurheartj/eht420; Doerries C, 2007, CIRC RES, V100, P894, DOI 10.1161/01.RES.0000261657.76299.ff; Dubois E., 1936, BASAL METABOLISM HLT, P125; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Griffin MO, 2010, AM J PHYSIOL-CELL PH, V299, pC539, DOI 10.1152/ajpcell.00047.2010; Guccione JM, 2001, ANN THORAC SURG, V71, P654, DOI 10.1016/S0003-4975(00)02338-9; GUTGESELL HP, 1990, AM J CARDIOL, V65, P662, DOI 10.1016/0002-9149(90)91048-B; HOMANS DC, 1985, CIRCULATION, V71, P1038, DOI 10.1161/01.CIR.71.5.1038; Hu QS, 2006, AM J PHYSIOL-HEART C, V291, pH648, DOI 10.1152/ajpheart.01387.2005; Hudson MP, 2006, J AM COLL CARDIOL, V48, P15, DOI 10.1016/j.jacc.2006.02.055; Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6; JANSE MJ, 1979, CIRC RES, V44, P576, DOI 10.1161/01.RES.44.4.576; Kim YK, 2002, J MOL CELL CARDIOL, V34, P63, DOI 10.1006/jmcc.2001.1490; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Lee LC, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004995; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Lovett DH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00363; Lovett DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068154; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; MARKOVITZ LJ, 1989, ANN THORAC SURG, V48, P838, DOI 10.1016/0003-4975(89)90682-6; Mukherjee R, 2003, CIRCULATION, V107, P618, DOI 10.1161/01.CIR.0000046449.36178.00; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ruparelia N, 2013, INFLAMM RES, V62, P515, DOI 10.1007/s00011-013-0605-4; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimkunas R, 2014, AM J PHYSIOL-HEART C, V307, pH1150, DOI 10.1152/ajpheart.00463.2014; Soleimani M, 2011, ANN THORAC SURG, V92, P1614, DOI 10.1016/j.athoracsur.2011.05.117; Sun Jian, 2015, Biochem Biophys Rep, V4, P397, DOI 10.1016/j.bbrep.2015.11.003; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; Villarreal FJ, 2003, CIRCULATION, V108, P1487, DOI 10.1161/01.CIR.0000089090.05757.34; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wanga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136276; Zhang Z, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00086	38	10	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192720	10.1371/journal.pone.0192720	http://dx.doi.org/10.1371/journal.pone.0192720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432443	Green Submitted, Green Published, gold			2022-12-26	WOS:000424814300041
J	Yu, HH; Fang, LB; Sun, BY				Yu, Honghai; Fang, Libing; Sun, Boyang			The role of global economic policy uncertainty in long-run volatilities and correlations of US industry-level stock returns and crude oil	PLOS ONE			English	Article							PRICE SHOCKS; MARKET RETURNS; CONDITIONAL CORRELATION; POLITICAL UNCERTAINTY; IMPLIED VOLATILITY; CHINA; RISK	We investigate how Global Economic Policy Uncertainty (GEPU) drives the long-run components of volatilities and correlations in crude oil and U. S. industry-level stock markets. Using the modified generalized autoregressive conditional heteroskedasticity mixed data sampling (GARCH-MIDAS) and dynamic conditional correlation mixed data sampling (DCC-MIDAS) specifications, we find that GEPU is positively related to the long-run volatility of Financials and Consumer Discretionary industries; however, it is negatively related to Information Technology, Materials, Telecommunication Services and Energy. Unlike the mixed role of GEPU in the long-run volatilities, the long-run correlations are all positively related to GEPU across the industries. Additionally, the rankings of the correlations of Energy and Materials are time-invariant and classified as high, with the little exception of the latter. The Consumer Staples industry is time-invariant in the low-ranking group. Our results are helpful to policy makers and investors with long-term concerns.	[Yu, Honghai; Fang, Libing; Sun, Boyang] Nanjing Univ, Sch Management & Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University	Fang, LB (corresponding author), Nanjing Univ, Sch Management & Engn, Nanjing, Jiangsu, Peoples R China.	lbfang@nju.edu.cn			National Natural Science Foundation of China [71472085, 71401071, 71501131, 71672081, 71771117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	All of our funding for this manuscript comes from National Natural Science Foundation of China. The grant numbers are 71472085, 71401071, 71501131, 71672081 and 71771117. The website is http://www.nsfc.gov.cn/.; We would like to thank the helpful comments from the editors and the anonymous referees. We acknowledge financial support from the National Natural Science Foundation of China under Grant Nos. 71472085, 71401071, 71501131, 71672081 and 71771117.	Adrangi B, 2015, J ENERGY MARKETS, V8, P77; Antonakakis N, 2013, ECON LETT, V120, P87, DOI 10.1016/j.econlet.2013.04.004; Baker SR, 2016, Q J ECON, V131, P1593, DOI 10.1093/qje/qjw024; Baker SR, 2012, HAS EC UNCERTAINTY H; Bloom N, 2017, AUST ECON REV, V50, P79, DOI 10.1111/1467-8462.12203; Boutchkova M, 2012, REV FINANC STUD, V25, P1111, DOI 10.1093/rfs/hhr100; Broadstock DC, 2014, J INT FINANC MARK I, V33, P417, DOI 10.1016/j.intfin.2014.09.007; Brogaard J, 2015, MANAGE SCI, V61, P3, DOI 10.1287/mnsc.2014.2044; Christodoulakis GA, 2002, EUR J OPER RES, V139, P351, DOI 10.1016/S0377-2217(01)00361-7; Colacito R, 2011, J ECONOMETRICS, V164, P45, DOI 10.1016/j.jeconom.2011.02.013; Conrad C, 2014, J EMPIR FINANC, V29, P26, DOI 10.1016/j.jempfin.2014.03.009; Davis SJ, 2016, INDEX GLOBAL EC POLI, P22740; Elyasiani E, 2011, ENERG ECON, V33, P966, DOI 10.1016/j.eneco.2011.03.013; Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487; Engle RF, 2013, REV ECON STAT, V95, P776, DOI 10.1162/REST_a_00300; Fan QB, 2012, INT REV ECON FINANC, V22, P112, DOI 10.1016/j.iref.2011.09.004; Filis G, 2011, INT REV FINANC ANAL, V20, P152, DOI 10.1016/j.irfa.2011.02.014; Gogineni S, 2010, FINAN REV, V45, P995, DOI 10.1111/j.1540-6288.2010.00282.x; Goodell JW, 2013, J BANK FINANC, V37, P1108, DOI 10.1016/j.jbankfin.2012.12.001; Gulen H, 2016, REV FINANC STUD, V29, P523, DOI 10.1093/rfs/hhv050; Guo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022794; Hammoudeh S, 2005, J ECON BUS, V57, P1, DOI 10.1016/j.jeconbus.2004.08.002; Hammoudeh S, 2010, ENERG POLICY, V38, P3922, DOI 10.1016/j.enpol.2010.03.015; Hashem Pesaran M, 2014, CESIFO WORKING PAPER; He YA, 2010, ENERG ECON, V32, P868, DOI 10.1016/j.eneco.2009.12.005; JOHANSEN S, 1988, J ECON DYN CONTROL, V12, P231, DOI 10.1016/0165-1889(88)90041-3; Kang WS, 2013, J INT FINANC MARK I, V26, P305, DOI 10.1016/j.intfin.2013.07.001; Kilian L, 2009, INT ECON REV, V50, P1267, DOI 10.1111/j.1468-2354.2009.00568.x; Lee K, 2002, J MONETARY ECON, V49, P823, DOI 10.1016/S0304-3932(02)00114-9; Pastor L, 2013, J FINANC ECON, V110, P520, DOI 10.1016/j.jfineco.2013.08.007; Ren F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097711; Sadorsky P, 1999, ENERG ECON, V21, P449, DOI 10.1016/S0140-9883(99)00020-1; Sum V., 2012, J MONEY INVESTMENT B, V25, P99, DOI DOI 10.2139/SSRN.2094175; Xiong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141605; Zhu HM, 2016, ENERG ECON, V55, P30, DOI 10.1016/j.eneco.2015.12.027	35	8	8	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192305	10.1371/journal.pone.0192305	http://dx.doi.org/10.1371/journal.pone.0192305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420645	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900064
J	Simeonovic, CJ; Popp, SK; Starrs, LM; Brown, DJ; Ziolkowski, AF; Ludwig, B; Bornstein, SR; Wilson, JD; Pugliese, A; Kay, TWH; Thomas, HE; Loudovaris, T; Choong, FJ; Freeman, C; Parish, CR				Simeonovic, Charmaine J.; Popp, Sarah K.; Starrs, Lora M.; Brown, Debra J.; Ziolkowski, Andrew F.; Ludwig, Barbara; Bornstein, Stefan R.; Wilson, J. Dennis; Pugliese, Alberto; Kay, Thomas W. H.; Thomas, Helen E.; Loudovaris, Thomas; Choong, Fui Jiun; Freeman, Craig; Parish, Christopher R.			Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans	PLOS ONE			English	Article							INSULIN-SECRETION; IN-VITRO; MAMMALIAN HEPARANASE; PANCREATIC BIOPSY; BASEMENT-MEMBRANE; RECENT-ONSET; T-CELLS; MICE; TRANSPLANTATION; INFLAMMATION	Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing beta cells in pancreatic islets are progressively destroyed. Clinical trials of immunotherapies in recently diagnosed T1D patients have only transiently and partially impacted the disease course, suggesting that other approaches are required. Our previous studies have demonstrated that heparan sulfate (HS), a glycosaminoglycan conventionally expressed in extracellular matrix, is present at high levels inside normal mouse beta cells. Intracellular HS was shown to be critical for beta cell survival and protection from oxidative damage. T1D development in Non-Obese Diabetic (NOD) mice correlated with loss of islet HS and was prevented by inhibiting HS degradation by the endoglycosidase, heparanase. In this study we investigated the distribution of HS and heparan sulfate proteoglycan (HSPG) core proteins in normal human islets, a role for HS in human beta cell viability and the clinical relevance of intraislet HS and HSPG levels, compared to insulin, in human T1D. In normal human islets, HS (identified by 10E4 mAb) co-localized with insulin but not glucagon and correlated with the HSPG core proteins for collagen type XVIII (Col18) and syndecan-1 (Sdc1). Insulin-positive islets of T1D pancreases showed significant loss of HS, Col18 and Sdc1 and heparanase was strongly expressed by islet-infiltrating leukocytes. Human beta cells cultured with HS mimetics showed significantly improved survival and protection against hydrogen peroxide-induced death, suggesting that loss of HS could contribute to beta cell death in T1D. We conclude that HS depletion in beta cells, possibly due to heparanase produced by insulitis leukocytes, may function as an important mechanism in the pathogenesis of human T1D. Our findings raise the possibility that intervention therapy with dual activity HS replacers/heparanase inhibitors could help to protect the residual beta cell mass in patients recently diagnosed with T1D.	[Simeonovic, Charmaine J.; Popp, Sarah K.; Starrs, Lora M.; Brown, Debra J.; Ziolkowski, Andrew F.; Choong, Fui Jiun] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia; [Ludwig, Barbara; Bornstein, Stefan R.] Tech Univ Dresden, Carl Gustav Carus Med Sch, Dept Internal Med 3, Dresden, Germany; [Wilson, J. Dennis] Canberra Hosp, Dept Endocrinol, Woden, ACT, Australia; [Pugliese, Alberto] Univ Miami, Miller Sch Med, Diabet Res Inst, Dept Med, Miami, FL 33136 USA; [Pugliese, Alberto] Univ Miami, Miller Sch Med, Diabet Res Inst, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Kay, Thomas W. H.; Thomas, Helen E.; Loudovaris, Thomas] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Freeman, Craig; Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Dept Canc Biol & Therapeut, Canberra, ACT, Australia; [Ziolkowski, Andrew F.] John Hunter Hosp, Dept Mol Med, Newcastle, NSW, Australia	Australian National University; John Curtin School of Medical Research; Technische Universitat Dresden; Australian National University; Canberra Hospital; University of Miami; University of Miami; St. Vincent's Institute of Medical Research; Australian National University; John Curtin School of Medical Research; John Hunter Hospital	Simeonovic, CJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia.	Charmaine.Simeonovic@anu.edu.au	Simeonovic, Charmaine/AAG-9945-2020	Simeonovic, Charmaine/0000-0002-7161-5825; Loudovaris, Thomas/0000-0002-7038-2302; Parish, Christopher/0000-0001-7740-0430	National Health and Medical Research Council of Australia (NHMRC)/Juvenile Diabetes Research Foundation (JDRF) [418138]; Canberra Hospital Private Practice Fund; JDRF nPOD Research Grant [25-2010-716]; JDRF [47-2012-746]; NHMRC [1043284]; Network for Pancreatic Organ Donors with Diabetes (nPOD) - JDRF [25-2013-268]; Helmsley Charitable Trust George Eisenbarth nPOD Award for Team Science	National Health and Medical Research Council of Australia (NHMRC)/Juvenile Diabetes Research Foundation (JDRF); Canberra Hospital Private Practice Fund; JDRF nPOD Research Grant; JDRF(Juvenile Diabetes Research Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Network for Pancreatic Organ Donors with Diabetes (nPOD) - JDRF; Helmsley Charitable Trust George Eisenbarth nPOD Award for Team Science	This work was supported by a National Health and Medical Research Council of Australia (NHMRC; https://www.nhmrc.gov.au/)/Juvenile Diabetes Research Foundation (JDRF) Special Program Grant in Type 1 Diabetes (#418138), The Canberra Hospital Private Practice Fund (http://www.health.act.gov.au/research-publications/research/ppf-major-grants), JDRF nPOD Research Grant (#25-2010-716; http://www.jdrf.org), JDRF Research Grant (#47-2012-746) and NHMRC Project Grant (#1043284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD, www.JDRFnPOD.org), a collaborative Type 1 diabetes research project sponsored by JDRF (#25-2013-268). Organ Procurement Organizations (OPO) partnering with nPOD to provide research resources are listed at http://-wwwjdrinpod,org/for-partners/ npod partners/. A.P. was supported by the Helmsley Charitable Trust George Eisenbarth nPOD Award for Team Science. We thank the Tom Mandel Islet Program, St Vincent's Institute, Melbourne, Australia and the Integrated Islet Distribution Program (IIDP), City of Hope, CA, USA for providing isolated human islets. We are grateful to Progen Pharmaceuticals Limited (Brisbane, Queensland, Australia) for providing PI-88 and Beta Therapeutics (Canberra, ACT, Australia) for the use of BT548. We thank Anne Prins for preparing the histology of isolated human islets, Dr Harpreet Vohra for assistance with flow cytometry and Cathy Gillespie and Michael Devoy for their help with confocal and immunofluorescence microscopy.	Abu El-Asrar AM, 2015, INVEST OPHTH VIS SCI, V56, P8239, DOI 10.1167/iovs.15-18025; Anagandula M, 2014, J MED VIROL, V86, P1402, DOI 10.1002/jmv.23835; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Atkinson MA, 2015, DIABETES CARE, V38, P979, DOI 10.2337/dc15-0144; Battaglia M, 2015, DIABETES, V64, P1081, DOI 10.2337/db14-1208; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; Campbell-Thompson ML, 2013, DIABETOLOGIA, V56, P2541, DOI 10.1007/s00125-013-3043-5; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Casu B, 2002, BIOCHEMISTRY-US, V41, P10519, DOI 10.1021/bi020118n; Choong FJ, 2015, AM J TRANSPLANT, V15, P2851, DOI 10.1111/ajt.13366; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Garsen M, 2016, AM J PATHOL, V186, P805, DOI 10.1016/j.ajpath.2015.12.008; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Goldberg R, 2014, DIABETES, V63, P4302, DOI 10.2337/db14-0001; Greenbaum CJ, 2012, DIABETES, V61, P1323, DOI 10.2337/db11-1452; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; In't Veld P, 2014, SEMIN IMMUNOPATHOL, V36, P569, DOI 10.1007/s00281-014-0438-4; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; Irving-Rodgers HF, 2008, DIABETOLOGIA, V51, P1680, DOI 10.1007/s00125-008-1085-x; Khamaysi I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00715-6; Korpos E, 2013, DIABETES, V62, P531, DOI 10.2337/db12-0432; Krogvold L, 2015, DIABETES, V64, P2506, DOI 10.2337/db14-1911; Krogvold L, 2014, DIABETOLOGIA, V57, P841, DOI 10.1007/s00125-013-3155-y; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; LINDAHL U, 1973, J BIOL CHEM, V248, P7234; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Morgan NG, 2014, IUBMB LIFE, V66, P723, DOI 10.1002/iub.1330; Nepom GT, 2013, CLIN IMMUNOL, V149, P279, DOI 10.1016/j.clim.2013.02.003; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parish CR, 1999, CANCER RES, V59, P3433; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Richardson SJ, 2014, DIABETOLOGIA, V57, P647, DOI 10.1007/s00125-014-3167-2; Richardson SJ, 2011, SEMIN IMMUNOPATHOL, V33, P9, DOI 10.1007/s00281-010-0205-0; Rota C, 2005, ANAL BIOCHEM, V344, P193, DOI 10.1016/j.ab.2005.06.043; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Simeonovic CJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00471; Skyler JS, 2015, DIABETES TECHNOL THE, V17, pS80, DOI 10.1089/dia.2015.1510; Staeva TP, 2013, DIABETES, V62, P9, DOI 10.2337/db12-0562; Takahashi I, 2017, MOL CELL ENDOCRINOL; Takahashi I, 2012, J DIABETES INVEST, V3, P362, DOI 10.1111/j.2040-1124.2012.00205.x; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Theodoraki A, 2015, MOL CELL ENDOCRINOL, V399, P296, DOI 10.1016/j.mce.2014.09.011; Valle A, 2013, DIABETES, V62, P2072, DOI 10.2337/db12-1345; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Wang YD, 2014, DIABETES, V63, P4239, DOI 10.2337/db14-0480; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	57	26	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191360	10.1371/journal.pone.0191360	http://dx.doi.org/10.1371/journal.pone.0191360			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415062	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000424325300024
J	Yang, HL; Chen, JK				Yang, Haile; Chen, Jiakuan			Integrating landscape system and meta-ecosystem frameworks to advance the understanding of ecosystem function in heterogeneous landscapes: An analysis on the carbon fluxes in the Northern Highlands Lake District (NHLD) of Wisconsin and Michigan	PLOS ONE			English	Article							ECOLOGICAL BOUNDARIES; BAIYANGDIAN BASIN; NETWORK-ANALYSIS; SUBSIDIES; DYNAMICS; EMISSIONS; FEEDBACKS; STATE	The successful integration of ecosystem ecology with landscape ecology would be conducive to understanding how landscapes function. There have been several attempts at this, with two main approaches: (1) an ecosystem-based approach, such as the meta-ecosystem framework and (2) a landscape-based approach, such as the landscape system framework. These two frameworks are currently disconnected. To integrate these two frameworks, we introduce a protocol, and then demonstrate application of the protocol using a case study. The protocol includes four steps: 1) delineating landscape systems; 2) classifying landscape systems; 3) adjusting landscape systems to meta-ecosystems and 4) integrating landscape system and meta-ecosystem frameworks through meta-ecosystems. The case study is the analyzing of the carbon fluxes in the Northern Highlands Lake District (NHLD) of Wisconsin and Michigan using this protocol. The application of this protocol revealed that one could follow this protocol to construct a meta-ecosystem and analyze it using the integrative framework of landscape system and meta-ecosystem frameworks. That is, one could (1) appropriately describe and analyze the spatial heterogeneity of the meta-ecosystem; (2) understand the emergent properties arising from spatial coupling of local ecosystems in the meta-ecosystem. In conclusion, this protocol is a useful approach for integrating the meta-ecosystem framework and the landscape system framework, which advances the describing and analyzing of the spatial heterogeneity and ecosystem function of interconnected ecosystems.	[Yang, Haile; Chen, Jiakuan] Fudan Univ, Inst Biodivers Sci, Shanghai, Peoples R China; [Yang, Haile; Chen, Jiakuan] Fudan Univ, Sch Life Sci, Dept Ecol & Evolutionary Biol, Shanghai, Peoples R China; [Chen, Jiakuan] Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Jiangxi, Peoples R China	Fudan University; Fudan University; Nanchang University	Chen, JK (corresponding author), Fudan Univ, Inst Biodivers Sci, Shanghai, Peoples R China.; Chen, JK (corresponding author), Fudan Univ, Sch Life Sci, Dept Ecol & Evolutionary Biol, Shanghai, Peoples R China.; Chen, JK (corresponding author), Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Jiangxi, Peoples R China.	jkchen@fudan.edu.cn	Yang, Haile/J-9661-2019	Yang, Haile/0000-0003-2240-4236				Buffam I, 2011, GLOBAL CHANGE BIOL, V17, P1193, DOI 10.1111/j.1365-2486.2010.02313.x; Cadenasso ML, 2003, BIOSCIENCE, V53, P717, DOI 10.1641/0006-3568(2003)053[0717:AIASAT]2.0.CO;2; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; Cloern JE, 2007, AM NAT, V169, pE21, DOI 10.1086/510258; Crawford JT, 2016, GEOPHYS RES LETT, V43, P1973, DOI 10.1002/2015GL067599; Crawford JT, 2014, GLOBAL CHANGE BIOL, V20, P3408, DOI 10.1111/gcb.12614; Crawford JT, 2014, GLOBAL BIOGEOCHEM CY, V28, P197, DOI 10.1002/2013GB004661; Gounand I, 2018, TRENDS ECOL EVOL, V33, P36, DOI 10.1016/j.tree.2017.10.006; Gounand I, 2017, OIKOS, V126, P972, DOI 10.1111/oik.03922; Gounand I, 2014, AM NAT, V184, P752, DOI 10.1086/678406; Gravel D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12457; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Haegeman B, 2014, ECOL LETT, V17, P175, DOI 10.1111/ele.12214; Harvey E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1496; Huang J, 2014, PLOS ONE, V9; Ireland AW, 2012, J ECOL, V100, P586, DOI 10.1111/j.1365-2745.2012.01961.x; Jager CG, 2014, ECOL MONOGR, V84, P287, DOI 10.1890/13-0613.1; Largaespada C, 2012, ECOLOGY, V93, P324, DOI 10.1890/10-2359.1; Leroux SJ, 2012, ECOSYSTEMS, V15, P48, DOI 10.1007/s10021-011-9492-0; Limberger R, 2017, ECOLOGY, V98, P1082, DOI [10.1002/ecy.1742/suppinfo, 10.1002/ecy.1742]; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Lovett GM, 2005, Ecosystem Function in Heterogeneous Landscapes, P463, DOI 10.1007/0-387-24091-8_24; Lovett GM, 2005, Ecosystem Function in Heterogeneous Landscapes, P1, DOI 10.1007/0-387-24091-8_1; Mao XF, 2011, ECOL MODEL, V222, P3811, DOI 10.1016/j.ecolmodel.2011.10.002; Marleau JN, 2015, ECOL LETT, V18, P1163, DOI 10.1111/ele.12495; Marleau JN, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2094; Marleau JN, 2010, J THEOR BIOL, V266, P162, DOI 10.1016/j.jtbi.2010.06.022; Patricio J, 2004, ESTUAR COAST SHELF S, V60, P23, DOI 10.1016/j.ecss.2003.11.017; Ryabov AB, 2011, ECOL LETT, V14, P220, DOI 10.1111/j.1461-0248.2010.01574.x; Small GE, 2014, ECOL MODEL, V293, P150, DOI 10.1016/j.ecolmodel.2014.02.001; Spiecker B, 2016, ECOL APPL, V26, P264, DOI 10.1890/15-0478; Stanley EH, 2016, ECOL MONOGR, V86, P146, DOI 10.1890/15-1027; Turner M.G., 2015, LANDSCAPE ECOLOGY TH, P287; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Yang ZF, 2011, ECOL MODEL, V222, P3785, DOI 10.1016/j.ecolmodel.2011.09.013	36	0	0	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192569	10.1371/journal.pone.0192569	http://dx.doi.org/10.1371/journal.pone.0192569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415066	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300088
J	Mata-Balaguer, T; Cuchillo-Ibanez, I; Calero, M; Ferrer, I; Saez-Valero, J				Mata-Balaguer, Trinidad; Cuchillo-Ibanez, Inmaculada; Calero, Miguel; Ferrer, Isidro; Saez-Valero, Javier			Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease	FASEB JOURNAL			English	Article						brain; ApoE; DNMT1; methylation	MESSENGER-RNA EXPRESSION; APOLIPOPROTEIN-E; DNA METHYLATION; SYNAPTIC PLASTICITY; RECEPTOR; BRAIN; PROMOTER; LIGAND; BINDING; PROTEIN	Increasing evidence indicates that altered reelin signaling could contribute to synaptic dysfunction in Alzheimer's disease (AD). We found that reelin protein and mRNA levels were increased in the AD brain (particularly at advanced Braak stages in apolipoprotein E4 noncarriers), compared with that of control subjects. The beta-amyloid (A) protein impairs reelin activity and increases reelin expression through a mechanism that is not yet understood. To explore that mechanism, we examined the effect of A beta aa 1-42 (A beta(42)) on DNA methylation of the RELN promoter and the processing of reelin receptor apolipoprotein E receptor 2 (ApoER2) in differentiated SH-SY5Y cells because ApoER2 C-terminal fragments (CTFs), generated after reelin binding, regulate reelin expression. We found that A beta(42) decreased nuclear levels of DNA-methyltransferase 1. However, RELN promoter methylation did not change in A beta(42)-treated cells or in AD brain extracts. Instead, the levels of ApoER2-CTF appeared significantly lower in A beta(42)-treated cells and in AD extracts from advanced Braak stages of apolipoprotein E4 noncarriers. Our data show that ApoER2-CTF levels are decreased, whereas reelin expression is increased in AD brain at advanced Braak stages and after A treatment, supporting the view that ApoER2-CTF exerts a modulatory role on reelin expression. -Mata-Balaguer, T., Cuchillo-Ibanez, I., Calero, M., Ferrer, I., Saez-Valero, J. Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.	[Mata-Balaguer, Trinidad; Cuchillo-Ibanez, Inmaculada; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Crta Alicante Valencia Km 87, Alicante 03550, Spain; [Mata-Balaguer, Trinidad; Cuchillo-Ibanez, Inmaculada; Calero, Miguel; Ferrer, Isidro; Saez-Valero, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Calero, Miguel] Queen Sofia Fdn, Alzheimer Ctr, Ctr Nacl Invest Enfermedades Neurol CIEN Fdn, Alzheimer Dis Res Unit, Madrid, Spain; [Calero, Miguel] Carlos III Inst Hlth, Chron Dis Programme, Madrid, Spain; [Ferrer, Isidro] Univ Barcelona, Inst Neuropatol, Hosp Univ Bellvitge, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); CIBERNED; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Cuchillo-Ibanez, I; Saez-Valero, J (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Crta Alicante Valencia Km 87, Alicante 03550, Spain.	icuchillo@umh.es; j.saez@umh.es	Calero, Miguel/H-5691-2015; cuchillo, inmaculada/P-2975-2019	Calero, Miguel/0000-0001-5366-3324; /0000-0002-3689-5518	Fundacion Ramon Areces, Fondo de Investigaciones Sanitarias [PI15/00665]; Fondo Europeo de Desarrollo Regional (FEDER) "Investing in your future"; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in RD [SEV- 2013-0317]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (Instituto de Salud Carlos III, Madrid, Spain)	Fundacion Ramon Areces, Fondo de Investigaciones Sanitarias; Fondo Europeo de Desarrollo Regional (FEDER) "Investing in your future"; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in RD; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (Instituto de Salud Carlos III, Madrid, Spain)	The authors thank Prof. T. Curran (Eppley Institute, University of Nebraska Medical Center, Omaha, NE, USA), J. Nimpf (Max F. Perutz Laboratories, Department of Medical Biochemistry, Medical University of Vienna, Vienna, Austria), and W. Rebeck (Georgetown University Medical Center, Washington, D.C., USA) for generously providing cDNAs and antibodies. The authors also thank E. Llorens (Universidad Miguel Hernandez-CSIC, Sant Joan d'Alacant, Spain) for technical assistance. This work was supported by grants from the Fundacion Ramon Areces, Fondo de Investigaciones Sanitarias [PI15/00665, cofunded by the Fondo Europeo de Desarrollo Regional (FEDER) "Investing in your future"], and through Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED; Instituto de Salud Carlos III, Madrid, Spain). The authors also acknowledge financial support from the Spanish Ministerio de Economia y Competitividad, through the "Severo Ochoa" Programme for Centres of Excellence in R&D (SEV- 2013-0317). The authors declare no conflicts of interest.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Abraham H, 2003, HIPPOCAMPUS, V13, P715, DOI 10.1002/hipo.10125; Alcantara S, 1998, J NEUROSCI, V18, P7779; Bachmeier C, 2014, NEUROMOL MED, V16, P686, DOI 10.1007/s12017-014-8318-6; Balmaceda V, 2014, FASEB J, V28, P1543, DOI 10.1096/fj.13-239350; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Botella-Lopez A, 2010, NEUROBIOL DIS, V37, P682, DOI 10.1016/j.nbd.2009.12.006; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Calero O, 2009, J NEUROSCI METH, V183, P238, DOI 10.1016/j.jneumeth.2009.06.033; Carvajal AE, 2017, BBA-MOL BASIS DIS, V1863, P462, DOI 10.1016/j.bbadis.2016.11.028; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Cuchillo-Ibanez I, 2016, SCI REP-UK, V6, DOI 10.1038/srep31646; Cuchillo-Ibanez I, 2016, J ALZHEIMERS DIS, V52, P403, DOI 10.3233/JAD-151193; Cuchillo-Ibanez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072297; D'Aiuto L, 2011, DIFFERENTIATION, V82, P9, DOI 10.1016/j.diff.2011.03.003; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Day JJ, 2015, ANNU REV PHARMACOL, V55, P591, DOI 10.1146/annurev-pharmtox-010814-124527; Divekar SD, 2014, J BIOL CHEM, V289, P15894, DOI 10.1074/jbc.M113.537548; Dong E, 2015, SCHIZOPHR RES, V167, P35, DOI 10.1016/j.schres.2014.10.030; Eid Aseel, 2016, Alzheimers Dement (Amst), V2, P123, DOI 10.1016/j.dadm.2016.02.002; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Guidotti A, 2007, NEUROREPORT, V18, P57, DOI 10.1097/WNR.0b013e32800fefd7; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hinrich AJ, 2016, EMBO MOL MED, V8, P328, DOI 10.15252/emmm.201505846; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, BRAIN RES, V1112, P70, DOI 10.1016/j.brainres.2006.07.035; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hussain A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-49; Klein HU, 2016, ACTA NEUROPATHOL, V132, P503, DOI 10.1007/s00401-016-1612-7; Kobow K, 2009, J NEUROPATH EXP NEUR, V68, P356, DOI 10.1097/NEN.0b013e31819ba737; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kundakovic M, 2009, MOL PHARMACOL, V75, P342, DOI 10.1124/mol.108.051763; Lane-Donovan C, 2017, TRENDS ENDOCRIN MET, V28, P273, DOI 10.1016/j.tem.2016.12.001; Lane-Donovan C, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6674; Lee GH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00122; Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271; Lin L, 2017, HEMATOL ONCOL, V35, P685, DOI 10.1002/hon.2311; Lintas C, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9151-z; Liu DS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0002-2; Lu HY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00085; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martinez-Cerdeno V, 2002, CEREB CORTEX, V12, P1298, DOI 10.1093/cercor/12.12.1298; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Noh JS, 2005, P NATL ACAD SCI USA, V102, P1749, DOI 10.1073/pnas.0409648102; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pujadas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4443; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Saiz-Sanchez D, 2016, EXP NEUROL, V276, P13, DOI 10.1016/j.expneurol.2015.11.009; Sanchez-Mut JV, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.214; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Silveyra M. X., 2012, NEUROBIOL AGING, V33; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Sui L, 2010, STEROIDS, V75, P988, DOI 10.1016/j.steroids.2010.06.005; Tochigi M, 2008, BIOL PSYCHIAT, V63, P530, DOI 10.1016/j.biopsych.2007.07.003; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Yu JT, 2012, MOL NEUROBIOL, V45, P314, DOI 10.1007/s12035-012-8237-1	68	18	19	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3536	3546		10.1096/fj.201700736RR	http://dx.doi.org/10.1096/fj.201700736RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29442527				2022-12-26	WOS:000435104500005
J	Lin, J; Ma, JC; Yang, J; Yin, JY; Chen, XX; Guo, H; Wen, XM; Zhang, TJ; Qian, W; Qian, J; Deng, ZQ				Lin, J.; Ma, J. -C.; Yang, J.; Yin, J. -Y.; Chen, X. -X.; Guo, H.; Wen, X. -M.; Zhang, T. -J.; Qian, W.; Qian, J.; Deng, Z. -Q.			Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression	ONCOGENE			English	Article							CHRONIC MYELOID-LEUKEMIA; LONG NONCODING RNA; CANCER-CELLS; DOWN-REGULATION; STEM-CELLS; POOR SURVIVAL; GENOME-WIDE; EXPRESSION; METASTASIS; MICRORNAS	Cancer-testis (CT) antigens, rarely in normal tissues except testis, are expressed in many tumor types. In recent years, DDX43 has been shown to be expressed in several malignancies. However, the role of DDX43 during tumorigenesis is not well established. In the present study, we explored the function of DDX43 in chronic myeloid leukemia (CML). We found that DDX43 overexpression in CML cell lines enhanced survival and colony formation, inhibited cell apoptosis, promoted tumorigenesis, and CML progression. In contrast, silencing of DDX43 inhibited cell survival and tumorigenesis. Upregulated H19 and downregulated miR-186 were identified in DDX43-transfected cells. Furthermore, we demonstrated that miR-186 targeted DDX43, and overexpressed miR-186 increased apoptosis and decreased cell survival. We also showed that DDX43 regulated the expression of H19 through demethylation and silencing H19 inhibited cell survival. Taken together, these results indicate that DDX43 provides critical support to the progression of CML by enhancing cell survival, colony formation, and inhibiting cell apoptosis, thereby implicating DDX43 as a potential therapeutic target in CML.	[Lin, J.; Ma, J. -C.; Yin, J. -Y.; Guo, H.; Wen, X. -M.; Deng, Z. -Q.] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cent Lab, Zhenjiang, Jiangsu, Peoples R China; [Lin, J.; Ma, J. -C.; Guo, H.; Wen, X. -M.; Zhang, T. -J.; Qian, J.; Deng, Z. -Q.] Key Lab Precis Diag & Treatment Hematol Malignanc, Zhenjiang, Jiangsu, Peoples R China; [Yang, J.; Chen, X. -X.; Zhang, T. -J.; Qian, J.] Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China; [Qian, W.] Jiangsu Univ, Affiliated Peoples Hosp, Dept Otolaryngol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Deng, ZQ (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cent Lab, Zhenjiang, Jiangsu, Peoples R China.; Qian, J; Deng, ZQ (corresponding author), Key Lab Precis Diag & Treatment Hematol Malignanc, Zhenjiang, Jiangsu, Peoples R China.; Qian, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China.	qianjun0007@hotmail.com; zqdeng2002@163.com		Qian, Jun/0000-0001-7697-2875	National Natural Science Foundation of China [81172592, 81270630]; Medical Innovative Team of "Ke Jiao Qiang Wei" Project of Jiangsu Province [CXTDB2017002]; six talent peaks project in Jiangsu Province [2015-WSN-115]; China Postdoctoral Science Foundation [2016M601747]; Jiangsu Provincial "Innovative & entrepreneurial talent team" Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Innovative Team of "Ke Jiao Qiang Wei" Project of Jiangsu Province; six talent peaks project in Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Provincial "Innovative & entrepreneurial talent team" Program	This study was supported by National Natural Science Foundation of China (81172592, 81270630), Medical Innovative Team of "Ke Jiao Qiang Wei" Project of Jiangsu Province (CXTDB2017002), six talent peaks project in Jiangsu Province (2015-WSN-115), China Postdoctoral Science Foundation (2016M601747), and Jiangsu Provincial "Innovative & entrepreneurial talent team" Program.	Adams SP, 2002, LEUKEMIA, V16, P2238, DOI 10.1038/sj.leu.2402732; Bernaudo S, 2016, ONCOGENE, V35, P4816, DOI 10.1038/onc.2016.15; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Chen Q, 2013, GENET TEST MOL BIOMA, V17, P508, DOI 10.1089/gtmb.2012.0530; Chen Q, 2012, BRIT J HAEMATOL, V158, P293, DOI 10.1111/j.1365-2141.2012.09138.x; Chen Qin, 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V19, P1171; Conigliaro A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0426-x; Cui GH, 2014, TUMOR BIOL, V35, P8933, DOI 10.1007/s13277-014-2168-6; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Erdmann K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-82; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Ferrer G, 2013, LEUKEMIA LYMPHOMA, V54, P2016, DOI 10.3109/10428194.2012.763123; Giustacchini A, 2017, NAT MED, V23, P692, DOI 10.1038/nm.4336; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Huang YP, 2015, STEM CELLS, V33, P3481, DOI 10.1002/stem.2225; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Lee DF, 2015, CELL, V161, P240, DOI 10.1016/j.cell.2015.02.045; Li HL, 2013, CARCINOGENESIS, V34, P2145, DOI 10.1093/carcin/bgt158; Liggins Amanda P, 2010, Cancer Immun, V10, P8; Lin J, 2014, LEUKEMIA RES, V38, P601, DOI 10.1016/j.leukres.2014.02.012; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Ma JC, 2014, CELL PHYSIOL BIOCHEM, V34, P2266, DOI 10.1159/000369669; Martelange V, 2000, CANCER RES, V60, P3848; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rokavec M, 2017, CANCER RES, V77, P1854, DOI 10.1158/0008-5472.CAN-16-3236; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Si XX, 2016, ONCOTARGET, V7, P81452, DOI 10.18632/oncotarget.13263; Sidaway Peter, 2016, Nat Rev Clin Oncol, V13, P135, DOI 10.1038/nrclinonc.2016.13; Song YF, 2017, HEPATOLOGY, V66, P1183, DOI 10.1002/hep.29209; Vennin C, 2015, ONCOTARGET, V6, P29209, DOI 10.18632/oncotarget.4976; Wang Q, 2017, ONCOTARGET, V8, P2558, DOI 10.18632/oncotarget.13708; Wang W, 2015, BLOOD, V126, P1699, DOI 10.1182/blood-2015-05-646489; Zhang TJ, 2016, CLIN LAB, V62, P113, DOI 10.7754/Clin.Lab.2015.150606; Zheng J, 2015, ONCOTARGET, V6, P25339, DOI 10.18632/oncotarget.4509; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zhou JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10221; Zhou JD, 2018, J CELL PHYSIOL, V233, P2444, DOI 10.1002/jcp.26119; Zhou W, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9557; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84	42	21	21	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2432	2443		10.1038/s41388-018-0146-y	http://dx.doi.org/10.1038/s41388-018-0146-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29449695	Green Published, hybrid			2022-12-26	WOS:000431386000007
J	Sirkisoon, SR; Carpenter, RL; Rimkus, T; Anderson, A; Harrison, A; Lange, AM; Jin, GX; Watabe, K; Lo, HW				Sirkisoon, Sherona R.; Carpenter, Richard L.; Rimkus, Tadas; Anderson, Ashley; Harrison, Alexandria; Lange, Allison M.; Jin, Guangxu; Watabe, Kounosuke; Lo, Hui-Wen			Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; SONIC-HEDGEHOG; SPLICE VARIANT; SELF-RENEWAL; STEM-CELLS; GLI GENE; EXPRESSION; PROTEIN; ACTIVATION	Signal transducer and activator of transcription 3 (STAT3), glioma oncogene homolog 1 (GLI1), and truncated GLI1 (tGLI1) are oncogenic transcription factors playing important roles in breast cancer. tGLI1 is a gain-of-function GLI1 isoform. Whether STAT3 physically and/or functionally interacts with GLI1/tGLI1 has not been explored. To address this knowledge gap, we analyzed 47 node-positive breast cancer specimens using immunohistochemical staining and found that phosphorylated-STAT3 (Y705), GLI1, and tGLI1 are co-overexpressed in the majority of triple-negative breast carcinomas (64%) and HER2-enriched (68%) breast carcinomas, and in lymph node metastases (65%). Using gene set enrichment analysis, we analyzed 710 breast tumors and found that STAT3 activation and GLI1/tGLI1 activation signatures are co-enriched in triple-negative subtypes of breast cancers and HER2-enriched subtypes of breast cancers, but not in luminal subtypes of breast cancers. Patients with high levels of STAT3 and GLI1/tGLI1 co-activation in their breast tumors had worse metastasis-free survival compared to those with low levels. Since these proteins co-overexpress in breast tumors, we examined whether they form complexes and observed that STAT3 interacted with both GLI1 and tGLI1. We further found that the STAT3-GLI1 and STAT3-tGLI1 complexes bind to both consensus GLI1-binding and STAT3-binding sites using chromatin immunoprecipitation (ChIP) assay, and that the co-overexpression markedly activated a promoter controlled by GLI1-binding sites. To identify genes that can be directly co-activated by STAT3 and GLI1/tGLI1, we analyzed three ChIP-seq datasets and identified 34 potential target genes. Following validations using reverse transcription polymerase chain reaction and survival analysis, we identified three genes as novel transcriptional targets of STAT3 and GLI1/tGLI1, R-Ras2, Cep70, and UPF3A. Finally, we observed that co-overexpression of STAT3 with GLI1/tGLI1 promoted the ability of breast cancer cells to form mammospheres and that STAT3 only cooperates with tGLI1 in immortalized mammary epithelial cells. In summary, our study identified novel physical and functional cooperation between two families of oncogenic transcription factors, and the interaction contributes to aggressiveness of breast cancer cells and poor prognosis of triple-negative breast cancers and HER2-enriched breast cancers.	[Sirkisoon, Sherona R.; Carpenter, Richard L.; Rimkus, Tadas; Anderson, Ashley; Harrison, Alexandria; Lange, Allison M.; Watabe, Kounosuke; Lo, Hui-Wen] Dept Canc Biol, Winston Salem, NC 27104 USA; [Jin, Guangxu] Dept Radiol, Winston Salem, NC USA; [Watabe, Kounosuke; Lo, Hui-Wen] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Comprehens Canc Ctr, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center	Lo, HW (corresponding author), Dept Canc Biol, Winston Salem, NC 27104 USA.; Lo, HW (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Comprehens Canc Ctr, Winston Salem, NC 27109 USA.	hlo@wakehealth.edu		Carpenter, Richard/0000-0001-9986-6493	NIH [R01NS087169, T32CA079448, R01NS087169-3S1, P30CA012197]; DoD grant [W81XWH17-1-0044]; NATIONAL CANCER INSTITUTE [T32CA079448, P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge our colleagues Dr. Shadi Qasem for providing pathology support, and funding support for this project from NIH grants R01NS087169 (to H-WL), T32CA079448 (to SK, RLC), R01NS087169-3S1 (to H-WL and SRS), P30CA012197 (to BP; core facility), and DoD grant W81XWH17-1-0044 (to H-WL).	Abou-Bakr AA, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.317; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Balko JM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3001; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brouckaert O, 2012, INT J WOMENS HEALTH, V4, P511, DOI 10.2147/IJWH.S18541; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Carpenter RL, 2015, ONCOGENE, V34, P546, DOI 10.1038/onc.2013.582; Carpenter RL, 2015, ONCOTARGET, V6, P22653, DOI 10.18632/oncotarget.4248; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Clark GJ, 1996, ONCOGENE, V12, P169; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dahmane N, 2001, DEVELOPMENT, V128, P5201; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Brot M, 2009, REV ASSOC MED BRAS, V55, P529, DOI 10.1590/S0104-42302009000500014; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Fu XY, 1999, CELL DEATH DIFFER, V6, P1201, DOI 10.1038/sj.cdd.4400613; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Graham SM, 1999, ONCOGENE, V18, P2107, DOI 10.1038/sj.onc.1202517; Guo CC, 2012, P NATL ACAD SCI USA, V109, P17603, DOI 10.1073/pnas.1208807109; Han W, 2013, CANC HALLMARKS, V1, P28, DOI DOI 10.1166/CH.2013.1006; Han W, 2013, MOL CARCINOGEN, V52, P959, DOI 10.1002/mc.21936; Kameda C, 2009, ANTICANCER RES, V29, P871; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuba S, 2014, JPN J CLIN ONCOL, V44, P1025, DOI 10.1093/jjco/hyu126; Langlois B, 2014, ONCOTARGET, V5, P10529, DOI 10.18632/oncotarget.2470; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larive RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4881; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Milla LA, 2012, BIOL RES, V45, P223, DOI 10.4067/S0716-97602012000300004; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Shi XJ, 2017, AM J PATHOL, V187, P679, DOI 10.1016/j.ajpath.2016.11.005; Shi XJ, 2015, FEBS LETT, V589, P1771, DOI 10.1016/j.febslet.2015.06.017; Shi XJ, 2012, CELL CYCLE, V11, P1554, DOI 10.4161/cc.19954; Shi XJ, 2011, J BIOL CHEM, V286, P33401, DOI 10.1074/jbc.M111.252262; Shum EY, 2016, CELL, V165, P382, DOI 10.1016/j.cell.2016.02.046; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xu LS, 2010, BREAST CANCER RES TR, V123, P59, DOI 10.1007/s10549-009-0617-5; Yang Q, 2012, EXP MOL PATHOL, V93, P227, DOI 10.1016/j.yexmp.2012.04.009; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu H, 2014, CANCER LETT, V343, P51, DOI 10.1016/j.canlet.2013.09.014; Zhu H, 2010, CURR GENOMICS, V11, P238, DOI 10.2174/138920210791233108	66	57	59	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19					2502	2514		10.1038/s41388-018-0132-4	http://dx.doi.org/10.1038/s41388-018-0132-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29449694	Green Accepted			2022-12-26	WOS:000431873400004
J	Li, N; Truong, S; Nouri, M; Moore, J; Al Nakouzi, N; Lubik, AA; Buttyan, R				Li, Na; Truong, Sarah; Nouri, Mannan; Moore, Jackson; Al Nakouzi, Nader; Lubik, Amy Anne; Buttyan, Ralph			Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3	ONCOGENE			English	Article							SIGNALING PATHWAY; PROLIFERATION; TARGET; STEROIDOGENESIS; INTERFERENCE; DEGRADATION; MECHANISMS; PROTEASOME; RESISTANCE; PROMOTER	Hedgehog (Hh) is an oncogenic signaling pathway that regulates the activity of Gli transcription factors. Canonical Hh is a Smoothened-(Smo-) driven process that alters the post-translational processing of Gli2/Gli3 proteins. Though evidence supports a role for Gli action in prostate cancer (PCa) cell growth and progression, there is little indication that Smo is involved. Here we describe a non-canonical means for activation of Gli transcription in PCa cells mediated by the binding of transcriptionally-active androgen receptors (ARs) to Gli3. Androgens stimulated reporter expression from a Gli-dependent promoter in a variety of AR + PCa cells and this activity was suppressed by an anti-androgen, Enz, or by AR knockdown. Androgens also upregulated expression of endogenous Gli-dependent genes. This activity was associated with increased intranuclear binding of Gli3 to AR that was antagonized by Enz. Fine mapping of the AR binding domain on Gli2 showed that AR recognizes the Gli protein processing domain (PPD) in the C-terminus. Mutations in the arginine-/serine repeat elements of the Gli2 PPD involved in phosphorylation and ubiquitinylation blocked the binding to AR. beta-TrCP, a ubiquitin ligase that recognizes the Gli PPD, competed with AR for binding to this site. AR binding to Gli3 suppressed its proteolytic processing to the Gli3 repressor form (Gli3R) whereas AR knockdown increased Gli3R. Both full-length and truncated ARs were able to activate Gli transcription. Finally, we found that an ARbinding decoy polypeptide derived from the Gli2 Cterminus can compete with Gli3 for binding to AR. Exogenous overexpression of this decoy suppressed Gli transcriptional activity in PCa cells. Collectively, this work identifies a novel pathway for non-canonical activation of Hh signaling in PCa cells and identifies a means for interference that may have clinical relevance for PCa patients.	[Li, Na; Truong, Sarah; Moore, Jackson; Al Nakouzi, Nader; Lubik, Amy Anne] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Truong, Sarah; Nouri, Mannan; Buttyan, Ralph] Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC, Canada; [Buttyan, Ralph] Univ British Columbia, Urol Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Buttyan, R (corresponding author), Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC, Canada.; Buttyan, R (corresponding author), Univ British Columbia, Urol Sci, Vancouver, BC, Canada.	rbuttyan@prostatecentre.com		Nouri, Mannan/0000-0002-7442-9251	Canadian Institutes of Health Research [CIHR258931]; Prostate Cancer Canada-Movember Team [T2103]; US Department of Defense [PCRP W81XWH-10-1-0493]; Terry Fox Research Institute New Frontiers [PPG 1062]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Canada-Movember Team; US Department of Defense(United States Department of Defense); Terry Fox Research Institute New Frontiers	The authors acknowledge the helpful assistance of Dr Mengqian Chen of the South Carolina School of Pharmacy in the generation of the human Gli3 expression vector. Sources of Support: Canadian Institutes of Health Research (CIHR258931); Prostate Cancer Canada-Movember Team T2103; US Department of Defense PCRP W81XWH-10-1-0493; Terry Fox Research Institute New Frontiers PPG 1062.	Agathocleous M, 2007, CELL CYCLE, V6, P156, DOI 10.4161/cc.6.2.3745; Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Finco I, 2015, ANNU REV PHYSIOL, V77, P105, DOI 10.1146/annurev-physiol-061214-111754; Han BC, 2015, CELL REP, V13, P1046, DOI 10.1016/j.celrep.2015.09.063; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Koebernick K, 2002, DIFFERENTIATION, V70, P69, DOI 10.1046/j.1432-0436.2002.700201.x; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Levina E, 2012, PROSTATE, V72, P817, DOI 10.1002/pros.21500; Li N, 2014, PROSTATE, V74, P1400, DOI 10.1002/pros.22855; Lubik AA, 2017, INT J CANCER, V140, P358, DOI 10.1002/ijc.30450; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Penning TM, 2015, J STEROID BIOCHEM, V153, P105, DOI 10.1016/j.jsbmb.2015.05.010; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Schrader EK, 2011, J BIOL CHEM, V286, P39051, DOI 10.1074/jbc.M111.274993; Sirab N, 2012, INT J CANCER, V131, P1297, DOI 10.1002/ijc.27384; Stecca B, 2005, TRENDS MOL MED, V11, P199, DOI 10.1016/j.molmed.2005.03.004; Tickle C, 2013, WIRES DEV BIOL, V2, P275, DOI 10.1002/wdev.70; Toftgard R, 2000, CELL MOL LIFE SCI, V57, P1720, DOI 10.1007/PL00000654; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Ware KE, 2014, ENDOCR-RELAT CANCER, V21, pT87, DOI 10.1530/ERC-13-0470; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Xavier GM, 2016, DEV BIOL, V415, P198, DOI 10.1016/j.ydbio.2016.02.009; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhou JC, 2016, CANCER LETT, V370, P313, DOI 10.1016/j.canlet.2015.11.006; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	42	20	21	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2313	2325		10.1038/s41388-017-0098-7	http://dx.doi.org/10.1038/s41388-017-0098-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29429990	hybrid, Green Published			2022-12-26	WOS:000431100200008
J	Galea, JT; Wong, M; Munoz, M; Valle, E; Leon, SR; Perez, DD; Kolevic, L; Franke, M				Galea, Jerome T.; Wong, Milagros; Munoz, Maribel; Valle, Emiliano; Leon, Segundo R.; Diaz Perez, Dayana; Kolevic, Lenka; Franke, Molly			Barriers and facilitators to antiretroviral therapy adherence among Peruvian adolescents living with HIV: A qualitative study	PLOS ONE			English	Article							PERINATALLY ACQUIRED HIV; MEDICATION ADHERENCE; YOUTH; CHALLENGES; INFECTION; CHILDREN; AFRICA; HEALTH	AIDS deaths among adolescents are increasing globally. This qualitative study investigated the barriers and facilitators to cART adherence among Peruvian adolescents living with HIV. Guided by a social ecological model, we analyzed transcripts from 24 psychosocial support groups for HIV-positive adolescents aged 13-17 years and 15 individual, in-depth interviews with cART providers and caregivers to identify the barriers and facilitators to cART adherence at the individual, family/caregiver and hospital levels. Most barriers and facilitators to cART adherence clustered at the individual and family/caregiver levels, centering on support provided to adolescents; history of declining health due to suboptimal cART adherence; side effects from antiretroviral drugs; and cART misinformation. Interventions to support adolescent HIV cART adherence should begin at the individual and family/caregiver levels and include an educational component. No adolescent living with HIV should die from AIDS in an era of accessible cART.	[Galea, Jerome T.; Franke, Molly] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02215 USA; [Galea, Jerome T.; Wong, Milagros; Munoz, Maribel; Valle, Emiliano; Leon, Segundo R.] Socios Salud, Lima, Peru; [Diaz Perez, Dayana; Kolevic, Lenka] Inst Nacl Salud Nino, Lima, Peru	Harvard University; Harvard Medical School	Galea, JT (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02215 USA.; Galea, JT (corresponding author), Socios Salud, Lima, Peru.	jerome_galea@hms.harvard.edu	Galea, Jerome T./AAF-2172-2019; Galea, Jerome T/HGV-0203-2022; Leon, Segundo Ramos/J-3058-2019; Franke, Molly/AAK-7559-2020	Galea, Jerome T./0000-0001-8732-6959; Galea, Jerome T/0000-0001-8732-6959; Leon, Segundo Ramos/0000-0002-5630-5714; Franke, Molly/0000-0002-4890-5728; Kolevic-Roca, Lenka Angelita/0000-0003-0433-3622	Harvard University; David Rockefeller Center of Harvard University; Abundance Foundation Fellowship in Global Mental Health Implementation Science	Harvard University; David Rockefeller Center of Harvard University; Abundance Foundation Fellowship in Global Mental Health Implementation Science	The authors declare that no competing financial interests exist. Dr. Franke received funding from The William F. Milton Fund of Harvard University and the David Rockefeller Center of Harvard University. Dr. Galea received support from the Abundance Foundation Fellowship in Global Mental Health Implementation Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Ankrah DNA, 2016, PATIENT PREFER ADHER, V10, P329, DOI 10.2147/PPA.S96691; [Anonymous], SUPPL 2013 CONS GUID; [Anonymous], 2016, EVERY CHILD END AIDS; Bernays S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012934; Bhana A, 2014, AIDS CARE, V26, P1, DOI 10.1080/09540121.2013.806770; Burack G, 2010, J PEDIATR NURS, V25, P500, DOI 10.1016/j.pedn.2009.07.002; Butler K, 2016, LANCET HIV, V3, pE421, DOI 10.1016/S2352-3018(16)30054-6; Denison JA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19358; Dowse R, 2014, AIDS CARE, V26, P1400, DOI 10.1080/09540121.2014.931559; Erikson E., 1963, YOUTH CHANGE CHALLEN; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Kacanek D, 2015, AIDS, V29, P1227, DOI 10.1097/QAD.0000000000000697; Kim SH, 2015, AIDS PATIENT CARE ST, V29, P354, DOI 10.1089/apc.2014.0335; Kim SH, 2014, AIDS, V28, P1945, DOI 10.1097/QAD.0000000000000316; Kuhns LM, 2016, AIDS PATIENT CARE ST, V30, P185, DOI 10.1089/apc.2015.0328; Crozatti MTL, 2013, AIDS CARE, V25, P1462, DOI 10.1080/09540121.2013.774312; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Ministerio de Salud del Peru, 2014, INF NAC PROGR REAL P; Mofenson LM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18650; Naar-King S, 2013, J PEDIATR PSYCHOL, V38, P664, DOI 10.1093/jpepsy/jst017; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nyogea D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0753-y; Olds PK, 2015, AIDS BEHAV, V19, P584, DOI 10.1007/s10461-014-0924-7; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Pineirua A, 2015, LANCET INFECT DIS, V15, P833, DOI 10.1016/S1473-3099(15)00108-5; Reisner Sari L, 2009, Top HIV Med, V17, P14; Schlatter AF, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/1654938; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; UNAIDS, 2016, GLOB AIDS	33	14	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192791	10.1371/journal.pone.0192791	http://dx.doi.org/10.1371/journal.pone.0192791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447226	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900056
J	Romero-Espinoza, JA; Moreno-Valencia, Y; Coronel-Tellez, RH; Castillejos-Lopez, M; Hernandez, A; Dominguez, A; Miliar-Garcia, A; Barbachano-Guerrero, A; Perez-Padilla, R; Alejandre-Garcia, A; Vazquez-Perez, JA				Romero-Espinoza, Jose A.; Moreno-Valencia, Yazmin; Coronel-Tellez, Rodrigo H.; Castillejos-Lopez, Manuel; Hernandez, Andres; Dominguez, Aaron; Miliar-Garcia, Angel; Barbachano-Guerrero, Arturo; Perez-Padilla, Rogelio; Alejandre-Garcia, Alejandro; Vazquez-Perez, Joel A.			Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; MICROBIOME; SEVERITY; DISEASE; SAMPLES	Background Acute asthma exacerbations and pneumonia are important causes of morbidity and mortality in children and may coexist in the same children, although symptom overlap may lead to difficulties in diagnosis. Microbial and viral diversity and differential abundance of either may play an important role in infection susceptibility and the development of acute and chronic respiratory diseases. Objectives To describe the virome and bacteriome present in the upper respiratory tract of hospitalized children with a clinical diagnosis of asthma and pneumonia during an acute exacerbation and an acute respiratory illness ARI episode respectively. Methods During the winter seasons of 2013-2014 and 2014-2015, 134 nasopharyngeal swabs samples of children < 15 years of age with ARI hospitalized at a referral hospital for respiratory diseases were selected based on clinical diagnosis of asthma or pneumonia. The virome and bacteriome were characterized using Whole Genome Sequencing (WGS) and in-house bioinformatics analysis pipeline. Results The Asthma group was represented mainly by RV-C, BoV-1 and RSV-B and the pneumonia group by Bacteriophage EJ-1 and TTMV. TTV was found in both groups with a similar amount of reads. About bacterial composition Moraxella catarrhalis, Propionibacterium acnes and Acinetobacter were present in asthma and Veillonella parvula and Mycoplasma pneumoniae in pneumonia. Streptococcus pneumoniae and Haemophilus influenzae were mostly found with both asthma and pneumonia. Conclusions Our results show a complex viral and bacterial composition in asthma and pneumonia groups with a strong association of RV-C presence in asthmatic children. We observed Streptococcus pneumoniae and Haemophilus influenzae concurrently in both groups.	[Romero-Espinoza, Jose A.; Moreno-Valencia, Yazmin; Vazquez-Perez, Joel A.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Virol, Mexico City, DF, Mexico; [Coronel-Tellez, Rodrigo H.] Inst Biol Integrat Cellule, Signalisat & Reseaux Regulat Bacteriens, Paris, France; [Castillejos-Lopez, Manuel; Hernandez, Andres] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Vigilancia Epidemiol, Mexico City, DF, Mexico; [Dominguez, Aaron; Miliar-Garcia, Angel] Inst Politecn Nacl, Escuela Super Med, Secc Posgrad & Invest, Mexico City, DF, Mexico; [Barbachano-Guerrero, Arturo] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Perez-Padilla, Rogelio] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Tabaquismo, Mexico City, DF, Mexico; [Perez-Padilla, Rogelio] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, EPOC, Mexico City, DF, Mexico; [Alejandre-Garcia, Alejandro] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Unidad Urgencias Pediat, Mexico City, DF, Mexico	UDICE-French Research Universities; Universite Paris Saclay; Instituto Politecnico Nacional - Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Vazquez-Perez, JA (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Virol, Mexico City, DF, Mexico.	joevazpe@gmail.com	Vazquez-Perez, Joel/F-3476-2019; HERNANDEZ-GARCIA, ANDRES/B-9051-2014	Vazquez-Perez, Joel/0000-0002-8508-3698; HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Coronel-Tellez, Rodrigo Hernan/0000-0002-8041-8196; Castillejos-Lopez, Manuel de Jesus/0000-0001-8689-9755; Barbachano-Guerrero, Arturo/0000-0001-7483-839X; Romero Espinoza, Jose Angel Ivan/0000-0001-8568-5333	Institute de Ciencia y Tecnologia DF (ICYTDF) [PICSA12-64]; Fundacion Miguel Aleman A.G	Institute de Ciencia y Tecnologia DF (ICYTDF); Fundacion Miguel Aleman A.G	This work was supported by Institute de Ciencia y Tecnologia DF (ICYTDF) grant PICSA12-64 to JAVP and Fundacion Miguel Aleman A.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal A, 2016, J CLIN VIROL, V82, pS5, DOI 10.1016/j.jcv.2016.08.010; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Dupouey J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-31; Dy R, 2016, CURR OPIN PULM MED, V22, P196, DOI 10.1097/MCP.0000000000000268; Feldman AS, 2015, PEDIAT ALLER IMM PUL, V28, P117, DOI 10.1089/ped.2014.0463; Feyzioglu B, 2014, INT J CLIN EXP MED, V7, P3461; Galmes J, 2013, EUR RESPIR J, V42, P470, DOI 10.1183/09031936.00107212; Gao Zhancheng, 2014, Genomics Proteomics & Bioinformatics, V12, P144, DOI 10.1016/j.gpb.2014.06.001; Ge XL, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.23; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Kowalski ML, 2017, ALLERGY; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Kwon Jang-Mi, 2014, Korean J Pediatr, V57, P29, DOI 10.3345/kjp.2014.57.1.29; Lee KH, 2016, EVOL MED PUBLIC HLTH, P95, DOI 10.1093/emph/eow007; Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875; Moesker F M, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.06.014; Moreno-Valencia Y, 2015, INFLUENZA OTHER RESP; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Pifferi M, 2005, J INFECT DIS, V192, P1141, DOI 10.1086/444389; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Sachdev H P, 1994, Indian Pediatr, V31, P1251; Taboada B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113570; Taylor SL, 2016, CELL MICROBIOL, V18, P652, DOI 10.1111/cmi.12589; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Vazquez-Perez JA, 2016, INFLUENZA OTHER RESP, V10, P154, DOI 10.1111/irv.12384; Wang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.01.006; Wiersbitzky S, 1991, Kinderarztl Prax, V59, P299; Wylie K.M., 2012, PLOS ONE, V7, P10, DOI DOI 10.1371/J0URNAL.P0NE.0027735; Yang J, 2011, J CLIN MICROBIOL, V49, P3463, DOI 10.1128/JCM.00273-11; Yoon H, 2017, J KOREAN MED SCI, V32, P287, DOI 10.3346/jkms.2017.32.2.287; Zoll J, 2015, J CLIN VIROL, V66, P6, DOI 10.1016/j.jcv.2015.02.010	33	22	22	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192878	10.1371/journal.pone.0192878	http://dx.doi.org/10.1371/journal.pone.0192878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447223	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900065
J	Gunnarsdottir, J; Cnattingius, S; Lundgren, M; Selling, K; Hogberg, U; Wikstrom, AK				Gunnarsdottir, Johanna; Cnattingius, Sven; Lundgren, Maria; Selling, Katarina; Hogberg, Ulf; Wikstrom, Anna-Karin			Prenatal exposure to preeclampsia is associated with accelerated height gain in early childhood	PLOS ONE			English	Article							BODY-MASS INDEX; CATCH-UP GROWTH; RISK-FACTORS; GESTATIONAL HYPERTENSION; REFERENCE VALUES; PRETERM BIRTH; HEART-DISEASE; FINAL HEIGHT; LATER LIFE; IN-UTERO	Background Preeclampsia is associated with low birth weight, both because of increased risks of preterm and of small-for-gestational-age (SGA) births. Low birth weight is associated with accelerated childhood height gain and cardiovascular diseases later in life. The aim was to investigate if prenatal exposure to preeclampsia is associated with accelerated childhood height gain, also after adjustments for SGA-status and gestational age at birth. Methods In a cohort of children prenatally exposed to preeclampsia (n = 865) or unexposed (n = 22,898) we estimated height gain between birth and five years of age. The mean difference in height gain between exposed and unexposed children was calculated and adjustments were done with linear regression models. Results Children exposed to preeclampsia were on average born shorter than unexposed. Exposed children grew on average two cm more than unexposed from birth to five years of age. After adjustments for maternal characteristics including socioeconomic factors, height, body mass index (BMI) and diabetes, as well as for parents smoking habits, infant's breastfeeding and childhood obesity, the difference was 1.6 cm (95% CI 1.3-1.9 cm). Further adjustment for SGA birth only slightly attenuated this estimate, but adjustment for gestational age at birth decreased the estimate to 0.5 cm (95% CI 0.1-0.7 cm). Conclusion Prenatal exposure to preeclampsia is associated with accelerated height gain in early childhood. The association seemed independent on SGA-status, but partly related to shorter gestational age at birth.	[Gunnarsdottir, Johanna; Lundgren, Maria; Selling, Katarina; Hogberg, Ulf; Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Cnattingius, Sven; Wikstrom, Anna-Karin] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Gunnarsdottir, J (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	johanna.gunnardottir@kbh.uu.se		Gunnarsdottir, Johanna/0000-0002-2989-7160	Fodelsefonden; Swedish Research Council [2014-3561]	Fodelsefonden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Johanna Gunnarsdottir received stipend from Fodelsefonden, donated from the parents of Josephine Neiman. Dr Wikstrom was supported by the Swedish Research Council, project number 2014-3561.	Anderson CM, 2014, BIOL RES NURS, V16, P409, DOI 10.1177/1099800413508645; BARKER DJP, 1989, LANCET, V2, P577; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Barquera S, 2015, ARCH MED RES, V46, P328, DOI 10.1016/j.arcmed.2015.06.006; Beukers F, 2013, ARCH DIS CHILD, V98, P30, DOI 10.1136/archdischild-2012-302510; Bocca-Tjeertes IFA, 2013, NEONATOLOGY, V103, P293, DOI 10.1159/000347094; Botton J, 2010, EARLY HUM DEV, V86, P445, DOI 10.1016/j.earlhumdev.2010.06.001; Byberg KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176627; Conti E, 2013, CYTOKINE GROWTH F R, V24, P411, DOI 10.1016/j.cytogfr.2013.05.008; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Derraik JGB, 2017, AM J EPIDEMIOL, V185, P48, DOI 10.1093/aje/kww116; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Geelhoed JJM, 2010, CIRCULATION, V122, P1192, DOI 10.1161/CIRCULATIONAHA.110.936674; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Halldorsson TI, 2011, HYPERTENSION, V58, P8, DOI 10.1161/HYPERTENSIONAHA.111.170985; He J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-472; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Li LJ, 2016, J CLIN ENDOCR METAB, V101, P1816, DOI 10.1210/jc.2015-3760; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P590, DOI 10.1016/0002-9378(95)90287-2; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Regnault N, 2010, AM J CLIN NUTR, V92, P594, DOI 10.3945/ajcn.2010.29292; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Ros HS, 2001, PEDIATR RES, V49, P763, DOI 10.1203/00006450-200106000-00008; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Scioscia M, 2015, J REPROD IMMUNOL, V108, P42, DOI 10.1016/j.jri.2015.01.009; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Wallby T, 2011, ACTA PAEDIATR, V100, P1495, DOI 10.1111/j.1651-2227.2011.02344.x; Wells JCK, 2012, REV ENDOCR METAB DIS, V13, P93, DOI 10.1007/s11154-012-9213-9; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216	34	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192514	10.1371/journal.pone.0192514	http://dx.doi.org/10.1371/journal.pone.0192514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438394	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400026
J	Kalmbach, DA; Pillai, V; Drake, CL				Kalmbach, David A.; Pillai, Vivek; Drake, Christopher L.			Nocturnal insomnia symptoms and stress-induced cognitive intrusions in risk for depression: A 2-year prospective study	PLOS ONE			English	Article							SLEEP DISTURBANCE; RUMINATION; WORRY; MINDFULNESS; PATHWAY; MODEL; ONSET; MOOD	Nearly half of US adults endorse insomnia symptoms. Sleep problems increase risk for depression during stress, but the mechanisms are unclear. During high stress, individuals having difficulty falling or staying asleep may be vulnerable to cognitive intrusions after stressful events, given that the inability to sleep creates a period of unstructured and socially isolated time in bed. We investigated the unique and combined effects of insomnia symptoms and stress-induced cognitive intrusions on risk for incident depression. 1126 non-depressed US adults with no history of DSM-5 insomnia disorder completed 3 annual web-based surveys on sleep, stress, and depression. We examined whether nocturnal insomnia symptoms and stress-induced cognitive intrusions predicted depression 1y and 2y later. Finally, we compared depression-risk across four groups: non-perseverators with good sleep, non-perseverators with insomnia symptoms, perseverators with good sleep, and perseverators with insomnia symptoms. Insomnia symptoms (beta = .10-.13, p<.001) and cognitive intrusions (beta = .19-.20, p<.001) predicted depression severity 1y and 2y later. Depression incidence across 2 years was 6.2%. Perseverators with insomnia had the highest rates of depression (13.0%), whereas good sleeping non-perseverators had the lowest rates (3.3%, Relative Risk = 3.94). Perseverators with sleep latency >30 m reported greater depression than good sleeping perseverators (t = 2.09, p<.04). Cognitive intrusions following stress creates a depressogenic mindset, and nocturnal wakefulness may augment the effects of cognitive arousal on depression development. Poor sleepers may be especially vulnerable to cognitive intrusions when having difficulty initiating sleep. As treatable behaviors, nighttime wakefulness and cognitive arousal may be targeted to reduce risk for depression in poor sleepers.	[Kalmbach, David A.] Univ Michigan, Dept Psychiat, Med Sch, Ann Arbor, MI 48109 USA; [Pillai, Vivek; Drake, Christopher L.] Henry Ford Hosp, Sleep Disorders & Res Ctr, Detroit, MI 48202 USA	University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital	Drake, CL (corresponding author), Henry Ford Hosp, Sleep Disorders & Res Ctr, Detroit, MI 48202 USA.	cdrake1@hfhs.org	Kalmbach, David/GVS-3289-2022; Drake, Christopher/L-6274-2017	Drake, Christopher/0000-0002-5486-3587	NIMH Grant [R01 MH082785]; NHLBI Grant [T32 HL110952]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110952] Funding Source: NIH RePORTER	NIMH Grant; NHLBI Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by an NIMH Grant (R01 MH082785) awarded to Dr. Drake. Dr. Kalmbach's effort was supported by an NHLBI Grant (T32 HL110952) awarded to Dr. Allan I. Pack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Batterham PJ, 2012, AUST NZ J PSYCHIAT, V46, P1089, DOI 10.1177/0004867412457997; Berset M, 2011, STRESS HLTH, V27; Bootzin RR, 1997, UNDERSTANDING SLEEP, P315; Brosschot JF, 2007, INT J PSYCHOPHYSIOL, V63, P39, DOI 10.1016/j.ijpsycho.2006.07.016; Calmes CA, 2007, COGNITIVE THER RES, V31, P343, DOI 10.1007/s10608-006-9026-9; Carney Colleen E, 2006, Behav Sleep Med, V4, P228, DOI 10.1207/s15402010bsm0404_3; Connor-Smith JK, 2002, COGNITIVE THER RES, V26, P39, DOI 10.1023/A:1013889504101; Deyo M, 2009, EXPLORE-NY, V5, P265, DOI 10.1016/j.explore.2009.06.005; Dickson KS, 2012, BEHAV THER, V43, P629, DOI 10.1016/j.beth.2011.11.002; Drake CL, 2014, SLEEP, V37, P1295, DOI 10.5665/sleep.3916; Drake CL, 2015, SLEEP, V39, P13; Espie CA, 2006, SLEEP MED REV, V10, P215, DOI 10.1016/j.smrv.2006.03.002; Espie CA, 2013, SLEEP MED CLIN, V8, P407, DOI 10.1016/j.jsmc.2013.06.001; Fernandez-Mendoza J, 2014, J SLEEP RES, V23, P489, DOI 10.1111/jsr.12168; Fernandez-Mendoza J, 2010, PSYCHOSOM MED, V72, P397, DOI 10.1097/PSY.0b013e3181d75319; Grandner MA, 2013, J CLIN SLEEP MED, V9, P897, DOI 10.5664/jcsm.2990; Guastella AJ, 2007, PERS INDIV DIFFER, V42, P1151, DOI 10.1016/j.paid.2006.04.028; Harvey A. G, 2002, J COGN PSYCHOTHER, V16, P161, DOI DOI 10.1891/JC0P.16.2.161.63992; Harvey AG, 2000, BRIT J CLIN PSYCHOL, V39, P275, DOI 10.1348/014466500163284; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; Hobson CJ, 1998, INT J STRESS MANAGE, V5, P1, DOI 10.1023/A:1022978019315; Hom MA, 2017, J AFFECT DISORDERS, V209, P114, DOI 10.1016/j.jad.2016.11.032; Jackson CL, 2015, ANNU REV PUBL HEALTH, V36, P417, DOI 10.1146/annurev-publhealth-031914-122838; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Kalmbach DA, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw048; Kalmbach DA, 2016, SLEEP, V39, P2101, DOI 10.5665/sleep.6306; Kalmbach DA, 2016, SLEEP MED, V21, P63, DOI 10.1016/j.sleep.2016.02.005; Kalmbach DA, 2016, SLEEP, V39, P449, DOI 10.5665/sleep.5462; Kalmbach DA, 2016, AUST J PSYCHOL, V68, P52, DOI 10.1111/ajpy.12090; Kendler KS, 2000, AM J PSYCHIAT; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; LICHSTEIN KL, 1980, J ABNORM PSYCHOL, V89, P105, DOI 10.1037/0021-843X.89.1.105; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Luik AI, 2017, CURRENT SLEEP MED RE, P1; Michl LC, 2013, J ABNORM PSYCHOL, V122, P339, DOI 10.1037/a0031994; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Palagini L, 2015, ARCH ITAL BIOL, V153; Palagini L, 2017, SLEEP MED, V30, P97, DOI 10.1016/j.sleep.2016.11.004; Perlis ML, 1997, J AFFECT DISORDERS, V42, P209, DOI 10.1016/S0165-0327(96)01411-5; Petrov ME, 2015, SLEEP MED; Pigeon W., 2007, INT J SLEEP DISORD, V1, P82, DOI DOI 10.1007/S11920-009-0066-1; Pillai V, 2014, SLEEP; Pillai V, 2014, SLEEP AFFECT ASSESSM, P201; Pillai V, 2014, SLEEP, V37, P1199, DOI 10.5665/sleep.3838; Pillai V, 2014, J PSYCHOSOM RES, V77, P70, DOI 10.1016/j.jpsychores.2014.05.004; Riemann D, 2012, PHARMACOPSYCHIATRY, V45, P167, DOI 10.1055/s-0031-1299721; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Robinson MS, 2003, COGNITIVE THER RES, V27, P275, DOI 10.1023/A:1023914416469; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sadeh A, 2004, HEALTH PSYCHOL, V23, P542, DOI 10.1037/0278-6133.23.5.542; Schmidt RE, 2011, INT J AGING HUM DEV, V73, P371, DOI 10.2190/AG.73.4.f; Scully JA, 2000, EDUC PSYCHOL MEAS, V60, P864, DOI 10.1177/00131640021970952; Segerstrom SC, 2000, COGNITIVE THER RES, V24, P671, DOI 10.1023/A:1005587311498; Singareddy R, 2012, SLEEP MED, V13, P346, DOI 10.1016/j.sleep.2011.10.033; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; Taylor DJ, 2008, SLEEP, V31, P447, DOI 10.1093/sleep/31.4.447; Thomsen DK, 2003, PERS INDIV DIFFER, V34, P1293, DOI 10.1016/S0191-8869(02)00120-4; Thomsen DK, 2006, COGNITION EMOTION, V20, P1216, DOI 10.1080/02699930500473533; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Weiss Daniel S., 1997, P399; Zoccola PM, 2009, PSYCHOSOM MED, V71, P771, DOI 10.1097/PSY.0b013e3181ae58e8	69	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192088	10.1371/journal.pone.0192088	http://dx.doi.org/10.1371/journal.pone.0192088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW1TV	29438400	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400010
J	Kawakami, R; Nozato, Y; Nakagami, H; Ikeda, Y; Shimamura, M; Yoshida, S; Sun, J; Kawano, T; Takami, Y; Noma, T; Rakugi, H; Minamino, T; Morishita, R				Kawakami, Ryo; Nozato, Yoichi; Nakagami, Hironori; Ikeda, Yuka; Shimamura, Munehisa; Yoshida, Shota; Sun, Jiao; Kawano, Tomohiro; Takami, Yoichi; Noma, Takahisa; Rakugi, Hiromi; Minamino, Tetsuo; Morishita, Ryuichi			Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; C-TERMINAL DOMAIN; FAMILIAL HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; LDL; CHOLESTEROL; DEFICIENCY; ANTIBODY; BINDING	Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates expression of low-density lipoprotein (LDL) receptors via receptor internalization and subsequent lysosomal degradation. Thus, an anti-PCSK9 antibody is well known as an anti-hyperlipidemia drug. Here, we aimed to develop vaccine for a long-term treatment of dyslipidemia targeted to PCSK9. In This study, we designed a peptide vaccine for mouse PCSK-9, which consisted of short peptides conjugated to keyhole limpet hemocyanin (KLH) as a carrier protein. Vaccines were administered to male apolipoprotein E (ApoE) deficient mice with adjuvants and significantly elicited an antibody response against PCSK9. The PCSK9 vaccines were administered to mice three times in 2-week intervals, and antibody titers and lipoprotein levels were evaluated up to 24 weeks after the first immunization to determine the therapeutic effect. Anti-PCSK9 antibody titers reached peak levels 6 weeks after the first immunization, and theses titers were maintained for up to 24 weeks. Decreased plasma levels of total cholesterol, very low-density lipoprotein (VLDL), and chylomicron (CM) were maintained for up to 24 weeks. Immunized mice exhibited a significant increase in cell-surface LDL receptor expression. Stimulation with KLH, but not PCSK9, induced the production of INF-gamma and interleukin-4 (IL-4), as determined with ELISPOT assays, thus indicating that PCSK9 vaccine did not elicit T-cell activation in our vaccine system. The present anti-PCSK9 vaccine induced long-lasting anti-PCSK9 antibody production and improved lipoprotein profiles. Thus, anti-PCSK9 vaccine could become a new option for the treatment of dyslipidemia as a long-acting therapy in future.	[Kawakami, Ryo; Noma, Takahisa; Minamino, Tetsuo] Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Fac Med, Kagawa, Japan; [Kawakami, Ryo; Ikeda, Yuka; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Nozato, Yoichi; Takami, Yoichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, Suita, Osaka, Japan; [Nakagami, Hironori; Shimamura, Munehisa; Yoshida, Shota; Sun, Jiao] Osaka Univ, Dept Hlth Dev & Med, Grad Sch Med, Suita, Osaka, Japan; [Kawano, Tomohiro] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan	Kagawa University; Osaka University; Osaka University; Osaka University; Osaka University	Morishita, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan.; Nakagami, H (corresponding author), Osaka Univ, Dept Hlth Dev & Med, Grad Sch Med, Suita, Osaka, Japan.	nakagami@gts.med.osaka-u.ac.jp; morishit@cgt.med.osaka-u.ac.jp	Nakagami, Hironori/GLU-0570-2022	Nakagami, Hironori/0000-0003-4494-3601; Rakugi, Hiromi/0000-0001-6508-4338; Yoshida, Shota/0000-0002-6830-7063; Ikeda-Iwabu, Yuka/0000-0003-3550-7891	Japan Society for the Promotion of Science [13358176]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 13358176).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Catapano AL, 2013, ATHEROSCLEROSIS, V228, P18, DOI 10.1016/j.atherosclerosis.2013.01.044; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Crossey E, 2015, VACCINE, V33, P5747, DOI 10.1016/j.vaccine.2015.09.044; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Do RQ, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0345-z; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Galabova G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114469; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Kanduc D, 2009, EXPERT OPIN BIOL TH, V9, P45, DOI [10.1517/14712590802614041, 10.1517/14712590802614041 ]; Kanduc D, 2009, CURR PHARM DESIGN, V15, P3283, DOI 10.2174/138161209789105135; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Koriyama H, 2015, HYPERTENSION, V66, P167, DOI 10.1161/HYPERTENSIONAHA.114.04534; Liu MY, 2016, BIOCHEM BIOPH RES CO, V469, P456, DOI 10.1016/j.bbrc.2015.11.064; MasucciMagoulas L, 1997, SCIENCE, V275, P391, DOI 10.1126/science.275.5298.391; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Millar JS, 2005, ARTERIOSCL THROM VAS, V25, P560, DOI 10.1161/01.ATV.0000155323.18856.a2; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Pang ZD, 2014, P NATL ACAD SCI USA, V111, pE1256, DOI 10.1073/pnas.1322009111; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Teusink B, 2001, J BIOL CHEM, V276, P40693, DOI 10.1074/jbc.M106396200; Usui S, 2002, J LIPID RES, V43, P805; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang LW, 2012, INT J BIOL SCI, V8, P310, DOI 10.7150/ijbs.3524; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	39	28	28	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0191895	10.1371/journal.pone.0191895	http://dx.doi.org/10.1371/journal.pone.0191895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438441	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400009
J	Domingues, RMSM; Saraceni, V; Leal, MD				Soares Madeira Domingues, Rosa Maria; Saraceni, Valeria; Leal, Maria do Carmo			Mother to child transmission of HIV in Brazil: Data from the "Birth in Brazil study", a national hospital-based study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; METROPOLITAN-AREA; PREVALENCE; INFECTION; DIAGNOSIS; INFANTS; ACCESS	Aims to estimate the mother to child transmission (MTCT) of HIV among infected pregnant women identified in the "Birth in Brazil" study and to evaluate care practices provided in order to identify missed opportunities at preventing the MTCT of HIV infection in the country. Methods Descriptive study using data obtained from the consultation of different databases: the "Birth in Brazil" study database and the Brazilian National Information Systems (NIS) databases. We used cases of pregnant women infected with HIV identified in the "Birth in Brazil" study, and cases of AIDS in children under 5 years old identified in the NIS, to estimate the MTCT of HIV infection in the country, with a 95% confidence interval. We also estimated the HIV cascade (HIV diagnosis; use of antiretroviral treatment (ART) during pregnancy, labour, and for the newborn; adequate care during childbirth considering viral load at birth; and no breastfeeding) using data from the same sources. Results MTCT of HIV of 2.0% (95% CI 0.3%-13.8%). At birth, 84.0% of HIV infected woman showed a positive HIV diagnosis, 74.9% received combined ART during pregnancy, 80.7% received ART during childbirth, 77.1% received adequate care during childbirth, 86.8% of newborns received ART within the first 24 hours after birth, and 2.8% of newborns were breastfed. Considering all steps, 61.3% of the women (95% CI 48.3%-72.8%) received all available medical interventions. In the analysis restricted to women identified in the NIS, 65.3% (95% CI 48.0%-79.3%) of HIV infected women received all available medical interventions. Conclusion Brazil has healthcare policies that guarantee free access to tests, ART and substitutes for maternal milk. However, missed opportunities to prevent MTCT of HIV were identified in at least one-third of women and may be making it difficult to reach HIV-elimination targets especially in the less developed country regions.	[Soares Madeira Domingues, Rosa Maria] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DS Aids, Rio De Janeiro, Brazil; [Saraceni, Valeria] Secretaria Municipal Saude Rio de Janeiro, Coordenacao Anal Situacao Saude, Rio De Janeiro, Brazil; [Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitat Saude, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Domingues, RMSM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DS Aids, Rio De Janeiro, Brazil.	rosa.domingues@ini.fiocruz.br	Domingues, Rosa/AAS-3606-2020	Domingues, Rosa/0000-0001-5722-8127	National Council of Technological and Scientific Development (CNPq); National School of Public Health, Oswaldo Cruz Foundation (I NOVA Project); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National School of Public Health, Oswaldo Cruz Foundation (I NOVA Project); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The "Birth in Brazil' study was supported by the funding from the National Council of Technological and Scientific Development (CNPq); the National School of Public Health, Oswaldo Cruz Foundation (I NOVA Project); and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara KC, 2012, J CLIN VIROL, V54, P15, DOI 10.1016/j.jcv.2012.01.011; [Anonymous], 2012, GUIA DO US; Calvet Guilherme Amaral, 2007, Rev. bras. epidemiol., V10, P323; Camargo K R Jr, 2000, Cad Saude Publica, V16, P439; Chetty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-146; Gouveia PAD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1232; Gouveia PAD, 2013, TROP MED INT HEALTH, V18, P276, DOI 10.1111/tmi.12042; da Rosa MC, 2015, J PEDIAT-BRAZIL, V91, P523, DOI 10.1016/j.jped.2014.12.005; Dal Fabbro Márcia Maria Ferrairo Janini, 2005, Braz J Infect Dis, V9, P20, DOI 10.1590/S1413-86702005000100005; Soeiro CMD, 2011, REV SOC BRAS MED TRO, V44, P537, DOI 10.1590/S0037-86822011000500001; Delicio AM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-35; Department of HIV/AIDs the Global Hepatitis Programme, 2017, WORLD HEP DAY 2017; de Lemos LMD, 2015, REV SOC BRAS MED TRO, V48, P326, DOI 10.1590/0037-8682-0257-2014; Gibbons L, 2010, 30 WHO; Hoffmann IC, 2016, SAO PAULO MED J, V134, P508, DOI 10.1590/1516-3180.2016.0139140616; Idele P, 2017, AIDS BEHAV, V21, pS23, DOI 10.1007/s10461-016-1670-9; Kakehasi FM, 2008, MEM I OSWALDO CRUZ, V103, P351, DOI 10.1590/S0074-02762008000400007; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; Matida LH, 2011, JAIDS-J ACQ IMM DEF, V57, pS164, DOI 10.1097/QAI.0b013e31821e9d13; Pereira GFM, 2016, REV BRAS GINECOL OBS, V38, P391, DOI 10.1055/s-0036-1592102; Ministerio da Saude. Secretaria de Vigilancia em Saude - Departamento de DST Aids e Hepatites Virais, 2016, MIN SAUD B EP HIV AI; Miranda AE, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00118215; Panditrao M, 2011, AIDS CARE, V23, P593, DOI 10.1080/09540121.2010.516348; Araujo ESP, 2014, BRAZ J INFECT DIS, V18, P252, DOI 10.1016/j.bjid.2013.11.002; Domingues RMSM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0837-8; Vasconcelos MTL, 2014, CAD SAUDE PUBLICA S1, V30, P549; Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2014, GLOB GUID CRIT PROC	29	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192985	10.1371/journal.pone.0192985	http://dx.doi.org/10.1371/journal.pone.0192985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438439	Green Published, gold, Green Submitted			2022-12-26	WOS:000425083400065
J	Wu, ZQ; Zou, Q; Chang, T; Zhang, D; Huang, LL				Wu, Zhi-Qiang; Zou, Qi; Chang, Tao; Zhang, Dong; Huang, Liang-Liang			Seasonal dynamics of the juvenile fish community structure in the Maowei Sea mangroves	PLOS ONE			English	Article							CORAL-REEF FISH; SPECIES COMPOSITION; HABITAT; MARINE; LARVAL; ESTUARY; CONSERVATION; ASSEMBLAGES; ORIENTATION; DIVERSITY	More than 50% of Chinese mangroves were lost between 1950 and 2000 to habitat destruction, prompting an urge for conservation. To assess the importance of the protected Maowei Gulf mangrove estuary for fish population assemblage in the Beibu Gulf (China), we studied species composition and abundance of juvenile fish (including larvae) from July 2012 to June 2013. A total of 11 691 specimens were collected, which belonged to 24 species and 15 families. Six perciform species constituted 93% of the total sample. Pseudogobius javanicus (53.29%) was the dominant species from August to November, Omobranchus elegans (28.49%) from April to July, non-identified species in December and January, and Liza carinata in February and March. A number of commercially important fish species were also identified. Abundance was the highest in summer/early autumn (max 162.4 in Sep), and lowest in winter/early spring (Mar = 4.5). Diversity (H') and richness (D-ma) indices (both max. in May: 1.67 and 1.95 respectively) were generally positively correlated with tide and temperature, and negatively with salinity. Seasonal variations play a more important role in the fish assemblage structure than tidal rhythm, with differences particularly pronounced between colder and warmer months. Despite the prominent seasonal differences in abiotic factors, this study indicates that Maowei mangroves provide habitat and food for juvenile fish throughout the year and thus are indispensable for the fish diversity in the Beibu Gulf.	[Wu, Zhi-Qiang; Zou, Qi; Chang, Tao; Huang, Liang-Liang] Guilin Univ Technol, Coll Environm Sci & Engn, Guilin, Guangxi Provinc, Peoples R China; [Wu, Zhi-Qiang] Guangxi Univ, Nanning, Guangxi Provinc, Peoples R China; [Zhang, Dong] Qinzhou Marine Adm, Qinzhou, Guangxi Provinc, Peoples R China	Guilin University of Technology; Guangxi University	Wu, ZQ; Huang, LL (corresponding author), Guilin Univ Technol, Coll Environm Sci & Engn, Guilin, Guangxi Provinc, Peoples R China.; Wu, ZQ (corresponding author), Guangxi Univ, Nanning, Guangxi Provinc, Peoples R China.	bruce2986@163.com; llhuang@glut.edu.cn	wu, zhi/GXH-3041-2022		National Natural Science Foundation of China [51379038, 51509042]; Natural Science Foundation in Guangxi Province, China [2016GXNSFAA380104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation in Guangxi Province, China	This work was supported by the National Natural Science Foundation of China (No.: 51379038; No.: 51509042) and the Natural Science Foundation in Guangxi Province, China (No. 2016GXNSFAA380104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2013, ENCY ESTUARIES, P393; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Baran E, 1998, MAR POLLUT BULL, V37, P431; Barletta M, 2010, ECOL STUD-ANAL SYNTH, V211, P171, DOI 10.1007/978-3-642-13457-9_11; Blaber SJM, 2007, B MAR SCI, V80, P457; Chen LZ, 2009, J PLANT ECOL, V2, P45, DOI 10.1093/jpe/rtp009; Chen Zuo-zhi, 2008, Yingyong Shengtai Xuebao, V19, P1604; Chen ZZ, 2011, OCEAN COAST MANAGE, V54, P601, DOI 10.1016/j.ocecoaman.2011.06.003; Clarke K.R., 2001, CHANGE MARINE COMMUN, Vsecond, P172; Clough B.F., 1983, BIOL ECOLOGY MANGROV, V8, P151, DOI [10.1007/978-94-017-0914-9_17, DOI 10.1007/978-94-017-0914-9_17, DOI 10.1007/978-94-017-0914-9_]; CYRUS DP, 1987, J EXP MAR BIOL ECOL, V109, P71, DOI 10.1016/0022-0981(87)90186-9; DelVecchia AG, 2014, PEERJ, V2, DOI 10.7717/peerj.388; FAO. FISHSTAT, 2014, FISHSTAT GLOB AQ PRO; Faunce CH, 2006, MAR ECOL PROG SER, V318, P1, DOI 10.3354/meps318001; Hajisamae S, 2006, ESTUAR COAST SHELF S, V68, P647, DOI 10.1016/j.ecss.2006.03.020; Huang B., 2013, INT J ADV MANUF TECH, P1; Igulu MM, 2013, MAR ECOL PROG SER, V493, P243, DOI 10.3354/meps10542; Igulu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114715; Ikejima K, 2003, ESTUAR COAST SHELF S, V56, P447, DOI 10.1016/S0272-7714(02)00194-4; IUCN, 2021, WIKIPEDIA; Kendall A., 1981, ONTOG SYST FISHES, P1; Kendall AW., 2011, IDENTIFICATION EGGS; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; LAEGDSGAARD P, 1995, MAR ECOL PROG SER, V126, P67, DOI 10.3354/meps126067; Lan W.L., 2011, J GUANGXI ACAD SCI, V27, P109; Lecchini D, 2005, OECOLOGIA, V143, P326, DOI 10.1007/s00442-004-1805-y; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Leis JM, 2004, FAUNA MALESIANA HDB; Liu Y, 2009, ELECTRON J DIFFER EQ; Lu YQ., 2009, J HEBEI AGR SCI, V13, P97; Margalef R., 1989, PERSPECTIVES ECOLOGI, VIII; NGUYEN L. K., 2008, IEEE MIL COMM C 2008, P1; Okiyama M, 1988, ATLAS EARLY STAGE FI, P1154; Ooi AL, 2011, CONT SHELF RES, V31, P1599, DOI 10.1016/j.csr.2011.06.016; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; [乔延龙 QIAO Yanlong], 2008, [中国水产科学, Journal of Fishery Sciences of China], V15, P816; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; Rog SM, 2017, DIVERS DISTRIB, V23, P221, DOI 10.1111/ddi.12514; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Termvidchakorn A, 2013, GUIDE LARVAE JUVENIL; Tse P, 2008, ESTUAR COAST SHELF S, V80, P235, DOI 10.1016/j.ecss.2008.08.002; TZENG WN, 1992, MAR BIOL, V113, P481, DOI 10.1007/BF00349175; Yokoo T., 2008, LAGUNA, V15, P77; Zhang BH, 2010, J MAR SCI, V28, P9, DOI 10.1016/j.rsma.2015.04.001; Zhang R. Z., 1985, FISH EGGS LARVAE OFF; Zhou MY, 2011, ACTA OCEANOL SIN, V30, P94, DOI 10.1007/s13131-011-0095-6; Zhuang J., 2009, GUANGXI SCI, V16, P96	48	4	5	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192426	10.1371/journal.pone.0192426	http://dx.doi.org/10.1371/journal.pone.0192426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438434	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400024
J	Azbel-Jackson, L; Heffernan, C; Gunn, G; Brownlie, J				Azbel-Jackson, Lena; Heffernan, Claire; Gunn, George; Brownlie, Joe			Exploring the role of voluntary disease schemes on UK farmer bio-security behaviours: Findings from the Norfolk-Suffolk Bovine Viral Diarrhoea control scheme	PLOS ONE			English	Article							SHEEP FARMERS; BIOSECURITY; VIRUS; INFECTION; CATTLE; ERADICATION	The article describes the influence of a disease control scheme (the Norfolk-Suffolk Bovine Viral Diarrhoea Disease (BVD) Eradication scheme) on farmers' bio-security attitudes and behaviours. In 2010, a survey of 100 cattle farmers (53 scheme members vs. 47 out of scheme farmers) was undertaken among cattle farmers residing in Norfolk and Suffolk counties in the UK. A cross-sectional independent measures design was employed. The main analytical tool was content analysis. The following variables at the farmer-level were explored: the specific BVD control measures adopted, livestock disease priorities, motivation for scheme membership, wider knowledge acquisition, biosecurity behaviours employed and training course attendance. The findings suggest that participation in the BVD scheme improved farmers' perception of the scheme benefits and participation in training courses. However, no association was found between the taking part in the BVD scheme and livestock disease priorities or motivation for scheme participation, or knowledge about BVD bio-security measures employed. Equally importantly, scheme membership did appear to influence the importance accorded specific bio-security measures. Yet such ranking did not appear to reflect the actual behaviours undertaken. As such, disease control efforts alone while necessary, are insufficient. Rather, to enhance farmer bio-security behaviours significant effort must be made to address underlying attitudes to the specific disease threat involved.	[Azbel-Jackson, Lena] Univ Reading, Sch Agr Policy & Dev, Livestock Dev Grp, Reading, Berks, England; [Heffernan, Claire] London Int Dev Ctr, London, England; [Gunn, George] Scotlands Rural Coll, Epidemiol Res Unit, Future Farming Syst, Drummondhill, Inverness, Scotland; [Brownlie, Joe] Royal Vet Coll, Hawkshead Lane, Hatfield, Herts, England	University of Reading; Scotland's Rural College; University of London; University of London Royal Veterinary College	Heffernan, C (corresponding author), London Int Dev Ctr, London, England.	claire.heffernan@lidc.bloomsbury.ac.uk			UK Department for Environment, Food & Rural Affairs Project [SE4003]	UK Department for Environment, Food & Rural Affairs Project	The study was funded by the UK Department for Environment, Food & Rural Affairs Project SE4003 (PIs Professors Joe Brownlie and George Gunn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON M, 1989, VET MED-US, V84, P816; Austin EJ, 2001, EUR J PERSONALITY, V15, pS123, DOI 10.1002/per.421; Bingham N, 2008, ENVIRON PLANN A, V40, P1528, DOI 10.1068/a4173; Bitsch V, 2000, VET MICROBIOL, V77, P137, DOI 10.1016/S0378-1135(00)00270-4; Blackstock KL, 2010, SCI TOTAL ENVIRON, V408, P5631, DOI 10.1016/j.scitotenv.2009.04.029; Bolin CA, 1998, P 20 WORLD ASS BUIAR, P899; Devitt C, 2014, HERD OWNER EXPERIENC, V174; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; Gunn GJ, 2005, PREV VET MED, V72, P149, DOI 10.1016/j.prevetmed.2005.08.012; Heffernan C, 2009, VET REC, V164, P163, DOI 10.1136/vr.164.6.163; Heffernan C, 2008, PREV VET MED, V87, P358, DOI 10.1016/j.prevetmed.2008.05.007; Heffernan C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152295; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; Jones SRG, 1998, AM J SOCIOL, V98, P451; Negron M, 2011, PREV VET MED, V99, P130, DOI 10.1016/j.prevetmed.2010.12.008; Norfolk S., 2012, S NORFOLK SUFF BVD C; Santarossa JM, 2005, PREV VET MED, V72, P183, DOI 10.1016/j.prevetmed.2005.08.019; Sayers R., 2014, INT C CORK IR, P1; Small B, 2005, 2005 C AUG 26 27 NEL; Smith DR, 2004, VET CLIN N AM-FOOD A, V20, P131, DOI 10.1016/j.cvfa.2003.11.008; Stahl K, 2007, VET RES, V38, P517, DOI 10.1051/vetres:2007012; Stemler D., 2001, OV CONT AN; Toma L, 2013, PREV VET MED, V108, P321, DOI 10.1016/j.prevetmed.2012.11.009; van Schaik G, 2002, PREV VET MED, V54, P279, DOI 10.1016/S0167-5877(02)00004-1	24	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0179877	10.1371/journal.pone.0179877	http://dx.doi.org/10.1371/journal.pone.0179877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432435	Green Published, Green Submitted, gold			2022-12-26	WOS:000424814300002
J	Oskorouchi, HR; Nie, P; Sousa-Poza, A				Oskorouchi, Hamid Reza; Nie, Peng; Sousa-Poza, Alfonso			The effect of floods on anemia among reproductive age women in Afghanistan	PLOS ONE			English	Article							CLIMATE-CHANGE; HEALTH; DISORDERS; STRESS	This study uses biomarker information from the 2013 National Nutrition Survey Afghanistan and satellite precipitation driven modeling results from the Global Flood Monitoring System to analyze how floods affect the probability of anemia in Afghan women of reproductive age (15-49). In addition to establishing a causal relation between the two by exploiting the quasi-random variation of floods in different districts and periods, the analysis demonstrates that floods have a significant positive effect on the probability of anemia through two possible transmission mechanisms. The first is a significant effect on inflammation, probably related to water borne diseases carried by unsafe drinking water, and the second is a significant negative effect on retinol concentrations. Because the effect of floods on anemia remains significant even after we control for anemia's most common causes, we argue that the condition may also be affected by elevated levels of psychological stress.	[Oskorouchi, Hamid Reza; Nie, Peng; Sousa-Poza, Alfonso] Univ Hohenheim, Inst Hlth Care & Publ Management, Fruwirthstr 48,Kavalierhaus 4, D-70599 Stuttgart, Germany; [Oskorouchi, Hamid Reza] Univ Florence, Dept Econ & Management, Florence, Italy; [Oskorouchi, Hamid Reza] Univ Trento, Dept Econ & Management, Trento, Italy; [Sousa-Poza, Alfonso] IZA, Bonn, Germany	University Hohenheim; University of Florence; University of Trento; IZA Institute Labor Economics	Oskorouchi, HR (corresponding author), Univ Hohenheim, Inst Hlth Care & Publ Management, Fruwirthstr 48,Kavalierhaus 4, D-70599 Stuttgart, Germany.; Oskorouchi, HR (corresponding author), Univ Florence, Dept Econ & Management, Florence, Italy.; Oskorouchi, HR (corresponding author), Univ Trento, Dept Econ & Management, Trento, Italy.	hamid.oskorouchi@uni-hohenheim.de	Nie, Peng/AFO-4955-2022; Oskorouchi, Hamid Reza/AAH-9027-2020; Nie, Peng/AAU-3473-2020; Nie, Peng/GQI-1872-2022	Nie, Peng/0000-0002-5322-6324; Oskorouchi, Hamid Reza/0000-0003-1241-9645; Sousa-Poza, Alfonso/0000-0002-6524-9654				AGCHO, 2012, AFGH SHAP 2 ADM DIV; Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Alderman K, 2012, ENVIRON INT, V47, P37, DOI 10.1016/j.envint.2012.06.003; [Anonymous], 2012, GUID DAIL IR FOL AC; [Anonymous], 2014, CREACT PROT CONC MAR; Ballard T., 2011, HOUSEHOLD HUNGER SCA, P2; Center for International Earth Science Information Network (CIESIN) & NASA Socioeconomic Data and Applications Center (SEDAC), 2016, GRIDD POP WORLD VERS; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; CSO, 2013, SETTL POP CIV DIV UR; DAD, 2015, AFGH NAT BUDG AID MA; Du WW, 2010, PREHOSP DISASTER MED, V25, P265, DOI 10.1017/S1049023X00008141; Flores-Martinez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156878; Gordley LB, 2000, J OCCUP ENVIRON MED, V42, P871, DOI 10.1097/00043764-200009000-00005; Greene W.H., 2012, ECONOMETRIC ANAL; Gruebner O, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0008-6; Hagen E, 2009, NATO SCI PEACE SECUR, P179, DOI 10.1007/978-90-481-2344-5_19; Haines A, 2004, JAMA-J AM MED ASSOC, V291, P99, DOI 10.1001/jama.291.1.99; Hejazi MI, 2009, J HYDROL ENG, V14, P606, DOI 10.1061/(ASCE)HE.1943-5584.0000020; Hellevik O, 2009, QUAL QUANT, V43, P59, DOI 10.1007/s11135-007-9077-3; Laurenson E.M., 1964, J HYDROL, V2, P141, DOI [10.1016/0022-1694(64)90025-3, DOI 10.1016/0022-1694(64)90025-3]; Maclean JC, 2016, SOC SCI MED, V151, P78, DOI 10.1016/j.socscimed.2016.01.006; Manickavelu A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169416; Moise IK, 2016, PREVENTING CHRONIC D, P13; NEINSTEIN LS, 1985, WESTERN J MED, V143, P476; Noronha JA, 2012, J SAFOG, V4, P64, DOI [10.5005/jp-journals-10006-1177, DOI 10.5005/JP-JOURNALS-10006-1177, DOI 10.5005/JPJOURNALS-10006-1177]; OCHA, 2014, AFGH OV NAT DIS NAT; Ramin BM, 2009, ECOHEALTH, V6, P52, DOI 10.1007/s10393-009-0222-4; Rutstein S.O., 2008, DHS WEALTH INDEX APP; Shapley M, 2003, J Obstet Gynaecol, V23, P48; Sundberg R, 2013, J PEACE RES, V50, P523, DOI 10.1177/0022343313484347; UNICEF, 2014, AFGH NAT NUTR SURV 2; UNIDSR & CRED, 2016, POV DEATH DIS MORT 1; USGS, 2013, WAT RES ASS MON CAP; Wei CL, 2008, INT J HEMATOL, V88, P52, DOI 10.1007/s12185-008-0105-4; WHO, 2011, SER FERR CONC ASS IR; WHO, 2011, WHO GLOBAL DATABASE; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS; Wu H, 2014, WATER RESOUR RES, V50, P2693, DOI 10.1002/2013WR014710	38	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0191726	10.1371/journal.pone.0191726	http://dx.doi.org/10.1371/journal.pone.0191726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425219	Green Submitted, gold, Green Published			2022-12-26	WOS:000424700800008
J	Wilson, SM; Eriksson, DK; Schneck, SM; Lucanie, JM				Wilson, Stephen M.; Eriksson, Dana K.; Schneck, Sarah M.; Lucanie, Jillian M.			A quick aphasia battery for efficient, reliable, and multidimensional assessment of language function	PLOS ONE			English	Article							PRIMARY PROGRESSIVE APHASIA; SINGLE WORD COMPREHENSION; SPONTANEOUS SPEECH; SEMANTIC DEMENTIA; STROKE APHASIA; PORCH INDEX; RECOVERY; IMPAIRMENT; ABILITY; SCALE	This paper describes a quick aphasia battery (QAB) that aims to provide a reliable and multidimensional assessment of language function in about a quarter of an hour, bridging the gap between comprehensive batteries that are time-consuming to administer, and rapid screening instruments that provide limited detail regarding individual profiles of deficits. The QAB is made up of eight subtests, each comprising sets of items that probe different language domains, vary in difficulty, and are scored with a graded system to maximize the informativeness of each item. From the eight subtests, eight summary measures are derived, which constitute a multidimensional profile of language function, quantifying strengths and weaknesses across core language domains. The QAB was administered to 28 individuals with acute stroke and aphasia, 25 individuals with acute stroke but no aphasia, 16 individuals with chronic post-stroke aphasia, and 14 healthy controls. The patients with chronic post-stroke aphasia were tested 3 times each and scored independently by 2 raters to establish test-retest and inter-rater reliability. The Western Aphasia Battery (WAB) was also administered to these patients to assess concurrent validity. We found that all QAB summary measures were sensitive to aphasic deficits in the two groups with aphasia. All measures showed good or excellent test-retest reliability (overall summary measure: intraclass correlation coefficient (ICC) = 0.98), and excellent inter-rater reliability (overall summary measure: ICC = 0.99). Sensitivity and specificity for diagnosis of aphasia (relative to clinical impression) were 0.91 and 0.95 respectively. All QAB measures were highly correlated with corresponding WAB measures where available. Individual patients showed distinct profiles of spared and impaired function across different language domains. In sum, the QAB efficiently and reliably characterized individual profiles of language deficits.	[Wilson, Stephen M.; Schneck, Sarah M.; Lucanie, Jillian M.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA; [Eriksson, Dana K.] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ USA	Vanderbilt University; University of Arizona	Wilson, SM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA.	stephen.m.wilson@vanderbilt.edu		Schneck, Sarah/0000-0001-9447-4431; Wilson, Stephen/0000-0001-9884-2852	National Institutes of Health (National Institute on Deafness and Other Communication Disorders) [R01 DC013270, R21 DC016080]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC016080, R01DC013270] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Deafness and Other Communication Disorders)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported in part by the National Institutes of Health (National Institute on Deafness and Other Communication Disorders) under grants R01 DC013270 and R21 DC016080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuar C, 2013, J NEUROL, V260, P2110, DOI 10.1007/s00415-013-6943-x; Bartha L, 2003, BRAIN LANG, V85, P93, DOI 10.1016/S0093-934X(02)00502-3; Bastiaanse R, 2011, J NEUROLINGUIST, V24, P652, DOI 10.1016/j.jneuroling.2011.07.001; Bates E, 2005, BRAIN LANG, V92, P106, DOI 10.1016/j.bandl.2004.06.108; Benson D. F., 1967, CORTEX MILANO, V3, P373, DOI DOI 10.1016/S0010-9452(67)80025-X; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Butler RA, 2014, BRAIN, V137, P3248, DOI 10.1093/brain/awu286; Caplan D., 1988, DISORDERS SYNTACTIC; Casilio M., 2017, AUDITORY PERCEPTUAL; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; CLARK C, 1979, BRAIN LANG, V7, P240, DOI 10.1016/0093-934X(79)90020-8; CLARK C, 1979, BRAIN LANG, V7, P1, DOI 10.1016/0093-934X(79)90001-4; del Toro CM, 2011, J SPEECH LANG HEAR R, V54, P1089, DOI 10.1044/1092-4388(2010/09-0119); DISIMONI FG, 1975, J SPEECH HEAR RES, V18, P491, DOI 10.1044/jshr.1803.491; DISIMONI FG, 1980, J SPEECH HEAR RES, V23, P511, DOI 10.1044/jshr.2303.511; Duffy J. R., 2013, MOTOR SPEECH DISORDE; Enderby P M, 1987, Int Rehabil Med, V8, P166; Fitch-West J, 1998, BEST 2 BEDSIDE EVALU; Flamand-Roze C, 2011, STROKE, V42, P1224, DOI 10.1161/STROKEAHA.110.609503; Goodglass H., 1983, BOSTON NAMING TEST; Goodglass H., 1964, CORTEX, V1, P133, DOI [10.1016/S0010-9452(64)80018-6, DOI 10.1016/S0010-9452(64)80018-6]; Goodglass H., 1993, UNDERSTANDING APHASI; Goodglass H., 2001, TEST BOSTON DIAGNOST, V3a; Hachioui H.E., 2017, J NEUROL, V264, P211, DOI DOI 10.1007/S00415-016-8170-8; HANSON WR, 1982, BRAIN LANG, V15, P369, DOI 10.1016/0093-934X(82)90066-9; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Jefferies E, 2006, BRAIN, V129, P2132, DOI 10.1093/brain/awl153; Kay J, 1992, PALPA PSYCHOLINGUIST; Kertesz A., 2007, WAB R W APHASIA BATT; Lichtheim Ludwig, 1885, BRAIN, V7, P433, DOI DOI 10.1093/BRAIN/7.4.433; LINCOLN NB, 1980, BRIT J DISORD COMMUN, V15, P183; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; Marshall RC, 2007, AM J SPEECH-LANG PAT, V16, P295, DOI 10.1044/1058-0360(2007/035); McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mirman D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7762; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; PHILLIPS PP, 1978, ARCH PHYS MED REHAB, V59, P327; Porch B., 1974, PORCH INDEX COMMUNIC; Prins R, 2004, APHASIOLOGY, V18, P1075, DOI 10.1080/02687030444000534; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; SELNES OA, 1984, BRAIN LANG, V21, P72, DOI 10.1016/0093-934X(84)90037-3; SELNES OA, 1983, ANN NEUROL, V13, P558, DOI 10.1002/ana.410130515; Spreen O., 2003, ASSESSMENT APHASIA; Strand EA, 2014, J COMMUN DISORD, V51, P43, DOI 10.1016/j.jcomdis.2014.06.008; Swinburn K., 2004, COMPREHENSIVE APHASI; Thompson CK, 2012, APHASIOLOGY, V26, P20, DOI 10.1080/02687038.2011.584691; WAGENAAR E, 1975, BRAIN LANG, V2, P281, DOI 10.1016/S0093-934X(75)80071-X; Warrington EK, 1998, NEUROPSYCHOL REHABIL, V8, P143; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Wertz R. T, 1984, CLIN APH P C; Wilson SM, 2014, J COGNITIVE NEUROSCI, V26, P970, DOI 10.1162/jocn_a_00550; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; ZIMMERMAN DW, 1993, APPL PSYCH MEAS, V17, P1, DOI 10.1177/014662169301700101	54	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192773	10.1371/journal.pone.0192773	http://dx.doi.org/10.1371/journal.pone.0192773			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV6OL	29425241	Green Published, Green Submitted, gold			2022-12-26	WOS:000424700800043
J	Getz, KD; Miller, TP; Seif, AE; Li, YM; Huang, YSV; Fisher, BT; Aplenc, R				Getz, Kelly D.; Miller, Tamara P.; Seif, Alix E.; Li, Yimei; Huang, Yuan-Shung V.; Fisher, Brian T.; Aplenc, Richard			Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia	PLOS ONE			English	Article							CANCER PAIN MANAGEMENT; UNITED-STATES; EMERGENCY-DEPARTMENT; CHILDRENS HOSPITALS; SEX-DIFFERENCES; ANALGESIA USE; CARE; QUALITY; METAANALYSIS; DISPARITY	Purpose A cohort of pediatric patients with AML treated at hospitals contributing to the Pediatric Health Information System was used to evaluate differences in opioid utilization by sex, age, race, and insurance. Methods Billing data were used to compute the prevalence of opioid exposure and to quantify rates of utilization among those exposed to opioids as days of use per 1000 inpatient days. Multivariable regressions were used to compare opioid prevalence, and rates of utilization among those exposed. Results On average across courses, 95.2% of patients were exposed to analgesics, 84.7% were exposed to non-opioid analgesics and 77.7% were exposed to opioids. The proportion of opioid-exposed patients increased with age, but did not differ by gender, race, or insurance status. Analyses limited to patients exposed to opioids revealed modest differences in days of opioid use among female patients (adjusted rate ratio (aRR) = 1.19, 95% CI: 1.11, 1.28), patients <1 year (aRR = 1.37, 95% CI: 1.21, 1.55) or >= 10 years of age (aRR = 1.63, 95% CI: 1.46, 1.82), whereas Asian patients received fewer days of opioids compared with white patients (aRR = 0.76, 95% CI: 0.61, 0.95). There was moderate hospital-level variability in both the prevalence of opioid utilization overall and preference for specific opioid medications. There was greater inconsistency in practice concerning choices for supplemental and alternative opioids than in first-line opioid utilization. Conclusion Additional work is needed to discern whether observed differences in opioid utilization by age and race reflect a difference in treatment or a difference in the experience of pain. Future studies should also explore the factors which guide decisions on opioid selections in an attempt to explain the variability across institutions.	[Getz, Kelly D.; Miller, Tamara P.; Seif, Alix E.; Li, Yimei; Aplenc, Richard] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Getz, Kelly D.; Huang, Yuan-Shung V.; Fisher, Brian T.; Aplenc, Richard] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Seif, Alix E.; Fisher, Brian T.; Aplenc, Richard] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA USA; [Li, Yimei; Fisher, Brian T.; Aplenc, Richard] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Fisher, Brian T.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Getz, KD (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA.; Getz, KD (corresponding author), Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA.	getzk@email.chop.edu	Miller, Tamara P./AAB-2282-2020; Getz, Kelly/W-8190-2018; Seif, Alix/B-9918-2013	Getz, Kelly/0000-0003-2020-5153; Fisher, Brian/0000-0002-8224-4281; Seif, Alix/0000-0002-1799-2582	Alex's Lemonade Stand Foundation; NIH [R01CM 65277-01]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from Alex's Lemonade Stand Foundation (https://www.alexslemonade.org/grants/search; PI: Aplenc) and NIH (R01CM 65277-01, PI: Aplenc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameringer S, 2010, PAIN MANAG NURS, V11, P224, DOI 10.1016/j.pmn.2009.05.006; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Boerner KE, 2014, PAIN, V155, P983, DOI 10.1016/j.pain.2014.01.031; Chen CH, 2012, PALLIATIVE MED, V26, P206, DOI 10.1177/0269216311402711; Child Health Corporation of America, 2014, CHILD HLTH CORP AM A; Cintron A, 2006, J PALLIAT MED, V9, P1454, DOI 10.1089/jpm.2006.9.1454; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Collins JJ, 2001, MED J AUSTRALIA, V175, P453, DOI 10.5694/j.1326-5377.2001.tb143673.x; Dahl June L, 2004, J Natl Cancer Inst Monogr, P124; Dickason RM, 2015, WEST J EMERG MED, V16, P372, DOI 10.5811/westjem.2015.3.23893; Elder K, 2014, J PEDIATR-US, V165, P434, DOI 10.1016/j.jpeds.2014.06.046; Gordon DB, 2005, ARCH INTERN MED, V165, P1574, DOI 10.1001/archinte.165.14.1574; Green CR, 2011, CANCER-AM CANCER SOC, V117, P1994, DOI 10.1002/cncr.25761; Hechler T, 2014, PAIN, V155, P118, DOI 10.1016/j.pain.2013.09.015; Heden L, 2013, J PAIN SYMPTOM MANAG, V46, P366, DOI 10.1016/j.jpainsymman.2012.09.012; Hewitt M, 2008, J PEDIATR, V152, P39, DOI 10.1016/j.jpeds.2007.07.005; Kavcic M, 2013, PEDIATR BLOOD CANCER, V60, P508, DOI 10.1002/pbc.24402; Kozlowski LJ, 2014, PAIN MANAG NURS, V15, P22, DOI 10.1016/j.pmn.2012.04.003; Kwon JH, 2014, J CLIN ONCOL, V32, P1727, DOI 10.1200/JCO.2013.52.4827; Ljungman G, 2000, PEDIATR HEMAT ONCOL, V17, P211, DOI 10.1080/088800100276389; Marinangeli F, 2004, J PAIN SYMPTOM MANAG, V27, P409, DOI 10.1016/j.jpainsymman.2003.10.006; Maude SL, 2014, PEDIATR CRIT CARE ME, V15, P112, DOI 10.1097/PCC.0000000000000042; McNeill JA, 2007, ONCOL NURS FORUM, V34, P1121, DOI 10.1188/07.ONF.1121-1128; Meghani SH, 2014, J CLIN ONCOL, V32, P2773, DOI 10.1200/JCO.2013.54.7992; Mercadante S, 2014, CRIT REV ONCOL HEMAT, V91, P93, DOI 10.1016/j.critrevonc.2014.01.005; Miller Elizabeth, 2011, Oncol Nurs Forum, V38, pE382, DOI 10.1188/11.ONF.E382-E393; Mills AM, 2011, AM J EMERG MED, V29, P752, DOI 10.1016/j.ajem.2010.02.023; Narayan MC, 2010, AM J NURS, V110, P38, DOI 10.1097/01.NAJ.0000370157.33223.6d; Orsey AD, 2009, PEDIATR BLOOD CANCER, V52, P761, DOI 10.1002/pbc.21824; Rasooly IR, 2014, J PEDIATR-US, V165, P618, DOI 10.1016/j.jpeds.2014.04.059; Sadhasivam S, 2015, PAIN MED, V16, P985, DOI 10.1111/pme.12660; Smith AW, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00075; Stevens BJ, 2012, J PAIN, V13, P857, DOI 10.1016/j.jpain.2012.05.010; Sung L, 2009, BRIT J CANCER, V100, P82, DOI 10.1038/sj.bjc.6604826; van de Wetering MD, 2011, SEMIN ONCOL, V38, P374, DOI 10.1053/j.seminoncol.2011.03.006; Varni JW, 2004, J DEV BEHAV PEDIATR, V25, P239, DOI 10.1097/00004703-200408000-00003; Womer J, 2014, J PAIN SYMPTOM MANAG, V48, P903, DOI 10.1016/j.jpainsymman.2013.12.241; World Health Organization, 2012, WHO GUID PHARM TREAT	38	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192529	10.1371/journal.pone.0192529	http://dx.doi.org/10.1371/journal.pone.0192529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420604	Green Submitted, Green Published, gold			2022-12-26	WOS:000424517900089
J	Sarikhani, M; Maity, S; Mishra, S; Jain, A; Tamta, AK; Ravi, V; Kondapalli, MS; Desingu, PA; Khan, D; Kumar, S; Rao, S; Inbaraj, M; Pandit, AS; Sundaresan, NR				Sarikhani, Mohsen; Maity, Sangeeta; Mishra, Sneha; Jain, Aditi; Tamta, Ankit K.; Ravi, Venkatraman; Kondapalli, Mrudula S.; Desingu, Perumal A.; Khan, Danish; Kumar, Shweta; Rao, Swathi; Inbaraj, Meena; Pandit, Anwit S.; Sundaresan, Nagalingam Ravi			SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart failure; cardiac hypertrophy; sirtuin; NFAT transcription factor; cardiomyocyte; SIRT2; lysine acetylation	HEART-FAILURE; GENE-EXPRESSION; PROTEIN-SYNTHESIS; CALORIE RESTRICTION; IN-VITRO; KAPPA-B; HYPERTROPHY; CALCINEURIN; CARDIOMYOCYTES; CARDIOMYOPATHY	Heart failure is an aging-associated disease that is the leading cause of death worldwide. Sirtuin family members have been largely studied in the context of aging and aging-associated diseases. Sirtuin 2 (SIRT2) is a cytoplasmic protein in the family of sirtuins that are NAD(+)-dependent class III histone deacetylases. In this work, we studied the role of SIRT2 in regulating nuclear factor of activated T-cells (NFAT) transcription factor and the development of cardiac hypertrophy. Confocal microscopy analysis indicated that SIRT2 is localized in the cytoplasm of cardiomyocytes and SIRT2 levels are reduced during pathological hypertrophy of the heart. SIRT2-deficient mice develop spontaneous pathological cardiac hypertrophy, remodeling, fibrosis, and dysfunction in an age-dependent manner. Moreover, young SIRT2-deficient mice develop exacerbated agonist-induced hypertrophy. In contrast, SIRT2 overexpression attenuated agonist-induced cardiac hypertrophy in cardiomyocytes in a cell-autonomous manner. Mechanistically, SIRT2 binds to and deacetylates NFATc2 transcription factor. SIRT2 deficiency stabilizes NFATc2 and enhances nuclear localization of NFATc2, resulting in increased transcription activity. Our results suggest that inhibition of NFAT rescues the cardiac dysfunction in SIRT2-deficient mice. Thus, our study establishes SIRT2 as a novel endogenous negative regulator of NFAT transcription factor.	[Sarikhani, Mohsen; Maity, Sangeeta; Mishra, Sneha; Jain, Aditi; Tamta, Ankit K.; Ravi, Venkatraman; Kondapalli, Mrudula S.; Desingu, Perumal A.; Khan, Danish; Kumar, Shweta; Rao, Swathi; Inbaraj, Meena; Pandit, Anwit S.; Sundaresan, Nagalingam Ravi] Indian Inst Sci, Dept Microbiol & Cell Biol, Bengaluru 560012, India	Indian Institute of Science (IISC) - Bangalore	Sundaresan, NR (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Div Biol Sci, Lab SB 02, Bengaluru 560012, Karnataka, India.	rsundaresan@iisc.ac.in	Desingu, P./AGM-5446-2022; Ravi, Venkatraman/C-7967-2014; Jain, Aditi/AAD-8922-2019; Desingu, Perumal/AGH-9777-2022	Desingu, P./0000-0003-4395-4472; Maity, Sangeeta/0000-0003-4426-1715; Ravi, Venkatraman/0000-0002-1409-682X	Department of Science and Technology Extra Mural Research Funding [EMR/2014/000065]; Department of Biotechnology Extramural Research Grants [BRB/10/1294/2014, MED/30/1454/2014]; Council for Scientific and Industrial Research [37(1646)/15/EMR-II]; SERB-National Post-Doctoral Fellowship (N-PDF); Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India	Department of Science and Technology Extra Mural Research Funding; Department of Biotechnology Extramural Research Grants; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); SERB-National Post-Doctoral Fellowship (N-PDF); Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India	This work was supported by research funding from the Department of Science and Technology Extra Mural Research Funding EMR/2014/000065, the Department of Biotechnology Extramural Research Grants BRB/10/1294/2014 and MED/30/1454/2014, and the Council for Scientific and Industrial Research extramural research support 37(1646)/15/EMR-II (to N. R. S.). This work was supported by the SERB-National Post-Doctoral Fellowship (N-PDF) (to M. S. K. and S. M.) and by the Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India (to N. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023; Dirkx E, 2013, NAT CELL BIOL, V15, P1282, DOI 10.1038/ncb2866; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Fang J, 2017, HYPERTENSION, V70, P515, DOI 10.1161/HYPERTENSIONAHA.116.08728; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2007, COLD SH Q B, V72, P483, DOI 10.1101/sqb.2007.72.024; Han XF, 2010, ACTA PHARMACOL SIN, V31, P1111, DOI 10.1038/aps.2010.146; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Hojayev B, 2012, MOL CELL BIOL, V32, P4025, DOI 10.1128/MCB.05948-11; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jain A, 2017, INT J CARDIOL, V232, P160, DOI 10.1016/j.ijcard.2017.01.036; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim JH, 2011, BIOCHEM J, V436, P253, DOI 10.1042/BJ20110062; Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mittmann C, 1998, CARDIOVASC RES, V39, P267, DOI 10.1016/S0008-6363(98)00139-4; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Park SH, 2012, TRANSL CANCER RES, V1, P15, DOI 10.3978/j.issn.2218-676X.2012.05.01; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Pillai VB, 2011, MOL CELL BIOL, V31, P2349, DOI 10.1128/MCB.01205-10; Pina IL, 1996, CHEST, V110, P1317, DOI 10.1378/chest.110.5.1317; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tang XQ, 2017, CIRCULATION, V136, P2051, DOI 10.1161/CIRCULATIONAHA.117.028728; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Wen HY, 2002, J CELL MOL MED, V6, P235, DOI 10.1111/j.1582-4934.2002.tb00190.x; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Yang XY, 2017, J CLIN INVEST, V127, P1505, DOI 10.1172/JCI88574; Yu W, 2014, MOL MED REP, V9, P1218, DOI 10.3892/mmr.2014.1944; Yuan Q, 2015, EUR J PHARMACOL, V764, P554, DOI 10.1016/j.ejphar.2015.07.045	60	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5281	5294		10.1074/jbc.RA117.000915	http://dx.doi.org/10.1074/jbc.RA117.000915			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440391	Green Published, hybrid			2022-12-26	WOS:000429409300032
J	Kofler, N; Corti, F; Rivera-Molina, F; Deng, Y; Toomre, D; Simons, M				Kofler, Natalie; Corti, Federico; Rivera-Molina, Felix; Deng, Yong; Toomre, Derek; Simons, Michael			The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular endothelial growth factor receptor-2 (VEGFR2)-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLATERAL CIRCULATION; ANGIOGENESIS; KINASE; CELLS; INTERNALIZATION; ARTERIOGENESIS; MORPHOGENESIS; ACTIVATION; LETHALITY; DOMAIN	As a master regulator of endothelial cell function, vascular endothelial growth factor receptor-2 (VEGFR2) activates multiple downstream signaling pathways that are critical for vascular development and normal vessel function. VEGFR2 trafficking through various endosomal compartments modulates its signaling output. Accordingly, proteins that regulate the speed and direction by which VEGFR2 traffics through endosomes have been demonstrated to be particularly important for arteriogenesis. However, little is known about how these proteins control VEGFR2 trafficking and about the implications of this control for endothelial cell function. Here, we show that Rab GTPase-binding effector protein 2 (RABEP2), a Rab-effector protein implicated in arteriogenesis, modulates VEGFR2 trafficking. By employing high-resolution microscopy and biochemical assays, we demonstrate that RABEP2 interacts with the small GTPase Rab4 and regulates VEGFR2 endosomal trafficking to maintain cell-surface expression of VEGFR2 and VEGF signaling. Lack of RABEP2 also led to prolonged retention of VEGFR2 in Rab5-positive sorting endosomes, which increased VEGFR2' s exposure to phosphotyrosine phosphatase 1b (PTP1b), causing diminished VEGFR2 signaling. Finally, the loss of RABEP2 increased VEGFR2 degradation by diverting VEGFR2 to Rab7positive endosomes destined for the lysosome. These results implicate RABEP2 as a key modulator of VEGFR2 endosomal trafficking, and demonstrate the importance of RABEP2 and Rab4 for VEGFR2 signaling in endothelial cells.	[Kofler, Natalie; Corti, Federico; Deng, Yong; Simons, Michael] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med,Yale Cardiovasc Res Ctr, New Haven, CT 06520 USA; [Rivera-Molina, Felix; Toomre, Derek; Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Simons, M (corresponding author), 300 George St,Rm 759, New Haven, CT 06511 USA.	michael.simons@yale.edu	Corti, Federico/R-6262-2016	Corti, Federico/0000-0003-2160-245X	National Institutes of Health [T32 HL007778-20, R01 HL053793, HL084619, PO1 5P01HL107205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007778, R01HL084619, R01HL053793, P01HL107205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institutes of Health Training Grant T32 HL007778-20 (to N. K.) and National Institutes of Health Grants R01 HL053793, HL084619, and PO1 5P01HL107205 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bautch VL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a008268; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Boucher JM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15699; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Heinolainen K, 2017, CIRC RES, V120, P1414, DOI 10.1161/CIRCRESAHA.116.310477; Horowitz A, 2012, CELL SIGNAL, V24, P1810, DOI 10.1016/j.cellsig.2012.05.007; Jeltsch M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009183; Jopling HM, 2014, CELLS-BASEL, V3, P363, DOI 10.3390/cells3020363; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Jopling HM, 2009, ARTERIOSCL THROM VAS, V29, P1119, DOI 10.1161/ATVBAHA.109.186239; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kofler Natalie M, 2015, F1000Prime Rep, V7, P26, DOI 10.12703/P7-26; Kofler Natalie M, 2011, Genes Cancer, V2, P1106, DOI 10.1177/1947601911423030; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Lucitti JL, 2016, STROKE, V47, P3022, DOI 10.1161/STROKEAHA.116.014160; Moraes F, 2013, CIRC RES, V113, P1076, DOI 10.1161/CIRCRESAHA.113.301340; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pardanaud L, 2016, CIRC RES, V119, P607, DOI 10.1161/CIRCRESAHA.116.308473; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ren B, 2010, J CLIN INVEST, V120, P1217, DOI 10.1172/JCI39837; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Sealock R, 2014, CIRC RES, V114, P660, DOI 10.1161/CIRCRESAHA.114.302931; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; van Lessen M, 2015, ARTERIOSCL THROM VAS, V35, P1815, DOI 10.1161/ATVBAHA.115.305473; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6	44	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4805	4817		10.1074/jbc.M117.812172	http://dx.doi.org/10.1074/jbc.M117.812172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29425100	Green Published, hybrid			2022-12-26	WOS:000428848300021
J	Herbert, RD; Broderick, CR; Barnes, C; Billot, L; Zhou, A; Latimer, J				Herbert, Robert D.; Broderick, Carolyn R.; Barnes, Chris; Billot, Laurent; Zhou, Albert; Latimer, Jane			Optimization of prophylaxis for hemophilia A	PLOS ONE			English	Article							RECOMBINANT FACTOR-VIII; PHARMACOKINETICS; CHILDREN	Background & aims Prophylactic injections of factor VIII reduce the incidence of bleeds and slow the development of joint damage in people with hemophilia. The aim of this study was to identify optimal person-specific prophylaxis regimens for children with hemophilia A. Methods Analytic and numerical methods were used to identify prophylaxis regimens which maximize the time for which plasma factor VIII concentrations exceed a threshold, maximize the lowest plasma factor VIII concentrations, and minimize risk of bleeds. Results It was demonstrated analytically that, for any injection schedule, the regimen that maximizes the lowest factor VIII concentration involves sharing doses between injections so that all of the trough concentrations in a prophylaxis cycle are equal. Numerical methods were used to identify optimal prophylaxis schedules and explore the trade-offs between efficacy and acceptability of different prophylaxis regimens. The prophylaxis regimen which minimizes risk of bleeds depends on the person's pattern of physical activity and may differ greatly from prophylaxis regimens that optimize pharmacokinetic parameters. Prophylaxis regimens which minimize risk of bleeds also differ from prophylaxis regimens that are typically prescribed. Predictions about which regimen is optimal are sensitive to estimates of the effects on risk of bleeds of factor VIII concentration and physical activity. Conclusion The methods described here can be used to identify optimal, person-specific prophylaxis regimens for children with hemophilia A.	[Herbert, Robert D.] Neurosci Res Australia NeuRA, Randwick, NSW, Australia; [Herbert, Robert D.; Broderick, Carolyn R.; Billot, Laurent] Univ New South Wales, Kensington, NSW, Australia; [Broderick, Carolyn R.] Childrens Hosp Westmead, Westmead, NSW, Australia; [Barnes, Chris] Royal Childrens Hosp, Melbourne, Vic, Australia; [Billot, Laurent] George Inst Global Hlth, Camperdown, NSW, Australia; [Zhou, Albert; Latimer, Jane] Univ Sydney, Camperdown, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; Royal Children's Hospital Melbourne; George Institute for Global Health; University of Sydney; University of Sydney	Herbert, RD (corresponding author), Neurosci Res Australia NeuRA, Randwick, NSW, Australia.; Herbert, RD (corresponding author), Univ New South Wales, Kensington, NSW, Australia.	r.herbert@neura.edu.au	Billot, Laurent/Y-1241-2019	Billot, Laurent/0000-0002-4975-9793; Zhou, Albert/0000-0002-2416-2130; Herbert, Rob/0000-0003-4188-9195; Broderick, Carolyn/0000-0003-0096-796X	National Health and Medical Research Council of Australia [RG153190]; Shire; National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Shire; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	RDH is supported by a research fellowship from the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/; RG153190). This study was supported in part by an Investigator Initiated Research Grant from Baxalta, now part of Shire (https://www.shire.com/), awarded to RDH, CRB and JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Professor Lynne Bilston and Dr. Bart Bolsterlee for helpful advice. RH is supported by a research fellowship from the National Health and Medical Research Council of Australia.	Barnes C, 2006, HAEMOPHILIA, V12, P40, DOI 10.1111/j.1365-2516.2006.01333.x; Bjorkman S, 1997, HAEMOPHILIA, V3, P1, DOI 10.1046/j.1365-2516.1997.00074.x; Bjorkman S, 2012, BLOOD, V119, P612, DOI 10.1182/blood-2011-07-360594; Broderick CR, 2012, JAMA-J AM MED ASSOC, V308, P1452, DOI 10.1001/jama.2012.12727; Collins PW, 2012, HAEMOPHILIA, V18, P131, DOI 10.1111/j.1365-2516.2012.02838.x; Collins PW, 2011, HAEMOPHILIA, V17, P2, DOI 10.1111/j.1365-2516.2010.02370.x; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; Den Uijl IEM, 2011, HAEMOPHILIA, V17, P849, DOI 10.1111/j.1365-2516.2011.02539.x; Diao L, 2014, CLIN PHARMACOKINET, V53, P467, DOI 10.1007/s40262-013-0129-7; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Nestorov I, 2015, CLIN PHARM DRUG DEV, V4, P163, DOI 10.1002/cpdd.167; Oldenburg J, 2015, BLOOD, V125, P2038, DOI 10.1182/blood-2015-01-528414	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192783	10.1371/journal.pone.0192783	http://dx.doi.org/10.1371/journal.pone.0192783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447219	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900055
J	Huang, YK; Chen, J; Sun, B; Zheng, R; Li, BN; Li, Z; Tan, YY; Wei, JH; Pan, GQ; Li, CF; Zhou, ZY				Huang, Yukang; Chen, Jie; Sun, Bin; Zheng, Rong; Li, Boning; Li, Zeng; Tan, Yaoyao; Wei, Junhong; Pan, Guoqing; Li, Chunfeng; Zhou, Zeyang			Engineered resistance to Nosema bombycis by in vitro expression of a single-chain antibody in Sf9-III cells	PLOS ONE			English	Article							YEAST ASCOSPORE WALL; MALARIA TRANSMISSION; PROTEIN; MICROSPORIDIA; SILKWORM; MORI	Nosema bombycis is a destructive, obligate intracellular parasite of the Bombyx mori. In this study, a single-chain variable fragment (scFv) dependent technology is developed for the purpose of inhibiting parasite proliferation in insect cells. The scFv-G4, which we prepared from a mouse G4 monoclonal antibody, can target the N. bombycis spore wall protein 12 (NbSWP12). Indirect immunofluorescence assays showed that NbSWP12 located mainly on the outside of the N. bombycis cytoskeleton, although some of it co-localized with beta-tubulin in the meront-stage of parasites. When meront division began, NbSWP12 became concentrated at both ends of each meront. Western blotting showed that scFv-G4 could express in Sf9-III cells and recognized native NbSWP12. The transgenic Sf9-III cell line showed better resistance than the controls when challenged with N. bombycis, indicating that NbSWP12 is a promising target in this parasite and this scFv dependent strategy could be a solution for construction of N. bombycis-resistant Bombyx mori.	[Huang, Yukang; Chen, Jie; Sun, Bin; Zheng, Rong; Li, Boning; Li, Zeng; Tan, Yaoyao; Wei, Junhong; Pan, Guoqing; Li, Chunfeng; Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Chen, Jie; Wei, Junhong; Pan, Guoqing; Li, Chunfeng; Zhou, Zeyang] Southwest Univ, Agr Minist, Key Lab Sericulture Funct Genom & Biotechnol, Chongqing, Peoples R China; [Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China	Southwest University - China; Southwest University - China; Chongqing Normal University	Li, CF; Zhou, ZY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.; Li, CF; Zhou, ZY (corresponding author), Southwest Univ, Agr Minist, Key Lab Sericulture Funct Genom & Biotechnol, Chongqing, Peoples R China.; Zhou, ZY (corresponding author), Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China.	licf@swu.edu.cn; zyzhou@swu.edu.cn	Li, Chunfeng/ABD-8502-2020; Wei, JunHong/GRS-6681-2022	Huang, Yukang/0000-0002-7108-8340	National Basic Research Program of China [2012CB114604]; Fundamental Research Funds for the Central Universities [XDJK2015A010]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program of China (No.2012CB114604), Fundamental Research Funds for the Central Universities (XDJK2015A010) to CFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Basic Research Program of China (No.2012CB114604), Fundamental Research Funds for the Central Universities (XDJK2015A010). We thank Sandra Cheesman, PhD, from Liwen Bianji, Edanz Group China (www.liwenbianii.cn/ac), for editing the English text of a draft of this manuscript.	Bigliardi E, 1996, J EUKARYOT MICROBIOL, V43, P181, DOI 10.1111/j.1550-7408.1996.tb01388.x; Bigliardi E, 2001, MICROBES INFECT, V3, P373, DOI 10.1016/S1286-4579(01)01393-4; BRIZA P, 1986, J BIOL CHEM, V261, P4288; BRIZA P, 1988, J BIOL CHEM, V263, P11569; Cali Ann, 1999, P85; Chen J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179618; Chen J, 2013, PARASITOLOGY, V140, P1394, DOI 10.1017/S0031182013000875; Dean P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005870; Duffy PE, 1997, INFECT IMMUN, V65, P1109, DOI 10.1128/IAI.65.3.1109-1113.1997; Franzen C, 2004, TRENDS PARASITOL, V20, P275, DOI 10.1016/j.pt.2004.04.009; Geng L, 2013, SCI SERICULT, V39, P928; Guo R, 2016, PARASITOL RES, V115, P3093, DOI 10.1007/s00436-016-5064-8; HAN MS, 1988, J INVERTEBR PATHOL, V51, P41, DOI 10.1016/0022-2011(88)90086-9; Harrison RL, 2016, METHOD MOL BIOL, V1350, P341; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; KAWARABATA T, 1984, J INVERTEBR PATHOL, V44, P52, DOI 10.1016/0022-2011(84)90045-4; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; NAGELI KW, 1857, BOT Z, V15, P760; Qi YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006427; Schook LB, 1987, MONOCLONAL ANTIBODY; Sumitani M, 2013, INSECT MOL BIOL, V22, P41, DOI 10.1111/j.1365-2583.2012.01168.x; Varga J., 1976, Comparative Pathobiol, V1, P1; Wang ZY, 2010, J INVERTEBR PATHOL, V104, P134, DOI 10.1016/j.jip.2009.11.007; Wu Z, 2010, PROTEOMICS, V8, P2447; Wu ZL, 2009, J EUKARYOT MICROBIOL, V56, P113, DOI 10.1111/j.1550-7408.2008.00375.x; Xu JS, 2006, INT J PARASITOL, V36, P1049, DOI [10.1016/j.ijpara.2006.04.010, 10.1016/j.ijpara.2006.09.010]; Xue RY, 2009, J BIOTECHNOL, V144, P272, DOI 10.1016/j.jbiotec.2009.09.004; Yadav P, 2016, IMMUN INFLAMM DIS, V4, P362, DOI 10.1002/iid3.119; Yuan QP, 1997, APPL ENVIRON MICROB, V63, P263, DOI 10.1128/AEM.63.1.263-269.1997; Yusakul G, 2016, J NAT MED-TOKYO, V70, P592, DOI 10.1007/s11418-016-0981-5	31	18	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193065	10.1371/journal.pone.0193065	http://dx.doi.org/10.1371/journal.pone.0193065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447266	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900107
J	Markt, SC; Tang, TY; Cronin, AM; Katz, IT; Howitt, BE; Horowitz, NS; Lee, LJ; Wright, AA				Markt, Sarah C.; Tang, Tianyu; Cronin, Angel M.; Katz, Ingrid T.; Howitt, Brooke E.; Horowitz, Neil S.; Lee, Larissa J.; Wright, Alexi A.			Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival	PLOS ONE			English	Article							HEALTH-CARE; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; ETHNIC-DIFFERENCES; LANGUAGE BARRIERS; WOMEN; POPULATION; MORTALITY; IMPACT; STAGE	Cervical cancer outcomes remain poor among disadvantaged populations, including ethnic minorities, low-income, and underinsured women. The aim of this study was to evaluate the mechanisms that underlie the observed association between race/ethnicity and cervical cancer survival. We identified 13,698 women, ages 21 to 64 years, diagnosed with stages I-III primary cervical cancer between 2007-2013 in Surveillance, Epidemiology, and End Results (SEER). Multivariable Cox proportional hazards regression models evaluated associations between race/ethnicity (Non-Hispanic White, Non-Hispanic Black, Hispanic, Other) and cervical cancer-specific mortality. We conducted mediation analysis to calculate the mediation proportion and its 95% confidence interval. Non-Hispanic black women had an increased risk of cervical cancer-specific mortality (HR: 1.23, 95% CI: 1.08-1.39), and Hispanic women a decreased risk of dying from their disease (HR: 0.82, 95% CI: 0.72-0.93), compared with non-Hispanic white. The estimated proportion of excess cervical cancer mortality for non-Hispanic black women relative to non-Hispanic white women that was mediated by insurance was 18.6% and by treatment was 47.2%. Furthermore, non-Hispanic black women were more likely to receive radiation and less likely to receive surgery for early-stage disease. In this population-based study we found that some of the excess cervical cancer-specific mortality for non-Hispanic black women is mediated by factors such as insurance status and treatment. These findings suggest that enhancing existing insurance coverage and ensuring equal and adequate treatment in all women may be a key strategy for improving cervical cancer outcomes.	[Markt, Sarah C.; Tang, Tianyu] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Cronin, Angel M.; Horowitz, Neil S.; Lee, Larissa J.; Wright, Alexi A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Cronin, Angel M.; Katz, Ingrid T.; Howitt, Brooke E.; Lee, Larissa J.; Wright, Alexi A.] Harvard Med Sch, Boston, MA 02115 USA; [Katz, Ingrid T.; Horowitz, Neil S.; Wright, Alexi A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Katz, Ingrid T.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Howitt, Brooke E.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Horowitz, Neil S.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, 75 Francis St, Boston, MA 02115 USA; [Lee, Larissa J.] Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Wright, AA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Wright, AA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Wright, AA (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	alexi_wright@dfci.harvard.edu	Markt, Sarah/O-7554-2019; Wright, Alexi/T-5793-2019	Markt, Sarah/0000-0003-2873-0358; Howitt, Brooke/0000-0002-0309-6680	National Cancer Institute (NCI) [K07 CA166210]; NCI [T32 CA09001]; National Institute of Mental Health (NIMH) [K23 MH097667]; NATIONAL CANCER INSTITUTE [K07CA166210] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AAW is supported by the National Cancer Institute (NCI) K07 CA166210, SCM is supported by the NCI T32 CA09001, and ITK is supported by the National Institute of Mental Health (NIMH) K23 MH097667.	[Anonymous], 2015, CERV CANC RAT RAC ET; [Anonymous], SEER CANC STAT FACTS; Barbera L, 2006, INT J RADIAT ONCOL, V64, P1389, DOI 10.1016/j.ijrobp.2005.09.046; Barrington DA, 2016, GYNECOL ONCOL, V143, P617, DOI 10.1016/j.ygyno.2016.10.004; Beavis AL, 2017, CANCER-AM CANCER SOC, V123, P1044, DOI 10.1002/cncr.30507; Bradley CJ, 2004, AM J PUBLIC HEALTH, V94, P2098, DOI 10.2105/AJPH.94.12.2098; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; (CDC) CfDCaP, 2014, VIT SIGNS CERV CANC; Chatterjee S, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00036; Churilla T, DISPARITIES MANAGEME, DOI [10.1016/j.ygyno.2016.03.025, DOI 10.1016/J.YGYNO.2016.03.025]; Coker AL, 2006, GYNECOL ONCOL, V102, P278, DOI 10.1016/j.ygyno.2005.12.016; Coker AL, 2009, J WOMENS HEALTH, V18, P1577, DOI 10.1089/jwh.2008.1342; Cowburn S, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130034; del Carmen MG, 1999, GYNECOL ONCOL, V75, P113, DOI 10.1006/gyno.1999.5543; Echeverria SE, 2006, MED CARE, V44, P788, DOI 10.1097/01.mlr.0000215863.24214.41; Eggleston KS, 2006, J WOMENS HEALTH, V15, P941, DOI 10.1089/jwh.2006.15.941; Farley JH, 2001, CANCER, V91, P869, DOI 10.1002/1097-0142(20010215)91:4<869::AID-CNCR1075>3.0.CO;2-D; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fleming S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104344; Flores G, 2006, NEW ENGL J MED, V355, P229, DOI 10.1056/NEJMp058316; Grant SR, 2015, INT J RADIAT ONCOL, V93, P968, DOI 10.1016/j.ijrobp.2015.08.036; Grigsby PW, 2000, GYNECOL ONCOL, V79, P357, DOI 10.1006/gyno.2000.5974; Howell EA, 1999, OBSTET GYNECOL, V94, P509, DOI 10.1016/S0029-7844(99)00334-8; Jun HJ, 2010, CANCER CAUSE CONTROL, V21, P1817, DOI 10.1007/s10552-010-9609-3; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Mundt AJ, 1998, GYNECOL ONCOL, V71, P151, DOI 10.1006/gyno.1998.5203; Patel DA, 2005, GYNECOL ONCOL, V97, P550, DOI 10.1016/j.ygyno.2005.01.045; Pearcey R, 2007, J CLIN ONCOL, V25, P2383, DOI 10.1200/JCO.2006.09.1926; Rauh-Hain JA, 2013, CANCER-AM CANCER SOC, V119, P3644, DOI 10.1002/cncr.28261; Robbins AS, 2015, JAMA-J AM MED ASSOC, V314, P2189, DOI 10.1001/jama.2015.10546; Schyve PM, 2007, J GEN INTERN MED, V22, P360, DOI 10.1007/s11606-007-0365-3; Sheppard CS, 2016, INT J CANCER, V138, P2622, DOI 10.1002/ijc.29996; Simard EP, 2012, CANCER-AM CANCER SOC, V118, P5110, DOI 10.1002/cncr.27606; Timmins CL, 2002, J MIDWIFERY WOM HEAL, V47, P80, DOI 10.1016/S1526-9523(02)00218-0; Valeri L, 1531, SAS MACRO CAUSAL MED; VanderWeele TJ, 1531, CAUSAL MEDIATION ANA, DOI [10.1097/EDE.0b013e31821db37e, DOI 10.1097/EDE.0B013E31821DB37E]; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Ward E, 2008, CA-CANCER J CLIN, V58, P9, DOI 10.3322/CA.2007.0011	39	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193047	10.1371/journal.pone.0193047	http://dx.doi.org/10.1371/journal.pone.0193047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447263	gold, Green Submitted, Green Published			2022-12-26	WOS:000425283900102
J	van den Bogerd, N; Dijkstra, SC; Seidell, JC; Maas, J				van den Bogerd, Nicole; Dijkstra, S. Coosje; Seidell, Jacob C.; Maas, Jolanda			Greenery in the university environment: Students' preferences and perceived restoration likelihood	PLOS ONE			English	Article							MENTAL-HEALTH; STRESS; SPACES; LANDSCAPES; FRAMEWORK; CONNECTEDNESS; ADOLESCENTS; PERCEPTIONS; PERFORMANCE; EXPOSURE	A large body of evidence shows that interaction with greenery can be beneficial for human stress reduction, emotional states, and improved cognitive function. It can, therefore, be expected that university students might benefit from greenery in the university environment. Before investing in real-life interventions in a university environment, it is necessary to first explore students' perceptions of greenery in the university environment. This study examined (1) preference for university indoor and outdoor spaces with and without greenery (2) perceived restoration likelihood of university outdoor spaces with and without greenery and (3) if preference and perceived restoration likelihood ratings were modified by demographic characteristics or connectedness to nature in Dutch university students (N = 722). Digital photographic stimuli represented four university spaces (lecture hall, classroom, study area, university outdoor space). For each of the three indoor spaces there were four or five stimuli conditions: (1) the standard design (2) the standard design with a colorful poster (3) the standard design with a nature poster (4) the standard design with a green wall (5) the standard design with a green wall plus interior plants. The university outdoor space included: (1) the standard design (2) the standard design with seating (3) the standard design with colorful artifacts (4) the standard design with green elements (5) the standard design with extensive greenery. Multi-level analyses showed that students gave higher preference ratings to the indoor spaces with a nature poster, a green wall, or a green wall plus interior plants than to the standard designs and the designs with the colorful posters. Students also rated preference and perceived restoration likelihood of the outdoor spaces that included greenery higher than those without. Preference and perceived restoration likelihood were not modified by demographic characteristics, but students with strong connectedness to nature rated preference and perceived restoration likelihood overall higher than students with weak connectedness to nature. The findings suggest that students would appreciate the integration of greenery in the university environment.	[van den Bogerd, Nicole; Dijkstra, S. Coosje; Seidell, Jacob C.] Vrije Univ Amsterdam, Dept Hlth Sci, Fac Sci, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Maas, Jolanda] Vrije Univ Amsterdam, Dept Neuro Clin & Dev Psychol, Fac Behav & Movement Sci, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van den Bogerd, N (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Fac Sci, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.	n.vanden.bogerd@vu.nl	seidell, jacob/AAF-5362-2019	seidell, jacob/0000-0002-9262-9062; van den Bogerd, Nicole/0000-0002-2162-8580	Triodos Foundation	Triodos Foundation	This study was funded by the Triodos Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghazzeh TM, 1999, ENVIRON BEHAV, V31, P764, DOI 10.1177/00139169921972344; Arsenio WF, 2014, J GENET PSYCHOL, V175, P76, DOI 10.1080/00221325.2013.806293; Bagot KL, 2015, J ENVIRON PSYCHOL, V41, P1, DOI 10.1016/j.jenvp.2014.11.005; Benfield JA, 2013, ENVIRON BEHAV, V47, P140; Berto R, 2007, INT J PSYCHOL, V42, P331, DOI 10.1080/00207590601000590; Beukeboom CJ, 2012, J ALTERN COMPLEM MED, V18, P329, DOI 10.1089/acm.2011.0488; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Bringslimark T, 2009, J ENVIRON PSYCHOL, V29, P422, DOI 10.1016/j.jenvp.2009.05.001; Cervinka R, 2012, J HEALTH PSYCHOL, V17, P379, DOI 10.1177/1359105311416873; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Dopko R. L., 2014, ECOPSYCHOLOGY, V6, P207, DOI DOI 10.1089/ECO.2014.0042; Doxey JS, 2009, HORTSCIENCE, V44, P384, DOI 10.21273/HORTSCI.44.2.384; Driessen M, 2011, GEESTELIJKE ONGEZOND; Felsten G, 2009, J ENVIRON PSYCHOL, V29, P160, DOI 10.1016/j.jenvp.2008.11.006; Floriade, 2015, GROWING GREEN CITIES; Hartig T, 2006, J ENVIRON PSYCHOL, V26, P215, DOI 10.1016/j.jenvp.2006.07.007; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Herzog TR, 2003, J ENVIRON PSYCHOL, V23, P159, DOI 10.1016/S0272-4944(02)00113-5; Horne WR, LEARNING ASSISTANCE, P22; Hovinga D, 2016, LEER KRACHT SCHOOLPL; Hurst CS, 2013, STRESS HEALTH, V29, P275, DOI 10.1002/smi.2465; Jahncke H, 2015, NOISE HEALTH, V17, P1, DOI 10.4103/1463-1741.149559; Jalil NA, 2012, PROCD SOC BEHV, V35, P54, DOI 10.1016/j.sbspro.2012.02.062; Kaplan R, 1989, EXPERIENCE NATURE PS; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kaya N., 2004, COLL STUD J, V38, P396; Kessler RC, 2007, LIFETIME PREVALENCE; Kirkpatrick JB, 2007, LANDSCAPE URBAN PLAN, V79, P314, DOI 10.1016/j.landurbplan.2006.03.006; Korpela KM, 2008, HEALTH PLACE, V14, P636, DOI 10.1016/j.healthplace.2007.10.008; Lachowycz K, 2013, LANDSCAPE URBAN PLAN, V118, P62, DOI 10.1016/j.landurbplan.2012.10.012; Macaskill A, 2013, BRIT J GUID COUNS, V41, P426, DOI 10.1080/03069885.2012.743110; Mahnke F., 1996, COLOR ENV HUMAN RESP; Mayer FS, 2009, ENVIRON BEHAV, V41, P607, DOI 10.1177/0013916508319745; McFarland AL, 2008, HORTTECHNOLOGY, V18, P232, DOI 10.21273/HORTTECH.18.2.232; McSweeney J, 2015, HEALTH PROMOT INT, V30, P126, DOI 10.1093/heapro/dau081; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; Ozguner H, 2006, LANDSCAPE URBAN PLAN, V74, P139, DOI 10.1016/j.landurbplan.2004.10.003; Palmer JF, 2001, LANDSCAPE URBAN PLAN, V54, P149, DOI 10.1016/S0169-2046(01)00133-5; Park SH, 2009, J ALTERN COMPLEM MED, V15, P975, DOI 10.1089/acm.2009.0075; Purcell T, 2001, ENVIRON BEHAV, V33, P93, DOI 10.1177/00139160121972882; Regan CL, 2005, J ENVIRON PSYCHOL, V25, P57, DOI 10.1016/j.jenvp.2005.01.001; Robotham D, 2008, HIGH EDUC, V56, P735, DOI 10.1007/s10734-008-9137-1; Schmidt E, 2013, PSYCHISCHE KLACHTEN; Scott MJ, 1997, J ENVIRON PSYCHOL, V17, P263, DOI 10.1006/jevp.1997.0068; Seitz C. M., 2014, ECOPSYCHOLOGY, V6, P98, DOI [DOI 10.1089/ECO.2013.0103, 10.1089/eco.2013.0103]; Sklenicka P, 2010, ENVIRON MANAGE, V46, P424, DOI 10.1007/s00267-010-9513-3; Speake J., 2013, HUM GEOGR, V7, P21, DOI DOI 10.5719/HGEO.2013.71.21; Staats H, 2003, J ENVIRON PSYCHOL, V23, P147, DOI 10.1016/S0272-4944(02)00112-3; Stamps A.E., 1999, J PLAN LIT, V14, P155, DOI [DOI 10.1177/08854129922092630, 10.1177/08854129922092630]; Statistiek CBv, 2016, WAT VERST CBS OND AL; Storrie K, 2010, INT J NURS PRACT, V16, P1, DOI 10.1111/j.1440-172X.2009.01813.x; Suhrcke M, 2011, IMPACT HLTH HLTH BEH; Twisk J.W.R., 2006, PRACTICAL GUIDES BIO; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1986, LANDSCAPE URBAN PLAN, V13, P29, DOI 10.1016/0169-2046(86)90005-8; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; van den Berg A. E, 2016, ENVIRON BEHAV; van den Berg AE, 2003, J ENVIRON PSYCHOL, V23, P135, DOI 10.1016/S0272-4944(02)00111-1; Van den Berg AE, 2006, LANDSCAPE URBAN PLAN, V78, P362, DOI 10.1016/j.landurbplan.2005.11.006; Van den Berg AE, 2014, LANDSCAPE URBAN PLAN, V127, P173, DOI 10.1016/j.landurbplan.2014.04.012; van den Berg AE, 2010, URBAN FOR URBAN GREE, V9, P179, DOI 10.1016/j.ufug.2010.01.006; van den Berg M, 2015, URBAN FOR URBAN GREE, V14, P806, DOI 10.1016/j.ufug.2015.07.008; van den Broek A, 2014, STUDENTENMONITOR 201; White EV, 2011, J ENVIRON PSYCHOL, V31, P89, DOI 10.1016/j.jenvp.2010.11.002; White M, 2010, J ENVIRON PSYCHOL, V30, P482, DOI 10.1016/j.jenvp.2010.04.004; Wilkie S, 2013, URBAN FOR URBAN GREE, V12, P163, DOI 10.1016/j.ufug.2013.01.004; Ziekenhuizen. GG, GROEN GEZ ZIEK 2015	67	32	32	9	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192429	10.1371/journal.pone.0192429	http://dx.doi.org/10.1371/journal.pone.0192429			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447184	Green Published, Green Submitted, gold			2022-12-26	WOS:000425283900032
J	Eberhardt, C; Wurnig, MC; Wirsching, A; Rossi, C; Feldmane, I; Lesurtel, M; Boss, A				Eberhardt, Christian; Wurnig, Moritz C.; Wirsching, Andrea; Rossi, Cristina; Feldmane, Idana; Lesurtel, Mickael; Boss, Andreas			Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer	PLOS ONE			English	Article							PARTIAL LIVER-TRANSPLANTATION; PROTON RELAXATION; WATER-CONTENT; REGENERATION; RAT; RESECTION; SURGERY; MICE; TIME; MECHANISM	This study aimed to monitor the course of liver regeneration by multiparametric magnetic-resonance imaging (MRI) after partial liver resection characterizing Small-for-Size Syndrome (SFSS), which frequently leads to fatal post-hepatectomy liver failure (PLF). Twenty-two C57BL/6 mice underwent either conventional 70% partial hepatectomy (cPH), extended 86% partial hepatectomy (ePH) or SHAM operation. Subsequent MRI scans on days 0, 1, 2, 3, 5 and 7 in a 4.7T MR Scanner quantified longitudinal and transverse relaxation times, apparent diffusion coefficient (ADC) and the magnetization-transfer ratio (MTR) of the regenerating liver parenchyma. Histological examination was performed by hematoxylin-eosin staining. After hepatectomy, an increase of T1 time was detected being larger for ePH on day 1: 18% for cPH vs. 40% for ePH and on day 2: 24% for cPH vs. 49% for ePH. An increase in T2 time, again greater in ePH was most pronounced on day 5: 21% for cPH vs. 41% for ePH. ADC and MTR showed a decrease on day 1: 21% for ePH vs. 13% for cPH for ADC, 15% for ePH vs. 11% for cPH for MTR. Subsequently, all MR parameters converged towards initial values in surviving animals. Dying PLF animals exhibited the strongest increase of T1 relaxation time and most prominent decreases of ADC and MTR. The retrieved MRI biomarkers indicate SFSS and potentially developing PLF at an early stage, likely reflecting cellular hypertrophy with extended water content and concomitantly diluted cellular components as features of liver regeneration, appearing more intense in ePH as compared to cPH.	[Eberhardt, Christian; Wurnig, Moritz C.; Rossi, Cristina; Feldmane, Idana; Boss, Andreas] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Wirsching, Andrea; Lesurtel, Mickael] Univ Hosp Zurich, Dept Surg, Swiss Hepatopancreaticobiliary & Transplantat Ctr, Zurich, Switzerland; [Lesurtel, Mickael] Croix Rousse Univ Hosp, Dept Digest Surg & Liver Transplantat, Lyon, France	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; CHU Lyon	Eberhardt, C (corresponding author), Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.	christian.eberhardt@usz.ch	Lesurtel, Mickaël/J-3710-2019	Lesurtel, Mickaël/0000-0003-2397-4599; Rossi, Cristina/0000-0002-9041-2222; Wurnig, Moritz/0000-0001-7865-4010	Clinical Research Priority Program - Molecular Imaging Network Zurich (CRPP - MINZ); Swiss National Science Foundation [PP00P3_152990]; Clinical Research Priority Program-Molecular Imaging Network Zurich	Clinical Research Priority Program - Molecular Imaging Network Zurich (CRPP - MINZ); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Clinical Research Priority Program-Molecular Imaging Network Zurich	This work was supported by the Clinical Research Priority Program - Molecular Imaging Network Zurich (CRPP - MINZ) received by AB and ML. ML received support by a professorship grant from the Swiss National Science Foundation (PP00P3_152990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the excellent maintenance of the Bruker MRI facility by Udo Ungethuem and the outstanding technical assistance of Ursula Suess, Pia Fuchs and Nadja Bain for the tissue examination by IHC. This study was funded by the Clinical Research Priority Program-Molecular Imaging Network Zurich. ML is supported by a professorship grant from the Swiss National Science Foundation (PP00P3_152990).	Clavien PA, 2008, SWISS MED WKLY, V138, P361, DOI 2008/25/smw-12231; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713; DECERTAINES JD, 1982, LIFE SCI, V31, P505, DOI 10.1016/0024-3205(82)90477-5; Eida S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19051; FANTAZZINI P, 1984, BIOCHIM BIOPHYS ACTA, V803, P250, DOI 10.1016/0167-4889(84)90114-9; FEX G, 1970, BIOCHIM BIOPHYS ACTA, V202, P415, DOI 10.1016/0005-2760(70)90112-8; Garbow JR, 2004, MAGN RESON MED, V52, P177, DOI 10.1002/mrm.20107; GIRARD A, 1971, BIOCHIM BIOPHYS ACTA, V248, P105, DOI 10.1016/0005-2760(71)90080-4; GLENDE EA, 1968, EXP MOL PATHOL, V8, P190, DOI 10.1016/0014-4800(68)90015-4; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hemming AW, 2002, ANN SURG, V235, P850, DOI 10.1097/00000658-200206000-00013; INCH WR, 1974, J NATL CANCER I, V52, P353, DOI 10.1093/jnci/52.2.353; KIN Y, 1994, WORLD J SURG, V18, P143, DOI 10.1007/BF00348207; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Lehmann K, 2012, GASTROENTEROLOGY, V143, P1609, DOI 10.1053/j.gastro.2012.08.043; Li W. Y., 2016, SHOCK VIB, V2016, P1, DOI DOI 10.1007/S00542-016-2993-1; Melloul E, 2013, J SURG RES; Michalski CW, 2015, SURG ONCOL CLIN N AM, V24, P57, DOI 10.1016/j.soc.2014.09.007; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Okamura S, 2016, DIGEST LIVER DIS, V48, P945, DOI 10.1016/j.dld.2016.05.020; Palmes D, 2004, TRANSPL INT, V17, P862, DOI 10.1111/j.1432-2277.2004.tb00522.x; Patrizio G, 1990, Radiol Med, V79, P453; PIZZARELLO DJ, 1986, INVEST RADIOL, V21, P320, DOI 10.1097/00004424-198604000-00005; Schmitt P, 2004, MAGN RESON MED, V51, P661, DOI 10.1002/mrm.20058; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOSTMAN HD, 1985, HEPATOLOGY, V5, P538, DOI 10.1002/hep.1840050403; STOWELL RE, 1948, ARCH PATHOL, V46, P164; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x; Vauthey JN, 2000, SURGERY, V127, P512, DOI 10.1067/msy.2000.105294; YOKOYAMA HO, 1953, CANCER RES, V13, P80	33	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192847	10.1371/journal.pone.0192847	http://dx.doi.org/10.1371/journal.pone.0192847			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444146	Green Published, Green Accepted, gold			2022-12-26	WOS:000425183500096
J	Sisic, A; Bacanovic-Sisic, J; Karlovsky, P; Wittwer, R; Walder, F; Campiglia, E; Radicetti, E; Friberg, H; Baresel, JP; Finckh, MR				Sisic, Adnan; Bacanovic-Sisic, Jelena; Karlovsky, Petr; Wittwer, Raphael; Walder, Florian; Campiglia, Enio; Radicetti, Emanuele; Friberg, Hanna; Baresel, Joerg Peter; Finckh, Maria R.			Roots of symptom-free leguminous cover crop and living mulch species harbor diverse Fusarium communities that show highly variable aggressiveness on pea (Pisum sativum)	PLOS ONE			English	Article							DNA-SEQUENCE DATABASE; FIELD PEA; SUBTERRANEAN CLOVER; ROT; AVENACEUM; GRAIN; PATHOGENICITY; IDENTIFICATION; TRICHOTHECENE; GRAMINEARUM	Leguminous cover crop and living mulch species show not only great potential for providing multiple beneficial services to agro-ecosystems, but may also present pathological risks for other crops in rotations through shared pathogens, especially those of the genus Fusarium. Disease severity on roots of subterranean clover, white clover, winter and summer vetch grown as cover crop and living mulch species across five European sites as well as the frequency, distribution and aggressiveness to pea of Fusarium spp. recovered from the roots were assessed in 2013 and 2014. Disease symptoms were very low at all sites. Nevertheless, out of 1480 asymptomatic roots, 670 isolates of 14 Fusarium spp. were recovered. The most frequently isolated species in both years from all hosts were F. oxysporum and F. avenaceum accounting for 69% of total isolation percentage. They were common at the Swiss, Italian and German sites, whereas at the Swedish site F. oxysporum dominated and F. avenaceum occurred only rarely. The agressiveness and effect on pea biomass were tested in greenhouse assays for 72 isolates of six Fusarium species. Isolates of F. avenaceum caused severe root rot symptoms with mean severity index (DI) of 82 and 74% mean biomass reduction compared to the non-inoculated control. Fusarium oxysporum and F. solani isolates were higly variable in agressiveness and their impact on pea biomass. DI varied between 15 and 50 and biomass changes relative to the non-inoculated control -40% to + 10%. Isolates of F. tricinctum, F. acuminatum and F. equiseti were non to weakly agressive often enhancing pea biomass. This study shows that some of the major pea pathogens are characterized by high ecological plasticity and have the ability to endophytically colonize the hosts studied that thus may serve as inoculum reservoir for susceptible main legume grain crops such as pea.	[Sisic, Adnan; Finckh, Maria R.] Univ Kassel, Dept Ecol Plant Protect, Witzenhausen, Germany; [Bacanovic-Sisic, Jelena] Univ Kassel, Sect Organ Plant Breeding & Agrobiodivers, Witzenhausen, Germany; [Karlovsky, Petr] Univ Gottingen, Dept Mol Phytopathol & Mycotoxin Res, Gottingen, Germany; [Wittwer, Raphael; Walder, Florian] Agroscope, Inst Sustainabil Sci, Plant Soil Interact Grp, Zurich, Switzerland; [Campiglia, Enio; Radicetti, Emanuele] Univ Tuscia, Dept Agr & Forestry Sci DAFNE, Viterbo, Italy; [Friberg, Hanna] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Baresel, Joerg Peter] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Inst Plant Nutr, Freising Weihenstephan, Germany	Universitat Kassel; Universitat Kassel; University of Gottingen; Swiss Federal Research Station Agroscope; Tuscia University; Swedish University of Agricultural Sciences; Technical University of Munich	Sisic, A (corresponding author), Univ Kassel, Dept Ecol Plant Protect, Witzenhausen, Germany.	adnan_sisic@uni-kassel.de	Campiglia, Enio/AAC-6044-2020; Šišić, Adnan/AAJ-2223-2021; Finckh, Maria/ABH-3204-2020; Radicetti, Emanuele/O-4326-2019	Šišić, Adnan/0000-0001-7715-1817; Finckh, Maria/0000-0003-2925-4058; Radicetti, Emanuele/0000-0001-8654-3177; Walder, Florian/0000-0001-7731-7469; Karlovsky, Petr/0000-0002-6532-5856	European Commission FP7 Project [289277: OSCAR]; University of Kassel	European Commission FP7 Project; University of Kassel	This work was financed by the European Commission FP7 Project n.289277: OSCAR (Optimizing Subsidiary Crop Applications in Rotations), and A. S. was supported by a doctoral scholarship provided by the University of Kassel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoud R, 1997, PHYTOPHTHORA ROOT RO; [Anonymous], 2006, BLACKWELL PUB PROF; [Anonymous], 2015, PLANT DIS THEIR MANA; Arias MMD, 2013, PLANT DIS, V97, P1557, DOI 10.1094/PDIS-11-12-1059-RE; Arias MMD, 2013, PHYTOPATHOLOGY, V103, P822, DOI 10.1094/PHYTO-08-12-0207-R; Bacanovic J., 2015, THESIS; Barbetti M, 2007, PHYTOPATHOL MEDITERR, V46, P239; Basch G, 2011, P 5 WORLD C CONS AGR, P316; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandfass C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-4; Chitrampalam P., 2014, PLANT HLTH PROG, V15, P124, DOI [10.1094/PHP-RS-14-0014, DOI 10.1094/PHP-RS-14-0014]; Chittem K, 2015, EUR J PLANT PATHOL, V143, P641, DOI 10.1007/s10658-015-0714-8; Clarke K., 2001, PRIMER V5 USER MANUA; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; D'arcy C.J., 2001, PLANT HLTH INSTRUCTO; Dastjerdi R., 2014, THESIS; de Mendiburu F., AGRICOLAE STAT PROCE; Doohan FM, 1998, PLANT PATHOL, V47, P197, DOI 10.1046/j.1365-3059.1998.00218.x; EUROSTAT, 2017, REG STAT REF GUID; Feng J, 2010, PLANT PATHOL, V59, P845, DOI 10.1111/j.1365-3059.2010.02313.x; Ferrigo D, 2016, MOLECULES, V21, DOI 10.3390/molecules21050627; Fletcher AL, 2016, CROP PASTURE SCI, V67, P1252, DOI 10.1071/CP16211; FLETT SP, 1994, AUST J EXP AGR, V34, P1125, DOI 10.1071/EA9941125; Fox J., 2019, R COMPANION APPL REG, V.; Fuchs JG, 2014, APPL SOIL ECOL, V79, P26, DOI 10.1016/j.apsoil.2014.02.013; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; German Agricultural Research Alliance (DAFA), 2012, LEG EXP FOR SCI EC S; Guddat C, 2010, LEITLINIE EFFIZIENTE; Hauggaard-Nielsen' H, 2008, RENEW AGR FOOD SYST, V23, P3, DOI 10.1017/S1742170507002025; Hayes RC, 2017, RENEW AGR FOOD SYST, V32, P276, DOI [10.1017/s1742170516000260, 10.1017/S1742170516000260]; Holtz MD, 2011, CAN J PLANT PATHOL, V33, P61, DOI 10.1080/07060661.2011.536651; HWANG SF, 1989, CAN PLANT DIS SURV, V69, P139; Jongman RHG, 2006, LANDSCAPE ECOL, V21, P409, DOI 10.1007/s10980-005-6428-0; Karkanis A, 2016, NOT BOT HORTI AGROBO, V44, P325, DOI 10.15835/nbha44210618; Kertesz A, 2014, INT SOIL WATER CONSE, V2, P91, DOI 10.1016/S2095-6339(15)30016-2; Knudsen MT, 2004, J AGR SCI-CAMBRIDGE, V142, P617, DOI 10.1017/S0021859604004745; Kraft J. M., 1984, COMPENDIUM PEA DIS, P13; KRAFT JM, 1994, AGRONOMIE, V14, P561, DOI 10.1051/agro:19940901; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05035-170440; Kulik T, 2008, J APPL GENET, V49, P305, DOI 10.1007/BF03195628; Lager J, 2002, Z PFLANZENK PFLANZEN, V109, P142; Langdale G. W., 1991, P C JACKS, P15; LAUREN DR, 1992, MYCOPATHOLOGIA, V120, P167, DOI 10.1007/BF00436395; LAUREN DR, 1988, NEW ZEAL J AGR RES, V31, P219; Meisinger J., 1991, COVER CROPS CLEAN WA, P793; Mueller T, 2001, BIOL AGRIC HORTIC, V18, P345, DOI 10.1080/01448765.2001.9754897; Mule G, 2004, FEMS MICROBIOL LETT, V230, P235, DOI 10.1016/S0378-1097(03)00926-1; Nan ZB, 1989, THESIS; Nicholson P, 2004, EUR J PLANT PATHOL, V110, P503, DOI 10.1023/B:EJPP.0000032390.65641.a7; Nicholson P, 1998, PHYSIOL MOL PLANT P, V53, P17, DOI 10.1006/pmpp.1998.0170; Nielsen LK, 2011, PHYTOPATHOLOGY, V101, P960, DOI 10.1094/PHYTO-07-10-0188; Nirenberg HI, 1976, MITT BIOL BUNDESANST, V169, P1, DOI DOI 10.1002/JPLN.19771400220; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell K, 2010, J CLIN MICROBIOL, V48, P3708, DOI 10.1128/JCM.00989-10; Parry DW, 1996, PLANT PATHOL, V45, P383, DOI 10.1046/j.1365-3059.1996.d01-133.x; Persson L, 1997, PLANT DIS, V81, P171, DOI 10.1094/PDIS.1997.81.2.171; Pflughoft O, 2012, GESUNDE PFLANZ, V64, P39, DOI 10.1007/s10343-011-0270-x; Pflughoft O., 2008, THESIS; Pohlert T., 2014, PAIRWISE MULTIPLE CO; R Core Team, 2013, LANG ENV STAT COMP; Roldan A, 2003, SOIL TILL RES, V72, P65, DOI 10.1016/S0167-1987(03)00051-5; Rufelt S., 1986, THESIS; Satyaprasad K, 2000, J PHYTOPATHOL, V148, P211, DOI 10.1046/j.1439-0434.2000.00494.x; Scauflaire J, 2011, EUR J PLANT PATHOL, V131, P59, DOI 10.1007/s10658-011-9787-1; Schilling AG, 1996, PHYTOPATHOLOGY, V86, P515, DOI 10.1094/Phyto-86-515; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sisic A, 2017, EUR J PLANT PATHOL, V148, P271, DOI 10.1007/s10658-016-1086-4; Taheri AE, 2017, EUR J PLANT PATHOL, V147, P489, DOI 10.1007/s10658-016-1017-4; Tan Diana C, 2011, Mycotoxin Res, V27, P123, DOI 10.1007/s12550-010-0085-0; Teasdale JR, 2007, NON CHEMICAL WEED MANAGEMENT: PRINCIPLES, CONCEPTS AND TECHNOLOGY, P49, DOI 10.1079/9781845932909.0049; Uhlig S, 2007, INT J FOOD MICROBIOL, V119, P17, DOI 10.1016/j.ijfoodmicro.2007.07.021; West JS, 2012, EUR J PLANT PATHOL, V133, P315, DOI 10.1007/s10658-011-9932-x; WONG DH, 1985, AUST J EXP AGR, V25, P574, DOI 10.1071/EA9850574; Yli-Mattila T, 2010, EUR J PLANT PATHOL, V126, P13, DOI 10.1007/s10658-009-9516-1; Zhang JX, 2010, CAN J PLANT SCI, V90, P767, DOI 10.4141/CJPS09133	75	20	20	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191969	10.1371/journal.pone.0191969	http://dx.doi.org/10.1371/journal.pone.0191969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444142	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500046
J	Hinz, M; Klein, A; Schmitz, A; Schmitz, H				Hinz, Marcel; Klein, Adrian; Schmitz, Anke; Schmitz, Helmut			The impact of infrared radiation in flight control in the Australian "firebeetle" Merimna atrata	PLOS ONE			English	Article							MELANOPHILA-ACUMINATA; LOCUSTA-MIGRATORIA; COLEOPTERA BUPRESTIDAE; FOREST-FIRES; ANTENNA; ORGAN; THERMORECEPTORS; SENSITIVITY; BEHAVIOR; RECEPTOR	Infrared (IR) receptors are rare in insects and have only been found in the small group of so-called pyrophilous insects, which approach forest fires. In previous work the morphology of the IR receptors and the physiology of the inherent sensory cells have been investigated. It was shown that receptors are located on the thorax and the abdomen respectively and show an astounding diversity with respect to structure and the presumed transduction mechanism. What is completely missing, however, is any behavioral evidence for the function of the IR receptors in pyrophilous insects. Here we describe the responses of the Australian "firebeetle", Merimna atrata to IR radiation. Beetles in a restrained flight were laterally stimulated with IR radiation of an intensity 20% above a previously determined electrophysiological threshold of the IR organs (40 mW/cm(2)). After exposure, beetles always showed an avoidance response away from the IR source. Reversible ablation experiments showed that the abdominal IR receptors are essential for the observed behavior. Tests with weaker IR radiation (11.4 mW/cm(2)) also induced avoidance reactions in some beetles pointing to a lower threshold. In contrast, beetles were never attracted by the IR source. Our results suggest that the IR receptors in Merimna atrata serve as an early warning system preventing an accidental landing on a hot surface. We also tested if another fire specific stimulus, the view of a large smoke plume, influenced the flight. However, due to an unexpected insensitivity of the flying beetles to most visual stimuli results were ambiguous.	[Hinz, Marcel; Klein, Adrian; Schmitz, Anke; Schmitz, Helmut] Univ Bonn, Inst Zool, Meckenheimer Allee 169, Bonn, Germany	University of Bonn	Schmitz, H (corresponding author), Univ Bonn, Inst Zool, Meckenheimer Allee 169, Bonn, Germany.	h.schmitz@uni-bonn.de			German Research Foundation (DFG) [SCHM1161/12-1]; Parks and Wildlife Service of the Department of Biodiversity, Conservation and Attractions (DBCA), Wanneroo, Western Australia	German Research Foundation (DFG)(German Research Foundation (DFG)); Parks and Wildlife Service of the Department of Biodiversity, Conservation and Attractions (DBCA), Wanneroo, Western Australia	This work was funded by the German Research Foundation (DFG) Grant No. SCHM1161/12-1 to H.S. URL:www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Brian Inglis, Leigh Sage, Clayton Sanders and Brett Sinclair from the Parks and Wildlife Service of the Department of Biodiversity, Conservation and Attractions (DBCA), Wanneroo, Western Australia, for generous support during our field work on burnt areas. Thanks also to all other people from DBCA in Wanneroo and Perth who supported us. We also thank an anonymous referee for his helpful comments.	ALTNER H, 1981, CELL TISSUE RES, V215, P289; AMEISMEIER F, 1988, J COMP PHYSIOL A, V163, P507, DOI 10.1007/BF00604904; Apel K. H., 1988, Beitrage fur die Forstwirtschaft, V22, P45; Apel K.-H., 1989, Entomologische Nachrichten und Berichte, V33, P278; Auerswald L, 1998, J EXP BIOL, V201, P1651; Bellamy C.L., 2008, PENSOFT SERIES FAUNI, V3, P1; Ebert J, 2006, J COMP PHYSIOL A, V192, P941, DOI 10.1007/s00359-006-0131-8; EVANS WG, 1966, ANN ENTOMOL SOC AM, V59, P873, DOI 10.1093/aesa/59.5.873; EVANS WG, 1966, ECOLOGY, V47, P1061, DOI 10.2307/1935658; Evans WG, 1965, P 12 INT C ENT, P286; Gingl E, 2001, J COMP PHYSIOL A, V187, P467; Hawkeswood T.J., 1982, Victorian Naturalist (Blackburn), V99, P240; Hawkeswood Trevor J., 2007, Calodema, V9, P12; Kitchin D. R., 2009, Australian Entomologist, V36, P1; Kruppel T, 1985, INS LOC P S 45 17 IN; Linsley E. Gorton, 1943, JOUR ECON ENT, V36, P341, DOI 10.1093/jee/36.2.341; Mainz T, 2004, ARTHROPOD STRUCT DEV, V33, P419, DOI 10.1016/j.asd.2004.06.004; MCINTYRE DA, 1993, ANN OCCUP HYG, V37, P191, DOI 10.1093/annhyg/37.2.191; Paczkowski S, 2013, SENSOR ACTUAT B-CHEM, V183, P273, DOI 10.1016/j.snb.2013.03.123; Poulton EB, 1915, T ENTOMOLOGICAL SO 1, P3; Robertson RM, 1996, J EXP BIOL, V199, P1383; Schmitz Anke, 2015, Records of the Western Australian Museum, V30, P1; Schmitz H, 1998, J COMP PHYSIOL A, V182, P647, DOI 10.1007/s003590050210; Schmitz H, 2003, J COMP PHYSIOL A, V189, P715, DOI 10.1007/s00359-003-0447-6; Schmitz H, 2001, ARTHROPOD STRUCT DEV, V30, P99, DOI 10.1016/S1467-8039(01)00028-7; Schmitz H, 2000, NATURWISSENSCHAFTEN, V87, P542, DOI 10.1007/s001140050775; Schmitz H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037627; Schneider ES, 2014, J MORPHOL, V275, P991, DOI 10.1002/jmor.20276; Schneider ES, 2013, ARTHROPOD STRUCT DEV, V42, P135, DOI 10.1016/j.asd.2012.11.001; Schutz S, 1999, NATURE, V398, P298, DOI 10.1038/18585; Vondran T, 1995, TISSUE CELL, V27, P645, DOI 10.1016/S0040-8166(05)80020-5; Wikars L.O, 1997, THESIS; Wikars LO, 2002, J INSECT CONSERV, V6, P1, DOI 10.1023/A:1015734630309; Wyniger Denise, 2002, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V75, P61; ZARNACK W, 1989, J EXP BIOL, V147, P111; Zermoglio PF, 2017, J INSECT PHYSIOL, V100, P9, DOI 10.1016/j.jinsphys.2017.04.010	36	2	4	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192865	10.1371/journal.pone.0192865	http://dx.doi.org/10.1371/journal.pone.0192865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432476	Green Published, Green Submitted, gold			2022-12-26	WOS:000424814300055
J	Itoh, M; Kajihara, R; Kato, Y; Takano-Shimizu, T; Inoue, Y				Itoh, Masanobu; Kajihara, Ryutaro; Kato, Yasuko; Takano-Shimizu, Toshiyuki; Inoue, Yutaka			Frequencies of chromosomal inversions in Drosophila melanogaster in Fukushima after the nuclear power plant accident	PLOS ONE			English	Article							INDUCED GENETIC-DAMAGE; NATURAL-POPULATIONS; MUTATION FREQUENCY; POLYMORPHIC INVERSIONS; TRANSPOSABLE ELEMENTS; HYBRID DYSGENESIS; RADIATION; CHERNOBYL; DNA; IRRADIATION	In order to investigate genetic impact of a large amount of radionuclides released by the Fukushima Dai-ichi Nuclear Power Plant accident in 2011, we surveyed 2,304 haploid genomes of Drosophila melanogaster collected in three localities in Fukushima in 2012 and 2013 for chromosomal inversions. No unique inversion was found in 298 genomes in 2012 and only two in 2,006 genomes in 2013. The observed frequencies were even lower than the long-term average frequency of unique inversions in Japan. The common cosmopolitan inversions were also examined in Fukushima, Kyoto, and Iriomote (Okinawa) in 2012. Among three samples in Fukushima, the flies in Iizaka, where environmental radiation level was the highest, showed the lowest frequency of In(2L)t, but the highest frequency of In(3R)P, contrary to the expectation of decreasing of their frequencies in higher polluted areas. These results suggest that, at this level of genetic analysis, Fukushima populations of D. melanogaster would not have been negatively impacted following the release of radionuclides. Transposable P-element mobility was not likely to induce DNA damage solely or synergistically with radioactivity, because their transposition activity was totally repressed in the Fukushima strains. However, it should be noted that, because of limitations in access to the exclusion zone, we could only sample the populations in areas of relatively low radioactive contamination (0.39 +/- 0.63 mu Sv/h). Therefore, the present study is likely to be underpowered to detect any effects that might be expected in heavily contaminated areas.	[Itoh, Masanobu; Kajihara, Ryutaro] Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan; [Itoh, Masanobu; Kato, Yasuko; Takano-Shimizu, Toshiyuki] Kyoto Inst Technol, Adv Insect Res Promot Ctr, Kyoto, Japan; [Kato, Yasuko] Kyoto Inst Technol, Inst Promot Univ Strategy, Global Excellence, Kyoto, Japan; [Inoue, Yutaka] Osaka Univ, Ctr Educ Liberal Arts & Sci, Toyonaka, Osaka, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology; Kyoto Institute of Technology; Osaka University	Itoh, M (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan.; Itoh, M (corresponding author), Kyoto Inst Technol, Adv Insect Res Promot Ctr, Kyoto, Japan.	mitoh@kit.ac.jp						Andolfatto P, 1999, GENETICS, V153, P1297; ANXOLABEHERE D, 1985, P NATL ACAD SCI USA, V82, P5418, DOI 10.1073/pnas.82.16.5418; ANXOLABEHERE D, 1988, MOL BIOL EVOL, V5, P252; Ashburner M, 2005, DROSOPHILA LAB HDB, pxxviii; BALTER H, 1992, MUTAT RES, V267, P31, DOI 10.1016/0027-5107(92)90108-E; Bonisoli-Alquati A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09432; Bonnivard E, 1999, J EVOLUTION BIOL, V12, P633, DOI 10.1046/j.1420-9101.1999.00063.x; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Callaway E, 2013, NATURE, V499, P265, DOI 10.1038/499265a; Corbett-Detig RB, 2012, GENETICS, V192, P131, DOI 10.1534/genetics.112.141622; Cuttler JM, 2013, DOSE-RESPONSE, V11, P432, DOI 10.2203/dose-response.13-008.Cuttler; ENGELS WR, 1980, GENETICS, V95, P111; Fujita Y, 2014, EUR J WILDLIFE RES, V60, P145, DOI 10.1007/s10344-013-0767-y; Garnier-Laplace J, 2011, ENVIRON SCI TECHNOL, V45, P5077, DOI 10.1021/es201637c; Hatano Y, 1999, GENES GENET SYST, V74, P219, DOI 10.1266/ggs.74.219; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; INOUE Y, 1994, JPN J GENET, V69, P105, DOI 10.1266/jjg.69.105; INOUE Y, 1988, MUTAT RES, V197, P85, DOI 10.1016/0027-5107(88)90143-1; INOUE Y, 1979, JPN J GENET, V54, P69, DOI 10.1266/jjg.54.69; INOUE Y, 2011, DROS INF SERV, V94, P69; Kennington WJ, 2006, GENETICS, V172, P1655, DOI 10.1534/genetics.105.053173; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1994, J HERED, V85, P339, DOI 10.1093/oxfordjournals.jhered.a111478; KNIBB WR, 1981, GENETICS, V98, P833; Koana T, 2012, RADIAT RES, V177, P265, DOI 10.1667/RR2630.1; Kozeretska IA, 2008, CYTOL GENET+, V42, P267, DOI 10.3103/S0095452708040099; Kubota Y, 2015, ENVIRON SCI TECHNOL, V49, P10074, DOI 10.1021/acs.est.5b01554; Lachaise D, 2004, GENETICA, V120, P17, DOI 10.1023/B:GENE.0000017627.27537.ef; Lefevre G., 1976, PHOTOGRAPHIC REPRSEN, P31; MARGULIES L, 1987, MUTAT RES, V179, P183, DOI 10.1016/0027-5107(87)90309-5; METTLER LE, 1977, GENETICS, V87, P169; Moller AP, 2017, INT J PLANT SCI, V178, P537, DOI 10.1086/692763; Moller AP, 2015, J ORNITHOL, V156, pS287, DOI 10.1007/s10336-015-1173-x; Moller AP, 2015, J ORNITHOL, V156, pS297, DOI 10.1007/s10336-015-1197-2; Moller AP, 2016, INT J PLANT SCI, V177, P727, DOI 10.1086/688873; Moller AP, 2013, ECOL INDIC, V24, P75, DOI 10.1016/j.ecolind.2012.06.001; Mousseau TA, 2014, J HERED, V105, P704, DOI 10.1093/jhered/esu040; MUKAI T, 1985, P NATL ACAD SCI USA, V82, P7671, DOI 10.1073/pnas.82.22.7671; Ochiai K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05793; Ogura K, 2009, RADIAT RES, V171, P1, DOI 10.1667/RR1288.1; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Qiu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43156; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Sankaranarayanan K, 1976, ABERRATION INDUCTION, P1251; Schaeffer SW, 2003, P NATL ACAD SCI USA, V100, P8319, DOI 10.1073/pnas.1432900100; Schiermeier Q, 2011, NATURE, V472, P505, DOI 10.1038/nj7344-505a; STONE WS, 1958, P NATL ACAD SCI USA, V44, P565, DOI 10.1073/pnas.44.6.565; Tubiana M, 2005, DOSE EFFECT RELATION; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; UNSCEAR, 2012, REP UN SCI COMM EFF; VANDELDEN W, 1991, GENETICS, V127, P507; WATANABE TK, 1976, GENETICS, V82, P697; Yablokov Alexey V, 2009, Ann N Y Acad Sci, V1181, P221, DOI 10.1111/j.1749-6632.2009.04830.x; ZAINULLIN VG, 1992, SCI TOTAL ENVIRON, V112, P37, DOI 10.1016/0048-9697(92)90236-L	54	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192096	10.1371/journal.pone.0192096	http://dx.doi.org/10.1371/journal.pone.0192096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420572	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900039
J	Krause, PJ; Carroll, M; Fedorova, N; Brancato, J; Dumouchel, C; Akosa, F; Narasimhan, S; Fikrig, E; Lane, RS				Krause, Peter J.; Carroll, Madeleine; Fedorova, Natalia; Brancato, Janna; Dumouchel, Cecilia; Akosa, Fredua; Narasimhan, Sukanya; Fikrig, Erol; Lane, Robert S.			Human Borrelia miyamotoi infection in California: Serodiagnosis is complicated by multiple endemic Borrelia species	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; LYME-DISEASE; RELAPSING-FEVER; IXODES-PACIFICUS; NORTHWESTERN CALIFORNIA; TICK; SPIROCHETE; VECTOR; MENINGOENCEPHALITIS; COMMUNITY	To determine whether human Borrelia miyamotoi infection occurs in the far-western United States, we tested archived sera from northwestern California residents for antibodies to this emerging relapsing fever spirochete. These residents frequently were exposed to I. pacificus ticks in a region where B. miyamotoi tick infection has been reported. We used a two-step B. miyamotoi rGlpQ assay and a B. miyamotoi whole-cell lysate (WCL) assay to detect B. miyamotoi antibody. We also employed Borrelia hermsii and Borrelia burgdorferi WCL assays to examine if these Borrelia induce cross reacting antibody to B. miyamotoi. Sera were collected from 101 residents in each of two consecutive years. The sera of 12 and 14 residents in years one and two, respectively, were B. miyamotoi rGlpQ seroreactive. Sufficient sera were available to test 15 of the 26 seropositive samples using B. miyamotoi and B. hermsii WCL assays. Two residents in year one and seven residents in year two were seroreactive to both Borrelia antigens. Although discernible differences in seroreactivity were evident between the B. miyamotoi and B. hermsii WCL assays, infection with one or the other could not be determined with certainty. Sera from two Borrelia burgdorferi/B. miyamotoi seropositive subjects reacted strongly against B. miyamotoi and B. hermsii WCL antigens. Ecological, epidemiological, and clinical data implicated B. miyamotoi as the probable cause of infection among those whose sera reacted against both antigens. Our findings suggest that human B. miyamotoi infection occurs in northern California and that B. hermsii and B. burgdorferi infections produce antibodies that cross-react with B. miyamotoi antigens. Health care professionals in the far-western United States should be aware that B. miyamotoi disease may occur throughout the geographic distribution of I. pacificus and that improved relapsing fever group spirochete antibody assays are urgently needed.	[Krause, Peter J.; Carroll, Madeleine; Brancato, Janna; Dumouchel, Cecilia; Akosa, Fredua] Yale Sch Publ Hlth, Dept Epidemiol Infect Dis, New Haven, CT 06510 USA; [Krause, Peter J.; Narasimhan, Sukanya; Fikrig, Erol] Yale Sch Med, Dept Infect Dis, New Haven, CT 06511 USA; [Fedorova, Natalia; Lane, Robert S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Yale University; Yale University; University of California System; University of California Berkeley	Krause, PJ (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Infect Dis, New Haven, CT 06510 USA.; Krause, PJ (corresponding author), Yale Sch Med, Dept Infect Dis, New Haven, CT 06511 USA.	peter.krause@yale.edu		krause, peter/0000-0003-3498-9454	NIH [1R56AI114859-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported in part by generous gifts from The Gordon and Llura Gund Foundation to PJK, Tom Eames and Geneva Anderson to RSL and by NIH grant 1R56AI114859-01 to PJK, SN, and EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Boden K, 2016, EMERG INFECT DIS, V22, P1617, DOI 10.3201/eid2209.152034; Cook VJ, 2016, EMERG INFECT DIS, V22, P2205, DOI 10.3201/eid2212.152046; Crowder CD, 2014, EMERG INFECT DIS, V20, P1678, DOI 10.3201/eid2010.131583; Davis GE, 1941, PUBLIC HEALTH REP, V56, P2426, DOI 10.2307/4583956; Division of Communicable Disease Control Center for Infectious Diseases California Department of Public Health, 2001, YEARL SUMM SEL GEN C; Finch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084758; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Furman D.P., 1984, Bulletin of the California Insect Survey, V25, P1; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Jobe DA, 2016, EMERG INFECT DIS, V22, P1471, DOI 10.3201/eid2208.151878; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; LANE RS, 1985, SCIENCE, V230, P85, DOI 10.1126/science.3898367; LANE RS, 1992, AM J EPIDEMIOL, V136, P1358, DOI 10.1093/oxfordjournals.aje.a116448; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; LANE RS, 1990, J CLIN MICROBIOL, V28, P1774, DOI 10.1128/JCM.28.8.1774-1779.1990; MAGNARELLI LA, 1984, J CLIN MICROBIOL, V20, P181, DOI 10.1128/JCM.20.2.181-184.1984; MAGNARELLI LA, 1987, J INFECT DIS, V156, P183, DOI 10.1093/infdis/156.1.183; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Molloy PJ, 2017, CLIN INFECT DIS; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Salkeld DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134812; Salkeld DJ, 2014, TICKS TICK-BORNE DIS, V5, P790, DOI 10.1016/j.ttbdis.2014.05.002; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Sudhindra P, 2016, DIAGN MICR INFEC DIS, V86, P93, DOI 10.1016/j.diagmicrobio.2016.06.015; Wagemakers A, 2016, J IMMUNOL, V196, P4185, DOI 10.4049/jimmunol.1600014	35	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191725	10.1371/journal.pone.0191725	http://dx.doi.org/10.1371/journal.pone.0191725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420552	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900020
J	Kribus-Shmiel, L; Zeilig, G; Sokolovski, B; Plotnik, M				Kribus-Shmiel, Lotem; Zeilig, Gabi; Sokolovski, Boris; Plotnik, Meir			How many strides are required for a reliable estimation of temporal gait parameters? Implementation of a new algorithm on the phase coordination index	PLOS ONE			English	Article							BILATERAL COORDINATION; PARKINSONS-DISEASE; DATA RECONCILIATION; TREADMILL WALKING; OLDER-ADULTS; VARIABILITY; IDENTIFICATION; SPEED	Background The Phase coordination index (PCI), a temporal gait measure that quantifies consistency and accuracy in generating the anti-phased left-right stepping pattern, assesses bilateral coordination of gait in various cohorts (e.g., Parkinson's disease, post stroke). As PCI is based on mean values calculated across a series of gait cycles, individuals are required to perform lengthy walking trials, prolonging gait assessments which cause discomfort to some of them. This study introduces an algorithm to identify the required number of strides to obtain a reliable, characteristic PCI value. Methods Simulated data sets, as well as physiological data (obtained from healthy elderly and young persons, from over ground and treadmill trials) were used in this research. A series of N-1 PCI values was calculated for i = 2,3,4... N gait cycles for each participant. There is a value i = k, representing certain number of cycles, for which no significant change in PCI occurs as additional cycles are added, termed point of stabilization (POS). The algorithm presented here uses a 2-stage iterative process to determine POS. Stage 1 searches for the gross location of the interval of PCI values containing the POS. In stage 2, the algorithm performs a high-resolution recursive, iterative process within this interval to find the exact point. The criterion for defining stability within a window of PCI values is a coefficient of variation (CV) of <= 5%. Results Our recursive, iterative algorithm indicates that similar to 23 strides on average should be captured to attain a characteristic PCI. Conclusions Gait trials with at least 23 strides on average should suffice to obtain a reliable estimation of PCI in healthy young adults. While this methodology may be considered generic, future studies should obtain POS values based on additional cohorts (e.g., disabled participants, fixed walking speeds).	[Kribus-Shmiel, Lotem; Plotnik, Meir] Sheba Med Ctr, Ctr Adv Technol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabi; Sokolovski, Boris] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Zeilig, Gabi] Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Ramat Gan, Israel; [Plotnik, Meir] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Plotnik, Meir] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Plotnik, M (corresponding author), Sheba Med Ctr, Ctr Adv Technol Rehabil, Tel Hashomer, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	meir.plontik@sheba.health.gov.il		Plotnik, Meir/0000-0003-2637-3457				Beauchet O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-37; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bethea R.M., 1991, APPL ENG STAT; Bhat SA, 2004, IND ENG CHEM RES, V43, P4323, DOI 10.1021/ie030563u; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Cash C. R., 1992, P 24 C WINT SIM; Chufu Li B C, 2004, J TSINGHUA U NATURAL, V44, P1160; Crow E.L., 1960, STAT MANUAL EXAMPLES; Dingwell JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124879; Flehmig F, 1998, COMPUT CHEM ENG, V22, pS491, DOI 10.1016/S0098-1354(98)00092-1; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Hoad K, 2010, J OPER RES SOC, V61, P1389, DOI 10.1057/jors.2009.87; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; HOLLY W, 1989, CAN J CHEM ENG, V67, P595, DOI 10.1002/cjce.5450670411; Jackway P, 1992, METHODOLOGY INITIALI; Jiang TW, 2003, COMPUT CHEM ENG, V27, P569, DOI 10.1016/S0098-1354(02)00235-1; Kribus-Shmiel L, 2017, INT SOC POST GAINT R; Lada EK, P 35 C WINT SIM DRIV; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; NARASIMHAN S, 1987, AICHE J, V33, P1930, DOI 10.1002/aic.690331125; Nelson BL, 1992, HDB IND ENG TECHNOLO, P2469; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Pawlikowski K., 1990, ACM COMPUT SURV, V22, P123; Peterson DS, 2012, PARKINSONISM RELAT D, V18, P1022, DOI 10.1016/j.parkreldis.2012.05.019; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Plotnik M., 2008, MOVEMENT DISORDERS, V23; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Plotnik M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0002-z; Priest AW, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-29; Robinson S., 2004, SIMULATION PRACTICE, V1, P5; Robinson S, 2007, EUR J OPER RES, V176, P332, DOI 10.1016/j.ejor.2005.07.014; Rossetti MD, P 37 C WINT SIM 2005; Schladt M, 2007, CHEM ENG PROCESS, V46, P1107, DOI 10.1016/j.cep.2006.06.022; Sloot LH, 2014, GAIT POSTURE, V39, P939, DOI 10.1016/j.gaitpost.2013.12.005; Sloot LH, 2014, GAIT POSTURE, V39, P478, DOI 10.1016/j.gaitpost.2013.08.022; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; White Jr KP, P 32 C WINT SIM 2000; White KP, 1997, SIMULATION, V69, P323, DOI 10.1177/003754979706900601; Wu JG, 2016, IEEE T AUTOM SCI ENG, V13, P688, DOI 10.1109/TASE.2014.2378150; Wu JG, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4024041; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	47	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192049	10.1371/journal.pone.0192049	http://dx.doi.org/10.1371/journal.pone.0192049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420580	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900036
J	Wong, SK; Chin, KY; Suhaimi, FH; Ahmad, F; Ima-Nirwana, S				Wong, Sok Kuan; Chin, Kok-Yong; Suhaimi, Farihah Hj; Ahmad, Fairus; Ima-Nirwana, Soelaiman			Effects of metabolic syndrome on bone mineral density, histomorphometry and remodelling markers in male rats	PLOS ONE			English	Article							DIET; MICE; OSTEOPOROSIS; MASS; MEN; ASSOCIATION; STRENGTH; DISEASE; LEPTIN; TISSUE	This study aimed to evaluate the effects of metabolic syndrome (MetS) induced by high-carbohydrate high-fat (HCHF) diet on bone mineral density (BMD), histomorphometry and remodelling markers in male rats. Twelve male Wistar rats aged 12 weeks old were randomized into two groups. The normal group was given standard rat chow while the HCHF group was given HCHF diet to induce MetS. Abdominal circumference, blood glucose, blood pressure, and lipid profile were measured for the confirmation of MetS. Bone mineral density, histomorphometry and remodelling markers were evaluated for the confirmation of bone loss. The HCHF diet caused central obesity, hyperglycaemia, hypertension, and dyslipidaemia in male rats. No significant difference was observed in whole body bone mineral content and BMD between the normal and HCHF rats (p>0.05). For bone histomorphometric parameters, HCHF diet-fed animals had significantly lower osteoblast surface, osteoid surface, osteoid volume, and significantly higher eroded surface; resulting in a reduction in trabecular bone volume (p<0.05). Feeding on HCHF diet caused a significantly higher CTX-1 level (p<0.05), but did not cause any significant change in osteocalcin level compared to normal rats (p>0.05). In conclusion, HCHF diet-induced MetS causes imbalance in bone remodelling, leading to the deterioration of trabecular bone structure.	[Wong, Sok Kuan; Chin, Kok-Yong; Ima-Nirwana, Soelaiman] Univ Kebangsaan Malaysia, Fac Med, Dept Pharmacol, Jalan Yaakob Latif, Kuala Lumpur, Malaysia; [Suhaimi, Farihah Hj; Ahmad, Fairus] Univ Kebangsaan Malaysia, Fac Med, Dept Anat, Jalan Yaakob Latif, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Ima-Nirwana, S (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Pharmacol, Jalan Yaakob Latif, Kuala Lumpur, Malaysia.	imasoel@ppukm.ukm.edu.my	Chin, Kok-Yong/B-6309-2015; Wong, Sok Kuan/I-1243-2016; Soelaiman, Ima Nirwana/C-4289-2017	Chin, Kok-Yong/0000-0001-6628-1552; Wong, Sok Kuan/0000-0003-1184-4551; Soelaiman, Ima Nirwana/0000-0001-9655-438X; Ahmad, Fairus/0000-0002-2452-6459	Universiti Kebangsaan Malaysia [GUP-2017-012, FF-2016-431]	Universiti Kebangsaan Malaysia	The authors thank Universiti Kebangsaan Malaysia for funding the studies via grants GUP-2017-012 to SI-N and FF-2016-431 to K-YC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Universiti Kebangsaan Malaysia for funding the studies via GUP-2017-012 and FF-2016-431 grants.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Aschner P, 2010, EXPERT REV CARDIOVAS, V8, P407, DOI [10.1586/erc.10.13, 10.1586/ERC.10.13]; Beederman Maureen, 2013, J Biomed Sci Eng, V6, P32; Bernabei R, 2014, CLIN CASES MINER BON, V11, P201, DOI 10.11138/ccmbm/2014.11.3.201; Campos RMS, 2012, ENDOCRINE, V42, P146, DOI 10.1007/s12020-012-9613-3; Cao JJ, 2016, NUTR RES, V36, P320, DOI 10.1016/j.nutres.2015.12.008; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; de Mello- Sampayo C, 2017, INT J ENDOCRINOL, V2017, P9; Demigne C, 2006, EUR J NUTR, V45, P298, DOI 10.1007/s00394-006-0599-6; Doucette CR, 2015, J CELL PHYSIOL, V230, P2032, DOI 10.1002/jcp.24954; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Fehrendt H, 2014, INT J ENDOCRINOL, V2014, P9; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Harvey N, 2013, PRIMER METABOLIC BON, V8th, P348; HODSMAN AB, 1993, J CLIN INVEST, V91, P1138, DOI 10.1172/JCI116273; Hwang DK, 2010, OSTEOPOROSIS INT, V21, P425, DOI 10.1007/s00198-009-0990-2; Felice JI, 2017, DIABETES RES CLIN PR, V126, P202, DOI 10.1016/j.diabres.2017.02.011; Felice JI, 2014, METABOLISM, V63, P296, DOI 10.1016/j.metabol.2013.11.002; Kapustin AN, 2011, ARTERIOSCL THROM VAS, V31, P2169, DOI 10.1161/ATVBAHA.111.233601; Kim HY, 2010, CALCIFIED TISSUE INT, V86, P350, DOI 10.1007/s00223-010-9347-2; Kinjo M, 2007, J CLIN ENDOCR METAB, V92, P4161, DOI 10.1210/jc.2007-0757; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lavet C, 2016, J BONE MINER RES, V31, P98, DOI 10.1002/jbmr.2596; Lee K, 2015, CALCIFIED TISSUE INT, V97, P487, DOI 10.1007/s00223-015-0033-2; Li Y, 2015, J DENT RES, V94, P362, DOI 10.1177/0022034514561658; Macri EV, 2012, EUR J NUTR, V51, P399, DOI 10.1007/s00394-011-0223-2; Malvi P, 2014, BIOCHEM BIOPH RES CO, V455, P133, DOI 10.1016/j.bbrc.2014.10.131; Kulak CAM, 2010, ARQ BRAS ENDOCRINOL, V54, P87, DOI 10.1590/S0004-27302010000200002; Pirih F, 2012, J BONE MINER RES, V27, P309, DOI 10.1002/jbmr.541; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Slyfield CR, 2012, J BONE MINER RES, V27, P486, DOI 10.1002/jbmr.553; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Upadhyay J, 2015, METABOLISM, V64, P105, DOI 10.1016/j.metabol.2014.10.021; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; von Muhlen D, 2007, OSTEOPOROSIS INT, V18, P1337, DOI 10.1007/s00198-007-0385-1; Wang DC, 2014, CELL BIOCHEM BIOPHYS, V70, P1297, DOI 10.1007/s12013-014-0054-x; Wang Y, 2016, NUTR RES, V36, P742, DOI 10.1016/j.nutres.2016.03.002; Wong S. K., 2016, NUTR METAB, P13; Wong SK, 2017, EXPT CLIN ENDOCRINOL; Wong SK, 2018, BIOMED PHARMACOTHER, V98, P191, DOI 10.1016/j.biopha.2017.12.042; Wong SK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060347; Yaturu S, 2009, MED SCI MONITOR, V15, pCR5	43	30	32	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192416	10.1371/journal.pone.0192416	http://dx.doi.org/10.1371/journal.pone.0192416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420594	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900071
J	Zhao, L; Wu, S; Huang, EY; Gnatenko, D; Bahou, WF; Zhu, W				Zhao, Lu; Wu, Song; Huang, Erya; Gnatenko, Dimitri; Bahou, Wadie F.; Zhu, Wei			Integrated micro/messenger RNA regulatory networks in essential thrombocytosis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-1; MICRORNA; EXPRESSION; INFLAMMATION; MECHANISMS	Essential thrombocytosis (ET) is a chronic myeloproliferative disorder with an unregulated surplus of platelets. Complications of ET include stroke, heart attack, and formation of blood clots. Although platelet-enhancing mutations have been identified in ET cohorts, genetic networks causally implicated in thrombotic risk remain unestablished. In this study, we aim to identify novel ET-related miRNA-mRNA regulatory networks through comparisons of transcriptomes between healthy controls and ET patients. Four network discovery algorithms have been employed, including (a) Pearson correlation network, (b) sparse supervised canonical correlation analysis (sSCCA), (c) sparse partial correlation network analysis (SPACE), and, (d) (sparse) Bayesian network analysis-all through a combined data-driven and knowledge-based analysis. The result predicts a close relationship between an 8-miRNA set (miR-9, miR-490-5p, miR-490-3p, miR-182, miR-34a, miR-196b, miR-34b*, miR-181a-2*) and a 9-mRNA set (CAV2, LAPTM4B, TIMP1, PKIG, WASF1, MMP1, ERVH-4, NME4, HSD17B12). The majority of the identified variables have been linked to hematologic functions by a number of studies. Furthermore, it is observed that the selected mRNAs are highly relevant to ET disease, and provide an initial framework for dissecting both platelet-enhancing and functional consequences of dysregulated platelet production.	[Zhao, Lu; Wu, Song; Huang, Erya; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Gnatenko, Dimitri; Bahou, Wadie F.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zhao, L (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	luzhao1986@gmail.com			National Institutes of Health [HL091939, CA205172, RR03211201A1]; NIH/NHLBI DNA Resequencing and Genotyping Service [G175]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI DNA Resequencing and Genotyping Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Study Design is supported by HL091939 https://www.nih.gov/ National Institutes of Health WB. Data Collection is supported Subcontract G175 from https://www.nhlbi.nih.gov/research/resources/genetics-genomics/rsg NIH/NHLBI DNA Resequencing and Genotyping Service, WB. Modeling and data analysis is supported by HL091939 https://www.nih.gov/ National Institutes of Health WZ. Modeling and data analysis is also supported by CA205172 https://www.nih.gov/ National Institutes of Health SW. Data collection is also supported by RR03211201A1 https://www.nih.gov/ National Institutes of Health DG.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andonovska B, 2008, VOJNOSANIT PREGL, V65, P882, DOI 10.2298/VSP0812882A; Bahou WF, 2013, HEMATOL ONCOL CLIN N, V27, P443, DOI 10.1016/j.hoc.2013.03.002; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Bruchova H, 2008, HAEMATOL-HEMATOL J, V93, P1009, DOI 10.3324/haematol.12706; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Chu G, 2001, SIGNIFICANCE ANAL MI; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu WJJ, 1998, J COMPUT GRAPH STAT, V7, P397, DOI 10.2307/1390712; Gabor B, 2009, BIOINFORMATICS, V25, P1063, DOI 10.1093/bioinformatics/btp018; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477; Gnatenko DV, 2005, THROMB HAEMOSTASIS, V94, P412, DOI 10.1160/TH05-01-0037; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He Y, 2009, ZHONGHUA XUE YE XUE, V5; Herouy Y, 2001, J DERMATOL SCI, V25, P198, DOI 10.1016/S0923-1811(00)00128-6; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jayaswal V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-138; Karim SMM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2300-z; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Olga Troyanskaya MC, 2001, BIOINFORMATICS, V17, P6; Parkhomenko E, 2007, BMC P; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Schulze H, 2004, SEMIN THROMB HEMOST, V30, P389, DOI 10.1055/s-2004-833474; Schwertz H, 2010, BLOOD, V115, P3801, DOI 10.1182/blood-2009-08-239558; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048; William J., 2000, BLOOD, V96, P8; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Xiang J., 2013, PROC 26 INT C ADV NE, P2418; Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264; Zhang BB, 2003, WORLD J GASTROENTERO, V9, P2490	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191932	10.1371/journal.pone.0191932	http://dx.doi.org/10.1371/journal.pone.0191932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420626	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900032
J	Li, SB; Ma, LL; Wang, YC; Wang, XJ; Li, YZ; Qin, L				Li, Sibin; Ma, Lanlan; Wang, Yuchen; Wang, Xuejiao; Li, Yingzhuo; Qin, Ling			Auditory steady-state responses in primary and non-primary regions of the auditory cortex in neonatal ventral hippocampal lesion rats	PLOS ONE			English	Article							EFFERENT CONNECTIONS; EXCITOTOXIC LESIONS; 40 HZ; SCHIZOPHRENIA; MODEL; FIELD; ORGANIZATION; STIMULATION; HALLUCINATIONS; PROJECTIONS	Auditory steady-state responses (ASSRs) represent the electrophysiological activity of the auditory nervous system in response to a periodic acoustic stimulus. Spectrogram analysis can reveal the frequency and phase information entrained in ASSRs. Clinically, the ASSR is used to detect abnormalities in electroencephalographs obtained from schizophrenia patients, who show reduced power and phase locking of ASSRs. The neonatal ventral hippocampal lesion (NVHL) rat is a widely used model to investigate the neurodevelopmental mechanisms of schizophrenia. It has been established that NVHL rats exhibit several schizophrenia-like behavioral and molecular abnormalities. However, no clear abnormalities in ASSRs have been reported to date. The present study compared ASSRs of adult NVHL and sham-operated rats. We inserted microelectrodes into the primary auditory cortex (A1) or posterior auditory field (PAF) and recorded the local field potential (LFP) in response to 40- and 80-Hz click train stimuli. Spectrogram analysis was performed to obtain the mean trial power (MTP) and phase-locking factor (PLF) of the click train-evoked LFPs. We found that in the control animals, A1 showed a stronger MTP and PLF of ASSR than PAF, and NVHL operation mainly impaired the ASSR in PAF. Analysis of spike activity also indicated that NVHL operation extended the duration of tone-evoked responses in PAF neurons. Our results reveal, for the first time, that NVHL may distinctly influence the neural activities of primary and non-primary fields of the auditory cortex.	[Li, Sibin; Ma, Lanlan; Wang, Yuchen; Wang, Xuejiao; Li, Yingzhuo; Qin, Ling] China Med Univ, Coll Basic Med Sci, Dept Physiol, Shenyang, Liaoning, Peoples R China	China Medical University	Qin, L (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Physiol, Shenyang, Liaoning, Peoples R China.	qinlingling@yahoo.com			National Nature Science Foundation of China [31471057, 31671080]; Research project of Liaoning Provincial Department of Education [LK201631]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research project of Liaoning Provincial Department of Education	The study design, data collection and analysis, decision to publish, and preparation of the manuscript were supported by the following grants: National Nature Science Foundation of China under a grant (31471057 and 31671080 to LQ), Research project of Liaoning Provincial Department of Education (LK201631 to LM).	Atiani S, 2014, NEURON, V82, P486, DOI 10.1016/j.neuron.2014.02.029; Beas-Zarate C, 2001, NEUROCHEM INT, V39, P1, DOI 10.1016/S0197-0186(01)00008-0; Brady A.M., 2016, CURR PROTOC NEUROSCI, V77; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P1, DOI 10.1016/0013-4694(66)90136-2; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Edeline JM, 1999, HEARING RES, V131, P135, DOI 10.1016/S0378-5955(99)00026-X; Halim ND, 2000, BRAIN RES, V873, P60, DOI 10.1016/S0006-8993(00)02497-5; IMIG TJ, 1985, J NEUROPHYSIOL, V53, P309, DOI 10.1152/jn.1985.53.1.309; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kimura A, 2007, EUR J NEUROSCI, V25, P2819, DOI 10.1111/j.1460-9568.2007.05519.x; Kimura A, 2004, NEUROSCIENCE, V128, P399, DOI 10.1016/j.neuroscience.2004.07.010; Krishnan GP, 2009, NEUROIMAGE, V47, P1711, DOI 10.1016/j.neuroimage.2009.03.085; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; LINS OG, 1995, EVOKED POTENTIAL, V96, P420, DOI 10.1016/0168-5597(95)00048-W; Ma HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052942; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; MacDonald ML, 2015, BIOL PSYCHIAT, V77, P959, DOI 10.1016/j.biopsych.2014.09.006; Macedo CE, 2010, BEHAV BRAIN RES, V207, P161, DOI 10.1016/j.bbr.2009.10.002; Pandya PK, 2008, CEREB CORTEX, V18, P301, DOI 10.1093/cercor/bhm055; Pastor MA, 2002, J NEUROSCI, V22, P10501; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Plourde G, 1998, ANESTHESIOLOGY, V89, P844, DOI 10.1097/00000542-199810000-00008; Plourde G, 1996, ANESTH ANALG, V82, P75, DOI 10.1097/00000539-199601000-00013; PLOURDE G, 1991, BRIT J ANAESTH, V66, P683, DOI 10.1093/bja/66.6.683; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Profant O, 2013, HEARING RES, V296, P51, DOI 10.1016/j.heares.2012.11.021; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Romero-Pimentel AL, 2014, SCHIZOPHR RES, V159, P450, DOI 10.1016/j.schres.2014.09.009; Sandner G, 2010, NEUROIMAGE, V53, P44, DOI 10.1016/j.neuroimage.2010.06.007; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Sivarao DV, 2016, NEUROPSYCHOPHARMACOL, V41, P2232, DOI 10.1038/npp.2016.17; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Stevens KE, 2012, SENSORY SENSORIMOTOR, P240; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Swerdlow NR, 2001, BRAIN RES BULL, V55, P71, DOI 10.1016/S0361-9230(01)00492-0; Szalda K, 2005, HEARING RES, V203, P32, DOI 10.1016/j.heares.2004.11.014; Tahraoui SL, 2001, BRAIN PATHOL, V11, P56; Thune H, 2016, JAMA PSYCHIAT, V73, P1145, DOI 10.1001/jamapsychiatry.2016.2619; Tseng KY, 2009, BEHAV BRAIN RES, V204, P295, DOI 10.1016/j.bbr.2008.11.039; Vohs JL, 2012, INT J PSYCHOPHYSIOL, V86, P136, DOI 10.1016/j.ijpsycho.2012.04.002; Vohs JL, 2010, INT J NEUROPSYCHOPH, V13, P487, DOI 10.1017/S1461145709990307; Vohs JL, 2009, NEUROPSYCHOBIOLOGY, V60, P12, DOI 10.1159/000234813; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006	52	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192103	10.1371/journal.pone.0192103	http://dx.doi.org/10.1371/journal.pone.0192103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415081	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300049
J	Zhu, YM; Zhang, XJ; Ding, XH; Chong, HH; Cui, S; He, JS; Wang, XQ; He, YX				Zhu, Yuanmei; Zhang, Xiujuan; Ding, Xiaohui; Chong, Huihui; Cui, Sheng; He, Jinsheng; Wang, Xinquan; He, Yuxian			Exceptional potency and structural basis of a T1249-derived lipopeptide fusion inhibitor against HIV-1, HIV-2, and simian immunodeficiency virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); HIV-1; HIV-2; antiviral agent; membrane fusion; inhibitor; peptides; structure-function; crystal structure; fusion inhibitor; lipopeptide; T1249; T20	ENFUVIRTIDE-RESISTANT HIV-1; VIRAL MEMBRANE-FUSION; ANTIRETROVIRAL ACTIVITY; SYNTHETIC PEPTIDE; ENVELOPE PROTEIN; ATOMIC-STRUCTURE; COILED-COIL; TYPE-1 GP41; DRUG TARGET; WILD-TYPE	Enfuvirtide (T20) is the only viral fusion inhibitor approved for clinical use, but it has relatively weak anti-HIV activity and easily induces drug resistance. In succession to T20, T1249 has been designed as a 39-mer peptide composed of amino acid sequences derived from HIV-1, HIV-2, and simian immunodeficiency virus (SIV); however, its development has been suspended due to formulation difficulties. We recently developed a T20-based lipopeptide (LP-40) showing greatly improved pharmaceutical properties. Here, we generated a T1249-based lipopeptide, termed LP-46, by replacing its C-terminal tryptophan-rich sequence with fatty acid. As compared with T20, T1249, and LP-40, the truncated LP-46 (31-mer) had dramatically increased activities in inhibiting a large panel of HIV-1 subtypes, with IC50 values approaching low picomolar concentrations. Also, LP-46 was an exceptionally potent inhibitor against HIV-2, SIV, and T20-resistant variants, and it displayed obvious synergistic effects with LP-40. Furthermore, we showed that LP-46 had increased helical stability and binding affinity with the target site. The crystal structure of LP-46 in complex with a target surrogate revealed its critical binding motifs underlying the mechanism of action. Interestingly, it was found that the introduced pocket-binding domain in LP-46 did not interact with the gp41 pocket as expected; instead, it adopted a mode similar to that of LP-40. Therefore, our studies have provided an exceptionally potent and broad fusion inhibitor for developing new anti-HIV drugs, which can also serve as a tool to exploit the mechanisms of viral fusion and inhibition.	[Zhu, Yuanmei; Ding, Xiaohui; Chong, Huihui; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhu, Yuanmei; Ding, Xiaohui; Chong, Huihui; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhu, Yuanmei; Ding, Xiaohui; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China; [Zhang, Xiujuan; He, Jinsheng] Beijing Jiaotong Univ, Sch Sci, Coll Life Sci & Bioengn, Beijing 100044, Peoples R China; [Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Jiaotong University; Tsinghua University	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; He, YX (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.; He, YX (corresponding author), Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China.	yhe@ipbcams.ac.cn	HE, Jin-Sheng/G-4585-2011; Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020; Zhang, Xiujuan/AAG-9780-2020	HE, Jin-Sheng/0000-0002-6592-0540; Sheng, CUI/0000-0001-6329-3582; 	National Natural Science Foundation of China [81630061, 81473255, 81673484]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2017-I2M-1-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences	This work was supported by National Natural Science Foundation of China Grants 81630061, 81473255, and 81673484 and Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences Grant 2017-I2M-1-014. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ashkenazi A, 2012, FASEB J, V26, P4628, DOI 10.1096/fj.12-215111; Augusto MT, 2014, J ANTIMICROB CHEMOTH, V69, P1286, DOI 10.1093/jac/dkt529; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Borrego P, 2013, AIDS, V27, P1081, DOI 10.1097/QAD.0b013e32835edc1d; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chong H., 2017, J VIROL, V91; Chong HH, 2016, AIDS, V30, P1187, DOI 10.1097/QAD.0000000000001073; Chong HH, 2015, AIDS, V29, P13, DOI 10.1097/QAD.0000000000000498; Chong HH, 2013, FASEB J, V27, P1203, DOI 10.1096/fj.12-222547; Chong HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032599; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu SD, 2013, BIOORG MED CHEM LETT, V23, P5114, DOI 10.1016/j.bmcl.2013.07.026; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Crespillo S, 2014, P NATL ACAD SCI USA, V111, P18207, DOI 10.1073/pnas.1413592112; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Ding X., 2017, J VIROL, V91; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Egelhofer M, 2004, J VIROL, V78, P568, DOI 10.1128/JVI.78.2.568-575.2004; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2013, CURR PHARM DESIGN, V19, P1800, DOI 10.2174/1381612811319100004; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Peterson K, 2012, ANTIVIR THER, V17, P435, DOI 10.3851/IMP2031; Qiu ZL, 2015, AIDS, V29, P1015, DOI 10.1097/QAD.0000000000000683; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Wexler-Cohen Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000509; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Witvrouw M, 2004, ANTIVIR THER, V9, P57; Xiong S, 2017, J VIROL, V91; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005; YAHI N, 1995, P NATL ACAD SCI USA, V92, P4867, DOI 10.1073/pnas.92.11.4867	59	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5323	5334		10.1074/jbc.RA118.001729	http://dx.doi.org/10.1074/jbc.RA118.001729			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29425101	Green Published, hybrid			2022-12-26	WOS:000429409300035
J	Falace, A; Kaleb, S; De La Fuente, G; Asnaghi, V; Chiantore, M				Falace, Annalisa; Kaleb, Sara; De La Fuente, Gina; Asnaghi, Valentina; Chiantore, Mariachiara			Ex situ cultivation protocol for Cystoseira amentacea var. stricta (Fucales, Phaeophyceae) from a restoration perspective	PLOS ONE			English	Article							UV-RADIATION; SEASONAL-VARIATIONS; AMINO-ACIDS; ALGA; SEA; TAMARISCIFOLIA; REPRODUCTION; RECRUITMENT; IRRADIANCE; RESPONSES	Due to multiple impacts, Cystoseira forests are experiencing a significant decline, which is affecting the ecosystem services they provide. Despite conservation efforts, there is an urgent need to develop best practices and large-scale restoration strategies. To implement restoration actions, we developed an ex situ protocol for the cultivation of Cystoseira. amen-tacea var. stricta, aimed at reducing the time needed for laboratory culture, thus avoiding prolonged maintenance and minimizing costs. Specifically, we tested the effects of temperature, light and substratum on settlement and growth of early life stages using a factorial experiment. Temperature (20 and 24 degrees C) and photoperiod (15L:9D) were selected to reflect the conditions experienced in the field during the reproductive period. Two light intensities (125 and 250 mu mol photons m(-2) s(-1)) were selected to mimic the condition experienced in the absence of canopy (i.e. barren-higher light intensity) or in the understory (lower light intensity) during gamete release. The tested substrata were flat polished pebbles and rough clay tiles. The release of gametes and the successive survival and development of embryo and germlings were followed for two weeks. Regardless of the culture conditions, rougher tiles showed higher zygote settlement, but the substrata did not affect the successive development. Zygote mortality after one week averaged 50% and at the end of the second week, embryonic survival was higher under lower light and temperature conditions, which also determined the growth of larger embryos.	[Falace, Annalisa; Kaleb, Sara] Univ Trieste, Dept Life Sci, Trieste, Italy; [De La Fuente, Gina; Asnaghi, Valentina; Chiantore, Mariachiara] Univ Genoa, Dept Earth Environm & Life Sci, Genoa, Italy	University of Trieste; University of Genoa	Falace, A (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	falace@units.it	Asnaghi, Valentina/AFT-8900-2022; Kaleb, Sara/O-9409-2015; FALACE, Annalisa/O-9473-2015; Chiantore, Mariachiara/C-7070-2017	Kaleb, Sara/0000-0002-8584-7280; FALACE, Annalisa/0000-0002-9671-5283; Chiantore, Mariachiara/0000-0002-5862-1470; Asnaghi, Valentina/0000-0003-1659-2613; De La Fuente, Gina/0000-0003-1222-9091	European Community, project ROC-POP-LIFE [LIFE16 NAT/IT/000816]	European Community, project ROC-POP-LIFE	This study was conducted with the contribution of the LIFE financial instrument of the European Community, project ROC-POP-LIFE (LIFE16 NAT/IT/000816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Diaz RT, 2006, MAR BIOL, V148, P459, DOI 10.1007/s00227-005-0102-6; Alongi G, 1999, CRYPTOGAMIE ALGOL, V20, P25, DOI 10.1016/S0181-1568(99)80004-X; Altamirano M, 2003, AQUAT BOT, V75, P9, DOI 10.1016/S0304-3770(02)00149-3; AMSLER CD, 1990, MAR BIOL, V107, P297, DOI 10.1007/BF01319829; [Anonymous], 1992, OFFICIAL J EUROPEAN, P7; [Anonymous], 2013, KELP FARMING MANUAL; BAGHDADLI D, 1990, Journal of Applied Phycology, V2, P281, DOI 10.1007/BF02179786; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Blanfune A, 2016, ESTUAR COAST SHELF S, V181, P196, DOI 10.1016/j.ecss.2016.08.049; Blanfune A, 2017, ECOL INDIC, V72, P249, DOI 10.1016/j.ecolind.2016.07.049; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Buonomo R, 2017, MOL ECOL, V26, P766, DOI 10.1111/mec.13960; Celis-Pla PSM, 2014, AQUAT BIOL, V22, P227, DOI 10.3354/ab00573; Celis-Pla PSM, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00026; Celis-Pla PSM, 2014, SCI MAR, V78, P377, DOI 10.3989/scimar.04053.05A; CHAPMAN ARO, 1978, J PHYCOL, V14, P195, DOI 10.1111/j.1529-8817.1978.tb02448.x; CLAYTON MN, 1990, AUST J ECOL, V15, P439, DOI 10.1111/j.1442-9993.1990.tb01469.x; COUDRET A, 1985, CR ACAD SCI III-VIE, V301, P827; CRITCHLEY C, 1994, PHYSIOL PLANTARUM, V92, P188, DOI 10.1111/j.1399-3054.1994.tb06670.x; Delgado O, 1995, BOT MAR, V38, P127, DOI 10.1515/botm.1995.38.1-6.127; Dudgeon S, 2005, OIKOS, V109, P405, DOI 10.1111/j.0030-1299.2005.13782.x; EPIARDLAHAYE M, 1988, CRYPTOGAMIE ALGOL, V9, P211; Falace A, 2006, HYDROBIOLOGIA, V555, P193, DOI 10.1007/s10750-005-1116-2; Falace A, 2006, B MAR SCI, V78, P161; Falace A, 2010, CHEM ECOL, V26, P77, DOI 10.1080/02757541003689837; Figueroa FL, 2001, J APPL PHYCOL, V13, P235, DOI 10.1023/A:1011126007656; Franklin LA, 2003, ADV PHOTO RESPIRAT, V14, P351; Fraschetti S, 2011, AQUAT CONSERV, V21, P299, DOI 10.1002/aqc.1185; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Giakoumi S, 2012, ESTUAR COAST SHELF S, V109, P1, DOI 10.1016/j.ecss.2011.06.004; GUENTHER JE, 1990, PHOTOSYNTH RES, V23, P105, DOI 10.1007/BF00030070; Guern M, 1962, VIE MILIEU, V13, P649; GUIRY MD, 1984, PHYCOLOGIA, V23, P357, DOI 10.2216/i0031-8884-23-3-357.1; Hader DP, 1997, PHOTOCHEM PHOTOBIOL, V66, P1, DOI 10.1111/j.1751-1097.1997.tb03132.x; Hanelt D., 2012, SEAWEED BIOL, P3, DOI [10.1007/978-3-642-28451-9_1, DOI 10.1007/978-3-642-28451-9_1]; Hays CG, 2007, ECOLOGY, V88, P149, DOI 10.1890/0012-9658(2007)88[149:APDATI]2.0.CO;2; Huovinen P, 2006, AQUAT BOT, V84, P308, DOI 10.1016/j.aquabot.2005.12.002; Hwang EK, 2006, J APPL PHYCOL, V18, P251, DOI 10.1007/s10811-006-9021-2; Johnson LE, 1998, OECOLOGIA, V117, P517, DOI 10.1007/s004420050688; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kerrison P, 2016, J APPL PHYCOL, V28, P481, DOI 10.1007/s10811-015-0580-y; Kinlan BP, 2003, J PHYCOL, V39, P47, DOI 10.1046/j.1529-8817.2003.02087.x; Korbee N, 2005, J PHOTOCH PHOTOBIO B, V80, P71, DOI 10.1016/j.jphotobiol.2005.03.002; Lamote M, 2008, MAR ECOL PROG SER, V368, P93, DOI 10.3354/meps07592; Liu W, 2016, CHIN J OCEANOL LIMN, V34, P492, DOI 10.1007/s00343-016-5041-1; Mangialajo L, 2007, MAR POLLUT BULL, V55, P30, DOI 10.1016/j.marpolbul.2006.08.022; Martinez B, 2002, J PHYCOL, V38, P1082, DOI 10.1046/j.1529-8817.2002.01217.x; Marzinelli EM, 2014, J APPL PHYCOL, V26, P1089, DOI 10.1007/s10811-013-0158-5; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; Micheli F, 2013, PLOS ONE, V8; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Morelissen B, 2013, J EXP MAR BIOL ECOL, V448, P197, DOI 10.1016/j.jembe.2013.07.009; Munda Ivka M., 1993, Hydrobiologia, V260-261, P239, DOI 10.1007/BF00049025; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; Orfanidis S., 2003, ECOL INDIC, V3, P27, DOI DOI 10.1016/S1470-160X(03)00008-6; Pang SJ, 2009, J APPL PHYCOL, V21, P413, DOI 10.1007/s10811-008-9386-5; Peinado NK, 2004, J PHYCOL, V40, P248, DOI 10.1046/j.1529-8817.2004.03013.x; PerezLlorens JL, 1996, EUR J PHYCOL, V31, P349, DOI 10.1080/09670269600651581; Ramus J., 1981, BIOL SEAWEEDS, V17, P458; Reed DC, 1999, MAR BIOL, V133, P737, DOI 10.1007/s002270050515; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sales M, 2015, EUR J PHYCOL, V50, P108; Sales M, 2011, ESTUAR COAST SHELF S, V92, P347, DOI 10.1016/j.ecss.2011.01.008; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stekoll Michael S., 1996, Hydrobiologia, V326-327, P311, DOI 10.1007/BF00047824; Sun JZ, 2009, FISHERIES SCI, V5, P41; Susini ML, 2007, HYDROBIOLOGIA, V580, P241, DOI 10.1007/s10750-006-0449-9; Susini M-L., 2006, THESIS; Templado J, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P479, DOI 10.1007/978-94-007-6704-1_28; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thibaut T, 2015, MEDITERR MAR SCI, V16, P206, DOI 10.12681/mms.1032; Thibaut T, 2016, CRYPTOGAMIE ALGOL, V37, P233, DOI 10.7872/crya/v37.iss4.2016.233; Thibaut T, 2016, CRYPTOGAMIE ALGOL, V37, P61, DOI 10.7872/crya/v37.iss1.2016.61; Thibaut T, 2014, MAR POLLUT BULL, V89, P305, DOI 10.1016/j.marpolbul.2014.09.043; van Tamelen PG, 1997, MAR ECOL PROG SER, V160, P265, DOI 10.3354/meps160265; VASQUEZ JA, 1995, J APPL PHYCOL, V7, P347, DOI 10.1007/BF00003791; Verdura J, 2015, EUR J PHYCOL, V50, P214; VERGARA JJ, 1995, MAR ECOL PROG SER, V122, P253, DOI 10.3354/meps122253; von Stosch H., 1964, P INT SEAWEED S, V4, P142; Wiencke C, 2000, MAR ECOL PROG SER, V197, P217, DOI 10.3354/meps197217; Wilhelm C, 2011, J PLANT PHYSIOL, V168, P79, DOI 10.1016/j.jplph.2010.07.012; Yakovleva IM, 1998, RUSS J PLANT PHYSL+, V45, P45; Yan XH, 2014, J APPL PHYCOL, V26, P577, DOI 10.1007/s10811-013-0102-8; Yatsuya Kousuke, 2010, Bulletin of Fisheries Research Agency, P69; Yoon JT, 2014, J APPL PHYCOL, V26, P505, DOI 10.1007/s10811-013-0058-8; Yu YQ, 2012, ECOL ENG, V44, P10, DOI 10.1016/j.ecoleng.2012.03.016; Zhao ZG, 2008, J APPL PHYCOL, V20, P925, DOI 10.1007/s10811-008-9311-y	87	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193011	10.1371/journal.pone.0193011	http://dx.doi.org/10.1371/journal.pone.0193011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447238	gold, Green Published, Green Submitted			2022-12-26	WOS:000425283900095
J	Kwon, JE; Lim, J; Kim, I; Kim, D; Kang, SC				Kwon, Jeong Eun; Lim, Jaewon; Kim, Inhye; Kim, Donghyuk; Kang, Se Chan			Isolation and identification of new bacterial stains producing equol from Pueraria lobata extract fermentation	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; HUMAN FECES; GEN-NOV.; CHROMATOGRAPHY; EGGERTHELLA; ISOFLAVONE; INTESTINE; DAIDZEIN; SEQUENCE; BARCODE	Equol is a nonsteroidal estrogen that is produced by intestinal bacterial metabolism. Equol and equol-producing bacteria have been extensively investigated with soybean-based materials under anaerobic condition. In this study, an under-appreciated plant material, Pueraria lobata, was used to find new bacterial strains that produce equol under aerobic conditions. Three new intestinal bacteria, CS1, CS2, and CS3, were isolated, and internal transcribed spacer analysis revealed that belonging to genus Pediococcus and Lactobacillus. HPLC analysis showed that these strains produced equol or its related intermediates when fermenting P. lobata extract. In comparison to fermentation of P. lobata extract, soybean germ extract was also fermented. While the isolated strains did not produce equol in this extract, they produced other equol-related precursors. To test the modularity effect of these fermentation mixtures with the newly isolated bacteria, MCF-7 cell proliferation assay was performed, which showed that all extracts fermented with those strains has a modularity effect. Fermenting P. lobata extract with strain CS1 demonstrated the best modularity effect.	[Kwon, Jeong Eun; Lim, Jaewon; Kim, Inhye; Kim, Donghyuk; Kang, Se Chan] Kyung Hee Univ, Coll Life Sci, Yongin, South Korea	Kyung Hee University	Kim, D; Kang, SC (corresponding author), Kyung Hee Univ, Coll Life Sci, Yongin, South Korea.	donghyuk.kim@khu.ac.kr; sckang@khu.ac.kr	Kim, Donghyuk/AAS-9141-2020		Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ01128101]; Kyung Hee University [KHU-20160596, KHU-20160597]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Kyung Hee University	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01128101) to SCK, Rural Development Administration, Republic of Korea. This work was also supported by a grant from Kyung Hee University in 2016."(KHU-20160596, and KHU-20160597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01128101), Rural Development Administration, Republic of Korea. This work was also supported by a grant from Kyung Hee University in 2016."(KHU-20160596, and KHU-20160597)	Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4; DICKSON RB, 1986, ENDOCRINOLOGY, V118, P138, DOI 10.1210/endo-118-1-138; Guillamon JM, 1998, ARCH MICROBIOL, V169, P387, DOI 10.1007/s002030050587; Hubert J, 2008, FOOD CHEM, V109, P709, DOI 10.1016/j.foodchem.2007.12.081; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Lee Eunji, 2016, Journal of Plant Biotechnology, V43, P125, DOI 10.5010/JPB.2016.43.1.125; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Maruo T, 2008, INT J SYST EVOL MICR, V58, P1221, DOI 10.1099/ijs.0.65404-0; Matkowski A, 2004, J PLANT PHYSIOL, V161, P343, DOI 10.1078/0176-1617-01145; Minamida K, 2008, INT J SYST EVOL MICR, V58, P1238, DOI 10.1099/ijs.0.64894-0; Minamida K, 2006, J BIOSCI BIOENG, V102, P247, DOI 10.1263/jbb.102.247; Resende FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074881; Ruegger PM, 2014, J MICROBIOL METH, V105, P82, DOI 10.1016/j.mimet.2014.07.001; Rufer CE, 2006, DRUG METAB DISPOS, V34, P51, DOI 10.1124/dmd.105.004929; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Wang XL, 2005, APPL ENVIRON MICROB, V71, P214, DOI 10.1128/AEM.71.1.214-219.2005; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Yaakob H, 2011, FOOD SCI BIOTECHNOL, V20, P1525, DOI 10.1007/s10068-011-0211-6; Yokoyama S, 2008, BIOSCI BIOTECH BIOCH, V72, P2660, DOI 10.1271/bbb.80329; Yokoyama S, 2007, J NUTR SCI VITAMINOL, V53, P43, DOI 10.3177/jnsv.53.43; Yokoyama S, 2011, J BACTERIOL, V193, P5570, DOI 10.1128/JB.05626-11	25	15	16	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192490	10.1371/journal.pone.0192490	http://dx.doi.org/10.1371/journal.pone.0192490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447179	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900036
J	Taylor, GT; Ackerman, JT; Shaffer, SA				Taylor, Gregory T.; Ackerman, Joshua T.; Shaffer, Scott A.			Egg turning behavior and incubation temperature in Forster's terns in relation to mercury contamination	PLOS ONE			English	Article							SAN-FRANCISCO BAY; ADELIE PENGUINS; BIRD EGGS; CORTICOSTERONE LEVELS; AVIAN INCUBATION; CASSINS AUKLET; STERNA-HIRUNDO; SPACE USE; PROLACTIN; TOXICITY	Egg turning behavior is an important determinant of egg hatchability, but it remains relatively understudied. Here, we examined egg turning rates and egg temperatures in Forster's terns (Sterna forsteri). We used artificial eggs containing a data logger with a 3-D accelerometer, a magnetometer, and a temperature thermistor to monitor parental incubation behavior of 131 tern nests. Overall, adults turned their eggs an average (+/- SD) of 3.8 +/- 0.8 turns h(-1), which is nearly two times higher than that of other seabirds. Egg turning rates increased with nest initiation date. We also examined egg turning rates and egg temperatures in relation to egg mercury contamination. Mercury contamination has been shown to be associated with reduced egg hatchability, and we hypothesized that mercury may decrease egg hatchability via altered egg turning behavior by parents. Despite the high variability in egg turning rates among individuals, the rate of egg turning was not related to mercury concentrations in sibling eggs. These findings highlight the need for further study concerning the potential determinants of egg turning behavior.	[Taylor, Gregory T.; Shaffer, Scott A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Ackerman, Joshua T.] US Geol Survey, Western Ecol Res Ctr, Dixon Field Stn, CA USA	California State University System; San Jose State University; United States Department of the Interior; United States Geological Survey	Taylor, GT (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	gregory.taylor@sjsu.edu	Shaffer, Scott A/D-5015-2009; Ackerman, Joshua T./AAF-9503-2019	Shaffer, Scott A/0000-0002-7751-5059; 	California State University Council on Ocean Affairs, Science and Technology [CSUCOAST-TAYLOR-SJSU-AY1415]; Myers Oceanographic and Marine Biology Trust [1327]; Myers Oceanographic and Marine Biology Trust (Baldridge Award); San Jose State University Department of Biological Sciences Graduate Fellowship; State of California Coastal Conservancy; South Bay Salt Pond Restoration Project; U.S. Geological Survey's Environmental Health Mission Area	California State University Council on Ocean Affairs, Science and Technology; Myers Oceanographic and Marine Biology Trust; Myers Oceanographic and Marine Biology Trust (Baldridge Award); San Jose State University Department of Biological Sciences Graduate Fellowship; State of California Coastal Conservancy; South Bay Salt Pond Restoration Project; U.S. Geological Survey's Environmental Health Mission Area	GTT received funding from the California State University Council on Ocean Affairs, Science and Technology (award number CSUCOAST-TAYLOR-SJSU-AY1415); the Myers Oceanographic and Marine Biology Trust (award #1327 and the Baldridge Award); and the San Jose State University Department of Biological Sciences Graduate Fellowship. JTA was supported by the State of California Coastal Conservancy, South Bay Salt Pond Restoration Project, and U.S. Geological Surveys Environmental Health Mission Area. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Hartman, K. Sawyer, C. Shore, J. Fasan and S. Lei for their help with field data collection and M. Toney and M. Herzog for help with laboratory analysis. We thank C. Strong and the U.S. Fish and Wildlife Service for permission and logistical support to conduct research at the Don Edwards San Francisco Bay National Wildlife Refuge. JTA was supported by the State of California Coastal Conservancy, South Bay Salt Pond Restoration Project, and U.S. Geological Survey's Environmental Health Mission Area. The use of trade, product, or firm names in the publication is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Accurso L. M., 1992, THESIS; Ackerman JT, 2008, ENVIRON TOXICOL CHEM, V27, P897, DOI 10.1897/07-230.1; Ackerman JT, 2016, SCI TOTAL ENVIRON, V568, P749, DOI 10.1016/j.scitotenv.2016.03.071; Ackerman JT, 2016, ENVIRON POLLUT, V210, P145, DOI 10.1016/j.envpol.2015.12.016; Ackerman JT, 2014, J WILDLIFE MANAGE, V78, P818, DOI 10.1002/jwmg.728; Ackerman JT, 2013, ENVIRON SCI TECHNOL, V47, P2052, DOI 10.1021/es304385y; Ackerman JT, 2010, CONDOR, V112, P438, DOI 10.1525/cond.2010.090070; Ackerman JT, 2009, ENVIRON SCI TECHNOL, V43, P2166, DOI 10.1021/es803159c; Ball G.F., 1991, P984; Beaulieu M, 2010, POLAR BIOL, V33, P485, DOI 10.1007/s00300-009-0725-z; Beaulieu M, 2010, FUNCT ECOL, V24, P93, DOI 10.1111/j.1365-2435.2009.01638.x; BEER C. G., 1961, BEHAVIOR, V18, P62, DOI 10.1163/156853961X00286; Bluso-Demers J, 2008, WATERBIRDS, V31, P357, DOI 10.1675/1524-4695-31.3.357; Bluso-Demers JD, 2010, ARDEA, V98, P59, DOI 10.5253/078.098.0108; Boulton RL, 2012, J AVIAN BIOL, V43, P289, DOI 10.1111/j.1600-048X.2012.05657.x; Bustnes JO, 2001, J APPL ECOL, V38, P791, DOI 10.1046/j.1365-2664.2001.00633.x; Byerly TC, 1937, POULTRY SCI, V17, P200; CAREY C, 1980, BIOSCIENCE, V30, P819, DOI 10.2307/1308374; Clatterbuck C., 2014, THESIS; Collar N. J., 2014, International Zoo Yearbook, V48, P7, DOI 10.1111/izy.12039; Deeming DC, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P196; Deeming D.C., 1991, P307, DOI 10.1017/CBO9780511585739.020; Deeming D.C., 2002, AVIAN INCUBATION BEH; Deeming DC, 2009, AVIAN BIOL RES, V2, P67, DOI 10.3184/175815509X431849; Dinsmore JJ, 1970, THESIS; Drent R., 1975, AVIAN BIOL, P333; Drent RH, 1970, BEHAVIOUR S17, V17; Eagles-Smith CA, 2009, ENVIRON POLLUT, V157, P1993, DOI 10.1016/j.envpol.2009.03.030; Elibol O, 2004, BRIT POULTRY SCI, V45, P631, DOI 10.1080/00071660400006271; Environmental Protection Agency, 2000, MERC SOL SOL THERM D; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Fraser G, 1997, COLON WATERBIRD, V20, P87, DOI 10.2307/1521767; French NA, 2000, BRIT POULTRY SCI, V41, P377, DOI 10.1080/713654928; FRENCH NA, 1994, BRIT POULTRY SCI, V35, P363, DOI 10.1080/00071669408417701; Funk E.M., 1953, RES B MO AGR EXP STA, V502, DOI [10.3382/ps.0390784, DOI 10.3382/PS.0390784]; FUNK EM, 1960, POULTRY SCI, V39, P784, DOI 10.3382/ps.0390784; Goldsmith A.R., 1991, P2063; Grant GS, 1982, ORNITHOL MONOGR, V30, piii; HALL JA, 1989, NORTHWEST SCI, V63, P90; HAMBURGER V, 1967, J EXP ZOOL, V166, P171, DOI 10.1002/jez.1401660203; Hansen K, 2006, NZ FAIRY TERN STERNA, V57; Herring G, 2012, ENVIRON SCI TECHNOL, V46, P6339, DOI 10.1021/es300668c; Herring G, 2010, ENVIRON TOXICOL CHEM, V29, P1788, DOI 10.1002/etc.208; Herzog MP, 2016, ECOTOXICOLOGY, V25, P770, DOI 10.1007/s10646-016-1635-9; HOFFMAN DJ, 1990, REV ENVIRON CONTAM T, V115, P39; HOWELL THOMAS R., 1962, CONDOR, V64, P6, DOI 10.2307/1365438; HOWELL THOMAS R., 1961, AUK, V78, P343; HOWELL THOMAS R., 1961, CONDOR, V63, P185, DOI 10.2307/1365682; HOWEY P, 1984, IBIS, V126, P16, DOI 10.1111/j.1474-919X.1984.tb03660.x; Huggins RA, 1941, ECOLOGY, V22, P148, DOI 10.2307/1932209; HUTT F. B., 1930, POULTRY SCI, V9, P194; Jayasena N., 2010, THESIS; Kasielke S., 2007, HAND REARING BIRDS, P39; Kelsey EC, 2016, J WILDLIFE MANAGE, V80, P292, DOI 10.1002/jwmg.1012; King'ori A.M., 2011, INDIAN J POULTRY SCI, V10, P483, DOI DOI 10.3923/ijps.2011.483.492; Love OP, 2004, HORM BEHAV, V46, P59, DOI 10.1016/j.yhbeh.2004.02.001; Ludwigs JD, 2002, ARDEA, V90, P389; MANUWAL DA, 1974, CONDOR, V76, P421, DOI 10.2307/1365815; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; McNicholl MK, 1971, THESIS; Molenaar R, 2010, POULTRY SCI, V89, P2010, DOI 10.3382/ps.2010-00787; Moore CS, 2014, ENVIRON TOXICOL CHEM, V33, P1072, DOI 10.1002/etc.2521; NEW DAT, 1957, J EMBRYOL EXP MORPH, V5, P293; Page GW, 1999, CONDOR, V101, P461, DOI 10.2307/1370176; PIEROTTI R, 1981, AUK, V98, P532; Poulsen H., 1953, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V115, P1; PULLIAINEN E, 1978, Ornis Fennica, V55, P141; ROBERTSON I, 1961, J AGR SCI, V57, P57, DOI 10.1017/S0021859600050012; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Shaffer SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097898; Stenzel Lynne E., 2002, Western Birds, V33, P69; TAKESHITA K, 1982, POULTRY SCI, V61, P667, DOI 10.3382/ps.0610667; Tartu S, 2015, SCI TOTAL ENVIRON, V505, P180, DOI 10.1016/j.scitotenv.2014.10.008; THAXTON JP, 1982, ARCH ENVIRON CON TOX, V11, P509, DOI 10.1007/BF01056080; Thierry AM, 2013, HORM BEHAV, V64, P737, DOI 10.1016/j.yhbeh.2013.06.003; Thierry AM, 2013, HORM BEHAV, V63, P475, DOI 10.1016/j.yhbeh.2012.12.011; Tona K, 2005, POULTRY SCI, V84, P315, DOI 10.1093/ps/84.2.315; TULLETT SG, 1987, BRIT POULTRY SCI, V28, P239, DOI 10.1080/00071668708416958; UNESCO, 1971, UN TREAT SERIES, V14583; Valenne K., 1966, Suomen Riista, V19, P30; Van Roo BL, 2003, HORM BEHAV, V44, P435, DOI 10.1016/j.yhbeh.2003.07.001; VLECK CM, 1983, AUK, V100, P76, DOI 10.1093/auk/100.1.76; Weaver R. L., 1943, Auk, V60, P492; WELLER M. W., 1961, WILSON BULL, V73, P11; Wendeln H, 1997, COLON WATERBIRD, V20, P235, DOI 10.2307/1521689; WESTERSKOV K, 1950, J WILDLIFE MANAGE, V14, P56, DOI 10.2307/3795978; Wilson HR, 2003, J APPL POULTRY RES, V12, P14, DOI 10.1093/japr/12.1.14	87	7	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0191390	10.1371/journal.pone.0191390	http://dx.doi.org/10.1371/journal.pone.0191390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447185	Green Published, gold			2022-12-26	WOS:000425283900014
J	Cuevas, HE; Prom, LK; Rosa-Valentin, G				Cuevas, Hugo E.; Prom, Louis K.; Rosa-Valentin, Giseiry			Population structure of the NPGS Senegalese sorghum collection and its evaluation to identify new disease resistant genes	PLOS ONE			English	Article							BICOLOR L. MOENCH; GRAIN-MOLD; F-STATISTICS; SSR MARKERS; GERMPLASM; ANTHRACNOSE; DIVERSITY; TRAITS; ASSOCIATION; SOFTWARE	Sorghum germplasm from West and Central Africa is cultivated in rainy and high humidity regions and is an important source of resistance genes to fungal diseases. Mold and anthracnose are two important biotic constraints to sorghum production in wet areas worldwide. Here, 158 National Plant Germplasm System (NPGS) accessions from Senegal were evaluated for agronomic traits, anthracnose, and grain mold resistance at two locations, and genetically characterized according to 20 simple sequence repeat markers. A total of 221 alleles were amplified with an average of 11 alleles per locus. Each accession had a unique genetic profile (i.e., no duplicates), and the average genetic distance between accessions was 0.42. Population structure and cluster analysis separated the collection into four populations with pairwise F-ST values >0.15. Three of the populations were composed of Guinea-race sorghum germplasm, and one included multiple races. Anthracnose resistant accessions were present at high frequency and evenly distributed among the three Guinea-race populations. Fourteen accessions showed resistance to grain mold, and eight were resistant to both diseases. These results indicated that the NPGS of Senegal is a genetically diverse collection with a high frequency of disease resistant accessions. Nevertheless, its population structure suggests the presence of few sources of resistance to both grain mold and anthracnose, which are fixed in the germplasm. The phenotypic and genotypic information for these accessions provides a valuable resource for its correct use to broaden the genetic base of breeding programs.	[Cuevas, Hugo E.; Rosa-Valentin, Giseiry] ARS, USDA, Trop Agr Res Stn, Mayaguez, PR 00680 USA; [Prom, Louis K.] ARS, USDA, Southern Plains Agr Res Ctr, College Stn, TX USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cuevas, HE (corresponding author), ARS, USDA, Trop Agr Res Stn, Mayaguez, PR 00680 USA.	hugo.cuevas@ars.usda.gov			Department of Energy (DEO) Office of Science, Office of Biological and Environmental Research (BER) [DE-SC001417]; United States Department of Agriculture, Agriculture Research Service, CRIS [6635-21000-053-00D]	Department of Energy (DEO) Office of Science, Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE)); United States Department of Agriculture, Agriculture Research Service, CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was partially supported by the Department of Energy (DEO) Office of Science, Office of Biological and Environmental Research (BER), grant no. DE-SC001417, and by the United States Department of Agriculture, Agriculture Research Service, CRIS Project 6635-21000-053-00D.	Ali ML, 2008, MOL BREEDING, V21, P497, DOI 10.1007/s11032-007-9149-z; Audilakshmi S, 2005, EUPHYTICA, V145, P95, DOI 10.1007/s10681-005-0534-6; Billot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059714; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Cuevas HE, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3475-7; Cuevas HE, 2015, CROP PROT, V79, P43, DOI 10.1016/j.cropro.2015.10.007; Cuevas HE, 2014, PLANT BREEDING, V133, P234, DOI 10.1111/pbr.12133; Cuevas HE, 2013, GENET RESOUR CROP EV, V60, P1817, DOI 10.1007/s10722-013-9956-5; Dahlberg J., 2000, SORGHUM ORIGIN HIST, P99; Das I. K., 2013, INDIAN J PLANT PROT, V41, P238; Das IK., 2012, EUR J PLANT SCI BIOT, V6, P45; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Erpelding J. E., 2006, Plant Pathology Journal (Faisalabad), V5, P106; Erpelding J. E., 2006, Plant Pathology Journal (Faisalabad), V5, P28; Erpelding J. E., 2004, Plant Pathology Journal, V3, P65; Erpelding John E., 2011, Plant Protection Science, V47, P149; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; HARLAN JR, 1972, CROP SCI, V12, P172, DOI 10.2135/cropsci1972.0011183X001200020005x; Hmon KPW, 2013, PLANT GENET RESOUR-C, V11, P258, DOI 10.1017/S1479262113000154; Isakeit T., 2008, PLANT DIS MANAG REP, V2; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Klein RR, 2001, THEOR APPL GENET, V102, P307, DOI 10.1007/s001220051647; Lasky JR, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400218; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; MILLER FR, 1984, CROP SCI, V24, P1219, DOI 10.2135/cropsci1984.0011183X002400060066x; Milton JM, 1995, BREEDING FIELD CROPS, P243; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Navi SS, 2005, PLANT DIS, V89, P872, DOI 10.1094/PD-89-0872; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; Prom LK, 2012, EUR J PLANT PATHOL, V133, P671, DOI 10.1007/s10658-012-9946-z; Prom L. K., 2012, American Journal of Plant Sciences, V3, P125, DOI 10.4236/ajps.2012.31014; Prom L.K., 2009, TROP SUBTROPICAL AGR, V10, P457; Prom LK, 2011, CROP PROT, V30, P566, DOI 10.1016/j.cropro.2010.12.025; Rami JF, 1998, THEOR APPL GENET, V97, P605, DOI 10.1007/s001220050936; Ratnadass A, 2003, CROP PROT, V22, P837, DOI 10.1016/S0261-2194(03)00066-8; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Rosenow D.T., 2000, SORGHUM ORIGIN HIST; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SNOWDEN JD, 1936, CULTIVATED RACES SOR; Thakur R., 2007, SCREENING TECHNIQUES; Thakur R.P., 2006, SORGHUM GRAIN MOLD I; Thakur RP., 2000, COMPENDIUM SORGHUM D, P10; Upadhyaya HD, 2009, CROP SCI, V49, P1769, DOI 10.2135/cropsci2009.01.0014; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILLIAMS RJ, 1981, TROP PEST MANAGE, V27, P200, DOI 10.1080/09670878109413652	50	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191877	10.1371/journal.pone.0191877	http://dx.doi.org/10.1371/journal.pone.0191877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444109	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500039
J	Simm, D; Kollmar, M				Simm, Dominic; Kollmar, Martin			Waggawagga-CLI: A command-line tool for predicting stable single a-helices (SAH-domains), and the SAH-domain distribution across eukaryotes	PLOS ONE			English	Article							SMOOTH-MUSCLE CALDESMON; ALPHA-HELICES; SALT BRIDGES; ION-PAIRS; PEPTIDES; STABILITY; COMPLEX; LONG; COIL; STABILIZATION	Stable single-alpha helices (SAH-domains) function as rigid connectors and constant force springs between structural domains, and can provide contact surfaces for protein-protein and protein-RNA interactions. SAH-domains mainly consist of charged amino acids and are monomeric and stable in polar solutions, characteristics which distinguish them from coiled-coil domains and intrinsically disordered regions. Although the number of reported SAH-domains is steadily increasing, genome-wide analyses of SAH-domains in eukaryotic genomes are still missing. Here, we present Waggawagga-CLI, a command-line tool for predicting and analysing SAH-domains in protein sequence datasets. Using Waggawagga-CLI we predicted SAH-domains in 24 datasets from eukaryotes across the tree of life. SAH-domains were predicted in 0.5 to 3.5% of the protein-coding content per species. SAH-domains are particularly present in longer proteins supporting their function as structural building block in multi-domain proteins. In human, SAH-domains are mainly used as alternative building blocks not being present in all transcripts of a gene. Gene ontology analysis showed that yeast proteins with SAH-domains are particular enriched in macromolecular complex subunit organization, cellular component biogenesis and RNA metabolic processes, and that they have a strong nuclear and ribonucleoprotein complex localization and function in ribosome and nucleic acid binding. Human proteins with SAH-domains have roles in all types of RNA processing and cytoskeleton organization, and are predicted to function in RNA binding, protein binding involved in cell and cell-cell adhesion, and cytoskeletal protein binding. Waggawagga-CLI allows the user to adjust the stabilizing and destabilizing contribution of amino acid interactions in i,i+3 and i, i+4 spacings, and provides extensive flexibility for user-designed analyses.	[Simm, Dominic; Kollmar, Martin] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Grp Syst Biol Motor Prot, Gottingen, Germany; [Simm, Dominic] Georg August Univ Gottingen, Inst Comp Sci, Theoret Comp Sci & Algorithm Methods, Gottingen, Germany	Max Planck Society; University of Gottingen	Kollmar, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Grp Syst Biol Motor Prot, Gottingen, Germany.	mako@nmr.mpibpc.mpg.de	Kollmar, Martin/AAF-4966-2020	Kollmar, Martin/0000-0002-9768-1855; Simm, Dominic/0000-0003-1689-1947				Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Chui AJ, 2015, BIOCHEMISTRY-US, V54, P1717, DOI 10.1021/bi500894q; DUNNILL P, 1968, BIOPHYS J, V8, P865, DOI 10.1016/S0006-3495(68)86525-7; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P80; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kuhlman B, 1997, J MOL BIOL, V270, P640, DOI 10.1006/jmbi.1997.1146; LYU PC, 1989, J AM CHEM SOC, V111, P2733, DOI 10.1021/ja00189a067; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Meuzelaar H, 2016, BIOPHYS J, V110, P2328, DOI 10.1016/j.bpj.2016.04.015; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Samejima K, 2015, J BIOL CHEM, V290, P21460, DOI 10.1074/jbc.M115.645317; SCHOLTZ JM, 1993, BIOCHEMISTRY-US, V32, P9668, DOI 10.1021/bi00088a019; Simm D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174639; Simm D, 2015, BIOINFORMATICS, V31, P767, DOI 10.1093/bioinformatics/btu700; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Sommese RF, 2010, PROTEIN SCI, V19, P2001, DOI 10.1002/pro.469; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Ulrich AKC, 2016, STRUCTURE, V24, P1972, DOI 10.1016/j.str.2016.09.007; WANG CLA, 1991, J BIOL CHEM, V266, P13958; Wang EZ, 1996, ARCH BIOCHEM BIOPHYS, V329, P156, DOI 10.1006/abbi.1996.0204; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wolny M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44341	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191924	10.1371/journal.pone.0191924	http://dx.doi.org/10.1371/journal.pone.0191924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444145	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500045
J	Atieh, T; El Ayoubi, MD; Aubry, F; Priet, S; de Lamballerie, X; Nougairede, A				Atieh, Therese; El Ayoubi, Miriam Diala; Aubry, Fabien; Priet, Stephane; de Lamballerie, Xavier; Nougairede, Antoine			Haiku: New paradigm for the reverse genetics of emerging RNA viruses	PLOS ONE			English	Article							VACCINES; SYSTEMS; ZIKA	Reverse genetics is key technology for producing wild-type and genetically modified viruses. The ISA (Infectious Subgenomic Amplicons) method is a recent versatile and user-friendly reverse genetics method to rescue RNA viruses. The main constraint of its canonic protocol was the requirement to produce (e.g., by DNA synthesis or fusion PCR) 5' and 3' modified genomic fragments encompassing the human cytomegalovirus promoter (pCMV) and the hepatitis delta virus ribozyme/simian virus 40 polyadenylation signal (HDR/SV40pA), respectively. Here, we propose the ultimately simplified "Haiku" designs in which terminal pCMV and HDR/SV40pA sequences are provided as additional separate DNA amplicons. This improved procedure was successfully applied to the rescue of a wide range of viruses belonging to genera Flavivirus, Alphavirus and Enterovirus in mosquito or mammalian cells using only standard PCR amplification techniques and starting from a variety of original materials including viral RNAs extracted from cell supernatant media or animal samples. We also demonstrate that, in specific experimental conditions, the presence of the HDR/SV40pA is not necessary to rescue the targeted viruses. These ultimately simplified "Haiku" designs provide an even more simple, rapid, versatile and cost-effective tool to rescue RNA viruses since only generation of overlapping amplicons encompassing the entire viral genome is now required to generate infectious virus. This new approach may completely modify our capacity to obtain infectious RNA viruses.	[Atieh, Therese; El Ayoubi, Miriam Diala; Aubry, Fabien; Priet, Stephane; de Lamballerie, Xavier; Nougairede, Antoine] Aix Marseille Univ, UMR Emergence Pathol Virales EPV, IRD 190, Inserm 1207,EHESP,IHU Mediterranee Infect, Marseille, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Nougairede, A (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales EPV, IRD 190, Inserm 1207,EHESP,IHU Mediterranee Infect, Marseille, France.	antoine.nougairede@univ-amu.fr	Priet, Stéphane/N-7952-2017; Priet, Stéphane/ABD-4869-2020	Priet, Stéphane/0000-0001-7102-3654; Priet, Stéphane/0000-0001-7102-3654; Aubry, Fabien/0000-0002-7733-7694	French "Agence Nationale de la Recherche" [ANR-14-CE14-0001]; European Virus Archive goes global project (EVAg); European Virus Archive goes global project (European Union Horizon programme) [653316]	French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); European Virus Archive goes global project (EVAg); European Virus Archive goes global project (European Union Horizon programme)	This work was supported by the French "Agence Nationale de la Recherche" (grant agreement no. ANR-14-CE14-0001) and the European Virus Archive goes global project (EVAg; European Union Horizon 2020 programme under grant agreement no. 653316; http://www.european-virus-archive.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001; Atieh T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14522-6; Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384; Aubry F, 2013, GENOME ANNOUNCEMENTS, V1; Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703; Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007; Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0; Bradley T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15711; Conzelmann KK, 2004, CURR TOP MICROBIOL, V283, P1; de Fabritus L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159564; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428; Nougairede A, 2014, J CLIN VIROL, V61, P118, DOI 10.1016/j.jcv.2014.05.022; Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172; Pijlman GP, 2015, BIOTECHNOL J, V10, P659, DOI 10.1002/biot.201400427; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Tan CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162771	18	3	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0193069	10.1371/journal.pone.0193069	http://dx.doi.org/10.1371/journal.pone.0193069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438402	gold, Green Published, Green Submitted			2022-12-26	WOS:000425083400067
J	Zhou, ZW; Li, ZA; Ren, JY; He, MY; Huang, YQ; Tian, WD; Tang, W				Zhou, ZhongWei; Li, Zhang'ao; Ren, Jiayin; He, Mingyun; Huang, Yongqing; Tian, WeiDong; Tang, Wei			Digital diagnosis and treatment of mandibular condylar fractures based on Extensible Neuro imaging Archive Toolkit (XNAT)	PLOS ONE			English	Article							FIXATION	Objectives The treatment of condylar fractures has long been controversial. In this paper, we established a database for accurate measurement, storage, management and analysis of patients' data, in order to help determine the best treatment plan. Methods First of all, the diagnosis and treatment database was established based on XNAT, including 339 cases of condylar fractures and their related information. Then image segmentation, registration and three-dimensional (3D) measurement were used to measure and analyze the condyle shapes. Statistical analysis was used to analyze the anatomical structure changes of condyle and the surrounding tissues at different stages before and after treatment. The processes of condylar fracture reestablishment at different stages were also dynamically monitored. Finally, based on all these information, the digital diagnosis and treatment plans for condylar fractures were developed. Results For the patients less than 18 years old with no significant dislocation, surgical treatment and conservative treatment were equally effective for intracapsular fracture, and had no significant difference for neck and basal fractures. For patients above 18 years old, there was no significant difference between the two treatment methods for intracapsular fractures; but for condylar neck and basal fractures, surgical treatment was better than conservative treatment. When condylar fracture shift angle was greater than 11 degrees, and mandibular ramus height reduction was greater than 4mm, the patients felt the strongest pain, and their mouths opening was severely restricted. There were 170 surgical cases with condylar fracture shift angel greater than 11 degrees, and 118 of them (69.4%) had good prognosis, 52 of them (30.6%) had complications such as limited mouth opening. There were 173 surgical cases with mandibular ramus height reduction more than 4mm, and 112 of them (64.7%) had good prognosis, 61 of them (35.3%) had complications such as limited mouth opening. Conclusions The establishment of XNAT condylar fracture database is helpful for establishing a digital diagnosis and treatment workflow for mandibular condylar fractures, providing new theoretical foundation and application basis for diagnosis and treatment of condylar fractures.	[Zhou, ZhongWei; Huang, Yongqing] Ningxia Med Univ, Dept Oral & Maxillofacial Surg, Gen Hosp, Ningxia, Peoples R China; [Li, Zhang'ao; Ren, Jiayin; Tang, Wei] Sichuan Univ, Dept Oral & Maxillofacial Surg, West China Coll Stomatol, Chengdu, Sichuan, Peoples R China; [He, Mingyun; Tian, WeiDong] Univ Elect Sci & Technol China, Coll Informat Software Engn, Chengdu, Sichuan, Peoples R China; [Tian, WeiDong] Sichuan Univ, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China	Ningxia Medical University; Sichuan University; University of Electronic Science & Technology of China; Sichuan University	Tang, W (corresponding author), Sichuan Univ, Dept Oral & Maxillofacial Surg, West China Coll Stomatol, Chengdu, Sichuan, Peoples R China.; Tian, WD (corresponding author), Univ Elect Sci & Technol China, Coll Informat Software Engn, Chengdu, Sichuan, Peoples R China.; Tian, WD (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.	drtwd@sina.com; mydrtw@vip.sina.com		Tang, Wei/0000-0001-7568-2884; Tian, Weidong/0000-0003-0175-1132	National Natural Science Foundation of China [81170940]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (81170940). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (81170940).	Alpert B, 2009, ORAL MAXIL SURG CLIN, V21, P185, DOI 10.1016/j.coms.2008.12.002; Aquilina P, 2013, BRIT J ORAL MAX SURG, V51, P326, DOI 10.1016/j.bjoms.2012.08.007; Baeyer CL, 2009, PAIN, V143, P223, DOI DOI 10.1016/J.PAIN.2009.03.002; Cascone P, 2008, J ORAL MAXIL SURG, V66, P265, DOI 10.1016/j.joms.2007.06.621; Chan Hong Jin, 2007, Aust Orthod J, V23, P55; Cornelius CP, 2014, CRANIOMAX TRAUM REC, V7, pS31, DOI 10.1055/s-0034-1389558; Gao Y, 2013, SPIE MED IMAGING; Glazer M, 2011, INT J PEDIATR OTORHI, V75, P62, DOI 10.1016/j.ijporl.2010.10.008; Goth S, 2012, J CRANIOFAC SURG, V23, P47, DOI 10.1097/SCS.0b013e318240c8ab; Hlawitschka M, 2005, INT J ORAL MAX SURG, V34, P597, DOI 10.1016/j.ijom.2005.02.004; Saccucci M, 2012, HEAD FACE MED, V8, DOI 10.1186/1746-160X-8-15; van Vlijmen OJC, 2010, INT J ORAL MAX SURG, V39, P156, DOI 10.1016/j.ijom.2009.11.017; Yitschaky O, 2011, ANGLE ORTHOD, V81, P11, DOI 10.2319/031710-157.1; Yu YH, 2013, BRIT J ORAL MAX SURG, V51, P133, DOI 10.1016/j.bjoms.2012.03.019	14	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192831	10.1371/journal.pone.0192831	http://dx.doi.org/10.1371/journal.pone.0192831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432477	gold, Green Published, Green Submitted			2022-12-26	WOS:000424814300051
J	Talevi, R; Sudhakaran, S; Barbato, V; Merolla, A; Braun, S; Di Nardo, M; Costanzo, V; Ferraro, R; Iannantuoni, N; Catapano, G; Gualtieri, R				Talevi, Riccardo; Sudhakaran, Sam; Barbato, Vincenza; Merolla, Anna; Braun, Sabrina; Di Nardo, Maddalena; Costanzo, Valentina; Ferraro, Raffaele; Iannantuoni, Nicola; Catapano, Gerardo; Gualtieri, Roberto			Is oxygen availability a limiting factor for in vitro folliculogenesis?	PLOS ONE			English	Article							OVARIAN TISSUE CRYOPRESERVATION; PRE-ANTRAL FOLLICLES; FREE CULTURE-SYSTEM; PRIMORDIAL FOLLICLES; DEVELOPMENTAL COMPETENCE; FERTILITY PRESERVATION; CORTICAL TISSUE; FOLLICULAR DEVELOPMENT; GROWTH; BOVINE	Transplantation of ovarian tissue for the preservation of fertility in oncological patients is becoming an accepted clinical practice. However, the risk of re-introducing tumour cells at transplantation has stirred an increased interest for complete in vitro folliculogenesis. This has not yet been achieved in humans possibly for the lack of knowledge on the environmental milieu that orchestrates folliculogenesis in vivo. The main aim of this study was to investigate the effect of oxygen availability on follicle health and growth during in vitro culture of ovarian tissue strips. To this end, a model was developed to predict the dissolved oxygen concentration in tissue under varying culture conditions. Ovarian cortical strips of bovine, adopted as an animal model, and human tissue were cultured in conventional (CD) and gas permeable (PD) dishes under different media column heights and gaseous oxygen tensions for 3, 6 and 9 days. Follicle quality, activation of primordial follicles to the primary stage, and progression to the secondary stage were analysed through histology. Follicle viability was assessed through a live-dead assay at the confocal scanning laser microscope. Findings showed a higher follicle quality and viability after culture of bovine ovarian strips in PD in adequate medium height and oxygen tensions. The best culture conditions found in the bovine were adopted for human ovarian strip culture and promoted a higher follicle quality, viability and progression. Overall, data demonstrated that modulation of oxygen availability in tissue plays a key role in maintaining follicles' health and their ability to survive and progress to the secondary stage during ovarian tissue in vitro culture. Such culture conditions could increase the yield of healthy secondary follicles for subsequent dissection and individual culture to obtain competent oocytes.	[Talevi, Riccardo; Barbato, Vincenza; Merolla, Anna; Braun, Sabrina; Di Nardo, Maddalena; Costanzo, Valentina; Gualtieri, Roberto] Univ Napoli Federico II, Complesso Univ Monte S Angelo, Dipartimento Biol, Naples, Italy; [Sudhakaran, Sam] St Bartholomews Hosp, London, England; [Ferraro, Raffaele] Genesis Day Surg Sdc, Caserta, Italy; [Iannantuoni, Nicola] ASL Napoli 2 Nord, Osped S Maria Grazie, Pozzuoli, Italy; [Catapano, Gerardo] Univ Calabria, Dept Environm & Chem Engn, Arcavacata Di Rende, Italy	University of Naples Federico II; University of London; Queen Mary University London; University of Calabria	Gualtieri, R (corresponding author), Univ Napoli Federico II, Complesso Univ Monte S Angelo, Dipartimento Biol, Naples, Italy.	roberto.gualtieri@unina.it	Gualtieri, Roberto/AAT-3748-2020	Gualtieri, Roberto/0000-0002-0424-5254; Di Nardo, Maddalena/0000-0002-1481-2101	Merck Serono S.p.A. (Rome, Italy)	Merck Serono S.p.A. (Rome, Italy)	This work was supported by Merck Serono S.p.A. (Rome, Italy), grant "Optimizing ovarian tissue vitrification and subsequent in vitro culture using oxygen permeable dishes for sustaining in vitro follicle growth". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Merck Serono S.p.A. (Rome, Italy) with the grant "Optimizing ovarian tissue vitrification and subsequent in vitro culture using oxygen permeable dishes for sustaining in vitro follicle growth".	Abir R, 2006, HISTOL HISTOPATHOL, V21, P887, DOI 10.14670/HH-21.887; Abir R, 2014, REPROD BIOMED ONLINE, V28, P255, DOI 10.1016/j.rbmo.2013.10.011; Adriaens I, 2004, HUM REPROD, V19, P398, DOI 10.1093/humrep/deh074; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; Carlsson IB, 2006, REPRODUCTION, V131, P641, DOI 10.1530/rep.1.00868; Connolly JM, 2016, REPROD FERT DEVELOP, V28, P1570, DOI 10.1071/RD14471; Dolmans MM, 2010, BLOOD, V116, P2908, DOI 10.1182/blood-2010-01-265751; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Fortune JE, 1998, THERIOGENOLOGY, V49, P441, DOI 10.1016/S0093-691X(97)00416-0; Fortune JE, 2000, MOL CELL ENDOCRINOL, V163, P53, DOI 10.1016/S0303-7207(99)00240-3; Fortune JE, 1999, J REPROD FERTIL, P439; Gigli I, 2006, THERIOGENOLOGY, V66, P344, DOI 10.1016/j.theriogenology.2005.11.021; Gook DA, 2014, MOL HUM REPROD, V20, P31, DOI 10.1093/molehr/gat062; GOUGEON A, 1986, HUM REPROD, V1, P81, DOI 10.1093/oxfordjournals.humrep.a136365; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Guzel Y, 2017, MOL REPROD DEV, V84, P544, DOI 10.1002/mrd.22822; Higuchi CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143114; Hornick JE, 2012, HUM REPROD, V27, P1801, DOI 10.1093/humrep/der468; Ishikawa T, 2014, J REPROD DEVELOP, V60, P460, DOI 10.1262/jrd.2014-009; Jemal A, 2017, JNCI-J NATL CANCER I, V109, P1539; Jensen AK, 2017, J ASSIST REPROD GEN, V34, P336, DOI 10.1007/s10815-017-0873-y; Jorssen EPA, 2014, THERIOGENOLOGY, V82, P387, DOI 10.1016/j.theriogenology.2014.04.019; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kim SS, 2004, FERTIL STERIL, V82, P679, DOI 10.1016/j.fertnstert.2004.05.022; Kondapalli LA, 2014, QUAL LIFE RES, V23, P585, DOI 10.1007/s11136-013-0473-y; Langbeen A, 2015, THERIOGENOLOGY, V84, P477, DOI 10.1016/j.theriogenology.2015.04.009; Laronda MM, 2014, J ASSIST REPROD GEN, V31, P1013, DOI 10.1007/s10815-014-0252-x; Larrea X, 2009, INVEST OPHTH VIS SCI, V50, P1076, DOI 10.1167/iovs.08-2479; McLaughlin M, 2017, HUM REPROD, V32, P165, DOI 10.1093/humrep/dew260; McLaughlin M, 2010, REPRODUCTION, V139, P971, DOI 10.1530/REP-10-0025; Morimoto Y, 2007, HUM REPROD, V22, P3170, DOI 10.1093/humrep/dem314; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Schmidt KT, 2010, BJOG-INT J OBSTET GY, V117, P163, DOI 10.1111/j.1471-0528.2009.02408.x; Silber S, 2016, J ASSIST REPROD GEN, V33, P1595, DOI 10.1007/s10815-016-0814-1; Smitz J, 2010, HUM REPROD UPDATE, V16, P395, DOI 10.1093/humupd/dmp056; Talevi R, 2016, FERTIL STERIL, V105, DOI 10.1016/j.fertnstert.2016.01.043; Talevi R, 2013, REPROD BIOMED ONLINE, V27, P381, DOI 10.1016/j.rbmo.2013.07.003; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Telfer EE, 2013, FERTIL STERIL, V99, P1523, DOI 10.1016/j.fertnstert.2013.03.043; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; West ER, 2007, SEMIN REPROD MED, V25, P287, DOI 10.1055/s-2007-980222; Wycherley G, 2004, REPRODUCTION, V127, P669, DOI 10.1530/rep.1.00040; Xu J, 2011, HUM REPROD, V26, P1061, DOI 10.1093/humrep/der049; Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228; Yin H, 2016, HUM REPROD, V31, P1531, DOI 10.1093/humrep/dew049	46	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192501	10.1371/journal.pone.0192501	http://dx.doi.org/10.1371/journal.pone.0192501			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425251	Green Published, Green Submitted, gold			2022-12-26	WOS:000424700800025
J	Evstafieva, AG; Kovaleva, IE; Shoshinova, MS; Budanov, AV; Chumakov, PM				Evstafieva, Alexandra G.; Kovaleva, Irina E.; Shoshinova, Maria S.; Budanov, Andrei V.; Chumakov, Peter M.			Implication of KRT16, FAM129A and HKDC1 genes as ATF4 regulated components of the integrated stress response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; EPIDERMAL-GROWTH-FACTOR; TRANSCRIPTION FACTOR 4; TRANSLATIONAL CONTROL; C-JUN; EXPRESSION; PHOSPHORYLATION; INDUCTION; DISEASE; CANCER	The ATF4 transcription factor is a key regulator of the adaptive integrated stress response (ISR) induced by various stresses and pathologies. Identification of novel transcription targets of ATF4 during ISR would contribute to the understanding of adaptive networks and help to identify novel therapeutic targets. We were previously searching for genes that display an inverse regulation mode by the transcription factors ATF4 and p53 in response to mitochondrial respiration chain complex III inhibition. Among the selected candidates the human genes for cytokeratine 16 (KRT16), anti-apoptotic protein Niban (FAM129A) and hexokinase HKDC1 have been found highly responsive to ATF4 overexpression. Here we explored potential roles of the induction of KRT16, FAM129A and HKDC1 genes in ISR. As verified by RT-qPCR, a dysfunction of mitochondrial respiration chain and ER stress resulted in a partially ATF4-dependent stimulation of KRT16, FAM129A and HKDC1 expression in the HCT116 colon carcinoma cell line. ISRIB, a specific inhibitor of ISR, was able to downregulate the ER stress-induced levels of KRT16, FAM129A and HKDC1 transcripts. An inhibition of ATF4 by RNAi attenuated the induction of KRT16, FAM129A and HKDC1 mRNAs in response to ER stress or to a dysfunctional mitochondrial respiration. The similar induction of the three genes was observed in another tumor-derived cervical carcinoma cell line HeLa. However, in HaCaT and HEK293T cells that display transformed phenotypes, but do not originate from patient-derived tumors, the ER stress-inducing treatments resulted in an upregulation of FAM129A and HKDC1, but not KRT16 transcripts, By a luciferase reporter approach we identified a highly active ATF4-responsive element within the upstream region of the KRT16 gene. The results suggest a conditional regulation of KRT16 gene by ATF4 that may be inhibited in normal cells, but engaged during cancer progression. Potential roles of KRT16, FAM129A and HKDC1 genes upregulation in adaptive stress responses and pathologies are discussed.	[Evstafieva, Alexandra G.; Kovaleva, Irina E.] Lomonosov Moscow State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Evstafieva, Alexandra G.; Shoshinova, Maria S.] Lomonosov Moscow State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Budanov, Andrei V.; Chumakov, Peter M.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Budanov, Andrei V.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Chumakov, Peter M.] Russian Acad Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Fed Sci Ctr Res & Dev Immune Biol Prod, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Trinity College Dublin; Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Russian Academy of Sciences	Evstafieva, AG (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia.; Chumakov, PM (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.; Chumakov, PM (corresponding author), Russian Acad Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Fed Sci Ctr Res & Dev Immune Biol Prod, Moscow, Russia.	evstaf@genebee.msu.ru; peterchumakov@gmail.com	Budanov, Andrei V/HGD-5487-2022	Budanov, Andrei V/0000-0002-7943-1000; Chumakov, Peter/0000-0002-8078-2908	Russian Fund for Basic Research [15-04-04945-a]; Russian Science Foundation [14-50-00060, 17-14-01420]; Russian Science Foundation [17-14-01420] Funding Source: Russian Science Foundation	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Fund for Basic Research, grant number 15-04-04945-a (A.G.E.), http://www.rfbr.ru/rffi/eng/; Russian Science Foundation grant number 14-50-00060 (P.M.C.) and 17-14-01420 (A.V.B.), www.rscf.ru/en.	Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bell D, 2016, CANCER-AM CANCER SOC, V122, P1513, DOI 10.1002/cncr.29959; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carvalheira G, 2015, ONCOTARGET, V6, P28357, DOI 10.18632/oncotarget.4947; Chiang CK, 2011, MOL MED, V17, P1295, DOI 10.2119/molmed.2011.00131; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eliason MJ, 2012, J AM ACAD DERMATOL, V67, P680, DOI 10.1016/j.jaad.2011.12.009; Endo H, 2008, ENVIRON HEALTH PERSP, V116, P873, DOI 10.1289/ehp.10696; Evstafieva AG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.469; Garaeva AA, 2016, CELL CYCLE, V15, P64, DOI 10.1080/15384101.2015.1120929; Guo C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7069; Hameetman L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-58; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Horiguchi M, 2013, CANCER RES, V73, P2639, DOI 10.1158/0008-5472.CAN-12-2492; Huang MLH, 2013, AM J PATHOL, V183, P745, DOI 10.1016/j.ajpath.2013.05.032; Irwin DM, 2008, COMP BIOCHEM PHYS D, V3, P96, DOI 10.1016/j.cbd.2007.11.002; Ito S, 2010, HEAD NECK-J SCI SPEC, V32, P96, DOI 10.1002/hed.21153; Ji HT, 2012, EMBO REP, V13, P554, DOI 10.1038/embor.2012.53; Khutornenko AA, 2014, ACTA NATURAE, V6, P69, DOI 10.32607/20758251-2014-6-1-69-75; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kovaleva IE, 2016, GENE, V590, P177, DOI 10.1016/j.gene.2016.06.037; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Li GH, 2014, BIOINFORMATICS, V30, P748, DOI 10.1093/bioinformatics/btt606; Machesney M, 1998, AM J PATHOL, V152, P1133; Matsumoto F, 2006, HUM PATHOL, V37, P1592, DOI 10.1016/j.humpath.2006.06.022; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Ohno M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00022; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Sun GD, 2007, BIOCHEM BIOPH RES CO, V360, P181, DOI 10.1016/j.bbrc.2007.06.021; Sun XT, 2013, J NEUROSCI, V33, P2398, DOI 10.1523/JNEUROSCI.2292-12.2013; Sykes EK, 2016, CANCERS, V8, DOI 10.3390/cancers8030030; van 't Wout EFA, 2014, AM J RESP CELL MOL, V50, P1005, DOI 10.1165/rcmb.2014-0019TR; Wang YN, 2006, MOL PHARMACOL, V69, P85, DOI 10.1124/mol.105.016220; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Young SK, 2016, J BIOL CHEM, V291, P16927, DOI 10.1074/jbc.R116.733899; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986; Zha C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122322	46	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191107	10.1371/journal.pone.0191107	http://dx.doi.org/10.1371/journal.pone.0191107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420561	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900010
J	Sweeney, S; Adamcakova-Dodd, A; Thorne, PS; Assouline, JG				Sweeney, Sean; Adamcakova-Dodd, Andrea; Thorne, Peter S.; Assouline, Jose G.			Multifunctional nanoparticles for real-time evaluation of toxicity during fetal development	PLOS ONE			English	Article							MESOPOROUS SILICA NANOPARTICLES; HUMAN PLACENTAL PERFUSION; IN-VITRO; DRUG-DELIVERY; MICE; BARRIER; MODEL; VIVO; MRI; ENDOCYTOSIS	Increasing production of nanomaterials in industrial quantities has led to public health concerns regarding exposure, particularly among pregnant women and developing fetuses. Information regarding the barrier capacity of the placenta for various nanomaterials is limited due to challenges working with ex vivo human placentas or in vivo animal models. To facilitate real-time in vivo imaging of placental transport, we have developed a novel, multifunctional nanoparticle, based on a core of mesoporous silica nanoparticles (MSN), and functionalized for magnetic resonance imaging (MRI), ultrasound, and fluorescent microscopy. Our MSN particles were tested as a tracking method for harmful and toxic nanomaterials. In gravid mice, intravenous injections of MSN were administered in the maternal circulation in early gestation (day 9) and late gestation (day 14). MRI and ultrasound were used to track the MSN following the injections. Changes in contrast relative to control mice indicated that MSN were observed in the embryos of mice following early gestation injections, while MSN were excluded from the embryo by the placenta following late gestation injections. The timing of transplacental barrier porosity is consistent with the notion that in mice there is a progressive increasing segregation by the placenta in later gestation. In addition, built-in physico-chemical properties of our MSN may present options for the therapeutic treatment of embryonic exposure. For example, if preventive measures such as detoxification of harmful compounds are implemented, the particle size and exposure timing can be tailored to selectively distribute to the maternal side of the trophoblast or delivered to the fetus.	[Sweeney, Sean; Assouline, Jose G.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Sweeney, Sean; Assouline, Jose G.] NanoMedTrix LLC, Coralville, IA 52241 USA; [Adamcakova-Dodd, Andrea; Thorne, Peter S.] Univ Iowa, Environm Hlth Sci Res Ctr, Iowa City, IA USA; [Adamcakova-Dodd, Andrea; Thorne, Peter S.] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Assouline, JG (corresponding author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.; Assouline, JG (corresponding author), NanoMedTrix LLC, Coralville, IA 52241 USA.	jose-assouline@uiowa.edu		Thorne, Peter/0000-0002-5045-0929	Iowa Economic Development Authority Demonstration Fund [13-DEMO-005]; NSF SBIR [IIP-1345646]; EHSRC pilot study NIEHS/NIH [P30 ES005605]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Iowa Economic Development Authority Demonstration Fund; NSF SBIR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); EHSRC pilot study NIEHS/NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work is funded by Iowa Economic Development Authority Demonstration Fund #13-DEMO-005 to J.G.A., NSF SBIR grant #IIP-1345646 to J.G.A., and EHSRC pilot study NIEHS/NIH P30 ES005605 to P.S.T. J.G.A. is founder and sole proprietor of NanoMedTrix, LLC who provided support in the form of salaries for authors J.G.A. and S.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JG, 1979, ULTRASONIC IMAGING, V1, P303, DOI 10.1016/0161-7346(79)90024-5; Adamcakova-Dodd A, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0105-5; Avni R, 2015, PLACENTA, V36, P615, DOI 10.1016/j.placenta.2015.04.003; Blum JL, 2012, TOXICOL SCI, V126, P478, DOI 10.1093/toxsci/kfs008; Bobak M, 2000, ENVIRON HEALTH PERSP, V108, P173, DOI 10.2307/3454517; Campbell M, 2009, P NATL ACAD SCI USA, V106, P17817, DOI 10.1073/pnas.0908561106; Carney Edward W, 2004, Birth Defects Res C Embryo Today, V72, P345, DOI 10.1002/bdrc.20027; Carreira SC, 2015, NANOTOXICOLOGY, V9, P66, DOI 10.3109/17435390.2013.833317; Casciaro S, 2010, INVEST RADIOL, V45, P715, DOI 10.1097/RLI.0b013e3181e6f42f; Chen B, 2012, INT J NANOMED, V7, P199, DOI 10.2147/IJN.S26763; Chu MQ, 2010, SMALL, V6, P670, DOI 10.1002/smll.200902049; Delgado D, 2011, EUR J PHARM BIOPHARM, V79, P495, DOI 10.1016/j.ejpb.2011.06.005; Du MR, 2014, CELL MOL IMMUNOL, V11, P438, DOI 10.1038/cmi.2014.68; Favaron PO, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-10; Grafmueller S, 2015, ENVIRON HEALTH PERSP, V123, P1280, DOI 10.1289/ehp.1409271; Heller M, 2014, BIRTH DEFECTS RES A, V100, P277, DOI 10.1002/bdra.23232; Hill MA, 2007, CLIN OBSTET GYNECOL, V50, P2, DOI 10.1097/GRF.0b013e31802f119d; Hong CW, 2015, BJU INT, V115, P772, DOI 10.1111/bju.12871; Hougaard KS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-16; Hu HH, 2010, J MAGN RESON IMAGING, V31, P1195, DOI 10.1002/jmri.22162; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Juch H, 2013, REPROD TOXICOL, V41, P73, DOI 10.1016/j.reprotox.2013.05.011; Kannan S, 2006, ENVIRON HEALTH PERSP, V114, P1636, DOI 10.1289/ehp.9081; Kaul G, 2005, J PHARM SCI-US, V94, P184, DOI 10.1002/jps.20216; Kording F, 2015, PLACENTA, V36, P255, DOI 10.1016/j.placenta.2014.12.010; Lee MJ, 2011, KOREAN J RADIOL, V12, P358, DOI 10.3348/kjr.2011.12.3.358; Lin YS, 2011, J AM CHEM SOC, V133, P20444, DOI 10.1021/ja208567v; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Myllynen PK, 2008, REPROD TOXICOL, V26, P130, DOI 10.1016/j.reprotox.2008.06.008; Park JY, 2009, ACS NANO, V3, P3663, DOI 10.1021/nn900761s; Plaks V, 2011, MOL IMAGING BIOL, V13, P481, DOI 10.1007/s11307-010-0390-1; Plaks V, 2011, BIOL REPROD, V84, P537, DOI 10.1095/biolreprod.110.085951; Qiao L, 2016, NANOSCALE, V8, P17241, DOI 10.1039/c6nr05943k; Rafi AA, 2016, EUR J PHARM SCI, V93, P64, DOI 10.1016/j.ejps.2016.08.005; Remus CC, 2013, PLACENTA, V34, P899, DOI 10.1016/j.placenta.2013.06.304; Salvado O, 2006, IEEE T MED IMAGING, V25, P539, DOI 10.1109/TMI.2006.871418; Salvado O, 2006, INT J BIOMED IMAGING, V2006, DOI 10.1155/IJBI/2006/92092; Saunders M, 2009, WIRES NANOMED NANOBI, V1, P671, DOI 10.1002/wnan.53; Shimizu M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-20; Shinohara RT, 2014, NEUROIMAGE-CLIN, V6, P9, DOI 10.1016/j.nicl.2014.08.008; Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943; Sood A, 2011, NAT NANOTECHNOL, V6, P824, DOI [10.1038/nnano.2011.188, 10.1038/NNANO.2011.188]; Sweeney S, 2017, J BIOMED NANOTECHNOL, V13, P544, DOI 10.1166/jbn.2017.2369; Sweeney SK, 2017, J BIOMED NANOTECHNOL, V13, P232, DOI 10.1166/jbn.2017.2339; Sweeney Sean K, 2016, Cancer Nanotechnol, V7, P3, DOI 10.1186/s12645-016-0015-8; Takenaka S, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3454667; Tang MX, 2011, INTERFACE FOCUS, V1, P520, DOI 10.1098/rsfs.2011.0026; Valenstein JS, 2012, ACS APPL MATER INTER, V4, P1003, DOI 10.1021/am201647t; Veid J, 2011, TOXICOL LETT, V205, P257, DOI 10.1016/j.toxlet.2011.06.014; Wick P, 2010, ENVIRON HEALTH PERSP, V118, P432, DOI 10.1289/ehp.0901200; Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]; Yang H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00847; Yang PH, 2005, BIOCONJUGATE CHEM, V16, P494, DOI 10.1021/bc049775d; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k	56	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192474	10.1371/journal.pone.0192474	http://dx.doi.org/10.1371/journal.pone.0192474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420606	Green Submitted, gold, Green Published			2022-12-26	WOS:000424517900078
J	Nikonorova, IA; Mirek, ET; Signore, CC; Goudie, MP; Wek, RC; Anthony, TG				Nikonorova, Inna A.; Mirek, Emily T.; Signore, Christina C.; Goudie, Michael P.; Wek, Ronald C.; Anthony, Tracy G.			Time-resolved analysis of amino acid stress identifies eIF2 phosphorylation as necessary to inhibit mTORC1 activity in liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic initiation factor 2 (eIF2); mTOR complex (mTORC); liver; endoplasmic reticulum stress (ER stress); amino acid; translation regulation; ATF4; GCN2; PERK	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; TRANSCRIPTION FACTOR ATF4; PEGYLATED ARGINASE I; CELL-DEATH; LEUCINE DEPRIVATION; GENE-EXPRESSION; KINASE GCN2; PATHWAY	Amino acid availability is sensed by GCN2 (general control nonderepressible 2) and mechanistic target of rapamycin complex 1 (mTORC1), but how these two sensors coordinate their respective signal transduction events remains mysterious. In this study we utilized mouse genetic models to investigate the role of GCN2 in hepatic mTORC1 regulation upon amino acid stress induced by a single injection of asparaginase. We found that deletion of Gcn2 prevented hepatic phosphorylation of eukaryotic initiation factor 2 to asparaginase and instead unleashed mTORC1 activity. This change in intracellular signaling occurred within minutes and resulted in increased 5-terminal oligopyrimidine mRNA translation instead of activating transcription factor 4 synthesis. Asparaginase also promoted hepatic mRNA levels of several genes which function as mTORC1 inhibitors, and these genes were blunted or blocked in the absence of Gcn2, but their timing could not explain the early discordant effects in mTORC1 signaling. Preconditioning mice with a chemical endoplasmic reticulum stress agent before amino acid stress rescued normal mTORC1 repression in the liver of Gcn2(-/-) mice but not in livers with both Gcn2 and the endoplasmic reticulum stress kinase, Perk, deleted. Furthermore, treating wildtype and Gcn2(-/-) mice with ISRIB, an inhibitor of PERK signaling, also failed to alter hepatic mTORC1 responses to asparaginase, although administration of ISRIB alone had an inhibitory GCN2-independent effect on mTORC1 activity. Taken together, the data show that activating transcription factor 4 is not required, but eukaryotic initiation factor 2 phosphorylation is necessary to prevent mTORC1 activation during amino acid stress.	[Nikonorova, Inna A.; Mirek, Emily T.; Signore, Christina C.; Goudie, Michael P.; Anthony, Tracy G.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Rutgers State University New Brunswick; Indiana University System; Indiana University Bloomington	Anthony, TG (corresponding author), 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tracy.anthony@rutgers.edu		Nikonorova, Inna/0000-0001-8498-848X; Mirek, Emily/0000-0002-9683-8216	National Institutes of Health [HD070487, DK109714]; Institutional Research and Academic Career Development Awards (IRACDA) New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health postdoctoral training Grant [K12GM093854]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research and Academic Career Development Awards (IRACDA) New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health postdoctoral training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HD070487 (to T. G. A.) and DK109714 (to T. G. A. and R. C. W.). This work was also supported by Institutional Research and Academic Career Development Awards (IRACDA) New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health postdoctoral training Grant K12GM093854 (to I. A. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Al-Baghdadi RJT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01041-7; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Averous J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27698; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hadinnapola C, 2017, CIRCULATION, V136, P2022, DOI 10.1161/CIRCULATIONAHA.117.028351; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hernandez CP, 2010, BLOOD, V115, P5214, DOI 10.1182/blood-2009-12-258822; Kardos GR, 2015, MOL CANCER RES, V13, P1408, DOI 10.1158/1541-7786.MCR-15-0048; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kimball SR, 2012, BIOCHEM BIOPH RES CO, V427, P485, DOI 10.1016/j.bbrc.2012.09.074; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Mazor KM, 2016, AMINO ACIDS, V48, P2831, DOI 10.1007/s00726-016-2318-9; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Morrow K, 2013, LEUKEMIA, V27, P569, DOI 10.1038/leu.2012.247; Ng S, 2011, AUTOPHAGY, V7, P1173, DOI 10.4161/auto.7.10.16681; Ni Y, 2008, CANCER LETT, V261, P1, DOI 10.1016/j.canlet.2007.11.038; Nikonorova IA, 2017, J BIOL CHEM, V292, P6786, DOI [10.1074/jbc.m116.768408, 10.1074/jbc.M116.768408]; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Patil MD, 2016, ONCOGENE, V35, P4957, DOI 10.1038/onc.2016.37; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Reith RM, 2011, NEUROBIOL DIS, V43, P113, DOI 10.1016/j.nbd.2011.02.014; Sabatini DM, 2017, P NATL ACAD SCI USA, V114, P11818, DOI 10.1073/pnas.1716173114; Shan JX, 2016, NUCLEIC ACIDS RES, V44, P9719, DOI 10.1093/nar/gkw667; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1124, DOI 10.1152/ajpendo.00080.2013; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yau T, 2013, INVEST NEW DRUG, V31, P99, DOI 10.1007/s10637-012-9807-9; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	48	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5005	5015		10.1074/jbc.RA117.001625	http://dx.doi.org/10.1074/jbc.RA117.001625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449374	Green Published, hybrid			2022-12-26	WOS:000429409300005
J	Garcia-Aguilar, MC; Turrent, C; Elorriaga-Verplancken, FR; Arias-Del-Razo, A; Schramm, Y				Garcia-Aguilar, Maria C.; Turrent, Cuauhtemoc; Elorriaga-Verplancken, Fernando R.; Arias-Del-Razo, Alejandro; Schramm, Yolanda			Climate change and the northern elephant seal (Mirounga angustirostris) population in Baja California, Mexico	PLOS ONE			English	Article							SURFACE-TEMPERATURE; COASTAL CALIFORNIA; HALICHOERUS-GRYPUS; PHOCA-VITULINA; PUP PRODUCTION; IMPACT; PINNIPEDS; BEHAVIOR; ISLANDS; OCEAN	The Earth's climate is warming, especially in the mid- and high latitudes of the Northern Hemisphere. The northern elephant seal (Mirounga angustirostris) breeds and haul-outs on islands and the mainland of Baja California, Mexico, and California, U.S.A. At the beginning of the 21st century, numbers of elephant seals in California are increasing, but the status of Baja California populations is unknown, and some data suggest they may be decreasing. We hypothesize that the elephant seal population of Baja California is experiencing a decline because the animals are not migrating as far south due to warming sea and air temperatures. Here we assessed population trends of the Baja California population, and climate change in the region. The numbers of northern elephant seals in Baja California colonies have been decreasing since the 1990s, and both the surface waters off Baja California and the local air temperatures have warmed during the last three decades. We propose that declining population sizes may be attributable to decreased migration towards the southern portions of the range in response to the observed temperature increases. Further research is needed to confirm our hypothesis; however, if true, it would imply that elephant seal colonies of Baja California and California are not demographically isolated which would pose challenges to environmental and management policies between Mexico and the United States.	[Garcia-Aguilar, Maria C.] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanol Biol, Ensenada, Baja California, Mexico; [Turrent, Cuauhtemoc] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanol Fis, Ensenada, Baja California, Mexico; [Elorriaga-Verplancken, Fernando R.] Inst Politecn Nacl, Dept Pesquerias & Biol Marina, Ctr Interdisciplinario Ciencias Marinas, La Paz, Baja California, Mexico; [Arias-Del-Razo, Alejandro] Univ Americas Puebla, Dept Ciencias Quim Biol, Cholula, Mexico; [Schramm, Yolanda] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Instituto Politecnico Nacional - Mexico; Universidad Americas Puebla (UDLAP); Universidad Autonoma de Baja California	Garcia-Aguilar, MC (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Oceanol Biol, Ensenada, Baja California, Mexico.	gaguilar@cicese.mx		Arias Del Razo, Alejandro/0000-0002-0422-682X; Turrent, Cuauhtemoc/0000-0003-2058-8115; Garcia-Aguilar, M. Concepcion/0000-0002-7451-9361; Schramm, Yolanda/0000-0001-6951-4884				Abadia-Cardoso A., 2006, THESIS; Abadia-Cardoso A, 2017, J HERED, V108, P618, DOI 10.1093/jhered/esx053; Arias-Del Razo A, 2017, AQUAT MAMM, V43, P40, DOI 10.1578/AM.43.1.2017.40; BONNELL ML, 1974, SCIENCE, V184, P908, DOI 10.1126/science.184.4139.908; Carretta JV, 2016, 577 NOAA, V577; Casten RF, 2005, AIP CONF PROC, V769, P27, DOI 10.1063/1.1944951; Caughley G., 1997, ANAL VERTEBRATE POPU; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Codde SA, 2016, J THERM BIOL, V61, P98, DOI 10.1016/j.jtherbio.2016.09.001; Condit R, 2007, MAR MAMMAL SCI, V23, P834, DOI 10.1111/j.1748-7692.2007.00141.x; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Crocker DE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P11, DOI 10.1086/663634; Elorriaga-Verplancken FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155034; Elorriaga-Verplancken FR, 2015, CIENC MAR, V41, P269, DOI 10.7773/cm.v41i4.2545; Elorriaga-Verplancken FR, MAR MAMM SC IN PRESS; Emery W. J., 2004, DATA ANAL METHODS PH, V2nd; Ferguson SH, 2005, MAR MAMMAL SCI, V21, P121, DOI 10.1111/j.1748-7692.2005.tb01212.x; Fischbach AS, 2009, 20091291 US DEP INT; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Franco-Ortiz M., 2012, THESIS; Garcia-Aguilar M. C., 2005, THESIS; Garcia-Aguilar MC, 2004, AQUAT MAMM, V27, P92; Hammill MO, 1998, CAN J FISH AQUAT SCI, V55, P423, DOI 10.1139/cjfas-55-2-423; Hansen S, 1997, PHYSIOL ZOOL, V70, P436, DOI 10.1086/515849; HANSEN S, 1995, PHYSIOL ZOOL, V68, P290, DOI 10.1086/physzool.68.2.30166505; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Hoezel AR, 2002, J EVOLUTION BIOL, V15, P567; Huckstadt L., 2015, IUCN RED LIST THREAT; Ivarez-Coronado GC, 2003, THESIS; Junak S.A., 2000, P 5 CALIFORNIA ISLAN, P235; Junak S, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P229; Kawai Y, 2007, J OCEANOGR, V63, P721, DOI 10.1007/s10872-007-0063-0; Kendall M.G., 1975, RANK CORRELATION MEA; Khamas WA, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-46; Kovacs KM, 2012, MAR MAMMAL SCI, V28, P414, DOI 10.1111/j.1748-7692.2011.00479.x; Le Boeuf B.J., 1975, Transactions San Diego Soc Nat Hist, V18, P1; Le Boeuf Burney J., 1994, P1; Lebassi B, 2009, J CLIMATE, V22, P3558, DOI 10.1175/2008JCLI2111.1; LEBOEUF BJ, 1978, J MAMMAL, V59, P621, DOI 10.2307/1380241; Libiseller C, 2002, ENVIRONMETRICS, V13, P71, DOI 10.1002/env.507; Lowry MS, 2014, AQUAT MAMM, V40, P20, DOI 10.1578/AM.40.1.2014.20; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McDonald BI, 2006, PHYSIOL BIOCHEM ZOOL, V79, P484, DOI 10.1086/501056; Messie M, 2011, J CLIMATE, V24, P4314, DOI 10.1175/2011JCLI3941.1; Nemani RR, 2001, CLIMATE RES, V19, P25, DOI 10.3354/cr019025; Newman M, 2016, J CLIMATE, V29, P4399, DOI 10.1175/JCLI-D-15-0508.1; Pachauri R.K., 2014, CONTRIBUTION WORKING; RICE DALE W., 1965, TRANS SAN DIEGO SOC NATUR HIST, V14, P73; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Rothery P., 1987, Symposia of the Zoological Society of London, P211; Salogni E, 2016, MAR MAMMAL SCI, V32, P743, DOI 10.1111/mms.12273; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stewart Brent S., 1994, P29; STEWART BS, 1995, J MAMMAL, V76, P196, DOI 10.2307/1382328; TRITES AW, 1990, FUNCT ECOL, V4, P753, DOI 10.2307/2389442; Van Boeckel TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049528; WHITE FN, 1971, J MAMMAL, V52, P758, DOI 10.2307/1378924	58	7	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193211	10.1371/journal.pone.0193211	http://dx.doi.org/10.1371/journal.pone.0193211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447288	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900119
J	Han, KC; Park, JH; Yang, SG; Lee, DH; Tsauo, J; Kim, KY; Kim, MT; Gang, SG; Kim, DK; Kim, DH; Song, HY				Han, Kichang; Park, Jung-Hoon; Yang, Su-Geun; Lee, Deok Hee; Tsauo, Jiaywei; Kim, Kun Yung; Kim, Min Tae; Gang, Sung Gwon; Kim, Dae-Kee; Kim, Dong-Hyun; Song, Ho-Young			EW-7197 eluting nano-fiber covered self-expandable metallic stent to prevent granulation tissue formation in a canine urethral model	PLOS ONE			English	Article							I RECEPTOR KINASE; TGF-BETA; NITINOL STENTS; PLACEMENT; INHIBITOR; STRICTURES; FIBROSIS; HYPERPLASIA; OBSTRUCTION; MANAGEMENT	Purpose To evaluate an EW-7197-eluting nanofiber-covered stent (NFCS) for suppressing granulation tissue formation after stent placement in a canine urethral model. Materials and methods All experiments were approved by the committee of animal research. A total of 12 NFCSs were placed in the proximal and distal urethras of six dogs. Dogs were divided into two groups with 3 dogs each. The control stent (CS) group received NFCSs and the drug stent (DS) group received EW-7197 (1000 mu g)-eluting NFCSs. All dogs were sacrificed 8 weeks after stent placement Histologic findings of the stented urethra were compared using the Mann-Whitney U test. Results Stent placement was technically successful in all dogs without procedure-related complications. On urethrographic analysis, the mean luminal diameter was significantly larger in the DS group than in the CS group at 4 and 8 weeks after stent placement (all p < 0.001). On histological examination, mean thicknesses of the papillary projection, thickness of submucosal fibrosis, number of epithelial layers, and degree of collagen deposition were significantly lower in the DS group than in the CS group (all p < 0.001), whereas the mean degree of inflammatory cell infiltration was not significantly different (p > 0.05). Conclusion The EW-7197-eluting NFCS is effective and safe for suppressing granulation tissue formation after stent placement in a canine urethral model.	[Han, Kichang] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea; [Park, Jung-Hoon; Lee, Deok Hee; Tsauo, Jiaywei; Kim, Kun Yung; Kim, Min Tae; Gang, Sung Gwon; Song, Ho-Young] Univ Ulsan, Dept Radiol, Res Inst Radiol, Asan Med Ctr,Coll Med, Seoul, South Korea; [Park, Jung-Hoon] Univ Ulsan, Dept Biomed Engn, Res Ctr, Asan Med Ctr,Coll Med, Seoul, South Korea; [Park, Jung-Hoon; Kim, Dong-Hyun] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Yang, Su-Geun] Inha Univ, Coll Med, Dept New Drug Dev, Incheon, South Korea; [Yang, Su-Geun] Inha Univ, Coll Med, WCSL, Incheon, South Korea; [Kim, Dae-Kee] Ewha Womans Univ, Coll Pharm, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Northwestern University; Feinberg School of Medicine; Inha University; Inha University; Ewha Womans University	Lee, DH (corresponding author), Univ Ulsan, Dept Radiol, Res Inst Radiol, Asan Med Ctr,Coll Med, Seoul, South Korea.; Yang, SG (corresponding author), Inha Univ, Coll Med, Dept New Drug Dev, Incheon, South Korea.; Yang, SG (corresponding author), Inha Univ, Coll Med, WCSL, Incheon, South Korea.	Sugeun.Yang@Inha.ac.kr; dhlee@amc.seoul.kr	Park, Jung-Hoon/ABI-7964-2020	Park, Jung-Hoon/0000-0001-9114-7750; Han, Kichang/0000-0002-9701-9757; Lee, Deok Hee/0000-0003-0355-0449	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2017R1A2A2A07001272]; WCSL (World Class Smart Lab); Asan Institute of Life Sciences, Asan Medical Center, Seoul, Korea [2016-329]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; WCSL (World Class Smart Lab); Asan Institute of Life Sciences, Asan Medical Center, Seoul, Korea	This work was supported by 1. Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2017R1A2A2A07001272) (Su-Geun Yang); 2. WCSL (World Class Smart Lab) research grant directed by Inha Univeristy (Su-Geun Yang); 3. Research Grant (2016-329) from the Asan Institute of Life Sciences, Asan Medical Center, Seoul, Korea (Deok Hee Lee). The funders had no role in this study.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Choi EK, 2007, AM J ROENTGENOL, V189, P1517, DOI 10.2214/AJR.07.2149; Culha M, 2014, INT J CLIN EXP MED, V7, P3415; Hohn AN, 2008, GASTROINTEST ENDOSC, V67, P20, DOI 10.1016/j.gie.2007.04.031; Jin CH, 2014, J MED CHEM, V57, P4213, DOI 10.1021/jm500115w; Jordan GH, 2013, J UROLOGY, V190, P130, DOI 10.1016/j.juro.2013.01.014; Jun EJ, 2017, GASTROINTEST ENDOSC, V86, P219, DOI 10.1016/j.gie.2017.01.013; Karagiannidis C, 2006, CHEST, V129, P1298, DOI 10.1378/chest.129.5.1298; Kim EY, 2013, RADIOLOGY, V267, P396, DOI 10.1148/radiol.12120361; Kim JH, 2010, RADIOLOGY, V255, P75, DOI 10.1148/radiol.09090670; Kim MJ, 2016, CELL PHYSIOL BIOCHEM, V38, P571, DOI 10.1159/000438651; Kim SY, 2014, BIOMED MICRODEVICES, V16, P897, DOI 10.1007/s10544-014-9894-9; Ko GY, 2002, RADIOLOGY, V223, P83, DOI 10.1148/radiol.2231010734; Krishnaiah M, 2015, BIOORG MED CHEM LETT, V25, P5228, DOI 10.1016/j.bmcl.2015.09.058; Liu W, 2004, CURR GENE THER, V4, P123, DOI 10.2174/1566523044578004; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Moon S, 2011, BIOMATERIALS, V32, P3603, DOI 10.1016/j.biomaterials.2011.01.070; Na HK, 2012, AM J ROENTGENOL, V198, pW55, DOI 10.2214/AJR.11.6792; Park CG, 2011, MACROMOL RES, V19, P1210, DOI 10.1007/s13233-011-1112-5; Park JH, 2016, EUR RADIOL, V26, P4249, DOI 10.1007/s00330-016-4289-3; Park JH, 2014, J VASC INTERV RADIOL, V25, P1257, DOI 10.1016/j.jvir.2014.03.023; Park JH, 2012, AM J ROENTGENOL, V199, P1380, DOI 10.2214/AJR.10.6306; Park SA, 2015, CELL MOL LIFE SCI, V72, P2023, DOI 10.1007/s00018-014-1798-6; Shin JH, 2005, EUR RADIOL, V15, P1241, DOI 10.1007/s00330-004-2564-1; Shin JH, 2005, RADIOLOGY, V234, P438, DOI 10.1148/radiol.2342040006; Song HY, 2003, RADIOLOGY, V226, P433, DOI 10.1148/radiol.2262012160; SONG HY, 1994, RADIOLOGY, V193, P689, DOI 10.1148/radiology.193.3.7526414; Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192430	10.1371/journal.pone.0192430	http://dx.doi.org/10.1371/journal.pone.0192430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447198	Green Submitted, Green Published, gold			2022-12-26	WOS:000425283900033
J	Sampson, C; Covaci, AD; Hamilton, JGC; Hassan, N; Al-Zaidi, S; Kirk, WDJ				Sampson, Clare; Covaci, Anca D.; Hamilton, James G. C.; Hassan, Nayem; Al-Zaidi, Shakir; Kirk, William D. J.			Reduced translucency and the addition of black patterns increase the catch of the greenhouse whitefly, Trialeurodes vaporariorum, on yellow sticky traps	PLOS ONE			English	Article							FRANKLINIELLA-OCCIDENTALIS THYSANOPTERA; BEMISIA-TABACI HOMOPTERA; THRIPS THYSANOPTERA; MUSCA-DOMESTICA; ALEYRODIDAE; APHIDS; RESPONSES; BEHAVIOR; COLOR; SIZE	The greenhouse whitefly Trialeurodes vaporariorum (Westwood) (Hemiptera: Aleyrodidae) is a pest of a wide range of vegetable and ornamental crops in greenhouses around the world. Yellow sticky traps are highly attractive to flying adults and so are frequently used to monitor the pest. Our aim was to test whether changes in trap translucency or the addition of printed black patterns could increase the catch on yellow sticky traps in greenhouses. Field trials were carried out in commercial crops of strawberry and tomato under glass over three years. Reduced trap translucency increased trap catches by a factor of 1.5 to 7.0 and the catch increased significantly for both females and males. Spectrometer measurements showed that the increased catch was consistent with an increased landing stimulus from a colour opponency mechanism i.e. the ratio of energy from 500-640 nm to the energy from 300-500 nm. Printed black patterns increased trap catches on specific types of trap, by a factor of 1.4 to 2.3, and the catch increased significantly for both females and males. The patterns increased trap catch on moderately translucent traps, but decreased trap catch on less translucent traps. The evidence points to a contrast/edge effect of pattern, but laboratory experiments are needed to clarify this. Exploitation of these translucency and pattern effects could improve the efficacy of yellow traps for monitoring and mass trapping in crops.	[Sampson, Clare; Covaci, Anca D.; Kirk, William D. J.] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Huxley Bldg, Newcastle Under Lyme, Staffs, England; [Sampson, Clare; Hassan, Nayem; Al-Zaidi, Shakir] Russell IPM Ltd, Deeside Ind Pk, Deeside, Flint, Wales; [Hamilton, James G. C.] Univ Lancaster, Div Biomed & Life Sci, Lancaster, England	Keele University; Lancaster University	Kirk, WDJ (corresponding author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Huxley Bldg, Newcastle Under Lyme, Staffs, England.	w.d.j.kirk@keele.ac.uk	Hamilton, Gordon/AAA-6960-2022; Hassan, Nayem/ABD-2271-2021	hamilton, james/0000-0001-6678-0765; hamilton, james/0000-0001-9196-8516; Kirk, William/0000-0001-8586-4518	Innovate UK [KTP009757]; Russell IPM Ltd.; Russell IPM Ltd	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Russell IPM Ltd.; Russell IPM Ltd	The work was funded by a Knowledge Transfer Partnership (KTP009757) from Innovate UK (https://www.gov.uk/government/organisations/innovate-uk) awarded to WDJK and JGCH. It was co-funded by the Company Partner, Russell IPM Ltd. NH is an employee of Russell IPM Ltd. CS became an employee of Russell IPM Ltd in October 2016. SA is the managing director and part-owner of Russell IPM Ltd. Russell IPM Ltd provided support in the form of salaries for authors NH, SA and CS, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Russell IPM Ltd could object to publication if it were prejudicial to intellectual property or commercial interests. No objections were raised.	AFFELDT HA, 1983, J ECON ENTOMOL, V76, P1405, DOI 10.1093/jee/76.6.1405; Bernays EA, 1994, HOST PLANT SELECTION; Bockmann E, 2015, J PEST SCI, V88, P439, DOI 10.1007/s10340-014-0601-7; BYRNE DN, 1990, WHITEFLIES : THEIR BIONOMICS, PEST STATUS AND MANAGEMENT, P227; Chapman JW, 1999, MED VET ENTOMOL, V13, P132, DOI 10.1046/j.1365-2915.1999.00147.x; Chu CC, 2003, J ECON ENTOMOL, V96, P543, DOI 10.1603/0022-0493-96.3.543; COOMBE PE, 1981, J COMP PHYSIOL, V144, P83, DOI 10.1007/BF00612801; Coombe PE, 1981, THESIS; COSTA CL, 1967, ENTOMOL EXP APPL, V10, P485, DOI 10.1007/BF00430072; Darshanee HLC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01285; Diclaro JW, 2012, J MED ENTOMOL, V49, P94, DOI 10.1603/ME10257; DISNEY R H L, 1982, Field Studies, V5, P607; Doring TF, 2016, ANN APPL BIOL, V168, P421, DOI 10.1111/aab.12273; Doring TF, 2007, ARTHROPOD-PLANT INTE, V1, P3, DOI 10.1007/s11829-006-9000-1; GILLESPIE DR, 1992, CAN ENTOMOL, V124, P907, DOI 10.4039/Ent124907-5; GILLESPIE DR, 1990, J ECON ENTOMOL, V83, P971, DOI 10.1093/jee/83.3.971; Gratwick M, 1992, CROP PESTS UK COLLEC, P490; HANRAHAN P, 1993, ACM C COMP GRAPH INT, V20, P165, DOI DOI 10.1145/166117.166139; HARDIE J, 1989, J INSECT PHYSIOL, V35, P619, DOI 10.1016/0022-1910(89)90124-8; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; Kaas J.P., 2005, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V16, P109; KENNEDY JS, 1961, ANN APPL BIOL, V49, P1, DOI 10.1111/j.1744-7348.1961.tb03587.x; Kim S, 2011, CROP PROT, V30, P508, DOI 10.1016/j.cropro.2010.12.016; KIRK WDJ, 1984, ECOL ENTOMOL, V9, P35, DOI 10.1111/j.1365-2311.1984.tb00696.x; KIRK WDJ, 1987, J AUST ENTOMOL SOC, V26, P299; LIU TX, 1994, J ENTOMOL SCI, V29, P222, DOI 10.18474/0749-8004-29.2.222; Lloyd L., 1921, Bulletin of Entomological Research London, V12, P355, DOI 10.1017/S0007485300040220; Lu YS, 2012, OXID MED CELL LONGEV, V2012, DOI [10.1155/2012/740280, 10.1155/2012/489690]; MACDOWALL FD, 1972, CAN ENTOMOL, V104, P299, DOI 10.4039/Ent104299-3; Mainali BP, 2010, APPL ENTOMOL ZOOL, V45, P207, DOI 10.1303/aez.2010.207; Mellor HE, 1997, ENTOMOL EXP APPL, V83, P11, DOI 10.1023/A:1002940410960; Moericke V., 1966, Zeitschrift fuer Pflanzenkrankheiten Pflanzenpathologie und Pflanzenschutz, V73, P6; Pinto-Zevallos DM, 2013, CROP PROT, V47, P74, DOI 10.1016/j.cropro.2013.01.009; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Steiner MY, 1999, AUST J ENTOMOL, V38, P367, DOI 10.1046/j.1440-6055.1999.00114.x; Stukenberg N, 2015, J APPL ENTOMOL, V139, P268, DOI 10.1111/jen.12172; VAISHAMPAYAN SM, 1975, ENTOMOL EXP APPL, V18, P412, DOI 10.1007/BF00304644; VAISHAMPAYAN SM, 1975, ENTOMOL EXP APPL, V18, P344, DOI 10.1007/BF00628364; VERNON R S, 1990, Journal of the Entomological Society of British Columbia, V87, P38; VERNON RS, 1990, ENVIRON ENTOMOL, V19, P1229, DOI 10.1093/ee/19.5.1229; VERNON RS, 1995, J ECON ENTOMOL, V88, P288, DOI 10.1093/jee/88.2.288; Vrdoljak SM, 2012, J INSECT CONSERV, V16, P345, DOI 10.1007/s10841-011-9420-9; Walker Gregory P., 2010, P109; WEBB RE, 1985, CROP PROT, V4, P381, DOI 10.1016/0261-2194(85)90042-0	45	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193064	10.1371/journal.pone.0193064	http://dx.doi.org/10.1371/journal.pone.0193064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447272	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000425283900106
J	Bicknell, RDC; Klinkhamer, AJ; Flavel, RJ; Wroe, S; Paterson, JR				Bicknell, Russell D. C.; Klinkhamer, Ada J.; Flavel, Richard J.; Wroe, Stephen; Paterson, John R.			A 3D anatomical atlas of appendage musculature in the chelicerate arthropod Limulus polyphemus	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; SOFT-TISSUE ANATOMY; HORSESHOE-CRAB; 3-DIMENSIONAL VISUALIZATION; PHYLOGENETIC IMPLICATIONS; WALKING LEGS; MORPHOLOGY; GASTROPODA; SYSTEMATICS; XIPHOSURA	Limulus polyphemus, an archetypal chelicerate taxon, has interested both biological and paleontological researchers due to its unique suite of anatomical features and as a useful modern analogue for fossil arthropod groups. To assist the study and documentation of this iconic taxon, we present a 3D atlas on the appendage musculature, with specific focus on the muscles of the cephalothoracic appendages. As L. polyphemus appendage musculature has been the focus of extensive study, depicting the muscles in 3D will facilitate a more complete understanding thereof for future researchers. A large museum specimen was CT scanned to illustrate the major exoskeletal features of L. polyphemus. Micro-CT scans of iodine-stained appendages from fresh, non-museum specimens were digitally dissected to interactively depict appendage sections and muscles. This study has revealed the presence of two new muscles: one within the pushing leg, located dorsally relative to all other patella muscles, and the other within the male pedipalp, located in the modified tibiotarsus. This atlas increases accessibility to important internal and external morphological features of L. polyphemus and reduces the need for destructive fresh tissue dissection of specimens. Scanning, digitally dissecting, and documenting taxa in 3D is a pivotal step towards creating permanent digital records of life on Earth.	[Bicknell, Russell D. C.; Paterson, John R.] Univ New England, Sch Environm & Rural Sci, Palaeosci Res Ctr, Armidale, NSW, Australia; [Klinkhamer, Ada J.; Wroe, Stephen] Univ New England, Sch Environm & Rural Sci, Palaeosci Res Ctr, FEARLab, Armidale, NSW, Australia; [Flavel, Richard J.] Univ New England, Sch Environm & Rural Sci, Agron & Soil Sci, Armidale, NSW, Australia	University of New England; University of New England; University of New England	Bicknell, RDC (corresponding author), Univ New England, Sch Environm & Rural Sci, Palaeosci Res Ctr, Armidale, NSW, Australia.	rdcbicknell@gmail.com	Flavel, Richard/I-6100-2016	Paterson, John/0000-0003-2947-3912; Bicknell, Russell/0000-0001-8541-9035; Flavel, Richard/0000-0001-7867-2104; Wroe, Stephen/0000-0002-6365-5915	Australian Postgraduate Award; Australian Research Council Future Fellowship [FT120100770]	Australian Postgraduate Award(Australian Government); Australian Research Council Future Fellowship(Australian Research Council)	This research is supported by funding from an Australian Postgraduate Award (to RDCB) and an Australian Research Council Future Fellowship (FT120100770 to JRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank: Dean Woods and Malcolm Lambert for granting us access to the chemicals needed for iodine staining; Vera Weisbecker for her information on approaches to iodine staining; and Jason Dunlop and an anonymous referee for their helpful reviews. This research is supported by funding from an Australian Postgraduate Award (to RDCB) and an Australian Research Council Future Fellowship (FT120100770 to JRP).	Baeumler N, 2008, ZOOSYMPOSIA, V1, P101, DOI 10.11646/zoosymposia.1.1.9; BARTHEL KW, 1974, NATURWISSENSCHAFTEN, V61, P428, DOI 10.1007/BF00597201; Battelle BA, 2006, ARTHROPOD STRUCT DEV, V35, P261, DOI 10.1016/j.asd.2006.07.002; Beutel RG, 2008, ARTHROPOD STRUCT DEV, V37, P418, DOI 10.1016/j.asd.2008.02.002; Bock C, 2001, MAGN RESON IMAGING, V19, P1113, DOI 10.1016/S0730-725X(01)00414-3; Botton Mark L., 2003, P133; BOTTON ML, 1984, MAR BIOL, V81, P199, DOI 10.1007/BF00393118; Brenzinger B, 2013, ORG DIVERS EVOL, V13, P33, DOI 10.1007/s13127-012-0093-3; Deans AR, 2012, INVERTEBR SYST, V26, P323, DOI 10.1071/IS12063; Dietl J, 2000, ESTUARIES, V23, P509, DOI 10.2307/1353142; Dunlop JA, 2017, ARTHROPOD STRUCT DEV, V46, P395, DOI 10.1016/j.asd.2016.05.002; EAGLES DA, 1973, COMP BIOCHEM PHYSIOL, V46, P391, DOI 10.1016/0300-9629(73)90428-3; Engelhorn T, 2009, NEUROSCI LETT, V458, P28, DOI 10.1016/j.neulet.2009.04.033; FAHRENBACH WH, 1999, MICROSCOPIC ANATOM A, V8, P21; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fernandez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096617; FOURTNER CR, 1972, CAN J ZOOLOG, V50, P1447, DOI 10.1139/z72-193; Gerhart SD, FISH AND WILDLIFE RE; Gignac PM, 2014, J EXP ZOOL PART B, V322, P166, DOI 10.1002/jez.b.22561; Godfray HCJ, 2007, SYST BIOL, V56, P943, DOI 10.1080/10635150701777521; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Grabe V, 2015, J COMP NEUROL, V523, P530, DOI 10.1002/cne.23697; Haszprunar G, 2011, ORG DIVERS EVOL, V11, P201, DOI 10.1007/s13127-011-0048-0; HAYES WF, 1967, J EXP ZOOL, V165, P195, DOI 10.1002/jez.1401650205; Holliday CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062806; Klaus AV, 2003, J MICROSC-OXFORD, V212, P107, DOI 10.1046/j.1365-2818.2003.01235.x; Lankester E. R., 1881, Q J MICROSC SCI, V21, P504; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lautenschlager S, 2014, PALAEONTOL Z, V88, P111, DOI 10.1007/s12542-013-0184-2; Lehmann T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030474; LEVINE RJC, 1991, J CELL BIOL, V113, P563, DOI 10.1083/jcb.113.3.563; MANTON SM, 1964, PHILOS T ROY SOC B, V247, P1, DOI 10.1098/rstb.1964.0001; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Michels J, 2012, J MICROSC-OXFORD, V245, P1, DOI 10.1111/j.1365-2818.2011.03523.x; Neusser TP, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-20; Owen R., 1872, T LINN SOC LOND, V28, P459, DOI DOI 10.5962/BHL.TITLE.11275; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pohlmann A, 2007, MAGN RESON IMAGING, V25, P129, DOI 10.1016/j.mri.2006.08.019; PRINGLE JWS, 1956, J EXP BIOL, V33, P658; Quayle MR, 2014, PEERJ, V2, DOI 10.7717/peerj.355; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Ruthensteiner B, 2010, J MOLLUS STUD, V76, P323, DOI 10.1093/mollus/eyq013; SCHOLL G, 1977, ZOOMORPHOLOGIE, V86, P99; SELDEN P A, 1981, Transactions of the Royal Society of Edinburgh Earth Sciences, V72, P9; Sharp AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117730; SHULTZ JW, 1989, ZOOL J LINN SOC-LOND, V97, P1, DOI 10.1111/j.1096-3642.1989.tb00552.x; Shultz JW, 2001, J ARACHNOL, V29, P283, DOI 10.1636/0161-8202(2001)029[0283:GMAOLP]2.0.CO;2; Smith SA, 2005, LAB ANIMAL, V34, P27, DOI 10.1038/laban0705-27; Snodgrass R.E., 1952, TXB ARTHROPOD ANATOM; Suzuki Y, 2008, ACTA PALAEONTOL POL, V53, P275, DOI 10.4202/app.2008.0208; van der Hammen L, 1986, ZOOL VERH, V226, P1; Vortsepneva E, 2013, ZOOMORPHOLOGY, V132, P359, DOI 10.1007/s00435-013-0199-y; WARD DV, 1969, BIOL BULL, V136, P288, DOI 10.2307/1539821; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; WYSE GA, 1971, Z VERGL PHYSIOL, V73, P249, DOI 10.1007/BF00297675; Wyse GA, 2010, CURR ZOOL, V56, P537, DOI 10.1093/czoolo/56.5.537; Xavier JC, 2015, J MAR BIOL ASSOC UK, V95, P999, DOI 10.1017/S0025315414000782; Yamasaki T., 1988, P69; Yamasaki T., 1988, P10; Zacai A, 2016, ARTHROPOD STRUCT DEV, V45, P200, DOI 10.1016/j.asd.2015.09.003; Ziegler A, 2011, ZOOMORPHOLOGY, V130, P227, DOI 10.1007/s00435-011-0138-8; Ziegler A, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-33	62	30	31	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191400	10.1371/journal.pone.0191400	http://dx.doi.org/10.1371/journal.pone.0191400			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444161	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500016
J	Ferro, JM; Cardozo, DE; Suarez, P; Boeris, JM; Blasco-Zuniga, A; Barbero, G; Gomes, A; Gazoni, T; Costa, W; Nagamachi, CY; Rivera, M; Parise-Maltempi, PP; Wiley, JE; Pieczarka, JC; Haddad, CFB; Faivovich, JAN; Baldo, D				Ferro, Juan M.; Cardozo, Dario E.; Suarez, Pablo; Boeris, Juan M.; Blasco-Zuniga, Ailin; Barbero, Gaston; Gomes, Anderson; Gazoni, Thiago; Costa, William; Nagamachi, Cleusa Y.; Rivera, Miryan; Parise-Maltempi, Patricia P.; Wiley, John E.; Pieczarka, Julio C.; Haddad, Celio F. B.; Faivovich, Julia A. N.; Baldo, Diego			Chromosome evolution in Cophomantini (Amphibia, Anura, Hylinae)	PLOS ONE			English	Article							SPECIES GROUP ANURA; NUCLEOLUS ORGANIZER REGIONS; CYTOGENETIC ANALYSIS; SEX-CHROMOSOMES; CONSERVED KARYOTYPES; TREE FROGS; LEIOPELMA-HOCHSTETTERI; HYLOSCIRTUS ANURA; B CHROMOSOMES; HYLIDAE	The hylid tribe Cophomantini is a diverse clade of Neotropical treefrogs composed of the genera Aplastodiscus, Boana, Bokermannohyla, Hyloscirtus, and Myersiohyla. The phylo-genetic relationships of Cophomantini have been comprehensively reviewed in the literature, providing a suitable framework for the study of chromosome evolution. Employing different banding techniques, we studied the chromosomes of 25 species of Boana and 3 of Hyloscirtus; thus providing, for the first time, data for Hyloscirtus and for 15 species of Boana. Most species showed karyotypes with 2n = 2x = 24 chromosomes; some species of the B. albopunctata group have 2n = 2x = 22, and H. alytolylax has 2n = 2x = 20. Karyotypes are all bi-armed in most species presented, with the exception of H. larinopygion (FN = 46) and H. alytolylax (FN = 38), with karyotypes that have a single pair of small telocentric chromosomes. In most species of Boana, NORs are observed in a single pair of chromosomes, mostly in the small chromosomes, although in some species of the B. albopunctata, B. pulchella, and B. semilineata groups, this marker occurs on the larger pairs 8, 1, and 7, respectively. In Hyloscirtus, NOR position differs in the three studied species: H. alytolylax (4p), H. palmeri (4q), and H. larinopygion (1p). Heterochromatin is a variable marker that could provide valuable evidence, but it would be necesserary to understand the molecular composition of the C-bands that are observed in different species in order to test its putative homology. In H. alytolylax, a centromeric DAPI+band was observed on one homologue of chromosome pair 2. The band was present in males but absent in females, providing evidence for an XX/XY sex determining system in this species. We review and discuss the importance of the different chromosome markers (NOR position, C-bands, and DAPI/CMA(3) patterns) for their impact on the taxonomy and karyotype evolution in Cophomantini.	[Ferro, Juan M.; Cardozo, Dario E.; Boeris, Juan M.; Baldo, Diego] Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, UNaM, Lab Genet Evolut,Inst Biol Subtrop,CONICET, Posadas, Misiones, Argentina; [Suarez, Pablo] UNaM, CONICET, Inst Biol Subtrop, Puerto Iguazu, Misiones, Argentina; [Blasco-Zuniga, Ailin; Rivera, Miryan] Pontificia Univ Catolica Ecuador, Ctr Invest Salud Amer Latina CISeAL, LICBA, Quito, Ecuador; [Barbero, Gaston] Univ Maimonides, CONICET, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina; [Gomes, Anderson] Inst Fed Educ Ciencia & Tecnol Para, Abaetetuba, Para, Brazil; [Gazoni, Thiago; Parise-Maltempi, Patricia P.] UNESP Univ Estadual Paulista, Inst Biociencias, Dept Biol, Campus Rio Claro, Sao Paulo, Brazil; [Costa, William] UNICAMP Univ Estadual Campinas, Inst Biol, Dept Biol Estrutural & Func, Campinas, SP, Brazil; [Nagamachi, Cleusa Y.; Pieczarka, Julio C.] Univ Fed Para, Inst Ciencias Biol, Lab Citogenet, Ctr Estudos Avancados Biodiversidade, Belem, Para, Brazil; [Wiley, John E.] East Carolina Univ, Brody Sch Med, Greenville, NC USA; [Haddad, Celio F. B.] UNESP Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [Haddad, Celio F. B.] UNESP Univ Estadual Paulista, Ctr Aquicultura, Inst Biociencias, Sao Paulo, Brazil; [Faivovich, Julia A. N.] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Naturales Bernardino Riv, Div Herpetol, Buenos Aires, DF, Argentina; [Faivovich, Julia A. N.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pontificia Universidad Catolica del Ecuador; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Federal do Para; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do Para; University of North Carolina; East Carolina University; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Baldo, D (corresponding author), Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, UNaM, Lab Genet Evolut,Inst Biol Subtrop,CONICET, Posadas, Misiones, Argentina.	diegobaldo@gmail.com	Faivovich, Julián/A-9887-2008; Fapesp, Biota/F-8655-2017; Cardozo, Dario/H-7118-2019; Pieczarka, Julio C/E-7585-2016; Gomes, anderson/AFO-4296-2022; Nagamachi, Cleusa/AAV-8985-2021; Haddad, Célio F. B./C-4267-2012	Fapesp, Biota/0000-0002-9887-8449; Cardozo, Dario/0000-0003-0612-2458; Pieczarka, Julio C/0000-0003-2951-8877; Haddad, Célio F. B./0000-0002-7044-5764; Pinheiro Costa, William/0000-0002-9436-1856; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734; RIVERA, MIRYAN/0000-0002-9944-7130; Faivovich, Julian/0000-0001-7157-8131; Barbero, Gaston/0000-0003-2374-235X; Blasco, Ailin/0000-0002-7318-2795; Gomes, Anderson/0000-0002-3887-3283; Ferro, Juan Martin/0000-0003-0287-5567	Agencia Nacional de Promocion Cientifica y Tecnologica [PICTS 0404/2013, 1343/2014, 1930/2014, 2035/2014, 0813/2015, 0820/2015, 2381/2015]; CONICET [PIP 11220110100889]; Sao Paulo Research Foundation (FAPESP) [2012/10000-5, 2013/50741-7]; CNPq	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DB, DC and JF thank Agencia Nacional de Promocion Cientifica y Tecnologica (PICTS 0404/2013, 1343/2014, 1930/2014, 2035/2014, 0813/2015, 0820/2015, 2381/2015). JF thanks CONICET (PIP 11220110100889). JF and CFBH thank the Sao Paulo Research Foundation (FAPESP Procs. #2012/10000-5, 2013/50741-7). CFBH was also supported with a CNPq research fellowship.	Nunes RDA, 2008, GENET MOL BIOL, V31, P982, DOI 10.1590/S1415-47572008005000024; Amaro-Ghilardi Renata Cecilia, 2006, Phyllomedusa, V5, P119; Peixoto MAA, 2015, GENETICA, V143, P729, DOI 10.1007/s10709-015-9870-1; Ananias F, 2004, HEREDITAS, V140, P42, DOI 10.1111/j.1601-5223.2004.01775.x; Anderson K., 1991, P299; Anderson Karen, 1996, Contributions to Herpetology, V12, P157; Antunes AP, 2008, COPEIA, P179, DOI 10.1643/CH-06-163; BALDISSERA FA, 1993, REV BRAS GENET, V16, P335; Baldo D, 2012, J HERPETOL, V46, P25, DOI 10.1670/10-293; Baraquet M, 2013, BAG, J. basic appl. genet., V24, P32; Barth A, 2014, CAN J ZOOL, V92, P795, DOI 10.1139/cjz-2013-0301; Berneck BVM, 2016, MOL PHYLOGENET EVOL, V97, P213, DOI 10.1016/j.ympev.2015.11.014; Berset-Brandli L, 2006, MOL BIOL EVOL, V23, P1104, DOI 10.1093/molbev/msk011; BOGART J P, 1971, Herpetologica, V27, P229; Bogart JP, 2013, CYTOGENET GENOME RES, V140, P117, DOI 10.1159/000351593; Bogart JP, 1973, EVOLUTIONARY BIOL AN, P337; Bruschi DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105608; Busin CS, 2008, GENETICA, V133, P119, DOI 10.1007/s10709-007-9189-7; Busin CS, 2000, GENETICA, V110, P131; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; Campos JRC, 2012, FOLIA BIOL-PRAGUE, V58, P144; Cardozo DE, 2011, COPEIA, P251, DOI 10.1643/CH-09-105; Carvalho K.A., 2009, Genetics and Molecular Research, V8, P1498, DOI 10.4238/vol8-4gmr697; Carvalho KA, 2009, CYTOGENET GENOME RES, V126, P359, DOI 10.1159/000264179; Carvalho MA, 2014, GENET MOL RES, V13, P7826, DOI 10.4238/2014.September.26.21; Catroli G. F., 2009, Publicatio UEPG - Ciencias Biologicas e da Saude, V15, P67, DOI 10.5212/Publ.Biologicas.v.15i1.067086; Catroli GF, 2011, J HERPETOL, V45, P120, DOI 10.1670/09-249.1; Coloma LA, 2012, ZOOTAXA, P1; De Carvalho TR, 2010, ZOOTAXA, P37; de Mattos TL, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-43; de Oliveira HHP, 2012, ESTUDOS, V339, P123; Dobigny G, 2004, SYST BIOL, V53, P470, DOI 10.1080/10635150490445698; Donnellan SC, 2004, AUST J ZOOL, V52, P1, DOI 10.1071/ZO02069; Dubois Alain, 2017, Bionomina, V11, P1, DOI 10.11646/bionomina.11.1.1; DUELLMAN WE, 1967, SYST ZOOL, V16, P38, DOI 10.2307/2411514; Duellman WE, 2001, HYLID FROGS MIDDLE A; DUELLMAN WILLIAM E., 1965, SYST ZOOL, V14, P139, DOI 10.2307/2411738; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Duellman William E., 1997, Scientific Papers Natural History Museum University of Kansas, V3, P1; Dufresnes C, 2015, MOL BIOL EVOL, V32, P2328, DOI 10.1093/molbev/msv113; Faivovich J, 2004, MOL PHYLOGENET EVOL, V32, P938, DOI 10.1016/j.ympev.2004.03.008; Faivovich J, 2005, B AM MUS NAT HIST, V11, P10; Faivovich J, 2006, COPEIA, P785; Faivovich J, 2013, AM MUS NOVIT, P1; Faivovich J, 2009, HERPETOLOGICA, V65, P303, DOI 10.1655/0018-0831-65.3.303; Ferro JM, 2012, HERPETOLOGICA, V68, P482, DOI 10.1655/HERPETOLOGICA-D-12-00020; FORMAS JR, 1994, J HERPETOL, V28, P394, DOI 10.2307/1564546; Fouquet A, 2016, ZOOTAXA, V4084, P79, DOI 10.11646/zootaxa.4084.1.3; Frost DR, AMPHIBIAN SPECIES WO; Garcia PCA, 2007, COPEIA, P933; Gatto KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156176; Gazoni T, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-109; Goloboff P, 2008, CLADISTICS, V24, P91; Grant T, 2017, S AM J HERPETOL, V12, pS1, DOI 10.2994/SAJH-D-17-00017.1; Green David M., 2007, Amphibian Biology, V7, P2757; GREEN DM, 1988, CHROMOSOMA, V97, P55, DOI 10.1007/BF00331795; GREEN DM, 1984, NEW ZEAL J ZOOL, V11, P457, DOI 10.1080/03014223.1984.10428261; Green DM, 1990, AMPHIBIAN CYTOGENETI, P431; Gruber SL, 2007, GENETICA, V130, P281, DOI 10.1007/s10709-006-9105-6; Gruber SL, 2014, COMP CYTOGENET, V8, P185, DOI 10.3897/CompCytogen.v8i3.7771; Gruber SL, 2012, COMP CYTOGENET, V6, P409, DOI 10.3897/CompCytogen.v6i4.3945; Gruber SL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-75; Gruber SL, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-28; Gruber SL, 2005, FOLIA BIOL-PRAGUE, V51, P68; Guayasamin Juan M., 2015, Neotropical Biodiversity, V1, P2, DOI 10.1080/23766808.2015.1074407; Hernandez-Guzman J, 2011, REV BIOL TROP, V59, P355; HOOGMOED M S, 1990, Zoologische Mededelingen (Leiden), V64, P71; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; KING M, 1980, CHROMOSOMA, V80, P191, DOI 10.1007/BF00286300; King M., 1990, ANIMAL CYTOGENETICS; Kohler J, 2010, ZOOL SCR, V39, P572, DOI 10.1111/j.1463-6409.2010.00448.x; Kuramoto Mitsuru, 1990, Bulletin of Fukuoka University of Education Part III Mathematics Natural Sciences and Technology, V39, P83; Lourenco LB, 2008, GENETICA, V132, P255, DOI 10.1007/s10709-007-9169-y; Lourenco LB, 2000, HEREDITAS, V133, P201, DOI 10.1111/j.1601-5223.2000.00201.x; Lourenco LB, 1998, CHROMOSOME RES, V6, P621, DOI 10.1023/A:1009253410553; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Medeiros LR, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-59; MENZIES J I, 1976, Journal of Herpetology, V10, P167, DOI 10.2307/1562977; Miura I, 2007, SEX DEV, V1, P323, DOI 10.1159/000111764; Miura I, 2012, CHROMOSOME RES, V20, P47, DOI 10.1007/s10577-011-9258-8; Nascimento J, 2010, GENETICA, V138, P1127, DOI 10.1007/s10709-010-9501-9; Nogueira L, 2015, GENET MOL BIOL, V38, P156, DOI 10.1590/S1415-4757382220140280; Nogueira L, 2015, COMP CYTOGENET, V9, P227, DOI 10.3897/CompCytogen.v9i2.4593; Paiva CR, 2010, ITAL J ZOOL, V77, P116, DOI 10.1080/11250000903187585; Perrin N, 2009, EVOLUTION, V63, P3043, DOI 10.1111/j.1558-5646.2009.00837.x; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; RABELLO MN, 1970, CARYOLOGIA, V23, P45, DOI 10.1080/00087114.1970.10796362; Raber Simone C., 2004, Phyllomedusa, V3, P43; Reeves A, 2000, MICROMEASURE VERSION; RICHARDS CM, 1977, J HERED, V68, P307, DOI 10.1093/oxfordjournals.jhered.a108842; Rivera-Correa M, 2016, ZOOTAXA, V4061, P29, DOI 10.11646/zootaxa.4061.1.3; Rosset SD, 2006, J HERPETOL, V40, P465, DOI 10.1670/0022-1511(2006)40[465:ROTGDO]2.0.CO;2; Sanchez DA, 2010, COPEIA, P351, DOI 10.1643/CH-10-010; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; SCHMID M, 1978, CHROMOSOMA, V66, P361, DOI 10.1007/BF00328536; SCHMID M, 1982, CHROMOSOMA, V87, P327, DOI 10.1007/BF00327634; Schmid M, 2016, CYTOGENET GENOME RES, V148, P211, DOI 10.1159/000446298; Schmid M, 2015, CYTOGENET GENOME RES, V145, P201, DOI 10.1159/000433481; Schweizer D, 1987, Results Probl Cell Differ, V14, P235; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; Stock M, 2013, SEX DEV, V7, P261, DOI 10.1159/000351089; Stock M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001062; Suarez P, 2013, CYTOGENET GENOME RES, V141, P295, DOI 10.1159/000354997; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Targueta CP, 2011, GENETICA, V139, P1339, DOI 10.1007/s10709-012-9636-y; Teixeira LSR, 2016, COMP CYTOGENET, V10, P753, DOI 10.3897/CompCytogen.v10i4.9972; Valente GT, 2014, MOL BIOL EVOL, V31, P2061, DOI 10.1093/molbev/msu148; Vittorazzi SE, 2014, COMP CYTOGENET, V8, P103, DOI 10.3897/CompCytogen.v8i2.6414; White MJD, 1954, ANIMAL CYTOLOGY EVOL; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Wiley JE, 2003, CYTOGENET GENOME RES, V101, P80, DOI 10.1159/000073422; WILEY JE, 1986, COPEIA, P531, DOI 10.2307/1445015; Yu SL, 1990, KOREAN J ZOOL, V33, P1	117	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192861	10.1371/journal.pone.0192861	http://dx.doi.org/10.1371/journal.pone.0192861			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444174	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500100
J	Gaughran, A; Kelly, DJ; MacWhite, T; Mullen, E; Maher, P; Good, M; Marples, NM				Gaughran, Aoibheann; Kelly, David J.; MacWhite, Teresa; Mullen, Enda; Maher, Peter; Good, Margaret; Marples, Nicola M.			Super-ranging. A new ranging strategy in European badgers	PLOS ONE			English	Article							HIGH-DENSITY POPULATION; BIALOWIEZA-PRIMEVAL-FOREST; MELES-MELES; BOVINE TUBERCULOSIS; SPATIAL-ORGANIZATION; EURASIAN BADGERS; BEHAVIOR; DISPERSAL; MOVEMENT; WILDLIFE	We monitored the ranging of a wild European badger (Meles meles) population over 7 years using GPS tracking collars. Badger range sizes varied seasonally and reached their maximum in June, July and August. We analysed the summer ranging behaviour, using 83 home range estimates from 48 individuals over 6974 collar-nights. We found that while most adult badgers (males and females) remained within their own traditional social group boundaries, several male badgers (on average 22%) regularly ranged beyond these traditional boundaries. These adult males frequently ranged throughout two (or more) social group's traditional territories and had extremely large home ranges. We therefore refer to them as super-rangers. While ranging across traditional boundaries has been recorded over short periods of time for extraterritorial mating and foraging forays, or for pre-dispersal exploration, the animals in this study maintained their super-ranges from 2 to 36 months. This study represents the first time such long-term extra-territorial ranging has been described for European badgers. Holding a super-range may confer an advantage in access to breeding females, but could also affect local interaction networks. In Ireland & the UK, badgers act as a wildlife reservoir for bovine tuberculosis (TB). Super-ranging may facilitate the spread of disease by increasing both direct interactions between conspecifics, particularly across social groups, and indirect interactions with cattle in their shared environment. Understanding super-ranging behaviour may both improve our understanding of tuberculosis epidemiology and inform future control strategies.	[Gaughran, Aoibheann; Kelly, David J.; Marples, Nicola M.] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [MacWhite, Teresa; Maher, Peter; Good, Margaret] Dept Agr Food & Marine, Kildare St, Dublin, Ireland; [Mullen, Enda] Dept Culture Heritage & Gaeltacht, Natl Parks & Wildlife Serv, Wicklow Mt Natl Pk, Laragh, Wicklow, Ireland	Trinity College Dublin	Gaughran, A (corresponding author), Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland.	gaughra@tcd.ie	Kelly, David/AAE-8278-2019	Gaughran, Aoibheann/0000-0002-1884-6077; Kelly, David/0000-0002-5880-4162; Good, Margaret/0000-0002-4720-2940	Department of Agriculture, Food and the Marine, Ireland; National Parks; National Parks and Wildlife Service, Ireland	Department of Agriculture, Food and the Marine, Ireland; National Parks; National Parks and Wildlife Service, Ireland	AG was supported by a PhD scholarship provided by the Department of Agriculture, Food and the Marine, Ireland. This project was conceived, carried out and funded by the Department of Agriculture, Food and the Marine, Ireland and National Parks and National Parks and Wildlife Service, Ireland.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 1978, USERS MANUAL PROGRAM; [Anonymous], 1982, ESTIMATION ANIMAL AB; [Anonymous], 1991, USERS GUIDE INTERACT; Barbier E, 2016, J APPL MICROBIOL; Blanco JC, 2007, J ZOOL, V273, P114, DOI 10.1111/j.1469-7998.2007.00305.x; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Byrne AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050807; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chambers MA, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00006; CHAO A, 1988, J WILDLIFE MANAGE, V52, P295, DOI 10.2307/3801237; Cheeseman C.L., 1993, P78; Cheeseman C.L., 1987, Symposia of the Zoological Society of London, P279; CHEESEMAN CL, 1988, MAMMAL REV, V18, P61, DOI 10.1111/j.1365-2907.1988.tb00073.x; CHEESEMAN CL, 1988, MAMMAL REV, V18, P51, DOI 10.1111/j.1365-2907.1988.tb00071.x; CHEESEMAN CL, 1981, J ZOOL, V194, P284, DOI 10.1111/j.1469-7998.1981.tb05780.x; Cheeseman CL, 1979, HDB BIOTELEMETRY RAD, V646, P656; CHRISTIAN SF, 1994, Z SAUGETIERKD, V59, P218; Conner MM, 2004, ECOL APPL, V14, P1870, DOI 10.1890/03-5309; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Corner LAL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138093; CRESSWELL WJ, 1988, MAMMAL REV, V18, P37, DOI 10.1111/j.1365-2907.1988.tb00069.x; Cresswell WJ, 1992, PHILOS T R SOC LON B; DAFM, 2016, IR TB PROGR 2016 201; DASILVA J, 1989, REV ECOL-TERRE VIE, V44, P275; DAVIES JM, 1987, J ZOOL, V211, P525, DOI 10.1111/j.1469-7998.1987.tb01550.x; Davis S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1004; Davison J, 2009, J ZOOL, V277, P45, DOI 10.1111/j.1469-7998.2008.00509.x; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Do Linh San E, 2007, CAN J ZOOL, V85, P973, DOI 10.1139/Z07-085; Elliott S, 2015, MAMMAL RES, V60, P331, DOI 10.1007/s13364-015-0242-0; Ellwood SA, 2017, METHODS ECOL EVOL; ERLINGE S, 1986, OIKOS, V47, P57, DOI 10.2307/3565919; Evans PG, 1989, J ZOOL; Eves JA, 1999, IRISH VET J, V52, P199; Frantz AC, 2010, HYSTRIX ITAL J MAMMA, V21; Garnett BT, 2005, APPL ANIM BEHAV SCI, V94, P331, DOI 10.1016/j.applanim.2005.02.013; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Gormley E, 2013, TRANSBOUND EMERG DIS, V60, P128, DOI 10.1111/tbed.12095; Gormley E, 2003, J APPL MICROBIOL, V94, p80S; Gormley E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168851; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gowtage S, 2017, VACCINE; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; HANCOX M, 1988, REV ECOL-TERRE VIE, V43, P399; Johnson DDP, 2002, J BIOGEOGR, V29, P411, DOI 10.1046/j.1365-2699.2002.00680.x; Kauhala K, 2006, ACTA THERIOL, V51, P1, DOI 10.1007/BF03192650; Kowalczyk R, 2003, CAN J ZOOL, V81, P74, DOI 10.1139/Z02-233; Kowalczyk R, 2006, WILDLIFE BIOL, V12, P385, DOI 10.2981/0909-6396(2006)12[385:DMATUB]2.0.CO;2; KREBS CJ, 1966, ECOL MONOGR, V36, P240, DOI 10.2307/1942418; KRUUK H, 1978, J ZOOL, V184, P1; KRUUK H, 1978, BEHAV ECOL SOCIOBIOL, V4, P75, DOI 10.1007/BF00302562; Macdonald DW, 2008, J MAMMAL, V89, P1077, DOI 10.1644/07-MAMM-A-185.1; MacDonald DW, 2006, BIOL CONSERV, V131, P268, DOI 10.1016/j.biocon.2006.05.006; Macdonald DW, 2015, WILDLIFE CONSERVATION ON FARMLAND, VOL 2: CONFLICT IN THE COUNTRYSIDE, P65; MacDonald DW, 2004, ANIM BEHAV, V67, P745, DOI 10.1016/j.anbehav.2003.08.021; MacWhite Teresa, 2013, Irish Naturalists' Journal, V32, P99; Martin SW, 1997, PREV VET MED, V31, P113, DOI 10.1016/S0167-5877(96)01111-7; MESSIER F, 1985, CAN J ZOOL, V63, P239, DOI 10.1139/z85-037; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Molina-Vacas G, 2009, VIE MILIEU, V59, P223; Mullen EM, 2015, APPL ANIM BEHAV SCI, V171, P170, DOI 10.1016/j.applanim.2015.08.021; MULLINEAUX E, 2003, BSAVA MANUAL WILDLIF; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; Murphy D, 2009, J WILDLIFE DIS, V45, P481, DOI 10.7589/0090-3558-45.2.481; O'Mahony DT, 2015, MAMM BIOL, V80, P484, DOI 10.1016/j.mambio.2015.07.002; Palphramand KL, 2007, BEHAV ECOL SOCIOBIOL, V61, P401, DOI 10.1007/s00265-006-0268-z; Payne A, 2012, EUR J WILDL RES, V59; Remonti L, 2006, ETHOL ECOL EVOL, V18, P61, DOI 10.1080/08927014.2006.9522727; Revilla E, 2002, J ANIM ECOL, V71, P497, DOI 10.1046/j.1365-2656.2002.00617.x; Revilla E, 1999, ACTA THERIOL, V44, P471, DOI 10.4098/AT.arch.99-45; Riordan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028904; Rogers LM, 1998, P ROY SOC B-BIOL SCI, V265, P1269, DOI 10.1098/rspb.1998.0429; Roper T, 2010, BADGER; Roper TJ, 2003, MAMMAL REV, V33, P314, DOI 10.1046/j.1365-2907.2003.00031.x; Rosalino LM, 2004, CAN J ZOOL, V82, P1493, DOI 10.1139/Z04-130; SANDELL M, 1992, AM NAT, V139, P177, DOI 10.1086/285319; Schley L, 2000, BADGER MELES MELES W; Sleeman DP, 2009, EUR J WILDLIFE RES, V55, P333, DOI 10.1007/s10344-008-0244-1; Sleeman D.P., 1992, P670; Sleeman DP, 2005, IRISH NAT J, P11; Tuyttens FAM, 2000, J ANIM ECOL, V69, P567, DOI 10.1046/j.1365-2656.2000.00419.x; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; Urbano F, 2010, PHILOS T R SOC B, V365, P2177, DOI 10.1098/rstb.2010.0081; Weber N, 2013, CURR BIOL, V23, pR915, DOI 10.1016/j.cub.2013.09.011; WOODROFFE R, 1993, SYM ZOOL S, P145; WOODROFFE R, 1995, J ZOOL, V237, P227, DOI 10.1111/j.1469-7998.1995.tb02760.x; Woodroffe R, 2016, J APPL ECOL; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	89	20	22	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191818	10.1371/journal.pone.0191818	http://dx.doi.org/10.1371/journal.pone.0191818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444100	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500034
J	Iannessi, A; Beaumont, H; Hebert, C; Dittlot, C; Falewee, MN				Iannessi, Antoine; Beaumont, Hubert; Hebert, Christophe; Dittlot, Claire; Falewee, Marie Noelle			Computer tomography-based body surface area evaluation for drug dosage: Quantitative radiology versus anthropomorphic evaluation	PLOS ONE			English	Article							CANCER; WEIGHT; HEIGHT; ADJUSTMENT; FORMULA; OBESITY	Objective The measure of body surface area (BSA) is a standard for planning optimal dosing in oncology. This index is derived from a model having questionable performances. In this study, we proposed measurement of BSA from whole body CT images (iBSA). We tested the reliability of iBSA assessments and simulated the impact of our approach on patient chemotherapy dosage planning. Methods We first evaluated accuracy and precision of iBSA in measuring 14 phantom and 11 CT test-retest images. Secondly, we retrospectively analyzed 26 whole body PET-CT scans to evaluate inter-method variability between iBSA and the most used anthropomorphic models, notably the "Du Bois and Du Bois" model. Finally, we simulated the impact on chemotherapy dose planning of capecitabine based on iBSA. Results Precision and accuracy of iBSA measurement featured a standard deviation of 1.11% and a mean error of 1.53%. Inter-method variability between iBSA and "Du Bois and Du Bois" assessment featured a standard deviation of 4.11% leading to a reclassification rate of capecitabine of 32.5%. Conclusions iBSA could help the oncologist in standardizing assessments for chemotherapy planning. iBSA could also be relevant for applications such as comprehensive body composition and provide a sensitive measurement for changes related to nutritional intake or other metabolism.	[Iannessi, Antoine] Ctr Antoine Lacassagne, Dept Radiol, Nice, France; [Beaumont, Hubert] Median Technol, Res & Dev, Valbonne, France; [Hebert, Christophe] Ctr Antoine Lacassagne, Dept Oncol, Nice, France; [Dittlot, Claire] CHU Nice, Dept Gerontol, Nice, France; [Falewee, Marie Noelle] Ctr Antoine Lacassagne, Dept Nutr, Nice, France	UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Antoine Lacassagne; CHU Nice; UNICANCER; Centre Antoine Lacassagne	Beaumont, H (corresponding author), Median Technol, Res & Dev, Valbonne, France.	hubert.beaumont@mediantechnologies.com	beaumont, hubert/A-3813-2019	beaumont, hubert/0000-0002-7624-8956				Abramson RG, 2015, ACAD RADIOL, V22, P25, DOI 10.1016/j.acra.2014.09.001; Alexa M, 2003, IEEE T VIS COMPUT GR, V9, P3, DOI 10.1109/TVCG.2003.1175093; Armato SG, 2008, CLIN PHARMACOL THER, V84, P448, DOI 10.1038/clpt.2008.161; Beumer JH, 2012, J CLIN ONCOL, V30, P3896, DOI 10.1200/JCO.2012.44.2863; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyd E., 1935, JAMA-J AM MED ASSOC, V106, P567; Canal P, 1998, DRUGS, V56, P1019, DOI 10.2165/00003495-199856060-00006; Chatelut E, 2012, BRIT J CANCER, V107, P1100, DOI 10.1038/bjc.2012.357; Daniell N, 2012, AM J PHYS ANTHROPOL, V148, P148, DOI 10.1002/ajpa.22051; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Food and Drug Administration, 2005, PROD DOOD; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Geraghty EM, 2003, RADIOLOGY, V228, P857, DOI 10.1148/radiol.2283020095; Goldberg RM, 2002, J CLIN ONCOL, V20, P4591, DOI 10.1200/JCO.2002.03.039; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Heaf JG, 2007, CLIN PHYSIOL FUNCT I, V27, P135, DOI 10.1111/j.1475-097X.2006.00718.x; Martinez-Moller A, 2007, J NUCL MED P ANN M S, V48, P44; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Ponce R, 2011, TOXICOL PATHOL, V39, P913, DOI 10.1177/0192623311416263; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Roubenoff R, 2008, LANCET ONCOL, V9, P605, DOI 10.1016/S1470-2045(08)70160-8; Saif MW, 2009, JNCI-J NATL CANCER I, V101, P1543, DOI 10.1093/jnci/djp328; Schloesser RL, 2011, NEONATOLOGY, V100, P260, DOI 10.1159/000327516; Verbraecken J, 2006, METABOLISM, V55, P515, DOI 10.1016/j.metabol.2005.11.004; Villa C, 2015, CLIN PHYSL FUNCT IMA; Wiczer T, 2015, J ONCOL PHARM PRACT; Yin WJ, 2015, ONCOTARGET, V6, P39365, DOI 10.18632/oncotarget.5460; Yu CY, 2003, APPL ERGON, V34, P273, DOI 10.1016/S0003-6870(03)00007-3; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192124	10.1371/journal.pone.0192124	http://dx.doi.org/10.1371/journal.pone.0192124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444120	Green Published, Green Submitted, gold			2022-12-26	WOS:000425183500052
J	Koronowicz, AA; Drozdowska, M; Wielgos, B; Piasna-Slupecka, E; Domagala, D; Dulinska-Litewka, J; Leszczynska, T				Koronowicz, Aneta A.; Drozdowska, Mariola; Wielgos, Barbara; Piasna-Slupecka, Ewelina; Domagala, Dominik; Dulinska-Litewka, Joanna; Leszczynska, Teresa			The effect of "Nutramil (TM) Complex," food for special medical purpose, on breast and prostate carcinoma cells	PLOS ONE			English	Article							SELENITE INDUCES APOPTOSIS; SODIUM SELENITE; COLORECTAL-CANCER; MAGNESIUM INTAKE; VITAMIN-E; PATHWAY; FAMILY; DEATH; ZINC; PROLIFERATION	Nutramil (TM) Complex is a multicomponent food product that meets the requirements of a food for special medical purpose. As a complete, high-energy diet it consists of properly balanced nutrients, vitamins and minerals. The aim of this study was to assess the effect of Nutramil (TM) Complex on breast and prostate carcinoma cells. Our results showed that Nutramil (TM) Complex reduced the viability and proliferation of breast and prostate cancer cells and that this process was associated with the induction of apoptosis via activation of caspase signalling. Data showed elevated levels of p53 tumour suppressor, up-regulation of p38 MAPK and SAPK / JNK proteins and downregulation of anti-apoptotic ERK1/2, AKT1 and HSP27. Treatment with Nutramil (TM) Complex also affected the expression of the BCL2 family genes. Results also showed down-regulation of anti-apoptotic BCL-2 and up-regulation of pro-apoptotic members such as BAX, BAD, BID. In addition, we also observed regulation of many other genes, including Ik beta alpha, Chk1 and Chk2, associated with apoptotic events. Taken together, our results suggest activation of the mitochondrial apoptotic pathway as most likely mechanism of anti-carcinogenic activity of Nutramil (TM) Complex.	[Koronowicz, Aneta A.; Drozdowska, Mariola; Piasna-Slupecka, Ewelina; Domagala, Dominik; Leszczynska, Teresa] Univ Agr, Fac Food Technol, Dept Human Nutr, Krakow, Poland; [Wielgos, Barbara] Olimp Labs Sp Zoo, Debica, Poland; [Dulinska-Litewka, Joanna] Jagiellonian Univ, Coll Med, Chair Med Biochem, Krakow, Poland	Agricultural University Krakow; Jagiellonian University; Collegium Medicum Jagiellonian University	Koronowicz, AA (corresponding author), Univ Agr, Fac Food Technol, Dept Human Nutr, Krakow, Poland.	aneta.koronowicz@gmail.com	Drozdowska, Mariola/ABH-6409-2020	Drozdowska, Mariola/0000-0002-1898-6280; Piasna-Slupecka, Ewelina/0000-0002-5046-495X; Koronowicz, Aneta/0000-0002-1653-2867	Polish Ministry of Science and Higher Education [DS 3710/KZCz/2017]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education DS 3710/KZCz/2017. The funder provided support in the form of salaries for authors [AAK, TL, MD, EPS, DD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; Bhatia E, 2011, NUTR CANCER, V63, P242, DOI 10.1080/01635581.2011.523498; Boulares HA, 2000, GENOME DEGRADATION D; Castiglioni S, 2011, MAGNESIUM RES, V24, pS92, DOI 10.1684/mrh.2011.0285; Chen N, 2015, J AGR FOOD CHEM, V63, P6739, DOI 10.1021/acs.jafc.5b01909; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen XJ, 2012, BIOL TRACE ELEM RES, V145, P1, DOI 10.1007/s12011-011-9154-2; Cho KS, 2010, LIPIDS, V45, P777, DOI 10.1007/s11745-010-3462-8; Comin-Anduix B, 2001, EUR J BIOCHEM, V268, P4177, DOI 10.1046/j.1432-1327.2001.02329.x; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Lange J, 2012, CELL DEATH DIFFER, V19, P980, DOI 10.1038/cdd.2011.182; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Domagala D, 2016, EPISTEME, V2, P13; Feng P, 2000, MOL UROL, V4, P31; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Franklin RB, 2007, ARCH BIOCHEM BIOPHYS, V463, P211, DOI 10.1016/j.abb.2007.02.033; Guan LY, 2009, APOPTOSIS, V14, P218, DOI 10.1007/s10495-008-0295-5; Hanberry BS, 2014, CANCER CHEMOTH PHARM, V73, P585, DOI 10.1007/s00280-014-2386-z; Hashmi S. I., 2010, Journal of Oilseed Brassica, V1, P43; Heise M, 2014, POSTEP HIG MED DOSW, V68, P653, DOI 10.5604/17322693.1104682; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Ion G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-81; Kaewsakhorn T, 2005, ANTICANCER RES, V25, P2689; Katsogiannou M, 2014, MOL CELL PROTEOMICS, V13, P3585, DOI 10.1074/mcp.M114.041228; Kline K, 2004, J NUTR, V134, p3458S, DOI 10.1093/jn/134.12.3458S; Ko SK, 2014, NAT CHEM, V6, P885, DOI [10.1038/NCHEM.2021, 10.1038/nchem.2021]; Kumar D, 2012, J APPL PHARM SCI, V02, P158, DOI DOI 10.7324/JAPS.2012.2513; Lamson Davis W, 2003, Altern Med Rev, V8, P303; Larsson SC, 2005, JAMA-J AM MED ASSOC, V293, P86, DOI 10.1001/jama.293.1.86; Leitzmann Michael F, 2012, Clin Epidemiol, V4, P1, DOI 10.2147/CLEP.S16747; Li YH, 2014, J PHARMACOL SCI, V125, P202, DOI 10.1254/jphs.14017FP; Liu XH, 2010, MOL CELL ENDOCRINOL, V320, P128, DOI 10.1016/j.mce.2010.02.004; Livak KJ, METHODS, V200, P402; Mamede AC, 2011, NUTR CANCER, V63, P479, DOI 10.1080/01635581.2011.539315; McMahon SB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014407; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Nelson AA, 2009, CLIN DERMATOL, V27, P46, DOI 10.1016/j.clindermatol.2008.09.005; Okada M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579961; Ostrakhovitch EA, 2005, APOPTOSIS, V10, P111, DOI 10.1007/s10495-005-6066-7; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; PAMUKCU AM, 1970, CANCER RES, V30, P2671; Park SH, 2012, TOXICOL LETT, V212, P252, DOI 10.1016/j.toxlet.2012.06.007; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piasna E, 2016, EPISTEME, V2, P91; Powers HJ, 2005, J NUTR, V135, p2960S, DOI 10.1093/jn/135.12.2960S; Riaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032081; Schwarz EC, 2003, BIOCHIM BIOPHYS ACTA, V1833, P1603; Shrivastava A, 2006, J BIOL CHEM, V281, P19762, DOI 10.1074/jbc.M600746200; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sylvester PW, 2005, FRONT BIOSCI, V10, P699, DOI 10.2741/1565; Tomczyk J, 2010, POSTEP HIG MED DOSW, V64, P590; Townsend K, 2005, CLIN CANCER RES, V11, P3579, DOI 10.1158/1078-0432.CCR-04-2359; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Tukiendorf A, 2004, MAGNESIUM RES, V17, P46; van den Brandt PA, 2007, BRIT J CANCER, V96, P510, DOI 10.1038/sj.bjc.6603577; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yang Y, 2009, ONCOL RES, V18, P1; Zuo L, 2004, ANN HEMATOL, V83, P751, DOI 10.1007/s00277-004-0920-5	61	1	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192860	10.1371/journal.pone.0192860	http://dx.doi.org/10.1371/journal.pone.0192860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444163	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500099
J	Kressler, J; Koeplin-Day, J; Muendle, B; Rosby, B; Santo, E; Domingo, A				Kressler, Jochen; Koeplin-Day, Joshua; Muendle, Benedikt; Rosby, Brice; Santo, Elizabeth; Domingo, Antoinette			Accuracy and precision of consumer-level activity monitors for stroke detection during wheelchair propulsion and arm ergometry	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-ADULTS; SLOW WALKING; VALIDITY; STEPS; HEALTH; DEVICE; ACCELEROMETER; INDIVIDUALS; FITBIT	The purpose of this study was to evaluate whether consumer-level activity trackers can estimate wheelchair strokes and arm ergometer revolutions. Thirty able-bodied participants wore three consumer-level activity trackers (Garmin VivoFit, FitBit Flex, and Jawbone UP24) on the wrist. Participants propelled a wheelchair at fixed frequencies (30, 45 and 60 strokes per minute (spm)) three minutes each and at pre-determined varied frequencies, (30-80 spm) for two minutes. Participants also freely wheeled through an obstacle course. 10 other participants performed arm-ergometry at 40, 60 and 80 revolutions per minute (rpm), for three minutes each. Mean percentage error (MPE(SD)) for 30 spm were >= 46 (26)% for all monitors, and declined to 3-6(2-7)% at 60 spm. For the obstacle course, MPE ranged from 12-17(7-13)% for all trackers. For arm-ergometry, MPE was at 1-96(0-37)% with the best measurement for the Fitbit at 60 and 80 rpm, and the Garmin at 80rpm, with MPE = 1(0-1)%. The consumer-level wrist-worn activity trackers we tested have higher accuracy/precision at higher movement frequencies but perform poorly at lower frequencies.	[Kressler, Jochen; Koeplin-Day, Joshua; Rosby, Brice; Santo, Elizabeth; Domingo, Antoinette] San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA; [Muendle, Benedikt] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland; [Domingo, Antoinette] San Diego State Univ, Phys Therapy Program, San Diego, CA 92182 USA	California State University System; San Diego State University; Swiss Federal Institutes of Technology Domain; ETH Zurich; California State University System; San Diego State University	Domingo, A (corresponding author), San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA.; Domingo, A (corresponding author), San Diego State Univ, Phys Therapy Program, San Diego, CA 92182 USA.	adomingo@mail.sdsu.edu						Bergman RJ, 2008, J PHYS ACT HEALTH, V5, pS166, DOI 10.1123/jpah.5.s1.s166; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Carrington P, 2015, BUT I DONT TAKE STEP, P2015; Diaz KM, 2015, INT J CARDIOL, V185, P138, DOI 10.1016/j.ijcard.2015.03.038; DICARLO SE, 1983, PHYS THER, V63, P1104, DOI 10.1093/ptj/63.7.1104; DICARLO SE, 1988, PHYS THER, V68, P40, DOI 10.1093/ptj/68.1.40; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Floegel TA, 2016, J GERONTOL A-BIOL, P1; Fulk GD, 2014, PHYS THER, V94, P222, DOI 10.2522/ptj.20120525; Furlanetto KC, 2010, ARCH PHYS MED REHAB, V91, P261, DOI 10.1016/j.apmr.2009.10.024; Goosey-Tolfrey VL, 2008, EUR J APPL PHYSIOL, V102, P189, DOI 10.1007/s00421-007-0576-7; Huang YJ, 2016, GAIT POSTURE, V48, P36, DOI 10.1016/j.gaitpost.2016.04.025; Klassen TD, 2016, PHYS THER, V96, P355, DOI 10.2522/ptj.20140611; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Krahn GL, 2015, AM J PUBLIC HEALTH, V105, pS198, DOI 10.2105/AJPH.2014.302182; Lauritzen J, 2013, STUD HEALTH TECHNOL, V192, P759, DOI 10.3233/978-1-61499-289-9-759; Lyons EJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3469; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; McMahon SK, 2016, JMIR MHEALTH UHEALTH, V4, P594, DOI 10.2196/mhealth.5120; Mercer K, 2016, JMIR MHEALTH UHEALTH, V4, P615, DOI 10.2196/mhealth.4461; Motl RW, 2011, DISABIL HEALTH J, V4, P52, DOI 10.1016/j.dhjo.2010.02.003; National Institute of Water and Atmospheric Research, 2013, LINS CONC 2013; Nelson MB, 2016, MED SCI SPORT EXER, V48, P1619, DOI 10.1249/MSS.0000000000000933; Rimmer JH, 2012, EXERC SPORT SCI REV, V40, P22, DOI 10.1097/JES.0b013e31823b8b82; Simpson LA, 2015, J REHABIL MED, V47, P830, DOI 10.2340/16501977-1993; Slowik JS, 2015, CLIN BIOMECH, V30, P927, DOI 10.1016/j.clinbiomech.2015.07.007; Storm FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118723; Storti KL, 2008, MED SCI SPORT EXER, V40, P59, DOI 10.1249/mss.0b013e318158b504; Symonds A, 2016, J REHABILITATION ASS, V3, P1; Takacs J, 2014, J SCI MED SPORT, V17, P496, DOI 10.1016/j.jsams.2013.10.241; Taraldsen K, 2011, PHYS THER, V91, P277, DOI 10.2522/ptj.20100159; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; US Department of Health and Human Services. The Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for, 2010, SECR ADV COMM NAT HL; Vooijs M, 2014, INTERACT J MED RES, V3, P12, DOI 10.2196/ijmr.3056; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191556	10.1371/journal.pone.0191556	http://dx.doi.org/10.1371/journal.pone.0191556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444105	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500023
J	Saribay, SA; Biten, AF; Meral, EO; Aldan, P; Trebicky, V; Kleisner, K				Saribay, S. Adil; Biten, Ali Furkan; Meral, Erdem Ozan; Aldan, Pinar; Trebicky, Vit; Kleisner, Karel			The Bogazici face database: Standardized photographs of Turkish faces with supporting materials	PLOS ONE			English	Article							SENTENCING OUTCOMES; EVALUATING FACES; FACIAL WIDTH; TRUSTWORTHINESS; INFERENCES; TESTOSTERONE; RECOGNITION; EXPOSURE; FEATURES	Many sets of human facial photographs produced in Western cultures are available for scientific research. We report here on the development of a face database of Turkish undergraduate student targets. High-resolution standardized photographs were taken and supported by the following materials: (a) basic demographic and appearance-related information, (b) two types of landmark configurations (for Webmorph and geometric morpho-metrics (GM)), (c) facial width-to-height ratio (fWHR) measurement, (d) information on photography parameters, (e) perceptual norms provided by raters. We also provide various analyses and visualizations of facial variation based on rating norms using GM. Finally, we found that there is sexual dimorphism in fWHR in our sample but that this is accounted for by body mass index. We present the pattern of associations between rating norms, GM and fWHR measurements. The database and supporting materials are freely available for scientific research purposes.	[Saribay, S. Adil; Aldan, Pinar] Bogazici Univ, Dept Psychol, Istanbul, Turkey; [Biten, Ali Furkan] Univ Autonoma Barcelona, Dept Comp Sci, Barcelona, Spain; [Meral, Erdem Ozan] Tilburg Univ, Dept Social Psychol, Tilburg, Netherlands; [Trebicky, Vit] Charles Univ Prague, Dept Philosophy & Hist Sci, Prague, Czech Republic; [Trebicky, Vit; Kleisner, Karel] Natl Inst Mental Hlth, Klecany, Czech Republic	Bogazici University; Autonomous University of Barcelona; Tilburg University; Charles University Prague; National Institute of Mental Health - Czech Republic	Saribay, SA (corresponding author), Bogazici Univ, Dept Psychol, Istanbul, Turkey.	adil.saribay@boun.edu.tr	Kleisner, Karel/M-2718-2017; Trebicky, Vit/P-3115-2016	Kleisner, Karel/0000-0002-3277-8365; Trebicky, Vit/0000-0003-1440-1772; Meral, Erdem Ozan/0000-0002-6326-7840	Scientific and Technological Research Council of Turkey (TUBITAK) [10596191600901]; Czech Science Foundation [18-10298S]; Czech Republic Ministry of Education, Youth and Sports NPU I program [LO1611]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Czech Science Foundation(Grant Agency of the Czech Republic); Czech Republic Ministry of Education, Youth and Sports NPU I program	The research was funded by a 2219 research grant (no: 10596191600901) from The Scientific and Technological Research Council of Turkey (TUBITAK) to S. Adil Saribay. Karel Kleisner was supported by Czech Science Foundation project 18-10298S. Vit Trebicky was supported by Czech Republic Ministry of Education, Youth and Sports NPU I program (No. LO1611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alkan C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-963; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Book AS, 2001, AGGRESS VIOLENT BEH, V6, P579, DOI 10.1016/S1359-1789(00)00032-X; Calder A., 2011, OXFORD HDB FACE PERC; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Danel DP, 2016, HOMO, V67, P337, DOI 10.1016/j.jchb.2016.05.002; DeBruine L. M., 2017, WEBMORPH; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Geniole SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132726; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hofstede G., 2001, CULTURES CONSEQUENCE; Kramer RSS, 2016, PEERJ, V4, DOI 10.7717/peerj.1801; Kramer RSS, 2015, EVOL PSYCHOL-US, V13, P197, DOI 10.1177/147470491501300112; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Linke L, 2016, PERS INDIV DIFFER, V99, P22, DOI 10.1016/j.paid.2016.04.076; Little AC, 2015, BEHAV ECOL, V26, P1470, DOI 10.1093/beheco/arv089; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Ma DS, 2015, BEHAV RES METHODS, V47, P1122, DOI 10.3758/s13428-014-0532-5; MAZUR A, 1984, AM J SOCIOL, V90, P125, DOI 10.1086/228050; Mitteroecker P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118374; Oberzaucher E., 2012, J EVOL PSYCHOL, V10, P163, DOI [10.1556/JEP.10.2012.4.1, DOI 10.1556/JEP.10.2012.4.1]; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Rohlf FJ, 2017, TPSDIG VERSION 2 30; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sutherland C.A.M, 2015, BASIC GUIDE PSYCHOMO; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2002, J PERS SOC PSYCHOL, V83, P1051, DOI 10.1037//0022-3514.83.5.1051; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Trebicky V, 2015, AGGRESSIVE BEHAV, V41, P331, DOI 10.1002/ab.21559; Trebicky V, 2013, PSYCHOL SCI, V24, P1664, DOI 10.1177/0956797613477117; Uleman JS, 2012, SOC PERSONAL PSYCHOL, V6, P657, DOI 10.1111/j.1751-9004.2012.00452.x; Unkelbach C, 2010, SOC PSYCHOL PERS SCI, V1, P378, DOI 10.1177/1948550610378381; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wilson JP, 2015, PSYCHOL SCI, V26, P1325, DOI 10.1177/0956797615590992; Zebrowitz L. A., 1997, READING FACES WINDOW; Zebrowitz LA, 2006, SOC COGNITION, V24, P657, DOI 10.1521/soco.2006.24.5.657; Zener B., 2007, PLOS ONE, V2, pe710	42	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192018	10.1371/journal.pone.0192018	http://dx.doi.org/10.1371/journal.pone.0192018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444180	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500049
J	Sun, CB; Zhang, JW; Zheng, DM; Wang, J; Yang, HM; Zhang, X				Sun, Changbin; Zhang, Jiawen; Zheng, Dongmin; Wang, Jian; Yang, Huanming; Zhang, Xi			Transcriptome variations among human embryonic stem cell lines are associated with their differentiation propensity	PLOS ONE			English	Article							EARLY FATE DECISIONS; RNA-SEQ EXPERIMENTS; SELF-RENEWAL; HUMAN ES; REGULATORY CIRCUITRY; EXPRESSION ANALYSIS; SIGNALING NETWORKS; PLURIPOTENCY; NANOG; ROLES	Human embryonic stem cells (hESCs) have the potential to form any cell type in the body, making them attractive cell sources in drug screening, regenerative medicine, disease and developmental processes modeling. However, not all hESC lines have the equal potency to generate desired cell types in vitro. Significant variations have been observed for the differentiation efficiency of various human ESC lines. The precise underpinning molecular mechanisms are still unclear. In this work, we compared transcriptome variations of four hESC lines H7, HUES1, HUES8 and HUES9. We found that hESC lines have different gene expression profiles, and these differentially expressed genes (DEGs) are significantly enriched in developmental processes, such as ectodermal, mesodermal and endodermal development. The enrichment difference between hESC lines was consistent with its lineage bias. Among these DEGs, some pluripotency factors and genes involved in signaling transduction showed great variations as well. The pleiotropic functions of these genes in controlling hESC identity and early lineage specification, implicated that different hESC lines may utilize distinct balance mechanisms to maintain pluripotent state. When the balance is broken in a certain environment, gene expression variation between them could impact on their different lineage specification behavior.	[Sun, Changbin] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen, Peoples R China; [Sun, Changbin; Zhang, Jiawen; Zheng, Dongmin; Wang, Jian; Yang, Huanming; Zhang, Xi] BGI Shenzhen, Shenzhen, Peoples R China; [Sun, Changbin; Zhang, Jiawen; Zheng, Dongmin; Zhang, Xi] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China; [Wang, Jian; Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Yang, HM; Zhang, X (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.; Zhang, X (corresponding author), BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China.; Yang, HM (corresponding author), James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China.	yanghm@genomics.cn; zhangxi1@genomics.cn			National Natural Science Foundation of China [31401259]; Shenzhen Municipal Government of China [JCYJ20140418203036946]; BGI-Shenzhen	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; BGI-Shenzhen	This work was supported by National Natural Science Foundation of China (No. 31401259 to XZ) and Shenzhen Municipal Government of China (No. JCYJ20140418203036946 to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by BGI-Shenzhen. The funder provided support in the form of salaries for CBS, JWZ, DMZ, JW, HMY, XZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Ashkenazi-Hoffnung L, 2010, HUM GENET, V127, P721, DOI 10.1007/s00439-010-0820-9; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Beby F, 2013, EXP EYE RES, V111, P9, DOI 10.1016/j.exer.2013.03.007; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen YG, 2012, CELL STEM CELL, V10, P231, DOI 10.1016/j.stem.2012.02.008; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cunningham JJ, 2001, CELL GROWTH DIFFER, V12, P387; Dalton S, 2013, CURR OPIN CELL BIOL, V25, P241, DOI 10.1016/j.ceb.2012.09.005; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Ferguson KL, 2000, J BIOL CHEM, V275, P33593, DOI 10.1074/jbc.M004879200; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Fotaki V, 2006, J NEUROSCI, V26, P9282, DOI 10.1523/JNEUROSCI.2673-06.2006; Gepstein L, 2002, CIRC RES, V91, P866, DOI 10.1161/01.RES.0000041435.95082.84; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Hoch RV, 2009, SEMIN CELL DEV BIOL, V20, P378, DOI 10.1016/j.semcdb.2009.02.005; Hupe M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2476; Iseki H, 2016, STEM CELLS, V34, P322, DOI 10.1002/stem.2243; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jiang W, 2013, STEM CELL REP, V1, P46, DOI 10.1016/j.stemcr.2013.03.003; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Kraus P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104568; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Lim S, 2012, STEM CELLS, V30, P1509, DOI 10.1002/stem.1114; Liu N, 2007, J CELL PHYSIOL, V211, P279, DOI 10.1002/jcp.20978; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Marchal L, 2009, P NATL ACAD SCI USA, V106, P17437, DOI 10.1073/pnas.0906352106; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Niwa H, 2011, NAT CELL BIOL, V13, P1024, DOI 10.1038/ncb2333; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Rao J, 2017, STEM CELLS, V35, P277, DOI 10.1002/stem.2527; Rao RR, 2004, BIOL REPROD, V71, P1772, DOI 10.1095/biolreprod.104.030395; Rho JY, 2006, HUM REPROD, V21, P405, DOI 10.1093/humrep/dei328; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schroter C, 2015, DEVELOPMENT, V142, P4205, DOI 10.1242/dev.127530; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shyh-Chang N, 2015, CELL METAB, V21, P349, DOI 10.1016/j.cmet.2015.02.011; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Sui LN, 2012, BIOCHEM BIOPH RES CO, V426, P380, DOI 10.1016/j.bbrc.2012.08.098; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wang H, 2011, J NEUROSCI, V31, P6440, DOI 10.1523/JNEUROSCI.4892-10.2011; Wang JC, 2016, NAT PROTOC, V11, P327, DOI 10.1038/nprot.2016.016; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Ward E, 2017, STEM CELLS DEV, V26, P1087, DOI 10.1089/scd.2017.0067; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Ware SM, 2006, DEV DYNAM, V235, P776, DOI 10.1002/dvdy.20668; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Weber FA, 2013, STEM CELLS, V31, P2364, DOI 10.1002/stem.1507; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang HM, 2015, NUCLEIC ACIDS RES, V43, pD76, DOI 10.1093/nar/gku887	86	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192625	10.1371/journal.pone.0192625	http://dx.doi.org/10.1371/journal.pone.0192625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444173	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500077
J	Weihbrecht, K; Goar, WA; Carter, CS; Sheffield, VC; Seo, S				Weihbrecht, Katie; Goar, Wesley A.; Carter, Calvin S.; Sheffield, Val C.; Seo, Seongjin			Genotypic and phenotypic characterization of the Sdccag8(Tn(sb-Tyr) 2161B.CA1C2Ove) mouse model	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; JOUBERT-SYNDROME; PSEUDOMONAS-AERUGINOSA; CENTROSOMAL PROTEIN; EPILYSIN MMP-28; GENE; MICE; CILIOPATHY; NEPHRONOPHTHISIS; MUTATIONS	Nephronophthisis-related ciliopathies (NPHP-RC) are a group of disorders that present with end-stage renal failure in childhood/adolescence, kidney cysts, retinal degeneration, and cerebellar hypoplasia. One disorder that shares clinical features with NPHP-RC is Bardet-Biedl Syndrome (BBS). Serologically defined colon cancer antigen 8 (SDCCAG8; also known as NPHP10 and BBS16) is an NPHP gene that is also associated with BBS. To better understand the patho-mechanisms of NPHP and BBS caused by loss of SDCCAG8 function, we characterized an SDCCAG8 mouse model (Sdccag8 Tn(sb-Tyr) 2161B. CA1C2Ove) generated by Sleeping Beauty Transposon (SBT)-mediated insertion mutagenesis. Consistent with the previously reported, independent SDCCAG8 mouse models, our mutant mice display pre-axial polydactyly in their hind limbs. In addition, we report patterning defects in the secondary palate, brain abnormalities, as well as neonatal lethality associated with developmental defects in the lung in our mouse model. The neonatal lethality phenotype is genetic background dependent and rescued by introducing 129S6/SvEvTac background. Genetic modifier(s) responsible for this effect were mapped to a region between SNPs rs3714172 and rs3141832 on chromosome 11. While determining the precise genetic lesion in our mouse model, we found that SBT insertion resulted in a deletion of multiple exons from both Sdccag8 and its neighboring gene Akt3. We ascribe the patterning defects in the limb and the secondary palate as well as lung abnormalities to loss of SDCCAG8, while the developmental defects in the brain are likely due to the loss of AKT3. This mouse model may be useful to study features not observed in other SDCCAG8 models but cautions are needed in interpreting data.	[Weihbrecht, Katie; Goar, Wesley A.; Carter, Calvin S.; Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Weihbrecht, Katie; Goar, Wesley A.; Carter, Calvin S.; Sheffield, Val C.; Seo, Seongjin] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Weihbrecht, Katie; Goar, Wesley A.; Carter, Calvin S.; Sheffield, Val C.; Seo, Seongjin] Univ Iowa, Inst Vis Res, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Seo, S (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.; Seo, S (corresponding author), Univ Iowa, Inst Vis Res, Iowa City, IA 52242 USA.	seongjin-seo@uiowa.edu		Sheffield, Val/0000-0002-6282-0835; Seo, Seongjin/0000-0002-7908-3210; Weihbrecht, Katie/0000-0001-6266-6690	National Institutes of Health [R01EY022616, R01EY011298, R01EY017168, T32GM008629]; Carver Charitable Trust; NIH [R01EY022616, R01EY011298, R01EY017168, T32GM008629]; RPOE Carver Charitable Trust; NATIONAL EYE INSTITUTE [R01EY017168, R01EY022616, R01EY011298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPOE Carver Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R01EY022616 (to S.S.), R01EY011298 (to V.C.S.), R01EY017168 (to V.C. S.), and T32GM008629 (to K.W.) and Carver Charitable Trust (to V.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Friedhelm Hildebrandt for providing SDCCAG8 antibodies. We also thank Kevin Bugge, Marc Humbert, and Valerie Buffert for their help in obtaining tail clips from mice, Charles Searby for his help genotyping the mice, Chantal Allamargot and Kathy Walters for their help with paraffin embedding and microtome instruction, and Todd Scheetz for his help in statistical analysis. This work was supported by NIH grants R01EY022616 (to S.S.), R01EY011298 (to V.C.S.), R01EY017168 (to V.C.S.), and T32GM008629 (to K.W.) and RPOE Carver Charitable Trust (to V.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed ZA, 2013, HUM MOL GENET, V22, P1358, DOI 10.1093/hmg/dds546; Airik R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156081; Airik R, 2014, J AM SOC NEPHROL, V25, P2573, DOI 10.1681/ASN.2013050565; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Coppieters F, 2010, HUM MUTAT, V31, pE1709, DOI 10.1002/humu.21336; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Guilbault C, 2005, LAB ANIM-UK, V39, P336, DOI 10.1258/0023677054306944; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Illman SA, 2003, BIOCHEM J, V375, P191, DOI 10.1042/BJ20030497; Insolera R, 2014, NEURON, V83, P805, DOI 10.1016/j.neuron.2014.06.029; Kenedy AA, 2003, GENE, V303, P35, DOI 10.1016/S0378-1119(02)01141-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Manicone AM, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-144; Manicone AM, 2009, J IMMUNOL, V182, P3866, DOI 10.4049/jimmunol.0713949; Masyukova SV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005841; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Sassano A, 2015, MOL CELL BIOL, V35, P2684, DOI 10.1128/MCB.00019-15; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Wolf MTF, 2015, CURR OPIN PEDIATR, V27, P201, DOI 10.1097/MOP.0000000000000194; Yamamura T, 2016, CLIN EXPT NEPHROLOGY; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Zaki MS, 2011, AM J MED GENET A, V155A, P3042, DOI 10.1002/ajmg.a.34173; Zhang Y, 2014, HUM MOL GENET, V23, P40, DOI 10.1093/hmg/ddt394	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192755	10.1371/journal.pone.0192755	http://dx.doi.org/10.1371/journal.pone.0192755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444170	gold, Green Published, Green Submitted			2022-12-26	WOS:000425183500086
J	Kuzuya, K; Ichihara, S; Suzuki, Y; Inoue, C; Ichihara, G; Kurimoto, S; Oikawa, S				Kuzuya, Kentaro; Ichihara, Sahoko; Suzuki, Yuka; Inoue, Chisa; Ichihara, Gaku; Kurimoto, Syota; Oikawa, Shinji			Proteomics analysis identified peroxiredoxin 2 involved in early-phase left ventricular impairment in hamsters with cardiomyopathy	PLOS ONE			English	Article							OXIDATIVE STRESS; DILATED CARDIOMYOPATHY; HEART-FAILURE; LIM-DOMAIN; TROPONIN-I; INHERITED CARDIOMYOPATHIES; PROTEIN; COMPLEX; MUSCLE; GENE	Given the hypothesis that inflammation plays a critical role in the progression of cardiovascular diseases, the aim of the present study was to identify new diagnostic and prognostic biomarkers of myocardial proteins involved in early-phase cardiac impairment, using proteomics analysis. Using the two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) combined with MALDI-TOF/TOF tandem mass spectrometry, we compared differences in the expression of proteins in the whole left ventricles between control hamsters, dilated cardiomyopathic hamsters (TO-2), and hypertrophy cardiomyopathic hamsters (Bio14.6) at 6 weeks of age (n = 6, each group). Proteomic analysis identified 10 protein spots with significant alterations, with 7 up-regulated and 3 down-regulated proteins in the left ventricles of both TO-2 and Bio 14.6 hamsters, compared with control hamsters. Of the total alterations, peroxiredoxin 2 (PRDX2) showed significant upregulation in the left ventricles of TO-2 and Bio 14.6 hamsters. Our data suggest that PRDX2, a redox regulating molecule, is involved in early-phase left ventricular impairment in hamsters with cardiomyopathy.	[Kuzuya, Kentaro; Ichihara, Sahoko; Inoue, Chisa] Mie Univ, Dept Human Funct Genom, Life Sci Res Ctr, Tsu, Mie, Japan; [Ichihara, Sahoko; Suzuki, Yuka] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie, Japan; [Ichihara, Gaku] Tokyo Univ Sci, Dept Occupat & Environm Hlth, Noda, Chiba, Japan; [Kurimoto, Syota; Oikawa, Shinji] Mie Univ, Dept Environm & Mol Med, Grad Sch Med, Tsu, Mie, Japan; [Ichihara, Sahoko] Jichi Med Univ, Dept Environm & Prevent Med, Sch Med, Shimotsuke, Japan; [Suzuki, Yuka] Mie Univ, Community Univ Res Cooperat Ctr, Tsu, Mie, Japan	Mie University; Mie University; Tokyo University of Science; Mie University; Jichi Medical University; Mie University	Ichihara, S (corresponding author), Mie Univ, Dept Human Funct Genom, Life Sci Res Ctr, Tsu, Mie, Japan.; Ichihara, S (corresponding author), Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie, Japan.; Ichihara, S (corresponding author), Jichi Med Univ, Dept Environm & Prevent Med, Sch Med, Shimotsuke, Japan.	saho@jichi.ac.jp		Ichihara, Gaku/0000-0001-5707-5300	 [26293149];  [15K15236];  [17H06396];  [26293148]; Grants-in-Aid for Scientific Research [17H06396] Funding Source: KAKEN	; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Grants-in aid for Scientific Research (#26293149 and #15K15236) for SI, (#17H06396) for GI, and (#26293148) for SO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Arrell DK, 2001, CIRC RES, V88, P763, DOI 10.1161/hh0801.090193; Cao G, 2014, INT J CARDIOL, V174, P153, DOI 10.1016/j.ijcard.2014.03.166; Chang J, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-8; Chang J, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-87; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Ichihara S, 2006, CARDIOVASC RES, V69, P726, DOI 10.1016/j.cardiores.2005.08.001; Ikeda Y, 2000, CURR OPIN CARDIOL, V15, P197, DOI 10.1097/00001573-200005000-00013; Jalili T, 1999, AM J PHYSIOL-HEART C, V277, pH2298, DOI 10.1152/ajpheart.1999.277.6.H2298; Jasmin G, 1979, Ann N Y Acad Sci, V317, P46, DOI 10.1111/j.1749-6632.1979.tb56509.x; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; KELLY DP, 1994, NEW ENGL J MED, V330, P913; Lee CK, 2007, BBA-PROTEINS PROTEOM, V1774, P848, DOI 10.1016/j.bbapap.2007.04.018; Lu Y, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-115; Maass AH, 2000, CURR OPIN CARDIOL, V15, P189, DOI 10.1097/00001573-200005000-00012; Macri J, 2001, TRENDS CARDIOVAS MED, V11, P66, DOI 10.1016/S1050-1738(01)00088-3; McDonough JL, 1999, CIRC RES, V84, P9; Murakami C, 2010, LEGAL MED, V12, P280, DOI 10.1016/j.legalmed.2010.07.002; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Nishizawa T, 2004, CIRC J, V68, P1051, DOI 10.1253/circj.68.1051; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Sakamoto A, 1999, FEBS LETT, V447, P124, DOI 10.1016/S0014-5793(99)00267-7; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Salmon M, 2004, FEBS LETT, V557, P26, DOI 10.1016/S0014-5793(03)01437-6; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Zhao W, 2009, BASIC RES CARDIOL, V104, P377, DOI 10.1007/s00395-008-0764-6; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	36	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192624	10.1371/journal.pone.0192624	http://dx.doi.org/10.1371/journal.pone.0192624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438398	Green Submitted, Green Published, gold			2022-12-26	WOS:000425083400035
J	Jones, ZW; Leander, R; Quaranta, V; Harris, LA; Tyson, DR				Jones, Zack W.; Leander, Rachel; Quaranta, Vito; Harris, Leonard A.; Tyson, Darren R.			A drift-diffusion checkpoint model predicts a highly variable and growth-factor-sensitive portion of the cell cycle G1 phase	PLOS ONE			English	Article							TRANSITION-PROBABILITY; RESTRICTION POINT; SIZE CONTROL; PROLIFERATION; VARIABILITY; QUIESCENCE; DIVISION; DYNAMICS; SYSTEMS; CANCER	Even among isogenic cells, the time to progress through the cell cycle, or the intermitotic time (IMT), is highly variable. This variability has been a topic of research for several decades and numerous mathematical models have been proposed to explain it. Previously, we developed a top-down, stochastic drift-diffusion+threshold (DDT) model of a cell cycle checkpoint and showed that it can accurately describe experimentally-derived IMT distributions [Leander R, Allen EJ, Garbett SP, Tyson DR, Quaranta V. Derivation and experimental comparison of cell-division probability densities. J. Theor. Biol. 2014; 358: 129-135]. Here, we use the DDT modeling approach for both descriptive and predictive data analysis. We develop a custom numerical method for the reliable maximum likelihood estimation of model parameters in the absence of a priori knowledge about the number of detectable checkpoints. We employ this method to fit different variants of the DDT model (with one, two, and three checkpoints) to IMT data from multiple cell lines under different growth conditions and drug treatments. We find that a two-checkpoint model best describes the data, consistent with the notion that the cell cycle can be broadly separated into two steps: the commitment to divide and the process of cell division. The model predicts one part of the cell cycle to be highly variable and growth factor sensitive while the other is less variable and relatively refractory to growth factor signaling. Using experimental data that separates IMT into G1 vs. S, G2, and M phases, we show that the model-predicted growth-factor-sensitive part of the cell cycle corresponds to a portion of G1, consistent with previous studies suggesting that the commitment step is the primary source of IMT variability. These results demonstrate that a simple stochastic model, with just a handful of parameters, can provide fundamental insights into the biological underpinnings of cell cycle progression.	[Jones, Zack W.; Leander, Rachel] Middle Tennessee State Univ, Dept Math Sci, Murfreesboro, TN 37132 USA; [Quaranta, Vito; Harris, Leonard A.; Tyson, Darren R.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Jones, Zack W.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	Middle Tennessee State University; Vanderbilt University; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Leander, R (corresponding author), Middle Tennessee State Univ, Dept Math Sci, Murfreesboro, TN 37132 USA.	rachel.leander@mtsu.edu	Harris, Leonard A/AAY-6434-2021; Tyson, Darren/Z-2815-2019	Harris, Leonard A/0000-0003-2112-6940; Tyson, Darren/0000-0002-3272-4308	Middle Tennessee State University, Faculty Research and Creative Activity Grant; National Cancer Institute [U54 CA113007, U54 CA174706, R01 CA186193]; NATIONAL CANCER INSTITUTE [U01CA215845, R01CA186193, U01CA174706] Funding Source: NIH RePORTER	Middle Tennessee State University, Faculty Research and Creative Activity Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the following sources: Middle Tennessee State University, Faculty Research and Creative Activity Grant (http://www.mtsu.edu/frcac/index.php), RL; National Cancer Institute, U54 CA113007 (https://www.cancer.gov/), VQ; National Cancer Institute, U54 CA174706 (https://www.cancer.gov/), DT; and National Cancer Institute, R01 CA186193 (https://www.cancer.gov/), VQ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Alfieri R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S16; Allen E., 2007, MATH MODELLING THEOR, DOI [10.1007/978-1-4020-5953-7, DOI 10.1007/978-1-4020-5953-7]; AXELROD DE, 1986, CELL TISSUE KINET, V19, P547, DOI 10.1111/j.1365-2184.1986.tb00755.x; Banerjee S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.116; Basse B, 2003, J MATH BIOL, V47, P295, DOI 10.1007/s00285-003-0203-0; Bernard S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000712; Britton NF, 2005, ESSENTIAL MATH BIOL; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cain SJ, 1997, J THEOR BIOL, V185, P55, DOI 10.1006/jtbi.1996.0289; Callard R, 2007, IMMUNOL REV, V216, P119; Cermak N, 2016, NAT BIOTECHNOL, V34, P1052, DOI 10.1038/nbt.3666; Chao HX, 2017, CELL SYST, V5, P445, DOI 10.1016/j.cels.2017.09.015; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; COOPER S, 1982, J THEOR BIOL, V94, P783, DOI 10.1016/0022-5193(82)90078-9; Dawson PJ, 1996, AM J PATHOL, V148, P313; Dowling MR, 2014, P NATL ACAD SCI USA, V111, P6377, DOI 10.1073/pnas.1322420111; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; FOLKS JL, 1978, J ROY STAT SOC B MET, V40, P263; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Fritz A, 2013, J CELL BIOCHEM, V114, P1074, DOI 10.1002/jcb.24447; Gabriel P, 2012, J THEOR BIOL, V311, P19, DOI 10.1016/j.jtbi.2012.07.001; Gerard C, 2016, WIRES SYST BIOL MED, V8, P140, DOI 10.1002/wsbm.1325; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Gillespie DT, 1992, MARKOV PROCESSES INT; Golubev A, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/7925106; Golubev A, 2016, J THEOR BIOL, V393, P203, DOI 10.1016/j.jtbi.2015.12.027; Golubev A, 2010, J THEOR BIOL, V262, P257, DOI 10.1016/j.jtbi.2009.10.005; Golubev A, 2012, BIOESSAYS, V34, P311, DOI 10.1002/bies.201100119; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harris LA, 2016, NAT METHODS, V13, P497, DOI [10.1038/NMETH.3852, 10.1038/nmeth.3852]; Hitomi M, 1999, MOL CELL BIOL, V19, P4623; HO PTC, 1989, J CELL PHYSIOL, V139, P398, DOI 10.1002/jcp.1041390224; Hogg R. V., 2013, INTRO MATH STAT; Horowitz JL, 2001, HDB ECONOMETRICS, V5, P266; Iyer-Biswas S, 2014, P NATL ACAD SCI USA, V111, P15912, DOI 10.1073/pnas.1403232111; Johnson A, 2013, CURR OPIN CELL BIOL, V25, P717, DOI 10.1016/j.ceb.2013.07.010; Jun S, 2015, TRENDS MICROBIOL, V23, P4, DOI 10.1016/j.tim.2014.12.001; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khodjakov Alexey, 2009, Journal of Biology (London), V8, P1, DOI 10.1186/jbiol195; Kirk P, 2013, CURR OPIN BIOTECH, V24, P767, DOI 10.1016/j.copbio.2013.03.012; KOCH AL, 1980, NATURE, V286, P80, DOI 10.1038/286080a0; Kohn KW, 1998, ONCOGENE, V16, P1065, DOI 10.1038/sj.onc.1201608; Leander R, 2014, J THEOR BIOL, V359, P129, DOI 10.1016/j.jtbi.2014.06.004; Leon K, 2004, J THEOR BIOL, V229, P455, DOI 10.1016/j.jtbi.2004.04.011; Mangel M, 2006, THEORETICAL BIOLOGIST'S TOOLBOX: QUANTITATIVE METHODS FOR ECOLOGY AND EVOLUTIONARY BIOLOGY, P1, DOI 10.2277/ 0521537487; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Martinsson HS, 2005, EXP CELL RES, V305, P383, DOI 10.1016/j.yexcr.2005.01.023; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Miller FR, 1996, ANTICANCER RES, V16, P1765; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagle RK, 2012, FUNDAMENTALS DIFFERE; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Quaranta V, 2009, METHOD ENZYMOL, V467, P23, DOI 10.1016/S0076-6879(09)67002-6; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SCHAECHTER M, 1962, J GEN MICROBIOL, V29, P421, DOI 10.1099/00221287-29-3-421; SENNERSTAM R, 1984, DEV BIOL, V103, P221, DOI 10.1016/0012-1606(84)90023-X; Sennerstam R, 1996, CELL PROLIFERAT, V29, P609, DOI 10.1111/j.1365-2184.1996.tb00975.x; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHIELDS R, 1977, NATURE, V267, P704, DOI 10.1038/267704a0; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; So Jae Young, 2012, Mol Cell Pharmacol, V4, P31; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Staudte RG, 1997, MATH BIOSCI, V143, P103, DOI 10.1016/S0025-5564(97)00006-0; Svetina S, 1978, BIOMATHEMATICS CELL, P71; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; TWEEDIE MCK, 1957, ANN MATH STAT, V28, P362, DOI 10.1214/aoms/1177706964; Tyson DR, 2012, NAT METHODS, V9, P923, DOI 10.1038/nmeth.2138; TYSON JJ, 1986, J THEOR BIOL, V118, P405, DOI 10.1016/S0022-5193(86)80162-X; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; Tyson JJ., 2013, HDB SYSTEMS BIOL, P265; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; VANWIJK R, 1979, CELL TISSUE KINET, V12, P659, DOI 10.1111/j.1365-2184.1979.tb00184.x; Vogelstein B., 2002, GENETIC BASIS HUMAN; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weber TS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003616; Yang HW, 2017, NATURE, V549, P404, DOI 10.1038/nature23880; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	86	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192087	10.1371/journal.pone.0192087	http://dx.doi.org/10.1371/journal.pone.0192087			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432467	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300015
J	Chen, YZ; Lu, XY; Liu, GD				Chen, Yao-Zhong; Lu, Xiao-Ying; Liu, Gen-Di			Effects of different radio-opacifying agents on physicochemical and biological properties of a novel root-end filling material	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; CYTOTOXICITY; HYDROXYAPATITE; RADIOPACITY; CEMENT; GLASS; BIOCOMPATIBILITY; FIBROBLASTS; RESPONSES	Background/Purpose Radio-opacity is an essential attribute of ideal root-end filling materials because it is important for clinicians to observe root canal filling and to facilitate the follow-up instructions. The novel root-end filling material (NRFM) has good cytocompatibility and physicochemical properties but low intrinsic radio-opacity value. To improve its radio-opacity value, three novel radio-opaque root-end filling materials (NRRFMs) were developed by adding barium sulphate (NRFM-Ba), bismuth trioxide (NRFM-Bi) and zirconium dioxide (NRFM-Zr) to NRFM, respectively. The purpose of this study was to identify the suitable radio-opacifier for NRFM through evaluating their physicochemical and biological properties, in comparison with NRFM and glass ionomer cement (GIC). Methods NRRFMs were characterized using X-ray diffraction (XRD) and Fourier transform infrared spectrophotometry (FTIR). Physicochemical properties including setting time, compressive strength, porosity, pH variation, solubility, washout resistance, contact angle and radiopacity were investigated. Cytocompatibility of both freshly mixed and set NRRFMs was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Alkaline phosphatase (ALP) activity assay and alizarin red staining were used to investigate the osteogenic differentiation potential of NRFM-Zr. Data were analyzed using two-way ANOVA (pH variation, solubility and ALP activity) and one-way ANOVA (for the other variables). Results (1) NRRFMs were primarily composed of hydroxyapatite, calcium carboxylate salt and the corresponding radio-opacity agents (barium sulphate, bismuth trioxide or zirconium dioxide). (2) Besides similar physicochemical properties in terms of setting time, pH variation, solubility, washout resistance and contact angle to NRFM, NRFM-Bi and NRFM-Zr exhibited lower porosity and greater compressive strength after being set for 7 days and their radio-opacity were greater than the 3 mm aluminium thickness specified in ISO 6876 (2001). (3) MTT assay revealed that freshly mixed and set NRFM-Zr presented better cell viability than NRFM-Ba and NRFM-Bi at 24 hours and 48 hours (P< 0.05). (4) NRFM-Zr significantly enhanced ALP activity and calcium formation of human osteoblast-like Saos-2 cells when compared with negative group and GIC (P< 0.05). Conclusion NRFM-Zr presents desirable physicochemical and biological properties, thus zirconium dioxide may be a suitable radio-opacifier for NRFM.	[Chen, Yao-Zhong; Liu, Gen-Di] Southeast Univ, Zhongda Hosp, Med Coll, Dept Operat Dent & Endodont, Nanjing, Jiangsu, Peoples R China; [Chen, Yao-Zhong; Lu, Xiao-Ying] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Lu, XY (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	luxy@seu.edu.cn		chen, yaozhong/0000-0002-2215-7354	Natural Science Foundation of China [30270391]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100092110027]; Research Fund of Health and Family Planning Commission of Jiangsu Province [H201642]; Medical Science Development Fund of Health and Family Planning Commission of Nanjing [YKK15244]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Fund of Health and Family Planning Commission of Jiangsu Province; Medical Science Development Fund of Health and Family Planning Commission of Nanjing	This work was supported by Natural Science Foundation of China (Grant No. 30270391 to Xiaoying Lu), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20100092110027 to Xiaoying Lu), the Research Fund of Health and Family Planning Commission of Jiangsu Province (Grant No. H201642 to Yaozhong Chen) and the Medical Science Development Fund of Health and Family Planning Commission of Nanjing (Grant No. YKK15244 to Yaozhong Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2009, 109935 ISO; Antonijevic D, 2014, CLIN ORAL INVEST, V18, P1597, DOI 10.1007/s00784-013-1130-0; ARAKI K, 1993, J ENDODONT, V19, P554, DOI 10.1016/S0099-2399(06)81285-9; Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015; Bodrumlu E, 2008, AUST ENDOD J, V34, P30, DOI 10.1111/j.1747-4477.2007.00085.x; Bortoluzzi EA, 2009, ORAL SURG ORAL MED O, V108, P628, DOI 10.1016/j.tripleo.2009.04.044; Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x; Camilleri J, 2010, INT ENDOD J, V43, P21, DOI 10.1111/j.1365-2591.2009.01621.x; Camilleri J, 2010, J ENDODONT, V36, P502, DOI 10.1016/j.joen.2009.10.018; Cao ZD, 2016, CHINESE MED J-PEKING, V129, P194, DOI 10.4103/0366-6999.173489; Chen CC, 2002, J BIOMED MATER RES, V60, P452, DOI 10.1002/jbm.1291; Chen YZ, 2013, INT ENDOD J, V46, P556, DOI 10.1111/iej.12028; Cho Y, 2015, J DENT RES, V94, P491, DOI 10.1177/0022034514566432; Chong B, 2005, ENDOD TOP, V11, P114; Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018; Gjorgievska E, 2015, MICROSC MICROANAL, V21, P392, DOI 10.1017/S1431927615000057; Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032; Haglund R, 2003, ORAL SURG ORAL MED O, V95, P739, DOI 10.1067/moe.2003.231; Han B, 2009, ACTA BIOMATER, V5, P3165, DOI 10.1016/j.actbio.2009.04.024; Duarte MAH, 2009, J ENDODONT, V35, P737, DOI 10.1016/j.joen.2009.02.006; International Organization for Standardization (ISO), 2009, 1099312 ISO; International Standards Organization, 2001, 6876 ISO; Jafarnia B, 2009, ORAL SURG ORAL MED O, V107, P739, DOI 10.1016/j.tripleo.2009.01.009; Khashaba RM, 2010, INT J BIOMATER, V2010, DOI 10.1155/2010/691452; Kim Hyeongseok, 2013, International Journal of Stem Cells, V6, P67; Kiran S, 2009, BIOMATERIALS, V30, P5552, DOI 10.1016/j.biomaterials.2009.06.049; Kulan P, 2016, J ENDODONT, V42, P276, DOI 10.1016/j.joen.2015.10.015; Lubben B, 2001, LARYNGO RHINO OTOL, V80, P214; Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011; Min KS, 2007, J ENDODONT, V33, P1342, DOI 10.1016/j.joen.2007.07.012; Mohn D, 2010, INT ENDOD J, V43, P210, DOI 10.1111/j.1365-2591.2009.01660.x; Moshaverinia A, 2008, ACTA BIOMATER, V4, P432, DOI 10.1016/j.actbio.2007.07.011; Murray PE, 2000, BIOMATERIALS, V21, P1711, DOI 10.1016/S0142-9612(00)00056-9; Nagaraja BM, 2007, J COLLOID INTERF SCI, V316, P645, DOI 10.1016/j.jcis.2007.09.004; Ndong F, 2012, INT ENDOD J, V45, P557, DOI 10.1111/j.1365-2591.2012.02011.x; Pepiol A, 2011, BIOMATERIALS, V32, P6389, DOI 10.1016/j.biomaterials.2011.05.056; SCHMALZ G, 1994, J MATER SCI-MATER M, V5, P43, DOI 10.1007/BF00121153; Schwarze T, 2002, J ENDODONT, V28, P784, DOI 10.1097/00004770-200211000-00009; Shah PMM, 1996, ORAL SURG ORAL MED O, V81, P476, DOI 10.1016/S1079-2104(96)80028-X; Shen YD, 2016, J BIOMED MATER RES B, V104, P96, DOI 10.1002/jbm.b.33363; Smith DC, 1998, BIOMATERIALS, V19, P467, DOI 10.1016/S0142-9612(97)00126-9; Sun M, 2010, ACTA POLYM SIN, P1430, DOI 10.3724/SP.J.1105.2010.09444; TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2; Viapiana R, 2014, INT ENDOD J, V47, P437, DOI 10.1111/iej.12167; Viapiana Raqueli, 2014, Dent Mater, V30, P1005, DOI 10.1016/j.dental.2014.05.007; Zhang W, 2010, INT ENDOD J, V43, P769, DOI 10.1111/j.1365-2591.2010.01733.x; Zhang XC, 2017, MOL MED REP, V15, P1673, DOI 10.3892/mmr.2017.6165; Zheng M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140278	48	1	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191123	10.1371/journal.pone.0191123	http://dx.doi.org/10.1371/journal.pone.0191123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420559	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900011
J	Friedman, A; Lai, XL				Friedman, Avner; Lai, Xiulan			Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model	PLOS ONE			English	Article							TALIMOGENE LAHERPAREPVEC; DENDRITIC CELLS; IMMUNE SUPPRESSION; CLINICAL-TRIAL; TUMOR; MELANOMA; MICROENVIRONMENT; IMMUNOTHERAPY; VIROTHERAPY; GLIOMA	Oncolytic virus (OV) is a replication competent virus that selectively invades cancer cells; as these cells die under the viral burden, the released virus particles proceed to infect other cancer cells. Oncolytic viruses are designed to also be able to stimulate the anticancer immune response. Thus, one may represent an OV by two parameters: its replication potential and its immunogenicity. In this paper we consider a combination therapy with OV and a checkpoint inhibitor, anti-PD-1. We evaluate the efficacy of the combination therapy in terms of the tumor volume at some later time, for example, 6 months from initial treatment. Since T cells kill not only virus-free cancer cells but also virus-infected cancer cells, the following question arises: Does increasing the amount of the checkpoint inhibitor always improve the efficacy? We address this question, by a mathematical model consisting of a system of partial differential equations. We use the model to construct, by simulations, an efficacy map in terms of the doses of the checkpoint inhibitor and the OV injection. We show that there are regions in the map where an increase in the checkpoint inhibitor actually decreases the efficacy of the treatment. We also construct efficacy maps with checkpoint inhibitor vs. the replication potential of the virus that show the same antagonism, namely, an increase in the checkpoint inhibitor may actually decrease the efficacy. These results have implications for clinical trials.	[Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Lai, Xiulan] Renmin Univ China, Inst Math Sci, Beijing, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Renmin University of China	Lai, XL (corresponding author), Renmin Univ China, Inst Math Sci, Beijing, Peoples R China.	xiulanlai@ruc.edu.cn	Lai, Xiula/GMX-1854-2022		Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; Renmin University of China; International Postdoctoral Exchange Fellowship Program by the Office of China Postdoctoral Council	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); Renmin University of China; International Postdoctoral Exchange Fellowship Program by the Office of China Postdoctoral Council	This work is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642 to AF), and by the Renmin University of China and the International Postdoctoral Exchange Fellowship Program 2016 by the Office of China Postdoctoral Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642), and by the Renmin University of China and the International Postdoctoral Exchange Fellowship Program 2016 by the Office of China Postdoctoral Council.	Aref S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100294; Blank CU, 2015, INT IMMUNOL, V27, P3, DOI 10.1093/intimm/dxu076; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Chen CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02503-8; Cheng X., HUMAN PD L1 B7 H1 CD; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; DAcunto B., 2004, SERIES ADV MATH APPL, V67; Dias JD, 2012, GENE THER, V19, P988, DOI 10.1038/gt.2011.176; Dummer R, 2017, CANCER IMMUNOL IMMUN, V66, P683, DOI 10.1007/s00262-017-1967-1; Engeland CE, 2014, MOL THER, V22, P1949, DOI 10.1038/mt.2014.160; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Fonteneau J., 2016, IMMUNOTHER OPEN ACC, V2; Fournier Philippe, 2013, Biology (Basel), V2, P936, DOI 10.3390/biology2030936; Fulci G, 2007, CANCER RES, V67, P9398, DOI 10.1158/0008-5472.CAN-07-1063; Funt SA, 2014, ONCOLOGY-NY, V28, P6; Hao W, 2017, B MATH BIOL; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hernandez-Alcoceba R, 2011, CLIN TRANSL ONCOL, V13, P229, DOI 10.1007/s12094-011-0647-4; Hwang TH, 2011, MOL THER, V19, P1913, DOI 10.1038/mt.2011.132; Jacobsen K, 2015, B MATH BIOL, V77, P984, DOI 10.1007/s11538-015-0074-8; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Johnson DB, 2015, IMMUNOTHERAPY-UK, V7, P611, DOI [10.2217/IMT.15.35, 10.2217/imt.15.35]; Koks CAE, 2015, J CANCER, V6, P203, DOI 10.7150/jca.10640; Lai XL, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0446-9; Lai XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178479; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Ma Y, 2013, J CANCER, V4, P36, DOI 10.7150/jca.5046; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Maroun J, 2017, FUTURE VIROL, V12, P193, DOI 10.2217/fvl-2016-0129; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Meisen WH, 2015, CLIN CANCER RES, V21, P3274, DOI 10.1158/1078-0432.CCR-14-3118; Melzer MK, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5010008; Muppidi M.R., 2015, J TARGET THER CANC, V4, P47; Nakao A, 2009, CANCER GENE THER, V18, P167; Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Patel MR, 2013, TRANSL RES, V161, P355, DOI 10.1016/j.trsl.2012.12.010; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Puzanov I, 2016, J CLIN ONCOL, V34, P2619, DOI 10.1200/JCO.2016.67.1529; Rajani KR, 2015, VIRUSES-BASEL, V7, P5889, DOI 10.3390/v7112914; Ratajczyk E, 2017, MATH BIOSCI ENG, V14, P305, DOI 10.3934/mbe.2017020; Rojas JJ, 2015, CLIN CANCER RES, V21, P5543, DOI 10.1158/1078-0432.CCR-14-2009; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Thorne SH, 2010, MOL THER, V18, P1698, DOI 10.1038/mt.2010.140; Thorne SH, 2007, J CLIN INVEST, V117, P3350, DOI 10.1172/JCI32727; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Wang LCS, 2012, MOL THER, V20, P736, DOI 10.1038/mt.2011.228; Wollmann G, 2010, J VIROL, V84, P1563, DOI 10.1128/JVI.02040-09; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095	53	30	31	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192449	10.1371/journal.pone.0192449	http://dx.doi.org/10.1371/journal.pone.0192449			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420595	gold, Green Submitted, Green Published			2022-12-26	WOS:000424517900076
J	Lalonde, RL; Akimenko, MA				Lalonde, Robert L.; Akimenko, Marie-Andree			Effects of fin fold mesenchyme ablation on fin development in zebrafish	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; IN-SITU HYBRIDIZATION; DEVELOPING LIMB; HOX-GENES; SONIC-HEDGEHOG; FEEDBACK LOOP; EVOLUTION; FISH; ACTINOTRICHIA; EXPRESSION	The evolution of the tetrapod limb involved an expansion and elaboration of the endoskeletal elements, while the fish fin rays were lost. Loss of fin-specific genes, and regulatory changes in key appendicular patterning genes have been identified as mechanisms of limb evolution, however their contributions to cellular organization and tissue differences between fins and limbs remains poorly understood. During early larval fin development, hoxa13a/hoxd13a-expressing fin fold mesenchyme migrate through the median and pectoral fin along actinotrichia fibrils, non-calcified skeletal elements crucial for supporting the fin fold. Fin fold mesenchyme migration defects have previously been proposed as a mechanism of fin dermal bone loss during tetrapod evolution as it has been shown they contribute directly to the fin ray osteoblast population. Using the nitroreductase/metronidazole system, we genetically ablated a subset of hoxa13a/hoxd13a-expressing fin fold mesenchyme to assess its contributions to fin development. Following the ablation of fin fold mesenchyme in larvae, the actinotrichia are unable to remain rigid and the median and pectoral fin folds collapse, resulting in a reduced fin fold size. The remaining cells following ablation are unable to migrate and show decreased actinodin1 mesenchymal reporter activity. Actinodin proteins are crucial structural component of the actinotrichia. Additionally, we show a decrease in hoxa13a, hoxd13a, fgf10a and altered shha, and ptch2 expression during larval fin development. A continuous treatment of metronidazole leads to fin ray defects at 30dpf. Fewer rays are present compared to stage-matched control larvae, and these rays are shorter and less defined. These results suggest the targeted hoxa13a/hoxd13a-expressing mesenchyme contribute to their own successful migration through their contributions to actinotrichia. Furthermore, due to their fate as fin ray osteoblasts, we propose their initial ablation, and subsequent disorganization produces truncated fin dermal bone elements during late larval stages.	[Lalonde, Robert L.; Akimenko, Marie-Andree] Univ Ottawa, Dept Biol, 20 Marie Curie, Ottawa, ON, Canada	University of Ottawa	Akimenko, MA (corresponding author), Univ Ottawa, Dept Biol, 20 Marie Curie, Ottawa, ON, Canada.	makimenko@uottawa.ca			Natural Sciences and Engineering Research Council of Canada [155817-2012, 429427-2012]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, #155817-2012 & #429427-2012 (http://www.nserc-crsng.gc.ca/index_eng.asp) to MM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Mumm for providing the pBK 2xNRSE-2xzHB9-5xUAS-TagYFP-T2A-NTR plasmid, and Samuel MacDonnell for creating the Tg(m-Inta11-beta-globin:mCherry) transgenic line. We also thank Dr. Marc Ekker and Dr. Qingming Qu for their critical reading of the manuscript. This work is supported by the Natural Sciences and Engineering Research Council of Canada (#155817-2012 & #429427-2012) to M.-A.A.	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; Ahlberg PE, 2006, NATURE, V440, P747, DOI 10.1038/440747a; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Clack Jennifer A., 2009, Evolution Education and Outreach, V2, P213; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Duran I, 2011, DEV BIOL, V354, P160, DOI 10.1016/j.ydbio.2011.03.014; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Freitas R, 2012, DEV CELL, V23, P1219, DOI 10.1016/j.devcel.2012.10.015; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; George D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022136; GERAUDIE J, 1977, J MORPHOL, V151, P353, DOI 10.1002/jmor.1051510304; GERAUDIE J, 1980, TISSUE CELL, V12, P637, DOI 10.1016/0040-8166(80)90018-X; Gori F, 2001, J CELL BIOCHEM, V82, P46, DOI 10.1002/jcb.1115; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kherdjemil Y, 2016, NATURE, V539, P89, DOI 10.1038/nature19813; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lalonde RL, 2016, DEV BIOL, V417, P91, DOI 10.1016/j.ydbio.2016.05.019; Lamoureux F, 2007, BIOESSAYS, V29, P758, DOI 10.1002/bies.20612; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Leite-Castro J, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4010010; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; Lu PF, 2008, DEVELOPMENT, V135, P1395, DOI 10.1242/dev.018945; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mathias JR, 2014, ZEBRAFISH, V11, P85, DOI 10.1089/zeb.2013.0937; Mercader N, 2007, DEV GROWTH DIFFER, V49, P421, DOI 10.1111/j.1440-169x.2007.00942.x; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Roberts JA, 2014, DEVELOPMENT, V141, P715, DOI 10.1242/dev.100347; Rodrigues AR, 2017, P NATL ACAD SCI USA, V114, P3139, DOI 10.1073/pnas.1620767114; Sakamoto K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005121; Sambrook J., MOL CLONING LAB MANU; Schneider I, 2013, TRENDS GENET, V29, P419, DOI 10.1016/j.tig.2013.01.012; Scotti M, 2015, GENESIS, V53, P366, DOI 10.1002/dvg.22859; Sheth R, 2013, DEVELOPMENT, V140, P2130, DOI 10.1242/dev.089409; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOROGOOD P, 1991, NATO ADV SCI I A-LIF, V205, P347; Tulenko FJ, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2780; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773; WOOD A, 1984, J CELL SCI, V66, P205; Yano T, 2013, J ANAT, V222, P100, DOI 10.1111/j.1469-7580.2012.01491.x; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137	62	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192500	10.1371/journal.pone.0192500	http://dx.doi.org/10.1371/journal.pone.0192500			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420592	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900084
J	Laucou, V; Launay, A; Bacilieri, R; Lacombe, T; Adam-Blondon, AF; Berard, A; Chauveau, A; de Andres, MT; Hausmann, L; Ibanez, J; Le Paslier, MC; Maghradze, D; Martinez-Zapater, JM; Maul, E; Ponnaiah, M; Topfer, R; Peros, JP; Boursiquot, JM				Laucou, Valerie; Launay, Amandine; Bacilieri, Roberto; Lacombe, Thierry; Adam-Blondon, Anne-Francoise; Berard, Aurelie; Chauveau, Aurelie; Teresa de Andres, Maria; Hausmann, Ludger; Ibanez, Javier; Le Paslier, Marie-Christine; Maghradze, David; Miguel Martinez-Zapater, Jose; Maul, Erika; Ponnaiah, Maharajah; Topfer, Reinhard; Peros, Jean-Pierre; Boursiquot, Jean-Michel			Extended diversity analysis of cultivated grapevine Vitis vinifera with 10K genome-wide SNPs	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION-STRUCTURE; CANDIDATE GENES; EVOLUTION; IDENTIFICATION; ASSOCIATION; SOFTWARE; L.; DIFFERENTIATION; DOMESTICATION	Grapevine is a very important crop species that is mainly cultivated worldwide for fruits, wine and juice. Identification of the genetic bases of performance traits through association mapping studies requires a precise knowledge of the available diversity and how this diversity is structured and varies across the whole genome. An 18k SNP genotyping array was evaluated on a panel of Vitis vinifera cultivars and we obtained a data set with no missing values for a total of 10207 SNPs and 783 different genotypes. The average inter-SNP spacing was similar to 47 kbp, the mean minor allele frequency (MAF) was 0.23 and the genetic diversity in the sample was high (He = 0.32). Fourteen SNPs, chosen from those with the highest MAF values, were sufficient to identify each genotype in the sample. Parentage analysis revealed 118 full parentages and 490 parent-offspring duos, thus confirming the close pedigree relationships within the cultivated grapevine. Structure analyses also confirmed the main divisions due to an eastern-western gradient and human usage (table vs. wine). Using a multivariate approach, we refined the structure and identified a total of eight clusters. Both the genetic diversity (He, 0.26-0.32) and linkage disequilibrium (LD, 28.8-58.2 kbp) varied between clusters. Despite the short span LD, we also identified some non-recombining haplotype blocks that may complicate association mapping. Finally, we performed a genome-wide association study that confirmed previous works and also identified new regions for important performance traits such as acidity. Taken together, all the results contribute to a better knowledge of the genetics of the cultivated grapevine.	[Laucou, Valerie; Launay, Amandine; Bacilieri, Roberto; Lacombe, Thierry; Peros, Jean-Pierre; Boursiquot, Jean-Michel] Univ Montpellier, INRA, AGAP, CIRAD,Montpellier SupAgro, Montpellier, France; [Lacombe, Thierry; Boursiquot, Jean-Michel] INRA, Unite Expt Vassal, Ctr Ressources Biol Vigne, Marseillan Plage, France; [Adam-Blondon, Anne-Francoise] Univ Paris Saclay, URGV, CNRS, INRA, Evry, France; [Berard, Aurelie; Chauveau, Aurelie; Le Paslier, Marie-Christine; Ponnaiah, Maharajah] Univ Paris Saclay, EPGV, CEA, IG CNG,INRA, Evry, France; [Teresa de Andres, Maria] IMIDRA, Finca El Encin, Madrid, Spain; [Hausmann, Ludger; Maul, Erika; Topfer, Reinhard] Inst Grapevine Breeding Geilweilerhof, JKI, Siebeldingen, Germany; [Ibanez, Javier; Miguel Martinez-Zapater, Jose] Univ La Rioja, CSIC, ICVV, Logrono, Spain; [Maghradze, David] Natl Wine Agcy Georgia, Tbilisi, Georgia; [Ponnaiah, Maharajah] Univ UPMC, LBD, CNRS, INSERM, Paris, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Laucou, V (corresponding author), Univ Montpellier, INRA, AGAP, CIRAD,Montpellier SupAgro, Montpellier, France.	valerie.laucou@inra.fr	Hausmann, Ludger/H-7869-2017; Ponnaiah/D-6142-2018; de Andres, María Teresa/B-4850-2008; Ibáñez, Javier/B-4094-2010; Hausmann, Ludger/GRR-4424-2022	Hausmann, Ludger/0000-0002-4046-9626; Ponnaiah/0000-0001-7761-4228; de Andres, María Teresa/0000-0003-0082-1784; Ibáñez, Javier/0000-0002-6286-5638; Hausmann, Ludger/0000-0002-4046-9626; Maghradze, David/0000-0001-8197-9502	Research project of Transnational Plant Alliance for Novel Technologies toward implementing the Knowledge Based Bio-Economy (PLANT - KBBE) in Europe (France, Germany and Spain)	Research project of Transnational Plant Alliance for Novel Technologies toward implementing the Knowledge Based Bio-Economy (PLANT - KBBE) in Europe (France, Germany and Spain)	The GrapeReSeq project (Large scale re sequencing in the Vitis genus for identification of resistance genes, SNP discovery and high throughput genotyping) was funded by Research project of Transnational Plant Alliance for Novel Technologies toward implementing the Knowledge Based Bio-Economy (PLANT - KBBE2008) in Europe (France, Germany and Spain). Coordinator: Anne-Francoise Adam-Blondon. https://urgi.versailles.inra.fr/Proiects/Achieved-proiects/GrapeReSeq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegenet Jombart T., 2008, BIOINFORMATICS, V24; ALLEWELDT G, 1988, THEOR APPL GENET, V75, P669, DOI 10.1007/BF00265585; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Bacilieri R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-25; Battilana J, 2009, THEOR APPL GENET, V118, P653, DOI 10.1007/s00122-008-0927-8; Bouby L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063195; BOURSIQUOT JM, 1987, AGRONOMIE, V7, P13, DOI 10.1051/agro:19870102; Bowers J, 1999, SCIENCE, V285, P1562, DOI 10.1126/science.285.5433.1562; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cabezas JA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-153; Caroli S, 2011, MOL ECOL RESOUR, V11, P733, DOI 10.1111/j.1755-0998.2011.02993.x; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Cipriani G, 2010, THEOR APPL GENET, V121, P1569, DOI 10.1007/s00122-010-1411-9; Correa J, 2014, THEOR APPL GENET, V127, P1143, DOI 10.1007/s00122-014-2286-y; Costantini L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-38; Cunha J, 2015, VITIS, V54, P59; De Andres MT, 2012, MOL ECOL, V21, P800, DOI 10.1111/j.1365-294X.2011.05395.x; De Lorenzis G, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0510-9; Di Vecchi-Staraz M, 2008, J HEREDITY, V100; Doligez A, 2006, MOL BREEDING, V18, P109, DOI 10.1007/s11032-006-9016-3; Doligez A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-217; Duchene E, 2009, THEOR APPL GENET, V118, P541, DOI 10.1007/s00122-008-0919-8; Duchene E, 2012, THEOR APPL GENET, V124, P623, DOI 10.1007/s00122-011-1734-1; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Emanuelli F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-241; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fanizza G, 2005, THEOR APPL GENET, V111, P658, DOI 10.1007/s00122-005-2016-6; Fechter I, 2014, THEOR APPL GENET, V127, P1857, DOI 10.1007/s00122-014-2310-2; Fechter I, 2012, MOL GENET GENOMICS, V287, P247, DOI 10.1007/s00438-012-0674-z; Fischer BM, 2004, THEOR APPL GENET, V108, P501, DOI 10.1007/s00122-003-1445-3; Fournier-Level A, 2010, HEREDITY, V104, P351, DOI 10.1038/hdy.2009.148; Fournier-Level A, 2009, GENETICS, V183, P1127, DOI 10.1534/genetics.109.103929; Freeman DC, 1997, BOT REV, V63, P65, DOI 10.1007/BF02857918; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gel B, 2017, BIOINFORMATICS; Gerber S, 2003, MOL ECOLOGY NOTES, V3; Ghaffari S, 2014, TREE GENET GENOMES, V10, P1103, DOI 10.1007/s11295-014-0746-9; Gomez A., 2007, REFUGIA REFUGIA PATT; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; Grzeskowiak L, 2013, THEORETICAL APPL GEN, V126; Zinelabidine LH, 2012, AM J ENOL VITICULT, V63, P121, DOI 10.5344/ajev.2011.11052; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hill W, 1988, THEORETICAL POPULATI, V33; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Ibanez J, 2012, AM J ENOL VITICULT, V63, P549, DOI 10.5344/ajev.2012.12012; Ibanez J, 2009, THEOR APPL GENET, V119, P1213, DOI 10.1007/s00122-009-1122-2; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lacombe T, 2013, THEOR APPL GENET, V126, P401, DOI 10.1007/s00122-012-1988-2; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Le Paslier M. C., 2013, 9 INT S GRAP PHYS BI; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marrano A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170655; Maul E, 38 WORLD C VIN WINE2; McGovern PE, 2003, ANCIENT WINE SEARCH; Mejia N, 2007, AM J ENOL VITICULT, V58, P499; Mejia N, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-57; Mercati F, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1021-z; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Negrul AM, 1946, AMPELOGRAPHY USSR; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicolas SD, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0754-z; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Picq S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0229-z; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruffa P, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1006-y; Salmaso M, 2004, MOL BREEDING, P14; Team RC, 2012, R LANG ENV STAT COMP; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Topfer R, 2011, GENETICS GENOMICS BR; Winkler AJ, 1974, GEN VITICULTURE; Winter DJ, 2012, MOL ECOL RESOUR, V12, P1158, DOI 10.1111/j.1755-0998.2012.03174.x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou YF, 2017, P NATL ACAD SCI USA, V114, P11715, DOI 10.1073/pnas.1709257114; Zinelabidine LH, 2015, VITIS, V54, P81; Zohary D., 1996, NEAR E ORIGINS ANCIE, P23; Zyprian E, 2015, VITIS, V54, P29	101	86	91	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192540	10.1371/journal.pone.0192540	http://dx.doi.org/10.1371/journal.pone.0192540			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420602	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900090
J	Tang, H; Xu, LX; Hu, FX				Tang, Hao; Xu, Liuxiong; Hu, Fuxiang			Hydrodynamic characteristics of knotted and knotless purse seine netting panels as determined in a flume tank	PLOS ONE			English	Article							FISH CAGES; NETS; DRAG	Nylon (PA) netting is widely used in purse seines and other fishing gears due to its high strength and good sinking performance. However, hydrodynamic properties of nylon netting of different characteristics are poorly understood. This study investigated hydrodynamic characteristics of nylon netting of different knot types and solidity ratios under different attack angles and flow velocities. It was found that the hydrodynamic coefficient of netting panels was related to Reynolds number, solidity ratio, attack angle, knot type and twine construction. The solidity ratio was found to positively correlate with drag coefficient when the netting was normal to the flow (C-D90), but not the case when the netting was parallel to the flow (C-D0). For netting panels inclined to the flow, the inclined drag coefficient had a negative relationship with the solidity ratio for attack angles between 0 degrees and 50 degrees, but a positive relationship for attack angles between 50 degrees and 90 degrees. The lift coefficient increased with the attack angle, reaching the culminating point at an attack angle of 50 degrees, before subsequent decline. We found that the drag generated by knot accounted for 15-25% of total drag, and the knotted netting with higher solidity ratio exhibited a greater C-D0, but it was not the case for the knotless netting. Compared to knotless polyethylene (PE) netting, the drag coefficients of knotless PA netting were dominant at higher Reynolds number (Re>2200).	[Tang, Hao; Xu, Liuxiong] Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China; [Tang, Hao] Tongji Univ, Sch Ocean & Earth Sci, Shanghai, Peoples R China; [Xu, Liuxiong] Natl Engn Res Ctr Ocean Fisheries, Shanghai, Peoples R China; [Xu, Liuxiong; Hu, Fuxiang] Shanghai Educ Commiss, Summit & Highland Discipline Construct Fisherie, Shanghai, Peoples R China; [Hu, Fuxiang] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Minato Ku, Tokyo, Japan	Shanghai Ocean University; Tongji University; National Engineering Research Center for Oceanic Fisheries; Tokyo University of Marine Science & Technology	Xu, LX (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China.; Xu, LX (corresponding author), Natl Engn Res Ctr Ocean Fisheries, Shanghai, Peoples R China.; Xu, LX (corresponding author), Shanghai Educ Commiss, Summit & Highland Discipline Construct Fisherie, Shanghai, Peoples R China.	lxxu@shou.edu.cn	Tang, Hao/GXH-6097-2022	Tang, Hao/0000-0002-3393-1683	Shanghai Education Commission "Summit and Highland" Discipline Construction for Fisheries Sciences [B2-5005-13-0001-5]; "Summit and Highland" Discipline Construction for Fisheries Sciences, the Shanghai Education Commission [B2-5005-13-0001-5]	Shanghai Education Commission "Summit and Highland" Discipline Construction for Fisheries Sciences; "Summit and Highland" Discipline Construction for Fisheries Sciences, the Shanghai Education Commission	Funding for this project was provided by the Shanghai Education Commission Summit and Highland Discipline Construction for Fisheries Sciences (No. B2-5005-13-0001-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by Summit and Highland Discipline Construction for Fisheries Sciences, the Shanghai Education Commission (No. B2-5005-13-0001-5). We would like to express many thanks to Shuchuang Dong from Tokyo University of Marine Science and Technology for his assistance in experimental work. Our thanks also extend to Professor He Pingguo, University of Massachusetts for his critical comments and English edits.	AARSNES JV, 1990, ENGINEERING FOR OFFSHORE FISH FARMING, P137; Balash C, 2009, AQUACULT ENG, V41, P14, DOI 10.1016/j.aquaeng.2009.04.003; Cha BJ, 2013, AQUACULT ENG, V56, P79, DOI 10.1016/j.aquaeng.2013.05.002; Fridman AL, 1976, RYBOLOVNOE HOZYAJSTV, V6, P38; Hosseini SA, 2011, FISHERIES SCI, V77, P503, DOI 10.1007/s12562-011-0371-6; Kawakami T., 1964, MODERN FISHING GEAR, V2; Kim HY, 2007, FISH RES, V88, P109, DOI 10.1016/j.fishres.2007.08.007; Kumazawa T, 2012, NIPPON SUISAN GAKK, V78, P180, DOI 10.2331/suisan.78.180; LoLand G, 1991, CURRENT FORCES FLOW; Matsuda K., 2001, PHYS FISHING GEAR, P29; Milne P. H, 1979, FISH SHELLFISH FARMI, P185; Miyazaki Y., 1964, J TOKYO U FISH, V50, P95; Tsukrov I, 2003, OCEAN ENG, V30, P251, DOI 10.1016/S0029-8018(02)00021-5; Tsukrov I, 2011, OCEAN ENG, V38, P1979, DOI 10.1016/j.oceaneng.2011.09.019; Zhan JM, 2006, AQUACULT ENG, V35, P91, DOI 10.1016/j.aquaeng.2005.08.013; Zhou C, 2015, OCEAN ENG, V110, P89, DOI 10.1016/j.oceaneng.2015.09.043	16	13	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192206	10.1371/journal.pone.0192206	http://dx.doi.org/10.1371/journal.pone.0192206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420569	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900052
J	Overbosch, FW; Schinkel, J; Stolte, IG; Prins, M; Sonder, GJB				Overbosch, Femke W.; Schinkel, Janke; Stolte, Ineke G.; Prins, Maria; Sonder, Gerard J. B.			Dengue virus infection among long-term travelers from the Netherlands: A prospective study, 2008-2011	PLOS ONE			English	Article								Background Dengue is increasing rapidly in endemic regions. Data on incidence among travelers to these areas are limited. Five prospective studies have been performed thus far, mainly among short-term travelers. Objective To obtain the attack and incidence rate (AR, IR) of dengue virus (DENV) infection among long-term travelers and identify associated risk factors. Methods A prospective study was performed among long-term travelers (12-52 weeks) attending the Public Health Service in Amsterdam. Clients planning to travel to (sub) tropical countries were invited to participate. Participants kept a travel diary, recording itinerary, symptoms, and physician visits. Pre- and post-travel blood samples were serologically tested for the presence of Anti-DENV IgG antibodies. Seroconversion was considered suggestive of a primary DENV infection. Anti-DENV IgG present in both corresponding samples in combination with a post-/pre-travel ratio of >= 4:1 was suggestive of a secondary infection. Risk factors for a DENV infection were studied using poisson regression. Results In total, 600 participants were included; median age was 25 years (IQR: 23-29), 35.5% were male, and median travel duration was 20 weeks (IQR: 15-25). In 39 of 600 participants (AR: 6.5%; 95% CI 4.5-8.5%) anti-DENV IgG test results were suggestive of a recent infection, yielding an IR of 13.9 per 1,000 person-months traveling (95% CI: 9.9-19.1). No secondary infections were found. IR for Asia, Africa, and America were comparable and 13.5, 15.8, and 13.6 per 1,000 person-months respectively. Of participants with a recent DENV infection, 51% did not report dengue-like illness (DLI) or fever, but 10% were hospitalized. In multivariable analysis, travelers who seroconverted were significantly more likely to be vaccinated with >= 2 flavivirus vaccines for the current trip or to have reported DLI in >1 consecutive weeks. Conclusions Long-term travelers are at substantial risk of DENV infection. Half of those with a DENV infection reported no symptoms, but 10% were hospitalized, demonstrating the importance of advising anti-mosquito measures during travel.	[Overbosch, Femke W.; Sonder, Gerard J. B.] Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands; [Overbosch, Femke W.; Sonder, Gerard J. B.] Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands; [Schinkel, Janke] Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, Amsterdam, Netherlands; [Stolte, Ineke G.; Prins, Maria] Publ Hlth Serv GGD, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands; [Stolte, Ineke G.; Prins, Maria] Acad Med Ctr, Amsterdam Infect & Immun Inst AI&II, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands; [Sonder, Gerard J. B.] Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, Amsterdam, Netherlands; [Stolte, Ineke G.] Inholland, Fac Hlth Sports & Social Work, Haarlem, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Overbosch, FW (corresponding author), Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.; Overbosch, FW (corresponding author), Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands.	foverbosch@ggd.amsterdam.nl			Netherlands Organization for Health Research and Development (ZonMW) [12501 0001]; Public Health Service Amsterdam, the Netherlands	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Public Health Service Amsterdam, the Netherlands(Netherlands Government)	This study was conducted within the Amsterdam Academic Collaborative Center on Public Health: a collaboration between the Public Health Service of Amsterdam and the Academic Medical Center of the University of Amsterdam, the Netherlands. The Amsterdam Academic Collaborative Center on Public Health is financially supported by the Netherlands Organization for Health Research and Development (ZonMW; grant number 12501 0001) to GJBS. The study was funded by the Public Health Service Amsterdam, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baaten GGG, 2011, EMERG INFECT DIS, V17, P821, DOI 10.3201/eid1705.101125; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x; Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Landelijk Coo E rdinatiecentrum Reizigersadvisering, 2008, NATIONAL COORDINATIO; Leder K, 2013, TRAVEL MED INFECT DI, V11, P210, DOI 10.1016/j.tmaid.2013.06.008; McBride WJH, 1998, AM J TROP MED HYG, V59, P457, DOI 10.4269/ajtmh.1998.59.457; Overbosch FW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-493; Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14; Potasman I, 1999, EMERG INFECT DIS, V5, P824, DOI 10.3201/eid0506.990615; Ratnam I, 2012, EUR J CLIN MICROBIOL, V31, P1203, DOI 10.1007/s10096-011-1429-1; Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; UN-United Nations, 2012, WORLD POP PROSP 2012; Wilder-Smith A, 2015, J TRAVEL MED, V22, P200, DOI 10.1111/jtm.12198; World Health Organization, 2015, DENG OV 2012; World Health Organization, 2017, DENG AND SEV DENG; World Tourism Organization, 2015, UNWTO TOUR HIGHL 201	20	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192193	10.1371/journal.pone.0192193	http://dx.doi.org/10.1371/journal.pone.0192193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415063	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300056
J	Tsuboi, T; Maeda, M; Hayashi, T				Tsuboi, Tomoe; Maeda, Morihiko; Hayashi, Toshio			Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARDIOVASCULAR-DISEASE; CELLULAR SENESCENCE; CELLS; ATHEROSCLEROSIS; TELOMERASE; SUPPLEMENTATION; SUPEROXIDE; EXPRESSION; MECHANISM	L-citrulline and L-arginine supplementation has been shown to have several beneficial effects on the cardiovascular system. Nitric oxide (NO) protects against the progression of atherosclerosis and is synthesized by nitric oxide synthase (NOS), which converts L-arginine (L-Arg) into L-citrulline (L-Cit). Our previous study revealed that chronic administration of a combination of L-Cit and L-Arg has a better therapeutic effect on high cholesterol-induced atherosclerosis in rabbits. We investigated how L-Arg and L-Cit affect endothelial function, aging and atherosclerosis. Following a 3-day stimulation of human umbilical venous endothelial cells (HUVECs) with high glucose (HG: 22 mM) and L-Arg (300 mu M), L-Cit (300 mu M) or L-Arg plus L-Cit (LALC: each 150 mu M) supplementation, endothelial senescence and function were evaluated. These amino acids were also administered to dyslipidemic type 2 diabetic (ZDFM) rats fed a high cholesterol diet. They were fed L-Arg or L-Cit or LALC for four weeks. Aortic senescence was investigated by measuring senescence-associated beta-galactosidase (SA-beta-gal), telomerase activity, DNA damage and p16(INK4a) protein expression. Only L-Cit and LALC supplementation retarded the HG-induced endothelial senescence, as evaluated by SA-beta-gal activity, a widely used marker of cellular senescence, p16(INK4a) expression, a senescence-related protein, and DNA damage. Under HG conditions, L-Cit and LCLA restored telomerase activity to levels observed under normal glucose (NG) conditions. Under HG conditions, L-Cit decreased ROS production, as measured by CM-H(2)DCFDA and the expression of p67(phox), a major component of NADPH oxidase. Under HG conditions, L-Cit and LALC increased NO production, as measured by DAF-2AM. Endothelial NO synthase (eNOS) and phosphorylated eNOS were decreased under HG conditions and L-Cit and LALC significantly increased these levels. Arginase 2 protein expression increased under the HG conditions, and L-Cit and LALC significantly attenuated this effect. In ZDFM rats, SA-beta-gal activity was detected on the aortic endothelial surface; however, L-Cit and LALC reduced these levels. L-Cit and LALC both decreased the proportion of senescent cells. Furthermore, treatment with LALC for 4 weeks increased plasma NO production. Therefore conclusively, L-citrulline supplementation rescued NO levels better than L-arginine supplementation by inhibiting ROS production and arginase 2 protein expression. Consequently, L-Cit and LCLA supplementation retaeded HG-induced endothelial senescence.	[Tsuboi, Tomoe; Maeda, Morihiko; Hayashi, Toshio] Nagoya Univ, Grad Sch Med, Sch Hlth Sci, Dept Geriatr,Higashi Ku, Nagoya, Aichi, Japan; [Tsuboi, Tomoe] Chubu Univ, Grad Sch Biosci & Biotechnol, Matsumoto Cho, Kasugai, Aichi, Japan	Nagoya University; Chubu University	Hayashi, T (corresponding author), Nagoya Univ, Grad Sch Med, Sch Hlth Sci, Dept Geriatr,Higashi Ku, Nagoya, Aichi, Japan.	hayashi@med.nagoya-u.ac.jp	Hayashi, Toshio/I-7346-2014	Hayashi, Toshio/0000-0002-7711-2700	KYOWA HAKKO BIO CO., LTD.	KYOWA HAKKO BIO CO., LTD.	This work was supported by a grant from KYOWA HAKKO BIO CO., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from KYOWA HAKKO BIO CO., LTD.	Breitschopf K, 2001, FEBS LETT, V493, P21, DOI 10.1016/S0014-5793(01)02272-4; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Buys CHCM, 2000, NEW ENGL J MED, V342, P1282, DOI 10.1056/NEJM200004273421710; Dworakowski R, 2008, J AM COLL CARDIOL, V51, P1349, DOI 10.1016/j.jacc.2007.12.033; El-Kirsh AAA, 2011, CELL BIOCHEM FUNCT, V29, P414, DOI 10.1002/cbf.1766; Fukatsu A, 2007, AM J PHYSIOL-HEART C, V293, pH790, DOI 10.1152/ajpheart.01141.2006; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hardy TA, 2002, FREE RADICAL BIO MED, V32, P122, DOI 10.1016/S0891-5849(01)00781-X; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hayashi T, 2005, P NATL ACAD SCI USA, V102, P13681, DOI 10.1073/pnas.0506595102; HAYASHI T, 1991, ATHEROSCLEROSIS, V87, P23, DOI 10.1016/0021-9150(91)90229-V; Hayashi T, 2004, CARDIOVASC RES, V61, P339, DOI 10.1016/j.cardiores.2003.09.027; Hayashi T, 2014, PLOS ONE, pe88391; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P10485, DOI 10.1073/pnas.0603918103; Hayashi T, 2014, P NATL ACAD SCI USA, V111, P1168, DOI 10.1073/pnas.1322153111; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Ignarro Louis J, 2004, Curr Atheroscler Rep, V6, P281, DOI 10.1007/s11883-004-0059-9; Jamaluddin MS, 2014, CURR PHARM DESIGN, V20, P3563, DOI 10.2174/13816128113196660744; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Maeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123169; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Miyazaki-Akita A, 2007, J PHARMACOL EXP THER, V320, P591, DOI 10.1124/jpet.106.111641; Morita M, 2014, BIOCHEM BIOPH RES CO, V454, P53, DOI 10.1016/j.bbrc.2014.10.029; Ochiai M, 2012, INT J CARDIOL, V155, P257, DOI 10.1016/j.ijcard.2010.10.004; Resnick HE, 2001, J CLIN EPIDEMIOL, V54, P869, DOI 10.1016/S0895-4356(01)00359-6; Romero MJ, 2006, CARDIOVASC DRUG REV, V24, P275, DOI 10.1111/j.1527-3466.2006.00275.x; Scalera F, 2009, BIOCHEM BIOPH RES CO, V386, P650, DOI 10.1016/j.bbrc.2009.06.091; Simon A, 2003, CIRC RES, V93, P813, DOI 10.1161/01.RES.0000097761.19223.0D; van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yokoi N, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/103731; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634	36	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192252	10.1371/journal.pone.0192252	http://dx.doi.org/10.1371/journal.pone.0192252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415069	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300063
J	Kwon, A; John, M; Ruan, Z; Kannan, N				Kwon, Annie; John, Mihir; Ruan, Zheng; Kannan, Natarajan			Coupled regulation by the juxtamembrane and sterile motif (SAM) linker is a hallmark of ephrin tyrosine kinase evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; receptor tyrosine kinase; structure-function; protein sequence; bioinformatics; protein evolution	C-TERMINAL TAIL; CRYSTAL-STRUCTURE; PROTEIN-KINASES; EPHB2 RECEPTOR; DOMAIN; ACTIVATION; BINDING; MECHANISM; RESIDUES; EPHA3	Ephrin (Eph) receptor tyrosine kinases have evolutionarily diverged from other tyrosine kinases to respond to specific activation and regulatory signals that require close coupling of kinase catalytic and regulatory functions. However, the evolutionary basis for such functional coupling is not fully understood. We employed an evolutionary systems approach involving statistical mining of large sequence and structural data sets to define the hallmarks of Eph kinase evolution and functional specialization. We found that some of the most distinguishing Eph-specific residues structurally tether the flanking juxtamembrane and sterile motif (SAM) linker regions to the kinase domain, and substitutions of these residues in EphA3 resulted in faster kinase activation. We report for the first time that the SAM domain linker is functionally coupled to the juxtamembrane through co-conserved residues in the kinase domain and that together these residues provide a structural framework for coupling catalytic and regulatory functions. The unique organization of Eph-specific tethering networks and the identification of other Eph-specific sequence features of unknown functions provide new hypotheses for future functional studies and new clues to disease mutations altering Eph kinase-specific functions.	[Kwon, Annie; Ruan, Zheng; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [John, Mihir; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, 120 Green St, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kannan, N (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 Green St, Athens, GA 30602 USA.	nkannan@uga.edu		Ruan, Zheng/0000-0002-4412-4916	National Institutes of Health [5RO1GM114409]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5RO1GM114409 (to N. K). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Brunet FG, 2016, GENOME BIOL EVOL, V8, P1600, DOI 10.1093/gbe/evw103; Chen SG, 2007, PROTEIN SCI, V16, P572, DOI 10.1110/ps.062631007; Davis TL, 2008, STRUCTURE, V16, P873, DOI 10.1016/j.str.2008.03.008; Drescher U, 2002, CURR OPIN GENET DEV, V12, P397, DOI 10.1016/S0959-437X(02)00316-7; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gajiwala KS, 2013, PROTEIN SCI, V22, P995, DOI 10.1002/pro.2283; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Mirza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014310; Mohanty S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005885; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Neuwald AF, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-66; Neuwald AF, 2009, BIOINFORMATICS, V25, P1869, DOI 10.1093/bioinformatics/btp342; Oruganty K, 2013, P NATL ACAD SCI USA, V110, P924, DOI 10.1073/pnas.1207104110; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Plaza-Menacho I, 2016, CELL REP, V17, P3319, DOI 10.1016/j.celrep.2016.11.061; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schulze JO, 2016, CELL CHEM BIOL, V23, P1193, DOI 10.1016/j.chembiol.2016.06.017; Shi GF, 2010, CELL RES, V20, P1263, DOI 10.1038/cr.2010.115; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh DR, 2017, BBA-MOL CELL RES, V1864, P31, DOI 10.1016/j.bbamcr.2016.10.011; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; Singla N, 2011, CHEM BIOL, V18, P361, DOI 10.1016/j.chembiol.2011.01.011; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Nguyen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119636; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xi G, 2010, J BIOL CHEM, V285, P6937, DOI 10.1074/jbc.M109.069872; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	56	10	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5102	5116		10.1074/jbc.RA117.001296	http://dx.doi.org/10.1074/jbc.RA117.001296			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29432127	Green Published, hybrid			2022-12-26	WOS:000429409300017
J	Morgan, R; Keen, J; Halligan, D; O'Callaghan, A; Andrew, R; Livingstone, D; Abernethie, A; Maltese, G; Walker, B; Hadoke, P				Morgan, Ruth; Keen, John; Halligan, Daniel; O'Callaghan, Alan; Andrew, Ruth; Livingstone, Dawn; Abernethie, Amber; Maltese, Giorgia; Walker, Brian; Hadoke, Patrick			Species-specific regulation of angiogenesis by glucocorticoids reveals contrasting effects on inflammatory and angiogenic pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOSTATIC STEROIDS; CELL MIGRATION; GENE ONTOLOGY; EXPRESSION; RAT; PROTEINS; CANCER; DIFFERENTIATION; CORTICOSTEROIDS	Glucocorticoids are potent inhibitors of angiogenesis in the rodent in vivo and in vitro but the mechanism by which this occurs has not been determined. Administration of glucocorticoids is used to treat a number of conditions in horses but the angiogenic response of equine vessels to glucocorticoids and, therefore, the potential role of glucocorticoids in pathogenesis and treatment of equine disease, is unknown. This study addressed the hypothesis that glucocorticoids would be angiostatic both in equine and murine blood vessels. The mouse aortic ring model of angiogenesis was adapted to assess the effects of cortisol in equine vessels. Vessel rings were cultured under basal conditions or exposed to: foetal bovine serum (FBS; 3%); cortisol (600 nM), cortisol (600nM) plus FBS (3%), cortisol (600nM) plus either the glucocorticoid receptor antagonist RU486 or the mineralocorticoid receptor antagonist spironolactone. In murine aortae cortisol inhibited and FBS stimulated new vessel growth. In contrast, in equine blood vessels FBS alone had no effect but cortisol alone, or in combination with FBS, dramatically increased new vessel growth compared with controls. This effect was blocked by glucocorticoid receptor antagonism but not by mineralocorticoid antagonism. The transcriptomes of murine and equine angiogenesis demonstrated cortisolinduced down-regulation of inflammatory pathways in both species but up-regulation of proangiogenic pathways selectively in the horse. Genes up-regulated in the horse and downregulated in mice were associated with the extracellular matrix. These data call into question our understanding of glucocorticoids as angiostatic in every species and may be of clinical relevance in the horse.	[Morgan, Ruth; Andrew, Ruth; Livingstone, Dawn; Abernethie, Amber; Maltese, Giorgia; Walker, Brian; Hadoke, Patrick] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Morgan, Ruth; Keen, John] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Halligan, Daniel; O'Callaghan, Alan] Fios Genom Ltd, Edinburgh Bioquarter 9, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Morgan, R (corresponding author), Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.; Morgan, R (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	ruth.morgan@ed.ac.uk	Andrew, Ruth/C-2727-2008	Andrew, Ruth/0000-0002-6916-2994; Halligan, Daniel/0000-0003-4726-6343; Keen, John/0000-0002-7862-5321; Morgan, Ruth/0000-0003-1117-2273	Biological and Biotechnological Sciences Research Council; Zoetis Animal Health [R42126, R82976]; PetPlan Insurance [S13-62]; Biotechnology and Biological Sciences Research Council [1151241] Funding Source: researchfish; British Heart Foundation [RG/11/4/28734] Funding Source: researchfish	Biological and Biotechnological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis Animal Health; PetPlan Insurance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by the Biological and Biotechnological Sciences Research Council and Zoetis Animal Health (Grant No R42126 and R82976, author RAM,) with additional funding from PetPlan Insurance (S13-62). Work was carried out at the British Heart Foundation Centre of Research Excellence at the University of Edinburgh. Authors DH and AO are employed by FIOS Genomics Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials.	ACKERMAN N, 1975, J AM VET MED ASSOC, V166, P58; Ahluwalia A, 2010, J PHYSIOL PHARMACOL, V61, P133; ALLEN D, 1990, AM J VET RES, V51, P1930; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Briggs RC, 2006, CANCER RES, V66, P4645, DOI 10.1158/0008-5472.CAN-06-0229; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; Chuang TD, 2015, AM J PHYSIOL-CELL PH, V309, pC117, DOI 10.1152/ajpcell.00254.2014; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Cui M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16455; DEJANA E, 1985, J CLIN INVEST, V75, P11, DOI 10.1172/JCI111661; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Drebert Z, 2017, VASC PHARMACOL, V89, P19, DOI 10.1016/j.vph.2016.10.004; Dutta S, 2016, SCI REPORTS, P6; El Zaoui I, 2015, TOXICOL SCI, V143, P441, DOI 10.1093/toxsci/kfu243; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; FOLKMAN J, 1987, ANN SURG, V206, P374, DOI 10.1097/00000658-198709000-00016; Glynn ERA, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-40; Go Ronald S., 2003, Angiogenesis, V6, P25, DOI 10.1023/A:1025876030744; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Hayashi Y, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0088-z; Hida K, 2016, PATHOL INT, V66, P687, DOI 10.1111/pin.12474; HOOD DM, 1994, EQUINE VET J, V26, P191, DOI 10.1111/j.2042-3306.1994.tb04368.x; Hori Y, 1996, BRIT J PHARMACOL, V118, P1584, DOI 10.1111/j.1476-5381.1996.tb15578.x; Huang XD, 2014, PATHOL RES PRACT, V210, P719, DOI 10.1016/j.prp.2014.07.001; Johnson PJ, 2004, COMP CONT EDUC PRACT, V26, P547; Johnson PJ, 2004, EQUINE VET J, V36, P41, DOI 10.2746/0425164044864750; Johnson PJ, 2002, VET CLIN N AM-EQUINE, V18, P219, DOI 10.1016/S0749-0739(02)00015-9; Jung Sung P., 2001, Angiogenesis, V4, P175, DOI 10.1023/A:1014089706107; Kaczynski P, 2016, REPRODUCTION, V151, P539, DOI 10.1530/REP-15-0496; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keen John A., 2008, Journal of Pharmacological and Toxicological Methods, V57, P92, DOI 10.1016/j.vascn.2007.10.005; KEIGHTLEY MC, 1995, STEROIDS, V60, P87, DOI 10.1016/0039-128X(94)00014-4; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Lahteenvuo J, 2012, CIRC RES, V110, P1252, DOI 10.1161/CIRCRESAHA.111.246116; Lin YC, 2017, ARTERIOSCL THROM VAS, V37, P144, DOI 10.1161/ATVBAHA.116.308546; Logie JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014476; LONGENECKER JP, 1982, J CELL PHYSIOL, V113, P197, DOI 10.1002/jcp.1041130203; Lopez-Ilasaca M, 2003, MOL BIOL CELL, V14, P5038, DOI 10.1091/mbc.E03-06-0383; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; MARAGOUDAKIS ME, 1989, J PHARMACOL EXP THER, V251, P679; Mayer W, 2000, DEV DYNAM, V217, P1, DOI 10.1002/(SICI)1097-0177(200001)217:1<1::AID-DVDY1>3.0.CO;2-4; Mitre-Aguilar IB, 2015, INT J CLIN EXP PATHO, V8, P1; Mongiat M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111822; Morgan RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163815; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; NICOSIA RF, 1990, LAB INVEST, V63, P115; NIXON AJ, 1992, AM J VET RES, V53, P2364; PEPINE CJ, 1990, CIRCULATION, V81, P1753, DOI 10.1161/01.CIR.81.6.1753; Pivonello R, 2016, LANCET DIABETES ENDO, V4, P611, DOI 10.1016/S2213-8587(16)00086-3; Pross C, 2002, J VASC SURG, V35, P1253, DOI 10.1067/mva.2002.123332; Riessen R, 2001, ARTERIOSCL THROM VAS, V21, P47, DOI 10.1161/01.ATV.21.1.47; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Shikatani EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046625; Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Tahergorabi Z, 2012, INT J PREVENTIVE MED, V3, P827, DOI 10.4103/2008-7802.104853; Taintor J, 2011, EQUINE VET EDUC, V23, P205, DOI 10.1111/j.2042-3292.2010.00200.x; Thiruchelvam U, 2016, J LEUKOCYTE BIOL, V99, P1165, DOI 10.1189/jlb.5A0215-061RR; Wagener R, 1998, FEBS LETT, V436, P123, DOI 10.1016/S0014-5793(98)01111-9; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Wang AS, 2013, AM J SURG, V206, P410, DOI 10.1016/j.amjsurg.2012.11.018; Wykoff CC, 2017, CURR OPIN OPHTHALMOL, V28, P213, DOI 10.1097/ICU.0000000000000364; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106	72	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192746	10.1371/journal.pone.0192746	http://dx.doi.org/10.1371/journal.pone.0192746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447208	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900050
J	Steffensen, JL; Dufault-Thompson, K; Zhang, Y				Steffensen, Jon Lund; Dufault-Thompson, Keith; Zhang, Ying			FindPrimaryPairs: An efficient algorithm for predicting element-transferring reactant/product pairs in metabolic networks	PLOS ONE			English	Article							BIOCHEMICAL REACTIONS; PATHWAYS; VISUALIZATION; CYTOSCAPE; MODELS; KEGG	The metabolism of individual organisms and biological communities can be viewed as a network of metabolites connected to each other through chemical reactions. In metabolic networks, chemical reactions transform reactants into products, thereby transferring elements between these metabolites. Knowledge of how elements are transferred through reactant/product pairs allows for the identification of primary compound connections through a metabolic network. However, such information is not readily available and is often challenging to obtain for large reaction databases or genome-scale metabolic models. In this study, a new algorithm was developed for automatically predicting the element-transferring reactant/product pairs using the limited information available in the standard representation of metabolic networks. The algorithm demonstrated high efficiency in analyzing large datasets and provided accurate predictions when benchmarked with manually curated data. Applying the algorithm to the visualization of metabolic networks highlighted pathways of primary reactant/product connections and provided an organized view of element-transferring biochemical transformations. The algorithm was implemented as a new function in the open source software package PSAMM in the release v0.30 (https://zhanglab.github.io/psamm/).	[Steffensen, Jon Lund; Dufault-Thompson, Keith; Zhang, Ying] Univ Rhode Isl, Coll Environm & Life Sci, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Rhode Island	Zhang, Y (corresponding author), Univ Rhode Isl, Coll Environm & Life Sci, Dept Cell & Mol Biol, Kingston, RI 02881 USA.	yingzhang@uri.edu	Zhang, Ying/ABA-6518-2021	Zhang, Ying/0000-0001-8759-0194; Dufault-Thompson, Keith/0000-0002-0991-2255	National Science Foundation [1553211]; USDA National Institute of Food and Agriculture [RI0015-H002, 1007170]; National Science Foundation EPSCoR [1655221]; Div Of Biological Infrastructure [1553211] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation EPSCoR(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation under grant #1553211 and the USDA National Institute of Food and Agriculture, Hatch fund, RI0015-H002, accession #1007170. KDT was supported in part by the National Science Foundation EPSCoR Cooperative Agreement 1655221. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agency.	Bourqui R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-29; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Croes D, 2006, J MOL BIOL, V356, P222, DOI 10.1016/j.jmb.2005.09.079; Dufault-Thompson K, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00165-16; Fooshee D, 2013, J CHEM INF MODEL, V53, P2812, DOI 10.1021/ci400326p; He S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-31; Heinonen M, 2011, J COMPUT BIOL, V18, P43, DOI 10.1089/cmb.2009.0216; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Jensen PA, 2014, BIOINFORMATICS, V30, P1327, DOI 10.1093/bioinformatics/btt758; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; King ZA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004321; Konig M, 2012, BIOINFORMATICS, V28, P2402, DOI 10.1093/bioinformatics/bts432; Latendresse M, 2012, J CHEM INF MODEL, V52, P2970, DOI 10.1021/ci3002217; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; McShan DC, 2003, BIOINFORMATICS, V19, P1692, DOI 10.1093/bioinformatics/btg217; Noronha A, 2017, BIOINFORMATICS, V33, P605, DOI 10.1093/bioinformatics/btw667; Noronha A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0420-0; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Pey J, 2014, BIOINFORMATICS, V30, P975, DOI 10.1093/bioinformatics/btt653; Planes FJ, 2009, DISCRETE APPL MATH, V157, P2244, DOI 10.1016/j.dam.2008.06.035; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steffensen JL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004732; Tervo CJ, 2016, BIOTECHNOL J, P1; Villeger AC, 2010, BIOINFORMATICS, V26, P1470, DOI 10.1093/bioinformatics/btq154; Yamada T, 2005, GENOME INFORM	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192891	10.1371/journal.pone.0192891	http://dx.doi.org/10.1371/journal.pone.0192891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447218	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900066
J	Baskin, E				Baskin, Ernest			Increasing influenza vaccination rates via low cost messaging interventions	PLOS ONE			English	Article							IMPLEMENTATION INTENTIONS; MONETARY INCENTIVES; REGULATORY FOCUS; HEALTH BEHAVIOR; IMMUNIZATION; METAANALYSIS; PERFORMANCE; PREVENTION; BARRIERS; PROMPTS	This article tests low cost interventions to increase influenza vaccination rates. By changing an email announcement sent out to employees in 2014 (n > 30,000), the following interventions are tested: incentives, attention to the negative impacts of not get vaccinated, and showing a map to the vaccination centers at the end of the email announcement. Only the map condition helped increase influenza vaccination rates. The use of low-cost interventions can improve influenza vaccination rates though not all interventions work as well as others in the field. In particular, while including maps helped increase vaccination rates, other factors such as negative impact reminders and incentives, which previous studies have found to be successful in the laboratory, did not.	[Baskin, Ernest] St Josephs Univ, Dept Food Mkt, Haub Sch Business, Philadelphia, PA 19131 USA	Saint Joseph's University	Baskin, E (corresponding author), St Josephs Univ, Dept Food Mkt, Haub Sch Business, Philadelphia, PA 19131 USA.	ebaskin@sju.edu	Baskin, Ernest/HGB-2757-2022	Baskin, Ernest/0000-0001-9484-2839				Anderson D, 1980, J SCH HLTH, V50, P50; Baas M, 2008, PSYCHOL BULL, V134, P779, DOI 10.1037/a0012815; BARTON MB, 1990, AM J PUBLIC HEALTH, V80, P534, DOI 10.2105/AJPH.80.5.534; Bonner SE, 2002, ACCOUNT ORG SOC, V27, P303, DOI 10.1016/S0361-3682(01)00052-6; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brownell KD, 1980, AM J PSYCHIAT; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; CATE TR, 1987, AM J MED, V82, P15, DOI 10.1016/0002-9343(87)90555-9; CDC, 2017, NAT IMM SURV; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chapman GB., 2016, BEHAV SCI POLICY, V2, P40, DOI DOI 10.1353/BSP.2016.0014; Chapman GB, 2010, JAMA-J AM MED ASSOC, V304, P43, DOI 10.1001/jama.2010.892; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Dempsey AF, 2015, AM J PREV MED, V49, pS445, DOI 10.1016/j.amepre.2015.04.013; Dolan MS, 2006, OBES REV, V7, P25, DOI 10.1111/j.1467-789X.2006.00219.x; Flatt K, 1996, 124 ANN M EXP AM PUB; Getsinger C., 2014, ONSITE FLU SHOTS SAV; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Grivas PD, 2017, J CANCER EDUC, V32, P871, DOI 10.1007/s13187-016-1017-2; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; JEFFERSON N, 1987, BRIT MED J, V294, P423, DOI 10.1136/bmj.294.6569.423; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Johnson EJ, 2012, MARKET LETT, V23, P487, DOI 10.1007/s11002-012-9186-1; Kalantar JS, 1999, J CLIN EPIDEMIOL, V52, P1117, DOI 10.1016/S0895-4356(99)00051-7; LEVENTHAL H, 1965, J PERS SOC PSYCHOL, V2, P20, DOI 10.1037/h0022089; Milkman KL, 2011, P NATL ACAD SCI USA, V108, P10415, DOI 10.1073/pnas.1103170108; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Moran WP, 1996, AM J MED, V101, P612, DOI 10.1016/S0002-9343(96)00327-0; Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Perez C., 2016, RT DECISION MAKERS R, V29, P14; SCHOENBAUM SC, 1987, AM J MED, V82, P26, DOI 10.1016/0002-9343(87)90557-2; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Stinchfield PK, 2008, AM J MED, V121, pS11, DOI 10.1016/j.amjmed.2008.05.003; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Wall J, 2006, NUTR REV, V64, P518, DOI [10.1301/nr.2006.dec.518-531, 10.1111/j.1753-4887.2006.tb00185.x]; Westman S, 1997, AM J PUBLIC HEALTH, V87, P293	37	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192594	10.1371/journal.pone.0192594	http://dx.doi.org/10.1371/journal.pone.0192594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW3CM	29444147	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500076
J	Gill, RM; O'Brien, M; Young, A; Gardiner, D; Mailloux, RJ				Gill, Robert M.; O'Brien, Marisa; Young, Adrian; Gardiner, Danielle; Mailloux, Ryan J.			Protein S-glutathionylation lowers superoxide/hydrogen peroxide release from skeletal muscle mitochondria through modification of complex I and inhibition of pyruvate uptake	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; REDOX REGULATION; CYS RESIDUES; OXIDATION; GLUTAREDOXIN-2; DEHYDROGENASE; EMISSION; PROGRESS; INJURY; HEART	Protein S-glutathionylation is a reversible redox modification that regulates mitochondrial metabolism and reactive oxygen species (ROS) production in liver and cardiac tissue. However, whether or not it controls ROS release from skeletal muscle mitochondria has not been explored. In the present study, we examined if chemically-induced protein S-glutathionylation could alter superoxide (O-2(center dot-))/hydrogen peroxide (H2O2) release from isolated muscle mitochondria. Disulfiram, a powerful chemical S-glutathionylation catalyst, was used to S-glutathionylate mitochondrial proteins and ascertain if it can alter ROS production. It was found that O-2(center dot-)/H2O2 release rates from permeabilized muscle mitochondria decreased with increasing doses of disulfiram (100-500 mu M). This effect was highest in mitochondria oxidizing succinate or palmitoyl-carnitine, where a similar to 80-90% decrease in the rate of ROS release was observed. Similar effects were detected in intact mitochondria respiring under state 4 conditions. Incubation of disulfiram-treated mitochondria with DTT (2 mM) restored ROS release confirming that these effects were associated with protein S-glutathionylation. Disulfiram treatment also inhibited phosphorylating and proton leak-dependent respiration. Radiolabelled substrate uptake experiments demonstrated that disulfiram inhibited pyruvate import but had no effect on carnitine uptake. Immunoblot analysis of complex I revealed that it contained several protein S-glutathionylation targets including NDUSF1, a subunit required for NADH oxidation. Taken together, these results demonstrate that O-2(center dot-)/H2O2 release from muscle mitochondria can be altered by protein S-glutathionylation. We attribute these changes to the protein S-glutathionylation complex I and inhibition of mitochondrial pyruvate carrier.	[Gill, Robert M.; O'Brien, Marisa; Young, Adrian; Gardiner, Danielle; Mailloux, Ryan J.] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada	Memorial University Newfoundland	Mailloux, RJ (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	rjmailloux@mun.ca		Mailloux, Ryan/0000-0003-3986-9830; O'Brien, Marisa/0000-0002-5040-894X	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-04829]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC # RGPIN-2016-04829).; We would like to thank Dr. John T. Brosnan and Kathy Clow for providing us with space and administrative support for the solute uptake assays. This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC # RGPIN-2016-04829).	Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056; Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Chalker J, 2018, REDOX BIOL, V15, P216, DOI 10.1016/j.redox.2017.12.006; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Giangregorio N, 2013, BBA-GEN SUBJECTS, V1830, P5299, DOI 10.1016/j.bbagen.2013.08.003; Giustarini D, 2015, FREE RADICAL BIO MED, V89, P972, DOI 10.1016/j.freeradbiomed.2015.10.410; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Jones DP, 2015, ANTIOXID REDOX SIGN, V23, P734, DOI 10.1089/ars.2015.6247; Kramer PA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00347; Kuksal N, 2017, BIOL CHEM, V398, P1209, DOI 10.1515/hsz-2017-0160; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lewis NA, 2015, SPORTS MED, V45, P379, DOI 10.1007/s40279-014-0276-5; Mailloux RJ, 2016, FREE RADICAL BIO MED, V97, P501, DOI 10.1016/j.freeradbiomed.2016.06.014; Mailloux RJ, 2016, REDOX BIOL, V8, P285, DOI 10.1016/j.redox.2016.02.002; Mailloux RJ, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00068; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mailloux RJ, 2014, J BIOL CHEM, V289, P14812, DOI 10.1074/jbc.M114.550574; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; Mailloux RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393538; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; McLain AL, 2013, FREE RADICAL BIO MED, V61, P161, DOI 10.1016/j.freeradbiomed.2013.03.020; O'Brien M, 2017, FREE RADICAL BIO MED, V106, P302, DOI 10.1016/j.freeradbiomed.2017.02.046; Pastore A, 2013, INT J MOL SCI, V14, P20845, DOI 10.3390/ijms141020845; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Pfefferle A, 2013, BBA-MOL CELL RES, V1833, P80, DOI 10.1016/j.bbamcr.2012.10.006; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Rossi R, 2006, BIOCHEM PHARMACOL, V72, P608, DOI 10.1016/j.bcp.2006.05.021; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Zhang YQ, 2013, FASEB J, V27, P3536, DOI 10.1096/fj.13-228130	43	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192801	10.1371/journal.pone.0192801	http://dx.doi.org/10.1371/journal.pone.0192801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444156	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500090
J	Kang, KW; Lee, SR; Kim, DS; Yu, ES; Sung, HJ; Kim, SJ; Choi, CW; Park, Y; Kim, BS				Kang, Ka-Won; Lee, Se Ryeon; Kim, Dae Sik; Yu, Eun Sang; Sung, Hwa Jung; Kim, Seok Jin; Choi, Chul Won; Park, Yong; Kim, Byung Soo			Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; CLINICAL-PRACTICE GUIDELINES; ATOMIC-BOMB SURVIVORS; CANCER-RISKS; CT SCANS; REMISSION; FOLLOW-UP(AEURO); CLASSIFICATION; POPULATION; DIAGNOSIS	Surveillance computed tomography (CT) is usual practice for patients with aggressive non-Hodgkin lymphoma (aNHL) in complete remission (CR). However, evidence to support this strategy is lacking. We retrospectively analyzed our institutional lymphoma registry, including patients with lymphoma consecutively enrolled from June 1995 to October 2016. Of 1,385 patients with aNHL, 664 achieved CR and were followed up with or without surveillance CT. Surveillance CT was performed for 609 patients every 3 or 6 months for the first 2 years, then every 6 or 12 months thereafter. Relapse was detected in 171 patients, of whom 152 underwent surveillance CT during follow-up. Of these 152 patients, asymptomatic relapse was detected in 67 (44%) using surveillance CT, and symptomatic relapse outside the surveillance interval was detected in the remaining 85 (56%). Detection of asymptomatic relapse using surveillance CT did not improve the overall or post-relapse survival in patients with relapsed aNHL. Surveillance CT interval (3 or 6 months) did not affect survival. No subgroups were identified that favored the use of surveillance CT to detect relapse. The results of this study suggest that routine surveillance CT in patients with aNHL to detect asymptomatic relapse might have a limited role in improving survival. CT is recommended when a relapse is clinically suspected.	[Kang, Ka-Won; Lee, Se Ryeon; Kim, Dae Sik; Yu, Eun Sang; Sung, Hwa Jung; Choi, Chul Won; Park, Yong; Kim, Byung Soo] Korea Univ, Div Hematol Oncol, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Seok Jin] Sungkyunkwan Univ, Div Hematol Oncol, Dept Internal Med, Sch Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU)	Park, Y; Kim, BS (corresponding author), Korea Univ, Div Hematol Oncol, Dept Internal Med, Coll Med, Seoul, South Korea.	paark76@hanmail.net; kbs0309@korea.ac.kr		Choi, Chul Won/0000-0002-3032-4239	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2750, HR14C0007]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by grants from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2750 and HR14C0007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2750 and HR14C0007).	American College of Radiology, 2016, ACR MANUAL ON CONTRA; Ansell SM, 2012, MAYO CLIN PROC, V87, P571, DOI 10.1016/j.mayocp.2012.03.006; Armitage JO, 2012, J CLIN ONCOL, V30, P2579, DOI 10.1200/JCO.2012.42.6189; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; CARBONE PP, 1971, CANCER RES, V31, P1860; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Crocchiolo R, 2009, ANN HEMATOL, V88, P1229, DOI 10.1007/s00277-009-0752-4; d'Amore F, 2015, ANN ONCOL, V26, pV108, DOI 10.1093/annonc/mdv201; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; El-Galaly TC, 2014, AM J HEMATOL, V89, P575, DOI 10.1002/ajh.23688; El-Galaly TC, 2015, J CLIN ONCOL, V33, P3993, DOI 10.1200/JCO.2015.62.0229; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Gandikota N, 2015, CANCER-AM CANCER SOC, V121, P1985, DOI 10.1002/cncr.29277; Goldschmidt N, 2011, ANN HEMATOL, V90, P165, DOI 10.1007/s00277-010-1044-8; Guppy AE, 2003, LEUKEMIA LYMPHOMA, V44, P123, DOI 10.1080/1042819021000040323; Hicks LK, 2013, BLOOD, V122, P3879, DOI 10.1182/blood-2013-07-518423; Horwitz SM, 2016, J NATL COMPR CANC NE, V14, P1067, DOI 10.6004/jnccn.2016.0117; Jones JGA, 2012, WEST J EMERG MED, V13, P202, DOI 10.5811/westjem.2011.11.6804; Launay-Vacher V, 2007, CANCER-AM CANCER SOC, V110, P1376, DOI 10.1002/cncr.22904; Liedtke M, 2006, ANN ONCOL, V17, P909, DOI 10.1093/annonc/mdl049; Lin TL, 2012, ANN HEMATOL, V91, P1741, DOI 10.1007/s00277-012-1508-0; Nabhan C, 2016, JAMA-J AM MED ASSOC, V315, P2115, DOI 10.1001/jama.2016.4913; Nikolsky Eugenia, 2003, Rev Cardiovasc Med, V4 Suppl 1, pS7; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Truong Q, 2014, CL LYMPH MYELOM LEUK, V14, P50, DOI 10.1016/j.clml.2013.08.009; Rose TA, 2015, AM J MED, V128, P943, DOI 10.1016/j.amjmed.2015.02.018; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Shenoy P, 2010, CL LYMPH MYELOM LEUK, V10, P270, DOI 10.3816/CLML.2010.n.056; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Tang T, 2016, CL LYMPH MYELOM LEUK, V16, P117, DOI 10.1016/j.clml.2015.12.006; Thompson CA, 2010, ANN ONCOL, V21, P2262, DOI 10.1093/annonc/mdq215; Thompson CA, 2014, J CLIN ONCOL, V32, P3506, DOI 10.1200/JCO.2014.55.7561; Tilly H, 2015, ANN ONCOL, V26, pV116, DOI 10.1093/annonc/mdv304; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, SOURCES AND EFFECTS	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192656	10.1371/journal.pone.0192656	http://dx.doi.org/10.1371/journal.pone.0192656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444176	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500082
J	Pelz, T; Drose, DR; Fleck, D; Henkel, B; Ackels, T; Spehr, M; Neuhaus, EM				Pelz, Thomas; Drose, Daniela R.; Fleck, David; Henkel, Bastian; Ackels, Tobias; Spehr, Marc; Neuhaus, Eva M.			An ancestral TMEM16 homolog from Dictyostelium discoideum forms a scramblase	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; OLFACTORY SENSORY NEURONS; SACCHAROMYCES-CEREVISIAE; BLOOD-COAGULATION; LIPID SCRAMBLASE; ION-CHANNEL; PROTEIN; ANOCTAMINS; EXPRESSION; PHOSPHATIDYLSERINE	TMEM16 proteins are a recently identified protein family comprising Ca2+-activated Cl- channels that generate outwardly rectifying ionic currents in response to intracellular Ca2+ elevations. Some TMEM16 family members, such as TMEM16F/ANO6 are also essential for Ca2+-dependent phospholipid scrambling. TMEM16-like genes are present in the genomes of most eukaryotic species, the function(s) of TMEM16 family members from evolutionary ancient eukaryotes is not completely clear. Here, we provide insight into the evolution of these TMEM16 proteins by similarity searches for ancestral sequences. All eukaryotic genomes contain TMEM16 homologs, but only vertebrates have the full repertoire of ten distinct subtypes. TMEM16 homologs studied so far belong to the opisthokont branch of the phylogenetic tree, which includes the animal and fungal kingdoms. An organism outside this group is Dictyostelium discoideum, a representative of the amoebozoa group that diverged from the metazoa before fungi. We here functionally investigated the TMEM16 family member from Dictyostelium discoideum. When recombinantly expressed in HEK293 cells, DdTMEM16 induces phospholipid scrambling. However, in several electrophysiological experiments we did not find evidence for a Ca2+-activated Cl- channel function of DdTMEM16.	[Pelz, Thomas; Henkel, Bastian; Neuhaus, Eva M.] Friedrich Schiller Univ Jena, Jena Univ Hosp, Pharmacol & Toxicol, Jena, Germany; [Pelz, Thomas; Henkel, Bastian; Neuhaus, Eva M.] Charite, Cluster Excellence NeuroCure, Berlin, Germany; [Drose, Daniela R.; Fleck, David; Ackels, Tobias; Spehr, Marc] Rhein Westfal TH Aachen, Inst Biol 2, Dept Chemosensat, Aachen, Germany; [Ackels, Tobias] Francis Crick Inst, Neurophysiol Behav Lab, London, England	Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; Francis Crick Institute	Neuhaus, EM (corresponding author), Friedrich Schiller Univ Jena, Jena Univ Hosp, Pharmacol & Toxicol, Jena, Germany.; Neuhaus, EM (corresponding author), Charite, Cluster Excellence NeuroCure, Berlin, Germany.	eva.neuhaus@med.uni-jena.de	Ackels, Tobias/AAU-7528-2021; Spehr, Marc/AAK-3162-2021; Spehr, Marc/B-3140-2011; Neuhaus, Eva/L-1428-2015	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Ackels, Tobias/0000-0002-4964-1162; Fleck, David/0000-0002-6692-2388; Neuhaus, Eva/0000-0003-3363-1231	Deutsche Forschungsgemeinschaft [Exc257, SPP1392]; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by the Deutsche Forschungsgemeinschaft, www.dfg.de, Exc257, SPP1392, and the Volkswagen Foundation, www.volkswagenstiftung.de. MS is a Lichtenberg-Professor of the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Thierry Soldati (Universite de Geneve) for donating mRNA from Dictyostelium discoideum. Julia Karius, Susanne Lipartowski and Corinna Engelhardt provided excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (Exc257, SPP1392) and the Volkswagen Foundation. MS is a Lichtenberg-Professor of the Volkswagen Foundation.	Amjad A, 2015, J GEN PHYSIOL, V145, P285, DOI 10.1085/jgp.201411348; Barzilai MG, 2012, CELL REP, V2, P242, DOI 10.1016/j.celrep.2012.06.016; Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; BONNER JT, 1970, P NATL ACAD SCI USA, V65, P110; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Eichinger L, 2005, CURR OPIN MICROBIOL, V8, P606, DOI 10.1016/j.mib.2005.08.009; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hahn Y, 2009, INT J MOL MED, V24, P51, DOI 10.3892/ijmm_00000205; Henkel B, 2015, CHEM SENSES, V40, P73, DOI 10.1093/chemse/bju061; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Jegla T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051366; Kawli T, 2002, DIFFERENTIATION, V70, P272, DOI 10.1046/j.1432-0436.2002.700605.x; Kay JG, 2011, SENSORS-BASEL, V11, P1744, DOI 10.3390/s110201744; Kim Y, 2005, EUKARYOT CELL, V4, P281, DOI 10.1128/EC.4.2.281-288.2005; Kunzelmann K, 2016, PFLUG ARCH EUR J PHY, V468, P475, DOI 10.1007/s00424-015-1767-4; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Lavieu G, 2010, P NATL ACAD SCI USA, V107, P6876, DOI 10.1073/pnas.1002536107; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Martinson AS, 2014, P NATL ACAD SCI USA, V111, P5712, DOI 10.1073/pnas.1321716111; Milenkovic VM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-319; Moran Y, 2014, GENOME BIOL EVOL, V6, P2210, DOI 10.1093/gbe/evu177; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; Neuhaus EM, 1999, PROTIST, V150, P235, DOI 10.1016/S1434-4610(99)70026-X; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szteyn K, 2012, CELL PHYSIOL BIOCHEM, V30, P1319, DOI 10.1159/000343321; Tran TT, 2014, J CELL PHYSIOL, V229, P181, DOI 10.1002/jcp.24431; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; van Kruchten R, 2013, BLOOD, V121, P1850, DOI 10.1182/blood-2012-09-454314; Veitinger S, 2011, J PHYSIOL-LONDON, V589, P5033, DOI 10.1113/jphysiol.2011.216309; Wolf W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085418; Wolf W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039703; Wong XM, 2013, ELIFE, V2, DOI 10.7554/eLife.00862; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0	58	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191219	10.1371/journal.pone.0191219	http://dx.doi.org/10.1371/journal.pone.0191219			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444117	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500014
J	Yamasaki, YK; Graves, EE; Houston, RS; OConnor, BM; Kysar, PE; Straub, MH; Foley, JE; Tell, LA				Yamasaki, Youki K.; Graves, Emily E.; Houston, Robin S.; OConnor, Barry M.; Kysar, Patricia E.; Straub, Mary H.; Foley, Janet E.; Tell, Lisa A.			Evaluation of Proctophyllodes huitzilopochtlii on feathers from Anna's (Calypte anna) and Black-chinned (Archilochus alexandri) Hummingbirds: Prevalence assessment and imaging analysis using light and tabletop scanning electron microscopy	PLOS ONE			English	Article							MITES ASTIGMATA; ACARI; BIRDS; GENUS; PASSERINES; ANALGOIDEA; INSIGHTS; BEHAVIOR	Proctophyllodes huitzilopochtlii Atyeo & Braasch 1966 (Acariformes: Astigmata: Proctophyllodidae), a feather mite, was found on feathers collected from five hummingbird species in California. This mite has not been previously documented on feathers from Anna's (Calypte anna [Lesson 1829]) or Black-chinned (Archilochus alexandri [Bourcier & Mulsant 1846]) Hummingbirds. A total of 753 hummingbirds were evaluated for the presence of mites by species (Allen's n = 112; Anna's n = 500; Black-chinned n = 122; Rufous n = 18; Calliope n = 1), sex (males n = 421; females n = 329; 3 unidentified), and age (juvenile n = 199; after-hatch-year n = 549; 5 unidentified). Of these 753 hummingbirds evaluated, mites were present on the rectrices of 40.9% of the birds. Significantly more Anna's Hummingbirds were positive for rectricial mites (59.2%) compared with 8.2% of Black-chinned, 0.9% of Allen's, 5.6% of Rufous Hummingbirds, and 0% for Calliope (p-value < 0.0001). Across all hummingbird species, male hummingbirds (44.9%) had a higher prevalence of rectricial mites compared to female hummingbirds (36.2%; p-value = 0.004), while juvenile hummingbirds (46.2%) had a non-significantly higher prevalence compared to after-hatch-year hummingbirds (39.0%; p-value = 0.089). On average, the percentage of the long axis of the rachis occupied by mites for the outer rectrices (R4 and R5) was 19%, compared to 11% for inner rectrices (R1 and R2), a significant difference (p-value = < 0.0001). There was a marginal lack of significance for symmetrical distribution of tail mites with the mean left side percentage of long axis of the rachis occupied by mites being 16% and very close to the mean right side score of 18% (p-value = 0.003). The identification of the feather mite species was based on light microscopic morphometry, and mite distribution on feathers was further evaluated using tabletop scanning electron microscopy (TSEM). The hummingbird-feather mite relationship is not well understood, but the specialized TSEM technique may be especially useful in examining natural positioning and developmental aspects of the mites since it allows in situ feather examination of live mites.	[Yamasaki, Youki K.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Yamasaki, Youki K.; Houston, Robin S.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Graves, Emily E.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [OConnor, Barry M.] Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Kysar, Patricia E.] Univ Calif Davis, Electron Microscopy Core Lab, Dept Cell Biol & Human Anat, Univ Calif Davis Hlth Syst, Davis, CA 95616 USA; [Straub, Mary H.; Foley, Janet E.; Tell, Lisa A.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	Washington State University; University of California System; University of California Davis; University of California System; University of California Davis; University of Michigan System; University of Michigan; University of California System; University of California Davis; University of California System; University of California Davis	Tell, LA (corresponding author), Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA.	latell@ucdavis.edu			Tell; Hunter-Jelks Fund (Tell)	Tell; Hunter-Jelks Fund (Tell)	This study was partially funded by donations from Dr. Grant Patrick (Tell) and the Hunter-Jelks Fund (Tell).	Atyeo W. T., 1966, Bulletin of the University of Nebraska State Museum, V5, P1; ATYEO WT, 1984, J KANSAS ENTOMOL SOC, V57, P456; Baltosser W. H., 1987, N AM BIRD BANDER, V12, P151; Blanco G, 2001, J AVIAN BIOL, V32, P271, DOI 10.1111/j.0908-8857.2001.320310.x; Clark CJ, 2011, SCIENCE, V333, P1430, DOI 10.1126/science.1205222; Clark CJ, 2009, P ROY SOC B-BIOL SCI, V276, P3047, DOI 10.1098/rspb.2009.0508; Dabert J, 2008, ZOOTAXA, P41; Dona J, 2017, ECOL ENTOMOL, V42, P492, DOI 10.1111/een.12408; Dubinin V. B., 1951, Fauna USSR Moscow, V6, P1; Galvan I, 2008, J EVOLUTION BIOL, V21, P133, DOI 10.1111/j.1420-9101.2007.01459.x; Galvan I, 2012, J AVIAN BIOL, V43, P273, DOI 10.1111/j.1600-048X.2012.05686.x; GAUD J, 1990, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V60, P133; Gaud J., 1996, ANN MUSEE ROYAL LAFR, V277, P1; Godoy LA, 2014, J ORNITHOL, V155, P1, DOI 10.1007/s10336-013-0990-z; Gonzalez-Acuna D, 2011, REV MEX BIODIVERS, V82, P1333; Greig EI, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0256; Jovani R, 2006, CAN J ZOOL, V84, P729, DOI 10.1139/Z06-042; Jovani R, 2004, J AVIAN BIOL, V35, P16, DOI 10.1111/j.0908-8857.2004.03213.x; Jovani R, 2001, ANIM BEHAV, V62, P723, DOI 10.1006/anbe.2001.1814; Kanegae Mieko Ferreira, 2008, Biota Neotrop., V8, P31, DOI 10.1590/S1676-06032008000100003; Klimov PB, 2017, MOL PHYLOGENET EVOL, V114, P212, DOI 10.1016/j.ympev.2017.06.008; Mironov S.V., 2002, Parazitologiya (St. Petersburg), V36, P356; Mironov S. V., 2012, Acarina, V20, P130; Mironov S.V., 1997, Acarina, V4, P27; Mironov S.V., 2009, P ZOOLOGICAL I RUSSI, V313, P97; Pap PL, 2006, BEHAV ECOL, V17, P277, DOI 10.1093/beheco/arj026; PARK C K, 1973, Journal of the Georgia Entomological Society, V8, P39; PARK C K, 1975, Journal of the Georgia Entomological Society, V10, P128; PARK C K, 1973, Journal of the Georgia Entomological Society, V8, P221; PARK C K, 1974, Journal of the Georgia Entomological Society, V9, P18; PARK C K, 1972, Journal of the Kansas Entomological Society, V45, P327; PARK C K, 1971, Florida Entomologist, V54, P221, DOI 10.2307/3493717; Park C.K, 1974, J GEORGIA ENTOMOLOGI, V9, P156, DOI DOI 10.1016/S0169-5347(00)01924-8.PMID:10931667; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; Russell SM, 2001, N AM BAND COUNC; STILES FG, 1972, CONDOR, V74, P25, DOI 10.2307/1366446; Valim MP, 2011, INT J ACAROL, V37, P293, DOI 10.1080/01647954.2010.519719; Wiles PR, 2000, CAN J ZOOL, V78, P1397, DOI 10.1139/cjz-78-8-1397	38	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0191323	10.1371/journal.pone.0191323	http://dx.doi.org/10.1371/journal.pone.0191323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444089	Green Submitted, Green Published, gold			2022-12-26	WOS:000425183500015
J	Pachernegg, S; Eilebrecht, S; Eilebrecht, E; Schoneborn, H; Neumann, S; Benecke, AG; Hollmann, M				Pachernegg, Svenja; Eilebrecht, Sebastian; Eilebrecht, Elke; Schoeneborn, Hendrik; Neumann, Sebastian; Benecke, Arndt G.; Hollmann, Michael			The siRNA-mediated knockdown of GluN3A in 46C-derived neural stem cells affects mRNA expression levels of neural genes, including known iGluR interactors	PLOS ONE			English	Article							RECEPTOR SUBUNIT NR3A; PROTEIN PHOSPHATASE 2A; HUNTINGTONS-DISEASE MODELS; NMDA RECEPTOR; REGIONAL EXPRESSION; DEVELOPMENTAL EXPRESSION; NR3A-CONTAINING NMDARS; SYNAPTIC-TRANSMISSION; COGNITIVE FUNCTIONS; AMPA RECEPTORS	For years, GluN3A was solely considered to be a dominant-negative modulator of NMDARs, since its incorporation into receptors alters hallmark features of conventional NMDARs composed of GluN1/GluN2 subunits. Only recently, increasing evidence has accumulated that GluN3A plays a more diversified role. It is considered to be critically involved in the maturation of glutamatergic synapses, and it might act as a molecular brake to prevent premature synaptic strengthening. Its expression pattern supports a putative role during neural development, since GluN3A is predominantly expressed in early pre- and postnatal stages. In this study, we used RNA interference to efficiently knock down GluN3A in 46C-derived neural stem cells (NSCs) both at the mRNA and at the protein level. Global gene expression profiling upon GluN3A knockdown revealed significantly altered expression of a multitude of neural genes, including genes encoding small GTPases, retinal proteins, and cytoskeletal proteins, some of which have been previously shown to interact with GluN3A or other iGluR subunits. Canonical pathway enrichment studies point at important roles of GluN3A affecting key cellular pathways involved in cell growth, proliferation, motility, and survival, such as the mTOR pathway. This study for the first time provides insights into transcriptome changes upon the specific knockdown of an NMDAR subunit in NSCs, which may help to identify additional functions and downstream pathways of GluN3A and GluN3A-containing NMDARs.	[Pachernegg, Svenja] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Pachernegg, Svenja; Hollmann, Michael] Ruhr Univ Bochum, Dept Biochem Receptor Biochem 1, Bochum, Germany; [Pachernegg, Svenja] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Pachernegg, Svenja] Ruhr Univ Bochum, Ruhr Univ, Res Sch, Bochum, Germany; [Eilebrecht, Sebastian; Benecke, Arndt G.] Univ Paris 06, CNRS, UMR8246, Paris, France; [Eilebrecht, Sebastian] German Canc Res Ctr, Heidelberg, Germany; [Eilebrecht, Elke] Fraunhofer Inst Mol Biol & Appl Ecol, Schmallenberg, Germany; [Schoeneborn, Hendrik] Ruhr Univ Bochum, Dept Biochem Mol Neurobiochem 2, Bochum, Germany; [Neumann, Sebastian] Ruhr Univ Bochum, Dept Biochem Mol Biochem 2, Bochum, Germany; [Benecke, Arndt G.] Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Seattle, WA USA	Florey Institute of Neuroscience & Mental Health; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; German Cancer Research Center (DKFZ); Fraunhofer Gesellschaft; Ruhr University Bochum; Ruhr University Bochum; University of Washington; University of Washington Seattle	Pachernegg, S (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.; Pachernegg, S (corresponding author), Ruhr Univ Bochum, Dept Biochem Receptor Biochem 1, Bochum, Germany.; Pachernegg, S (corresponding author), Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany.; Pachernegg, S (corresponding author), Ruhr Univ Bochum, Ruhr Univ, Res Sch, Bochum, Germany.	Svenja.Pachernegg@ruhr-uni-bochum.de	Benecke, Arndt G./T-1079-2019	Neumann, Sebastian/0000-0003-3706-9012; Schoneborn, Hendrik/0000-0002-8913-2987; Hollmann, Michael/0000-0001-8000-7787; Eilebrecht, Elke/0000-0003-0180-8936	International Graduate School of Neuroscience, Ruhr University Bochum, Germany; Ruhr University Research School, Ruhr University Bochum, Germany; International Graduate School of Neuroscience (IGSN), Ruhr University Bochum; Ruhr University Research School, Ruhr University Bochum	International Graduate School of Neuroscience, Ruhr University Bochum, Germany; Ruhr University Research School, Ruhr University Bochum, Germany; International Graduate School of Neuroscience (IGSN), Ruhr University Bochum; Ruhr University Research School, Ruhr University Bochum	SP and EE received PhD scholarships from the International Graduate School of Neuroscience, Ruhr University Bochum, Germany (https://www.ruhr-uni-bochum.de/igsn/) and the Ruhr University Research School, Ruhr University Bochum, Germany (http://www.research-school.rub.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the International Graduate School of Neuroscience (IGSN), Ruhr University Bochum (SP and EE) and the Ruhr University Research School, Ruhr University Bochum (SP and EE). We thank Jan Terhag for the densitometric analysis of Western blots.	Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Brysbaert Guillaume, 2010, Genomics Proteomics & Bioinformatics, V8, P57, DOI 10.1016/S1672-0229(10)60006-X; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chowdhury D, 2013, J NEUROSCI, V33, P4151, DOI 10.1523/JNEUROSCI.2721-12.2013; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; D'Adamo P, 2014, NEUROSCI BIOBEHAV R, V46, P302, DOI 10.1016/j.neubiorev.2013.12.009; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Eilebrecht S, 2011, RNA BIOL, V8, P1084, DOI 10.4161/rna.8.6.17015; Eilebrecht S, 2011, RNA BIOL, V8, P143, DOI 10.4161/rna.8.1.14261; Eriksson M, 2007, BIOCHEM BIOPH RES CO, V361, P127, DOI 10.1016/j.bbrc.2007.06.179; Eriksson M, 2010, NEUROSCI LETT, V475, P33, DOI 10.1016/j.neulet.2010.03.039; Fiuza M, 2013, P NATL ACAD SCI USA, V110, P20807, DOI 10.1073/pnas.1312211110; Fuhrer DK, 1996, BIOCHEM BIOPH RES CO, V224, P289, DOI 10.1006/bbrc.1996.1023; Fukaya M, 2005, EUR J NEUROSCI, V21, P1432, DOI 10.1111/j.1460-9568.2005.03957.x; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Guenther E, 2004, FASEB J, V18, P1433, DOI 10.1096/fj.03-0618fje; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Henson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042327; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ishihama K, 2005, ARCH HISTOL CYTOL, V68, P321, DOI 10.1679/aohc.68.321; Kaur C, 2012, J NEUROPATH EXP NEUR, V71, P330, DOI 10.1097/NEN.0b013e31824deb21; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lee JH, 2015, AM J PHYSIOL-CELL PH, V308, pC570, DOI 10.1152/ajpcell.00353.2014; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liets LC, 2001, PROG BRAIN RES, V134, P1; Liu B, 2009, NEUROBIOL DIS, V33, P104, DOI 10.1016/j.nbd.2008.09.020; Madry C, 2007, BIOCHEM BIOPH RES CO, V354, P102, DOI 10.1016/j.bbrc.2006.12.153; Mahfooz K, 2016, NEUROBIOL DIS, V93, P47, DOI 10.1016/j.nbd.2016.04.001; Marco S, 2013, NAT MED, V19, P1030, DOI 10.1038/nm.3246; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; Mohamad O, 2013, J PHYSIOL-LONDON, V591, P149, DOI 10.1113/jphysiol.2012.239251; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Musante V, 2011, J NEUROCHEM, V117, P516, DOI 10.1111/j.1471-4159.2011.07223.x; Muth-Kohne E, 2010, CELL PHYSIOL BIOCHEM, V26, P935, DOI 10.1159/000324002; Muth-Kohne E, 2010, MOL CELL NEUROSCI, V43, P209, DOI 10.1016/j.mcn.2009.11.002; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Noth S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-307; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P90, DOI 10.1016/S1672-0229(06)60021-1; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P212, DOI 10.1016/S1672-0229(07)60002-3; Pachernegg S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00241; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Pollard SM, 2006, REGEN MED, V1, P111, DOI 10.2217/17460751.1.1.111; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Rozeboom AM, 2015, NEUROBIOL LEARN MEM, V125, P265, DOI 10.1016/j.nlm.2015.10.005; Sarfare S, 2007, EXP EYE RES, V85, P173, DOI 10.1016/j.exer.2006.03.011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shibata T, 1997, J NEUROSCI, V17, P9212; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Stephenson SEM, 2005, J BIOL CHEM, V280, P33270, DOI 10.1074/jbc.M505889200; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Sucher NJ, 2003, INVEST OPHTH VIS SCI, V44, P4451, DOI 10.1167/iovs.02-1259; Suchera NJ, 2010, NEUROSIGNALS, V18, P203, DOI 10.1159/000322206; Sun LX, 1998, FEBS LETT, V441, P392, DOI 10.1016/S0014-5793(98)01590-7; Sun LX, 2000, SYNAPSE, V35, P212, DOI 10.1002/(SICI)1098-2396(20000301)35:3<212::AID-SYN6>3.0.CO;2-O; Tchitchek Nicolas, 2012, Genomics Proteomics & Bioinformatics, V10, P127, DOI 10.1016/j.gpb.2012.06.002; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tong G, 2008, J NEUROPHYSIOL, V99, P122, DOI 10.1152/jn.01044.2006; Wanigasekara Y, 2003, NEUROREPORT, V14, P2421, DOI 10.1097/00001756-200312190-00026; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017	75	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192242	10.1371/journal.pone.0192242	http://dx.doi.org/10.1371/journal.pone.0192242			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438442	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400016
J	Jansen, W; Woudstra, S; Muller, A; Grabowski, N; Schoo, G; Gerulat, B; Klein, G; Kehrenberg, C				Jansen, Wiebke; Woudstra, Svenja; Mueller, Anja; Grabowski, Nils; Schoo, Gundela; Gerulat, Bettina; Klein, Guenter; Kehrenberg, Corinna			The safety and quality of pork and poultry meat imports for the common European market received at border inspection post Hamburg Harbour between 2014 and 2015	PLOS ONE			English	Article							ENTEROBACTERIACEAE; SALMONELLA; RETAIL	Though imports of products of animal origin into the European Union (EU) have to comply with legal requirements and quality standards of the community, food consignment rejections at external EU borders have been increasing in recent years. This study explored microbiological metrics according to national target and critical values valid for samples at consumer level of 498 fresh poultry meat and 136 fresh pork filets from consignments subjected to physical checks during clearing at the border inspection post Hamburg harbour between January 2014 and December 2015 with ISO standard methods. Quantitative results indicated that critical thresholds for aerobic counts, Enterobacteriaceae, and E. coli were never surpassed. Merely for staphylococci, one poultry sample (0.2%) and 10 pork samples (9.3%) exceeded the critical limit (3.7 log cfu/g). However, qualitative analyses revealed that, Staphylococcus aureus was present in 16% and 10% of all poultry and pork samples, respectively, though no methicillin-resistant Staphylococcus aureus could be confirmed. Moreover, E. coli was present in 50% and 67% of all pork and poultry samples, respectively, and thereof 33 isolates were confirmed as extended-spectrum beta-lactamase-producing E. coli. Only 1.2% of the poultry samples were unacceptable due to the presence of Salmonella spp., whereas they were not detected in any pork sample. Campylobacter spp. were not detected in any sample. Though imported pork and poultry meat complies mostly with national market requirements, it might pose a potential risk to public health, especially for a direct or indirect foodborne transmission of imported, uncommon strains of zoonotic bacteria.	[Jansen, Wiebke; Woudstra, Svenja; Mueller, Anja; Grabowski, Nils; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [Jansen, Wiebke; Woudstra, Svenja; Mueller, Anja; Grabowski, Nils; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany; [Schoo, Gundela; Gerulat, Bettina] Civil Author Hlth & Consumer Protect, Border Inspect Post Hamburg Harbour, Hamburg, Germany; [Jansen, Wiebke] Univ Namur, Integrated Vet Res Unit, Narilis, Namur, Belgium; [Woudstra, Svenja] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Namur; University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.; Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Müller, Anja/AAM-3406-2021; Kehrenberg, Corinna/GSI-9835-2022	Muller, Anja/0000-0002-3179-6684; Woudstra, Svenja/0000-0003-4668-1799	German Federal Ministry of Education and Research within the research program for civil security: security of food and the food chain (ZooGloW) [FKZ 13N12697]	German Federal Ministry of Education and Research within the research program for civil security: security of food and the food chain (ZooGloW)	This work was funded by the German Federal Ministry of Education and Research within the research program for civil security: security of food and the food chain (ZooGloW, project FKZ 13N12697) to GK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 1027212006 ISO; [Anonymous], 2013, 483322013 ISO; [Anonymous], 2002, 6579 ISO, V4th; Commission European, 2013, SHORT TERM OUTL AR C; DEBOER E, 1991, INT J FOOD MICROBIOL, V12, P375, DOI 10.1016/0168-1605(91)90151-E; EFSA, 2016, EFSA J, V14, DOI [10.2903/j.efsa.2016.4375, 10.2903/j.efsa.2016.4584]; Egervarn M, 2014, INT J FOOD MICROBIOL, V171, P8, DOI 10.1016/j.ijfoodmicro.2013.11.005; European Commission, SHAR EU WORLD TRAD S; European Commission, 2017, MARK SECT POULTR MEA; European Commission, 2017, MARK SECT PIG MEAT; European Commission, 2014, EU MARK SIT POULTR; International Organization for Standardization, 2003, 688722003 ISO; International Organization for Standardization, 688811999 ISO; International Organization for Standardization (ISO), 2017, 6579 ISO; International Trade Centre, 2017, TRAD MAP TRAD STAT I; ISO, 2001, 1664922001 ISO; ISO, 2004, 2152822004 ISO; Jansen W, 2016, ZOONOSES PUBLIC HLTH, V63, P53, DOI 10.1111/zph.12204; Muller A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167864; Muller A, 2017, 7 S ANT RES AN ENV B; Medeiros MAN, 2011, REV PANAM SALUD PUBL, V30, P555, DOI 10.1590/S1020-49892011001200010; Peeler EJ, 2015, TRANSBOUND EMERG DIS, V62, P480, DOI 10.1111/tbed.12180; Ramamurthy T, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00103; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Velasco V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097617; Zogg AL, 2016, SCHWEIZ ARCH TIERH, V158, P451, DOI 10.17236/sat00071	26	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192550	10.1371/journal.pone.0192550	http://dx.doi.org/10.1371/journal.pone.0192550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425222	Green Submitted, Green Published, gold			2022-12-26	WOS:000424700800029
J	Martinez-Ballesta, MD; Garcia-Gomez, P; Yepes-Molina, L; Guarnizo, AL; Teruel, JA; Carvajal, M				del Carmen Martinez-Ballesta, Maria; Garcia-Gomez, Pablo; Yepes-Molina, Lucia; Guarnizo, Angel L.; Teruel, Jose A.; Carvajal, Micaela			Plasma membrane aquaporins mediates vesicle stability in broccoli	PLOS ONE			English	Article							OSMOTIC WATER PERMEABILITY; INFRARED-SPECTROSCOPY; POSTTRANSLATIONAL MODIFICATIONS; MASS-SPECTROMETRY; AQUEOUS-SOLUTIONS; CHANNEL ACTIVITY; HIGHER-PLANTS; PROTEINS; TRANSPORT; SALINITY	The use of in vitro membrane vesicles is attractive because of possible applications in therapies. Here we aimed to compare the stability and functionality of plasma membrane vesicles extracted from control and salt-treated broccoli. The impact of the amount of aquaporins was related to plasma membrane osmotic water permeability and the stability of protein secondary structure. Here, we describe for first time an increase in plant aquaporins acetylation under high salinity. Higher osmotic water permeability in NaCl vesicles has been related to higher acetylation, upregulation of aquaporins, and a more stable environment to thermal denaturation. Based on our findings, we propose that aquaporins play an important role in vesicle stability.	[del Carmen Martinez-Ballesta, Maria; Garcia-Gomez, Pablo; Yepes-Molina, Lucia; Guarnizo, Angel L.; Carvajal, Micaela] CSIC, CEBAS, Plant Nutr Dept, Aquaporin Grp, Campus Espinardo, Murcia, Espinardo, Spain; [Teruel, Jose A.] Univ Murcia, Fac Vet, Dept Bioquim & Biol Mol A, Murcia, Espinardo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia	Carvajal, M (corresponding author), CSIC, CEBAS, Plant Nutr Dept, Aquaporin Grp, Campus Espinardo, Murcia, Espinardo, Spain.	mcarvaja@cebas.csic.es	Garcia-Gomez, Pablo/Y-9459-2019; Carvajal, Micaela/H-8920-2015; Garcia-Gomez, Pablo/AAB-5067-2021; luigi, angel/ABG-1087-2020; Puche, José Antonio Teruel/R-4137-2018; Martinez Ballesta, MCarmen/C-2190-2009	Carvajal, Micaela/0000-0001-7321-4956; Garcia-Gomez, Pablo/0000-0002-6087-8056; Puche, José Antonio Teruel/0000-0003-2256-3368; Luigi, Angel/0000-0002-2486-2348; Yepes Molina, Lucia/0000-0001-6158-6955; Martinez Ballesta, MCarmen/0000-0002-4372-5525	Spanish Ministerio de Economia, Industria y Competitividad [AGL2016-80247-C2-1-R]	Spanish Ministerio de Economia, Industria y Competitividad	This work was funded by Spanish Ministerio de Economia, Industria y Competitividad (grant no. AGL2016-80247-C2-1-R to MC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Alleva K, 2006, J EXP BOT, V57, P609, DOI 10.1093/jxb/erj046; Ampilogova YN, 2006, RUSS J PLANT PHYSL+, V53, P622, DOI 10.1134/S1021443706050050; ARRONDO JLR, 1989, FEBS LETT, V252, P118, DOI 10.1016/0014-5793(89)80901-9; Atay S, 2014, P NATL ACAD SCI USA, V111, P711, DOI 10.1073/pnas.1310501111; Barrajon-Catalan E, 2010, CANCER LETT, V290, P192, DOI 10.1016/j.canlet.2009.09.010; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Basiglio CL, 2009, CHEM-BIOL INTERACT, V179, P297, DOI 10.1016/j.cbi.2008.12.008; Basyuni M, 2012, AQUAT BOT, V97, P17, DOI 10.1016/j.aquabot.2011.10.005; Bayle V, 2011, PLANT CELL, V23, P1523, DOI 10.1105/tpc.110.081067; Bellati J, 2016, MOL CELL PROTEOMICS, V15, P3473, DOI 10.1074/mcp.M116.060087; Bernfur K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071206; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvajal M., 2011, Patent, Patent No. [EP2716280, 2716280]; Casado-Vela J, 2010, J PROTEOME RES, V9, P3479, DOI 10.1021/pr901150g; Chalbi N, 2015, J PLANT PHYSIOL, V175, P148, DOI 10.1016/j.jplph.2014.12.003; Chevalier AS, 2015, PLANT CELL PHYSIOL, V56, P819, DOI 10.1093/pcp/pcu203; CLARK AH, 1981, INT J PEPT PROT RES, V17, P353; CORBALANGARCIA S, 1994, BIOCHEMISTRY-US, V33, P8247, DOI 10.1021/bi00193a011; Martinez-Ballesta MD, 2016, COLLOID SURFACE B, V143, P318, DOI 10.1016/j.colsurfb.2016.03.056; di Pietro M, 2013, MOL CELL PROTEOMICS, V12, P3886, DOI 10.1074/mcp.M113.028241; Dominguez-Perles R, 2010, J FOOD SCI, V75, pC383, DOI 10.1111/j.1750-3841.2010.01606.x; Dong AC, 2000, J BIOL CHEM, V275, P27689; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Forrest KL, 2007, FUNCT INTEGR GENOMIC, V7, P263, DOI 10.1007/s10142-007-0049-4; Gerbeau P, 2002, PLANT J, V30, P71, DOI 10.1046/j.1365-313X.2002.01268.x; Giglione C, 2015, BIOCHIMIE, V114, P134, DOI 10.1016/j.biochi.2014.11.008; Gutierrez DB, 2011, EXP EYE RES, V93, P912, DOI 10.1016/j.exer.2011.10.007; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Ishibashi K, 2006, BBA-BIOMEMBRANES, V1758, P989, DOI 10.1016/j.bbamem.2006.02.024; KUIPER PJC, 1985, PHYSIOL PLANTARUM, V64, P118, DOI 10.1111/j.1399-3054.1985.tb01221.x; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173; Li ST, 2017, SCI REP-UK, V7, DOI 10.1038/srep41397; LILJENBERG CS, 1992, PROG LIPID RES, V31, P335, DOI 10.1016/0163-7827(92)90012-8; Lopez D, 2012, J EXP BOT, V63, P2217, DOI 10.1093/jxb/err404; Lopez-Perez L, 2009, PHYTOCHEMISTRY, V70, P492, DOI 10.1016/j.phytochem.2009.01.014; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O; Maurel C, 1997, P NATL ACAD SCI USA, V94, P7103, DOI 10.1073/pnas.94.13.7103; Monneuse JM, 2011, PROTEOMICS, V11, P1789, DOI 10.1002/pmic.201000660; Muries B, 2013, PLANTA, V237, P1297, DOI 10.1007/s00425-013-1849-5; Muries B, 2011, MOL BIOSYST, V7, P1322, DOI 10.1039/c0mb00285b; Niemietz CM, 2002, FEBS LETT, V531, P443, DOI 10.1016/S0014-5793(02)03581-0; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Qi SR, 2016, J MEMBRANE SCI, V508, P94, DOI 10.1016/j.memsci.2016.02.013; Robinson DC, 1996, PLANT PHYSIOL, V111, P645, DOI 10.1104/pp.111.2.645; Sadok W, 2010, J EXP BOT, V61, P821, DOI 10.1093/jxb/erp350; Santoni V, 2003, BIOCHEM J, V373, P289, DOI 10.1042/BJ20030159; Santoni V, 2006, BIOCHEM J, V400, P189, DOI 10.1042/BJ20060569; Silva C, 2007, J PLANT BIOL, V50, P650, DOI 10.1007/BF03030609; Silva C, 2011, J COLLOID INTERF SCI, V358, P192, DOI 10.1016/j.jcis.2011.02.048; Sun GF, 2013, COLLOID SURFACE B, V102, P466, DOI 10.1016/j.colsurfb.2012.08.009; SUSI H, 1986, METHOD ENZYMOL, V130, P290; SUSI H, 1967, J BIOL CHEM, V242, P5460; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Trofimova MS, 2003, PHYSIOL PLANTARUM, V118, P232, DOI 10.1034/j.1399-3054.2003.00102.x; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Winkler K, 2005, COLLOID SURFACE B, V45, P57, DOI 10.1016/j.colsurfb.2005.07.006; Zangi R, 2012, CHEM-BIOL INTERACT, V197, P47, DOI 10.1016/j.cbi.2012.02.001; Zaragoza A, 2012, LANGMUIR, V28, P1381, DOI 10.1021/la203879t	66	10	11	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192422	10.1371/journal.pone.0192422	http://dx.doi.org/10.1371/journal.pone.0192422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420651	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900072
J	Uluseker, C; Simoni, G; Marchetti, L; Dauriz, M; Matone, A; Priami, C				Uluseker, Cansu; Simoni, Giulia; Marchetti, Luca; Dauriz, Marco; Matone, Alice; Priami, Corrado			A closed-loop multi-level model of glucose homeostasis	PLOS ONE			English	Article							MATHEMATICAL-MODEL; BODY-WEIGHT; INSULIN-RESISTANCE; LEPTIN SECRETION; FOOD-INTAKE; GHRELIN; SYSTEM; ENERGY; TRANSPORT; GLUCAGON	Background The pathophysiologic processes underlying the regulation of glucose homeostasis are considerably complex at both cellular and systemic level. A comprehensive and structured specification for the several layers of abstraction of glucose metabolism is often elusive, an issue currently solvable with the hierarchical description provided by multi-level models. In this study we propose a multi-level closed-loop model of whole-body glucose homeostasis, coupled with the molecular specifications of the insulin signaling cascade in adipocytes, under the experimental conditions of normal glucose regulation and type 2 diabetes. Methodology/Principal findings The ordinary differential equations of the model, describing the dynamics of glucose and key regulatory hormones and their reciprocal interactions among gut, liver, muscle and adipose tissue, were designed for being embedded in a modular, hierarchical structure. The closed-loop model structure allowed self-sustained simulations to represent an ideal in silico subject that adjusts its own metabolism to the fasting and feeding states, depending on the hormonal context and invariant to circadian fluctuations. The cellular level of the model provided a seamless dynamic description of the molecular mechanisms downstream the insulin receptor in the adipocytes by accounting for variations in the surrounding metabolic context. Conclusions/Significance The combination of a multi-level and closed-loop modeling approach provided a fair dynamic description of the core determinants of glucose homeostasis at both cellular and systemic scales. This model architecture is intrinsically open to incorporate supplementary layers of specifications describing further individual components influencing glucose metabolism.	[Uluseker, Cansu; Simoni, Giulia; Marchetti, Luca; Matone, Alice; Priami, Corrado] Univ Trento, Ctr Computat & Syst Biol COSBI, Microsoft Res, Rovereto, TN, Italy; [Dauriz, Marco] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, Verona, Italy; [Priami, Corrado] Univ Pisa, Dept Comp Sci, Pisa, Italy	University of Trento; University of Verona; University of Pisa	Priami, C (corresponding author), Univ Trento, Ctr Computat & Syst Biol COSBI, Microsoft Res, Rovereto, TN, Italy.; Priami, C (corresponding author), Univ Pisa, Dept Comp Sci, Pisa, Italy.	priami@cosbi.eu	Dauriz, Marco/S-5843-2016	Dauriz, Marco/0000-0002-5542-5941; Uluseker, Cansu/0000-0001-9828-0458; Matone, Alice/0000-0003-4530-908X; Marchetti, Luca/0000-0001-9043-7705	Provincia Autonoma di Trento [2015-AG12-01091]	Provincia Autonoma di Trento(Autonomous Province of Trento)	This work was supported by Grant number 2015-AG12-01091 from Provincia Autonoma di Trento. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Barazzoni R, 2014, DIABETES, V63, P2213, DOI 10.2337/db14-0407; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brubaker PL, 2007, ANN BIOMED ENG, V35, P1286, DOI 10.1007/s10439-007-9274-1; Castiglione F, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2854; Caumo A, 2000, J CLIN ENDOCR METAB, V85, P4396, DOI 10.1210/jc.85.11.4396; CELESTE R, 1978, B MATH BIOL, V40, P59, DOI 10.1016/S0092-8240(78)80030-5; Chew YH, 2009, MOL CELL ENDOCRINOL, V303, P13, DOI 10.1016/j.mce.2009.01.018; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Dalla Man C, 2005, AM J PHYSIOL-ENDOC M, V289, pE909, DOI 10.1152/ajpendo.00299.2004; De Gaetano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070875; De Gaetano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1462, DOI 10.1152/ajpendo.90444.2008; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gallenberger M, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-46; Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x; Golden PL, 1997, J CLIN INVEST, V99, P14, DOI 10.1172/JCI119125; Gostner R, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2633461; Grasman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074997; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Groop L, 2014, MOL CELL ENDOCRINOL, V382, P726, DOI 10.1016/j.mce.2013.04.002; Gruetter R, 1998, J NEUROCHEM, V70, P397; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; IDF Diabet Atlas Grp, 2015, DIABETES RES CLIN PR, V109, P461, DOI 10.1016/j.diabres.2015.05.037; International Diabetes Federation, 2006, DIABETES ATLAS; Jacquier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100073; Jequier E, 1999, PHYSIOL REV, V79, P451, DOI 10.1152/physrev.1999.79.2.451; Kang H, 2012, ISLETS, V4, P84, DOI 10.4161/isl.19505; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Levy JR, 2000, AM J PHYSIOL-ENDOC M, V278, pE892, DOI 10.1152/ajpendo.2000.278.5.E892; Lodish H., 2007, MOL CELL BIOL; Lozada S, 2010, GLUCOSE REGULATION D; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marchetti L., 2017, SIMULATION ALGORITHM; Marchetti L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36029; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Nussey S, 2001, ENDOCRINOLOGY INTEGR, V2, P23; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Palumbo P, 2013, MATH BIOSCI, V244, P69, DOI 10.1016/j.mbs.2013.05.006; Pattaranit R, 2008, J R SOC INTERFACE, V5, P1119, DOI 10.1098/rsif.2008.0216; Poretsky L, 2010, PRINCIPLES DIABETES, P1; PORTE D, 1981, DIABETOLOGIA, V20, P274, DOI 10.1007/BF00254493; Pratt AC, 2015, MATH BIOSCI, V262, P167, DOI 10.1016/j.mbs.2014.12.012; Sakata Ichiro, 2010, Int J Pept, V2010, DOI 10.1155/2010/945056; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022; Sulston K.W., 2006, ATLANTIC, V1, P31; Taborsky Gerald J Jr, 2010, J Diabetes Sci Technol, V4, P1338; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Toghaw P, 2013, INT J MATH COMPUT SI, V7, P439; Toghaw P, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-16; Topp B, 2000, J THEOR BIOL, V206, P605, DOI 10.1006/jtbi.2000.2150; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037	62	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0190627	10.1371/journal.pone.0190627	http://dx.doi.org/10.1371/journal.pone.0190627			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420588	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900006
J	Thor, P; Vermandele, F; Carignan, MH; Jacque, S; Calosi, P				Thor, Peter; Vermandele, Fanny; Carignan, Marie-Helene; Jacque, Sarah; Calosi, Piero			No maternal or direct effects of ocean acidification on egg hatching in the Arctic copepod Calanus glacialis	PLOS ONE			English	Article							CO2-INDUCED ACIDIFICATION; METABOLIC-RATES; ELEVATED CO2; FINMARCHICUS; SEA; TEMPERATURE; CARBON; PH; REPRODUCTION; MORTALITY	Widespread ocean acidification (OA) is transforming the chemistry of the global ocean and the Arctic is recognised as the region where this transformation will occur at the fastest rate. Moreover, many Arctic species are considered less capable of tolerating OA due to their lower capacity for acid-base regulation. This inability may put severe restraints on many fundamental functions, such as growth and reproductive investments, which ultimately may result in reduced fitness. However, maternal effects may alleviate severe effects on the offspring rendering them more tolerant to OA. In a highly replicated experiment we studied maternal and direct effects of OA predicted for the Arctic shelf seas on egg hatching time and success in the keystone copepod species Calanus glacialis. We incubated females at present day conditions (pH(T) 8.0) and year 2100 extreme conditions (pH(T) 7.5) during oogenesis and subsequently reciprocally transplanted laid eggs between these two conditions. Statistical tests showed no effects of maternal or direct exposure to OA at this level. We hypothesise that C. glacialis may be physiologically adapted to egg production at low pH since oogenesis can also take place at conditions of potentially low haemolymph pH of the mother during hibernation in the deep.	[Thor, Peter] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Vermandele, Fanny; Carignan, Marie-Helene; Jacque, Sarah; Calosi, Piero] Univ Quebec Rimouski, Dept Biol Chim & Geog, Rimouski, PQ, Canada	Norwegian Polar Institute; University of Quebec; Universite du Quebec a Rimouski	Thor, P (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	peter.thor@npolar.no	Thor, Peter/ABF-1114-2021; Thor, Peter/A-7522-2009	Thor, Peter/0000-0002-2603-2284; Thor, Peter/0000-0002-2603-2284; Vermandele, Fanny/0000-0002-0239-3835; Calosi, Piero/0000-0003-3378-2603	FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship	FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship	The study was financially supported by a grant from the FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAP, 2013, AMAP ASS 2013 ARCT O; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnkvaern G, 2005, POLAR BIOL, V28, P528, DOI 10.1007/s00300-005-0715-8; Bailey A, 2017, ECOLOGY EVOLUTION; Bailey A, 2017, ICES J MAR SCI, V74, P996, DOI 10.1093/icesjms/fsw066; Bernardo J, 1996, AM ZOOL, V36, P83; Bonnet D, 2004, J PLANKTON RES, V26, P937, DOI 10.1093/plankt/fbh087; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Cao L, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028605; CLARKE A, 1980, BIOL J LINN SOC, V14, P77, DOI 10.1111/j.1095-8312.1980.tb00099.x; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Daase M, 2013, CAN J FISH AQUAT SCI, V70, P871, DOI 10.1139/cjfas-2012-0401; Davidson E. H., 1976, GENE ACTIVITY EARLY; De Wit P, 2016, EVOL APPL, V9, P1112, DOI 10.1111/eva.12335; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Dupont S, 2013, NATURE, V498, P429, DOI 10.1038/498429a; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Eiane K, 2004, MAR ECOL PROG SER, V268, P183, DOI 10.3354/meps268183; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fransson A, 2016, POLAR BIOL, V39, P1841, DOI 10.1007/s00300-016-1955-5; Fransson A, 2001, CONT SHELF RES, V21, P225, DOI 10.1016/S0278-4343(00)00088-1; Freese D, 2015, LIMNOL OCEANOGR, V60, P2121, DOI 10.1002/lno.10158; GIESKES JM, 1969, LIMNOL OCEANOGR, V14, P679, DOI 10.4319/lo.1969.14.5.0679; Hildebrandt N, 2016, ICES J MAR SCI, V73, P927, DOI 10.1093/icesjms/fsv226; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; Karnovsky NJ, 2003, MAR ECOL PROG SER, V253, P289, DOI 10.3354/meps253289; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lowry L., 1993, BOWHEAD WHALES; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mayor DJ, 2012, J PLANKTON RES, V34, P258, DOI 10.1093/plankt/fbr107; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Mumm N, 1998, POLAR BIOL, V20, P189, DOI 10.1007/s003000050295; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; Nielsen TG, 2014, MAR BIOL, V161, P1299, DOI 10.1007/s00227-014-2419-5; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2010, GUIDE BEST PRACTICE, P137; Rastrick SPS, 2011, PHYSIOL BIOCHEM ZOOL, V84, P154, DOI 10.1086/658857; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Runge JA, 2016, ICES J MAR SCI, V73, P937, DOI 10.1093/icesjms/fsv258; Sell AF, 2001, LIMNOL OCEANOGR, V46, P953, DOI 10.4319/lo.2001.46.4.0953; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Strickland JD, 1972, PRACTICAL HDB SEAWAT, V167, P310; Thor P, 2008, MAR ECOL PROG SER, V359, P151, DOI 10.3354/meps07376; Thor P, 2007, MAR ECOL PROG SER, V331, P131, DOI 10.3354/meps331131; Thor P, 2018, GLOBAL CHANGE BIOL, V24, pE365, DOI 10.1111/gcb.13870; Thor P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168735; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Titelman J, 2003, MAR ECOL PROG SER, V247, P137, DOI 10.3354/meps247137; Turner LM, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2984-x; Turner LM, 2015, J EXP BIOL, V218, P2148, DOI 10.1242/jeb.117705; Vehmaa A., 2015, BIOGEOSCIENCES DISCU, V12, P18541, DOI [10.5194/bgd-12-18541-2015, DOI 10.5194/BGD-12-18541-2015]; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Weydmann A, 2016, POLAR BIOL, P1; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Zervoudaki S, 2014, MEDITERR MAR SCI, V15, P74, DOI 10.12681/mms.553	69	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192496	10.1371/journal.pone.0192496	http://dx.doi.org/10.1371/journal.pone.0192496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415083	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300081
J	Soliman, C; Walduck, AK; Yuriev, E; Richards, JS; Cywes-Bentley, C; Pier, GB; Ramsland, PA				Soliman, Caroline; Walduck, Anna K.; Yuriev, Elizabeth; Richards, Jack S.; Cywes-Bentley, Colette; Pier, Gerald B.; Ramsland, Paul A.			Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; carbohydrate-binding protein; crystal structure; vaccine development; monoclonal antibody; Staphylococcus aureus (S; aureus); biofilm; antibody structure; poly-N-acetyl-D-glucosamine	MONOCLONAL-ANTIBODIES; SHIGELLA-FLEXNERI; RECOGNITION; LIPOPOLYSACCHARIDE; RESISTANCE; FRAGMENTS; ANTIGEN; PNAG; FAB	In response to the widespread emergence of antibiotic-resistant microbes, new therapeutic agents are required for many human pathogens. A non-mammalian polysaccharide, poly-N-acetyl-d-glucosamine (PNAG), is produced by bacteria, fungi, and protozoan parasites. Antibodies that bind to PNAG and its deacetylated form (dPNAG) exhibit promising in vitro and in vivo activities against many microbes. A human IgG1 mAb (F598) that binds both PNAG and dPNAG has opsonic and protective activities against multiple microbial pathogens and is undergoing preclinical and clinical assessments as a broad-spectrum antimicrobial therapy. Here, to understand how F598 targets PNAG, we determined crystal structures of the unliganded F598 antigen-binding fragment (Fab) and its complexes with N-acetyl-d-glucosamine (GlcNAc) and a PNAG oligosaccharide. We found that F598 recognizes PNAG through a large groove-shaped binding site that traverses the entire light- and heavy-chain interface and accommodates at least five GlcNAc residues. The Fab-GlcNAc complex revealed a deep binding pocket in which the monosaccharide and a core GlcNAc of the oligosaccharide were almost identically positioned, suggesting an anchored binding mechanism of PNAG by F598. The Fab used in our structural analyses retained binding to PNAG on the surface of an antibiotic-resistant, biofilm-forming strain of Staphylococcus aureus. Additionally, a model of intact F598 binding to two pentasaccharide epitopes indicates that the Fab arms can span at least 40 GlcNAc residues on an extended PNAG chain. Our findings unravel the structural basis for F598 binding to PNAG on microbial surfaces and biofilms.	[Soliman, Caroline; Walduck, Anna K.; Ramsland, Paul A.] RMIT Univ, Sch Sci, Plenty Rd, Bundoora, Vic 3083, Australia; [Yuriev, Elizabeth] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Richards, Jack S.; Ramsland, Paul A.] Burnet Inst, Dis Eliminat Program, Melbourne, Vic 3004, Australia; [Richards, Jack S.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3052, Australia; [Richards, Jack S.] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [Richards, Jack S.] Alfred Hosp, Dept Infect Dis, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Cywes-Bentley, Colette; Pier, Gerald B.] Harvard Med Sch, Div Infect Dis, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg, Austin Hlth, Heidelberg, Vic 3084, Australia	Royal Melbourne Institute of Technology (RMIT); Monash University; Burnet Institute; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Ramsland, PA (corresponding author), RMIT Univ, Sch Sci, Plenty Rd, Bundoora, Vic 3083, Australia.	paul.ramsland@rmit.edu.au	Yuriev, Elizabeth/A-7132-2016; Pier, Gerald/AAO-2692-2021	Yuriev, Elizabeth/0000-0002-3909-0379; Pier, Gerald/0000-0002-9112-2331; Soliman, Caroline/0000-0003-2714-5341; Ramsland, Paul/0000-0002-2107-2738; Walduck, Anna/0000-0002-9624-4370; Cywes Bentley, Colette/0000-0002-6301-0930	National Health and Medical Research Council of Australia [GNT1125788, GNT1037722]; Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Alopexx Vaccine, LLC; Morris Animal Foundation; National Institutes of Health	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Alopexx Vaccine, LLC; Morris Animal Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant GNT1125788 and Research Fellowship GNT1037722 (to J. S. R.). G. B. P. is an inventor of intellectual properties (human monoclonal antibody to PNAG and PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC, entities in which G. B. P. also holds equity. As an inventor of intellectual properties, G. B. P. also has the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC. G. B. P.'s interests were reviewed and are managed by the Brigham and Women's Hospital and Partners Healthcare in accordance with their conflict of interest policies. G. B. P. has received funding from the Morris Animal Foundation and National Institutes of Health to conduct studies on the development of vaccines and antibody therapies targeting the microbial antigen PNAG. C. C.-B. is an inventor of intellectual properties (use of human monoclonal antibody to PNAG and use of PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC. As an inventor of intellectual properties, C. C.-B. has the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Anish C, 2014, CHEM BIOL, V21, P38, DOI 10.1016/j.chembiol.2014.01.002; Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007; Banin E, 2017, FEMS MICROBIOL REV, V41, P450, DOI 10.1093/femsre/fux016; Carboni F, 2017, P NATL ACAD SCI USA, V114, P5017, DOI 10.1073/pnas.1701885114; Coleman J. P., 2011, XPHARM COMPREHENSIVE, P1; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CYGLER M, 1993, BIOCHEM SOC T, V21, P437, DOI 10.1042/bst0210437; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Dubel S., 2012, HDB THERAPEUTIC ANTI; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan ZC, 1999, J MOL RECOGNIT, V12, P19, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y; Franca A, 2013, INT J BIOL SCI, V9, P518, DOI 10.7150/ijbs.6102; Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010; Gening ML, 2013, PURE APPL CHEM, V85, P1879, DOI 10.1351/PAC-CON-12-09-06; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Haji-Ghassemi O, 2015, GLYCOBIOLOGY, V25, P920, DOI 10.1093/glycob/cwv037; Haji-Ghassemi O, 2014, J BIOL CHEM, V289, P16644, DOI 10.1074/jbc.M113.528224; Hutter Julia, 2015, Methods Mol Biol, V1331, P1, DOI 10.1007/978-1-4939-2874-3_1; Irani V, 2015, MOL IMMUNOL, V67, P171, DOI 10.1016/j.molimm.2015.03.255; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Murase T, 2009, J MOL BIOL, V392, P381, DOI 10.1016/j.jmb.2009.06.074; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2013, J BIOL CHEM, V288, P33784, DOI 10.1074/jbc.M113.496224; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Parker MJ, 2014, GLYCOBIOLOGY, V24, P442, DOI 10.1093/glycob/cwu009; Reichert JM, 2017, MABS-AUSTIN, V9, P167, DOI 10.1080/19420862.2016.1269580; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Roux D, 2012, J ANTIMICROB CHEMOTH, V67, P2785, DOI 10.1093/jac/dks335; Skurnik D, 2016, EXPERT REV VACCINES, V15, P1041, DOI 10.1586/14760584.2016.1159135; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; The Antibody Society, 2017, APPR ANT THER MON AN; Vlock D., 2010, 50 ICAAC 2010; Vulliez-Le Normand B, 2008, P NATL ACAD SCI USA, V105, P9976, DOI 10.1073/pnas.0801711105; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Weaver LG, 2013, CARBOHYD RES, V371, P68, DOI 10.1016/j.carres.2013.01.008; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao G, 2016, INVEST OPHTH VIS SCI, V57, P6797, DOI 10.1167/iovs.16-20358	45	20	21	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5079	5089		10.1074/jbc.RA117.001170	http://dx.doi.org/10.1074/jbc.RA117.001170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449370	Green Published, hybrid			2022-12-26	WOS:000429409300015
J	Abraham, PE; Garcia, BJ; Gunter, LE; Jawdy, SS; Engle, N; Yang, XH; Jacobson, DA; Hettich, RL; Tuskan, GA; Tschaplinski, TJ				Abraham, Paul E.; Garcia, Benjamin J.; Gunter, Lee E.; Jawdy, Sara S.; Engle, Nancy; Yang, Xiaohan; Jacobson, Daniel A.; Hettich, Robert L.; Tuskan, Gerald A.; Tschaplinski, Timothy J.			Quantitative proteome profile of water deficit stress responses in eastern cottonwood (Populus deltoides) leaves	PLOS ONE			English	Article							CHLOROPHYLL DEGRADATION; PEPTIDE IDENTIFICATION; ARABIDOPSIS-THALIANA; DROUGHT; POPLAR; GENES; LEAF; EXPRESSION; ANNOTATION; METABOLISM	Drought stress is a recurring feature of world climate and the single most important factor influencing agricultural yield worldwide. Plants display highly variable, species-specific responses to drought and these responses are multifaceted, requiring physiological and morphological changes influenced by genetic and molecular mechanisms. Moreover, the reproducibility of water deficit studies is very cumbersome, which significantly impedes research on drought tolerance, because how a plant responds is highly influenced by the timing, duration, and intensity of the water deficit. Despite progress in the identification of drought-related mechanisms in many plants, the molecular basis of drought resistance remains to be fully understood in trees, particularly in poplar species because their wide geographic distribution results in varying tolerances to drought. Herein, we aimed to better understand this complex phenomenon in eastern cottonwood (Populus deltoides) by performing a detailed contrast of the proteome changes between two different water deficit experiments to identify functional intersections and divergences in proteome responses. We investigated plants subjected to cyclic water deficit and compared these responses to plants subjected to prolonged acute water deficit. In total, we identified 108,012 peptide sequences across both experiments that provided insight into the quantitative state of 22,737 Populus gene models and 8,199 functional protein groups in response to drought. Together, these datasets provide the most comprehensive insight into proteome drought responses in poplar to date and a direct proteome comparison between short period dehydration shock and cyclic, post-drought re-watering. Overall, this investigation provides novel insights into drought avoidance mechanisms that are distinct from progressive drought stress. Additionally, we identified proteins that have been associated as drought-relevant in previous studies. Importantly, we highlight the RD26 transcription factor as a gene regulated at both the transcript and protein level, regardless of species and drought condition, and, thus, represents a key, universal drought marker for Populus species.	[Abraham, Paul E.; Hettich, Robert L.] Oak Ridge Natl Lab, Chem Sci Div, Oak Ridge, TN USA; [Garcia, Benjamin J.; Gunter, Lee E.; Jawdy, Sara S.; Engle, Nancy; Yang, Xiaohan; Jacobson, Daniel A.; Tuskan, Gerald A.; Tschaplinski, Timothy J.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Tschaplinski, TJ (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.	tschaplinstj@ornl.gov	Abraham, Paul E/K-5599-2015; Yang, Xiaohan/AAM-2449-2020; Gunter, Lee E/L-3480-2016; Engle, Nancy L/D-6494-2018; Hettich, Robert L/N-1458-2016; Yang, Xiaohan/A-6975-2011; Tschaplinski, Timothy/D-6382-2018	Yang, Xiaohan/0000-0001-5207-4210; Gunter, Lee E/0000-0003-1211-7532; Engle, Nancy L/0000-0003-0290-7987; Hettich, Robert L/0000-0001-7708-786X; Yang, Xiaohan/0000-0001-5207-4210; Tschaplinski, Timothy/0000-0002-9540-6622; Jacobson, Daniel/0000-0002-9822-8251; Garcia, Benjamin/0000-0001-5524-6946; Abraham, Paul/0000-0003-2685-9123	Plant Microbe Interfaces Science Focus Area - U.S. Department of Energy (DOE); Office of Biological and Environmental Research (OBER); Center for Bioenergy Innovation (CBI) [FWP ERK886]; Office of Science, OBER	Plant Microbe Interfaces Science Focus Area - U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Biological and Environmental Research (OBER)(United States Department of Energy (DOE)); Center for Bioenergy Innovation (CBI); Office of Science, OBER(United States Department of Energy (DOE))	This work was supported by the Plant Microbe Interfaces Science Focus Area supported by the U.S. Department of Energy (DOE), Office of Biological and Environmental Research (OBER), and by Center for Bioenergy Innovation (CBI, FWP ERK886), which is a U.S. DOE Bioenergy Research Center supported by the Office of Science, OBER. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Abraham P, 2013, MOL CELL PROTEOMICS, V12, P106, DOI 10.1074/mcp.M112.022996; Abraham P, 2012, J PROTEOME RES, V11, P449, DOI 10.1021/pr200851y; Bechtold U, 2016, PLANT CELL, V28, P345, DOI 10.1105/tpc.15.00910; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bohler S, 2013, PROTEOMICS, V13, P1737, DOI 10.1002/pmic.201200193; Bonhomme L, 2009, PHYTOCHEMISTRY, V70, P988, DOI 10.1016/j.phytochem.2009.05.013; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Chang SH, 2017, PLANT PHYSIOL, V174, P435, DOI 10.1104/pp.17.00248; Chen YY, 2013, J PROTEOME RES, V12, P4111, DOI 10.1021/pr400438q; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Durand TC, 2011, J PROTEOMICS, V74, P1396, DOI 10.1016/j.jprot.2011.03.013; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellison CT, 2011, PLANT PHYSIOL, V155, P988, DOI 10.1104/pp.110.164277; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gao S, 2016, MOL PLANT, V9, P1272, DOI 10.1016/j.molp.2016.06.006; Gebre GM, 1998, TREE PHYSIOL, V18, P645; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; He CY, 2008, TREES-STRUCT FUNCT, V22, P803, DOI 10.1007/s00468-008-0241-8; HOLM S, 1979, SCAND J STAT, V6, P65; Hoque TS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01341; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Li DM, 2016, P NATL ACAD SCI USA, V113, P9375, DOI 10.1073/pnas.1602960113; Li JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137762; Li S, 2016, PLANT CELL REP, V35, P1729, DOI 10.1007/s00299-016-1991-1; Linster E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8640; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Ma X, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-164; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Pan L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00519; PEZESHKI SR, 1982, CAN J FOREST RES, V12, P761, DOI 10.1139/x82-115; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Rymaszewski W, 2017, PLANT PHYSIOL, V174, P1913, DOI 10.1104/pp.17.00318; Sannigrahi P, 2010, BIOFUEL BIOPROD BIOR, V4, P209, DOI 10.1002/bbb.206; Sengupta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00656; Shao HB, 2008, CR BIOL, V331, P215, DOI 10.1016/j.crvi.2008.01.002; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swire-Clark GA, 1999, PLANT MOL BIOL, V39, P117, DOI 10.1023/A:1006106906345; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; TSCHAPLINSKI TJ, 1995, NEW PHYTOL, V131, P169, DOI 10.1111/j.1469-8137.1995.tb05718.x; Tschaplinski TJ, 2006, TREE PHYSIOL, V26, P595, DOI 10.1093/treephys/26.5.595; Tschaplinski TJ, 1998, TREE PHYSIOL, V18, P653; Tsugama D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103930; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; TYREE MT, 1992, TREE PHYSIOL, V10, P411, DOI 10.1093/treephys/10.4.411; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Xu ZZ, 2010, PLANT SIGNAL BEHAV, V5, P649, DOI 10.4161/psb.5.6.11398; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226; Yang PF, 2007, PROTEOMICS, V7, P2459, DOI 10.1002/pmic.200600215; Yildirim K, 2017, PLANT PHYSIOL BIOCH, V115, P183, DOI 10.1016/j.plaphy.2017.03.020; Yin M, 2017, J EXP BOT; Yoon SK, 2014, PLANT PHYSIOL BIOCH, V84, P158, DOI 10.1016/j.plaphy.2014.09.008; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	61	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0190019	10.1371/journal.pone.0190019	http://dx.doi.org/10.1371/journal.pone.0190019			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447168	Green Submitted, gold, Green Published			2022-12-26	WOS:000425283900005
J	Bryant, RA; Hutanamon, T				Bryant, Richard A.; Hutanamon, Thea			Activating attachments enhances heart rate variability	PLOS ONE			English	Article							STRESS; REPRESENTATIONS; ACCESSIBILITY; SECURITY; SENSE; PAIN	Although activating mental representations of attachment figures is beneficial for psychological health, there is a paucity of knowledge of the underlying mechanisms. We investigated how priming attachment figures may modulate parasympathetic stress response. Participants (N = 62) with varying degrees of attachment security underwent a cold pressor test, and then imagined an attachment or non-attachment figure. Heart rate variability was assessed throughout the study. Participants with low avoidant attachment levels displayed less negative affect and greater heart rate variability following the attachment prime than those who imagined the non-attachment prime. This beneficial effect of attachment priming was not observed in participants with high avoidant attachment levels. These findings highlight that activating attachment representations can enhance the parasympathetic stress response in people with secure attachment styles, and provides one explanation for the psychological benefits of attachment proximity.	[Bryant, Richard A.; Hutanamon, Thea] Univ New South Wales, Sydney, NSW, Australia	University of New South Wales Sydney	Bryant, RA (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X	National Health and Medical Research Council [1073041]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by the National Health and Medical Research Council (1073041). The funder had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Andreano JM, 2008, PSYCHONEUROENDOCRINO, V33, P874, DOI 10.1016/j.psyneuen.2008.03.009; BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Bowlby J., 1969, ATTACHMENT LOSS, V1; Brennan KA, 1998, J PERS, V66, P835, DOI 10.1111/1467-6494.00034; Brown JL, 2003, PSYCHOSOM MED, V65, P276, DOI 10.1097/01.PSY.0000030388.62434.46; Bryant RA, PSYCHONEURO IN PRESS; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Camm AJ, 1996, CIRCULATION, V93, P1043; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DOZIER M, 1992, CHILD DEV, V63, P1473, DOI 10.2307/1131569; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Fraley RC, 1997, J PERS SOC PSYCHOL, V73, P1080, DOI 10.1037/0022-3514.73.5.1080; Jackson T, 2005, J PAIN, V6, P228, DOI 10.1016/j.jpain.2004.12.004; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Master SL, 2009, PSYCHOL SCI, V20, P1316, DOI 10.1111/j.1467-9280.2009.02444.x; Maunder RG, 2006, J PSYCHOSOM RES, V60, P283, DOI 10.1016/j.jpsychores.2005.08.013; Mikulincer M, 2000, J PERS SOC PSYCHOL, V78, P509, DOI 10.1037/0022-3514.78.3.509; Mikulincer M, 2003, BASIC APPL SOC PSYCH, V25, P299, DOI 10.1207/S15324834BASP2504_4; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M, 2002, J PERS SOC PSYCHOL, V83, P881, DOI 10.1037//0022-3514.83.4.881; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P305, DOI 10.1037//0022-3514.81.2.305; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P1205, DOI 10.1037/0022-3514.81.6.1205; Mikulincer M, 2006, EMOTION REGULATION F, P77, DOI [10.1037/11468-004, DOI 10.1037/11468-004]; Mikulincer M., 1995, J PERS SOC PSYCHOL, V72, P1217; Mikulincer M, 2007, PSYCHOL INQ, V18, P139, DOI 10.1080/10478400701512646; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Porges SW, 2011, POLYVAGAL THEORY NEU; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001	30	17	19	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0151747	10.1371/journal.pone.0151747	http://dx.doi.org/10.1371/journal.pone.0151747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447167	Green Published, gold			2022-12-26	WOS:000425283900001
J	Cosin-Roger, J; Spalinger, MR; Ruiz, PA; Stanzel, C; Terhalle, A; Wolfram, L; Melhem, H; Atrott, K; Lang, S; Frey-Wagner, I; Fried, M; Scharl, M; Hausmann, M; Rogler, G				Cosin-Roger, Jesus; Spalinger, Marianne R.; Ruiz, Pedro A.; Stanzel, Claudia; Terhalle, Anne; Wolfram, Lutz; Melhem, Hassan; Atrott, Kirstin; Lang, Silvia; Frey-Wagner, Isabelle; Fried, Michael; Scharl, Michael; Hausmann, Martin; Rogler, Gerhard			Gp96 deficiency affects TLR4 functionality and impairs ERK and p38 phosphorylation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; SHOCK-PROTEIN GP96; INTESTINAL MACROPHAGES; INNATE IMMUNITY; DENDRITIC CELLS; CHAPERONE; GRP94; INTEGRINS; MONOCYTES	Gp96 is an endoplasmic reticulum chaperone for multiple protein substrates. Its lack in intestinal macrophages of Crohn's disease (CD) patients is correlated with loss of tolerance against the host gut flora. Gp96 has been stablished to be an essential chaperone for Toll-like receptors (TLRs). We studied the impact of gp96-knockdown on TLR-function in macrophages. TLR2 and TLR4 expression was only decreased but not abolished when gp96 was knocked-down in cell lines, whereas in a monocyte/macrophage specific knock-out mouse model (LysMCre) TLR4 was abolished, while TLR2 was still present. Lipopolysaccharide (LPS)-induced NF-kappa B activation was still observed in the absence of gp96, and gp96-deficient macrophages were able to up-regulate surface TLR4 upon LPS treatment, suggesting that there is another chaperone involved in the folding of TLR4 upon stress responses. Moreover, LPS-dependent pro-inflammatory cytokines were still expressed, although to a lesser extent in the absence of gp96, which reinforces the fact that gp96 is involved in regulating signaling cascades downstream of TLR4 are impaired upon loss of gp96. In addition, we have also found a reduced phosphorylation of ERK and p38 kinases and an impaired response upon CSF1R activation in gp96 deficient macrophages. Our findings indicate that the loss of gp96 not only impairs TLR4 signaling, but is also associated with a diminished phosphorylation of ERK and mitogen-activated stress kinases resulting in an impaired signalling through several receptors, including CSF1R.	[Cosin-Roger, Jesus; Spalinger, Marianne R.; Ruiz, Pedro A.; Stanzel, Claudia; Terhalle, Anne; Wolfram, Lutz; Melhem, Hassan; Atrott, Kirstin; Lang, Silvia; Frey-Wagner, Isabelle; Fried, Michael; Scharl, Michael; Hausmann, Martin; Rogler, Gerhard] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Rogler, G (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland.	gerhard.rogler@usz.ch		Ruiz-Castro, Pedro Antonio/0000-0001-7528-1474; Cosin roger, Jesus/0000-0002-2468-4908; Scharl, Michael/0000-0002-6729-1469	Swiss National Science Foundation [310030_138410, 310030-120312, 31003A_127247]; Swiss IBD Cohort [3347CO-108792]; ECCO Fellowship from European Crohn's and Colitis Organisation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort; ECCO Fellowship from European Crohn's and Colitis Organisation	This research was funded by research grants from the Swiss National Science Foundation (Grant No. 310030_138410 and 310030-120312 to GR and Grant No. 31003A_127247 to MH), as well as the Swiss IBD Cohort (Grant No. 3347CO-108792) J. CR is supported by the ECCO Fellowship from European Crohn's and Colitis Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anas AA, 2016, J PATHOL, V238, P74, DOI 10.1002/path.4637; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291, DOI 10.1111/j.1365-2249.1995.tb03667.x; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hong F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169260; Hua YP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02415-7; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Landy J, 2016, WORLD J GASTROENTERO, V22, P3117, DOI 10.3748/wjg.v22.i11.3117; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Mahida YR, 2000, INFLAMM BOWEL DIS, V6, P21, DOI 10.1097/00054725-200002000-00004; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Ramirez SR, 2005, CELL STRESS CHAPERON, V10, P221, DOI 10.1379/CSC-117R.1; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Reed RC, 2003, J BIOL CHEM, V278, P31853, DOI 10.1074/jbc.M305480200; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; RUGTVEIT J, 1994, GUT, V35, P669, DOI 10.1136/gut.35.5.669; RUGTVEIT J, 1995, GUT, V37, P367, DOI 10.1136/gut.37.3.367; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Schild H, 2000, NAT IMMUNOL, V1, P100, DOI 10.1038/77770; Schreiter K, 2005, GUT, V54, P935, DOI 10.1136/gut.2004.053116; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Wolfram L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076350; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	31	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193003	10.1371/journal.pone.0193003	http://dx.doi.org/10.1371/journal.pone.0193003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447283	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000425283900090
J	Suh, S; Cho, YR; Park, MK; Kim, DK; Cho, NH; Lee, MK				Suh, Sunghwan; Cho, Young Rak; Park, Mi Kyoung; Kim, Duk Kyu; Cho, Nam H.; Lee, Moon-Kyu			Relationship between serum bilirubin levels and cardiovascular disease	PLOS ONE			English	Article							METABOLIC SYNDROME; BELGIAN POPULATION; KOREAN ADULTS; RISK; LUNG; SMOKING; MEN	We tested the hypothesis that higher levels of bilirubin, a bile pigment with antioxidant properties, are associated with a decreased risk of cardiovascular disease (CVD). This study analyzed data from the Korean Health and Genome Study to examine the association between serum total bilirubin (TB) on CVD and CVD death. Serum TB was measured in a total of 8,844 subjects (4,196 males and 4,648 females) and evaluated for the development of new onset CVD from 2001 to 2012 (mean 8.1 years of follow-up). During the follow-up period, 689 cases of incident CVD (7.8%) were identified, and the prevalence of metabolic syndrome (MetS) at baseline was 26.1%. The prevalence of MetS decreased across bilirubin tertile categories. In addition to MetS itself, individual components of MetS significantly decreased with increased bilirubin tertiles. Moreover, the incidence of CVD decreased across bilirubin tertile categories. The hazard ratios (HRs) for developing coronary heart disease (CHD, HR 0.769, 95% CI 0.655-1.000) and CVD death (HR 0.513, 95% CI 0.267-0.985) was significantly lower in the highest tertile group (> 0.63 mg/dL) in comparison to the lowest tertile group (< 0.44 mg/dL) after adjusting for all confounding variables. In the present longitudinal study, a significant negative relationship was demonstrated between baseline bilirubin levels and incident CHD and CVD death.	[Suh, Sunghwan; Cho, Young Rak; Park, Mi Kyoung; Kim, Duk Kyu] Dong A Univ, Med Ctr, Coll Med, Dept Internal Med, Busan, South Korea; [Cho, Nam H.] Ajou Univ, Sch Med, Dept Prevent Med, Suwon, South Korea; [Lee, Moon-Kyu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea	Dong A University; Ajou University; Sungkyunkwan University (SKKU); Samsung Medical Center	Cho, NH (corresponding author), Ajou Univ, Sch Med, Dept Prevent Med, Suwon, South Korea.; Lee, MK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea.	chnaha@ajou.ac.kr; leemk@skku.edu		Suh, Sunghwan/0000-0001-6865-966X	Dong-A University	Dong-A University	This work was supported by the research fund of Dong-A University to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001; Deetman PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090886; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gul M, 2014, J CRIT CARE, V29, P305, DOI 10.1016/j.jcrc.2013.11.019; Gupta Nancy, 2016, World J Gastrointest Pharmacol Ther, V7, P469; Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291; Jung CH, 2014, METABOLISM, V63, P87, DOI 10.1016/j.metabol.2013.09.011; Kim NH, 2016, NICOTINE TOB RES, V18, P572, DOI 10.1093/ntr/ntv251; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Kunutsor SK, 2015, ARTERIOSCL THROM VAS, V35, P716, DOI 10.1161/ATVBAHA.114.304929; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lim S, 2006, J ENDOCRINOL INVEST, V29, P313, DOI 10.1007/BF03344102; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Oda E, 2013, ACTA DIABETOL, V50, P417, DOI 10.1007/s00592-012-0447-5; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Schooling CM, 2012, ANN EPIDEMIOL, V22, P789, DOI 10.1016/j.annepidem.2012.08.003; Song YS, 2014, AM J CARDIOL, V114, P1695, DOI 10.1016/j.amjcard.2014.08.043; Suh S, 2014, ENDOCRINOL METAB, V29, P522, DOI 10.3803/EnM.2014.29.4.522; Suh S, 2014, J ATHEROSCLER THROMB, V21, pS31; Targher G, 2014, ARTERIOSCL THROM VAS, V34, P702, DOI 10.1161/ATVBAHA.114.303279; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; Villard PH, 1998, PHARMACOL TOXICOL, V82, P74, DOI 10.1111/j.1600-0773.1998.tb01401.x; Vitek L, 2017, PHYSIOL RES, V66, pS11, DOI 10.33549/physiolres.933581; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Wagner KH, 2015, CLIN SCI, V129, P1, DOI 10.1042/CS20140566	29	23	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193041	10.1371/journal.pone.0193041	http://dx.doi.org/10.1371/journal.pone.0193041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW4LB	29447261	Green Published, gold, Green Submitted			2022-12-26	WOS:000425283900101
J	Kumar, S; Chen, CX; Indugu, N; Werlang, GO; Singh, M; Kim, WK; Thippareddi, H				Kumar, Sanjay; Chen, Chongxiao; Indugu, Nagaraju; Werlang, Gabriela Orosco; Singh, Manpreet; Kim, Woo Kyun; Thippareddi, Harshavardhan			Effect of antibiotic withdrawal in feed on chicken gut microbial dynamics, immunity, growth performance and prevalence of foodborne pathogens	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; BROILER-CHICKENS; BACTERIAL COMMUNITY; ANTIMICROBIAL PEPTIDES; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; MICROFLORA; SALMONELLA; BACITRACIN; ILEUM	Development of antibiotic resistance in foodborne pathogens, Salmonella spp. and Campylobacter, is a public health concern. Public demand to reduce the use of sub-therapeutic antibiotic growth promoters (AGP) in poultry feeding has resulted in greater adoption of anti-biotic-free poultry production systems. There is a need to understand the effects of AGP removal from poultry feed on gut microbiota and its impact on prevalence of foodborne pathogens. The effect of antibiotic withdrawal from poultry feed on gut microbial community, host performance and immunity, and prevalence of Salmonella and Campylobacter was evaluated. Birds were raised on three phase diets (starter [d0-22], grower [d23-35] and finisher [d36-42]) with and without bacitracin dimethyl salicyclate (BMD). At early growth stage, bird performance was improved (P <= 0.05) with BMD treatment, whereas performance was better (P <= 0.05) in control group (no BMD in the feed) at the time of commercial processing. Acetate and butyrate production was affected (P <= 0.05) by age, whereas propionate production was affected (P <= 0.05) by both the treatment and age. The bacterial communities in the cecum were more diverse (P <= 0.001) and rich compared to the ileal communities, and they shifted in parallel to one another as the chicks matured. Differences in diversity and species richness were not observed (P > 0.05) between the BMD-fed and control groups. Comparing all ages, treatments and diets, the composition of cecal and ileal bacterial communities was different (P <= 0.001). Inclusion of BMD in the feed did not affect the bacterial phyla. However, predictable shift in the ileal and cecal bacterial population at lower taxonomic level was observed in control vs BMD-fed group. Cytokines gene expression (IL-10, IL-4, IFN-gamma, beta-defensin, and TLR-4) was affected (P <= 0.05) in the BMD-fed group at early stages of growth. The prevalence of foodborne pathogens, Campylobacter spp. and Salmonella spp. showed higher abundance in the ilea of BMD-fed chicks compared to control group. Overall, this study provided insight of the impact of AGP supplementation in the feed on gut microbial modulations, bird performance, host immunity and pathogen prevalence. This information can assist in designing alternative strategies to replace antibiotics in modern poultry production and for food safety.	[Kumar, Sanjay; Chen, Chongxiao; Singh, Manpreet; Kim, Woo Kyun; Thippareddi, Harshavardhan] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA; [Indugu, Nagaraju] Univ Penn, New Bolton Ctr, Kennett Sq, PA USA; [Werlang, Gabriela Orosco] Univ Fed Rio Grande do Sul, Prevent Vet Med Dept, Porto Alegre, RS, Brazil	University System of Georgia; University of Georgia; University of Pennsylvania; Universidade Federal do Rio Grande do Sul	Thippareddi, H (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	harsha.thippareddi@uga.edu	Indugu, Nagaraju/AAT-7497-2021	Indugu, Nagaraju/0000-0001-9424-2155; Chen, Chongxiao/0000-0002-4597-4031; Kumar, Sanjay/0000-0002-0937-918X	University of Georgia, College of Agricultural and Environmental Sciences; University of Georgia College of Agricultural and Environmental Sciences	University of Georgia, College of Agricultural and Environmental Sciences; University of Georgia College of Agricultural and Environmental Sciences	The corresponding author received financial support from the University of Georgia, College of Agricultural and Environmental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the generous support of the University of Georgia College of Agricultural and Environmental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge the technical assistance of Amanda K Howard, Mayuri S Ukidwe, and Jeferson Laurenco. We are thankful to Dr. Lawton for VFA analysis.	Adzitey F, 2012, FOODBORNE PATHOG DIS, V9, P498, DOI 10.1089/fpd.2011.1109; Akbari MR, 2008, CLIN VACCINE IMMUNOL, V15, P1689, DOI 10.1128/CVI.00242-08; Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, PACKAGE VEGAN COMMUN; Ballou AL, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00002; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; BARNES EM, 1972, BRIT POULTRY SCI, V13, P311, DOI 10.1080/00071667208415953; Bates D., 2013, LME4 LINEAR MIXED EF; Bates D., 2014, IME4 LINEAR MIXED EF; Brisbin JT, 2011, CLIN VACCINE IMMUNOL, V18, P1447, DOI 10.1128/CVI.05100-11; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Campbell JM, 1997, J NUTR, V127, P130, DOI 10.1093/jn/127.1.130; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; COTTYN BG, 1968, J AGR FOOD CHEM, V16, P105, DOI 10.1021/jf60155a002; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Danzeisen JL, 2013, PEERJ, V1, DOI 10.7717/peerj.237; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Danzeisen JL, 2015, FRONTIERS VET SCI, V2; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; DROLESKEY RE, 1994, AVIAN DIS, V38, P275, DOI 10.2307/1591949; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2014, COMPARATIVE MED, V64, P90; Gong J, 2008, J APPL MICROBIOL, V104, P1372, DOI 10.1111/j.1365-2672.2007.03699.x; Gong JH, 2002, FEMS MICROBIOL ECOL, V41, P171, DOI 10.1111/j.1574-6941.2002.tb00978.x; Gong JH, 2002, FEMS MICROBIOL LETT, V208, P1, DOI 10.1111/j.1574-6968.2002.tb11051.x; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Haghighi HR, 2005, CLIN DIAGN LAB IMMUN, V12, P1387, DOI 10.1128/CDLI.12.12.1387-1392.2005; Hammons S, 2010, SYST APPL MICROBIOL, V33, P275, DOI 10.1016/j.syapm.2010.04.003; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; HARMS RH, 1989, POULTRY SCI, V68, P86, DOI 10.3382/ps.0680086; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hughes RJ, 2008, BRIT POULTRY SCI, V49, P716, DOI 10.1080/00071660802449145; Institute S, 2011, SAS IML 9 3 US GUID; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; Klindworth A., 2012, NUCLEIC ADDS RES; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; Koenen ME, 2004, BRIT POULTRY SCI, V45, P355, DOI 10.1080/00071660410001730851; Lei F, 2012, APPL ENVIRON MICROB, V78, P5763, DOI 10.1128/AEM.00327-12; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mwangi WN, 2010, DEV COMP IMMUNOL, V34, P406, DOI 10.1016/j.dci.2009.11.009; Neish AS, 2002, MICROBES INFECT, V4, P309, DOI 10.1016/S1286-4579(02)01543-5; Oakley BB, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00011; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Pitta DW, 2014, J ANIM SCI, V92, P4014, DOI 10.2527/jas.2014-7621; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rehman HU, 2007, ARCH ANIM NUTR, V61, P319, DOI 10.1080/17450390701556817; RICE GE, 1982, J COMP PHYSIOL, V147, P61, DOI 10.1007/BF00689291; Rosen G. D., 1995, BIOTECHNOLOGY ANIMAL, P172; Ruiz R, 2015, J ANIM SCI, V93, P3410, DOI 10.2527/jas.2015-8905; SALANITRO JP, 1974, APPL MICROBIOL, V27, P678, DOI 10.1128/AEM.27.4.678-687.1974; Scupham AJ, 2009, APPL ENVIRON MICROB, V75, P3564, DOI 10.1128/AEM.01409-08; Shaufi MAM, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0051-7; Shimizu M, 2008, POULTRY SCI, V87, P2653, DOI 10.3382/ps.2008-00210; Singh M, 2008, VET WORLD, V1, P141; Stanley D, 2013, VET MICROBIOL, V164, P85, DOI 10.1016/j.vetmic.2013.01.030; Sun H, 2013, TROP ANIM HEALTH PRO, V45, P987, DOI 10.1007/s11250-012-0322-y; Temelli S, 2012, POULTRY SCI, V91, P724, DOI 10.3382/ps.2011-01863; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; van der Wielen PWJJ, 2000, APPL ENVIRON MICROB, V66, P2536, DOI 10.1128/AEM.66.6.2536-2540.2000; Van Immerseel F, 2004, AVIAN PATHOL, V33, P537, DOI 10.1080/03079450400013162; WALDROUP PW, 1986, POULTRY SCI, V65, P757, DOI 10.3382/ps.0650757; Wei S, 2013, VET MICROBIOL, V166, P595, DOI 10.1016/j.vetmic.2013.06.006; Yang H, 2016, SCI REPORTS, V6; Yeoman Carl J., 2012, Animal Health Research Reviews, V13, P89, DOI 10.1017/S1466252312000138; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	71	75	78	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2018	13	2							e0192450	10.1371/journal.pone.0192450	http://dx.doi.org/10.1371/journal.pone.0192450			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW3CM	29444134	Green Published, gold, Green Submitted			2022-12-26	WOS:000425183500066
J	Aghamohammadi, A; Ang, MC; Sundararajan, EA; Weng, NK; Mogharrebi, M; Banihashem, SY				Aghamohammadi, Amirhossein; Ang, Mei Choo; Sundararajan, Elankovan A.; Weng, Ng Kok; Mogharrebi, Marzieh; Banihashem, Seyed Yashar			A parallel spatiotemporal saliency and discriminative online learning method for visual target tracking in aerial videos	PLOS ONE			English	Article							MOVING OBJECT DETECTION; LOCALIZATION; COLOR	Visual tracking in aerial videos is a challenging task in computer vision and remote sensing technologies due to appearance variation difficulties. Appearance variations are caused by camera and target motion, low resolution noisy images, scale changes, and pose variations. Various approaches have been proposed to deal with appearance variation difficulties in aerial videos, and amongst these methods, the spatiotemporal saliency detection approach reported promising results in the context of moving target detection. However, it is not accurate for moving target detection when visual tracking is performed under appearance variations. In this study, a visual tracking method is proposed based on spatiotemporal saliency and discriminative online learning methods to deal with appearance variations difficulties. Temporal saliency is used to represent moving target regions, and it was extracted based on the frame difference with Sauvola local adaptive thresholding algorithms. The spatial saliency is used to represent the target appearance details in candidate moving regions. SLIC superpixel segmentation, color, and moment features can be used to compute feature uniqueness and spatial compactness of saliency measurements to detect spatial saliency. It is a time consuming process, which prompted the development of a parallel algorithm to optimize and distribute the saliency detection processes that are loaded into the multi-processors. Spatiotemporal saliency is then obtained by combining the temporal and spatial saliencies to represent moving targets. Finally, a discriminative online learning algorithm was applied to generate a sample model based on spatiotemporal saliency. This sample model is then incrementally updated to detect the target in appearance variation conditions. Experiments conducted on the VIVID dataset demonstrated that the proposed visual tracking method is effective and is computationally efficient compared to state-of-the-art methods.	[Aghamohammadi, Amirhossein; Ang, Mei Choo; Mogharrebi, Marzieh] Univ Kebangsaan Malaysia, Inst Visual Informat, Bangi, Selangor, Malaysia; [Sundararajan, Elankovan A.] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Ctr Software Technol & Management SOFTAM, Bangi, Selangor, Malaysia; [Weng, Ng Kok] Ind Design Ctr, Sirim Berhad, Selangor, Malaysia; [Banihashem, Seyed Yashar] Buien Zahra Tech Univ, Dept Elect & Comp Engn, Buien Zahra, Iran; [Aghamohammadi, Amirhossein; Mogharrebi, Marzieh] Iran Univ Sci & Technol, Image Proc lab, Sch Elect Engn, Tehran, Iran	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; SIRIM Berhad; Iran University Science & Technology	Aghamohammadi, A (corresponding author), Univ Kebangsaan Malaysia, Inst Visual Informat, Bangi, Selangor, Malaysia.; Aghamohammadi, A (corresponding author), Iran Univ Sci & Technol, Image Proc lab, Sch Elect Engn, Tehran, Iran.	amho.mohammadi@gmail.com	Ang, Mei Choo/G-5520-2010; Ng, Kok Weng/C-5757-2009; banihashem, seyed yashar/B-5267-2014	Ang, Mei Choo/0000-0001-5316-3936; Ng, Kok Weng/0000-0001-6910-0040; banihashem, seyed yashar/0000-0002-2456-7920; Sundararajan, Elankovan/0000-0003-2711-0659	Universiti Kebangsaan Malaysia (UKM) [DIP-2014-037]	Universiti Kebangsaan Malaysia (UKM)	We would also like to acknowledge Universiti Kebangsaan Malaysia (UKM) financial support for this project via DIP-2014-037.r The authors would like to thank Dr. Seyed Mostafa Mousavi Kahaki for useful advices and suggestions. We would also like to thank the anonymous reviewers for their useful that resulted in the improvements to this paper. We would also like to acknowledge Universiti Kebangsaan Malaysia (UKM) financial support for this project via DIP-2014-037.	Achanta R, EPFLREPORT149300; Achanta R, 2009, PROC CVPR IEEE, P1597, DOI 10.1109/CVPRW.2009.5206596; Aeschliman C, 2014, IEEE T AERO ELEC SYS, V50, P429, DOI 10.1109/TAES.2013.120404; Avidan S, 2007, IEEE T PATTERN ANAL, V29, P261, DOI 10.1109/TPAMI.2007.35; Babenko B, 2009, PROC CVPR IEEE, P983, DOI 10.1109/CVPRW.2009.5206737; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cao XB, 2014, NEUROCOMPUTING, V124, P168, DOI 10.1016/j.neucom.2013.07.014; Chen F, 2011, IMAGE VISION COMPUT, V29, P787, DOI 10.1016/j.imavis.2011.08.006; Chi Z, 2013, OBJECT LEVEL SALIENC, P2475; Collins R, 2005, OPEN SOURCE TRACKING; Collins RT, 2005, IEEE T PATTERN ANAL, V27, P1631, DOI 10.1109/TPAMI.2005.205; Das A, 2014, J FIELD ROBOT, V31, P75, DOI 10.1002/rob.21490; GONZALEZ R., 2002, DIGITAL IMAGE PROCES; Gopalakrishnan V, 2009, IEEE T MULTIMEDIA, V11, P892, DOI 10.1109/TMM.2009.2021726; He J, 2005, COMPARISON BINARIZAT, P538; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jiang N, 2011, PROC CVPR IEEE, P1329, DOI 10.1109/CVPR.2011.5995537; Kalal Z, 2010, PROC CVPR IEEE, P49, DOI 10.1109/CVPR.2010.5540231; Kashiwase Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070922; Kwon J, 2013, IEEE T PATTERN ANAL, V35, P1011, DOI 10.1109/TPAMI.2012.161; Lan XS, 2014, INT CONF COMPUT INFO, P187, DOI 10.1109/CIT.2014.29; Leichter I, 2009, IEEE T PATTERN ANAL, V31, P164, DOI 10.1109/TPAMI.2008.194; Li C, 2013, SENSORS-BASEL, V13, P3409, DOI 10.3390/s130303409; Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039; Li X, 2013, IEEE T PATTERN ANAL, V35, P863, DOI 10.1109/TPAMI.2012.166; Liang DW, 2010, PROC CVPR IEEE, P1387, DOI 10.1109/CVPR.2010.5539808; Lou J, 2014, REGIONAL PRINCIPAL C; Luo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116315; Nandy M, 2015, ANAL STUDY DIFFERENT; Perez P, 2002, LECT NOTES COMPUT SC, V2350, P661; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Ren C.Y, 2011, GSLIC REAL TIME IMPL, P1; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Schauerte B., 2012, IEEE WORKSH APPL COM, P137; Shen CH, 2007, IEEE T IMAGE PROCESS, V16, P1457, DOI 10.1109/TIP.2007.894233; Shen H, 2013, CHINESE J AERONAUT, V26, P1211, DOI 10.1016/j.cja.2013.07.038; Smeulders AWM, 2014, IEEE T PATTERN ANAL, V36, P1442, DOI 10.1109/TPAMI.2013.230; Song Y, 2016, INT J AUTOM COMPUT, V13, P565, DOI 10.1007/s11633-016-0949-7; Strat T, 2005, VIVID TRACKING EVALU; TBB I, THREAD BUILD BLOCKS; Tian M, 2007, LECT NOTES COMPUT SC, V4843, P355; Wang JY, 2005, PROC CVPR IEEE, P1037; Wang TS, 2007, INT CONF ACOUST SPEE, P933; Wang WN, 2014, SIGNAL PROCESS-IMAGE, V29, P424, DOI 10.1016/j.image.2014.01.004; Wen LY, 2012, LECT NOTES COMPUT SC, V7575, P716, DOI 10.1007/978-3-642-33765-9_51; Yang F, 2014, IEEE WINT CONF APPL, P854, DOI 10.1109/WACV.2014.6836014; Yang HX, 2011, NEUROCOMPUTING, V74, P3823, DOI 10.1016/j.neucom.2011.07.024; Yang M, 2007, SPATIAL SELECTION AT, P1; Yin ZZ, 2009, ADV PATTERN RECOGNIT, P271, DOI 10.1007/978-1-84800-277-7_12; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu Q, 2009, MOTION PATTERN INTER, P2671; Zeisl B, 2010, PROC CVPR IEEE, P1879, DOI 10.1109/CVPR.2010.5539860; Zha YF, 2010, PATTERN RECOGN, V43, P187, DOI 10.1016/j.patcog.2009.06.011; Zhai Y, 2006, VISUAL ATTENTION DET, P815; Zhang KH, 2014, LECT NOTES COMPUT SC, V8693, P127, DOI 10.1007/978-3-319-10602-1_9; Zhang SP, 2013, NEUROCOMPUTING, V100, P31, DOI 10.1016/j.neucom.2011.11.031; Zhang YN, 2015, SENSORS-BASEL, V15, P8214, DOI 10.3390/s150408214; Zhou SHK, 2004, IEEE T IMAGE PROCESS, V13, P1491, DOI 10.1109/TIP.2004.836152; Zhu ML, 2006, IEEE T PATTERN ANAL, V28, P1274, DOI 10.1109/TPAMI.2006.172	59	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2018	13	2							e0192246	10.1371/journal.pone.0192246	http://dx.doi.org/10.1371/journal.pone.0192246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW1TV	29438421	Green Published, Green Submitted, gold			2022-12-26	WOS:000425083400017
J	Feeny, S; Posso, A; McDonald, L; Chuyen, TTK; Tung, ST				Feeny, Simon; Posso, Alberto; McDonald, Lachlan; Truong Thi Kim Chuyen; Tung, Son Thanh			Beyond monetary benefits of restoring sight in Vietnam: Evaluating well-being gains from cataract surgery	PLOS ONE			English	Article								A more holistic understanding of the benefits of sight-restoring cataract surgery requires a focus that goes beyond income and employment, to include a wider array of well-being measures. The objective of this study is to examine the monetary and non-monetary benefits of cataract surgery on both patients as well as their caregivers in Vietnam. Participants were randomly recruited from a Ho-Chi-Minh City Hospital. A total of 82 cataract patients and 83 caregivers participated in the survey conducted for this study. Paired t-tests, Wilcoxon Signed Rank tests, and regression analysis are used to detect any statistically significant differences in various measures of well-being for patients and caregivers before and after surgery. There are statistically significant improvements in monetary and non-monetary measures of well-being for both patients and caregivers approximately three months after undergoing cataract surgery, compared with baseline assessments collected prior to surgery. Non-monetary measures of well-being include self-assessments of overall health, mental health, hope, self-efficacy, happiness and life satisfaction. For patients, the benefits included statistically significant improvements in earnings, mobility, self-care, the ability to undertake daily activities, self-assessed health and mental health, life satisfaction, hope, and self-efficacy (p<0.01). For caregivers, attendance at work improved alongside overall health, mental health, hope, self-efficacy, happiness and life satisfaction, three months post-surgery (p<0.01). Restoring sight has positive impacts for those suffering from cataracts and their caregivers. Sometimes the benefits are almost equal in their magnitude. The study has also demonstrated that many of these impacts are non-monetary in nature. It is clear that estimates of the rate of return to restoring sight that focus only on financial gains will underestimate the true returns to society of restoring sight from cataract surgeries.	[Feeny, Simon; Posso, Alberto; McDonald, Lachlan] RMIT Univ, Int Dev & Trade Res Grp, Melbourne, Vic, Australia; [Truong Thi Kim Chuyen; Tung, Son Thanh] Ho Chi Minh City Univ Social Sci & Humanities, Ho Chi Minh City, Vietnam	Royal Melbourne Institute of Technology (RMIT)	Posso, A (corresponding author), RMIT Univ, Int Dev & Trade Res Grp, Melbourne, Vic, Australia.	alberto.posso@rmit.edu.au		McDonald, Lachlan/0000-0003-4839-8102; Posso, Alberto/0000-0003-4226-7072; Feeny, Simon/0000-0002-5955-0045	Fred Hollows Foundation	Fred Hollows Foundation	This research was supported through funding from The Fred Hollows Foundation (https://www.hollows.org/au/research) to Simon Feeny and Alberto Posso. The information and opinions contained in it do not necessarily reflect the views or policy of The Fred Hollows Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported through funding from The Fred Hollows Foundation to Simon Feeny and Alberto Posso. The information and opinions contained in it do not necessarily reflect the views or policy of The Fred Hollows Foundation. The funding source did not participate in the analysis or interpretation of the data. The authors are thankful to Dr Vo Thi Chinh Nga and Dr Phi Duy Tien and other staff of the Ho-Chi-Minh City Ophthalmologic Hospital for support, advice and providing access to patients and carers, as well as to facilities to conduct interviews. We are also grateful to Beatrice Varga and Sarity Dodson, research managers at The Fred Hollows Foundation, Melbourne, Dr Phuc Huynh and Mr Anh Pham Quoc in The Fred Hollows Foundation's Vietnam office and to the following research assistants at the Ho-Chi-Minh City University of Social Sciences and Humanities: Ngo Thi Thu Trang; Ho Kim Thi; Le Thi Hanh; Ha Thi Minh Phuc; and Chau Thi Thu Thuy. We are also thankful to: Trong Anh Trinh, RMIT University; Dr Bob Baulch, RMIT International, Vietnam and to the editor and two anonymous referees for helpful comments and advice.	Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; Cruess AF, 2008, PHARMACOECONOMICS, V26, P57, DOI 10.2165/00019053-200826010-00006; Essue BM, 2014, OPHTHALMOLOGY, V121, P2138, DOI 10.1016/j.ophtha.2014.05.014; Finger RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044268; Goodrich K, 2012, VALUE HEALTH, V15, P975, DOI 10.1016/j.jval.2012.05.009; Grosh M., 2000, DESIGNING HOUSEHOLD; Horowitz A, 2003, GENERATIONS, V27, P32; Lansingh VC, 2009, ARCH OPHTHALMOL-CHIC, V127, P1183, DOI 10.1001/archophthalmol.2009.113; McDonald L., 2015, ROUGH GUIDE EYE HLTH; McDonald L, 2014, TECHNICAL CONSULTATI; Ulldemolins AR, 2012, INDIAN J OPHTHALMOL, V60, P368, DOI 10.4103/0301-4738.100529; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Snyder CR, 1997, J PEDIATR PSYCHOL, V22, P399, DOI 10.1093/jpepsy/22.3.399; Torres-reyna O, 2007, PANEL DATA ANAL FIXE; Viet Nam Ministry of Health, 2015, NAT SURV AV BLINDN V; World Health Organization, UN EYE HLTH GLOB ACT	17	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192774	10.1371/journal.pone.0192774	http://dx.doi.org/10.1371/journal.pone.0192774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432447	Green Published, Green Submitted, gold			2022-12-26	WOS:000424814300044
J	Monteschio, JD; Burin, PC; Leonardo, AP; Fausto, DA; da Silva, ALA; Ricardo, HD; da Silva, MC; de Souza, MR; de Vargas, FM				Monteschio, Jessica de Oliveira; Burin, Poliana Campos; Leonardo, Ariadne Patricia; Fausto, Daiane Aparecido; Alves da Silva, Adrielly Lais; Ricardo, Helio de Almeida; da Silva, Marcelo Correa; de Souza, Marcio Rodrigues; de Vargas Junior, Fernando Miranda			Different physiological stages and breeding systems related to the variability of meat quality of indigenous Pantaneiro sheep	PLOS ONE			English	Article							SENSORY CHARACTERISTICS; LAMB; EWES; CROSSBREEDS; SLAUGHTER; TRAITS; WEIGHT; MUSCLE; GOATS; COLOR	This study configures a first report regarding the variability of meat quality of locally adapted Pantaneiro sheep depending on different physiological stages and breeding systems. Pantaneiro sheep are raised in Brazil under a tropical wetland ecosystem denominated Pantanal. Twenty-nine Pantaneiro sheep from different sex and physiological stages were sorted into three groups, simulating three of the most representative ovine meat products commercialized by South American industries: a) non castrated male lambs (n = 11); b) wethers (n = 9); c) cull ewes (n = 9). Animals from each physiological stage were submitted to different breeding systems, resembling farming strategies adopted in several developing countries of South America. The effect of physiological stages on the quality of meat was accessed using 16 variables measured in the longissimus thoracis et lumborum (LM) and the semimembranosus (SM) muscles. The variables were related to brightness, color, physical aspects, soluble and total collagen as well as chemical traits. The physiological stage was defined as a classification variable in order to proceed ANOVA tests and comparison of means (P<0.05). Multivariate analysis was used to identify patterns of similarity and differentiation between samples of different physiological stages (a, b, c). The results revealed that meat quality varies according to different physiological stages, especially between lambs (a) and cull ewes (c). As a consequence, the physiological stage at slaughter should be taken into consideration to cote the quality of meat from indigenous sheep raised in tropical regions. The results contribute towards sensorial evaluation and the characterization of potential food products derived from indigenous sheep bred under tropical climate in developing countries.	[Monteschio, Jessica de Oliveira] Univ Estadual Maringa, Anim Sci Dept, Maringa, Parana, Brazil; [Burin, Poliana Campos; Leonardo, Ariadne Patricia; Alves da Silva, Adrielly Lais; Ricardo, Helio de Almeida; da Silva, Marcelo Correa; de Souza, Marcio Rodrigues; de Vargas Junior, Fernando Miranda] Fundacao Univ Fed Grande Dourados, Anim Sci Dept, Dourados, MG, Brazil; [Fausto, Daiane Aparecido] Escola Luiz de Queiroz, Anim Sci Dept, Piracicaba, SP, Brazil	Universidade Estadual de Maringa; Universidade Federal da Grande Dourados	Monteschio, JD (corresponding author), Univ Estadual Maringa, Anim Sci Dept, Maringa, Parana, Brazil.	jessicamonteschio@hotmail.com	Ricardo, Hélio/D-4476-2015; Silva, Marcelo/AAE-4532-2021; Silva, Adrielly Laís Alves/G-2850-2019; de Vargas Junior, Fernando Miranda/E-9221-2013; Monteschio, jessica/D-6498-2018; Miranda de Vargas Junior, Fernando/D-1496-2018	Ricardo, Hélio/0000-0003-4536-2059; Silva, Marcelo/0000-0002-7599-1967; Silva, Adrielly Laís Alves/0000-0002-0207-0198; Monteschio, jessica/0000-0003-1331-3260; Miranda de Vargas Junior, Fernando/0000-0002-3050-7107	Brazilian funding institute CAPES; Brazilian funding institute CNPq; Brazilian funding institute FUNDECT	Brazilian funding institute CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian funding institute CNPq; Brazilian funding institute FUNDECT	The authors would like to thank the Brazilian funding institutes CAPES, CNPq and FUNDECT.	Aksoy Y, 2016, ITAL J FOOD SCI, V28, P131, DOI 10.14674/1120-1770%2Fijfs.v465; Bailey A. J., 1989, CONNECTIVE TISSUES M; Bech-Larsen T, 2016, TRENDS FOOD SCI TECH, V50, P249, DOI 10.1016/j.tifs.2016.01.020; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Beserra FJ, 2004, SMALL RUMINANT RES, V55, P177, DOI 10.1016/j.smallrumres.2004.02.002; Pinheiro RSB, 2009, REV BRAS ZOOTECN, V38, P1790, DOI 10.1590/S1516-35982009000900022; Brown O, 2001, MICROPLATE ASSAY MEA, V38-40; Caneque V., 2000, Monografias - INIA: Ganadera, P255; Conti CMDDM, 2015, CARACTERIZACAO SENSO; Correa MPC, 2012, SMALL RUMINANT RES, V104, P70, DOI 10.1016/j.smallrumres.2011.11.001; de Boer J, 2016, APPETITE, V103, P95, DOI 10.1016/j.appet.2016.03.028; Ekiz B, 2009, MEAT SCI, V82, P64, DOI 10.1016/j.meatsci.2008.12.001; da Silva ACF, 2016, SEMIN-CIENC AGRAR, V37, P911, DOI 10.5433/1679-0359.2016v37n2p911; Tejeda JF, 2008, MEAT SCI, V80, P1061, DOI 10.1016/j.meatsci.2008.04.026; FNP I, 2010, AN, P380; Gracia A, 2016, SPAN J AGRIC RES, V14, DOI 10.5424/sjar/2016142-8230; Gracia A, 2014, EMPIR ECON, V47, P111, DOI 10.1007/s00181-013-0738-x; HAMM REINER, 1960, ADVANCES IN FOOD RES, V10, P355; Hopkins D, 2010, MEASURING SHEAR FORC; JEFFREY AB, 1983, J SCI FOOD AGR, V34, P1020; LAMBUTH TR, 1970, J ANIM SCI, V30, P27, DOI 10.2527/jas1970.30127x; Lawrie R. A., 2005, CIENCIA CARNE, V6a; Lee S, 2005, MEAT SCI, V70, P683, DOI 10.1016/j.meatsci.2005.02.017; Lukasiewicz M, 2015, J SCI FOOD AGR, V95, P1730, DOI 10.1002/jsfa.6883; MARSH BB, 1977, J FOOD SCI, V42, P295, DOI 10.1111/j.1365-2621.1977.tb01485.x; Minolta MK, 1998, PRECISE COLOR COMMUN; Moloney AP, 2012, MEAT SCI, V92, P1, DOI 10.1016/j.meatsci.2012.03.011; Monaco CA, 2015, J SCI FOOD AGR, V95, P1747, DOI 10.1002/jsfa.6894; Monin G, 1998, MEAT SCI, V49, pS231, DOI [10.1016/S0309-1740(98)90051-1, 10.1016/S0309-1740(98)00087-4]; Montesinos I.S., 2012, Arch. zootec., V61, P505, DOI 10.4321/s0004-05922012000400003; Natarajan Subhashree, 2016, International Journal of Applied Management Science, V8, P83; NRC, 2007, NATL RES COUNCIL NRC, P347; OFFER G, 1983, MEAT SCI, V8, P245, DOI 10.1016/0309-1740(83)90013-X; Perez J, 2003, B TECNICO, P61; Pinheiro RSB, 2012, ARQ BRAS MED VET ZOO, V64, P1053, DOI 10.1590/S0102-09352012000400035; Prandl O, 1994, TECNOLOGIA HYGIENE C, P854; Resende Kléber Tomás de, 2010, R. Bras. Zootec., V39, P369, DOI 10.1590/S1516-35982010001300040; Russel AJF, 1969, SUBJECTIVE ASSESSMEN, P451; Sanudo C, 2000, MEAT SCI, V54, P339, DOI 10.1016/S0309-1740(99)00108-4; Silva MC, 2013, SMALL RUMINANT RES, V110, P15, DOI 10.1016/j.smallrumres.2012.09.002; Silva Sobrinho A. G., 2001, PRODUCAO ANIMAL N VI, P425; Sobrinho AGD, 2005, PESQUI AGROPECU BRAS, V40, P1129, DOI 10.1590/S0100-204X2005001100011; Soeparno, 1995, CARCASS MEAT PRODUCT; Sorio A, 2010, OVINOCULTURA ABATE C; Stankov IK, 2002, ASIAN AUSTRAL J ANIM, V15, P283, DOI 10.5713/ajas.2002.283; Suarez VH, 2000, SMALL RUMINANT RES, V36, P85, DOI 10.1016/S0921-4488(99)00111-X; Tarrant V, 2001, 1 C BRAS CIENC TECN, P380; Vargas FM, 2015, SMALL RUMINANT RES, V124, P55, DOI 10.1016/j.smallrumres.2014.12.007; Wilches D, 2011, MEAT SCI, V88, P415, DOI 10.1016/j.meatsci.2011.01.020; Yakan A, 2010, TROP ANIM HEALTH PRO, V42, P751, DOI 10.1007/s11250-009-9483-8; Zapata J. F. F., 2003, Boletim da Sociedade Brasileira de Ciencia e Tecnologia de Alimentos, V37, P146	51	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191668	10.1371/journal.pone.0191668	http://dx.doi.org/10.1371/journal.pone.0191668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432430	Green Published, gold			2022-12-26	WOS:000424814300009
J	Zajaczkowski, S; Ziolkowski, W; Badtke, P; Zajaczkowski, MA; Flis, DJ; Figarski, A; Smolinska-Bylanska, M; Wierzba, TH				Zajaczkowski, Stanislaw; Ziolkowski, Wieslaw; Badtke, Piotr; Zajaczkowski, Milosz A.; Flis, Damian J.; Figarski, Adam; Smolinska-Bylanska, Maria; Wierzba, Tomasz H.			Promising effects of xanthine oxidase inhibition by allopurinol on autonomic heart regulation estimated by heart rate variability (HRV) analysis in rats exposed to hypoxia and hyperoxia	PLOS ONE			English	Article							CAROTID-BODY; BLOOD-PRESSURE; CARDIOVASCULAR VARIABILITY; VENTRICULAR-ARRHYTHMIAS; SUPEROXIDE-DISMUTASE; FREE-RADICALS; REPERFUSION; INACTIVATION; MODEL; HYPERTENSION	Background It has long been suggested that reactive oxygen species (ROS) play a role in oxygen sensing via peripheral chemoreceptors, which would imply their involvement in chemoreflex activation and autonomic regulation of heart rate. We hypothesize that antioxidant affect neurogenic cardiovascular regulation through activation of chemoreflex which results in increased control of sympathetic mechanism regulating heart rhythm. Activity of xanthine oxidase (XO), which is among the major endogenous sources of ROS in the rat has been shown to increase during hypoxia promote oxidative stress. However, the mechanism of how XO inhibition affects neurogenic regulation of heart rhythm is still unclear. Aim The study aimed to evaluate effects of allopurinol-driven inhibition of XO on autonomic heart regulation in rats exposed to hypoxia followed by hyperoxia, using heart rate variability (HRV) analysis. Material and methods 16 conscious male Wistar rats (350 g): control-untreated (N = 8) and pretreated with Allopurinol-XO inhibitor (5 mg/kg, followed by 50 mg/kg), administered intraperitoneally (N = 8), were exposed to controlled hypobaric hypoxia (1h) in order to activate chemoreflex. The treatment was followed by 1h hyperoxia (chemoreflex suppression). Time-series of 1024 RR-intervals were extracted from 4kHz ECG recording for heart rate variability (HRV) analysis in order to calculate the following time-domain parameters: mean RR interval (RRi), SDNN (standard deviation of all normal NN intervals), rMSSD (square root of the mean of the squares of differences between adjacent NN intervals), frequency-domain parameters (FFT method): TSP (total spectral power) as well as low and high frequency band powers (LF and HF). At the end of experiment we used rat plasma to evaluate enzymatic activity of XO and markers of oxidative stress: protein carbonyl group and 8-isoprostane concentrations. Enzymatic activity of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were measures in erythrocyte lysates. Results Allopurinol reduced oxidative stress which was the result of hypoxia/hyperoxia, as shown by decreased 8-isoprostane plasma concentration. XO inhibition did not markedly influence HRV parameters in standard normoxia. However, during hypoxia, as well as hyperoxia, allopurinol administration resulted in a significant increase of autonomic control upon the heart as shown by increased SDNN and TSP, with an increased vagal contribution (increased rMSSD and HF), whereas sympathovagal indexes (LF/HF, SDNN/rMSSD) remained unchanged. Conclusions Observed regulatory effects of XO inhibition did not confirm preliminary hypothesis which suggested that an antioxidant such as allopurinol might activate chemoreflex resulting in augmented sympathetic discharge to the heart. The HRV regulatory profile of XO inhibition observed during hypoxia as well as post-hypoxic hyperoxia corresponds to reported reduced risk of sudden cardiovascular events. Therefore our data provide a new argument for therapeutical use of allopurinol in hypoxic conditions.	[Zajaczkowski, Stanislaw; Badtke, Piotr; Smolinska-Bylanska, Maria; Wierzba, Tomasz H.] Med Univ Gdansk, Dept Physiol, Gdansk, Poland; [Ziolkowski, Wieslaw; Flis, Damian J.] Gdansk Univ Phys Educ & Sport, Fac Rehabil & Kinesiol, Dept Bioenerget & Nutr, Gdansk, Poland; [Zajaczkowski, Milosz A.] Med Univ Gdansk, Dept Clin Anat, Gdansk, Poland; [Figarski, Adam] Med Univ Gdansk, Dept Med Chem, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Gdansk University of Physical Education & Sport; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Wierzba, TH (corresponding author), Med Univ Gdansk, Dept Physiol, Gdansk, Poland.	twierzba@gumed.edu.pl	Flis, Damian J/O-3849-2018; Figarski, Adam/ABI-7703-2020	Flis, Damian J/0000-0002-6176-4536; Figarski, Adam/0000-0001-7513-7157; Ziolkowski, wieslaw/0000-0001-8371-4153; Wierzba, Tomasz/0000-0003-4146-0487	National Science Center [DEC-2011/01/N/NZ4/01132]	National Science Center(National Science Centre, Poland)	The study was supported by National Science Center (DEC-2011/01/N/NZ4/01132) to SZ, https://www.ncn.gov.pl/?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Agapito MT, 2009, AM J PHYSIOL-CELL PH, V296, pC620, DOI 10.1152/ajpcell.00542.2008; Altimiras J, 1999, COMP BIOCHEM PHYS A, V124, P447, DOI 10.1016/S1095-6433(99)00137-3; Angdin M, 2003, J CARDIOTHOR VASC AN, V17, P314, DOI 10.1016/S1053-0770(03)00053-3; Ansari MA, 2013, EUR REV MED PHARMACO, V17, P170; BAKER JE, 1988, P NATL ACAD SCI USA, V85, P2786, DOI 10.1073/pnas.85.8.2786; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Borkowski T, 2004, POL J THORAC CARDIOV, V1, P191; BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043; Buntrock RE, 2006, MERCK INDEX ENCY CHE; Camm AJ, 1996, EUR HEART J, V17, P354; Carnevali L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00118; Carnevali L, 2014, PHYSIOL BEHAV, V128, P16, DOI 10.1016/j.physbeh.2014.01.033; Carnevali L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064519; Chouchou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086434; CROME R, 1988, CARDIOVASC DRUG THER, V2, P295, DOI 10.1007/BF00054636; Day RO, 2007, CLIN PHARMACOKINET, V46, P623, DOI 10.2165/00003088-200746080-00001; Del Rio R, 2015, EXP PHYSIOL, V100, P121, DOI 10.1113/expphysiol.2014.079350; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; El-Bassossy HM, 2015, TRANSL RES, V165, P621, DOI 10.1016/j.trsl.2014.11.008; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; Gawinski L, 2006, ANN ACAD MED GEDANEN, V36, P53; Goncalves H, 2008, PHYSIOL MEAS, V29, P1133, DOI 10.1088/0967-3334/29/9/010; Gonzalez C, 2002, RESP PHYSIOL NEUROBI, V132, P17, DOI 10.1016/S1569-9048(02)00047-2; Hare JM, 2008, J AM COLL CARDIOL, V51, P2301, DOI 10.1016/j.jacc.2008.01.068; Hatayama M, 2015, CURR CLIN PHARMACOL, V10, P160, DOI 10.2174/1574884710666150126143421; Iturriaga R, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0073-8; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; KONO Y, 1982, J BIOL CHEM, V257, P5751; Labudda O, 2006, J PEPT SCI, V12, P775, DOI 10.1002/psc.812; Lee BE, 2009, J INVEST MED, V57, P902, DOI 10.2310/JIM.0b013e3181bca50c; Li YL, 2007, CARDIOVASC RES, V75, P546, DOI 10.1016/j.cardiores.2007.04.006; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Mansier P, 1996, CARDIOVASC RES, V31, P371; Matchett G, 2014, CHAOS, V24, DOI 10.1063/1.4882395; Muntzel M, 2017, FASEB J, V31; Murasato Y, 1998, AM J PHYSIOL-HEART C, V275, pH797, DOI 10.1152/ajpheart.1998.275.3.H797; MUXFELDT M, 1987, BASIC RES CARDIOL, V82, P486, DOI 10.1007/BF01907096; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Nunes FC, 2010, BRAIN RES, V1351, P141, DOI 10.1016/j.brainres.2010.07.001; OLIVER CN, 1987, ARCH BIOCHEM BIOPHYS, V253, P62, DOI 10.1016/0003-9861(87)90637-0; Ortiz FC, 2013, RESP PHYSIOL NEUROBI, V185, P600, DOI 10.1016/j.resp.2012.11.015; Ozgur BG, 2015, PHARMACOL BIOCHEM BE, V138, P91, DOI 10.1016/j.pbb.2015.09.016; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Parati G, 2006, CURR HYPERTENS REP, V8, P199, DOI 10.1007/s11906-006-0051-6; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Prabhakar NR, 2013, J PHYSIOL-LONDON, V591, P2245, DOI 10.1113/jphysiol.2012.247759; Rahman K, 2007, CLIN INTERV AGING, V2, P219; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Sacha J, 2005, J ELECTROCARDIOL, V38, P47, DOI 10.1016/j.jelectrocard.2004.09.015; Sagor MAT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/478039; Schultz HD, 2007, RESP PHYSIOL NEUROBI, V157, P171, DOI 10.1016/j.resp.2007.02.011; Shehab AMA, 2001, BRIT J CLIN PHARMACO, V51, P329, DOI 10.1046/j.1365-2125.2001.01361.x; Singh JA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0816-6; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Stone PH, 2011, J AM COLL CARDIOL, V58, P829, DOI 10.1016/j.jacc.2011.02.072; Sugimura M, 2008, AUTON NEUROSCI-BASIC, V141, P94, DOI 10.1016/j.autneu.2008.05.008; Swynghedauw B, 1997, CARDIOVASC DRUG THER, V10, P677, DOI 10.1007/BF00053024; Szasz T, 2010, J CARDIOVASC PHARM, V56, P627, DOI 10.1097/FJC.0b013e3181f80194; Talwar S, 2010, EUR J CARDIO-THORAC, V38, P86, DOI 10.1016/j.ejcts.2010.01.027; Volders PGA, 2010, HEART RHYTHM, V7, P1900, DOI 10.1016/j.hrthm.2010.06.003; Wang HM, 2012, MOD SIMUL ENG, V2012, DOI 10.1155/2012/931943; Wierzba TH, 2004, P PROG BIOMED SCI, V1, P11; Wierzba TH, 2007, ANN ACAD MED GEDA S4, V34; Yamamoto Y, 2006, HYPERTENS RES, V29, P915, DOI 10.1291/hypres.29.915; Zajaczkowski S, 2014, COMPUT CARDIOL CONF, V41, P785; Zigon-Japundzic N, 1998, JUGOSLAV PHYSL PHARM, V34, P111; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	74	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0192781	10.1371/journal.pone.0192781	http://dx.doi.org/10.1371/journal.pone.0192781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432445	gold, Green Submitted, Green Published			2022-12-26	WOS:000424814300045
J	Bogestam, K; Vondracek, M; Karlsson, M; Fang, H; Giske, CG				Bogestam, Katja; Vondracek, Martin; Karlsson, Mattias; Fang, Hong; Giske, Christian G.			Introduction of a hydrolysis probe PCR assay for high-throughput screening of methicillin-resistant Staphylococcus aureus with the ability to include or exclude detection of Staphylococcus argenteus	PLOS ONE			English	Article							REAL-TIME PCR; CLINICAL-SAMPLES; SELECTIVE-BROTH; SURVEILLANCE	Many countries using sensitive screening methods for detection of carriage of methicillin-resistant Staphylococcus aureus (MRSA) have a sustained low incidence of MRSA infections. For diagnostic laboratories with high sample volumes, MRSA screening requires stability, low maintenance and high performance at a low cost. Herein we designed oligonucleotides for a new nuc targeted hydrolysis probe PCR to replace the standard in-house nuc SybrGreen PCR assay. This new, more time-efficient, PCR assay resulted in a 40% increase in daily sample capacity, with maintained high specificity and sensitivity. The assay was also able to detect Staphylococcus aureus clonal cluster 75 (CC75) lineage strains, recently re-classified as Staphylococcus argenteus, with a sensitivity considerably increased compared to our previous assay. While awaiting consensus if the CC75 lineage of S. aureus should be considered as S. argenteus, and whether methicillin-resistant S. argenteus should be included in the MRSA definition, many diagnostic laboratories need to update their MRSA assay sensitivity/specificity towards this lineage/species. The MRSA screening assay presented in this manuscript is comprised of nuc oligonucleotides separately targeting S. aureus and CC75 lineage strains/S. argenteus, thus providing high user flexibility for the detection of CC75 lineage strains/S. argenteus.	[Bogestam, Katja; Vondracek, Martin; Karlsson, Mattias; Fang, Hong; Giske, Christian G.] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Giske, Christian G.] Karolinska Inst, Dept Lab Med, Div Microbiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Bogestam, K (corresponding author), Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.	katja.bogestam@sll.se						Arbefeville SS, 2011, J CLIN MICROBIOL, V49, P2996, DOI 10.1128/JCM.00046-11; Blanc DS, 2011, J CLIN MICROBIOL, V49, P722, DOI 10.1128/JCM.01988-10; Chantratita N, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.01.008; Fang H, 2006, J CLIN MICROBIOL, V44, P592, DOI 10.1128/JCM.44.2.592-594.2006; Fang H, 2003, J CLIN MICROBIOL, V41, P2894, DOI 10.1128/JCM.41.7.2894-2899.2003; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Hill-Cawthorne GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101419; Hoegh SV, 2014, J MED MICROBIOL, V63, P1020, DOI 10.1099/jmm.0.076638-0; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Nilsson P, 2005, CLIN MICROBIOL INFEC, V11, P1027, DOI 10.1111/j.1469-0691.2005.01291.x; Smyth RW, 2001, J HOSP INFECT, V48, P103, DOI 10.1053/jhin.2001.0933; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; Tong SYC, 2015, INT J SYST EVOL MICR, V65, P15, DOI 10.1099/ijs.0.062752-0; Tunsjo HS, 2017, EUR J CLIN MICROBIOL, V36, P65, DOI 10.1007/s10096-016-2771-0; Vondracek M, 2011, J INFECTION, V62, P472, DOI 10.1016/j.jinf.2011.04.010; Zhang DF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4149-9; Zhang M, 2013, ANTIMICROB AGENTS CH, V57, P2890, DOI 10.1128/AAC.00174-13	19	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192782	10.1371/journal.pone.0192782	http://dx.doi.org/10.1371/journal.pone.0192782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425233	gold, Green Published, Green Submitted			2022-12-26	WOS:000424700800044
J	Zhang, WK; Li, ZT; Wang, ZH; Yue, CY; Zheng, H; Li, R; Zhou, MX; Hu, ZY; Wei, ZW; Li, Q				Zhang, Weikai; Li, Zhitao; Wang, Zihua; Yue, Chunyan; Zheng, Hui; Li, Ren; Zhou, Mingxing; Hu, Zhiyuan; Wei, Zewen; Li, Qin			Generation of a monoclonal antibody recognizing the heavily glycosylated CD45 protein and its application on identifying circulating tumor cells	PLOS ONE			English	Article							CANCER-PATIENTS; IDENTIFICATION; MARKER; BLOOD; ELISA	Here, we provide direct evidence that using recombinant proteins expressed in eukaryotic cells as antigen is a practical way to generate monoclonal antibodies (mAbs) against heavily glycosylated proteins. Heavily glycosylated proteins are typically difficult targets for mAb generation, being limited by unsatisfactory affinity and low specificity. Using the heavily glycosylated CD45 protein as an example, we demonstrate the entire process of expressing the protein in eukaryotic cells and using it as an antigen to generate CD45-targeting mAbs in mice. The mAbs generated showed robust affinity and specificity, which are crucial factors for differentiate circulating tumor cells from white blood cells in human breast cancer patient samples. Only 1 cell fusion and 2 cyclic sub-cloning steps were necessary before mAbs with satisfactory performance were obtained.	[Zhang, Weikai; Li, Zhitao] Henan Univ Sci & Technol, Med Coll, Luoyang, Peoples R China; [Zhang, Weikai; Li, Qin] Beijing Inst Technol, Sch Life Sci, Dept Biomed Engn, Beijing, Peoples R China; [Zhang, Weikai; Wang, Zihua; Yue, Chunyan; Zheng, Hui; Li, Ren; Zhou, Mingxing; Hu, Zhiyuan; Wei, Zewen] Natl Ctr Nanosci & Technol China, CAS Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Hu, Zhiyuan] Univ Chinese Acad Sci, Sinodanish Coll, Beijing, Peoples R China; [Hu, Zhiyuan] Yangtze River Delta Acad Nanotechnol & Ind Dev Re, Jiaxing, Zhejiang, Peoples R China	Henan University of Science & Technology; Beijing Institute of Technology; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Q (corresponding author), Beijing Inst Technol, Sch Life Sci, Dept Biomed Engn, Beijing, Peoples R China.; Hu, ZY; Wei, ZW (corresponding author), Natl Ctr Nanosci & Technol China, CAS Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China.; Hu, ZY (corresponding author), Univ Chinese Acad Sci, Sinodanish Coll, Beijing, Peoples R China.; Hu, ZY (corresponding author), Yangtze River Delta Acad Nanotechnol & Ind Dev Re, Jiaxing, Zhejiang, Peoples R China.	huzy@nanoctr.cn; weizw@nanoctr.cn; liqin@bit.edu.cn	Zihua, Wang/AAF-3674-2020; Li, qingna/GWN-0664-2022; Zihua, Wang/W-6938-2018	Zihua, Wang/0000-0001-6178-3422; Zihua, Wang/0000-0001-6178-3422	National Natural Science Foundation of China [31270875, 31470049, 31400702, 61204118]; National High-Tech R&D Program of China [2015AA0201771, 2015AA020408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (No. 31270875, 31470049, 31400702 and 61204118, URL: http://www.nsfc.gov.cn/) and the National High-Tech R&D Program of China (No. 2015AA0201771 and 2015AA020408. URL: www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2015, CYTOM PART A, V87A, P137, DOI 10.1002/cyto.a.22613; Bai LL, 2014, J MATER CHEM B, V2, P4080, DOI 10.1039/c4tb00456f; Couchman JR, 2009, J HISTOCHEM CYTOCHEM, V57, P7, DOI 10.1369/jhc.2008.952820; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Jin N, 2014, TOXICON, V90, P226, DOI 10.1016/j.toxicon.2014.08.057; LAKAYAN D, 2016, J CHROMATOGR A, P8874, DOI DOI 10.1016/J.CHR0MA.2016.05.033; Ma HL, 2014, BIOMARKERS, V19, P578, DOI 10.3109/1354750X.2014.951880; Pradidarcheep W, 2008, J HISTOCHEM CYTOCHEM, V56, P1099, DOI 10.1369/jhc.2008.952101; Prassas I, 2014, CLIN CHEM, V60, P381, DOI 10.1373/clinchem.2013.215236; Pukazhendhi Geetha, 2014, J Carcinog, V13, P8, DOI 10.4103/1477-3163.135578; Satelli A, 2015, CLIN CHEM, V61, P259, DOI 10.1373/clinchem.2014.228122; TROWBRIDGE IS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P46, DOI 10.1016/0167-4889(91)90043-W; Wang HW, 2011, INT IMMUNOPHARMACOL, V11, P1732, DOI 10.1016/j.intimp.2011.06.007; Wu YQ, 2013, METHODS, V64, P169, DOI 10.1016/j.ymeth.2013.09.006; Zhang YJ, 2015, INT J CANCER, V136, P1228, DOI 10.1002/ijc.29070; Zhao S, 2013, CELL BIOCHEM BIOPHYS, V65, P263, DOI 10.1007/s12013-012-9426-2	17	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2018	13	2							e0192506	10.1371/journal.pone.0192506	http://dx.doi.org/10.1371/journal.pone.0192506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV6OL	29425242	gold, Green Published, Green Submitted			2022-12-26	WOS:000424700800026
J	Armstrong-Hough, M; Kishore, SP; Byakika, S; Mutungi, G; Nunez-Smith, M; Schwartz, JI				Armstrong-Hough, Mari; Kishore, Sandeep P.; Byakika, Sarah; Mutungi, Gerald; Nunez-Smith, Marcella; Schwartz, Jeremy I.			Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment	PLOS ONE			English	Article							CARE; PREVENTION; MANAGEMENT; FACILITIES; COUNTRIES; DELIVERY; ACCESS	Objective Although the WHO-developed Service Availability and Readiness Assessment (SARA) tool is a comprehensive and widely applied survey of health facility preparedness, SARA data have not previously been used to model predictors of readiness. We sought to demonstrate that SARA data can be used to model availability of essential medicines for treating non-communicable diseases (EM-NCD). Methods We fit a Poisson regression model using 2013 SARA data from 196 Ugandan health facilities. The outcome was total number of different EM-NCD available. Basic amenities, equipment, region, health facility type, managing authority, NCD diagnostic capacity, and range of HIV services were tested as predictor variables. Findings In multivariate models, we found significant associations between EM-NCD availability and region, managing authority, facility type, and range of HIV services. For-profit facilities' EM-NCD counts were 98% higher than public facilities (p < .001). General hospitals and referral health centers had 98% (p = .004) and 105% (p = .002) higher counts compared to primary health centers. Facilities in the North and East had significantly lower counts than those in the capital region (p = 0.015; p = 0.003). Offering HIV care was associated with 35% lower EM-NCD counts (p = 0.006). Offering HIV counseling and testing was associated with 57% higher counts (p = 0.048). Conclusion We identified multiple within-country disparities in availability of EM-NCD in Uganda. Our findings can be used to identify gaps and guide distribution of limited resources. While the primary purpose of SARA is to assess and monitor health services readiness, we show that it can also be an important resource for answering complex research and policy questions requiring multivariate analysis.	[Armstrong-Hough, Mari] Yale Sch Publ Hlth, Epidemiol Microbial Dis Dept, New Haven, CT USA; [Kishore, Sandeep P.] Mt Sinai Sch Med, Arnhold Inst Global Hlth, New York, NY USA; [Byakika, Sarah] Uganda Minist Hlth, Qual Assurance Dept, Kampala, Uganda; [Mutungi, Gerald] Uganda Minist Hlth, Programme Prevent & Control Noncommunicable Dis, Kampala, Uganda; [Mutungi, Gerald; Schwartz, Jeremy I.] Uganda Initiat Integrated Management Noncommun, Kampala, Uganda; [Nunez-Smith, Marcella; Schwartz, Jeremy I.] Yale Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA; [Nunez-Smith, Marcella; Schwartz, Jeremy I.] Yale Sch Med, Equity Res & Innovat Ctr, New Haven, CT 06510 USA	Yale University; Icahn School of Medicine at Mount Sinai; Yale University; Yale University	Schwartz, JI (corresponding author), Uganda Initiat Integrated Management Noncommun, Kampala, Uganda.; Schwartz, JI (corresponding author), Yale Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA.; Schwartz, JI (corresponding author), Yale Sch Med, Equity Res & Innovat Ctr, New Haven, CT 06510 USA.	jeremy.schwartz@yale.edu	Armstrong-Hough, Mari/AGF-1466-2022	Nunez-Smith, Marcella/0000-0003-2797-4756; Schwartz, Jeremy/0000-0003-0139-2600	Yale Global Health Leadership Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Yale Global Health Leadership Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Yale Global Health Leadership Institute provided funding to support travel for JIS through the Hecht-Albert Pilot Innovation Award for Junior Faculty (http://ghli.yale.edu).	[Anonymous], 2011, A REPUBLICA, P1; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Bukuluki P., 2013, GLOBAL HLTH GOVERNAN, V6; Ewen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171284; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; International HA, 2010, MED PRIC MON UG; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kibirige D, 2017, INT J EQUITY HLTH BI, V16, P885; Kishore SP, 2015, HEALTH AFFAIR, V34, P1569, DOI 10.1377/hlthaff.2015.0375; Ministry of Health ROU, 2012, ESS MED HLTH SUPPL L; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Oyekale AS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2112-8; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Richard OT, 2015, AM J PUBLIC HLTH RES, P1; Schwartz JI, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26537; Schwartz JI, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0077-5; Siddharthan T, 2015, HEALTH AFFAIR, V34, P1506, DOI 10.1377/hlthaff.2015.0382; World Health Organization, SERV AV READ ASS SAR; World Health Organization, WHO DAT CAT; World Health Organization, 2016, SEL US ESS MED	23	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192332	10.1371/journal.pone.0192332	http://dx.doi.org/10.1371/journal.pone.0192332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420640	Green Published, gold, Green Submitted			2022-12-26	WOS:000424517900066
J	Atujuna, M; Newman, PA; Wallace, M; Eluhu, M; Rubincam, C; Brown, B; Bekker, LG				Atujuna, Millicent; Newman, Peter A.; Wallace, Melissa; Eluhu, Megan; Rubincam, Clara; Brown, Ben; Bekker, Linda-Gail			Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; RECTAL MICROBICIDES; YOUNG MEN; VACCINE; SEX; INFECTION; RISK; CHALLENGES; EFFICACY; TRIALS	Background New biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships. Methods We conducted six focus groups and 12 in-depth interviews with adolescents, and adult heterosexual men, women, and men who have sex with men (MSM) (n = 48), and eight indepth interviews with key informant healthcare workers. The interview guide described preexposure prophylaxis (PrEP), vaginal rings, rectal microbicides and HIV vaccines, and explored acceptability and product preferences. Focus groups and in-depth interviews (45-80 minutes) were conducted in Xhosa, audiotaped, and transcribed and translated into English. Data were coded and reviewed using framework analysis with NVivo software. Results Overall, initial enthusiasm and willingness to use NPTs evolved into concerns about how particular NPTs might affect or require alterations in one's everyday lifestyle and practices. Different product preferences and motivations emerged by population based on similarity to existing practices and contexts of vulnerability. Adult women and female adolescents preferred a vaginal ring and HIV vaccine, motivated by longer duration of protection to mitigate feared repercussions from male partners, including threats to their marriage and safety, and a context of ubiquitous rape. Male adolescents preferred an HIV vaccine, seen as protection in serodiscordant relationships and convenient in obviating the HIV stigma and cost involved in buying condoms. Adult men preferred PrEP, given familiarity with oral medications and mistrust of injections, seen as enabling serodiscordant couples to have a child. MSM preferred a rectal microbicide given familiarity with gel-based lubricants, with concerns about duration of protection in the context of unplanned consensual sex and rape. Conclusions Biomedical interventions to prevent HIV transmission, rather than obviating social-structural factors that produce vulnerability, may be limited by these same factors. Implementation of NPTs should engage local communities to understand real-world constraints and strategise to deliver effective, multi-level combination prevention.	[Atujuna, Millicent; Wallace, Melissa; Eluhu, Megan; Brown, Ben; Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Fdn, Hlth Sci Fac, Inst Infect Dis, Cape Town, South Africa; [Newman, Peter A.; Rubincam, Clara] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada	University of Cape Town; University of Toronto	Newman, PA (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	p.newman@utoronto.ca	Bekker, Linda-Gail/AAZ-8929-2020; Newman, Peter A/P-7056-2019	Newman, Peter A/0000-0003-0444-5915; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Atujuna, Millicent/0000-0003-1287-2634; Wallace, Melissa/0000-0001-7007-1910	Canadian Institutes of Health Research [THA-118570]; Canada Research Chairs Program (Canada Research Chair in Health and Social Justice)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program (Canada Research Chair in Health and Social Justice)	This study was funded by a grant from the Canadian Institutes of Health Research (THA-118570) to the CHVI Team in Social and Behavioral Research on HIV Vaccines (PI: PN). PN was supported by the Canada Research Chairs Program (Canada Research Chair in Health and Social Justice). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulai MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-40; Amico KR, 2017, AIDS BEHAV, V21, P1361, DOI 10.1007/s10461-016-1458-y; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Bauermeister J, 2016, AIDS EDUC PREV, V28, P1, DOI 10.1521/aeap.2016.28.1.1; Bekker LG, LANCET HIV; Cameron MP, 2013, VACCINE, V31, P3712, DOI 10.1016/j.vaccine.2013.05.089; Chakrapani V, 2007, AIDS EDUC PREV, V19, P346, DOI 10.1521/aeap.2007.19.4.346; Chakrapani V, 2017, QUAL HEALTH RES, V27, P1236, DOI 10.1177/1049732317697947; Cluver LD, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20646; DiClemente RJ, 2010, JAIDS-J ACQ IMM DEF, V54, pS12, DOI 10.1097/QAI.0b013e3181e1e2c0; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Fassin, 2007, BODIES REMEMBER EXPE; Fassin D, 2003, BMJ-BRIT MED J, V326, P495, DOI 10.1136/bmj.326.7387.495; Gafos M, 2013, AIDS CARE, V25, P573, DOI 10.1080/09540121.2012.722604; Galea JT, 2014, AM J PUBLIC HEALTH, V104, pE113, DOI 10.2105/AJPH.2013.301731; Giguere R, 2012, CULT HEALTH SEX, V14, P151, DOI 10.1080/13691058.2011.630099; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Harrington M., PIPELINE REPORT 2017; Harrison A, 2001, SOC TRANSITION, V31, P69, DOI DOI 10.1080/21528586.2001.10419031; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; Lee SJ, 2014, VACCINE, V32, P5013, DOI 10.1016/j.vaccine.2014.07.018; Luecke EH, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20875; Mack Natasha, 2014, J Int AIDS Soc, V17, P19157, DOI 10.7448/IAS.17.3.19157; Madlala SL, 2002, SOC DYNAMICS, V28, P1; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mcgowan I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125363; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Middelkoop K, 2010, AM J RESP CRIT CARE, V182, P1080, DOI 10.1164/rccm.201004-0598OC; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Navarro Vicente, 2009, Glob Health Promot, V16, P5, DOI 10.1177/1757975908100746; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Newman PA, 2004, AIDS PATIENT CARE ST, V18, P691, DOI 10.1089/apc.2004.18.691; Newman PA, 2008, VACCINE, V26, P2528, DOI 10.1016/j.vaccine.2008.03.004; Newman PA, 2016, AIDS BEHAV, V20, P2588, DOI 10.1007/s10461-015-1258-9; Newman PA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18476; Newman PA, 2012, EXPERT REV VACCINES, V11, P1, DOI [10.1586/erv.11.162, 10.1586/ERV.11.162]; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; NIH National Institute of Allergy and Infectious Diseases, NIH SPONS HIV VACC T; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Pettifor A, 2013, JAIDS-J ACQ IMM DEF, V63, pS155, DOI 10.1097/QAI.0b013e31829871fb; Preston-Whyte Eleanor M, 2003, Afr J AIDS Res, V2, P89, DOI 10.2989/16085906.2003.9626563; Rees H, 2015, 2015 C RETR OPP INF; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Roberts Kathleen Johnston, 2005, J Natl Med Assoc, V97, P1662; Rubincam C, 2016, EXPERT REV VACCINES, V15, P331, DOI 10.1586/14760584.2016.1118349; Sayles JN, 2010, HEALTH EDUC BEHAV, V37, P193, DOI 10.1177/1090198109335654; Seeley J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17397; Simbayi L., 2014, S AFRICAN NATL HIV P, P194; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tarantola D, 2011, VACCINE, V29, pD135, DOI 10.1016/j.vaccine.2011.07.027; UNAIDS, FAST TRACK COMB PREV; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Varga C.A., 1997, HLTH TRANSITION R S3, V7, P45; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; World Health Organization (WHO), 2016, WHO CONS GUID HIV PR, pxii; Zanoni BC, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000004	66	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191251	10.1371/journal.pone.0191251	http://dx.doi.org/10.1371/journal.pone.0191251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420549	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900013
J	Lau, Y; Htun, TP; Kwong, HKD				Lau, Ying; Tha Pyai Htun; Kwong, Ho Keung Dennis			Sociodemographic, obstetric characteristics, antenatal morbidities, and perinatal depressive symptoms: A three-wave prospective study	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; PREGNANT-WOMEN; RISK-FACTORS; MATERNAL DEPRESSION; POSTNATAL DEPRESSION; UNPLANNED PREGNANCY; ANXIETY; ASSOCIATION; PREVALENCE; PREDICTORS	Objectives This study aimed (1) to investigate the pattern of perinatal depressive symptoms, and (2) to determine the relationships between sociodemographic characteristics, obstetric factors, antenatal morbidities, postnatal conditions, and perinatal depressive symptoms using a structural equation model (SEM). Method A three-wave prospective longitudinal design was used for 361 women in their second trimester, third trimester, and at six weeks postpartum. The Edinburgh Postnatal Depression Scale (EPDS) was used to assess the depressive symptoms. Results The intensity of depressive symptoms was the highest in the second trimester among the three waves. The SEM showed that unmarried status, unplanned pregnancy, gestational diabetes, and headache were significantly associated with EPDS in the first and second waves. The EPDS in the first wave was able to predict the EPDS in the second and third waves. The SEM has satisfactorily fit with the data (chi-square/degree of freedom = 1.42, incremental fit index = 0.91, Tucker-Lewis index = 0.90, comparative fit index = 0.91, and root mean square error of approximation = 0.03). Conclusion The findings highlight the significance of monitoring depressive symptoms in the second trimester. Findings from this study could be useful in the design of effective intervention among women with unmarried status, unplanned pregnancy, gestational diabetes, and headache in order to reduce risk of perinatal depressive symptoms.	[Lau, Ying; Tha Pyai Htun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore, Singapore; [Kwong, Ho Keung Dennis] Macao Polytech Inst, Sch Hlth Sci, Macau, Peoples R China	National University of Singapore; Macao Polytechnic University	Lau, Y (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore, Singapore.	nurly@nus.edu.sg	YING, LAU/HHS-2619-2022	LAU, Ying/0000-0002-8289-3441	Macao Polytechnic Institute [RP/ESS/01/2011]	Macao Polytechnic Institute	The study was funded by Macao Polytechnic Institute, Grant numbers:RP/ESS/01/2011 to YL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrpt.	Abujilban SK, 2014, HEALTH CARE WOMEN IN, V35, P200, DOI 10.1080/07399332.2013.817411; Agrati D, 2016, HORM BEHAV, V77, P141, DOI 10.1016/j.yhbeh.2015.07.016; Lara MA, 2015, J AFFECT DISORDERS, V175, P18, DOI 10.1016/j.jad.2014.12.035; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Bayrampour H, 2015, MIDWIFERY, V31, P582, DOI 10.1016/j.midw.2015.02.009; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Betts KS, 2015, DEPRESS ANXIETY, V32, P82, DOI 10.1002/da.22272; Bjerke SEY, 2008, J MATERN-FETAL NEO M, V21, P889, DOI 10.1080/14767050802320340; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Byrn M, 2015, JOGNN-J OBST GYN NEO, V44, P246, DOI 10.1111/1552-6909.12554; Byrn Mary A, 2013, Nurs Womens Health, V17, P22, DOI 10.1111/1751-486X.12003; Byrne BM, 2010, STUCTURAL EQUATION M; Cheng CY, 2013, HEALTH CARE WOMEN IN, V34, P539, DOI 10.1080/07399332.2012.655389; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Everitt B. S., 2001, APPL MULTIVARIATE DA; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Field A., 2013, DISCOVERING STAT USI; Field T, 2010, INFANT BEHAV DEV, V33, P23, DOI 10.1016/j.infbeh.2009.10.004; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Frediani F, 2007, NEUROL SCI, V28, pS161, DOI 10.1007/s10072-007-0771-7; Gaillard A, 2014, PSYCHIAT RES, V215, P341, DOI 10.1016/j.psychres.2013.10.003; Gonulal D, 2014, TURKISH J PEDIATR, V56, P171; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hassanein IMA, 2014, INT J GYNECOL OBSTET, V125, P138, DOI 10.1016/j.ijgo.2013.11.006; Hein A, 2014, ARCH GYNECOL OBSTET, V289, P755, DOI 10.1007/s00404-013-3046-y; Hodgkinson EL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-330; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Jeong HG, 2013, GEN HOSP PSYCHIAT, V35, P354, DOI 10.1016/j.genhosppsych.2013.02.009; Katz ER, 2012, PSYCHOL MED, V42, P943, DOI 10.1017/S0033291711002121; Kim DR, 2013, ARCH WOMEN MENT HLTH, V16, P475, DOI 10.1007/s00737-013-0371-x; Kline R.B., 2011, PRINCIPLES PRACTICE; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lau Y, 2010, INT J NURS STUD, V47, P1139, DOI 10.1016/j.ijnurstu.2010.02.005; Lau Y, 2010, ARCH WOMEN MENT HLTH, V13, P153, DOI 10.1007/s00737-009-0134-x; Lee YS, 1996, J PSYCHOLINGUIST RES, V25, P527, DOI 10.1007/BF01758181; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Madigan S, 2014, CHILD ABUSE NEGLECT, V38, P1160, DOI 10.1016/j.chiabu.2014.04.002; Martini J, 2015, J AFFECT DISORDERS, V175, P385, DOI 10.1016/j.jad.2015.01.012; Matijasevich A, 2015, J AFFECT DISORDERS, V174, P424, DOI 10.1016/j.jad.2014.12.012; McArdle J.J., 2014, LONGITUDINAL DATA AN; Montazeri A, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-11; Ngai FW, 2015, J PSYCHOSOM RES, V78, P156, DOI 10.1016/j.jpsychores.2014.12.003; Nunally J. C., 1994, PSYCHOMETRIC THEORY; Orta OR, 2015, J AFFECT DISORDERS, V172, P390, DOI 10.1016/j.jad.2014.10.032; Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605; Pinsonneault JK, 2013, ARCH WOMEN MENT HLTH, V16, P499, DOI 10.1007/s00737-013-0373-8; Rallis S, 2014, WOMEN BIRTH, V27, pE36, DOI 10.1016/j.wombi.2014.08.002; Roca A, 2013, J AFFECT DISORDERS, V150, P807, DOI 10.1016/j.jad.2013.02.040; Roomruangwong C, 2011, ASIAN BIOMED, V5, P179, DOI 10.5372/1905-7415.0502.024; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Setse R, 2009, MATERN CHILD HLTH J, V13, P577, DOI 10.1007/s10995-008-0392-7; Sheskin DJ, 2011, HDB PARAMETRIC NONPA; Sundaram S, 2014, WOMEN HEALTH ISS, V24, pE381, DOI 10.1016/j.whi.2014.05.001; Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Verreault N, 2014, J PSYCHOSOM OBST GYN, V35, P84, DOI 10.3109/0167482X.2014.947953; Vivilaki VG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-329; Wang YQ, 2009, INT J NURS STUD, V46, P813, DOI 10.1016/j.ijnurstu.2009.01.010; Weobong B, 2015, DEPRESS ANXIETY, V32, P108, DOI 10.1002/da.22218; West S. G., 1995, STRUCTURAL EQUATION, P56; Wiener S, 2015, LANG COGN NEUROSCI, V30, P1048, DOI 10.1080/23273798.2014.946934; Woody CA, 2017, J AFFECT DISORDERS, V219, P86, DOI 10.1016/j.jad.2017.05.003; Yanikkerem E, 2013, J OBSTET GYNAECOL RE, V39, P180, DOI 10.1111/j.1447-0756.2012.01958.x; Yee LM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.029; Yilmaz E, 2016, J PEDIATR ADOL GYNEC, V29, P65, DOI 10.1016/j.jpag.2015.06.010; Zeng ZL, 2014, INT J TOUR RES, V16, P105, DOI 10.1002/jtr.1902	70	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0188365	10.1371/journal.pone.0188365	http://dx.doi.org/10.1371/journal.pone.0188365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420535	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900001
J	Zhou, Y; Zhou, GF; Broughton, S; Westcott, S; Zhang, XQ; Xu, YH; Xu, L; Li, CD; Zhang, WY				Zhou, Yi; Zhou, Gaofeng; Broughton, Sue; Westcott, Sharon; Zhang, Xiaoqi; Xu, Yanhao; Xu, Le; Li, Chengdao; Zhang, Wenying			Towards the identification of a gene for prostrate tillers in barley (Hordeum vulgare L.)	PLOS ONE			English	Article							GROWTH HABIT; RICE; GRAVITROPISM; MAIZE; LOCUS; LAZY1	Tiller angle, an important agronomic trait, contributes to crop production and plays a vital role in breeding for plant architecture. A barley line V-V-HD, which has prostrate tillers during vegetative growth and erect tillers after booting, is considered the ideal type for repressing weed growth and increasing leaf area during early growth. Genetic analysis identified that the prostrate trait in V-V-HD is controlled by a single gene. A double haploid population with 208 lines from V-V-HD x Buloke was used to map the prostrate growth gene. Ninety-six SNP markers were used for primary mapping, and subsequently, SSR and InDel markers were used for fine mapping. The gene was fine-mapped to a 3.53 Mb region on chromosome 3HL between the markers InDelz3028 and InDelz3032 with 52 candidate genes located in this region. Gene annotation analysis of the 52 genes within the target region indicated that a gene involved in zinc-ion binding (gene ID HORVU3Hr1G090910) is likely to be the candidate gene for prostrate growth in V-V-HD, and is linked to the denso/sdw gene. Association analysis showed that prostrate plants were shorter, flowered later.	[Zhou, Yi; Xu, Yanhao; Xu, Le; Zhang, Wenying] Yangtze Univ, Sch Agr, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China; [Zhou, Yi; Zhou, Gaofeng; Zhang, Xiaoqi; Xu, Yanhao; Li, Chengdao] Murdoch Univ, WA State Agr Biotechnol Ctr, Western Barley Genet Alliance, Murdoch, WA, Australia; [Broughton, Sue; Westcott, Sharon; Li, Chengdao] Govt Western Australia, Dept Primary Ind & Reg Dev, S Perth, WA, Australia	Yangtze University; Murdoch University	Zhang, WY (corresponding author), Yangtze Univ, Sch Agr, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China.; Li, CD (corresponding author), Murdoch Univ, WA State Agr Biotechnol Ctr, Western Barley Genet Alliance, Murdoch, WA, Australia.; Li, CD (corresponding author), Govt Western Australia, Dept Primary Ind & Reg Dev, S Perth, WA, Australia.	c.Li@murdoch.edu.au; wyzhang@yangtzeu.edu.cn	Zhang, Wenying/P-2509-2018	Zhang, Wenying/0000-0002-9926-4115; Xu, Yanhao/0000-0002-7917-8885	National Natural Science Foundation of China [31471496]; Grains Research & Development Corporation of Australia [UMU00050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grains Research & Development Corporation of Australia(Grains R&D Corp)	This work was supported by the National Natural Science Foundation of China (No. 31471496) to Wenying Zhang and Grains Research & Development Corporation of Australia (UMU00050) to Chengdao Li.	Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collar C, 2014, EUR FOOD RES TECHNOL, V238, P459, DOI 10.1007/s00217-013-2128-1; Corcoran M, 1948, PLANT PHYSIOL, V75, P105; Dabbert T, 2010, THEOR APPL GENET, V121, P705, DOI 10.1007/s00122-010-1342-5; Dabbert T, 2009, THEOR APPL GENET, V118, P1351, DOI 10.1007/s00122-009-0985-6; Didon UME, 2002, J AGRON CROP SCI, V188, P176, DOI 10.1046/j.1439-037X.2002.00566.x; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; DONALD CM, 1979, J AGR SCI, V93, P261, DOI 10.1017/S0021859600037941; Dong HJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006412; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; He JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178177; Howard TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087053; Hussien A, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0032; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kuczynska A, 2014, ELECTRON J BIOTECHN, V17, P217, DOI 10.1016/j.ejbt.2014.07.005; LAURIE DA, 1993, PLANT BREEDING, V111, P198, DOI 10.1111/j.1439-0523.1993.tb00630.x; Lewis MJ, 2001, KIRK OTHMER ENCY CHE, P561; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Liu XQ, 2008, J MULTIVARIATE ANAL, V99, P1503, DOI 10.1016/j.jmva.2008.01.004; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Nevo E, 2012, P NATL ACAD SCI USA, V109, P3412, DOI 10.1073/pnas.1121411109; Okagaki RJ, 2013, FUNCT INTEGR GENOMIC, V13, P33, DOI 10.1007/s10142-012-0299-7; OZMINKOWSKI RH, 1990, HORTSCIENCE, V25, P914, DOI 10.21273/HORTSCI.25.8.914; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Van Overbeek J, 1936, J HERED, V27, P93; Voorrips R, 2001, JOINMAP 3 0 SOFTWARE; Wang YH, 2008, NAT GENET, V40, P1273, DOI 10.1038/ng1108-1273; Xu YH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0964-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x	35	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192263	10.1371/journal.pone.0192263	http://dx.doi.org/10.1371/journal.pone.0192263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420581	Green Published, Green Submitted, gold			2022-12-26	WOS:000424517900058
J	van Hooft, P; Dougherty, ER; Getz, WM; Greyling, BJ; Zwaan, BJ; Bastos, ADS				van Hooft, Pim; Dougherty, Eric R.; Getz, Wayne M.; Greyling, Barend J.; Zwaan, Bas J.; Bastos, Armanda D. S.			Genetic responsiveness of African buffalo to environmental stressors: A role for epigenetics in balancing autosomal and sex chromosome interactions?	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; BOVINE TUBERCULOSIS; NATURAL-SELECTION; MODEL SELECTION; SYNCERUS-CAFFER; MALE-FERTILITY; RATIO; INHERITANCE; MAINTENANCE; PREDATION	In the African buffalo (Syncerus caffer) population of the Kruger National Park (South Africa) a primary sex-ratio distorter and a primary sex-ratio suppressor have been shown to occur on the Y chromosome. A subsequent autosomal microsatellite study indicated that two types of deleterious alleles with a negative effect on male body condition, but a positive effect on relative fitness when averaged across sexes and generations, occur genome-wide and at high frequencies in the same population. One type negatively affects body condition of both sexes, while the other acts antagonistically: it negatively affects male but positively affects female body condition. Here we show that high frequencies of male-deleterious alleles are attributable to Y-chromosomal distorter-suppressor pair activity and that these alleles are suppressed in individuals born after three dry pre-birth years, likely through epigenetic modification. Epigenetic suppression was indicated by statistical interactions between pre-birth rainfall, a proxy for parental body condition, and the phenotypic effect of homozygosity/heterozygosity status of microsatellites linked to male-deleterious alleles, while a role for the Y-chromosomal distorter-suppressor pair was indicated by between-sex genetic differences among pre-dispersal calves. We argue that suppression of male-deleterious alleles results in negative frequency-dependent selection of the Y distorter and suppressor; a prerequisite for a stable polymorphism of the Y distorter-suppressor pair. The Y distorter seems to be responsible for positive selection of male-deleterious alleles during resource-rich periods and the Y suppressor for positive selection of these alleles during resource-poor periods. Male-deleterious alleles were also associated with susceptibility to bovine tuberculosis, indicating that Kruger buffalo are sensitive to stressors such as diseases and droughts. We anticipate that future genetic studies on African buffalo will provide important new insights into gene fitness and epigenetic modification in the context of sex-ratio distortion and infectious disease dynamics.	[van Hooft, Pim] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [van Hooft, Pim; Greyling, Barend J.; Bastos, Armanda D. S.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Herts, South Africa; [Dougherty, Eric R.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Greyling, Barend J.] Agr Res Council, Irene, South Africa; [Zwaan, Bas J.] Wageningen Univ, Lab Genet, Wageningen, Netherlands	Wageningen University & Research; University of Pretoria; University of California System; University of California Berkeley; University of Kwazulu Natal; Agricultural Research Council of South Africa; Wageningen University & Research	van Hooft, P (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.; van Hooft, P (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Herts, South Africa.	pim.vanhooft@wur.nl	Bastos, Armanda/B-6357-2009; Zwaan, Bas/D-8721-2015	Bastos, Armanda/0000-0002-9223-4204; Zwaan, Bas/0000-0002-8221-4998; Dougherty, Eric/0000-0001-5140-1646	US NIH/NSF Ecology of Infectious Disease [GM83863]	US NIH/NSF Ecology of Infectious Disease	Laboratory analyses were supported by US NIH/NSF Ecology of Infectious Disease Grant GM83863 awarded to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Barson NJ, 2015, NATURE, V528, P405, DOI 10.1038/nature16062; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beechler BR, 2015, TRANSBOUND EMERG DIS, V62, P24, DOI 10.1111/tbed.12197; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Calcagno V, 2010, J STAT SOFTW, V34, P1; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Carvalho AB, 1999, HEREDITY, V83, P221, DOI 10.1038/sj.hdy.6886100; Chango A, 2015, NUTRIENTS, V7, P2748, DOI 10.3390/nu7042748; CLARK AG, 1990, GENETICS, V125, P527; CLARK AG, 1987, GENETICS, V115, P569; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; de Garine-Wichatitsky M, 2010, EMERG INFECT DIS, V16, P884, DOI 10.3201/eid1605.090710; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; De Vos V, 1983, POPULATION CONTROL L; Dean AM, 2005, GENETICS, V169, P1147, DOI 10.1534/genetics.104.036053; Ezenwa VO, 2009, AFR J ECOL, V47, P476, DOI 10.1111/j.1365-2028.2008.00960.x; Gardner A, 2011, J EVOLUTION BIOL, V24, P1801, DOI 10.1111/j.1420-9101.2011.02310.x; Gomendio M, 2006, SCIENCE, V314, P1445, DOI 10.1126/science.1133064; Gorsich EE, 2015, J ANIM ECOL, V84, P999, DOI 10.1111/1365-2656.12356; Greyling BJ, 2008, AFR J BIOTECHNOL, V7, P655; Hager R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-303; Hay CT, 2008, J ANIM ECOL, V77, P850, DOI 10.1111/j.1365-2656.2008.01409.x; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jaenike J, 1999, EVOLUTION, V53, P164, DOI 10.1111/j.1558-5646.1999.tb05342.x; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; James WH, 2017, EARLY HUM DEV, V109, P50, DOI 10.1016/j.earlhumdev.2017.03.002; Kerry R, 2013, INT J GEOGR INF SCI, V27, P47, DOI 10.1080/13658816.2012.663917; Lane-deGraaf KE, 2015, CONSERV GENET, V16, P289, DOI 10.1007/s10592-014-0658-0; Lindholm AK, 2016, TRENDS ECOL EVOL, V31, P315, DOI 10.1016/j.tree.2016.02.001; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Navara KJ, 2013, INTEGR COMP BIOL, V53, P877, DOI 10.1093/icb/ict081; Novakovic B, 2012, PLACENTA, V33, P959, DOI 10.1016/j.placenta.2012.10.003; Orr HA, 2001, GENETICS, V157, P875; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; Price TAR, 2008, EVOLUTION, V62, P1644, DOI 10.1111/j.1558-5646.2008.00386.x; Price TAR, 2008, GENETICA, V132, P295, DOI 10.1007/s10709-007-9173-2; Rodwell TC, 2001, J WILDLIFE DIS, V37, P258, DOI 10.7589/0090-3558-37.2.258; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Smitz N, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0203-2; Spencer HG, 2016, AM NAT, V187, P658, DOI 10.1086/685827; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; van Hooft P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111778; van Hooft P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001086; van Otterdijk SD, 2016, FASEB J, V30, P2457, DOI 10.1096/fj.201500083; VANHOOFT P, 2010, BMC EVOL BIOL, V10, DOI DOI 10.1186/1471-2148-1110-1106; Visscher DR, 2004, J ZOOL, V264, P111, DOI 10.1017/S0952836904005436; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vosloo W, 2009, TRANSBOUND EMERG DIS, V56, P18, DOI 10.1111/j.1865-1682.2008.01059.x; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191481	10.1371/journal.pone.0191481	http://dx.doi.org/10.1371/journal.pone.0191481			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415077	Green Published, gold			2022-12-26	WOS:000424325300029
J	Abdollah, D; Lopez, Y; Lal, SP; Taherzadeh, G; Sattar, A; Tsunoda, T; Sharma, A				Dehzangi, Abdollah; Lopez, Yosvany; Lal, Sunil Pranit; Taherzadeh, Ghazaleh; Sattar, Abdul; Tsunoda, Tatsuhiko; Sharma, Alok			Improving succinylation prediction accuracy by incorporating the secondary structure via helix, strand and coil, and evolutionary information from profile bigrams	PLOS ONE			English	Article							ACCESSIBLE SURFACE-AREA; AMINO-ACID-COMPOSITION; LYSINE SUCCINYLATION; SUBCELLULAR-LOCALIZATION; SCORING MATRIX; POSTTRANSLATIONAL MODIFICATION; PSEUDO COMPONENTS; WEB SERVER; K-TUPLE; SITES	Post-translational modification refers to the biological mechanism involved in the enzymatic modification of proteins after being translated in the ribosome. This mechanism comprises a wide range of structural modifications, which bring dramatic variations to the biological function of proteins. One of the recently discovered modifications is succinylation. Although succinylation can be detected through mass spectrometry, its current experimental detection turns out to be a timely process unable to meet the exponential growth of sequenced proteins. Therefore, the implementation of fast and accurate computational methods has emerged as a feasible solution. This paper proposes a novel classification approach, which effectively incorporates the secondary structure and evolutionary information of proteins through profile bigrams for succinylation prediction. The proposed predictor, abbreviated as SSEvol-Suc, made use of the above features for training an AdaBoost classifier and consequently predicting succinylated lysine residues. When SSEvol-Suc was compared with four benchmark predictors, it outperformed them in metrics such as sensitivity (0.909), accuracy (0.875) and Matthews correlation coefficient (0.75).	[Dehzangi, Abdollah] Morgan State Univ, Dept Comp Sci, Baltimore, MD 21239 USA; [Lopez, Yosvany; Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan; [Lopez, Yosvany; Tsunoda, Tatsuhiko; Sharma, Alok] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Lal, Sunil Pranit] Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand; [Taherzadeh, Ghazaleh; Sattar, Abdul] Griffith Univ, Sch Informat & Commun Technol, Nathan, Qld, Australia; [Sattar, Abdul; Sharma, Alok] Griffith Univ, Inst Integrated & Intelligent Syst, Nathan, Qld, Australia; [Tsunoda, Tatsuhiko] JST, CREST, Tokyo, Japan; [Sharma, Alok] Univ South Pacific, Sch Phys & Engn, Suva, Fiji	Morgan State University; Tokyo Medical & Dental University (TMDU); RIKEN; Massey University; Griffith University; Griffith University; Japan Science & Technology Agency (JST); University of the South Pacific	Lopez, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan.; Lopez, Y (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan.	yosvany.lopez.alvarez@gmail.com	Sousa, Caio Victor/D-7060-2016; Knechtle, Beat/ABC-5529-2020; Sharma, Alok/AAE-4725-2022; Nikolaidis, Pantelis Theodoros/K-8664-2017; Tsunoda, Tatsuhiko/K-2061-2014	Sousa, Caio Victor/0000-0002-0499-2372; Knechtle, Beat/0000-0002-2412-9103; Sharma, Alok/0000-0002-7668-3501; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sattar, Abdul/0000-0002-2567-2052; Di Gangi, Stefania/0000-0002-2847-6399	Grants-in-Aid for Scientific Research [15F15385] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2017, NAT SCI, DOI DOI 10.4236/NS.2017.99032; Ansari NA, 2011, DIS MARKERS, V30, P317, DOI [10.3233/DMA-2011-0791, 10.1155/2011/718694]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen W, 2017, ONCOTARGET, V8, P4208, DOI 10.18632/oncotarget.13758; Chen W, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.37; Chen W, 2015, ANAL BIOCHEM, V490, P26, DOI 10.1016/j.ab.2015.08.021; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Cheng X, 2018, GENOMICS, V110, P231, DOI 10.1016/j.ygeno.2017.10.002; Cheng X, 2018, GENOMICS, V110, P50, DOI 10.1016/j.ygeno.2017.08.005; Chou K.-C., 2009, NAT SCI, V1, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2017, CURR TOP MED CHEM, V17, P2337, DOI 10.2174/1568026617666170414145508; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; COMB DG, 1966, J BIOL CHEM, V241, P1857; Dehzangi Abdollah, 2013, Pattern Recognition in Bioinformatics. 8th IAPR International Conference, PRIB 2013. Proceedings: LNCS 7986, P208, DOI 10.1007/978-3-642-39159-0_19; Dehzangi Abdollah, 2013, Pattern Recognition in Bioinformatics. 8th IAPR International Conference, PRIB 2013. Proceedings: LNCS 7986, P196, DOI 10.1007/978-3-642-39159-0_18; Dehzangi A, 2010, AUSTR J INTELLIGENT, V10, P32; Dehzangi A, 2017, J THEOR BIOL, V425, P97, DOI 10.1016/j.jtbi.2017.05.005; Dehzangi A, 2015, INT J DATA MIN BIOIN, V11, P115, DOI 10.1504/IJDMB.2015.066359; Dehzangi A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S4-S1; Dehzangi A, 2015, J THEOR BIOL, V364, P284, DOI 10.1016/j.jtbi.2014.09.029; Dehzangi A, 2014, IEEE ACM T COMPUT BI, V11, P510, DOI 10.1109/TCBB.2013.2296317; Dehzangi A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S2; Dehzangi A, 2013, IEEE ACM T COMPUT BI, V10, P564, DOI 10.1109/TCBB.2013.65; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Feng PM, 2017, MOL THER-NUCL ACIDS, V7, P155, DOI 10.1016/j.omtn.2017.03.006; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hasan MM, 2016, MOL BIOSYST, V12, P786, DOI 10.1039/c5mb00853k; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Jia JH, 2016, BIOINFORMATICS, V32, P3133, DOI 10.1093/bioinformatics/btw387; Jia JH, 2016, ONCOTARGET, V7, P34558, DOI 10.18632/oncotarget.9148; Jia JH, 2016, J THEOR BIOL, V394, P223, DOI 10.1016/j.jtbi.2016.01.020; Jia JH, 2016, ANAL BIOCHEM, V497, P48, DOI 10.1016/j.ab.2015.12.009; Knorre DG, 2009, ACTA NATURAE, V1, P29, DOI 10.32607/20758251-2009-1-3-29-51; Lamoliatte F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6409; Liu B., 2017, NAT SCI, V09, P67, DOI [10.4236/ns.2017.94007, DOI 10.4236/NS.2017.94007]; Liu B, 2017, MOL THER-NUCL ACIDS, V7, P267, DOI 10.1016/j.omtn.2017.04.008; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, J THEOR BIOL, V385, P153, DOI 10.1016/j.jtbi.2015.08.025; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu LM, 2017, MED CHEM, V13, P552, DOI 10.2174/1573406413666170515120507; Liu ZX, 2014, NUCLEIC ACIDS RES, V42, pD531, DOI 10.1093/nar/gkt1093; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; Liu Z, 2015, ANAL BIOCHEM, V474, P69, DOI 10.1016/j.ab.2014.12.009; Lopez Y, 2017, ANAL BIOCHEM, V527, P24, DOI 10.1016/j.ab.2017.03.021; Lyons J, 2014, J COMPUT CHEM, V35, P2040, DOI 10.1002/jcc.23718; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Niu B, 2017, ONCOTARGET, V8, P57149, DOI 10.18632/oncotarget.19169; Paliwal KK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S12; Paliwal KK, 2014, IEEE T NANOBIOSCI, V13, P44, DOI 10.1109/TNB.2013.2296050; Qiu WR, 2017, MED CHEM, V13, P734, DOI 10.2174/1573406413666170623082245; Qiu WR, 2017, MOL INFORM, V36, DOI 10.1002/minf.201600010; Qiu WR, 2017, ONCOTARGET, V8, P41178, DOI 10.18632/oncotarget.17104; Qiu WR, 2016, ONCOTARGET, V7, P51270, DOI 10.18632/oncotarget.9987; Qiu WR, 2016, ONCOTARGET, V7, P44310, DOI 10.18632/oncotarget.10027; Qiu WR, 2016, BIOINFORMATICS, V32, P3116, DOI 10.1093/bioinformatics/btw380; Qiu WR, 2015, J BIOMOL STRUCT DYN, V33, P1731, DOI 10.1080/07391102.2014.968875; Qiu WR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947416; Saini H, 2015, J THEOR BIOL, V380, P291, DOI 10.1016/j.jtbi.2015.05.030; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089890; Sharma A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-233; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Sharma R, 2015, IEEE T NANOBIOSCI, V14, P915, DOI 10.1109/TNB.2015.2500186; Su Q, 2017, ONCOTARGET, V8, P49359, DOI 10.18632/oncotarget.17210; Xiao X, 2015, J BIOMOL STRUCT DYN, V33, P2221, DOI 10.1080/07391102.2014.998710; Xu HD, 2015, BIOINFORMATICS, V31, P3748, DOI 10.1093/bioinformatics/btv439; Xu MF, 2016, MOLECULES, V21, DOI 10.3390/molecules21010086; Xu Y, 2017, MED CHEM, V13, P544, DOI 10.2174/1573406413666170419150052; Xu Y, 2016, CURR TOP MED CHEM, V16, P591, DOI 10.2174/1568026615666150819110421; Xu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10184; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105018; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yang YD, 2017, METHODS MOL BIOL, V1484, P55, DOI 10.1007/978-1-4939-6406-2_6; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao XW, 2015, J THEOR BIOL, V374, P60, DOI 10.1016/j.jtbi.2015.03.029	87	55	56	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191900	10.1371/journal.pone.0191900	http://dx.doi.org/10.1371/journal.pone.0191900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432431	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300013
J	Nikolaidis, PT; Di Gangi, S; de Sousa, CV; Valeri, F; Rosemann, T; Knechtle, B				Nikolaidis, Pantelis Theodoros; Di Gangi, Stefania; de Sousa, Caio Victor; Valeri, Fabio; Rosemann, Thomas; Knechtle, Beat			Sex difference in open-water swimming-The Triple Crown of Open Water Swimming 1875-2017	PLOS ONE			English	Article							PERFORMANCE; MEN; SWIMMERS	The aim of the present study was to compare swimming performances of successful finishers of the ' Triple Crown of Open Water Swimming' from 1875 to 2017, assessing the effects of sex, the place of event and the nationality of swimmers. Data from 535 finishers in ` Catalina Channel Swim', 1,606 finishers in ` English Channel Swim' and 774 finishers in ` Manhattan Island Marathon Swim' were analysed. We performed different analyses and regression model fittings for all swimmers and annual top-5 finishers. Effects (sex, event, time, nationality) and interaction terms (event D time) were examined through a multi-variable spline mixed regression model. Considering all swimmers, we found that (i) women were approximately 0.06 km/h faster than men (p = 0.011) and (ii) Australians were 0.13 km/h faster than Americans (p = 0.004) and Americans were 0.19 km/h faster than British (p< 0.001) and 0.21 km/h faster than Canadians (p = 0.015). When considering annual top-5 finishers, we found that (i) women were 0.07 km/h slower than men (p = 0.042) and (ii) Australians were not faster than Americans (p = 0.149) but Americans were 0.21 km/h faster than British (p< 0.001). Our findings improved the knowledge about swim performances over time, in the three events, considering the effects of sex and the nationality of swimmers.	[Nikolaidis, Pantelis Theodoros] Exercise Physiol Lab, Nikaia, Greece; [Di Gangi, Stefania; Valeri, Fabio; Rosemann, Thomas; Knechtle, Beat] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [de Sousa, Caio Victor] Univ Catolica Brasilia, Grad Program Phys Educ, Brasilia, DF, Brazil; [Knechtle, Beat] Medbase St Gallen Vadianpl, St Gallen, Switzerland	University of Zurich; Universidade Catolica de Brasilia	Knechtle, B (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.; Knechtle, B (corresponding author), Medbase St Gallen Vadianpl, St Gallen, Switzerland.	beat.knechtle@hispeed.ch	Sousa, Caio Victor/D-7060-2016; Knechtle, Beat/ABC-5529-2020; Sharma, Alok/AAE-4725-2022; Nikolaidis, Pantelis Theodoros/K-8664-2017; Tsunoda, Tatsuhiko/K-2061-2014	Sousa, Caio Victor/0000-0002-0499-2372; Knechtle, Beat/0000-0002-2412-9103; Sharma, Alok/0000-0002-7668-3501; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sattar, Abdul/0000-0002-2567-2052; Di Gangi, Stefania/0000-0002-2847-6399	Grants-in-Aid for Scientific Research [15F15385] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bam J, 1997, MED SCI SPORT EXER, V29, P244, DOI 10.1097/00005768-199702000-00013; Beneke R, 2005, BRIT J SPORT MED, V39, P410, DOI 10.1136/bjsm.2004.017574; Coast JR, 2004, CAN J APPL PHYSIOL, V29, P139, DOI 10.1139/h04-010; Dahler P, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-16; Eichenberger E, 2013, J STRENGTH COND RES, V27, P1362, DOI 10.1519/JSC.0b013e318265a3e9; Eichenberger E, 2012, J SPORT SCI, V30, P1295, DOI 10.1080/02640414.2012.709264; Fischer G, 2013, SCAND J MED SCI SPOR, V23, pe48, DOI 10.1111/sms.12008; Gerrard DF, 1999, CLIN SPORT MED, V18, P337, DOI 10.1016/S0278-5919(05)70149-6; Knechtle B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1086-4; Knechtle B, 2014, INT J SPORT PHYSIOL, V9, P913, DOI 10.1123/ijspp.2013-0375; Knechtle B, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-34; Nikolaidis PT, 2018, RES SPORTS MED, V26, P332, DOI 10.1080/15438627.2018.1447471; Pyne DB, 2004, J SPORT SCI, V22, P613, DOI 10.1080/02640410310001655822; Rust CA, 2014, APPL PHYSIOL NUTR ME, V39, P270, DOI 10.1139/apnm-2013-0222; Rust CA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-86; Trewin CB, 2004, J SPORT SCI, V22, P339, DOI 10.1080/02640410310001641610; Vogt P, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-603; Zingg MA, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-7; Zingg MA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-2	19	55	56	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202003	10.1371/journal.pone.0202003	http://dx.doi.org/10.1371/journal.pone.0202003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	29432431	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000443071400024
